PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kishi, A; Van Dongen, HPA; Natelson, BH; Bender, AM; Palombini, LO; Bittencourt, L; Tufik, S; Ayappa, I; Rapoport, DM				Kishi, Akifumi; Van Dongen, Hans P. A.; Natelson, Benjamin H.; Bender, Amy M.; Palombini, Luciana O.; Bittencourt, Lia; Tufik, Sergio; Ayappa, Indu; Rapoport, David M.			Sleep continuity is positively correlated with sleep duration in laboratory nighttime sleep recordings	PLOS ONE			English	Article							STAGE TRANSITIONS; LONG; PERFORMANCE; PHYSIOLOGY; DYNAMICS; DEPRIVATION; GUIDELINES; PRESSURE; QUALITY; MODEL	Sleep duration varies widely across individuals and appears to be trait-like. Differences in the stability of underlying sleep processes may underlie this phenomenon. To investigate underlying mechanisms, we examined the relationship between sleep duration and sleep continuity in baseline polysomnography (PSG) recordings from three independently collected datasets: 1) 134 healthy controls (ages 37 +/- 13 years) from the Sao Paulo Epidemiologic Sleep Study, who spent one night in a sleep laboratory, 2) 21 obstructive sleep apnea (OSA) patients who were treated with continuous positive airway pressure for at least 2 months (45 +/- 12 years, respiratory disturbance index <15), who spent one night in a sleep laboratory with previous experience of multiple PSG studies, and 3) 62 healthy controls (28 +/- 6 years) who, as part of larger experiments, spent 2 consecutive nights in a sleep laboratory. For each dataset, we used total sleep time (TST) to separate subjects into those with shorter sleep (S-TST) and those with longer sleep (L-TST). In all three datasets, survival curves of continuous sleep segments showed greater sleep continuity in L-TST than in S-TST. Correlation analyses with TST as a continuous variable corroborated the results; and the results also held true after controlling for age. There were no significant differences in baseline waking performance and sleepiness between S-TST and L-TST. In conclusion, in both healthy controls and treated OSA patients, sleep continuity was positively correlated with sleep duration. These findings suggest that S-TST may differ from L-TST in processes underlying sleep continuity, shedding new light on mechanisms underlying individual differences in sleep duration.	[Kishi, Akifumi; Ayappa, Indu; Rapoport, David M.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Kishi, Akifumi; Natelson, Benjamin H.] Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA; [Kishi, Akifumi; Natelson, Benjamin H.] Albert Einstein Coll Med, New York, NY USA; [Kishi, Akifumi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Van Dongen, Hans P. A.; Bender, Amy M.] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA; [Palombini, Luciana O.; Bittencourt, Lia; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Discipline Med & Biol Sono, Sao Paulo, SP, Brazil; [Natelson, Benjamin H.] Mt Sinai Beth Israel, Dept Neurol, New York, NY USA; [Natelson, Benjamin H.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ayappa, Indu; Rapoport, David M.] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, Dept Med, New York, NY 10029 USA	New York University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University; University of Tokyo; Washington State University; Universidade Federal de Sao Paulo (UNIFESP); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kishi, A (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA.; Kishi, A (corresponding author), Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA.; Kishi, A (corresponding author), Albert Einstein Coll Med, New York, NY USA.; Kishi, A (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	kishi@p.u-tokyo.ac.jp	Van Dongen, Hans P. A./GPW-9160-2022; Bittencourt, Lia/C-6551-2012	Van Dongen, Hans P. A./0000-0002-4678-2971; Bittencourt, Lia/0000-0001-7738-0927; Kishi, Akifumi/0000-0002-9324-536X; Rapoport, David/0000-0002-4855-2600	JSPS KAKENHI [15K16416]; Foundation for Research in Sleep Disorders; Georg Waechter Foundation; NIH [R01HL70154, R01HL81310]; ONR [N00014-13-1-0302]; AFIP; FAPESP [98/14303-3]; the Japan Society for the Promotion of Science; CNPq fellowships	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Foundation for Research in Sleep Disorders; Georg Waechter Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); AFIP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by JSPS KAKENHI Grant Number 15K16416, grants from the Foundation for Research in Sleep Disorders and the Georg Waechter Foundation to A.K., NIH grant R01HL70154 and ONR grant N00014-13-1-0302 to H.V.D., NIH grant R01HL81310 to I.A., and AFIP and FAPESP (CEPID no. 98/14303-3) grants to L.O.P., L.B. and S.T. In addition, A.K. received a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science, and L.B. and S.T. received CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Aeschbach D, 2001, NEUROSCIENCE, V102, P493, DOI 10.1016/S0306-4522(00)00518-2; Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41, DOI 10.1152/ajpregu.1996.270.1.R41; American Academy of Sleep Medicine, 2005, INTERNATIONAL CLASSI; Ayappa I, 2000, SLEEP, V23, P763, DOI 10.1093/sleep/23.6.763; Bender AM, 2012, THESIS; Borbely A A, 1982, Hum Neurobiol, V1, P195; BRENDEL DH, 1990, PSYCHOPHYSIOLOGY, V27, P677, DOI 10.1111/j.1469-8986.1990.tb03193.x; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chen CY, 2013, SLEEP MED, V14, P1076, DOI 10.1016/j.sleep.2013.06.011; Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204; Comte JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056127; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; de Castro JM, 2002, PHYSIOL BEHAV, V76, P479, DOI 10.1016/S0031-9384(02)00699-6; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Grant DA, 2013, GENETIC BASIS OF SLEEP AND SLEEP DISORDERS, P189; Gumenyuk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059007; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Kishi A, 2011, SLEEP, V34, P1423, DOI 10.5665/SLEEP.1292; Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793; Klerman EB, 2013, NEUROBIOL AGING, V34, P309, DOI 10.1016/j.neurobiolaging.2012.05.018; Kuo TBJ, 2008, SLEEP, V31, P311, DOI 10.1093/sleep/31.3.311; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Norman RG, 2006, SLEEP, V29, P1625, DOI 10.1093/sleep/29.12.1625; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; Rasch B, 2007, PSYCHONEUROENDOCRINO, V32, P884, DOI 10.1016/j.psyneuen.2007.06.007; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Somiah M, 2012, J CLIN SLEEP MED, V8, P489, DOI 10.5664/jcsm.2138; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Van Dongen HPA, 2011, SLEEP, V34, P917, DOI 10.5665/SLEEP.1128; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Van Dongen HPA, 2010, FMCSAMCRRR10062; WEBB WB, 1970, SCIENCE, V168, P146, DOI 10.1126/science.168.3927.146; Zhang JH, 2011, SLEEP, V34, P225, DOI 10.1093/sleep/34.2.225	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175504	10.1371/journal.pone.0175504	http://dx.doi.org/10.1371/journal.pone.0175504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394943	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800042
J	Pieraccini, M; Betti, M; Forcellini, D; Dei, D; Papi, F; Bartoli, G; Facchini, L; Corazzi, R; Kovacevic, VC				Pieraccini, Massimiliano; Betti, Michele; Forcellini, Davide; Dei, Devis; Papi, Federico; Bartoli, Gianni; Facchini, Luca; Corazzi, Riccardo; Kovacevic, Vladimir Cerisano			Radar detection of pedestrian-induced vibrations on Michelangelo's David	PLOS ONE			English	Article							INTERFEROMETRIC RADAR; IDENTIFICATION	This paper summarizes the results of a two-day dynamic monitoring of Michelangelo's David subject to environmental loads (city traffic and pedestrian loading induced by tourists visiting the Accademia Gallery). The monitoring was carried out by a no-contact technique using an interferometric radar, whose effectiveness in measuring the resonant frequencies of structures and historic monuments has proved over the last years through numerous monitoring activities. Owing to the dynamic behavior of the measurement system (radar and tripod), an accelerometer has been installed on the radar head to filter out the movement component of the measuring instrument from the measurement of the David's displacement. Measurements were carried out in the presence and absence of visitors, to assess their influence on the dynamic behavior of the statue. A numerical model of the statue was employed to evaluate the experimental results.	[Pieraccini, Massimiliano; Papi, Federico] Univ Florence, Dept Informat Engn DINFO, Florence, Italy; [Betti, Michele; Bartoli, Gianni; Facchini, Luca; Corazzi, Riccardo; Kovacevic, Vladimir Cerisano] Univ Florence, Dept Civil & Environm Engn DICEA, Florence, Italy; [Forcellini, Davide] Univ San Marino, San Marino, San Marino; [Dei, Devis] Florence Engn Srl, Florence, Italy	University of Florence; University of Florence	Betti, M (corresponding author), Univ Florence, Dept Civil & Environm Engn DICEA, Florence, Italy.	mbetti@dicea.unifi.it	Betti, Michele/F-2911-2013; Forcellini, Davide/AAS-1650-2020; Bartoli, Gianni/O-3743-2015	Betti, Michele/0000-0002-8389-3355; Forcellini, Davide/0000-0003-1253-8572; Bartoli, Gianni/0000-0002-5536-3269	foundation "Friends of Florence"	foundation "Friends of Florence"	The Authors wish to acknowledge the support of Dr. Angelo Tartuferi, former Director of the Accademia Gallery in Florence. The authors also express their gratitude to Prof. Marc Levoy (Stanford University) for the release of the 3D laser scan of the Michelangelo's David, here employed to build the FE model. This research was financially supported by the foundation "Friends of Florence" (www.friendsofflorence.org) that is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeni C, 2010, IEEE GEOSCI REMOTE S, V7, P185, DOI 10.1109/LGRS.2009.2030903; Borri A, 2006, J CULT HERIT, V7, P273, DOI 10.1016/j.culher.2006.06.004; Corti G, 2015, J CULT HERIT, V16, P26, DOI 10.1016/j.culher.2014.03.001; Facchini L, 2014, COMPUT STRUCT, V138, P183, DOI 10.1016/j.compstruc.2014.01.013; Falletti F, 2003, DAVID GREAT ART MICH; Fratini M, 2011, J CULT HERIT, V12, P323, DOI 10.1016/j.culher.2011.01.003; Peruzzi G, 2016, INT J NEW TECHNOLOGY, V2, P95; Pieraccini M, 2013, SENSOR ACTUAT A-PHYS, V204, P25, DOI 10.1016/j.sna.2013.09.028; Pieraccini M, 2013, J NONDESTRUCTIVE EVA, V32; Pieraccini M, 2007, NDT&E INT, V40, P390, DOI 10.1016/j.ndteint.2006.12.010; Pieraccini M, 2006, IEEE T GEOSCI REMOTE, V44, P3284, DOI 10.1109/TGRS.2006.879112; Pieraccini M, 2014, J CULT HERIT, V15, P275, DOI 10.1016/j.culher.2013.07.006; Pieraccini M, 2013, SCI WORLD J, DOI 10.1155/2013/786961; Pieraccini M, 2008, NDT&E INT, V41, P258, DOI 10.1016/j.ndteint.2007.11.002; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	15	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174480	10.1371/journal.pone.0174480	http://dx.doi.org/10.1371/journal.pone.0174480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394932	Green Published, gold			2022-12-27	WOS:000399954800003
J	Rogers, S; Hii, H; Huang, J; Ancliffe, M; Gottardo, NG; Dallas, P; Lee, S; Endersby, R				Rogers, Sasha; Hii, Hilary; Huang, Joel; Ancliffe, Mathew; Gottardo, Nick G.; Dallas, Peter; Lee, Sharon; Endersby, Raelene			A novel technique of serial biopsy in mouse brain tumour models	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; DIAGNOSIS; RESECTION; TISSUE; ASTROCYTOMA; EPENDYMOMA; ACCURACY; MICE	Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments can be appropriately tailored. Dacomitinib (PF-00299804) is a tyrosine kinase inhibitor (TKI), which is predicted to only be effective in cancers where the targets of this drug (EGFR, ERBB2, ERBB4) are abnormally active. Here we describe a method by which serial biopsy can be used to validate response to dacomitinib treatment in vivo using a mouse glioblastoma model. In order to determine the feasibility of conducting serial brain biopsies in mouse models with minimal morbidity, and if successful, investigate whether this can facilitate evaluation of chemotherapeutic response, an orthotopic model of glioblastoma was used. Immunodeficient mice received cortical implants of the human glioblastoma cell line, U87MG, modified to express the constitutively-active EGFR mutant, EGFRvIII, GFP and luciferase. Tumour growth was monitored using bioluminescence imaging. Upon attainment of a moderate tumour size, free-hand biopsy was performed on a subgroup of animals. Animal monitoring using a neurological severity score (NSS) showed that all mice survived the procedure with minimal perioperative morbidity and recovered to similar levels as controls over a period of five days. The technique was used to evaluate dacomitinib-mediated inhibition of EGFRvIII two hours after drug administration. We show that serial tissue samples can be obtained, that the samples retain histological features of the tumour, and are of sufficient quality to determine response to treatment. This approach represents a significant advance in murine brain surgery that may be applicable to other brain tumour models. Importantly, the methodology has the potential to accelerate the preclinical in vivo drug screening process.	[Rogers, Sasha; Hii, Hilary; Huang, Joel; Ancliffe, Mathew; Gottardo, Nick G.; Dallas, Peter; Endersby, Raelene] Telethon Kids Inst, Perth, WA, Australia; [Rogers, Sasha; Hii, Hilary; Ancliffe, Mathew; Dallas, Peter; Endersby, Raelene] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Rogers, Sasha; Lee, Sharon] Princess Margaret Hosp, Dept Neurosurg, Perth, WA, Australia; [Gottardo, Nick G.] Princess Margaret Hosp, Dept Oncol, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Rogers, S (corresponding author), Telethon Kids Inst, Perth, WA, Australia.; Rogers, S (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia.; Rogers, S (corresponding author), Princess Margaret Hosp, Dept Neurosurg, Perth, WA, Australia.	sjoerog1@gmail.com	Endersby, Raelene/A-2969-2013	Endersby, Raelene/0000-0003-3554-2769; Gottardo, Nicholas/0000-0002-1082-6776	Ethan Davies Scholarship for Brain Cancer Research (SR); Raine Clinician Research Fellowship (NGG); Telethon Adventurers; Cure Brain Cancer Foundation; Bright Blue: the Police Commissioner's Fund for Sick Kids	Ethan Davies Scholarship for Brain Cancer Research (SR); Raine Clinician Research Fellowship (NGG); Telethon Adventurers; Cure Brain Cancer Foundation; Bright Blue: the Police Commissioner's Fund for Sick Kids	We wish to acknowledge the support of the Ethan Davies Scholarship for Brain Cancer Research (SR) and Raine Clinician Research Fellowship (NGG). Funding was also provided by the Telethon Adventurers and Cure Brain Cancer Foundation. We acknowledge Bright Blue: the Police Commissioner's Fund for Sick Kids for supporting the purchase of microscopy equipment for the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker FV, 2005, NEUROPATHOLOGY, V25, P207, DOI 10.1111/j.1440-1789.2005.00634.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; David KA, 2014, ONCOTARGET, V5, P11017, DOI 10.18632/oncotarget.2669; FEIDEN W, 1991, NEUROSURG REV, V14, P51; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; Hesselager G, 2003, NEUROSURGERY, V53, P685, DOI 10.1227/01.NEU.0000081304.57547.B5; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kim JH, 2013, CLIN TRANSL ONCOL, V15, P759, DOI 10.1007/s12094-013-1041-1; Krieger MD, 1998, SEMIN SURG ONCOL, V14, P13; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lesniak MS, 2004, NAT REV DRUG DISCOV, V3, P499, DOI 10.1038/nrd1414; Mittler MA, 1996, J NEUROSURG, V85, P1091, DOI 10.3171/jns.1996.85.6.1091; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tilgner J, 2005, NEUROSURGERY, V56, P257, DOI 10.1227/01.neu.0000148899.39020.87	20	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175169	10.1371/journal.pone.0175169	http://dx.doi.org/10.1371/journal.pone.0175169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394918	gold, Green Published			2022-12-27	WOS:000399954800019
J	Roodi, FZ; Aminzadeh, S; Farrokhi, N; Karkhane, A; Haghbeen, K				Roodi, Fatemeh Zebardast; Aminzadeh, Saeed; Farrokhi, Naser; Karkhane, AliAsghar; Haghbeen, Kamahldin			Cohnella amylopullulanases: Biochemical characterization of two recombinant thermophilic enzymes	PLOS ONE			English	Article							GENE-ENCODING AMYLOPULLULANASE; ALPHA-1,6 HYDROLYTIC ACTIVITY; ION-EXCHANGE CHROMATOGRAPHY; GEOBACILLUS-THERMOLEOVORANS; PYROCOCCUS-FURIOSUS; PULLULANASE; EXPRESSION; PURIFICATION; CHITINASE; AMYLASE	Some industries require newer, more efficient recombinant enzymes to accelerate their ongoing biochemical reactions in harsh environments with less replenishment. Thus, the search for native enzymes from extremophiles that are suitable for use under industrial conditions is a permanent challenge for R & D departments. Here and toward such discoveries, two sequences homologous to amylopullulanases (EC 3.2.1.41, GH57) from an endogenous Cohnella sp., [ Coh00831 (KP335161; 1998 bp) and Coh01133 (KP335160: 3678 bp)] were identified. The genes were heterologously expressed in E. coli to both determine their type and further characterize their properties. The isolated DNA was PCR amplified with gene specific primers and cloned in pET28a, and the recombinant proteins were expressed in E. coliBL21 (DE3). The temperatures and pH optima of purified recombinants Coh 01133 and Coh 00831 enzymes were 70 degrees C and 8, and 60 degrees C and 6, respectively. These enzymes are stable more than 0% in 60 degrees C and 50 degrees C for 90 min respectively. The major reactions released sugars which could be fractionated by HPLC analysis, from soluble starch were mainly maltose (G2), maltotriose (G3) and maltotetraose (G4). The enzymes hydrolyzed pullulan to maltotriose (G3) only. Enzyme activities for both proteins were improved in the availability of Mn2+, Ba2+, Ca2+, and Mg2+ and reduced in the presence of Fe2+, Li2+, Na2+, Triton X100 and urea. Moreover, Co2+, K+, and Cu2+ had a negative effect only on Coh 01133 enzyme.	[Roodi, Fatemeh Zebardast; Aminzadeh, Saeed; Karkhane, AliAsghar; Haghbeen, Kamahldin] NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran; [Farrokhi, Naser] Shahid Beheshti Univ, GC, Fac New Technol Engn, Dept Biotechnol Engn, Tehran, Iran	Shahid Beheshti University	Aminzadeh, S (corresponding author), NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran.	aminzade@nigeb.ac.ir	Farrokhi, Naser/AAS-2481-2021	Farrokhi, Naser/0000-0003-4676-1545	NIGEB [920901-I-473]; National Institute of Genetic Engineering and Biotechnology (NIGEB) [920901-I-473]	NIGEB; National Institute of Genetic Engineering and Biotechnology (NIGEB)	This study was supported by 920901-I-473 (NIGEB).r We would like to thank National Institute of Genetic Engineering and Biotechnology (NIGEB) for the financial support under grant number 920901-I-473.	Aliabadi N, 2016, BRAZ J MICROBIOL, V47, P931, DOI 10.1016/j.bjm.2016.07.009; ARA K, 1995, BBA-GEN SUBJECTS, V1243, P315, DOI 10.1016/0304-4165(94)00148-Q; Asoodeh A, 2012, PROCESS BIOCH; Babashpour S, 2012, BIOCHEM GENET, V50, P722, DOI 10.1007/s10528-012-9515-3; BROWN SH, 1993, APPL ENVIRON MICROB, V59, P2614, DOI 10.1128/AEM.59.8.2614-2621.1993; Chen JT, 2001, BIOTECHNOL APPL BIOC, V33, P189, DOI 10.1042/BA20010003; Dewan SS, 2014, GLOBAL MARKETS ENZYM; Doman-Pytka M, 2004, CRIT REV MICROBIOL, V30, P107, DOI 10.1080/10408410490435115; Dong GQ, 1997, APPL ENVIRON MICROB, V63, P3577, DOI 10.1128/AEM.63.9.3577-3584.1997; Duffner F, 2000, J BACTERIOL, V182, P6331, DOI 10.1128/JB.182.22.6331-6338.2000; Erra-Pujada M, 1999, J BACTERIOL, V181, P3284, DOI 10.1128/JB.181.10.3284-3287.1999; Fernandes Pedro, 2010, Enzyme Res, V2010, P862537, DOI 10.4061/2010/862537; Ghollasi M, 2008, BIOLOGIA, V63, P1051, DOI 10.2478/s11756-008-0174-0; Golaki BP, 2015, PROTEIN EXPRES PURIF, V109, P120, DOI 10.1016/j.pep.2014.10.002; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HAMILTON PB, 1962, ANN NY ACAD SCI, V102, P55, DOI 10.1111/j.1749-6632.1962.tb13625.x; Han T, 2013, LETT APPL MICROBIOL, V57, P336, DOI 10.1111/lam.12118; Hii Siew Ling, 2009, American Journal of Biochemistry and Biotechnology, V5, P170, DOI 10.3844/ajbbsp.2009.170.179; KIM CH, 1993, BIOSCI BIOTECH BIOCH, V57, P1632, DOI 10.1271/bbb.57.1632; Kim JH, 2009, J BIOSCI BIOENG, V107, P124, DOI 10.1016/j.jbiosc.2008.10.019; Kim JH, 2008, J BIOSCI BIOENG, V106, P449, DOI 10.1263/jbb.106.449; KIMURA T, 1990, APPL MICROBIOL BIOT, V34, P52; KITAGAWA N, 1988, J CHROMATOGR, V443, P133, DOI 10.1016/S0021-9673(00)94788-5; Leveque E, 2000, ENZYME MICROB TECH, V26, P3, DOI 10.1016/S0141-0229(99)00142-8; Lin HY, 2008, EXTREMOPHILES, V12, P641, DOI 10.1007/s00792-008-0168-4; MATHUPALA SP, 1993, J BIOL CHEM, V268, P16332; Mehta D, 2017, CURRENT DEVELOPMENTS IN BIOTECHNOLOGY AND BIOENGINEERING: FUNCTIONAL GENOMICS AND METABOLIC ENGINEERING, P45, DOI 10.1016/B978-0-444-63667-6.00003-1; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nisha M, 2017, APPL MICROBIOL BIOT, V101, P2357, DOI 10.1007/s00253-016-8025-3; Nisha M, 2013, BIOENGINEERED, V4, P388, DOI 10.4161/bioe.24629; Nisha M, 2013, APPL MICROBIOL BIOT, V97, P6279, DOI 10.1007/s00253-012-4538-6; Noorwez S. M., 2006, Indian Journal of Biotechnology, V5, P337; Puspasari F, 2011, STARCH-STARKE, V63, P461, DOI 10.1002/star.201000127; SAHA BC, 1990, APPL ENVIRON MICROB, V56, P881, DOI 10.1128/AEM.56.4.881-886.1990; Sambrook J, 1989, MOL CLONING; Zhang QG, 2017, PROCESS BIOCHEM, V53, P88, DOI 10.1016/j.procbio.2016.11.012	36	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175013	10.1371/journal.pone.0175013	http://dx.doi.org/10.1371/journal.pone.0175013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394913	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800014
J	Gai, ZJ; Zhang, JT; Li, CF				Gai, Zhijia; Zhang, Jingtao; Li, Caifeng			Effects of starter nitrogen fertilizer on soybean root activity, leaf photosynthesis and grain yield	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATION; SEED YIELD; NODULE FORMATION; PLANTING DATE; GROWTH; SOIL; SIMULATION; WEIGHT; MODEL; FIELD	The objective of this study was to examine the impact of starter nitrogen fertilizer on soybean root activity, leaf photosynthesis, grain yield and their relationship. To achieve this objective, field experiments were conducted in 2013 and 2014, using a randomized complete block design, with three replications. Nitrogen was applied at planting at rates of 0, 25, 50, and 75 kg N ha-1. In both years, starter nitrogen fertilizer benefited root activity, leaf photosynthesis, and consequently its yield. Statistically significant correlation was found among root activity, leaf photosynthetic rate, and grain yield at the developmental stage. The application of N25, N50, and N75 increased grain yield by 1.28%, 2.47%, and 1.58% in 2013 and by 0.62%, 2.77%, and 2.06% in 2014 compared to the N0 treatment. Maximum grain yield of 3238.91 kg ha-1 in 2013 and 3086.87 kg ha-1 in 2014 were recorded for N50 treatment. Grain yield was greater for 2013 than 2014, possibly due to more favorable environmental conditions. This research indicated that applying nitrogen as starter is necessary to increase soybean yield in Sangjiang River Plain in China.	[Gai, Zhijia; Li, Caifeng] Northeast Univ Agr, Dept Agron, Harbin, Heilongjiang, Peoples R China; [Gai, Zhijia; Zhang, Jingtao] Heilongjiang Acad Agr Sci, Jiamusi Branch, Jiamusi, Heilongjiang, Peoples R China	Heilongjiang Academy of Agricultural Sciences	Li, CF (corresponding author), Northeast Univ Agr, Dept Agron, Harbin, Heilongjiang, Peoples R China.	licaifeng@neau.edu.cn	Zhang, Jing/GWZ-7332-2022		National Key Technology Support Program [2014BAD11B01-A02]	National Key Technology Support Program(National Key Technology R&D Program)	This research was supported by National Key Technology Support Program. The grant number is 2014BAD11B01-A02.	Adeli A, 2005, AGRON J, V97, P314, DOI 10.2134/agronj2005.0314; Anten NPR, 2005, ANN BOT-LONDON, V95, P495, DOI 10.1093/aob/mci048; BEARD BH, 1971, AGRON J, V63, P815, DOI 10.2134/agronj1971.00021962006300050051x; BERGERSEN FJ, 1958, J GEN MICROBIOL, V19, P312, DOI 10.1099/00221287-19-2-312; BHAGSARI AS, 1977, CROP SCI, V17, P929, DOI 10.2135/cropsci1977.0011183X001700060028x; Board JE, 1996, AGRON J, V88, P567, DOI 10.2134/agronj1996.00021962008800040012x; Boroomandan P, 2009, Pak J Biol Sci, V12, P378, DOI 10.3923/pjbs.2009.378.382; BRUN WA, 1967, CROP SCI, V7, P451, DOI 10.2135/cropsci1967.0011183X000700050013x; Chen GH, 2010, AGRON J, V102, P1731, DOI 10.2134/agronj2010.0219; DARRAH PR, 1993, PLANT SOIL, V155, P1, DOI 10.1007/BF00024980; Di W, 2010, J NUCL AGR SCI, V24, P612; Dong ShouKun, 2010, Plant Nutrition and Fertilizer Science, V16, P65; DORNHOFF GM, 1970, CROP SCI, V10, P42, DOI 10.2135/cropsci1970.0011183X001000010016x; Du WG, 1988, SOYBEAN SCI, V7, P337; EGLI DB, 1992, AGR FOREST METEOROL, V62, P19, DOI 10.1016/0168-1923(92)90003-M; Fageria N. K., 2006, PHYSL CROP PRODUCTIO; [盖志佳 Gai Zhijia], 2016, [核农学报, Journal of Nuclear Agricultural Sciences], V30, P822; HARDY RWF, 1971, PLANT SOIL, P561, DOI 10.1007/BF02661879; Harper J.E., 1987, SOYBEANS IMPROVEMENT, P497; HARPER JE, 1974, CROP SCI, V14, P255, DOI 10.2135/cropsci1974.0011183X001400020026x; HATFIELD JL, 1974, AGRON J, V66, P112, DOI 10.2134/agronj1974.00021962006600010032x; HERBERT SJ, 1982, CROP SCI, V22, P1074, DOI 10.2135/cropsci1982.0011183X002200050044x; HESKETH J D, 1981, Photosynthesis Research, V2, P21, DOI 10.1007/BF00036162; JAYAPAUL P, 1990, INDIAN J AGRON, V35, P329; Jeffery D., 2006, CROP SCI, V46, P52; KRAMER PJ, 1981, BIOSCIENCE, V31, P29, DOI 10.2307/1308175; [刘丽君 Liu Lijun], 2005, [东北农业大学学报, Journal of Northeast Agricultural University], V36, P133; Liu X, 2008, FIELD CROP RES, V105, P157, DOI 10.1016/j.fcr.2007.09.003; Mathew JP, 2000, AGRON J, V92, P1156, DOI 10.2134/agronj2000.9261156x; MUCHOW RC, 1986, FIELD CROP RES, V15, P143, DOI 10.1016/0378-4290(86)90083-3; Osborne SL, 2006, AGRON J, V98, P1569, DOI 10.2134/agronj2006.0089; Oz M, 2008, AFR J BIOTECHNOL, V7, P4464; PEET MM, 1977, CROP SCI, V17, P287, DOI 10.2135/cropsci1977.0011183X001700020014x; Pikul JL, 2001, SOIL TILL RES, V60, P21, DOI 10.1016/S0167-1987(01)00174-X; Purell DE, 1996, J PLANT NUTR, V19, P949; Ray JD, 2006, CROP SCI, V46, P52, DOI 10.2135/cropsci2005.0043; Rotundo JL, 2009, FIELD CROP RES, V110, P147, DOI 10.1016/j.fcr.2008.07.012; Seadh S. E., 2013, Journal of Agronomy, V12, P46, DOI 10.3923/ja.2013.46.52; Serraj R, 1998, PLANT SOIL, V202, P159, DOI 10.1023/A:1004300819535; Setiyono TD, 2008, FIELD CROP RES, V108, P82, DOI 10.1016/j.fcr.2008.03.005; [申晓慧 Shen Xiaohui], 2012, [大豆科学, Soybean Science], V31, P73; SIJ JW, 1979, COMMUN SOIL SCI PLAN, V10, P1451, DOI 10.1080/00103627909366999; Sincik M, 2009, TURK J AGRIC FOR, V33, P111, DOI 10.3906/tar-0807-26; SORENSEN RC, 1978, AGRON J, V70, P213, DOI 10.2134/agronj1978.00021962007000020001x; Starling ME, 1998, AGRON J, V90, P658, DOI 10.2134/agronj1998.00021962009000050015x; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; [孙贵荒 Sun Guihuang], 2003, [辽宁农业科学, Liaoning Agricultural sciences], V0, P13; Taylor RS, 2005, CROP SCI, V45, P854, DOI 10.2135/cropsci2003.0344; THOMPSON JA, 1995, CROP SCI, V35, P1575, DOI 10.2135/cropsci1995.0011183X003500060010x; Thompson JA, 1996, PHOTOSYNTH RES, V49, P1, DOI 10.1007/BF00029422; Tian HY, 2007, THESIS NE AGR U CHIN; TOUCHTON JT, 1986, SOIL SCI SOC AM J, V50, P234, DOI 10.2136/sssaj1986.03615995005000010045x; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Wan T., 2013, THESIS; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104023; Wang ShuQi, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P1069, DOI 10.3724/SP.J.1011.2009.01069; Wang Xia, 2010, Acta Agronomica Sinica, V36, P1674; Zhang H., 2007, METHANE HYDRATE NEWS, V2007, P1, DOI DOI 10.1007/S11103-006-9072-4; Zhang HengShan, 2001, Soybean Science, V20, P275; Zhang MC, 2014, J INTEGR AGR, V13, P2778, DOI 10.1016/S2095-3119(13)60535-3; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE; Zhu GJ, 2002, ACTA BOT SIN, V44, P725	62	47	51	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174841	10.1371/journal.pone.0174841	http://dx.doi.org/10.1371/journal.pone.0174841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388620	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800012
J	Lackmann, F; Belikov, S; Wieslander, L				Lackmann, Fredrik; Belikov, Sergey; Wieslander, Lars			Linker 2 of the eukaryotic pre-ribosomal processing factor Mrd1p is an essential interdomain functionally coupled to upstream RNA Binding Domain 2 (RBD2)	PLOS ONE			English	Article							RECOGNITION MOTIF; YEAST; PROTEIN; BIOGENESIS; SUBUNITS; 90S; CELLS; RBM19	Ribosome synthesis is an essential process in all cells. In Sacharomyces cerevisiae, the precursor rRNA, 35S pre-rRNA, is folded and assembled into a 90S pre-ribosomal complex. The 40S ribosomal subunit is processed from the pre-ribosomal complex. This requires concerted action of small nucleolar RNAs, such as U3 snoRNA, and a large number of transacting factors. Mrd1p, one of the essential small ribosomal subunit synthesis factors is required for cleavage of the 35S pre-rRNA to generate 18S rRNA of the small ribosomal subunit. Mrd1p is evolutionary conserved in all eukaryotes and in yeast it contains five RNA Binding Domains (RBDs) separated by linker regions. One of these linkers, Linker 2 between RBD2 and RBD3, is conserved in length, predicted to be structured and contains conserved clusters of amino acid residues. In this report, we have analysed Linker 2 mutations and demonstrate that it is essential for Mrd1p function during pre-ribosomal processing. Extensive changes of amino acid residues as well as specific changes of conserved clusters of amino acid residues were found to be incompatible with synthesis of pre-40S ribosomes and cell growth. In addition, gross changes in primary sequence of Linker 2 resulted in Mrd1p instability, leading to degradation of the N-terminal part of the protein. Our data indicates that Linker 2 is functionally coupled to RBD2 and argues for that these domains constitute a functional module in Mrd1p. We conclude that Linker 2 has an essential role for Mrd1p beyond just providing a defined length between RBD2 and RBD3.	[Lackmann, Fredrik; Belikov, Sergey; Wieslander, Lars] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden	Stockholm University	Wieslander, L (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.	lars.wieslander@su.se	Wieslander, Lars/B-4670-2016	Wieslander, Lars/0000-0003-3271-6946	Swedish Research Council [621-2010-5236]; Carl Tryggers Stiftelse [CTS 15:531]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse	This work was supported by the Swedish Research Council (VR.se) 621-2010-5236 grant to LW; Carl Tryggers Stiftelse, project number CTS 15:531, grant to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bjork P, 2002, MOL BIOL CELL, V13, P3683, DOI 10.1091/mbc.E02-03-0138; Cao YQ, 2011, RES MICROBIOL, V162, P729, DOI 10.1016/j.resmic.2011.05.004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Jin SB, 2002, J BIOL CHEM, V277, P18431, DOI 10.1074/jbc.M112395200; Kallberg Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043786; Lorenzen JA, 2005, GENE EXPR PATTERNS, V6, P45, DOI 10.1016/j.modgep.2005.05.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lundkvist P, 2009, MOL CELL BIOL, V29, P5763, DOI 10.1128/MCB.00428-09; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Segerstolpe A, 2013, NUCLEIC ACIDS RES, V41, P1178, DOI 10.1093/nar/gks1129; Stelter P, 2012, MOL CELL, V47, P788, DOI 10.1016/j.molcel.2012.06.015; Wang B, 2017, NUCLEIC ACIDS RES; Weir M, 2014, METHODS MOL BIOL, V1205, P29, DOI 10.1007/978-1-4939-1363-3_3; WISE JA, 1991, METHOD ENZYMOL, V194, P405; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; YOLOV AA, 1990, NUCLEIC ACIDS RES, V18, P3983, DOI 10.1093/nar/18.13.3983; Zhang J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-115; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175506	10.1371/journal.pone.0175506	http://dx.doi.org/10.1371/journal.pone.0175506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388671	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800063
J	Tu, MC; Lo, CP; Huang, CF; Hsu, YH; Huang, WH; Deng, JF; Lee, YC				Tu, Min-Chien; Lo, Chung-Ping; Huang, Ching-Feng; Hsu, Yen-Hsuan; Huang, Wen-Hui; Deng, Jie Fu; Lee, Yung-Chuan			Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; NATIONAL INSTITUTE; DEMENTIA; DIAGNOSIS; ABNORMALITIES; GUIDELINES; PATHOLOGY; BATTERY; VERSION	Objective To describe and compare diffusion tensor imaging (DTI) parameters between patients with subcortical ischemic vascular disease (SIVD) and Alzheimer's disease (AD) diagnosed using structuralized neuropsychiatric assessments, and investigate potential neuronal substrates related to cognitive performance. Methods Thirty-five patients with SIVD, 40 patients with AD, and 33 cognitively normal control (NC) subjects matched by age and education level were consecutively recruited and underwent cognitive function assessments and DTI examinations. Comparisons among these three subgroups with regards to cognitive performance and DTI parameters including fractional anisotropy (FA) and mean diffusivity (MD) values were performed. Partial correlation analysis after controlling for age and education was used to evaluate associations between cognitive performance and DTI parameters. Results With regards to cognitive performance, the patients with SIVD had lower total scores in frontal assessment battery (FAB) compared to those with AD (p < 0.05) in the context of comparable Mini-Mental Status Examination and Cognitive Abilities Screening Instrument scores. With regards to DTI parameters, there were more regions of significant differences in FA among these three subgroups compared with MD. Compared with NC group, the patients with SIVD had significant global reductions in FA (p < 0.001 similar to 0.05), while significant reductions in FA among the patients with AD were regionally confined within the left superior longitudinal fasciculus, genu and splenium of the corpus callosum, and bilateral forceps major, and the anterior thalamic radiation, uncinate fasciculus, and cingulum of the left side (p < 0.01 similar to 0.05). Analysis of FA values within the left forceps major, left anterior thalamic radiation, and genu of the corpus callosum revealed a 71.8% overall correct classification (p < 0.001) with sensitivity of 69.4%, specificity of 73.8%, positive predictive value of 69.4%, and negative predictive value of 73.8% in discriminating patients with SIVD from those with AD. In combined analysis of the patients with SIVD and AD (n = 75), the total FAB score was positively correlated with FA within the bilateral forceps minor, genu of the corpus callosum, left forceps major, left uncinate fasciculus, and right inferior longitudinal fasciculus (p = 0.001 similar to 0.038), and inversely correlated with MD within the right superior longitudinal fasciculus, genu and body of the corpus callosum, bilateral forceps minor, right uncinate fasciculus, and right inferior longitudinal fasciculus (p = 0.003 similar to 0.040) Conclusions Our findings suggest the effectiveness of DTI measurements in distinguishing patients with early-stage AD from those with SIVD, with discernible changes in spatial distribution and magnitude of significance of the DTI parameters. Strategic FA assessments provided the most robust discriminative power to differentiate SIVD from AD, and FAB may serve as an additional cognitive marker. We also identified the neuronal substrates responsible for FAB performance.	[Tu, Min-Chien; Huang, Ching-Feng; Huang, Wen-Hui; Deng, Jie Fu] Taichung Tzu Chi Hosp, Dept Neurol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Lo, Chung-Ping] Taichung Tzu Chi Hosp, Dept Radiol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Hsu, Yen-Hsuan] Natl Chung Cheng Univ, Dept Psychol, Chiayi, Taiwan; [Lee, Yung-Chuan] Asia Univ, Dept Business Adm, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Chung Cheng University; Asia University Taiwan	Tu, MC (corresponding author), Taichung Tzu Chi Hosp, Dept Neurol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan.	tmctmc30@yahoo.com.tvv		Hsu, Yen-Hsuan/0000-0002-2585-3339	 [TTCRD 103-05]		The current study is supported by a research program of our hospital (Project No.: TTCRD 103-05).	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Altamura C, 2016, J CLIN NEUROL, V12, P201, DOI 10.3988/jcn.2016.12.2.201; Alves GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/291658; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Boutoleau-Bretonniere C, 2012, J ALZHEIMERS DIS, V28, P323, DOI 10.3233/JAD-2011-110761; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Chang CC, 2010, J INT NEUROPSYCH SOC, V16, P244, DOI 10.1017/S1355617709991184; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Fu JL, 2012, ACTA RADIOL, V53, P312, DOI 10.1258/ar.2011.110272; Golden Z, 2005, INT J NEUROSCI, V115, P1569, DOI 10.1080/00207450590957953; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Haller S, 2013, AM J NEURORADIOL, V34, P283, DOI 10.3174/ajnr.A3223; Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Jellinger KA, 2008, J ALZHEIMERS DIS, V14, P107; Kalaria RN, 2016, ACTA NEUROPATHOL, V131, P659, DOI 10.1007/s00401-016-1571-z; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matioli MNPS, 2010, ARQ NEURO-PSIQUIAT, V68, P185, DOI 10.1590/S0004-282X2010000200006; Mayzel-Oreg O, 2007, J NEUROL SCI, V257, P105, DOI 10.1016/j.jns.2007.01.048; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; OBrien JT, 1996, INT J GERIATR PSYCH, V11, P681; Pimentel Érica Maria Lima, 2009, Dement. neuropsychol., V3, P214, DOI 10.1590/S1980-57642009DN30300007; Selnes P, 2013, J ALZHEIMERS DIS, V33, P723, DOI 10.3233/JAD-2012-121603; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Shyu YIL, 2001, J FORMOS MED ASSOC, V100, P676; Snyder S, 2005, AM FAM PHYSICIAN, V72, P1723; Sugihara S, 2004, ACTA RADIOL, V45, P658, DOI 10.1080/02841850410008388; Tu Min-Chien, 2010, Acta Neurol Taiwan, V19, P168; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yuspeh RL, 2002, J CLIN EXP NEUROPSYC, V24, P745, DOI 10.1076/jcen.24.6.745.8399	50	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175143	10.1371/journal.pone.0175143	http://dx.doi.org/10.1371/journal.pone.0175143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388630	Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800024
J	Villar-Garcia, J; Guerri-Fernandez, R; Moya, A; Gonzalez, A; Hernandez, JJ; Lerma, E; Guelar, A; Sorli, L; Horcajada, JP; Artacho, A; D'Auria, G; Knobel, H				Villar-Garcia, Judit; Guerri-Fernandez, Robert; Moya, Andres; Gonzalez, Alicia; Hernandez, Juan J.; Lerma, Elisabet; Guelar, Ana; Sorli, Luisa; Horcajada, Juan P.; Artacho, Alejandro; D'Auria, Giuseppe; Knobel, Hernando			Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIVtreated patients: A double-blind, randomised, placebo-controlled trial	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SYSTEMIC IMMUNE ACTIVATION; HIV-INFECTED INDIVIDUALS; PLASMA-LEVELS; CELL COUNT; TRANSLOCATION; LIPOPOLYSACCHARIDE; DISEASE; INFLAMMATION; PROGRESSION	Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immunologic non-response. In a double-blind, randomised, placebo-controlled trial, we recently showed that, compared to placebo, 12 weeks treatment with probiotic Saccharomyces boulardii significantly reduced plasma levels of bacterial translocation (Lipopolysaccharide-binding protein or LBP) and systemic inflammation (IL-6) in 44 HIV virologically suppressed patients, half of whom (n = 22) had immunologic non-response to antiretroviral therapy (<270 CD4+Tcells/mu L despite long-term suppressed viral load). The aim of the present study was to investigate if this beneficial effect of the probiotic Saccharomyces boulardii is due to modified gut microbiome composition, with a decrease of some species associated with higher systemic levels of microbial translocation and inflammation. In this study, we used 16S rDNA gene amplification and parallel sequencing to analyze the probiotic impact on the composition of the gut microbiome (faecal samples) in these 44 patients randomized to receive oral supplementation with probiotic or placebo for 12 weeks. Compared to the placebo group, in individuals treated with probiotic we observed lower concentrations of some gut species, such as those of the Clostridiaceae family, which were correlated with systemic levels of bacterial translocation and inflammation markers. In a sub-study of these patients, we observed significantly higher parameters of microbial translocation (LBP, soluble CD14) and systemic inflammation in immunologic non-responders than in immunologic responders, which was correlated with a relative abundance of specific gut bacterial groups (Lachnospiraceae genus and Proteobacteria). Thus, in this work, we propose a new therapeutic strategy using the probiotic yeast S. boulardii to modify gut microbiome composition. Identifying pro-inflammatory species in the gut microbiome could also be a useful new marker of poor immune response and a new therapeutic target.	[Villar-Garcia, Judit; Guerri-Fernandez, Robert; Gonzalez, Alicia; Lerma, Elisabet; Guelar, Ana; Sorli, Luisa; Horcajada, Juan P.; Knobel, Hernando] Hosp del Mar, Dept Infect Dis, Barcelona, Spain; [Villar-Garcia, Judit; Guerri-Fernandez, Robert; Gonzalez, Alicia; Lerma, Elisabet; Guelar, Ana; Sorli, Luisa; Horcajada, Juan P.; Knobel, Hernando] Hosp del Mar, Inst Hosp del Mar Invest Med, Med Res Inst, IMIM, Barcelona, Spain; [Villar-Garcia, Judit; Guerri-Fernandez, Robert; Horcajada, Juan P.; Knobel, Hernando] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Moya, Andres; Artacho, Alejandro; D'Auria, Giuseppe] Univ Valencia, Joint Unit Res Genom & Hlth, Fdn Promot Hlth & Biomed Res Valencian Community, Valencia, Spain; [Moya, Andres; Artacho, Alejandro; D'Auria, Giuseppe] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Moya, Andres; D'Auria, Giuseppe] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Hernandez, Juan J.] Reference Lab Catalonia, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Villar-Garcia, J (corresponding author), Hosp del Mar, Dept Infect Dis, Barcelona, Spain.; Villar-Garcia, J (corresponding author), Hosp del Mar, Inst Hosp del Mar Invest Med, Med Res Inst, IMIM, Barcelona, Spain.; Villar-Garcia, J (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.	jvillar@hospitalidelmar.cat	Artacho, Alejandro/Z-4613-2019; D'Auria, Giuseppe/E-6583-2010; Horcajada, Juan P./AAU-7717-2021; Knobel, Hernando/B-5223-2016; Knobel, Hernando/AAD-3582-2020; Moya, Andrés/A-8190-2008; Guerri-Fernandez, Robert/I-1306-2013	Horcajada, Juan P./0000-0001-9873-5459; Knobel, Hernando/0000-0003-3186-6416; Knobel, Hernando/0000-0003-3186-6416; Moya, Andrés/0000-0002-2867-1119; Guerri-Fernandez, Robert/0000-0002-9794-9161; Villar, Judit/0000-0003-2813-8426; D'Auria, Giuseppe/0000-0003-0672-2541	Spanish Health Ministry [EC-11-541]	Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government)	This work is supported by a Spanish Health Ministry "Grant for independent clinical research 2012" (EC-11-541) to Judit Villar, the principal investigator, www.msssi.gob.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Assimakopoulos SF, 2014, INFECTION, V42, P951, DOI 10.1007/s15010-014-0666-5; Benveniste O, 2005, J INFECT DIS, V191, P1670, DOI 10.1086/429670; Blodget E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042624; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Canonici A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045047; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Ciubotaru I, 2015, TRANSL RES, V166, P401, DOI 10.1016/j.trsl.2015.06.015; Cunningham-Rundles S, 2011, NUTRIENTS, V3, P1042, DOI 10.3390/nu3121042; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Ellis CL, 2011, JAIDS-J ACQ IMM DEF, V57, P363, DOI 10.1097/QAI.0b013e31821a603c; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Hummelen R, 2011, GUT MICROBES, V2, P80, DOI 10.4161/gmic.2.2.15787; Im E, 2010, GASTROEN CLIN BIOL, V34, pS62, DOI 10.1016/S0399-8320(10)70023-3; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Klase Z, 2015, MUCOSAL IMMUNOL, V8, P1009, DOI 10.1038/mi.2014.128; Klatt NR, 2013, J CLIN INVEST, V123, P903, DOI 10.1172/JCI66227; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lozupone CA, 2014, GUT MICROBES, V5, P562, DOI 10.4161/gmic.32132; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Marks MA, 2013, AIDS, V27, P469, DOI 10.1097/QAD.0b013e32835c1333; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Moreno-Indias I, 2016, AM J TRANSL RES, V8, P5672; Mutlu EA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003829; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Noguera-Julian M, 2016, EBIOMEDICINE, V5, P135, DOI 10.1016/j.ebiom.2016.01.032; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Perez-Santiago J, 2013, AIDS, V27, P1921, DOI 10.1097/QAD.0b013e3283611816; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Sandler NG, 2014, J INFECT DIS, V210, P1549, DOI 10.1093/infdis/jiu305; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Stiksrud B, 2015, JAIDS-J ACQ IMM DEF, V70, P329, DOI 10.1097/QAI.0000000000000784; Swidsinski A, 2010, GASTROEN CLIN BIOL, V34, pS79, DOI 10.1016/S0399-8320(10)70025-7; Swidsinski A, 2016, SYST APPL MICROBIOL, V39, P67, DOI 10.1016/j.syapm.2015.11.002; Thomas S, 2009, CLIN EXP IMMUNOL, V156, P78, DOI 10.1111/j.1365-2249.2009.03878.x; Tincati C, 2009, ANTIVIR THER, V14, P321; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vazquez-Castellanos JF, 2015, MUCOSAL IMMUNOL, V8, P760, DOI 10.1038/mi.2014.107; Villar-Garcia J, 2015, JAIDS-J ACQ IMM DEF, V68, P256, DOI 10.1097/QAI.0000000000000468; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williams B, 2016, AIDS RES HUM RETROV, V32, P935, DOI 10.1089/aid.2016.0034	54	35	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0173802	10.1371/journal.pone.0173802	http://dx.doi.org/10.1371/journal.pone.0173802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388647	Green Published, gold			2022-12-27	WOS:000399375800002
J	Afreen, S; Shamsi, TN; Baig, MA; Ahmad, N; Fatima, S; Qureshi, MI; Hassan, MI; Fatma, T				Afreen, Sumbul; Shamsi, Tooba Naz; Baig, Mohd Affan; Ahmad, Nadeem; Fatima, Sadaf; Qureshi, M. Irfan; Hassan, Md. Imtaiyaz; Fatma, Tasneem			A novel multicopper oxidase (laccase) from cyanobacteria: Purification, characterization with potential in the decolorization of anthraquinonic dye	PLOS ONE			English	Article							PLEUROTUS-OSTREATUS; PHENOL OXIDASE; EXTRACELLULAR LACCASE; FUNGUS; DEGRADATION; STREPTOMYCES; ISOZYMES; EFFLUENT; CADMIUM; COPPER	A novel extracellular laccase enzyme produced from Spirulina platensis CFTRI was purified by ultrafiltration, cold acetone precipitation, anion exchange and size exclusion chromatography with 51.5% recovery and 5.8 purification fold. The purified laccase was a monomeric protein with molecular mass of similar to 66 kDa that was confirmed by zymogram analysis and peptide mass fingerprinting. The optimum pH and temperature of the enzyme activity was found at 3.0 and 30 degrees C using ABTS as substrate but the enzyme was quite stable at high temperature and alkaline pH. The laccase activity was enhanced by Cu+2, Zn+2 and Mn+2. In addition, the dye decolorization potential of purified laccase was much higher in terms of extent as well as time. The purified laccase decolorized ( 96%) of anthraquinonic dye Reactive blue- 4 within 4 h and its biodegradation studies was monitored by UV visible spectra, FTIR and HPLC which concluded that cyanobacterial laccase can be efficiently used to decolorize synthetic dye and help in waste water treatment.	[Afreen, Sumbul; Ahmad, Nadeem; Fatma, Tasneem] Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India; [Shamsi, Tooba Naz; Baig, Mohd Affan; Fatima, Sadaf; Qureshi, M. Irfan] Jamia Millia Islamia, Dept Biotechnol, New Delhi, India; [Hassan, Md. Imtaiyaz] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India	Jamia Millia Islamia; Jamia Millia Islamia; Jamia Millia Islamia	Fatma, T (corresponding author), Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India.	fatma_cbl@yahoo.com	Shamsi, Tooba/ADE-5752-2022; Hassan, Md Imtaiyaz/G-7072-2017; Hassan, Mohammad/GZA-7507-2022; Qureshi, M Irfan/CAF-0824-2022; Hassan, Imtaiyaz/ABF-6485-2020	Shamsi, Tooba/0000-0001-7164-0791; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Qureshi, M Irfan/0000-0001-9625-0036; Hassan, Imtaiyaz/0000-0002-3663-4940; Baig, Affan/0000-0002-6203-2097; Fatma, Tasneem/0000-0003-3712-8692				Attala MM, 2015, EGYPT PHARM J, V11, P93; Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2005, RES MICROBIOL, V156, P670, DOI 10.1016/j.resmic.2005.03.007; Baldrian P, 2000, APPL ENVIRON MICROB, V66, P2471, DOI 10.1128/AEM.66.6.2471-2478.2000; Binz T, 1996, MYCOL RES, V100, P1060, DOI 10.1016/S0953-7562(96)80213-9; BOURBONNAIS R, 1992, APPL MICROBIOL BIOT, V36, P823, DOI 10.1007/BF00172202; Brijwani K, 2010, ENZYM RES; Chefetz B, 1998, APPL ENVIRON MICROB, V64, P3175; Chen CY, 2013, APPL MICROBIOL BIOT, V97, P8977, DOI 10.1007/s00253-013-4727-y; Christiane A., 2013, Journal of Bioremediation and Biodegradation, V4, P206; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; d'Acunzo F, 2004, J MOL CATAL B-ENZYM, V31, P25, DOI 10.1016/j.molcatb.2004.07.001; Das N, 2001, J BASIC MICROB, V41, P261, DOI 10.1002/1521-4028(200110)41:5&lt;261::AID-JOBM261&gt;3.0.CO;2-V; De Souza CGM, 2003, J BASIC MICROB, V43, P278, DOI 10.1002/jobm.200390031; Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151, DOI 10.1128/AEM.62.4.1151-1158.1996; Endo K, 2002, MICROBIOL-SGM, V148, P1767, DOI 10.1099/00221287-148-6-1767; Forootanfar H, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-27; Garg N, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-75; Huang YC, 2011, BIORESOURCE TECHNOL, V102, P8117, DOI 10.1016/j.biortech.2011.05.062; Iyer G, 2003, FEMS MICROBIOL LETT, V227, P121, DOI 10.1016/S0378-1097(03)00658-X; Jaiswal N, 2015, INT J BIOL MACROMOL, V72, P326, DOI 10.1016/j.ijbiomac.2014.08.032; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZY, 2010, BIOPROC BIOSYST ENG, V33, P639, DOI 10.1007/s00449-009-0389-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu L, 2007, APPL MICROBIOL BIOT, V74, P1232, DOI 10.1007/s00253-006-0767-x; Mansur M, 2003, MYCOLOGIA, V95, P1013, DOI 10.2307/3761909; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Michniewicz A, 2006, APPL MICROBIOL BIOT, V69, P682, DOI 10.1007/s00253-005-0015-9; Munoz C, 1997, CURR MICROBIOL, V34, P1, DOI 10.1007/s002849900134; Murugesan K, 2006, APPL MICROBIOL BIOT, V72, P939, DOI 10.1007/s00253-006-0403-9; Murugesan K, 2009, J HAZARD MATER, V168, P523, DOI 10.1016/j.jhazmat.2009.02.075; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Olukanni OD, 2010, J HAZARD MATER, V184, P290, DOI 10.1016/j.jhazmat.2010.08.035; Otto B, 2014, PLANTA, V240, P1225, DOI 10.1007/s00425-014-2144-9; Paavol N, 1998, BIOCHEM J, V254, P877; Paavola ML, 2004, ENZYME MICROBIAL TEC, V35, P100; Palanisami S, 2010, WORLD J MICROB BIOT, V26, P63, DOI 10.1007/s11274-009-0143-y; PALMIERI G, 1993, APPL MICROBIOL BIOT, V39, P632, DOI 10.1007/BF00205066; Pandey A, 2007, INT BIODETER BIODEGR, V59, P73, DOI 10.1016/j.ibiod.2006.08.006; Parikh A, 2005, BIOTECHNOL LETT, V27, P323, DOI 10.1007/s10529-005-0691-7; Patel H, 2014, 3 BIOTECH, V4, P77, DOI 10.1007/s13205-013-0129-1; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Sadhasivam S, 2008, PROCESS BIOCHEM, V43, P736, DOI 10.1016/j.procbio.2008.02.017; Sahay R, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P2068; Salony, 2006, APPL MICROBIOL BIOT, V71, P646, DOI 10.1007/s00253-005-0206-4; Sathishkumar P, 2014, J MOL CATAL B-ENZYM, V100, P111, DOI 10.1016/j.molcatb.2013.12.008; Semple KT, 1999, FEMS MICROBIOL LETT, V170, P291, DOI 10.1111/j.1574-6968.1999.tb13386.x; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Sheikhi F, 2012, INDIAN J MICROBIOL, V52, P701, DOI 10.1007/s12088-012-0298-3; Soares GMB, 2001, J BIOTECHNOL, V89, P123, DOI 10.1016/S0168-1656(01)00302-9; Somero GN., 2004, COMP BIOCH PHYSL B, V139, P312; Sondhi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096951; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110834; YOUN HD, 1995, FEMS MICROBIOL LETT, V132, P183, DOI 10.1111/j.1574-6968.1995.tb07831.x; Zarrouk C., 1996, THESIS	61	53	54	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175144	10.1371/journal.pone.0175144	http://dx.doi.org/10.1371/journal.pone.0175144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384218	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900100
J	Arsic, N; Ho-Pun-Cheung, A; Lopez-Crapez, E; Assenat, E; Jarlier, M; Anguille, C; Colard, M; Pezet, M; Roux, P; Gadea, G				Arsic, Nikola; Ho-Pun-Cheung, Alexandre; Lopez-Crapez, Evelyne; Assenat, Eric; Jarlier, Marta; Anguille, Christelle; Colard, Manon; Pezet, Mikael; Roux, Pierre; Gadea, Gilles			The p53 isoform delta133p53 beta regulates cancer cell apoptosis in a RhoB-dependent manner (vol 12, e0172125, 2017)	PLOS ONE			English	Correction														Gilles, Gadea/0000-0001-6325-4866; Crapez, evelyne/0000-0002-8261-3470				Arsic N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172125	1	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175607	10.1371/journal.pone.0175607	http://dx.doi.org/10.1371/journal.pone.0175607			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384271	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900182
J	Feckler, A; Schrimpf, A; Bundschuh, M; Barlocher, F; Baudy, P; Cornut, J; Schulz, R				Feckler, Alexander; Schrimpf, Anne; Bundschuh, Mirco; Barlocher, Felix; Baudy, Patrick; Cornut, Julien; Schulz, Ralf			Quantitative real-time PCR as a promising tool for the detection and quantification of leaf-associated fungal species - A proof-of-concept using Alatospora pulchella	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GMO ANALYSES; RT-PCR; LITTER; STREAM; DECOMPOSITION; COMMUNITIES; EXPRESSION; DIVERSITY; BREAKDOWN	Traditional methods to identify aquatic hyphomycetes rely on the morphology of released conidia, which can lead to misidentifications or underestimates of species richness due to convergent morphological evolution and the presence of non-sporulating mycelia. Molecular methods allow fungal identification irrespective of the presence of conidia or their morphology. As a proof-of-concept, we established a quantitative real-time polymerase chain reaction (qPCR) assay to accurately quantify the amount of DNA as a proxy for the biomass of an aquatic hyphomycete species (Alatospora pulchella). Our study showed discrimination even among genetically closely-related species, with a high sensitivity and a reliable quantification down to 9.9 fg DNA (3 PCR forming units; LoD) and 155.0 fg DNA (47 PCR forming units; LoQ), respectively. The assay's specificity was validated for environmental samples that harboured diverse microbial communities and likely contained PCR-inhibiting substances. This makes qPCR a promising tool to gain deeper insights into the ecological roles of aquatic hyphomycetes and other microorganisms.	[Feckler, Alexander; Schrimpf, Anne; Bundschuh, Mirco; Baudy, Patrick; Schulz, Ralf] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Feckler, Alexander; Bundschuh, Mirco] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Barlocher, Felix] Mt Allison Univ, Dept Biol, Sackville, NB, Canada; [Cornut, Julien] Univ Lorraine, UMR CNRS 7360, Lab Interdisciplinaire Environm Continentaux, Metz, France; [Cornut, Julien] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Expt Limnol, Stechlin, Germany; [Cornut, Julien] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, Coimbra, Portugal	University of Koblenz & Landau; Swedish University of Agricultural Sciences; Mount Allison University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Universidade de Coimbra	Schulz, R (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	schulz@uni-landau.de	Baerlocher, Felix/C-1307-2011; Schulz, Ralf/G-3674-2011; Bundschuh, Mirco/H-4559-2014; Schulz, Ralf/ABI-4526-2020	Baerlocher, Felix/0000-0003-2404-625X; Schulz, Ralf/0000-0002-6348-6971; Bundschuh, Mirco/0000-0003-4876-220X; Schulz, Ralf/0000-0002-6348-6971	German Research Foundation (DFG) [SCHU 2271/14-1]; Carl Tryggers Foundation, Stockholm [CTS 13:72]; Fix Stiftung, Landau; Portuguese Foundation for Science and Technology [SFRH/BPD/108779/2015]	German Research Foundation (DFG)(German Research Foundation (DFG)); Carl Tryggers Foundation, Stockholm; Fix Stiftung, Landau; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the German Research Foundation (DFG) (grant number SCHU 2271/14-1), the Carl Tryggers Foundation, Stockholm (grant number CTS 13:72), and the Fix Stiftung, Landau. Financial support by the Portuguese Foundation for Science and Technology to Julien Cornut (SFRH/BPD/108779/2015) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSUFFI TL, 1989, OECOLOGIA, V79, P30, DOI 10.1007/BF00378236; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barlocher F, 2016, FUNGAL ECOL, V19, P14, DOI 10.1016/j.funeco.2015.05.005; Baerlocher Felix, 2007, Fungal Biology Reviews, V21, P19, DOI 10.1016/j.fbr.2007.02.003; Barlocher F, 2000, CAN J BOT, V78, P157, DOI 10.1139/cjb-78-2-157; BARLOCHER F, 2005, FUNGAL COMMUNITY ITS, P39, DOI DOI 10.1201/9781420027891.CH3; Berdal KG, 2001, EUR FOOD RES TECHNOL, V213, P432, DOI 10.1007/s002170100403; Berdal KG, 2008, EUR FOOD RES TECHNOL, V227, P1149, DOI 10.1007/s00217-008-0830-1; BERMINGHAM S, 1995, MYCOL RES, V99, P479, DOI 10.1016/S0953-7562(09)80650-3; Bermingham S, 1997, MICROBIAL ECOL, V33, P223, DOI 10.1007/s002489900025; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Bundschuh M, 2011, AQUAT TOXICOL, V104, P32, DOI 10.1016/j.aquatox.2011.03.010; Bundschuh M, 2009, ENVIRON TOXICOL CHEM, V28, P197, DOI 10.1897/08-075.1; Dangles O, 2004, J APPL ECOL, V41, P365, DOI 10.1111/j.0021-8901.2004.00888.x; Fernandes I, 2011, OECOLOGIA, V166, P1019, DOI 10.1007/s00442-011-1930-3; Gessner M. O., 2007, P301; Gessner MO, 2003, FUNG DIVERS RES SER, V10, P127; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Gulis Vladislav, 2005, P153, DOI 10.1007/1-4020-3466-0_21; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Holst-Jensen A, 2004, J AOAC INT, V87, P927; Ingold CT, 1975, SCI PUBLICATION, V30; Manerkar MA, 2008, MICROB ECOL, V56, P467, DOI 10.1007/s00248-008-9365-z; MARVANOVA L, 1985, BOT J LINN SOC, V91, P1, DOI 10.1111/j.1095-8339.1985.tb01130.x; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Pascoal C, 2005, FUNGAL DIVERS, V19, P109; Raidl S, 2005, PLANT BIOLOGY, V7, P713, DOI 10.1055/s-2005-873003; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seena S, 2010, FUNGAL DIVERS, V44, P77, DOI 10.1007/s13225-010-0056-y; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Sole M, 2008, SCI TOTAL ENVIRON, V389, P557, DOI 10.1016/j.scitotenv.2007.09.010; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Strand DA, 2011, DIS AQUAT ORGAN, V95, P9, DOI 10.3354/dao02334; THOMAS K, 1992, AUST J MAR FRESH RES, V43, P491; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Vralstad T, 2009, VET MICROBIOL, V137, P146, DOI 10.1016/j.vetmic.2008.12.022; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Yao Y, 2006, MOL CELL PROBE, V20, P311, DOI 10.1016/j.mcp.2006.03.003; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zubrod JP, 2015, J APPL ECOL, V52, P310, DOI 10.1111/1365-2664.12393; Zubrod JP, 2015, ENVIRON SCI TECHNOL, V49, P1173, DOI 10.1021/es5050453	44	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174634	10.1371/journal.pone.0174634	http://dx.doi.org/10.1371/journal.pone.0174634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384166	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900023
J	Kawaguchi, T; Yanagihara, T; Yokoyama, T; Suetsugu-Ogata, S; Hamada, N; Harada-Ikeda, C; Suzuki, K; Maeyama, T; Kuwano, K; Nakanishi, Y				Kawaguchi, Tomonobu; Yanagihara, Toyoshi; Yokoyama, Tetsuya; Suetsugu-Ogata, Saiko; Hamada, Naoki; Harada-Ikeda, Chika; Suzuki, Kunihiro; Maeyama, Takashige; Kuwano, Kazuyoshi; Nakanishi, Yoichi			Probucol attenuates hyperoxia-induced lung injury in mice	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; CELL-DEATH; ACTIVATION; APOPTOSIS; PROTECTS	Hyperoxic lung injury is pathologically characterized by alveolar edema, interlobular septal edema, hyaline membrane disease, lung inflammation, and alveolar hemorrhage. Although the precise mechanism by which hyperoxia causes lung injury is not well defined, oxidative stress, epithelial cell death, and proinflammatory cytokines are thought to be involved. Probucol-a commercially available drug for treating hypercholesterolemia-has been suggested to have antioxidant and antiapoptotic effects. This study aimed to assess whether probucol could attenuate hyperoxic lung injury in mice. Mice were exposed to 95% O-2 for 72 h, with or without pre-treatment with 130 mu g/kg probucol intratracheally. Probucol treatment significantly decreased both the number of inflammatory cells in the bronchoalveolar lavage fluid and the degree of lung injury in hyperoxia-exposed mice. Probucol treatment reduced the number of cells positive for 8-hydroxyl-2'-deoxyguanosine or terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and suppressed NF-kappa B activation, Bax expression, and caspase-9 activation in lung tissues from hyperoxia-exposed mice. These results suggest that probucol can reduce oxidative DNA damage, apoptotic cell death, and inflammation in lung tissues. Intratracheal administration of probucol may be a novel treatment for lung diseases induced by oxidative stress, such as hyperoxic lung injury and acute respiratory distress syndrome.	[Kawaguchi, Tomonobu; Yanagihara, Toyoshi; Yokoyama, Tetsuya; Suetsugu-Ogata, Saiko; Hamada, Naoki; Harada-Ikeda, Chika; Suzuki, Kunihiro; Maeyama, Takashige; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan; [Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Div Resp Dis, Dept Internal Med, Tokyo, Japan	Kyushu University; Jikei University	Yanagihara, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan.	yanagiha@kokyu.med.kyushu-u.ac.jp	Yanagihara, Toyoshi/AAI-1037-2020		JSPS [23591150]; Health and Labor Sciences Research Grants on Diffuse Lung Disease from the Japanese Ministry of Health, Labor and Welfare	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labor Sciences Research Grants on Diffuse Lung Disease from the Japanese Ministry of Health, Labor and Welfare	This work was supported by JSPS Grant-in-Aid for Scientific Research (Grant Number 23591150) and the Health and Labor Sciences Research Grants on Diffuse Lung Disease from the Japanese Ministry of Health, Labor and Welfare.	Aoki M, 2001, HYPERTENSION, V38, P48, DOI 10.1161/01.HYP.38.1.48; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Chen H, 2007, EXP MOL PATHOL, V83, P377, DOI 10.1016/j.yexmp.2007.08.016; CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Jones N, 2003, J CELL PHYSIOL, V196, P326, DOI 10.1002/jcp.10308; Jung YS, 2016, ACTA PHARMACOL SIN, V37, P1031, DOI 10.1038/aps.2016.51; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kasai I, 2012, PROBUCOL THERAPY IMP, V220, P463; Kufner S, 2016, JACC-CARDIOVASC INTE, V9, P784, DOI 10.1016/j.jcin.2016.01.009; KUZUYA M, 1991, J LIPID RES, V32, P197; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Mantell LL, 1997, CELL DEATH DIFFER, V4, P600, DOI 10.1038/sj.cdd.4400278; Mao Q, 2008, AM J RESP CELL MOL, V39, P717, DOI 10.1165/rcmb.2008-0052OC; O'Reilly MA, 2000, LAB INVEST, V80, P1845, DOI 10.1038/labinvest.3780195; Petrache I, 1999, AM J PHYSIOL-LUNG C, V277, pL589, DOI 10.1152/ajplung.1999.277.3.L589; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Umeji K, 2006, AM J PHYSIOL-HEART C, V291, pH2522, DOI 10.1152/ajpheart.01198.2005; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Vitiello PF, 2008, FREE RADICAL BIO MED, V44, P367, DOI 10.1016/j.freeradbiomed.2007.09.021; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Whitehead GS, 2006, IMMUNOGENETICS, V58, P793, DOI 10.1007/s00251-006-0147-9; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Zhang XC, 2003, AM J RESP CELL MOL, V28, P305, DOI 10.1165/rcmb.2002-0156OC	25	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175129	10.1371/journal.pone.0175129	http://dx.doi.org/10.1371/journal.pone.0175129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384256	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900095
J	Kim, YM; Kim, J; Han, Y; Jeon, BH; Cheong, HK; Ahn, K				Kim, Young-Min; Kim, Jihyun; Han, Youngshin; Jeon, Byoung-Hak; Cheong, Hae-Kwan; Ahn, Kangmo			Short-term effects of weather and air pollution on atopic dermatitis symptoms in children: A panel study in Korea	PLOS ONE			English	Article							DIURNAL TEMPERATURE-RANGE; CLIMATE-CHANGE; UNITED-STATES; PARTICULATE MATTER; CHILDHOOD ASTHMA; RISK-FACTOR; ECZEMA; PREVALENCE; OZONE; EXPOSURE	Introduction The effects of weather and air pollution on the severity and persistence of atopic dermatitis (AD) are important issues that have not been investigated in detail. The objective of our study was to determine the short-term effects of meteorological variables and air pollution on AD symptoms in children. Methods We enrolled 177 AD patients with 5 years or younger from the Seoul Metropolitan Area, Korea, and followed for 17 months between August 2013 and December 2014. Symptoms records of 35,158 person-days, including itching, sleep disturbance, erythema, dry skin, oozing, and edema, were obtained. We estimated the effect of meteorological variables including daily mean temperature, relative humidity (RH), diurnal temperature range (DTR), rainfall and air pollutants including particulate matter with an aerodynamic diameter <= 10 mu m (PM10), nitrogen dioxide (NO2), and tropospheric ozone (O-3) on AD symptoms using a generalized linear mixed model with adjustment for related confounding factors. Results A 5 degrees C increase in outdoor temperature and a 5% increase in outdoor RH was associated with 12.8% (95% confidence intervals (CI): 10.5, 15.2) and 3.3% (95% CI: 1.7, 4.7) decrease in AD symptoms, respectively, on the same day. An increase of rainfall by 5 mm increased AD symptoms by 7.3% (95% CI: 3.6, 11.1) for the days with <40 mm rainfall. The risk of AD symptoms increased by 284.9% (95% CI: 67.6, 784.2) according to a 5 degrees C increase in DTR when it was >14 degrees C. An increase in PM10, NO2, and O3 by 10 units increased the risk of AD symptoms on the same day by 3.2% (95% CI: 1.5, 4.9), 5.0% (95% CI: 1.4, 8.8), and 6.1% (95% CI: 3.2, 9.0), respectively. Conclusion Exposure to meteorological variables and air pollutants are associated with AD symptoms in young children.	[Kim, Young-Min; Kim, Jihyun; Han, Youngshin; Ahn, Kangmo] Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea; [Kim, Young-Min; Kim, Jihyun; Ahn, Kangmo] Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Jeon, Byoung-Hak; Cheong, Hae-Kwan] Sungkyunkwan Univ, Dept Social & Prevent Med, Sch Med, Suwon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Ahn, K (corresponding author), Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea.	kmaped@skku.edu	Jeon, Byoung-Hak/GXM-9445-2022; Ahn, Kangmo/F-4609-2014	Jeon, Byoung-Hak/0000-0001-5246-0357; Cheong, Hae-Kwan/0000-0003-2758-9399	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program" [2013001360002]; Kangmo Ahn at the Department of Pediatrics; Samsung Medical Center, Sungkyunkwan University School of Medicine	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"; Kangmo Ahn at the Department of Pediatrics; Samsung Medical Center, Sungkyunkwan University School of Medicine	This study was funded by the Korea Ministry of Environment (MOE) as "the Environmental Health Action Program" (2013001360002) and was contracted to Kangmo Ahn at the Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Boguniewicz M, 2013, J ALLERGY CLIN IMMUN, V132, P511, DOI 10.1016/j.jaci.2013.06.030; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Byremo G, 2006, ALLERGY, V61, P1403, DOI 10.1111/j.1398-9995.2006.01209.x; Chen GH, 2007, INT J CARDIOL, V116, P408, DOI 10.1016/j.ijcard.2006.03.067; Chernyshov PV, 2012, INT J DERMATOL, V51, P290, DOI 10.1111/j.1365-4632.2011.04997.x; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Eberlein-Konig B, 1998, J ALLERGY CLIN IMMUN, V101, P141, DOI 10.1016/S0091-6749(98)70212-X; Ebi KL, 2008, ENVIRON HEALTH PERSP, V116, P1449, DOI 10.1289/ehp.11463; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gao Y, 2013, ATMOS CHEM PHYS, V13, P9607, DOI 10.5194/acp-13-9607-2013; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Harris JM, 2001, BRIT J DERMATOL, V144, P795, DOI 10.1046/j.1365-2133.2001.04135.x; Hashimoto M, 2004, PEDIATR INT, V46, P48, DOI 10.1111/j.1442-200X.2004.01835.x; Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacob DJ, 2009, ATMOS ENVIRON, V43, P51, DOI 10.1016/j.atmosenv.2008.09.051; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Kim MJ, 2015, ATMOS ENVIRON, V101, P103, DOI 10.1016/j.atmosenv.2014.11.016; Kim YM, 2015, CLIMATIC CHANGE, V128, P71, DOI 10.1007/s10584-014-1290-1; Korea Meteorological Administration (KMA), 2012, KOR PEN CLIM CHANG O; Kramer U, 2005, J INVEST DERMATOL, V124, P514, DOI 10.1111/j.0022-202X.2005.23625.x; Langan SM, 2006, BRIT J DERMATOL, V154, P979, DOI 10.1111/j.1365-2133.2006.07153.x; Lee JY, 2016, ATMOS POLLUT RES, V7, P664, DOI 10.1016/j.apr.2016.02.007; Lee JY, 2016, ATMOS ENVIRON, V127, P100, DOI 10.1016/j.atmosenv.2015.12.020; Lee YL, 2008, J INVEST DERMATOL, V128, P2412, DOI 10.1038/jid.2008.110; Lim YH, 2012, SCI TOTAL ENVIRON, V417, P55, DOI 10.1016/j.scitotenv.2011.12.048; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Suarez-Varela MM, 2008, INT J BIOMETEOROL, V52, P833, DOI 10.1007/s00484-008-0177-0; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Park YM, 2016, ASIAN PAC J ALLERGY, V34, P65, DOI 10.12932/AP0621.34.1.2016; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Sargen MR, 2014, J INVEST DERMATOL, V134, P51, DOI 10.1038/jid.2013.274; Schneider L, 2013, J ALLERGY CLIN IMMUN, V131, P295, DOI 10.1016/j.jaci.2012.12.672; Silverberg JI, 2013, J INVEST DERMATOL, V133, P1752, DOI 10.1038/jid.2013.19; Song GX, 2008, RESPIROLOGY, V13, P1066, DOI 10.1111/j.1440-1843.2008.01401.x; Song S, 2011, ENVIRON RES, V111, P394, DOI 10.1016/j.envres.2010.10.010; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Stone MR, 2014, PREV MED, V65, P122, DOI 10.1016/j.ypmed.2014.05.008; Tagin MA, 2012, ARCH PEDIAT ADOLESC, V166, P707; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; Uekert SJ, 2006, J ALLERGY CLIN IMMUN, V118, P1375, DOI 10.1016/j.jaci.2006.09.008; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Williams H, 2008, J ALLERGY CLIN IMMUN, V121, P947, DOI 10.1016/j.jaci.2007.11.004; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Xu ZW, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-12; Yu JS, 2012, J KOREAN MED SCI, V27, P681, DOI 10.3346/jkms.2012.27.6.681	48	49	52	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175229	10.1371/journal.pone.0175229	http://dx.doi.org/10.1371/journal.pone.0175229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384276	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900128
J	Lekander, I; Willers, C; von Euler, M; Lilja, M; Sunnerhagen, KS; Pessah-Rasmussen, H; Borgstrom, F				Lekander, Ingrid; Willers, Carl; von Euler, Mia; Lilja, Mikael; Sunnerhagen, Katharina S.; Pessah-Rasmussen, Helene; Borgstrom, Fredrik			Relationship between functional disability and costs one and two years post stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR THROMBECTOMY; SWEDEN; CARE; THROMBOLYSIS; METAANALYSIS; QUALITY; TRIALS; BURDEN	Background and purpose Stroke affects mortality, functional ability, quality of life and incurs costs. The primary objective of this study was to estimate the costs of stroke care in Sweden by level of disability and stroke type (ischemic (IS) or hemorrhagic stroke (ICH)). Method Resource use during first and second year following a stroke was estimated based on a research database containing linked data from several registries. Costs were estimated for the acute and post-acute management of stroke, including direct (health care consumption and municipal services) and indirect (productivity losses) costs. Resources and costs were estimated per stroke type and functional disability categorised by Modified Rankin Scale (mRS). Results The results indicated that the average costs per patient following a stroke were 350,000SEKI 37,000-480,000SEKI 50,000, dependent on stroke type and whether it was the first or second year post stroke. Large variations were identified between different subgroups of functional disability and stroke type, ranging from annual costs of 100,000SEK/10,000-1,100,000SEK/120,000 per patient, with higher costs for patients with ICH compared to IS and increasing costs with more severe functional disability. Conclusion Functional outcome is a major determinant on costs of stroke care. The stroke type associated with worse outcome (ICH) was also consistently associated to higher costs. Measures to improve function are not only important to individual patients and their family but may also decrease the societal burden of stroke.	[Lekander, Ingrid; Willers, Carl] Ivbar Inst AB, Stockholm, Sweden; [Lekander, Ingrid; Borgstrom, Fredrik] Karolinska Inst, Med Management Ctr, LIME, Stockholm, Sweden; [Willers, Carl; von Euler, Mia] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [von Euler, Mia] Karolinska Inst, Stroke Res Network, Sodersjukhuset, Stockholm, Sweden; [Lilja, Mikael] Umea Univ, Ostersund Hosp, Dept Publ Hlth & Clin Med, Unit Res Educ & Dev, Ostersund, Sweden; [Sunnerhagen, Katharina S.] Univ Gothenburg, Inst Neurosci & Physiol, Rehabil Med, Gothenburg, Sweden; [Pessah-Rasmussen, Helene] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Pessah-Rasmussen, Helene] Skane Univ Hosp, Dept Neurol & Rehabil Med, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Umea University; University of Gothenburg; Lund University; Lund University; Skane University Hospital	Lekander, I (corresponding author), Ivbar Inst AB, Stockholm, Sweden.; Lekander, I (corresponding author), Karolinska Inst, Med Management Ctr, LIME, Stockholm, Sweden.	ingrid.lekander@ivbar.com	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Willers, Carl/0000-0002-7616-9238; von Euler, Mia/0000-0002-3845-8100	Sveus, a research collaboration in which seven Swedish regions develop systems for value-based monitoring and reimbursement of health care; Forte programme [2012/1688]	Sveus, a research collaboration in which seven Swedish regions develop systems for value-based monitoring and reimbursement of health care; Forte programme	Funding for this research was provided by Sveus, a research collaboration in which seven Swedish regions develop systems for value-based monitoring and reimbursement of health care. Partial funding from Forte programme grant 2012/1688 ("Value and choice") is gratefully acknowledged.	AHLSIO B, 1984, STROKE, V15, P886, DOI 10.1161/01.STR.15.5.886; Aronsson M, 2016, NEUROLOGY, V86, P1053, DOI 10.1212/WNL.0000000000002439; Dawson J, 2007, STROKE, V38, P1893, DOI 10.1161/STROKEAHA.106.472381; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; Ehlers L, 2007, STROKE, V38, P85, DOI 10.1161/01.STR.0000251790.19419.a8; Elgendy IY, 2015, J AM COLL CARDIOL, V66, P2498, DOI 10.1016/j.jacc.2015.09.070; Eriksson M, 2007, STROKE, V38, P1384, DOI 10.1161/01.STR.0000260102.97954.9c; Ghatnekar O, 2004, INT J TECHNOL ASSESS, V20, P375, DOI 10.1017/S0266462304001217; Ghatnekar O, 2014, INT J TECHNOL ASSESS, V30, P203, DOI 10.1017/S0266462314000075; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hodgson T, 1982, HEALTH SOC, V60, P429; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Joo H, 2014, J STROKE CEREBROVASC, V23, P1753, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.017; Lindgren P, 2008, EUR J CARDIOV PREV R, V15, P230, DOI 10.1097/HJR.0b013e3282f37a22; Lobotesis K, 2016, J MED ECON, P1; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Penaloza-Ramos MC, 2014, STROKE, V45, P553, DOI 10.1161/STROKEAHA.113.003216; Persson J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-341; Spieler JF, 2004, CEREBROVASC DIS, V17, P134, DOI 10.1159/000075782; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Yarbrough CK, 2015, STROKE, V46, P3177, DOI 10.1161/STROKEAHA.115.009847	21	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174861	10.1371/journal.pone.0174861	http://dx.doi.org/10.1371/journal.pone.0174861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384164	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900043
J	Onofre, T; Oliver, N; Carlos, R; Fellsmino, A; Corte, RC; Silva, E; Bruno, S				Onofre, Tatiana; Oliver, Nicole; Carlos, Renata; Fellsmino, Amanda; Corte, Renata Cristina; Silva, Eliane; Bruno, Selma			Oxygen uptake efficiency slope as a useful measure of cardiorespiratory fitness in morbidly obese women	PLOS ONE			English	Article							HEART-FAILURE; MINUTE VENTILATION; FUNCTIONAL RESERVE; EXERCISE CAPACITY; INDEX; REPRODUCIBILITY; INDIVIDUALS; RESPONSES; VALIDITY; ADULTS	Cardiopulmonary assessment through oxygen uptake efficiency slope (OUES) data has shown encouraging results, revealing that we can obtain important clinical information about functional status. Until now, the use of OUES has not been established as a measure of cardiorespiratory capacity in an obese adult population, only in cardiac and pulmonary diseases or pediatric patients. The aim of this study was to characterize submaximal and maximal levels of OUES in a sample of morbidly obese women and analyze its relationship with traditional measures of cardiorespiratory fitness, anthropometry and pulmonary function. Thirty-three morbidly obese women (age 39.1 +/- 9.2 years) performed Cardiopulmonary Exercise Testing (CPX) on a treadmill using the ramp protocol. In addition, anthropometric measurements and pulmonary function were also evaluated. Maximal and submaximal OUES were measured, being calculated from data obtained in the first 50% (OUES50%) and 75% (OUES75%) of total CPX duration. In one-way ANOVA analysis, OUES did not significantly differ between the three different exercise intensities, as observed through a Bland-Altman concordance of 58.9 mL/min/log(L/min) between OUES75% and OUES100%, and 0.49 mL/kg/min/log(l/min) between OUES/kg75% and OUES/kg100%. A strong positive correlation between the maximal (r = 0.79) and submaximal (r = 0.81) OUES/kg with oxygen consumption at peak exercise (VO2peak) and ventilatory anaerobic threshold (VO2VAT) was observed, and a moderate negative correlation with hip circumference (r = -0.46) and body adiposity index (r = -0.50) was also verified. There was no significant difference between maximal and submaximal OUES, showing strong correlations with each other and oxygen consumption (peak and VAT). These results indicate that OUES can be a useful parameter which could be used as a cardiopulmonary fitness index in subjects with severe limitations to perform CPX, as for morbidly obese women.	[Onofre, Tatiana; Oliver, Nicole; Carlos, Renata; Fellsmino, Amanda; Corte, Renata Cristina] Univ Fed Rio Grande do Norte, Postgrad Phys Therapy Program, Cardiopulm & Metab Rehabil Lab, Natal, RN, Brazil; [Silva, Eliane] Univ Fed Rio Grande do Norte, Integrated Med Dept, Natal, RN, Brazil; [Bruno, Selma] Univ Fed Rio Grande do Norte, Phys Therapy Dept, Cardiopulm & Metab Rehabil Lab, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Bruno, S (corresponding author), Univ Fed Rio Grande do Norte, Phys Therapy Dept, Cardiopulm & Metab Rehabil Lab, Natal, RN, Brazil.	selma.bruno@gmail.com	Onofre, Tatiana/AAS-8968-2020	Onofre, Tatiana/0000-0003-4985-1466				Ammenwerth W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102333; Antoine-Jonville S, 2012, MED SCI SPORT EXER, V44, P428, DOI 10.1249/MSS.0b013e31822f8427; Arena R, 2014, PROG CARDIOVASC DIS, V56, P457, DOI 10.1016/j.pcad.2013.08.001; Arena R, 2012, INT J CARDIOL, V154, P384, DOI 10.1016/j.ijcard.2011.11.038; Arena R, 2010, INT J CARDIOL, V144, P101, DOI 10.1016/j.ijcard.2008.12.143; Arena R, 2009, J CARDIOPULM REHABIL, V29, P248, DOI 10.1097/HCR.0b013e3181a3338c; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Baba R, 1999, EUR J APPL PHYSIOL O, V80, P397, DOI 10.1007/s004210050610; Baba R, 1999, J SPORT MED PHYS FIT, V39, P202; Babbo TG, 2008, CHEST, V134, P704, DOI 10.1378/chest.07-1728; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Barron A, 2016, JACC-HEART FAIL, V4, P252, DOI 10.1016/j.jchf.2015.11.003; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bongers BC, 2012, PEDIATR EXERC SCI, V24, P129, DOI 10.1123/pes.24.1.129; Breithaupt PG, 2012, PEDIATR EXERC SCI, V24, P357, DOI 10.1123/pes.24.3.357; Buys R, 2015, EUR J PREV CARDIOL, V22, P356, DOI 10.1177/2047487314547658; Santarem GCDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130268; de Souza SAF, 2005, OBES SURG, V15, P1238, DOI 10.1381/096089205774512627; deJong Adam T, 2008, Prev Cardiol, V11, P100; Di Thommazo-Luporini L, 2012, BRAZ J PHYS THER, V16, P469, DOI 10.1590/S1413-35552012005000036; Evans RA, 2014, CHEST, V146, P81, DOI 10.1378/chest.13-2060; Giardini A, 2009, INT J CARDIOL, V133, P74, DOI 10.1016/j.ijcard.2007.11.092; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Heine M, 2014, J REHABIL MED, V46, P656, DOI 10.2340/16501977-1825; Herdy AH, 2016, ARQ BRAS CARDIOL, V106, P389, DOI 10.5935/abc.20160070; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Hulens M, 2001, SCAND J MED SCI SPOR, V11, P305, DOI 10.1034/j.1600-0838.2001.110509.x; King WC, 2012, SURG OBES RELAT DIS, V8, P48, DOI 10.1016/j.soard.2011.07.003; Kress JP, 1999, AM J RESP CRIT CARE, V160, P883, DOI 10.1164/ajrccm.160.3.9902058; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Lorenzo S, 2013, CHEST, V144, P1330, DOI 10.1378/chest.12-3022; Marinov B, 2003, Acta Physiol Pharmacol Bulg, V27, P59; Miller WM, 2012, OBESITY, V20, P505, DOI 10.1038/oby.2011.262; O'Donnell DE, 2012, PULM MED, V2012, DOI 10.1155/2012/818925; Ofir D, 2007, J APPL PHYSIOL, V102, P2217, DOI 10.1152/japplphysiol.00898.2006; Oliver N, 2015, OBES SURG, V25, P1658, DOI 10.1007/s11695-014-1548-8; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Ramos RP, 2014, EUR RESPIR J, V43, P1510, DOI 10.1183/09031936.00167713; Runhaar J, 2011, OBES REV, V12, P1071, DOI 10.1111/j.1467-789X.2011.00916.x; Silva OB, 2003, ARQ BRAS CARDIOL, V81, P42, DOI DOI 10.1590/S0066-782X2003000900004; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; Van Laethem C, 2005, AM HEART J, V149, P175, DOI 10.1016/j.ahj.2004.07.004; Van Laethem C, 2009, EUR J CARDIOV PREV R, V16, P493, DOI 10.1097/HJR.0b013e32832c88a8; Wasserman K, 2005, PRINCIPLES EXERCISE; Wasserman K, 1990, CIRCULATION S2, V81, P1114	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0172894	10.1371/journal.pone.0172894	http://dx.doi.org/10.1371/journal.pone.0172894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384329	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900003
J	Simis, SGH; Ylostalo, P; Kallio, KY; Spilling, K; Kutser, T				Simis, Stefan G. H.; Ylostalo, Pasi; Kallio, Kari Y.; Spilling, Kristian; Kutser, Tiit			Contrasting seasonality in optical-biogeochemical properties of the Baltic Sea	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; LIGHT-SCATTERING; CYANOBACTERIAL BLOOMS; SPECTRAL ABSORPTION; PARTICULATE MATTER; MARINE PARTICLES; TRANSITION ZONE; CDOM ABSORPTION; PHYTOPLANKTON; COASTAL	Optical-biogeochemical relationships of particulate and dissolved organic matter are presented in support of remote sensing of the Baltic Sea pelagic. This system exhibits strong seasonality in phytoplankton community composition and wide gradients of chromophoric dissolved organic matter (CDOM), properties which are poorly handled by existing remote sensing algorithms. Absorption and scattering properties of particulate matter reflected the seasonality in biological (phytoplankton succession) and physical (thermal stratification) processes. Inherent optical properties showed much wider variability when normalized to the chlorophyll-a concentration compared to normalization to either total suspended matter dry weight or particulate organic carbon. The particle population had the largest optical variability in summer and was dominated by organic matter in both seasons. The geographic variability of CDOM and relationships with dissolved organic carbon (DOC) are also presented. CDOM dominated light absorption at blue wavelengths, contributing 81% (median) of the absorption by all water constituents at 400 nm and 63% at 442 nm. Consequentially, 90% of water-leaving radiance at 412 nm originated from a layer (z(90)) no deeper than approximately 1.0 m. With water increasingly attenuating light at longer wavelengths, a green peak in light penetration and reflectance is always present in these waters, with z(90) up to 3.0-3.5 m depth, whereas z(90) only exceeds < 5 m at biomass < 5 mg Chla m(-3). High absorption combined with a weakly scattering particle population (despite median phytoplankton biomass of 14.1 and 4.3 mg Chla m(-3) in spring and summer samples, respectively), characterize this sea as a dark water body for which dedicated or exceptionally robust remote sensing techniques are required. Seasonal and regional optical-biogeochemical models, data distributions, and an extensive set of simulated remote-sensing reflectance spectra for testing of remote sensing algorithms are provided as supplementary data.	[Simis, Stefan G. H.] Plymouth Marine Lab, Plymouth, Devon, England; [Simis, Stefan G. H.; Ylostalo, Pasi; Kallio, Kari Y.; Spilling, Kristian] Marine Res Ctr, Finnish Environm Inst SYKE, Helsinki, Finland; [Kutser, Tiit] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia	Plymouth Marine Laboratory; Finnish Environment Institute; University of Tartu; Estonian Marine Institute	Simis, SGH (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.; Simis, SGH (corresponding author), Marine Res Ctr, Finnish Environm Inst SYKE, Helsinki, Finland.	stsi@pml.ac.uk	Spilling, Kristian/L-7932-2014; Kutser, Tiit/H-1304-2015	Spilling, Kristian/0000-0002-8390-8270; Ylostalo, Pasi/0000-0003-4702-2840; Simis, Stefan/0000-0002-6296-9146	EOMORE (SYKE); Algalume (Academy of Finland) [132409]; EC FP7 projects PROTOOL [226880]; WaterS [251527]; CoBiOS [263295]; Jerico [262584]; DEVOTES [308392]; BONUS FerryScope; INTERREG IV Central Baltic project GES-REG; LIFE+ MARMONI [LIFE09/NAT/LV/000238]; Estonian Basic Research [SF0180009s11]	EOMORE (SYKE); Algalume (Academy of Finland); EC FP7 projects PROTOOL; WaterS; CoBiOS; Jerico; DEVOTES; BONUS FerryScope; INTERREG IV Central Baltic project GES-REG; LIFE+ MARMONI; Estonian Basic Research	This work was financially supported through projects EOMORE (SYKE), Algalume (Academy of Finland grant 132409), EC FP7 projects PROTOOL (Grant 226880), WaterS (251527), CoBiOS (263295), Jerico (262584), DEVOTES (308392) and BONUS FerryScope, INTERREG IV Central Baltic project GES-REG and LIFE+ MARMONI (LIFE09/NAT/LV/000238), and Estonian Basic Research Grant SF0180009s11.	Aarnos H, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2010JG001633; AHN YH, 1992, DEEP-SEA RES, V39, P1835, DOI 10.1016/0198-0149(92)90002-B; Asmala E, 2013, BIOGEOSCIENCES, V10, P6969, DOI 10.5194/bg-10-6969-2013; Asmala E, 2012, ESTUAR COAST SHELF S, V111, P107, DOI 10.1016/j.ecss.2012.06.015; Attila J, 2013, REMOTE SENS ENVIRON, V128, P138, DOI 10.1016/j.rse.2012.07.009; Babin M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000882; Babin M, 2003, LIMNOL OCEANOGR, V48, P843, DOI 10.4319/lo.2003.48.2.0843; Berthon JF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043227; Boss E, 2001, APPL OPTICS, V40, P5503, DOI 10.1364/AO.40.005503; Bowers DG, 2008, J MARINE SYST, V73, P1, DOI 10.1016/j.jmarsys.2007.07.001; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Bryant D. A., 1986, PHOTOSYNTHETIC PICOP, V214, P423; Darecki M, 2005, INT J REMOTE SENS, V26, P247, DOI 10.1080/01431160410001720298; Darecki M, 2004, REMOTE SENS ENVIRON, V89, P326, DOI 10.1016/j.rse.2003.10.012; Doxaran D, 2009, LIMNOL OCEANOGR, V54, P1257, DOI 10.4319/lo.2009.54.4.1257; Ferrari GM, 1998, ESTUAR COAST SHELF S, V47, P91, DOI 10.1006/ecss.1997.0309; Fleming V, 2006, HYDROBIOLOGIA, V554, P57, DOI 10.1007/s10750-005-1006-7; GORDON HR, 1975, APPL OPTICS, V14, P413, DOI 10.1364/AO.14.000413; Groetsch PMM, 2016, BIOGEOSCIENCES, V13, P4959, DOI 10.5194/bg-13-4959-2016; Groetsch PMM, 2014, J MARINE SYST, V140, P50, DOI 10.1016/j.jmarsys.2014.05.015; Hakanson L, 2005, ECOL MODEL, V189, P130, DOI 10.1016/j.ecolmodel.2005.03.015; Harvey ET, 2015, AMBIO, V44, pS392, DOI 10.1007/s13280-015-0658-4; Haverkamp THA, 2009, ISME J, V3, P397, DOI 10.1038/ismej.2008.118; HELCOM, 2013, APPR METH EUTR TARG; HELCOM, 2013, 5 BALT SEA POLL LOAD; Hojerslev NK, 1996, CONT SHELF RES, V16, P1329, DOI 10.1016/0278-4343(95)00075-5; Hojersley NK, 1988, NATURAL OCCURENCES O; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Johnsen G, 1996, SCI MAR, V60, P47; Kahru M, 2007, MAR ECOL PROG SER, V343, P15, DOI 10.3354/meps06943; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kowalczuk P, 2005, INT J REMOTE SENS, V26, P345, DOI 10.1080/01431160410001720270; Kowalczuk P, 1999, J GEOPHYS RES-OCEANS, V104, P30047, DOI 10.1029/1999JC900198; Kowalczuk P, 2006, MAR CHEM, V101, P1, DOI 10.1016/j.marchem.2005.12.005; Kratzer S, 2003, AMBIO, V32, P577, DOI 10.1639/0044-7447(2003)032[0577:ASAPZD]2.0.CO;2; Kutser T, 2004, LIMNOL OCEANOGR, V49, P2179, DOI 10.4319/lo.2004.49.6.2179; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P303, DOI 10.1016/j.ecss.2005.11.024; Kutser T, 2008, ESTUAR COAST SHELF S, V78, P649, DOI 10.1016/j.ecss.2008.02.024; Kutser T, 2009, BOREAL ENVIRON RES, V14, P305; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; Matthews MW, 2013, BIOGEOSCIENCES, V10, P8139, DOI 10.5194/bg-10-8139-2013; Mitchell BG, 1990, OCEAN OPTICS; Neumann T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001450; Olenina I, 2006, BIOVOLUMES SIZE CLAS, P408; Petzold T.J., 1977, LIGHT SEA, P152; Seppala J, 2005, INT J REMOTE SENS, V26, P387, DOI 10.1080/01431160410001723682; Simis SGH, 2012, LIMNOL OCEANOGR-METH, V10, P214, DOI 10.4319/lom.2012.10.214; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Stal LJ, 2003, CONT SHELF RES, V23, P1695, DOI 10.1016/j.csr.2003.06.001; Stedmon CA, 2000, ESTUAR COAST SHELF S, V51, P267, DOI 10.1006/ecss.2000.0645; Stedmon CA, 2010, ESTUAR COAST SHELF S, V87, P156, DOI 10.1016/j.ecss.2009.12.022; Tassan S, 1995, LIMNOL OCEANOGR, V40, P1358, DOI 10.4319/lo.1995.40.8.1358; Volten H, 1998, LIMNOL OCEANOGR, V43, P1180, DOI 10.4319/lo.1998.43.6.1180; Whitmire AL, 2010, OPT EXPRESS, V18, P15073, DOI 10.1364/OE.18.015073; YENTSCH CS, 1962, LIMNOL OCEANOGR, V7, P207, DOI 10.4319/lo.1962.7.2.0207; Ylostalo P, 2016, MAR CHEM, V186, P58, DOI 10.1016/j.marchem.2016.07.004; Zhou W, 2012, OPT EXPRESS, V20, P11189, DOI 10.1364/OE.20.011189	57	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173357	10.1371/journal.pone.0173357	http://dx.doi.org/10.1371/journal.pone.0173357			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384157	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000399371900007
J	Weeks, HR; Tadler, SC; Smith, KW; Iacob, E; Saccoman, M; White, AT; Landvatter, JD; Chelune, GJ; Suchy, Y; Clark, E; Cahalan, MK; Bushnell, L; Sakata, D; Light, AR; Light, KC				Weeks, Howard R., III; Tadler, Scott C.; Smith, Kelly W.; Iacob, Eli; Saccoman, Mikala; White, Andrea T.; Landvatter, Joshua D.; Chelune, Gordon J.; Suchy, Yana; Clark, Elaine; Cahalan, Michael K.; Bushnell, Lowry; Sakata, Derek; Light, Alan R.; Light, Kathleen C.			Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression (vol 8, e69809, 2013)	PLOS ONE			English	Correction													Tadler, Scott C./AAG-3595-2019					Weeks HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069809	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175668	10.1371/journal.pone.0175668	http://dx.doi.org/10.1371/journal.pone.0175668			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384319	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900202
J	Agrawal, R; Wang, JA; Ko, AG; Getsy, JE				Agrawal, Ritwick; Wang, Julie A.; Ko, Anita G.; Getsy, Joanne E.			A real-world comparison of apnea-hypopnea indices of positive airway pressure device and polysomnography	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; ADULTS	The apnea hypopnea index (AHI) reported by positive airway pressure (PAP) device is widely used in clinical practice, yet its correlation with standardized AHI obtained during the sleep study is not established. The current study was conducted to investigate the correlation between AHI estimated by the PAP device and reported on the smart card with the AHI found during the PAP polysomnography (PSG) in the "real world" setting at an academic sleep center. We retrospectively reviewed the medical records of 280 patients who underwent a PAP titration PSG at Drexel sleep center, and were later prescribed a PAP device. The AHI was categorized in clinically relevant subgroups (as AHI <5 and AHI >5). The AHI at the final pressure on the PSG and the average AHI from the prescribed PAP device were compared. The results showed that in the majority (77.3%) of patients (126 of 163), the AHI from both PAP device and PSG correlated well and were in the same category (AHI <5 and AHI >5 respectively). The majority of patients (80.7%) with PSG AHI of <5 had PAP device AHI <5 as well. By contrast, if PSG AHI was >5, 61.5% patients reported good control, with AHI <5 on PAP device AHI. We conclude that in a majority of patients who were optimally titrated in the sleep laboratory, the PAP device continued to show optimal control at home.	[Agrawal, Ritwick] Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Wang, Julie A.; Ko, Anita G.; Getsy, Joanne E.] Drexel Univ, Coll Med, Div Pulm Crit Care & Sleep Med, Philadelphia, PA 19104 USA	Baylor College of Medicine; Drexel University	Agrawal, R (corresponding author), Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA.	ritwick.agrawal@bcm.edu		Agrawal, Ritwick/0000-0002-7001-581X				Baltzan MA, 2006, SLEEP, V29, P557; Berry RB, 2020, AASM MANUAL SCORING; Berry RB, 2012, SLEEP, V35, P361, DOI 10.5665/sleep.1696; Corda L, 2009, SLEEP BREATH, V13, P187, DOI 10.1007/s11325-008-0219-1; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; Price D, 2015, BREATHE, V11, P26, DOI 10.1183/20734735.015414; Schwab RJ, 2013, AM J RESP CRIT CARE, V188, P613, DOI 10.1164/rccm.201307-1282ST; Stepnowsky C., 2013, SLEEP DISORD, V2013	9	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174458	10.1371/journal.pone.0174458	http://dx.doi.org/10.1371/journal.pone.0174458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379985	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500048
J	Ahmad, I; Gribble, A; Murtza, I; Ikram, M; Pop, M; Vitkin, A				Ahmad, Iftikhar; Gribble, Adam; Murtza, Iqbal; Ikram, Masroor; Pop, Mihaela; Vitkin, Alex			Polarization image segmentation of radiofrequency ablated porcine myocardial tissue	PLOS ONE			English	Article							CATHETER ABLATION; SHRINKAGE; VISUALIZATION; POLARIMETRY; LIGHT	Optical polarimetry has previously imaged the spatial extent of a typical radiofrequency ablated (RFA) lesion in myocardial tissue, exhibiting significantly lower total depolarization at the necrotic core compared to healthy tissue, and intermediate values at the RFA rim region. Here, total depolarization in ablated myocardium was used to segment the total depolarization image into three (core, rim and healthy) zones. A local fuzzy thresholding algorithm was used for this multi- region segmentation, and then compared with a ground truth segmentation obtained from manual demarcation of RFA core and rim regions on the histopathology image. Quantitative comparison of the algorithm segmentation results was performed with evaluation metrics such as dice similarity coefficient (DSC = 0.78 +/- 0.02 and 0.80 +/- 0.02), sensitivity (S-n = 0.83 +/- 0.10 and 0.91 +/- 0.08), specificity (S-p = 0.76 +/- 0.17 and 0.72 +/- 0.17) and accuracy (Acc = 0.81 +/- 0.09 and 0.71 +/- 0.10) for RFA core and rim regions, respectively. This automatic segmentation of parametric depolarization images suggests a novel application of optical polarimetry, namely its use in objective RFA image quantification.	[Ahmad, Iftikhar; Ikram, Masroor] PIEAS, Dept Phys & Appl Math, Islamabad, Pakistan; [Gribble, Adam; Vitkin, Alex] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Gribble, Adam; Vitkin, Alex] Univ Hlth Network, Princess Margaret Canc Ctr, Div Biophys & Bioimaging, 610 Univ Ave, Toronto, ON, Canada; [Murtza, Iqbal] PIEAS, Dept Comp & Informat Sci, Islamabad, Pakistan; [Pop, Mihaela] Univ Toronto, Sunnybrook Res Inst, Dept Med Biophys, 2075 Bayview Ave, Toronto, ON, Canada; [Vitkin, Alex] Univ Toronto, Dept Radiat Oncol, 610 Univ Ave, Toronto, ON, Canada	Pakistan Institute of Engineering & Applied Science; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Pakistan Institute of Engineering & Applied Science; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Ahmad, I (corresponding author), PIEAS, Dept Phys & Appl Math, Islamabad, Pakistan.	iahmadmp@gmail.com	Pop, Mihaela/AAO-8942-2020; Ahmad, Iftikhar/AAB-7802-2019; Vitkin, Alex/I-8166-2012	Ahmad, Iftikhar/0000-0002-2377-5808; Vitkin, Alex/0000-0001-5495-8888; Murtza, Iqbal/0000-0001-7541-8581	Natural Sciences and Engineering Research Council of Canada (NSERC) [707606790]; Higher Education Commission of Pakistan [HEC/IRSIP-27-PS-21]; IT Endowment and Telecom Fund [ITETF/13579]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); IT Endowment and Telecom Fund	This work was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) - http://www.nserc-crsng.gc.ca/index_eng.asp - 707606790 awarded to AV, Higher Education Commission of Pakistan - http://www.hec.gov.pk/english/Pages/Home.aspx - HEC/IRSIP-27-PS-21 awarded to MI, IT Endowment and Telecom Fund - http://www.pieas.edu.pk/admissions/default_ms.cshtml - ITETF/13579 awarded to IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahirwar Anamika, 2013, International Journal of Information Technology and Computer Science, V5, P44, DOI 10.5815/ijitcs.2013.05.06; Ahmad I, 2015, J BIOPHOTONICS, V10, P1; Ahmad I, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.056012; Aja-Fernandez S, 2015, KNOWL-BASED SYST, V83, P1, DOI 10.1016/j.knosys.2015.02.029; Alali S, 2014, BIOMED OPT EXPRESS, V5, P621, DOI 10.1364/BOE.5.000621; Alali S, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003250; Alali S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.086010; Alali S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.045004; Chen CH, 2012, J CHIN MED ASSOC, V75, P109, DOI 10.1016/j.jcma.2012.02.006; Dana N, 2014, HEART RHYTHM, V11, P150, DOI 10.1016/j.hrthm.2013.09.071; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egger J, 2015, IEEE ENG MED BIO, P2423, DOI 10.1109/EMBC.2015.7318883; Eyerly SA, 2010, J CARDIOVASC ELECTR, V21, P557, DOI 10.1111/j.1540-8167.2009.01664.x; Fleming CP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3459134; Fleming CP, 2010, OPT EXPRESS, V18, P3079, DOI 10.1364/OE.18.003079; Fred HL, 2004, TEX HEART I J, V31, P345; Gardner ES, 2001, DERMATOL SURG, V27, P813, DOI 10.1046/j.1524-4725.2001.01017.x; Ghosh N, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3652896; Guo X, 2008, OPT COMMUN, V281, P380, DOI 10.1016/j.optcom.2007.09.043; Herranz D, 2015, BIOMED OPT EXPRESS, V6, P3268, DOI 10.1364/BOE.6.003268; Jacques SL, 2002, J BIOMED OPT, V7, P329, DOI 10.1117/1.1484498; Lardo AC, 2000, CIRCULATION, V102, P698, DOI 10.1161/01.CIR.102.6.698; Lazebnik RS, 2005, ACAD RADIOL, V12, P1491, DOI 10.1016/j.acra.2005.07.011; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106; Manhas S, 2015, OPT EXPRESS, V23, P3047, DOI 10.1364/OE.23.003047; O'Hara GE, 2007, CAN J CARDIOL, V23, p67B, DOI 10.1016/S0828-282X(07)71013-9; Olabarriaga SD, 2001, MED IMAGE ANAL, V5, P127, DOI 10.1016/S1361-8415(00)00041-4; Pang GA, 2015, J CARDIOVASC ELECTR, V26, P339, DOI 10.1111/jce.12584; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pierangelo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046014; Pierangelo A, 2013, OPT EXPRESS, V21, P14120, DOI 10.1364/OE.21.014120; Pierangelo A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.066009; Pop M, 2003, PHYS MED BIOL, V48, P2509, DOI 10.1088/0031-9155/48/15/317; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Stevenson WG, 2000, HEART, V84, P553, DOI 10.1136/heart.84.5.553; Stevenson WG, 2010, LANCET, V375, P4, DOI 10.1016/S0140-6736(09)61915-2; Swartling J, 2003, MED BIOL ENG COMPUT, V41, P403, DOI 10.1007/BF02348082; Tata A, 2015, CHEM SCI; Thomsen S, 1999, P SOC PHOTO-OPT INS, V3594, P82, DOI 10.1117/12.348748; Tobias OJ, 2002, IEEE T IMAGE PROCESS, V11, P1457, DOI 10.1109/TIP.2002.806231; Tung R, 2010, CIRCULATION, V122, pE389, DOI 10.1161/CIRCULATIONAHA.110.963371; Wallenburg MA, 2010, J INNOV OPT HEAL SCI, V3, P109, DOI 10.1142/S1793545810000976; Wood MFG, 2011, PHYS MED BIOL, V56, pN115, DOI 10.1088/0031-9155/56/8/N01; Wood MFG, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3469844; Wright M, 2011, HEART RHYTHM, V8, P304, DOI 10.1016/j.hrthm.2010.10.039; Wu HS, 2000, J MICROSC-OXFORD, V197, P296, DOI 10.1046/j.1365-2818.2000.00653.x; Yeap BH, 2007, ASIAN J SURG, V30, P183, DOI 10.1016/S1015-9584(08)60020-2; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175173	10.1371/journal.pone.0175173	http://dx.doi.org/10.1371/journal.pone.0175173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380013	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500105
J	Buttelmann, D; Buttelmann, F; Carpenter, M; Call, J; Tomasello, M				Buttelmann, David; Buttelmann, Frances; Carpenter, Melinda; Call, Josep; Tomasello, Michael			Great apes distinguish true from false beliefs in an interactive helping task	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; HUMAN INFANTS; CHILDREN; REPRESENTATION; ATTRIBUTION; IMITATION; IMPLICIT	Understanding the behavior of others in a wide variety of circumstances requires an understanding of their psychological states. Humans' nearest primate relatives, the great apes, understand many psychological states of others, for example, perceptions, goals, and desires. However, so far there is little evidence that they possess the key marker of advanced human social cognition: an understanding of false beliefs. Here we demonstrate that in a nonverbal (implicit) false-belief test which is passed by human 1-year-old infants, great apes as a group, including chimpanzees (Pan troglodytes), bonobos (Pan paniscus), and orangutans (Pongo abelii), distinguish between true and false beliefs in their helping behavior. Great apes thus may possess at least some basic understanding that an agent's actions are based on her beliefs about reality. Hence, such understanding might not be the exclusive province of the human species.	[Buttelmann, David; Carpenter, Melinda; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, Leipzig, Germany; [Buttelmann, David] Univ Bern, Dept Dev Psychol, Fabrikstr 8, Bern, Switzerland; [Buttelmann, Frances] Friedrich Schiller Univ Jena, Dept Dev Psychol, Steiger 3-1, Jena, Germany; [Buttelmann, Frances; Carpenter, Melinda; Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Tomasello, Michael] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Max Planck Society; University of Bern; Friedrich Schiller University of Jena; University of St Andrews; Duke University	Buttelmann, D (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, Leipzig, Germany.; Buttelmann, D (corresponding author), Univ Bern, Dept Dev Psychol, Fabrikstr 8, Bern, Switzerland.	david.buttelmann@eva.mpg.de		Carpenter, Malinda/0000-0003-3983-2034; Call Balaguer, Josep/0000-0002-8597-8336				[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Buttelmann D, 2008, ANIM COGN, V11, P117, DOI 10.1007/s10071-007-0095-2; Buttelmann D, 2012, ANIM COGN, V15, P1037, DOI 10.1007/s10071-012-0528-4; Buttelmann D, 2009, COGNITION, V112, P337, DOI 10.1016/j.cognition.2009.05.006; Buttelmann D, 2009, DEVELOPMENTAL SCI, V12, P688, DOI 10.1111/j.1467-7687.2008.00802.x; Call J, 1998, J COMP PSYCHOL, V112, P192, DOI 10.1037/0735-7036.112.2.192; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hare B, 1999, ANIM BEHAV, V59, P771; He ZJ, 2011, DEVELOPMENTAL SCI, V14, P292, DOI 10.1111/j.1467-7687.2010.00980.x; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; KRACHUN C., 2010, INT J COMP PSYCHOL, V23, P145; Krachun C, 2009, DEVELOPMENTAL SCI, V12, P521, DOI 10.1111/j.1467-7687.2008.00793.x; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Martin A, 2014, COGNITION, V130, P300, DOI 10.1016/j.cognition.2013.11.016; Myowa-Yamakoshi M, 1999, J COMP PSYCHOL, V113, P128, DOI 10.1037/0735-7036.113.2.128; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Scott RM, 2010, COGNITIVE PSYCHOL, V61, P366, DOI 10.1016/j.cogpsych.2010.09.001; Scott RM, 2009, CHILD DEV, V80, P1172, DOI 10.1111/j.1467-8624.2009.01324.x; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Thoermer C, 2012, BRIT J DEV PSYCHOL, V30, P172, DOI 10.1111/j.2044-835X.2011.02067.x; Tomasello M, 2005, MONOGRAPHS SOC RES C, P70; Trauble B, 2010, INFANCY, V15, P434, DOI 10.1111/j.1532-7078.2009.00025.x; Voelter C, APA HDB COM IN PRESS; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	35	57	58	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173793	10.1371/journal.pone.0173793	http://dx.doi.org/10.1371/journal.pone.0173793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379987	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500024
J	Chen, H; Chen, LJ				Chen, Hai; Chen, Lijun			Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 1 INFECTION; RANDOMIZED CONTROLLED-TRIAL; VIRUS-RELATED CIRRHOSIS; HEALTH-STATE UTILITIES; QUALITY-OF-LIFE; NATURAL-HISTORY; LIVER-DISEASE; FOLLOW-UP; FIBROSIS PROGRESSION	Background All-oral regimens are associated with higher effectiveness and shorter treatment duration for chronic hepatitis C. Given its superior effect and enormous patients in China, clinicians or patients may be compelled to consider delaying treatment for all-oral regimen. Objective To estimate cost-effectiveness of delaying treatment for all-oral regimen in the subsequent years under different assumptions about their price and efficacy compared with standard of care in China. Methods A state-transition Markov model was developed to estimate lifetime costs and quality-adjusted life years (QALYs). Incremental cost-effectiveness ratio (ICER) and net monetary benefit (NB) were calculated. And sensitivity analyses were also performed to assess the impact of uncertainty. Results For treatment naive patients with Genotype 1, immediate treatment with all-oral regimen under assumed cost and efficacy at present was cost-effective compared with peginterferon alpha-2a (PegIFN) regimen at present with an ICER of $12536 per QALY gained and a positive NB of $6832 at a willingness-to-pay threshold of $21209. And it was more than 95% likely to be cost-effective if weekly drug cost was less than $1000. Moreover, patients delaying treatment for all-oral regimen in the 1st year were associated with increase in QALYs of 0.62 and increase in cost of $10114 compared with initiating PegIFN regimen at present, which resulted in a positive NB of $3115. Conclusion From a payer perspective, all-oral regimen is associated with good long-term health and economic benefit for treatment-naive patients infected with HCV genotype 1. Particularly, if all-oral regimen would become available at lower price in the future, delaying treatment for all-oral regimen may be a good choice for patients in China.	[Chen, Hai; Chen, Lijun] Wuxi Ctr Dis Control & Prevent, Dept Infect Dis Control, Wuxi, Jiangsu, Peoples R China		Chen, H (corresponding author), Wuxi Ctr Dis Control & Prevent, Dept Infect Dis Control, Wuxi, Jiangsu, Peoples R China.	dr.chenhai@outlook.com			Scientific Research Program of Jiangsu Province "333" Project [BRA2014042]; Scientific Research Project of Wuxi Health Bureau [Z201304]	Scientific Research Program of Jiangsu Province "333" Project; Scientific Research Project of Wuxi Health Bureau	This work was supported by the Scientific Research Program of Jiangsu Province "333" Project (BRA2014042) and Scientific Research Project of Wuxi Health Bureau (Z201304).	Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chinese Society of Hepatology, 2015, CHINESE HEPATOLOGY, V33, P192; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Deuffic-Burban S, 2014, J HEPATOL, V61, P7, DOI 10.1016/j.jhep.2014.03.011; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Duan ZP, 2014, VALUE HEALTH, V17, pA805, DOI 10.1016/j.jval.2014.08.515; Duan ZP, 2014, J CLIN GASTROENTEROL, V48, P679, DOI 10.1097/MCG.0000000000000109; Feng B, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-47; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hao XG, 2011, J PRACTICAL HEPATOLO, V14, P436; Hiligsmann M, 2009, VALUE HEALTH, V12, P687, DOI 10.1111/j.1524-4733.2008.00497.x; Hu M, 2009, VALUE HEALTH, V12, pS89, DOI 10.1111/j.1524-4733.2009.00636.x; Hui AY, 2002, J CLIN GASTROENTEROL, V34, P569, DOI 10.1097/00004836-200205000-00018; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kuwabara H, 2015, J MED ECON, V18, P502, DOI 10.3111/13696998.2015.1029492; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Li JF, 2014, INT J INFECT DIS, V27, P49, DOI 10.1016/j.ijid.2014.07.003; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu JP, 2012, EUR J GASTROEN HEPAT, V24, P186, DOI 10.1097/MEG.0b013e32834dda64; Mao WCW, 2012, CHINA J PHARM EC, V1, P6; Martinot-Peignoux M, 2010, HEPATOLOGY, V51, P1122, DOI 10.1002/hep.23444; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; National Bureau of Statistics of China, CENS DAT; National Bureau of Statistics of China, NAT DAT; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Rao HY, 2012, J GASTROEN HEPATOL, V27, P526, DOI 10.1111/j.1440-1746.2011.06880.x; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Toy M, 2014, HEPATOLOGY, V60, P46, DOI 10.1002/hep.26934; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wang SB, 2012, CHINESE MED J-PEKING, V125, P2157, DOI 10.3760/cma.j.issn.0366-6999.2012.12.014; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Younossi ZM, 2015, ALIMENT PHARM THER, V41, P544, DOI 10.1111/apt.13081; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009; Zhang C, 2015, CLIN DRUG INVEST, V35, P197, DOI 10.1007/s40261-015-0273-y; Zhao SH, 2009, INT J CLIN PRACT, V63, P1334, DOI 10.1111/j.1742-1241.2009.02082.x	47	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175189	10.1371/journal.pone.0175189	http://dx.doi.org/10.1371/journal.pone.0175189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380022	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500106
J	Chow, NA; Lindsley, MD; McCotter, OZ; Kangiser, D; Wohrle, RD; Clifford, WR; Yaglom, HD; Adams, LE; Komatsu, K; Durkin, MM; Baker, RJ; Shubitz, LF; Derado, G; Chiller, TM; Litvintseva, AP				Chow, Nancy A.; Lindsley, Mark D.; McCotter, Orion Z.; Kangiser, Dave; Wohrle, Ron D.; Clifford, Wayne R.; Yaglom, Hayley D.; Adams, Laura E.; Komatsu, Kenneth; Durkin, Michelle M.; Baker, Rocky J.; Shubitz, Lisa F.; Derado, Gordana; Chiller, Tom M.; Litvintseva, Anastasia P.			Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species	PLOS ONE			English	Article							WASHINGTON-STATE; IMMITIS; INFECTION; ANIMALS; SEROPREVALENCE; HISTOPLASMIN; SENSITIVITY; ENDEMICITY; CALIFORNIA; SEROLOGY	Coccidioides is a soil-dwelling fungus that causes coccidioidomycosis, a disease also known as Valley fever, which affects humans and a variety of animal species. Recent findings of Coccidioides in new, unexpected areas of the United States have demonstrated the need for a better understanding of its geographic distribution. Large serological studies on animals could provide important information on the geographic distribution of this pathogen. To facilitate such studies, we used protein A/G, a recombinant protein that binds IgG antibodies from a variety of mammalian species, to develop an enzyme immunoassay (EIA) that detects IgG antibodies against Coccidioides in a highly sensitive and high-throughput manner. We showed the potential of this assay to be adapted to multiple animal species by testing a collection of serum and/or plasma samples from dogs, mice, and humans with or without confirmed coccidioidomycosis. We then evaluated the performance of the assay in dogs, using sera from dogs residing in a highly endemic area, and found seropositivity rates significantly higher than those in dogs of non-endemic areas. We further evaluated the specificity of the assay in dogs infected with other fungal pathogens known to cross-react with Coccidioides. Finally, we used the assay to perform a cross-sectional serosurvey investigating dogs from Washington, a state in which infection with Coccidioides has recently been documented. In summary, we have developed a Coccidioides EIA for the detection of antibodies in canines that is more sensitive and has higher throughput than currently available methods, and by testing this assay in mice and humans, we have shown a proof of principle of its adaptability for other animal species.	[Chow, Nancy A.; Lindsley, Mark D.; McCotter, Orion Z.; Chiller, Tom M.; Litvintseva, Anastasia P.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30333 USA; [Kangiser, Dave; Wohrle, Ron D.; Clifford, Wayne R.] Washington State Dept Hlth, Off Environm Publ Hlth Sci, Zoonot Dis Program, Olympia, WA USA; [Yaglom, Hayley D.; Adams, Laura E.; Komatsu, Kenneth] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Durkin, Michelle M.] MiraVista Diagnost, Indianapolis, IN USA; [Baker, Rocky J.] Oregon State Univ, Oregon Vet Diagnost Lab, Corvallis, OR 97331 USA; [Shubitz, Lisa F.] Univ Arizona, Valley Fever Ctr Excellence, Tucson, AZ USA; [Derado, Gordana] Ctr Dis Control & Prevent, Biostat & Informat Management Off, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Adams, Laura E.] Ctr Dis Control & Prevent, Field Serv Branch, Div State & Local Readiness, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Arizona Department of Health Services; Oregon State University; University of Arizona; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Chow, NA; Litvintseva, AP (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30333 USA.	yln3@cdc.gov; frg8@cdc.gov	Galgiani, John/GLT-7012-2022					Ashburn LL, 1942, ARCH PATHOL, V34, P791; Benedict K, 2015, EMERG INFECT DIS, V21, P1935, DOI 10.3201/eid2111.141950; Bhide MR, 2004, COMP IMMUNOL MICROB, V27, P191, DOI 10.1016/j.cimid.2003.10.001; COWPER H. H., 1953, CALIFORNIA MED, V79, P97; DOTO IL, 1972, AM J EPIDEMIOL, V95, P464, DOI 10.1093/oxfordjournals.aje.a121413; Durkin M, 2008, CLIN INFECT DIS, V47, pE69, DOI 10.1086/592073; EDWARDS PQ, 1957, DIS CHEST, V31, P35, DOI 10.1378/chest.31.1.35; ELIASSON M, 1988, J BIOL CHEM, V263, P4323; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Gautam R, 2013, ZOONOSES PUBLIC HLTH, V60, P174, DOI 10.1111/j.1863-2378.2012.01526.x; Graupmann-Kuzma A, 2008, J AM ANIM HOSP ASSOC, V44, P226, DOI 10.5326/0440226; Grayzel SE, 2016, TRANSBOUND EMERG DIS; Higgins JC, 2005, JAVMA-J AM VET MED A, V226, P1888, DOI 10.2460/javma.2005.226.1888; Huckabone SE, 2015, J WILDLIFE DIS, V51, P295, DOI 10.7589/2014-06-143; HUPPERT M, 1982, MYCOPATHOLOGIA, V78, P107, DOI 10.1007/BF00442634; KAUFMAN L, 1995, J CLIN MICROBIOL, V33, P618, DOI 10.1128/JCM.33.3.618-619.1995; Kirsch EJ, 2012, CLIN VACCINE IMMUNOL, V19, P343, DOI 10.1128/CVI.05631-11; Lindsley MD, 2015, CLIN VACCINE IMMUNOL, V22, P1090, DOI 10.1128/CVI.00375-15; Litvintseva AP, 2015, CLIN INFECT DIS, V60, pE1, DOI 10.1093/cid/ciu681; MADDY K T, 1965, Ariz Med, V22, P281; MADDY KT, 1960, PUBLIC HEALTH REP, V75, P955, DOI 10.2307/4590968; Marsden-Haug N, 2013, CLIN INFECT DIS, V56, P847, DOI 10.1093/cid/cis1028; Nguyen C, 2013, CLIN MICROBIOL REV, V26, P505, DOI 10.1128/CMR.00005-13; PAPPAGIANIS D, 1990, CLIN MICROBIOL REV, V3, P247, DOI 10.1128/CMR.3.3.247-268.1990; Pappagianis D, 2001, Semin Respir Infect, V16, P242, DOI 10.1053/srin.2001.29315; Shubitz LF, 2005, JAVMA-J AM VET MED A, V226, P1846, DOI 10.2460/javma.2005.226.1846; Shubitz LE, 2007, ANN NY ACAD SCI, V1111, P395, DOI 10.1196/annals.1406.007; SUN SH, 1979, SABOURAUDIA, V17, P265; Wack EE, 2015, CLIN INFECT DIS, V61, P787, DOI 10.1093/cid/civ388; Zhang DL, 2010, CLIN VACCINE IMMUNOL, V17, P485, DOI 10.1128/CVI.00479-09	30	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175081	10.1371/journal.pone.0175081	http://dx.doi.org/10.1371/journal.pone.0175081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380017	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500095
J	Kim, S; Blake, R; Lee, M; Kim, CY				Kim, Sujin; Blake, Randolph; Lee, Minyoung; Kim, Chai-Youn			Audio-visual interactions uniquely contribute to resolution of visual conflict in people possessing absolute pitch	PLOS ONE			English	Article							BINOCULAR-RIVALRY; STOCHASTIC PROPERTIES; FUNCTIONAL-ANATOMY; PLANUM TEMPORALE; PROCESS TONES; PERCEPTION; RECOGNITION; MEMORY; BRAIN; CONNECTIVITY	Individuals possessing absolute pitch (AP) are able to identify a given musical tone or to reproduce it without reference to another tone. The present study sought to learn whether this exceptional auditory ability impacts visual perception under stimulus conditions that provoke visual competition in the form of binocular rivalry. Nineteen adult participants with 3-19 years of musical training were divided into two groups according to their performance on a task involving identification of the specific note associated with hearing a given musical pitch. During test trials lasting just over half a minute, participants dichoptically viewed a scrolling musical score presented to one eye and a drifting sinusoidal grating presented to the other eye; throughout the trial they pressed buttons to track the alternations in visual awareness produced by these dissimilar monocular stimuli. On "pitch-congruent" trials, participants heard an auditory melody that was congruent in pitch with the visual score, on "pitch-incongruent" trials they heard a transposed auditory melody that was congruent with the score in melody but not in pitch, and on "melody-incongruent" trials they heard an auditory melody completely different from the visual score. For both groups, the visual musical scores predominated over the gratings when the auditory melody was congruent compared to when it was incongruent. Moreover, the AP participants experienced greater predominance of the visual score when it was accompanied by the pitch-congruent melody compared to the same melody transposed in pitch; for non-AP musicians, pitch-congruent and pitch-incongruent trials yielded equivalent predominance. Analysis of individual durations of dominance revealed differential effects on dominance and suppression durations for AP and non-AP participants. These results reveal that AP is accompanied by a robust form of bisensory interaction between tonal frequencies and musical notation that boosts the salience of a visual score.	[Kim, Sujin; Lee, Minyoung; Kim, Chai-Youn] Korea Univ, Dept Psychol, Seoul, South Korea; [Blake, Randolph] Vanderbilt Univ, Dept Psychol Sci, Vanderbilt Vis Res Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Blake, Randolph] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea	Korea University; Vanderbilt University; Seoul National University (SNU)	Kim, CY (corresponding author), Korea Univ, Dept Psychol, Seoul, South Korea.	chaikim@korea.ac.kr		Kim, Sujin/0000-0002-1436-3748	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technologies (ICT) and Future Planning [NRF2013R1A1A1010923]; National Institutes of Health [P30-EY008126]; Centennial Professor research funds from Vanderbilt University	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technologies (ICT) and Future Planning; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centennial Professor research funds from Vanderbilt University	This work was supported by NRF2013R1A1A1010923 from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communications Technologies (ICT) and Future Planning, by Core Grant P30-EY008126 from the National Institutes of Health, and by Centennial Professor research funds from Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2015, OXFORD HDB PERCEPTUA, P775; Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Alsius A, 2013, PSYCHOL SCI, V24, P423, DOI 10.1177/0956797612457378; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bermudez P, 2005, J NEUROSCI, V25, P7718, DOI 10.1523/JNEUROSCI.1560-05.2005; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2005, J VISION, V5, P287, DOI 10.1167/5.4.1; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; Carter OL, 2003, PERCEPTION, V32, P295, DOI 10.1068/p3472; Chang S, 2013, J VISION, V13, DOI 10.1167/13.10.4; Chen Y-C, 2011, FRONT PSYCHOL, P54; Conrad V, 2010, J VISION, V10, DOI 10.1167/10.10.27; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cox D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00722; Deutsch D, 2004, MUSIC PERCEPT, V21, P339, DOI 10.1525/mp.2004.21.3.339; Dooley K, 2010, J ACOUST SOC AM, V128, P890, DOI 10.1121/1.3458848; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOX R, 1975, VISION RES, V15, P849, DOI 10.1016/0042-6989(75)90265-5; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Hancock S, 2012, I-PERCEPTION, V3, P88, DOI 10.1068/i0486; Hantz EC, 1997, MUSIC PERCEPT, V15, P69; HANTZ EC, 1992, MUSIC PERCEPT, V10, P25; Hantz EC., 1995, PSYCHOMUSICOLOGY, V14, P53; Hasegawa T, 2004, COGNITIVE BRAIN RES, V20, P510, DOI 10.1016/j.cogbrainres.2004.04.005; Hirose H, 2002, NEUROSCI LETT, V330, P247, DOI 10.1016/S0304-3940(02)00812-1; Hoffman Donald D, 2000, VISUAL INTELLIGENCE; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; HOLLINS M, 1980, ATTEN PERCEPT PSYCHO, V27, P550; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Jancke L, 2012, J COGNITIVE NEUROSCI, V24, P1447, DOI 10.1162/jocn_a_00227; Kang MS, 2009, J VISION, V9, DOI 10.1167/9.2.8; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; KLEIN M, 1984, SCIENCE, V223, P1306, DOI 10.1126/science.223.4642.1306; Kogo N, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00111; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee M, 2015, P NATL ACAD SCI USA, V112, P8493, DOI 10.1073/pnas.1509529112; Lepage M, 2003, NEUROSCI LETT, V346, P73, DOI 10.1016/S0304-3940(03)00578-0; Levelt WJM, 1965, BINOCULAR RIVALRY; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Loui P, 2012, NEUROIMAGE, V63, P632, DOI 10.1016/j.neuroimage.2012.07.030; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Lunghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058754; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Miyazaki K, 2004, JPN PSYCHOL RES, V46, P270, DOI 10.1111/j.1468-5584.2004.00260.x; Miyazaki K, 2002, PERCEPT PSYCHOPHYS, V64, P1337, DOI 10.3758/BF03194776; Moore G., 1962, AM I TOO LOUD MEMORI; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; Pearson J, 2008, CURR BIOL, V18, P982, DOI 10.1016/j.cub.2008.05.048; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETRIDES M, 1990, NEUROPSYCHOLOGIA, V28, P137, DOI 10.1016/0028-3932(90)90096-7; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; RCore Team, 2020, R LANG ENV STAT COMP; Renninger LB, 2003, MUSIC PERCEPT, V20, P357; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Schulze K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-106; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; WALKER P, 1979, VISION RES, V19, P247, DOI 10.1016/0042-6989(79)90169-X; WALKER P, 1975, PERCEPT PSYCHOPHYS, V18, P467, DOI 10.3758/BF03204122; WALKER P, 1978, PSYCHOL BULL, V85, P376, DOI 10.1037/0033-2909.85.2.376; Ward W.D, 1963, SOUND, V2, P33; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson C., 1911, MUSICAL OPINION, V34, P753; Wilson SJ, 2012, MUSIC PERCEPT, V29, P285, DOI 10.1525/MP.2012.29.3.285; Xu YS, 2006, HUM BRAIN MAPP, V27, P173, DOI 10.1002/hbm.20176; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	81	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175103	10.1371/journal.pone.0175103	http://dx.doi.org/10.1371/journal.pone.0175103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380058	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500098
J	de Boer, R; Musgrave, J; Andersson, N; Lutscher, F				de Boer, Rebecca; Musgrave, Jeffrey; Andersson, Neil; Lutscher, Frithjof			The importance of choice disability and structural intervention in the HIV epidemic in Sub-Saharan Africa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SOUTHERN AFRICA; SENSITIVITY-ANALYSIS; UNAIDS ESTIMATION; CONDOM USE; RISK; TRANSMISSION; PREVENTION; COUNTRIES; VIOLENCE	Background Despite massive investment in HIV control programs, HIV incidence rates in countries with generalized epidemics have not fallen for most of the last decade. It appears that those at risk are not adopting effective prevention strategies. Those who are unable to implement their prevention preferences are referred to as choice disabled. We examined how and to what extent structural intervention measures that support choice-disabled individuals can reduce HIV transmission and prevalence. Methods A mathematical model was developed to describe HIV transmission among and between choice-disabled and choice-enabled individuals. Data were available from field trials identifying factors and effects of choice disability. The model was used to estimate the potential impact of an intervention strategy in which choice-disabled individuals are enabled to make prevention choices. Several scenarios were considered and compared: supporting only one or both genders; supporting only HIV-individuals or also HIV+ choice-disabled individuals. Results Substantial declines in HIV incidence and prevalence are observed when supportive interventions are included in the model. The magnitude of these declines depends on the scope of the intervention program. The largest positive effect occurs when the support program is offered regardless of HIV status. Conclusions Addressing the effects of choice disability in any HIV intervention program could be crucial to the program's success. Structural intervention programs to support choice-disabled individuals in implementing prevention strategies greatly reduce HIV incidence and prevalence in mathematical models.	[de Boer, Rebecca; Musgrave, Jeffrey; Lutscher, Frithjof] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Andersson, Neil] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Lutscher, Frithjof] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa; McGill University; University of Ottawa	Lutscher, F (corresponding author), Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada.; Lutscher, F (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	flutsche@uottawa.ca	Lutscher, Frithjof/C-9484-2012; Andersson, Neil/G-2248-2011	Lutscher, Frithjof/0000-0001-7380-7647; 	CIET Canada	CIET Canada	This work was supported by CIET Canada http://www.ciet.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson N, 2008, AIDS, V22, pS73, DOI 10.1097/01.aids.0000341778.73038.86; Andersson N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-274; Andersson N, 2012, AIDS BEHAV, V16, P189, DOI 10.1007/s10461-011-9912-3; Bao L, 2012, SEX TRANSM INFECT, V88, pI3, DOI 10.1136/sextrans-2012-050637; Beksinska ME, 1999, SEX TRANSM INFECT, V75, P178, DOI 10.1136/sti.75.3.178; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Cameron M, 2014, AIDS CARE, V26, P1534, DOI 10.1080/09540121.2014.931560; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; Duflo E, 2006, ED HIV AIDS PREVENTI; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallfors D, 2011, AM J PUBLIC HEALTH, V101, P1082, DOI 10.2105/AJPH.2010.300042; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P1749, DOI 10.1080/03610928008827996; Jacquez J.A., 1989, MATH STAT APPROACHES, V83, P301, DOI [10.1007/978-3-642-93454-415, DOI 10.1007/978-3-642-93454-415]; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Malunguza N, 2010, COMPUT MATH METHOD M, V11, P201, DOI 10.1080/17486700903325167; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; UNAIDS, 2016, PREV GAP REP; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175297	10.1371/journal.pone.0175297	http://dx.doi.org/10.1371/journal.pone.0175297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399137	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000028
J	Liu, SW; Du, F; Li, X; Wang, MM; Duan, RX; Zhang, JX; Wu, YR; Zhang, Q				Liu, Shiwei; Du, Fang; Li, Xin; Wang, Mingming; Duan, Ruixue; Zhang, Jiaxin; Wu, Yaru; Zhang, Qi			Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic beta cells	PLOS ONE			English	Article							IMPROVES ENDOTHELIAL FUNCTION; DIFFERENTIATION; MARKERS; PATHWAY; MICE	Pancreatic beta cell dysfunction and reduction due to glucose toxicity play a crucial role in the development of type 2 diabetes mellitus (T2DM). Irisin, a novel exercise-induced myokine, reduces obesity, improves insulin resistance and lowers blood glucose by promoting the browning of white adipose tissue, thereby enhancing thermogenesis and increasing energy expenditure. Recent studies have reported that irisin promotes cell proliferation and protects cells from apoptosis. However, the effects of irisin on pancreatic beta cells are unknown. Thus, the aim of this study was to investigate the effects and the potential underlying mechanisms of irisin on pancreatic beta cell proliferation and apoptosis induced by high glucose. Both in vitro (INS-1 cells) and in vivo ( a T2DM rat model) experiments were conducted. Irisin significantly increased the proliferation of INS-1 cells, with the most significant effect observed at 24 h with 100 ng/ml irisin. Irisin also promoted INS-1 cell proliferation via the ERK and p38 MAPK signaling pathways, protected the cells from high-glucose-induced apoptosis by regulating the expression of caspases, Bad, Bax, Bcl-2 and Bcl-xl, and improved pancreatic beta cell function. Irisin significantly reduced the body weight and blood glucose values and increased the serum insulin levels of the diabetic rats. An oral glucose tolerance test (OGTT) indicated that irisin also improved the glucose tolerance of T2DM rats. Together, these findings suggest that irisin may have applications in the prevention and treatment of T2DM because of its protective effect on the secretion of pancreatic beta cells.	[Liu, Shiwei] Shanxi Med Univ, Dept Endocrinol, Shanxi DAYI Hosp, Taiyuan, Peoples R China; [Du, Fang; Li, Xin; Wang, Mingming; Duan, Ruixue; Zhang, Jiaxin; Wu, Yaru; Zhang, Qi] Shanxi Med Univ, Grad Sch, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University	Liu, SW (corresponding author), Shanxi Med Univ, Dept Endocrinol, Shanxi DAYI Hosp, Taiyuan, Peoples R China.	lswspring6@aliyun.com			National Natural Science Foundation of China [81200591, 81471025]; Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province [2013-251]; International Science and Technology Cooperation Project in Shanxi Province [2015081029]; Research Project Supported Shanxi Scholarship Council of China [2015-109]; Transformation of Scientific and Technological Achievements in Shanxi Province [201604D131003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province; International Science and Technology Cooperation Project in Shanxi Province; Research Project Supported Shanxi Scholarship Council of China; Transformation of Scientific and Technological Achievements in Shanxi Province	This research was supported by the National Natural Science Foundation of China (#81200591&81471025), Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province (#2013-251), International Science and Technology Cooperation Project in Shanxi Province (#2015081029), Research Project Supported Shanxi Scholarship Council of China (#2015-109), Transformation of Scientific and Technological Achievements in Shanxi Province (#201604D131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Han F, 2015, AM J PHYSIOL-HEART C, V309, pH1501, DOI 10.1152/ajpheart.00443.2015; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Kisielewska J, 2009, DEV BIOL, V334, P383, DOI 10.1016/j.ydbio.2009.07.043; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Park MJ, 2015, CELL SIGNAL, V27, P1831, DOI 10.1016/j.cellsig.2015.04.010; Qiao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18732; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Wu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134662; Zhu D, 2015, J MOL CELL CARDIOL, V87, P138, DOI 10.1016/j.yjmcc.2015.07.015	13	64	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175498	10.1371/journal.pone.0175498	http://dx.doi.org/10.1371/journal.pone.0175498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394923	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800041
J	Wittmann, F; Marques, MCM; Damasceno, G; Budke, JC; Piedade, MTF; Wittmann, AD; Montero, JC; de Assis, RL; Targhetta, N; Parolin, P; Junk, WJ; Householder, JE				Wittmann, Florian; Marques, Marcia C. M.; Damasceno Junior, Geraldo; Budke, Jean Carlos; Piedade, Maria T. F.; Wittmann, Astrid de Oliveira; Montero, Juan Carlos; de Assis, Rafael L.; Targhetta, Natalia; Parolin, Pia; Junk, Wolfgang J.; Householder, J. Ethan			The Brazilian freshwater wetscape: Changes in tree community diversity and composition on climatic and geographic gradients	PLOS ONE			English	Article							VARZEA FORESTS; SPECIES DISTRIBUTION; DROUGHT SENSITIVITY; ALPHA-DIVERSITY; RIPARIAN FOREST; GLOBAL PATTERNS; BIODIVERSITY; FLOODPLAIN; CONSERVATION; DYNAMICS	Wetlands harbor an important compliment of regional plant diversity, but in many regions data on wetland diversity and composition is still lacking, thus hindering our understanding of the processes that control it. While patterns of broad-scale terrestrial diversity and composition typically correlate with contemporary climate it is not clear to what extent patterns in wetlands are complimentary, or conflicting. To elucidate this, we consolidate data from wetland forest inventories in Brazil and examine patterns of diversity and composition along temperature and rainfall gradients spanning five biomes. We collated 196 floristic inventories covering an area >220 ha and including >260,000 woody individuals. We detected a total of 2,453 tree species, with the Amazon alone accounting for nearly half. Compositional patterns indicated differences in freshwater wetland floras among Brazilian biomes, although biomes with drier, more seasonal climates tended to have a larger proportion of more widely distributed species. Maximal alpha diversity increased with annual temperature, rainfall, and decreasing seasonality, patterns broadly consistent with upland vegetation communities. However, alpha diversity-climate relationships were only revealed at higher diversity values associated with the uppermost quantiles, and in most sites diversity varied irrespective of climate. Likewise, mean biome-level differences in alpha-diversity were unexpectedly modest, even in comparisons of savanna-area wetlands to those of nearby forested regions. We describe attenuated wetland climate-diversity relationships as a shifting balance of local and regional effects on species recruitment. Locally, excessive waterlogging strongly filters species able to colonize from regional pools. On the other hand, increased water availability can accommodate a rich community of drought-sensitive immigrant species that are able to track buffered wetland microclimates. We argue that environmental conditions in many wetlands are not homogeneous with respect to regional climate, and that responses of wetland tree communities to future climate change may lag behind that of non-wetland, terrestrial habitat.	[Wittmann, Florian; Householder, J. Ethan] Karlsruhe Inst Technol, Inst Geog & Geoecol, Dept Floodplain Ecol, Karlsruhe, Germany; [Wittmann, Florian; Piedade, Maria T. F.; de Assis, Rafael L.; Targhetta, Natalia] Inst Nacl Pesquisas Espaciais, MAUA Working Grp, Manaus, Amazonas, Brazil; [Marques, Marcia C. M.] Univ Fed Parana, Curitiba, Parana, Brazil; [Damasceno Junior, Geraldo] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil; [Budke, Jean Carlos] Univ Reg Integrada Alto Uruguai & Missaes, Erechim, RS, Brazil; [Wittmann, Astrid de Oliveira] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Montero, Juan Carlos] Confederac Pueblos Indigenes Bolivia, Gobernanza Recursos Nat, Santa Cruz, Santa Cruz, Bolivia; [de Assis, Rafael L.] Norwegian Univ Life Sci, As, Akershus, Norway; [Parolin, Pia] Univ Hamburg, Bioctr Klein Flottbek, Dept Plant Diversity, Hamburg, Germany; [Junk, Wolfgang J.] Inst Nacl Areas Umidas, Cuiaba, Mato Grosso, Brazil; [Householder, J. Ethan] Bot Res Inst Texas, Ft Worth, TX USA	Helmholtz Association; Karlsruhe Institute of Technology; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Federal do Parana; Universidade Federal de Mato Grosso do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal de Amazonas; Norwegian University of Life Sciences; University of Hamburg	Householder, JE (corresponding author), Karlsruhe Inst Technol, Inst Geog & Geoecol, Dept Floodplain Ecol, Karlsruhe, Germany.; Householder, JE (corresponding author), Bot Res Inst Texas, Ft Worth, TX USA.	john.householder@kit.edu	Piedade, Maria Teresa/C-5372-2013; Parolin, Pia/M-8268-2018; Parolin, Pia/AAN-7298-2021; Marques, Marcia Cristina Mendes/F-8699-2012; Damasceno Junior, Geraldo/ABG-2834-2021	Piedade, Maria Teresa/0000-0002-7320-0498; Parolin, Pia/0000-0003-1368-6614; Parolin, Pia/0000-0003-1368-6614; Marques, Marcia Cristina Mendes/0000-0002-1003-9596; 	INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus); Brazilian Council of Science and Technology - CNPq [479599/2008-4]; PELD-MAUA; PRONEX - FAPEAM - CNPq ("Tipologias alagaveis")	INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus); Brazilian Council of Science and Technology - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PELD-MAUA; PRONEX - FAPEAM - CNPq ("Tipologias alagaveis")	Field work from several published inventories in the Amazon was made possible by financial support from the INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus), and the Brazilian Council of Science and Technology-CNPq (Universal 479599/2008-4), PELD-MAUA and PRONEX-FAPEAM-CNPq ("Tipologias alagaveis", 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the National Institute for Amazon Research (INPA) for assistance. Field work from several published inventories in the Amazon was made possible by financial support from the INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus), and the Brazilian Council of Science and Technology-CNPq (Universal 479599/2008-4), PELD-MAUA and PRONEX-FAPEAM-CNPq ("Tipologias alagaveis", 2007). Comments from several anonymous reviewers improved the manuscript.	Alroy J, 2015, ECOLOGY, V96, P575, DOI 10.1890/14-0471.1; [Anonymous], 2021, LANG ENV STAT COMP; Assis RL, 2015, PLANT ECOL, V216, P41, DOI 10.1007/s11258-014-0415-y; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Budke JC, 2007, PLANT ECOL, V189, P187, DOI 10.1007/s11258-006-9174-8; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Daly DC, 2000, IMPERFECT BALANCE LA, P391; Damasceno-Junior GA, 2005, FLORA, V200, P119, DOI 10.1016/j.flora.2004.09.002; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; FELFILI JM, 1995, VEGETATIO, V117, P1, DOI 10.1007/BF00033255; Ferreira CS, 2009, AQUAT BOT, V90, P246, DOI 10.1016/j.aquabot.2008.10.006; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; GIULIETTI A. M., 2002, VEGETACAO FLORA CAAT, P103; Gopal B, 2000, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 1, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hamann A, 2013, B AM METEOROL SOC, V94, P1307, DOI 10.1175/BAMS-D-12-00145.1; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Householder JE, 2016, FOREST STRUCTURE FUN, P145; Hsieh TC, 2016, INT SYMP WIREL; Hubbell Stephen P., 2001, V32, pi; IPCC, 2014, IPCC CLIMATE CHANGE; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Junk WJ, 2014, AQUAT CONSERV, V24, P5, DOI 10.1002/aqc.2386; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Kellman M, 1997, J BIOGEOGR, V24, P23, DOI 10.1111/j.1365-2699.1997.tb00047.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Killeen TJ, 2008, PHILOS T R SOC B, V363, P1881, DOI 10.1098/rstb.2007.0018; Koenker R., 2015, QUANTREG QUANTILE RE, V5, P19; Konar M, 2013, ADV WATER RESOUR, V51, P317, DOI 10.1016/j.advwatres.2012.02.009; Kurzatkowski D, 2015, ACTA OECOL, V69, P21, DOI 10.1016/j.actao.2015.08.002; Latrubesse EM, 2008, GEOMORPHOLOGY, V101, P130, DOI 10.1016/j.geomorph.2008.05.035; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; MAC ARTHUR ROBERT H., 1967; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; MEAVE J, 1991, GLOBAL ECOL BIOGEOGR, V1, P69, DOI 10.2307/2997492; Metzger JP, 1997, PLANT ECOL, V133, P135, DOI 10.1023/A:1009791831294; Montero JC, 2014, HYDROBIOLOGIA, V729, P229, DOI 10.1007/s10750-012-1381-9; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Oksanen J, 2022, R PACKAGE VERSION; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Parolin P, 2009, ANN BOT-LONDON, V103, P359, DOI 10.1093/aob/mcn216; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Phillips O, 2002, GLOBAL PATTERNS PLAN; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pitman NCA, 2014, ECOGRAPHY, V37, P902, DOI 10.1111/ecog.00774; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; PRANCE G T, 1975, Acta Amazonica, V5, P207; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Safford HD, 2007, J BIOGEOGR, V34, P1701, DOI 10.1111/j.1365-2699.2007.01732.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SALO J, 1986, NATURE, V322, P254, DOI 10.1038/322254a0; Sculthorpe CD, 1985, BIOL AQUATIC VASCULA; Slik JWF, 2015, P NATL ACAD SCI USA, V112, P7472, DOI 10.1073/pnas.1423147112; Stehmann J. R., 2009, PLANTAS FLORESTA ATL; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Veloso HP, 1991, CLASSIFICAC TEMA UNI; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wittmann F, 2002, J TROP ECOL, V18, P805, DOI 10.1017/S0266467402002523; Wittmann F., 2015, RES REPORTS BIODIVER, V4, P47, DOI [10.2147/rrbs.s64502, DOI 10.2147/RRBS.S64502, 10.2147/RRBS.S64502]; Wittmann F., 2012, MYCORRHIZA OCCURRENC, P223; Wittmann F, 2006, J BIOGEOGR, V33, P1334, DOI 10.1111/j.1365-2699.2006.01495.x; Wittmann F, 2013, ECOGRAPHY, V36, P690, DOI 10.1111/j.1600-0587.2012.07723.x; WORBES M, 1992, J VEG SCI, V3, P553, DOI 10.2307/3235812	81	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175003	10.1371/journal.pone.0175003	http://dx.doi.org/10.1371/journal.pone.0175003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394937	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800013
J	Loux, SC; Scoggin, KE; Bruemmer, JE; Canisso, IF; Troedsson, MHT; Squires, EL; Ball, BA				Loux, Shavahn C.; Scoggin, Kirsten E.; Bruemmer, Jason E.; Canisso, Igor F.; Troedsson, Mats H. T.; Squires, Edward L.; Ball, Barry A.			Evaluation of circulating miRNAs during late pregnancy in the mare	PLOS ONE			English	Article							CELL INVASION; RNA-BINDING; MICRORNAS; STAT3; PROLIFERATION; ACTIVATION; EXPRESSION; BIOMARKERS; DISCOVERY; PATHWAYS	MicroRNAs (miRNAs) are small, non-coding RNAs which are produced throughout the body. Individual tissues tend to have a specific expression profile and excrete many of these miRNAs into circulation. These circulating miRNAs may be diagnostically valuable biomarkers for assessing the presence of disease while minimizing invasive testing. In women, numerous circulating miRNAs have been identified which change significantly during pregnancy -related complications (e.g. chorioamnionitis, eclampsia, recurrent pregnancy loss); however, no prior work has been done in this area in the horse. To identify pregnancy-specific miRNAs, we collected serial whole blood samples in pregnant mares at 8, 9, 10 m of gestation and post-partum, as well as from non-pregnant (diestrous) mares. In total, we evaluated a panel of 178 miRNAs using qPCR, eventually identifying five miRNAs of interest. One miRNA (miR-374b) was differentially regulated through late gestation and four miRNAs (miR-454, miR-133b, miR-486-5p and miR-204b) were differentially regulated between the pregnant and non-pregnant samples. We were able to identify putative targets for the differentially regulated miRNAs using two separate target prediction programs, miRDB and Ingenuity Pathway Analysis. The targets for the miRNAs differentially regulated during pregnancy were predicted to be involved in signaling pathways such as the STAT3 pathway and P13/AKT signaling pathway, as well as more endocrine-based pathways, including the GnRH, prolactin and insulin signaling pathways. In summary, this study provides novel information about the changes occurring in circulating miRNAs during normal pregnancy, as well as attempting to predict the biological effects induced by these miRNAs.	[Loux, Shavahn C.; Scoggin, Kirsten E.; Troedsson, Mats H. T.; Squires, Edward L.; Ball, Barry A.] Univ Kentucky, Dept Vet Sci, Lexington, KY 40506 USA; [Bruemmer, Jason E.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA; [Canisso, Igor F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Kentucky; Colorado State University; University of Illinois System; University of Illinois Urbana-Champaign	Ball, BA (corresponding author), Univ Kentucky, Dept Vet Sci, Lexington, KY 40506 USA.	b.a.ball@uky.edu	Loux, Shavahn C/AAG-9141-2019	Loux, Shavahn C/0000-0001-5193-6675; Scoggin, Kirsten/0000-0003-1348-641X; Ball, Barry/0000-0002-0502-0276; Bruemmer, Jason/0000-0002-4236-756X	Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners; Albert Clay Endowment; Paul Mellon post-doctoral fellowship; Geoffrey Hughes doctoral fellowship	Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners; Albert Clay Endowment; Paul Mellon post-doctoral fellowship; Geoffrey Hughes doctoral fellowship	This work was funded by the Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners (http://www.kentuckybred.org), the Albert Clay Endowment and the Paul Mellon post-doctoral fellowship, and the Geoffrey Hughes doctoral fellowship. Due to their relatively small size, not all funding sources have a website or grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arendt LM, 2015, J MAMMARY GLAND BIOL, V20, P9, DOI 10.1007/s10911-015-9337-0; Backes C, 2016, MOL DIAGNOSIS THERAP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brogaard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21812; Chen CY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131250; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Choi SY, 2013, PLACENTA, V34, P799, DOI 10.1016/j.placenta.2013.06.006; Cretoiu D, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/3851054; Doss JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2156-2; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Ghai V, 2016, ARCH TOXICOLOGY; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; Hromadnikova I, 2016, THROMB RES, V137, P126, DOI 10.1016/j.thromres.2015.11.032; Kanhoush R, 2010, NUCLEUS-PHILA, V1, P109, DOI 10.4161/nucl.1.1.10857; Klohonatz KM, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142935; Ladomery MR, 2011, INT J MOL EPIDEMIOL, V2, P253; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lim W, 2016, MOL CELL ENDOCRINOL, V428, P28, DOI 10.1016/j.mce.2016.03.018; Llovera M, 2000, ONCOGENE, V19, P4695, DOI 10.1038/sj.onc.1203846; Maegdefessel L, 2014, J INTERN MED, V276, P633, DOI 10.1111/joim.12298; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Mouillet JF, 2015, AM J OBSTET GYNECOL, V213, pS163, DOI 10.1016/j.ajog.2015.05.057; Pontes TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129399; Rudolph LM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12405; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Seeliger C, 2016, STEM CELLS DEV, V25, P1261, DOI 10.1089/scd.2016.0133; Sferruzzi-Perri AN, 2016, P NATL ACAD SCI USA, V113, P11255, DOI 10.1073/pnas.1602012113; Singh R, 2016, CANCER LETT, V381, P113, DOI 10.1016/j.canlet.2016.07.002; Suman P, 2014, AM J REPROD IMMUNOL, V72, P65, DOI 10.1111/aji.12248; Unger L, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0224-5; Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; Wang Y, 2015, MOL CELL, V60, P118, DOI 10.1016/j.molcel.2015.08.014; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yu LJ, 2015, PLACENTA, V36, P581, DOI 10.1016/j.placenta.2015.02.013; Yu Y, 2015, BIOCHEM BIOPH RES CO, V463, P285, DOI 10.1016/j.bbrc.2015.05.052; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026	43	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175045	10.1371/journal.pone.0175045	http://dx.doi.org/10.1371/journal.pone.0175045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388652	Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800017
J	Savoy, T; Maceda, L; Roy, NK; Peterson, D; Wirgin, I				Savoy, Tom; Maceda, Lorraine; Roy, Nirmal K.; Peterson, Doug; Wirgin, Isaac			Evidence of natural reproduction of Atlantic sturgeon in the Connecticut River from unlikely sources	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS-OXYRINCHUS; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; RE-IMPLEMENTATION; SIBSHIP INFERENCE; ALTAMAHA RIVER; NEW-YORK; N-E; MICROSATELLITE; SOFTWARE	Atlantic Sturgeon is listed under the U.S. Endangered Species Act as five Distinct Population Segments (DPS). The "endangered" New York Bight (NYB) DPS is thought to only harbor two populations; one in the Hudson River and a second smaller one in the Delaware River. Historically, the Connecticut River probably supported a spawning population of Atlantic Sturgeon that was believed extirpated many decades ago. In 2014, we successfully collected pre -migratory juvenile specimens from the lower Connecticut River which were subjected to mitochondrial DNA (mtDNA) control region sequence and microsatellite analyses to determine their genetic relatedness to other populations coastwide. Haplotype and allelic frequencies differed significantly between the Connecticut River collection and all other populations coastwide. Sibship analyses of the microsatellite data indicated that the Connecticut River collection was comprised of a small number of families that were likely the offspring of a limited number of breeders. This was supported by analysis of effective population size (Ne) and number of breeders (Nb). STRUCTURE analysis suggested that there were 11 genetic clusters among the coastwide collections and that from the Connecticut River was distinct from those in all other rivers. This was supported by UPGMA analyses of the microsatellite data. In AMOVA analyses, among region variation was maximized, and among population within regions variation minimized when the Connecticut River collection was separate from the other two populations in the NYB DPS indicating the dissimilarity between the Connecticut River collection and the other two populations in the NYB DPS. Use of mixed stock analysis indicated that the Connecticut River juvenile collection was comprised of specimens primarily of South Atlantic and Chesapeake Bay DPS origins. The most parsimonious explanation for these results is that the Connecticut River hosted successful natural reproduction in 2013 and that its offspring were descendants of a small number of colonizers from populations south of the NYB DPS, most notably the South Atlantic DPS. Our results run contrary to the belief that re -colonizers of extirpated populations primarily originate in proximal populations.	[Savoy, Tom] Connecticut Dept Energy & Environm Protect, Marine Fisheries Div, Hartford, CT USA; [Maceda, Lorraine; Roy, Nirmal K.; Wirgin, Isaac] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10003 USA; [Peterson, Doug] Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA	New York University; University System of Georgia; University of Georgia	Wirgin, I (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10003 USA.	issac.wirgin@nyumc.org			Connecticut Sea Grant; Connecticut State Wildlife Grant; National Institute of Environmental Health Sciences Center [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Connecticut Sea Grant; Connecticut State Wildlife Grant; National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Connecticut Sea Grant, Connecticut State Wildlife Grant, and a National Institute of Environmental Health Sciences Center Grant ES00260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APOSTLE R, 2013, J INT WILDLIFE LAW P, V16, P170, DOI DOI 10.1080/13880292.2013.805062; [ASSRT Team ASSR], 2007, REP NAT MAR FISH SER; Bain MB, 1997, ENVIRON BIOL FISH, V48, P347, DOI 10.1023/A:1007325814893; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Breece MW, 2016, METHODS ECOL EVOL, V7, P725, DOI 10.1111/2041-210X.12532; Brown JJ, 2010, FISHERIES, V35, P72, DOI 10.1577/1548-8446-35.2.72; Chambers RC, 2012, ENVIRON TOXICOL CHEM, V31, P2324, DOI 10.1002/etc.1953; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; DOVEL WL, 1983, NEW YORK FISH GAME J, V30, P140; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elvira B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145728; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Federal Register, 2012, ENDANGERED THREATENE, V77; Fritts MW, 2016, T AM FISH SOC, V145, P69, DOI 10.1080/00028487.2015.1094131; Galligan J. P., 1960, WILDLIFE CONSERVATIO, V6, P1; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grunwald C, 2008, CONSERV GENET, V9, P1111, DOI 10.1007/s10592-007-9420-1; Hale EA, 2016, T AM FISH SOC, V145, P1193, DOI 10.1080/00028487.2016.1214177; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; HUDSON RR, 1992, GENETICS, V132, P583; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kahn DM, 2012, ENDANGERED ATLANTIC; Kahnle AW, 2007, AM FISH S S, V56, P347; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2008, ONCOR SOFTWARE GENET; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Kinziger AP, 2011, ECOL EVOL, V1, P73, DOI 10.1002/ece3.8; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; MURAWSKI SA, 1977, BIOL FISHERIES DATA; Nei M., 1987, MOL EVOLUTIONARY GEN; O'Leary SJ, 2014, CONSERV GENET, V15, P1173, DOI 10.1007/s10592-014-0609-9; Ong TL, 1996, COPEIA, P464, DOI 10.2307/1446867; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson DL, 2008, T AM FISH SOC, V137, P393, DOI 10.1577/T06-231.1; Peterson Douglas L., 2000, North American Journal of Fisheries Management, V20, P231, DOI 10.1577/1548-8675(2000)020<0231:EODROA>2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, J HEREDITY, V86; Register F., 2016, ENDANGERED THREATENE, V81, P35701; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Savoy T, 2003, T AM FISH SOC, V132, P1, DOI 10.1577/1548-8659(2003)132<0001:MAIHOS>2.0.CO;2; Schueller P, 2010, T AM FISH SOC, V139, P1526, DOI 10.1577/T09-127.1; Secor DH, 1999, AM FISH S S, V23, P203; Smith JA, 2015, T AM FISH SOC, V144, P48, DOI 10.1080/00028487.2014.965344; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; Tajima F., 1993, INTRO MOL PALEOPOPUL; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waldman JR, 2013, ESTUAR COAST, V36, P257, DOI 10.1007/s12237-012-9573-0; Waldman JR, 1998, CONSERV BIOL, V12, P631, DOI 10.1046/j.1523-1739.1998.97041.x; Waldman JR, 1996, T AM FISH SOC, V125, P364, DOI 10.1577/1548-8659(1996)125<0364:SCOTNY>2.3.CO;2; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wenzel IV J, 2014, RARE STURGEON FOUND; Wirgin I, 2015, J FISH BIOL, V86, P1251, DOI 10.1111/jfb.12631; Wirgin I, 2000, T AM FISH SOC, V129, P476, DOI 10.1577/1548-8659(2000)129&lt;0476:GSOASP&gt;2.0.CO;2; WIRGIN II, 1990, BIOCHEM GENET, V28, P459, DOI 10.1007/BF00554374; Wirgin I, 2007, N AM J FISH MANAGE, V27, P1214, DOI 10.1577/M06-269.1; Wirgin I, 2015, N AM J FISH MANAGE, V35, P20, DOI 10.1080/02755947.2014.963751; Wirgin I, 2012, T AM FISH SOC, V141, P1389, DOI 10.1080/00028487.2012.700899; WRIGHT S, 1951, ANN EUGENIC, V15, P323	74	8	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175085	10.1371/journal.pone.0175085	http://dx.doi.org/10.1371/journal.pone.0175085			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388618	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800019
J	Trageser, SJ; Ghose, A; Faisal, M; Mro, P; Mro, P; Rahman, SC				Trageser, Scott J.; Ghose, Animesh; Faisal, Muzaffar; Mro, Passing; Mro, Poroy; Rahman, Shahriar Caesar			Pangolin distribution and conservation status in Bangladesh	PLOS ONE			English	Article								Asian pangolins are a highly-threatened species group, mainly due to the perceived medicinal value of their scales. Increased demand from China has resulted in pangolins being the most trafficked mammal in the world. Three pangolin species are reported to occur in Bangladesh: Manis pentadactyla, M. crassicaudata, and M. javanica. No peer-reviewed studies exist detailing these species' current distribution or status within Bangladesh. A literature review was conducted resulting in the clarification of conflicting reports and misidentified observations and specimen records. In this paper, we also report the current status of pangolins (Manis spp.) in Bangladesh based on semi-structured interviews, camera trapping, media queries, and field surveys employing traditional ecological knowledge and non-randomized transect surveys. Ethnozoological knowledge pertaining to the natural history of M. pentadactyla is also reported from experienced Mro tribal hunters. The critically endangered M. pentadactyla was verified to occur in northwest, northeast, and southeast Bangladesh in natural and degraded habitats. Interviews with the Mro tribe in the southeast indicate that pangolin populations there were likely extirpated in 2014 due to skilled commercial collection beginning in 2010. Evidence of extant M. crassicaudata and M. javanica populations remain unverified and questionable, and historical records of M. crassicaudata and M. javanica are likely a result of misidentification.	[Trageser, Scott J.; Ghose, Animesh; Faisal, Muzaffar; Mro, Passing; Mro, Poroy; Rahman, Shahriar Caesar] Creat Conservat Alliance, Dhaka, Bangladesh		Trageser, SJ (corresponding author), Creat Conservat Alliance, Dhaka, Bangladesh.	trageser.scott@gmail.com	Ghose, Animesh/AAZ-5259-2020		Bangladesh Python Project's International Volunteer Program; Center for Advanced Research in Natural Resources and Management (CARINAM), Bangladesh; Orianne Society, USA	Bangladesh Python Project's International Volunteer Program; Center for Advanced Research in Natural Resources and Management (CARINAM), Bangladesh; Orianne Society, USA	This project was supported through the Bangladesh Python Projects International Volunteer Program, the Center for Advanced Research in Natural Resources and Management (CARINAM), Bangladesh, and the Orianne Society, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 1992, MAMMALIAN FAUNA W BE, V3; Ahmed Z.U., 2008, ENCY FLORA FAUNA BAN, V12; Ahmed ZU, 2009, ENCY FLORA FAUNA BAN, V27; Ahsan M. Farid, 2008, Bangladesh Journal of Zoology, V36, P131; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 1985, MAMMALS BANGLADESH F; [Anonymous], 2014, IUCN RED LIST THREAT; Athreya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142647; Baillie J, 2014, IUCN RED LIST THREAT; Choudrury Anwaruddin, 2004, Journal of the Bombay Natural History Society, V101, P444; Hansen M. C., 2013, SCIENCE; Heath M. E., 1992, MAMMALIAN SPECIES, V414, P1, DOI DOI 10.2307/3504143; Heath Martha E., 1995, Mammalian Species, V513, P1; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; IUCN Bangladesh, 2003, BANGL BIP BONN PRAN; Katuwal Hem Bahadur, 2015, Journal of Threatened Taxa, V7, P7563; Khan M.M.H., 2008, NISHORGO SUPPORT PRO, P304; Khan MAR, 2010, WILDLIFE BANGLADESH; Lagrada L, 2014, IUCN RED LIST THREAT; Lewin Thomas Herbert, 1869, HILL TRACTS CHITTAGO; Lin J.H., 2011, THESIS; Mahony Stephen, 2008, Hamadryad, V32, P34; Platt SG, 2010, CHELONIAN CONSERV BI, V9, P114, DOI 10.2744/CCB-0813.1; Rasul G, 2007, ENVIRON CONSERV, V34, P153, DOI 10.1017/s0376892907003888; Reza AHMA., 2010, DIVERSITY AMPHIBIANS; WCMC IUCN/SSC TRAFFIC, 1999, REV SIGN TRAD AN SPE; Zhou ZM, 2014, FRONT ECOL ENVIRON, V12, P97, DOI 10.1890/14.WB.001	27	26	26	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175450	10.1371/journal.pone.0175450	http://dx.doi.org/10.1371/journal.pone.0175450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388644	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800056
J	Zhui, TT; Zhang, L; Zhao, FY; Qu, Y; Mu, DZ				Zhui, TingTing; Zhang, Li; Zhao, FengYan; Qu, Yi; Mu, Dezhi			Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysis	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; RISK-FACTORS; ANGIOGENIC FACTORS; PREECLAMPSIA; OUTCOMES	Backgroud The role of maternal hypertensive disorders in pregnancy (HDP) in the development of retinopathy of prematurity (ROP) is unclear. Methods Studies were retrieved through literature searches in PubMed, EMBASE, Web of Science and the Cochrane Library up to May 5, 2016 without language restrictions. Cohort or case-control studies that reported the association of maternal hypertensive disorders and retinopathy of prematurity were eligible. Either a fixed- or a random-effects model was used to calculate the overall combined risk estimates. Results Thirteen cohort studies involving a total of 45082 individuals were included in the review. The pooled odds ratios of maternal hypertensive disorders in pregnancy for any stage and severe stages of ROP was 1.12 (95%CI: 0.90-1.40) and 0.80 (95%CI: 0.47-1.35), respectively. Sensitivity analyses confirmed that no single study qualitatively influenced the pooled OR. However, substantial heterogeneity and publication bias were observed in the meta-analysis. Conclusions Additional larger, prospective and well-adjusted studies are needed to determine the association between HDP and ROP, especially regarding the effects of different types of maternal hypertensive disorders in pregnancy on retinopathy of prematurity.	[Zhui, TingTing; Zhang, Li; Zhao, FengYan; Qu, Yi; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Peoples R China; [Zhui, TingTing; Zhang, Li; Zhao, FengYan; Qu, Yi; Mu, Dezhi] Sichuan Univ, Key Lab Obstetr Gynecol & Pediat Dis & Birth Defe, Minist Educ, Chengdu, Sichuan, Peoples R China; [Mu, Dezhi] Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Francisco	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Peoples R China.; Mu, DZ (corresponding author), Sichuan Univ, Key Lab Obstetr Gynecol & Pediat Dis & Birth Defe, Minist Educ, Chengdu, Sichuan, Peoples R China.; Mu, DZ (corresponding author), Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA.	mudz@scu.edu.cn		Qu, Yi/0000-0002-9993-8810; Mu, Dezhi/0000-0002-2599-7041	National Science Foundation of China [81330016, 81630038, 81270724]; State Commission of Science Technology of China [2012BAI041304]; Ministry of Education of China [IRT0935]; Science and Technology Bureau of Sichuan province [2014SZ0149]; clinical discipline program (neonatology) from the Ministry of Health of China [1311200003303]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Commission of Science Technology of China; Ministry of Education of China(Ministry of Education, China); Science and Technology Bureau of Sichuan province; clinical discipline program (neonatology) from the Ministry of Health of China	This work was supported by the National Science Foundation of China (No.81330016, 81630038, and 81270724), grants from the State Commission of Science Technology of China (2012BAI041304), grants from the Ministry of Education of China (IRT0935), grants from the Science and Technology Bureau of Sichuan province (2014SZ0149), and a grant of clinical discipline program (neonatology) from the Ministry of Health of China (1311200003303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Araz-Ersan B, 2013, BRIT J OPHTHALMOL, V97, P15, DOI 10.1136/bjophthalmol-2011-301411; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Engels T, 2013, HYPERTENS PREGNANCY, V32, P459, DOI 10.3109/10641955.2013.827205; Fortes JB, 2011, J PEDIATR-US, V158, P372, DOI 10.1016/j.jpeds.2010.08.051; Gagliardi L, 2014, PEDIATRICS, V134, pE154, DOI 10.1542/peds.2013-3898; Gagliardi L, 2013, PEDIATR RES, V73, P794, DOI 10.1038/pr.2013.52; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gilbert C, 2003, BMJ-BRIT MED J, V327, P760, DOI 10.1136/bmj.327.7418.760; Holmstrom G, 1996, ACTA OBSTET GYN SCAN, V75, P628, DOI 10.3109/00016349609054687; Holmstrom G, 2013, CLIN PERINATOL, V40, P311, DOI 10.1016/j.clp.2013.02.008; Huang Hsin-Chung, PREECLAMPSIA RETINOP; Martinez-Castellanos MA, 2013, RETINA-J RET VIT DIS, V33, P329, DOI 10.1097/IAE.0b013e318275394a; Mehmet S, 2011, INT J OPHTHALMOL-CHI, V4, P634, DOI 10.3980/j.issn.2222-3959.2011.06.12; Ozkan H, 2011, J PERINAT MED, V39, P523, DOI [10.1515/JPM.2011.071, 10.1515/jpm.2011.071]; Rana S, 2012, HYPERTENSION, V60, P451, DOI 10.1161/HYPERTENSIONAHA.112.195065; Roberts JM, 2009, J CLIN ENDOCR METAB, V94, P2252, DOI 10.1210/jc.2009-0945; Sahay AS, 2014, HYPERTENS RES, V37, P753, DOI 10.1038/hr.2014.71; Schaarschmidt W, 2013, J PERINAT MED, V41, P511, DOI 10.1515/jpm-2012-0248; Schmidt B, 2014, JAMA-J AM MED ASSOC, V311, P523, DOI 10.1001/jama.2013.282153; Seiberth V, 2000, OPHTHALMOLOGICA, V214, P131, DOI 10.1159/000027482; Shah VA, 2005, ANN ACAD MED SINGAP, V34, P169; Wells G.A., NEWCASTLE OTTAWA SCA; Yang CY, 2011, PEDIATR NEONATOL, V52, P321, DOI 10.1016/j.pedneo.2011.08.004; Yu XD, 2012, PEDIATRICS, V130, pE101, DOI 10.1542/peds.2011-3881; Zayed MA, 2010, INVEST OPHTH VIS SCI, V51, P4983, DOI 10.1167/iovs.10-5283; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952; Zhang M, 2009, CURR EYE RES, V34, P401, DOI 10.1080/02713680902862971	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175374	10.1371/journal.pone.0175374	http://dx.doi.org/10.1371/journal.pone.0175374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388642	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800046
J	Daimon, M; Kamba, A; Murakami, H; Mizushiri, S; Osonoi, S; Yamaichi, M; Matsuki, K; Sato, E; Tanabe, J; Takayasu, S; Matsuhashi, Y; Yanagimachi, M; Terui, K; Kageyama, K; Tokuda, I; Takahashi, I; Nakaji, S				Daimon, Makoto; Kamba, Aya; Murakami, Hiroshi; Mizushiri, Satoru; Osonoi, Sho; Yamaichi, Masato; Matsuki, Kota; Sato, Eri; Tanabe, Jutaro; Takayasu, Shinobu; Matsuhashi, Yuki; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori; Tokuda, Itoyo; Takahashi, Ippei; Nakaji, Shigeyuki			Association between serum prolactin levels and insulin resistance in non-diabetic men	PLOS ONE			English	Article							GROWTH-HORMONE; CELL GROWTH; WEIGHT-LOSS; RISK; RELEASE; GLUCOSE; HYPERPROLACTINEMIA; DIFFERENTIATION; CABERGOLINE; EXPRESSION	Prolactin (PRL) has roles in various physiological functions. Although experimental studies showed that PRL has both beneficial and adverse effects on type 2 diabetes mellitus, clinical findings in subjects with hyperprolactinemia indicate adverse effects on glucose metabolism. However, effects of PRL within the physiological range in human are controversial. A population-based study of 370 Japanese men enrolled in the 2014 Iwaki study (aged 52.0 +/- 14.8 years). In this cross-sectional study, associations between serum PRL levels and homeostatic model assessment (HOMA) indices representing glucose metabolism in a physiological setting were examined using multivariable regression analysis. Although univariate linear regression analyses showed significant associations between serum PRL levels and HOMA indices, adjustment with multiple factors made the association with HOMA-beta (insulin secretion) insignificant, while those with HOMA-R (insulin resistance) remained significant (beta = 0.084, p = 0.035). Non-linear regression analyses showed a regression curve with a peak at serum PRL level, 12.4 ng/mL and a positive association of serum PRL level with HOMA-R below the peak (beta = 0.119, p = 0.004). Higher serum PRL levels within the physiological range seem to be associated with insulin resistance in men.	[Daimon, Makoto; Kamba, Aya; Murakami, Hiroshi; Mizushiri, Satoru; Osonoi, Sho; Yamaichi, Masato; Matsuki, Kota; Sato, Eri; Tanabe, Jutaro; Takayasu, Shinobu; Matsuhashi, Yuki; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan; [Tokuda, Itoyo; Takahashi, Ippei; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Daimon, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan.	mdaimon@hirosaki-u.ac.jp	Takayasu, Shinobu/ABH-9199-2020; Daimon, Makoto/AAY-1289-2020	Daimon, Makoto/0000-0002-3775-1719	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Center of Innovation Program from Japan Science and Technology Agency.	Balbach L, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-12; Baptista T, 2000, PHARMACOPSYCHIATRY, V33, P81, DOI 10.1055/s-2000-8451; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berinder K, 2011, PITUITARY, V14, P199, DOI 10.1007/s11102-010-0277-9; Bouckenooghe T, 2014, BBA-MOL BASIS DIS, V1842, P584, DOI 10.1016/j.bbadis.2013.12.005; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Chirico V, 2013, CLIN ENDOCRINOL, V79, P537, DOI 10.1111/cen.12183; Cignarella A, 2010, TRENDS PHARMACOL SCI, V31, P183, DOI 10.1016/j.tips.2010.01.001; Ciresi A, 2013, CLIN ENDOCRINOL, V79, P845, DOI 10.1111/cen.12204; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Corona G, 2011, INT J ANDROL, V34, P217, DOI 10.1111/j.1365-2605.2010.01076.x; Corona G, 2014, J SEX MED, V11, P240, DOI 10.1111/jsm.12327; Daimon M, 2016, J CLIN ENDOCR METAB, V101, P889, DOI 10.1210/jc.2015-3568; Doknic M, 2002, EUR J ENDOCRINOL, V147, P77, DOI 10.1530/eje.0.1470077; Silva CMD, 2011, OBESITY, V19, P800, DOI 10.1038/oby.2010.150; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Georgiopoulos GA, 2009, HYPERTENSION, V54, P98, DOI 10.1161/HYPERTENSIONAHA.109.132100; Glintborg D, 2014, HUM REPROD, V29, P1773, DOI 10.1093/humrep/deu133; Greenman Y, 1998, CLIN ENDOCRINOL, V48, P547, DOI 10.1046/j.1365-2265.1998.00403.x; Haring R, 2014, EUR HEART J, V35, P1215, DOI 10.1093/eurheartj/ehs233; Haring R, 2012, ATHEROSCLEROSIS, V221, P570, DOI 10.1016/j.atherosclerosis.2012.01.017; IMAGAWA W, 1990, ENDOCR REV, V11, P494, DOI 10.1210/edrv-11-4-494; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; KNUDTZON J, 1986, LIFE SCI, V39, P617, DOI 10.1016/0024-3205(86)90042-1; Kok P, 2004, J CLIN ENDOCR METAB, V89, P4445, DOI 10.1210/jc.2003-032184; Kok P, 2006, AM J PHYSIOL-ENDOC M, V290, pE218, DOI 10.1152/ajpendo.00156.2005; Lamos EM, 2016, PRIM CARE DIABETES, V10, P60, DOI 10.1016/j.pcd.2015.10.008; Vicchi FL, 2016, PHARMACOL RES, V109, P74, DOI 10.1016/j.phrs.2015.12.029; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV 2; Nilsson L, 2005, BIOCHEM BIOPH RES CO, V331, P1120, DOI 10.1016/j.bbrc.2005.04.026; Petryk A, 2000, J ENDOCRINOL, V164, P277, DOI 10.1677/joe.0.1640277; Reis FM, 1997, J ENDOCRINOL, V153, P423, DOI 10.1677/joe.0.1530423; Sauve D, 2000, BRAIN RES, V868, P306, DOI 10.1016/S0006-8993(00)02344-1; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Serri O, 2006, CLIN ENDOCRINOL, V64, P366, DOI 10.1111/j.1365-2265.2006.02469.x; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Wang TG, 2013, DIABETES CARE, V36, P1974, DOI 10.2337/dc12-1893; Zhang LX, 2010, J HYPERTENS, V28, P1400, DOI 10.1097/HJH.0b013e328339f254	40	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175204	10.1371/journal.pone.0175204	http://dx.doi.org/10.1371/journal.pone.0175204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384295	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900119
J	Kolpakova, J; Li, L; Hatcher, JT; Gu, H; Zhang, XG; Chen, J; Cheng, ZXJ				Kolpakova, Jenya; Li, Liang; Hatcher, Jeffrey T.; Gu, He; Zhang, Xueguo; Chen, Jin; Cheng, Zixi Jack			Responses of Nucleus Tractus Solitarius (NTS) early and late neurons to blood pressure changes in anesthetized F344 rats	PLOS ONE			English	Article							VAGAL AFFERENT INNERVATION; BARORECEPTOR REFLEX; HEART-FAILURE; AORTIC-ARCH; RECEPTORS; BAROREFLEX; GLUTAMATE; CHEMORECEPTORS; TRANSMISSION; STIMULATION	Previously, many different types of NTS barosensitive neurons were identified. However, the time course of NTS barosensitive neuronal activity (NA) in response to arterial pressure (AP) changes, and the relationship of NA-AP changes, have not yet been fully quantified. In this study, we made extracellular recordings of single NTS neurons firing in response to AP elevation induced by occlusion of the descending aorta in anesthetized rats. Our findings were that: 1) Thirty-five neurons (from 46 neurons) increased firing, whereas others neurons either decreased firing upon AP elevation, or were biphasic: first decreased firing upon AP elevation and then increased firing during AP decrease. 2) Fourteen neurons with excitatory responses were activated and rapidly increased their firing during the early phase of AP increase (early neurons); whereas 21 neurons did not increase firing until the mean arterial pressure changes (Delta MAP) reached near/after the peak (late neurons). 3) The early neurons had a significantly higher firing rate than late neurons during AP elevation at a similar rate. 4) Early neuron NA-Delta MAP relationship could be well fitted and characterized by the sigmoid logistic function with the maximal gain of 29.3. 5) The increase of early NA correlated linearly with the initial heart rate (HR) reduction. 6) The late neurons did not contribute to the initial HR reduction. However, the late NA could be well correlated with HR reduction during the late phase. Altogether, our study demonstrated that the NTS excitatory neurons could be grouped into early and late neurons based on their firing patterns. The early neurons could be characterized by the sigmoid logistic function, and different neurons may differently contribute to HR regulation. Importantly, the grouping and quantitative methods used in this study may provide a useful tool for future assessment of functional changes of early and late neurons in disease models.	[Kolpakova, Jenya; Li, Liang; Hatcher, Jeffrey T.; Gu, He; Chen, Jin; Cheng, Zixi Jack] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Zhang, Xueguo] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	State University System of Florida; University of Central Florida; Henry Ford Health System; Henry Ford Hospital	Cheng, ZXJ (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	zixi.cheng@ucf.edu	Chen, Jin/M-1837-2019	Chen, Jin/0000-0001-7617-1664	NIH [A21020]; UCF institutional fund; NATIONAL INSTITUTE ON AGING [R01AG021020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCF institutional fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant A21020 and UCF institutional fund to ZC.	Accorsi-Mendonca D, 2013, AUTON NEUROSCI-BASIC, V175, P3, DOI 10.1016/j.autneu.2012.12.002; Al J, 2009, NEUROSCIENCE, V164, P658, DOI 10.1016/j.neuroscience.2009.06.066; Andresen MC, 2004, BRAZ J MED BIOL RES, V37, P549, DOI 10.1590/S0100-879X2004000400012; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; BROWN AM, 1980, CIRC RES, V46, P1, DOI 10.1161/01.RES.46.1.1; Canesin RO, 2000, BRAIN RES, V852, P68, DOI 10.1016/S0006-8993(99)02196-4; Chen MJ, 2014, SCI CHINA LIFE SCI, V57, P502, DOI 10.1007/s11427-014-4649-7; Cheng Z, 1997, J AUTONOM NERV SYST, V67, P1, DOI 10.1016/S0165-1838(97)00085-4; Cheng ZX, 1997, J COMP NEUROL, V381, P1, DOI 10.1002/(SICI)1096-9861(19970428)381:1<1::AID-CNE1>3.0.CO;2-5; Dampney RAL, 2003, CELL MOL NEUROBIOL, V23, P597, DOI 10.1023/A:1025080314925; Deuchars J, 2000, J COMP NEUROL, V417, P233; Gao J, 2014, AM J HYPERTENS, V27, P1248, DOI 10.1093/ajh/hpu044; Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989; Gu H, 2008, NEUROSCIENCE, V152, P741, DOI 10.1016/j.neuroscience.2007.11.030; Gu H, 2007, AM J PHYSIOL-HEART C, V293, pH2809, DOI 10.1152/ajpheart.00358.2007; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; HINES T, 1994, CIRC RES, V74, P1188, DOI 10.1161/01.RES.74.6.1188; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; Li LH, 2010, J COMP NEUROL, V518, P2771, DOI 10.1002/cne.22363; Ma XY, 2002, AM J PHYSIOL-REG I, V283, pR1033, DOI 10.1152/ajpregu.00768.2001; Machado BH, 2000, AM J PHYSIOL-HEART C, V279, pH67, DOI 10.1152/ajpheart.2000.279.1.H67; Mifflin SW, 2001, NEWS PHYSIOL SCI, V16, P266; OHTA H, 1994, AM J PHYSIOL-REG I, V267, pR1065, DOI 10.1152/ajpregu.1994.267.4.R1065; Paton JFR, 2001, ANN NY ACAD SCI, V940, P157; Potts JT, 2002, CLIN EXP PHARMACOL P, V29, P103, DOI 10.1046/j.1440-1681.2002.03613.x; ROGERS RF, 1993, AM J PHYSIOL, V265, pR1355, DOI 10.1152/ajpregu.1993.265.6.R1355; Schreihofer AM, 2002, CLIN EXP PHARMACOL P, V29, P514, DOI 10.1046/j.1440-1681.2002.03665.x; SEAGARD JL, 1990, CIRC RES, V66, P1499, DOI 10.1161/01.RES.66.6.1499; Seagard JL, 2001, ANN NY ACAD SCI, V940, P142; SEAGARD JL, 1995, NEUROSCI LETT, V191, P13, DOI 10.1016/0304-3940(95)11545-1; Seagard JL, 1999, J PHYSIOL-LONDON, V520, P243, DOI 10.1111/j.1469-7793.1999.00243.x; Spitzer, 2008, FUNDAMENTAL NEUROSCI, P829; Wang WZ, 2007, AM J PHYSIOL-REG I, V292, pR1137, DOI 10.1152/ajpregu.00590.2006; Wang WZ, 2006, NEUROSCI LETT, V409, P146, DOI 10.1016/j.neulet.2006.09.032; Zhang J, 2000, J PHYSIOL-LONDON, V529, P431, DOI 10.1111/j.1469-7793.2000.00431.x; Zhang J, 1997, J PHARMACOL EXP THER, V282, P639; Zhang J, 2000, AM J PHYSIOL-REG I, V278, pR1595, DOI 10.1152/ajpregu.2000.278.6.R1595; Zhang XG, 2003, J PHYSIOL-LONDON, V553, P1005, DOI 10.1113/jphysiol.2003.045906; Zhang XG, 2003, AUTON NEUROSCI-BASIC, V103, P19, DOI 10.1016/S1566-0702(02)00145-5	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0169529	10.1371/journal.pone.0169529	http://dx.doi.org/10.1371/journal.pone.0169529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384162	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900002
J	Liu, TY; Iavarone, AT; Doudna, JA				Liu, Tina Y.; Iavarone, Anthony T.; Doudna, Jennifer A.			RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System (vol 12, e0170552, 2017)	PLOS ONE			English	Correction														Liu, Tina/0000-0003-1297-7102				Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552	1	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175612	10.1371/journal.pone.0175612	http://dx.doi.org/10.1371/journal.pone.0175612			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384323	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900187
J	Manz, KM; Clowes, P; Kroidl, I; Kowuor, DO; Geldmacher, C; Ntinginya, NE; Maboko, L; Hoelscher, M; Saathoff, E				Manz, Kirsi M.; Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Geldmacher, Christof; Ntinginya, Nyanda E.; Maboko, Leonard; Hoelscher, Michael; Saathoff, Elmar			Trichuris trichiura infection and its relation to environmental factors in Mbeya region, Tanzania: A cross-sectional, population-based study	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; EPIDEMIOLOGY; SCHISTOSOMIASIS; METAANALYSIS; VARIABLES; HOOKWORM; AFRICA; DRUGS	Background The intestinal nematode Trichuris trichiura is among the most common causes of human infectious disease worldwide. As for other soil-transmitted nematodes, its reproductive success and thus prevalence and intensity of infection in a given area strongly depend on environmental conditions. Characterization of the influence of environmental factors can therefore aid to identify infection hot spots for targeted mass treatment. Methodology We analyzed data from a cross-sectional survey including 6234 participants from nine distinct study sites in Mbeya region, Tanzania. A geographic information system was used to combine remotely sensed and individual data, which were analyzed using uni- and multivariable Poisson regression. Household clustering was accounted for and when necessary, fractional polynomials were used to capture non-linear relationships between T. trichiura infection prevalence and environmental variables. Principal findings T. trichiura infection was restricted to the Kyela site, close to Lake Nyasa with only very few cases in the other eight sites. The prevalence of T. trichiura infection in Kyela was 26.6% (95% confidence interval (CI) 23.9 to 29.6%). Multivariable models revealed a positive association of infection with denser vegetation (prevalence ratio (PR) per 0.1 EVI units = 2.12, CI 1.28 to 3.50) and inverse associations with rainfall (PR per 100 mm = 0.54, CI 0.44 to 0.67) and elevation (PR per meter = 0.89, CI 0.86 to 0.93) while adjusting for age and previous worm treatment. Slope of the terrain was modelled non-linearly and also showed a positive association with T. trichiura infection (p-value p<0.001). Conclusion/Significance Higher prevalences of T. trichiura infection were only found in Kyela, a study site characterized by denser vegetation, high rainfall, low elevation and flat terrain. But even within this site, we found significant influences of vegetation density, rainfall, elevation and slope on T. trichiura infection. The inverse association of rainfall with infection in Kyela is likely due to the fact, that rainfall in this site is beyond the optimum conditions for egg development. Our findings demonstrate that use of remotely sensed environmental data can aid to predict high-risk areas for targeted helminth control.	[Manz, Kirsi M.] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Manz, Kirsi M.; Clowes, Petra; Kroidl, Inge; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Ntinginya, Nyanda E.; Maboko, Leonard; Hoelscher, Michael] NIMR Mbeya Med Res Ctr MMRC, Mbeya, Tanzania; [Kroidl, Inge; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany	University of Munich; University of Munich; German Center for Infection Research	Manz, KM (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany.; Manz, KM (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.	manz@ibe.med.uni-muenchen.de	Hoelscher, Michael/D-3436-2012	Manz, Kirsi/0000-0002-7740-4076	European Commission [SANTE/2004/078-545/130, SANTE/2006/129-931]; German Science foundation DFG [SA 1878/1-1]; German Federal Ministry of Education and Research BMBF [01 KA 0904]; European Commission's Seventh Framework Programme (EC-GA) [241642]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Science foundation DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); European Commission's Seventh Framework Programme (EC-GA)	The EMINI study was funded by the European Commission (SANTE/2004/078-545/130 & SANTE/2006/129-931). Helminth data collection was supported by the German Science foundation DFG (SA 1878/1-1) and the German Federal Ministry of Education and Research BMBF (01 KA 0904) with additional support from the European Commission's Seventh Framework Programme (EC-GA no 241642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; BUNDY DAP, 1989, ADV PARASIT, V28, P107; Chammartin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-152; Cross J.H, 1996, MED MICROBIOLOGY; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Jann B., 2008, NLCHECK STATA MODULE; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Montresor A., 1998, WORLD HLTH ORG; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; NASA Land Processes Distributed Active Archive Center (LP DAAC), 2001, MODIS 11A2 MODIS 13Q; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oluwole AS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003740; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Riess H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002408; Rogers WH, 1993, STATA TECHN B, V13, P19; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 1997, J ROY STAT SOC D-STA, V46, P411; Saathoff E, 2005, TROP MED INT HEALTH, V10, P412, DOI 10.1111/j.1365-3156.2005.01406.x; Scholte RGC, 2013, GEOSPATIAL HEALTH, V8, P97, DOI 10.4081/gh.2013.58; Siza JE, 2015, KOREAN J PARASITOL, V53, P525, DOI 10.3347/kjp.2015.53.5.525; Uneke CJ, 2010, TANZAN J HLTH RES, V12, P86; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212	35	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175137	10.1371/journal.pone.0175137	http://dx.doi.org/10.1371/journal.pone.0175137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384306	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000399371900098
J	Mustonen, M; Haimi, J; Kesaniemi, J; Hogmander, H; Knott, KE				Mustonen, Marina; Haimi, Jari; Kesaniemi, Jenni; Hogmander, Harri; Knott, K. Emily			Variation in gene expression within clones of the earthworm Dendrobaena octaedra	PLOS ONE			English	Article							POPULATIONS; LUMBRICIDAE; OLIGOCHAETA; METHYLATION; ADAPTATION; DIVERSITY; RESPONSES; GENOMICS; CADMIUM; COPPER	Gene expression is highly plastic, which can help organisms to both acclimate and adapt to changing environments. Possible variation in gene expression among individuals with the same genotype (among clones) is not widely considered, even though it could impact the results of studies that focus on gene expression phenotypes, for example studies using clonal lines. We examined the extent of within and between clone variation in gene expression in the earthworm Dendrobaena octaedra, which reproduces through apomictic parthenogenesis. Five microsatellite markers were developed and used to confirm that offspring are genetic clones of their parent. After that, expression of 12 genes was measured from five individuals each from six clonal lines after exposure to copper contaminated soil. Variation in gene expression was higher over all genotypes than within genotypes, as initially assumed. A subset of the genes was also examined in the offspring of exposed individuals in two of the clonal lines. In this case, variation in gene expression within genotypes was as high as that observed over all genotypes. One gene in particular (chymotrypsin inhibitor) also showed significant differences in the expression levels among genetically identical individuals. Gene expression can vary considerably, and the extent of variation may depend on the genotypes and genes studied. Ensuring a large sample, with many different genotypes, is critical in studies comparing gene expression phenotypes. Researchers should be especially cautious inferring gene expression phenotypes when using only a single clonal or inbred line, since the results might be specific to only certain genotypes.	[Mustonen, Marina; Haimi, Jari; Knott, K. Emily] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kesaniemi, Jenni] Univ Oulu, Dept Ecol, Oulu, Finland; [Hogmander, Harri] Univ Jyvaskyla, Dept Math & Stat, Jyvaskyla, Finland	University of Jyvaskyla; University of Oulu; University of Jyvaskyla	Mustonen, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	marina.s.mustonen@jyu.fi		Knott, Karelyn Emily/0000-0003-2564-1560; Kesaniemi, Jenni/0000-0001-8328-558X; Haimi, Jari/0000-0003-3582-5697	Maj and Tor Nessling Foundation [2015038]; Doctoral Programme in Biological and Environmental Science at University of Jyvaskyla	Maj and Tor Nessling Foundation; Doctoral Programme in Biological and Environmental Science at University of Jyvaskyla	This work was supported by the Maj and Tor Nessling Foundation (project number 2015038) and the Doctoral Programme in Biological and Environmental Science at University of Jyvaskyla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dudycha JL, 2012, ECOL EVOL, V2, P329, DOI 10.1002/ece3.30; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Fisker KV, 2011, ECOTOXICOLOGY, V20, P563, DOI 10.1007/s10646-011-0610-8; Fisker KV, 2013, COMP BIOCHEM PHYS C, V157, P220, DOI 10.1016/j.cbpc.2012.11.007; Fisker KV, 2011, COMP BIOCHEM PHYS C, V154, P204, DOI 10.1016/j.cbpc.2011.05.009; Grapputo A, 2006, MOL ECOL NOTES, V6, P1177, DOI 10.1111/j.1471-8286.2006.01483.x; Haimi J, 2007, EUR J SOIL BIOL, V43, pS268, DOI 10.1016/j.ejsobi.2007.08.026; Hansen PL, 2006, PEDOBIOLOGIA, V50, P225, DOI 10.1016/j.pedobi.2005.12.001; Heckmann LH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-250; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HONGELL K, 1989, HEREDITAS, V110, P179, DOI 10.1111/j.1601-5223.1989.tb00440.x; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Knott KE, 2010, HEREDITY, V105, P341, DOI 10.1038/hdy.2010.31; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Loxdale HD, 2003, BIOL J LINN SOC, V79, P3, DOI 10.1046/j.1095-8312.2003.00177.x; Loxdale HD, 2008, AGR FOREST ENTOMOL, V10, P81, DOI 10.1111/j.1461-9563.2008.00364.x; Lukkari T, 2005, ECOTOX ENVIRON SAFE, V62, P35, DOI 10.1016/j.ecoenv.2004.11.012; Mustonen M, 2014, ECOTOXICOLOGY, V23, P1732, DOI 10.1007/s10646-014-1338-z; Nota B, 2013, ENVIRON SCI TECHNOL, V47, P1155, DOI 10.1021/es303983z; Omodeo P., 1955, Caryologia, V8, P135; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Roelofs D, 2008, FUNCT ECOL, V22, P8, DOI 10.1111/j.1365-2435.2007.01312.x; Rosa BA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002678; Rozen A, 2006, SOIL BIOL BIOCHEM, V38, P489, DOI 10.1016/j.soilbio.2005.06.003; Rozen S, 2000, Methods Mol Biol, V132, P365; Rue P, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145549; Schoofs L, 2002, CURR PHARM DESIGN, V8, P483, DOI 10.2174/1381612023395718; Simonsen V, 2008, HEREDITAS, V145, P212, DOI 10.1111/j.0018-0661.2008.02045.x; Simonsen V, 2008, PEDOBIOLOGIA, V52, P51, DOI 10.1016/j.pedobi.2008.02.003; Snoek LB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03912; TERHIVUO J, 1990, PEDOBIOLOGIA, V34, P113; Terhivuo J, 2006, BIOL INVASIONS, V8, P1205, DOI 10.1007/s10530-006-9015-7; Viney M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1104; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Wolff GL, 1996, FUND APPL TOXICOL, V29, P176, DOI 10.1006/faat.1996.0019; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	45	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174960	10.1371/journal.pone.0174960	http://dx.doi.org/10.1371/journal.pone.0174960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384196	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900064
J	Thudi, M; Upadhyaya, HD; Rathore, A; Gaur, PM; Krishnamurthy, L; Roorkiwal, M; Nayak, SN; Chaturvedi, SK; Basu, PS; Gangarao, NVPR; Fikre, A; Kimurto, P; Sharma, PC; Sheshashayee, MS; Tobita, S; Kashiwagi, J; Ito, O; Killian, A; Varshne, RK				Thudi, Mahendar; Upadhyaya, Hari D.; Rathore, Abhishek; Gaur, Pooran Mal; Krishnamurthy, Lakshmanan; Roorkiwal, Manish; Nayak, Spurthi N.; Chaturvedi, Sushi Kumar; Basu, Partha Sarathi; Gangarao, N. V. P. R.; Fikre, Asnake; Kimurto, Paul; Sharma, Prakash C.; Sheshashayee, M. S.; Tobita, Satoshi; Kashiwagi, Junichi; Ito, Osamu; Killian, Andrzej; Varshne, Rajeev Kumar			Genetic Dissection of Drought and Heat Tolerance in Chickpea through Genome-Wide and Candidate Gene-Based Association Mapping Approaches (vol 9, e96758, 2014)	PLOS ONE			English	Correction												T.Mabendar@CGIAR.ORG; R.K.Varsbney@CGIAR.ORG	Gaur, Pooran/AAR-5729-2021; Roorkiwal, Manish/E-9822-2011; Gaur, Pooran Mal/ABE-6102-2020; THUDI, MAHENDAR/GXA-1578-2022; Kimurto, Paul/ABC-3322-2021	Roorkiwal, Manish/0000-0001-6595-281X; Gaur, Pooran Mal/0000-0002-7086-5873; THUDI, MAHENDAR/0000-0003-2851-6837; Nadigatla, Ganga Rao V.P.R/0000-0002-3278-3324				Thudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096758	1	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175609	10.1371/journal.pone.0175609	http://dx.doi.org/10.1371/journal.pone.0175609			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384343	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900184
J	Trenado, C; Elben, S; Friggemann, L; Gruhn, S; Groiss, SJ; Vesper, J; Schnitzler, A; Wojtecki, L				Trenado, Carlos; Elben, Saskia; Friggemann, Lena; Gruhn, Sonja; Groiss, Stefan Jun; Vesper, Jan; Schnitzler, Alfons; Wojtecki, Lars			Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease (vol 12, e0168151, 2017)	PLOS ONE			English	Correction													Schnitzler, Alfons/Q-5520-2019; Wojtecki, Lars/AAT-6604-2021; Schnitzler, Alfons/K-4625-2014	Schnitzler, Alfons/0000-0002-6414-7939; Wojtecki, Lars/0000-0002-6205-4405; Schnitzler, Alfons/0000-0002-6414-7939				Trenado C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168151	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175602	10.1371/journal.pone.0175602	http://dx.doi.org/10.1371/journal.pone.0175602			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384357	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900178
J	Xing, H; Mallon, JC; Currie, ML				Xing, Hai; Mallon, Jordan C.; Currie, Margaret L.			Supplementary cranial description of the types of Edmontosaurus regalis (Ornithischia: Hadrosauridae), with comments on the phylogenetics and biogeography of Hadrosaurinae	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; PRINCE CREEK FORMATION; DINOSAURIA HADROSAURIDAE; LAMBEOSAURINE DINOSAUR; NORTH SLOPE; ALBERTA; TAPHONOMY; ORNITHOPODA; BRAINCASE; PROVINCE	The cranial anatomy of the flat-skulled hadrosaurine Edmontosaurus regalis (Ornithischia: Hadrosauridae) is extensively described here, based on the holotype and paratype collected from the middle part of the Horseshoe Canyon Formation in southern Alberta. Focus is given to previously undocumented features of ontogenetic and phylogenetic importance. This description facilitates overall osteological comparisons between E. regalis and other hadrosaurids (especially E. annectens), and revises the diagnosis of E. regalis, to which a new autapomorphy (the dorsal half of the jugal anterior process bearing a sharp posterolateral projection into the orbit) is added. We consider the recently named Ugrunaaluk kuukpikensis from the upper Campanian/lower Maastrichtian of Alaska a nomen dubium, and conservatively regard the Alaskan material as belonging to Edmontosaurus sp.. A phylogenetic analysis of Hadrosauroidea using maximum parsimony further corroborates the sistertaxon relationship between E. regalis and E. annectens. In the strict consensus tree, Hadrosaurus foulkii occurs firmly within the clade comprising all non-lambeosaurine hadrosaurids, supporting the taxonomic scheme that divides Hadrosauridae into Hadrosaurinae and Lambeosaurinae. Within Edmontosaurini, Kerberosaurus is posited as the sister taxon to the clade of Shantungosaurus + Edmontosaurus. The biogeographic reconstruction of Hadrosaurinae in light of the time-calibrated cladogram and probability calculation of ancestral areas for all internal nodes reveals a significantly high probability for the North American origin of the clade. However, the Laramidia-Appalachia dispersals around the Santonian-Campanian boundary, inferred from the biogeographic scenario for the North American origin of Hadrosaurinae, are in conflict with currently accepted paleogeographic models. By contrast, the Asian origin of Hadrosaurinae with its relatively low probability resulting from the biogeographic analysis is worth seriously considering, despite the lack of fossil material from the Santonian and lower Campanian of Asia. Extra fossil collecting in appropriate geographic locations and stratigraphic intervals of Asia and Europe will help to clarify the biogeographic dynamics of hadrosaurine dinosaurs in the near future.	[Xing, Hai] Beijing Acad Sci & Technol, Beijing Museum Nat Hist, Beijing, Peoples R China; [Mallon, Jordan C.; Currie, Margaret L.] Canadian Museum Nat, Palaeobiol, Ottawa, ON, Canada	Beijing Academy of Science & Technology	Xing, H (corresponding author), Beijing Acad Sci & Technol, Beijing Museum Nat Hist, Beijing, Peoples R China.	xinghai@bmnh.org.cn		Mallon, Jordan/0000-0002-8209-8827	National Natural Science Foundation of China [41602006, 41120124002]; Beijing Natural Science Foundation [5174032]; National Basic Research Program of China (973 Program) [2012CB822002]; Youth Backbone Training Plan [201601]; Innovative Team Program of the Beijing Academy of Science and Technology [IG201705N]; Beijing Millions of Talents Project in the New Century; Canadian Museum of Nature; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Youth Backbone Training Plan; Innovative Team Program of the Beijing Academy of Science and Technology; Beijing Millions of Talents Project in the New Century; Canadian Museum of Nature; China Scholarship Council(China Scholarship Council)	Funding was provided by the National Natural Science Foundation of China (No. 41602006 and 41120124002), the Beijing Natural Science Foundation (No. 5174032), the National Basic Research Program of China (973 Program, No. 2012CB822002), the Youth Backbone Training Plan (No. 201601) and Innovative Team Program (No. IG201705N) of the Beijing Academy of Science and Technology, the Beijing Millions of Talents Project in the New Century, the Canadian Museum of Nature, and the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PR, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0062; Bell PR, 2014, CURR BIOL, V24, P70, DOI 10.1016/j.cub.2013.11.008; Blakey R., 2009, GLOBAL PALEOGEOGRAPH; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; Brett-Surman MK., 1989, THESIS GEORGE WASHIN, P1; Brown CM, 2015, PEERJ, V3, DOI 10.7717/peerj.818; Campione Nicolas E., 2014, P208; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Conrad JE, 1992, US GEOLOGICAL SURV C, V1990C, pC1, DOI DOI 10.1016/J.CRETRES.2015.10.007; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cruzado-Caballero P, 2013, J VERTEBR PALEONTOL, V33, P1367, DOI 10.1080/02724634.2013.772061; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2015, CAN J EARTH SCI, V52, P642, DOI 10.1139/cjes-2014-0184; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fiorillo Anthony R., 2001, Historical Biology, V15, P323, DOI 10.1080/0891296021000037327; Fowler EAF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141304; Gangloff RA, 2010, PALAIOS, V25, P299, DOI 10.2110/palo.2009.p09-103r; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2015, J SYST PALAEONTOL, V13, P711, DOI 10.1080/14772019.2014.950614; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Gilmore CW, 1924, CANADA DEP MINES B G, V43, P13; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gower DJ, 1998, BIOL REV, V73, P367, DOI 10.1017/S0006323198005222; HEATON MJ, 1972, CAN J EARTH SCI, V9, P185, DOI 10.1139/e72-015; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Lambe L. M., 1917, Ottawa Naturalist, V31; Lambe L.M., 1918, OTTAWA NATURALIST, V31, P135; Lambe L.M., 1920, GEOLOGICAL SURVEY CA, V120, P1, DOI [DOI 10.4095/101655, 10.4095/101655]; Langston W., 1960, Fieldiana Geology Memoir, V3, P313; Larson Derek W., 2014, P136; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Lund Eric K., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P263; Maddison WP., 2021, MESQUITE MODULAR SYS; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mori H, 2016, ACTA PALAEONTOL POL, V61, P15, DOI 10.4202/app.00152.2015; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Phillips RL, 2003, CRETACEOUS RES, V24, P499, DOI 10.1016/S0195-6671(03)00068-5; Prieto-Marquez A, 2016, J VERTEBR PALEONTOL, P1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P838, DOI 10.1080/02724631003762971; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Tan Qing-Wei, 2015, Vertebrata Palasiatica, V53, P245; Vanderven E, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0064; Wang RF, 2017, HIST BIOL, V29, P17, DOI 10.1080/08912963.2015.1118688; Xing H, 2014, ACTA GEOL SIN-ENGL, V88, P1623, DOI 10.1111/1755-6724.12334; Xing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098821; Xing Hai, 2012, Vertebrata Palasiatica, V50, P160; Zharkov MA, 1998, STRATIGR GEO CORREL+, V6, P209	63	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175253	10.1371/journal.pone.0175253	http://dx.doi.org/10.1371/journal.pone.0175253			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384240	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900139
J	Zhang, JH; Sun, XD; Wang, JM; Zhang, FH; Li, XH; Han, J				Zhang, Jinhua; Sun, Xudong; Wang, Jiemin; Zhang, Fuhua; Li, Xiaohua; Han, Jian			Association of the IL-1RN variable number of tandem repeat polymorphism and Helicobacter pylori infection: A meta-analysis	PLOS ONE			English	Article							INDUCED GASTRODUODENAL DISEASES; CYTOKINE GENE POLYMORPHISMS; GASTRIC-CANCER; INTERLEUKIN-1 POLYMORPHISMS; ATROPHIC GASTRITIS; VIRULENCE FACTORS; DUODENAL-ULCER; INCREASED RISK; POPULATION; SUSCEPTIBILITY	The aim of this study was to clarify the association of IL-1RN variable number of tandem repeat (VNTR) polymorphism and H. pylori infection. We performed a meta-analysis of studies retrieved by systematic searches of Pubmed, Embase and the Cochrane Library. Data were analyzed with STATA 13.1 using pooled odds ratios (ORs) with 95% confidence intervals (CIs). A total of 18 studies were included in our meta-analysis, and IL-1RN VNTR was found to be significantly associated with H. pylori infection in the comparisons of 22+2L vs. LL (OR = 1.17, 95% CI = 1.02-1.33) and 2 allele vs. L allele (OR = 1.18, 95% CI = 1.00- 1.40). Stratified analyses on study designs and ethnicities were also conducted. IL-1RN VNTR was positively correlated with H. pylori infection in Asian subgroup and HospitalBased subgroup (i.e., study samples obtained from hospital inpatients). In conclusion, our study demonstrated that IL-1RN VNTR polymorphism might increase the risk of H. pylori infection, especially in Asians.	[Zhang, Jinhua; Zhang, Fuhua] Second Hosp Gansu Prov, Dept Gastroenterol, Lanzhou, Peoples R China; [Zhang, Jinhua; Zhang, Fuhua] Northwest Univ Nationalities, Sch Clin Med 2, Dept Med, Lanzhou, Peoples R China; [Sun, Xudong; Han, Jian] Lanzhou Univ, Sch Basic Med Sci, Dept Pathogen Biol, Lanzhou, Peoples R China; [Wang, Jiemin; Li, Xiaohua] Liangzhou Hosp, Dept Gastroenterol, Wuwei, Peoples R China	Northwest Minzu University; Lanzhou University	Zhang, JH (corresponding author), Second Hosp Gansu Prov, Dept Gastroenterol, Lanzhou, Peoples R China.; Zhang, JH (corresponding author), Northwest Univ Nationalities, Sch Clin Med 2, Dept Med, Lanzhou, Peoples R China.; Han, J (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Dept Pathogen Biol, Lanzhou, Peoples R China.	zjh51272@163.com; hanj@lzu.edu.cn			Fundamental Research Funds for the Central Universities [31920150058]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Fundamental Research Funds for the Central Universities (No. 31920150058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar-Alpizar W, 2005, CLIN EXP MED, V5, P169, DOI 10.1007/s10238-005-0082-3; Chakravorty M, 2006, HUM MUTAT, V27, P411, DOI 10.1002/humu.20299; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; De DD, 2015, WORLD J GASTROENTERO, V21, P2883, DOI 10.3748/wjg.v21.i10.2883; Drici Ael M, 2016, LIBYAN J MED, V11, P31576; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Omar EM, 2006, BEST PRACT RES CL GA, V20, P675, DOI 10.1016/j.bpg.2006.04.006; Figueiredo CA, 2014, WORLD J GASTROENTERO, V20, P5235, DOI 10.3748/wjg.v20.i18.5235; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Oliveira JG, 2012, MOL BIOL REP, V39, P7617, DOI 10.1007/s11033-012-1596-x; Garcia-Gonzalez MA, 2009, HUM IMMUNOL, V70, P935, DOI 10.1016/j.humimm.2009.07.024; Gatti LL, 2004, CLIN EXP MED, V4, P93, DOI 10.1007/s10238-004-0043-2; Gobert AP, 2016, TRENDS MICROBIOL; Gorouhi F, 2008, BRIT J CANCER, V98, P1443, DOI 10.1038/sj.bjc.6604277; Goto Hidemi, 2003, Nagoya J Med Sci, V66, P77; Hamajima N, 2001, JPN J CANCER RES, V92, P383, DOI 10.1111/j.1349-7006.2001.tb01106.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; He BS, 2011, DIGEST DIS SCI, V56, P2017, DOI 10.1007/s10620-010-1557-y; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Kang JM, 2012, HELICOBACTER, V17, P86, DOI 10.1111/j.1523-5378.2011.00918.x; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kim N, 2006, HELICOBACTER, V11, P105, DOI 10.1111/j.1523-5378.2006.00384.x; Kimang'a AN, 2012, ETHIOP J HEALTH SCI, V22, P163; Kulmambetova GN, 2014, ASIAN PAC J CANCER P, V15, P7763, DOI 10.7314/APJCP.2014.15.18.7763; Kumar S, 2012, J GASTROEN HEPATOL, V27, P431; Kumar S, 2009, BIOCHEM BIOPH RES CO, V387, P456, DOI 10.1016/j.bbrc.2009.07.033; Li C, 2007, J GASTROEN HEPATOL, V22, P234, DOI 10.1111/j.1440-1746.2006.04379.x; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Martinez T, 2011, REV MED CHILE, V139, P1313, DOI [10.4067/S0034-98872011001000010, /S0034-98872011001000010]; Mattar R, 2013, CLIN EXP GASTROENTER, V6, P35, DOI 10.2147/CEG.S42260; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; Perez-Rodriguez M, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12326; Queiroz D. M. M., 2013, PLoS ONE, V8, pe57420, DOI 10.1371/journal.pone.0057420; Queiroz DMM, 2009, MICROBES INFECT, V11, P980, DOI 10.1016/j.micinf.2009.07.008; Rad R, 2003, J INFECT DIS, V188, P272, DOI 10.1086/376458; Robin WJ, 1983, LANCET LONDON ENGLAN, V1, P1273; Robinson K, 2007, BEST PRACT RES CL GA, V21, P237, DOI 10.1016/j.bpg.2007.01.001; Santos JC, 2012, BRAZ J MED BIOL RES, V45, P811, DOI 10.1590/S0100-879X2012007500099; Sgouras DN, 2015, HELICOBACTER, V20, P8, DOI 10.1111/hel.12251; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; STOLTE M, 1992, LANCET, V339, P745, DOI 10.1016/0140-6736(92)90645-J; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Sugimoto M, 2009, J GASTROEN HEPATOL, V24, P1725, DOI 10.1111/j.1440-1746.2009.06047.x; Sun X-Y, 2016, EUR SPINE J, V2016, P1, DOI DOI 10.1371/J0URNAL.P0NE.0147410; Sun XD, 2015, MICROB PATHOGENESIS, V86, P45, DOI 10.1016/j.micpath.2015.07.010; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Uno M, 2002, INT J MOL MED, V10, P321; Vilaichone RK, 2005, SCAND J GASTROENTERO, V40, P530, DOI 10.1080/00365520510012299; Wells BSGA, 2011, NEWCASTLE OTTAWA SCA; Xue HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028083; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yang J, 2004, WORLD CHINESE J DIGE, V12, P1769; Zhang BB, 2013, HUM IMMUNOL, V74, P1170, DOI 10.1016/j.humimm.2013.06.023; Zhang LW, 2010, MOL BIOL REP, V37, P3983, DOI 10.1007/s11033-010-0057-7; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046017	59	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175052	10.1371/journal.pone.0175052	http://dx.doi.org/10.1371/journal.pone.0175052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384207	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900078
J	Asadzadeh, M; Ahmad, S; Al-Sweih, N; Khan, Z				Asadzadeh, Mohammad; Ahmad, Suhail; Al-Sweih, Noura; Khan, Ziauddin			Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait	PLOS ONE			English	Article							ANTIFUNGAL-DRUG-RESISTANCE; BLOOD-STREAM INFECTIONS; FUNGAL-INFECTION; ALBICANS; MECHANISMS; PREVALENCE; FITNESS; SUSCEPTIBILITY; EPIDEMIOLOGY; EVOLUTION	Candida dubliniensis and Candida albicans are two closely related species. Although C. dubliniensis is less pathogenic, it has a higher propensity to develop resistance to fluconazole and some strains exhibit intrinsic resistance to 5-flucytosine (5-FC). All 5-FC-resistant isolates from Kuwait were previously shown to belong to one of seven internal transcribed spacer (ITS) region of rDNA-based haplotypes. This study performed fingerprinting of C. dubliniensis isolates by multilocus sequence typing (MLST) to determine population structure of 5-FC-resistant and -susceptible strains and compared the results with data from a global collection of isolates. Fifty-two C. dubliniensis isolates previously analyzed and 58 additional isolates mostly collected during 2010-2013 and characterized by phenotypic and molecular methods were used. ITS-based haplotypes were identified by haplotype-specific PCR and/or by PCR-DNA sequencing of rDNA. Population structure was determined by 8-loci-based MLST. E-test was used to determine susceptibility to 5-FC, fluconazole, voriconazole and amphotericin B. Five ITS haplotypes (ITSH) were detected among 110 C. dubliniensis isolates. The ITSH1 was most common (n = 80 isolates) followed by ITSH4 (n = 25 isolates). Two isolates each belonged to ITSH5 and ITSH8 while one isolate belonged to ITSH7. MLST identified 16 diploid sequence types (DSTs) including six new DSTs. DST11 (n = 52) and DST14 (n = 25) were dominant genotypes and were confined (together with DST21) to Middle-Eastern countries. Other DSTs (excluding some new DSTs) had a wider global distribution as they were identified from various other countries. Only ITSH4 isolates (n = 25) belonged to DST14, were resistant to 5-FC and contained S29L mutation in CdFCA1. ITSH5, ITSH7 and ITSH8 isolates belonged to different DSTs. Thus, clinical C. dubliniensis isolates in Kuwait exhibited limited genotypic heterogeneity and most isolates belonged to region-specific DSTs. All 5-FC-resistant C. dubliniensis isolates belonged to ITSH4 and MLST-based DST14 genotype. Placement of some isolates into additional ITS haplotypes is also supported by MLST data.	[Asadzadeh, Mohammad; Ahmad, Suhail; Al-Sweih, Noura; Khan, Ziauddin] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Khan, Z (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	Zkhan@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021	asadzadeh, Mohammad/0000-0002-9151-1505	College of Graduate Studies and Research Sector, Kuwait University [YM10/11, GM01/05, SRUL02/13]	College of Graduate Studies and Research Sector, Kuwait University	This study was funded by the College of Graduate Studies and Research Sector, Kuwait University with grant award numbers YM10/11, GM01/05 and SRUL02/13 to Ziauddin Khan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, J MED MICROBIOL, V53, P633, DOI 10.1099/jmm.0.05315-0; Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Ahmad S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-230; Ahmad S, 2012, MED MYCOL, V50, P244, DOI 10.3109/13693786.2011.597446; Al Mosaid A, 2005, J CLIN MICROBIOL, V43, P4026, DOI 10.1128/JCM.43.8.4026-4036.2005; Al-Sweih N, 2005, MYCOSES, V48, P347, DOI 10.1111/j.1439-0507.2005.01143.x; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00247; Ben-Ami R, 2012, VIRULENCE, V3, P95, DOI 10.4161/viru.3.1.18886; Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351; Borecka S, 2011, CAN J MICROBIOL, V57, P416, DOI [10.1139/W11-025, 10.1139/w11-025]; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI S; Cowen LE, 2001, J BACTERIOL, V183, P2971, DOI 10.1128/JB.183.10.2971-2978.2001; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002; Idelevich EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114834; Joly S, 1999, J CLIN MICROBIOL, V37, P1035, DOI 10.1128/JCM.37.4.1035-1044.1999; Jordan RPC, 2014, MED MYCOL, V52, P254, DOI 10.1093/mmy/myt032; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Khan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032952; Khan ZU, 2004, CLIN MICROBIOL INFEC, V10, P590, DOI 10.1111/j.1469-0691.2004.00923.x; Kolaczkowska A, 2016, J ANTIMICROB CHEMOTH, V71, P1438, DOI 10.1093/jac/dkv445; Loreto ES, 2010, MYCOPATHOLOGIA, V169, P431, DOI 10.1007/s11046-010-9286-5; McManus BA, 2008, J CLIN MICROBIOL, V46, P652, DOI 10.1128/JCM.01574-07; McManus BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/j.meegid.2013.11.008; McManus BA, 2009, ANTIMICROB AGENTS CH, V53, P4678, DOI 10.1128/AAC.00607-09; Mokaddas E, 2011, MYCOSES, V54, pE29, DOI 10.1111/j.1439-0507.2009.01822.x; Moran Gary P, 2012, Int J Microbiol, V2012, P205921, DOI 10.1155/2012/205921; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Orasch C, 2014, CLIN MICROBIOL INFEC, V20, P698, DOI 10.1111/1469-0691.12440; Pannanusorn S, 2013, MYCOSES, V56, P264, DOI 10.1111/myc.12014; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pinjon E, 2005, ANTIMICROB AGENTS CH, V49, P1312, DOI 10.1128/AAC.49.4.1312-1318.2005; Pujol C, 2004, ANTIMICROB AGENTS CH, V48, P262, DOI 10.1128/AAC.48.1.262-266.2004; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X; Taj-Aldeen SJ, 2014, MED MYCOL, V52, P549, DOI 10.1093/mmycol/myu016; Tsai MH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.06.024; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Wahab AA, 2014, INT J INFECT DIS, V24, P14, DOI 10.1016/j.ijid.2014.03.1380; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175269	10.1371/journal.pone.0175269	http://dx.doi.org/10.1371/journal.pone.0175269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380072	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500114
J	Carlice-dos-Reis, T; Viana, J; Moreira, FC; Cardoso, GD; Guerreiro, J; Santos, S; Ribeiro-dos-Santos, A				Carlice-dos-Reis, Tania; Viana, Jaime; Moreira, Fabiano Cordeiro; Cardoso, Greice de Lemos; Guerreiro, Joao; Santos, Sidney; Ribeiro-dos-Santos, Andrea			Investigation of mutations in the HBB gene using the 1,000 genomes database	PLOS ONE			English	Article							BETA-CHAIN VARIANT; THALASSEMIA MUTATIONS; MOLECULAR-BASIS; O THALASSEMIA; HEMOGLOBIN; SARDINIA; DISEASE; PROTEIN; CANCER	Mutations in the HBB gene are responsible for several serious hemoglobinopathies, such as sickle cell anemia and 6-thalassemia. Sickle cell anemia is one of the most common mono genic diseases worldwide. Due to its prevalence, diverse strategies have been developed for a better understanding of its molecular mechanisms. In silico analysis has been increasingly used to investigate the genotype-phenotype relationship of many diseases, and the sequences of healthy individuals deposited in the 1,000 Genomes database appear to be an excellent tool for such analysis. The objective of this study is to analyze the variations in the HBB gene in the 1,000 Genomes database, to describe the mutation frequencies in the different population groups, and to investigate the pattern of pathogenicity. The computational tool SNPEFF was used to align the data from 2,504 samples of the 1,000 Genomes database with the HG19 genome reference. The pathogenicity of each amino acid change was investigated using the databases CLINVAR, dbSNP and HbVar and five different predictors. Twenty different mutations were found in 209 healthy individuals. The African group had the highest number of individuals with mutations, and the European group had the lowest number. Thus, it is concluded that approximately 8.3% of phenotypically healthy individuals from the 1,000 Genomes database have some mutation in the HBB gene. The frequency of mutated genes was estimated at 0.042, so that the expected frequency of being homozygous or compound heterozygous for these variants in the next generation is approximately 0.002. In total, 193 subjects had a non-synonymous mutation, which 186 (7.4%) have a deleterious mutation. Considering that the 1,000 Genomes database is representative of the world's population, it can be estimated that fourteen out of every 10,000 individuals in the world will have a hemoglobinopathy in the next generation.	[Carlice-dos-Reis, Tania; Viana, Jaime; Moreira, Fabiano Cordeiro; Cardoso, Greice de Lemos; Guerreiro, Joao; Santos, Sidney; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil; [Viana, Jaime] Fed Rural Univ Amazon, Capanema Campus, Belem, Para, Brazil; [Moreira, Fabiano Cordeiro; Santos, Sidney; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Res Ctr Oncol, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil.; Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Res Ctr Oncol, Belem, Para, Brazil.	akelyufpa@gmail.com	Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Moreira, Fabiano/I-2817-2015	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Moreira, Fabiano/0000-0002-2799-3546; dos Reis, Tania Carlice/0000-0001-9209-1971	Rede de Pesquisa em GenOmica Populacional Humana (RPGPH) [3381/2013]; FADESP/PROPESP/UFPA (Universidade Federal do Para); FAPESPA (Fundacao Amazonia Paraense de Amparo a Pesquisa) [ICAAF 083/2013]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CNPq/Produtividade (CNPQ) [304413/2015-1, 305258/2013-3]	Rede de Pesquisa em GenOmica Populacional Humana (RPGPH); FADESP/PROPESP/UFPA (Universidade Federal do Para); FAPESPA (Fundacao Amazonia Paraense de Amparo a Pesquisa)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Produtividade (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Rede de Pesquisa em GenOmica Populacional Humana (RPGPH) - 3381/2013 CAPES-BioComputacional, FADESP/PROPESP/UFPA (Universidade Federal do Para), FAPESPA (Fundacao Amazonia Paraense de Amparo a Pesquisa) ICAAF 083/2013, and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). ANDREA RIBEIRO-DOS-SANTOS supported by CNPq/Produtividade (CNPQ 304413/2015-1); SIDNEY SANTOS supported by CNPq/ Produtividade (CNPq 305258/2013-3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2002, NCBI HDB; AULEHLASCHOLZ C, 1990, HUM GENET, V84, P195; BAUR EW, 1965, HUMANGENETIK, V1, P621; BLACKWELL RQ, 1970, BIOCHIM BIOPHYS ACTA, V214, P396; Carter TE, 2014, AM J TROP MED HYG, V91, P406, DOI 10.4269/ajtmh.13-0572; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; Chassanidis C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157393; CHEHAB FF, 1987, BLOOD, V69, P1141; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; DEIDDA G, 1990, HEMOGLOBIN, V14, P431, DOI 10.3109/03630269009032003; Ghansah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034565; HALL GW, 1991, BRIT J HAEMATOL, V79, P342, DOI 10.1111/j.1365-2141.1991.tb04548.x; HARANO T, 1982, HEMOGLOBIN, V6, P531, DOI 10.3109/03630268209083766; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; IMAMURA T, 1969, J CLIN INVEST, V48, P2341, DOI 10.1172/JCI106200; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; KIMURA A, 1983, J BIOL CHEM, V258, P2748; Kulkarni GD, 2012, GENET TEST MOL BIOMA, V16, P138, DOI 10.1089/gtmb.2011.0035; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; LANGDOWN JV, 1994, HEMOGLOBIN, V18, P333, DOI 10.3109/03630269408996199; Lelliott PM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0809-x; Lettre G, 2012, PERSPECT MED, V2, P1; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; MERAULT G, 1986, HEMOGLOBIN, V10, P593, DOI 10.3109/03630268609036564; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; Onda M, 2005, BRIT J CANCER, V92, P2216, DOI 10.1038/sj.bjc.6602634; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; Orlando GM, 2000, REV BRAS HEMATOL HEM, V22, P111; Pianezze G, 2016, HEMOGLOBIN, V40, P143, DOI 10.3109/03630269.2016.1150292; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saraf SL, 2014, PAEDIATR RESPIR REV, V15, P4, DOI 10.1016/j.prrv.2013.11.003; SCHNEIDER RG, 1968, BLOOD, V32, P250, DOI 10.1182/blood.V32.2.250.250; Singh PK, 2016, GENE, V576, P141, DOI 10.1016/j.gene.2015.09.084; Sirdah MM, 2013, BLOOD CELL MOL DIS, V50, P247, DOI 10.1016/j.bcmd.2012.12.004; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; Sultana GNN, 2016, COMPLETE SPECTRUM BE, V3, P1; Torres Lidiane de Souza, 2015, Rev. Bras. Hematol. Hemoter., V37, P120, DOI 10.1016/j.bjhh.2015.02.007; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323	46	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174637	10.1371/journal.pone.0174637	http://dx.doi.org/10.1371/journal.pone.0174637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379995	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500055
J	Gonzalez-Dominguez, B; Studer, MS; Hagedorn, F; Niklaus, PA; Abiven, S				Gonzalez-Dominguez, Beatriz; Studer, Mirjam S.; Hagedorn, Frank; Niklaus, Pascal A.; Abiven, Samuel			Leaching of soils during laboratory incubations does not affect soil organic carbon mineralisation but solubilisation	PLOS ONE			English	Article							NITROGEN MINERALIZATION; MICROBIAL RESPIRATION; MATTER	Laboratory soil incubations provide controlled conditions to investigate carbon and nutrient dynamics; however, they are not free of artefacts. As carbon and nitrogen cycles are tightly linked, we aimed at investigating whether the incubation-induced accumulation of mineral nitrogen (N-min) biases soil organic carbon (SOC) mineralisation. For this, we selected two soils representative of the C: N ratio values found in European temperate forests, and applied two incubation systems: 'closed' beakers and 'open' microlysimeters. The latter allowed leaching the soil samples during the incubation. By the end of the 121-day experiment, the low C: N soil significantly accumulated more N-min in beakers (5.12 g kg(-1) OC) than in microlysimeters (3.00 g kg(-1) OC) but there was not a significant difference in SOC mineralisation at any point of the experiment. On the other hand, N-min did not accumulate in the high C: N soil but, by the end of the experiment, leaching had promoted 33.9% more SOC solubilisation than beakers. Therefore, we did not find evidence that incubation experiments introduce a bias on SOC mineralisation. This outcome strengthens results from soil incubation studies.	[Gonzalez-Dominguez, Beatriz; Studer, Mirjam S.; Abiven, Samuel] Univ Zurich, Dept Geog, Soil Sci & Biogeochem, Zurich, Switzerland; [Gonzalez-Dominguez, Beatriz; Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Hagedorn, Frank] Swiss Fed Inst Snow Forest & Landscape Res WSL, Forest Soils & Biogeochem, Birmensdorf, Switzerland	University of Zurich; University of Zurich	Abiven, S (corresponding author), Univ Zurich, Dept Geog, Soil Sci & Biogeochem, Zurich, Switzerland.	samuel.abiven@geo.uzh.ch	Niklaus, Pascal A/G-5786-2010; Abiven, Samuel/J-5328-2013	Niklaus, Pascal A/0000-0002-2360-1357; Abiven, Samuel/0000-0002-5663-0912; Gonzalez-Dominguez, Beatriz/0000-0002-2428-3119; Hagedorn, Frank/0000-0001-5218-7776	Swiss National Science Foundation [143026, 68]; Geography Department of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Geography Department of the University of Zurich	This study was funded by the Swiss National Science Foundation (project-no. 143026) in the frame of the National Research Programme 68. (hip //www.nrp68.ch/en). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Geography Department of the University of Zurich for their support. We also thank the Swiss Federal Institute for Forest, Snow and Landscape Research, their team on the Long-term Forest Ecosystem Research Programme and specially Lorenz Walthert and Stephan Zimmermann, for giving us access to the research sites and to the database.We thank Rebecca Navarro, Rene Husi and Miguel Jales Hon for their technical assistance. Finally, we thank two anonymous reviewers for their helpful comments on this manuscript.	Andresen LC, 2016, SOIL DISCUSS, V2016, P1; [Anonymous], 2016, SOIL DISCUSS, V2016, P1, DOI DOI 10.1039/C6GC01133K'; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2016, 14239 ISODIS; Bracho R, 2016, SOIL BIOL BIOCHEM, V97, P1, DOI 10.1016/j.soilbio.2016.02.008; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Gonzalez-Dominguez B, 2017, DATABASE LEACHING SO; Hagedorn F, 2004, EUR J SOIL SCI, V55, P91, DOI 10.1046/j.1365-2389.2003.00578.x; Hopkins DW, 2006, SOIL BIOL BIOCHEM, V38, P3130, DOI 10.1016/j.soilbio.2006.01.012; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Keuskamp JA, 2013, SOIL BIOL BIOCHEM, V57, P822, DOI 10.1016/j.soilbio.2012.08.007; Kim H, 2011, J MICROBIOL, V49, P369, DOI 10.1007/s12275-011-0421-x; Lavoie M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001629; Lorenz W, 2013, SWISS FEDERAL I FORE; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; NADELHOFFER KJ, 1990, SOIL SCI SOC AM J, V54, P411, DOI 10.2136/sssaj1990.03615995005400020019x; Niklewski B, 1912, ZENTRALBLATT BAKTERI, V32, P209; Paul E., 2001, ASSESSMENT METHODS S, V14, P193; Persson T, 2000, ECOL STU AN, V142, P14; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, SOIL BIOL BIOCHEM, V42, P2336, DOI 10.1016/j.soilbio.2010.08.032; Recous S, 1995, SOIL BIOL BIOCHEM, V27, P1529, DOI 10.1016/0038-0717(95)00096-W; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; TIPPING E, 1991, J SOIL SCI, V42, P437, DOI 10.1111/j.1365-2389.1991.tb00421.x; Walthert L, 2004, GRUNDLAGEN REGION JA, V1; WOLLUM AG, 1970, ECOLOGY, V51, P555	29	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174725	10.1371/journal.pone.0174725	http://dx.doi.org/10.1371/journal.pone.0174725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380005	Green Accepted, Green Published, gold			2022-12-27	WOS:000399353500061
J	Karoubi, N; Leibovich, T; Segevl, R				Karoubi, Naomi; Leibovich, Tali; Segevl, Ronen			Symbol-value association and discrimination in the archerfish	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; NUMERICAL COMPETENCE; ORDINAL JUDGMENTS; NUMBER; CHIMPANZEES; SUMMATION; FISH; COGNITION; QUANTITY; MONKEYS	One of the most important aspects of mathematical cognition in humans is the ability to symbolically represent magnitudes and quantities. In the last 20 years it has been shown that not only humans but also other primates, birds and dolphins can use symbolic representation of quantities. However, it remains unclear to what extent this ability is spread across the animal kingdom. Here, by training archerfish to associate variable amounts of rewards with different geometric shapes, we show for the first time that lower vertebrates can also associate a value with a symbol and make a decision that maximizes their food intake based on this information. In addition, the archerfish is able to understand up to four different quantities and organize them mentally in an ordinal manner, similar to observations in higher vertebrates. These findings point in the direction of the existence of an approximate magnitude system in fish.	[Karoubi, Naomi; Segevl, Ronen] Ben Gurion Univ Negev, Life Sci Dept, Beer Sheva, Israel; [Karoubi, Naomi; Segevl, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Leibovich, Tali] Univ Western Ontario, Psychol Dept, London, ON, Canada; [Leibovich, Tali] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada	Ben Gurion University; Ben Gurion University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Segevl, R (corresponding author), Ben Gurion Univ Negev, Life Sci Dept, Beer Sheva, Israel.; Segevl, R (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel.	ronensgv@bgu.ac.il		Segev, Ronen/0000-0002-8109-1076; Leibovich-Raveh, Tali/0000-0002-8692-9480	Israel Science Foundation [211/15]; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev	Israel Science Foundation(Israel Science Foundation); Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev	We gratefully acknowledge financial support from the Israel Science Foundation (grant No. 211/15), and the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev.r We thank Gustavo Glusman and Asya Mikhaylov for technical assistance and Zvika Abramsky for his valuable suggestions. We gratefully acknowledge financial support from the Israel Science Foundation (grant No. 211/15), and the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev.	Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Beran MJ, 2005, J EXP PSYCHOL-ANIM B, V31, P351, DOI 10.1037/0097-7403.31.3.351; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Biro D, 2001, Anim Cogn, V4, P193, DOI 10.1007/s100710100086; Bisazza A, 2014, J EXP BIOL, V217, P1902, DOI 10.1242/jeb.101683; Bouton ME, 2004, NEUROSCI BIOBEHAV R, V28, P663, DOI 10.1016/j.neubiorev.2004.09.001; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Boysen ST, 1999, ANNU REV PSYCHOL, V50, P683, DOI 10.1146/annurev.psych.50.1.683; Brysbaert M, 1998, COGNITION, V66, P51, DOI 10.1016/S0010-0277(98)00006-7; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Dehaene S, 1997, THE NUMBER SENSE HOW; DeLong CM, 2016, BEHAV PROCESSES; Fechner G., 1965, ELEMENTS PSYCHOPHYSI; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FERSTER CB, 1964, SCI AM, V210, P98, DOI 10.1038/scientificamerican0564-98; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Gebuis T, 2016, ACTA PSYCHOL, V171, P17, DOI 10.1016/j.actpsy.2016.09.003; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Jordan KE, 2006, ANIM COGN, V9, P159, DOI 10.1007/s10071-006-0017-8; Katz MW, 2013, AM NAT, V181, P381, DOI 10.1086/669156; Kilian A, 2003, LEARN BEHAV, V31, P133; Leibovich T, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000960; Leibovich T, 2014, Q J EXP PSYCHOL, V67, P899, DOI 10.1080/17470218.2013.837940; Leibovich T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00375; Lucon-Xiccato T, 2017, BEHAV PROCESS, V141, P184, DOI 10.1016/j.beproc.2017.01.015; Lucon-Xiccato T, 2016, ANIM COGN, V19, P733, DOI 10.1007/s10071-016-0969-2; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Mamuneas D, 2015, BEHAV ECOL, V26, P91, DOI 10.1093/beheco/aru160; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; Merkley R, 2015, Q J EXP PSYCHOL, V68, P1860, DOI 10.1080/17470218.2014.994538; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Olthof A, 2000, J COMP PSYCHOL, V114, P158, DOI 10.1037/0735-7036.114.2.158; Olthof A, 1997, J EXP PSYCHOL ANIM B, V23, P325, DOI 10.1037/0097-7403.23.3.325; Pepperberg IM, 2006, ANIM COGN, V9, P377, DOI 10.1007/s10071-006-0034-7; Pepperberg IM, 2012, COGNITION, V125, P219, DOI 10.1016/j.cognition.2012.07.003; Pepperberg IM, 2012, ANIM COGN, V15, P711, DOI [10.1007/s10071-012-0470-5, 10.1007/s10071-012-0476-5]; Petrazzini MEM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15497; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Schuster S, 2004, CURR BIOL, V14, P1565, DOI 10.1016/j.cub.2004.08.050; Spaepen E, 2011, P NATL ACAD SCI USA, V108, P3163, DOI 10.1073/pnas.1015975108; WASHBURN DA, 1991, PSYCHOL SCI, V2, P190, DOI 10.1111/j.1467-9280.1991.tb00130.x; Wilson ML, 2002, P ROY SOC B-BIOL SCI, V269, P1107, DOI 10.1098/rspb.2001.1926; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174044	10.1371/journal.pone.0174044	http://dx.doi.org/10.1371/journal.pone.0174044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379988	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500029
J	Pang, KH; Rosario, DJ; Morgan, SL; Catto, JWF				Pang, Karl H.; Rosario, Derek J.; Morgan, Susan L.; Catto, James W. F.			Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies	PLOS ONE			English	Article							PCA3; ANTIGEN; RISK; IDENTIFICATION; EXPRESSION; MICRORNAS; OUTCOMES	Background Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We recently identified a short ncRNA expressed from intron 1 of PCA3. Here we test the ability of this ncRNA to predict the presence of cancer in men with a biopsy without PCa. Methods We selected men whose initial biopsy did not identify PCa and selected matched cohorts whose subsequent biopsies revealed PCa or benign tissue. We extracted RNA from the initial biopsy and measured PCA3-shRNA2, PCA3 and PSA (qRT-PCR). Results We identified 116 men with and 94 men without an eventual diagnosis of PCa in 2-5 biopsies (mean 26 months), collected from 2002-2008. The cohorts were similar for age, PSA and surveillance period. We detected PSA and PCA3-shRNA2 RNA in all samples, and PCA3 RNA in 90% of biopsies. The expression of PCA3 and PCA3-shRNA2 were correlated (Pearson's r = 0.37, p<0.01). There was upregulation of PCA3 (2.1-fold, t-test p = 0.02) and PCA3-shRNA2 (1.5-fold) in men with PCa on subsequent biopsy, although this was not significant for the latter RNA (p = 0.2). PCA3 was associated with the future detection of PCa (C-index 0.61, p = 0.01). This was not the case for PCA3-shRNA2 (C-index 0.55, p = 0.2). Conclusions PCA3 and PCA3-shRNA2 expression are detectable in historic biopsies and their expression is correlated suggesting co-expression. PCA3 expression was upregulated in men with PCa diagnosed at a future date, the same did not hold for PCA3-shRNA2. Futures studies should explore expression in urine and look at a time course between biopsy and PCa detection.	[Pang, Karl H.; Rosario, Derek J.; Catto, James W. F.] Univ Sheffield, Dept Oncol & Human Metab, Acad Urol Unit, Sheffield, S Yorkshire, England; [Pang, Karl H.; Rosario, Derek J.; Catto, James W. F.] Univ Sheffield, Dept Oncol & Human Metab, Acad Unit Mol Oncol, Sheffield, S Yorkshire, England; [Morgan, Susan L.] Royal Hallamshire Hosp, Dept Histopathol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Catto, JWF (corresponding author), Univ Sheffield, Dept Oncol & Human Metab, Acad Urol Unit, Sheffield, S Yorkshire, England.; Catto, JWF (corresponding author), Univ Sheffield, Dept Oncol & Human Metab, Acad Unit Mol Oncol, Sheffield, S Yorkshire, England.	j.catto@sheffield.acuk	Rosario, Derek/C-2028-2017	Rosario, Derek/0000-0002-9086-3592; catto, james/0000-0003-2787-8828	Royal College of Surgeons of England; Urology Foundation	Royal College of Surgeons of England; Urology Foundation	KHP received a Research Fellowship from the Royal College of Surgeons of England (https.//www.rcseng.ac.uk/standards-and-research/research/fellowships-awards-grants/fellowships/current-and-past/one year-fellowships 2013-2014/), and a Research Scholarship from The Urology Foundation (http.//wwwtheurologyfoundation.org/professionals/our-programmes/research-programmes/220-tufcurrent-projects).	Aakula A, 2016, EUR UROL, V69, P1120, DOI 10.1016/j.eururo.2015.09.019; Alinezhad S, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.12.014; Bokhorst LP, 2015, EUR UROL, V68, P814, DOI 10.1016/j.eururo.2015.06.012; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Catto JWF, 2009, CLIN CANCER RES, V15, P3150, DOI 10.1158/1078-0432.CCR-08-1960; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; de Kok JB, 2002, CANCER RES, V62, P2695; Djavan B, 2001, J UROLOGY, V166, P1679, DOI 10.1016/S0022-5347(05)65652-2; Drayton RM, 2015, CANCER EPIDEM BIOMAR, V24, P268, DOI 10.1158/1055-9965.EPI-14-0377; Gandaglia G, 2016, EUR UROL, V69, P998, DOI 10.1016/j.eururo.2015.05.046; Haese A, 2008, EUR UROL, V54, P1081, DOI 10.1016/j.eururo.2008.06.071; Herawi M, 2006, J UROLOGY, V175, P121, DOI 10.1016/S0022-5347(05)00064-9; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Klecka J, 2010, ANTICANCER RES, V30, P665; Miah S, 2012, BRIT J CANCER, V107, P123, DOI 10.1038/bjc.2012.221; Mottet N, 2016, EUR UROL; Paziewska A, 2014, BRIT J CANCER, V111, P781, DOI 10.1038/bjc.2014.337; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Salagierski M, 2010, PROSTATE, V70, P70, DOI 10.1002/pros.21040; Schroder FH, 2014, UROLOGY, V83, P613, DOI 10.1016/j.urology.2013.12.005; Svoronos AA, 2016, CANCER RES, V76, P3666, DOI 10.1158/0008-5472.CAN-16-0359; Tomlins SA, 2016, EUR UROL, V70, P45, DOI 10.1016/j.eururo.2015.04.039; Vedder MM, 2014, EUR UROL, V66, P1109, DOI 10.1016/j.eururo.2014.08.011	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175070	10.1371/journal.pone.0175070	http://dx.doi.org/10.1371/journal.pone.0175070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380027	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500093
J	Xiang, Y; Lu, LM; Chen, XK; Wen, ZH				Xiang, Yu; Lu, Liming; Chen, Xiankun; Wen, Zehuai			Does Tai Chi relieve fatigue? A systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							BREAST-CANCER SURVIVORS; MULTIPLE-SCLEROSIS; EXERCISE; HEALTH; INTERVENTIONS; ARTHRITIS; QUALITY; PEOPLE; QIGONG; ADULTS	Background Fatigue is not only a familiar symptom in our daily lives, but also a common ailment that affects all of our bodily systems. Several randomized controlled trials (RCTs) have proven Tai Chi to be beneficial for patients suffering from fatigue, however conclusive evidence is still lacking. A systematic review and meta-analysis was performed on all RCTs reporting the effects of Tai Chi for fatigue. Methods In the end of April 2016, seven electronic databases were searched for RCTs involving Tai Chi for fatigue. The search terms mainly included Tai Chi, Tai-ji, Taiji, fatigue, tiredness, weary, weak, and the search was conducted without language restrictions. Methodological quality was assessed using the Cochrane Risk of Bias tool. RevMan 5.3 software was used for meta-analysis. Publication bias was estimated with a funnel plot and Egger's test. We also assessed the quality of evidence with the GRADE system. Results Ten trials (n = 689) were included, and there was a high risk of bias in the blinding. Two trials were determined to have had low methodological quality. Tai Chi was found to have improved fatigue more than conventional therapy (standardized mean difference (SMD): -0.45, 95% confidence interval (CI): -0.70, -0.20) overall, and have positive effects in cancer-related fatigue (SMD:-0.38, 95% CI: -0.65, -0.11). Tai Chi was also more effective on vitality (SMD: 0.63, 95% CI: 0.20, 1.07), sleep (SMD: -0.32, 95% CI: -0.61, -0.04) and depression (SMD: -0.58, 95% CI: -1.04, -0.11). However, no significant difference was found in multiple sclerosis-related fatigue (SMD: -0.77, 95% CI: -1.76, 0.22) and age-related fatigue (SMD: -0.77, 95% CI: -1.78, 0.24). No adverse events were reported among the included studies. The quality of evidence was moderate in the GRADE system. Conclusions The results suggest that Tai Chi could be an effective alternative and/or complementary approach to existing therapies for people with fatigue. However, the quality of the evidence was only moderate and may have the potential for bias. There is still absence of adverse events data to evaluate the safety of Tai Chi. Further multi-center RCTs with large sample sizes and high methodological quality, especially carefully blinded design, should be conducted in future research.	[Xiang, Yu] Guangzhou Univ Chinese Med, Clin Coll 2, Guangzhou, Guangdong, Peoples R China; [Lu, Liming; Chen, Xiankun; Wen, Zehuai] Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, Guangzhou, Guangdong, Peoples R China; [Wen, Zehuai] Guangzhou Univ Chinese Med, Natl Ctr Design Measurement & Evaluat Clin Res, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Wen, ZH (corresponding author), Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, Guangzhou, Guangdong, Peoples R China.; Wen, ZH (corresponding author), Guangzhou Univ Chinese Med, Natl Ctr Design Measurement & Evaluat Clin Res, Guangzhou, Guangdong, Peoples R China.	wenzh@gzucm.edu.cn	Wen, Zehuai/A-5103-2015	Wen, Zehuai/0000-0002-1797-2047	National Key Technology R&D Program for the 12th Five year Plan of Ministry of Science and Technology, China [2013BAI02B10]; TCM Science and Technology Project of Guangdong Provincial Hospital of Chinese Medicine [YN2015MS14, YK2013BIN05]	National Key Technology R&D Program for the 12th Five year Plan of Ministry of Science and Technology, China; TCM Science and Technology Project of Guangdong Provincial Hospital of Chinese Medicine	This work was supported by the National Key Technology R&D Program for the 12th Five year Plan of Ministry of Science and Technology, China (No.2013BAI02B10), and TCM Science and Technology Project of Guangdong Provincial Hospital of Chinese Medicine (No.YN2015MS14 and No.YK2013BIN05). This funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Bidonde J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011336; Burschka JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0165-4; Callahan LF, 2016, J AGING PHYS ACTIV, V24, P101, DOI 10.1123/japa.2014-0211; Chan AWK, 2013, COMPLEMENT THER MED, V21, P585, DOI 10.1016/j.ctim.2013.09.008; Crane PB, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00055; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; Denman M, 2016, ANN INTERN MED, V164, pJC55, DOI 10.7326/ACPJC-2016-164-10-055; Du SZ, 2015, INT J NURS STUD, V52, P368, DOI 10.1016/j.ijnurstu.2014.05.009; Fiest Kirsten M, 2016, Int J MS Care, V18, P96, DOI 10.7224/1537-2073.2015-070; Meneses-Echavez JF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1069-4; Galantino ML, 2013, ALTERN THER HEALTH M, V19, P38; Galantino ML, 2003, REHABIL ONCOL, V21, P17, DOI DOI 10.1097/01893697-200321010-00012; Garcia-Hermoso A, 2015, J BACK MUSCULOSKELET, V28, P609, DOI 10.3233/BMR-140562; Gemmell C, 2006, BRAIN INJURY, V20, P151, DOI 10.1080/02699050500442998; Hall AM, 2011, ARTHRITIS CARE RES, V63; Han A, 2004, COCHRANE DATABASE SY, V3, DOI DOI 10.1002/14651858.CD004849; Hartley L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010366.pub2; Heine M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009956.pub2; Irwin MR, 2014, SLEEP, V37, P1543, DOI 10.5665/sleep.4008; Jiang M.Y., 2013, CHIN NURS RES, V27, P420, DOI [DOI 10.3969/J.ISSN.1009-6493.2013.05.018, 10.3969/j.issn.1009]; Kim SH, 2013, J INVEST MED, V61, P827, DOI [10.2310/JIM.0b013e3182906862, 10.231/JIM.0b013e3182906862]; Kong LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25325; Larkey LK, 2015, ANN BEHAV MED, V49, P165, DOI 10.1007/s12160-014-9645-4; Lee Kang-Yi, 2006, Taehan Kanho Hakhoe Chi, V36, P278; Li C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0723-0; Li G. F., 2011, THESIS; Li L., 2012, J COMMUNITY MED, V10, P50; Liu Xin, 2015, Evidence-based Complementary and Alternative Medicine, V2015, P879712; Liu X, 2015, COMPLEMENT THER MED, V23, P516, DOI 10.1016/j.ctim.2015.05.001; LIU Y, 2015, COCHRANE DB SYST REV, V1; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Castro-Sanchez AM, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/473963; Mercier J, 2016, SLEEP MED REV; Mock V, 2000, ONCOLOGY-NY, V14, P151; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099377; Pan XH, 2016, J ZHEJIANG UNIV-SC B, V17, P640, DOI 10.1631/jzus.B1600052; Payne C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008427.pub2; Persson PB, 2016, ACTA PHYSIOL, V218, P3, DOI 10.1111/apha.12756; Platta ME, 2016, ARCH PHYS MED REHAB, V97, P1564, DOI 10.1016/j.apmr.2016.01.023; Ream E, 1996, INT J NURS STUD, V33, P519, DOI 10.1016/0020-7489(96)00004-1; Redwine LS, 2012, J ALTERN COMPLEM MED, V18, P744, DOI 10.1089/acm.2011.0314; Reid-Arndt Stephanie A, 2012, Complement Ther Clin Pract, V18, P26, DOI 10.1016/j.ctcp.2011.02.005; Roland NJ, 2012, CLIN OTOLARYNGOL, V37, P393, DOI 10.1111/coa.12032; Romero-Zurita A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/614196; Savovic J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-37; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; Shephard RJ, 2016, SPRINGER SER EPIDEMI, P1, DOI 10.1007/978-3-319-29577-0_1; Shi CM, 2013, WUHUN, V9, P8; Tan L, 2004, J SHE SPORT U, V23, P375; Wang Chenchen, 2010, BMC Complement Altern Med, V10, P23, DOI 10.1186/1472-6882-10-23; Wang Chenchen, 2008, V52, P218, DOI 10.1159/000134302; Wong WS, 2010, J AFFECT DISORDERS, V127, P248, DOI 10.1016/j.jad.2010.04.029; Zhang LL, 2016, J PAIN SYMPTOM MANAG, V51, P504, DOI 10.1016/j.jpainsymman.2015.11.020	56	21	21	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174872	10.1371/journal.pone.0174872	http://dx.doi.org/10.1371/journal.pone.0174872			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380067	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500072
J	Ziaukas, P; Alabdulgader, A; Vainoras, A; Navickas, Z; Ragulskis, M				Ziaukas, Pranas; Alabdulgader, Abdullah; Vainoras, Alfonsas; Navickas, Zenonas; Ragulskis, Minvydas			New approach for visualization of relationships between RR and JT intervals	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; QT INTERVAL	This paper presents the concept of perfect matrices of Lagrange differences which are used to analyze relationships between RR and JT intervals during the bicycle ergometry exercise. The concept of the perfect matrix of Lagrange differences, its parameters, the construction of the load function and the corresponding optimization problem, the introduction of internal and external smoothing, embedding of the scalar parameter time series into the phase plane all these computational techniques allow visualization of complex dynamical processes taking place in the cardiovascular system during the load and the recovery processes. Detailed analysis is performed with one person's RR and JT records only but the presented techniques open new possibilities for novel interpretation of the dynamics of the cardiovascular system.	[Ziaukas, Pranas; Navickas, Zenonas; Ragulskis, Minvydas] Kaunas Univ Technol, Res Grp Math & Numer Anal Dynam Syst, Kaunas, Lithuania; [Alabdulgader, Abdullah] Prince Sultan Cardiac Ctr, Al Hasa, Al Hofuf, Saudi Arabia; [Vainoras, Alfonsas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania	Kaunas University of Technology; Prince Sultan Cardiac Center; Lithuanian University of Health Sciences	Ragulskis, M (corresponding author), Kaunas Univ Technol, Res Grp Math & Numer Anal Dynam Syst, Kaunas, Lithuania.	minvydas.ragulskis@ktu.it	Ragulskis, Minvydas/A-1546-2008	Ragulskis, Minvydas/0000-0002-3348-9717; Alabdulagader, Abdullah/0000-0002-5425-460X; Navickas, Zenonas/0000-0002-8725-3005; Vainoras, Alfonsas/0000-0002-5732-8520	Lithuanian University of Health Sciences; Lithuanian Science Council [MIP078=15]	Lithuanian University of Health Sciences(Research Council of Lithuania (LMTLT)); Lithuanian Science Council(Research Council of Lithuania (LMTLT))	Lithuanian University of Health Sciences is acknowledged for covering the open access publication fee. Financial support from the Lithuanian Science Council under project no. MIP078=15 is acknowledged.	AHNVE S, 1985, AM HEART J, V109, P568, DOI 10.1016/0002-8703(85)90564-2; Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bieri T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152693; Bonomini MP, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-15; Camm AJ, 1996, CIRCULATION, V93, P1043; Cysarz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019400; Djousse L, 2005, J AM COLL CARDIOL, V45, P1716, DOI 10.1016/j.jacc.2005.01.060; Erem B, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042218; Gargasas L, 2006, 6 NORD C EHEALTH TEL, P255; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Gomes RL, 2016, INT J CLIN EXP MED, V9, P2047; Henriques TS, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0252-0; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; Korsakas S, 1997, BIOMED TECH, P114; Malik M, 2002, HEART, V87, P220, DOI 10.1136/heart.87.3.220; Misigoj-Durakovic M, 2016, ANN NONINVAS ELECTRO, V21, P595, DOI 10.1111/anec.12374; Mukherjee S, 2015, PHYSICA A, V439, P93, DOI 10.1016/j.physa.2015.07.030; Orfanidis SJ, 2009, INTRO SIGNAL PROCESS; Ragulskis M, 2009, NEUROCOMPUTING, V72, P2618, DOI 10.1016/j.neucom.2008.10.010; Rautaharju PM, 2004, AM J CARDIOL, V93, P1017, DOI 10.1016/j.amjcard.2003.12.055; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schuldberg D, 2015, NONLIN DYNAM PSYCHOL, V19, P553; Slapikas R, 1997, VI ASIAN-PACIFIC SYMPOSIUM ON CARDIAC PACING AND ELECTROPHYSIOLOGY, P405; Vainoras A, 1997, P 26 INT C EL EL 97, P253; Vazquez P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00037; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZHOU SH, 1993, J ELECTROCARDIOL, V25, P131, DOI 10.1016/0022-0736(92)90079-F; Zywietz Ch, 1994, ANN KAUNAS I CARDIOL, V1, P66	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174279	10.1371/journal.pone.0174279	http://dx.doi.org/10.1371/journal.pone.0174279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379976	Green Submitted, gold, Green Published			2022-12-27	WOS:000399353500039
J	Munkhammar, J; Mattsson, L; Ryden, J				Munkhammar, Joakim; Mattsson, Lars; Ryden, Jesper			Polynomial probability distribution estimation using the method of moments	PLOS ONE			English	Article							HANKEL-MATRICES; MODELS	We suggest a procedure for estimating Nth degree polynomial approximations to unknown (or known) probability density functions (PDFs) based on N statistical moments from each distribution. The procedure is based on the method of moments and is setup algorithmically to aid applicability and to ensure rigor in use. In order to show applicability, polynomial PDF approximations are obtained for the distribution families Normal, Log-Normal, Weibull as well as for a bimodal Weibull distribution and a data set of anonymized household electricity use. The results are compared with results for traditional PDF series expansion methods of Gram-Charlier type. It is concluded that this procedure is a comparatively simple procedure that could be used when traditional distribution families are not applicable or when polynomial expansions of probability distributions might be considered useful approximations. In particular this approach is practical for calculating convolutions of distributions, since such operations become integrals of polynomial expressions. Finally, in order to show an advanced applicability of the method, it is shown to be useful for approximating solutions to the Smoluchowski equation.	[Munkhammar, Joakim] Uppsala Univ, BEESG, Dept Engn Sci, Uppsala, Sweden; [Mattsson, Lars] KTH Royal Inst Technol, NORDITA, SE-10691 Stockholm, Sweden; [Mattsson, Lars] Stockholm Univ, SE-10691 Stockholm, Sweden; [Ryden, Jesper] Uppsala Univ, Dept Math, SE-75106 Uppsala, Sweden; [Munkhammar, Joakim] Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden	Uppsala University; Nordic Institute for Theoretical Physics; Royal Institute of Technology; Stockholm University; Uppsala University; Uppsala University	Munkhammar, J (corresponding author), Uppsala Univ, BEESG, Dept Engn Sci, Uppsala, Sweden.; Munkhammar, J (corresponding author), Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden.	joakim.munkhammar@angstrom.uu.se		Ryden, Jesper/0000-0002-5451-4563; Munkhammar, Joakim/0000-0003-0051-4098	Lundstrom-Amans scholarship; Swedish Energy Agency; mathematical department at Uppsala university; Swedish Research Council [2015-04505]	Lundstrom-Amans scholarship; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); mathematical department at Uppsala university; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Joakim Munkhammar was funded primarily by the Swedish Energy Agency, and Lundstrom-Amans scholarship. Jesper Ryden was funded by the mathematical department at Uppsala university. Lars Mattsson was funded by the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) with grant number 2015-04505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Prof. Svante Janson, Prof. Rolf Larsson and Dr. Johan Bjorklund at the department of mathematics at Uppsala University for discussions on the method presented in this paper. This work was partially funded by the Lundstrom-Amans scholarship.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldous DJ, 1999, BERNOULLI, V5, P3, DOI 10.2307/3318611; BARTON DE, 1952, BIOMETRIKA, V39, P425, DOI 10.1093/biomet/39.3-4.425; Casella G, 2002, STATISTICAL INFERENC; Chabrier G., 2013, GALACTIC STELLAR AND, V114, P763; CHOI MD, 1983, AM MATH MON, V90, P301, DOI 10.2307/2975779; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; DasGupta A, 2008, SPRINGER TEXTS STAT, P1; Fasino D, 1995, J COMPUT APPL MATH, V65, P145, DOI 10.1016/0377-0427(95)00108-5; Gallier Jean, 1999, CURVES SURFACES GEOM; Golovin A., 1963, GEOPHYS SER, V5, P482; Gupta A.K., 2011, INT ENCY STAT SCI, P144; Hollands KGT, 2013, SOL ENERGY, V96, P103, DOI 10.1016/j.solener.2013.07.007; Jeffreys H., 1988, METHODS MATH PHYS, P446; Jondeau E, 2001, J ECON DYN CONTROL, V25, P1457, DOI 10.1016/S0165-1889(99)00082-2; Kendall M, 1987, KENDALLS ADVANCED TH, V1; Kolassa J.E., 2006, SERIES APPROXIMATION; Kotz S, 1985, ENCYCLOPEDIA OF STAT, V5; Kotz S, 1982, ENCYCLOPEDIA OF STAT, V1; Mattsson L, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201015572; MITA K, 1989, J BIOMED ENG, V11, P315, DOI 10.1016/0141-5425(89)90066-6; Monahan AH, 2007, J CLIMATE, V20, P5798, DOI 10.1175/2007JCLI1609.1; Munkhammar J, 2014, APPL ENERG, V135, P382, DOI 10.1016/j.apenergy.2014.08.093; Ochi MK, 1991, OCEAN WAVES THE STOC; Ochi MK, 1992, APPLIED PROBABILITY; Partington JR, 1988, LMS STUDENT TEXTS, V13; Runge C, 1901, Z MATH PHYS, V46, P224, DOI DOI 10.2307/2323093; Shohat JA, 1943, MATH SURVEYS, V1; Smoluchowski M., 1916, Z PHYS, V17, P557; Titterington DM, 1985, STAT ANAL; TRENCH WF, 1965, J SOC IND APPL MATH, V13, P1102, DOI 10.1137/0113078; Wand MP., 1994, KERNEL SMOOTHING; Weierstrass K., 1885, UBER U DIE ANALYTISC; Yim JZ, 2000, ATMOS ENVIRON, V34, P1583, DOI 10.1016/S1352-2310(99)00414-8; Zimmermann JP, 2009, REPORT	35	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174573	10.1371/journal.pone.0174573	http://dx.doi.org/10.1371/journal.pone.0174573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394949	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800004
J	Georgi, E; Walter, MC; Pfalzgraf, MT; Northoff, BH; Holdt, LM; Scholz, HC; Zoeller, L; Zange, S; Antwerpen, MH				Georgi, Enrico; Walter, Mathias C.; Pfalzgraf, Marie-Theres; Northoff, Bernd H.; Holdt, Lesca M.; Scholz, Holger C.; Zoeller, Lothar; Zange, Sabine; Antwerpen, Markus H.			Whole genome sequencing of Brucella melitensis isolated from 57 patients in Germany reveals high diversity in strains from Middle East	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; VARIABLE-NUMBER; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; RPOB GENE; BIOVAR 1; MLVA; EVOLUTION; ALIGNMENT	Brucellosis, a worldwide common bacterial zoonotic disease, has become quite rare in Northern and Western Europe. However, since 2014 a significant increase of imported infections caused by Brucella (B.) melitensis has been noticed in Germany. Patients predominantly originated from Middle East including Turkey and Syria. These circumstances afforded an opportunity to gain insights into the population structure of Brucella strains. Brucella-isolates from 57 patients were recovered between January 2014 and June 2016 with culture confirmed brucellosis by the National Consultant Laboratory for Brucella. Their whole genome sequences were generated using the Illumina MiSeq platform. A whole genome-based SNP typing assay was developed in order to resolve geographically attributed genetic clusters. Results were compared to MLVA typing results, the current gold-standard of Brucella typing. In addition, sequences were examined for possible genetic variation within target regions of molecular diagnostic assays. Phylogenetic analyses revealed spatial clustering and distinguished strains from different patients in either case, whereas multiple isolates from a single patient or technical replicates showed identical SNP and MLVA profiles. By including WGS data from the NCBI database, five major genotypes were identified. Notably, strains originating from Turkey showed a high diversity and grouped into seven subclusters of genotype II. MLVA analysis congruently clustered all isolates and predominantly matched the East Mediterranean genetic clade. This study confirms whole-genome based SNP-analysis as a powerful tool for accurate typing of B. melitensis. Furthermore it allows special allocation and therefore provides useful information on the geographic origin for trace-back analysis. However, the lack of reliable metadata in public databases often prevents a resolution below geographic regions or country levels and corresponding precise trace-back analysis. Once this obstacle is resolved, WGS-derived bacterial typing adds an important method to complement epidemiological surveys during outbreak investigations. This is the first report of a detailed genetic investigation of an extensive collection of B. melitensis strains isolated from human cases in Germany.	[Georgi, Enrico; Walter, Mathias C.; Pfalzgraf, Marie-Theres; Scholz, Holger C.; Zoeller, Lothar; Zange, Sabine; Antwerpen, Markus H.] Bundeswehr Inst Microbiol, Munich, Germany; [Northoff, Bernd H.; Holdt, Lesca M.] Ludwig Maximilians Univ Munchen, Inst Lab Med, Munich, Germany; [Scholz, Holger C.; Zoeller, Lothar; Zange, Sabine] Natl Consultant Lab Brucella, Munich, Germany	Bundeswehr Institute of Microbiology (IMB); University of Munich	Antwerpen, MH (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	markusantwerpen@bundeswehr.org	Walter, Mathias/AGP-4944-2022	Walter, Mathias/0000-0003-3012-2626; Zange, Sabine/0000-0001-8721-9248; Antwerpen, Markus/0000-0003-4013-8808; Northoff, Bernd/0000-0002-7333-3231	German Ministry of Defence Medical Service [57-2014-03]	German Ministry of Defence Medical Service	This study was supported by internal funding of the German Ministry of Defence Medical Service as part of project no. 57-2014-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab H, 2011, SCAND J INFECT DIS, V43, P536, DOI 10.3109/00365548.2011.562531; Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; [Anonymous], 2016, MBIO; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Azam S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/3034756; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Massis F, 2015, TRANSBOUND EMERG DIS, V62, P463, DOI 10.1111/tbed.12397; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Foster JT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-110; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Garofolo Giuliano, 2016, BMC Res Notes, V9, P277, DOI 10.1186/s13104-016-2074-7; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Gyuranecz M, 2016, VET MICROBIOL, V186, P8, DOI 10.1016/j.vetmic.2016.02.009; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Ke YH, 2012, J BACTERIOL, V194, P5489, DOI 10.1128/JB.01293-12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; Mayer-Scholl A, 2010, J MICROBIOL METH, V80, P112, DOI 10.1016/j.mimet.2009.10.015; Moreno E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00213; Musallam II, 2016, EPIDEMIOL INFECT, V144, P671, DOI 10.1017/S0950268815002575; Osterman B., 2006, INT J SYST EVOL MICR, V56, P1173, DOI [DOI 10.1099/IJS.0.64349-0, DOI 10.1099/ijs.0.64349-0]; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Sayan M, 2009, JPN J INFECT DIS, V62, P160; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Scholz HC, 2013, REV SCI TECH OIE, V32, P149; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Scholz HC, 2008, J MED MICROBIOL, V57, P64, DOI 10.1099/jmm.0.47507-0; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Tan KK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1294-x; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Vollmar P, 1946, DEUT MED WOCHENSCHR, V141, P1014; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00	45	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175425	10.1371/journal.pone.0175425	http://dx.doi.org/10.1371/journal.pone.0175425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388689	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800052
J	Kucuker, MA; Wieczorek, N; Kuchta, K; Copty, NK				Kucuker, Mehmet Ali; Wieczorek, Nils; Kuchta, Kerstin; Copty, Nadim K.			Biosorption of neodymium on Chlorella vulgaris in aqueous solution obtained from hard disk drive magnets	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; NDFEB MAGNETS; ION-EXCHANGE; METAL-IONS; ADSORPTION; RECOVERY; REMOVAL; EQUILIBRIUM; COPPER(II); LANTHANUM	In recent years, biosorption is being considered as an environmental friendly technology for the recovery of rare earth metals (REE). This study investigates the optimal conditions for the biosorption of neodymium (Nd) from an aqueous solution derived from hard drive disk magnets using green microalgae (Chlorella vulgaris). The parameters considered include solution pH, temperature and biosorbent dosage. Best-fit equilibrium as well as kinetic biosorption models were also developed. At the optimal pH of 5, the maximum experimental Nd uptakes at 21, 35 and 50 degrees C and an initial Nd concentration of 250 mg/L were 126.13, 157.40 and 77.10 mg/g, respectively. Analysis of the optimal equilibrium sorption data showed that the data fitted well (R-2 = 0.98) to the Langmuir isotherm model, with maximum monolayer coverage capacity (q(max)) of 188.68 mg/g, and Langmuir isotherm constant (K-L) of 0.029 L/mg. The corresponding separation factor (R-L) is 0.12 indicating that the equilibrium sorption was favorable. The sorption kinetics of Nd ion follows well a pseudo-second order model (R-2 > 0.99), even at low initial concentrations. These results show that Chlorella vulgaris has greater biosorption affinity for Nd than activated carbon and other algae types such as: A. Gracilis, Sargassum sp. and A. Densus.	[Kucuker, Mehmet Ali; Wieczorek, Nils; Kuchta, Kerstin] Hamburg Univ Technol TUHH, Inst Environm Technol & Energy Econ, Waste Resources Management, Hamburg, Germany; [Copty, Nadim K.] Bogazici Univ, Inst Environm Sci, Istanbul, Turkey	Hamburg University of Technology; Bogazici University	Kuchta, K (corresponding author), Hamburg Univ Technol TUHH, Inst Environm Technol & Energy Econ, Waste Resources Management, Hamburg, Germany.	kuchta@tuhh.de	Copty, Nadim K/Q-2749-2015; Kucuker, Mehmet Ali/ABG-6276-2020	Copty, Nadim K/0000-0002-4807-7790; Kucuker, Mehmet Ali/0000-0001-9648-8925; Wieczorek, Nils/0000-0001-8392-3772	BMBF (The Federal Ministry of Education and Research) through the project "Biotechnological Approach For Recovery Of Rare Earth Elements And Precious Metals From E-Waste - (BIOREEs )" [1DL14004]; Scientific and Technological Research Council of Turkey (TUBITAK) [113Y011]	BMBF (The Federal Ministry of Education and Research) through the project "Biotechnological Approach For Recovery Of Rare Earth Elements And Precious Metals From E-Waste - (BIOREEs )"(Federal Ministry of Education & Research (BMBF)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The authors acknowledge the financial support from BMBF (The Federal Ministry of Education and Research) through the project "Biotechnological Approach For Recovery Of Rare Earth Elements And Precious Metals From E-Waste - (BIOREEs )", Project Number :1DL14004. Nadim K. Copty gratefully acknowledges the financial support provided by the Scientific and Technological Research Council of Turkey (TUBITAK, project no. 113Y011).	AjayKumar A.V., 2009, WORLD APPL SCI J, V5, P32; Aksu Z, 2005, PROCESS BIOCHEM, V40, P3031, DOI 10.1016/j.procbio.2005.02.004; Bhalara PD, 2014, J ENVIRON CHEM ENG, V2, P1621, DOI 10.1016/j.jece.2014.06.007; Carrillo PFR, 2014, ENV TECHNOL, V35; Dada A., 2012, IOSR J APPL CHEM, V3, P38, DOI [10.9790/5736-0313845, DOI 10.9790/5736-0313845]; Das N, 2013, J RARE EARTH, V31, P933, DOI 10.1016/S1002-0721(13)60009-5; Das N, 2010, HYDROMETALLURGY, V103, P180, DOI 10.1016/j.hydromet.2010.03.016; Diniz V, 2005, WATER RES, V39, P2229, DOI 10.1016/j.watres.2005.04.004; Ramos SND, 2015, IND CROP PROD, V74, P357, DOI 10.1016/j.indcrop.2015.05.022; Donmez GC, 1999, PROCESS BIOCHEM, V34, P885; Dziwulska U, 2004, ANAL LETT, V37, P2189, DOI 10.1081/AL-200026696; Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fomina M, 2014, BIORESOURCE TECHNOL, V160, P3, DOI 10.1016/j.biortech.2013.12.102; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Fujiwara K, 2007, J HAZARD MATER, V146, P39, DOI 10.1016/j.jhazmat.2006.11.049; Gautam R.K., 2013, WASTEWATER REUSE MAN, P305, DOI [DOI 10.1007/978-94-007-4942-9_10, 10.1007/978-94-007-4942-9_10]; HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011; Ho YS, 2006, POL J ENVIRON STUD, V15, P81; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 2001, SEPAR SCI TECHNOL, V36, P241, DOI 10.1081/SS-100001077; HOSEA M, 1986, INORG CHIM A-BIOINOR, V123, P161, DOI 10.1016/S0020-1693(00)86339-2; Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9; Kucuker M.A., 2016, INT J PLANT ANIM ENV, V2016, P197; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lodeiro P, 2006, J HAZARD MATER, V137, P244, DOI 10.1016/j.jhazmat.2006.01.061; Mohan SV, 1997, ENVIRON POLLUT, V97, P183, DOI 10.1016/S0269-7491(97)00025-0; Moldoveanu GA, 2012, HYDROMETALLURGY, V117, P71, DOI 10.1016/j.hydromet.2012.02.007; Onoda H, 2014, J ENVIRON CHEM ENG, V2, P1186, DOI 10.1016/j.jece.2014.04.019; Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2; Palmieri MC, 2002, HYDROMETALLURGY, V67, P31, DOI 10.1016/S0304-386X(02)00133-0; Palmieri MC, 2000, PROCESS BIOCHEM, V36, P441, DOI 10.1016/S0032-9592(00)00236-3; Palmieri MC, 2003, 15 INT BIOH S HELL; Cazon JP, 2013, J ENVIRON MANAGE, V129, P423, DOI 10.1016/j.jenvman.2013.07.011; REES LVC, 1986, ZEOLITES, V6, P201, DOI 10.1016/0144-2449(86)90048-5; Riano S, 2015, GREEN CHEM, V17, P2931, DOI 10.1039/c5gc00230c; Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biortech.2006.09.026; Sag Y, 2000, BIOCHEM ENG J, V6, P145, DOI 10.1016/S1369-703X(00)00083-8; Saini AS, 2013, BIORESOURCE TECHNOL, V149, P155, DOI 10.1016/j.biortech.2013.09.034; Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n; Sekomo CB, 2012, WATER AIR SOIL POLL, V223, P533, DOI 10.1007/s11270-011-0880-z; Sert S, 2008, HYDROMETALLURGY, V90, P13, DOI 10.1016/j.hydromet.2007.09.006; Smith J.M., 1981, CHEM ENG KINETICS; Takahashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114858; Takeda O, 2005, J ALLOY COMPD, V392, P206, DOI 10.1016/j.jallcom.2004.09.020; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Tang JW, 2010, CHEM GEOL, V279, P120, DOI 10.1016/j.chemgeo.2010.10.011; Tangaromsuk J, 2002, BIORESOURCE TECHNOL, V85, P103, DOI 10.1016/S0960-8524(02)00066-4; TING YP, 1995, J APPL PHYCOL, V7, P97, DOI 10.1007/BF00003557; Tuncuk A, 2012, MINER ENG, V25, P28, DOI 10.1016/j.mineng.2011.09.019; VAISHNAV V, 2011, INT J SCI ENG RES, V2, P2229; Vander Hoogerstraete T, 2014, RSC ADV, V4, P64099, DOI 10.1039/c4ra13787f; Varsihini CJS, 2014, J RARE EARTH, V32, P745, DOI 10.1016/S1002-0721(14)60136-8; Vijayaraghavan K, 2014, ENVIRON PROG SUSTAIN, V33, P147, DOI 10.1002/ep.11770; Vijayaraghavan K, 2011, DESALINATION, V265, P54, DOI 10.1016/j.desal.2010.07.030; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; VOLESKY B, 1987, TRENDS BIOTECHNOL, V5, P96, DOI 10.1016/0167-7799(87)90027-8; Volesky B., 2003, SORPTION BIOSORPTION; WANG JL, 2009, BIOTECHNOL ADV, V27, P195, DOI DOI 10.1016/J.BIOTECHADV.2008.11.002; Wieczorek N, 2014, APPL ENERG, V132, P108, DOI 10.1016/j.apenergy.2014.07.003; Yang XL, 2015, SEP PURIF TECHNOL, V142, P203, DOI 10.1016/j.seppur.2014.11.050	62	47	47	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175255	10.1371/journal.pone.0175255	http://dx.doi.org/10.1371/journal.pone.0175255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388641	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800031
J	Rodriguez-Hidalgo, R; Perez-Otanez, X; Garces-Carrera, S; Vanwambeke, SO; Madder, M; Benitez-Ortiz, W				Rodriguez-Hidalgo, Richar; Perez-Otanez, Ximena; Garces-Carrera, Sandra; Vanwambeke, Sophie O.; Madder, Maxime; Benitez-Ortiz, Washington			The current status of resistance to alpha-cypermethrin, ivermectin, and amitraz of the cattle tick (Rhipicephalus microplus) in Ecuador	PLOS ONE			English	Article							BOOPHILUS-MICROPLUS; ACARICIDE RESISTANCE; UNITED-STATES; IXODIDAE; TESTS; BIOASSAY; BIOLOGY; BRAZIL	Rhipicephalus microplus is widely distributed in tropical and subtropical areas of the world where livestock is a principal activity with great veterinary and economic importance. In Ecuador, this hematophagous ectoparasite has been observed between 0 and 2600 masl. One of the main tick control measures is the use of acaricides, which have been indiscriminately used worldwide and in Ecuador. In this country, no studies on acaricide resistance in Rhipicephalus microplus have been published. The current study aims to characterise the level of resistance of R. microplus against three main acaricides commonly used in Ecuador i.e. amitraz, alpha-cypermethrin and ivermectin to determine the level and pattern of dose-responses for R. microplus in 12 field populations (farms). The level of acaricide resistance was evaluated using three different bioassays: adult immersion test (AIT), larval package test (LPT) and larval immersion test (LIT), as recommended by the FAO. The predictive dose-responses were analysed by binomial logistics regression of the larval survival rate (resistance). In general, we found resistance of 67% for amitraz; 50% for alpha-cypermethrin and from 25 to 42% for ivermectin in the twelve field populations analysed. Resistance levels were studied in larval and adult bioassays, respectively, which were slightly modified for this study. For larval bioassays based on corrected mortality i.e. high (above 51%), medium (2150%) and low (1120%) resistance, percentages less than 10% were considered as susceptible. For the adult test, two resistance levels were used i.e. high (more than 76%) and medium (51 to 75%) resistance. Percentages lower than 50% were considered as susceptible. In this context, for larval bioassays, amitraz showed 21%, 38% and 8% for high, medium and low resistance, respectively. Alpha-cypermethrin presented 8%, 4 and 38% for high, medium and low resistance, respectively. Ivermectin presented 8%, 25% and 8% for high, medium and low resistance, respectively. For adult tests with amitraz 50% and 17% of the field populations showed average and high resistance, with evidences of average resistance to alpha-cypermethrin in 50% of the samples and average resistance against ivermectin in 25% of the farms. No statistical difference amongst the three bioassays was found and acaricide resistance was confirmed by logistic regression analysis; hence resistance (dose-responses) in each field populations differed, depending on the choice of the acaricide, frequent usage, frequency of treatment and farm management. The effective estimated dose needed to eliminate 99% of ticks is higher than dose recommended by the manufacturer. In conclusion, amitraz showed the highest resistance followed by ivermectin and alpha-cypermethrin and reveals differences on resistance in each individual field population. This information is important in order to establish the monitoring of resistance on each farm individually, contributing to the rational use of acaricides included in an integrated control program for R. microplus.	[Rodriguez-Hidalgo, Richar; Benitez-Ortiz, Washington] Univ Cent Ecuador, Inst Invest Salud Publ & Zoonosis, Quito, Ecuador; [Rodriguez-Hidalgo, Richar; Perez-Otanez, Ximena; Benitez-Ortiz, Washington] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [Garces-Carrera, Sandra] Inst Nacl Invest Agr, Quito, Ecuador; [Vanwambeke, Sophie O.] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Louvain La Neuve, Belgium; [Madder, Maxime] Inst Trop Med, Antwerp, Belgium; [Madder, Maxime] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa	Universidad Central del Ecuador; Universidad Central del Ecuador; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); University of Pretoria	Rodriguez-Hidalgo, R (corresponding author), Univ Cent Ecuador, Inst Invest Salud Publ & Zoonosis, Quito, Ecuador.; Rodriguez-Hidalgo, R (corresponding author), Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador.	rrodriguez@uce.edu.ec		Vanwambeke, Sophie/0000-0001-6620-6173; Perez Otanez, Ximena/0000-0001-8688-6487; Rodriguez-Hidalgo, Richar/0000-0002-9338-1062	Central University of Ecuador, Research Program [17]; SENESCYTECUADOR postdoctoral fellowship [AR2Q-7446]; Academie de Recherche et d'Enseignement superior (ARES)	Central University of Ecuador, Research Program; SENESCYTECUADOR postdoctoral fellowship; Academie de Recherche et d'Enseignement superior (ARES)	This work was supported by the Central University of Ecuador, Research Program No.17; SENESCYTECUADOR postdoctoral fellowship AR2Q-7446; Academie de Recherche et d'Enseignement superior (ARES) for the publication payment.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas RZ, 2014, VET PARASITOL, V203, P6, DOI 10.1016/j.vetpar.2014.03.006; Alonso-Diaz MA, 2006, ARCH MED VET, V38, P105, DOI 10.4067/S0301-732X2006000200003; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Andreotti R, 2011, REV BRAS PARASITOL V, V20, P127, DOI 10.1590/S1984-29612011000200007; Araque Alejandra, 2014, rev.udcaactual.divulg.cient., V17, P161; Barros-Battesti D.M., 2006, VOXICTTD3BUTANTAN; Santos TRB, 2013, REV BRAS PARASITOL V, V22, P495, DOI 10.1590/S1984-29612013000400008; Bravo Maribel J, 2008, Zootecnia Trop., V26, P41; Busch JD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-188; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Castro-Janer E, 2011, VET PARASITOL, V178, P148, DOI 10.1016/j.vetpar.2010.12.035; Cooley RA., 1946, NATL I HEAL B, V187; Coronado A., 1997, GAC CIEN CIAS VETERN, V25, P5; Cortes Vecino AJ, 2010, CORPORACION COLOMB I, V11, P73; CUPP EW, 1991, VET CLIN N AM-SMALL, V21, P1, DOI 10.1016/S0195-5616(91)50001-2; DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130; EDIFARM, 2011, VAD VET, P208; FAO, 2004, TICKS AC RES DIAGN M, P1; ffrench Constant RH, 1990, PESTICIDE RESISTANCE, P4; Food and Agriculture Organization, 1984, PRACTICAL FIELD MANU, VVolume I, P299; Gallardo S., 1999, SCIENCE, V11, P77; Gonzalez-Coloma A, 2013, DESARROLLO METODOS B, P58; Guillen N, 2013, ESTUDIO TAXONOMICO N; Veiga LPHN, 2012, REV BRAS PARASITOL V, V21, P133, DOI 10.1590/S1984-29612012000200011; Jonsson NN, 2007, VET PARASITOL, V146, P307, DOI 10.1016/j.vetpar.2007.02.031; Junte RD, 2008, ACARICIDE RESISTANCE, P41; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; Ojeda-Chi MM, 2011, REV MEX CIENC PECU, V2, P177; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; Mekonnen S, 2003, J S AFR VET ASSOC, V74, P41; Mekonnen S, 2002, J VET; Mendes MC, 2011, VET PARASITOL, V178, P383, DOI 10.1016/j.vetpar.2011.01.006; Muyobela J, 2015, TROP ANIM HEALTH PRO, V47, P1599, DOI 10.1007/s11250-015-0906-4; NARI A.E.C., 2003, RESISTENCIA ANTIPARA; Otero JS, 2002, INTRO DISENO EXPT, P4; Pavon-Leyva J., 2014, CIENC TECNOL, V18, P50; Perez-Otanez X, 2016, RESISTENCIA ALFA CIP; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Ritz C, 2009, ENVIRON TOXICOL CHEM, V28, P2009, DOI 10.1897/08-480.1; Rivera G, 2009, 27 REUN CIENT TECN F; Rosario-Cruz R, 2009, PARASITOL RES, V105, P1145, DOI 10.1007/s00436-009-1539-1; Soberanes Cespedes N., 2002, Tecnica Pecuaria en Mexico, V40, P81; Stone NE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0456-z; Valencia GL, 2010, CES MED VET ZOOTEC, V4, P57; Valle MR, 2004, EXP APPL ACAROL, V34, P375, DOI 10.1023/B:APPA.0000049223.92326.02; Vargas V. M., 2006, Agronomia Costarricense, V30, P101; Whitlock C, 2009, ANAL BIOL DATA, P231	48	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174652	10.1371/journal.pone.0174652	http://dx.doi.org/10.1371/journal.pone.0174652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388639	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800008
J	Nirvanappa, AC; Mohan, CD; Rangappa, S; Ananda, H; Sukhorukov, AY; Shanmugam, MK; Sundaram, MS; Nayaka, SC; Girish, KS; Chinnathambi, A; Zayed, ME; Alharbi, SA; Sethi, G; Basappa; Rangappa, KS				Nirvanappa, Anilkumar C.; Mohan, Chakrabhavi Dhananjaya; Rangappa, Shobith; Ananda, Hanumappa; Sukhorukov, Alexey Yu; Shanmugam, Muthu K.; Sundaram, Mahalingam S.; Nayaka, Siddaiah Chandra; Girish, Kesturu S.; Chinnathambi, Arunachalam; Zayed, M. E.; Alharbi, Sulaiman Ali; Sethi, Gautam; Basappa; Rangappa, Kanchugarakoppal S.			Novel Synthetic Oxazines Target NF-kappa B in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo (vol 11, e0163209, 2016)	PLOS ONE			English	Correction													Sukhorukov, Alexey Yu./N-4877-2016; Sethi, Gautam/F-2372-2011; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; KS, Girish/GWZ-7128-2022; Rangappa, Shobith/AAI-2169-2020	Sukhorukov, Alexey Yu./0000-0003-4413-9453; Sethi, Gautam/0000-0002-8677-8475; Rangappa, Shobith/0000-0002-9800-7192				Nirvanappa AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163209	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175659	10.1371/journal.pone.0175659	http://dx.doi.org/10.1371/journal.pone.0175659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384360	gold, Green Published			2022-12-27	WOS:000399371900199
J	Olariu, V; Nilsson, J; Jonsson, H; Peterson, C				Olariu, Victor; Nilsson, Julia; Jonsson, Henrik; Peterson, Carsten			Different reprogramming propensities in plants and mammals: Are small variations in the core network wirings responsible?	PLOS ONE			English	Article							STEM-CELL HOMEOSTASIS; NANOG AUTOREPRESSION; GENE-EXPRESSION; SHOOT; PLURIPOTENCY; WUSCHEL; ARABIDOPSIS; MERISTEM; INDUCTION; COMPLEX	Although the plant and animal kingdoms were separated more than 1,6 billion years ago, multicellular development is for both guided by similar transcriptional, epigenetic and post-transcriptional machinery. One may ask to what extent there are similarities and differences in the gene regulation circuits and their dynamics when it comes to important processes like stem cell regulation. The key players in mouse embryonic stem cells governing pluripotency versus differentiation are Oct4, Sox2 and Nanog. Correspondingly, the WUSCHEL and CLAVATA3 genes represent a core in the Shoot Apical Meristem regulation for plants. In addition, both systems have designated genes that turn on differentiation. There is very little molecular homology between mammals and plants for these core regulators. Here, we focus on functional homologies by performing a comparison between the circuitry connecting these players in plants and animals and find striking similarities, suggesting that comparable regulatory logics have been evolved for stem cell regulation in both kingdoms. From in silico simulations we find similar differentiation dynamics. Further when in the differentiated state, the cells are capable of regaining the stem cell state. We find that the propensity for this is higher for plants as compared to mammalians. Our investigation suggests that, despite similarity in core regulatory networks, the dynamics of these can contribute to plant cells being more plastic than mammalian cells, i.e. capable to reorganize from single differentiated cells to whole plants-reprogramming. The presence of an incoherent feed-forward loop in the mammalian core circuitry could be the origin of the different reprogramming behaviour.	[Olariu, Victor; Nilsson, Julia; Jonsson, Henrik; Peterson, Carsten] Lund Univ, Computat Biol & Biol Phys, Lund, Sweden; [Olariu, Victor] Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, Copenhagen, Denmark; [Jonsson, Henrik] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Jonsson, Henrik] Univ Cambridge, DAMTP, Cambridge, England	Lund University; University of Copenhagen; Niels Bohr Institute; University of Cambridge; University of Cambridge	Jonsson, H; Peterson, C (corresponding author), Lund Univ, Computat Biol & Biol Phys, Lund, Sweden.; Jonsson, H (corresponding author), Univ Cambridge, Sainsbury Lab, Cambridge, England.; Jonsson, H (corresponding author), Univ Cambridge, DAMTP, Cambridge, England.	Henrik.Jonsson@slcu.cam.ac.uk; Carsten.Peterson@thep.lu.se			Swedish Research Council [VR 621-2013-4547, VR 621-2013-4632]; Swedish Foundation for Strategic Research [A3 04 159p]; Gatsby Charitable Foundation (GB) [GAT3395-PR4]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Gatsby Charitable Foundation (GB)	This work was supported Swedish Research Council, grant VR 621-2013-4547 to CP; the Swedish Foundation for Strategic Research, grant A3 04 159p to CP; the Gatsby Charitable Foundation (GB), grant GAT3395-PR4 to HJ and the Swedish Research Council, grant VR 621-2013-4632 to HJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchabke-Coussa O, 2013, PLANT CELL REP, V32, P675, DOI 10.1007/s00299-013-1402-9; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-98; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kornet N, 2008, COLD SPRING HARB S Q; Laux T, 1996, DEVELOPMENT, V122, P87; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; Livigni A, 2013, CURR BIOL, V23, P2233, DOI 10.1016/j.cub.2013.09.048; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Olariu V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25438; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pikaard CS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019315; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Sun B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00017; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas P., 2011, J CHEM PHYS, V135; Tsai SY, 2011, STEM CELLS, V29, P964, DOI 10.1002/stem.649; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	53	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175251	10.1371/journal.pone.0175251	http://dx.doi.org/10.1371/journal.pone.0175251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384293	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900137
J	Vanroy, J; Seghers, J; Bogaerts, A; Devloo, K; De Cock, S; Boen, F				Vanroy, Jari; Seghers, Jan; Bogaerts, An; Devloo, Karlien; De Cock, Stijn; Boen, Filip			Short- and long-term effects of a need-supportive physical activity intervention among patients with type 2 diabetes mellitus: A randomized controlled pilot trial	PLOS ONE			English	Article							EXERCISE; METAANALYSIS; BEHAVIOR; FITNESS; ARMBAND; ADVICE; PEOPLE	Objective This pilot trial evaluated the short- and long-term effects of a six-week need-supportive physical activity (PA) intervention among patients with type 2 diabetes mellitus, on health-related (HbA1c and physical fitness) and behavioral (objectively-measured and self-reported PA) outcomes. Methods To support the basic psychological needs for autonomy, relatedness and competence, the intervention included one in- and outtake session with a PA coach, an individualized PA program and a weekly PA group session. The intervention was set up in collaboration with a health insurance fund and with general practitioners. A total of forty-eight patients participated in the study and were randomly assigned to an intervention (n = 27) or a waiting-list control condition (n = 21). Results Linear mixed models did not reveal any significant interaction effects between time and condition (ps > .05). However, significant time effects across conditions were found: a decrease in HbA1c at short term and increases in self-reported PA at both short and long term and in physical fitness at long term (ps < .05). Conclusion Although the intervention as a whole did not produce the expected impact, there seems a potential for brief but regular expert visit and measurement.	[Vanroy, Jari; Seghers, Jan; Devloo, Karlien; Boen, Filip] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Flemish Brabant, Belgium; [Bogaerts, An] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Leuven, Flemish Brabant, Belgium; [De Cock, Stijn] Christian Hlth Insurance Fund, Dept Hlth Promot, Leuven, Flemish Brabant, Belgium	KU Leuven; KU Leuven	Vanroy, J (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Leuven, Flemish Brabant, Belgium.	Jari.vanroy@kuleuven.be	Seghers, Jan/O-2843-2015; Boen, Filip/D-8057-2018	Seghers, Jan/0000-0002-2930-1259; Boen, Filip/0000-0002-5295-4776	Christian Health Insurance Fund (CM)	Christian Health Insurance Fund (CM)	This work was supported by the Christian Health Insurance Fund (CM). CM provided a salary for author SDC and a project-related budget,which included financial compensations for the project related working hours of authors AB and KD. CM also assisted in the study design, recruitment of participants, communication with GP's, writing of the manuscript and decision to submit the manuscript for publication.CM did not play a direct role in the data collection and analysis regarding the present manuscript. The specific roles of the authors are articulated in the 'authorcontributions' section.	Almeida GJM, 2011, PHYS THER, V91, P1367, DOI 10.2522/ptj.20100291; [Anonymous], 1991, MOTIVATIONAL INTERVI; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Ball K, 2000, AUST NZ J PUBL HEAL, V24, P331, DOI 10.1111/j.1467-842X.2000.tb01579.x; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Biddle SJH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143398; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Chase JAD, 2013, NURS RES, V62, P294, DOI 10.1097/NNR.0b013e3182a0395c; De Greef K, 2010, HEALTH EDUC RES, V25, P724, DOI 10.1093/her/cyq017; Deci EL, 1985, INTRINSIC MOTIVATION; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Glasgow RE, 2003, DIABETES CARE, V26, P2451, DOI 10.2337/diacare.26.8.2451; Godin G., 2011, ACSMS HEALTH FIT J, V4; Gracia-Marco L, 2013, J SPORT SCI, V31, P1831, DOI 10.1080/02640414.2013.803595; Haase AM, 2010, MENT HEALTH PHYS ACT, V3, P85, DOI DOI 10.1016/J.MHPA.2010.09.004; Harris SB, 2003, CAN FAM PHYSICIAN, V49, P1618; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Lenters-Westra E, 2014, NETH J MED, V72, P462; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Ortlieb S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-28; PATE RR, 1988, QUEST, V40, P174, DOI 10.1080/00336297.1988.10483898; Rosner B., 1995, FUNDAMENTALS BIOSTAT, P221; Smith BJ, 2000, BRIT J SPORT MED, V34, P262, DOI 10.1136/bjsm.34.4.262; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Tomaz SA, 2016, EUR J SPORT SCI, V16, P149, DOI 10.1080/17461391.2014.987323; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Waters L, 2012, J PHYS ACT HEALTH, V9, P884, DOI 10.1123/jpah.9.6.884; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; World Health Organization, 10 FACTS DIAB 2015	32	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174805	10.1371/journal.pone.0174805	http://dx.doi.org/10.1371/journal.pone.0174805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384237	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900039
J	Wang, SB; Wang, XC; Ma, Y; Liu, KD; Xing, YQ				Wang, Si-Bo; Wang, Xiao-Cong; Ma, Yan; Liu, Kang-Ding; Xing, Ying-Qi			Right-to-left shunt detection using contrast-enhanced transcranial Doppler: A comparison of provocation maneuvers between coughing and a modified Valsalva maneuver	PLOS ONE			English	Article							PATENT FORAMEN OVALE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ULTRASOUND; DIAGNOSIS; MIGRAINE; CLOSURE; STROKE	Contrast-enhanced transcranial Doppler (c-TCD) has been used to detect right-to-left shunts (RLS) because it is highly sensitive and cost-effective. The use of provocation maneuvers, such as physiologic maneuvers (e.g., coughing) and the Valsalva maneuver (VM) to transiently increase right atrial pressure and induce RLS increases the sensitivity of RLS detection. In this study, we sought to determine whether coughing is as effective as the VM in aiding the detection of RLS. We evaluated 162 subjects for RLS, using c-TCD under three different conditions: (i) resting state, (ii) coughing, and (iii) modified VM (m-VM), which involved blowing into a tube connected to a sphygmomanometer at 40 mmHg for 10 s. The positive rate of RLS detection with the m-VM was significantly higher than that with coughing. In addition, a difference between the two maneuvers was observed in terms of the degree of RLS seen. The m-VM should be widely used to detect RLS, because it is reliable, standardized, and cost-effective.	[Wang, Si-Bo; Liu, Kang-Ding; Xing, Ying-Qi] Jilin Univ, Hosp 1, Dept Neurol, Neurosci Ctr, Changchun, Peoples R China; [Wang, Xiao-Cong; Ma, Yan] Jilin Univ, Hosp 1, Cardiovasc Ctr, Dept Echocardiog, Changchun, Peoples R China	Jilin University; Jilin University	Liu, KD; Xing, YQ (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Neurosci Ctr, Changchun, Peoples R China.	kangdingliu@163.com; xingyq2009@sina.com		Xing, Yingqi/0000-0002-7403-5789				Anzola Gian Paolo, 2002, Eur J Ultrasound, V16, P11, DOI 10.1016/S0929-8266(02)00043-5; Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Aparci M, 2016, ACTA NEUROL SCAND, V133, P313, DOI 10.1111/ane.12485; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Droste DW, 1999, STROKE, V30, P1827, DOI 10.1161/01.STR.30.9.1827; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gempp E, 2009, INT J SPORTS MED, V30, P150, DOI 10.1055/s-2008-1038844; Guo YZ, 2016, ULTRASOUND MED BIOL, V42, P1124, DOI 10.1016/j.ultrasmedbio.2015.12.020; Hao N, 2014, ULTRASOUND MED BIOL, V40, P2317, DOI 10.1016/j.ultrasmedbio.2014.03.011; Homma S, 2005, CIRCULATION, V112, P1063, DOI 10.1161/CIRCULATIONAHA.104.524371; JAUSS M, 1994, STROKE, V25, P1265, DOI 10.1161/01.STR.25.6.1265; Jauss M, 2000, CEREBROVASC DIS, V10, P490, DOI 10.1159/000016119; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim BJ, 2014, STROKE, V45, P3707, DOI 10.1161/STROKEAHA.114.007453; Lao AY, 2008, J NEUROIMAGING, V18, P402, DOI 10.1111/j.1552-6569.2007.00218.x; Mojadidi MK, 2014, JACC-CARDIOVASC IMAG, V7, P236, DOI 10.1016/j.jcmg.2013.12.011; Nedeltchev K, 2006, FRONT NEUROL NEUROSC, V21, P206, DOI 10.1159/000092432; Pfleger S, 2001, Eur J Echocardiogr, V2, P88, DOI 10.1053/euje.2000.0052; Rengifo-Moreno P, 2013, EUR HEART J, V34, P3342, DOI 10.1093/eurheartj/eht285; Sastry S, 2009, J CLIN ULTRASOUND, V37, P276, DOI 10.1002/jcu.20564; Silvestry FE, 2015, J AM SOC ECHOCARDIOG, V28, P910, DOI 10.1016/j.echo.2015.05.015; Spencer FA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004282; STODDARD MF, 1993, AM HEART J, V125, P185, DOI 10.1016/0002-8703(93)90073-I; Stone DA, 1996, AM HEART J, V131, P158, DOI 10.1016/S0002-8703(96)90065-4; Wessler BS, 2015, CEREBROVASC DIS, V40, P52, DOI 10.1159/000430998; Xing YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39081; Xu WH, 2014, EUR J NEUROL, V21, P525, DOI 10.1111/ene.12351; Yang Y, 2012, EUR J NEUROL, V19, P1367, DOI 10.1111/j.1468-1331.2012.03793.x; Zanette EM, 1996, STROKE, V27, P2251, DOI 10.1161/01.STR.27.12.2251	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175049	10.1371/journal.pone.0175049	http://dx.doi.org/10.1371/journal.pone.0175049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384297	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900076
J	Yang, KL; Chang, WT; Hong, MY; Hung, KC; Chuang, CC				Yang, Kun-Lin; Chang, Wen-Teng; Hong, Ming-Yuan; Hung, Kuo-Chen; Chuang, Chia-Chang			Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative antioxidant through suppression of ROS, inflammation and hepatic stellate cells activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ANTRODIA-CAMPHORATA; IN-VITRO; INHIBITION; PROMOTER; GENE; OVEREXPRESSION; EXPRESSION; TGF-BETA-1; INDUCTION	Current anti-fibrotic effect of antioxidants in vivo is disappointing due probably to the fact that once liver fibrogenesis is established it is too advanced to be reversed by anti-oxidation mechanism. We consider antioxidant may only act on the early phase of fibrogenesis. Thus, we had previously established an early liver fibrosis animal model using an inducible expression vector (pPK9a), which contains TGF-beta gene and was hydro-dynamically transferred into mice to induce a transient liver fibrosis. TGF-beta 1 has been well documented to up-regulate the expression of alpha 2(1) collagen (Col 1A2) gene in the liver via the reactive oxygen species (ROS); the process triggers inflammation, leading to hepatic stellate cells (HSC) activation and liver fibrogenesis. Using our animal model and ROS, cyclooxygenase-2 (Cox-2) and Col 1A2 promoter assays as screening targets, we report here that a maleic acid derivative isolated from the Antrodia camphorata mycelium strongly decreases ROS production, promoter activity of Cox-2 and Col 1A2, intracellular calcium, expression of alpha-smooth muscle actin (alpha-SMA), Smad4-p-Smad2/3 co-localization in cell nucleus and the DNA binding activity of Sp1. Our results suggest that the maleic acid derivative prevents liver fibrosis at an early phase both in vitro and in vivo through the inhibition of ROS, inflammation and the activation of HSC.	[Yang, Kun-Lin] Natl Pei Men Senior Agr & Ind Vocat Sch, Dept Anim Sci, Tainan, Taiwan; [Yang, Kun-Lin] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chang, Wen-Teng] Chung Hwa Univ Med Technol, Dept Biol Sci & Technol, Tainan, Taiwan; [Hong, Ming-Yuan; Chuang, Chia-Chang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Coll Med, Tainan, Taiwan; [Hung, Kuo-Chen] Yuans Gen Hosp, Dept Gen Surg, Kaohsiung, Taiwan	National Kaohsiung Normal University; Chung Hua University; National Cheng Kung University; National Cheng Kung University Hospital	Chuang, CC (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Coll Med, Tainan, Taiwan.	chuanger@mail.ncku.edu.tw		Hong, Ming-Yuan/0000-0003-0320-1484	National Science Council, Taiwan [NSC 93-2622-B-006-002-CC3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by a grant from the National Science Council, Taiwan (NSC 93-2622-B-006-002-CC3). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthemanuscript.	Chang WT, 2004, J BIOL CHEM, V279, P14542, DOI 10.1074/jbc.M309825200; Chang WW, 2003, J HEPATOL, V39, P834, DOI 10.1016/S0168-8278(03)00389-1; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Chen RH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134887; Cho JH, 2002, CARCINOGENESIS, V23, P1163, DOI 10.1093/carcin/23.7.1163; Dooley S, 2001, FEBS LETT, V502, P4, DOI 10.1016/S0014-5793(01)02656-4; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Grant MB, 2000, INVEST OPHTH VIS SCI, V41, P2296; Hseu YC, 2005, INT IMMUNOPHARMACOL, V5, P1914, DOI 10.1016/j.intimp.2005.06.013; Hseu YC, 2002, LIFE SCI, V71, P469, DOI 10.1016/S0024-3205(02)01686-7; Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Kobayashi N, 2005, ADV DRUG DELIVER REV, V57, P713, DOI 10.1016/j.addr.2004.12.006; Kubota K, 2003, J SURG RES, V109, P43, DOI 10.1016/S0022-4804(02)00037-9; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mori Y, 2000, EXP CELL RES, V258, P374, DOI 10.1006/excr.2000.4930; SAMUEL SK, 1992, EMBO J, V11, P1599, DOI 10.1002/j.1460-2075.1992.tb05205.x; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Song TY, 2002, J AGR FOOD CHEM, V50, P3322, DOI 10.1021/jf011671z; Swart PJ, 1999, J HEPATOL, V31, P1034, DOI 10.1016/S0168-8278(99)80316-X; Vogel S, 2000, J LIPID RES, V41, P882; Yang Kun-Lin, 2007, Comp Hepatol, V6, P9, DOI 10.1186/1476-5926-6-9; Yang KL, 2008, BIOCHEM BIOPH RES CO, V373, P219, DOI 10.1016/j.bbrc.2008.05.192; Yang KL, 2008, BIOCHEM BIOPH RES CO, V365, P484, DOI 10.1016/j.bbrc.2007.10.203; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	27	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174008	10.1371/journal.pone.0174008	http://dx.doi.org/10.1371/journal.pone.0174008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384213	Green Published, gold			2022-12-27	WOS:000399371900011
J	Zhang, KR; Liu, ZF; Cao, XH; Yang, CX; Xu, Y; Xu, T; Xu, C; Yang, Z				Zhang, Kerang; Liu, Zhifen; Cao, Xiaohua; Yang, Chunxia; Xu, Yong; Xu, Ting; Xu, Cheng; Yang, Zhi			Amplitude of low-frequency fluctuations in first-episode, drug-naive depressive patients: A 5-year retrospective study	PLOS ONE			English	Article							BIPOLAR DISORDER; FUNCTIONAL CONNECTIVITY; MAJOR DEPRESSION; RESPONSE-INHIBITION; NEURAL RESPONSE; TREATMENT-RESISTANT; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; MEDICATION-NAIVE; IMAGING ANALYSIS	Despite different treatments and courses of illness, depressive symptoms appear similar in bipolar disorder (BD) and major depressive disorder (MDD), causing BD with an onset of depressive episode being frequently misdiagnosed as MDD, and leading to inappropriate treatment and poor clinical outcomes. Therefore, there is an urgent need to explore underlying neural basis to distinguish BD from MDD. The medical records of 80 first-episode, drug-naive depressive patients with an initial diagnosis of MDD and illness duration of at least 5 years were reviewed retrospectively for this study. Fourteen bipolar depressed patients with a diagnosis conversion from MDD to BD, 14 patients with diagnosis of MDD, and 14 healthy subjects demographically matched with the BD group, were selected to participate in the study. Firstly, we examined whether there were differences among the three groups in whole brain fALFF during resting state. Secondly, clusters showing group differences in fALFF in any two groups were chosen as regions of interest (ROI) and then correlation between clinical features and fALFF values of ROIs were calculated. The BD group showed increased fALFF in bilateral putamen relative to both the MDD group and controls, while the MDD group exhibited decreased fALFF in left superior frontal gyrus (SFG) relative to both the BD group and controls (p < 0.05, corrected). Positive correlations between abnormality in the putamen and symptom severity were observed (significant for the MDD group, p = 0.043; marginally significant for the BD group, p = 0.060/0.076). These results implicate that abnormalities of key regions in the striatum and prefrontal areas may be trait markers for BD and MDD.	[Zhang, Kerang; Liu, Zhifen; Cao, Xiaohua; Yang, Chunxia; Xu, Yong] Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China; [Xu, Ting; Yang, Zhi] Chinese Acad Sci, Key Lab Behav Sci, Beijing, Peoples R China; [Xu, Ting; Yang, Zhi] Chinese Acad Sci, Magnet Resonance Imaging Res Ctr, Inst Psychol, Beijing, Peoples R China; [Xu, Ting; Yang, Zhi] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Beijing, Peoples R China; [Xu, Cheng] Shanxi Prov Hosp, Dept Radiol, Taiyuan, Peoples R China	Shanxi Medical University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Zhang, KR (corresponding author), Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China.	krzhang_sxmu@vip.163.com	Yang, Zhi/W-6459-2019	Yang, Zhi/0000-0002-2222-2312	National Natural Science Foundation of China [81171290, 81471379]; Natural Science Foundation for Young Scientists of Shanxi Province, China [2012021036-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Young Scientists of Shanxi Province, China(Natural Science Foundation of Shanxi Province)	This study was funded by National Natural Science Foundation of China (No. 81171290, 81471379, KZ. http://www.nsfc. gov.cn/) and the Natural Science Foundation for Young Scientists of Shanxi Province, China (No. 2012021036-2, XC.http://www.sxinfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Almeida JRC, 2010, BIOL PSYCHIAT, V67, P414, DOI 10.1016/j.biopsych.2009.09.027; Baldessarini RJ, 2010, BIPOLAR DISORD, V12, P264, DOI 10.1111/j.1399-5618.2010.00812.x; Bertocci MA, 2012, PSYCHOL MED, V42, P1417, DOI 10.1017/S003329171100242X; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumberg HP, 2003, AM J PSYCHIAT, V160, P1345, DOI 10.1176/appi.ajp.160.7.1345; Chang K, 2004, ARCH GEN PSYCHIAT, V61, P781, DOI 10.1001/archpsyc.61.8.781; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Chen ZF, 2012, PROG NEURO-PSYCHOPH, V36, P231, DOI 10.1016/j.pnpbp.2011.11.002; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Delvecchio G, 2012, EUR NEUROPSYCHOPHARM, V22, P100, DOI 10.1016/j.euroneuro.2011.07.003; Deveney CM, 2012, PROG NEURO-PSYCHOPH, V38, P127, DOI 10.1016/j.pnpbp.2012.02.014; Diler RS, 2014, J CAN ACAD CHILD ADO, V23, P10; Diler RS, 2013, PSYCHIAT RES-NEUROIM, V214, P277, DOI 10.1016/j.pscychresns.2013.06.013; First MB, 2002, STRUCTURED CLIN INTE; Fournier JC, 2013, BIPOLAR DISORD, V15, P741, DOI 10.1111/bdi.12106; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gong Yun, 2014, Shanghai Arch Psychiatry, V26, P207, DOI 10.3969/j.issn.1002-0829.2014.04.004; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guo WB, 2013, PROG NEURO-PSYCHOPH, V40, P153, DOI 10.1016/j.pnpbp.2012.08.014; Guo WB, 2012, J PSYCHIATR RES, V46, P1366, DOI 10.1016/j.jpsychires.2012.07.003; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029; Haller S, 2011, J PSYCHIATR NEUROSCI, V36, P391, DOI 10.1503/jpn.100140; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; He H, 2016, J AFFECT DISORDERS, V190, P483, DOI 10.1016/j.jad.2015.10.042; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hummer TA, 2013, BIOL PSYCHIAT, V73, P136, DOI 10.1016/j.biopsych.2012.06.036; HUSAIN MM, 1991, PSYCHIAT RES-NEUROIM, V40, P95, DOI 10.1016/0925-4927(91)90001-7; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Jung J, 2014, J AFFECT DISORDERS, V169, P179, DOI 10.1016/j.jad.2014.08.018; Keck PE, 2008, J PSYCHIATR PRACT, V14, P31, DOI 10.1097/01.pra.0000320124.91799.2a; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Lai CH, 2014, J AFFECT DISORDERS, V160, P74, DOI 10.1016/j.jad.2013.12.036; Lai CH, 2014, J NEUROPSYCH CLIN N, V26, P34, DOI 10.1176/appi.neuropsych.12060143; Liu CH, 2013, PROG NEURO-PSYCHOPH, V41, P52, DOI 10.1016/j.pnpbp.2012.11.010; Liu F, 2013, J AFFECT DISORDERS, V146, P401, DOI 10.1016/j.jad.2012.10.001; Machino A, 2014, J AFFECT DISORDERS, V168, P229, DOI 10.1016/j.jad.2014.06.030; MacMaster FP, 2014, BRAIN IMAGING BEHAV, V8, P119, DOI 10.1007/s11682-013-9264-x; Marchand WR, 2013, J AFFECT DISORDERS, V150, P527, DOI 10.1016/j.jad.2013.01.028; Marchand WR, 2012, NEUROSCI LETT, V514, P86, DOI 10.1016/j.neulet.2012.02.063; Marchand WR, 2010, BRAIN STRUCT FUNCT, V215, P73, DOI 10.1007/s00429-010-0280-y; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Meyer JH, 2006, AM J PSYCHIAT, V163, P1594, DOI 10.1176/appi.ajp.163.9.1594; Noga JT, 2001, PSYCHIAT RES-NEUROIM, V106, P25, DOI 10.1016/S0925-4927(00)00084-6; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pavuluri MN, 2010, J CLIN PSYCHIAT, V71, P1526, DOI 10.4088/JCP.09m05504yel; Perlis RH, 2006, AM J PSYCHIAT, V163, P225, DOI 10.1176/appi.ajp.163.2.225; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qin JL, 2014, MAGN RESON IMAGING, V32, P1314, DOI 10.1016/j.mri.2014.08.037; Radaelli D, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.04.001; ROBINSON R G, 1989, Journal of Geriatric Psychiatry, V22, P1; Schiller CE, 2013, J AFFECT DISORDERS, V151, P756, DOI 10.1016/j.jad.2013.06.016; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Strakowski SM, 2002, AM J PSYCHIAT, V159, P1841, DOI 10.1176/appi.ajp.159.11.1841; Sundermann B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00692; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Surguladze SA, 2010, NEUROIMAGE, V53, P58, DOI 10.1016/j.neuroimage.2010.05.069; Tavares JVT, 2008, NEUROIMAGE, V42, P1118, DOI 10.1016/j.neuroimage.2008.05.049; Valenti Marc, 2012, J Clin Psychiatry, V73, pe271, DOI 10.4088/JCP.11m07166; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang Y, 2015, BIPOLAR DISORD, V17, P486, DOI 10.1111/bdi.12315; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Xu K, 2014, J AFFECT DISORDERS, V152, P237, DOI 10.1016/j.jad.2013.09.017; Xu T, 2015, SCI BULL, V60, P86, DOI 10.1007/s11434-014-0698-3; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	78	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174564	10.1371/journal.pone.0174564	http://dx.doi.org/10.1371/journal.pone.0174564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384269	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900020
J	Casos, K; Ferrer-Curriu, G; Soler-Ferrer, P; Perez, ML; Permanyer, E; Blasco-Lucas, A; Gracia-Baena, JM; Castro, MA; Sureda, C; Barquinero, J; Galinanes, M				Casos, Kelly; Ferrer-Curriu, Gemma; Soler-Ferrer, Paula; Perez, Maria L.; Permanyer, Eduard; Blasco-Lucas, Arnau; Manuel Gracia-Baena, Juan; Castro, Miguel A.; Sureda, Carlos; Barquinero, Jordi; Galinanes, Manuel			Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; OXIDATIVE STRESS; FREE-RADICALS; ESTROGEN; COMPLICATIONS; CHANNEL	Background The diseased human myocardium is highly susceptible to ischemia/reoxygenation (I/R)induced injury but its response to protective interventions such as ischemic preconditioning (IPreC) is unclear. Cardiac and other pre-existing clinical conditions as well as previous or ongoing medical treatment may influence the myocardial response to I/R injury and protection. This study investigated the effect of both on myocardial susceptibility to I/R-induced injury and the protective effects of IPreC. Methods and results Atrial myocardium from cardiac surgery patients (n = 300) was assigned to one of three groups: aerobic control, I/R alone, and IPreC. Lactate dehydrogenase leakage, as a marker of cell injury, and cell viability were measured. The basal redox status was determined in samples from 90 patients. The response to I/R varied widely. Myocardium from patients with aortic valve disease was the most susceptible to injury whereas myocardium from dyslipidemia patients was the least susceptible. Tissue from females was better protected than tissue from males. Myocardium from patients with mitral valve disease was the least responsive to IPreC. The basal redox status was altered in the myocardium from patients with mitral and aortic valve disease. Conclusions The response of the myocardium to I/R and IPreC is highly variable and influenced by the underlying cardiac pathology, dyslipidemia, sex, and the basal redox status. These results should be taken into account in the design of future clinical studies on the prevention of I/R injury and protection.	[Casos, Kelly; Ferrer-Curriu, Gemma; Soler-Ferrer, Paula; Perez, Maria L.; Galinanes, Manuel] Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Vall dHebron Res Inst VHIR, Reparat Therapy Heart, Barcelona, Spain; [Permanyer, Eduard; Blasco-Lucas, Arnau; Manuel Gracia-Baena, Juan; Castro, Miguel A.; Sureda, Carlos; Galinanes, Manuel] Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Dept Cardiac Surg, Barcelona, Spain; [Barquinero, Jordi] UAB, Gene & Cell & Therapy Lab VHIR, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Galinanes, M (corresponding author), Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Vall dHebron Res Inst VHIR, Reparat Therapy Heart, Barcelona, Spain.; Galinanes, M (corresponding author), Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Dept Cardiac Surg, Barcelona, Spain.	manuel.galinanes@gmail.com	Barquinero, Jordi/F-6979-2011; Blasco-Lucas, Arnau/AFL-9427-2022; Llusa-Perez, Manuel/ABF-6891-2021; Blasco-Lucas, Arnau/AAH-1531-2022	Barquinero, Jordi/0000-0002-1677-9851; Llusa-Perez, Manuel/0000-0003-2807-563X; Gracia Baena, Juan Manuel/0000-0001-5277-3847; Ferrer Curriu, Gemma/0000-0002-2651-649X	Institute de Salud Carlos III (FIS) [12/00119]	Institute de Salud Carlos III (FIS)	This study was supported by the Institute de Salud Carlos III (FIS) [grant number 12/00119].	Adams KF, 1999, CIRCULATION, V99, P1816, DOI 10.1161/01.CIR.99.14.1816; ALLARD MF, 1994, J MOL CELL CARDIOL, V26, P1551, DOI 10.1006/jmcc.1994.1175; ANDERSON PG, 1990, CIRC RES, V67, P948, DOI 10.1161/01.RES.67.4.948; Cao YK, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187940; Carluccio E, 2000, INT J CARDIOL, V74, P177, DOI 10.1016/S0167-5273(00)00264-3; Cavalca V, 2013, INTERACT CARDIOV TH, V17, P923, DOI 10.1093/icvts/ivt386; Chandrashekhar Y, 2009, LANCET, V374, P1271, DOI 10.1016/S0140-6736(09)60994-6; Correale M, 2012, CURR VASC PHARMACOL, V12, P873; Csonka C, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3863726; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Fernandez-Jimenez R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001218; Ferrara AL, 2003, NUTR METAB CARDIOVAS, V13, P126, DOI 10.1016/S0939-4753(03)80171-0; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Galinanes M, 2004, CARDIOVASC RES, V61, P512, DOI 10.1016/j.cardiores.2003.11.028; Genereux P, 2014, J AM COLL CARDIOL, V64, P2605, DOI 10.1016/j.jacc.2014.08.052; Hawkes AL, 2006, VASC HEALTH RISK MAN, V2, P477, DOI 10.2147/vhrm.2006.2.4.477; He F, 2015, INT J MOL SCI, V16, P27770, DOI 10.3390/ijms161126059; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Juranek I, 2005, GEN PHYSIOL BIOPHYS, V24, P263; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Lee TM, 2000, J MOL CELL CARDIOL, V32, P1147, DOI 10.1006/jmcc.2000.1167; Linares-Palomino J, J PHYSL, V588, P2173; Malek LA, 2012, EUR J RADIOL, V81, pE177, DOI 10.1016/j.ejrad.2011.01.088; MENASCHE P, 1985, AM HEART J, V110, P1204, DOI 10.1016/0002-8703(85)90014-6; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Schwarzenberger JC, 2003, CRIT CARE MED, V31, P689, DOI 10.1097/01.CCM.0000055442.84685.4D; SINK JD, 1981, J THORAC CARDIOV SUR, V81, P865; Skyschally A, 2003, AM J PHYSIOL-HEART C, V284, pH698, DOI 10.1152/ajpheart.00693.2002; SPEECHLYDICK ME, 1995, CIRC RES, V77, P1030, DOI 10.1161/01.RES.77.5.1030; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tritto I, 1997, CIRC RES, V80, P743, DOI 10.1161/01.RES.80.5.743; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wang MJ, 2006, J MOL CELL CARDIOL, V40, P205, DOI 10.1016/j.yjmcc.2005.06.019; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766; Zhang JG, 2000, CARDIOVASC RES, V45, P93; Zuo Li, 2013, [Frontiers in Biology, 生物学前沿], V8, P305; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174588	10.1371/journal.pone.0174588	http://dx.doi.org/10.1371/journal.pone.0174588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380047	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500053
J	Chehelcheraghi, M; van Leeuwen, C; Steur, E; Nakatani, C				Chehelcheraghi, Mojtaba; van Leeuwen, Cees; Steur, Erik; Nakatani, Chie			A neural mass model of cross frequency coupling	PLOS ONE			English	Article							SYNCHRONIZED GAMMA-OSCILLATIONS; NEURONAL OSCILLATIONS; PHASE SYNCHRONIZATION; INTERNEURON NETWORKS; SYNAPTIC INHIBITION; MATHEMATICAL-MODEL; HIPPOCAMPUS; MODULATION; RHYTHMS; BRAIN	Electrophysiological signals of cortical activity show a range of possible frequency and amplitude modulations, both within and across regions, collectively known as cross-frequency coupling. To investigate whether these modulations could be considered as manifestations of the same underlying mechanism, we developed a neural mass model. The model provides five out of the theoretically proposed six different coupling types. Within model components, slow and fast activity engage in phase-frequency coupling in conditions of low ambient noise level and with high noise level engage in phase-amplitude coupling. Between model components, these couplings can be coordinated via slow activity, giving rise to more complex modulations. The model, thus, provides a coherent account of cross-frequency coupling, both within and between components, with which regional and crossregional frequency and amplitude modulations could be addressed.	[Chehelcheraghi, Mojtaba; van Leeuwen, Cees; Steur, Erik; Nakatani, Chie] Katholieke Univ Leuven, Brain & Cognit Res Unit, Leuven, Belgium; [van Leeuwen, Cees] TU Kaiserslautern, Ctr Cognit Sci, Kaiserslautern, Germany; [Steur, Erik] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands; [Steur, Erik] Eindhoven Univ Technol, Dept Mech Engn, Eindhoven, Netherlands	KU Leuven; University of Kaiserslautern; Eindhoven University of Technology; Eindhoven University of Technology	Nakatani, C (corresponding author), Katholieke Univ Leuven, Brain & Cognit Res Unit, Leuven, Belgium.	chie.nakatani@kuleuven.be	van Leeuwen, Cees/AAB-9525-2022; van Leeuwen, Cees/G-2644-2010; Nakatani, Chie/I-9183-2017	van Leeuwen, Cees/0000-0002-4441-2440; van Leeuwen, Cees/0000-0002-4441-2440; Nakatani, Chie/0000-0001-6743-4709	Odysseus grant from the Flemish organizations for science (FWO)	Odysseus grant from the Flemish organizations for science (FWO)	This research is founded by an Odysseus grant from the Flemish organizations for science (FWO) awarded to Cees van Leeuwen.; This research was supported by an Odysseus grant from the Flemish organizations for science (FWO) awarded to Cees van Leeuwen.	Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bekisz M, 1999, NEUROREPORT, V10, P3589, DOI 10.1097/00001756-199911260-00023; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunner C., 2013, BIOMED ENG BIOMED TE; Bruns A, 2000, NEUROREPORT, V11, P1509, DOI 10.1097/00001756-200005150-00028; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chehelcheraghi M, 2017, ZENODO; Chehelcheraghi M, MATH MODEL IN PRESS; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cona F, 2014, J COMPUT NEUROSCI, V37, P125, DOI 10.1007/s10827-013-0493-1; Cona F, 2011, NEUROIMAGE, V57, P1045, DOI 10.1016/j.neuroimage.2011.05.007; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Davis J., 1994, LARGE SCALE NEURONAL; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Garnier A, 2015, NEURAL COMPUT, V27, P329, DOI 10.1162/NECO_a_00696; Goodfellow M, 2011, NEUROIMAGE, V55, P920, DOI 10.1016/j.neuroimage.2010.12.074; Huang G, 2011, NEUROCOMPUTING, V74, P1026, DOI 10.1016/j.neucom.2010.11.019; Hyafil A, 2015, TRENDS NEUROSCI, V38, P725, DOI 10.1016/j.tins.2015.09.001; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Lefebvre J, 2015, J NEUROSCI, V35, P2895, DOI 10.1523/JNEUROSCI.3609-14.2015; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mina F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00094; Moran R, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00057; Nakhnikian A, 2016, J NEUROSCI METH, V269, P61, DOI 10.1016/j.jneumeth.2016.04.019; Neymotin SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076285; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Park H, 2011, BRAIN CONNECT, V1, P460, DOI 10.1089/brain.2011.0046; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Sen Bhattacharya B, 2011, NEURAL NETWORKS, V24, P631, DOI 10.1016/j.neunet.2011.02.009; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Ursino M, 2010, NEUROIMAGE, V52, P1080, DOI 10.1016/j.neuroimage.2009.12.084; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang XJ, 1996, J NEUROSCI, V16, P6402; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Youssofzadeh V, 2015, NEUROIMAGE, V108, P364, DOI 10.1016/j.neuroimage.2014.12.067	66	12	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173776	10.1371/journal.pone.0173776	http://dx.doi.org/10.1371/journal.pone.0173776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380064	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500022
J	Pitt, JI; Lange, L; Lacey, AE; Vuong, D; Midgley, DJ; Greenfield, P; Bradbury, MI; Lacey, E; Busk, PK; Pilgaard, B; Chooi, YH; Piggott, AM				Pitt, John I.; Lange, Lene; Lacey, Alastair E.; Vuong, Daniel; Midgley, David J.; Greenfield, Paul; Bradbury, Mark I.; Lacey, Ernest; Busk, Peter K.; Pilgaard, Bo; Chooi, Yit-Heng; Piggott, Andrew M.			Aspergillus hancockii sp nov., a biosynthetically talented fungus endemic to southeastern Australian soils	PLOS ONE			English	Article							ACID BIOSYNTHESIS; TRICHOTHECENE BIOSYNTHESIS; OXINDOLE ALKALOIDS; GENE-CLUSTER; KOJIC ACID; CLASSIFICATION; IDENTIFICATION; CONSTITUTION; SPERADINE; RESOURCE	Aspergillus hancockii sp. nov., classified in Aspergillus subgenus Circumdati section Flavi, was originally isolated from soil in peanut fields near Kumbia, in the South Burnett region of southeast Queensland, Australia, and has since been found occasionally from other substrates and locations in southeast Australia. It is phylogenetically and phenotypically related most closely to A. leporis States and M. Chr., but differs in conidial colour, other minor features and particularly in metabolite profile. When cultivated on rice as an optimal substrate, A. hancockii produced an extensive array of 69 secondary metabolites. Eleven of the 15 most abundant secondary metabolites, constituting 90% of the total area under the curve of the HPLC trace of the crude extract, were novel. The genome of A. hancockii, approximately 40 Mbp, was sequenced and mined for genes encoding carbohydrate degrading enzymes identified the presence of more than 370 genes in 114 gene clusters, demonstrating that A. hancockii has the capacity to degrade cellulose, hemicellulose, lignin, pectin, starch, chitin, cutin and fructan as nutrient sources. Like most Aspergillus species, A. hancockii exhibited a diverse secondary metabolite gene profile, encoding 26 polyketide synthase, 16 nonribosomal peptide synthase and 15 nonribosomal peptide synthase-like enzymes.	[Pitt, John I.; Midgley, David J.; Greenfield, Paul; Bradbury, Mark I.] CSIRO, N Ryde, NSW, Australia; [Lange, Lene; Busk, Peter K.; Pilgaard, Bo] Tech Univ Denmark, Dept Chem & Biochem Engn, Lyngby, Denmark; [Lacey, Alastair E.; Vuong, Daniel; Lacey, Ernest] Microbial Screening Technol, Smithfield, Australia; [Chooi, Yit-Heng] Univ Western Australia, Sch Chem & Biochem, Crawley, Australia; [Piggott, Andrew M.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Technical University of Denmark; University of Western Australia; Macquarie University	Pitt, JI (corresponding author), CSIRO, N Ryde, NSW, Australia.; Piggott, AM (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.	John.Pitt@csiro.au; andrew.piggott@mq.edu.au	Midgley, David/GOV-4218-2022; Chooi, Yit Heng/D-4338-2013; Piggott, Andrew M/G-9259-2012; Kamp Busk, Peter/Q-8145-2016	Chooi, Yit Heng/0000-0001-7719-7524; Piggott, Andrew M/0000-0002-5308-5314; Vuong, Daniel/0000-0002-2451-3148; Pilgaard, Bo/0000-0002-8697-6041; Bradbury, Mark/0000-0002-3727-9055; Kamp Busk, Peter/0000-0003-1920-636X	Austrailian Research Council [FT130100142]; Macquarie University; CSIRO; Microbial Screening Technologies; Technical University of Denmark; University of Western Austrailia	Austrailian Research Council; Macquarie University; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Microbial Screening Technologies; Technical University of Denmark; University of Western Austrailia	This work was supported in part by the Austrailian Research Council (FT130100142), Macquarie University, CSIRO, Microbial Screening Technologies, Technical University of Denmark and University of Western Austrailia. The funders provided support in the form of salaries for authors LL, AEL, DV, DJM, PG, MIB, EL, PKB, BP, Y-HC and AMP but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Ali H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098212; [Anonymous], 2003, MICROBIOL AUST; BENTLEY R, 1962, J BIOL CHEM, V237, P859; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; Busk PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114138; Busk PK, 2013, APPL ENVIRON MICROB, V79, P3380, DOI 10.1128/AEM.03803-12; Busk PK, 2012, Patent application, Patent No. [PCT/EP2012/051099, 2012051099]; Cacho RA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00774; Cardoza RE, 2011, APPL ENVIRON MICROB, V77, P4867, DOI 10.1128/AEM.00595-11; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Clutterbuck PW, 1935, BIOCHEM J, V29, P871, DOI 10.1042/bj0290871; da Silva JV, 2013, NAT PROD RES, V27, P9, DOI 10.1080/14786419.2011.647021; Fujita T, 2004, BIOSCI BIOTECH BIOCH, V68, P820, DOI 10.1271/bbb.68.820; Fujita T, 2002, BIOSCI BIOTECH BIOCH, V66, P1697, DOI 10.1271/bbb.66.1697; Gao X, 2011, J AM CHEM SOC, V133, P2729, DOI 10.1021/ja1101085; Greenfield P, 2014, BIOINFORMATICS, V30, P2723, DOI 10.1093/bioinformatics/btu368; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Hornbogen T, 2007, CHEMBIOCHEM, V8, P1048, DOI 10.1002/cbic.200700076; Hu X, 2014, CHEM PHARM BULL, V62, P942, DOI 10.1248/cpb.c14-00312; Hu X, 2014, HETEROCYCLES, V89, P1662, DOI 10.3987/COM-14-13004; JACOBSEN JP, 1978, TETRAHEDRON LETT, P1081; Kato N, 2011, CHEMBIOCHEM, V12, P1376, DOI 10.1002/cbic.201000672; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kornerup A, 1978, METHUEN HDB COLOUR, DOI DOI 10.1093/NAR/GKV437; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacey HJ, 2016, AUST J CHEM, V69, P152, DOI 10.1071/CH15488; Li SM, 2011, J ANTIBIOT, V64, P45, DOI 10.1038/ja.2010.128; Ma XH, 2015, TETRAHEDRON, V71, P3522, DOI 10.1016/j.tet.2015.03.050; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Marui J, 2011, J BIOSCI BIOENG, V112, P40, DOI 10.1016/j.jbiosc.2011.03.010; MAYERL F, 1993, J ANTIBIOT, V46, P1082, DOI 10.7164/antibiotics.46.1082; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; McCormick SP, 2004, APPL ENVIRON MICROB, V70, P2044, DOI 10.1128/AEM.70.4.2044-2051.2004; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mundt K, 2012, CHEMBIOCHEM, V13, P2583, DOI 10.1002/cbic.201200523; Perez-Victoria I, 2012, J NAT PROD, V75, P1210, DOI 10.1021/np3000987; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Semeiks J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-590; Seshime Y, 2009, BIOORG MED CHEM LETT, V19, P3288, DOI 10.1016/j.bmcl.2009.04.073; SHOJI JI, 1989, J ANTIBIOT, V42, P1729, DOI 10.7164/antibiotics.42.1729; STATES JS, 1966, MYCOLOGIA, V58, P738, DOI 10.2307/3756848; Sussmuth R, 2011, NAT PROD REP, V28, P99, DOI 10.1039/c001463j; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEPASKE MR, 1991, TETRAHEDRON LETT, V32, P5687, DOI 10.1016/S0040-4039(00)93530-5; TERUI Y, 1990, J ANTIBIOT, V43, P1245, DOI 10.7164/antibiotics.43.1245; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; Tokuoka M, 2015, BIOSCI BIOTECH BIOCH, V79, P2081, DOI 10.1080/09168451.2015.1065167; Tsuda M, 2003, TETRAHEDRON, V59, P3227, DOI 10.1016/S0040-4020(03)00413-7; Varga J, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.69.05; Velkov T, 2011, CHEM BIOL, V18, P464, DOI 10.1016/j.chembiol.2011.01.017; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Wang D, 2015, CHEM NAT COMPD+, V51, P733, DOI 10.1007/s10600-015-1395-4; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Yabuta T, 1924, J CHEM SOC, V125, P575, DOI 10.1039/ct9242500575; YAMAZAKI M, 1971, CHEM PHARM BULL, V19, P1739, DOI 10.1248/cpb.19.1739; Yang XL, 2014, CHEMBIOCHEM, V15, P1578, DOI 10.1002/cbic.201402172; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang SG, 2007, FUNGAL GENET BIOL, V44, P1342, DOI 10.1016/j.fgb.2007.06.005; Zhu HC, 2015, CHEM BIODIVERS, V12, P1547, DOI 10.1002/cbdv.201400412	64	29	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0170254	10.1371/journal.pone.0170254	http://dx.doi.org/10.1371/journal.pone.0170254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379953	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500002
J	Rohena-Rivera, K; Sanchez-Vazquez, MM; Aponte-Colon, DA; Forestier-Roman, IS; Quintero-Aguilo, ME; Martinez-Ferrer, M				Rohena-Rivera, Krizia; Sanchez-Vazquez, Maria M.; Aponte-Colon, Diana A.; Forestier-Roman, Ingrid S.; Quintero-Aguilo, Mario E.; Martinez-Ferrer, Magaly			IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; NEUTROPHIL ELASTASE; REACTIVE STROMA; INTERLEUKIN-15; BREAST; CELLS; ADIPONECTIN; PROGRESSION; CHEMOKINES; INHIBITION	Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer. In the United States it is second leading cause of cancer related deaths in men. PCa is often treated via radical prostatectomy (RP). However, 15-30% of the patients develop biochemical recurrence (i. e. increased serum prostate specific antigen (PSA) levels). Interleukin-15 (IL-15) is a secreted cytokine found over expressed in patients with recurrence-free survival after RP. In our study, we aim to determine the role of IL-15 in PCa using in vitro and in vivo models, and gene expression analysis. PC3 (androgen-independent) and 22RV1 (androgen- dependent) cell lines were treated with IL-15 at 0.0013 ng/mL and 0.1 ng/mL. Tumor growth was evaluated using an orthotopic xenograft model. The anterior prostate lobes of SCID mice were injected with 250,000 22RV1 cells and IL-15 was administered bi-weekly with intraperitoneal (IP) injections during 4 weeks. Tumor tissue was collected for immunohistochemical and gene expression analysis. To study changes in gene expression, we looked at "Tumor Metastasis" and "PI3K pathway" using commercially available PCR arrays. In addition, we employed a microarray approach using the Affymetrix Hugene 2.0 ST array chip followed by analysis with Ingenuity Pathways Analysis (IPA) software. In vitro studies showed that IL-15 decreased PCa cell motility at both concentrations. In vivo studies showed that IL-15 increased neutrophil infiltration, and the expression of adiponectin, desmin and alpha smooth muscle actin (a-sma) in the tumor tissue. Angiogenesis analysis, using CD31 immunohistochemistry, showed that IL-15 decreased the number of blood vessels. Gene expression analysis identified Cancer, Cell Death, Immune Response and Lipid Metabolism as the major diseases and functions altered in tumors treated with IL-15. This suggests that IL-15 causes inflammation and changes in stroma that can promote decreased tumor cell proliferation.	[Rohena-Rivera, Krizia; Forestier-Roman, Ingrid S.; Martinez-Ferrer, Magaly] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Rohena-Rivera, Krizia; Sanchez-Vazquez, Maria M.; Aponte-Colon, Diana A.; Forestier-Roman, Ingrid S.; Quintero-Aguilo, Mario E.; Martinez-Ferrer, Magaly] Univ Puerto Rico, Comprehens Canc Ctr San Juan, San Juan, PR 00936 USA; [Martinez-Ferrer, Magaly] Univ Puerto Rico, Sch Pharm San Juan, Dept Pharmaceut Sci, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico	Martinez-Ferrer, M (corresponding author), Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA.; Martinez-Ferrer, M (corresponding author), Univ Puerto Rico, Comprehens Canc Ctr San Juan, San Juan, PR 00936 USA.; Martinez-Ferrer, M (corresponding author), Univ Puerto Rico, Sch Pharm San Juan, Dept Pharmaceut Sci, San Juan, PR 00936 USA.	magaly.martinez1@upr.edu			NIH [K01 CA140711]; MBRS-RISE grant [R25GM061838]; NIH MARC grants [5T34GM007821-35, 5T34GM007821-36]; University of Puerto Rico Comprehensive Cancer Center; School of Pharmacy; RCMI Center for Genomics in Health Disparities and Rare Diseases (RCMI, Medical Science Campus) [8G12-MD007600, NIMHDG: 12RR0305]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MBRS-RISE grant; NIH MARC grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico Comprehensive Cancer Center; School of Pharmacy; RCMI Center for Genomics in Health Disparities and Rare Diseases (RCMI, Medical Science Campus); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded by NIH grant K01 CA140711, MBRS-RISE grant R25GM061838, NIH MARC grants 5T34GM007821-35 and 5T34GM007821-36, and Institutional funds from the University of Puerto Rico Comprehensive Cancer Center and the School of Pharmacy.; Special thanks to Dr. Carmen Cadilla and Jessica Renta of the RCMI Center for Genomics in Health Disparities and Rare Diseases (RCMI, Medical Science Campus, grants 8G12-MD007600 and NIMHDG: 12RR0305) for their aid with microarray experiments.	Alva A, 2014, CURR TREAT OPTION ON, V15, P127, DOI 10.1007/s11864-013-0272-2; Assi K, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-42; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Barb D, 2007, ENDOCR-RELAT CANCER, V14, P995, DOI 10.1677/ERC-06-0091; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bickers B, 2009, ANTICANCER RES, V29, P3289; Blum DL, 2008, CLIN CANCER RES, V14, P7790, DOI 10.1158/1078-0432.CCR-08-1716; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruce Justine Yang, 2012, Clin Adv Hematol Oncol, V10, P716; Bub JD, 2006, BIOCHEM BIOPH RES CO, V340, P1158, DOI 10.1016/j.bbrc.2005.12.103; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Cassatella MA, 2000, CURR OPIN HEMATOL, V7, P174, DOI 10.1097/00062752-200005000-00008; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Fu GP, 2012, J IMMUNOL, V189, P2326, DOI 10.4049/jimmunol.1103458; Garratt LW, 2015, EUR RESPIR J, V46, P384, DOI 10.1183/09031936.00212114; Goktas S, 2005, UROLOGY, V65, P1168, DOI 10.1016/j.urology.2004.12.053; Hammond ME, 1950, J IMMUNOL, V155, p1428 ; Huber RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057793; ISAACS JT, 1988, PROSTATE, V13, P165; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu Ai-jun, 2007, Journal of Zhejiang University-Science B, V8, P853, DOI 10.1631/jzus.2007.B0853; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Marchion DC, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.004; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Meyer K, 2015, MOL CELL BIOL, V35, P2991, DOI 10.1128/MCB.01149-14; Morris JC, 2014, GENE THER, V21, P393, DOI 10.1038/gt.2014.10; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Oliveros J. C., INTERACTIVE TOOL COM; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Pourmand Gholamreza, 2007, Urol J, V4, P95; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Serrano-Pertierra E, 2014, J LEUKOCYTE BIOL, V95, P487, DOI 10.1189/jlb.0613316; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skvortsov S, 2014, BRIT J CANCER, V110, P2677, DOI 10.1038/bjc.2014.221; Stanelle J, 2010, BLOOD, V116, P4202, DOI 10.1182/blood-2010-01-265827; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Stephenson KB, 2012, CANCER GENE THER, V19, P238, DOI 10.1038/cgt.2011.81; Takaku M, 2015, GENE EXPRESSION, V16, P163, DOI 10.3727/105221615X14399878166113; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075885; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Van de Walle I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11171; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Waldmann TA, 2014, EXPERT REV CLIN IMMU, V10, P1689, DOI 10.1586/1744666X.2014.973856; Wang C, 2015, CURR OPIN IMMUNOL, V37, P6, DOI 10.1016/j.coi.2015.08.001; Wang J, 2013, EUR REV MED PHARMACO, V17, P596; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wu JP, 2014, ASIAN J ANDROL, V16, P710, DOI 10.4103/1008-682X.129131; Xie B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149199; Yu P, 2012, P NATL ACAD SCI USA, V109, P6187, DOI 10.1073/pnas.1203479109; Zabransky DJ, 2012, PROSTATE, V72, P487, DOI 10.1002/pros.21449; Zhang W. C., 2010, 2010 IEEE 3rd International Nanoelectronics Conference (INEC 2010), P1, DOI 10.1109/INEC.2010.5425054	63	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172786	10.1371/journal.pone.0172786	http://dx.doi.org/10.1371/journal.pone.0172786			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379958	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500009
J	Arnold, D; Tomaschek, F; Sering, K; Lopez, F; Baayen, RH				Arnold, Denis; Tomaschek, Fabian; Sering, Konstantin; Lopez, Florence; Baayen, R. Harald			Words from spontaneous conversational speech can be recognized with human-like accuracy by an error-driven learning algorithm that discriminates between meanings straight from smart acoustic features, bypassing the phoneme as recognition unit	PLOS ONE			English	Article							MODEL; REPRESENTATION; ACQUISITION; LANGUAGE; SPARSE; SIGNAL	Sound units play a pivotal role in cognitive models of auditory comprehension. The general consensus is that during perception listeners break down speech into auditory words and subsequently phones. Indeed, cognitive speech recognition is typically taken to be computationally intractable without phones. Here we present a computational model trained on 20 hours of conversational speech that recognizes word meanings within the range of human performance (model 25%, native speakers 20-44%), without making use of phone or word form representations. Our model also generates successfully predictions about the speed and accuracy of human auditory comprehension. At the heart of the model is a 'wide' yet sparse two-layer artificial neural network with some hundred thousand input units representing summaries of changes in acoustic frequency bands, and proxies for lexical meanings as output units. We believe that our model holds promise for resolving longstanding theoretical problems surrounding the notion of the phone in linguistic theory.	[Arnold, Denis; Tomaschek, Fabian; Sering, Konstantin; Lopez, Florence; Baayen, R. Harald] Eberhard Karls Univ Tubingen, Quantitat Linguist, Seminar Sprachwissensch, Tubingen, Germany; [Arnold, Denis] Inst Deutsch Sprache, Mannheim, Germany	Eberhard Karls University of Tubingen; Institut fur Deutsche Sprache (IDS)	Arnold, D (corresponding author), Eberhard Karls Univ Tubingen, Quantitat Linguist, Seminar Sprachwissensch, Tubingen, Germany.; Arnold, D (corresponding author), Inst Deutsch Sprache, Mannheim, Germany.	denis.arnold@uni-tuebingen.de		Baayen, Harald/0000-0003-3178-3944; Arnold, Denis/0000-0003-0540-3872	Alexander von Humboldt Chair	Alexander von Humboldt Chair	This paper was funded by the Alexander von Humboldt Chair awarded to R. H. Baayen.	[Anonymous], 2021, LANG ENV STAT COMP; Arnold D., 2017, ACOUSTICNDLCODER COD; Baayen H., 2005, CORPUS LINGUIST LING, V1       (2), P183, DOI [10.1515/cllt.2005.1.2.183, DOI 10.1515/CLLT.2005.1.2.183]; Baayen H, 2017, J MEM LANG, V94, P206, DOI 10.1016/j.jml.2016.11.006; Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Baayen RH, 2015, COMPREHENSION SEGMEN; BROAD DJ, 1970, J ACOUST SOC AM, V47, P1572, DOI 10.1121/1.1912090; Brockwell P.J., 1991, TIME SERIES DATA ANA, Vsecond; Burgess C, 1998, COGNITIVE DYNAMICS C, P117; Charniak E., 1993, STAT LANGUAGE PROCES; Cucchiarini C., 2003, P ICPHS, P347; Cutler Anne, 2012, NATIVE LISTENING LAN; Ellis DPW, 2005, ONL WEB RES; Ernestus M, 2002, BRAIN LANG, V81, P162, DOI 10.1006/brln.2001.2514; Gaskell MG, 1996, J EXP PSYCHOL HUMAN, V22, P144, DOI 10.1037/0096-1523.22.1.144; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hannun A., 2014, ARXIV E PRINTS; Hay J, 2010, LINGUISTICS, V48, P865, DOI 10.1515/LING.2010.027; Hendrix P, 2016, NOTE 2 LAYER N UNPUB; Jackson, 1953, COMMUN THEORY, P486; Johnson Keith., 2004, SPONTANEOUS SPEECH D, P29; Junqua J.-C., 2012, ROBUSTNESS AUTOMATIC, V341; Kemps R, 2004, BRAIN LANG, V90, P117, DOI 10.1016/S0093-934X(03)00425-5; Kitaoka N, 2014, COMPUT SPEECH LANG, V28, P769, DOI 10.1016/j.csl.2013.09.009; Kohler K.J., 1990, SPEECH PRODUCTION SP, P21; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lippmann RP, 1997, SPEECH COMMUN, V22, P1, DOI 10.1016/S0167-6393(97)00021-6; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Mbu Nyamsi Ruben G., 1994, Bioacoustics, V5, P187; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Milin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171935; MILLER RR, 1995, PSYCHOL BULL, V117, P363, DOI 10.1037/0033-2909.117.3.363; Nearey T., 2003, PAPERS LAB PHONOLOGY, P197; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Nusbaum H. C., 1985, 11 IND U; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Port RF, 2005, LANGUAGE, V81, P927, DOI 10.1353/lan.2005.0195; Port RF, 2006, 2 LANGUAGE SPEECH LE; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Ramscar M, 2013, CHILD DEV, V84, P1308, DOI 10.1111/cdev.12044; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; RAPHAEL LJ, 1972, J ACOUST SOC AM, V51, P1296, DOI 10.1121/1.1912974; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Scharenborg O, 2005, COGNITIVE SCI, V29, P867, DOI 10.1207/s15516709cog0000_37; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schweitzer A, 2013, P INT 2013 LYON; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; ten Bosch L, 2014, INTERSPEECH, P462; ten Bosch L, 2009, FUND INFORM, V90, P229, DOI 10.3233/FI-2009-0016; Tomaschek F., 2013, P INT LYON, P1302; Tomaschek F., 2014, P 10 ISSP COL, P425; Trimmer PC, 2012, J THEOR BIOL, V302, P39, DOI 10.1016/j.jtbi.2012.02.014; Tuske Z, 2014, INTERSPEECH, P890; van den Oord A., 2016, SSW; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; ZERLIN S, 1969, J ACOUST SOC AM, V46, P1011, DOI 10.1121/1.1911792	62	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174623	10.1371/journal.pone.0174623	http://dx.doi.org/10.1371/journal.pone.0174623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ET0LV	28394938	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800005
J	Gates, I; DuVall, M; Ju, H; Tondella, ML; Pawloski, L				Gates, Irina; DuVall, Marina; Ju, Hong; Tondella, M. Lucia; Pawloski, Lucia		Pertussis Working Grp	Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production	PLOS ONE			English	Article							PROTECTIVE ACTIVITIES; PERTACTIN; STRAINS	Bordetella pertussis infection has been increasing in the US, with reported cases reaching over 50,000 in 2012, a number last observed in the 1950s. Concurrently, B. pertussis lacking the pertactin protein, one of the immunogens included in the acellular vaccine formulations, has rapidly emerged since 2010, and has become the predominant circulating phenotype. Monitoring the production of the remaining acellular vaccine immunogens, such as pertussis toxin (Pt), is a critical next step. To date, methods for screening Pt have been either through genomic sequencing means or by conventional ELISAs. However, sequencing limits detection to the DNA level, missing potential disruptions in transcription or translation. Conventional ELISAs are beneficial for detecting the protein; however, they can often suffer from poor sensitivity and specificity. Here we describe a rapid, highly sensitive and specific electrochemiluminescent capture ELISA that can detect Pt production in prepared inactivated bacterial suspensions. Over 340 isolates were analyzed and analytical validation parameters, such as precision, reproducibility, and stability, were rigorously tested. Intraplate and inter-plate variability measured at 9.8% and 11.5%, respectively. Refrigerated samples remained stable for two months and variability was unaffected (coefficient of variation was 12%). Interestingly, despite the intention of being a qualitative method, the assay was sensitive enough to detect a small, but statistically significant, difference in protein production between different pertussis promoter allelic groups of strains, ptxP1 and ptxP3. This technology has the ability to perform screening of multiple antigens at one time, thus, improving testing characteristics while minimizing costs, specimen volume, and testing time.	[Gates, Irina; DuVall, Marina; Ju, Hong; Tondella, M. Lucia; Pawloski, Lucia; Pertussis Working Grp] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pawloski, L (corresponding author), Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA 30333 USA.	ecz6@cdc.gov		, Lucia/0000-0002-1495-0379				Acosta AM, 2015, PEDIATRICS, V135, P981, DOI [10.1542/peds.2014-3358, 10.1542/peds.2014-4118]; [Anonymous], J PEDIAT, DOI DOI 10.1016/J.JPEDS.2012.05.041; Barkoff AM, 2014, J IMMUNOL METHODS, V408, P142, DOI 10.1016/j.jim.2014.06.001; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Bowden KE, 2014, J CLIN MICROBIOL, V52, P3549, DOI 10.1128/JCM.01189-14; Clark TA, 2012, TRENDS MICROBIOL, V20, P211, DOI 10.1016/j.tim.2012.03.003; Clarke M, 2016, J INFECTION, V72, P171, DOI 10.1016/j.jinf.2015.11.004; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066150; Martin SW, 2015, CLIN INFECT DIS, V60, P223, DOI 10.1093/cid/ciu788; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; Mooi FR, 2013, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Pawloski L, 2016, 11 INT BORD S BUEN A; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; Safarchi A, 2016, VACCINE, V34, P3967, DOI 10.1016/j.vaccine.2016.06.052; SATO H, 1990, INFECT IMMUN, V58, P3369, DOI 10.1128/IAI.58.10.3369-3374.1990; SATO H, 1991, INFECT IMMUN, V59, P3832, DOI 10.1128/IAI.59.10.3832-3835.1991; Schmidtke AJ, 2012, EMERG INFECT DIS, V18, P1248, DOI 10.3201/eid1808.120082; Weigand MR, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00806-16; Williams MM, 2016, EMERG INFECT DIS, V22, P319, DOI 10.3201/eid2202.151332; Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	25	5	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175326	10.1371/journal.pone.0175326	http://dx.doi.org/10.1371/journal.pone.0175326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394915	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800027
J	Okumura, F; Joo-Okumura, A; Nakatsukasa, K; Kamura, T				Okumura, Fumihiko; Joo-Okumura, Akiko; Nakatsukasa, Kunio; Kamura, Takumi			Hypoxia-inducible factor-2a stabilizes the von Hippel-Lindau (VHL) disease suppressor, Myb-related protein 2	PLOS ONE			English	Article							PROLYL HYDROXYLATION; CELL CARCINOMA; GENE-EXPRESSION; HIF-ALPHA; COMPLEX; BINDING; FAMILY; CANCER; DESTRUCTION; PROTEOLYSIS	Ubiquitin ligase von Hippel-Lindau tumor suppressor (pVHL) negatively regulates protein levels of hypoxia-inducible factor-alpha (HIF-alpha). Loss of pVHL causes HIF-alpha accumulation, which contributes to the pathogenesis of von Hippel-Lindau (VHL) disease. In contrast, v-Myb avian myeloblastosis viral oncogene homolog-like 2 (MYBL2; B-Myb), a transcription factor, prevents VHL pathogenesis by regulating gene expression of HIF-independent pathways. Both HIF-alpha and B-Myb are targets of pVHL-mediated polyubiquitination and proteasomal degradation. Here, we show that knockdown of HIF-2 alpha induces downregulation of BMyb in 786-O cells, which are deficient in pVHL, and this downregulation is prevented by proteasome inhibition. In the presence of pVHL and under hypoxia-like conditions, B-Myb and HIF-2 alpha are both upregulated, and the upregulation of B-Myb requires expression of HIF-2 alpha. We also show that HIF-2 alpha and B-Myb interact in the nucleus, and this interaction is mediated by the central region of HIF-2 alpha and the C-terminal region of B-Myb. These data indicate that oncogenic HIF-2 alpha stabilizes B-Myb to suppress VHL pathogenesis.	[Okumura, Fumihiko; Joo-Okumura, Akiko; Nakatsukasa, Kunio; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi, Japan	Nagoya University	Okumura, F; Kamura, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi, Japan.	okumura.fumihiko@a.mbox.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp			Japan society for the promotion of science (JSPS) KAKENHI [25291023, 25860043, 24112006, 15K14474, 25870312, 15K18503, 13J40160]; Uehara Memorial Foundation; Inamori Foundation	Japan society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Inamori Foundation	This work was supported by the Japan society for the promotion of science (JSPS) KAKENHI Grant Numbers 25291023 (to F.O. and T. K.), 25860043 (to F.O.), 24112006 and 15K14474 (to T.K.), 25870312 and 15K18503 (to K.N.), 13J40160 (to A.J.O), and the Uehara Memorial Foundation (to F.O.) and the Inamori Foundation (to F.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Deivanayagam CCS, 2000, ACTA CRYSTALLOGR D, V56, P266, DOI 10.1107/S0907444999016571; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Khatua S, 2003, CANCER RES, V63, P1865; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Liu MY, 2003, CANCER RES, V63, P2675; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Okumura F, 2016, MOL CELL BIOL; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Oppici E, 2015, BBA-PROTEINS PROTEOM, V1854, P1212, DOI 10.1016/j.bbapap.2014.12.029; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Ryther RCC, 2004, ENDOCRINOLOGY, V145, P2988, DOI 10.1210/en.2003-1724; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175593	10.1371/journal.pone.0175593	http://dx.doi.org/10.1371/journal.pone.0175593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394947	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800044
J	Pan, CL; Li, QF; Lu, YQ; Zhang, JP; Yang, XM; Li, XQ; Li, LH; Liu, WH				Pan, Cuili; Li, Qingfeng; Lu, Yuqing; Zhang, Jinpeng; Yang, Xinming; Li, Xiuquan; Li, Lihui; Liu, Weihua			Chromosomal localization of genes conferring desirable agronomic traits from Agropyron cristatum chromosome 1P	PLOS ONE			English	Article							TRITICUM-AESTIVUM L; ADDITION LINES; MOLECULAR MARKERS; BREAD WHEAT; DURUM-WHEAT; IDENTIFICATION; TRANSLOCATION; RESISTANCE; 6P; GENOME	Agropyron cristatum (L.) Gaertn. (2n = 4x = 28, PPPP), a wild relative of common wheat, possesses many potentially valuable genes for wheat breeding. To transfer these genes into wheat, a series of wheat-A. cristatum derivatives have been obtained in our laboratory. In this study, a wheat-A. cristatum derivative II-3-1 was obtained, which was proven to contain a 1P (1A) disomic substitution and 2P disomic addition line with 40 wheat chromosomes and two pairs of A. cristatum chromosomes by genomic in situ hybridization (GISH) and molecular markers analysis. By further backcrossing with the wheat parent Fukuhokomugi (Fukuho) and self-fertilization, three different lines were separated from II-3-1, including wheat-A. cristatum 1P disomic addition line II-3-1a, 2P disomic addition line II-3-1b and 1P (1A) disomic substitution line II-3-1c. Because 2P addition line had been reported before, we aimed to investigate 1P disomic addition line II-3-1a and wheat-A. cristatum 1P (1A) disomic substitution line II-3-1c. Analysis of different genetic populations demonstrated that 1P chromosome harbored multiple agronomic traits, such as elevated spike length, increased tillering ability, reduced plant height and spikelet density. Besides, bristles on the glume ridges as an important morphological marker was located on 1P chromosome. Therefore, the novel 1P addition and substitution lines will be used as important genetic materials to widen the genetic resources of wheat.	[Pan, Cuili; Li, Qingfeng; Lu, Yuqing; Zhang, Jinpeng; Yang, Xinming; Li, Xiuquan; Li, Lihui; Liu, Weihua] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China; [Li, Qingfeng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Northwest A&F University - China	Li, LH; Liu, WH (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China.	lilihui@caas.cn; liuweihua@caas.cn			National Key Technology Support Program of China [2013BAD01B02]; National Natural Science Foundation of China [31271714]; National Key Research and Development Program of China [2016YFD0100102, 2016YFD0100302]	National Key Technology Support Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was funded by the National Key Technology Support Program of China (No.2013BAD01B02) [http://www.most.gov.cn/kjjh/gjkjjh/] to LHL; the National Natural Science Foundation of China (No. 31271714), [http://www.most.gov.cn/kjjh/gjkjjh/] to YQL; and the National Key Research and Development Program of China (2016YFD0100102) [http://www.most.gov.cn/kjjh/gjkjjh/] to WHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was funded by the National Key Research and Development Program of China (2016YFD0100102 and 2016YFD0100302).	AHMAD F, 1991, PLANT BREEDING, V106, P275, DOI 10.1111/j.1439-0523.1991.tb00512.x; ANAMTHAWATJONSSON K, 1995, GENOME, V38, P814, DOI 10.1139/g95-104; Bayat H, 2016, ARCH AGRON SOIL SCI, V62, P769, DOI 10.1080/03650340.2015.1094182; BLANCO A, 1987, THEOR APPL GENET, V74, P328, DOI 10.1007/BF00274714; CHEN Q, 1990, GENOME, V33, P663, DOI 10.1139/g90-098; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dewey DR, 1984, GENOMIC SYSTEM CLASS; Dobrovolskaya OB, 2009, RUSS J GENET+, V45, P1368, DOI 10.1134/S1022795409110118; Du WL, 2013, MOL BREEDING, V31, P879, DOI 10.1007/s11032-013-9841-0; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Han HM, 2017, PLANTA, V245, P425, DOI 10.1007/s00425-016-2616-1; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; ISLAM AKMR, 1981, GENET RES, V37, P215, DOI 10.1017/S0016672300020188; Jauhar PP, 2006, PLANT BREEDING, V125, P19, DOI 10.1111/j.1439-0523.2006.01176.x; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; LARKIN PJ, 1995, GENOME, V38, P385, DOI 10.1139/g95-050; Li GR, 2016, PLANTA, V244, P865, DOI 10.1007/s00425-016-2554-y; Li HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145928; Li L.H., 1997, ACTA GENET SIN, V24, P154; LI LH, 1991, THEOR APPL GENET, V81, P312, DOI 10.1007/BF00228669; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li QF, 2016, CROP SCI, V56, P2390, DOI 10.2135/cropsci2015.10.0638; LIMIN AE, 1990, GENOME, V33, P581, DOI 10.1139/g90-085; Lin ZS, 2006, PLANT BREEDING, V125, P114, DOI 10.1111/j.1439-0523.2006.01167.x; Liu Shu-hui, 2008, Xibei Zhiwu Xuebao, V28, P1554; Liu WH, 2010, GENOME, V53, P472, DOI [10.1139/G10-023, 10.1139/g10-023]; Lu MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159577; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; Mullan DJ, 2005, GENOME, V48, P811, DOI 10.1139/g05-040; Niu ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/genetics.110.123588; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Ren TH, 2009, EUPHYTICA, V169, P207, DOI 10.1007/s10681-009-9924-5; Schneider A, 2016, THEOR APPL GENET, V129, P1045, DOI 10.1007/s00122-016-2682-6; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Song LQ, 2016, THEOR APPL GENET, V129, P1023, DOI 10.1007/s00122-016-2680-8; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069501; Sourdille P, 1998, HEREDITAS, V128, P41, DOI 10.1111/j.1601-5223.1998.00041.x; Taketa S, 2001, BREEDING SCI, V51, P199, DOI 10.1270/jsbbs.51.199; Uhrin A, 2012, EUPHYTICA, V186, P45, DOI 10.1007/s10681-011-0483-1; VILLAREAL RL, 1991, PLANT BREEDING, V106, P77, DOI 10.1111/j.1439-0523.1991.tb00482.x; Wang YH, 2016, J GENET GENOMICS, V43, P45, DOI 10.1016/j.jgg.2015.10.004; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Wu M, 2010, EUPHYTICA, V172, P363, DOI 10.1007/s10681-009-0033-2; Ye XL, 2015, THEOR APPL GENET, V128, P797, DOI 10.1007/s00122-015-2466-4; Zhang J, 2016, PLANTA, V244, P853, DOI 10.1007/s00425-016-2550-2; Zhang JP, 2015, GENOMICS, V106, P129, DOI 10.1016/j.ygeno.2015.04.003	47	10	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175265	10.1371/journal.pone.0175265	http://dx.doi.org/10.1371/journal.pone.0175265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394901	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800023
J	Hsu, CH; Soong, K				Hsu, Chia-Hsuan; Soong, Keryea			Mechanisms causing size differences of the land hermit crab Coenobita rugosus among eco-islands in Southern Taiwan	PLOS ONE			English	Article							COMMERCIAL PENAEID PRAWNS; BODY-SIZE; BEHAVIORAL ECOLOGY; GROWTH; POPULATIONS; PREDATION; RESOURCE; DISTRIBUTIONS; QUEENSLAND; CARNIVORES	Numerous environmental factors can influence body size. Comparing populations in different ecological contexts is one potential approach to elucidating the most critical of such factors. In the current study, we found that the body size of the land hermit crab Coenobita rugosus was significantly larger on Dongsha Island in the South China Sea than on other eco-islands around Southern Taiwan. We hypothesized that this could be due to differences in (1) shell resources, (2) parasite impact, (3) competition, (4) predation, and (5) food. We found no supporting evidence for the first three hypotheses; the shells used by the hermit crabs on Dongsha were in poorer condition than were those used elsewhere, extremely few individuals in the region had ectoparasites, and the density of hermit crabs varied considerably among localities within each island. However, significantly higher percentages of C. rugosus reached age 3 years on Dongsha than at Siziwan bay in Taiwan. Two growth rate indices inferred from size structures suggested faster growth on Dongsha than at Siziwan. The condition index (i. e., the body mass/shield length ratio of C. rugosus) was also greater on Dongsha than at Siziwan. Therefore, Dongsha hermit crabs seem to have superior diet and growth performance. Seagrass debris accumulation at the shore of Dongsha was considerable, whereas none was observed at Siziwan or on the other islands, where dicot leaves were the dominant food item for the vegetarian hermit crabs. We then experimentally evaluated the possible role of seagrass as food for C. rugosus. The crabs on Dongsha preferred seagrass to dicot leaves, and their growth increment was faster when they fed on seagrass than when they fed on dicot leaves; no such differences were found in the Siziwan hermit crabs. The aforementioned results are compatible with the food hypothesis explaining the size differences among the islands. The predator hypothesis could explain the greater life span but not the other findings. Populations of C. rugosus on islands with seagrass debris piles probably contribute more to the gene pool of the species because higher proportions of these populations could achieve high fecundity. The fate of these terrestrial hermit crabs may rely on the health of underwater seagrass ecosystems that are under threat from global change.	[Hsu, Chia-Hsuan; Soong, Keryea] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan	National Sun Yat Sen University	Soong, K (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan.	keryea@gmail.com		Soong, Keryea/0000-0002-4371-7103; Hsu, Chia-Hsuan/0000-0002-5128-5902	Marine National Park for a graduate-student fellowship; Ministry of Science and Technology, Taiwan, through Asian-Pacific Ocean Research Center of National SunYat-sen University [105-2811-M-110-001]; Asian Pacific Ocean Research Center; National Sun Yat-senUniversity, Taiwan	Marine National Park for a graduate-student fellowship; Ministry of Science and Technology, Taiwan, through Asian-Pacific Ocean Research Center of National SunYat-sen University; Asian Pacific Ocean Research Center; National Sun Yat-senUniversity, Taiwan	The authors would like to thank Marine National Park for a graduate-student fellowship to CH. Financial support from Ministry of Science and Technology, Taiwan, 105-2811-M-110-001, http:// web1.most.gov.tw/ROC, through Asian-Pacific Ocean Research Center of National SunYat-sen University to KS made this study possible; Asian Pacific Ocean Research Center, National Sun Yat-senUniversity, Taiwan, No grantnumber, http://top.nsysu.edu.tw/files/13-1201-40630.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2007, J ANIM ECOL, V76, P289, DOI 10.1111/j.1365-2656.2007.01210.x; ALEXANDER HGL, 1979, PHILOS T ROY SOC B, V286, P241, DOI 10.1098/rstb.1979.0031; Amarillo-Suarez AR, 2011, ECOL EVOL, V1, P1, DOI 10.1002/ece3.1; Barber I, 2008, BEHAVIOUR, V145, P647, DOI 10.1163/156853908792451403; Barnes DKA, 2005, MAR BIOL, V146, P625, DOI 10.1007/s00227-004-1451-2; Barnes DKA, 2003, MAR BIOL, V142, P549, DOI 10.1007/s00227-002-0968-5; Barnes DKA, 2002, FUNCT ECOL, V16, P714, DOI 10.1046/j.1365-2435.2002.00677.x; BERTNESS MD, 1981, CRUSTACEANA, V40, P197, DOI 10.1163/156854081X00598; BERTNESS MD, 1982, J EXP MAR BIOL ECOL, V64, P159, DOI 10.1016/0022-0981(82)90151-4; BHATTACHARYA CG, 1967, BIOMETRICS, V23, P115, DOI 10.2307/2528285; BOUDREAU PR, 1989, CAN J FISH AQUAT SCI, V46, P614, DOI 10.1139/f89-078; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Buck TL, 2003, J EXP MAR BIOL ECOL, V292, P103, DOI 10.1016/S0022-0981(03)00146-1; CHILDRESS JR, 1972, ECOLOGY, V53, P960, DOI 10.2307/1934316; COLES RG, 1987, AUST J MAR FRESH RES, V38, P103; Damuth J., 2005, BODY SIZE MAMMALIAN; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Elwood RW, 1995, J EXP MAR BIOL ECOL, V193, P41, DOI 10.1016/0022-0981(95)00109-3; FOTHERINGHAM N, 1976, J EXP MAR BIOL ECOL, V23, P299, DOI 10.1016/0022-0981(76)90027-7; Gause GF, 1932, Q REV BIOL, V7, P27, DOI 10.1086/394394; Green SO, 2003, B MAR SCI, V73, P443; Grudemo J, 1999, J EXP MAR BIOL ECOL, V239, P167, DOI 10.1016/S0022-0981(98)00198-1; HAZLETT B A, 1970, Zeitschrift fuer Tierpsychologie, V27, P369; HAZLETT BA, 1981, ANNU REV ECOL SYST, V12, P1, DOI 10.1146/annurev.es.12.110181.000245; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hsu C-H, 2015, TESTING MECH CAUSING; Jorgensen C, 2013, J SEA RES, V75, P8, DOI 10.1016/j.seares.2012.04.003; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kharlamenko VI, 2001, MAR ECOL PROG SER, V220, P103, DOI 10.3354/meps220103; King M, 2007, FISHERIES BIOL ASSES, P189; KUHLMANN ML, 1992, J EXP MAR BIOL ECOL, V157, P143, DOI 10.1016/0022-0981(92)90159-8; Latham ADM, 2002, MAR BIOL, V141, P1131, DOI 10.1007/s00227-002-0913-7; Lively CM, 2002, EVOL ECOL RES, V4, P219; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; McLaughlin PA, 2007, CATALOG HERMIT CRABS; Morgan BJ, 2003, J ZOOL, V259, P337, DOI 10.1017/S0952836902003291; Morrison LW, 2006, J BIOGEOGR, V33, P314, DOI 10.1111/j.1365-2699.2005.01399.x; Pechenik JA, 2015, MAR ECOL PROG SER, V529, P171, DOI 10.3354/meps11298; Peters RH, 1986, ECOLOGICAL IMPLICATI; Roche DG, 2012, AUST J ZOOL, V60, P330, DOI 10.1071/ZO12130; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Stahlschmidt ZR, 2015, COMP BIOCHEM PHYS A, V187, P1, DOI 10.1016/j.cbpa.2015.04.007; Vasilakopoulos P, 2011, ICES J MAR SCI, V68, P1525, DOI 10.1093/icesjms/fsr075; WATSON RA, 1993, AUST J MAR FRESH RES, V44, P211; Wolverton S, 2009, AM MIDL NAT, V162, P403, DOI 10.1674/0003-0031-162.2.403; Yom-Tov Y, 2003, FUNCT ECOL, V17, P323, DOI 10.1046/j.1365-2435.2003.00735.x	46	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174319	10.1371/journal.pone.0174319	http://dx.doi.org/10.1371/journal.pone.0174319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388638	Green Submitted, gold, Green Published			2022-12-27	WOS:000399375800005
J	Nilsson, A; Wahlin-Larsson, B; Kadi, F				Nilsson, Andreas; Wahlin-Larsson, Britta; Kadi, Fawzi			Physical activity and not sedentary time per se influences on clustered metabolic risk in elderly community-dwelling women	PLOS ONE			English	Article							UNITED-STATES; SITTING TIME; BREAKING; ASSOCIATION; BEHAVIOR; METAANALYSIS; PATTERNS; ADULTS	Introduction Whether amount of time spent in sedentary activities influences on clustered metabolic risk in elderly, and to what extent such an influence is independent of physical activity behavior, remain unclear. Therefore, the aim of the study was to examine cross-sectional associations of objectively assessed physical activity and sedentary behavior on metabolic risk outcomes in a sample of elderly community-dwelling women. Methods Metabolic risk outcomes including waist circumference, systolic and diastolic blood pressures, fasting levels of plasma glucose, HDL-cholesterol and triglycerides were assessed in 120 community-dwelling older women (65-70 yrs). Accelerometers were used to retrieve daily sedentary time, breaks in sedentary time, daily time in light (LPA) and moderate-to-vigorous physical activity (MVPA), and total amount of accelerometer counts. Multivariate regression models were used to examine influence of physical activity and sedentary behavior on metabolic risk outcomes including a clustered metabolic risk score. Results When based on isotemporal substitution modeling, replacement of a 10-min time block of MVPA with a corresponding time block of either LPA or sedentary activities was associated with an increase in clustered metabolic risk score (beta = 0.06 to 0.08, p < 0.05), and an increase in waist circumference (beta = 1.78 to 2.19 p < 0.01). All associations indicated between sedentary time and metabolic risk outcomes were lost once variation in total accelerometer counts was adjusted for. Conclusions Detrimental influence of a sedentary lifestyle on metabolic health is likely explained by variations in amounts of physical activity rather than amount of sedentary time per se. Given our findings, increased amounts of physical activity with an emphasis on increased time in MVPA should be recommended in order to promote a favorable metabolic health profile in older women.	[Nilsson, Andreas; Wahlin-Larsson, Britta; Kadi, Fawzi] Univ Orebro, Sch Hlth Sci, Orebro, Sweden	Orebro University	Nilsson, A (corresponding author), Univ Orebro, Sch Hlth Sci, Orebro, Sweden.	andreas.nilsson@oru.se		Nilsson, Andreas/0000-0003-3793-335X; kadi, fawzi/0000-0002-9831-0896	Swedish National Centre for Research [P2012/102, P2014-117, P2015-120]	Swedish National Centre for Research	This work was supported by grants from the Swedish National Centre for Research (P2012/102, P2014-117 and P2015-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Carr LJ, 2012, J OBES, V2012, DOI 10.1155/2012/460271; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Henson J, 2016, DIABETES CARE, V39, P130, DOI 10.2337/dc15-1240; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Jefferis BJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0361-2; Keadle SK, 2016, PREV MED, V89, P37, DOI 10.1016/j.ypmed.2016.05.009; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118078; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Maher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086403; Pate RR, 2010, EXERCISE SPORT SCI R, V38, P105; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Schmid D, 2016, MED SCI SPORT EXER, V48, P1312, DOI 10.1249/MSS.0000000000000913; Shiroma EJ, 2013, JAMA-J AM MED ASSOC, V310, P2562, DOI 10.1001/jama.2013.278896; Strandberg E, 2015, J APPL PHYSIOL, V119, P918, DOI 10.1152/japplphysiol.00066.2015; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vishram JKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107294; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	34	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175496	10.1371/journal.pone.0175496	http://dx.doi.org/10.1371/journal.pone.0175496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388679	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800060
J	Nolte, L; Tinne, N; Schulze, J; Heinemann, D; Antonopoulos, GC; Meyer, H; Nothwang, HG; Lenarz, T; Heisterkamp, A; Warnecke, A; Ripken, T				Nolte, Lena; Tinne, Nadine; Schulze, Jennifer; Heinemann, Dag; Antonopoulos, Georgios C.; Meyer, Heiko; Nothwang, Hans Gerd; Lenarz, Thomas; Heisterkamp, Alexander; Warnecke, Athanasia; Ripken, Tammo			Scanning laser optical tomography for in toto eimaging of the murine cochlea	PLOS ONE			English	Article							AIDED 3-DIMENSIONAL RECONSTRUCTION; 3D RECONSTRUCTION; CONFOCAL MICROSCOPY; IMAGE-ANALYSIS; SECTIONS; PLATFORM; HEARING	The mammalian cochlea is a complex macroscopic structure due to its helical shape and the microscopic arrangements of the individual layers of cells. To improve the outcomes of hearing restoration in deaf patients, it is important to understand the anatomic structure and composition of the cochlea ex vivo. Hitherto, only one histological technique based on confocal laser scanning microscopy and optical clearing has been developed for in toto optical imaging of the murine cochlea. However, with a growing size of the specimen, e.g., human cochlea, this technique reaches its limitations. Here, we demonstrate scanning laser optical tomography (SLOT) as a valuable imaging technique to visualize the murine cochlea in toto without any physical slicing. This technique can also be applied in larger specimens up to cm 3 such as the human cochlea. Furthermore, immunolabeling allows visualization of inner hair cells (otoferlin) or spiral ganglion cells (neurofilament) within the whole cochlea. After image reconstruction, the 3D dataset was used for digital segmentation of the labeled region. As a result, quantitative analysis of position, length and curvature of the labeled region was possible. This is of high interest in order to understand the interaction of cochlear implants (CI) and cells in more detail.	[Nolte, Lena; Tinne, Nadine; Heinemann, Dag; Antonopoulos, Georgios C.; Meyer, Heiko; Heisterkamp, Alexander; Ripken, Tammo] Laser Zentrum Hannover eV, Ind & Biomed Opt Dept, Hannover, Germany; [Tinne, Nadine; Schulze, Jennifer; Heinemann, Dag; Nothwang, Hans Gerd; Lenarz, Thomas; Heisterkamp, Alexander; Warnecke, Athanasia; Ripken, Tammo] Cluster Excellence Hearing4all, Hannover, Germany; [Tinne, Nadine; Schulze, Jennifer; Heinemann, Dag; Nothwang, Hans Gerd; Lenarz, Thomas; Heisterkamp, Alexander; Warnecke, Athanasia; Ripken, Tammo] Cluster Excellence Hearing4all, Oldenburg, Germany; [Schulze, Jennifer; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Meyer, Heiko; Lenarz, Thomas; Heisterkamp, Alexander; Ripken, Tammo] Biofabricat NIFE, Hannover, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Neurogenet, Oldenburg, Germany; [Heisterkamp, Alexander] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	Hannover Medical School; Carl von Ossietzky Universitat Oldenburg; Leibniz University Hannover	Nolte, L (corresponding author), Laser Zentrum Hannover eV, Ind & Biomed Opt Dept, Hannover, Germany.	l.nolte@lzh.de	Warnecke, Athanasia/HHC-6174-2022; Heinemann, Dag/AAZ-9970-2021; Heinemann, Dag/A-2861-2019; Heisterkamp, Alexander/V-5376-2017	Heinemann, Dag/0000-0003-3506-1762; Heisterkamp, Alexander/0000-0001-8770-0859; Nothwang, Hans Gerd/0000-0001-7695-6437	DFG Cluster of Excellence [EXC 1077/1]; Ministry of Lower Saxony; VolkswagenStiftung (both BIOFABRICATION FOR NIFE) [VWZN2860]	DFG Cluster of Excellence(German Research Foundation (DFG)); Ministry of Lower Saxony; VolkswagenStiftung (both BIOFABRICATION FOR NIFE)	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" (https://hearing4all.eu/) and the Ministry of Lower Saxony and the VolkswagenStiftung (both BIOFABRICATION FOR NIFE: VWZN2860, http:// bidabrication.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 2010, MICROSC SCI TECHNOL, V2, P1356; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; ARIYASU L, 1989, OTOLARYNG HEAD NECK, V100, P87, DOI 10.1177/019459988910000201; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; Christensen GE, 2003, ACAD RADIOL, V10, P988, DOI 10.1016/S1076-6332(03)00121-1; Coleman B, 2009, J NEUROSCI METH, V176, P144, DOI 10.1016/j.jneumeth.2008.09.007; Eaton J.W., 2021, GNU OCTAVE VERSION 6; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Hardie NA, 2004, BRAIN RES, V1000, P200, DOI 10.1016/j.brainres.2003.10.071; Heidrich M, 2011, BIOMED OPT EXPRESS, V2, P2982, DOI 10.1364/BOE.2.002982; Kawano A, 1996, ANN OTO RHINOL LARYN, V105, P701, DOI 10.1177/000348949610500906; Kellner M, 2012, J APPL PHYSIOL, V113, P975, DOI 10.1152/japplphysiol.00026.2012; Korsawe J., 2012, MATLAB CENTRAL FILE; Kraemer R., 2015, OTOLARYNGOL ONLINE J, V5, P39; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lorbeer RA, 2011, OPT EXPRESS, V19, P5419, DOI 10.1364/OE.19.005419; MacDonald GH, 2008, HEARING RES, V243, P1, DOI 10.1016/j.heares.2008.05.009; Manji SSM, 2012, AM J PATHOL, V180, P1560, DOI 10.1016/j.ajpath.2011.12.034; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; PLASSMANN W, 1987, BRAIN BEHAV EVOLUT, V30, P82, DOI 10.1159/000118639; Poznyakovskiy AA, 2008, HEARING RES, V243, P95, DOI 10.1016/j.heares.2008.06.008; Santi PA, 2009, BIOTECHNIQUES, V46, P287, DOI 10.2144/000113087; Sato M, 1999, HEARING RES, V135, P29, DOI 10.1016/S0378-5955(99)00086-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Tinne N, 2016, SPIE P, V9689; Voie AH, 2002, HEARING RES, V171, P119, DOI 10.1016/S0378-5955(02)00493-8; Voie AH, 1993, J MICROSC-OXFORD, P170; Wada H, 1998, HEARING RES, V120, P1, DOI 10.1016/S0378-5955(98)00007-0; Yoo SK, 2000, IEEE T BIO-MED ENG, V47, P1392, DOI 10.1109/10.871413; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175431	10.1371/journal.pone.0175431	http://dx.doi.org/10.1371/journal.pone.0175431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388662	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800053
J	Almeida, FM; Ventura, TLB; Amaral, EP; Ribeiro, SCM; Calixto, SD; Manhaes, MR; Rezende, AL; Souza, GS; de Carvalho, IS; Silva, EC; da Silva, JA; Carvalho, ECQ; Kritski, AL; Lasunskaia, EB				Almeida, Fabricio M.; Ventura, Thatiana L. B.; Amaral, Eduardo P.; Ribeiro, Simone C. M.; Calixto, Sanderson D.; Manhaes, Marcelle R.; Rezende, Andreza L.; Souza, Giliane S.; de Carvalho, Igor S.; Silva, Elisangela C.; da Silva, Juliana Azevedo; Carvalho, Eulogio C. Q.; Kritski, Afranio L.; Lasunskaia, Elena B.			Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice (vol 12, e0173715, 2017)	PLOS ONE			English	Correction													Silva, Elisangela/AAW-5193-2020; Kritski, Afranio/I-6760-2016	Silva, Elisangela/0000-0001-9833-1825; 				Almeida FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173715	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175652	10.1371/journal.pone.0175652	http://dx.doi.org/10.1371/journal.pone.0175652			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384318	Green Published, gold			2022-12-27	WOS:000399371900197
J	Horng, S; Sontag, DA; Halpern, Y; Jernite, Y; Shapiro, NI; Nathanson, LA				Horng, Steven; Sontag, David A.; Halpern, Yoni; Jernite, Yacine; Shapiro, Nathan I.; Nathanson, Larry A.			Creating an automated trigger for sepsis clinical decision support at emergency department triage using machine learning	PLOS ONE			English	Article							PROGRAM; PERFORMANCE; OUTCOMES; SYSTEMS; CARE	Objective To demonstrate the incremental benefit of using free text data in addition to vital sign and demographic data to identify patients with suspected infection in the emergency department. Methods This was a retrospective, observational cohort study performed at a tertiary academic teaching hospital. All consecutive ED patient visits between 12/17/08 and 2/17/13 were included. No patients were excluded. The primary outcome measure was infection diagnosed in the emergency department defined as a patient having an infection related ED ICD-9-CM discharge diagnosis. Patients were randomly allocated to train (64%), validate (20%), and test (16%) data sets. After preprocessing the free text using bigram and negation detection, we built four models to predict infection, incrementally adding vital signs, chief complaint, and free text nursing assessment. We used two different methods to represent free text: a bag of words model and a topic model. We then used a support vector machine to build the prediction model. We calculated the area under the receiver operating characteristic curve to compare the discriminatory power of each model. Results A total of 230,936 patient visits were included in the study. Approximately 14% of patients had the primary outcome of diagnosed infection. The area under the ROC curve (AUC) for the vitals model, which used only vital signs and demographic data, was 0.67 for the training data set, 0.67 for the validation data set, and 0.67 (95% CI 0.65-0.69) for the test data set. The AUC for the chief complaint model which also included demographic and vital sign data was 0.84 for the training data set, 0.83 for the validation data set, and 0.83 (95% CI 0.81-0.84) for the test data set. The best performing methods made use of all of the free text. In particular, the AUC for the bag-of-words model was 0.89 for training data set, 0.86 for the validation data set, and 0.86 (95% CI 0.85-0.87) for the test data set. The AUC for the topic model was 0.86 for the training data set, 0.86 for the validation data set, and 0.85 (95% CI 0.84-0.86) for the test data set. Conclusion Compared to previous work that only used structured data such as vital signs and demographic information, utilizing free text drastically improves the discriminatory ability (increase in AUC from 0.67 to 0.86) of identifying infection.	[Horng, Steven; Shapiro, Nathan I.; Nathanson, Larry A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA USA; [Sontag, David A.] MIT, Inst Med Engn & Sci, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Halpern, Yoni] Google, Cambridge, MA USA; [Jernite, Yacine] NYU, Dept Comp Sci, Courant Inst Math Sci, York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT); Google Incorporated; New York University	Sontag, DA (corresponding author), MIT, Inst Med Engn & Sci, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dsontag@mit.edu			Center for Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity [12-1262, W81XWH-09-2-0001]; National Center for the Advancement of Translational Science (NCATS), National Institutes of Health [UL1 TR000038]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity; National Center for the Advancement of Translational Science (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	SH, DS, NIS and LAN were partially supported by the Center for Integration of Medicine and Innovative Technology (CIMIT) Award No. 12-1262 under U.S. Army Medical Research Acquisition Activity Cooperative Agreement W81XWH-09-2-0001. DS and YH were partially supported by grant UL1 TR000038 from the National Center for the Advancement of Translational Science (NCATS), National Institutes of Health. The information contained herein does not necessarily reflect the position or policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Chapman WW, 2013, STUD HEALTH TECHNOL, V192, P677, DOI 10.3233/978-1-61499-289-9-677; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; [Committee on the Future of Emergency Care in the United States Health System Institute of Medicine (U.S.)], 2007, HOSP BAS EM CAR BREA, pxxiii; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gultepe E, 2014, J AM MED INFORM ASSN, V21, P315, DOI 10.1136/amiajnl-2013-001815; Handler JA, 2004, ACAD EMERG MED, V11, P1135, DOI 10.1197/j.aem.2004.08.007; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Horsky J, 2012, J BIOMED INFORM, V45, P1202, DOI 10.1016/j.jbi.2012.09.002; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Mani S, 2014, J AM MED INFORM ASSN, V21, P326, DOI 10.1136/amiajnl-2013-001854; McCallum, 2002, MALLET MACHINE LEARN; McGillicuddy DC, 2011, ACAD EMERG MED, V18, P482, DOI 10.1111/j.1553-2712.2011.01056.x; Nachimuthu Senthil K, 2012, AMIA Annu Symp Proc, V2012, P653; Nelson JL, 2011, ANN EMERG MED, V57, P500, DOI 10.1016/j.annemergmed.2010.12.008; Ohno-Machado L, 2011, J AM MED INFORM ASSN, V18, P539, DOI 10.1136/amiajnl-2011-000501; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Sawyer AM, 2011, CRIT CARE MED, V39, P469, DOI 10.1097/CCM.0b013e318205df85; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Stanculescu I, 2014, IEEE J BIOMED HEALTH, V18, P1560, DOI 10.1109/JBHI.2013.2294692; Tafelski S, 2010, J INT MED RES, V38, P1605, DOI 10.1177/147323001003800505; Tsoukalas A, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.3445	25	136	140	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174708	10.1371/journal.pone.0174708	http://dx.doi.org/10.1371/journal.pone.0174708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384212	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900029
J	Molli, AEI; Panero, J; Dos Santos, PC; Gonzalez, CD; Vilarino, J; Sereday, M; Cerrone, GE; Slavutsky, I; Frechtel, GD				Iglesias Molli, Andrea E.; Panero, Julieta; Dos Santos, Patricia C.; Gonzalez, Claudio D.; Vilarino, Jorge; Sereday, Marta; Cerrone, Gloria E.; Slavutsky, Irma; Frechtel, Gustavo D.			Metabolically healthy obese women have longer telomere length than obese women with metabolic syndrome	PLOS ONE			English	Article							UNHEALTHY NORMAL-WEIGHT; PERIPHERAL-BLOOD CELLS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; CIGARETTE-SMOKING; RISK; ASSOCIATION; STRESS; DIET; AGE	Introduction Obesity is the principal component in the Metabolic Syndrome (MetS) that determines the progression of metabolic complications. Metabolically healthy obese (MHO) individuals seem to be protected against those complications. Telomere length (TL) as a novel marker of cellular aging had a complex relationship to the MetS. The principal aim of this study was to investigate the TL in MHO, and to study the association between TL and the worsening of the metabolic condition. Material and methods We have determined the absolute TL (aTL) in 400 women (mean age of 46.76 +/- 15.47 years; range: 18-86 years), grouped according to the metabolic condition in three groups: metabolically healthy non-obese women (MHNO), MHO and obese women with MetS (MSO); and grouped according to the number of components of MetS. Results We found that MHO displays significantly higher aTL than MSO (p = 0.033; r = -4.63; 95% CI r = -8.89/-0.37), but did not differ from MHNO. A decrease in aTL with the progressive increase in the number of MetS components was also observed (p < 0.001; r = -2.06; 95% CI r = -3.13/-0.99). In this way, our results indicate that aTL is influenced by the presence of MetS, but it is not affected by the presence of obesity. Discussion We found that shorter aTL is not associated with MHO, but is related to MetS and with the increased number of metabolic abnormalities.	[Iglesias Molli, Andrea E.; Frechtel, Gustavo D.] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Lab Diabet & Metab, Buenos Aires, DF, Argentina; [Panero, Julieta; Dos Santos, Patricia C.; Slavutsky, Irma] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina; [Gonzalez, Claudio D.] Univ Buenos Aires, Fac Med, Dept Farmacol, Catedra 2, Buenos Aires, DF, Argentina; [Vilarino, Jorge] Hosp FLENI, Dept Cardiol, Buenos Aires, DF, Argentina; [Sereday, Marta] Hosp Fiorito, Serv Endocrinol, Buenos Aires, DF, Argentina; [Cerrone, Gloria E.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol, Catedra Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Molli, AEI (corresponding author), Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Lab Diabet & Metab, Buenos Aires, DF, Argentina.	andrea.iglesiasmolli@gmail.com		Gonzalez, Claudio/0000-0002-3772-8850	Sanofi Aventis Laboratory	Sanofi Aventis Laboratory	This work was financially supported by an unrestricted grant of Sanofi Aventis Laboratory to Gustavo D. Frechtel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955; Aung K, 2014, J CLIN ENDOCR METAB, V99, P462, DOI 10.1210/jc.2013-2832; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Gallagher EJ, 2008, ENDOCRIN METAB CLIN, V37, P559, DOI 10.1016/j.ecl.2008.05.002; Gao X, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0095-9; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1749, DOI 10.1093/ije/dyv171; Mathew H, 2016, METABOLISM, V65, P73, DOI 10.1016/j.metabol.2015.10.019; Navarro E, 2015, MOL NUTR FOOD RES, V59, P75, DOI 10.1002/mnfr.201400521; Njajou OT, 2012, INT J OBESITY, V36, P1176, DOI 10.1038/ijo.2011.196; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Panero J, 2015, MOL BIOTECHNOL, V57, P155, DOI 10.1007/s12033-014-9811-8; Rehkopf DH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002188; Revesz D, 2014, J CLIN ENDOCR METAB, V99, P1; Revesz D, 2015, J CLIN ENDOCR METAB, V100, P3050, DOI 10.1210/JC.2015-1995; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Satoh H, 1996, JPN J HUM GENET, V41, P413, DOI 10.1007/BF01876332; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Shaharyar S, 2015, J OBES, V2015, DOI 10.1155/2015/178526; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Verde Z, 2015, ENVIRON RES, V140, P488, DOI 10.1016/j.envres.2015.05.008; Vilarino J, 2015, REVISTA ALAD, V4, P140; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174945	10.1371/journal.pone.0174945	http://dx.doi.org/10.1371/journal.pone.0174945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384193	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900060
J	Ludington, WB; Seher, TD; Applegate, O; Li, XD; Kliegman, JI; Langelier, C; Atwill, ER; Harter, T; DeRisi, JL				Ludington, William B.; Seher, Thaddeus D.; Applegate, Olin; Li, Xunde; Kliegman, Joseph I.; Langelier, Charles; Atwill, Edward R.; Harter, Thomas; DeRisi, Joseph L.			Assessing biosynthetic potential of agricultural groundwater through metagenomic sequencing: A diverse anammox community dominates nitrate-rich groundwater	PLOS ONE			English	Article							SHALLOW GROUNDWATER; ANAEROBIC AMMONIUM; CENTRAL VALLEY; GENERATION; OXIDATION; QUALITY; BLAST; WATER; METABOLISM; BACTERIAL	Background Climate change produces extremes in both temperature and precipitation causing increased drought severity and increased reliance on groundwater resources. Agricultural practices, which rely on groundwater, are sensitive to but also sources of contaminants, including nitrate. How agricultural contamination drives groundwater geochemistry through microbial metabolism is poorly understood. Methods On an active cow dairy in the Central Valley of California, we sampled groundwater from three wells at depths of 4.3 m (two wells) and 100 m (one well) below ground surface (bgs) as well as an effluent surface water lagoon that fertilizes surrounding corn fields. We analyzed the samples for concentrations of solutes, heavy metals, and USDA pathogenic bacteria of the Escherichia coli and Enterococcus groups as part of a long term groundwater monitoring study. Whole metagenome shotgun sequencing and assembly revealed taxonomic composition and metabolic potential of the community. Results Elevated nitrate and dissolved organic carbon occurred at 4.3m but not at 100m bgs. Metagenomics confirmed chemical observations and revealed several Planctomycete genomes, including a new Brocadiaceae lineage and a likely Planctomycetes OM190, as well novel diversity and high abundance of nano-prokaryotes from the Candidate Phyla Radiation (CPR), the Diapherotrites, Parvarchaeota, Aenigmarchaeota, Nanoarchaeota, Nanohaloarchaea (DPANN) and the Thaumarchaeota, Aigarchaeota, Crenarchaeota, Korarchaeota (TACK) superphyla. Pathway analysis suggests community interactions based on complimentary primary metabolic pathways and abundant secondary metabolite operons encoding antimicrobials and quorum sensing systems. Conclusions The metagenomes show strong resemblance to activated sludge communities from a nitrogen removal reactor at a wastewater treatment plant, suggesting that natural bioremediation occurs through microbial metabolism. Elevated nitrate and rich secondary metabolite biosynthetic capacity suggest incomplete remediation and the potential for novel pharmacologically active compounds.	[Ludington, William B.; Seher, Thaddeus D.] Univ Calif Berkeley, Mol Cell Biol Dept, Berkeley, CA 94720 USA; [Applegate, Olin; Harter, Thomas] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Li, Xunde; Atwill, Edward R.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Li, Xunde; Atwill, Edward R.] Univ Calif Davis, Western Inst Food Safety & Secur, Davis, CA 95616 USA; [Kliegman, Joseph I.; Langelier, Charles; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Seher, Thaddeus D.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Merced	Ludington, WB (corresponding author), Univ Calif Berkeley, Mol Cell Biol Dept, Berkeley, CA 94720 USA.	will.ludington@berkeley.edu	Harter, Thomas/AAB-7355-2020	Harter, Thomas/0000-0001-8526-3843; Kliegman, Joseph/0000-0002-7362-6085	California State Water Resources Control Board [03-244-555-01, 04-184-555-0, 11-168-150]; Howard Hughes Medical Institute; NIH [1DP50D017851, 5K12HL119997-04]; UC Berkeley Bowes Fellows Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017851] Funding Source: NIH RePORTER	California State Water Resources Control Board; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley Bowes Fellows Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for our research projects was provided by the late Henry "Sam" Wheeler (WBL, JIK, JLD), the California State Water Resources Control Board (swrcb.ca.gov) contracts 03-244-555-01, 04-184-555-0, and 11-168-150 (ERA, XL, OA, TH), the Howard Hughes Medical Institute (hhmi.org) (JLD), NIH (nih.gov) grant 1DP50D017851 (WBL), NIH grant 5K12HL119997-04 (CL), and the UC Berkeley Bowes Fellows Program (WBL). The funders played no role in the research.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burton CA, 2012, 20115218 CALI GAMA P, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Clark ML, 2006, WATER QUALITY CHARAC, P2006; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Hafner SC, 2016, J ENVIRON QUAL, V45, P480, DOI 10.2134/jeq2015.05.0251; Harpole WS, 2016, NATURE, V537, P93, DOI 10.1038/nature19324; Harter T, 2002, J CONTAM HYDROL, V55, P287, DOI 10.1016/S0169-7722(01)00189-9; Harter T, 2012, ADDRESSING NITRATE C, P1; Harter T, 2003, GROUNDWATER SAMPLING; Harter T, 2014, GROUNDWATER, V52, P126, DOI 10.1111/gwat.12222; Hill VR, 2005, APPL ENVIRON MICROB, V71, P6878, DOI 10.1128/AEM.71.11.6878-6884.2005; Hu ZY, 2013, APPL ENVIRON MICROB, V79, P2807, DOI 10.1128/AEM.03987-12; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jetten MSM, 2003, APPL MICROBIOL BIOT, V63, P107, DOI 10.1007/s00253-003-1422-4; Jewell TNM, 2016, ISME J, V10, P2106, DOI 10.1038/ismej.2016.25; Jurgens BC, 2010, GROUND WATER, V48, P913, DOI 10.1111/j.1745-6584.2009.00635.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kiparsky M, 2016, DESIGNING EFFECTIVE, P1; Krasnv J, 2007, GROUNDWATER FRACTURE; Laczny CC, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0066-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li X, 2013, ENVIRON MONIT ASSESS, V186, P1253; Li XD, 2015, J ENVIRON QUAL, V44, P1435, DOI 10.2134/jeq2015.03.0139; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P6802, DOI 10.1128/AEM.05539-11; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; MURTHY GK, 1967, J DAIRY SCI, V50, P818, DOI 10.3168/jds.S0022-0302(67)87527-1; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ransom KM, 2016, WATER RESOUR RES, V52, P5577, DOI 10.1002/2015WR018523; Ruby JG, 2013, PRICE SOFTWARE TARGE; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shen LD, 2014, APPL ENVIRON MICROB, V80, P7611, DOI 10.1128/AEM.02379-14; Smith MB, 2015, MBIO, V6, DOI 10.1128/mBio.00326-15; Speth DR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11172; Speth DR, 2012, FRONTIERS MICROBIOLO, V3; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Thorgersen MP, 2015, APPL ENVIRON MICROB; Unc A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010775; Villanueva L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weber T., 2015, NUCL ACIDS RES; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	61	13	13	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174930	10.1371/journal.pone.0174930	http://dx.doi.org/10.1371/journal.pone.0174930			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384184	Green Published, gold			2022-12-27	WOS:000399371900056
J	Place, ES; Smith, JC				Place, Elsie S.; Smith, James C.			Zebrafish atoh8 mutants do not recapitulate morpholino phenotypes (vol 12, e0171143, 2017)	PLOS ONE			English	Correction														Smith, Jim/0000-0003-2413-9392				Place ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171143	1	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175608	10.1371/journal.pone.0175608	http://dx.doi.org/10.1371/journal.pone.0175608			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384291	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900183
J	Wei, JY; Liu, GY; Liu, DB; Chen, YY				Wei, Junya; Liu, Guoyin; Liu, Debing; Chen, Yeyuan			Influence of irrigation during the growth stage on yield and quality in mango (Mangifera indica L)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; DEFICIT IRRIGATION; FRUIT-GROWTH; PHOTOSYNTHESIS; PHYSIOLOGY	Although being one of the few drought-tolerant plants, mango trees are irrigated to ensure optimum and consistent productivity in China. In order to better understand the effects of soil water content on mango yield and fruit quality at fruit growth stage, irrigation experiments were investigated and the object was to determine the soil water content criteria at which growth and quality of mango would be optimal based on soil water measured by RHD-JS water-saving irrigation system through micro-sprinkling irrigation. Five soil water content treatments (relative to the percentage of field water capacity) for irrigation (T1:79%-82%, T2:75%-78%, T3:71%-74%, T4:65%-70%, T5:63%-66%) were compared in 2013. Amount of applied irrigation water for different treatments varied from 2.93m(3) to 1.08 m(3). The results showed that mango fruit production and quality at fruit growth stage were significantly affected under different irrigation water amounts. Variation in soil water content not only had effects on fruit size, but also on fruit yield. The highest fruit yield and irrigation water use efficiency were obtained from the T4 treatment. Irrigation water amount also affected fruit quality parameters like fruit total soluble solids, soluble sugar, starch, titratable acid and vitamin C content. Comprehensive evaluation of the effect of indexs of correlation on irrigation treatment by subordinate function showed that when the soil moisture content were controlled at about 65-70% of the field water moisture capacity, water demand in the growth and development of mango could be ensured, and maximum production efficiency of irrigation and the best quality of fruit could be achieved. In conclusion, treatment T4 was the optimum irrigation schedule for growing mango, thus achieving efficient production of mango in consideration of the compromise among mango yield, fruit quality and water use efficiency.	[Wei, Junya; Liu, Guoyin; Liu, Debing] Hainan Univ, Appl Sci & Technol Coll, Haikou, Hainan, Peoples R China; [Wei, Junya; Chen, Yeyuan] Chinese Acad Trop Agr Sci, Natl Trop Fruit Improvement Ctr, Hainan Trop Fruit Cultivat Engn Technol Res Ctr, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences	Liu, DB (corresponding author), Hainan Univ, Appl Sci & Technol Coll, Haikou, Hainan, Peoples R China.	ldebing@126.com			National Nonprofit Institute Research Grant of CATAS-TCGRI [163003201206, 0315137]; Science and technology project of Hainan Province [ZDXM2015016]	National Nonprofit Institute Research Grant of CATAS-TCGRI; Science and technology project of Hainan Province	The study was conducted under the support of National Nonprofit Institute Research Grant of CATAS-TCGRI(163003201206, 0315137; Science and technology project of Hainan Province (ZDXM2015016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHBOUDIAN MH, 1994, SCI HORTIC-AMSTERDAM, V60, P89, DOI 10.1016/0304-4238(94)90064-7; BLANCO MJS, 1989, PLANT SOIL, V120, P299, DOI 10.1007/BF02377080; Cao J., 2007, EXPT GUIDANCE POSTHA; CASPARI HW, 1994, J AM SOC HORTIC SCI, V119, P383, DOI 10.21273/JASHS.119.3.383; Chen Y. Y., 2006, TROPICAL TROPICAL S; CRISOSTO CH, 1994, HORTSCIENCE, V29, P1169, DOI 10.21273/HORTSCI.29.10.1169; Doorenbos J., 1979, 24 UNFAO; Dumas Y, 2006, ACTA HORTIC, P235, DOI 10.17660/ActaHortic.2006.724.29; Huang XM, 2000, SCI HORTIC-AMSTERDAM, V83, P227, DOI 10.1016/S0304-4238(99)00083-7; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kato Y, 2009, FIELD CROP RES, V113, P328, DOI 10.1016/j.fcr.2009.06.010; Lechaudel M, 2005, J SCI FOOD AGR, V85, P251, DOI 10.1002/jsfa.1968; Liu D. B., 2012, J S CHINA FRUITS, V41, P83; Liu DB, 2011, 3RD CONFERENCE ON KEY TECHNOLOGY OF HORTICULTURE, CKTH 2011, P132; Liu Debing, 2011, S CHINA FRUITS, V40, P64; Liu G. Y., 2014, JIANGSU AGR SCI J, V42, P124; Liu H., 2008, THESIS; Liu Z.T., 2007, J CHINA TROP AGR, V1, P32; Madigu NO, 2009, ACTA HORTIC, V837, P299, DOI 10.17660/ActaHortic.2009.837.40; Nagle M, 2010, SCI HORTIC-AMSTERDAM, V125, P771, DOI 10.1016/j.scienta.2010.04.044; Pavel EW, 2004, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2004.646.7; Singh Z, 2005, J PLANT NUTR, V28, P1723, DOI 10.1080/01904160500250771; Spreer W, 2009, ACTA HORTIC, V820, P357; Tezara W, 2002, J EXP BOT, V53, P1781, DOI 10.1093/jxb/erf021	24	17	18	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174498	10.1371/journal.pone.0174498	http://dx.doi.org/10.1371/journal.pone.0174498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384647	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900018
J	Negrin, LL; Halat, G; Kettner, S; Gregori, M; Ristl, R; Hajdu, S; Heinz, T				Negrin, Lukas L.; Halat, Gabriel; Kettner, Stephan; Gregori, Markus; Ristl, Robin; Hajdu, Stefan; Heinz, Thomas			Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of pulmonary complications in polytraumatized patients with severe chest trauma	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; VENTILATOR-ASSOCIATED PNEUMONIA; GLYCATION END-PRODUCTS; NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; SERUM CYFRA 21-1; CLINICAL-OUTCOMES; RISK-FACTOR; EXPRESSION; PLASMA	Background Acute respiratory distress syndrome (ARDS) and pneumonia have a great impact on the treatment regimen of polytraumatized patients with severe chest trauma. The objective of our study was to determine whether biomarker levels assessed shortly after multiple trauma may predict the occurrence of these conditions. Methods and findings Our patient population included 71 men and 30 women (mean age, 40.3 +/- 15.8 years) with an Injury Severity Score that ranged from 17 to 59 and an Abbreviated Injury Scale Thorax of at least 3. They were admitted to our level I trauma center within one post-traumatic hour and survived for at least 24 hours after the trauma occurred. Thirty-five patients developed ARDS, 30 patients pneumonia and 21 patients both. Five individuals died during hospitalization. The levels of five selected biomarkers, which were identified by a literature search, were assessed at admission (initial levels) and on day 2 after trauma. We performed comparisons of medians, logistic regression analyses and receiver operating characteristic analyses for initial and day-2 levels of each biomarker. With regard to ARDS, initial levels of cytokeratin fragment 21-1, the soluble fragment of cytokeratin 19 (CYFRA21-1) and of the club cell protein 16 (CC16) provided significant results in each statistical analysis. With regard to pneumonia, each statistical analysis supplied significant results for both initial and day-2 levels of CYFRA21-1 and CC16. Consistently, initial CYFRA21-1 levels were identified as the most promising predictor of ARDS, whereas day-2 CC16 levels have to be considered as most appropriate for predicting pneumonia. Conclusions CYFRA21-1 levels exceeding cut-off value of 1.85 ng/ml and 2.49 ng/ml in the serum shortly after multiple injury occurred may identify polytraumatized patients at risk for ARDS and pneumonia, respectively. However, CC16 levels exceeding 30.51 ng/ml on day 2 may allow a firmer diagnosis for the development of pneumonia.	[Negrin, Lukas L.; Halat, Gabriel; Gregori, Markus; Hajdu, Stefan; Heinz, Thomas] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Kettner, Stephan] Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Managemen, Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Ctr Med Stat & Informat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Negrin, LL (corresponding author), Med Univ Vienna, Dept Trauma Surg, Vienna, Austria.	lukas.negrin@meduniwien.ac.at		Ristl, Robin/0000-0002-4163-9236; Negrin, Lukas/0000-0002-7195-2223; Halat, Gabriel/0000-0002-2480-7381	Oesterreichische Nationalbank, grant [14497]	Oesterreichische Nationalbank, grant	This work was supported by the funds of the Oesterreichische Nationalbank, grant number 14497 to LLN (https://www.oenb.at/Ueber-Uns/ Forschungsfoerderung/Jubilaeumsfonds.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon A, 2005, CLIN CHEST MED, V26, P39, DOI 10.1016/j.ccm.2004.10.013; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; Becher RD, 2012, J TRAUMA ACUTE CARE, V73, P1229, DOI 10.1097/TA.0b013e31825b2124; BODENMULLER H, 1995, SCAND J CLIN LAB INV, V55, P60, DOI 10.3109/00365519509090566; Broeckaert F, 2000, ANN NY ACAD SCI, V923, P68; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Determann RM, 2009, BMC PULMONARY MED, V9; DIERYNCK I, 1995, AM J RESP CELL MOL, V12, P205, DOI 10.1165/ajrcmb.12.2.7865218; Dohmoto K, 2001, INT J CANCER, V91, P468; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Ferguson KL, 1997, ACAD EMERG MED, V4, P1035, DOI 10.1111/j.1553-2712.1997.tb03676.x; Gadani H, 2010, INDIAN J ANAESTH, V54, P535, DOI 10.4103/0019-5049.72643; Gu W, 2014, INT J CLIN EXP MED, V15, P12; Hanes SD, 2002, CLIN INFECT DIS, V35, P228, DOI 10.1086/341022; Hayashi Y, 2004, INVEST OPHTH VIS SCI, V45, P2212, DOI 10.1167/iovs.03-0988; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Hyllienmark P, 2013, ACTA ANAESTH SCAND, V57, P848, DOI 10.1111/aas.12111; Iyonaga K, 1997, J PATHOL, V182, P217; Jain R, 2010, APPL IMMUNOHISTO M M, V18, P9, DOI 10.1097/PAI.0b013e3181ad36ea; Johnston CJ, 1997, AM J RESP CELL MOL, V17, P147, DOI 10.1165/ajrcmb.17.2.2676; Kosacka M, 2009, POL ARCH MED WEWN, V119, P33, DOI 10.20452/pamw.598; Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; LEVIN SW, 1986, LIFE SCI, V38, P1813, DOI 10.1016/0024-3205(86)90135-9; Liu KQ, 2011, EXP THER MED, V2, P563, DOI 10.3892/etm.2011.241; Liu XW, 2012, CRIT CARE, V16, DOI 10.1186/cc11354; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Mangram AJ, 2015, AM J SURG, V210, P1056, DOI 10.1016/j.amjsurg.2015.06.029; Mica L, 2013, J TRAUMA ACUTE CARE, V75, P693, DOI 10.1097/TA.0b013e31829a0bdd; Michelet P, 2010, J TRAUMA, V68, P395, DOI 10.1097/TA.0b013e3181a601cb; Miller PR, 2002, AM SURGEON, V68, P845; Mommsen P, 2012, J SURG RES, V176, P239, DOI 10.1016/j.jss.2011.09.018; Nakamura H, 1997, AM J RESP CRIT CARE, V155, P1217, DOI 10.1164/ajrccm.155.4.9105057; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Nathani N, 2008, CRIT CARE, V12, DOI 10.1186/cc6785; Ono A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-354; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Pierrakos Charalampos, 2012, J Clin Med Res, V4, P7, DOI 10.4021/jocmr761w; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; RASTEL D, 1994, EUR J CANCER, V30A, P601, DOI 10.1016/0959-8049(94)90528-2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Stern JB, 2006, INTENS CARE MED, V32, P910, DOI 10.1007/s00134-006-0124-7; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Timonen KL, 2004, OCCUP ENVIRON MED, V61, P908, DOI 10.1136/oem.2004.012849; VASANTHAKUMAR G, 1988, BIOCHEM PHARMACOL, V37, P389, DOI 10.1016/0006-2952(88)90204-3; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watson TM, 2001, AM J PHYSIOL-LUNG C, V281, pL1523, DOI 10.1152/ajplung.2001.281.6.L1523; Yao XL, 1998, AM J RESP CELL MOL, V19, P629, DOI 10.1165/ajrcmb.19.4.3129; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	58	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175303	10.1371/journal.pone.0175303	http://dx.doi.org/10.1371/journal.pone.0175303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380043	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500115
J	Newman, LE; Schiavon, CR; Zhou, CJ; Kahn, RA				Newman, Laura E.; Schiavon, Cara R.; Zhou, Chengjing; Kahn, Richard A.			The abundance of the ARL2 GTPase and its GAP, ELMOD2, at mitochondria are modulated by the fusogenic activity of mitofusins and stressors	PLOS ONE			English	Article							RIBOSYLATION FACTOR FAMILY; SACCHAROMYCES-CEREVISIAE; PDE-DELTA; ENDOPLASMIC-RETICULUM; FARNESYLATED CARGO; ACTIVATING PROTEIN; DISTINCT FUNCTIONS; STRUCTURAL BASIS; MAMMALIAN-CELLS; COFACTOR-D	Mitochondria are essential, dynamic organelles that respond to a number of stressors with changes in morphology that are linked to several mitochondrial functions, though the mechanisms involved are poorly understood. We show that the levels of the regulatory GTPase ARL2 and its GAP, ELMOD2, are specifically increased at mitochondria in immortalized mouse embryo fibroblasts deleted for Mitofusin 2 (MFN2), but not MFN1. Elevated ARL2 and ELMOD2 in MEFs deleted for MFN2 could be reversed by re-introduction of MFN2, but only when the mitochondrial fragmentation in these MEFs was also reversed, demonstrating that reversal of elevated ARL2 and ELMOD2 requires the fusogenic activity of MFN2. Other stressors with links to mitochondrial morphology were investigated and several, including glucose or serum deprivation, also caused increases in ARL2 and ELMOD2. In contrast, a number of pharmacological inhibitors of energy metabolism caused increases in ARL2 without affecting ELMOD2 levels. Together we interpret these data as evidence of two ARL2-sensitive pathways in mitochondria, one affecting ATP levels that is independent of ELMOD2 and the other leading to mitochondrial fusion involving MFN2 that does involve ELMOD2.	[Newman, Laura E.; Schiavon, Cara R.; Zhou, Chengjing; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; , PEP-MX Core/AGV-4051-2022	Kahn, Richard/0000-0002-0259-0601; Newman, Laura/0000-0001-5559-713X; Schiavon, Cara/0000-0002-9311-2145	National Institutes of Health [P30NS055077, 5R01GM090158, 1F31GM111047]; American Heart Association [14PRE18840040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institutes of Health [https://www.nih.gov/] P30NS055077, 5R01GM090158 to RAK, 1F31GM111047 to LEN; and the American Heart Association [http://www.heart.org/HEARTORG/] 14PRE18840040 to LEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fansa EK, 2016, SMALL GTPASES, P1; Fansa EK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11366; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2016, J BIOL CHEM, V291, P20766, DOI 10.1074/jbc.M116.741827; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LEE JUN BONG, 2014, [Journal of IFA, Korea, 조세학술논집], V30, P1, DOI 10.9725/kstle.2014.30.1.1; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Newman Laura E, 2016, Cell Logist, V6, pe1247939, DOI 10.1080/21592799.2016.1247939; Newman LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099270; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; STEARNS T, 1990, GENETICS, V124, P251; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; TAPPER DP, 1983, METHOD ENZYMOL, V97, P426; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Watzlich D, 2013, EMBO REP, V14, P465, DOI 10.1038/embor.2013.37; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WICK AN, 1957, J BIOL CHEM, V224, P963; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	66	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175164	10.1371/journal.pone.0175164	http://dx.doi.org/10.1371/journal.pone.0175164			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380071	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500104
J	Stratford, JK; Yan, F; Hill, RA; Major, MB; Graves, LM; Der, CJ; Yeh, JJ				Stratford, Jeran K.; Yan, Feng; Hill, Rebecca A.; Major, Michael B.; Graves, Lee M.; Der, Channing J.; Yeh, Jen Jen			Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; NEGATIVE BREAST-CANCER; DUCTAL ADENOCARCINOMA; MPS1 KINASE; KINETOCHORE LOCALIZATION; MITOTIC CHECKPOINT; TPR DOMAIN; EXPRESSION; ANEUPLOIDY; PROTEIN	Pancreatic ductal adenocarcinoma, which accounts for the majority of pancreatic cancers, is a lethal disease with few therapeutic options. Genomic profiling of pancreatic ductal adenocarcinoma has identified a complex and heterogeneous landscape. Understanding the molecular characteristics of pancreatic ductal adenocarcinoma will facilitate the identification of potential therapeutic strategies. We analyzed the gene expression profiles of primary tumors from patients compared to normal pancreas and identified high co-overexpression of core components of the spindle assembly checkpoint, including the protein kinase TTK (also known as MPS-1). We found overexpression of TTK protein in a subset of pancreatic ductal adenocarcinoma primary tumors and cell lines. siRNA-mediated depletion or catalytic inhibition of TTK resulted in an aberrant cell cycle profile, multi-and micro-nucleation, induction of apoptosis, and decreased cell proliferation and transformed growth. Selective catalytic inhibition of TTK caused override of the spindle assembly checkpoint-induced cell cycle arrest. Interestingly, we identified ubiquitin specific peptidase 16 (Usp16), an ubiquitin hydrolase, as a phosphorylation substrate of TTK. Usp16 regulates chromosomal condensation and G2/M progression by deubiquitinating histone H2A and polo-like kinase 1. Phosphomimetic mutants of Usp16 show enhanced proteosomal degradation and may prolong the G2/M transition allowing for correction of replication errors. Taken together, our results suggest a critical role for TTK in preventing aneuploidyinduced cell death in pancreatic cancer.	[Stratford, Jeran K.; Graves, Lee M.; Der, Channing J.; Yeh, Jen Jen] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Stratford, Jeran K.; Hill, Rebecca A.; Major, Michael B.; Graves, Lee M.; Der, Channing J.; Yeh, Jen Jen] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yan, Feng; Major, Michael B.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Major, Michael B.] Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Yeh, JJ (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Yeh, JJ (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Yeh, JJ (corresponding author), Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA.	jjyeh@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022	Der, Channing/0000-0002-7751-2747; Major, Michael/0000-0002-6753-8513; Stratford, Jeran/0000-0003-4305-1468	National Institutes of Health [R01-CA042978, R01-CA14024, T32CA071341, 5F31CA165623-02]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA193650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Institutes of Health R01-CA042978 (CJD), R01-CA14024 (JJY), T32CA071341 (JKS), and 5F31CA165623-02 (JKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.14; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chou A, 2013, GENOME MED, V5, DOI 10.1186/gm482; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gotoh M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/780836; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; GOWER WR, 1994, IN VITRO CELL DEV-AN, V30A, P151, DOI 10.1007/BF02631438; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Heidenblad M, 2004, CANCER RES, V64, P3052, DOI 10.1158/0008-5472.CAN-03-3159; Hennrich ML, 2013, J PROTEOME RES, V12, P2214, DOI 10.1021/pr400074f; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang YS, 2009, LASERS ELECTRO-OPT R, P1; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jemaa M, 2013, CELL DEATH DIFFER; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kaistha BP, 2014, BRIT J CANCER, V111, P1780, DOI 10.1038/bjc.2014.460; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lee S, 2012, J BIOL CHEM, V287, P5988, DOI 10.1074/jbc.M111.307355; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Maachani UB, 2015, MOL CANCER RES, V13, P852, DOI 10.1158/1541-7786.MCR-14-0462-T; Maia ARR, 2015, ANN ONCOL, V26, P2180, DOI 10.1093/annonc/mdv293; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x; Moskovitz AH, 2003, GENE CHROMOSOME CANC, V37, P201, DOI 10.1002/gcc.10189; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schreiner B, 2003, GENE CHROMOSOME CANC, V38, P240, DOI 10.1002/gcc.10285; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slee RB, 2014, MOL CANCER THER, V13, P307, DOI 10.1158/1535-7163.MCT-13-0324; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tannous BA, 2013, J NATL CANC I; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thykjaer T, 2001, CANCER RES, V61, P2492; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Von Hoff DD, 2014, NEW ENGL J MED, V370, P479, DOI 10.1056/NEJMc1314761; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; von Schubert C, 2015, CELL REP, V12, P66, DOI 10.1016/j.celrep.2015.06.007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200; Zhuo XL, 2015, J CELL BIOL, V210, P727, DOI 10.1083/jcb.201502044	85	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174863	10.1371/journal.pone.0174863	http://dx.doi.org/10.1371/journal.pone.0174863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380042	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500070
J	Du, HX; Yang, JJ; Bai, JY; Ming, K; Shi, JT; Yao, FK; Zhang, W; Yu, Y; Chen, Y; Xiong, W; Wu, Y; Wang, DY; Hu, YL; Liu, JG				Du, Hongxu; Yang, Jingjing; Bai, Jingying; Ming, Ke; Shi, Jintong; Yao, Fangke; Zhang, Wei; Yu, Yang; Chen, Yun; Xiong, Wen; Wu, Yi; Wang, Deyun; Hu, Yuanliang; Liu, Jiaguo			A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type	PLOS ONE			English	Article							OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; LIVER-INJURY; CELL-DEATH; MEDICINE; SEROTYPE; PROTEIN	The principal target organ of duck hepatitis A virus type 1 (DHAV-1) is duckling liver, which is an energy-intensive organ and plays important roles in body's energy metabolism and conversion. As the "power house" of the hepatocytes, mitochondria provide more than 90% of the energy. However, mitochondria are much vulnerable to the oxidative stress for their rich in polyunsaturated fatty acids. Although previous researches have demonstrated that DHAV-1 could induce the oxidative stress in the serum of the infected ducklings, no related study on the mitochondria during the pathological process of DVH has been reported by far. To address this issue, we examined the HE stained tissue pathological slices, detected the hepatic SOD, CAT and GPX activities and MDA contents and analyzed the ATP content, mitochondrial ultrastructure and the mitochondrial SOD, GPX activities and MDA content in the liver tissues. The results showed that the hepatic redox status was significantly disturbed so that causing the mitochondrial dysfunction, ATP depletion and mitochondrial oxidative stress during the process of the DHAV-1 infection, and a prescription formulated with Hypericum japonicum flavone, Radix Rehmanniae Recens polysaccharide and Salvia plebeia flavone (HRS), which had been demonstrated with good anti-oxidative activity in serum, could effectively alleviate the hepatic injury and the oxidative stress in liver tissue induced by DHAV-1 thus alleviating the mitochondrial injury and oxidative stress. In a word, this research discovers the oxidative stress induced mitochondrial dysfunction and oxidative stress during the DVH pathological process and demonstrates HRS exerts good anti-oxidative activity in liver tissue to protect mitochondria against reactive oxygen species (ROS).	[Du, Hongxu; Yang, Jingjing; Bai, Jingying; Ming, Ke; Shi, Jintong; Yao, Fangke; Zhang, Wei; Yu, Yang; Chen, Yun; Xiong, Wen; Wu, Yi; Wang, Deyun; Hu, Yuanliang; Liu, Jiaguo] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Peoples R China	Nanjing Agricultural University	Liu, JG (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Peoples R China.	liujiaguo@njau.edu.cn			National Natural Science Foundation of China [31172355, 31572557]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Funds for Agro-scientific Research of Public Interest [201303040, 201403051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Funds for Agro-scientific Research of Public Interest	This work was supported by the National Natural Science Foundation of China (grant no. 31172355, 31572557, URLs: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), Project Funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Special Funds for Agro-scientific Research of Public Interest (201303040 and 201403051, URLs: http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016; Al-Qabandi W, 2012, MED PRIN PRACT, V21, P264, DOI 10.1159/000334491; Arakawa S, 2015, BIOCHEM BIOPH RES CO, V467, P1006, DOI 10.1016/j.bbrc.2015.10.022; ASPLIN FD, 1965, VET REC, V77, P1529; Auger C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00040; Bacchetta R, 2016, ENVIRON RES, V148, P376, DOI 10.1016/j.envres.2016.04.028; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chen Y, 2015, VIRUS RES, V204, P58, DOI 10.1016/j.virusres.2015.04.013; Chen Y, 2014, INT J BIOL MACROMOL, V66, P186, DOI 10.1016/j.ijbiomac.2014.02.038; Chen ZG, 2015, J ETHNOPHARMACOL, V162, P287, DOI 10.1016/j.jep.2015.01.002; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Clark R, 2005, J INVEST DERMATOL, V125, P629, DOI 10.1111/j.0022-202X.2005.23856.x; Du HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146046; Gui SY, 2005, WORLD J GASTROENTERO, V11, P2984, DOI 10.3748/wjg.v11.i19.2984; HAIDER SA, 1979, AVIAN DIS, V23, P715, DOI 10.2307/1589748; Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; LEVINE PP, 1950, CORNELL VET, V40, P71; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Liu P, 2005, WORLD J GASTROENTERO, V11, P2892, DOI 10.3748/wjg.v11.i19.2892; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Polo M, 2015, BRIT J PHARMACOL, V172, P1713, DOI 10.1111/bph.13018; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Sanz A, 2016, BBA-BIOENERGETICS, V1857, P1116, DOI 10.1016/j.bbabio.2016.03.018; Sekine S, 2015, TOXICOL APPL PHARM, V282, P237, DOI 10.1016/j.taap.2014.12.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang YH, 2012, FOOD CHEM TOXICOL, V50, P1194, DOI 10.1016/j.fct.2012.02.008; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Wang LQ, 2015, ACTA PHARM SIN B, V5, P310, DOI [10.1016/j.apsb.2015.05.005, 10.1016//j.apsb.2015.05.005]; Wiesenfeld PW, 2006, FOOD CHEM TOXICOL, V44, P579, DOI 10.1016/j.fct.2005.09.005; Zeng T, 2008, TOXICOLOGY, V252, P86, DOI 10.1016/j.tox.2008.07.062; Zhang R, 2010, FOOD CHEM TOXICOL, V48, P922, DOI 10.1016/j.fct.2010.01.001	39	3	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175495	10.1371/journal.pone.0175495	http://dx.doi.org/10.1371/journal.pone.0175495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394931	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800039
J	Sobrero, P; Schluter, JP; Lanner, U; Schlosser, A; Becker, A; Valverde, C				Sobrero, Patricio; Schluter, Jan-Philip; Lanner, Ulrike; Schlosser, Andreas; Becker, Anke; Valverde, Claudio			Quantitative Proteomic Analysis of the Hfq-Regulon in Sinorhizobium meliloti 2011 (vol 7, e48494, 2012)	PLOS ONE			English	Correction																		Sobrero P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048494	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175832	10.1371/journal.pone.0175832	http://dx.doi.org/10.1371/journal.pone.0175832			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394919	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800048
J	Rozani, V; Giladi, N; El-Ad, B; Gurevich, T; Tsamir, J; Hemo, B; Peretz, C				Rozani, Violetta; Giladi, Nir; El-Ad, Baruch; Gurevich, Tanya; Tsamir, Judith; Hemo, Beatriz; Peretz, Chava			Statin adherence and the risk of Parkinson's disease: A population-based cohort study	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; SERUM-CHOLESTEROL; SIMVASTATIN; THERAPY; PREVENTS	Background While experimental data provided some compelling evidence on the benefits of statins on dopaminergic neurons, observational studies reported conflicting results regarding the potential of statins to effect the risk of Parkinson's disease (PD). Objectives To evaluate the association between changes in statin adherence over time and PD risk. Methods A population-based cohort of new statin users (ages 40-79, years 1999-2012) was derived from a large Israeli healthcare services organization. Data included history of statin purchases and low density lipoprotein cholesterol (LDL-C) levels. Personal statin adherence was measured annually by the proportion of days covered (PDC). PD was detected employing a drug-tracer approach. Stratified (by sex, LDL-C levels at baseline and age) Cox proportional hazards models with time-dependent covariates were used to compute adjusted Hazard Ratio (HR) with 95%Cl. Results The cohort included 232,877 individuals, 49.3% men. Mean age at first statin purchase was 56.5 (9.8) years for men and 58.7 (9.2) years for women. PDC distribution for the whole follow up period differed between men and women: medians 58.3% and 54.1% respectively. During a mean follow up of 7.6 (3.4) years, 2,550 (1.1%) PD cases were identified. In a 1 year lagged analysis, we found no association between annual statin adherence and PD risk in all age-groups regardless of statin type and potency. Age-pooled HR (95%C1) for men and women with LDL-C levels at baseline <160mg/dL were: 0.99 (0.99-1.01), 1.01 (1.00-1.02); and for men and women with LDL-C >160mg/dL levels: 0.99 (0.98-1.01), 0.97 (0.98-1.01). Conclusions Our findings suggest that statin adherence over time does not affect PD risk. Future studies should use large-scale cohorts and refining assessments of long-term profiles in statin adherence.	[Rozani, Violetta; Peretz, Chava] Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol, Sackler Fac Med, Tel Aviv, Israel; [Giladi, Nir; Gurevich, Tanya] Tel Aviv Med Ctr & Sch Med, Neurol Inst, Tel Aviv, Israel; [Giladi, Nir; Gurevich, Tanya] Tel Aviv Univ, Sagol Sch Neurosci, Sackler Fac Med, Tel Aviv, Israel; [El-Ad, Baruch; Tsamir, Judith; Hemo, Beatriz] Maccabi Healthcare Serv, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Giladi, N (corresponding author), Tel Aviv Med Ctr & Sch Med, Neurol Inst, Tel Aviv, Israel.; Giladi, N (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Sackler Fac Med, Tel Aviv, Israel.	nirg@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522; Rozani, Dr. Violetta/0000-0001-6306-6267	Teva Pharmaceutical Industries Ltd; Israeli National Network of Excellence in Neuroscience (NNE); MHS	Teva Pharmaceutical Industries Ltd(Teva Pharmaceutical Industries); Israeli National Network of Excellence in Neuroscience (NNE); MHS	Teva Pharmaceutical Industries Ltd. provided funding in the form of a scholarship to author VR as part of the Israeli National Network of Excellence in Neuroscience (NNE). The MHS provided support in the form of salaries for authors [BE; JT; BH]. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agouridis AP, 2016, CURR PHARM DESIGN, V22, P18, DOI 10.2174/1381612822666151109111511; [Anonymous], 2015, WHO COLL CTR DRUG ST; Arfe A, 2016, J CLIN EPIDEMIOL, V4356, P300; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Barzi F, 2004, AM J EPIDEMIOL, V160, P34, DOI 10.1093/aje/kwh175; Becker C, 2008, DRUG SAFETY, V31, P399, DOI 10.2165/00002018-200831050-00004; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bijlsma MJ, 2016, PHARMACOEPIDEM DR S, V25, P325, DOI 10.1002/pds.3935; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Bykov K, 2016, PHARMACOEPIDEM DR S, V16, P4049; Chillag-Talmor O, 2011, J PARKINSON DIS, V1, P35, DOI 10.3233/JPD-2011-11024; Chodick G, 2008, CLIN THER, V30, P2167, DOI 10.1016/j.clinthera.2008.11.012; Claassen DO, 2010, NEUROLOGY, V75, P494, DOI 10.1212/WNL.0b013e3181ec7fac; de Lau LML, 2007, MOVEMENT DISORD, V22, P1985, DOI 10.1002/mds.21582; Friedman B, 2013, AM J MANAG CARE, V19, P626; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Howe Chanelle J, 2015, Curr Epidemiol Rep, V2, P162; Huang XM, 2015, MOVEMENT DISORD, V30, P552, DOI 10.1002/mds.26152; Korhonen MJ, 2011, EUR J CLIN PHARMACOL, V67, P925, DOI 10.1007/s00228-011-1019-2; Korhonen MJ, 2009, EUR J CLIN PHARMACOL, V65, P1167, DOI 10.1007/s00228-009-0701-0; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Rajanikant GK, 2007, CURR MED CHEM, V14, P103, DOI 10.2174/092986707779313462; Ritz B, 2010, MOVEMENT DISORD, V25, P1210, DOI 10.1002/mds.23102; Samii A, 2008, J CLIN NEUROSCI, V15, P1272, DOI 10.1016/j.jocn.2008.01.016; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Tabenkin H, 2013, CLIN GUIDELINES ISRA; Tan EK, 2013, NEUROLOGY, V81, P406, DOI 10.1212/WNL.0b013e31829d87bb; U. S. Department of Health and Human Services National Institutes of Health National Heart Lung and Blood, 2005, YOUR GUID LOW YOUR C; Ubeda-Bannon I, 2014, BRAIN STRUCT FUNCT, V219, P1513, DOI 10.1007/s00429-013-0651-2; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wolkewitz M, 2012, J CLIN EPIDEMIOL, V65, P1171, DOI 10.1016/j.jclinepi.2012.04.008; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175054	10.1371/journal.pone.0175054	http://dx.doi.org/10.1371/journal.pone.0175054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388626	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800018
J	Zhang, J; Liu, C; Huang, RZ; Chen, HF; Liao, ZX; Sung, JY; Xia, XK; Wang, FX				Zhang, Jing; Liu, Chao; Huang, Ri-Zhen; Chen, Hui-Feng; Liao, Zhi-Xin; Sun, Jin-Yue; Xia, Xue-Kui; Wang, Feng-Xiang			Three new C-27-carboxylated-lupane-triterpenoid derivatives from Potentilla discolor Bunge and their in vitro antitumor activities	PLOS ONE			English	Article							MEDICINAL-PLANTS; TRITERPENOIDS; APOPTOSIS; CELLS; EXTRACTS; GROWTH; ACID	Three new lupane-triterpenoids (1-3) along with six known compounds (4-9) were isolated from the ethanolic extract of whole plant of Potentilla discolor Bunge. The structures of Compounds 1-3 were established by extensive 1D and 2D NMR together with other spectrum analysis, indicating that their C-27 positions were highly oxygenated, which were rarely found in nature. Their in vitro anti-proliferative activities against HepG-2, MCF-7 and T-84 cell lines were evaluated by Cell Counting Kit-8 (CCK-8) assay, and the results showed different activities for three cell lines with IC50 values ranging from 17.84 to 40.64 mu M. In addition, the results from Hoechst 33258 and AO/EB staining as well as annexinV-FITC assays exhibited Compound 1 caused a markedly increased HepG-2 cellular apoptosis in a dose-dependent manner. The further mechanisms of Compound 1-induced cellular apoptosis were confirmed that 1 induced the production of ROS and the alteration of pro-and anti-apoptotic proteins, which led to the dysfunction of mitochondria and activation of caspase-9 and caspase-3 and finally caused cellular apoptosis. These results would be useful in search for new potential antitumor agents and for developing semisynthetic lupane-triterpenoid derivatives with high antitumor activity.	[Zhang, Jing; Huang, Ri-Zhen; Chen, Hui-Feng; Liao, Zhi-Xin] Southeast Univ, Sch Chem & Chem Engn, Dept Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Jing; Liu, Chao; Sun, Jin-Yue] Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Jinan, Peoples R China; [Xia, Xue-Kui] Shandong Acad Sci, Biotechnol Ctr, Jinan, Peoples R China; [Wang, Feng-Xiang] Inst Shandong River Wetlands, Laiwu, Peoples R China	Southeast University - China; Shandong Academy of Agricultural Sciences; Qilu University of Technology	Liao, ZX (corresponding author), Southeast Univ, Sch Chem & Chem Engn, Dept Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.; Sung, JY (corresponding author), Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Jinan, Peoples R China.	zxliao@seu.edu.cn; moon_s731@hotmail.com			Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University) [CMEMR2016-B06]; Priority Academic Program Development of Jiangsu Higher Education Institutions [1107047002]; Taishan Overseas Talents Introduction Program of Shandong, China [tshw20120747]	Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University); Priority Academic Program Development of Jiangsu Higher Education Institutions; Taishan Overseas Talents Introduction Program of Shandong, China	This study was supported by Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University) (CMEMR2016-B06 to ZXL), the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 1107047002 to ZXL), and the Taishan Overseas Talents Introduction Program of Shandong, China (No. tshw20120747 to JYS).	[Anonymous], 2015, MON POT DISC, VI, P383; [Anonymous], 2017, MON TORM RHIZ TORM T, P1542; Chen KL, 2005, J ETHNOPHARMACOL, V96, P201, DOI 10.1016/j.jep.2004.09.020; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Cheng L, 2010, HELV CHIM ACTA, V93, P2263, DOI 10.1002/hlca.201000131; Connolly JD, 1996, NAT PROD REP, V13, P151, DOI 10.1039/np9961300151; Editorial Committee of Chinese Flora, 1985, FLOR CHIN, P291; Garner DL, 1999, MOL REPROD DEV, V53, P222, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;222::AID-MRD11&gt;3.0.CO;2-L; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Han JH, 2015, J NAT PROD, V78, P1005, DOI 10.1021/np5009174; Hill RA, 2012, NAT PROD REP, V29, P780, DOI 10.1039/c2np20027a; Hua SX, 2015, EUR J MED CHEM, V95, P435, DOI 10.1016/j.ejmech.2015.03.051; Ibrahim M, 2014, ASIAN J CHEM, V26, P1011, DOI 10.14233/ajchem.2014.15765; Jang Dae Sik, 2006, Agricultural Chemistry and Biotechnology, V49, P48; Jang DaeSik, 2007, Natural Product Sciences, V13, P160; Jiangsu New Medical College, 1975, DICT CHIN MAT MED, P2705; Jin Quan, 2011, Chinese Journal of Natural Medicines, V9, P61, DOI 10.1016/S1875-5364(11)60022-8; KHAC DD, 1990, PHYTOCHEMISTRY, V29, P251, DOI 10.1016/0031-9422(90)89044-A; Konoshima T, 1996, BIOL PHARM BULL, V19, P962, DOI 10.1248/bpb.19.962; Li C. L., 2003, FLORA CHINA, V9, P291; Li J., 2013, MED FLORA SHANDONG, P283; Li YL, 2008, MOLECULES, V13, P1931, DOI 10.3390/molecules13081931; Liu C, 2014, PLANTA MED, V80, P936, DOI 10.1055/s-0034-1368612; Lu MY, 2013, FITOTERAPIA, V85, P119, DOI 10.1016/j.fitote.2013.01.006; MANANDHAR NP, 1995, J ETHNOPHARMACOL, V48, P1, DOI 10.1016/0378-8741(95)01269-J; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; McCutcheon AR, 1995, J ETHNOPHARMACOL, V49, P101, DOI 10.1016/0378-8741(95)90037-3; Mei QX, 2016, CHIN HERB MED, V8, P75, DOI 10.1016/S1674-6384(16)60011-4; [孟令云 Meng Lingyun], 2004, [中国药理学通报, Chinese Pharmacological Bulletin], V20, P588; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Oikonomakos NG, 2002, CURR PROTEIN PEPT SC, V3, P561, DOI 10.2174/1389203023380422; Ovesna Z, 2004, NEOPLASMA, V51, P327; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Quan ZW, 2010, CANCER LETT, V295, P252, DOI 10.1016/j.canlet.2010.03.008; Spiridonov NA, 2005, PHYTOTHER RES, V19, P428, DOI 10.1002/ptr.1616; Sun HX, 2006, BIOORGAN MED CHEM, V14, P1189, DOI 10.1016/j.bmc.2005.09.043; Tomczyk M, 2009, J ETHNOPHARMACOL, V122, P184, DOI 10.1016/j.jep.2008.12.022; Tosun A, 2006, TURK J PHARM SCI, V3, P167; Wada S, 1998, BIOORG MED CHEM LETT, V8, P2829, DOI 10.1016/S0960-894X(98)00515-0; Webster D, 2008, J ETHNOPHARMACOL, V115, P140, DOI 10.1016/j.jep.2007.09.014; Xue PF, 2006, BIOCHEM SYST ECOL, V34, P825, DOI 10.1016/j.bse.2006.07.003; [薛培凤 Xue Peifeng], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1052; Yang J, 2008, MAGN RESON CHEM, V46, P794, DOI 10.1002/mrc.2253; Zhang JY, 2007, CANCER BIOL THER, V6, P1413; Zhang N, 2014, CHIN HERB MED, V6, P164, DOI 10.1016/S1674-6384(14)60026-5; Zhang ZhongLi, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1490	47	12	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e175502	10.1371/journal.pone.0175502	http://dx.doi.org/10.1371/journal.pone.0175502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388692	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800061
J	Farrar, D; Simmonds, M; Bryant, M; Lawlor, DA; Dunne, F; Tuffnell, D; Sheldon, TA				Farrar, Diane; Simmonds, Mark; Bryant, Maria; Lawlor, Debbie A.; Dunne, Fidelma; Tuffnell, Derek; Sheldon, Trevor A.			Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts	PLOS ONE			English	Review							MELLITUS; POPULATION; STRATEGY; MODEL; ASSOCIATION; PREVALENCE; INDICATORS; OUTCOMES; INSULIN	Background Easily identifiable risk factors including: obesity and ethnicity at high risk of diabetes are commonly used to indicate which women should be offered the oral glucose tolerance test (OGTT) to diagnose gestational diabetes (GDM). Evidence regarding these risk factors is limited however. We conducted a systematic review (SR) and meta-analysis and individual participant data (IPD) analysis to evaluate the performance of risk factors in identifying women with GDM. Methods We searched MEDLINE, Medline in Process, Embase, Maternity and Infant Care and the Cochrane Central Register of Controlled Trials (CENTRAL) up to August 2016 and conducted additional reference checking. We included observational, cohort, case-control and cross-sectional studies reporting the performance characteristics of risk factors used to identify women at high risk of GDM. We had access to IPD from the Born in Bradford and Atlantic Diabetes in Pregnancy cohorts, all pregnant women in the two cohorts with data on risk factors and OGTT results were included. Results Twenty nine published studies with 211,698 women for the SR and a further 14,103 women from two birth cohorts (Born in Bradford and the Atlantic Diabetes in Pregnancy study) for the IPD analysis were included. Six studies assessed the screening performance of guidelines; six examined combinations of risk factors; eight evaluated the number of risk factors and nine examined prediction models or scores. Meta-analysis using data from published studies suggests that irrespective of the method used, risk factors do not identify women with GDM well. Using IPD and combining risk factors to produce the highest sensitivities, results in low specificities (and so higher false positives). Strategies that use the risk factors of age (>25 or >30) and BMI (>25 or 30) perform as well as other strategies with additional risk factors included. Conclusions Risk factor screening methods are poor predictors of which pregnant women will be diagnosed with GDM. A simple approach of offering an OGTT to women 25 years or older and/or with a BMI of 25kg/m(2) or more is as good as more complex risk prediction models. Research to identify more accurate (bio)markers is needed.	[Farrar, Diane; Bryant, Maria] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Farrar, Diane; Sheldon, Trevor A.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Simmonds, Mark] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England; [Bryant, Maria] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England; [Lawlor, Debbie A.] Univ Bristol, MRC, Integrat Epidemiol Unit, Oakfield House, Bristol, Avon, England; [Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Dunne, Fidelma] Natl Univ Ireland, Galway Diabet Res Ctr, Galway, Ireland; [Dunne, Fidelma] Natl Univ Ireland, Sch Med, Galway, Ireland; [Tuffnell, Derek] Bradford Womens & Newborn Unit, Bradford, W Yorkshire, England	Bradford Royal Infirmary; University of York - UK; University of York - UK; University of Leeds; University of Bristol; University of Bristol; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Farrar, D (corresponding author), Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford, W Yorkshire, England.; Farrar, D (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	Diane.Farrar@bthft.nhs.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913; Bryant, Maria/0000-0001-7690-4098; Farrar, Diane/0000-0002-5625-761X; Lawlor, Debbie A/0000-0002-6793-2262	National Institute for Health Research (NIHR), Health Technology Assessment (HTA) programme [11/99/02]; NIHR [PD-2014-07-019, NF-SI-0611-10196]; University of Bristol; UK Medical Research Council [MC_UU_12013/5]; MRC [MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5] Funding Source: researchfish; National Institute for Health Research [11/99/02, NF-SI-0611-10196] Funding Source: researchfish	National Institute for Health Research (NIHR), Health Technology Assessment (HTA) programme; NIHR(National Institute for Health Research (NIHR)); University of Bristol; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research (NIHR), Health Technology Assessment (HTA) programme, project number 11/99/02. DF holds a NIHR Post-doctoral Research Fellowship award (PD-2014-07-019). DAL works in a Unit that is supported by the University of Bristol and UK Medical Research Council (MC_UU_12013/5) and she holds a NIHR Senior Investigator award (NF-SI-0611-10196). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA, NIHR, MRC, United Kingdom National Health Service (NHS) or the Department of Health.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American Diabetes Association, 2017, DIABETES CARE, V40; [Anonymous], 2013, OBSTET GYNECOL, V122, P358, DOI 10.1097/AOG.0b013e31829c3e64; Avalos GE, 2013, DIABETES CARE, V36, P3040, DOI 10.2337/dc12-2669; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bryant M, 2014, INT J OBESITY, V38, P444, DOI 10.1038/ijo.2013.117; Caliskan E, 2004, ACTA OBSTET GYN SCAN, V83, P524, DOI 10.1111/j.0001-6349.2004.00389.x; Casey BM, 1997, OBSTET GYNECOL, V90, P869, DOI 10.1016/S0029-7844(97)00542-5; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; Cosson E, 2013, DIABETES CARE, V36, P598, DOI 10.2337/dc12-1428; COUSTAN DR, 1989, OBSTET GYNECOL, V73, P557; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Cypryk Katarzyna, 2008, Endokrynol Pol, V59, P393; Danilenko-Dixon DR, 1999, AM J OBSTET GYNECOL, V181, P798, DOI 10.1016/S0002-9378(99)70304-2; Dunne FP, 2009, DIABETES CARE, V32, P1205, DOI [10.2337/dc09-1118, 10.2337/dc09-0118]; Erem C, 2015, ARCH MED SCI, V11, P724, DOI 10.5114/aoms.2015.53291; Farrar D, 2016, HLTH TECHNOL ASSESS, V20; Gabbay-Benziv R, 2015, J PERINAT MED, V43, P299, DOI 10.1515/jpm-2014-0041; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P1383, DOI 10.1067/S0002-9378(03)00601-X; Jensen DM, 2003, DIABETIC MED, V20, P51, DOI 10.1046/j.1464-5491.2003.00857.x; Jimenez-Moleon JJ, 2002, EUR J ENDOCRINOL, V146, P831, DOI 10.1530/eje.0.1460831; Kirke AB, 2014, RURAL REMOTE HEALTH, V14; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Lawlor DA, 2014, DIABETOLOGIA, V57, P2492, DOI 10.1007/s00125-014-3386-6; Marquette G P, 1985, Am J Perinatol, V2, P7, DOI 10.1055/s-2007-999901; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moses RG, 1998, DIABETES CARE, V21, P1803, DOI 10.2337/diacare.21.11.1803; Nagalla Srinivasa R, 2015, Indian J Endocrinol Metab, V19, P155, DOI 10.4103/2230-8210.140226; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Nankervis A., 2014, ADIPS CONSENSUS GUID; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN DIAB; Naylor CD, 1997, NEW ENGL J MED, V337, P1591, DOI 10.1056/NEJM199711273372204; Nielsen KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151311; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Ostlund I, 2003, ACTA OBSTET GYN SCAN, V82, P103, DOI 10.1034/j.1600-0412.2003.00001.x; OSULLIVAN JB, 1980, DIABETES CARE, V3, P482, DOI 10.2337/diacare.3.3.482; Phaloprakarn C, 2009, EUR J OBSTET GYN R B, V145, P71, DOI 10.1016/j.ejogrb.2009.04.016; Pintaudi B, 2014, EUR J ENDOCRINOL, V170, P87, DOI 10.1530/EJE-13-0759; Raynor P, 2012, INT J EPIDEMIOL, V42, P1; SACKS DA, 1987, OBSTET GYNECOL, V70, P89; Savona-Ventura C, 2013, INT J GYNECOL OBSTET, V120, P240, DOI 10.1016/j.ijgo.2012.10.016; Schytte T, 2004, CLIN CHEM LAB MED, V42, P1036, DOI 10.1515/CCLM.2004.209; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Shamsuddin K, 2001, INT J GYNECOL OBSTET, V75, P27, DOI 10.1016/S0020-7292(01)00468-4; Shirazian N, 2009, ARCH GYNECOL OBSTET, V280, P933, DOI 10.1007/s00404-009-1027-y; Simmonds MC, 2012, J MED SCREEN, V19, P201, DOI 10.1258/jms.2012.012076; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Sunsaneevithayakul Prasert, 2003, Journal of the Medical Association of Thailand, V86, P708; Syngelaki A, 2016, METABOLISM, V65, P131, DOI 10.1016/j.metabol.2015.10.029; Syngelaki A, 2015, FETAL DIAGN THER, V38, P14, DOI 10.1159/000369970; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; van Leeuwen M, 2010, BJOG-INT J OBSTET GY, V117, P69, DOI 10.1111/j.1471-0528.2009.02425.x; van Leeuwen M, 2009, DIABETES RES CLIN PR, V85, P96, DOI 10.1016/j.diabres.2009.04.025; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO, 2013, DIAGN CRIT CLASS HYP; Williams CB, 1999, DIABETES CARE, V22, P418, DOI 10.2337/diacare.22.3.418; Yang XL, 2002, DIABETES CARE, V25, P796, DOI 10.2337/diacare.25.4.796	60	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175288	10.1371/journal.pone.0175288	http://dx.doi.org/10.1371/journal.pone.0175288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384264	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000399371900146
J	Guo, WY; Cai, YQ; Zhang, HX; Yang, YF; Yang, G; Wang, XJ; Zhao, JY; Lin, JT; Zhu, JF; Li, WQ; Lv, LX				Guo, Weiyun; Cai, Yaqi; Zhang, Hongxing; Yang, Yongfeng; Yang, Ge; Wang, Xiujuan; Zhao, Jingyuan; Lin, Juntang; Zhu, Jinfu; Li, Wenqiang; Lv, Luxian			Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; LINKED MENTAL-RETARDATION; GENOME-WIDE ASSOCIATION; P190 RHOGAP; NEURODEVELOPMENTAL HYPOTHESIS; RHOA ACTIVITY; MIGRATION; COMPLEX; GENE; SUSCEPTIBILITY	Numerous developmental genes have been linked to schizophrenia (SZ) by case-control and genome-wide association studies, suggesting that neurodevelopmental disturbances are major pathogenic mechanisms. However, no neurodevelopmental deficit has been definitively linked to SZ occurrence, likely due to disease heterogeneity and the differential effects of various gene variants across ethnicities. Hence, it is critical to examine linkages in specific ethnic populations, such as Han Chinese. The newly identified RhoGAP ARH-GAP18 is likely involved in neurodevelopment through regulation of RhoA/C. Here we describe four single nucleotide polymorphisms (SNPs) in ARHGAP18 associated with SZ across a cohort of >2000 cases and controls from the Han population. Two SNPs, rs7758025 and rs9483050, displayed significant differences between case and control groups both in genotype (P = 0.0002 and P = 7.54x10(-6)) and allelic frequencies (P = 4.36x10(-5) and P = 5.98x10(-7)), respectively. The AG haplotype in rs7758025-rs9385502 was strongly associated with the occurrence of SZ (P = 0.0012, OR = 0.67, 95% CI = 0.48 - 0.93), an association that still held following a 1000-times random permutation test (P = 0.022). In an independently collected validation cohort, rs9483050 was the SNP most strongly associated with SZ. In addition, the allelic frequencies of rs12197901 remained associated with SZ in the combined cohort (P = 0.021), although not in the validation cohort alone (P = 0.251). Collectively, our data suggest the ARHGAP18 may confer vulnerability to SZ in the Chinese Han population, providing additional evidence for the involvement of neurodevelopmental dysfunction in the pathogenesis of schizophrenia.	[Guo, Weiyun; Lin, Juntang] Xinxiang Med Univ, Coll Life Sci & Technol, Xinxiang, Peoples R China; [Guo, Weiyun; Cai, Yaqi; Zhang, Hongxing; Yang, Yongfeng; Yang, Ge; Wang, Xiujuan; Lin, Juntang; Li, Wenqiang; Lv, Luxian] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China; [Cai, Yaqi; Zhang, Hongxing; Yang, Yongfeng; Yang, Ge; Wang, Xiujuan; Zhao, Jingyuan; Li, Wenqiang; Lv, Luxian] Xinxiang Med Univ, Henan Mental Hosp, Dept Psychiat, Affiliated Hosp 2, Xinxiang, Peoples R China; [Lin, Juntang; Zhu, Jinfu] Friedrich Schiller Univ Jena, Inst Anat 1, Jena, Germany; [Zhu, Jinfu] Xinxiang Med Univ, Dept Psychol, Xinxiang, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Friedrich Schiller University of Jena; Xinxiang Medical University	Li, WQ; Lv, LX (corresponding author), Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China.; Li, WQ; Lv, LX (corresponding author), Xinxiang Med Univ, Henan Mental Hosp, Dept Psychiat, Affiliated Hosp 2, Xinxiang, Peoples R China.	lwq781603@163.com; lvx928@126.com			National Natural Science Foundation of China [81201040, U1404811, 81571315]; Natural Science Foundation of Henan [122300413212, 162102310488, 132102310164]; Scientific Research Fund of Xinxiang Medical University [ZD2011-20, 2013QN102]; Open Fund of Henan Key lab of Biological Psychiatry [ZDSYS2014002]; Disciplinary group of Psychology and Neuroscience to Xinxiang Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan; Scientific Research Fund of Xinxiang Medical University; Open Fund of Henan Key lab of Biological Psychiatry; Disciplinary group of Psychology and Neuroscience to Xinxiang Medical University	This work was supported by the following: (1) the National Natural Science Foundation of China (to WL, 81201040; to YY, U1404811; to HZ, 81571315), http://www.nsfc.gov.cn/. (2) the Natural Science Foundation of Henan (to WL, 122300413212; to WG, 162102310488; to J. Zhu, 132102310164), http://www.hnkjt.gov.cn/. (3) the Scientific Research Fund of Xinxiang Medical University (to WL, ZD2011-20; to YY, 2013QN102), http://www.xxmu.edu.cn/. (4) the Open Fund of Henan Key lab of Biological Psychiatry (to WG, ZDSYS2014002). (5) the support project for the Disciplinary group of Psychology and Neuroscience to Xinxiang Medical University, http://www.haedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2015, GENE, V558, P220, DOI 10.1016/j.gene.2014.12.064; Azzarelli R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4405; Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Cannon TD, 2015, TRENDS COGN SCI, V19, P744, DOI 10.1016/j.tics.2015.09.009; Chang Garry H K, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.975002; Datta D, 2015, BIOL PSYCHIAT, V78, P775, DOI 10.1016/j.biopsych.2015.03.030; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Foletta VC, 2002, MOL BRAIN RES, V107, P65, DOI 10.1016/S0169-328X(02)00448-5; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hu XF, 2013, PROG NEURO-PSYCHOPH, V43, P197, DOI 10.1016/j.pnpbp.2012.12.007; Katayama KI, 2013, DEVELOPMENT, V140, P3139, DOI 10.1242/dev.092585; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Kitaoka Y, 2004, BRAIN RES, V1018, P111, DOI 10.1016/j.brainres.2004.05.070; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Li JJ, 2011, DEV CELL, V20, P409, DOI 10.1016/j.devcel.2011.04.001; Li WQ, 2011, PROG NEURO-PSYCHOPH, V35, P1505, DOI 10.1016/j.pnpbp.2011.04.007; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Ma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057865; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Mulherkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067015; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Sakurai T, 2015, PROG NEUROBIOL, V134, P178, DOI 10.1016/j.pneurobio.2015.09.010; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Schaefer L, 1997, GENOMICS, V46, P268, DOI 10.1006/geno.1997.5040; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Voineskos AN, 2015, SCHIZOPHR RES, V161, P50, DOI 10.1016/j.schres.2014.03.034; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	48	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175209	10.1371/journal.pone.0175209	http://dx.doi.org/10.1371/journal.pone.0175209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384650	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900120
J	Hanaoka, H; Kiyokawa, T; Iida, H; Ishimori, K; Takakuwa, Y; Okazaki, T; Yamada, H; Ichikawa, D; Shirai, S; Koike, J; Ozaki, S				Hanaoka, Hironari; Kiyokawa, Tomofumi; Iida, Harunobu; Ishimori, Kana; Takakuwa, Yukiko; Okazaki, Takahiro; Yamada, Hidehiro; Ichikawa, Daisuke; Shirai, Sayuri; Koike, Junki; Ozaki, Shoichi			Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study	PLOS ONE			English	Article							IMMUNOSUPPRESSIVE THERAPY; MYCOPHENOLIC-ACID; SYSTEMIC DAMAGE; ERYTHEMATOSUS; TACROLIMUS; CYCLOPHOSPHAMIDE; INDEX; GLOMERULONEPHRITIS; PHARMACOKINETICS; CLASSIFICATION	The recent recommendations for the management of lupus nephritis suggest that racial background should be considered while choosing induction therapy. However, the responses to different induction regimens have been poorly studied in Japanese population. Here, we assessed the renal response to different induction therapies in Japanese patients with lupus nephritis class III or IV. The records of 64 patients with biopsy-proven lupus nephritis class III or IV were retrospectively evaluated according to therapy received: monthly intravenous cyclophosphamide (IVCY), the Euro-lupus nephritis trial (ELNT) protocol-IVCY, tacrolimus (TAC), or mycophenolate mofetil (MMF). We investigated cumulative complete renal response (CR) rates and relapse rates for each group for 3 years. Organ damage was assessed with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). There were 22 patients on monthly IVCY, 18 on ELNT-IVCY, 13 on TAC, and 11 on MMF. Lower systemic lupus erythematosus disease activity index (SLEDAI) and higher CH50 were found in the TAC group at baseline (p < 0.01 and p< 0.01, respectively). There were no significant differences of cumulative CR rates and relapse free survival for 3 years among the four different therapeutic regimens (p = 0.2 and p = 0.2, respectively). There was a tendency to have early response and early relapse in TAC group and late response in MMF group. The SDI increase over 3 years was found more frequently in the TAC group than in the monthly-IVCY group (p = 0.04). Multivariate analysis indicated that CR at 3 months was independent prognosticator for low damage accrual. Regarding lower damage accrual, early CR achievement might be essential in induction therapy regardless of immunosuppressant choice.	[Hanaoka, Hironari; Kiyokawa, Tomofumi; Iida, Harunobu; Ishimori, Kana; Takakuwa, Yukiko; Okazaki, Takahiro; Yamada, Hidehiro; Ozaki, Shoichi] St Marianna Univ, Dept Internal Med, Div Rheumatol & Allergol, Sch Med, Kawasaki, Kanagawa, Japan; [Ichikawa, Daisuke; Shirai, Sayuri] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Koike, Junki] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University	Hanaoka, H (corresponding author), St Marianna Univ, Dept Internal Med, Div Rheumatol & Allergol, Sch Med, Kawasaki, Kanagawa, Japan.	hhanaoka1208@yahoo.co.ip						Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; BALDWIN DS, 1977, AM J MED, V62, P12, DOI 10.1016/0002-9343(77)90345-X; Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chen YE, 2008, CLIN J AM SOC NEPHRO, V3, P46, DOI 10.2215/CJN.03280807; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2003, J RHEUMATOL, V30, P1955; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hanaoka H, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1202-z; Hanaoka H, 2015, MOD RHEUMATOL, V25, P714, DOI 10.3109/14397595.2014.1003172; Hannah J, 2016, AUTOIMMUN REV, V15, P93, DOI 10.1016/j.autrev.2015.09.006; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Illei GG, 2002, ARTHRITIS RHEUM, V46, P995, DOI 10.1002/art.10142; Joo YB, LUPUS; Lee YH, 2011, LUPUS, V20, P636, DOI 10.1177/0961203310389486; Lertdumrongluk P, 2010, KIDNEY INT, V78, P389, DOI 10.1038/ki.2010.170; Miura M, 2008, THER DRUG MONIT, V30, P559, DOI 10.1097/FTD.0b013e3181838063; Mok CC, 2005, KIDNEY INT, V68, P813, DOI 10.1111/j.1523-1755.2005.00461.x; Mok CC, 2004, ARTHRITIS RHEUM, V50, P2559, DOI 10.1002/art.20364; Mok CC, 2016, ANN RHEUM DIS, V75, P30, DOI 10.1136/annrheumdis-2014-206456; Rahman P, 2001, LUPUS, V10, P93, DOI 10.1191/096120301670679959; Rathi M, 2016, KIDNEY INT, V89, P235, DOI 10.1038/ki.2015.318; Stahl-Hallengren C, 2000, J RHEUMATOL, V27, P685; Szeto CC, 2008, RHEUMATOLOGY, V47, P1678, DOI 10.1093/rheumatology/ken335; Tesar V, 2011, NAT REV NEPHROL, V7, P96, DOI 10.1038/nrneph.2010.170; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Uchino A, 2010, CLIN EXP RHEUMATOL, V28, P6; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	31	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175152	10.1371/journal.pone.0175152	http://dx.doi.org/10.1371/journal.pone.0175152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384208	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900102
J	Mambres, DH; Boarbi, S; Michel, P; Bouker, N; Escobar-Calle, L; Desqueper, D; Fancello, T; Van Esbroeck, M; Godfroid, J; Fretin, D; Mori, M				Mambres, Delphine Hanot; Boarbi, Samira; Michel, Patrick; Bouker, Nora; Escobar-Calle, Luisa; Desqueper, Damien; Fancello, Tiziano; Van Esbroeck, Marjan; Godfroid, Jacques; Fretin, David; Mori, Marcella			Imported human brucellosis in Belgium: Bio and molecular typing of bacterial isolates, 1996-2015	PLOS ONE			English	Article							GENETIC DIVERSITY; MELITENSIS; ABORTUS; INFECTION; MARKERS; ASSAY	Objectives The aim of this study was to characterize by classical biotyping and Multi-Locus variable number tandem repeats (VNTR) Analysis (MLVA) all Brucella spp. derived from human cases in Belgium from 1996 to 2015. Final goals were to determine the species and biovar, to trace-back on genetic grounds the origin of each strain when patient history and risk factors were missing, and to survey for particular trends at the national level. Methods A total of 37 Brucella strains, isolated from 37 patients in Belgium, were analyzed by both classical biotyping and MLVA, and the genetic patterns compared to those of human strains isolated worldwide. Results Classical biotyping revealed that isolates were mainly Brucella melitensis. Most of them belonged to biovar 3, the most abundant biovar in the Mediterranean region. MLVA confirmed that Brucella melitensis is too diverse in VNTRs to be able to make clusters associated to each biovar, but it allowed retrieving precious epidemiological information. The analysis highlighted the imported nature of the strains from all over the world with a dominant part from the Mediterranean countries. Findings of the MLVA11 testing were in line with the travel history of patients coming from Italy, Turkey, Lebanon and Peru. The analysis was particularly useful because it suggested the geographical origin of the infection for 12/16 patients for whom no case history was available. Conclusion Classical biotyping and MLVA analysis are not exclusive but remain complementary tools for Brucella melitensis strain surveillance. MLVA11 is sufficient for Brucella-free countries such as Belgium to trace the geographical origin of infection, but complete MLVA16 is needed to search for links with endemic areas.	[Mambres, Delphine Hanot; Boarbi, Samira; Michel, Patrick; Bouker, Nora; Escobar-Calle, Luisa; Desqueper, Damien; Fancello, Tiziano; Fretin, David; Mori, Marcella] CODA CERVA, Bacterial Zoonoses Livestock, Operat Directorate Bacterial Dis, Vet & Agrochem Res Ctr, Brussels, Belgium; [Michel, Patrick; Desqueper, Damien; Fancello, Tiziano; Van Esbroeck, Marjan; Fretin, David; Mori, Marcella] Natl Reference Ctr Human Brucellosis, Brussels, Belgium; [Van Esbroeck, Marjan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Godfroid, Jacques] Univ Tromso, Arctic Univ Norway, Fac Biosci Fisheries & Econ, Tromso, Norway	Institute of Tropical Medicine (ITM); UiT The Arctic University of Tromso	Mori, M (corresponding author), CODA CERVA, Bacterial Zoonoses Livestock, Operat Directorate Bacterial Dis, Vet & Agrochem Res Ctr, Brussels, Belgium.; Mori, M (corresponding author), Natl Reference Ctr Human Brucellosis, Brussels, Belgium.	Marcella.Mori@coda-cerva.be	Mori, Marcella/U-3810-2018; Godfroid, Jacques/U-3524-2017; Godfroid, Jacques/HCI-7835-2022	Mori, Marcella/0000-0002-7191-9191; Godfroid, Jacques/0000-0002-0782-7858; Van Esbroeck, Marjan/0000-0002-7294-6319	Belgian National Institute for Health and Disability Insurance (RIZIV/INAMI)	Belgian National Institute for Health and Disability Insurance (RIZIV/INAMI)	This work was partly funded by the Belgian National Institute for Health and Disability Insurance (RIZIV/INAMI; https://nrchm.wiv-isp.be/ nl/ref_centra_labo/default.aspx). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Allen A, 2015, PLOS ONE; BARR SC, 1986, J AM VET MED ASSOC, V189, P686; Bricker BJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-37; Bricker BJ, 2003, HOOF PRINTS STRAIN T, P13; CLOECKAERT A, 1995, MICROBIOL-UK, V141, P2111, DOI 10.1099/13500872-141-9-2111; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; De Massis F, 2015, MLVA EPIDEMIOLOGICAL, P1; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Gregoire F, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-80; Rodriguez-Hidalgo RI, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00045; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Joint FAO/WHO Expert Committee on Brucellosis, 1986, 6 REP; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Mailles A., 2016, MED MAL INFECT; Maquart M, 2009, MLVA 16 TYPING 295 M, V11, P1; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; Nockler K, 2009, J CLIN MICROBIOL, V47, P3147, DOI 10.1128/JCM.00900-09; Ocampo-Sosa AA, 2005, VET MICROBIOL, V110, P41, DOI 10.1016/j.vetmic.2005.06.007; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Shevtsov A, 2015, INFECT GENET EVOL, V34, P173, DOI 10.1016/j.meegid.2015.07.008; Smits HL, 2009, T ROY SOC TROP MED H, V103, P399, DOI 10.1016/j.trstmh.2008.10.004; Sun MJ, 2016, INFECT GENET EVOL, V44, P522, DOI 10.1016/j.meegid.2016.07.025; VERGER JM, 1985, INT J SYST BACTERIOL, V35, P292, DOI 10.1099/00207713-35-3-292; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34	31	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174756	10.1371/journal.pone.0174756	http://dx.doi.org/10.1371/journal.pone.0174756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384245	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900033
J	Oguma, T; Nagaoka, T; Kurahashi, M; Kobayashi, N; Yamamori, S; Tsuji, C; Takiguchi, H; Niimi, K; Tomomatsu, H; Tomomatsu, K; Hayama, N; Aoki, T; Urano, T; Magatani, K; Takeda, S; Abe, T; Asano, K				Oguma, Tsuyoshi; Nagaoka, Takashi; Kurahashi, Muneshige; Kobayashi, Naofumi; Yamamori, Shinji; Tsuji, Chizuko; Takiguchi, Hiroto; Niimi, Kyoko; Tomomatsu, Hiromi; Tomomatsu, Katsuyoshi; Hayama, Naoki; Aoki, Takuya; Urano, Tetsuya; Magatani, Kazushige; Takeda, Sunao; Abe, Tadashi; Asano, Koichiro			Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer	PLOS ONE			English	Article							BREATH; JAPAN; COPD	Background Exhaled volatile organic compounds (VOC) are being considered as biomarkers for various lungs diseases, including cancer. However, the accurate measurement of extremely low concentrations of VOC in expired air is technically challenging. We evaluated the clinical contribution of exhaled VOC measured with a new, double cold-trap method in the diagnosis of lung cancer. Methods Breath samples were collected from 116 patients with histologically confirmed lung cancer and 37 healthy volunteers (controls) after inspiration of purified air, synthesized through a cold-trap system. The exhaled VOC, trapped in the same system, were heat extracted. We analyzed 14 VOC with gas chromatography. Results The concentrations of exhaled cyclohexane and xylene were significantly higher in patients with lung cancer than in controls (p = 0.002 and 0.0001, respectively), increased significantly with the progression of the clinical stage of cancer (both p < 0.001), and decreased significantly after successful treatment of 6 patients with small cell lung cancer (p = 0.06 and 0.03, respectively). Conclusion Measurements of exhaled VOCs by a double cold-trap method may help diagnose lung cancer and monitor its progression and regression.	[Oguma, Tsuyoshi; Takiguchi, Hiroto; Niimi, Kyoko; Tomomatsu, Hiromi; Tomomatsu, Katsuyoshi; Hayama, Naoki; Aoki, Takuya; Urano, Tetsuya; Abe, Tadashi; Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa, Japan; [Nagaoka, Takashi; Takeda, Sunao] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan; [Kurahashi, Muneshige; Kobayashi, Naofumi; Yamamori, Shinji] Nihon Kohden Corp, Ogino Mem Lab, Tokyo, Japan; [Tsuji, Chizuko] Tokai Univ, Sch Med, Dept Physiol, Hiratsuka, Kanagawa, Japan; [Magatani, Kazushige] Tokai Univ, Sch Engn, Dept Elect & Elect Engn, Hiratsuka, Kanagawa, Japan	Tokai University; Waseda University; Nihon Kohden Corporation; Tokai University; Tokai University	Oguma, T (corresponding author), Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa, Japan.	tyoguma@tokai-u.jp		Nagaoka, Takashi/0000-0002-7460-5008				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Buszewski B, 2009, BIOMED CHROMATOGR, V23, P551, DOI 10.1002/bmc.1141; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Fuchs D, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027101; Gasparri R, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/016007; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Mazzone PJ, 2012, J THORAC ONCOL, V7, P137, DOI 10.1097/JTO.0b013e318233d80f; Nagaoka T, 2015, ADV BIOMED ENG, V4, P112, DOI 10.14326/abe.4.112; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Poli Diana, 2008, Acta Biomed, V79 Suppl 1, P64; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Solano-Serena F, 1998, BIODEGRADATION, V9, P319, DOI 10.1023/A:1008305906032; Song G, 2010, LUNG CANCER, V67, P227, DOI 10.1016/j.lungcan.2009.03.029; Stock TH, 2004, ENV HLTH PERSPECT, V112, P1386; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; van de Kant KDG, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-117	18	27	33	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174802	10.1371/journal.pone.0174802	http://dx.doi.org/10.1371/journal.pone.0174802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384298	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900038
J	Paal, P; Bukki, J				Paal, Piret; Buekki, Johannes			"If I had stayed back home, I would not be alive any more..." - Exploring end-of-life preferences in patients with migration background	PLOS ONE			English	Article							PALLIATIVE CARE; UNITED-KINGDOM; ETHNIC-GROUPS; PHYSICIANS; MIGRANTS	Background In patients with life-limiting conditions and a history of migration, a higher risk of not dying at home and limited access to palliative care services has been reported. Aim To explore the views and end-of-life preferences of patients with a migration history in Germany and to identify migration specific themes. Design Two-armed study using Kaufmann's 'understanding interview' ('focused interview') method and grounded theory approach. Thematic content analysis was applied using MaxQDA 12 software. Setting/Participants Migrant and non-migrant adult patients with far advanced, life-limiting disease receiving palliative care in different specialist level settings (specialist home palliative care, palliative care inpatient unit, inpatient hospice). Results The 37 interviewees (19 native Germans and 18 patients from Europe and the U.S., Israel, Turkey, and Indonesia) expressed eleven themes covering health care-and patient-related issues, of which four emerged to be specific for migrants: worse survival in home country; the perception of an altered identity and 'not belonging'; language skills as prerequisite to survive; and longing for 'home' while being attached to Germany. From these categories, three overarching themes were derived: (1) a limited understanding of the concept of 'palliative care'; (2) the suppression of end of life discussions for its association with suffering and loss of autonomy; and (3) the significance of complex individual migration histories. Conclusions Based on these findings, the concept of a 'double home' experience is proposed. Barriers to access to palliative care should be minimized for all patients while cultural stereotyping has to be avoided.	[Paal, Piret; Buekki, Johannes] Hospice Care DaSein, Dept Res & Dev, Munich, Germany; [Buekki, Johannes] Paracelsus Med Univ, Inst Nursing Sci & Palliat Care, Salzburg, Austria	Paracelsus Private Medical University	Bukki, J (corresponding author), Hospice Care DaSein, Dept Res & Dev, Munich, Germany.	dr.j.buekki@hospiz-da-sein.de	Paal, Piret/J-4565-2019; Bukki, Johannes/D-4980-2015	Bukki, Johannes/0000-0003-1232-1103; Paal, Piret/0000-0002-1341-3248	Bavarian Ministry of Health (Bayerisches Staatsministerium fur Gesundheit und Pflege) [VI 5/33454/20/15]; Bavarian Ministry of Health officials	Bavarian Ministry of Health (Bayerisches Staatsministerium fur Gesundheit und Pflege); Bavarian Ministry of Health officials	This work has been kindly funded by the Bavarian Ministry of Health (Bayerisches Staatsministerium fur Gesundheit und Pflege https://www.stmgp.bayern.de), grant number: VI 5/33454/20/15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to Iemkje Stiemer and Iryna Tretiakova who diligently conducted the transcriptions, and to the Bavarian Ministry of Health officials who generously supported this research project and provided administrative advice.	Bade KJ, 2010, CYCLOPEDIA MIGRATION; Bosma H, 2010, PALLIATIVE MED, V24, P510, DOI 10.1177/0269216309351380; Briggs C. L., 1986, LEARNING ASK; Buiting HM, 2008, EUR J PUBLIC HEALTH, V18, P681, DOI 10.1093/eurpub/ckn084; Burt RS, 2005, BROKERAGE CLOSURE IN; Ceuterick M, 2017, SOC SCI MED, V177, P43, DOI 10.1016/j.socscimed.2017.01.026; Coupland VH, 2011, PALLIATIVE MED, V25, P314, DOI 10.1177/0269216310395986; Crawley LaVera M, 2005, J Palliat Med, V8 Suppl 1, pS58; de Graaff Fuusje M, 2010, BMC Palliat Care, V9, P19, DOI 10.1186/1472-684X-9-19; Epner DE, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds086; Evans N, 2012, J PAIN SYMPTOM MANAG, V43, P261, DOI 10.1016/j.jpainsymman.2011.04.012; Gunaratnam Y, 2014, SUBJECTIVITY, V7, P74, DOI 10.1057/sub.2013.21; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Holloway I., 2003, QUAL RES, V3, P345, DOI [https://doi.org/10.1177/1468794103033004, DOI 10.1177/1468794103033004, 10.1177/1468794103033004]; Jansky M, 2015, PALLIATIVE HOSPICE C; Jansky M, 2017, BUNDESGESUNDHEITSBLA, V60, P45, DOI 10.1007/s00103-016-2473-x; Kars MC, 2016, PALLIATIVE MED, V30, P533, DOI 10.1177/0269216315616759; Kaufmann Jean-Claude, 1999, UNDERSTANDING INTERV; LeBlanc TW, 2013, J ONCOL PRACT, V9, P277, DOI 10.1200/JOP.2013.000996; Milberg A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165452; Razum O, 2016, BUNDESGESUNDHEITSBLA, V59, P259, DOI 10.1007/s00103-015-2286-3; Salis Gross C, 2014, PALLIATIVE CARE SENS; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; Taylor B, 2011, QUAL HEALTH RES, V21, P1576, DOI 10.1177/1049732311415288; Torres S, 2016, J INTERCULT STUD, V37, P103, DOI 10.1080/07256868.2016.1141756; United Nations Department of Economic and Social Affairs report, 2016, TRENDS INT MIGRANT S; Vaismoradi M, 2016, J NUR ED PR, V6, P100, DOI DOI 10.5430/JNEP.V6N5P100; van Dijk TA, 2006, DISCOURSE STUD, V8, P159, DOI 10.1177/1461445606059565; Venkatasalu MR, 2014, PALLIATIVE MED, V28, P264, DOI 10.1177/0269216313506765; Volker Deborah L, 2005, Am J Hosp Palliat Care, V22, P442, DOI 10.1177/104990910502200610	30	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175314	10.1371/journal.pone.0175314	http://dx.doi.org/10.1371/journal.pone.0175314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384309	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900154
J	Walton, Z; Samelius, G; Odden, M; Willebrand, T				Walton, Zea; Samelius, Gustaf; Odden, Morten; Willebrand, Tomas			Variation in home range size of red foxes Vulpes vulpes along a gradient of productivity and human landscape alteration	PLOS ONE			English	Article							INTRA-SPECIFIC VARIATION; POPULATION-DENSITY; URBAN FOXES; HABITAT USE; SPACE-USE; TERRITORIALITY; PATTERNS; MOVEMENTS; MODEL; FOOD	Home range size is a fundamental concept for understanding animal dispersion and ecological needs, and it is one of the most commonly reported ecological attributes of free-ranging mammals. Previous studies indicate that red foxes Vulpes vulpes display great variability in home range size. Yet, there has been little consensus regarding the reasons why home range sizes of red foxes vary so extensively. In this study, we examine possible causes of variation in red fox home range sizes using data from 52 GPS collared red foxes from four study areas representing a gradient of landscape productivity and human landscape alteration in Norway and Sweden. Using 90% Local Convex Hull home range estimates, we examined how red fox home range size varied in relation to latitude, elevation, vegetation zone, proportion of agricultural land and human settlement within a home range, and sex and age. We found considerable variation in red fox home range sizes, ranging between 0.95 km(2) to 44 km(2) (LoCoH 90%) and 2.4 km(2) to 358 km(2) (MCP 100%). Elevation, proportion of agricultural land and sex accounted for 50% of the variation in home range size found amongst foxes, with elevation having the strongest effect. Red foxes residing in more productive landscapes (those in more southern vegetation zones), had home ranges approximately four times smaller than the home ranges of foxes in the northern boreal vegetation zone. Our results indicate that home range size was influenced by a productivity gradient at both the landscape (latitude) and the local (elevation) scale. The influence of the proportion of agriculture land on home range size of foxes illustrates how human landscape alteration can affect the space use and distribution of red foxes. Further, the variation in home range size found in this study demonstrates the plasticity of red foxes to respond to changing human landscape alteration as well as changes in landscape productivity, which may be contributing to red fox population increases and northern range expansions.	[Walton, Zea; Odden, Morten; Willebrand, Tomas] Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Campus Evenstad, Koppang, Norway; [Samelius, Gustaf] Snow Leopard Trust, Seattle, WA USA	Inland Norway University of Applied Sciences	Walton, Z (corresponding author), Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Campus Evenstad, Koppang, Norway.	zea.walton@inn.no		Walton, Zea/0000-0003-3859-3676	Swedish Nature Protection Board [DNR 15/155]; Swedish Hunters Association [5861/2016]; Karl Erik Onnesjos Stiftelse, Sweden; Norwegian Directorate for Nature Management [13F6CC7, 15SA0283, 16SA3A43]; Gotaas Fund, Norway [13/00282]	Swedish Nature Protection Board; Swedish Hunters Association; Karl Erik Onnesjos Stiftelse, Sweden; Norwegian Directorate for Nature Management; Gotaas Fund, Norway	Funding for this study was provided by the Swedish Nature Protection Board (DNR 15/155), Swedish Hunters Association (5861/2016), Karl Erik Onnesjos Stiftelse, Sweden, and the Norwegian Directorate for Nature Management (grant numbers: 13F6CC7, 15SA0283, 16SA3A43) and the Gotaas Fund, Norway (13/00282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLES ED, 1969, J MAMMAL, V50, P108, DOI 10.2307/1378635; Andren H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120570; ANGELSTAM P, 1985, HOLARCTIC ECOL, V8, P285; Aronsson M, 2016, ECOL EVOL, V6, P2957, DOI 10.1002/ece3.2032; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Barton, 2009, MUMIN MULTIMODEL INT; Barton KA, 2007, GLOBAL ECOL BIOGEOGR, V16, P281, DOI 10.1111/j.1466-8238.2007.00299.x; Bastille-Rousseau G, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0080-y; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Buchmann CM, 2011, OIKOS, V120, P106, DOI 10.1111/j.1600-0706.2010.18556.x; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burnham KP, 1998, INTRO MODEL SELECTIO, P1; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; COMAN BJ, 1991, WILDLIFE RES, V18, P215, DOI 10.1071/WR9910215; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; DONCASTER CP, 1991, J ANIM ECOL, V60, P423, DOI 10.2307/5288; Duncan C, 2015, REMOTE SENS ECOL CON, V1, P39, DOI 10.1002/rse2.6; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; ESRI, 2011, ARCGIS REL 10 ARCGIS REL 10; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Goszczynski J, 2002, ACTA THERIOL, V47, P103, DOI 10.1007/BF03192482; Hagen D, 2013, ECOL SOC, V18, DOI 10.5751/ES-05891-180434; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; HARRISON DJ, 1989, J WILDLIFE MANAGE, V53, P181, DOI 10.2307/3801327; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; JONES DM, 1982, CAN J ZOOL, V60, P807, DOI 10.1139/z82-111; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kreeger T. J., 2012, HDB WILDLIFE CHEM IM, V4th; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; Lucherini M, 1996, BEHAV PROCESS, V36, P103, DOI 10.1016/0376-6357(95)00018-6; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; MAJOR JT, 1987, J WILDLIFE MANAGE, V51, P606, DOI 10.2307/3801278; Maletzke BT, 2014, ECOL EVOL, V4, P2178, DOI 10.1002/ece3.1089; Mattisson J, 2013, OECOLOGIA, V173, P813, DOI 10.1007/s00442-013-2668-x; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Meia JS, 1995, CAN J ZOOL, V73, P1960, DOI 10.1139/z95-230; Moen A., 1998, NASJONALATLAS NORGE; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Nilsen EB, 2007, ECOLOGICAL RES, V23, P635; Panzacchi M, 2010, FOREST ECOL MANAG, V259, P1536, DOI 10.1016/j.foreco.2010.01.030; Pearce F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2122; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rotem G, 2011, J WILDLIFE MANAGE, V75, P132, DOI 10.1002/jwmg.9; Rydin H., 1999, SWEDISH PLANT GEOGRA; Saeki M, 2007, J MAMMAL, V88, P1098, DOI 10.1644/06-MAMM-A-208R1.1; Said S, 2009, OIKOS, V118, P1299, DOI 10.1111/j.1600-0706.2009.17346.x; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sinclair ARE, 2005, WILDLIFE ECOLOGY CON; STGEORGES M, 1995, CAN J ZOOL, V73, P755, DOI 10.1139/z95-089; TRAVAINI A, 1993, ACTA THERIOL, V38, P427, DOI 10.4098/AT.arch.93-33; Tsukada H, 1997, J ETHOL, V15, P27, DOI 10.1007/BF02767323; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; VOIGT D R, 1984, Acta Zoologica Fennica, V171, P261; White G.C., 1990, ANAL WILDLIFE RADIO	74	52	53	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175291	10.1371/journal.pone.0175291	http://dx.doi.org/10.1371/journal.pone.0175291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384313	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900147
J	Dorji, P; Fearns, P				Dorji, Passang; Fearns, Peter			Impact of the spatial resolution of satellite remote sensing sensors in the quantification of total suspended sediment concentration: A case study in turbid waters of Northern Western Australia	PLOS ONE			English	Article							DIFFUSE ATTENUATION COEFFICIENT; 250 M IMAGERY; PARTICULATE MATTER; COASTAL WATERS; ATMOSPHERIC CORRECTION; ENVIRONMENTAL IMPACTS; TAMPA-BAY; MODIS; LANDSAT; QUALITY	The impact of anthropogenic activities on coastal waters is a cause of concern because such activities add to the total suspended sediment (TSS) budget of the coastal waters, which have negative impacts on the coastal ecosystem. Satellite remote sensing provides a powerful tool in monitoring TSS concentration at high spatiotemporal resolution, but coastal managers should be mindful that the satellite-derived TSS concentrations are dependent on the satellite sensor's radiometric properties, atmospheric correction approaches, the spatial resolution and the limitations of specific TSS algorithms. In this study, we investigated the impact of different spatial resolutions of satellite sensor on the quantification of TSS concentration in coastal waters of northern Western Australia. We quantified the TSS product derived from MODerate resolution Imaging Spectroradiometer (MODIS)-Aqua, Landsat-8 Operational Land Image (OLI), and WorldView-2 (WV2) at native spatial resolutions of 250 m, 30 m and 2 m respectively and coarser spatial resolution (resampled up to 5 km) to quantify the impact of spatial resolution on the derived TSS product in different turbidity conditions. The results from the study show that in the waters of high turbidity and high spatial variability, the high spatial resolution WV2 sensor reported TSS concentration as high as 160 mg L-1 while the low spatial resolution MODIS-Aqua reported a maximum TSS concentration of 23.6 mg L-1. Degrading the spatial resolution of each satellite sensor for highly spatially variable turbid waters led to variability in the TSS concentrations of 114.46%, 304.68% and 38.2% for WV2, Landsat-8 OLI and MODIS-Aqua respectively. The implications of this work are particularly relevant in the situation of compliance monitoring where operations may be required to restrict TSS concentrations to a pre-defined limit.	[Dorji, Passang; Fearns, Peter] Curtin Univ, Remote Sensing & Satellite Res Grp, Perth, WA, Australia	Curtin University	Dorji, P (corresponding author), Curtin Univ, Remote Sensing & Satellite Res Grp, Perth, WA, Australia.	dorji.passang@postgrad.curtin.edu.au		Dorji, Passang/0000-0002-1130-0581	Western Australian Marine Science Institute (WAMSI) through the Dredging Science Node Project [2/3]; Curtin University	Western Australian Marine Science Institute (WAMSI) through the Dredging Science Node Project; Curtin University	This study was funded by the Western Australian Marine Science Institute (WAMSI) through the Dredging Science Node Project 2/3. Also, Curtin University provided a postgraduate research scholarship to PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021852; Australia P, 2014, DREDG AUSTR PORTS SU; Binding CE, 2005, REMOTE SENS ENVIRON, V94, P373, DOI 10.1016/j.rse.2004.11.002; Binding CE, 2003, INT J REMOTE SENS, V24, P3791, DOI 10.1080/0143116021000024131; Brando VE, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020150; Brewin RJW, 2015, REMOTE SENS ENVIRON, V162, P271, DOI 10.1016/j.rse.2013.09.016; Brezonik P, 2005, LAKE RESERV MANAGE, V21, P373, DOI 10.1080/07438140509354442; Bureau of Meteorology, 2015, CLIM STAT AUSTR LOC; Burenkov VI, 2001, OCEANOLOGY+, V41, P622; Chen J, 2014, REMOTE SENS ENVIRON, V140, P78, DOI 10.1016/j.rse.2013.08.031; Chen XL, 2010, INT J APPL EARTH OBS, V12, pS203, DOI 10.1016/j.jag.2009.10.002; Chen ZQ, 2007, REMOTE SENS ENVIRON, V109, P207, DOI 10.1016/j.rse.2006.12.019; Chevron, 2014, WSO000HESRPTCVX00000; Dekker AG, 2002, INT J REMOTE SENS, V23, P15, DOI 10.1080/01431160010006917; DigitalGlobe, 2017, RES SAT INF DIGITALG; Dorji P, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070556; Doxaran D, 2002, REMOTE SENS ENVIRON, V81, P149, DOI 10.1016/S0034-4257(01)00341-8; Doxaran D, 2006, INT J REMOTE SENS, V27, P2303, DOI 10.1080/01431160500396865; Doxaran D, 2009, ESTUAR COAST SHELF S, V81, P321, DOI 10.1016/j.ecss.2008.11.013; Ekercin S, 2007, WATER AIR SOIL POLL, V183, P239, DOI 10.1007/s11270-007-9373-5; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Eugenio F, 2013, 2013 PROCEEDINGS OF THE 21ST EUROPEAN SIGNAL PROCESSING CONFERENCE (EUSIPCO); Feldman G.C., 2010, L2GEN OCEAN COLOR SE; Fettweis M, 2007, CONT SHELF RES, V27, P1568, DOI 10.1016/j.csr.2007.01.017; Forkuor G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170478; Gernez P, 2015, REMOTE SENS-BASEL, V7, P9507, DOI 10.3390/rs70809507; Glover D. M., 2011, MODELING METHODS MAR; GORDON HR, 1994, APPL OPTICS, V33, P443, DOI 10.1364/AO.33.000443; Hanley JR, 2011, APPEA J, V2011, P273; Havens KE, 2011, J PLANKTON RES, V33, P1081, DOI 10.1093/plankt/fbr002; Hu CM, 2004, REMOTE SENS ENVIRON, V93, P423, DOI 10.1016/j.rse.2004.08.007; Islam M. S., 2007, J COMPUTER SCI, V1, P15; Kallio K, 2008, ENVIRON MANAGE, V42, P511, DOI 10.1007/s00267-008-9146-y; Kloiber SN, 2002, REMOTE SENS ENVIRON, V82, P38, DOI 10.1016/S0034-4257(02)00022-6; Koponen S, 2002, REMOTE SENS ENVIRON, V79, P51, DOI 10.1016/S0034-4257(01)00238-3; Koponen S, 2007, CONT SHELF RES, V27, P228, DOI 10.1016/j.csr.2006.10.006; Kotchenova SY, 2006, APPL OPTICS, V45, P6762, DOI 10.1364/AO.45.006762; Kratzer S, 2008, REMOTE SENS ENVIRON, V112, P2284, DOI 10.1016/j.rse.2007.10.006; Lee ZP, 1999, APPL OPTICS, P38; Li J, 2010, ACTA OCEANOL SIN, V29, P38, DOI 10.1007/s13131-010-0049-4; Martin J, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010037; Miller RL, 2011, REMOTE SENS-BASEL, V3, P962, DOI 10.3390/rs3050962; Miller RL, 2004, REMOTE SENS ENVIRON, V93, P259, DOI 10.1016/j.rse.2004.07.012; Min JE, 2012, MAR POLLUT BULL, V64, P382, DOI 10.1016/j.marpolbul.2011.10.025; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; Mostafa YE, 2012, AIN SHAMS ENG J, V3, P1, DOI 10.1016/j.asej.2011.12.004; Myint SW, 2002, INT J REMOTE SENS, V23, P3229, DOI 10.1080/01431160110104700; Odermatt D, 2008, SENSORS-BASEL, V8, P4582, DOI 10.3390/s8084582; Ody A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030245; Olmanson LG, 2008, REMOTE SENS ENVIRON, V112, P4086, DOI 10.1016/j.rse.2007.12.013; Onderka M, 2008, SCI TOTAL ENVIRON, V397, P238, DOI 10.1016/j.scitotenv.2008.02.044; Ostlund C, 2001, SCI TOTAL ENVIRON, V268, P139, DOI 10.1016/S0048-9697(00)00683-5; Ouillon S, 2005, OPT EXPRESS, V13, P2531, DOI 10.1364/OPEX.13.002531; Passang D, 2016, SEMIANALYTIC MODEL E; Petus C, 2010, CONT SHELF RES, V30, P379, DOI 10.1016/j.csr.2009.12.007; Ruddick K., 2000, APPL OPTICS, V39, P912; Sanderson PG, 2001, AMBIO, V30, P43, DOI 10.1639/0044-7447(2001)030[0043:TAOSRS]2.0.CO;2; Shi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40326; Shi K, 2014, REMOTE SENS ENVIRON, V140, P365, DOI 10.1016/j.rse.2013.09.013; SKM Sinclair Knight Merz Pty Ltd., 2013, IMPR DREDG MAT MAN G; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sun DY, 2013, IEEE T GEOSCI REMOTE, V51, P3871, DOI 10.1109/TGRS.2012.2227976; Tang SL, 2013, INT J REMOTE SENS, V34, P6562, DOI 10.1080/01431161.2013.804222; URS, 2014, ONSL WAT INFR UPGR P; Vanhellemont Q, 2015, REMOTE SENS ENVIRON, V161, P89, DOI 10.1016/j.rse.2015.02.007; Vanhellemont Q, 2014, REMOTE SENS ENVIRON, V145, P105, DOI 10.1016/j.rse.2014.01.009; WA EPA, 2011, ENV ASS GUID MAR DRE; WAMSI, 2014, DREDG SCI NOD W AUST; Wang F, 2009, ENVIRON GEOL, V56, P1093, DOI 10.1007/s00254-008-1209-0; Wang JJ, 2010, SCI TOTAL ENVIRON, V408, P1131, DOI 10.1016/j.scitotenv.2009.11.057; Wang JJ, 2009, EARTH SURF PROC LAND, V34, P1082, DOI 10.1002/esp.1795; Wang MH, 2009, REMOTE SENS ENVIRON, V113, P635, DOI 10.1016/j.rse.2008.11.005; WAPC, 2011, ONSL REG HOTSP LAND; Wu GF, 2008, INT J REMOTE SENS, V29, P2183, DOI 10.1080/01431160701422254; Wu M, 2009, ENVIRON MONIT ASSESS, V148, P255, DOI 10.1007/s10661-008-0156-2; Yueh MF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037705, 10.1371/journal.pone.0043606]; Zhang MW, 2010, REMOTE SENS ENVIRON, V114, P392, DOI 10.1016/j.rse.2009.09.016; Zhao WJ, 2001, REMOTE SENS ENVIRON, V76, P202, DOI 10.1016/S0034-4257(00)00204-2; Zhou W, 2006, INT J REMOTE SENS, V27, P1177, DOI 10.1080/01431160500353825	79	31	32	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175042	10.1371/journal.pone.0175042	http://dx.doi.org/10.1371/journal.pone.0175042			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380059	Green Submitted, gold, Green Published			2022-12-27	WOS:000399353500090
J	Hansen, J; Asberg, S; Kumlien, E; Zelano, J				Hansen, Julia; Asberg, Signild; Kumlien, Eva; Zelano, Johan			Cause of death in patients with poststroke epilepsy: Results from a nationwide cohort study	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; RISK-FACTORS; SEIZURES; LEVETIRACETAM; CARBAMAZEPINE; MONOTHERAPY; VALIDATION; PREDICTORS; INPATIENT; REGISTER	The risk of death is increased for persons with epilepsy. The literature on causes of death in epilepsy is based mainly on cohorts with epilepsy of mixed aetiologies. For clinical purposes and improved understanding of mortality in different epilepsies, more information is needed on mortality in epilepsies of specific causes. In poststroke epilepsy (PSE), seizures occur in a setting of vascular disease and high mortality rates. The extent to which epilepsy contributes to mortality in this patient group is poorly understood. We therefore aimed to describe causes of death (COD) in PSE on a national scale. A previously identified cohort of 7740 patients with epilepsy or seizures after a stroke in 2005-2010 was investigated. A total of 4167 deaths occurred before the end of 2014. The standardized mortality ratio for the study cohort was 3.56 (95% CI: 3.45-3.67). The main underlying causes of death were disorders of the circulatory system (60%) followed by neoplasms (12%). Diseases of the nervous system were the sixth leading underlying COD (3%), and epilepsy or status epilepticus was considered the underlying COD in approximately a similar proportion of cases as neurodegenerative disorders (0.9% and 1.1%, respectively). Epilepsy was considered a contributing COD in 14% of cases. Our findings highlight the importance of optimal management of vascular morbidity in patients with PSE. The large proportion of patients with epilepsy as a contributing COD indicate the need of high ambitions also regarding the management of seizures in patients with PSE.	[Hansen, Julia; Zelano, Johan] Univ Gothenburg, Dept Neurol, Sahlgrenska Univ Hosp, Gothenburg, Sweden; [Hansen, Julia; Zelano, Johan] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Asberg, Signild] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Kumlien, Eva] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Uppsala University; Uppsala University	Zelano, J (corresponding author), Univ Gothenburg, Dept Neurol, Sahlgrenska Univ Hosp, Gothenburg, Sweden.; Zelano, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	johan.zelano@neuro.gu.se	Åsberg, Signild/AAU-8162-2020; Zelano, Johan/AAF-1708-2021	Åsberg, Signild/0000-0001-8693-1014; Zelano, Johan/0000-0001-9445-4545	Swedish Society of Medicine, Jeanssons foundation; Gbteborg Medical Society; Sahlgrenska university hospital	Swedish Society of Medicine, Jeanssons foundation; Gbteborg Medical Society; Sahlgrenska university hospital	This project was funded by Swedish Society of Medicine, Jeanssons foundation, The Gbteborg Medical Society, and Sahlgrenska university hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Belcastro V, 2008, EPILEPSY RES, V82, P223, DOI 10.1016/j.eplepsyres.2008.08.008; Consoli D, 2012, CEREBROVASC DIS, V34, P282, DOI 10.1159/000342669; Ferlazzo E, 2016, EPILEPSIA, V57, P1205, DOI 10.1111/epi.13448; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Gilad R, 2007, CLIN NEUROPHARMACOL, V30, P189, DOI 10.1097/WNF.0B013E3180333069; Graham NSN, 2013, STROKE, V44, P605, DOI 10.1161/STROKEAHA.111.000220; Jungehulsing GJ, 2013, ACTA NEUROL SCAND, V127, P427, DOI 10.1111/ane.12070; Keezer MR, 2016, NEUROLOGY, V86, P704, DOI 10.1212/WNL.0000000000002390; Kutlu G, 2008, EPILEPSY BEHAV, V13, P542, DOI 10.1016/j.yebeh.2008.04.025; Lindsten H, 2000, EPILEPSIA, V41, P1469, DOI 10.1111/j.1528-1157.2000.tb00124.x; Loiseau J, 1999, EPILEPSIA, V40, P1388, DOI 10.1111/j.1528-1157.1999.tb02010.x; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mattsson P, 2010, NEUROLOGY, V74, P295, DOI 10.1212/WNL.0b013e3181cbcd5c; Nevalainen O, 2016, EUR J EPIDEMIOL, V31, P445, DOI 10.1007/s10654-015-0095-5; Nevalainen O, 2012, EPILEPSIA, V53, pe212, DOI 10.1111/epi.12006; Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x; Rafnsson V, 2001, NEUROEPIDEMIOLOGY, V20, P232, DOI 10.1159/000054795; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Socialstyrelsen, 2010, PROD TILLF RLITL KOM; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; Trinka E, 2013, EPILEPSIA, V54, P495, DOI 10.1111/epi.12014; Zelano J, 2016, EUR STROKE J, V1, P272, DOI 10.1177/2396987316669000; Zelano J, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.366	25	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174659	10.1371/journal.pone.0174659	http://dx.doi.org/10.1371/journal.pone.0174659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380003	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500056
J	Ishiguro, S; Uppalapati, D; Goldsmith, Z; Robertson, D; Hodge, J; Holt, H; Nakashima, A; Turner, K; Tamura, M				Ishiguro, Susumu; Uppalapati, Deepthi; Goldsmith, Zachary; Robertson, Dana; Hodge, Jacob; Holt, Hayley; Nakashima, Arashi; Turner, Katie; Tamura, Masaaki			Exopolysaccharides extracted from Parachlorella kessleri inhibit colon carcinoma growth in mice via stimulation of host antitumor immune responses	PLOS ONE			English	Article							UNICELLULAR GREEN-ALGAE; CHLORELLA-VULGARIS; ATTENUATES GROWTH; CELL-WALL; TUMOR; POLYSACCHARIDES; GLYCOPROTEIN; RESISTANCE; LIPOPOLYSACCHARIDE; STRAIN	The newly purified extracellular polysaccharides (exopolysaccharides) from Parachlorella kessleri (PCEPS) were evaluated on their antitumor and immunomodulatory effects in cell culture and mouse colon carcinoma peritoneal dissemination model. In two-dimensional cell culture, the PCEPS treatment inhibited cell growth of both murine and human colon carcinoma cells in a dose- and time-dependent manner. In contrast, the growth of mouse splenocytes (SPLs) and bone marrow cells (BMCs) were stimulated by the treatment with PCEPS. The treatment with PCEPS also increased specific subpopulations of the cells in BMCs: antigen presenting cells (CD19(+) B cells, 33D1(+) dendritic cells and CD68(+) macrophage) and CD8(+) cytotoxic T cells. In three-dimensional spheroid culture, spheroid growth of CT26 cells co-cultured with HL-60 human neutrophilic promyeloblasts and Jurkat cells (human lymphoblasts), but not THP1 human monocyte/macrophage was significantly attenuated by PCEPS treatment. In a mouse CT26 colon carcinoma peritoneal dissemination model, intraperitoneal injection of PCEPS (10 mg/kg, twice per week) significantly attenuated the growth of CT26 colon carcinoma in syngeneic mice. The present study suggests that PCEPS inhibits colon carcinoma growth via direct cell growth inhibition and a stimulation of the host antitumor immune responses. Taken together, the current study suggests that exopolysaccharides derived from Parachlorella kessleri contain significant bioactive materials that inhibit colon carcinoma growth.	[Tamura, Masaaki] Kansas State Univ, Coll Vet Med, Dept Anat, Manhattan, KS 66506 USA; Kansas State Univ, Coll Vet Med, Dept Physiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Tamura, M (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat, Manhattan, KS 66506 USA.	mtamura@vet.ksu.edu		Tamura, Masaaki/0000-0003-4863-3379; Ishiguro, Susumu/0000-0002-3268-7754	Kansas State University Johnson Cancer Research Center [2011JCRCEQ, 2014CRA, 2015CRA, 2016CRA]; College of Veterinary Medicine Dean's funds [2010CVM-EQ]; NIH [P20 RR017686]	Kansas State University Johnson Cancer Research Center; College of Veterinary Medicine Dean's funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by funds from Kansas State University Johnson Cancer Research Center 2011JCRCEQ (MT), 2014CRA (ZG and MT), 2015CRA (JH, HH, AN and MT), 2016CRA (HH and MT), College of Veterinary Medicine Dean's funds 2010CVM-EQ (MT), and NIH grant P20 RR017686 (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, COLORECTAL CANCER FA; Armstrong MT, 2006, FASEB J, V20, P2145, DOI 10.1096/fj.05-5484fje; Armstrong PB, 2002, BIOL BULL, V203, P203, DOI 10.2307/1543397; Bot J, 2003, PATHOL RES PRACT, V199, P341, DOI 10.1078/0344-0338-00427; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buono S, 2014, FOOD FUNCT, V5, P1669, DOI [10.1039/C4FO00125G, 10.1039/c4fo00125g]; Coragliotti A. FS, 2012, Microalgal polysaccharide compositions. United States patent US, Patent No. 20120202768; Raposo MFD, 2013, MAR DRUGS, V11, P233, DOI 10.3390/md11010233; Doi C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-67; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; El-Sheekh MM, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-10; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Hasegawa T, 2002, INT IMMUNOPHARMACOL, V2, P579, DOI 10.1016/S1567-5769(02)00002-4; HASEGAWA T, 1995, INT J IMMUNOPHARMACO, V17, P505, DOI 10.1016/0192-0561(95)00035-Z; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; IBUSUKI K, 1990, NAT IMMUN CELL GROW, V9, P121; Ishiguro S, 2016, PHARM RES-DORDR, V33, P2517, DOI 10.1007/s11095-016-1976-3; Ishiguro S, 2015, CANCER BIOL THER, V16, P307, DOI 10.1080/15384047.2014.1002357; Justo GZ, 2001, IMMUNOPHARM IMMUNOT, V23, P119, DOI 10.1081/IPH-100102573; Kawabata A, 2012, CANCER BIOL THER, V13, P880, DOI 10.4161/cbt.20840; Kawakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084704; KONISHI F, 1985, CANCER IMMUNOL IMMUN, V19, P73; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li P, 2001, Biotechnol Genet Eng Rev, V18, P375; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Matsuzuka T, 2010, LUNG CANCER, V70, P28, DOI 10.1016/j.lungcan.2010.01.003; Merchant Randall E., 2002, Journal of Medicinal Food, V5, P141, DOI 10.1089/10966200260398170; MIKHEYSKAYA LV, 1977, J BACTERIOL, V130, P1; MIYAZAWA Y, 1988, J ETHNOPHARMACOL, V24, P135, DOI 10.1016/0378-8741(88)90145-6; Mohamed ZA, 2008, ECOTOXICOLOGY, V17, P504, DOI 10.1007/s10646-008-0204-2; Noda K, 1996, PLANTA MED, V62, P423, DOI 10.1055/s-2006-957931; Ohta N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123756; OKAMOTO K, 1978, JPN HEART J, V19, P622; OSBORN MJ, 1964, SCIENCE, V145, P783, DOI 10.1126/science.145.3634.783; Ou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087223; PANAC CO. LTD, 2014, Japan patent, Patent No. [JP2014-025035A, 2014025035]; Ramos AL, 2010, NUTR CANCER, V62, P1170, DOI 10.1080/01635581.2010.513801; Royce CL, 1996, J ENDOTOXIN RES, V3, P437, DOI 10.1177/096805199600300601; SANO T, 1987, ARTERY, V14, P76; SANO T, 1988, ARTERY, V15, P217; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEMPLE TU, 1978, CANCER RES, V38, P1345; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; TANAKA K, 1984, CANCER IMMUNOL IMMUN, V17, P90, DOI 10.1007/BF00200042; TANAKA K, 1990, IMMUNOPHARM IMMUNOT, V12, P277, DOI 10.3109/08923979009019673; Tanaka K, 1998, CANCER IMMUNOL IMMUN, V45, P313, DOI 10.1007/s002620050448; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Zheng WF, 2006, INT IMMUNOPHARMACOL, V6, P1093, DOI 10.1016/j.intimp.2006.01.020	49	17	17	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175064	10.1371/journal.pone.0175064	http://dx.doi.org/10.1371/journal.pone.0175064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380056	Green Published, gold			2022-12-27	WOS:000399353500091
J	Heuch, I; Heuch, I; Hagen, K; Zwart, JA				Heuch, Ingrid; Heuch, Ivar; Hagen, Knut; Zwart, John-Anker			Physical activity level at work and risk of chronic low back pain: A follow-up in the Nord-Trondelag Health Study	PLOS ONE			English	Article							TRONDELAG-HEALTH; LEISURE-TIME; PROSPECTIVE COHORT; POPULATION; PREDICTORS; ASSOCIATION; NORWAY; DISABILITY; EDUCATION; VALIDITY	Background Physical activity in leisure time seems to reduce the risk of low back pain, but it is not known whether occupational activity, as recorded in a representative working population, produces a higher or lower risk. Objective To study associations between physical activity level at work and risk of chronic low back pain. Methods Associations were examined in a Norwegian prospective study using data from the HUNT2 and HUNT3 surveys carried out in the whole county of Nord-Tremptysetndelag. Participants were 7580 women and 7335 men who supplied information about physical activity level at work. Levels considered were sedentary work, work involving walking but no heavy lifting, work involving walking and heavy lifting, and particularly strenuous physical work. Nobody in the cohort was affected by chronic low back pain at baseline. After 11 years, participants reported whether they suffered from chronic low back pain. Generalized linear modelling with adjustment for potential confounders was applied to assess associations with risk factors. Results In age-adjusted analyses both women and men showed statistically significant associations between physical activity at work and risk of chronic low back pain, suggesting positive relationships. For particularly strenuous physical work the relative risk of chronic low back pain was 1.30 (95% CI: 1.00-1.71) in women and 1.36 (95% CI 1.17-1.59) in men, compared to sedentary work. Women still showed a general association with activity level after adjustment for education, leisure time physical activity, BMI, smoking and occupational category. In men, the higher risk was only maintained for particularly strenuous work. Conclusion In this cohort, women had a higher risk of chronic low back pain with work involving walking and heavy lifting or particularly strenuous work, compared to sedentary work. Men participating in particularly strenuous work also experienced a higher risk of chronic low back pain.	[Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Heuch, Ivar] Univ Bergen, Dept Math, Bergen, Norway; [Hagen, Knut] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Hagen, Knut] St Olavs Hosp, Dept Neurol, Norwegian Natl Headache Ctr, Trondheim, Norway; [Zwart, John-Anker] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Bergen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo	Heuch, I (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.; Heuch, I (corresponding author), Oslo Univ Hosp, FORMI, Oslo, Norway.	ingrid.heuch@ous-hf.no	Heuch, Ivar/A-4510-2008	Heuch, Ivar/0000-0003-3386-9688				Andersen JH, 2007, ARTHRITIS RHEUM-US, V56, P1355, DOI 10.1002/art.22513; BERGENUDD H, 1988, SPINE, V13, P58, DOI 10.1097/00007632-198801000-00014; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Bogduk N, 2004, MED J AUSTRALIA, V180, P79, DOI 10.5694/j.1326-5377.2004.tb05805.x; Chen SM, 2009, INT ARCH OCC ENV HEA, V82, P797, DOI 10.1007/s00420-009-0410-0; Coenen P, 2014, OCCUP ENVIRON MED, V71, P871, DOI 10.1136/oemed-2014-102346; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631; Hagen KB, 2006, SOC SCI MED, V63, P1267, DOI 10.1016/j.socscimed.2006.03.041; Hagen KB, 2002, SPINE, V27, P1790, DOI 10.1097/00007632-200208150-00019; Hartvigsen J, 2000, SCAND J PUBLIC HEALT, V28, P230, DOI 10.1177/14034948000280030201; Hartvigsen J, 2001, SPINE, V26, P1788, DOI 10.1097/00007632-200108150-00011; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heuch I, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2970-8; Heuch I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141268; Heuch I, 2013, SPINE, V38, P133, DOI 10.1097/BRS.0b013e3182647af2; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2013, INT ARCH OCC ENV HEA, V86, P463, DOI 10.1007/s00420-012-0781-5; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Keogh E, 2006, J MENS HLTH GEND, V3, P236, DOI DOI 10.1016/J.JMHG.2006.03.006; Keogh E, 2006, PAIN, V123, P275, DOI 10.1016/j.pain.2006.03.004; Kopec JA, 2004, SPINE, V29, P70, DOI 10.1097/01.BRS.0000103942.81227.7F; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kujala UM, 1996, EUR J APPL PHYSIOL O, V73, P452, DOI 10.1007/BF00334423; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Kwon BK, 2011, OCCUP MED-OXFORD, V61, P541, DOI 10.1093/occmed/kqr092; Leboeuf-Yde C, 1999, SPINE, V24, P1463, DOI 10.1097/00007632-199907150-00012; Liebers F, 2013, BUNDESGESUNDHEITSBLA, V56, P367, DOI 10.1007/s00103-012-1619-8; Macfarlane GJ, 1997, SPINE, V22, P1143, DOI 10.1097/00007632-199705150-00015; Miranda H, 2008, SCAND J WORK ENV HEA, V34, P411, DOI 10.5271/sjweh.1290; National Education Association, 2010, FOC AM IND AL NAT, P2; Roffey DM, 2010, SPINE J, V10, P639, DOI 10.1016/j.spinee.2010.04.028; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Sterud T, 2013, OCCUP ENVIRON MED, V70, P296, DOI 10.1136/oemed-2012-101116	39	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175086	10.1371/journal.pone.0175086	http://dx.doi.org/10.1371/journal.pone.0175086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394896	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800016
J	Maesato, K; Ohtake, T; Mochida, Y; Ishioka, K; Oka, M; Moriya, H; Hidaka, S; Kobayashi, S				Maesato, Kyoko; Ohtake, Takayasu; Mochida, Yasuhiro; Ishioka, Kunihiro; Oka, Machiko; Moriya, Hidekazu; Hidaka, Sumi; Kobayashi, Shuzo			Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SMALL-VESSEL DISEASE; CEREBRAL-BLOOD-FLOW; COGNITIVE IMPAIRMENT; HOMOCYSTEINE LEVELS; ALZHEIMERS-DISEASE; FOLIC-ACID; ATHEROSCLEROSIS; DIALYSIS; BRAIN	Background Cognitive impairment is one of the important critical issues in hemodialysis (HD) patients. However, the associating factors of brain atrophy in HD patients have not been fully elucidated. Purpose and methods Brain magnetic resonance imaging (MRI) was performed in 34 of total 72 HD outpatients in our dialysis center. These MRI images were analyzed by an application software; Voxel-based Specific Regional Analysis System for Alzheimer's Disease (VSRAD). VSRAD quantitatively calculates the extent of brain atrophy (percent of volume reduction) comparing with a MRI imaging database of 80 age-matched healthy controls. The extent of both hippocampal and whole-brain atrophy was evaluated with possible contributing factors. Results In all patients, the mean extent of hippocampal atrophy was 27.3%, and the mean extent of whole-brain atrophy was 11.2%. The extent of hippocampal atrophy was significantly correlated with low body mass index (BMI), total serum homocysteine (tHcy) levels, and brachialankle pulse wave velocity (baPWV). The extent of whole-brain atrophy showed significant correlations with age, hypoalbuminemia, and baPWV. Based on the multiple regression analysis, tHcy was an independent determinant of hippocampal atrophy (beta = 0.460, R-2 = 0.189, P<0.01); while age was an independent determinant of whole-brain atrophy (beta = 0.594, R-2 = 0.333, P<0.01). Conclusions In this exploratory pilot study, hippocampal atrophy was significantly correlated with hyperhomocysteinemia in HD patients.	[Maesato, Kyoko] Shonan Kamakura Gen Hosp, Dept Kidney Dis, Kamakura, Kanagawa, Japan; Shonan Kamakura Gen Hosp, Transplant Ctr, Kamakura, Kanagawa, Japan		Maesato, K (corresponding author), Shonan Kamakura Gen Hosp, Dept Kidney Dis, Kamakura, Kanagawa, Japan.	kyoko.maesato@tokushukai.jp						Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; Balla S, 2013, CURR OPIN PHARMACOL, V13, P192, DOI 10.1016/j.coph.2012.12.001; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Cacciapuoti F, 2013, J THROMB THROMBOLYS, V36, P258, DOI 10.1007/s11239-012-0856-x; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Huang RFS, 2001, LIFE SCI, V68, P2799, DOI 10.1016/S0024-3205(01)01066-9; Isshiki R, 2014, THER APHER DIAL, V18, P291, DOI 10.1111/1744-9987.12107; Jardine MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3533; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Kampoli AM, 2012, CURR MED CHEM, V19, P2521, DOI 10.2174/092986712800493039; Kloppenborg RP, 2014, NEUROLOGY, V82, P777, DOI 10.1212/WNL.0000000000000168; Kobayashi S, 2014, HYPERTENS RES, V37, P636, DOI 10.1038/hr.2014.57; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Post JB, 2012, AM J NEPHROL, V35, P120, DOI 10.1159/000334871; Righetti M, 2012, CURR MED CHEM, V19, P3502, DOI 10.2174/092986712801323261; RODGERS GM, 1990, BLOOD, V75, P895; Shimomura T, 2011, EUR J CLIN INVEST, V41, P751, DOI 10.1111/j.1365-2362.2010.02464.x	20	8	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175102	10.1371/journal.pone.0175102	http://dx.doi.org/10.1371/journal.pone.0175102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394902	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800017
J	De Leon, TB; Linscombe, S; Subudhi, PK				De Leon, Teresa B.; Linscombe, Steven; Subudhi, Prasanta K.			Identification and validation of QTLs for seedling salinity tolerance in introgression lines of a salt tolerant rice landrace 'Pokkali'	PLOS ONE			English	Article							ORYZA-SATIVA L.; QUANTITATIVE TRAIT LOCI; ADVANCED BACKCROSS POPULATION; MOLECULAR DISSECTION; SUBSTITUTION LINES; YIELD COMPONENTS; RUFIPOGON; WILD; GERMPLASM; SEGMENTS	Salinity is a major threat to rice production worldwide. Several studies have been conducted to elucidate the molecular basis of salinity tolerance in rice. However, the genetic information such as quantitative trait loci (QTLs) and molecular markers, emanating from these studies, were rarely exploited for marker-assisted breeding. To better understand salinity tolerance and to validate previously reported QTLs at seedling stage, a set of introgression lines (ILs) of a salt tolerant donor line 'Pokkali' developed in a susceptible high yielding rice cultivar 'Bengal' background was evaluated for several morphological and physiological traits under salt stress. Both SSR and genotyping-by-sequencing (GBS) derived SNP markers were utilized to characterize the ILs and identify QTLs for traits related to salinity tolerance. A total of eighteen and thirty-two QTLs were detected using SSR and SNP markers, respectively. At least fourteen QTLs detected in the RIL population developed from the same cross were validated in IL population. Analysis of phenotypic responses, genomic composition, and QTLs present in the tolerant ILs suggested that the mechanisms of tolerance could be Na+ dilution in leaves, vacuolar Na+ compartmentation, and possibly synthesis of compatible solutes. Our results emphasize the use of salt injury score (SIS) QTLs in marker-assisted breeding to improve salinity tolerance. The tolerant lines identified in this study will serve as improved breeding materials for transferring salinity tolerance without the undesirable traits of Pokkali. Additionally, the lines will be useful for fine mapping and map-based cloning of genes responsible for salinity tolerance.	[De Leon, Teresa B.; Subudhi, Prasanta K.] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Linscombe, Steven] Louisiana State Univ, Ctr Agr, Rice Res Stn, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Subudhi, PK (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	PSubudhi@agcenter.lsu.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [2013-6701321238]; Louisiana Rice Research Board	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Louisiana Rice Research Board	This research was supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture (Grant No. 2013-6701321238) and the Louisiana Rice Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 2011, PLANT BREEDING, V130, P430, DOI 10.1111/j.1439-0523.2010.01837.x; Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Arbelaez JD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0276-7; Bimpong IK., 2013, MOL PLANT BREED, V5, P47; Blair MW, 2012, THEOR APPL GENET, V125, P1015, DOI 10.1007/s00122-012-1891-x; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Chen DH, 1999, PLANT MOL BIOL REP, V17, P53, DOI 10.1023/A:1007585532036; De Leon TB, 2016, RICE, V9, DOI 10.1186/s12284-016-0125-2; De Leon TB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00374; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; ESHED Y, 1995, GENETICS, V141, P1147; Flowers TJ, 2005, AGR WATER MANAGE, V78, P15, DOI 10.1016/j.agwat.2005.04.015; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; Furuta T, 2014, BREEDING SCI, V63, P468, DOI 10.1270/jsbbs.63.468; Gouget A, 2006, PLANT PHYSIOL, V140, P81, DOI 10.1104/pp.105.066464; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Gregorio GB, 1997, THESIS; Gu JF, 2012, J EXP BOT, V63, P455, DOI 10.1093/jxb/err292; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huyen L. T. N., 2012, American Journal of Plant Sciences, V3, P981, DOI 10.4236/ajps.2012.37116; Jones Jr J. B., 1990, SSSA BOOK SERIES, V3, P389; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Lee SY, 2007, PLANT BREEDING, V126, P43, DOI 10.1111/j.1439-0523.2007.01265.x; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Lorieux M., 2005, CSSL FINDER FREE PRO; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; SAS Institute Inc, 2012, SAS 9 4 SYST OPT REF; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Singh R, 2016, PLANT SCI, V242, P278, DOI 10.1016/j.plantsci.2015.08.008; Subudhi PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130650; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; Ulloa M, 2016, GENETICA, V144, P167, DOI 10.1007/s10709-016-9887-0; Usatov AV., 2015, AM J AGR BIOL SCI, V10, P165, DOI [DOI 10.3844/AJABSSP.2015.165.169, 10.3844/ajabssp.2015.165.169]; Wang J., 2016, USERS MANUAL QTL ICI; Wang ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051202; Xu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131846; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595	49	44	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175361	10.1371/journal.pone.0175361	http://dx.doi.org/10.1371/journal.pone.0175361			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388633	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800044
J	Zhang, L; Gan, XQ; He, YT; Zhu, ZL; Zhu, JF; Yu, HY				Zhang, Ling; Gan, Xueqi; He, Yuting; Zhu, Zhuoli; Zhu, Junfei; Yu, Haiyang			Drp1-dependent mitochondrial fission mediates osteogenic dysfunction in inflammation through elevated production of reactive oxygen species	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; MC3T3-E1 CELLS; TNF-ALPHA; DIFFERENTIATION; ACTIVATION; DRP1; BLOCKADE; DIVISION; OXIDANTS	Although previous studies have implicated pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), to be detrimental for osteogenic activity, the related regulatory mechanisms are not yet fully validated. Since mitochondria host several essential metabolic processes and play a pivotal role in cellular functions, whether and how mitochondrial function contributes to inflammation-induced bone destruction needs further exploration. Our findings revealed that TNF-alpha impaired osteoblast function, including decreased mRNA levels of osteogenic markers, suppressed ALP expression and activity, and compromised cellular viability. Moreover, increased reactive oxygen species (ROS)mediated oxidative stress in the TNF-alpha-treated group enhanced excessive mitochondrial fragmentation and disrupted mitochondrial function. However, treatment with antioxidant N-acetyl cysteine (NAC) or mitochondrial division inhibitor Mdivi-1 protected the cells from these adverse phenomena. These findings provide new insights into the role of the Drp1-dependent mitochondrial pathway in the osteogenic dysfunction during inflammation, indicating that this pathway may be a target for the development of new therapeutic approaches for the prevention and treatment of inflammation-induced bone destruction.	[Zhang, Ling; Gan, Xueqi; He, Yuting; Zhu, Zhuoli; Zhu, Junfei; Yu, Haiyang] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China	Sichuan University	Yu, HY (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China.	yhyang6812@scu.edu.cn			Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province [2014SZ0037]; National Natural Science Foundation of China [81400483]; National Key Research and Development Project [2016YFC1102704]	Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was sponsored by the Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province (no. 2014SZ0037), the National Natural Science Foundation of China (no. 81400483) and the National Key Research and Development Project (no. 2016YFC1102704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2013, BIOMED RES-TOKYO, V34, P161, DOI 10.2220/biomedres.34.161; Arias-Loza PA, 2013, PFLUG ARCH EUR J PHY, V465, P739, DOI 10.1007/s00424-013-1247-7; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; Choi EM, 2012, INFLAMMATION, V35, P1204, DOI 10.1007/s10753-012-9430-0; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duarte PM, 2009, CLIN ORAL IMPLAN RES, V20, P514, DOI 10.1111/j.1600-0501.2008.01680.x; Durhuus JA, 2015, MITOCHONDRION, V20, P7, DOI 10.1016/j.mito.2014.10.004; Gan XQ, 2015, BIOCHEM BIOPH RES CO, V468, P719, DOI 10.1016/j.bbrc.2015.11.022; Gan XQ, 2014, FREE RADICAL BIO MED, V75, P230, DOI 10.1016/j.freeradbiomed.2014.07.021; Gan XQ, 2014, BONE, V62, P67, DOI 10.1016/j.bone.2014.01.018; Gan XQ, 2014, BBA-MOL BASIS DIS, V1842, P220, DOI 10.1016/j.bbadis.2013.11.009; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Grcevic D, 2001, CROAT MED J, V42, P384; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Kawai VK, 2012, CURR OPIN RHEUMATOL, V24, P576, DOI 10.1097/BOR.0b013e328356d212; Kitaura H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/181849; Kozawa O, 1997, J BIOL CHEM, V272, P25099, DOI 10.1074/jbc.272.40.25099; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Ma S, 2013, DENT MATER, V29, P1219, DOI 10.1016/j.dental.2013.09.008; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Niedzwiedzki T, 2015, J MOL ENDOCRINOL, V55, pR23, DOI 10.1530/JME-15-0067; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Smith SS, 2009, TOXICOL IN VITRO, V23, P60, DOI 10.1016/j.tiv.2008.10.011; Stock M, 2013, ARTHRITIS RHEUM-US, V65, P2310, DOI 10.1002/art.38054; Takei H, 2000, J BIOMED MATER RES, V52, P382, DOI 10.1002/1097-4636(200011)52:2<382::AID-JBM19>3.0.CO;2-V; Thapa D, 2015, J MOL CELL CARDIOL, V79, P212, DOI 10.1016/j.yjmcc.2014.11.008; Wang YW, 2015, J CRANIOFAC SURG, V26, P2081, DOI 10.1097/SCS.0000000000001971; Xu ZS, 2011, FREE RADICAL BIO MED, V50, P1314, DOI 10.1016/j.freeradbiomed.2011.02.016; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang L, 2016, BIOCHEM BIOPH RES CO, V470, P510, DOI 10.1016/j.bbrc.2016.01.120	40	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175262	10.1371/journal.pone.0175262	http://dx.doi.org/10.1371/journal.pone.0175262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388678	Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800032
J	Ansari, FA; Ali, SN; Arif, H; Khan, AA; Mahmood, R				Ansari, Fariheen Aisha; Ali, Shaikh Nisar; Arif, Hussain; Khan, Aijaz Ahmed; Mahmood, Riaz			Acute oral dose of sodium nitrite induces redox imbalance, DNA damage, metabolic and histological changes in rat intestine	PLOS ONE			English	Article							PROTEIN CROSS-LINKS; CARBOHYDRATE-METABOLISM; CATALASE INACTIVATION; ANTIOXIDANT POWER; OXIDATIVE STRESS; REACTIVE OXYGEN; OXIDE; GLUTATHIONE; ACID; METHEMOGLOBINEMIA	Industrialization and unchecked use of nitrate/nitrite salts for various purposes has increased human exposure to high levels of sodium nitrite (NaNO2) which can act as a pro-oxidant and pro-carcinogen. Oral exposure makes the gastrointestinal tract particularly susceptible to nitrite toxicity. In this work, the effect of administration of a single acute oral dose of NaNO2 on rat intestine was studied. Animals were randomly divided into four groups and given single doses of 20, 40, 60 and 75 mg NaNO2/kg body weight. Untreated animals served as the control group. An NaNO2 dose-dependent decline in the activities of brush border membrane enzymes, increase in lipid peroxidation, protein oxidation, hydrogen peroxide levels and decreased thiol content was observed in all treated groups. The activities of various metabolic and antioxidant defense enzymes were also altered. NaNO2 induced a dose-dependent increase in DNA damage and DNA-protein crosslinking. Histopathological studies showed marked morphological damage in intestinal cells. The intestinal damage might be due to nitrite-induced oxidative stress, direct action of nitrite anion or chemical modification by reaction intermediates.	[Ansari, Fariheen Aisha; Ali, Shaikh Nisar; Arif, Hussain; Mahmood, Riaz] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India; [Khan, Aijaz Ahmed] Aligarh Muslim Univ, Dept Anat, Jawaharlal Nehru Med Coll, Fac Med, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Mahmood, R (corresponding author), Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India.	riazmahmood2002@Yahoo.co.in		Mahmood, Riaz/0000-0001-6726-157X; Arif, Hussain/0000-0002-7596-343X	University Grants Commission, India (SAP-DRS III); Department of Science and Technology (DST-FIST), India	University Grants Commission, India (SAP-DRS III)(University Grants Commission, India); Department of Science and Technology (DST-FIST), India(Department of Science & Technology (India))	This work was supported by the University Grants Commission, India (SAP-DRS III) and the Department of Science and Technology (DST-FIST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Gayyar MMH, 2016, REDOX REP, V21, P50, DOI 10.1179/1351000215Y.0000000035; Ansari FA, 2016, CELL BIOL INT, V40, P887, DOI 10.1002/cbin.10628; Archer MC, 2012, NUTR TOXICOL, V1, P327; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Barrett KE, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1931; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; Bryan NS, 2011, NUTR HEALTH SER, P279, DOI 10.1007/978-1-60761-616-0_17; Buege J A, 1978, Methods Enzymol, V52, P302; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chui JSW, 2005, ANAESTHESIA, V60, P496, DOI 10.1111/j.1365-2044.2004.04076.x; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; CRANE RK, 1953, J BIOL CHEM, V203, P273; Eiserich JP, 1996, J BIOL CHEM, V271, P19199, DOI 10.1074/jbc.271.32.19199; Escobar JA, 1996, FREE RADICAL BIO MED, V20, P285, DOI 10.1016/0891-5849(95)02037-3; Evans GA, 1990, CELL, V61, P17, DOI DOI 10.1016/0092-8674(90)90210-6; Farooq N, 2004, NUTR RES, V24, P407, DOI 10.1016/j.nutres.2004.01.004; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; GLOSSMANN H, 1972, FEBS LETT, V19, P340, DOI 10.1016/0014-5793(72)80075-9; GOLDMANN DR, 1976, BIOCHIM BIOPHYS ACTA, V419, P251, DOI 10.1016/0005-2736(76)90351-5; Gui Guan, 2016, Yaoxue Xuebao, V51, P59, DOI 10.16438/j.0513-4870.2015-0551; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HARTMAN Z, 1994, ENVIRON MOL MUTAGEN, V24, P168, DOI 10.1002/em.2850240305; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hord NG, 2011, CURR ATHEROSCLER REP, V13, P484, DOI 10.1007/s11883-011-0209-9; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; Jia R, 2015, AQUAT TOXICOL, V169, P1, DOI 10.1016/j.aquatox.2015.09.016; KAPLAN A, 1990, S AFR MED J, V77, P300; Katabami K, 2016, CASE REP EMERG MED, V2016; KEMPSON SA, 1979, AM J PHYSIOL, V237, pE465, DOI 10.1152/ajpendo.1979.237.5.E465; Khundmiri SJ, 2004, J NEPHROL, V17, P377; Lawniczak AE, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5167-9; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCA D, 1987, MUTAT RES, V189, P333, DOI 10.1016/0165-1218(87)90065-6; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; McNally B, 2016, MOL NUTR FOOD RES, V60, P67, DOI 10.1002/mnfr.201500153; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Mithieux G, 2014, DIABETES RES CLIN PR, V105, P295, DOI 10.1016/j.diabres.2014.04.008; MOHRENWEISER HW, 1982, AM J HUM GENET, V34, P425; Montenegro MF, 2012, N-S ARCH PHARMACOL, V385, P509, DOI 10.1007/s00210-011-0712-0; Montenegro MF, 2011, FREE RADICAL BIO MED, V51, P144, DOI 10.1016/j.freeradbiomed.2011.04.005; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; National Toxicology Program, 2001, Natl Toxicol Program Tech Rep Ser, V495, P7; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; Ohshima H, 1998, FREE RADICAL BIO MED, V25, P1057, DOI 10.1016/S0891-5849(98)00141-5; Ozen H, 2014, EXP TOXICOL PATHOL, V66, P367, DOI 10.1016/j.etp.2014.05.003; Payne CM, 1999, ANTIOXID REDOX SIGN, V1, P449, DOI 10.1089/ars.1999.1.4-449; Penhoat A, 2014, METABOLISM, V63, P104, DOI 10.1016/j.metabol.2013.09.005; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; QUIGLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V173, P456, DOI 10.1016/0005-2736(69)90010-8; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rubenchik BL, 1990, J ENVIRON PATHOL TOX, V10, P6; Sawa T, 2006, NITRIC OXIDE-BIOL CH, V14, P91, DOI 10.1016/j.niox.2005.06.005; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sen NP, 2001, J AGR FOOD CHEM, V49, P2096, DOI 10.1021/jf0011384; Sherif IO, 2013, EUR CYTOKINE NETW, V24, P114, DOI 10.1684/ecn.2013.0341; Shingles R, 1997, J BIOENERG BIOMEMBR, V29, P611, DOI 10.1023/A:1022491220299; SHONK CE, 1964, CANCER RES, V24, P709; Singh M, 2012, NITRIC OXIDE-BIOL CH, V26, P61, DOI 10.1016/j.niox.2011.12.002; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Slaoui M, 2011, METHODS MOL BIOL, V691, P69, DOI 10.1007/978-1-60761-849-2_4; Sohn CH, 2014, CLIN TOXICOL, V52, P44, DOI 10.3109/15563650.2013.863327; Spencer JPE, 2000, FREE RADICAL BIO MED, V28, P1039, DOI 10.1016/S0891-5849(00)00190-8; Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Titov VY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P627, DOI 10.1023/A:1024609624652; WHO (World Health Organization), 2011, NITR NITR DRINK WAT, P1; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Zhao KC, 2001, METHOD ENZYMOL, V335, P296; ZHITKOVICH A, 1992, CARCINOGENESIS, V13, P1485, DOI 10.1093/carcin/13.8.1485; Zhou L, 2016, NUTR CANCER, V68, P105, DOI 10.1080/01635581.2016.1102298	81	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175196	10.1371/journal.pone.0175196	http://dx.doi.org/10.1371/journal.pone.0175196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384248	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900117
J	Balaguier, R; Madeleine, P; Rose-Dulcina, K; Vuillerme, N				Balaguier, Romain; Madeleine, Pascal; Rose-Dulcina, Kevin; Vuillerme, Nicolas			Trunk kinematics and low back pain during pruning among vineyard workers-A field study at the Chateau Larose-Trintaudon	PLOS ONE			English	Article							FLEXION-RELAXATION RESPONSE; RISK-FACTORS; PRESSURE PAIN; MUSCULOSKELETAL DISORDERS; LUMBAR FLEXION; POSTURES; EPIDEMIOLOGY; PREVALENCE; EXERCISE; INCLINOMETRY	The prevalence of low back disorders is dramatically high in viticulture. Field measurements that objectively quantify work exposure can provide information on the relationship between the adopted trunk postures and low back pain. The purposes of the present study were three-fold (1) to carry out a kinematics analysis of vineyard-workers' pruning activity by extracting the duration of bending and rotation of the trunk, (2) to question separately the relationship between the duration of forward bending or trunk rotation with low back pain intensity and pressure pain sensitivity and (3) to question the relationship between the combined duration of forward bending and trunk rotation on low back pain intensity and pressure pain sensitivity. Fifteen vineyard-workers were asked to perform pruning activity for 12 minutes with a wireless triaxial accelerometer placed on their trunk. Kinematic analysis of the trunk showed that vineyard-workers spent more than 50% of the time with the trunk flexed greater than 30 degrees and more than 20% with the trunk rotated greater than 10 degrees. These results show that pruning activity lead to the adoption of forward bended and rotated trunk postures that could significantly increase the risk of work related musculoskeletal disorders in the low back. However, this result was mitigated by the observation of an absence of significant association between the duration of forward bending and trunk rotation with low back pain intensity or pressure pain sensitivity. Even if prospective field measurements and studies assessing the effects of low back pain confounders are needed, this field study provides new genuine information on trunk kinematics during pruning activity.	[Balaguier, Romain; Rose-Dulcina, Kevin; Vuillerme, Nicolas] Univ Grenoble Alpes, AGEIS, Grenoble, France; [Balaguier, Romain; Madeleine, Pascal; Rose-Dulcina, Kevin; Vuillerme, Nicolas] Aalborg Univ, Dept Hlth Sci & Technol, SMI, Phys Act & Human Performance Grp, Aalborg, Denmark; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Aalborg University; Institut Universitaire de France	Vuillerme, N (corresponding author), Univ Grenoble Alpes, AGEIS, Grenoble, France.; Vuillerme, N (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, SMI, Phys Act & Human Performance Grp, Aalborg, Denmark.; Vuillerme, N (corresponding author), Inst Univ France, Paris, France.	nicolas.vuillerme@agim.eu	Madeleine, Pascal/AAD-3201-2021; Balaguier, Romain/ABD-8496-2020; VUILLERME, Nicolas/U-5767-2019	Rose-Dulcina, Kevin/0000-0002-8698-3268; Balaguier, Romain/0000-0001-6393-1556; VUILLERME, Nicolas/0000-0003-3773-393X	grant from the French Ministry of Higher Education and Research; French National Research Agency in the framework of the "Investissements d'avenir" program [ANR-10-AIRT-05]; Blaland French-Danish scientific cooperation program (Institut Francais du Danemark); Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France); Aalborg University (Denmark)	grant from the French Ministry of Higher Education and Research; French National Research Agency in the framework of the "Investissements d'avenir" program(French National Research Agency (ANR)); Blaland French-Danish scientific cooperation program (Institut Francais du Danemark); Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France); Aalborg University (Denmark)	This work is part of a joint PhD project financed by a grant from the French Ministry of Higher Education and Research. *This work was also supported by the French National Research Agency in the framework of the "Investissements d'avenir" program (ANR-10-AIRT-05).*EWS project has benefited from support from the Blaland French-Danish scientific cooperation program (Institut Francais du Danemark), the Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France) and Aalborg University (Denmark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to sincerely thank all the Larose-Trintaudon vineyard-workers for their active participation and their patience in this study. The authors are also grateful to Franck Bijon and Mathieu Maudet for their trust and their help during the implementation of this study. The authors would like to thank anonymous reviewers for helpful comments and suggestions. The presented work is also part of a larger pluri-disciplinary project called 'EWS' (Ergonomics at Work and in Sports). EWS project has benefited from support from the Blatand French-Danish scientific cooperation program (Institut Francais du Danemark), the Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France) and Aalborg University (Denmark).	Afshari D, 2014, APPL ERGON, V45, P278, DOI 10.1016/j.apergo.2013.04.015; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Balaguier R, 2014, INT S HUM FACT ORG D, P965; Balaguier R, 2016, BMC MUSCULOSKEL DIS, V17, P1; Balaguier R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160866; Bernard C, 2011, J OCCUP HEALTH, V53, P297, DOI 10.1539/joh.10-0031-OA; Bevan S, 2009, FIT WORK MUSCULOSKEL, P1; Binderup AT, 2010, EUR J PAIN, V14, P705, DOI 10.1016/j.ejpain.2009.11.001; Brumitt J, 2011, J AGROMEDICINE, V16, P72, DOI 10.1080/1059924X.2011.534041; Burrows NJ, 2014, OSTEOARTHR CARTILAGE, V22, P407, DOI 10.1016/j.joca.2013.12.023; Coenen P, 2016, ERGONOMICS, V59, P1182, DOI 10.1080/00140139.2015.1130862; Coenen P, 2015, APPL ERGON, V51, P322, DOI 10.1016/j.apergo.2015.06.005; Coenen P, 2013, J OCCUP REHABIL, V23, P11, DOI 10.1007/s10926-012-9375-z; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; De Rui M, 2015, GERODONTOLOGY, V32, P274, DOI 10.1111/ger.12117; de Zwart BCH, 2001, INT ARCH OCC ENV HEA, V74, P21; de la Morena JMD, 2013, J STRENGTH COND RES, V27, P3045, DOI 10.1519/JSC.0b013e31828bf2c9; Farioli A, 2014, SCAND J WORK ENV HEA, V40, P36, DOI 10.5271/sjweh.3381; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Freitag S, 2007, ANN OCCUP HYG, V51, P385, DOI 10.1093/annhyg/mem018; Ge HY, 2014, BMC MUSCULOSKEL DIS, V15, P1; Hansson GA, 2001, SCAND J WORK ENV HEA, V27, P30, DOI 10.5271/sjweh.584; Hendershot B, 2011, CLIN BIOMECH, V26, P250, DOI 10.1016/j.clinbiomech.2010.09.019; Hoogendoorn WE, 2000, SPINE, V25, P3087, DOI 10.1097/00007632-200012010-00018; Hoogendoorn WE, 2002, OCCUP ENVIRON MED, V59, P323, DOI 10.1136/oem.59.5.323; Hoozemans MJM, 2001, SCAND J WORK ENV HEA, V27, P125, DOI 10.5271/sjweh.599; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jansen JP, 2001, SCAND J WORK ENV HEA, V27, P373, DOI 10.5271/sjweh.629; Jansen JP, 2004, OCCUP ENVIRON MED, V61, P972, DOI 10.1136/oem.2003.012245; Jorgensen MB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-213; Kato AE, 2006, J AGRIC SAF HEALTH, V12, P17, DOI 10.13031/2013.20199; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lagersted-Olsen J, 2016, SCAND J WORK ENV HEA, V42, P528, DOI 10.5271/sjweh.3591; Manek NJ, 2005, CURR OPIN RHEUMATOL, V17, P134; Meyers James M, 2004, J Agromedicine, V9, P433; Milosavljevic S, 2007, APPL ERGON, V38, P299, DOI 10.1016/j.apergo.2006.04.026; Ning XP, 2011, CLIN BIOMECH, V26, P35, DOI 10.1016/j.clinbiomech.2010.08.012; Oakman J, 2016, INT ARCH OCC ENV HEA, V89, P1127, DOI 10.1007/s00420-016-1149-z; Osborne A, 2012, AM J IND MED, V55, P143, DOI 10.1002/ajim.21033; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; Prairie J, 2014, APPL ERGON, V45, P895, DOI 10.1016/j.apergo.2013.11.006; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Ramond-Roquin A, 2015, SPINE J, V15, P559, DOI 10.1016/j.spinee.2013.05.040; Roquelaure Y, 2002, INT ARCH OCC ENV HEA, V75, P591, DOI 10.1007/s00420-002-0366-9; Roquelaure Y, 2004, APPL ERGON, V35, P179, DOI 10.1016/j.apergo.2003.11.006; Schneider E, 2010, OSH FIGURES WORK REL; Shan XH, 2013, EUR SPINE J, V22, P1972, DOI 10.1007/s00586-013-2784-7; Solomonow M, 2004, J ELECTROMYOGR KINES, V14, P49, DOI 10.1016/j.jelekin.2003.09.011; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; Solomonow M, 2003, CLIN BIOMECH, V18, P273, DOI 10.1016/S0268-0033(03)00024-X; Spielholz P, 2001, ERGONOMICS, V44, P588, DOI 10.1080/00140130118050; Teschke K, 2009, ERGONOMICS, V52, P1067, DOI 10.1080/00140130902912811; Thomas JS, 2008, EUR SPINE J, V17, P97, DOI 10.1007/s00586-007-0532-6; Vaegter HB, 2016, CLIN J PAIN, V32, P58, DOI 10.1097/AJP.0000000000000223; van den Heuvel SG, 2004, SCAND J WORK ENV HEA, V30, P459, DOI 10.5271/sjweh.835; Villumsen M, 2017, APPL ERGON, V58, P273, DOI 10.1016/j.apergo.2016.06.017; Villumsen M, 2015, ERGONOMICS, V58, P246, DOI 10.1080/00140139.2014.969783; Wai EK, 2010, SPINE J, V10, P76, DOI 10.1016/j.spinee.2009.06.005; Walton D, 2011, J ORTHOP SPORT PHYS, V41, P644, DOI 10.2519/jospt.2011.3666; Widanarko B, 2012, APPL ERGON, V43, P727, DOI 10.1016/j.apergo.2011.11.004; Zwambag DP, 2016, J ELECTROMYOGR KINES, V30, P38, DOI 10.1016/j.jelekin.2016.05.008	63	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175126	10.1371/journal.pone.0175126	http://dx.doi.org/10.1371/journal.pone.0175126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384277	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900094
J	Byers, E; Yavas, M				Byers, Emily; Yavas, Mehmet			Vowel reduction in word-final position by early and late Spanish-English bilinguals	PLOS ONE			English	Article							FOREIGN ACCENT; LANGUAGE; L2; PRONUNCIATION; QUESTIONNAIRE; EQUIVALENCE; EXPERIENCE; DURATION; STRESS; INPUT	Vowel reduction is a prominent feature of American English, as well as other stress-timed languages. As a phonological process, vowel reduction neutralizes multiple vowel quality contrasts in unstressed syllables. For bilinguals whose native language is not characterized by large spectral and durational differences between tonic and atonic vowels, systematically reducing unstressed vowels to the central vowel space can be problematic. Failure to maintain this pattern of stressed-unstressed syllables in American English is one key element that contributes to a "foreign accent" in second language speakers. Reduced vowels, or "schwas" have also been identified as particularly vulnerable to the co-articulatory effects of adjacent consonants. The current study examined the effects of adjacent sounds on the spectral and temporal qualities of schwa in word-final position. Three groups of English-speaking adults were tested: Miami-based monolingual English speakers, early Spanish-English bilinguals, and late Spanish-English bilinguals. Subjects performed a reading task to examine their schwa productions in fluent speech when schwas were preceded by consonants from various points of articulation. Results indicated that monolingual English and late Spanish-English bilingual groups produced targeted vowel qualities for schwa, whereas early Spanish-English bilinguals lacked homogeneity in their vowel productions. This extends prior claims that schwa is targetless for F2 position for native speakers to highly-proficient bilingual speakers. Though spectral qualities lacked homogeneity for early Spanish-English bilinguals, early bilinguals produced schwas with near native-like vowel duration. In contrast, late bilinguals produced schwas with significantly longer durations than English monolinguals or early Spanish-English bilinguals. Our results suggest that the temporal properties of a language are better integrated into second language phonologies than spectral qualities. Finally, we examined the role of nonstructural variables (e.g. linguistic history measures) in predicting native-like vowel duration. These factors included: Age of L2 learning, amount of L1 use, and self-reported bilingual dominance. Our results suggested that different sociolinguistic factors predicted native-like reduced vowel duration than predicted native-like vowel qualities across multiple phonetic environments.	[Byers, Emily; Yavas, Mehmet] Florida Int Univ, Linguist Program, Miami, FL 33199 USA	State University System of Florida; Florida International University	Byers, E (corresponding author), Florida Int Univ, Linguist Program, Miami, FL 33199 USA.	elbyers@indiana.edu		Byers, Emily/0000-0001-5811-1609				Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Adank P, 2004, J ACOUST SOC AM, V116, P3099, DOI 10.1121/1.1795335; Alvord S, 2011, HISP LING S, P6; Amengual M, 2012, BILING-LANG COGN, V15, P517, DOI 10.1017/S1366728911000460; [Anonymous], 2016, TEST ENGL FOR LANG T; [Anonymous], 2016, AV FLOR DEM DAT; ARCHIBALD J, 1993, IRAL-INT REV APPL LI, V31, P129; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Barlow JA, 2013, BILING-LANG COGN, V16, P68, DOI 10.1017/S1366728912000235; Bialystok E, 1999, SEC LANG ACQ RES, P161; Bialystok E., 1997, SECOND LANG RES, V13, P116, DOI [10.1191/026765897677670241, DOI 10.1191/026765897677670241]; Birdsong D, 2001, J MEM LANG, V44, P235, DOI 10.1006/jmla.2000.2750; Boersma P., 2011, PRAAT DOING PHONETIC; Bongaerts T, 1995, AGE FACTOR IN SECOND LANGUAGE ACQUISITION, P30; Browman C.P., 1992, PAPERS LAB PHONOLOGY, P26, DOI DOI 10.1017/CB09780511519918.003; BROWMAN CP, 1990, J PHONETICS, V18, P299, DOI 10.1016/S0095-4470(19)30376-6; Byers E, 2012, THESIS; Byers E, 2014, INT J BILINGUAL, V20, P190; byers M, 2014, PRODUCTION VOICELESS, P242; Cekaite A, 2005, APPL LINGUIST, V26, P169, DOI 10.1093/applin/amh042; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Dalby J., 1986, PHONETIC STRUCTURE F; Davis SM, 1997, J MEM LANG, V36, P445, DOI 10.1006/jmla.1996.2503; Diez FG, 2001, INT J ENGL STUD, V1, P93; Dijkstra T., 1998, BILING-LANG COGN, V1, P51, DOI [10.1017/S1366728998000121, DOI 10.1017/S1366728998000121]; Dunn AL, 1997, BILING, V12, P273; Dunn AL, 2009, BILING-LANG COGN, V12, P273, DOI 10.1017/S1366728909990113; Dunn L. M., 1997, VOCABULARIO IMAGENES; Dunn L. M., 2015, PEABODY PICTURE VOCA, V4th; Dupoux E, 2010, COGNITION, V114, P266, DOI 10.1016/j.cognition.2009.10.001; Enzinna N., 2015, CORNELL WORKING PAPE; Erickson D, 2002, PHONETICA, V59, P134, DOI 10.1159/000066067; Escudero P, 2006, PHONOLOGY IN CONTEXT, P109; Escudero PR, 2001, PROC ANN BUCLD, P250; Flege J., 1995, SPEECH PERCEPTION LI, P78; Flege J., 2012, 6 INT C NAT NONN ACC; Flege J., 2001, STUD SECOND LANG ACQ, V23, P527, DOI [10.1017/S0272263101004041, DOI 10.1017/S0272263101004041]; Flege J. E., 1989, STUDIES 2 LANGUAGE A, V11, P35, DOI DOI 10.1017/S0272263100007828; Flege J. E., 1989, J ACOUST SOC AM, V85, pS85, DOI [10.1121/1.2027177, DOI 10.1121/1.2027177]; Flege J. E., 2003, PHONETICS PHONOLOGY, P319; Flege James E., 2007, LAB PHONOLOGY, V9, P353; Flege JE, 2006, J PHONETICS, V34, P153, DOI 10.1016/j.wocn.2005.05.001; Flege JE, 1997, J PHONETICS, V25, P169, DOI 10.1006/jpho.1996.0040; Flege JE, 2003, SPEECH COMMUN, V40, P467, DOI 10.1016/S0167-6393(02)00128-0; FLEGE JE, 1987, J PHONETICS, V15, P47, DOI 10.1016/S0095-4470(19)30537-6; FLEGE JE, 1988, J ACOUST SOC AM, V84, P70, DOI 10.1121/1.396876; Flemming E., 2009, PHONOLOGICAL WEAKNES, P78, DOI [DOI 10.1007/978-0-230-29686-2_5, 10.1007/978-0-230-29686-2_5]; Flemming E., 2007, J INT PHONETIC ASS, V37, P83, DOI [DOI 10.1017/S0025100306002817, 10.1017/S0025100306002817]; FOKES J, 1993, PHONETICA, V50, P102, DOI 10.1159/000261929; FOURAKIS M, 1991, J ACOUST SOC AM, V90, P1816, DOI 10.1121/1.401662; Gatbonton E, 2005, TESOL QUART, V39, P489, DOI 10.2307/3588491; Goldrick M, 2014, PSYCHOL SCI, V25, P1031, DOI 10.1177/0956797613520014; Goldstein B., 2001, COMMUNICATION DISORD, V23, P54, DOI [10.1177/152574010102300108, DOI 10.1177/152574010102300108]; Grosjean F, 2010, BILINGUAL; Guion SusanG., 2004, BILING-LANG COGN, V7, P207, DOI [10.1017/S1366728904001592, DOI 10.1017/S1366728904001592]; Hammond R., 2001, SOUNDS SPANISH ANAL; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jonathan Harrington, 2010, HDB PHONETIC SCI, P91; Kelm O., 1995, HISPANIC LINGUISTICS, V6, P435; KLATT DH, 1976, J ACOUST SOC AM, V59, P1208, DOI 10.1121/1.380986; Kondo Y., 1994, P ED LING DEP C, P63; Labov W., 2006, PHONOLOGY SOUND CHAN; Lee B, 2006, STUD SECOND LANG ACQ, V28, P487, DOI 10.1017/S0272263106060207; Leech G., 2014, WORD FREQUENCIES WRI; LENNEBERG EH, 1969, SCIENCE, V164, P635, DOI 10.1126/science.164.3880.635; Lennes M, 2011, SPECT SPEECH CORPUS; Li Y., 2014, PCI, V2, P17, DOI DOI 10.1103/PHYSREVB.90.205422; Likert R, 1932, ARCH PSYCHOL; LINDBLOM B, 1963, J ACOUST SOC AM, V35, P1773, DOI 10.1121/1.1918816; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; LoCasto PC, 2002, PERCEPT PSYCHOPHYS, V64, P208, DOI 10.3758/BF03195787; Long Michael, 1990, STUDIES 2 LANGUAGE A, V12, P251, DOI [10.1017/S0272263100009165, DOI 10.1017/S0272263100009165]; Mackey A, 2003, LANG LEARN, V53, P35, DOI 10.1111/1467-9922.00210; Marin Galvez R, 1994, ESTUDIOS LINGUISTICA, V10, P213; Marinova-Todd S., 2003, COMPREHENSIVE ANAL U; Marinova-Todd SH, 2000, TESOL QUART, V34, P9, DOI 10.2307/3588095; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Meisel J. M., 2001, TRENDS BILINGUAL ACQ, P11, DOI DOI 10.1075/TILAR.1.03MEI; Metz DE, 1997, J COMMUN DISORD, V30, P23, DOI 10.1016/0021-9924(95)00056-9; MOON SJ, 1994, J ACOUST SOC AM, V96, P40, DOI 10.1121/1.410492; Nord L., 1974, P SPEECH COMM SEM, V2, P149; Nusbaum H. C., 1984, RES SPEECH PERCEPTIO, V10, P357; Olive J. P., 1993, ACOUSTICS AM ENGLISH; Osterhout L, 2008, J NEUROLINGUIST, V21, P509, DOI 10.1016/j.jneuroling.2008.01.001; Patkowski M., 1994, 1 2 LANGUAGE PHONOLO, P205; Peirce B., 2012, TESOL Q, V29, P9; Peperkamp S, 2002, PHONOL PHON, V4-1, P203; Piske T, 2002, PHONETICA, V59, P49, DOI 10.1159/000056205; Piske T, 2001, J PHONETICS, V29, P191, DOI 10.1006/jpho.2001.0134; Racine I., 2002, J FR LANG STUD, V12, P307, DOI DOI 10.1017/S0959269502000340; Fabra LR, 2015, PHONETICA, V72, P162, DOI 10.1159/000430920; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Ronquest R., 2013, SEL P 15 HISP LING C, P151; Rota G, 2009, TRENDS APPL LINGUIST, V1, P67; Sancier ML, 1997, J PHONETICS, V25, P421, DOI 10.1006/jpho.1997.0051; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Stone M, 1996, J ACOUST SOC AM, V99, P3728, DOI 10.1121/1.414969; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Trofimovich P, 2006, STUD SECOND LANG ACQ, V28, P1, DOI 10.1017/S0272263106060013; VANBERGEM DR, 1994, SPEECH COMMUN, V14, P143, DOI 10.1016/0167-6393(94)90005-1; Watt D., 2002, LEEDS WORKING PAPERS, V9, P159; Willis E.W., 2005, SW J LINGUISTICS, V24, P185; Yavas M., 2016, APPL ENGLISH PHONOLO, P109; Yavas Mahmet, 2016, APPL ENGLISH PHONOLO, V3rd; Zuengler J., 1988, STUDIES 2 LANGUAGE A, V10, P33, DOI DOI 10.1017/S027226310000694X	105	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175226	10.1371/journal.pone.0175226	http://dx.doi.org/10.1371/journal.pone.0175226			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ES2QB	28384234	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900126
J	Gahring, LC; Myers, EJ; Dunn, DM; Weiss, RB; Rogers, SW				Gahring, Lorise C.; Myers, Elizabeth J.; Dunn, Diane M.; Weiss, Robert B.; Rogers, Scott W.			Nicotinic alpha 7 receptor expression and modulation of the lung epithelial response to lipopolysaccharide	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; NEUROEPITHELIAL BODIES; PULMONARY-FIBROSIS; GENE-EXPRESSION; STEM-CELLS; ACTIVATION; MOUSE; DYSFUNCTION; MECHANISMS; SURFACTANT	Nicotine modulates multiple inflammatory responses in the lung through the nicotinic acetylcholine receptor subtype alpha7 (alpha 7). Previously we reported that alpha 7 modulates both the hematopoietic and epithelium responses in the lung to the bacterial inflammogen, lipopolysaccharide (LPS). Here we apply immunohistochemistry, flow cytometry and RNA-Seq analysis of isolated distal lung epithelium to further define alpha 7-expression and function in this tissue. Mouse lines were used that co-express a bicistronic tau-green fluorescent protein (tGFP) as a reporter of alpha 7 (alpha 7(G)) expression and that harbor an alpha 7 with a specific point mutation (alpha 7(E260A:G)) that selectively uncouples it from cell calcium-signaling mechanisms. The tGFP reporter reveals strong cell-specific alpha 7-expression by alveolar macrophages (AM), Club cells and ATII cells. Ciliated cells do not express detectible tGFP, but their numbers decrease by one-third in the alpha 7(E260A:G) lung compared to controls. Transcriptional comparisons (RNA-Seq) between alpha 7(G) and a7(E260A:G) enriched lung epithelium 24 hours after challenge with either intra-nasal (i.n.)saline or LPS reveals a robust alpha 7-genotype impact on both the stasis and inflammatory response of this tissue. Overall the alpha 7(E260A:G) lung epithelium exhibits reduced inflammatory cytokine/chemokine expression to i.n. LPS. Transcripts specific to Club cells (e.g., CC10, secretoglobins and Muc5b) or to ATII cells (e.g., surfactant proteins) were constitutively decreased in in the alpha 7(E260A:G) lung, but they were strongly induced in response to i.n. LPS. Protein analysis applying immunohistochemistry and ELISA also revealed alpha 7-associated differences suggested by RNA-Seq including altered mucin protein 5b ( Muc5b) accumulation in the alpha 7(E260A:G) bronchia, that in some cases appeared to form airway plugs, and a substantial increase in extracellular matrix deposits around alpha 7(E260A:G) airway bronchia linings that was not seen in controls. Our results show that alpha 7 is an important modulator of normal gene expression stasis and the response to an inhaled inflammogen in the distal lung epithelium. Further, when normal alpha 7 signaling is disrupted, changes in lung gene expression resemble those associated with long-term lung pathologies seen in humans who use inhaled nicotine products.	[Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA; [Gahring, Lorise C.; Myers, Elizabeth J.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Dunn, Diane M.; Weiss, Robert B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Gahring, LC; Rogers, SW (corresponding author), Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.; Gahring, LC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA.; Rogers, SW (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	Lorise.Gahring@hsc.utah.edu; Scott.Rogers@hsc.utah.edu			VA MERIT REVIEW AWARD [101BX001798]; National Heart, Lung, and Blood Institute [R01 HL135610]; National Cancer Institute [5P01CA098262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135610] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	VA MERIT REVIEW AWARD(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the VA MERIT REVIEW AWARD, 101BX001798 to LCG; the National Heart, Lung, and Blood Institute, R01 HL135610 to LCG and SWR; and the National Cancer Institute, 5P01CA098262 to RBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen D, 1998, CELL TISSUE RES, V293, P395, DOI 10.1007/s004410051131; Adriaensen D, 2006, J APPL PHYSIOL, V101, P960, DOI 10.1152/japplphysiol.00267.2006; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araz O, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-74; Barnes FA, 2008, AM J RESP CELL MOL, V38, P377, DOI 10.1165/rcmb.2007-0388TR; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brasch F, 2004, EUR RESPIR J, V24, P426, DOI 10.1183/09031936.04.00076403; Brass David M, 2007, Proc Am Thorac Soc, V4, P92, DOI 10.1513/pats.200607-147JG; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eddins D, 2002, AM J PHYSIOL-CELL PH, V282, pC796, DOI 10.1152/ajpcell.00453.2001; Enioutina EY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121128; Evans CM, 2016, PHYSIOL REV, V96, P1567, DOI 10.1152/physrev.00004.2016; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103861; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Gahring LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-38; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Horiguchi K, 2009, J NEUROSCI RES, V87, P2740, DOI 10.1002/jnr.22102; Hume DA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00370; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurosawa N, 1996, J BIOL CHEM, V271, P15109, DOI 10.1074/jbc.271.25.15109; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Lee MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112666; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2011, J PHARMACOL EXP THER, V339, P62, DOI 10.1124/jpet.111.184671; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Makinde TO, 2013, EXP MOL PATHOL, V94, P45, DOI 10.1016/j.yexmp.2012.05.009; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meng QR, 2006, INHAL TOXICOL, V18, P555, DOI 10.1080/08958370600686226; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Nakano Y, 2016, AM J RESP CRIT CARE, V193, P464, DOI 10.1164/rccm.201509-1872LE; Noguchi M, 2015, CELL REP, V13, P2679, DOI 10.1016/j.celrep.2015.11.058; Osborne-Hereford AV, 2008, J NEUROIMMUNOL, V193, P130, DOI 10.1016/j.jneuroim.2007.10.029; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2014, BIOCH PHARM; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Reynolds PR, 2005, J BIOL CHEM, V280, P32548, DOI 10.1074/jbc.M502231200; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; Ritzenthaler JD, 2013, ALCOHOL CLIN EXP RES, V37, P914, DOI 10.1111/acer.12044; Rogan MP, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-29; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; Sakurai R, 2011, EXP LUNG RES, V37, P144, DOI 10.3109/01902148.2010.490288; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Su T, 2004, TOXICOL APPL PHARM, V199, P285, DOI 10.1016/j.taap.2003.11.029; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Volckaert T, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-8; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wongtrakool C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109602; Wright JR, 2003, J CLIN INVEST, V111, P1453, DOI 10.1172/JCI200318650; Yin H, 2013, MOL IMMUNOL, V56, P347, DOI 10.1016/j.molimm.2013.05.225; Zia S, 1997, RES COMMUN MOL PATH, V97, P243; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	82	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175367	10.1371/journal.pone.0175367	http://dx.doi.org/10.1371/journal.pone.0175367			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384302	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900163
J	Knight, J; Wells, S; Marshall, R; Exeter, D; Jackson, R				Knight, Josh; Wells, Susan; Marshall, Roger; Exeter, Daniel; Jackson, Rod			Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study	PLOS ONE			English	Article							BLOOD-PRESSURE; MICROSIMULATION	Background Many national cardiovascular disease (CVD) risk factor management guidelines now recommend that drug treatment decisions should be informed primarily by patients' multi-variable predicted risk of CVD, rather than on the basis of single risk factor thresholds. To investigate the potential impact of treatment guidelines based on CVD risk thresholds at a national level requires individual level data representing the multi-variable CVD risk factor profiles for a country's total adult population. As these data are seldom, if ever, available, we aimed to create a synthetic population, representing the joint CVD risk factor distributions of the adult New Zealand population. Methods and results A synthetic population of 2,451,278 individuals, representing the actual age, gender, ethnicity and social deprivation composition of people aged 30-84 years who completed the 2013 New Zealand census was generated using Monte Carlo sampling. Each 'synthetic' person was then probabilistically assigned values of the remaining cardiovascular disease (CVD) risk factors required for predicting their CVD risk, based on data from the national census national hospitalisation and drug dispensing databases and a large regional cohort study, using Monte Carlo sampling and multiple imputation. Where possible, the synthetic population CVD risk distributions for each non-demographic risk factor were validated against independent New Zealand data sources. Conclusions We were able to develop a synthetic national population with realistic multi-variable CVD risk characteristics. The construction of this population is the first step in the development of a micro-simulation model intended to investigate the likely impact of a range of national CVD risk management strategies that will inform CVD risk management guideline updates in New Zealand and elsewhere.	[Knight, Josh] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia; [Knight, Josh; Wells, Susan; Marshall, Roger; Exeter, Daniel; Jackson, Rod] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand	University of Melbourne; University of Auckland	Knight, J (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.; Knight, J (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand.	jost.knight@unimelb.edu.au		Exeter, Daniel/0000-0003-1061-5925; Knight, Josh/0000-0001-5268-8263	Health Research Council [03/183, 08/121]; PhD Scholarship	Health Research Council; PhD Scholarship	The PREDICT research project is supported by the Health Research Council (grants 03/183 and 08/121). JK was supported by a PhD Scholarship associated with the project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID MAN ABS CARD DI; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bachmann C, 2013, TRANSPORT RES C-EMER, V26, P33, DOI 10.1016/j.trc.2012.07.003; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Coppell KJ, 2013, NEW ZEAL MED J, V126, P23; Davis P, 2010, HEALTH POLICY, V97, P267, DOI 10.1016/j.healthpol.2010.05.014; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jo EC, 2015, HEALTHC INFORM RES, V21, P49, DOI 10.4258/hir.2015.21.1.49; Karmali KN, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006887.pub4; Kypridemos C, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2793; McLean RM, 2012, NEW ZEALAND MEDICAL, P126; Metcalf P, 2006, NEW ZEAL MED J, V119, P18; Ministry of Health, 2014, ANN UPD KEY RES 2013; Ministry of Health, 2014, TOB USE 2012 13 NZ H; Ministry of Health, 2013, CARD DIS RISK ASS NZ; Mitton L, 2000, MICROSIMULATION MODELLING FOR POLICY ANALYSIS: CHALLENGES AND INNOVATIONS, P1; Namazi-Rad MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094761; National Institute for Health and Clinical Excellence, 2016, CARD DIS RISK ASS RE; New Zealand Guidelines Group, 2003, ASS MAN CARD RISK; Nietert PJ, 2006, AM J HYPERTENS, V19, P147, DOI 10.1016/j.amjhyper.2005.08.016; Nsoesie Elaine, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.bb1e879a23137022ea79a8c508b030bc; Orcutt GH., 1957, REV ECON STAT, V39, P116, DOI 10.2307/1928528; R Development Core Team, 2001, R LANG ENV STAT COMP; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Statistics New Zealand, 2013, 2013 CENS DAT US GUI; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Sutherland H., 2013, INT J MICROSIMULATIO, V6, P4, DOI [10.34196/ijm.00075, DOI 10.34196/IJM.00075, https://doi.org/10.34196/ijm.00075]; The National Institute for Health and Care Excellence, 2014, CG181 NICE; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wells S, 2017, INT J EPIDEMIOL, V46, P22, DOI 10.1093/ije/dyv312; Wickham H., 2015, R PACKAGE VERSION 04; Zucchelli E, 2010, HLTH ECONOMETRICS DA, V10	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173170	10.1371/journal.pone.0173170	http://dx.doi.org/10.1371/journal.pone.0173170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384217	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900006
J	Kurczab, R; Bojarski, AJ				Kurczab, Rafal; Bojarski, Andrzej J.			The influence of the negative-positive ratio and screening database size on the performance of machine learning-based virtual screening	PLOS ONE			English	Article							CLASSIFICATION; DIVERSITY	The machine learning-based virtual screening of molecular databases is a commonly used approach to identify hits. However, many aspects associated with training predictive models can influence the final performance and, consequently, the number of hits found. Thus, we performed a systematic study of the simultaneous influence of the proportion of negatives to positives in the testing set, the size of screening databases and the type of molecular representations on the effectiveness of classification. The results obtained for eight protein targets, five machine learning algorithms (SMO, Naive Bayes, Ibk, J48 and Random Forest), two types of molecular fingerprints (MACCS and CDK FP) and eight screening databases with different numbers of molecules confirmed our previous findings that increases in the ratio of negative to positive training instances greatly influenced most of the investigated parameters of the ML methods in simulated virtual screening experiments. However, the performance of screening was shown to also be highly dependent on the molecular library dimension. Generally, with the increasing size of the screened database, the optimal training ratio also increased, and this ratio can be rationalized using the proposed cost-effectiveness threshold approach. To increase the performance of machine learning-based virtual screening, the training set should be constructed in a way that considers the size of the screening database.	[Kurczab, Rafal; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland	Polish Academy of Sciences	Kurczab, R (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland.	kurczab@if-pan.krakow.pl	Bojarski, Andrzej/GSO-0213-2022	Kurczab, Rafal/0000-0002-9555-3905; Bojarski, Andrzej/0000-0003-1417-6333	 [2011/03/N/NZ2/02478];  [Pol-Nor/198887/73/2013]	; 	The following grants supported the research: 2011/03/N/NZ2/02478 and Pol-Nor/198887/73/2013.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j; Chuprina A, 2010, J CHEM INF MODEL, V50, P470, DOI 10.1021/ci900464s; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Heikamp K, 2013, J CHEM INF MODEL, V53, P1595, DOI 10.1021/ci4002712; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kalliokoski T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061007; Krier M, 2006, J CHEM INF MODEL, V46, P512, DOI 10.1021/ci050352v; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Ma XH, 2008, J CHEM INF MODEL, V48, P1227, DOI 10.1021/ci800022e; Melville JL, 2009, COMB CHEM HIGH T SCR, V12, P332, DOI 10.2174/138620709788167980; Mitchell TM, 1997, MACHINE LEARNING ANN; Petrova T, 2012, MEDCHEMCOMM, V3, P571, DOI 10.1039/c2md00302c; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Provost F, 2000, P AAAI 2000 WORK IMB; Qiong Wei, 2013, PLOS ONE, P8; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Smusz S, 2013, CHEMOMETR INTELL LAB, V128, P89, DOI 10.1016/j.chemolab.2013.08.003; Smusz S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-17; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Voigt JH, 2001, J CHEM INF COMP SCI, V41, P702, DOI 10.1021/ci000150t; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707	29	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175410	10.1371/journal.pone.0175410	http://dx.doi.org/10.1371/journal.pone.0175410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384344	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900169
J	Paquin-Proulx, D; Greenspun, BC; Costa, EAS; Segurado, AC; Kallas, EG; Nixon, DF; Leal, FE				Paquin-Proulx, Dominic; Greenspun, Benjamin C.; Costa, Emanuela A. S.; Segurado, Aluisio C.; Kallas, Esper G.; Nixon, Douglas F.; Leal, Fabio E.			MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; HTLV-I; PROVIRAL LOAD; CYTOKINE EXPRESSION; INTERFERON-GAMMA; LEUKEMIA-VIRUS; HIV-INFECTION; TUBERCULOSIS; METABOLITES; ACTIVATION	HTLV-1 infection is associated with several inflammatory disorders, including the neurode-generative condition HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It is unclear why a minority of infected subjects develop HAM/TSP. The cellular immune response has been implicated in the development of inflammatory alterations in these patients; however the pathogenic mechanisms for disease progression remain unclear. Furthermore, HTLV-1-infected individuals have an increase incidence of Mycobacterium tuberculosis (Mtb) infection, suggesting that immunological defect are associated with HTLV-1 infection. Evidence suggests an important role for Mucosal-associated invariant T (MAIT) cells in the early control of Mtb infection. Chronic viral infections like HIV and HCV have been associated with decreased frequency and functionality of MAIT cells. We hypothesized that HTLV-1 infection is associated with similar perturbations in MAIT cells. We investigated MAIT cell frequency, phenotype, and function by flow cytometry in a cohort of 10 asymptomatic and 10 HAM/TSP HTLV-1 infected patients. We found that MAIT cells from HTLV-1-infected subjects were reduced and showed high co-expression of the activation markers CD38 and HLA-DR but normal levels of CCR6 and CD127. MAIT cells had a lower expression of the transcription factor PLZF in HAM/TSP patients. Unlike Tax-specific CD8+T cells, which are hyperfunctional, MAIT cells from HTLV-1-infected subjects had a poor IFN gamma response following antigen stimulation. MAIT cell perturbations in HTLV-1 infection were not associated with HTLV-1 proviral load and MAIT cells were not infected by HTLV-1 in vivo. Rather, MAIT cells loss was associated with immune activation. Overall, our results do not support a role for MAIT cells in HAM/TSP pathogenesis but reduced numbers of MAIT cells, together with their poor functionality, could contribute to the increased susceptibility of HTLV-1-infected individuals to other infectious agents.	[Paquin-Proulx, Dominic; Greenspun, Benjamin C.; Nixon, Douglas F.; Leal, Fabio E.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Costa, Emanuela A. S.; Segurado, Aluisio C.; Kallas, Esper G.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil	George Washington University; Universidade de Sao Paulo	Paquin-Proulx, D (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	dpaquin_proulx@gwu.edu	Nixon, Douglas/AAU-5734-2020; Paquin-Proulx, Dominic/AFS-1852-2022; Segurado, Aluisio C/K-2229-2012	Nixon, Douglas/0000-0002-2801-1786; Paquin-Proulx, Dominic/0000-0003-1407-3414; Segurado, Aluisio C/0000-0002-6311-8036; Kallas, Esper/0000-0003-2026-6925	NIH [AI117970]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI117970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been facilitated by the services and resources provided by the District of Columbia Center for AIDS Research, an NIH funded program (AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith B, 2005, J GEN VIROL, V86, P1515, DOI 10.1099/vir.0.80766-0; Azakami K, 2009, BLOOD, V114, P3208, DOI 10.1182/blood-2009-02-203042; Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Bastos MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-199; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brito-Melo GEA, 2007, CLIN EXP IMMUNOL, V147, P35, DOI 10.1111/j.1365-2249.2006.03252.x; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1; Dias J, 2016, J LEUKOCYTE BIOL, V100, P233, DOI 10.1189/jlb.4TA0815-391RR; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Furuya T, 1999, J NEUROIMMUNOL, V95, P185, DOI 10.1016/S0165-5728(98)00263-X; Garlet GP, 2010, CLIN INFECT DIS, V50, pE11, DOI 10.1086/649871; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Goon PKC, 2004, J IMMUNOL, V172, P1735, DOI 10.4049/jimmunol.172.3.1735; Greene JM, 2016, MUCOSAL IMMUNOL; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Hengst J, 2016, EUR J IMMUNOL; Hengst J, 2016, EUR J IMMUNOL, V46, P2204, DOI 10.1002/eji.201646447; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2016, NAT IMMUNOL; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Marinho J, 2005, JAIDS-J ACQ IMM DEF, V40, P625, DOI 10.1097/01.qai.0000174252.73516.7a; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943; MORGAN OS, 1989, LANCET, V2, P1184; Nakamura H, 1997, ANN RHEUM DIS, V56, P167, DOI 10.1136/ard.56.3.167; Ndhlovu LC, 2009, CLIN EXP IMMUNOL, V158, P294, DOI 10.1111/j.1365-2249.2009.04019.x; Ndhlovu LC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001030; NISHIOKA K, 1989, LANCET, V1, P441; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; Grassi MFR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1428-z; Rocha MC, 2012, TISSUE ANTIGENS, V80, P143, DOI 10.1111/j.1399-0039.2012.01887.x; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Salou M, 2016, CLIN IMMUNOL, V166, P1, DOI 10.1016/j.clim.2016.03.014; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Treiner E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00503; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	50	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175345	10.1371/journal.pone.0175345	http://dx.doi.org/10.1371/journal.pone.0175345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384290	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900161
J	Aguilar, C; Castet, E				Aguilar, Carlos; Castet, Eric			Evaluation of a gaze-controlled vision enhancement system for reading in visually impaired people	PLOS ONE			English	Article							PREFERRED RETINAL LOCUS; SIMULATED SCOTOMAS; MACULAR DISEASE; EYE-MOVEMENTS; SPEED; FIELD; PSYCHOPHYSICS; COMPUTER; DEVICE; REHABILITATION	People with low vision, especially those with Central Field Loss (CFL), need magnification to read. The flexibility of Electronic Vision Enhancement Systems (EVES) offers several ways of magnifying text. Due to the restricted field of view of EVES, the need for magnification is conflicting with the need to navigate through text (panning). We have developed and implemented a real-time gaze-controlled system whose goal is to optimize the possibility of magnifying a portion of text while maintaining global viewing of the other portions of the text (condition 1). Two other conditions were implemented that mimicked commercially available advanced systems known as CCTV (closed-circuit television systems) D conditions 2 and 3. In these two conditions, magnification was uniformly applied to the whole text without any possibility to specifically select a region of interest. The three conditions were implemented on the same computer to remove differences that might have been induced by dissimilar equipment. A gaze-contingent artificial 10 degrees scotoma (a mask continuously displayed in real time on the screen at the gaze location) was used in the three conditions in order to simulate macular degeneration. Ten healthy subjects with a gaze-contingent scotoma read aloud sentences from a French newspaper in nine experimental one-hour sessions. Reading speed was measured and constituted the main dependent variable to compare the three conditions. All subjects were able to use condition 1 and they found it slightly more comfortable to use than condition 2 (and similar to condition 3). Importantly, reading speed results did not show any significant difference between the three systems. In addition, learning curves were similar in the three conditions. This proof of concept study suggests that the principles underlying the gaze-controlled enhanced system might be further developed and fruitfully incorporated in different kinds of EVES for low vision reading.	[Aguilar, Carlos] Nice Sophia Antipolis Univ, CNRS, BCL, Nice, France; [Castet, Eric] Aix Marseille Univ, CNRS, LPC, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Castet, E (corresponding author), Aix Marseille Univ, CNRS, LPC, Marseille, France.	eric.castet@univ-amu.fr			Essilor International	Essilor International	This work was supported by a Ph. D. grant from Essilor International (http://mvw.essilor.com/fr) to CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour O, 2001, OPTOMETRY VISION SCI, V78, P914, DOI 10.1097/00006324-200112000-00014; Aguilar C, 2011, VISION RES, V51, P997, DOI 10.1016/j.visres.2011.02.010; Ashmore Michael, 2005, P GRAPHICS INTERFACE, P203; Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAJURA M, 1992, COMP GRAPH, V26, P203, DOI 10.1145/142920.134061; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann PJ, 1996, VISION RES, V36, P3723, DOI 10.1016/0042-6989(96)00084-3; Bernard JB, 2007, VISION RES, V47, P3447, DOI 10.1016/j.visres.2007.10.005; Bernard JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152506; Bernard JB, 2012, VISION RES, V66, P17, DOI 10.1016/j.visres.2012.06.012; Bier E. A., 1993, Computer Graphics Proceedings, P73, DOI 10.1145/166117.166126; Burggraaff MC, 2012, INVEST OPHTH VIS SCI, V53, P2142, DOI 10.1167/iovs.11-8407; Burggraaff MC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-62; Buring T, 2006, P WORK C ADV VIS INT, P233; Calabrese A, 2016, INVEST OPHTH VIS SCI, V57, P3192, DOI 10.1167/iovs.16-19318; Calabrese A, 2014, INVEST OPHTH VIS SCI, V55, P3638, DOI 10.1167/iovs.13-13408; Calabrese A, 2011, INVEST OPHTH VIS SCI, V52, P2417, DOI 10.1167/iovs.09-5056; Calabrese A, 2010, INVEST OPHTH VIS SCI, V51, P1247, DOI 10.1167/iovs.09-3682; Carver R. P., 1990, READING RATE REV RES; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Chung STL, 2008, OPTOMETRY VISION SCI, V85, P827, DOI 10.1097/OPX.0b013e31818527ea; Chung STL, 2013, J NEUROSCI, V33, P18080, DOI 10.1523/JNEUROSCI.2764-13.2013; Chung STL, 2013, OPTOMETRY VISION SCI, V90, P520, DOI 10.1097/OPX.0b013e318294c2da; Chung STL, 2011, INVEST OPHTH VIS SCI, V52, P1164, DOI 10.1167/iovs.10-6034; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Crossland MD, 2006, VISION RES, V46, P590, DOI 10.1016/j.visres.2005.05.015; Crossland MD, 2014, OPHTHAL PHYSL OPT, V34, P552, DOI 10.1111/opo.12136; Crossland MD, 2011, RETINA-J RET VIT DIS, V31, P2109, DOI 10.1097/IAE.0b013e31820d3fba; Culham LE, 2004, OPHTHAL PHYSL OPT, V24, P281, DOI 10.1111/j.1475-1313.2004.00193.x; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; CUMMINGS RW, 1985, AM J OPTOM PHYS OPT, V62, P833; Dickinson CM, 2000, OPTOMETRY VISION SCI, V77, P364, DOI 10.1097/00006324-200007000-00011; Duchowski A.T, 2007, EYE TRACKING METHODO, DOI DOI 10.1007/978-3-319-57883-5; Duchowski AT, 2009, GAZE CONTINGENT DISP, P9; Elliott DB, 1997, INVEST OPHTH VIS SCI, V38, P2566; Fine EM, 1999, VISION RES, V39, P1039, DOI 10.1016/S0042-6989(98)00208-9; Fine EM, 1996, OPTOMETRY VISION SCI, V73, P533, DOI 10.1097/00006324-199608000-00003; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Goodrich G L, 2001, Optometry, V72, P519; Han P, 2013, J VIS, P13; Harland S, 1998, OPTOMETRY VISION SCI, V75, P183, DOI 10.1097/00006324-199803000-00023; Hicks SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067695; HO JS, 1995, P SOC PHOTO-OPT INS, V2488, P417, DOI 10.1117/12.211991; Husk JS, 2015, J VISION, V15, DOI 10.1167/15.1.17; Hwang AD, 2014, OPTOMETRY VISION SCI, V91, P1021, DOI 10.1097/OPX.0000000000000326; JACOB RJK, 1991, ACM T INFORM SYST, V9, P152, DOI 10.1145/123078.128728; JUDAY RD, 1994, P SOC PHOTO-OPT INS, V2239, P92, DOI 10.1117/12.179299; JUDAY RD, 1992, P SOC PHOTO-OPT INS, V1705, P304, DOI 10.1117/12.138465; Kwon M, 2012, OPTOMETRY VISION SCI, V89, P1374, DOI 10.1097/OPX.0b013e3182678e52; Legge GB, 2007, PSYCHOPHYSICS OF REA; Legge GE, 2011, J VISION, V11, DOI 10.1167/11.5.8; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; LOSHIN DS, 1989, OPTOMETRY VISION SCI, V66, P389, DOI 10.1097/00006324-198906000-00009; Lovie-Kitchin Jan E, 1999, Clin Exp Optom, V82, P214; Luo G, 2006, INVEST OPHTH VIS SCI, V47, P4152, DOI 10.1167/iovs.05-1672; Mele ML, 2012, DISABIL REHABIL-ASSI, V7, P261, DOI 10.3109/17483107.2011.635326; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Neelam K, 2009, SURV OPHTHALMOL, V54, P167, DOI 10.1016/j.survophthal.2008.12.003; Nguyen NX, 2009, ACTA OPHTHALMOL, V87, P849, DOI 10.1111/j.1755-3768.2008.01423.x; Ortiz A, 1999, OPTOMETRY VISION SCI, V76, P755, DOI 10.1097/00006324-199911000-00024; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Peli E, 2001, OPTOMETRY VISION SCI, V78, P304, DOI 10.1097/00006324-200105000-00014; Peterson RC, 2003, AM J OPHTHALMOL, V136, P1129, DOI 10.1016/S0002-9394(03)00567-1; Petre KL, 2000, OPTOMETRY VISION SCI, V77, P34, DOI 10.1097/00006324-200001000-00011; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; Robert J. K., 1993, ADV HUM-COMPUT INTER, V4, P151; Rolland JP, 2000, MEDICAL VISUALIZATIO, P287; Rubin GS, 2013, VISION RES, V90, P43, DOI 10.1016/j.visres.2013.02.015; Rubin GS, 2001, EYE, V15, P430, DOI 10.1038/eye.2001.148; Saunders DR, 2013, BEHAV RES METHODS, P1; Scherlen AC, 2008, VISION RES, V48, P1870, DOI 10.1016/j.visres.2008.06.005; Seiple W, 2005, INVEST OPHTH VIS SCI, V46, P2886, DOI 10.1167/iovs.04-1296; Shardlow M, 2014, INT J ADV COMPUT SCI, V4, DOI 10.14569/Speciallssue.2014.040109; Siddharthan Advaith, 2014, INT J APPL LINGUISTI, V165, P259, DOI DOI 10.1075/ITL.165.2.06SID; Stellmach S., 2011, P C NOV GAZ CONTR AP, DOI [10.1145/1983302.1983303, DOI 10.1145/1983302.1983303]; Stellmach Sophie, 2012, P S EYE TRACK RES AP, P357, DOI [10.1145/2168556.2168636, DOI 10.1145/2168556.2168636]; Tarita-Nistor L, 2014, OPTOMETRY VISION SCI, V91, P86, DOI 10.1097/OPX.0000000000000108; Thiede C, 2008, LECT NOTES COMPUT SC, V5166, P178, DOI 10.1007/978-3-540-85412-8_16; Timberlake GT, 2006, J REHABIL RES DEV, V43, P749, DOI 10.1682/JRRD.2005.06.0102; Timberlake GT, 2005, OPTOMETRY VISION SCI, V82, P177, DOI 10.1097/01.OPX.0000156311.49058.C8; TIMBERLAKE GT, 1987, INVEST OPHTH VIS SCI, V28, P1268; Van Krevelen D., 2010, INT J VIRT REAL, V9, P1, DOI DOI 10.20870/IJVR.2010.9.2.2767; Velichkovsky BB, 2014, PROCEDIA COMPUT SCI, V39, P75, DOI 10.1016/j.procs.2014.11.012; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; WHITTAKER SG, 1993, OPTOMETRY VISION SCI, V70, P54, DOI 10.1097/00006324-199301000-00010; Wiecek E, 2012, INVEST OPHTH VIS SCI, V53, P6600, DOI 10.1167/iovs.12-10012; Wolffsohn JS, 2003, OPHTHAL PHYSL OPT, V23, P35, DOI 10.1046/j.1475-1313.2003.00087.x; Woods R. L., 2003, Journal of the Society for Information Display, V11, P191, DOI 10.1889/1.1831704; Woods RL, 2011, OPHTHAL PHYSL OPT, V31, P258, DOI 10.1111/j.1475-1313.2011.00833.x; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006; Yu DY, 2010, VISION RES, V50, P36, DOI 10.1016/j.visres.2009.10.005; Zhai Shumin, 1999, P SIGCHI C HUMAN FAC, P246, DOI DOI 10.1145/302979.303053; Zuur Alain F., 2009, P1	98	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174910	10.1371/journal.pone.0174910	http://dx.doi.org/10.1371/journal.pone.0174910			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380004	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500077
J	Chang, YF; Broyles, CN; Brook, FA; Davies, MJ; Turtle, CW; Nagai, T; Daniels, MJ				Chang, Yu-Fen; Broyles, Connor N.; Brook, Frances A.; Davies, Mark J.; Turtle, Cameron W.; Nagai, Takeharu; Daniels, Matthew J.			Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics	PLOS ONE			English	Article							GENETICALLY ENCODED CALCIUM; IN-VIVO; CA2+ INDICATORS; LIGHT; ELECTROPHYSIOLOGY; ARRHYTHMIAS; SECRETION; CHANNELS; ATRIAL; MUSCLE	Identification of drug induced electrical instability of the heart curtails development, and introduction, of potentially proarrhythmic drugs. This problem usually requires complimentary contact based approaches such as patch-clamp electrophysiology combined with field stimulation electrodes to observe and control the cell. This produces data with high signal to noise but requires direct physical contact generally preventing high-throughput, or prolonged, phenotyping of single cells or tissues. Combining genetically encoded optogenetic control and spectrally compatible calcium indicator tools into a single adenoviral vector allows the analogous capability for cell control with simultaneous cellular phenotyping without the need for contact. This combination can be applied to single rodent primary adult cardiomyocytes, and human stem cell derived cardiomyocytes, enabling contactless small molecule evaluation for inhibitors of sodium, potassium and calcium channels suggesting it may be useful for early toxicity work. In pancreatic beta-cells it reveals the effects of glucose and the KATP inhibitor gliclazide.	[Chang, Yu-Fen; Broyles, Connor N.; Brook, Frances A.; Davies, Mark J.; Turtle, Cameron W.; Daniels, Matthew J.] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Nagai, Takeharu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Nagai, Takeharu] Osaka Univ, Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Dept Biomol Sci & Engn, Ibaraki, Osaka, Japan; [Daniels, Matthew J.] Oxford Univ NHS Hosp Trust, Dept Cardiol, Oxford, England; [Daniels, Matthew J.] Univ Oxford, BHF Ctr Regenerat Med, Oxford, England; [Chang, Yu-Fen] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Turtle, Cameron W.] BridgeBio Pharmaceut, Pala Alto, CA USA	University of Oxford; Osaka University; Osaka University; Osaka University; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Taipei Veterans General Hospital	Daniels, MJ (corresponding author), Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England.; Daniels, MJ (corresponding author), Oxford Univ NHS Hosp Trust, Dept Cardiol, Oxford, England.; Daniels, MJ (corresponding author), Univ Oxford, BHF Ctr Regenerat Med, Oxford, England.	matthew.daniels@cardiov.ox.ac.uk		Nagai, Takeharu/0000-0003-2650-9895; Daniels, Matthew/0000-0002-9250-6214	Wellcome Trust [WT098519MA]; BHF Centre of Excellence award to Oxford University [RE/08/004/23915, RE/13/1/30181]; 'JSTSENTAN'; MEXT Scientific Research on Innovative Areas [3306]; JSPS Core-to Core Program	Wellcome Trust(Wellcome TrustEuropean Commission); BHF Centre of Excellence award to Oxford University; 'JSTSENTAN'(Japan Science & Technology Agency (JST)); MEXT Scientific Research on Innovative Areas; JSPS Core-to Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Work in MJD's lab is supported by the Wellcome Trust (WT098519MA) YFC was supported by a pump priming grant from the BHF Centre of Excellence award to Oxford University (RE/08/004/23915 & RE/13/1/30181). CT was a Rhodes Scholar. Mark Davies is an NIHR clinical academic trainee. TN is supported by 'JSTSENTAN', the MEXT Scientific Research on Innovative Areas, 'Spying minority in biological phenomena' (No. 3306) and the JSPS Core-to Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; ATTWELL D, 1981, J PHYSIOL-LONDON, V313, P439, DOI 10.1113/jphysiol.1981.sp013675; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Bingen BO, 2014, CARDIOVASC RES, V104, P194, DOI 10.1093/cvr/cvu179; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Burton RAB, 2015, NAT PHOTONICS, V9, P813, DOI [10.1038/NPHOTON.2015.196, 10.1038/nphoton.2015.196]; Chen Z, 2016, EUR HEART J; Colatsky T, 2016, J PHARM TOXICOL METH; Dempsey GT, 2016, J PHARM TOXICOL METH; Doss MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040288; Du DTM, 2015, BIOPHYS J, V108, P1, DOI 10.1016/j.bpj.2014.11.008; Gassanov N, 2008, DIFFERENTIATION, V76, P971, DOI 10.1111/j.1432-0436.2008.00283.x; Giudicessi JR, 2012, NAT REV CARDIOL, V9, P319, DOI 10.1038/nrcardio.2012.3; Harmer SC, 2016, BIOL CHEM, V397, P679, DOI 10.1515/hsz-2015-0306; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Inagaki S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42398; Jia ZH, 2011, CIRC-ARRHYTHMIA ELEC, V4, P753, DOI 10.1161/CIRCEP.111.964247; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; Kushibiki T, 2015, GENE THER, V22, P553, DOI 10.1038/gt.2015.23; Levy RL, 1922, J AMER MED ASSOC, V79, P1108, DOI 10.1001/jama.1922.02640140020008; Leyton-Mange JS, 2014, STEM CELL REP, V2, P163, DOI 10.1016/j.stemcr.2014.01.003; Melgari D, 2015, J MOL CELL CARDIOL, V86, P42, DOI 10.1016/j.yjmcc.2015.06.021; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nussinovitch U, 2015, NAT BIOTECHNOL, V33, P750, DOI 10.1038/nbt.3268; Reinbothe TM, 2014, ISLETS, V6, DOI 10.4161/isl.28095; Rodriguez B, 2015, EUROPACE; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schwartz PJ, 2016, J AM COLL CARDIOL, V67, P1639, DOI 10.1016/j.jacc.2015.12.063; Shinnawi R, 2015, STEM CELL REP, V5, P582, DOI 10.1016/j.stemcr.2015.08.009; Sinnecker D, 2014, PHARMACOL THERAPEUT, V143, P246, DOI 10.1016/j.pharmthera.2014.03.004; Spencer CI, 2014, STEM CELL REP, V3, P269, DOI 10.1016/j.stemcr.2014.06.003; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yajuan Xiao, 2012, Curr Chem Genomics, V6, P87, DOI 10.2174/1875397301206010087; Yu JZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16542; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174181	10.1371/journal.pone.0174181	http://dx.doi.org/10.1371/journal.pone.0174181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379974	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500036
J	Christian, LM; Young, AS; Mitchell, AM; Belury, MA; Gracious, BL; Arnold, LE; Fristad, MA				Christian, Lisa M.; Young, Andrea S.; Mitchell, Amanda M.; Belury, Martha A.; Gracious, Barbara L.; Arnold, L. Eugene; Fristad, Mary A.			Body weight affects omega-3 polyunsaturated fatty acid (PUFA) accumulation in youth following supplementation in post-hoc analyses of a randomized controlled trial	PLOS ONE			English	Article							PREGNANCY OUTCOMES; BIPOLAR DISORDER; RISK PREGNANCIES; GROWTH MEASURES; BLOOD-PRESSURE; METAANALYSIS; CHILDHOOD; CHILDREN; WOMEN; BIRTH	Guidelines for suggested intake of omega-3 polyunsaturated fatty acids (PUFAs) are limited in youth and rely primarily on age. However, body weight varies considerably within age classifications. The current analyses examined effects of body weight and body mass index (BMI) on fatty acid accumulation in 64 youth (7-14 years) with a diagnosed mood disorder in a double-blind randomized-controlled trial (2000 mg w-3 supplements or a control capsule) across 12 weeks. Weight and height were measured at the first study visit and EPA and DHA levels were determined using fasting blood samples obtained at both the first and end of-study visits. In the w-3 supplementation group, higher baseline body weight predicted less plasma accumulation of both EPA [B =-0.047, (95% CI =-0.077;-0.017), omega =-0.54, p = 0.003] and DHA [B =-0.02, (95% CI =-0.034;-0.007), omega =-0.52, p = 0.004]. Similarly, higher BMI percentile as well as BMI category (underweight, normal weight, overweight/obese) predicted less accumulation of EPA and DHA (ps<0.01). Adherence to supplementation was negatively correlated with BMI percentile [B =-0.002 (95% CI =-0.004; 0.00), omega =-0.44, p = 0.019], but did not meaningfully affect observed associations. As intended, the control supplement exerted no significant effect on plasma levels of relevant fatty acids regardless of youth body parameters. These data show strong linear relationships of both absolute body weight and BMI percentile with omega-3 PUFA accumulation in youth. A dose-response effect was observed across the BMI spectrum. Given increasing variability in weight within BMI percentile ranges as youth age, dosing based on absolute weight should be considered. Moreover, effects of weight should be incorporated into statistical models in studies examining clinical effects of omega-3 PUFAs in youth as well as adults, as weight-related differences in effects may contribute meaningfully to inconsistencies in the current literature.	[Christian, Lisa M.; Mitchell, Amanda M.; Gracious, Barbara L.; Arnold, L. Eugene; Fristad, Mary A.] Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.; Mitchell, Amanda M.] Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.; Fristad, Mary A.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Young, Andrea S.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Belury, Martha A.; Fristad, Mary A.] Ohio State Univ, Dept Human Sci, Program Nutr, Columbus, OH 43210 USA; [Gracious, Barbara L.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Johns Hopkins University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Christian, LM (corresponding author), Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH USA.	Lisa.Christian@osumc.edu	Young, Andrea/D-8766-2015; Fristad, Mary A/AAW-6472-2021; Christian, Lisa/E-2892-2011	Young, Andrea/0000-0002-8486-0643; Christian, Lisa/0000-0001-5571-050X	National Institute of Mental Health [R034 MH090148, R034 MH85875]; Ohio State University Clinical Research Center - National Center for Research Resources [UL1TR001070]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ohio State University Clinical Research Center - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grants from the National Institute of Mental Health (R034 MH090148 & R034 MH85875). The project described was supported by the Ohio State University Clinical Research Center, funded by the National Center for Research Resources (UL1TR001070). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the preparation or decision to submit the paper for publication.	Belury MA, 1997, LIPIDS, V32, P199, DOI 10.1007/s11745-997-0025-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Clayton EH, 2009, EUR J CLIN NUTR, V63, P1037, DOI 10.1038/ejcn.2008.81; Drotar D, 2009, J DEV BEHAV PEDIATR, V30, P574, DOI 10.1097/DBP.0b013e3181c3c3bb; Forsyth JS, 2003, BRIT MED J, V326, P953, DOI 10.1136/bmj.326.7396.953; Freedman David S, 2007, MedGenMed, V9, P26; Fristad M. A., J CLIN CHILD ADOLESC; Fristad MA, 2015, J CHILD ADOL PSYCHOP, V25, P764, DOI 10.1089/cap.2015.0132; Global Oranization for EPA and DHA Omega-35, 2014, GLOBAL RECOMMEDATION; Gould JF, 2013, AM J CLIN NUTR, V97, P531, DOI 10.3945/ajcn.112.045781; Gracious BL, 2006, BIPOLAR DISORD, V12, P124; Harris WS, 2010, CLIN BIOCHEM, V43, P338, DOI 10.1016/j.clinbiochem.2009.08.016; Horvath A, 2007, BRIT J NUTR, V98, P253, DOI 10.1017/S0007114507709078; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Jiao JJ, 2014, AM J CLIN NUTR, V100, P1422, DOI 10.3945/ajcn.114.095315; Klemens CM, 2011, BJOG-INT J OBSTET GY, V118, P916, DOI 10.1111/j.1471-0528.2010.02846.x; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; National Center for Chronic Disease Prevention and Health Promotion, USING BMI FOR AGE AS; Nemets H, 2006, AM J PSYCHIAT, V163, P1098, DOI 10.1176/appi.ajp.163.6.1098; Ogden CL, 2010, NCHS DATA BRIEF, P1, DOI DOI 10.2011/01/08:1-8; Ogden Cynthia L, 2004, Adv Data, P1; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Page GG, 2005, AACN ADV CRIT CARE, V16, P302, DOI 10.1097/00044067-200507000-00004; Pedersen MH, 2010, J PEDIATR-US, V157, P395, DOI 10.1016/j.jpeds.2010.04.001; SHANTHA NC, 1993, J AOAC INT, V76, P644; SIMOPOULOS AP, 1989, J NUTR, V119, P521, DOI 10.1093/jn/119.4.521; Skilton MR, 2013, HYPERTENSION, V61, P972, DOI 10.1161/HYPERTENSIONAHA.111.01030; Szajewska H, 2006, AM J CLIN NUTR, V83, P1337, DOI 10.1093/ajcn/83.6.1337; Vesco AT, 2015, J CHILD ADOL PSYCHOP, V25, P526, DOI 10.1089/cap.2013.0141; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wozniak J, 2007, EUR NEUROPSYCHOPHARM, V17, P440, DOI 10.1016/j.euroneuro.2006.11.006; Yee LD, 2010, AM J CLIN NUTR, V91, P1185, DOI 10.3945/ajcn.2009.29036; Young AS, J CLIN CHILD ADOLESC	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173087	10.1371/journal.pone.0173087	http://dx.doi.org/10.1371/journal.pone.0173087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379964	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500011
J	Kos, S; Blagus, T; Cemazar, M; Filipic, G; Sersa, G; Cvelbar, U				Kos, Spela; Blagus, Tanja; Cemazar, Maja; Filipic, Gregor; Sersa, Gregor; Cvelbar, Uros			Safety aspects of atmospheric pressure helium plasma jet operation on skin: In vivo study on mouse skin	PLOS ONE			English	Article							BARRIER DISCHARGE; MEDICINE; SURFACE	Biomedical applications of plasma require its efficacy for specific purposes and equally importantly its safety. Herein the safety aspects of cold plasma created with simple atmospheric pressure plasma jet produced with helium gas and electrode discharge are evaluated in skin damage on mouse, at different duration of exposure and gas flow rates. The extent of skin damage and treatments are systematically evaluated using stereomicroscope, labelling with fluorescent dyes, histology, infrared imaging and optical emission spectroscopy. The analyses reveal early and late skin damages as a consequence of plasma treatment, and are attributed to direct and indirect effects of plasma. The results indicate that direct skin damage progresses with longer treatment time and increasing gas flow rates which reflect changes in plasma properties. With increasing flow rates, the temperature on treated skin grows and the RONS formation rises. The direct effects were plasma treatment dependent, whereas the disclosed late D secondary effects were more independent on discharge parameters and related to diffusion of RONS species. Thermal effects and skin heating are related to plasma-coupling properties and are separated from the effects of other RONS. It is demonstrated that cumulative topical treatment with helium plasma jet could lead to skin damage. How these damages can be mitigated is discussed in order to provide guidance, when using atmospheric pressure plasma jets for skin treatments.	[Kos, Spela; Blagus, Tanja; Cemazar, Maja; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Filipic, Gregor; Cvelbar, Uros] Jozef Stefan Inst, Ljubljana, Slovenia	Institute of Oncology - Slovenia; University of Primorska; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.; Cvelbar, U (corresponding author), Jozef Stefan Inst, Ljubljana, Slovenia.	gsersa@onko-i.si; uros.cvelbar@ijs.si	Cvelbar, Uros/AAE-7916-2019; Filipič, Gregor/T-4900-2018	Filipič, Gregor/0000-0003-0153-5181; Cvelbar, Uros/0000-0002-1957-0789	Javna Agencija za Raziskovalno Dejavnost RS [P3-0003]; Javna Agencija za Raziskovalno Dejavnost (Uros Cvelbar); North Atlantic Treaty Organization [SPS.984555]; Javna Agencija za Raziskovalno Dejavnost [N3-0059]; Flanders (FWO)	Javna Agencija za Raziskovalno Dejavnost RS(Slovenian Research Agency - Slovenia); Javna Agencija za Raziskovalno Dejavnost (Uros Cvelbar); North Atlantic Treaty Organization(NATO (North Atlantic Treaty Organisation)); Javna Agencija za Raziskovalno Dejavnost; Flanders (FWO)(FWO)	This work was supported by Javna Agencija za Raziskovalno Dejavnost RS (P3-0003); Javna Agencija za Raziskovalno Dejavnost (Uros Cvelbar); North Atlantic Treaty Organization (SPS.984555); Flanders (FWO) and Javna Agencija za Raziskovalno Dejavnost (N3-0059).	Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Brisset JL, 2012, PLASMA CHEM PLASMA P, V32, P655, DOI 10.1007/s11090-012-9384-x; Buxadera-Palomero J, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4913376; Chernets N, 2015, PLASMA PROCESS POLYM, V12, P1400, DOI 10.1002/ppap.201500140; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Dunnill C, 2015, INT WOUND J; Duval A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083001; Foletto M, 2014, IEEE T PLASMA SCI, V42, P2436, DOI 10.1109/TPS.2014.2331393; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Isbary G, 2013, CLIN PLASMA MED, V1, P36, DOI 10.1016/j.cpme.2012.10.001; Judee F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21421; Kalghatgi S, 2009, TOXICITY DIRECT NONT, P1124; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/3/033001; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Kong M. G., 2009, NEW J PHYS, V11; Kuo SP, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115016; Laroussi M, 2007, PLASMA PROCESS POLYM, V4, P777, DOI 10.1002/ppap.200700066; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001; Pei X, 2016, PLASMA SOURCES SCI T, V25, DOI 10.1088/0963-0252/25/3/035013; Potter MJ, 2007, ANN PLAS SURG, V58, P608, DOI 10.1097/01.sap.0000252481.84134.fe; Reuter S, 2012, IEEE T PLASMA SCI, V40, P2986, DOI 10.1109/TPS.2012.2207130; Robert E, 2014, PLASMA SOURCES SCI T, V23; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Rumbach P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8248; Van der Paal J, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/15/155202; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0; Winter J., 2014, J PHYS D, V47; Yonemori S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/12/125401; Zaplotnik R, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/25001; Zaplotnik R, 2015, SPECTROCHIM ACTA B, V103, P124, DOI 10.1016/j.sab.2014.12.004; Zhou RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155584	43	36	37	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174966	10.1371/journal.pone.0174966	http://dx.doi.org/10.1371/journal.pone.0174966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379998	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500080
J	Latomme, J; Cardon, G; De Bourdeaudhuij, I; Lotova, V; Koletzko, B; Socha, P; Moreno, L; Androutsos, O; Manios, Y; De Craemer, M				Latomme, Julie; Cardon, Greet; De Bourdeaudhuij, Ilse; Lotova, Violeta; Koletzko, Berthold; Socha, Piotr; Moreno, Luis; Androutsos, Odysseas; Manios, Yannis; De Craemer, Marieke		ToyBox-Study Grp	Effect and process evaluation of a kindergarten-based, family-involved intervention with a randomized cluster design on sedentary behaviour in 4-to 6-year old European preschool children: The ToyBox-study	PLOS ONE			English	Article							SCHOOL-BASED INTERVENTIONS; MEASURED PHYSICAL-ACTIVITY; BALANCE-RELATED BEHAVIORS; ACTIVE PLAY INTERVENTION; PREVENT OBESITY; HEALTH-PROMOTION; EARLY CHILDHOOD.; CONTROLLED-TRIAL; TIME; PARENTS	Background The aim of the present study evaluated the effect and process of the ToyBox-intervention on proxy-reported sedentary behaviours in 4-to 6-year-old preschoolers from six European countries. Methods In total, 2434 preschoolers' parents/primary caregivers (mean age: 4.7 +/- 0.4 years, 52.2% boys) filled out a questionnaire, assessing preschoolers' sedentary behaviours (TV/DVD/ video viewing, computer/video games use and quiet play) on weekdays and weekend days. Multilevel repeated measures analyses were conducted to measure the intervention effects. Additionally, process evaluation data were included to better understand the intervention effects. Results Positive intervention effects were found for computer/video games use. In the total sample, the intervention group showed a smaller increase in computer/video games use on weekdays (beta = -3.40, p = 0.06; intervention: +5.48 min/day, control: + 8.89 min/day) and on weekend days (beta = -5.97, p = 0.05; intervention: +9.46 min/day, control: +15.43 min/day) from baseline to follow-up, compared to the control group. Country-specific analyses showed similar effects in Belgium and Bulgaria, while no significant intervention effects were found in the other countries. Process evaluation data showed relatively low teachers' and low parents' process evaluation scores for the sedentary behaviour component of the intervention (mean: 15.6/ 24, range: 2.5-23.5 and mean: 8.7/17, range: 0-17, respectively). Higher parents' process evaluation scores were related to a larger intervention effect, but higher teachers' process evaluation scores were not. Conclusions The ToyBox-intervention had a small, positive effect on European preschoolers' computer/ video games use on both weekdays and weekend days, but not on TV/DVD/video viewing or quiet play. The lack of larger effects can possibly be due to the fact that parents were only passively involved in the intervention and to the fact that the intervention was too demanding for the teachers. Future interventions targeting preschoolers' behaviours should involve parents more actively in both the development and the implementation of the intervention and, when involving schools, less demanding activities for teachers should be developed.	[Latomme, Julie; Cardon, Greet; De Bourdeaudhuij, Ilse; De Craemer, Marieke] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Lotova, Violeta] Med Univ Varna, Clin Paediat Endocrinol, Varna, Bulgaria; [Koletzko, Berthold] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Munich, Germany; [Socha, Piotr] Childrens Mem Inst, Warsaw, Poland; [Moreno, Luis] Univ Zaragoza, GENUD Growth Exercise Drinking Behav & Dev, Zaragoza, Spain; [Androutsos, Odysseas; Manios, Yannis] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece	Ghent University; Medical University Varna; University of Munich; Children's Memorial Health Institute; University of Zaragoza; Harokopio University Athens	Cardon, G (corresponding author), Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium.	greet.cardon@ugent.be	De Craemer, Marieke/P-6072-2016; Radkova, Zhaneta/AAM-1538-2020; Gibson, Leigh/B-5010-2010; Moreno, Luis/S-1780-2019; Androutsos, Odysseas/ABF-8670-2021; De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Craemer, Marieke/Z-3050-2019; Manios, Yannis/AAM-8953-2021	Radkova, Zhaneta/0000-0003-2007-8019; Gibson, Leigh/0000-0002-9789-7429; Moreno, Luis/0000-0003-0454-653X; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Manios, Yannis/0000-0001-6486-114X; Iotova, Violeta/0000-0003-4160-1200; Socha, Piotr/0000-0002-1621-464X; Ward, Dianne Stanton/0000-0001-6389-0168; Cardon, Greet/0000-0003-4983-6557; Gozdz, Magdalena/0000-0002-9753-568X; Gurzkowska, Beata/0000-0003-2681-3221; Kulaga, Zbigniew/0000-0003-0509-1004	European Commission [245200]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The ToyBox-study is funded by the Seventh Framework Programme (GORDIS FP7) of the European Commission under grant agreement no 245200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ToyBox-study is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission under grant agreement no 245200. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein.	Androutsos O, 2014, OBES REV, V15, P74, DOI 10.1111/obr.12185; Androutsos O, 2014, OBES REV, V15, P48, DOI 10.1111/obr.12182; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bartholomew LK, 2011, PLANNING HLTH PROMOT; Biddle SJH, 2014, BRIT J SPORT MED, V48, P182, DOI 10.1136/bjsports-2013-093078; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug J, 2012, PLOS ONE, V7; Cardon G, 2016, PLOS ONE, V11; De Bourdeaudhuij I, 2011, OBES REV, V12, P205, DOI 10.1111/j.1467-789X.2009.00711.x; De Craemer M, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0325-y; De Craemer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118303; De Craemer M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-38; De Decker E, 2012, OBES REV, V13, P75, DOI 10.1111/j.1467-789X.2011.00961.x; De Decker E, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-19; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dennison BA, 2004, ARCH PEDIAT ADOL MED, V158, P170, DOI 10.1001/archpedi.158.2.170; Department of Health and Ageing, GET UP AND GROW HEAL; Department of Health Physical Activity Health Improvement and Protection, START ACT STAY ACT R; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Flynn MAT, 2006, OBES REV, V7, P7, DOI 10.1111/j.1467-789X.2006.00242.x; Gonzalez-Gil EM, 2014, OBES REV, V15, P61, DOI 10.1111/obr.12184; Han SS, 2005, J ABNORM CHILD PSYCH, V33, P665, DOI 10.1007/s10802-005-7646-2; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Jordan AB, 2006, PEDIATRICS, V118, pE1303, DOI 10.1542/peds.2006-0732; Kipping RR, 2012, J PUBLIC HEALTH-UK, V34, P236, DOI 10.1093/pubmed/fdr076; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Leigh BC, 1998, J CLIN EPIDEMIOL, V51, P119, DOI 10.1016/S0895-4356(97)00262-X; Manios Y, 2014, OBES REV, V15, P5, DOI 10.1111/obr.12175; Manios Y, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2011.00977.x; Manios Y, 2012, OBES REV, V13, P3, DOI 10.1111/j.1467-789X.2011.00974.x; Marshall SJ, 2011, AM J LIFESTYLE MED, V5, P518, DOI 10.1177/1559827610395487; Moens E, 2007, J PEDIATR PSYCHOL, V32, P52, DOI 10.1093/jpepsy/jsl011; Moens E, 2012, BEHAV COGN PSYCHOTH, V40, P1, DOI 10.1017/S1352465811000403; Nock MK, 2005, J CONSULT CLIN PSYCH, V73, P872, DOI 10.1037/0022-006X.73.5.872; O'Dwyer MV, 2013, HEALTH EDUC RES, V28, P931, DOI 10.1093/her/cyt097; O'Dwyer MV, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-117; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pine CM, 2000, INT DENT J S, P312; Pinket AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152928; Pinket AS, 2015, PUBLIC HEALTH NUTR, P1; Rosen L, 2006, AM J PUBLIC HEALTH, V96, P1181, DOI 10.2105/AJPH.2004.061713; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sallis JF, 2008, ECOLOGICAL MODELS HL; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Sharma M, 2007, OBES REV, V8, P155, DOI 10.1111/j.1467-789X.2006.00268.x; Tones K, 2000, PATIENT EDUC COUNS, V39, P227, DOI 10.1016/S0738-3991(99)00035-X; Verloigne M, 2015, OBES REV, V16, P89, DOI 10.1111/obr.12353; WHITE KR, 1992, REV EDUC RES, V62, P91, DOI 10.3102/00346543062001091; Wilcox S, 2010, CONTEMP CLIN TRIALS, V31, P323, DOI 10.1016/j.cct.2010.03.011	50	14	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172730	10.1371/journal.pone.0172730	http://dx.doi.org/10.1371/journal.pone.0172730			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380053	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000399353500008
J	Ma, B; Xu, JK; Wu, WJ; Liu, HY; Kou, CK; Liu, N; Zhao, LL				Ma, Bin; Xu, Jia-ke; Wu, Wen-jing; Liu, Hong-yan; Kou, Cheng-kun; Liu, Na; Zhao, Lulu			Survey of basic medical researchers on the awareness of animal experimental designs and reporting standards in China	PLOS ONE			English	Article							QUALITY; BIAS	Objective To investigate the awareness and use of the Systematic Review Center for Laboratory Animal Experimentation's (SYRCLE) risk-of-bias tool, the Animal Research: Reporting of In Vivo Experiments (ARRIVE) reporting guidelines, and Gold Standard Publication Checklist (GSPC) in China in basic medical researchers of animal experimental studies. Methods A national questionnaire-based survey targeting basic medical researchers was carried in China to investigate the basic information and awareness of SYRCLE's risk of bias tool, ARRIVE guidelines, GSPC, and animal experimental bias risk control factors. The EpiData3.1 software was used for data entry, and Microsoft Excel 2013 was used for statistical analysis in this study. The number of cases (n) and percentage (%) of classified information were statistically described, and the comparison between groups (i.e., current students vs. research staff) was performed using chi-square test. Results A total of 298 questionnaires were distributed, and 272 responses were received, which included 266 valid questionnaires (from 118 current students and 148 research staff). Among the 266 survey participants, only 15.8% was aware of the SYRCLE's risk of bias tool, with significant difference between the two groups (P = 0.003), and the awareness rates of ARRIVE guidelines and GSPC were only 9.4% and 9.0%, respectively; 58.6% survey participants believed that the reports of animal experimental studies in Chinese literature were inadequate, with significant difference between the two groups (P = 0.004). In addition, only approximately 1/3 of the survey participants had read systematic reviews and meta-analysis reports of animal experimental studies; only 16/266 (6.0%) had carried out/participated in and 11/266 (4.1%) had published systematic reviews/meta-analysis of animal experimental studies. Conclusions The awareness and use rates of SYRCLE's risk-of-bias tool, the ARRIVE guidelines, and the GSPC were low among Chinese basic medical researchers. Therefore, specific measures are necessary to promote and popularize these standards and specifications and to introduce these standards into guidelines of Chinese domestic journals as soon as possible to raise awareness and increase use rates of researchers and journal editors, thereby improving the quality of animal experimental methods and reports.	[Ma, Bin; Xu, Jia-ke; Wu, Wen-jing; Liu, Hong-yan; Kou, Cheng-kun; Liu, Na; Zhao, Lulu] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China; [Ma, Bin] Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China; [Xu, Jia-ke; Zhao, Lulu] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University	Ma, B (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China.; Ma, B (corresponding author), Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China.	kitty_mab@163.com			National Natural Science Foundation of China [81303147]; Fundamental Research Funds for the Central Universities [lzujblry-201667]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The Project is Supported by National Natural Science Foundation of China (Grant No. 81303147) and the Fundamental Research Funds for the Central Universities(Number: lzujblry-201667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白皙 Bai Xi], 2016, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V16, P1020; Bebarta V, 2003, ACAD EMERG MED, V10, P1410; Beynen A. C., 2001, PRINCIPLES LAB ANIMA, V2nd; BRUGUEROLLE B, 1983, EUR J DRUG METAB PH, V8, P233, DOI 10.1007/BF03188753; BRUGUEROLLE B, 1983, THERAPIE, V38, P223; [陈匡阳 Chen Kuangyang], 2014, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V14, P1281; CLOUGH G, 1982, BIOL REV, V57, P487, DOI 10.1111/j.1469-185X.1982.tb00705.x; Clough G, 1984, STANDARDS LAB ANIMAL, V1, P7; DONNELLY H, 1993, LAB ANIM, V27, P385, DOI 10.1258/002367793780745598; [方泽萍 Fang Zeping], 2015, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V15, P797; Hess KR, 2011, CANCER RES, V71, P625, DOI 10.1158/0008-5472.CAN-10-3296; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hooijmans C, 2011, LAB ANIM-UK, V45, P61, DOI 10.1258/la.2010.010130; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Johnston NA, 2010, HDB LAB ANIMAL SCI, P343, DOI [10.1201/b10416-13, DOI 10.1201/B10416-13]; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Liu YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154657; MARRINO P, 1987, BIOCHIM BIOPHYS ACTA, V920, P277, DOI 10.1016/0005-2760(87)90105-6; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Sandercock P, 2002, LANCET, V360, P586, DOI 10.1016/S0140-6736(02)09812-4; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; VANDERSCHUREN LJMJ, 1995, PHYSIOL BEHAV, V58, P119, DOI 10.1016/0031-9384(94)00385-I; Yali L, 2011, CHINESE J EVIDENCE B, V6, P233	28	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174530	10.1371/journal.pone.0174530	http://dx.doi.org/10.1371/journal.pone.0174530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380050	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500052
J	Spoelstra-de Man, AME; Smorenberg, A; Groeneveld, ABJ				Spoelstra-de Man, Angelique M. E.; Smorenberg, Annemieke; Groeneveld, A. B. Johan			Different effects of fluid loading with saline, gelatine, hydroxyethyl starch or albumin solutions on acid-base status in the critically ill	PLOS ONE			English	Article							LACTATED RINGERS SOLUTION; ABDOMINAL AORTIC-ANEURYSM; MAJOR VASCULAR-SURGERY; DOUBLE-BLIND CROSSOVER; 0.9-PERCENT SALINE; HEALTHY-VOLUNTEERS; PULMONARY PERMEABILITY; CARDIAC RESPONSE; RESPONSIVENESS; INFUSIONS	Introduction Fluid administration in critically ill patients may affect acid-base balance. However, the effect of the fluid type used for resuscitation on acid-base balance remains controversial. Methods We studied the effect of fluid resuscitation of normal saline and the colloids gelatine 4%, hydroxyethyl starch (HES) 6%, and albumin 5% on acid-base balance in 115 clinically hypovolemic critically ill patients during a 90 minute filling pressure-guided fluid challenge by a post-hoc analysis of a prospective randomized clinical trial. Results About 1700 mL was infused per patient in the saline and 1500 mL in each of the colloid groups (P<0.001). Overall, fluid loading slightly decreased pH (P<0.001) and there was no intergroup difference. This mildly metabolic acidifying effect was caused by a small increase in chloride concentration and decrease in strong ion difference in the saline- and HES-, and an increase in (uncorrected) anion gap in gelatine- and albumin-loaded patients, independent of lactate concentrations. Conclusion In clinically hypovolemic, critically ill patients, fluid resuscitation by only 1500-1700 mL of normal saline, gelatine, HES or albumin, resulted in a small decrease in pH, irrespective of the type of fluid used. Therefore, a progressive metabolic acidosis, even with increased anion gap, should not be erroneously attributed to insufficient fluid resuscitation.	[Spoelstra-de Man, Angelique M. E.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Smorenberg, Annemieke] Ziekenhuis Amstelland, Dept Internal Med, Amstelland, Netherlands; [Groeneveld, A. B. Johan] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Smorenberg, A (corresponding author), Ziekenhuis Amstelland, Dept Internal Med, Amstelland, Netherlands.	a.smorenberg@vumc.nl		de Man, Angelique/0000-0001-8738-8295	B. Braun Medical Melsungen, Germany	B. Braun Medical Melsungen, Germany	This study has been supported by an unrestricted grant of B. Braun Medical Melsungen, Germany. The funder was not involved in the study design, data collection, analysis, writing, or submission of the manuscript.	Bellomo R, 2006, CRIT CARE MED, V34, P2891, DOI 10.1097/01.CCM.0000242159.32764.86; Bruegger D, 2005, CRIT CARE MED, V33, P556, DOI 10.1097/01.ccm.0000155986.01926.95; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Gattinoni L, 2013, CRIT CARE, V17, DOI 10.1186/cc11502; Groeneveld ABJ, 2011, ANN SURG, V253, P470, DOI 10.1097/SLA.0b013e318202ff00; Johansen L., 1997, INTEGRATIVE COMP PHY, V272, P549; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Kuiper AN, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-189; Liskaser F, 1999, CURR OPIN CRIT CARE, V5, P440; Lobo DN, 2010, CRIT CARE MED, V38, P464, DOI 10.1097/CCM.0b013e3181bc80f1; Lobo DN, 2001, CLIN SCI, V101, P173, DOI 10.1042/CS20000316; Mallat J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056635; MCFARLANE C, 1994, ANAESTHESIA, V49, P779; Morgan TJ, 2009, ANAESTH INTENS CARE, V37, P407, DOI 10.1177/0310057X0903700304; Morgan TJ, 2005, CRIT CARE, V9, P204, DOI 10.1186/cc2946; Nagaoka D, 2010, J CRIT CARE, V25, P525, DOI 10.1016/j.jcrc.2010.02.003; Rehm M, 2000, ANESTHESIOLOGY, V93, P1174, DOI 10.1097/00000542-200011000-00007; Story D A, 1999, Crit Care Resusc, V1, P156; Takil A, 2002, ANESTH ANALG, V95, P294, DOI 10.1213/01.ANE.0000020188.49502.39; Trof RJ, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-12; Trof RJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10062; Trof RJ, 2010, INTENS CARE MED, V36, P697, DOI 10.1007/s00134-010-1776-x; van der Heijden M, 2009, CRIT CARE MED, V37, P1275, DOI 10.1097/CCM.0b013e31819cedfd; Verheij J, 2006, BRIT J ANAESTH, V96, P21, DOI 10.1093/bja/aei286; Volta CA, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-29; Waters JH, 2000, ANESTHESIOLOGY, V93, P1184, DOI 10.1097/00000542-200011000-00008; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174507	10.1371/journal.pone.0174507	http://dx.doi.org/10.1371/journal.pone.0174507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380062	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500050
J	Nagara, Y; Takada, T; Nagata, Y; Kado, S; Kushiro, A				Nagara, Yusuke; Takada, Toshihiko; Nagata, Yuriko; Kado, Shoichi; Kushiro, Akira			Microscale spatial analysis provides evidence for adhesive monopolization of dietary nutrients by specific intestinal bacteria	PLOS ONE			English	Article							AMYLOMAIZE STARCH GRANULES; RESISTANT STARCH; GUT MICROBIOTA; BIFIDOBACTERIA; IDENTIFICATION; BIOSTRUCTURE; AMYLOPECTIN; DIVERSITY	Each species of intestinal bacteria requires a nutritional source to maintain its population in the intestine. Dietary factors are considered to be major nutrients; however, evidence directly explaining the in situ utilization of dietary factors is limited. Microscale bacterial distribution would provide clues to understand bacterial lifestyle and nutrient utilization. However, the detailed bacterial localization around dietary factors in the intestine remains uninvestigated. Therefore, we explored microscale habitats in the murine intestine by using histology and fluorescent in situ hybridization, focusing on dietary factors. This approach successfully revealed several types of bacterial colonization. In particular, bifidobacterial colonization and adhesion on granular starch was frequently and commonly observed in the jejunum and distal colon. To identify the bacterial composition of areas around starch granules and areas without starch, laser microdissection and next-generation sequencing-based 16S rRNA microbial profiling was performed. It was found that Bifidobacteriaceae were significantly enriched by 4.7 fold in peri-starch areas compared to ex- starch areas. This family solely consisted of Bifidobacterium pseudolongum. In contrast, there was no significant enrichment among the other major families. This murine intestinal B. pseudolongum had starchdegrading activity, confirmed by isolation from the mouse feces and in vitro analysis. Collectively, our results demonstrate the significance of starch granules as a major habitat and potential nutritional niche for murine intestinal B. pseudolongum. Moreover, our results suggest that colonizing bifidobacteria effectively utilize starch from the closest location and maintain the location. This may be a bacterial strategy to monopolize solid dietary nutrients. We believe that our analytical approach could possibly be applied to other nutritional factors, and can be a powerful tool to investigate in vivo relationships between bacteria and environmental factors in the intestine.	[Nagara, Yusuke; Takada, Toshihiko; Kushiro, Akira] Yakult Cent Inst, Dept Microbiol Res, Tokyo, Japan; [Nagata, Yuriko; Kado, Shoichi] Yakult Cent Inst, Safety Res Dept, Tokyo, Japan	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited	Nagara, Y (corresponding author), Yakult Cent Inst, Dept Microbiol Res, Tokyo, Japan.	yusuke-nagara@yakult.co.jp		Takada, Toshihiko/0000-0002-9914-8253	Yakult Central Institute	Yakult Central Institute	This work was funded by Yakult Central Institute (http://institute.yakult.co.jp/). All authors are employees of the funder, but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrit.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25; Bird AR, 2007, BRIT J NUTR, V97, P134, DOI 10.1017/S0007114507250433; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Brown IL, 1998, FOOD AUST, V50, P603; Cameron EA, 2014, MBIO, V5, DOI 10.1128/mBio.01441-14; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen P, 2011, CARBOHYD POLYM, V83, P1975, DOI 10.1016/j.carbpol.2010.11.001; Cockburn DW, 2015, MOL MICROBIOL, V95, P209, DOI 10.1111/mmi.12859; Crittenden R, 2001, APPL ENVIRON MICROB, V67, P3469, DOI 10.1128/AEM.67.8.3469-3475.2001; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Duranti S, 2014, APPL ENVIRON MICROB, V80, P6080, DOI 10.1128/AEM.01993-14; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kleessen B, 1997, J ANIM SCI, V75, P2453; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Leitch ECM, 2007, ENVIRON MICROBIOL, V9, P667, DOI 10.1111/j.1462-2920.2006.01186.x; Liu SL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0362-3; MACFARLANE GT, 1986, J APPL BACTERIOL, V60, P195, DOI 10.1111/j.1365-2672.1986.tb01073.x; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; Mitsouka T., 1984, BIFIDOBACTERIA MICRO, P11, DOI DOI 10.12938/BIFIDUS1982.3.1_; Morikawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163607; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Ryan SM, 2006, APPL ENVIRON MICROB, V72, P5289, DOI 10.1128/AEM.00257-06; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Walker AW, 2008, ENVIRON MICROBIOL, V10, P3275, DOI 10.1111/j.1462-2920.2008.01717.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang X, 2002, J APPL MICROBIOL, V93, P390, DOI 10.1046/j.1365-2672.2002.01704.x; Wang X, 1999, APPL ENVIRON MICROB, V65, P4848; Wang X, 1999, J APPL MICROBIOL, V87, P631, DOI 10.1046/j.1365-2672.1999.00836.x; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; YUKI N, 1999, J INTEST MICROBIOL, V12, P97; Ze XL, 2015, MBIO, V6, DOI 10.1128/mBio.01058-15; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4	43	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175497	10.1371/journal.pone.0175497	http://dx.doi.org/10.1371/journal.pone.0175497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394924	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800040
J	Chu, HW; Sun, P; Yin, JH; Liu, GM; Wang, YW; Zhao, PY; Zhu, YZ; Yang, XH; Zheng, TZ; Zhou, XZ; Jin, WL; Sun, CK				Chu, Hongwei; Sun, Pin; Yin, Jiahui; Liu, Guangming; Wang, Yiwei; Zhao, Pengyao; Zhu, Yizhun; Yang, Xiaohan; Zheng, Tiezheng; Zhou, Xuezhong; Jin, Weilin; Sun, Changkai			Integrated network analysis reveals potentially novel molecular mechanisms and therapeutic targets of refractory epilepsies	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENE ONTOLOGY; INTERNATIONAL-LEAGUE; ANTIEPILEPTIC DRUGS; COMMON EPILEPSIES; DISEASE-GENES; WEB SERVER; SEIZURES; DALFAMPRIDINE; DETERMINANTS	Epilepsy is a complex neurological disorder and a significant health problem. The pathogenesis of epilepsy remains obscure in a significant number of patients and the current treatment options are not adequate in about a third of individuals which were known as refractory epilepsies (RE). Network medicine provides an effective approach for studying the molecular mechanisms underlying complex diseases. Here we integrated 1876 disease-gene associations of RE and located those genes to human protein-protein interaction (PPI) network to obtain 42 significant RE-associated disease modules. The functional analysis of these disease modules showed novel molecular pathological mechanisms of RE, such as the novel enriched pathways (e.g., "presynaptic nicotinic acetylcholine receptors", "signaling by insulin receptor"). Further analysis on the relationships between current drug targets and the RE-related disease genes showed the rational mechanisms of most antiepileptic drugs. In addition, we detected ten potential novel drug targets (e.g., KCNA1, KCNA4-6, KCNC3, KCND2, KCNMA1, CAMK2G, CACNB4 and GRM1) located in three RE related disease modules, which might provide novel insights into the new drug discovery for RE therapy.	[Chu, Hongwei; Sun, Changkai] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China; [Chu, Hongwei; Wang, Yiwei; Yang, Xiaohan; Zheng, Tiezheng; Sun, Changkai] Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China; [Sun, Pin] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China; [Yin, Jiahui] Tongji Univ, Coll Elect & Informat Engn, Shanghai, Peoples R China; [Liu, Guangming; Zhao, Pengyao; Zhou, Xuezhong] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China; [Liu, Guangming; Zhao, Pengyao; Zhou, Xuezhong] Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Mining, Beijing, Peoples R China; [Zhu, Yizhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Jin, Weilin] Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Sch Elect Informat & Elect Engn,Minist Educ, Dept Instrument Sci & Engn,Key Lab Thin Film & Mi, Shanghai, Peoples R China; [Sun, Changkai] Dalian Univ Technol, Res Ctr Control Engn Translat Precis Med, Dalian, Peoples R China; [Sun, Changkai] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian, Peoples R China	Dalian University of Technology; Dalian Medical University; Fudan University; Tongji University; Beijing Jiaotong University; Beijing Jiaotong University; Fudan University; Shanghai Jiao Tong University; Dalian University of Technology; Dalian University of Technology	Sun, CK (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China.; Sun, CK (corresponding author), Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China.; Zhou, XZ (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China.; Zhou, XZ (corresponding author), Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Mining, Beijing, Peoples R China.; Jin, WL (corresponding author), Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Sch Elect Informat & Elect Engn,Minist Educ, Dept Instrument Sci & Engn,Key Lab Thin Film & Mi, Shanghai, Peoples R China.; Sun, CK (corresponding author), Dalian Univ Technol, Res Ctr Control Engn Translat Precis Med, Dalian, Peoples R China.; Sun, CK (corresponding author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian, Peoples R China.	xzzhou@bjtu.edu.cn; weiliniin@yahoo.com; cksun110@vip.sina.com	ZHOU, XUE/F-6129-2013; SUN, CHANG/GXM-3680-2022; Jin, Wei-Lin/A-8355-2013; Zhou, Xuezhong/AAZ-5025-2021; Zhu, Yi Zhun/ABG-8449-2021; Zhou, Xuezhong/I-4101-2014	Jin, Wei-Lin/0000-0001-8011-2405; Zhu, Yi Zhun/0000-0001-7700-8041; Zhou, Xuezhong/0000-0002-4713-3594	National Science and Technology Major Projects Subject [2012ZX09503-001-003]; National Natural Science Foundation of China [61105055, 81230086]; Special program of Traditional Chinese medicine [201407001]; Tsung-Dao Lee Chinese Undergraduate Research Endowment [14032]	National Science and Technology Major Projects Subject; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special program of Traditional Chinese medicine; Tsung-Dao Lee Chinese Undergraduate Research Endowment	The study is supported by National Science and Technology Major Projects Subject (No. 2012ZX09503-001-003) to Changkai Sun (http//wwwrnost.gov.cn/), National Natural Science Foundation of China (Nos. 61105055, 81230086) to Xuezhong Zhou (https//isisn.nsfc.gov.cn/), Special program of Traditional Chinese medicine (No. 201407001) to Xuezhong Zhou, and Hui-Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (No.14032) to Pin Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; [Anonymous], 1998, COLLECTIVEDYNAMICS S, P440; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beck H, 2012, ANTIEPILEPTOGENESIS; Bhalla D, 2011, EXPERT REV NEUROTHER, V11, P861, DOI [10.1586/ERN.11.51, 10.1586/ern.11.51]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chang HR, 2008, J MED CHEM, V51, P1534, DOI 10.1021/jm0706618; Che FY, 2015, SEIZURE-EUR J EPILEP, V25, P178, DOI 10.1016/j.seizure.2014.09.014; Chu H, 2014, NETWORK BASED DETECT, P132; Cormen Thomas H., 2009, INTRO ALGORITHMS; Delahaye-Duriez A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1097-7; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Dunn J, 2011, CURR MED RES OPIN, V27, P1415, DOI 10.1185/03007995.2011.583229; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ghaffarpour M, 2014, ARCH NEUROSCI, V1, DOI 10.5812/archneurosci.14182; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Guo LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12939; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He D, 2011, BMC GENOMICS, V12, P813; Hung CL, 2014, DRUG DEVELOP RES, V75, P412, DOI 10.1002/ddr.21222; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin SH, 2015, EPILEPSIA, V56, P772, DOI 10.1111/epi.12966; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kerr M, 2014, EPILEPSIA, V55, P1902, DOI 10.1111/epi.12848; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Ladino LD, 2014, EPILEPSY RES, V108, P765, DOI 10.1016/j.eplepsyres.2014.01.024; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Liu CC, 2014, NUCLEIC ACIDS RES, V42, pW137, DOI 10.1093/nar/gku412; Liu TT, 2014, AM J TRANSL RES, V6, P625; Liu Y, 2012, EUR REV MED PHARMACO, V16, P867; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MANCANO MA, 2013, HOSP PHARM, V48, P725, DOI DOI 10.1310/hpj4809-725; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Murphy JV, 2005, EXPERT REV MED DEVIC, V2, P175, DOI 10.1586/17434440.2.2.175; Musto AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116543; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; Najjar S, 2011, NEUROLOGIST, V17, P249, DOI 10.1097/NRL.0b013e31822aad04; Nelson M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0277-x; Nobili P, 2014, SEIZURE INDUCED PATH; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Ostendorf AP, 2015, CNS DRUGS, V29, P91, DOI 10.1007/s40263-014-0223-x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; [彭毓棻 PENG Yufen], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1230; Porto Juliana Antola, 2010, J. epilepsy clin. neurophysiol., V16, P26, DOI 10.1590/S1676-26492010000100006; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; Quek AML, 2012, ARCH NEUROL-CHICAGO, V69, P582, DOI 10.1001/archneurol.2011.2985; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074; Rong LL, 2014, EPILEPSY BEHAV, V31, P210, DOI 10.1016/j.yebeh.2013.11.022; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma A, 2015, HUM MOL GENET, V24, P3005, DOI 10.1093/hmg/ddv001; Sharma A, 2013, MOL CELL PROTEOMICS, V12, P3398, DOI 10.1074/mcp.M112.024851; Shu-Qiu W, 2014, PLOS ONE, V9; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Steinlein OK, 2002, CNS NEUROL DISORD-DR, V1, P443, DOI 10.2174/1568007023339193; Striano P, 2012, ARCH NEUROL-CHICAGO, V69, P322, DOI 10.1001/archneurol.2011.1999; Sudhop T, 1999, EPILEPSIA, V40, P480, DOI 10.1111/j.1528-1157.1999.tb00744.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tadmouri A, 2012, EMBO J, V31, P3730, DOI 10.1038/emboj.2012.226; Tan H, 2014, J PEDIATR ENDOCR MET, V18, P985; Van Poucke M, 2012, NEUROMUSCULAR DISORD, V22, P558, DOI 10.1016/j.nmd.2012.01.008; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang GF, 2015, GENE DEV, V29, P1535, DOI 10.1101/gad.260869.115; Wang QP, 2008, EUR J NEUROSCI, V27, P2177, DOI 10.1111/j.1460-9568.2008.06175.x; Wassenaar M, 2013, EPILEPSY RES, V106, P301, DOI 10.1016/j.eplepsyres.2013.06.013; Welch KA, 2014, J NEUROL NEUROSUR PS, V85, P593, DOI 10.1136/jnnp-2013-306267; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yoon HJ, 2014, TOXICOL LETT, V225, P147, DOI 10.1016/j.toxlet.2013.12.002; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	86	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174964	10.1371/journal.pone.0174964	http://dx.doi.org/10.1371/journal.pone.0174964			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388656	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800015
J	Kumssa, DB; Joy, EJM; Young, SD; Odee, DW; Ander, EL; Broadleyl, MR				Kumssa, Diriba B.; Joy, Edward J. M.; Young, Scott D.; Odee, David W.; Ander, E. Louise; Broadleyl, Martin R.			Variation in the mineral element concentration of Moringa oleifera Lam. and M-stenopetala (Bak. f.) Cuf.: Role in human nutrition	PLOS ONE			English	Article							WILD EDIBLE PLANTS; UNDERUTILIZED CROPS; LEAVES; SELENIUM; NUTRIENT; EXTRACTION; CHILDREN; VALLEY; PODS; TREE	Background Moringa oleifera (MO) and M. stenopetala (MS) (family Moringaceae; order Brassicales) are multipurpose tree/shrub species. They thrive under marginal environmental conditions and produce nutritious edible parts. The aim of this study was to determine the mineral composition of different parts of MO and MS growing in their natural environments and their potential role in alleviating human mineral micronutrient deficiencies (MND) in sub-Saharan Africa. Methods Edible parts of MO (n = 146) and MS (n = 50), co-occurring cereals/vegetables and soils (n = 95) underneath their canopy were sampled from localities in southern Ethiopia and Kenya. The concentrations of seven mineral elements, namely, calcium (Ca), copper (Cu), iodine (I), iron (Fe), magnesium (Mg), selenium (Se), and zinc (Zn) in edible parts and soils were determined using inductively coupled plasma-mass spectrometry. Results In Ethiopian crops, MS leaves contained the highest median concentrations of all elements except Cu and Zn, which were greater in Enset (a.k.a., false banana). In Kenya, Mo flowers and MS leaves had the highest median Se concentration of 1.56 mg kg(-1) and 3.96 mg kg(-1), respectively. The median concentration of Se in MS leaves was 7-fold, 10-fold, 23-fold, 117-fold and 147-fold more than that in brassica leaves, amaranth leaves, baobab fruits, sorghum grain and maize grain, respectively. The median Se concentration was 78-fold and 98-fold greater in MO seeds than in sorghum and maize grain, respectively. There was a strong relationship between soil total Se and potassium dihydrogen phosphate (KH2PO4)-extractable Se, and Se concentration in the leaves of MO and MS. Conclusion This study confirms previous studies that Moringa is a good source of several of the measured mineral nutrients, and it includes the first wide assessment of Se and I concentrations in edible parts of MO and MS grown in various localities. Increasing the consumption of MO and MS, especially the leaves as a fresh vegetable or in powdered form, could reduce the prevalence of MNDs, most notably Se deficiency.	[Kumssa, Diriba B.; Young, Scott D.; Broadleyl, Martin R.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Kumssa, Diriba B.; Ander, E. Louise] British Geol Survey, Ctr Environm Geochem, Keyworth, Notts, England; [Kumssa, Diriba B.] Univ Nottingham Malaysia Campus, Crops Future, Semenyih, Selangor, Malaysia; [Joy, Edward J. M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Odee, David W.] Kenya Forestry Res Inst, Nairobi, Kenya; [Odee, David W.] Ctr Ecol & Hydrol, Bush Estate, Penicuik, Midlothian, Scotland	University of Nottingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham Malaysia; University of London; London School of Hygiene & Tropical Medicine; UK Centre for Ecology & Hydrology (UKCEH)	Broadleyl, MR (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	martin.broadley@nottingham.ac.uk	Broadley, Martin/AAW-4638-2021; Kumssa, Diriba/AAR-7547-2020; Kumssa, Diriba B/C-3774-2017; broadley, martin r/E-9081-2011; Ander, E.L./D-2009-2013	Broadley, Martin/0000-0003-3964-7226; Kumssa, Diriba/0000-0002-5869-4864; Kumssa, Diriba B/0000-0002-5869-4864; broadley, martin r/0000-0003-3964-7226; Ander, E.L./0000-0003-3901-1949	Crops for the Future; NERC [nigl010001, ceh020005] Funding Source: UKRI; Natural Environment Research Council [nigl010001, ceh020005] Funding Source: researchfish	Crops for the Future; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Crops for the Future (http://www.cropsforthefuture.org/) funded DBK's studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2003, East Afr Med J, V80, P247; Ahmed T, 2010, P I CIVIL ENG-WAT M, V163, P381, DOI 10.1680/wama.900080; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Anjorin TS, 2010, INT J AGRIC BIOL, V12, P431; [Anonymous], [No title captured]; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Aslam M., 2005, ASIAN J PLANT SCI, V4, P417, DOI [10.3923/ajps.2005.417.421, DOI 10.3923/AJPS.2005.417.421]; Balemie K, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-53; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chilimba A. D. C., 2015, BMC NUTR, V1, P42, DOI DOI 10.1186/S40795-015-0036-4; Chilimba ADC, 2012, FIELD CROP RES, V125, P118, DOI 10.1016/j.fcr.2011.08.014; da Conceicao VM, 2015, CAN J CHEM ENG, V93, P37, DOI 10.1002/cjce.22101; Debela E, 2013, AGROFOREST SYST, V87, P1147, DOI 10.1007/s10457-013-9626-9; Degefu DM, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1719-6; Devi NS, 2007, ACTA HORTIC, P367, DOI 10.17660/ActaHortic.2007.752.64; Forster N, 2015, FOOD CHEM, V166, P456, DOI 10.1016/j.foodchem.2014.06.043; Foidl N, POTENTIAL MORINGA OL; Freiberger CE, 1998, PLANT FOOD HUM NUTR, V53, P57, DOI 10.1023/A:1008080508028; Gashu D, 2016, EUR J CLIN NUTR, V70, P929, DOI 10.1038/ejcn.2016.27; Gashu D, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0155-z; Gidamis AB, 2003, ECOL FOOD NUTR, V42, P399, DOI 10.1080/03670240390268857; Guo L, 2014, SELENIUM ENV HUMAN H, P86; IOM, 2003, DIET REF INT APPL DI, P248; JAHN SA, 1991, AMBIO, V20, P244; Jiru D., 2006, LEAF YIELD NUTR VALU; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Kifleyohannes Tsegabirhan, 2014, BMC Res Notes, V7, P390, DOI 10.1186/1756-0500-7-390; Kumssa DB, 2015, CROP PASTURE SCI, V66, P1278, DOI 10.1071/CP15096; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Kushwaha S, 2014, J FOOD SCI TECH MYS, V51, P3464, DOI 10.1007/s13197-012-0859-9; Leone A, 2015, INT J MOL SCI, V16, P18923, DOI 10.3390/ijms160818923; Lim TK., 2012, EDIBLE MED NONMEDICI, P453; Limmatvapirat C, 2015, INDIAN J PHARM SCI, V77, P485, DOI 10.4103/0250-474X.164782; Mabhaudhi T, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040302; Matshediso PG, 2015, FOOD CHEM, V172, P423, DOI 10.1016/j.foodchem.2014.09.047; Mayes S, 2012, J EXP BOT, V63, P1075, DOI 10.1093/jxb/err396; Melesse A, 2012, AGROFOREST SYST, V86, P505, DOI 10.1007/s10457-012-9514-8; MORTON JF, 1991, ECON BOT, V45, P318, DOI 10.1007/BF02887070; Moyo B, 2011, AFR J BIOTECHNOL, V10, P12925; Nouman W, 2013, TURK J AGRIC FOR, V37, P410, DOI 10.3906/tar-1206-29; NRC, 2006, MOR LOST CROPS AFR V, VII, P377; Ocho DL, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-30; Odee D., 1998, DRYLAND BIODIVERSITY, V2, P7; Ogbe AO, 2011, J MICROB BIOTEC FOOD, V1, P296; Ogunsina BS, 2014, J FOOD SCI TECH MYS, V51, P503, DOI 10.1007/s13197-011-0519-5; Olson ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159782; Olson ME, 2001, BOT J LINN SOC, V135, P315, DOI 10.1111/j.1095-8339.2001.tb00786.x; Padulosi S., 2008, P605, DOI 10.1079/9781845930998.0605; Popoola JO, 2013, J ETHNOPHARMACOL, V150, P682, DOI 10.1016/j.jep.2013.09.043; Price ML., MORINGA TREE 2007; Ritu Paliwal, 2011, Asian Journal of Biotechnology, V3, P317, DOI 10.3923/ajbkr.2011.317.328; Roskov Y., 2014, SPECIES 2000 ITIS CA; Shahzad U, 2013, CONSERV GENET, V14, P1161, DOI 10.1007/s10592-013-0503-x; Smolen S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00730; Stroud JL, 2012, INT J ENVIRON AN CH, V92, P222, DOI 10.1080/03067310903111661; Teklehaymanot T, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-23; Tesfaye EB, 2014, J APPL POULTRY RES, V23, P614, DOI 10.3382/japr.2013-00920; Toma Alemayehu, 2014, BMC Complement Altern Med, V14, P180, DOI 10.1186/1472-6882-14-180; Undie U. L., 2013, EUR J AGR FOR RES, V1, P17; Valdez-Solana MA, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/860381; Virchow D., 2008, 5th International Symposium on New Crops and Uses: their role in a rapidly changing world, University of Southampton, Southampton, UK, 3-4 September 2007, P79; White PJ, 2016, ANN BOT-LONDON, V117, P217, DOI 10.1093/aob/mcv180; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; Zaffer M, 2014, PAK J PHARM SCI, V27, P1857	64	24	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175503	10.1371/journal.pone.0175503	http://dx.doi.org/10.1371/journal.pone.0175503			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388674	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000399375800062
J	Bazmara, H; Soltani, M; Sefidgar, M; Bazargan, M; Naeenian, MM; Rahmim, A				Bazmara, Hossein; Soltani, Madjid; Sefidgar, Mostafa; Bazargan, Majid; Naeenian, Mojtaba Mousavi; Rahmim, Arman			The Vital Role of Blood Flow-Induced Proliferation and Migration in Capillary Network Formation in a Multiscale Model of Angiogenesis (vol 10, e0128878, 2015)	PLOS ONE			English	Correction													Sefidgar, Mostafa/AAO-8634-2021; Bazmara, Hossein/AAO-8162-2021; Rahmim, Arman/ACS-4963-2022; Bazargan, Majid/AAS-3204-2020	Rahmim, Arman/0000-0002-9980-2403; Bazargan, Majid/0000-0001-8747-664X				Bazmara H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128878	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175601	10.1371/journal.pone.0175601	http://dx.doi.org/10.1371/journal.pone.0175601			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384275	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900177
J	Greenville, AC; Dickman, CR; Wardle, GM				Greenville, Aaron C.; Dickman, Chris R.; Wardle, Glenda M.			75 years of dryland science: Trends and gaps in arid ecology literature	PLOS ONE			English	Article							EVOLUTION; DECLINE; TOOLS	Growth in the publication of scientific articles is occurring at an exponential rate, prompting a growing need to synthesise information in a timely manner to combat urgent environmental problems and guide future research. Here, we undertake a topic analysis of dryland literature over the last 75 years (8218 articles) to identify areas in arid ecology that are well studied and topics that are emerging. Four topics D wetlands, mammal ecology, litter decomposition and spatial modelling, were identified as 'hot topics' that showed higher than average growth in publications from 1940 to 2015. Five topics D remote sensing, climate, habitat and spatial, agriculture and soils-microbes, were identified as 'cold topics', with lower than average growth over the survey period, but higher than average numbers of publications. Topics in arid ecology clustered into seven broad groups on word-based similarity. These groups ranged from mammal ecology and population genetics, broad-scale management and ecosystem modelling, plant ecology, agriculture and ecophysiology, to populations and paleoclimate. These patterns may reflect trends in the field of ecology more broadly. We also identified two broad research gaps in arid ecology: population genetics, and habitat and spatial research. Collaborations between population genetics and ecologists and investigations of ecological processes across spatial scales would contribute profitably to the advancement of arid ecology and to ecology more broadly.	[Greenville, Aaron C.; Dickman, Chris R.; Wardle, Glenda M.] Univ Sydney, Sch Life & Environm Sci, Desert Ecol Res Grp, Sydney, NSW, Australia; [Greenville, Aaron C.; Dickman, Chris R.] Univ Sydney, Natl Environm Sci Programme Threatened Species Re, Sydney, NSW, Australia; [Greenville, Aaron C.; Dickman, Chris R.; Wardle, Glenda M.] Terr Ecosyst Res Network, Long Term Ecol Res Network, Sydney, NSW, Australia	University of Sydney; University of Sydney	Greenville, AC (corresponding author), Univ Sydney, Sch Life & Environm Sci, Desert Ecol Res Grp, Sydney, NSW, Australia.; Greenville, AC (corresponding author), Univ Sydney, Natl Environm Sci Programme Threatened Species Re, Sydney, NSW, Australia.; Greenville, AC (corresponding author), Terr Ecosyst Res Network, Long Term Ecol Res Network, Sydney, NSW, Australia.	aaron.greenville@sydney.edu.au	Wardle, Glenda/ABD-9228-2021; Greenville, Aaron/G-9718-2013; Dickman, Christopher/Q-4662-2019; Lobo, Diele/I-9106-2012; Wardle, Glenda/D-6533-2016	Wardle, Glenda/0000-0003-0189-1899; Greenville, Aaron/0000-0002-0113-4778; Dickman, Christopher/0000-0002-1067-3730; Wardle, Glenda/0000-0003-0189-1899	Australian Research Council; Australian Government	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was funded by the Australian Research Council and the Australian Government's Terrestrial Ecosystem Research Network (www.tern.gov.au), an Australian research infrastructure facility established under the National Collaborative Research Infrastructure Strategy and Education Infrastructure Fund - Super Science Initiative through the Department of Industry, Innovation, Science, Research and Tertiary Education. CRD was supported by an Australian Research Council Fellowship.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boyack KW, 2013, J AM SOC INF SCI TEC, V64, P1759, DOI 10.1002/asi.22896; Browning DM, 2015, FRONT ECOL ENVIRON, V13, P52, DOI 10.1890/140161; Budilova EV, 1997, SCIENTOMETRICS, V39, P147, DOI 10.1007/BF02457444; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Carmel Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059813; Chave J, 2013, ECOL LETT, V16, P4, DOI 10.1111/ele.12048; Greenville AC, 2016, SCIENCE, V353, P1360, DOI 10.1126/science.aag3057; Greenville AC, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1343; Greenville AC, 2017, 75 YEARS DRYLAND SCI; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Grimmer Justin, 2013, POLITICAL ANAL; Grun B, 2011, J STAT SOFTW, V40, P1; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Nano CEM, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P195; Neff MW, 2009, SCIENTOMETRICS, V80, P657, DOI 10.1007/s11192-008-2099-3; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; OECD, 2016, MEAS SCI TECHN INN; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Core Team, 2021, R LANGUAGE ENV STAT; Sutherland WJ, 2009, TRENDS ECOL EVOL, V24, P523, DOI 10.1016/j.tree.2009.04.008; Thompson JN, 2001, BIOSCIENCE, V51, P15, DOI 10.1641/0006-3568(2001)051[0015:FOE]2.0.CO;2; Van Noorden R, 2010, NATURE, V464, P474, DOI 10.1038/464474a; Verstraete MM, 2009, FRONT ECOL ENVIRON, V7, P421, DOI 10.1890/080119; Westgate MJ, 2015, CONSERV BIOL, V29, P1606, DOI 10.1111/cobi.12605; Whitford W., 2002, ECOLOGY DESERT SYSTE; Young R. F., 2006, Urban Ecosystems, V9, P179, DOI 10.1007/s11252-006-8589-2	28	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175014	10.1371/journal.pone.0175014	http://dx.doi.org/10.1371/journal.pone.0175014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384186	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900073
J	Lee, SJ; Leem, YE; Go, GY; Choi, Y; Song, YJ; Kim, I; Kim, DY; Kim, YK; Seo, DW; Kang, JS; Bae, GU				Lee, Sang-Jin; Leem, Young-Eun; Go, Ga-Yeon; Choi, Younhee; Song, Yoo Jin; Kim, Insol; Kim, Do Yoon; Kim, Yong Kee; Seo, Dong-Wan; Kang, Jong-Sun; Bae, Gyu-Un			Epicatechin elicits MyoD-dependent myoblast differentiation and myogenic conversion of fibroblasts	PLOS ONE			English	Article							SKELETAL-MUSCLE; SIGNALING PATHWAYS; GENE-EXPRESSION; (-)-EPICATECHIN; RESTRICTION; SARCOPENIA; PROMOTER; TEA	Prevention of age-associated reduction in muscle mass and function is required to manage a healthy life. Supplemental (-)-Epicatechin (EC) appears to act as a potential regulator for muscle growth and strength. However, its cellular and molecular mechanisms as a potential muscle growth agent have not been studied well. In the current study, we investigated a role of EC in differentiation of muscle progenitors to gain the molecular insight into how EC regulates muscle growth. EC enhanced myogenic differentiation in a dose-dependent manner through stimulation of promyogenic signaling pathways, p38MAPK and Akt. EC treatment elevated MyoD activity by enhancing its heterodimerization with E protein. Consistently, EC also positively regulated myogenic conversion and differentiation of fibroblasts. In conclusion, EC has a potential as a therapeutic or nutraceutical remedy to treat degenerative muscle diseases or age-related muscle weakness.	[Lee, Sang-Jin; Go, Ga-Yeon; Choi, Younhee; Song, Yoo Jin; Kim, Insol; Kim, Do Yoon; Kim, Yong Kee; Bae, Gyu-Un] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul, South Korea; [Leem, Young-Eun; Kang, Jong-Sun] Sungkyunkwan Univ, Dept Mol Cell Biol, Single Cell Network Res Ctr, Sch Med, Suwon, South Korea; [Seo, Dong-Wan] Dankook Univ, Coll Pharm, Cheonan, South Korea	Sookmyung Women's University; Sungkyunkwan University (SKKU); Dankook University	Bae, GU (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul, South Korea.	gbae@sookmyung.ac.kr		Seo, Dong-Wan/0000-0003-4971-834X	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2011-0030074, 2015R1A2A1A15056117, 2016R1A2134014868]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2011-0030074, 2015R1A2A1A15056117 and 2016R1A2134014868).	Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Gutierrez-Salmean G, 2014, J NUTR BIOCHEM, V25, P91, DOI 10.1016/j.jnutbio.2013.09.007; Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Kwik-Uribe C, 2008, ASIA PAC J CLIN NUTR, V17, P280; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892; Rondanelli M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/524948; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sousa-Victor P, 2016, MOL ASPECTS MED, Vxxx, pyy_zz; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TONIN PN, 1991, CANCER RES, V51, P5100; Wang S, 2006, J NUTR BIOCHEM, V17, P492, DOI 10.1016/j.jnutbio.2006.03.004; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Zeng XB, 2014, PHYTOMEDICINE, V21, P217, DOI 10.1016/j.phymed.2013.08.026	30	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175271	10.1371/journal.pone.0175271	http://dx.doi.org/10.1371/journal.pone.0175271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384253	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900144
J	Lin, JT; Cheng, DC				Lin, Jui-Teng; Cheng, Da-Chuan			Modeling the efficacy profiles of UV-light activated corneal collagen crosslinking	PLOS ONE			English	Article							STROMAL DEMARCATION LINE; RIBOFLAVIN; ULTRAVIOLET; PHOTOPOLYMERIZATION; OPTIMIZATION; ABSORPTION; STANDARD; KINETICS; SAFETY; LAW	Objective Analysis of the crosslink time, depth and efficacy profiles of UV-light-activated corneal collagen crosslinking (CXL). Methods A modeling system described by a coupled dynamic equations are numerically solved and analytic formulas are derived for the crosslinking time (T*) and crosslinking depth (z*). The z-dependence of the CXL efficacy is numerically produced to show the factors characterizing the profiles. Results Optimal crosslink depth (z*) and maximal CXL efficacy (Ceff) have opposite trend with respective to the UV light intensity and RF concentration, where z* is a decreasing function of the riboflavin concentration (C-o). In comparison, Ceff is an increasing function of C-o and the UV exposure time (for a fixed UV dose), but it is a decreasing function of the UV light intensity. CXL efficacy is a nonlinear increasing function of [C-o/I-o](- 0.5) and more accurate than that of the linear theory of Bunsen Roscoe law. Depending on the UV exposure time and depth, the optimal intensity ranges from 3 to 30 mW/cm(2) for maximal CXL efficacy. For steady state (with long exposure time), low intensity always achieves high efficacy than that of high intensity, when same dose is applied on the cornea. Conclusions The crosslinking depth (z*) and the crosslinking time (T*) have nonlinear dependence on the UV light dose and the efficacy of corneal collagen crosslinking should be characterized by both z* and the efficacy profiles. A nonlinear scaling law is needed for more accurate protocol.	[Lin, Jui-Teng] New Vis Inc, Taipei, Taiwan; [Cheng, Da-Chuan] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan	China Medical University Taiwan	Cheng, DC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	dccheng@mail.cmu.edu.tw		Lin, Jui-Teng/0000-0003-0890-4234	Ministry of Science and Technology (MOST), Taiwan [MOST 105-0221-E-039-006]; New Vision Inc	Ministry of Science and Technology (MOST), Taiwan; New Vision Inc	The second author (DC Cheng) thanks the partial financial support from Ministry of Science and Technology (MOST), Taiwan, under the grant number MOST 105-0221-E-039-006. The company (New Vision Inc) provided support in the form of salaries for the author JT Lin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The second author (DCC) thanks the partial financial support from Ministry of Science and Technology (MOST), Taiwan, under the grant number MOST 105-0221-E-039-006.	Afnawaiseh M, 2015, CORNEA, V34, P1427; Gatzioufas Z, 2016, J CATARACT REFR SURG, V42, P804, DOI 10.1016/j.jcrs.2016.02.043; Hafezi F, CORNEAL COLLAGEN CRO; Kamaev P, 2012, INVEST OPHTH VIS SCI, V53, P2360, DOI 10.1167/iovs.11-9385; Kling S, 2017, J REFRACT SURG, V33, P128, DOI 10.3928/1081597X-20161206-01; Koppen C, 2010, EYE CONTACT LENS, V36, P77, DOI 10.1097/ICL.0b013e3181d0b74b; Kymionis GD, 2014, J CATARACT REFR SURG, V40, P736, DOI 10.1016/j.jcrs.2013.10.029; Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0; Lin J-T, 2016, OPHTHALMOLOGY RES, P1, DOI [10.9734/OR/2016/28712, DOI 10.9734/OR/2016/28712]; Lin JT, 2016, J POLYM RES, V23, DOI 10.1007/s10965-016-0934-4; Lin JT, 2015, INVEST OPHTH VIS SCI, V56, P5740, DOI 10.1167/iovs.15-17537; Lin JT, 2014, POLYMERS-BASEL, V6, P1489, DOI 10.3390/polym6051489; Lin JT, 2014, POLYMERS-BASEL, V6, P552, DOI 10.3390/polym6020552; [Lin Juiteng 林瑞騰], 2015, [中华眼视光学与视觉科学杂志, Chinese Journal of Optometry Ophthalmology and Visual Science], V17, P140; Martin JW, 2003, PROG ORG COAT, V47, P292, DOI 10.1016/j.porgcoat.2003.08.002; Mita M, 2014, J CATARACT REFR SURG, V40, P1032, DOI 10.1016/j.jcrs.2013.12.014; Moramarco A, 2015, J CATARACT REFR SURG, V41, P2546, DOI 10.1016/j.jcrs.2015.04.033; Richoz O, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.7.6; Schumacher S, 2012, INVEST OPHTH VIS SCI, V53, P762, DOI 10.1167/iovs.11-8059; Schumacher S, 2012, J REFRACT SURG, V28, P91, DOI 10.3928/1081597X-20120117-01; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Semchishen A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1403, DOI 10.1111/php.12498; Sorkin N, 2014, OPHTHALMOLOGICA, V232, P10, DOI 10.1159/000357979; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Wernli J, 2013, INVEST OPHTH VIS SCI, V54, P1176, DOI 10.1167/iovs.12-11409; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1786, DOI 10.1016/S0886-3350(03)00343-2	26	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175002	10.1371/journal.pone.0175002	http://dx.doi.org/10.1371/journal.pone.0175002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384251	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900071
J	Lonnemann, J; Li, S; Zhao, P; Li, P; Linkersdorfer, J; Lindberg, S; Hasselhorn, M; Yan, S				Lonnemann, Jan; Li, Su; Zhao, Pei; Li, Peng; Linkersdoerfer, Janosch; Lindberg, Sven; Hasselhorn, Marcus; Yan, Song			Differences in arithmetic performance between Chinese and German adults are accompanied by differences in processing of non-symbolic numerical magnitude	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; ACUITY; REPRESENTATIONS; ABILITY	Human beings are assumed to possess an approximate number system (ANS) dedicated to extracting and representing approximate numerical magnitude information. The ANS is assumed to be fundamental to arithmetic learning and has been shown to be associated with arithmetic performance. It is, however, still a matter of debate whether better arithmetic skills are reflected in the ANS. To address this issue, Chinese and German adults were compared regarding their performance in simple arithmetic tasks and in a non-symbolic numerical magnitude comparison task. Chinese participants showed a better performance in solving simple arithmetic tasks and faster reaction times in the non-symbolic numerical magnitude comparison task without making more errors than their German peers. These differences in performance could not be ascribed to differences in general cognitive abilities. Better arithmetic skills were thus found to be accompanied by a higher speed of retrieving non-symbolic numerical magnitude knowledge but not by a higher precision of non-symbolic numerical magnitude representations. The group difference in the speed of retrieving non-symbolic numerical magnitude knowledge was fully mediated by the performance in arithmetic tasks, suggesting that arithmetic skills shape non-symbolic numerical magnitude processing skills.	[Lonnemann, Jan; Linkersdoerfer, Janosch; Hasselhorn, Marcus] German Inst Int Educ Res DIPF, Dept Educ & Human Dev, Frankfurt, Germany; [Lonnemann, Jan; Linkersdoerfer, Janosch; Lindberg, Sven; Hasselhorn, Marcus] Ctr Individual Dev & Adapt Educ Children Risk, Frankfurt, Germany; [Li, Su; Zhao, Pei] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China; [Zhao, Pei] Yunnan Normal Univ, Sch Educ & Management, Psychol Dept, Kunming, Peoples R China; [Lindberg, Sven] Paderborn Univ, Fac Arts & Humanities, Paderborn, Germany; [Hasselhorn, Marcus] Goethe Univ, Inst Psychol, Dept Educ Psychol, Frankfurt, Germany; [Yan, Song] Jacobs Univ Bremen, Dept Psychol & Methods, Bremen, Germany	German Institute for International Educational Research; Chinese Academy of Sciences; Institute of Psychology, CAS; Yunnan Normal University; University of Paderborn; Goethe University Frankfurt; Jacobs University	Lonnemann, J (corresponding author), German Inst Int Educ Res DIPF, Dept Educ & Human Dev, Frankfurt, Germany.; Lonnemann, J (corresponding author), Ctr Individual Dev & Adapt Educ Children Risk, Frankfurt, Germany.	lonnemann@dipf.de	Linkersdörfer, Janosch/L-1223-2016	Linkersdörfer, Janosch/0000-0002-1577-1233; Lonnemann, Jan/0000-0002-6619-0981; Li, Peng/0000-0003-1925-3836	Hessian initiative for the development of scientific and economic excellence (LOEWE); Open Access Fund of the Leibniz Association	Hessian initiative for the development of scientific and economic excellence (LOEWE); Open Access Fund of the Leibniz Association	This research was funded by the Hessian initiative for the development of scientific and economic excellence (LOEWE) and The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Arora, 2012, TIMSS 2011 INT RESUL; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Dietrich JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163076; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Geary DC, 1996, DEV PSYCHOL, V32, P254, DOI 10.1037/0012-1649.32.2.254; Gebuis T, 2016, ACTA PSYCHOL, V171, P17, DOI 10.1016/j.actpsy.2016.09.003; Guillaume M, 2013, ACTA PSYCHOL, V144, P506, DOI 10.1016/j.actpsy.2013.09.001; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Horn R, 2009, STANDARD PROGR MATRI; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Leibovich T., BEHAV BRAIN IN PRESS; Lindskog M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00462; Lonnemann J, 2015, TRENDS NEUROSCI EDUC, V4, P1, DOI 10.1016/j.tine.2015.03.002; Ng SSN, 2010, REV EDUC RES, V80, P180, DOI 10.3102/0034654310364764; Nys J, 2013, TRENDS NEUROSCI EDUC, V2, P13, DOI 10.1016/j.tine.2013.01.001; OECD, 2013, PISA 2012 RES WHAT S, VI; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Schneider M, DEV SCI IN PRESS; Siegler RS, 2014, CHILD DEV PERSPECT, V8, P144, DOI 10.1111/cdep.12077; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Wang J, 2013, EDUC RES REV-NETH, V10, P150, DOI 10.1016/j.edurev.2013.10.003; Wang JA, 2009, EDUC RES REV-NETH, V4, P177, DOI 10.1016/j.edurev.2009.06.003; Zebian S, 2012, PSYCHON B REV, V19, P93, DOI 10.3758/s13423-011-0175-9; Zhou XL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01364	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174991	10.1371/journal.pone.0174991	http://dx.doi.org/10.1371/journal.pone.0174991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384191	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900069
J	Moss, JA; Baum, MM; Easley, JT; Cox, DM; Smith, TJ				Moss, John A.; Baum, Marc M.; Easley, Jeremiah T.; Cox, Darren M.; Smith, Thomas J.			An intravaginal ring for real-time evaluation of adherence to therapy	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HIV-PREVENTION TRIALS; PREEXPOSURE PROPHYLAXIS; SUSTAINED DELIVERY; AFRICAN WOMEN; VAGINAL RING; PHARMACOKINETICS; INFECTION; SAFETY; DRUGS	Two recent Phase III clinical trials to investigate an intravaginal ring for preventing HIV infection demonstrated that adherence to prescribed device use was a primary driver of efficacy. Surrogate methods for determining adherence in the studies were limited in their inability to monitor temporal patterns of use and allow deconvolution of the effects of adherence and device efficacy on HIV infection rates. To address this issue, we have developed functionality in an intravaginal ring to continuously monitor when the device is being used and maintain a log of adherence that can be accessed by clinicians after it is removed. An electronic module fabricated with common, inexpensive electronic components was encapsulated in a silicone intravaginal ring. The device uses temperature as a surrogate measure of periods of device insertion and removal, and stores a record of the data for subsequent retrieval. The adherence-monitoring intravaginal ring accurately recorded the device status over 33 simulated IN-OUT cycles and more than 1000 measurement cycles in vitro. Following initial in vitro testing in a temperature-controlled chamber, the device was evaluated in vivo in sheep using a predetermined insertion/removal pattern to simulate intravaginal ring use. After insertion into the vaginal cavity of a sheep, the logged data correctly indicated the device status over 29 hours of continuous measurement including three cycles of insertion and removal. The device described here is a promising, low-cost method for real-time adherence assessment in clinical trials involving medicated intravaginal rings or other intravaginal devices.	[Moss, John A.; Baum, Marc M.; Cox, Darren M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA; [Easley, Jeremiah T.] Colorado State Univ, Preclin Surg Res Lab, Ft Collins, CO 80523 USA; [Smith, Thomas J.] Auritec Pharmaceut Inc, Pasadena, CA USA	Colorado State University	Moss, JA (corresponding author), Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA.	j.moss@oak-crest.org		Moss, John/0000-0001-8091-3245; Baum, Marc/0000-0003-1558-5649	National Institute for Allergies and Infectious Diseases of the National Institutes of Health (NIH) [1R41AI104549]; NIH Small Business Technology Transfer (STTR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI104549] Funding Source: NIH RePORTER	National Institute for Allergies and Infectious Diseases of the National Institutes of Health (NIH); NIH Small Business Technology Transfer (STTR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute for Allergies and Infectious Diseases of the National Institutes of Health (NIH) under grant 1R41AI104549 (JM). The funder provided support in the form of salaries for authors [JM, MB, JE, DC, and TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. TS is an employee of Auritec Pharmaceuticals, a for profit pharmaceutical company that was the private sector partner in the NIH Small Business Technology Transfer (STTR) grant funding this work. The specific roles of the authors are articulated in the 'author contributions' section.	Agot K, 2015, AIDS BEHAV, V19, P743, DOI 10.1007/s10461-014-0859-z; Amico KR, 2013, AIDS BEHAV, V17, P2143, DOI 10.1007/s10461-013-0429-9; Auritec Pharmaceuticals, 2000, AURITEC PHARMACEUTIC; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, NEW ENGL J MED; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Boyd P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125682; Brown E., 2016, 21 INT AIDS C AIDS 2; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunawardana M, 2014, J PHARM SCI-US, V103, P3611, DOI 10.1002/jps.24154; Gunawardana M, 2014, ANTIMICROB AGENTS CH, V58, P2262, DOI 10.1128/AAC.02542-13; Hillier S., 2016, RINGS AND THINGS; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2012, J ANTIMICROB CHEMOTH, V67, P2005, DOI 10.1093/jac/dks151; MacQueen KM, 2014, J INT AIDS SOC S2, V17, P19158, DOI DOI 10.7448/IAS.17.3.19158; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2012, AIDS BEHAV, V16, P1787, DOI 10.1007/s10461-012-0248-4; Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14; Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Quittner AL, 2000, J CLIN PSYCHOL MED S, V7, P41, DOI 10.1023/A:1009545319673; RAND CS, 1994, AM J RESP CRIT CARE, V149, pS69, DOI 10.1164/ajrccm/149.2_Pt_2.S69; Rand CS, 1998, HDB HLTH BEHAV CHANG, P114; Reece W. O., 2009, FUNCTIONAL ANATOMY P; Riekert KA, 2002, J CLIN PSYCHOL MED S, V9, P25, DOI 10.1023/A:1014131928789; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174729	10.1371/journal.pone.0174729	http://dx.doi.org/10.1371/journal.pone.0174729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384179	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000399371900031
J	Orre, M; Latorzeff, I; Flechon, A; Roubaud, G; Brouste, V; Gaston, R; Piechaud, T; Richaud, P; Chapet, O; Sargos, P				Orre, Mathieu; Latorzeff, Igor; Flechon, Aude; Roubaud, Guilhem; Brouste, Veronique; Gaston, Richard; Piechaud, Thierry; Richaud, Pierre; Chapet, Olivier; Sargos, Paul			Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study	PLOS ONE			English	Article							FAILURE RISK STRATIFICATION; LYMPH-NODE DISSECTION; RADIATION-THERAPY; UROTHELIAL CARCINOMA; LOCAL RECURRENCE; POSTOPERATIVE RADIOTHERAPY; LOCOREGIONAL FAILURE; BILHARZIAL BLADDER; PROSTATE-CANCER; SURVIVAL	Objectives Radical cystectomy (RC) and pelvic lymph-node dissection (LND) is standard treatment for non-metastatic muscle-invasive urothelial bladder cancer (MIBC). However, loco-regional recurrence (LRR) is a common early event associated with poor prognosis. We evaluate 3-year LRR-free (LRRFS), metastasis-free (MFS) and overall survivals (OS) after adjuvant radiotherapy (RT) for pathological high-risk MIBC. Material and methods We retrospectively reviewed data from patients in 3 institutions. Inclusion criteria were MIBC, histologically-proven urothelial carcinoma treated by RC and adjuvant RT. Patients with conservative surgery were excluded. Outcomes were evaluated by Kaplan-Meier method. Acute toxicities were recorded according to CTCAE V4.0 scale. Results Between 2000 and 2013, 57 patients [median age 66.3 years (45-84)] were included. Postoperative pathological staging was <= pT2, pT3 and pT4 in 16%, 44%, and 39%, respectively. PLND revealed 28% pN0, 26% pN1 and 42% pN2. Median number of lymph-nodes retrieved was 10 (2-33). Forty-eight patients (84%) received platin-based chemotherapy. For RT, clinical target volume 1 (CTV 1) encompassed pelvic lymph nodes for all patients. CTV 1 also included cystectomy bed for 37 patients (65%). CTV 1 median dose was 45 Gy (4-50). A boost of 16 Gy (5-22), corresponding to CTV 2, was administered for 30 patients, depending on pathological features. One third of patients received intensity-modulated RT. With median follow-up of 40.4 months, 8 patients (14%) had LRR. Three-year LRRFS, MFS and OS were 45% (95%CI 30-60), 37% (95%CI 24-51) and 49% (95%CI 33-63), respectively. Five (9%) patients had acute grade >= 3 toxicities (gastro-intestinal, genito-urinary and biological parameters). One patient died with intestinal fistula in a septic context. Conclusions Because of poor prognosis, an effective post-operative standard of care is needed for pathological high-risk MIBC. Adjuvant RT is feasible and may have oncological benefits. Prospective trials evaluating this approach with current RT techniques should be undertaken.	[Orre, Mathieu; Richaud, Pierre; Sargos, Paul] Inst Bergonie, Dept Radiotherapy, Bordeaux, France; [Latorzeff, Igor] Clin Pasteur, Dept Radiotherapy, Grp Oncorad Garonne, Toulouse, France; [Flechon, Aude] Ctr Leon Berard, Dept Med Oncol, Lyon, France; [Roubaud, Guilhem] Inst Bergonie, Dept Med Oncol, Bordeaux, France; [Brouste, Veronique] Inst Bergonie, Clin & Epidemiol Res Unit, Bordeaux, France; [Gaston, Richard; Piechaud, Thierry] Clin St Augustin, Dept Urol, Bordeaux, France; [Chapet, Olivier] CHU Lyon Sud, Dept Radiotherapy, Lyon, France	UNICANCER; Institut Bergonie; UNICANCER; Centre Leon Berard; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; CHU Lyon	Sargos, P (corresponding author), Inst Bergonie, Dept Radiotherapy, Bordeaux, France.	p.sargos@bordeaux.unicancer.fr						Abd El-Monim H, 2013, UROL ONCOL-SEMIN ORI, V31, P359, DOI 10.1016/j.urolonc.2011.01.008; Ahamad A, 2005, INT J RADIAT ONCOL, V62, P1117, DOI 10.1016/j.ijrobp.2004.12.029; Baumann BC, 2016, INT J RADIAT ONCOL, V96, P78, DOI 10.1016/j.ijrobp.2016.04.032; Baumann BC, 2016, INT J RADIAT ONCOL, V95, P703, DOI 10.1016/j.ijrobp.2016.01.034; Baumann BC, 2013, INT J RADIAT ONCOL, V85, P363, DOI 10.1016/j.ijrobp.2012.03.061; Baumann BC, 2013, INT J RADIAT ONCOL, V85, P81, DOI 10.1016/j.ijrobp.2012.03.007; Cheng L, 2000, CANCER-AM CANCER SOC, V88, P2326, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2326::AID-CNCR17>3.0.CO;2-T; Christodouleas JP, 2014, CANCER-AM CANCER SOC, V120, P1272, DOI 10.1002/cncr.28544; COLE CJ, 1995, INT J RADIAT ONCOL, V32, P331, DOI 10.1016/0360-3016(95)00086-E; de Vries RR, 2010, WORLD J UROL, V28, P431, DOI 10.1007/s00345-010-0512-z; Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Herr HW, 2003, J UROLOGY, V169, P943, DOI 10.1097/01.ju.0000032474.22093.06; Herr HW, 2002, J UROLOGY, V167, P1295, DOI 10.1016/S0022-5347(05)65284-6; Honma I, 2004, UROLOGY, V64, P744, DOI 10.1016/j.urology.2004.05.003; Ide H, 2008, JPN J CLIN ONCOL, V38, P360, DOI 10.1093/jjco/hyn036; Jensen JB, 2012, INT J UROL, V19, P39, DOI 10.1111/j.1442-2042.2011.02887.x; Kassouf W, 2008, J CLIN ONCOL, V26, P121, DOI 10.1200/JCO.2007.12.9247; Ku JH, 2014, INT J RADIAT ONCOL, V89, P1032, DOI 10.1016/j.ijrobp.2014.04.049; Larre S, 2012, PROG UROL, V22, P380, DOI 10.1016/j.purol.2012.02.002; Lawton CAF, 2009, INT J RADIAT ONCOL, V74, P383, DOI 10.1016/j.ijrobp.2008.08.002; Leow JJ, 2014, EUR UROL, V66, P42, DOI 10.1016/j.eururo.2013.08.033; Neuzillet Y, 2013, BJU INT, V111, P1253, DOI 10.1111/j.1464-410X.2012.11664.x; Novotny V, 2015, WORLD J UROL, V33, P1753, DOI 10.1007/s00345-015-1502-y; POLLACK A, 1995, J UROLOGY, V154, P2059, DOI 10.1016/S0022-5347(01)66693-X; Skinner EC, 2007, UROL ONCOL-SEMIN ORI, V25, P66, DOI 10.1016/j.urolonc.2006.05.010; Sonpavde G, 2011, J UROLOGY, V185, P456, DOI 10.1016/j.juro.2010.09.110; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sternberg CN, 2015, LANCET ONCOL, V16, P76, DOI 10.1016/S1470-2045(14)71160-X; Visser O, 2005, J UROLOGY, V174, P97, DOI 10.1097/01.ju.0000162055.58405.96; Wang-Chesebro A, 2006, INT J RADIAT ONCOL, V66, P654, DOI 10.1016/j.ijrobp.2006.05.037; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Zaghloul MS, 2016, INT J RADIAT ONCOL, V96, pS94, DOI 10.1016/j.ijrobp.2016.06.235; Zaghloul MS, 2010, FUTURE ONCOL, V6, P1177, DOI 10.2217/FON.10.82; ZAGHLOUL MS, 1986, RADIOTHER ONCOL, V6, P257, DOI 10.1016/S0167-8140(86)80192-X; ZAGHLOUL MS, 1992, INT J RADIAT ONCOL, V23, P511, DOI 10.1016/0360-3016(92)90005-3; Zaghloul MS, 2016, GEN CANC S SAN FRANC	38	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174978	10.1371/journal.pone.0174978	http://dx.doi.org/10.1371/journal.pone.0174978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384195	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900067
J	Streubel, J; Baum, H; Grau, J; Stuttmann, J; Boch, J				Streubel, Jana; Baum, Heidi; Grau, Jan; Stuttmann, Johannes; Boch, Jens			Dissection of TALE-dependent gene activation reveals that they induce transcription cooperatively and in both orientations (vol 12, e0173580, 2017)	PLOS ONE			English	Correction														Stuttmann, Johannes/0000-0002-6207-094X				Streubel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173580	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175653	10.1371/journal.pone.0175653	http://dx.doi.org/10.1371/journal.pone.0175653			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384283	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900198
J	Khaliq, A; Ravindran, R; Hussainy, SF; Krishnan, VV; Ambreen, A; Yusuf, NW; Irum, S; Rashid, A; Jamil, M; Zaffar, F; Chaudhry, MN; Gupta, PK; Akhtar, MW; Khan, IH				Khaliq, Aasia; Ravindran, Resmi; Hussainy, Syed Fahadulla; Krishnan, Viwanathan V.; Ambreen, Atiqa; Yusuf, Noshin Wasim; Irum, Shagufta; Rashid, Abdul; Jamil, Muhammad; Zaffar, Fareed; Chaudhry, Muhammad Nawaz; Gupta, Puneet K.; Akhtar, Muhammad Waheed; Khan, Imran H.			Field evaluation of a blood based test for active tuberculosis in endemic settings	PLOS ONE			English	Article							PLASMA ANTIBODY PROFILES; SPUTUM SMEAR MICROSCOPY; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; ASSAY; SERODIAGNOSIS; ANTIGENS; AMPLIFICATION; BIOMARKERS; RESPONSES	Over 9 million new active tuberculosis (TB) cases emerge each year from an enormous pool of 2 billion individuals latently infected with Mycobacterium tuberculosis (M. tb.) worldwide. About 3 million new TB cases per year are unaccounted for, and 1.5 million die. TB, however, is generally curable if diagnosed correctly and in a timely manner. The current diagnostic methods for TB, including state-of-the-art molecular tests, have failed in delivering the capacity needed in endemic countries to curtail this ongoing pandemic. Efficient, cost effective and scalable diagnostic approaches are critically needed. We report a multiplex TB serology panel using microbead suspension array containing a combination of 11 M. tb. antigens that demonstrated overall sensitivity of 91% in serum/plasma samples from TB patients confirmed by culture. Group wise sensitivities for sputum smear positive and negative patients were 95%, and 88%, respectively. Specificity of the test was 96% in untreated COPD patients and 91% in general healthy population. The sensitivity of this test is superior to that of the frontline sputum smear test with a comparable specificity (30-70%, and 9399%, respectively). The multiplex serology test can be performed with scalability from 1 to 360 patients per day, and is amenable to automation for higher (1000s per day) throughput, thus enabling a scalable clinical work flow model for TB endemic countries. Taken together, the above results suggest that well defined antibody profiles in blood, analyzed by an appropriate technology platform, offer a valuable approach to TB diagnostics in endemic countries.	[Khaliq, Aasia; Chaudhry, Muhammad Nawaz] Univ Punjab, Coll Earth & Environm Sci, Lahore, Pakistan; [Ravindran, Resmi; Krishnan, Viwanathan V.; Khan, Imran H.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Hussainy, Syed Fahadulla; Zaffar, Fareed] Lahore Univ Management Sci, Sch Sci & Engn, Dept Comp Sci, Lahore, Pakistan; [Krishnan, Viwanathan V.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Ambreen, Atiqa; Rashid, Abdul; Jamil, Muhammad] Gulab Devi Chest Hosp, Lahore, Pakistan; [Yusuf, Noshin Wasim; Irum, Shagufta] Allama lqbal Med Coll, Dept Pathol, Lahore, Pakistan; [Gupta, Puneet K.] NextGen Vitro Diagnost, New Delhi, India; [Akhtar, Muhammad Waheed] Univ Punjab, Sch Biol Sci, Lahore, Pakistan	University of Punjab; University of California System; University of California Davis; Lahore University of Management Sciences; California State University System; California State University Fresno; University of Punjab	Khan, IH (corresponding author), Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA.; Akhtar, MW (corresponding author), Univ Punjab, Sch Biol Sci, Lahore, Pakistan.	mwa.sbs@pu.edu.pk; ihkhan@ucdavis.edu	Khan, Imran Ali/GVT-0232-2022; Gupta, Puneet K/H-2841-2016; Nadeem, Muhammad Shahid/H-2372-2017; Khan, imran/GQQ-2176-2022	Khan, Imran Ali/0000-0002-8774-2896; Gupta, Puneet K/0000-0003-1108-5903; Nadeem, Muhammad Shahid/0000-0003-4112-0925; Khaliq, Aasia/0000-0003-1833-0940	NextGen In Vitro Diagnostics	NextGen In Vitro Diagnostics	The funder (NextGen In Vitro Diagnostics) provided support in the form of salary for author PG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Al Zahrani K, 2000, AM J RESP CRIT CARE, V162, P1323, DOI 10.1164/ajrccm.162.4.9912115; [Anonymous], 2006, DIAGNOSTICS TUBERCUL; Bianchi L, 2009, PEDIATR INFECT DIS J, V28, P510, DOI 10.1097/INF.0b013e31819abf6b; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1999, NEURAL COMPUT, V11, P1493, DOI 10.1162/089976699300016106; Brusasca PN, 2003, COMPARATIVE MED, V53, P165; Buijtels PCA, 2005, J MICROBIOL METH, V62, P83, DOI 10.1016/j.mimet.2005.01.010; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; De Almeida Isabela Neves, 2013, BMC Res Notes, V6, P561, DOI 10.1186/1756-0500-6-561; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Faisel A, 2006, SEX TRANSM INFECT, V82, P307, DOI 10.1136/sti.2005.018762; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10; Kanaujia GV, 2003, COMPARATIVE MED, V53, P602; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kumar P, 2014, J INFECTION, V69, P607, DOI 10.1016/j.jinf.2014.08.017; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1226; Lyashchenko KP, 2007, CLIN VACCINE IMMUNOL, V14, P1158, DOI 10.1128/CVI.00230-07; Mani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116262; MARTIN ME, 1968, APPL MICROBIOL, V16, P506, DOI 10.1128/AEM.16.3.506-508.1968; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mulcahy GM, 1996, J CLIN MICROBIOL, V34, P1348, DOI 10.1128/JCM.34.5.1348-1349.1996; Ohta S, 2008, J NETW SYST MANAG, V16, P399, DOI 10.1007/s10922-008-9102-4; Organization WH, 2011, COMMERCIAL SERODIAGN; Organization WH, 2010, WHO END NEW RAP TUB; Organization WH, 2009, PATHW BETT DIAGN TUB; Organization WH, US TUB INT GAMM REL; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ravindran R, 2014, J MED PRIMATOL, V43, P59, DOI 10.1111/jmp.12097; Ravindran R, 2013, CLIN VACCINE IMMUNOL, V20, P1283, DOI 10.1128/CVI.00213-13; ROELSGAARD E, 1957, Bull World Health Organ, V17, P187; Safianowska Aleksandra, 2012, Pneumonol Alergol Pol, V80, P6; Saitoh H, 1999, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V10, P103; Saqib Muhammad An, 2011, BMC Res Notes, V4, P165, DOI 10.1186/1756-0500-4-165; Singh S, 2011, INDIAN J MED RES, V134, P384, DOI 10.4103/0971-5916.90980; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195; WHO, 2015, GLOB TUB REP; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; Zhou Jin-song, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P830; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173359	10.1371/journal.pone.0173359	http://dx.doi.org/10.1371/journal.pone.0173359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380055	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500018
J	Toppen, W; Johansen, D; Sareh, S; Fernandez, J; Satou, N; Patel, KD; Kwon, M; Suh, W; Aksoy, O; Shemin, RJ; Benharash, P				Toppen, William; Johansen, Daniel; Sareh, Sohail; Fernandez, Josue; Satou, Nancy; Patel, Komal D.; Kwon, Murray; Suh, William; Aksoy, Olcay; Shemin, Richard J.; Benharash, Peyman			Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: Time to wake up?	PLOS ONE			English	Article							AORTIC-VALVE-REPLACEMENT; INTERMEDIATE-RISK PATIENTS; SINGLE-CENTER; TRANSCATHETER; METAANALYSIS; VALIDATION; CARE	Background Transcatheter aortic valve replacement (TAVR) has become a commonplace procedure for the treatment of aortic stenosis in higher risk surgical patients. With the high cost and steadily increasing number of patients receiving TAVR, emphasis has been placed on optimizing outcomes as well as resource utilization. Recently, studies have demonstrated the feasibility of conscious sedation in lieu of general anesthesia for TAVR. This study aimed to investigate the clinical as well as cost outcomes associated with conscious sedation in comparison to general anesthesia in TAVR. Methods Records for all adult patients undergoing TAVR at our institution between August 2012 and June 2016 were included using our institutional Society of Thoracic Surgeons (STS) and American College of Cardiology (ACC) registries. Cost data was gathered using the BIOME database. Patients were stratified into two groups according to whether they received general anesthesia (GA) or conscious sedation (CS) during the procedure. No-replacement propensity score matching was done using the validated STS predicted risk of mortality (PROM) as a propensity score. Primary outcome measure with survival to discharge and several secondary outcome measures were also included in analysis. According to our institution's data reporting guidelines, all cost data is presented as a percentage of the general anesthesia control group cost. Results Of the 231 patients initially identified, 225 (157 GA, 68 CS) were included for analysis. After no-replacement propensity score matching, 196 patients (147 GA, 49 CS) remained. Overall mortality was 1.5% in the matched population with a trend towards lower mortality in the CS group. Conscious sedation was associated with significantly fewer ICU hours (30 vs 96 hours, p = <0.001) and total hospital days (4.9 vs 10.4, p<0.001). Additionally, there was a 28% decrease in direct cost (p<0.001) as well as significant decreases in all individual all cost categories associated with the use of conscious sedation. There was no difference in composite major adverse events between groups. These trends remained on all subsequent subgroup analyses. Conclusion Conscious sedation is emerging as a safe and viable option for anesthesia in patients undergoing transcatheter aortic valve replacement. The use of conscious sedation was not only associated with similar rates of adverse events, but also shortened ICU and overall hospital stays. Finally, there were significant decreases in all cost categories when compared to a propensity matched cohort receiving general anesthesia.	[Toppen, William] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Johansen, Daniel; Sareh, Sohail; Fernandez, Josue; Satou, Nancy; Kwon, Murray; Shemin, Richard J.; Benharash, Peyman] Univ Calif Los Angeles, Div Cardiac Surg, Los Angeles, CA 90095 USA; [Patel, Komal D.] Univ Calif Los Angeles, Dept Anesthesia & Preoperat Med, Los Angeles, CA USA; [Suh, William; Aksoy, Olcay] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Benharash, P (corresponding author), Univ Calif Los Angeles, Div Cardiac Surg, Los Angeles, CA 90095 USA.	PBenharash@mednet.ucla.edu						American Society of Anesthesiologists, 2004, CONT DEPTH SED DEF G; Arora S, 2016, CARDIOVASC DIAGN THE, V6, P241, DOI 10.21037/cdt.2016.03.04; Babaliaros V, 2014, JACC-CARDIOVASC INTE, V7, P898, DOI 10.1016/j.jcin.2014.04.005; Collas VM, 2016, INTERACT CARDIOV TH, V22, P273, DOI 10.1093/icvts/ivv340; Frohlich GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-41; Goren O, 2015, J CLIN ANESTH, V27, P385, DOI 10.1016/j.jclinane.2015.03.025; Hannan EL, 2016, JACC-CARDIOVASC INTE, V9, P578, DOI 10.1016/j.jcin.2015.12.022; Jensen HA, 2016, ANN THORAC SURG; Krajcer Z, 2012, J CARDIOVASC SURG, V53, P695; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Reynolds MR, 2012, CIRCULATION, V125, P1102, DOI 10.1161/CIRCULATIONAHA.111.054072; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Spertus JA, 2015, CIRC-CARDIOVASC QUAL, V8, P469, DOI 10.1161/CIRCOUTCOMES.115.001958; Supino Phyllis G, 2006, Heart Fail Clin, V2, P379, DOI 10.1016/j.hfc.2006.09.010; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754	15	47	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173777	10.1371/journal.pone.0173777	http://dx.doi.org/10.1371/journal.pone.0173777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379981	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500023
J	Huang, HQ; Roh, J; Davis, CD; Wang, TTY				Huang, Haiqiu; Roh, Jamin; Davis, Cindy D.; Wang, Thomas T. Y.			An improved method to quantitate mature plant microRNA in biological matrices using modified periodate treatment and inclusion of internal controls	PLOS ONE			English	Article							MIRNAS; RNAS; BIOAVAILABILITY; QUANTIFICATION; IDENTIFICATION; BIOGENESIS; PCR	MicroRNAs (miRNAs) ubiquitously exist in microorganisms, plants, and animals, and appear to modulate a wide range of critical biological processes. However, no definitive conclusion has been reached regarding the uptake of exogenous dietary small RNAs into mammalian circulation and organs and cross-kingdom regulation. One of the critical issues is our ability to assess and distinguish the origin of miRNAs. Although periodate oxidation has been used to differentiate mammalian and plant miRNAs, validation of treatment efficiency and the inclusion of proper controls for this method were lacking in previous studies. This study aimed to address: 1) the efficiency of periodate treatment in a plant or mammalian RNA matrix, and 2) the necessity of inclusion of internal controls. We designed and tested spike-in synthetic miRNAs in various plant and mammalian matrices and showed that they can be used as a control for the completion of periodate oxidation. We found that overloading the reaction system with high concentration of RNA resulted in incomplete oxidation of unmethylated miRNA. The abundant miRNAs from soy and corn were analyzed in the plasma, liver, and fecal samples of C57BL/6 mice fed a corn and soy-based chow diet using our improved methodology. The improvement resulted in the elimination of the false positive detection in the liver, and we did not detect plant miRNAs in the mouse plasma or liver samples. In summary, an improved methodology was developed for plant miRNA detection that appears to work well in different sample matrices.	[Huang, Haiqiu; Roh, Jamin; Wang, Thomas T. Y.] USDA ARS, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA; [Huang, Haiqiu; Davis, Cindy D.] NIH, Off Dietary Supplements, Bethesda, MD 20892 USA	United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA	Wang, TTY (corresponding author), USDA ARS, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA.	Tom.Wang@ars.usda.gov	Huang, Haiqiu/J-8856-2012	Huang, Haiqiu/0000-0003-1543-3901	U.S. department of Agriculture appropriated fund [8040-51530-056-00D]; Office of Dietary Supplements Interagency Reimbursable Agreement [8040-51530-056-20-I]	U.S. department of Agriculture appropriated fund; Office of Dietary Supplements Interagency Reimbursable Agreement	Support was provided by the U.S. department of Agriculture appropriated fund #8040-51530-056-00D; and by the Office of Dietary Supplements Interagency Reimbursable Agreement #8040-51530-056-20-I.	Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beatty M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-933; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chiang KV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128089; Chin AR, 2016, CELL RES; Rosas-Cardenas FD, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-4; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146145; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang Y, 2010, MOL BIOL REP, V37, P3171, DOI 10.1007/s11033-009-9897-4; KEITH G, 1974, BIOCHEMISTRY-US, V13, P3601, DOI 10.1021/bi00714a031; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Liang HW, 2015, J NUTR BIOCHEM, V26, P505, DOI 10.1016/j.jnutbio.2014.12.002; Masotti A, 2009, BIOMED RES INT, V2009; Mico V, 2016, PLANT FOOD HUM NUTR, V71, P102, DOI 10.1007/s11130-016-0534-9; Ohara T, 2007, NATURE STRUCTURAL MO, V14; Philip A, 2015, MOL NUTR FOOD RES, V59, P1962, DOI 10.1002/mnfr.201500137; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ranjha R, 2013, INFLAMM RES, V62, P343, DOI 10.1007/s00011-013-0600-9; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Witwer KW, 2015, J NUTR BIOCHEM, V26, P1685, DOI 10.1016/j.jnutbio.2015.09.004; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137516; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2010, METHODS MOL BIOL, V592, P137, DOI 10.1007/978-1-60327-005-2_10; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	41	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175429	10.1371/journal.pone.0175429	http://dx.doi.org/10.1371/journal.pone.0175429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399134	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000037
J	Ferreira, J; Carvalho, E; Ferreira, BV; de Souza, C; Suhara, Y; Pentland, A; Pessin, G				Ferreira Junior, Jair; Carvalho, Eduardo; Ferreira, Bruno V.; de Souza, Cleidson; Suhara, Yoshihiko; Pentland, Alex; Pessin, Gustavo			Driver behavior profiling: An investigation with different smartphone sensors and machine learning	PLOS ONE			English	Article								Driver behavior impacts traffic safety, fuel/energy consumption and gas emissions. Driver behavior profiling tries to understand and positively impact driver behavior. Usually driver behavior profiling tasks involve automated collection of driving data and application of computer models to generate a classification that characterizes the driver aggressiveness profile. Different sensors and classification methods have been employed in this task, however, low-cost solutions and high performance are still research targets. This paper presents an investigation with different Android smartphone sensors, and classification algorithms in order to assess which sensor/method assembly enables classification with higher performance. The results show that specific combinations of sensors and intelligent methods allow classification performance improvement.	[Ferreira Junior, Jair; Carvalho, Eduardo; Ferreira, Bruno V.; de Souza, Cleidson; Pessin, Gustavo] Inst Tecnol Vale, Appl Comp Lab, Belem, PA, Brazil; [Ferreira Junior, Jair; de Souza, Cleidson; Pessin, Gustavo] Fed Univ Para, Inst Exact & Nat Sci, Belem, PA, Brazil; [Carvalho, Eduardo; Ferreira, Bruno V.] SENAI Inst Innovat Mineral Technol, Belem, PA, Brazil; [Suhara, Yoshihiko] Recruit Inst Technol, Mountain View, CA USA; [Pentland, Alex] MIT, Media Lab, Cambridge, MA 02139 USA	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal do Para; Massachusetts Institute of Technology (MIT)	Pessin, G (corresponding author), Inst Tecnol Vale, Appl Comp Lab, Belem, PA, Brazil.; Pessin, G (corresponding author), Fed Univ Para, Inst Exact & Nat Sci, Belem, PA, Brazil.	gustavo.pessin@itv.org	Pessin, Gustavo/A-8524-2013; de Souza, Cleidson R B/J-4409-2014	Pessin, Gustavo/0000-0002-7411-9229; de Souza, Cleidson R B/0000-0003-3240-3122; da Silva Ferreira Junior, Jair/0000-0003-0921-6660	MCTI/CT-Info/CNPq [277440880/2013-0]	MCTI/CT-Info/CNPq	This work was supported by MCTI/CT-Info/CNPq, process 277440880/2013-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P1005, DOI 10.1109/IVS.2012.6232304; Ben-Gal I, 2008, BAYESIAN NETWORKS; Blincoe Lawrence, 2015, EC SOC IMPACT MOTOR; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Castignani G, 2015, IEEE INTEL TRANSP SY, V7, P91, DOI 10.1109/MITS.2014.2328673; Castignani G, 2013, IEEE INT C INTELL TR, P552, DOI 10.1109/ITSC.2013.6728289; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dai J, 2010, P 4 INT ICST C PERV, P1, DOI DOI 10.1097/MPA.0B013E3181F7E09F; Domingos P., 2015, MASTER ALGORITHM QUE, DOI 10.5555/3217330; Engelbrecht J, 2015, IET INTELL TRANSP SY, V9, P924, DOI 10.1049/iet-its.2014.0248; Eren H, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P234, DOI 10.1109/IVS.2012.6232298; Evans L., 2004, TRAFFIC SAFETY; Fan Xiaoqiu, 2011, 2011 International Conference on Measuring Technology and Mechatronics Automation (ICMTMA), P370, DOI 10.1109/ICMTMA.2011.379; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fazeen M, 2012, IEEE T INTELL TRANSP, V13, P1462, DOI 10.1109/TITS.2012.2187640; Handel P, 2014, IEEE SYST J, V8, P1238, DOI 10.1109/JSYST.2013.2292721; Haworth N, 2001, P ROAD SAF RES POL E, P7; Haykin S., 2009, NEURAL NETWORKS LEAR, Vthird; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Johnson DA, 2011, IEEE INT C INTELL TR, P1609, DOI 10.1109/ITSC.2011.6083078; Mohan P, 2008, SENSYS'08: PROCEEDINGS OF THE 6TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS, P323; Paefgen J, 2012, ACM; Saiprasert C, 2013, PROCEEDINGS OF THE 2; Saiprasert C, 2014, INT CONF CONNECT VEH, P552, DOI 10.1109/ICCVE.2014.7297609; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Skog I, 2013, IEEE GLOB CONF SIG, P1135, DOI 10.1109/GlobalSIP.2013.6737098; Song H, 2009, TRANSP RES BOARD 88; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Van Mierlo J, 2004, P I MECH ENG D-J AUT, V218, P43, DOI 10.1243/095440704322829155; Vapnik V., 2000, STAT ENG INFORM SCI, DOI [DOI 10.1007/978-1-4757-3264-1, 10.1007/978-1-4757-3264-1]; Wahlstrom J, 2015, IEEE T INTELL TRANSP, V16, DOI 10.1109/TITS.2015.2431293; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; White J, 2011, MOBILE NETW APPL, V16, P285, DOI 10.1007/s11036-011-0304-8; Zhao CH, 2012, ENG APPL ARTIF INTEL, V25, P1677, DOI 10.1016/j.engappai.2012.09.018	37	107	111	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174959	10.1371/journal.pone.0174959	http://dx.doi.org/10.1371/journal.pone.0174959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394925	Green Published, gold			2022-12-27	WOS:000399954800010
J	Kasai, T; Kondo, M; Ishii, R; Tanaka, A; Ataka, S; Shimada, H; Tomiyama, T; Mori, H; Taylor, M; Allsop, D; Nakagawa, M; Mizuno, T; Tokuda, T				Kasai, Takashi; Kondo, Masaki; Ishii, Ryotaro; Tanaka, Akihiro; Ataka, Suzuka; Shimada, Hiroyuki; Tomiyama, Takami; Mori, Hiroshi; Taylor, Mark; Allsop, David; Nakagawa, Masanori; Mizuno, Toshiki; Tokuda, Takahiko			A beta levels in the jugular vein and high molecular weight A beta oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease	PLOS ONE			English	Article							PITTSBURGH COMPOUND-B; INTRAVENOUS IMMUNOGLOBULIN; HIGH-AFFINITY; MOUSE MODEL; PEPTIDE; TRIALS; IMMUNOTHERAPY; ANTIBODIES; BINDING; PLASMA	Intravenous immunoglobulin (IVIg) has been a candidate as a potential anti-amyloid immunotherapy for Alzheimer disease (AD) because it contains anti-amyloid beta (A beta) antibodies. Although several studies with IVIg in AD have been published, changing levels of A beta efflux from the brain, or disaggregation of A beta species induced by immunotherapy, have not been properly investigated. Here, we carried out an open label study of therapy with IVIg in five patients with AD. We collected plasma from a peripheral vein (peripheral-plasma) and from the internal jugular vein (jugular-plasma) to estimate directly the efflux of soluble A beta from the brain. We also measured high molecular weight (HMW) A beta oligomers in CSF as a marker to detect disaggregated A beta. IVIg infusions were well tolerated in the majority of cases. However, one study subject had epileptic seizures after IVIg. Levels of HMW CSF A beta oligomers in all participants were significantly increased after IVIg. A beta 40 and A beta 42 levels in jugular-plasma were continuously or temporarily elevated after treatment in three of five patients who showed preserved cognitive function, whereas levels of those in peripheral- plasma did not correlate with reactivity to the treatment. Other conventional biomarkers including C-11-Pittsburgh compound B retention were not altered after the treatment. These findings imply that HMW A beta oligomer levels could be a better biomarker to reflect the anti-amyloid effects of IVIg than conventional A beta species; moreover, A beta in jugular-plasma seems to be a more direct and precise biomarker to estimate clearance of A beta from the brain rather than A beta in peripheral-plasma.	[Kasai, Takashi; Kondo, Masaki; Ishii, Ryotaro; Tanaka, Akihiro; Nakagawa, Masanori; Mizuno, Toshiki; Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Neurol, Res Inst Geriatr, Kyoto, Japan; [Ataka, Suzuka; Shimada, Hiroyuki] Osaka City Univ, Grad Sch Med, Dept Geriatr & Neurol, Osaka, Japan; [Tomiyama, Takami; Mori, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Neurosci, Osaka, Japan; [Taylor, Mark; Allsop, David] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, North Med Ctr, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Res Inst Geriatr, Kyoto, Japan	Kyoto Prefectural University of Medicine; Osaka Metropolitan University; Osaka Metropolitan University; Lancaster University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T; Tokuda, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Res Inst Geriatr, Kyoto, Japan.; Tokuda, T (corresponding author), Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Res Inst Geriatr, Kyoto, Japan.	kasaita@koto.kpu-m.ac.jp; ttokuda@koto.kpu-m.ac.ja	Ishii, Ryotaro/K-4595-2019; Allsop, David/B-9725-2008; Mizuno, Toshiki/AAH-7155-2020	Allsop, David/0000-0002-0513-5575; 	Mitsubishi Tanabe Pharma Corporation [20-437]	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This work was supported by a grant to MN from Mitsubishi Tanabe Pharma Corporation (exsiting Japan Blood Product Organization). (Grant number: 20-437). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Carare RO, 2014, BRAIN BEHAV IMMUN, V36, P9, DOI 10.1016/j.bbi.2013.10.012; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2013, LANCET NEUROL, V12, P233, DOI 10.1016/S1474-4422(13)70014-0; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Fillit H, 2009, NEUROLOGY, V73, P180, DOI 10.1212/WNL.0b013e3181ae7aaf; Frenkel D, 1999, J NEUROIMMUNOL, V95, P136, DOI 10.1016/S0165-5728(99)00003-X; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gold R, 2007, NAT CLIN PRACT NEURO, V3, P36, DOI 10.1038/ncpneuro0376; Herskovits AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067898; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Kasai T, 2013, NEUROSCI LETT, V551, P17, DOI 10.1016/j.neulet.2013.06.029; Kasai T, 2012, BIOCHEM BIOPH RES CO, V422, P375, DOI 10.1016/j.bbrc.2012.04.146; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Loeffler DA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-70; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Relkin N, 2008, J NUCL MED S1, V49, P36; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009	31	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174630	10.1371/journal.pone.0174630	http://dx.doi.org/10.1371/journal.pone.0174630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394917	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800006
J	Lv, JJ; Zhang, LT; Liu, P; Li, JA				Lv, Jianjian; Zhang, Longtao; Liu, Ping; Li, Jian			Transcriptomic variation of eyestalk reveals the genes and biological processes associated with molting in Portunus trituberculatus	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; DIFFERENTIALLY EXPRESSED GENES; CRAYFISH PROCAMBARUS-CLARKII; PIGMENT-DISPERSING HORMONE; CENTRAL-NERVOUS-SYSTEM; SHORT NEUROPEPTIDE F; RNA-SEQ DATA; UCA-PUGILATOR; LITOPENAEUS-VANNAMEI; INHIBITING HORMONE	Background Molting is an essential biological process throughout the life history of crustaceans, which is regulated by many neuropeptide hormones expressed in the eyestalk. To better understand the molting mechanism in Portunus trituberculatus, we used digital gene expression (DGE) to analyze single eyestalk samples during the molting cycle by high-throughput sequencing. Results We obtained 14,387,942, 12,631,508 and 13,060,062 clean sequence reads from inter-molt (InM), pre-molt (PrM) and post-molt (PoM) cDNA libraries, respectively. A total of 1,394 molt-related differentially expressed genes (DEGs) were identified. GO and KEGG enrichment analysis identified some important processes and pathways with key roles in molting regulation, such as chitin metabolism, peptidase inhibitor activity, and the ribosome. We first observed a pattern associated with the neuromodulator-related pathways during the molting cycle, which were up-regulated in PrM and down-regulated in PoM. Four categories of important molting-related transcripts were clustered and most of them had similar expression patterns, which suggests that there is a connection between these genes throughout the molt cycle. Conclusion Our work is the first molt-related investigation of P. trituberculatus focusing on the eyestalk at the whole transcriptome level. Together, our results, including DEGs, identification of molting-related biological processes and pathways, and observed expression patterns of important genes, provide a novel insight into the function of the eyestalk in molting regulation.	[Lv, Jianjian; Zhang, Longtao; Liu, Ping; Li, Jian] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China; [Lv, Jianjian; Zhang, Longtao; Liu, Ping; Li, Jian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology	Li, JA (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China.; Li, JA (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Peoples R China.	lijian@ystri.ac.cn	LI, RUIJIAN/GYJ-0470-2022		National Natural Science Foundation of China [41576147]; Efficient Eco Agriculture Innovation Project of Taishan Leading Talent Project [LJNY2015002]; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Efficient Eco Agriculture Innovation Project of Taishan Leading Talent Project; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology	This research was supported by the National Natural Science Foundation of China (No. 41576147), Efficient Eco Agriculture Innovation Project of Taishan Leading Talent Project (No. LJNY2015002) and The Scientific and Technological Innovation Project financially supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ02).	Anders S., 2010, MOL BIOL; Andersen SO, 1999, COMP BIOCHEM PHYS A, V123, P203, DOI 10.1016/S1095-6433(99)00051-3; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; [Anonymous], 2008, ECDYSTEROID RECEPTOR; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Covi JA, 2012, INVERTEBR REPROD DEV, V56, P33, DOI 10.1080/07924259.2011.588009; DeKleijn DPV, 1995, COMP BIOCHEM PHYS B, V112, P573, DOI 10.1016/0305-0491(95)00126-3; Duangprom S, 2017, AQUACULTURE, V468, P481, DOI 10.1016/j.aquaculture.2016.11.008; Durica DS, 1999, AM ZOOL, V39, P758; Ernst J, THE SHORT TIME SERIE; FINGERMAN M, 1974, GEN PHARMACOL-VASC S, V5, P299, DOI 10.1016/S0306-3623(74)80042-X; GIRARDIE J, 1987, INSECT BIOCHEM, V17, P977, DOI 10.1016/0020-1790(87)90106-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hill RJ, 2012, ADV INSECT PHYSIOL, V43, P299, DOI 10.1016/B978-0-12-391500-9.00004-8; Hirano M, 2008, EXPRESSION ANAL ECDY; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Huang S.-W., 2015, SCI REPORTS, V5; Jie S, 2011, J FISH CHINA, P1481; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; Junzeng X, 1997, DONGHAI MARIN E SCIE, V15, P60; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kuballa AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-147; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loh JT, 2001, MOL MICROBIOL, V41, P1357, DOI 10.1046/j.1365-2958.2001.02603.x; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; Manfrin C, 2015, GENE, V557, P28, DOI 10.1016/j.gene.2014.12.001; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Ollivaux C, 2002, J COMP NEUROL, V444, P1, DOI 10.1002/cne.1426; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Pitts NL, 2017, COMP BIOCHEM PHYS A, V203, P328, DOI 10.1016/j.cbpa.2016.10.012; Qian ZY, 2014, COMP BIOCHEM PHYS A, V172, P10, DOI 10.1016/j.cbpa.2014.02.011; Ren Q, 2014, AQUACULTURE, V434, P108, DOI 10.1016/j.aquaculture.2014.08.008; Robert A, 2016, AQUAT TOXICOL, V175, P192, DOI 10.1016/j.aquatox.2016.03.025; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Shang YH, 2013, NEURON, V80, P171, DOI 10.1016/j.neuron.2013.07.029; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; Shyamal S, 2015, GEN COMP ENDOCR, V211, P39, DOI 10.1016/j.ygcen.2014.11.006; Skinner DM., 1985, INTEGUMENT PIGMENTS, P43; Stewart MJ, 2013, COMP BIOCHEM PHYS A, V164, P276, DOI 10.1016/j.cbpa.2012.10.029; Suwansa-ard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123848; Tan SH, 2000, MAR BIOTECHNOL, V2, P126; Techa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117278; Techa S, 2013, GENE, V527, P139, DOI 10.1016/j.gene.2013.05.035; Tom M, 2014, J EXP BIOL, V217, P4193, DOI 10.1242/jeb.109009; Cahansky AV, 2011, COMP BIOCHEM PHYS A, V158, P126, DOI 10.1016/j.cbpa.2010.09.016; Wang ChunJian, 2013, Acta Hydrobiologica Sinica, V37, P22; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Webster S. E., 2015, PHYSIOLOGY, P1; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xie X, 2016, COMP BIOCHEM PHYS B, V200, P69, DOI 10.1016/j.cbpb.2016.06.004; Xu ZQ, 2015, GENE, V569, P280, DOI 10.1016/j.gene.2015.05.075; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang SY, 2014, COMP BIOCHEM PHYS B, V167, P30, DOI 10.1016/j.cbpb.2013.09.009; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zou EM, 2004, COMP BIOCHEM PHYS C, V139, P225, DOI 10.1016/j.cca.2004.11.003	72	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175315	10.1371/journal.pone.0175315	http://dx.doi.org/10.1371/journal.pone.0175315			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394948	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800026
J	Bosch, X; Monclus, E; Escoda, O; Guerra-Garcia, M; Moreno, P; Guasch, N; Lopez-Soto, A				Bosch, Xavier; Monclus, Esther; Escoda, Ona; Guerra-Garcia, Mar; Moreno, Pedro; Guasch, Neus; Lopez-Soto, Alfons			Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients	PLOS ONE			English	Article							QUICK DIAGNOSIS UNITS; POTENTIALLY SEVERE DISEASES; SPANISH HEALTH-CARE; CONVENTIONAL HOSPITALIZATION; DELIVERY MODEL; CANCER; POPULATION; VALIDATION; REFERRALS; ANEMIA	Background Whereas there are numerous studies on unintentional weight loss (UWL), these have been limited by small sample sizes, short or variable follow-up, and focus on older patients. Although some case series have revealed that malignancies escaping early detection and uncovered subsequently are exceptional, reported follow-ups have been too short or unspecified and necropsies seldom made. Our objective was to examine the etiologies, characteristics, and long-term outcome of UWL in a large cohort of outpatients. Methods We prospectively enrolled patients referred to an outpatient diagnosis unit for evaluation of UWL as a dominant or isolated feature of disease. Eligible patients underwent a standard baseline evaluation with laboratory tests and chest X-ray. Patients without identifiable causes 6 months after presentation underwent a systematic follow-up lasting for 60 further months. Subjects aged >= 65 years without initially recognizable causes underwent an oral cavity examination, a videofluoroscopy or swallowing study, and a depression and cognitive assessment. Results Overall, 2677 patients (mean age, 64.4 [14.7] years; 51% males) were included. Predominant etiologies were digestive organic disorders (nonmalignant in 17% and malignant in 16%). Psychosocial disorders explained 16% of cases. Oral disorders were second to nonhematologic malignancies as cause of UWL in patients aged >= 65 years. Although 375 (14%) patients were initially diagnosed with unexplained UWL, malignancies were detected in only 19 (5%) within the first 28 months after referral. Diagnosis was established at autopsy in 14 cases. Conclusion This investigation provides new information on the relevance of follow-up in the long-term clinical outcome of patients with unexplained UWL and on the role of age on this entity. Although unexplained UWL seldom constitutes a short-term medical alert, malignancies may be undetectable until death. Therefore, these patients should be followed up regularly (eg yearly visits) for longer than reported periods, and autopsies pursued when facing unsolved deaths.	[Bosch, Xavier; Monclus, Esther; Escoda, Ona; Guerra-Garcia, Mar; Guasch, Neus] Univ Barcelona, Hosp Clin, Quick Diag Unit, Adult Day Care Ctr, Barcelona, Spain; [Bosch, Xavier; Monclus, Esther; Escoda, Ona; Moreno, Pedro; Lopez-Soto, Alfons] Univ Barcelona, Hosp Clin, Dept Internal Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Bosch, X (corresponding author), Univ Barcelona, Hosp Clin, Quick Diag Unit, Adult Day Care Ctr, Barcelona, Spain.; Bosch, X (corresponding author), Univ Barcelona, Hosp Clin, Dept Internal Med, Barcelona, Spain.	xavbasch@clinic.ub.es		Monclus Cols, Ester/0000-0001-5064-2632				Baicus C, 2006, EUR J INTERN MED, V17, P28, DOI 10.1016/j.ejim.2005.07.009; Baicus C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095286; Bilbao-Garay J, 2002, Eur J Intern Med, V13, P240, DOI 10.1016/S0953-6205(02)00032-8; BLAZER D, 1980, AM J PSYCHIAT, V137, P439; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Bosch X, 2015, HEALTH POLICY, V119, P107, DOI 10.1016/j.healthpol.2014.10.020; Bosch X, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000095; Bosch X, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-75; Bosch X, 2014, INT J HEALTH SERV, V44, P25, DOI 10.2190/HS.44.1.c; Bosch X, 2013, AM J EMERG MED, V31, P114, DOI 10.1016/j.ajem.2012.06.013; Bosch X, 2012, EUR J INTERN MED, V23, P720, DOI 10.1016/j.ejim.2012.08.006; Bosch X, 2012, ONCOLOGY-BASEL, V83, P283, DOI 10.1159/000341658; Bosch X, 2012, J HOSP MED, V7, P41, DOI 10.1002/jhm.931; Bosch X, 2012, EUR J INTERN MED, V23, P159, DOI 10.1016/j.ejim.2011.02.013; Bosch X, 2009, MED J AUSTRALIA, V191, P496, DOI 10.5694/j.1326-5377.2009.tb02912.x; Bouras EP, 2001, MAYO CLIN PROC, V76, P923; Brito-Zeron P, 2014, EUR J CLIN INVEST, V44, P707, DOI 10.1111/eci.12287; Campbell J, 2001, J ROY SOC MED, V94, P628, DOI 10.1177/014107680109401206; Capell S, 2004, MED CLIN-BARCELONA, V123, P247, DOI 10.1157/13065197; CarrLopez SM, 1996, DRUG AGING, V9, P221, DOI 10.2165/00002512-199609040-00001; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SP, 2010, ARCH GERONTOL GERIAT, V50, pS27, DOI 10.1016/S0167-4943(10)70008-X; Clarkston WK, 1997, AM J PHYSIOL-REG I, V272, pR243, DOI 10.1152/ajpregu.1997.272.1.R243; Evans AT, 2016, APPROACH PATIENT UNI; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Gaddey HL, 2014, AM FAM PHYSICIAN, V89, P718; Goldeberg RJ, 2005, LONG TERM CARE INTER, V6, P20; Gupta S, 2014, J HOSP MED, V9, P54, DOI 10.1002/jhm.2129; Lankisch PG, 2001, J INTERN MED, V249, P41, DOI 10.1046/j.1365-2796.2001.00771.x; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Loser C, 2007, DABI, V104, pA3411; MARTON KI, 1981, ANN INTERN MED, V95, P568, DOI 10.7326/0003-4819-95-5-568; McDonagh MS, 2000, HEALTH POLICY, V53, P157, DOI 10.1016/S0168-8510(00)00092-0; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Metalidis C, 2008, EUR J INTERN MED, V19, P345, DOI 10.1016/j.ejim.2007.09.019; MORLEY JE, 1994, J AM GERIATR SOC, V42, P583, DOI 10.1111/j.1532-5415.1994.tb06853.x; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Organisation for Economic Cooperation and Development, HLTH GLANC EUR 2014; Payette H, 2000, J CLIN EPIDEMIOL, V53, P579, DOI 10.1016/S0895-4356(99)00186-9; Pericas JM, 2013, EUR J CLIN INVEST, V43, P602, DOI 10.1111/eci.12087; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; ROBBINS LJ, 1989, GERIATRICS, V44, P31; Rubio-Rivas M, 2008, REV CLIN ESP, V208, P561, DOI 10.1016/S0014-2565(08)76034-X; Sanchez JLA, 2004, MED CLIN-BARCELONA, V122, P653; Sanclemente-Anso C, 2016, EUR J INTERN MED, V30, P11, DOI 10.1016/j.ejim.2015.12.015; Sanclemente-Anso C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1070-2; Sanclemente-Anso C, 2013, POL ARCH MED WEWN, V123, P582, DOI 10.20452/pamw.1966; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith HA, 2000, AGE AGEING, V29, P495, DOI 10.1093/ageing/29.6.495; Stajkovic S, 2011, CAN MED ASSOC J, V183, P443, DOI 10.1503/cmaj.101471; SULLIVAN DH, 1993, J AM GERIATR SOC, V41, P725, DOI 10.1111/j.1532-5415.1993.tb07461.x; Teran CMS, 2002, MED CLIN-BARCELONA, V118, P157; THOMPSON MP, 1991, J AM GERIATR SOC, V39, P497, DOI 10.1111/j.1532-5415.1991.tb02496.x; Vanderschueren Steven, 2005, Eur J Intern Med, V16, P160, DOI 10.1016/j.ejim.2005.01.004; WISE GR, 1994, POSTGRAD MED, V95, P143, DOI 10.1080/00325481.1994.11945824; Wong CJ, 2014, MED CLIN N AM, V98, P625, DOI 10.1016/j.mcna.2014.01.012	57	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175125	10.1371/journal.pone.0175125	http://dx.doi.org/10.1371/journal.pone.0175125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388637	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800021
J	Trillo, PA; Narvaez, AE; Ron, SR; Hoke, KL				Trillo, Paula A.; Narvaez, Andrea E.; Ron, Santiago R.; Hoke, Kim L.			Mating patterns and post-mating isolation in three cryptic species of the Engystomops petersi species complex	PLOS ONE			English	Article							PHYSALAEMUS-PETERSI; GENUS ENGYSTOMOPS; MATE CHOICE; FROGS; ANURA; DIVERSITY; DNA; INTROGRESSION; DIVERGENCE; SPECIATION	Determining the extent of reproductive isolation in cryptic species with dynamic geographic ranges can yield important insights into the processes that generate and maintain genetic divergence in the absence of severe geographic barriers. We studied mating patterns, propensity to hybridize in nature and subsequent fertilization rates, as well as survival and development of hybrid F-1 offspring for three nominal species of the Engystomops petersi species complex in Yasuni A National Park, Ecuador. We found at least two species in four out of six locations sampled, and 14.3% of the wild pairs genotyped were mixed-species (heterospecific) crosses. We also found reduced fertilization rates in hybrid crosses between E. petersi females and E. "magnus" males, and between E. "magnus" females and E. "selva" males but not in the reciprocal crosses, suggesting asymmetric reproductive isolation for these species. Larval development times decreased in F1 hybrid crosses compared to same species (conspecific) crosses, but we did not find significant reduction in larval survival or early metamorph survival. Our results show evidence of post-mating isolation for at least two hybrid crosses of the cryptic species we studied. The general decrease in fertilization rates in heterospecific crosses suggests that sexual selection and reinforcement might have not only contributed to the pattern of call variation and behavioral isolation we see between species today, but they may also contribute to further signal divergence and behavioral evolution, especially in locations where hybridization is common and fertilization success is diminished.	[Trillo, Paula A.] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima, Peru; [Trillo, Paula A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Trillo, Paula A.] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA; [Narvaez, Andrea E.; Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [Narvaez, Andrea E.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Hoke, Kim L.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Universidad Nacional Mayor de San Marcos; Smithsonian Institution; Smithsonian Tropical Research Institute; Gettysburg College; Pontificia Universidad Catolica del Ecuador; La Trobe University; Colorado State University	Trillo, PA (corresponding author), Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima, Peru.; Trillo, PA (corresponding author), Smithsonian Trop Res Inst, Balboa, Ancon, Panama.; Trillo, PA (corresponding author), Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA.	ptrillo@gettysburg.edu	Ron, Santiago/J-4203-2019	Ron, Santiago/0000-0001-6300-9350; Trillo, Paula/0000-0001-5994-5189; Narvaez, Andrea/0000-0002-5953-9233	National Science Foundation [IOS-0940466]; UNESCO-L'Oreal-CONCYTEC L'Oreal fellowship [001-2009]; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT,ArcadeNoeAInitiative); Pontificia Universidad Catolica del Ecuador(PUCE-DGA)	National Science Foundation(National Science Foundation (NSF)); UNESCO-L'Oreal-CONCYTEC L'Oreal fellowship; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT,ArcadeNoeAInitiative); Pontificia Universidad Catolica del Ecuador(PUCE-DGA)	This research was funded-by a National Science Foundation IOS-0940466 grant to KH and a UNESCO-L'Oreal-CONCYTEC 001-2009-L'Oreal fellowship to PAT. Laboratory work was funded by grants from the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT,ArcadeNoeAInitiative) and a Pontificia Universidad Catolica del Ecuador(PUCE-DGA) grant to SRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2014, SYST BIOL, V63, P518, DOI 10.1093/sysbio/syu017; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Boul KE, 2004, COPEIA, P624, DOI 10.1643/CH-03-153R2; CANNATELLA DC, 1984, COPEIA, P902, DOI 10.2307/1445335; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Drummond AJ, 2010, GENEIOUS V5 1; Elmer KR, 2008, ZOOTAXA, P11, DOI 10.11646/zootaxa.1784.1.2; Elmer KR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-59; Funk WC, 2009, J EVOLUTION BIOL, V22, P1839, DOI 10.1111/j.1420-9101.2009.01795.x; Funk WC, 2007, MOL PHYLOGENET EVOL, V44, P825, DOI 10.1016/j.ympev.2007.01.012; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Funk WC, 2008, HERPETOLOGICA, V64, P290, DOI 10.1655/08-019.1; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Guerra MA, 2008, BEHAV ECOL, V19, P1128, DOI 10.1093/beheco/arn098; Guerra MA, 2014, COPEIA, P123, DOI 10.1643/CG-13-051; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hotz H, 1999, P NATL ACAD SCI USA, V96, P2171, DOI 10.1073/pnas.96.5.2171; Jimenez de la Espada M, 1872, ANALES SOC ESPANOLA; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Lourenco LB, 1999, CAN J ZOOL, V77, P624, DOI 10.1139/cjz-77-4-624; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Romero-Carvajal A, 2009, DEV DYNAM, V238, P1444, DOI 10.1002/dvdy.21952; Ron SR, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.229.3580; Ron SR, 2006, MOL PHYLOGENET EVOL, V39, P392, DOI 10.1016/j.ympev.2005.11.022; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; Sanzo D, 2006, ENVIRON POLLUT, V140, P247, DOI 10.1016/j.envpol.2005.07.013; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Targueta CP, 2009, MOL PHYLOGENETICS EV; Teran-Valdez Andrea, 2009, PHYLLOMEDUSA, V8, P105; Touchon JC, 2013, ECOLOGY, V94, P850, DOI 10.1890/12-0194.1; Trillo PA, 2013, J EVOLUTION BIOL, V26, P216, DOI 10.1111/jeb.12041; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Warkentin KM, 1999, BEHAV ECOL, V10, P251, DOI 10.1093/beheco/10.3.251; Willink B, 2014, EVOL ECOL, V28, P103, DOI 10.1007/s10682-013-9661-z; Zwickl DJ, 2006, GARLI GENETIC ALGORI	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174743	10.1371/journal.pone.0174743	http://dx.doi.org/10.1371/journal.pone.0174743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388628	Green Published, gold			2022-12-27	WOS:000399375800010
J	van Aert, RCM; van Assen, MALM				van Aert, Robbie C. M.; van Assen, Marcel A. L. M.			Bayesian evaluation of effect size after replicating an original study	PLOS ONE			English	Article							PUBLICATION BIAS; METAANALYSIS; SELECTION; FAILURE	The vast majority of published results in the literature is statistically significant, which raises concerns about their reliability. The Reproducibility Project Psychology (RPP) and Experimental Economics Replication Project (EE-RP) both replicated a large number of published studies in psychology and economics. The original study and replication were statistically significant in 36.1% in RPP and 68.8% in EE-RP suggesting many null effects among the replicated studies. However, evidence in favor of the null hypothesis cannot be examined with null hypothesis significance testing. We developed a Bayesian meta-analysis method called snapshot hybrid that is easy to use and understand and quantifies the amount of evidence in favor of a zero, small, medium and large effect. The method computes posterior model probabilities for a zero, small, medium, and large effect and adjusts for publication bias by taking into account that the original study is statistically significant. We first analytically approximate the methods performance, and demonstrate the necessity to control for the original study's significance to enable the accumulation of evidence for a true zero effect. Then we applied the method to the data of RPP and EE-RP, showing that the underlying effect sizes of the included studies in EE-RP are generally larger than in RPP, but that the sample sizes of especially the included studies in RPP are often too small to draw definite conclusions about the true effect size. We also illustrate how snapshot hybrid can be used to determine the required sample size of the replication akin to power analysis in null hypothesis significance testing and present an easy to use web application (https://rvanaert.shinyapps.io/snapshot/) and R code for applying the method.	[van Aert, Robbie C. M.; van Assen, Marcel A. L. M.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands; [van Assen, Marcel A. L. M.] Univ Utrecht, Dept Sociol, Utrecht, Netherlands	Tilburg University; Utrecht University	van Aert, RCM (corresponding author), Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands.	R.C.M.vanAert@tilburguniversity.edu		van Assen, Marcel/0000-0002-7517-6081	Netherlands Organization for Scientific Research (RvA) [406-13-050]	Netherlands Organization for Scientific Research (RvA)	The preparation of this article was supported by Grant 406-13-050 from the Netherlands Organization for Scientific Research (RvA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Anderson SF, 2016, PSYCHOL METHODS, V21, P1, DOI 10.1037/met0000051; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Borenstein M., 2009, INTRO METAANALYSIS; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Bruns SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149144; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Camerer CF, 2016, SCIENCE, V351, P1433, DOI 10.1126/science.aaf0918; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Cohen J.E., 1988, STAT POWER ANAL BEHA; Etz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149794; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Gilbert DT, 2016, COMMENT ESTIMATING R, V351; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; LANE DM, 1978, BRIT J MATH STAT PSY, V31, P107, DOI 10.1111/j.2044-8317.1978.tb00578.x; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; McShane BB, 2016, PERSPECT PSYCHOL SCI, V11, P730, DOI 10.1177/1745691616662243; NEULIEP JW, 1993, J SOC BEHAV PERS, V8, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Raudenbush S.W., 2009, HDB RES SYNTHESIS ME, P295; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823; Ulrich R, 2015, J EXP PSYCHOL GEN, V144, P1137, DOI 10.1037/xge0000086; van Aert RCM, 2016, EXAMINING REPR UNPUB; van Aert RCM, 2016, PERSPECT PSYCHOL SCI, V11, P713, DOI 10.1177/1745691616650874; van Assen MALM, 2015, PSYCHOL METHODS, V20, P293, DOI 10.1037/met0000025; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175302	10.1371/journal.pone.0175302	http://dx.doi.org/10.1371/journal.pone.0175302			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388646	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800037
J	Li, ZJ; Chakraborty, S; Xu, GZ				Li, Zhijie; Chakraborty, Sayan; Xu, Guozhou			Differential CLE peptide perception by plant receptors implicated from structural and functional analyses of TDIF-TDR interactions	PLOS ONE			English	Article							STEM-CELL FATE; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; COMPLEX; KINASE; ACTIVATION; PROTEIN; POLYPEPTIDE; RECOGNITION; INHIBITOR	Tracheary Element Differentiation Inhibitory Factor (TDIF) belongs to the family of post-translationally modified CLE (CLAVATA3/embryo surrounding region (ESR)-related) peptide hormones that control root growth and define the delicate balance between stem cell proliferation and differentiation in SAM (shoot apical meristem) or RAM (root apical meristem). In Arabidopsis, Tracheary Element Differentiation Inhibitory Factor Receptor (TDR) and its ligand TDIF signaling pathway is involved in the regulation of procambial cell proliferation and inhibiting its differentiation into xylem cells. Here we present the crystal structures of the extracellular domains (ECD) of TDR alone and in complex with its ligand TDIF resolved at 2.65 angstrom and 2.75 angstrom respectively. These structures provide insights about the ligand perception and specific interactions between the CLE peptides and their cognate receptors. Our in vitro biochemical studies indicate that the interactions between the ligands and the receptors at the C-terminal anchoring site provide conserved binding. While the binding interactions occurring at the N-terminal anchoring site dictate differential binding specificities between different ligands and receptors. Our studies will open different unknown avenues of TDR-TDIF signaling pathways that will enhance our knowledge in this field highlighting the receptor ligand interaction, receptor activation, signaling network, modes of action and will serve as a structure function relationship model between the ligand and the receptor for various similar leucine-rich repeat receptor-like kinases (LRR-RLKs).	[Li, Zhijie; Chakraborty, Sayan; Xu, Guozhou] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Xu, GZ (corresponding author), North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.	gxu3@ncsu.edu	Chakraborty, Sayan/AAC-4933-2021	Chakraborty, Sayan/0000-0002-2580-5097	North Carolina State University; Dr. Xu's NCSU Faculty Research and Development award	North Carolina State University; Dr. Xu's NCSU Faculty Research and Development award	This work was supported by the new faculty start-up funds of North Carolina State University and Dr. Xu's NCSU Faculty Research and Development award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Goad DM, 2016, NEW PHYTOL; Han ZF, 2014, CURR OPIN PLANT BIOL, V20, P55, DOI 10.1016/j.pbi.2014.04.008; Hastwell AH, 2015, J EXP BOT, V66, P5271, DOI 10.1093/jxb/erv351; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Kinoshita A, 2007, PLANT CELL PHYSIOL, V48, P1821, DOI 10.1093/pcp/pcm154; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kondo T, 2008, BIOCHEM BIOPH RES CO, V377, P312, DOI 10.1016/j.bbrc.2008.09.139; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukoglu M, 2015, PHYSIOL PLANTARUM, V155, P74, DOI 10.1111/ppl.12358; Lease KA, 2006, PLANT PHYSIOL, V142, P831, DOI 10.1104/pp.106.086041; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Morita J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12383; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Reid DE, 2013, J EXP BOT, V64, P1575, DOI 10.1093/jxb/ert008; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Song XF, 2013, PLANT PHYSIOL, V161, P1076, DOI 10.1104/pp.112.211029; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Tabata R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00311; Tang J, 2015, CELL RES, V25, P110, DOI 10.1038/cr.2014.161; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Wang GD, 2010, PROTOPLASMA, V240, P33, DOI 10.1007/s00709-009-0095-y; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang HQ, 2016, CELL RES, V26, P543, DOI 10.1038/cr.2016.45; Zhang Z, 2013, J INTEGR PLANT BIOL, V55, P1212, DOI 10.1111/jipb.12080	45	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175317	10.1371/journal.pone.0175317	http://dx.doi.org/10.1371/journal.pone.0175317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384649	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900155
J	Pedram, A; Pedram, P; Bin Yusoff, N; Sorooshian, S				Pedram, Ali; Pedram, Payam; Bin Yusoff, Nukman; Sorooshian, Shahryar			Development of closed-loop supply chain network in terms of corporate social responsibility	PLOS ONE			English	Article							GENETIC ALGORITHM; NSGA-II; DESIGN; MODEL; SELECTION; LOCATION	Due to the rise in awareness of environmental issues and the depletion of virgin resources, many firms have attempted to increase the sustainability of their activities. One efficient way to elevate sustainability is the consideration of corporate social responsibility (CSR) by designing a closed loop supply chain (CLSC). This paper has developed a mathematical model to increase corporate social responsibility in terms of job creation. Moreover the model, in addition to increasing total CLSC profit, provides a range of strategic decision solutions for decision makers to select a best action plan for a CLSC. A proposed multi-objective mixed-integer linear programming (MILP) model was solved with non-dominated sorting genetic algorithm II (NSGA-II). Fuzzy set theory was employed to select the best compromise solution from the Pareto-optimal solutions. A numerical example was used to validate the potential application of the proposed model. The results highlight the effect of CSR in the design of CLSC.	[Pedram, Ali] Univ Malaya, Dept Mech Engn, Ctr Prod Design & Mfg, Fac Engn, Kuala Lumpur, Malaysia; [Pedram, Payam] Qazvin Islamic Azad Univ, Fac Elect Comp & Informat Technol, Dept Informat Technol, Qazvin, Iran; [Bin Yusoff, Nukman] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur, Malaysia; [Sorooshian, Shahryar] Univ Malaysia Pahang, Fac Ind Management, Gambang Kuantan, Pahang, Malaysia	Universiti Malaya; Islamic Azad University; Universiti Malaya; Universiti Malaysia Pahang	Pedram, A (corresponding author), Univ Malaya, Dept Mech Engn, Ctr Prod Design & Mfg, Fac Engn, Kuala Lumpur, Malaysia.	alipedram20@yahoo.com	pedram, ali/J-4604-2015; Bin Yusoff, Nukman/B-5302-2010; sorooshian, shahryar/J-4660-2016	pedram, ali/0000-0003-4311-3032; Bin Yusoff, Nukman/0000-0002-7389-2164; 	University of Malaya [RP018B-13AET]; University of Malaysia Pahang [RDU140107]; Centre of Manufacturing System Integration (MSI) of University Malaya; Centre for Product Design and Manufacturing (CPDM) of University Malaya	University of Malaya(Universiti Malaya); University of Malaysia Pahang; Centre of Manufacturing System Integration (MSI) of University Malaya; Centre for Product Design and Manufacturing (CPDM) of University Malaya	First author wishes to express his gratitude to the University of Malaya (Grant No. RP018B-13AET). Fourth author wishes to thank the University of Malaysia Pahang (Grant No. RDU140107).; This research was supported by the University Malaya with Grant No. RP018B-13AET. The authors would like to thank the Centre of Manufacturing System Integration (MSI) and Centre for Product Design and Manufacturing (CPDM) of University Malaya for their support. The authors wish to express their gratitude to the University of Malaysia Pahang for funding for the publication (Grant No. RDU140107).	Achillas C, 2010, WASTE MANAGE, V30, P870, DOI 10.1016/j.wasman.2009.11.029; Amin SH, 2012, EXPERT SYST APPL, V39, P6782, DOI 10.1016/j.eswa.2011.12.056; Amin SH, 2012, INT J ADV MANUF TECH, V58, P791, DOI 10.1007/s00170-011-3407-2; Bandyopadhyay S., 2011, J INTELL MANUF, P707; Bandyopadhyay S, 2014, J MANUF SYST, V33, P41, DOI 10.1016/j.jmsy.2013.12.001; Boyer O, 2013, J APPL MATH, DOI 10.1155/2013/435272; Das K, 2015, INT J PROD ECON, V163, P34, DOI 10.1016/j.ijpe.2015.02.012; De Giovanni P, 2014, ANN OPER RES, V220, P135, DOI 10.1007/s10479-011-0912-5; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Devika K, 2014, EUR J OPER RES, V235, P594, DOI 10.1016/j.ejor.2013.12.032; Dubey R., 2014, INT J LOGIST-RES APP, P1; Easwaran G, 2010, IIE TRANS, V42, P779, DOI 10.1080/0740817X.2010.504689; Fallah-Mehdipour E, 2012, EXPERT SYST APPL, V39, P2794, DOI 10.1016/j.eswa.2011.08.139; Garg K, 2015, J CLEAN PROD, V100, P297, DOI 10.1016/j.jclepro.2015.02.075; Ghayebloo S, 2015, J MANUF SYST, V36, P76, DOI 10.1016/j.jmsy.2015.02.011; Guide VDR, 2003, INTERFACES, V33, P3, DOI 10.1287/inte.33.6.3.25182; Hasani A, 2012, INT J PROD RES, V50, P4649, DOI 10.1080/00207543.2011.625051; Hong IH, 2012, TRANSPORT RES E-LOG, V48, P817, DOI 10.1016/j.tre.2012.01.006; Jindal A, 2014, INT J PROD RES, V52, P4156, DOI 10.1080/00207543.2013.861948; Jolai F., 2010, CENTRAL EUROPEAN J O, V19, P547; Kannan G, 2010, APPL MATH MODEL, V34, P655, DOI 10.1016/j.apm.2009.06.021; Ma RM, 2016, CHAOS SOLITON FRACT, V89, P195, DOI 10.1016/j.chaos.2015.10.028; Mota B., 2014, J CLEANER PRODUCTION; Mota B, 2015, J CLEAN PROD, V105, P14, DOI 10.1016/j.jclepro.2014.07.052; Oh J, 2014, SUSTAINABILITY-BASEL, V6, P9027, DOI 10.3390/su6129027; Ozkir V, 2012, INT J PROD RES, V50, P2218, DOI 10.1080/00207543.2011.575092; Pagell M, 2009, J SUPPLY CHAIN MANAG, V45, P37, DOI 10.1111/j.1745-493X.2009.03162.x; Pedram A, 2016, WASTE MANAGEMENT; Pishvaee MS, 2011, APPL MATH MODEL, V35, P637, DOI 10.1016/j.apm.2010.07.013; Pishvaee MS, 2010, COMPUT OPER RES, V37, P1100, DOI 10.1016/j.cor.2009.09.018; Ramezani M, 2014, KNOWL-BASED SYST, V59, P108, DOI 10.1016/j.knosys.2014.01.016; Sarrafha K, 2015, COMPUT OPER RES, V54, P35, DOI 10.1016/j.cor.2014.08.010; Sasikumar P, 2011, INT J PROD RES, V49, P3363, DOI 10.1080/00207541003794876; Savaskan RC, 2006, MANAGE SCI, V52, P1, DOI 10.1287/mnsc.1050.0454; Savaskan RC, 2004, MANAGE SCI, V50, P239, DOI 10.1287/mnsc.1030.0186; Shayeghi H, 2014, ENERG CONVERS MANAGE, V79, P344, DOI 10.1016/j.enconman.2013.12.028; Shi Y, 2013, J INTELL MANUF, V26, P387; Shi Y, 2013, J INTELLIGENT MANUFA; Soleimani H, 2013, INT J ADV MANUF TECH, V68, P917, DOI 10.1007/s00170-013-4953-6; Subramanian P, 2012, INT J PROD RES, V50, P593, DOI 10.1080/00207543.2011.593348; Subulan K, 2015, J MANUF SYST, V37, P243, DOI 10.1016/j.jmsy.2014.09.001; Subulan K, 2015, APPL MATH MODEL, V39, P2661, DOI 10.1016/j.apm.2014.11.004; Talaei M, 2016, J CLEAN PROD, V113, P662, DOI 10.1016/j.jclepro.2015.10.074; Taticchi P, 2013, INT J PRODUCT PERFOR, V62, P782, DOI 10.1108/IJPPM-03-2013-0037; Vahdani B, 2013, ENG OPTIMIZ, V45, P745, DOI 10.1080/0305215X.2012.704029; Van Stel AJ, 2004, REG STUD, V38, P893, DOI 10.1080/0034340042000280929; Wells P, 2005, SUPPLY CHAIN MANAG, V10, P249, DOI 10.1108/13598540510612712; Zarandi MHF, 2011, INT J ADV MANUF TECH, V56, P809, DOI 10.1007/s00170-011-3212-y; zceylan E, 2014, INT J PRODUCTION RES; Zhalechian M, 2016, TRANSPORT RES E-LOG, V89, P182, DOI 10.1016/j.tre.2016.02.011; Zitzler E, 2001, EVOLUTIONARY METHODS	52	16	18	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174951	10.1371/journal.pone.0174951	http://dx.doi.org/10.1371/journal.pone.0174951			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384250	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900061
J	Quinto-Mosquera, H; Moreno, F				Quinto-Mosquera, Harley; Moreno, Flavio			Net Primary Productivity and Edaphic Fertility in Two Pluvial Tropical Forests in the Choco A Biogeographical Region of Colombia (vol 12, e0168211, 2017)	PLOS ONE			English	Correction																		Quinto-Mosquera H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168211	1	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175620	10.1371/journal.pone.0175620	http://dx.doi.org/10.1371/journal.pone.0175620			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384356	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900194
J	Rademaker, RL; de Ven, VGV; Tong, F; Sack, AT				Rademaker, Rosanne L.; de Ven, Vincent G. van; Tong, Frank; Sack, Alexander T.			The impact of early visual cortex transcranial magnetic stimulation on visual working memory precision and guess rate	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FEATURE-BASED ATTENTION; NEURAL MECHANISMS; STATE-DEPENDENCY; PARIETAL CORTEX; CAPACITY LIMIT; CONSOLIDATION; REPRESENTATIONS; INFORMATION; REVEALS	Neuroimaging studies have demonstrated that activity patterns in early visual areas predict stimulus properties actively maintained in visual working memory. Yet, the mechanisms by which such information is represented remain largely unknown. In this study, observers remembered the orientations of 4 briefly presented gratings, one in each quadrant of the visual field. A 10Hz Transcranial Magnetic Stimulation (TMS) triplet was applied directly at stimulus offset, or midway through a 2-second delay, targeting early visual cortex corresponding retinotopically to a sample item in the lower hemifield. Memory for one of the four gratings was probed at random, and participants reported this orientation via method of adjustment. Recall errors were smaller when the visual field location targeted by TMS over-lapped with that of the cued memory item, compared to errors for stimuli probed diagonally to TMS. This implied topographic storage of orientation information, and a memory-enhancing effect at the targeted location. Furthermore, early pulses impaired performance at all four locations, compared to late pulses. Next, response errors were fit empirically using a mixture model to characterize memory precision and guess rates. Memory was more precise for items proximal to the pulse location, irrespective of pulse timing. Guesses were more probable with early TMS pulses, regardless of stimulus location. Thus, while TMS administered at the offset of the stimulus array might disrupt early-phase consolidation in a non-topographic manner, TMS also boosts the precise representation of an item at its targeted retinotopic location, possibly by increasing attentional resources or by injecting a beneficial amount of noise.	[Rademaker, Rosanne L.] Univ Calif San Diego, Psychol Dept, San Diego, CA 92103 USA; [Rademaker, Rosanne L.; de Ven, Vincent G. van; Sack, Alexander T.] Maastricht Univ, Cognit Neurosci Dept, Maastricht, Netherlands; [Tong, Frank] Vanderbilt Univ, Psychol Dept, Nashville, TN USA	University of California System; University of California San Diego; Maastricht University; Vanderbilt University	Rademaker, RL (corresponding author), Univ Calif San Diego, Psychol Dept, San Diego, CA 92103 USA.	rosanne.rademaker@gmail.com		Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (Graduate School for Cognitive and Clinical Neuroscience) [NWO 22.001.036]; European Research Council; ERC Grant [263472]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (Graduate School for Cognitive and Clinical Neuroscience); European Research Council(European Research Council (ERC)European Commission); ERC Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RLR was supported by a grant from the Netherlands Organization for Scientific Research (Graduate School for Cognitive and Clinical Neuroscience, NWO 22.001.036). ATS was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013) / ERC Grant agreement n [263472].	Abrahamyan A, 2011, J NEUROSCI, V31, P3290, DOI 10.1523/JNEUROSCI.6256-10.2011; Abrams J, 2012, VISION RES, V52, P70, DOI 10.1016/j.visres.2011.10.016; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2015, TRENDS COGN SCI, V19, P431, DOI 10.1016/j.tics.2015.06.004; Bays PM, 2014, J NEUROSCI, V34, P3632, DOI 10.1523/JNEUROSCI.3204-13.2014; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; BERLUCCHI G, 1968, SCIENCE, V159, P308, DOI 10.1126/science.159.3812.308; Bettencourt KC, 2016, NAT NEUROSCI, V19, P150, DOI 10.1038/nn.4174; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cattaneo Z, 2009, EUR J NEUROSCI, V30, P1393, DOI 10.1111/j.1460-9568.2009.06911.x; Chen YZ, 2012, NEURON, V74, P557, DOI 10.1016/j.neuron.2012.03.033; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de Graaf TA, 2014, NEUROSCI BIOBEHAV R, V45, P295, DOI 10.1016/j.neubiorev.2014.06.017; De Weerd P, 2012, J NEUROSCI, V32, P1981, DOI 10.1523/JNEUROSCI.3712-11.2011; Duecker F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073813; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Emrich SM, 2013, J NEUROSCI, V33, P6516, DOI 10.1523/JNEUROSCI.5732-12.2013; Ester EF, 2015, NEURON, V87, P893, DOI 10.1016/j.neuron.2015.07.013; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Ester EF, J COG NEUROSCI, V25, P754; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hollingworth A, 2006, J EXP PSYCHOL LEARN, V32, P58, DOI 10.1037/0278-7393.32.1.58; Jacobs C, 2014, CORTEX, V59, P1, DOI 10.1016/j.cortex.2014.06.017; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee SH, 2013, NAT NEUROSCI, V16, P997, DOI 10.1038/nn.3452; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Ling S, 2009, CURR BIOL, V19, P1458, DOI 10.1016/j.cub.2009.06.069; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Matthews PBC, 1999, J PHYSIOL-LONDON, V518, P867, DOI 10.1111/j.1469-7793.1999.0867p.x; Pasternak T, 2003, J NEUROPHYSIOL, V90, P2757, DOI 10.1152/jn.00422.2003; Pooresmaeili A, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.007; Pratte MS, 2017, J EXP PSYCHOL HUMAN, V43, P6, DOI 10.1037/xhp0000302; Pratte MS, 2014, J VISION, V14, DOI 10.1167/14.3.22; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Rose NS, 2016, SCIENCE, V354, P1136, DOI 10.1126/science.aah7011; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Schwarzkopf DS, 2011, J NEUROSCI, V31, P3143, DOI 10.1523/JNEUROSCI.4863-10.2011; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Silvanto J, 2012, NEUROIMAGE, V59, P840, DOI 10.1016/j.neuroimage.2011.07.062; Silvanto J, 2010, NEUROIMAGE, V50, P1683, DOI 10.1016/j.neuroimage.2010.01.021; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sneve MH, 2015, NEUROPSYCHOLOGIA, V66, P1, DOI 10.1016/j.neuropsychologia.2014.11.004; Soto D, 2012, J NEUROSCI, V32, P3447, DOI 10.1523/JNEUROSCI.6243-11.2012; Sreenivasan KK, 2014, J COGNITIVE NEUROSCI, V26, P1141, DOI 10.1162/jocn_a_00556; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; van Bergen RS, 2015, NAT NEUROSCI, V18, P1728, DOI 10.1038/nn.4150; van de Ven V, 2012, J NEUROSCI, V32, P4, DOI 10.1523/JNEUROSCI.3261-11.2012; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Wolff MJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00123; Woodman GF, 2012, VIS COGN, V20, P1, DOI 10.1080/13506285.2011.630694; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zaksas D, 2001, J NEUROPHYSIOL, V86, P912, DOI 10.1152/jn.2001.86.2.912; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	76	19	19	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175230	10.1371/journal.pone.0175230	http://dx.doi.org/10.1371/journal.pone.0175230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384347	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900129
J	Reimer, C; Deike, K; Graf, M; Reimer, P; Wiestler, B; Floca, RO; Kickingereder, P; Schlemmer, HP; Wick, W; Bendszus, M; Radbruch, A				Reimer, Caroline; Deike, Katerina; Graf, Markus; Reimer, Peter; Wiestler, Benedikt; Floca, Ralf Omar; Kickingereder, Philipp; Schlemmer, Heinz-Peter; Wick, Wolfgang; Bendszus, Martin; Radbruch, Alexander			Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; HIGH-GRADE GLIOMAS; ADJUVANT TEMOZOLOMIDE; IMAGING BIOMARKER; MALIGNANT GLIOMAS; TUMOR PROGRESSION; TRUE PROGRESSION; BRAIN-TUMOR; RADIOTHERAPY; CONCOMITANT	Purpose The purpose of this study was to investigate whether a voxel-wise analysis of apparent diffusion coefficient (ADC) values may differentiate between progressive disease (PD) and pseudoprogression (PsP) in patients with high-grade glioma using the parametric response map, a newly introduced postprocessing tool. Methods Twenty-eight patients with proven PD and seven patients with PsP were identified in this retrospective feasibility study. For all patients ADC baseline and follow-up maps on four subsequent MRIs were available. ADC maps were coregistered on contrast enhanced T1-weighted follow-up images. Subsequently, enhancement in the follow-up contrast enhanced T1-weighted image was manually delineated and a reference region of interest (ROI) was drawn in the contralateral white matter. Both ROIs were transferred to the ADC images. Relative ADC (rADC) (baseline)/reference ROI values and rADC (follow up)/reference ROI values were calculated for each voxel within the ROI. The corresponding voxels of rADC (follow up) and rADC (baseline) were subtracted and the percentage of all voxels within the ROI that exceeded the threshold of 0.25 was quantified. Results rADC voxels showed a decrease of 59.2% (1 st quartile (Q1) 36.7; 3rd quartile (Q3) 78.6) above 0.25 in patients with PD and 18.6% (Q1 3.04; Q3 26.5) in patients with PsP (p = 0.005). Receiver operating characteristic curve analysis showed the optimal decreasing rADC cut-off value for identifying PD of > 27.05% (area under the curve 0.844 +/- 0.065, sensitivity 0.86, specificity 0.86, p = 0.014). Conclusion This feasibility study shows that the assessment of rADC using parametric response maps might be a promising approach to contribute to the differentiation between PD and PsP. Further research in larger patient cohorts is necessary to finally determine its clinical utility.	[Reimer, Caroline; Wiestler, Benedikt; Kickingereder, Philipp; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany; [Deike, Katerina; Graf, Markus; Floca, Ralf Omar; Schlemmer, Heinz-Peter; Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany; [Reimer, Peter] Univ Freiburg, Acad Teaching Hosp, Klinikum Karlsruhe, Inst Diagnost & Intervent Radiol, Karlsruhe, Germany; [Wiestler, Benedikt] Tech Univ Munich, Dept Neuroradiol, Munich, Germany; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Dept Neurol, Med Ctr, Heidelberg, Germany; [Radbruch, Alexander] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, German Canc Consortium DKTK, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Municipal Hospital Karlsruhe; University of Freiburg; Technical University of Munich; Ruprecht Karls University Heidelberg; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany.; Radbruch, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany.; Radbruch, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.; Radbruch, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, German Canc Consortium DKTK, Heidelberg, Germany.	a.radbruch@dkfz.de	Radbruch, Alexander/ABA-6277-2021; Wick, Wolfgang/AAA-2545-2020; Vollmuth, Philipp/AAK-3267-2021; Reimer, Peter/AAO-7052-2020	Wick, Wolfgang/0000-0002-6171-634X; Deike, Katerina/0000-0002-4319-0428; Radbruch, Alexander/0000-0001-6238-6525; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Wiestler, Benedikt/0000-0002-2963-7772	grant of the German Cancer Research Center (DKFZ), Intramurales Forderprogram	grant of the German Cancer Research Center (DKFZ), Intramurales Forderprogram	The study was sponsored by a grant of the German Cancer Research Center (DKFZ), Intramurales Forderprogram.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023; Deike K, 2015, J NEUROONCOL; Dessouky BAM, 2010, EGYPT J RADIOL NUC M, V41, P441, DOI 10.1016/j.ejrnm.2010.08.005; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Gahramanov S, 2011, INT J RADIAT ONCOL, V79, P514, DOI 10.1016/j.ijrobp.2009.10.072; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Galldiks N, 2015, EUR J NUCL MED MOL I, V42, P685, DOI 10.1007/s00259-014-2959-4; Ganser KA, 1998, BILDVERABEITUNG MED, P422; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Kickingereder P, 2016, RADIOLOGY, V279, P542, DOI 10.1148/radiol.2015151172; Lee WJ, 2012, ACAD RADIOL, V19, P1353, DOI 10.1016/j.acra.2012.06.011; Lemasson B, 2013, TRANSL ONCOL, V6, P554, DOI 10.1593/tlo.13532; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Radbruch A, 2015, NEURO-ONCOLOGY, V17, P151, DOI 10.1093/neuonc/nou129; Shah AH, 2013, J NEURO-ONCOL, V112, P141, DOI 10.1007/s11060-013-1059-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634; Sundgren PC, 2006, MAGN RESON IMAGING, V24, P1131, DOI 10.1016/j.mri.2006.07.008; Verma N, 2013, NEURO-ONCOLOGY, V15, P515, DOI 10.1093/neuonc/nos307; Wang S, 2015, AJNR AM J NEURORADIO; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Young RJ, 2011, NEUROLOGY, V76, P1918, DOI 10.1212/WNL.0b013e31821d74e7; Yun TJ, 2015, RADIOLOGY, V274, P830, DOI 10.1148/radiol.14132632	39	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174620	10.1371/journal.pone.0174620	http://dx.doi.org/10.1371/journal.pone.0174620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384170	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900022
J	Urano-Morisawa, E; Takami, M; Suzawa, T; Matsumoto, A; Osumi, N; Baba, K; Kamijo, R				Urano-Morisawa, Eri; Takami, Masamichi; Suzawa, Tetsuo; Matsumoto, Akifumi; Osumi, Noriko; Baba, Kazuyoshi; Kamijo, Ryutaro			Induction of osteoblastic differentiation of neural crest-derived stem cells from hair follicles	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; OSTEOCLAST DIFFERENTIATION; STROMAL CELLS; MOUSE EMBRYOS; REGENERATION; MARROW; GENE; MAINTENANCE; RENEWAL	The neural crest (NC) arises near the neural tube during embryo development. NC cells migrate throughout the embryo and have potential to differentiate into multiple cell types, such as peripheral nerves, glial, cardiac smooth muscle, endocrine, and pigment cells, and craniofacial bone. In the present study, we induced osteoblast-like cells using whisker follicles obtained from the NC of mice. Hair follicle cells derived from the NC labeled with enhanced green fluorescent protein (EGFP) were collected from protein zero-Cre/floxedEGFP double transgenic mice and cultured, then treated and cultured in stem cell growth medium. After growth for 14 days, results of flow cytometry analysis showed that 95% of the EGFP-positive (EGFP(+)) hair follicle cells derived from the NC had proliferated and 76.2% of those expressed mesenchymal stem cells markers, such as platelet-derived growth factor a and stem cell antigen-1, and also showed constitutive expression of Runx2 mRNA. Cells stimulated with bone morphogenetic protein-2 expressed osteocalcin, osterix, and alkaline phosphatase mRNA, resulting in production of mineralized matrices, which were detected by von Kossa and alizarin red staining. Moreover, EGFP+ hair follicle cells consistently expressed macrophage colony-stimulating factor and osteoprotegerin (OPG). Addition of 1 alpha, 25-dihydroxyvitamin D-3 [1,25(OH) D-2(3)] (10(-8) M) to the cultures suppressed OPG expression and induced RANKL production in the cells. Furthermore, multinucleated osteoclasts appeared within 6 days after starting co-cultures of bone marrow cells with EGFP(+) cells in the presence of 1,25(OH) D-2(3) and PGE(2). These results suggest that NC-derived hair follicle cells possess a capacity for osteoblastic differentiation and may be useful for developing new bone regenerative medicine therapies.	[Urano-Morisawa, Eri; Takami, Masamichi; Suzawa, Tetsuo; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo, Japan; [Urano-Morisawa, Eri; Matsumoto, Akifumi; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo, Japan; [Takami, Masamichi] Showa Univ, Sch Dent, Dept Pharmacol, Tokyo, Japan; [Osumi, Noriko] Tohoku Univ, Div Dev Neurosci, Grad Sch Med, Sendai, Miyagi, Japan	Showa University; Showa University; Showa University; Tohoku University	Takami, M (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Tokyo, Japan.; Takami, M (corresponding author), Showa Univ, Sch Dent, Dept Pharmacol, Tokyo, Japan.	takami@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021; Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; Baba, Kazuyoshi/0000-0001-8025-2168; Takami, Masamichi/0000-0002-4506-3975	JSPS KAKENHI [24659830, 26293398]; Industry to Support Private Universities Building up Their Foundations of Strategic Research of MEXT [S1411009, S1201014, S0801016]; Grants-in-Aid for Scientific Research [17K19372] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Industry to Support Private Universities Building up Their Foundations of Strategic Research of MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant numbers 24659830, 26293398 and by Industry to Support Private Universities Building up Their Foundations of Strategic Research of MEXT (S1411009, S1201014, S0801016). These funders supported equipment purchase, data collection and analysis, decision to publish, and preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401; Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267; COULY GF, 1993, DEVELOPMENT, V117, P409; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Ebraheim N A, 2001, J Am Acad Orthop Surg, V9, P210; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fish JL, 2014, DEVELOPMENT, V141, P674, DOI 10.1242/dev.100107; Gazdag, 1995, J Am Acad Orthop Surg, V3, P1; Glotzer DJ, 2008, DEV BIOL, V315, P459, DOI 10.1016/j.ydbio.2008.01.005; Hagiwara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084072; HARRIS WH, 1969, NEW ENGL J MED, V280, P253, DOI 10.1056/NEJM196901302800507; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kaku M, 2015, J PROSTHODONT RES, V59, P96, DOI 10.1016/j.jpor.2015.02.001; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kellner JC, 2009, CELL STEM CELL, V5, P569, DOI 10.1016/j.stem.2009.11.010; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Kikuchi M, 2011, GENES CELLS, V16, P273, DOI 10.1111/j.1365-2443.2011.01485.x; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; Komada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046436; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; LEDOUARIN NM, 1984, CELL, V38, P353, DOI 10.1016/0092-8674(84)90490-2; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Shim JH, 2013, STEM CELLS DEV, V22, P1264, DOI 10.1089/scd.2012.0244; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Suda T, 2012, ARCH BIOCHEM BIOPHYS, V523, P22, DOI 10.1016/j.abb.2011.11.011; Suzuki J, 2013, NEUROSCI RES, V75, P112, DOI 10.1016/j.neures.2012.11.005; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yu H, 2010, J INVEST DERMATOL, V130, P1227, DOI 10.1038/jid.2009.322; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang W, 2013, J DENT RES, V92, P1136, DOI 10.1177/0022034513507581; Zhang XY, 2013, INT J MOL MED, V31, P913, DOI 10.3892/ijmm.2013.1272	73	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174940	10.1371/journal.pone.0174940	http://dx.doi.org/10.1371/journal.pone.0174940			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384239	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900059
J	Yokoyama, A; Katada, C; Yokoyama, T; Yano, T; Kaneko, K; Oda, I; Shimizu, Y; Doyama, H; Koike, T; Takizawa, K; Hirao, M; Okada, H; Yoshii, T; Konishi, K; Yamanouchi, T; Tsuda, T; Omori, T; Kobayashi, N; Suzuki, H; Tanabe, S; Hori, K; Nakayama, N; Kawakubo, H; Ishikawa, H; Muto, M				Yokoyama, Akira; Katada, Chikatoshi; Yokoyama, Tetsuji; Yano, Tomonori; Kaneko, Kazuhiro; Oda, Ichiro; Shimizu, Yuichi; Doyama, Hisashi; Koike, Tomoyuki; Takizawa, Kohei; Hirao, Motohiro; Okada, Hiroyuki; Yoshii, Takako; Konishi, Kazuo; Yamanouchi, Takenori; Tsuda, Takashi; Omori, Tai; Kobayashi, Nozomu; Suzuki, Haruhisa; Tanabe, Satoshi; Hori, Keisuke; Nakayama, Norisuke; Kawakubo, Hirofumi; Ishikawa, Hideki; Muto, Manabu			Alcohol abstinence and risk assessment for second esophageal cancer in Japanese men after mucosectomy for early esophageal cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ENDOSCOPIC MUCOSAL RESECTION; ALDEHYDE DEHYDROGENASE-2 GENOTYPES; UPPER AERODIGESTIVE TRACT; LUGOL-VOIDING LESIONS; NECK-CANCER; GENETIC POLYMORPHISMS; SUBMUCOSAL DISSECTION; PHARYNGEAL CANCER; APPRAISAL MODELS	Background Alcohol consumption combined with inactive aldehyde dehydrogenase-2 (ALDH2) and the presence of multiple esophageal Lugol-voiding lesions (LVLs; dysplasia) are strong predictors for multiple development of esophageal squamous cell carcinoma (ESCC) in East Asians. We invented a health risk appraisal (HRA) model for predicting the risk of ESCC based on drinking, smoking, dietary habits, and alcohol flushing, i.e., past or present facial flushing after drinking a glass of beer, a surrogate marker for inactive ALDH2. Methods Prospective follow-up examinations (median follow-up time, 50.3 months) were performed in 278 Japanese men after endoscopic mucosectomy for early ESCC (UMIN Clinical Trials Registry ID: UMIN000001676). Results Sixty-four subjects developed metachronous ESCC. A receiver operating characteristic curve showed that HRA scores >= 12 best predicted the development of metachronous ESCC. The ESCC detection rate per 100 person-years was 9.8 in the high-HRA-score group (n = 104) and 4.5 in the low-HRA-score group (n = 174), and the risk of development of metachronous ESCC was higher in the high-HRA-score group than in the low-HRA-score group (adjusted hazard ratio: 2.00 [95% CI: 1.12-3.30]). Multiple LVLs was a very strong predictor of the development of metachronous SCC, but high HRA scores predicted it independently. The cumulative incidences of metachronous ESCC decreased after drinking cessation in the high-HRA-score drinker group (adjusted hazard ratio: 0.37 [0.14-0.97]). Conclusions Both the HRA model that included alcohol flushing and the multiple LVL grade predicted the development of metachronous ESCC in Japanese men after endoscopic mucosectomy for ESCC. Drinking cessation in the high-HRA-score drinker group reduced the rate of metachronous ESCC.	[Yokoyama, Akira] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan; [Katada, Chikatoshi] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Yano, Tomonori; Kaneko, Kazuhiro; Hori, Keisuke] Natl Canc Ctr Hosp East, Dept Gastroenterol & Endoscopy, Chiba, Japan; [Oda, Ichiro; Suzuki, Haruhisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Shimizu, Yuichi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Kokkaido, Japan; [Doyama, Hisashi] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Koike, Tomoyuki] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi, Japan; [Takizawa, Kohei] Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan; [Hirao, Motohiro] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Okada, Hiroyuki] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yoshii, Takako; Nakayama, Norisuke] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Kanagawa, Japan; [Konishi, Kazuo] Showa Univ, Sch Med, Dept Med, Div Gastroenterol, Tokyo, Japan; [Yamanouchi, Takenori] Kumamoto Reg Med Ctr, Dept Gastroenterol, Kumamoto, Japan; [Tsuda, Takashi] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; [Omori, Tai] Kawasaki Municipal Ida Hosp, Endoscopy Ctr, Kawasaki, Kanagawa, Japan; [Kobayashi, Nozomu] Tochigi Canc Ctr, Dept Diagnost Imaging, Utsunomiya, Tochigi, Japan; [Tanabe, Satoshi] Kitasato Univ, Res & Dev Ctr New Frontiers, Sch Med, Sagamihara, Kanagawa, Japan; [Kawakubo, Hirofumi] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan; [Ishikawa, Hideki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan; [Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto, Japan	Kitasato University; National Institute of Public Health - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Hokkaido University; Ishikawa Prefectural Central Hospital; Tohoku University; Shizuoka Cancer Center; Osaka National Hospital; Okayama University; Kanagawa Prefectural Cancer Center; Showa University; Saint Marianna University; Tochigi Prefectural Cancer Center; Kitasato University; Keio University; Kyoto Prefectural University of Medicine; Kyoto University	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan.	a_yokoyama@kurihama1.hosp.go.jp	Kobayashi, Nozomu/ABB-8025-2020		National Cancer Center (NCC) Research and Development Fund 36 - Ministry of Health, Labor and Welfare of Japan	National Cancer Center (NCC) Research and Development Fund 36 - Ministry of Health, Labor and Welfare of Japan	Support was provided by the grant of National Cancer Center (NCC) Research and Development Fund 36 by the Ministry of Health, Labor and Welfare of Japan.	[Anonymous], 2010, IARC MONOGRAPHS EVAL; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Bosetti C, 2006, ORAL ONCOL, V42, P957, DOI 10.1016/j.oraloncology.2006.03.007; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Higuchi K, 2013, GASTROINTEST ENDOSC, V78, P704, DOI 10.1016/j.gie.2013.04.182; Hori K, 2011, AM J GASTROENTEROL, V106, P858, DOI 10.1038/ajg.2010.489; Jarl J, 2012, ADDICTION, V107, P1234, DOI 10.1111/j.1360-0443.2011.03772.x; Jin J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05229; Kagemoto K, 2016, CANCER MED-US, V5, P1397, DOI 10.1002/cam4.705; Katada C, 2010, ENDOSCOPY, V42, P185, DOI 10.1055/s-0029-1243963; Katada C, 2016, GASTROENTEROLOGY, V15; Katada C, 2012, LARYNGOSCOPE, V122, P1291, DOI 10.1002/lary.23249; Lachenmeier DW, 2008, FOOD CHEM TOXICOL, V46, P2903, DOI 10.1016/j.fct.2008.05.034; Makuuchi H, 2001, Gastrointest Endosc Clin N Am, V11, P445; Matsubara T, 2003, J CLIN ONCOL, V21, P4336, DOI 10.1200/JCO.2003.12.074; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Muto M, 2005, CARCINOGENESIS, V26, P1008, DOI 10.1093/carcin/bgi035; Muto M, 2011, GASTROINTEST ENDOSC, V74, P477, DOI 10.1016/j.gie.2011.04.027; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Shimizu Y, 2001, GASTROINTEST ENDOSC, V54, P190, DOI 10.1067/mge.2001.116877; Shimizu Y, 2003, ENDOSCOPY, V35, P322, DOI 10.1055/s-2003-38151; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Urabe Y, 2009, ENDOSCOPY, V41, P304, DOI 10.1055/s-0029-1214477; Wang YL, 2011, ASIAN PAC J CANCER P, V12, P2065; Yamaji T, 2008, INT J CANCER, V123, P1935, DOI 10.1002/ijc.23744; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yokoyama A, 2006, ALCOHOL CLIN EXP RES, V30, P491, DOI 10.1111/j.1530-0277.2006.00053.x; Yokoyama A, 2013, DIS ESOPHAGUS, V26, P148, DOI 10.1111/j.1442-2050.2012.01343.x; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 2002, CANCER EPIDEM BIOMAR, V11, P895; Yokoyama A, 1996, CANCER EPIDEM BIOMAR, V5, P99; Yokoyama A, 1996, CANCER-AM CANCER SOC, V77, P1986, DOI 10.1002/(SICI)1097-0142(19960515)77:10<1986::AID-CNCR4>3.0.CO;2-F; Yokoyama A, 2008, CANCER SCI, V99, P1164, DOI 10.1111/j.1349-7006.2008.00807.x; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2009, CANCER EPIDEM BIOMAR, V18, P651, DOI 10.1158/1055-9965.EPI-08-0758; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227; Yokoyama T, 2008, CANCER EPIDEM BIOMAR, V17, P2846, DOI 10.1158/1055-9965.EPI-08-0397	42	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175182	10.1371/journal.pone.0175182	http://dx.doi.org/10.1371/journal.pone.0175182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384229	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900111
J	Carlson, DE; Hedin, M				Carlson, David E.; Hedin, Marshal			Comparative transcriptomics of Entelegyne spiders (Araneae, Entelegynae), with emphasis on molecular evolution of orphan genes	PLOS ONE			English	Article							MULTI-TISSUE TRANSCRIPTOMICS; RNA-SEQ DATA; POSITIVE SELECTION; CAVE SPIDERS; WEB SPIDER; ALIGNMENT; SEQUENCE; REVEALS; SILK; ACCURACY	Next-generation sequencing technology is rapidly transforming the landscape of evolutionary biology, and has become a cost-effective and efficient means of collecting exome information for non-model organisms. Due to their taxonomic diversity, production of interesting venom and silk proteins, and the relative scarcity of existing genomic resources, spiders in particular are excellent targets for next-generation sequencing (NGS) methods. In this study, the transcriptomes of six entelegyne spider species from three genera (Cicurina travisae, C. vibora, Habronattus signatus, H. ustulatus, Nesticus bishopi, and N. cooperi) were sequenced and de novo assembled. Each assembly was assessed for quality and completeness and functionally annotated using gene ontology information. Approximately 100 transcripts with evidence of homology to venom proteins were discovered. After identifying more than 3,000 putatively orthologous genes across all six taxa, we used comparative analyses to identify 24 instances of positively selected genes. In addition, between 550 and 1,100 unique orphan genes were found in each genus. These unique, uncharacterized genes exhibited elevated rates of amino acid substitution, potentially consistent with lineage-specific adaptive evolution. The data generated for this study represent a valuable resource for future phylogenetic and molecular evolutionary research, and our results provide new insight into the forces driving genome evolution in taxa that span the root of entelegyne spider phylogeny.	[Carlson, David E.; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Carlson, David E.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	California State University System; San Diego State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carlson, DE (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Carlson, DE (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	david.carison@stonybrook.edu		Carlson, Dave/0000-0002-6987-9493	United States Fish and Wildlife Service [F13PX00770]; San Diego State University Grants Program	United States Fish and Wildlife Service(US Fish & Wildlife Service); San Diego State University Grants Program	This study was funded by a grant to MH from the United States Fish and Wildlife Service (contract #F13PX00770). https.//v/ww.fv/s.govi. This study was also funded by support to MH from the San Diego State University Grants Program (https llnewscenter sdsu eduiresearchaffairsiugp aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; Agnarsson I, 2013, J ZOOL SYST EVOL RES, V51, P100, DOI 10.1111/jzs.12007; Andrews S., 2010, FASTQC QUALITY CONTR; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arruda AP, 2007, BBA-BIOMEMBRANES, V1768, P1498, DOI 10.1016/j.bbamem.2007.03.016; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Brewer MS, 2015, EVOLUTION, V69, P162, DOI 10.1111/evo.12563; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chen JJ, 2008, TOXICON, V52, P794, DOI 10.1016/j.toxicon.2008.08.003; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Clarke TH, 2015, GENOME BIOL EVOL, V7, P1856, DOI 10.1093/gbe/evv110; Clarke TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-365; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Croucher PJP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-862; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Duan ZG, 2013, J PROTEOMICS, V78, P416, DOI 10.1016/j.jprot.2012.10.011; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Garrison NL, 2016, PEERJ, V4, DOI 10.7717/peerj.1719; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant J.R., 2012, PROTIST GENOMICS, V1, P3; Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a; Griswold CE, 1999, J ARACHNOL, V27, P53; Griswold CE., 1987, REVISION JUMPING SPI; Griswold Charles E., 2005, Proceedings of the California Academy of Sciences, V56, P1; Haney RA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-366; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; He QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081357; Hedin M, 2015, MOL ECOL, V24, P346, DOI 10.1111/mec.13036; Hedin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042888; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Jiang LP, 2013, TOXICON, V73, P23, DOI 10.1016/j.toxicon.2013.07.005; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Karashima T, 2000, DEVELOPMENT, V127, P1069; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Maddison W, 2003, SYST ENTOMOL, V28, P1, DOI 10.1046/j.1365-3113.2003.00195.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Markova-Raina P, 2011, GENOME RES, V21, P863, DOI 10.1101/gr.115949.110; Mattila TM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-70; Miller JA, 2010, MOL PHYLOGENET EVOL, V55, P786, DOI 10.1016/j.ympev.2010.02.021; Nery MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065491; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Niu JZ, 2012, INSECT MOL BIOL, V21, P422, DOI 10.1111/j.1365-2583.2012.01148.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Palmieri N, 2014, ELIFE, V3, DOI 10.7554/eLife.01311; Paquin P, 2009, ZOOTAXA, P1; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Posnien N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104885; Prabh N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1102-x; Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Prpic NM, 2004, DEV GENES EVOL, V214, P296, DOI 10.1007/s00427-004-0393-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Roux J, 2014, MOL BIOL EVOL, V31, P1661, DOI 10.1093/molbev/msu141; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; Santoferrara LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101418; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Silva DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143959; Sun W, 2015, FEBS LETT, V589, P2731, DOI 10.1016/j.febslet.2015.08.008; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Venables WN, 2008, INTRO R; Voit R, 2000, J BIOL CHEM, V275, P39339, DOI 10.1074/jbc.M005442200; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wheeler W.C., 2016, CLADISTICS; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yim KM, 2014, J HERED, V105, P771, DOI 10.1093/jhered/esu043; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286; Zhao YJ, 2014, INSECT SCI, V21, P687, DOI 10.1111/1744-7917.12068	117	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174102	10.1371/journal.pone.0174102	http://dx.doi.org/10.1371/journal.pone.0174102			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379977	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500031
J	Faulkner, KT; Robertson, MP; Rouget, M; Wilson, JRU				Faulkner, Katelyn T.; Robertson, Mark P.; Rouget, Mathieu; Wilson, John R. U.			Prioritising surveillance for alien organisms transported as stowaways on ships travelling to South Africa	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; BALLAST-WATER; RISK-ASSESSMENT; PLANT PESTS; MARINE; PATHWAYS; MODEL; MECHANISMS; HABITATS	The global shipping network facilitates the transportation and introduction of marine and terrestrial organisms to regions where they are not native, and some of these organisms become invasive. South Africa was used as a case study to evaluate the potential for shipping to contribute to the introduction and establishment of marine and terrestrial alien species (i.e. establishment debt) and to assess how this varies across shipping routes and seasons. As a proxy for the number of species introduced (i.e. 'colonisation pressure') shipping movement data were used to determine, for each season, the number of ships that visited South African ports from foreign ports and the number of days travelled between ports. Seasonal marine and terrestrial environmental similarity between South African and foreign ports was then used to estimate the likelihood that introduced species would establish. These data were used to determine the seasonal relative contribution of shipping routes to South Africa's marine and terrestrial establishment debt. Additionally, distribution data were used to identify marine and terrestrial species that are known to be invasive elsewhere and which might be introduced to each South African port through shipping routes that have a high relative contribution to establishment debt. Shipping routes from Asian ports, especially Singapore, have a particularly high relative contribution to South Africa's establishment debt, while among South African ports, Durban has the highest risk of being invaded. There was seasonal variation in the shipping routes that have a high relative contribution to the establishment debt of the South African ports. The presented method provides a simple way to prioritise surveillance effort and our results indicate that, for South Africa, port-specific prevention strategies should be developed, a large portion of the available resources should be allocated to Durban, and seasonal variations and their consequences for prevention strategies should be explored further.	[Faulkner, Katelyn T.; Wilson, John R. U.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Invas Species Programme, Claremont, South Africa; [Faulkner, Katelyn T.; Robertson, Mark P.] Univ Pretoria, Dept Zool & Entomol, Ctr Invas Biol, Hatfield, South Africa; [Rouget, Mathieu] CIRAD, UMR PVBMT, St Clotilde, La Reunion, France; [Wilson, John R. U.] Stellenbosch Univ, Dept Bot & Zool, Ctr Invas Biol, Matieland, South Africa	South African National Biodiversity Institute; University of Pretoria; CIRAD; Stellenbosch University	Faulkner, KT (corresponding author), South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Invas Species Programme, Claremont, South Africa.; Faulkner, KT (corresponding author), Univ Pretoria, Dept Zool & Entomol, Ctr Invas Biol, Hatfield, South Africa.	katelynfaulkner@gmail.com	Wilson, John/B-4101-2008	Wilson, John/0000-0003-0174-3239; Faulkner, Katelyn/0000-0002-3955-353X; Rouget, Mathieu/0000-0002-6172-3152	South African National Department of Environment Affairs through its funding of the South African National Biodiversity Institute's Invasive Species Programme; DST-NRF Centre for Invasion Biology; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa	South African National Department of Environment Affairs through its funding of the South African National Biodiversity Institute's Invasive Species Programme; DST-NRF Centre for Invasion Biology(Department of Science & Technology (India)); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by the South African National Department of Environment Affairs through its funding of the South African National Biodiversity Institute's Invasive Species Programme. Additional funding was provided by the DST-NRF Centre for Invasion Biology. MR acknowledges funding from the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areal FJ, 2008, J ENVIRON MANAGE, V89, P300, DOI 10.1016/j.jenvman.2007.06.017; Australian Department of Agriculture and Water Resources, 2016, AUSTR BALL WAT MAN R; Australian Department of Agriculture and Water Resources, 2015, BIOS ACT 2015; Australian Government, 2009, NAT BIOF MAN GUID CO; Azmi F, 2015, ICES J MAR SCI, V72, P1078, DOI 10.1093/icesjms/fsu236; Azmi F, 2015, ICES J MAR SCI, V72, P1069, DOI 10.1093/icesjms/fsu150; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; Bailey SA, 2011, ENVIRON SCI TECHNOL, V45, P2554, DOI 10.1021/es102655j; Barry SC, 2008, ICES J MAR SCI, V65, P121, DOI 10.1093/icesjms/fsn004; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bivand R.S., 2014, MAPTOOLS TOOLS READI; Botes L, 2003, GLOBALLAST MON SER, V7; Bradie J, 2015, BIOL INVASIONS, V17, P3455, DOI 10.1007/s10530-015-0970-8; Briski E, 2014, LIMNOL OCEANOGR, V59, P2068, DOI 10.4319/lo.2014.59.6.2068; Briski E, 2014, DIVERS DISTRIB, V20, P236, DOI 10.1111/ddi.12154; Briski E, 2013, LIMNOL OCEANOGR, V58, P1361, DOI 10.4319/lo.2013.58.4.1361; Briski E, 2011, LIMNOL OCEANOGR, V56, P1929, DOI 10.4319/lo.2011.56.5.1929; Briski E, 2011, DIVERS DISTRIB, V17, P593, DOI 10.1111/j.1472-4642.2011.00763.x; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; CARLTON JT, 1987, B MAR SCI, V41, P452; Costello C, 2007, J ENVIRON ECON MANAG, V54, P262, DOI 10.1016/j.jeem.2007.06.001; Crafton RE, 2015, HYDROBIOLOGIA, V746, P349, DOI 10.1007/s10750-014-2027-x; Crawley M.J., 2007, R BOOK; Davidson IC, 2009, BIOFOULING, V25, P645, DOI 10.1080/08927010903046268; Derraik JGB, 2004, AUST NZ J PUBL HEAL, V28, P433, DOI 10.1111/j.1467-842X.2004.tb00025.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Dytham C., 2011, CHOOSING USING STAT; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Faulkner KT, 2016, BIOL INVASIONS, V18, P73, DOI 10.1007/s10530-015-0990-4; Faulkner KT, 2014, BIOL CONSERV, V179, P25, DOI 10.1016/j.biocon.2014.08.014; Faulkner KT, 2015, ASSESSMENT INFORM CO, P45; Gollasch Stephan, 2007, Aquatic Invasions, V2, P313, DOI 10.3391/ai.2007.2.4.3; Gray DR, 2010, ECOL APPL, V20, P2300, DOI 10.1890/09-1540.1; Griffiths Charles L., 2009, V204, P393; Hewitt CL, 2007, MAR POLLUT BULL, V55, P395, DOI 10.1016/j.marpolbul.2007.01.005; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Hijmans RJ., 2015, GEOSPHERE SPHERICAL; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; JUPP PG, 1992, J AM MOSQUITO CONTR, V8, P321; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Katsanevakis S, 2013, OCEAN COAST MANAGE, V76, P64, DOI 10.1016/j.ocecoaman.2013.02.024; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lo VB, 2012, MAR POLLUT BULL, V64, P295, DOI 10.1016/j.marpolbul.2011.11.016; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1, DOI [10.1182/bloo d-2011-06-357442, DOI 10.1182/BLOOD-2011-06-357442]; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; MacIsaac HJ, 2002, CAN J FISH AQUAT SCI, V59, P1245, DOI 10.1139/F02-090; McClay T, 2015, VESSEL BIOFOULING PR; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; McGeoch MA, 2016, BIOL INVASIONS, V18, P299, DOI 10.1007/s10530-015-1013-1; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; Mitchell M, 2014, CIVIL ENG, V22, P74; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Neuwirth E, 2011, RCOLORBREWER COLORBR; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Oksanen J., 2020, VEGAN COMMUNITY ECOL; R Core Team, 2021, R LANGUAGE ENV STAT; Rouget M, 2016, DIVERS DISTRIB, V22, P445, DOI 10.1111/ddi.12408; Ruiz GM, 1997, AM ZOOL, V37, P621; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Seebens H, 2016, P NATL ACAD SCI USA, V113, P5646, DOI 10.1073/pnas.1524427113; Sink K.J., 2011, SPATIAL PLANNING IDE; Smit AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082381; Sprent P., 2007, APPL NONPARAMETRIC S; Stanaway MA, 2001, AUST J ENTOMOL, V40, P180, DOI 10.1046/j.1440-6055.2001.00215.x; Surkov IV, 2008, AGR ECON-BLACKWELL, V38, P363, DOI 10.1111/j.1574-0862.2008.00306.x; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P1249, DOI 10.1098/rspb.2005.3090; Wilson JR, 2016, DETECTING RESPONDING; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Zweng M. M., 2013, SALINITY, V2, DOI DOI 10.1182/BLOOD-2011-06-357442	79	18	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173340	10.1371/journal.pone.0173340	http://dx.doi.org/10.1371/journal.pone.0173340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379957	Green Published, gold			2022-12-27	WOS:000399353500017
J	Tsujii, N; Mikawa, W; Tsujimoto, E; Adachi, T; Niwa, A; Ono, H; Shirakawa, O				Tsujii, Noa; Mikawa, Wakako; Tsujimoto, Emi; Adachi, Toru; Niwa, Atsushi; Ono, Hisae; Shirakawa, Osamu			Reduced left precentral regional responses in patients with major depressive disorder and history of suicide attempts	PLOS ONE			English	Article							VERBAL-FLUENCY TASK; TRANSPORTER BINDING-CAPACITY; NEAR-INFRARED SPECTROSCOPY; JAPANESE VERSION; BIPOLAR DISORDER; BRAIN-SEROTONIN; ACTIVATION; BEHAVIOR; SCHIZOPHRENIA; VULNERABILITY	Previous neuroimaging studies have revealed frontal and temporal functional abnormalities in patients with major depressive disorder (MDD) and a history of suicidal behavior. However, it is unknown whether multi-channel near-infrared spectroscopy (NIRS) signal changes among individuals with MDD are associated with a history of suicide attempts and a diathesis for suicidal behavior (impulsivity, hopelessness, and aggression). Therefore, we aimed to explore frontotemporal hemodynamic responses in depressed patients with a history of suicide attempts using 52-channel NIRS. We recruited 30 patients with MDD and a history of suicidal behavior (suicide attempters; SAs), 38 patient controls without suicidal behavior (non-attempters; NAs), and 40 healthy controls (HCs) matched by age, gender ratio, and estimated IQ. Regional hemodynamic responses during a verbal fluency task (VFT) were monitored using NIRS. Our results showed that severities of depression, impulsivity, aggression, and hopelessness were similar between SAs and NAs. Both patient groups had significantly reduced activation compared with HCs in the bilateral frontotemporal regions. Post hoc analyses revealed that SAs exhibited a smaller hemodynamic response in the left precentral gyrus than NAs and HCs. Furthermore, the reduced response in the left inferior frontal gyrus was negatively correlated with impulsivity level and hemodynamic responses in the right middle frontal gyrus were negatively associated with hopelessness and aggression in SAs but not in NAs and HCs. Our findings suggest that MDD patients with a history of suicide attempts demonstrate patterns of VFT-induced NIRS signal changes different from those demonstrated by individuals without a history of suicidal behaviors, even in cases where clinical symptoms are similar. NIRS has a relatively high time resolution, which may help visually differentiate SAs from NAs.	[Tsujii, Noa; Mikawa, Wakako; Tsujimoto, Emi; Adachi, Toru; Niwa, Atsushi; Shirakawa, Osamu] Kindai Univ, Fac Med, Dept Neuropsychiat, Osaka, Osaka, Japan; [Tsujimoto, Emi; Ono, Hisae] Kwansei Gakuin Univ, Grad Sch Humanities, Dept Psychol Sci, Nishinomiya, Hyogo, Japan	Kindai University (Kinki University); Kwansei Gakuin University	Tsujii, N (corresponding author), Kindai Univ, Fac Med, Dept Neuropsychiat, Osaka, Osaka, Japan.	tujiinoa@med.kindai.ac.jp		ONO, HISAE/0000-0001-7099-3798; Tsujii, Noa/0000-0003-3434-6280	Japan Society for the Promotion of Science [25461792, 25380965, 16K10229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25461792, No. 25380965, No. 16K10229).	Aguilar EJ, 2008, PROG NEURO-PSYCHOPH, V32, P1673, DOI 10.1016/j.pnpbp.2008.06.016; Aman MG, 2009, J AM ACAD CHILD PSY, V48, P1143, DOI 10.1097/CHI.0b013e3181bfd669; Ando A, 1999, JPN J PSYCHOL, V70, P384, DOI 10.4992/jjpsy.70.384; Audenaert K, 2002, NUCL MED COMMUN, V23, P907, DOI 10.1097/00006231-200209000-00015; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; BARTFAI A, 1990, SUICIDE LIFE-THREAT, V20, P254; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Cope M, 1988, Adv Exp Med Biol, V222, P183; Ding Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.1; Ehlis AC, 2014, NEUROIMAGE, V85, P478, DOI 10.1016/j.neuroimage.2013.03.067; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Herrmann MJ, 2003, BRAIN RES BULL, V61, P51, DOI 10.1016/S0361-9230(03)00066-2; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Inada T, 2015, PSYCHIAT CLIN NEUROS, V69, P440, DOI 10.1111/pcn.12275; Jha A, 2015, CEREB CORTEX, V25, P4392, DOI 10.1093/cercor/bhv027; Jollant F, 2008, AM J PSYCHIAT, V165, P740, DOI 10.1176/appi.ajp.2008.07081239; Jollant F, 2011, WORLD J BIOL PSYCHIA, V12, P319, DOI 10.3109/15622975.2011.556200; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kobashi M, 2013, J PSYCHOL RISSHO U, V4, P53; Lindstrom MB, 2004, EUR NEUROPSYCHOPHARM, V14, P295, DOI 10.1016/S0924-977X(03)00218-9; Mann JJ, 2005, CRISIS, V26, P101, DOI 10.1027/0227-5910.26.3.101; Mann JJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0537; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Noda T, 2012, J PSYCHIATR RES, V46, P905, DOI 10.1016/j.jpsychires.2012.04.001; Ohtani T, 2015, J AFFECT DISORDERS, V176, P78, DOI 10.1016/j.jad.2015.01.042; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oquendo MA, 2003, ARCH GEN PSYCHIAT, V60, P14, DOI 10.1001/archpsyc.60.1.14; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Papmeyer M, 2015, BIOL PSYCHIAT, V78, P58, DOI 10.1016/j.biopsych.2014.10.018; Peng DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120704; Pu SH, 2015, J AFFECT DISORDERS, V181, P9, DOI 10.1016/j.jad.2015.04.010; Pu S, 2013, PSYCHIAT RES-NEUROIM, V214, P73, DOI 10.1016/j.pscychresns.2013.05.011; Reisch T, 2010, J AFFECT DISORDERS, V126, P321, DOI 10.1016/j.jad.2010.03.005; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Ryding E, 2006, PSYCHIAT RES-NEUROIM, V148, P195, DOI 10.1016/j.pscychresns.2006.06.001; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Sublette ME, 2013, ARCH SUICIDE RES, V17, P434, DOI 10.1080/13811118.2013.801813; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126; Tomioka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120828; Tsujii N, 2016, PSYCHIAT RES; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; van Heeringen K, 2017, J PSYCHIATR RES, V84, P243, DOI 10.1016/j.jpsychires.2016.10.011; van Heeringen K, 2014, CRISIS, V35, P1, DOI 10.1027/0227-5910/a000213; Wagner G, 2012, J PSYCHIATR RES, V46, P1449, DOI 10.1016/j.jpsychires.2012.07.013; Willeumier K, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.28; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Zhang XC, 2012, J AFFECT DISORDERS, V136, P443, DOI 10.1016/j.jad.2011.11.005	58	29	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175249	10.1371/journal.pone.0175249	http://dx.doi.org/10.1371/journal.pone.0175249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380030	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500110
J	Resende, TP; Marthaler, DG; Vannucci, FA				Resende, Talita P.; Marthaler, Douglas G.; Vannucci, Fabio A.			A novel RNA-based in situ hybridization to detect Seneca Valley virus in neonatal piglets and sows affected with vesicular disease	PLOS ONE			English	Article							NUCLEIC-ACID; PIGS; INFECTION; PICORNAVIRUS; PATHOGENESIS; EXPRESSION; BRAZIL	Seneca Valley virus (SVV) is the causative agent of an emerging vesicular disease in swine, which is clinically indistinguishable from other vesicular diseases such as foot- and-mouth disease. In addition, SVV has been associated with neonatal mortality in piglets. While a commercial SVV qRT-PCR is available, commercial antibodies are lacking to diagnose SVV infections by immunohistochemistry (IHC). Thus, a novel in situ hybridization technique-RNAscope (ISH) was developed to detect SVVRNA in infected tissues. From a total of 78 samples evaluated, 30 were positive by qRT-PCR and ISH-RNA, including vesicular lesions of affected sows, ulcerative lesions in the tongue of piglets and various other tissues with no evidence of histological lesions. Nineteen samples were negative for SVV by qRT-PCR and ISH-RNA. The Ct values of the qRT-PCR from ISH-RNA positive tissues varied from 12.0 to 32.6 ( 5.12 x 10(6) to 5.31 RNA copies/g, respectively). The ISH-RNA technique is an important tool in diagnosing and investigating the pathogenesis of SVV and other emerging pathogens.	[Resende, Talita P.] Univ Minnesota, Dept Vet & Biomed Sci, Coll Vet Med, St Paul, MN 55108 USA; [Marthaler, Douglas G.; Vannucci, Fabio A.] Univ Minnesota, Vet Diagnost Lab, Coll Vet Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Resende, TP (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Coll Vet Med, St Paul, MN 55108 USA.	resen023@umm.edu	Resende, Talita Pilar/AGZ-6654-2022	Resende, Talita Pilar/0000-0002-7705-714X; Marthaler, Douglas/0000-0001-8574-2473	CAPES-Brazil	CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	TPR was supported by CAPES - Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank all employees at histology and immunohistochemistry laboratories in MNVDL for the help during the ISH activities. TPR was supported by CAPES-Brazil.	Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Canning P, 2016, TRANSBOUND EMERG DIS; Chang SY, 2015, HUM PATHOL, V46, P1592, DOI 10.1016/j.humpath.2015.07.012; Gaynor AM, 2016, VET PATHOL, V53, P567, DOI 10.1177/0300985815594852; Joshi LR, 2016, J GEN VIROL, V97, P3267, DOI 10.1099/jgv.0.000631; Joshi LR, 2016, J CLIN MICROBIOL, V54, P1536, DOI 10.1128/JCM.03390-15; Leme RA, 2016, J COMP PATHOL, V155, P145, DOI 10.1016/j.jcpa.2016.06.011; Leme RA, 2015, TRANSBOUND EMERG DIS, V62, P603, DOI 10.1111/tbed.12430; Leme RA, 2016, EMERG INFECT DIS, V22, P1238, DOI 10.3201/eid2207.151583; Luff J, 2016, VET PATHOL; Maes RK, 2014, VET PATHOL, V51, P238, DOI 10.1177/0300985813505878; Marthaler D, 2012, VIROLOGY, V433, P85, DOI 10.1016/j.virol.2012.07.006; Montiel N, 2016, EMERG INFECT DIS, V22, P1246, DOI 10.3201/eid2207.151863; Palinski RM, 2016, J GEN VIROL, V97, P281, DOI 10.1099/jgv.0.000343; Palmer MV, 2015, J COMP PATHOL, V153, P150, DOI 10.1016/j.jcpa.2015.06.004; POTEL K, 1967, WISS Z KARLMARX U LP, V16, P153; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Tubbs RR, 2013, AM J CLIN PATHOL, V140, P736, DOI 10.1309/AJCPJTWK07FSABRJ; Vannucci FA, 2015, TRANSBOUND EMERG DIS, V62, P589, DOI 10.1111/tbed.12410; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wu Q, 2016, GENOME ANNOUNC, P4	21	23	32	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0173190	10.1371/journal.pone.0173190	http://dx.doi.org/10.1371/journal.pone.0173190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394893	gold, Green Published, Green Submitted			2022-12-27	WOS:000399954800002
J	Yuan, CW; Liu, WX; Wang, YB; Hou, JL; Zhang, LG; Wang, GQ				Yuan, Chaowen; Liu, Wenxin; Wang, Yingbo; Hou, Jinlong; Zhang, Liguo; Wang, Guoqing			Homologous recombination is a force in the evolution of canine distemper virus	PLOS ONE			English	Article							HEMAGGLUTININ GENES; MEASLES-VIRUS; PROTEIN GENE; CDV; FUSION; CORONAVIRUS; PROPAGATION; EMERGENCE; SEQUENCES; DISEASE	Canine distemper virus (CDV) is the causative agent of canine distemper (CD) that is a highly contagious, lethal, multisystemic viral disease of receptive carnivores. The prevalence of CDV is a major concern in susceptible animals. Presently, it is unclear whether intragenic recombination can contribute to gene mutations and segment reassortment in the virus. In this study, 25 full-length CDV genome sequences were subjected to phylogenetic and recombinational analyses. The results of phylogenetic analysis, intragenic recombination, and nucleotide selection pressure indicated that mutation and recombination occurred in the six individual genes segment (H, F, P, N, L, M) of the CDV genome. The analysis also revealed pronounced genetic diversity in the CDV genome according to the geographically distinct lineages (genotypes), namely Asia-1, Asia-2, Asia-3, Europe, America-1, and America-2. The six recombination events were detected using SimPlot and RDP programs. The analysis of selection pressure demonstrated that a majority of the nucleotides in the CDV individual gene were under negative selection. Collectively, these data suggested that homologous recombination acts as a key force driving the genetic diversity and evolution of canine distemper virus.	[Yuan, Chaowen; Wang, Yingbo; Hou, Jinlong; Wang, Guoqing] Northeastern Univ, Coll life & Hlth Sci, Shenyang, Liaoning, Peoples R China; [Liu, Wenxin] Affiliated Hosp Guangdong Med Coll, Hematol Lab, Guangzhou, Peoples R China; [Zhang, Liguo] Ctr Anim Dis Emergency Liaoning Prov, Shenyang, Liaoning, Peoples R China	Northeastern University - China; Guangdong Medical University	Wang, GQ (corresponding author), Northeastern Univ, Coll life & Hlth Sci, Shenyang, Liaoning, Peoples R China.	wangguoqing@mail.neu.edu.cn			Natural Science Foundation of China [31272615]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financed by the Natural Science Foundation of China (No.31272615). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aris-Brosou S, 2003, SYST BIOL, V52, P781, DOI 10.1080/10635150390258949; Bolt G, 1997, J GEN VIROL, V78, P367, DOI 10.1099/0022-1317-78-2-367; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Bruen TC, 2007, VIROLOGY, V364, P362, DOI 10.1016/j.virol.2007.03.023; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Cong YY, 2013, VIRUS GENES, V47, P66, DOI 10.1007/s11262-013-0926-y; Demeter Z, 2010, VET MICROBIOL, V142, P420, DOI 10.1016/j.vetmic.2009.10.017; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Han GZ, 2008, VIRUS RES, V136, P198, DOI 10.1016/j.virusres.2008.04.022; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; He HB, 2010, TALANTA, V82, P1562, DOI 10.1016/j.talanta.2010.07.055; Herrewegh AAPM, 1998, J VIROL, V72, P4508, DOI 10.1128/JVI.72.5.4508-4514.1998; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iwatsuki K, 2000, VET MICROBIOL, V71, P281, DOI 10.1016/S0378-1135(99)00172-8; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lan NT, 2006, VET MICROBIOL, V118, P177, DOI 10.1016/j.vetmic.2006.07.015; Lan NT, 2009, J VET MED SCI, V71, P155, DOI 10.1292/jvms.71.155; Lan NT, 2005, VET MICROBIOL, V110, P197, DOI 10.1016/j.vetmic.2005.07.016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lednicky JA, 2004, J VIROL METHODS, V118, P147, DOI 10.1016/j.jviromet.2004.02.004; Lednicky JA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-2; Liang Z, 2008, J VIROL, V82, P11545, DOI 10.1128/JVI.01160-08; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Martella V, 2007, VET MICROBIOL, V122, P32, DOI 10.1016/j.vetmic.2007.01.005; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Mochizuki M, 1999, J CLIN MICROBIOL, V37, P2936, DOI 10.1128/JCM.37.9.2936-2942.1999; Pardo IDR, 2005, J CLIN MICROBIOL, V43, P5009, DOI 10.1128/JCM.43.10.5009-5017.2005; Phillips ML, 1999, PEDIATRICS, V104, P1095, DOI 10.1542/peds.104.5.1095; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raaben M, 2010, J VIROL, V84, P7880, DOI 10.1128/JVI.00486-10; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SIDHU MS, 1993, VIROLOGY, V193, P66, DOI 10.1006/viro.1993.1103; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang Fu-Xu, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P862	45	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175416	10.1371/journal.pone.0175416	http://dx.doi.org/10.1371/journal.pone.0175416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394936	Green Submitted, gold, Green Published			2022-12-27	WOS:000399954800033
J	Martinez-Monino, AB; Zapata-Perez, R; Garcia-Saura, AG; Gil-Ortiz, F; Perez-Gilabert, M; Sanchez-Ferrer, A				Belen Martinez-Monino, Ana; Zapata-Perez, Ruben; Gines Garcia-Saura, Antonio; Gil-Ortiz, Fernando; Perez-Gilabert, Manuela; Sanchez-Ferrer, Alvaro			Characterization and mutational analysis of a nicotinamide mononucleotide deamidase from Agrobacterium tumefaciens showing high thermal stability and catalytic efficiency	PLOS ONE			English	Article							PYRIDINE-NUCLEOTIDE CYCLE; SALMONELLA-TYPHIMURIUM; ADENINE-DINUCLEOTIDE; AMIDOHYDROLASE; HOMEOSTASIS; METABOLISM; MECHANISM; SIRTUINS; MUTANTS; REVEALS	NAD(+) has emerged as a crucial element in both bioenergetic and signaling pathways since it acts as a key regulator of cellular and organismal homeostasis. Among the enzymes involved in its recycling, nicotinamide mononucleotide (NMN) deamidase is one of the key players in the bacterial pyridine nucleotide cycle, where it catalyzes the conversion of NMN into nicotinic acid mononucleotide (NaMN), which is later converted to NAD+ in the PreissHandler pathway. The biochemical characteristics of bacterial NMN deamidases have been poorly studied, although they have been investigated in some firmicutes, gamma-proteobacteria and actinobacteria. In this study, we present the first characterization of an NMN deamidase from an alphaproteobacterium, Agrobacterium tumefaciens (AtCinA). The enzyme was active over a broad pH range, with an optimum at pH 7.5. Moreover, the enzyme was quite stable at neutral pH, maintaining 55% of its activity after 14 days. Surprisingly, AtCinA showed the highest optimal (80 degrees C) and melting (85 C) temperatures described for an NMN deamidase. The above described characteristics, together with its high catalytic efficiency, make AtCinA a promising biocatalyst for the production of pure NaMN. In addition, six mutants (C32A, S48A, Y58F, Y58A, T105A and R145A) were designed to study their involvement in substrate binding, and two (S31A and K63A) to determine their contribution to the catalysis. However, only four mutants (C32A, S48A Y58F and T105A) showed activity, although with reduced catalytic efficiency. These results, combined with a thermal and structural analysis, reinforce the Ser/Lys catalytic dyad mechanism as the most plausible among those proposed.	[Belen Martinez-Monino, Ana; Zapata-Perez, Ruben; Gines Garcia-Saura, Antonio; Perez-Gilabert, Manuela; Sanchez-Ferrer, Alvaro] Univ Murcia, Fac Biol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, E-30100 Murcia, Spain; [Belen Martinez-Monino, Ana; Zapata-Perez, Ruben; Gines Garcia-Saura, Antonio; Perez-Gilabert, Manuela; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Gil-Ortiz, Fernando] CELLS ALBA Synchrotron Light Source, Barcelona, Spain	University of Murcia	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Fac Biol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, E-30100 Murcia, Spain.; Sanchez-Ferrer, A (corresponding author), Murcia Biomed Res Inst IMIB, Murcia, Spain.	alvaro@um.es	Pérez-Gilabert, Manuela/E-5676-2016; Zapata-Perez, Ruben/AAA-9782-2020; Sánchez-Ferrer, Alvaro/M-1631-2014	Pérez-Gilabert, Manuela/0000-0002-3706-5786; Zapata-Perez, Ruben/0000-0003-4432-9652; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Gil-Ortiz, Fernando/0000-0001-5897-2724	Spanish grants from MINECO-FEDER [B102013-45336-R]; Ayudas a los Grupos y Unidades de Excelencia Cientffica de la Region de Murcia, Fundacion Seneca-Agenda de Ciencia y Tecnologia de la Region de Murcia [19893/GERM/15]	Spanish grants from MINECO-FEDER; Ayudas a los Grupos y Unidades de Excelencia Cientffica de la Region de Murcia, Fundacion Seneca-Agenda de Ciencia y Tecnologia de la Region de Murcia	This study was partially supported by Spanish grants from MINECO-FEDER (B102013-45336-R) and from the Ayudas a los Grupos y Unidades de Excelencia Cientffica de la Region de Murcia, Fundacion Seneca-Agenda de Ciencia y Tecnologia de la Region de Murcia(19893/GERM/15, Programa de Apoyo a la Investigacion 2014).	Auerbach G, 1997, STRUCTURE, V5, P1475, DOI 10.1016/S0969-2126(97)00297-9; Butepage M, 2015, CELLS-BASEL, V4, P569, DOI 10.3390/cells4040569; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Covington JD, 2016, MOL NUTR FOOD RES, V60, P79, DOI 10.1002/mnfr.201500340; FOSTER JW, 1980, J BACTERIOL, V142, P1032, DOI 10.1128/JB.142.3.1032-1035.1980; FOSTER JW, 1979, J BACTERIOL, V137, P1165, DOI 10.1128/JB.137.3.1165-1175.1979; FRIEDMANN HC, 1973, BIOCHEM BIOPH RES CO, V50, P54, DOI 10.1016/0006-291X(73)91062-0; FYFE JA, 1969, J BIOL CHEM, V244, P1659; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gesto DS, 2013, J AM CHEM SOC, V135, P7146, DOI 10.1021/ja310165u; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; IMAI T, 1973, J BIOCHEM-TOKYO, V73, P139; Imanaka T, 2011, P JPN ACAD B-PHYS, V87, P587, DOI 10.2183/pjab.87.587; Garcia-Garcia MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096976; Kaimer C, 2010, ARCH MICROBIOL, V192, P549, DOI 10.1007/s00203-010-0583-7; Karuppiah V, 2014, J BIOL CHEM, V289, P33187, DOI 10.1074/jbc.M114.608448; KINNEY DM, 1979, J BACTERIOL, V140, P607, DOI 10.1128/JB.140.2.607-611.1979; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kupis W, 2016, J PHYSIOL BIOCHEM, V72, P371, DOI 10.1007/s13105-016-0492-6; Lespinet O, 2005, SCIENCE, V307, P42; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Opitz CA, 2015, BIOCHEM SOC T, V43, P1127, DOI 10.1042/BST20150133; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROBINSON CR, 1993, PROTEIN SCI, V2, P826, DOI 10.1002/pro.5560020512; Ruggieri S, 2015, BBA-PROTEINS PROTEOM, V1854, P1138, DOI 10.1016/j.bbapap.2015.02.021; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082705; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056727; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sorci L, 2014, DNA REPAIR, V23, P17, DOI 10.1016/j.dnarep.2014.07.014; Sorci L, 2014, FEBS LETT, V588, P1016, DOI 10.1016/j.febslet.2014.01.063; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Verheugd P, 2016, CURR PROTEIN PEPT SC, V17, P654, DOI 10.2174/1389203717666160419144846; Yang Y, 2016, BIOCH BIOPHYS ACTA	40	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174759	10.1371/journal.pone.0174759	http://dx.doi.org/10.1371/journal.pone.0174759			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388636	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800011
J	Berry, RS; Kulmatiski, A				Berry, Ryan S.; Kulmatiski, Andrew			A savanna response to precipitation intensity	PLOS ONE			English	Article							WOODY PLANT ENCROACHMENT; UNITED-STATES; TERRESTRIAL ECOSYSTEMS; RAINFALL VARIABILITY; SOUTH-AFRICA; GRASSLAND; MODEL; MANIPULATION; VEGETATION; EXTREMES	As the atmosphere warms, precipitation events are becoming less frequent but more intense. A three-year experiment in Kruger National Park, South Africa, found that fewer, more intense precipitation events encouraged woody plant encroachment. To test whether or not these treatment responses persisted over time, here, we report results from all five years of that experiment. Grass growth, woody plant growth, total fine root number and area and hydrologic tracer uptake by grasses and woody plants were measured in six treated plots (8 m by 8 m) and six control plots. Treatment effects on soil moisture were measured continuously in one treated and one control plot. During the fourth year, increased precipitation intensity treatments continued to decrease water flux in surface soils (0-10 cm), increase water flux in deeper soils (20+ cm), decrease grass growth and increase woody plant growth. Greater root numbers at 20-40 cm and greater woody plant uptake of a hydrological tracer from 45-60 cm suggested that woody plants increased growth by increasing root number and activity (but not root area) in deeper soils. During the fifth year, natural precipitation events were large and intense so treatments had little effect on precipitation intensity or plant available water. Consistent with this effective treatment removal, there was no difference in grass or woody growth rates between control and treated plots, although woody plant biomass remained higher in treated than control plots due to treatment effects in the previous four years. Across the five years of this experiment, we found that 1) small increases in precipitation intensity can result in large increases in deep (20-130 cm) soil water availability, 2) plant growth responses to precipitation intensity are rapid and disappear quickly, and 3) because woody plants accumulate biomass, occasional increases in precipitation intensity can result in long-term increases in woody plant biomass (i.e., shrub encroachment). While results are likely to be site-specific, they provide experimental evidence of large ecohydrological responses to small changes in precipitation intensity.	[Kulmatiski, Andrew] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Kulmatiski, A (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	andrew.kulmatiski@usu.edu	kulmatiski, andrew/J-2072-2015	kulmatiski, andrew/0000-0001-9977-5508	Andrew Mellon Foundation; Utah Agricultural Experiment Station, Utah State University [8965]	Andrew Mellon Foundation; Utah Agricultural Experiment Station, Utah State University	This research was supported by the Andrew Mellon Foundation and the Utah Agricultural Experiment Station, Utah State University and approved as journal paper #8965. Funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This research was supported by the Andrew Mellon Foundation and the Utah Agricultural Experiment Station, Utah State University and approved as journal paper #8965. We thank Kruger National Park and Isaak Smit for access to land and logistic support. Also a special thanks to our field crew: Isaac Lekgotla, Rudolph Sibuyi, Vhelaphi Sibuyi and Wisani Mashele.	Beier C, 2012, ECOL LETT; Buitenwerf R, 2012, GLOBAL CHANGE BIOL, V18, P675, DOI 10.1111/j.1365-2486.2011.02561.x; Buitenwerf R, 2014, KOEDOE, V56; Du Toit J, 2004, KRUGER EXPERIENCE EC; EMERMAN SH, 1995, J HYDROL, V171, P23, DOI 10.1016/0022-1694(95)02735-8; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; February EC, 2013, ECOLOGY, V94, P1155, DOI 10.1890/12-0540.1; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Hewitson BC, 2006, INT J CLIMATOL, V26, P1315, DOI 10.1002/joc.1314; Higgins RW, 2013, J HYDROMETEOROL, V14, P105, DOI 10.1175/JHM-D-12-062.1; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Huang J, 2013, CATENA, V104, P93, DOI 10.1016/j.catena.2012.10.013; Huxman TE, 2005, ECOLOGY, V86, P308, DOI 10.1890/03-0583; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kulmatiski A, 2013, NAT CLIM CHANGE, V3, P833, DOI [10.1038/nclimate1904, 10.1038/NCLIMATE1904]; Kulmatiski A, 2013, OECOLOGIA, V171, P25, DOI 10.1007/s00442-012-2390-0; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Laprise R, 2013, CLIM DYNAM, V41, P3219, DOI 10.1007/s00382-012-1651-2; Lauenroth WK, 2009, ECOHYDROLOGY, V2, P173, DOI 10.1002/eco.53; Lett MS, 2005, AM MIDL NAT, V153, P217, DOI 10.1674/0003-0031(2005)153[0217:WPEARI]2.0.CO;2; Mazzacavallo MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144300; Molnar P, 2015, HYDROL EARTH SYST SC, V19, P1753, DOI 10.5194/hess-19-1753-2015; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Petrie MD, 2015, ECOHYDROLOGY, V8, P1614, DOI 10.1002/eco.1614; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Schenk HJ, 2008, VADOSE ZONE J, V7, P1119, DOI 10.2136/vzj2007.0119; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Smith NG, 2016, J APPL ECOL, V53, P579, DOI 10.1111/1365-2664.12593; Smith NG, 2014, REV GEOPHYS, V52, P412, DOI 10.1002/2014RG000458; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Thomas BF, 2016, WATER-SUI, V8, DOI 10.3390/w8030090; Tietjen B, 2016, ECOL MODEL, V326, P13, DOI 10.1016/j.ecolmodel.2015.06.013; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Tsiko CT, 2012, PHYS CHEM EARTH, V47-48, P122, DOI 10.1016/j.pce.2011.06.009; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; Warren CP, 2015, J ARID ENVIRON, V121, P67, DOI 10.1016/j.jaridenv.2015.06.001; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wilcox BP, 2010, ECOHYDROLOGY, V3, P126, DOI 10.1002/eco.104; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Yan H, 2015, PLOS ONE, V10; Zambatis N., 2006, African Journal of Range & Forage Science, V23, P85, DOI 10.2989/10220110609485891; Zeng G, 2008, NEW PHYTOL, V177, P549, DOI 10.1111/j.1469-8137.2007.02271.x; Zhang DH, 2016, J HYDROL, V543, P270, DOI 10.1016/j.jhydrol.2016.10.003	51	28	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175402	10.1371/journal.pone.0175402	http://dx.doi.org/10.1371/journal.pone.0175402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388640	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800050
J	Ajabnoor, GMA; Bahijri, S; Sheik, NA; Borai, A; Alamoudi, AA; Al-Aama, JY; Chrousos, GP				Ajabnoor, Ghada M. A.; Bahijri, Suhad; Sheik, Noor Ahmad; Borai, Anwar; Alamoudi, Aliaa A.; Al-Aama, Jumana Y.; Chrousos, George P.			Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GAMMA-GLUTAMYL-TRANSFERASE; CIRCADIAN CLOCK; CARDIOVASCULAR RISK; ATHEROGENIC INDEX; PLASMA-PROTEIN; SLEEP DEBT; ADIPONECTIN; RESTRICTION; DISEASE	Background During the fasting month of Ramadan, practicing Saudis develop severe disturbances in sleeping and feeding patterns. Concomitantly, cortisol circadian rhythm is abolished, diurnal cortisol levels are elevated and circulating levels of several adipokines are altered favouring insulin resistance. Aim To examine changes in the expression of CLOCK and glucocorticoid-controlled genes, such as DUSP1 and IL-1 alpha in Saudi adults before and during Ramadan, and to investigate possible associations with selected cardiometabolic risk factors. Methods Healthy young volunteers (5 females, 18 males; mean age +SEM = 23.2 + 1.2 years) were evaluated before Ramadan and two weeks into it. Blood samples were collected at 9 am (+/- 1 hour) and twelve hours later for determination of serum lipid profile, high sensitivity CRP (hsCRP), and adiponectin. The expression of CLOCK, DUSP1 and IL-1 alpha was evaluated in circulating leukocytes. Results Mean levels of GGT and morning adiponectin decreased, while those of LDL-c/HDL-c and atherogenic index (AI) increased significantly in Ramadan compared to Shabaan. There was no significant difference between morning and evening adiponectin during Ramadan, while the diurnal rhythm of hsCRP was lost. CLOCK gene expression mean was significantly higher in morning than in evening during Shabaan. Mean morning and evening DUSP1 mRNA levels showed significant increase during Ramadan compared to Shabaan, however, its diurnal rhythm was maintained. Morning IL-1 alpha mRNA expression remained significantly higher than in the evening during Ramadan, but was markedly decreased compared to Shabaan. Discussion Ramadan fasting in Saudi Arabia is associated with improvements in some cardiometabolic risk factors, such as circulating GGT and hsCRP and leukocyte expression of IL-1 alpha mRNA, suggesting that intermittent fasting might have a beneficial component. These benefits may be offset by the previously reported dysregulation in the circadian rhythm, excess glucocorticoid levels and action, and insulin resistance, explaining increased prevalence of cardiometabolic disorders and type 2 diabetes mellitus.	[Ajabnoor, Ghada M. A.; Bahijri, Suhad; Alamoudi, Aliaa A.] King Abdulaziz Univ, Dept Clin Biochem, Fac Med, Jeddah, Saudi Arabia; [Ajabnoor, Ghada M. A.; Bahijri, Suhad; Borai, Anwar; Alamoudi, Aliaa A.; Al-Aama, Jumana Y.; Chrousos, George P.] King Abdulaziz Univ, King Fand Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah, Saudi Arabia; [Sheik, Noor Ahmad; Al-Aama, Jumana Y.] King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah, Saudi Arabia; [Sheik, Noor Ahmad; Al-Aama, Jumana Y.] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Borai, Anwar] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Coll Med, KAIMRC, Jeddah, Saudi Arabia; [Chrousos, George P.] Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Bahijri, S (corresponding author), King Abdulaziz Univ, Dept Clin Biochem, Fac Med, Jeddah, Saudi Arabia.; Bahijri, S (corresponding author), King Abdulaziz Univ, King Fand Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah, Saudi Arabia.	sbahijri@gmail.com	Bahijri, Suhad M/AAF-4141-2020; Al-aama, Jumana/AAA-8653-2021	Bahijri, Suhad M/0000-0001-6674-5409; alamoudi, aliaa/0000-0001-5428-8853	Deanship of Scientific Research, (DSR) at King Abdulaziz University - Jeddah - Kingdom of Saudi Arabia [HiCi/1432-6-2]	Deanship of Scientific Research, (DSR) at King Abdulaziz University - Jeddah - Kingdom of Saudi Arabia	The funding body is Deanship of Scientific Research, (DSR) at King Abdulaziz University - Jeddah - Kingdom of Saudi Arabia under grant number (HiCi/1432-6-2), URL:http:// dsr.kau.edu.sa/Default.aspx?Site_ID=305&Lng= AR. Given that no individuals employed or contracted by the funder, other than the authors, were involved in these tasks and the authors had unrestricted access to the data, we declared that the funders had no role in study design, data collection and analysis, decisiont to publish, or preparation of the manuscript.	Ajabnoor GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096500; Bahijri S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060917, 10.1371/annotation/8d92315c-9944-4470-9bbb-806a26b0809b]; Bahijri SM, 2015, THER ADV ENDOCRINOL, V6, P223, DOI 10.1177/2042018815594527; Balachandran JS, 2012, AM J CARDIOL, V109, P140, DOI 10.1016/j.amjcard.2011.07.071; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Charmandari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025612; Dobiasova M, 2006, Vnitr Lek, V52, P64; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kino T, 2011, ENDOCR DEV, V20, P116, DOI 10.1159/000321232; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kocc M, 2011, TURK KARDIYOL DERN A, V39, P568, DOI 10.5543/tkda.2011.01649; Koc M, 2010, TEX HEART I J, V37, P42; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Liu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048878; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Nematy M, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-69; Nwagha UI, 2010, AFR HEALTH SCI, V10, P248; OIbrahim NK, 2010, INTRNET J CARDIOVASC, V7; Onat A, 2010, J CLIN LIPIDOL, V4, P89, DOI 10.1016/j.jacl.2010.02.005; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; POCKNEE RC, 1978, J NUTR, V108, P1266, DOI 10.1093/jn/108.8.1266; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shimada K, 2004, CLIN CHIM ACTA, V344, P1, DOI 10.1016/j.cccn.2004.02.020; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2003, REV NEUROL-FRANCE, V159, pS11; Takata M, 2002, JPN J PHARMACOL, V90, P263, DOI 10.1254/jjp.90.263; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Yang MY, 2011, J BIOL RHYTHM, V26, P136, DOI 10.1177/0748730410395527; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007	50	26	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174342	10.1371/journal.pone.0174342	http://dx.doi.org/10.1371/journal.pone.0174342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384165	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900016
J	Avansini, SH; Lima, BPD; Secolin, R; Santos, ML; Coan, AC; Vieira, AS; Torres, FR; Carvalho, BS; Alvim, MKM; Morita, ME; Yasuda, CL; Pimentel-Silva, LR; Dogini, DB; Rogerio, F; Cendes, F; Lopes-Cendes, I				Avansini, Simoni H.; de Sousa Lima, Beatriz Pereira; Secolin, Rodrigo; Santos, Marilza L.; Coan, Ana Carolina; Vieira, Andre S.; Torres, Fabio R.; Carvalho, Benilton S.; Alvim, Marina K. M.; Morita, Marcia E.; Yasuda, Clarissa L.; Pimentel-Silva, Luciana R.; Dogini, Danyella B.; Rogerio, Fabio; Cendes, Fernando; Lopes-Cendes, Iscia			MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy	PLOS ONE			English	Article							HIPPOCAMPAL SCLEROSIS; NONEPILEPTIC SEIZURES; MISDIAGNOSIS; CANCER; CLASSIFICATION; EXPRESSION; DISEASE; PLASMA	Epilepsy is misdiagnosed in up to 25% of patients, leading to serious and long-lasting consequences. Recently, circulating microRNAs have emerged as potential biomarkers in a number of clinical scenarios. The purpose of this study was to identify and to validate circulating microRNAs that could be used as biomarkers in the diagnosis of epilepsy. Quantitative real-time PCR was used to measure plasma levels of three candidate microRNAs in two phases of study: an initial discovery phase with 14 patients with mesial temporal lobe epilepsy (MTLE), 13 with focal cortical dysplasia (FCD) and 16 controls; and a validation cohort constituted of an independent cohort of 65 patients with MTLE and 83 controls. We found hsa-miR-134 downregulated in patients with MTLE (p = 0.018) but not in patients with FCD, when compared to controls. Furthermore, hsa-miR-134 expression could be used to discriminate MTLE patients with an area under the curve (AUC) of 0.75. To further assess the robustness of hsa-miR-134 as a biomarker for MTLE, we studied an independent cohort of 65 patients with MTLE, 27 of whom MTLE patients were responsive to pharmacotherapy, and 38 patients were pharmacoresistant and 83 controls. We confirmed that hsa-miR-134 was significantly downregulated in the plasma of patients with MTLE when compared with controls (p < 0.001). In addition, hsa-miR-134 identified patients with MTLE regardless of their response to pharmacotherapy or the presence of MRI signs of hippocampal sclerosis. We revealed that decreased expression of hsa-miR-134 could be a potential non-invasive biomarker to support the diagnosis of patients with MTLE.	[Avansini, Simoni H.; de Sousa Lima, Beatriz Pereira; Secolin, Rodrigo; Santos, Marilza L.; Vieira, Andre S.; Torres, Fabio R.; Dogini, Danyella B.; Lopes-Cendes, Iscia] Univ Estadual Campinas, UNICAMP, Dept Med Genet, Campinas, SP, Brazil; [Avansini, Simoni H.; de Sousa Lima, Beatriz Pereira; Secolin, Rodrigo; Santos, Marilza L.; Coan, Ana Carolina; Vieira, Andre S.; Torres, Fabio R.; Carvalho, Benilton S.; Alvim, Marina K. M.; Morita, Marcia E.; Yasuda, Clarissa L.; Pimentel-Silva, Luciana R.; Dogini, Danyella B.; Rogerio, Fabio; Cendes, Fernando; Lopes-Cendes, Iscia] Brazilian Inst Neurosci & Neurotechnol BRAIN, Campinas, SP, Brazil; [Coan, Ana Carolina; Alvim, Marina K. M.; Morita, Marcia E.; Yasuda, Clarissa L.; Pimentel-Silva, Luciana R.; Cendes, Fernando] Univ Estadual Campinas, UNICAMP, Dept Neurol, Campinas, SP, Brazil; [Carvalho, Benilton S.] Univ Estadual Campinas, UNICAMP, Inst Math Stat & Sci Comp, Dept Stat, Campinas, SP, Brazil; [Rogerio, Fabio] Univ Estadual Campinas, UNICAMP, Dept Anat Pathol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Lopes-Cendes, I (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Med Genet, Campinas, SP, Brazil.; Lopes-Cendes, I (corresponding author), Brazilian Inst Neurosci & Neurotechnol BRAIN, Campinas, SP, Brazil.	icendes@unicamp.br	Secolin, Rodrigo/AAG-2115-2019; yasuda, clarissa l/B-7934-2013; Lopes-Cendes, Iscia/B-9416-2013; Secolin, Rodrigo/G-1738-2010; Carvalho, Benilton/L-9329-2019; Torres, Fabio/H-8289-2014; Avansini, Simoni H/J-9269-2017; Dogini, Danyella/AAC-4900-2021; Coan, Ana Carolina/F-4982-2012; Rogerio, Fabio/B-9391-2013; Cendes, Fernando/C-1301-2012; yasuda, clarissa lin/D-4599-2018; Dogini, Danyella B/A-4520-2013; Pimentel-Silva, Luciana Ramalho/AAB-4792-2021; Coan, Ana Carolina/AAA-7887-2020; Schwambach Vieira, Andre/A-3819-2013	Secolin, Rodrigo/0000-0002-2485-9560; yasuda, clarissa l/0000-0001-9084-7173; Lopes-Cendes, Iscia/0000-0002-6221-6822; Secolin, Rodrigo/0000-0002-2485-9560; Carvalho, Benilton/0000-0001-5122-5646; Avansini, Simoni H/0000-0002-2490-7438; Dogini, Danyella/0000-0002-0757-3982; Coan, Ana Carolina/0000-0002-2888-929X; Cendes, Fernando/0000-0001-9336-9568; yasuda, clarissa lin/0000-0001-9084-7173; Dogini, Danyella B/0000-0002-0757-3982; Pimentel-Silva, Luciana Ramalho/0000-0001-5045-9512; Coan, Ana Carolina/0000-0002-2888-929X; Schwambach Vieira, Andre/0000-0001-5318-8957	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil [2013/07559-3, 2013/00099-7]; Conselho Nacional de Pesquisa, CNPq, Brazil; Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior, CAPES, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior, CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil, 2013/07559-3 and 2013/00099-7; Conselho Nacional de Pesquisa, CNPq, Brazil; and Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior, CAPES, Brazil.	[Anonymous], 2014, R LANG ENV STAT COMP; Avansini SH, FOCAL CORTICAL DYSPL; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bodde NMG, 2009, CLIN NEUROL NEUROSUR, V111, P1, DOI 10.1016/j.clineuro.2008.09.028; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; Coan AC, 2014, AM J NEURORADIOL, V35, P77, DOI 10.3174/ajnr.A3640; de Boer HC, 2013, EUR HEART J, V34, P3451, DOI 10.1093/eurheartj/eht007; De Timary P, 2002, SEIZURE-EUR J EPILEP, V11, P193, DOI 10.1053/seiz.2001.0617; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Ferrie CD, 2006, ARCH DIS CHILD, V91, P206, DOI 10.1136/adc.2005.088906; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; JACKSON GD, 1994, NEUROLOGY, V44, P42, DOI 10.1212/WNL.44.1.42; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Juarez-Garcia A, 2006, SEIZURE-EUR J EPILEP, V15, P598, DOI 10.1016/j.seizure.2006.08.005; Mathern GW, 2009, EPILEPSIA, V50, P45, DOI 10.1111/j.1528-1167.2009.02294.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Shorvon SD, 2011, EPILEPSIA, V52, P1052, DOI 10.1111/j.1528-1167.2011.03041.x; Simon N, 2011, J STAT SOFTW, V39, P1; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Sun JJ, 2016, MOL MED REP, V14, P5318, DOI 10.3892/mmr.2016.5906; Surges R, 2016, BIOCHEM BIOPH RES CO, V481, P13, DOI 10.1016/j.bbrc.2016.11.029; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Uldall P, 2006, ARCH DIS CHILD, V91, P219, DOI 10.1136/adc.2004.064477; Wang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10201; Wang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09522; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808	31	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173060	10.1371/journal.pone.0173060	http://dx.doi.org/10.1371/journal.pone.0173060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384161	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900004
J	Gracia, JCM; Van den Hoecke, S; Saelens, X; Van Reeth, K				Gracia, Jose Carlos Mancera; Van den Hoecke, Silvie; Saelens, Xavier; Van Reeth, Kristien			Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine	PLOS ONE			English	Article							A VIRUSES; RECEPTOR SPECIFICITY; GENETIC-CHARACTERIZATION; INTERNAL GENES; HOST-RANGE; TRANSMISSION; REPLICATION; HEMAGGLUTININ; EVOLUTION; CHINA	H9N2 avian influenza viruses are endemic in poultry in Asia and the Middle East. These viruses sporadically cause dead-end infections in pigs and humans raising concerns about their potential to adapt to mammals or reassort with human or swine influenza viruses. We performed ten serial passages with an avian H9N2 virus (A/quail/Hong Kong/G1/1997) in influenza naive pigs to assess the potential of this virus to adapt to swine. Virus replication in the entire respiratory tract and nasal virus excretion were examined after each passage and we deep sequenced viral genomic RNA of the parental and passage four H9N2 virus isolated from the nasal mucosa and lung. The parental H9N2 virus caused a productive infection in pigs with a predominant tropism for the nasal mucosa, whereas only 50% lung samples were virus-positive. In contrast, inoculation of pigs with passage four virus resulted in viral replication in the entire respiratory tract. Subsequent passages were associated with reduced virus replication in the lungs and infectious virus was no longer detectable in the upper and lower respiratory tract of inoculated pigs at passage ten. The broader tissue tropism after four passages was associated with an amino acid residue substitution at position 225, within the receptor-binding site of the hemagglutinin. We also compared the parental H9N2, passage four H9N2 and the 2009 pandemic H1N1 (pH1N1) virus in a direct contact transmission experiment. Whereas only one out of six contact pigs showed nasal virus excretion of the wild-type H9N2 for more than four days, all six contact animals shed the passage four H9N2 virus. Nevertheless, the amount of excreted virus was significantly lower when compared to that of the pH1N1, which readily transmitted and replicated in all six contact animals. Our data demonstrate that serial passaging of H9N2 virus in pigs enhances its replication and transmissibility. However, full adaptation of an avian H9N2 virus to pigs likely requires an extensive set of mutations.	[Gracia, Jose Carlos Mancera; Van Reeth, Kristien] Univ Ghent, Dept Virol Parasitol & Immunol, Lab Virol, Fac Vet Med, Merelbeke, Belgium; [Van den Hoecke, Silvie; Saelens, Xavier] VIB, Ctr Med Biotechnol, Ghent, Belgium; [Van den Hoecke, Silvie; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Van Reeth, K (corresponding author), Univ Ghent, Dept Virol Parasitol & Immunol, Lab Virol, Fac Vet Med, Merelbeke, Belgium.	kristien.vanreeth@ugent.be	Saelens, Xavier/N-5728-2015	, Xavier/0000-0002-3861-6965	EU FLUPIG project [FP7-GA 258084]; Fonds voor Wetenschappelijk Onderzoek [3G052412]	EU FLUPIG project; Fonds voor Wetenschappelijk Onderzoek(FWO)	JCMG was supported by the EU FLUPIG project (FP7-GA 258084). SVDH was supported by Fonds voor Wetenschappelijk Onderzoek (3G052412).; The authors would like to express their gratitude to Dr. John Nicholls for providing the H9N2 influenza viruses and Lieve Sys, Melanie Bauwens, Nele Dennequin and Laura Van Driessche for excellent technical assistance. This study was supported by the EU FLUPIG project (FP7-GA 258084). Silvie Van den Hoecke is supported by Fonds voor Wetenschappelijk Onderzoek (3G052412).	Baranovich T, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.75; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Blair PJ, 2013, J INFECT PUBLIC HEAL, V6, P69, DOI 10.1016/j.jiph.2012.11.005; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; De Vleeschauwer A, 2009, J INFECT DIS, V200, P1884, DOI 10.1086/648475; Dlugolenski D, 2011, ARCH VIROL, V156, P565, DOI 10.1007/s00705-010-0891-x; Gu M, 2014, VET MICROBIOL, V174, P309, DOI 10.1016/j.vetmic.2014.09.029; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Kahn RE, 2014, CURR TOP MICROBIOL, V385, P205, DOI 10.1007/82_2014_392; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Lakdawala SS, 2015, NATURE, V526, P122, DOI 10.1038/nature15379; Lewis NS, 2016, ELIFE, V5, DOI 10.7554/eLife.12217; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu QF, 2014, J VIROL, V88, P8153, DOI 10.1128/JVI.00894-14; Matrosovich M, 2015, TOP CURR CHEM, V367, P1, DOI 10.1007/128_2013_466; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Matsuoka Y, 2009, CURR PROTOC MICROBIO; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Qiao CL, 2012, J GEN VIROL, V93, P2337, DOI 10.1099/vir.0.044040-0; Richard M, 2014, FUTURE VIROL, V9, P513, DOI 10.2217/fvl.14.30; Romero-Tejeda A, 2013, INFLUENZA OTHER RESP, V7, P4, DOI 10.1111/irv.12075; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Shichinohe S, 2013, VIROLOGY, V444, P404, DOI 10.1016/j.virol.2013.07.007; Slomka MJ, 2013, VET MICROBIOL, V162, P530, DOI 10.1016/j.vetmic.2012.11.013; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Sun YP, 2015, PROTEIN CELL, V6, P18, DOI 10.1007/s13238-014-0111-7; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van den Hoecke S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1284-z; Van Poucke S, 2013, INFLUENZA OTHER RESP, V7, P151, DOI 10.1111/j.1750-2659.2012.00376.x; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang J, 2016, J VIROL, V90, P3506, DOI 10.1128/JVI.02605-15; Watson SJ, 2015, J VIROL, V89, P9920, DOI 10.1128/JVI.00840-15; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; World Health Organization, 2016, ANT GEN CHAR ZOON IN; World Health Organization, INFLUENZA AT THE HUM; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Yu H, 2011, VET MICROBIOL, V149, P254, DOI 10.1016/j.vetmic.2010.11.008; Zaraket H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7553; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhou P, 2014, J MED VIROL, V86, P597, DOI 10.1002/jmv.23869	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175267	10.1371/journal.pone.0175267	http://dx.doi.org/10.1371/journal.pone.0175267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384328	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900143
J	Ye, Q; Yin, WL; Zhang, L; Xiao, HJ; Qi, YM; Liu, SY; Qian, BX; Wang, FM; Han, T				Ye, Qing; Yin, Weili; Zhang, Lei; Xiao, Huijuan; Qi, Yumei; Liu, Shuye; Qian, Baoxin; Wang, Fengmei; Han, Tao			The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; ADVANCED LIVER-DISEASE; BODY-COMPOSITION; MASS-SPECTROMETRY; MALNUTRITION; SARCOPENIA; TRANSPLANTATION; MANAGEMENT; PROGNOSIS; UPLC/MS	The liver is essential for the regulation of energy, protein and amino acids, as well as in other aspects of metabolism. To identify efficient indexes for evaluation of nutritional status and metabolic characteristics during different Child-Pugh stages of hepatitis B cirrhosis, 83 patients and 35 healthy individuals were enrolled in our study. We found that grip strength, triceps skinfold thickness (TSF), body fat and skeletal muscle of the patients were reduced compared to the control group (P< 0.05). Ultra-high-performance liquid chromatography data combined with mass spectrometry (UPLC-MS) showed that levels of a variety of metabolites, including lysophosphatidylcholines (LysoPCs), glycerophosphocholine, ornithine and glucuronic acid were reduced in the serum of patients with hepatitis B cirrhosis (P< 0.001). However, glycerophosphoserine and taurocholic acid levels were higher than in the control group (P< 0.001). Moreover, grip strength was correlated with the Child-Pugh score (P< 0.05). Serum albumin, total cholesterol, LDL, LysoPCs, glycerophosphocholine, ornithine, glucuronic acid, glycerophosphoserine and taurocholic acid were correlated with the Child-Pugh score (P< 0.01). These findings suggested that grip strength and the above small molecular substances might be considered as sensitive and important indexes for evaluating nutritional status and metabolic characteristics of patients with hepatitis B cirrhosis, which may help assess prognosis and adjust nutritional treatment.	[Ye, Qing; Yin, Weili; Xiao, Huijuan; Qian, Baoxin; Wang, Fengmei; Han, Tao] Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China; [Ye, Qing; Yin, Weili; Qian, Baoxin; Wang, Fengmei; Han, Tao] Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Dept Gastroenterol & Hepatol, Tianjin Key Lab Artificial Cells, Tianjin, Peoples R China; [Zhang, Lei; Liu, Shuye] Tianjin Third Cent Hosp, Clin Lab, Tianjin, Peoples R China; [Xiao, Huijuan; Qi, Yumei] Tianjin Third Cent Hosp, Dept Nutriol, Tianjin, Peoples R China	Tianjin Medical University	Han, T (corresponding author), Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China.; Han, T (corresponding author), Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Dept Gastroenterol & Hepatol, Tianjin Key Lab Artificial Cells, Tianjin, Peoples R China.	hantaomd@126.com			Tianjin Science and Technology Commission Foundation Project [13RCGFSY19200]	Tianjin Science and Technology Commission Foundation Project	This study was supported by the Tianjin Science and Technology Commission Foundation Project (No.13RCGFSY19200) to TH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; Carretero A, 2014, ANAL BIOANAL CHEM, V406, P5465, DOI 10.1007/s00216-014-7983-5; Carvalho Luciana, 2006, Arq. Gastroenterol., V43, P269, DOI 10.1590/S0004-28032006000400005; Cheung K, 2012, CLIN GASTROENTEROL H, V10, P117, DOI 10.1016/j.cgh.2011.08.016; CSoIDaPaCSoHoCM. A, 2000, CHIN J HEPATOL, P324; Drzazga A, 2014, ACTA POL PHARM, V71, P887; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Fernandes SA, 2016, WORLD J HEPATOL, V8, P1205, DOI 10.4254/wjh.v8.i29.1205; Figueiredo FAF, 2005, J GASTROEN HEPATOL, V20, P209, DOI 10.1111/j.1440-1746.2004.03544.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005; Haverkort EB, 2015, EUR J CLIN NUTR, V69, P3, DOI 10.1038/ejcn.2014.203; Huisman EJ, 2011, EUR J GASTROEN HEPAT, V23, P982, DOI 10.1097/MEG.0b013e32834aa4bb; Johnson TM, 2013, NUTR CLIN PRACT, V28, P15, DOI 10.1177/0884533612469027; Kahraman A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-191; Kalaitzakis E, 2006, SCAND J GASTROENTERO, V41, P1464, DOI 10.1080/00365520600825117; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Matoori S, 2015, ADV DRUG DELIVER REV, V90, P55, DOI 10.1016/j.addr.2015.04.009; Mattar J A, 1996, New Horiz, V4, P493; Memon N, 2016, PEDIATR RES, V79, P378, DOI 10.1038/pr.2015.247; Merli M, 2010, LIVER INT, V30, P208, DOI 10.1111/j.1478-3231.2009.02135.x; Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061; Nie CY, 2014, J VIRAL HEPATITIS, V21, P53, DOI 10.1111/jvh.12122; Park HW, 2015, YONSEI MED J, V56, P95, DOI 10.3349/ymj.2015.56.1.95; Park JY, 2006, YONSEI MED J, V47, P817, DOI 10.3349/ymj.2006.47.6.817; Periyalwar P, 2012, CLIN LIVER DIS, V16, P95, DOI 10.1016/j.cld.2011.12.009; Pirlich M, 2000, HEPATOLOGY, V32, P1208, DOI 10.1053/jhep.2000.20524; Putadechakum Supanee, 2012, ISRN Gastroenterol, V2012, P690402, DOI 10.5402/2012/690402; Rachakonda V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159142; Rahimi RS, 2015, CLIN GERIATR MED, V31, P539, DOI 10.1016/j.cld.2015.04.008; Ritter Luciana, 2006, Arq. Gastroenterol., V43, P66, DOI 10.1590/S0004-28032006000100016; Ruiz-Margain A, 2015, DIGEST LIVER DIS, V47, P309, DOI 10.1016/j.dld.2014.12.015; Seijo S, 2016, LIVER INT, V36, P1051, DOI 10.1111/liv.12972; Subbaiah P V, 1986, Methods Enzymol, V129, P790; Tietge UJF, 1998, HEPATO-GASTROENTEROL, V45, P2255; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Tsai YW, 2015, EUR J CLIN NUTR, V69, P34, DOI 10.1038/ejcn.2014.66; Wang XN, 2016, J PROTEOME RES, V15, P1126, DOI 10.1021/acs.jproteome.5b00217; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Xiong J, 2015, CLINICS, V70, P563, DOI 10.6061/clinics/2015(08)06; Yan TM, 2015, PHARM RES-DORDR, V32, P1141, DOI 10.1007/s11095-014-1525-x; Zhao YY, 2014, CHEM-BIOL INTERACT, V220, P181, DOI 10.1016/j.cbi.2014.06.029	43	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175165	10.1371/journal.pone.0175165	http://dx.doi.org/10.1371/journal.pone.0175165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384211	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900106
J	Zhao, J; Chen, WC; Huang, XS; Peng, SM; Zhu, TH; Deng, ZH; Liang, P; Chang, H; Fan, BJ				Zhao, Jun; Chen, Wenchieh; Huang, Xiaosheng; Peng, Shiming; Zhu, Tianhui; Deng, Zhihui; Liang, Ping; Chang, Hui; Fan, Bao Jian			Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; GLUCOSE-6-PHOSPHATE ISOMERASE; AQUEOUS-HUMOR; CELLS; EXPRESSION; AUTOIMMUNITY; DYSFUNCTION; ARTHRITIS; DISEASE; GAMMA	Posner-Schlossman syndrome (PSS) shares some clinical features with uveitis and open angle glaucoma. Cytokines and autoantibodies have been associated with uveitis and open angle glaucoma. However, the role of serum cytokines and autoantibodies in the pathogenesis of PSS remains unknown. This study aimed to evaluate the associations of type 1 T helper (Th1) and Th17 related cytokines and autoantibodies with PSS. Peripheral blood serum samples were collected from 81 patients with PSS and 97 gender-and age-matched healthy blood donors. Th1 and Th17 related cytokines, including interleukin-1 beta (IL-1 beta), IL-12, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma. (IFN-gamma), IL-6 and IL-17, and glucose-6-phosphate isomerase (GPI) were determined by double antibody sandwich ELISA. Antinuclear antibody (ANA), anti-keratin antibody (AKA) and anti-neutrophil cytoplasmic antibody (ANCA) were detected by indirect immunofluorescence assay. Anti-cardiolipin antibody (ACA)-IgG, ACA-IgM, ACA-IgA, anti-double stranded DNA (anti-dsDNA) and anti-cyclic citrullinated peptide antibody (anti-CCP) were detected by indirect ELISA. Serum levels of IL-1 beta, IL-12 and IL-6 in PSS patients were significantly lower than those in controls (P < 0.003), and these associations survived the Bonferroni correction (P-c < 0.018). There was no significant difference in serum levels of TNF-alpha, IFN-gamma and IL-17 between the PSS and control groups (P-c > 0.12). Positive rate of serum anti-dsDNA in PSS patients was significantly higher than that in the control group (P = 0.002, P-c = 0.018), while positive rates of serum ANA, AKA, ANCA, ACA-IgG, ACA-IgM, ACA-IgA, GPI and anti-CCP in the PSS group were not significantly different from those in the control group (P-c > 0.09). These results suggest that anti-dsDNA may contribute to the pathogenesis of PSS, while Th1 and Th17 related cytokines and other autoantibodies may not be major contributors to PSS.	[Zhao, Jun; Chen, Wenchieh; Huang, Xiaosheng; Peng, Shiming; Zhu, Tianhui; Chang, Hui] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Zhao, Jun; Liang, Ping] Shenzhen Univ, Sch Ophthalmol & Optometry, Shenzhen, Guangdong, Peoples R China; [Deng, Zhihui] Shenzhen Blood Ctr, Immunogenet Lab, Shenzhen, Guangdong, Peoples R China; [Fan, Bao Jian] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA	Jinan University; Shenzhen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Zhao, J (corresponding author), Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China.; Zhao, J (corresponding author), Shenzhen Univ, Sch Ophthalmol & Optometry, Shenzhen, Guangdong, Peoples R China.; Fan, BJ (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA.	dotorzhaojun@163.com; baojian_fan@meei.harvard.edu		deng, zhihui/0000-0002-2046-1467; Fan, Baojian/0000-0002-6851-2737	Shenzhen Science & Technology Project, China [GJHZ20160229170608241, CXZZ20140418182638764]	Shenzhen Science & Technology Project, China	This work was supported by Shenzhen Science & Technology Project, China (No. GJHZ20160229170608241; No. CXZZ20140418182638764). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Chen W, 2015, CURR MOL MED, V15, P543, DOI 10.2174/1566524015666150731100012; Enriquez-de-Salamanca A, 2010, MOL VIS, V16, P862; Fan LY, 2010, CLIN CHIM ACTA, V411, P2049, DOI 10.1016/j.cca.2010.08.043; Fleisher LN, 2000, EXP EYE RES, V70, P271, DOI 10.1006/exer.1999.0787; Grajewski RS, 2008, J IMMUNOL, V181, P4791, DOI 10.4049/jimmunol.181.7.4791; Huang P, 2010, J GLAUCOMA, V19, P324, DOI 10.1097/IJG.0b013e3181b4cac7; Jap A, 2001, OPHTHALMOLOGY, V108, P913, DOI 10.1016/S0161-6420(01)00551-6; Joachim SC, 2003, EUR J OPHTHALMOL, V13, P752, DOI 10.1177/1120672103013009-1003; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Li J., 2012, THESCIENTIFICWORLDJO, V2012, P7, DOI [10.1100/2012/154939, DOI 10.1100/2012/154939]; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Megaw R, 2016, SURV OPHTHALMOL; Nikitina EY, 2005, CANCER RES, V65, P4309, DOI 10.1158/0008-5472.CAN-04-3119; Ohira S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147080; POSNER A, 1948, ARCH OPHTHALMOL-CHIC, V39, P517; Rodier-Bonifas C, 2011, J FR OPHTALMOL, V34, P24, DOI 10.1016/j.jfo.2010.10.008; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Seri Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13041; Shazly TA, 2011, SEMIN OPHTHALMOL, V26, P282, DOI 10.3109/08820538.2011.605821; Shen SC, 2010, INVEST OPHTH VIS SCI, V51, P272, DOI 10.1167/iovs.09-3849; Shin MS, 2013, J IMMUNOL, V190, P1407, DOI 10.4049/jimmunol.1201195; Tarrant TK, 1999, J EXP MED, V189, P219, DOI 10.1084/jem.189.2.219; Vasiliauskiene L, 2001, ANN RHEUM DIS, V60, P459, DOI 10.1136/ard.60.5.459; Wang ZG, 2016, J MED VIROL, V88, P852, DOI 10.1002/jmv.24391; Wong MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122184; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu YZ, 2010, MOL VIS, V16, P1689; Yamagami H, 2003, INVEST OPHTH VIS SCI, V44, P514, DOI 10.1167/iovs.02-0498; Yokoi H, 1997, EUR J IMMUNOL, V27, P641, DOI 10.1002/eji.1830270310; Yong PH, 2010, MOL VIS, V16, P2524; Zhang HY, 2016, SOFT ROBOT, V3, P3, DOI 10.1089/soro.2015.0017; Zhang MF, 2000, CURR EYE RES, V21, P913, DOI 10.1076/ceyr.21.6.913.6986; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132179; Zong M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0619-0	37	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175519	10.1371/journal.pone.0175519	http://dx.doi.org/10.1371/journal.pone.0175519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384257	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900174
J	Ye, Y; Wagner, MM; Cooper, GF; Ferraro, JP; Su, H; Gesteland, PH; Haug, PJ; Millett, NE; Aronis, JM; Nowalk, AJ; Ruiz, VM; Pineda, AL; Shi, LY; Van Bree, R; Ginter, T; Tsui, F				Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.; Ferraro, Jeffrey P.; Su, Howard; Gesteland, Per H.; Haug, Peter J.; Millett, Nicholas E.; Aronis, John M.; Nowalk, Andrew J.; Ruiz, Victor M.; Pineda, Arturo Lopez; Shi, Lingyun; Van Bree, Rudy; Ginter, Thomas; Tsui, Fuchiang			A study of the transferability of influenza case detection systems between two large healthcare systems	PLOS ONE			English	Article							INFECTIOUS-DISEASES; MODELS	Objectives This study evaluates the accuracy and transferability of Bayesian case detection systems (BCD) that use clinical notes from emergency department (ED) to detect influenza cases. Methods A BCD uses natural language processing (NLP) to infer the presence or absence of clinical findings from ED notes, which are fed into a Bayesain network classifier (BN) to infer patients' diagnoses. We developed BCDs at the University of Pittsburgh Medical Center (BCDUPMC) and Intermountain Healthcare in Utah (BCDIH). At each site, we manually built a rule-based NLP and trained a Bayesain network classifier from over 40,000 ED encounters between Jan. 2008 and May. 2010 using feature selection, machine learning, and expert debiasing approach. Transferability of a BCD in this study may be impacted by seven factors: development (source) institution, development parser, application (target) institution, application parser, NLP transfer, BN transfer, and classification task. We employed an ANOVA analysis to study their impacts on BCD performance. Results Both BCDs discriminated well between influenza and non-influenza on local test cases (AUCs > 0.92). When tested for transferability using the other institution's cases, BCDUPMC discriminations declined minimally (AUC decreased from 0.95 to 0.94, p< 0.01), and BCDIH discriminations declined more (from 0.93 to 0.87, p< 0.0001). We attributed the BCDIH decline to the lower recall of the IH parser on UPMC notes. The ANOVA analysis showed five significant factors: development parser, application institution, application parser, BN transfer, and classification task. Conclusion We demonstrated high influenza case detection performance in two large healthcare systems in two geographically separated regions, providing evidentiary support for the use of automated case detection from routinely collected electronic clinical notes in national influenza surveillance. The transferability could be improved by training Bayesian network classifier locally and increasing the accuracy of the NLP parser.	[Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.; Su, Howard; Millett, Nicholas E.; Aronis, John M.; Ruiz, Victor M.; Shi, Lingyun; Tsui, Fuchiang] Univ Pittsburgh, Dept Biomed Informat, Real Time Outbreak & Dis Surveillance Lab, Pittsburgh, PA USA; [Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.; Tsui, Fuchiang] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA; [Ferraro, Jeffrey P.; Gesteland, Per H.; Haug, Peter J.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Ferraro, Jeffrey P.; Gesteland, Per H.; Haug, Peter J.; Van Bree, Rudy] Intermt Healthcare, Salt Lake City, UT USA; [Gesteland, Per H.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Nowalk, Andrew J.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Pineda, Arturo Lopez] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Ginter, Thomas] VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; US Department of Veterans Affairs	Tsui, F (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Real Time Outbreak & Dis Surveillance Lab, Pittsburgh, PA USA.; Tsui, F (corresponding author), Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA.	tsui2@pitt.edu	Ye, Ye/T-2154-2019; Pineda, Arturo Lopez/B-1610-2015	Pineda, Arturo Lopez/0000-0002-3409-1815; Nowalk, Andrew/0000-0002-1374-3167; Ye, Ye/0000-0002-1138-9846	National Library of Medicine [R01LM011370]; NATIONAL LIBRARY OF MEDICINE [R01LM011370, T15LM007059] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Research reported in this publication was supported by grant R01LM011370 from the National Library of Medicine, https.//www.nih.gov/. YY, MMW, GFC, JPF, PHG, PJH, NEM, JMA, RVB, TG, and FT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold A., 2007, PROC 7 IEEE INT C DA, P77, DOI DOI 10.1109/ICDMW.2007.109; Aue A., 2005, P RECENT ADV NATURAL, V1, P1; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Chang W, 2005, 2005 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE (ITSC), P1120; Chapman W.W., 2005, ANN EMERG MED, V46, P445; Chute Christopher G, 2011, AMIA Annu Symp Proc, V2011, P248; Ciaramita M, 2010, PROCEEDINGS OF THE 2, P1; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Cooper GF, 2015, J BIOMED INFORM, V53, P15, DOI 10.1016/j.jbi.2014.08.011; Dai Wenyuan, 2007, AAAI, P540; Draper AJ, 2014, P ANN FALL S AM MED; Druzdzel MJ, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P902; DUCZMAL L, 2005, MMWR CDC S, V54, P187; Elkin PL, 2012, ANN INTERN MED, V156, P11, DOI 10.7326/0003-4819-156-1-201201030-00003; Espino JU, 2001, J AM MED INFORM ASSN, P164; Finkel Jenny Rose, 2009, P HUM LANG TECHN 200, P602, DOI DOI 10.3115/1620754.1620842; Gerbier-Colomban S, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-101; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Grant I., 1987, TEACH STAT, V9, P15; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hripcsak G, 1998, METHOD INFORM MED, V37, P1; Hripcsak G, 2015, OBSERVATIONAL HLTH D, P15; Huang J., 2006, ADV NEURAL INFORM PR, P601, DOI DOI 10.7551/MITPRESS/7503.003.0080; Inc SI, 2011, SAS STAT 9 3 US GUID; Ivanov Oleg, 2003, AMIA Annu Symp Proc, P318; Jiang J., 2008, DOMAIN ADAPTATION NA; Jiang Jing, 2007, P 16 ACM C INF KNOWL, P401; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1999, STAT IND TECHNOL, P303; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Lenert Leslie, 2012, Am J Public Health, V102, pe1, DOI 10.2105/AJPH.2011.300542; Lu J, 2015, KNOWL-BASED SYST, V80, P14, DOI 10.1016/j.knosys.2015.01.010; Neubauer AS, 1997, CLIN CHEM, V43, P594; Ni X, 2010, PROC 19 INT C WORLD, P751; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Pan SJ, 2011, IEEE T NEURAL NETWOR, V22, P199, DOI 10.1109/TNN.2010.2091281; Panackal AA, 2002, EMERG INFECT DIS, V8, P685, DOI 10.3201/eid0807.010493; Pineda AL, 2015, J BIOMED INFORM, V58, P60, DOI 10.1016/j.jbi.2015.08.019; Qin GS, 2008, STAT METHODS MED RES, V17, P207, DOI 10.1177/0962280207087173; Rexit R, 2015, INFORM SYST, V48, P151, DOI 10.1016/j.is.2014.05.008; Roy DM, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2599; Ruiz VM, 2014, THESIS; Ruiz VM, 2015, P ANN FALL S AM MED; Satpal S, 2007, LECT NOTES ARTIF INT, V4702, P224; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1177/096228029900800203; Skvortsov A, 2010, P 13 INT C INF FUS F, P1; Steininger C, 2009, CLIN MICROBIOL INFEC, V15, P267, DOI 10.1111/j.1469-0691.2008.02674.x; Tan SB, 2009, LECT NOTES COMPUT SC, V5478, P337; Tsui F, 2011, ONLINE J PUBLIC HLTH, V3, P22; Tsui F-C, 2010, AUTOMATED INFLUENZA; Villamarin R., 2011, EMERG HLTH THREATS J, V4, ps57; Wagner M, 2011, ONLINE J PUBLIC HLTH, V3, P22; Wagner Michael M, 2004, MMWR Suppl, V53, P28; Wagner Michael M, 2004, MMWR Suppl, V53, P40; Ye Y, 2014, J AM MED INFORM ASSN, V21, P815, DOI 10.1136/amiajnl-2013-001934; Zeng D, 2004, ITSC 2004: 7TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P106; Zhang JC, 2003, IEEE SENSOR, P748, DOI 10.1109/ICSENS.2003.1279041	68	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174970	10.1371/journal.pone.0174970	http://dx.doi.org/10.1371/journal.pone.0174970			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380048	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500081
J	Crowson, CS; Rollefstad, S; Kitas, GD; van Riel, PLCM; Gabriel, SE; Semb, AG				Crowson, Cynthia S.; Rollefstad, Silvia; Kitas, George D.; van Riel, Piet L. C. M.; Gabriel, Sherine E.; Semb, Anne Grete		A Trans-Atlantic Cardiovasc Risk C	Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis (vol 12, e0174656, 2017)	PLOS ONE			English	Correction													Kitas, George/AAO-6396-2020; van Riel, P.L.C.M./H-8082-2014		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046849] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR046849] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Crowson CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174656; CROWSON SC, 2017, PLOS ONE, V12, DOI DOI 10.1371/J0URNAL.P0NE.0174656	2	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175605	10.1371/journal.pone.0175605	http://dx.doi.org/10.1371/journal.pone.0175605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388688	Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800065
J	Giess, RM; Pfuhl, C; Behrens, JR; Rasche, L; Freitag, E; Khalighy, N; Otto, C; Wuerfel, J; Brandt, AU; Hofmann, J; Eberspacher, B; Bellmann-Strobl, J; Paul, F; Ruprecht, K				Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Khalighy, Nima; Otto, Carolin; Wuerfel, Jens; Brandt, Alexander U.; Hofmann, Joerg; Eberspaecher, Bettina; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens			Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis	PLOS ONE			English	Article							IMMUNE-RESPONSE; EBV; INFECTION; RISK; MS; MRI; REACTIVATION; ATROPHY; ANTIGEN; TITERS	Objective To investigate the association of Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1) and viral capsid antigen (VCA) immunoglobulin (Ig) G antibodies in serum as well as EBV DNA load in saliva with radiological and clinical disease activity in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS). Methods EBNA-1 and VCA immunoglobulin (Ig) G antibodies were determined in serum of 100 patients with CIS/early RRMS and 60 healthy controls. EBV DNA load was measured in saliva of 48 patients and 50 controls. Patients underwent clinical assessment with the Expanded Disability Status Scale (EDSS) and 3 Tesla magnetic resonance imaging at baseline and after a median of 20 months of follow-up (n = 63 for MRI, n = 71 for EDSS). The association of EBV parameters with occurrence of a second relapse, indicating conversion to clinically definite MS (CDMS), was evaluated over a median of 35 months of follow-up after the first clinical event (n = 89). Results EBNA-1 IgG antibody frequency (p = 0.00005) and EBNA-1 and VCA IgG antibody levels (p<0.0001 for both) were higher in patients than in controls. EBV DNA load in saliva did not differ between groups. Neither EBV antibody levels nor DNA load in saliva were associated with baseline or follow-up number or volume of T2-weighted (T2w) or contrast enhancing lesions, number of Barkhof criteria or the EDSS, or with the number of new T2w lesions, T2w lesion volume change or EDSS change on follow-up. Likewise, levels of EBV IgG antibodies in serum and DNA load in saliva were not associated with conversion to CDMS. Conclusions While these findings confirm the association of EBV infection with early MS, neither EBNA-1 nor VCA IgG antibodies in serum nor EBV DNA load in saliva were associated with radiological or clinical disease activity in patients with CIS/early RRMS. These data are compatible with the concept that EBV may be a trigger for MS acting very early during the development of the disease.	[Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Khalighy, Nima; Paul, Friedemann; Ruprecht, Klemens] Charite, Dept Neurol, Berlin, Germany; [Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Wuerfel, Jens; Brandt, Alexander U.; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Brandt, Alexander U.; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens] Charite, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Otto, Carolin] St Josefs Hosp, Potsdam, Germany; [Wuerfel, Jens] Univ Basel, MIAC AG, Basel, Switzerland; [Wuerfel, Jens] Univ Basel, Dept Biomed Engn, Basel, Switzerland; [Hofmann, Joerg; Eberspaecher, Bettina] Lab Berlin Charite Vivantes GmbH, Berlin, Germany; [Hofmann, Joerg] Charite, Inst Med Virol, Berlin, Germany; [Eberspaecher, Bettina] Vivantes Klinikum Neukolln, Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; University of Basel; Labor Berlin - Charite Vivantes GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; VIivantes Klinikum Neukolln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ruprecht, K (corresponding author), Charite, Dept Neurol, Berlin, Germany.; Ruprecht, K (corresponding author), Charite, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany.	klemens.ruprecht@charite.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Hofmann, Joerg/0000-0003-3966-515X; Wuerfel, Jens/0000-0002-0034-8053; Bellmann-Strobl, Judith/0000-0003-2615-1643	German Ministry of Education and Research [01G11312]; Charite Research Fund	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Charite Research Fund	Support was provided by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis, grant number 01G11312) and the Charite Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JH and BE are affiliated to Labor Berlin Charite-Vivantes GmbH but do not receive salaries from Labor Berlin Charite-Vivantes GmbH. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section."	Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; Cocuzza CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094497; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Deuschle K, 2013, MULT SCLER J, V19, P1242, DOI 10.1177/1352458512472751; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Franciotta D, 2009, ACTA NEUROL BELG, V109, P277; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Hollsberg P, 2005, ACTA NEUROL SCAND, V112, P395, DOI 10.1111/j.1600-0404.2005.00516.x; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Ingram G, 2010, EUR J NEUROL, V17, P1386, DOI 10.1111/j.1468-1331.2010.03083.x; Kuhle J., 2015, MULT SCLER; Kvistad S., 2014, MULT SCLER; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Latham LB, 2016, ACTA NEUROL SCAND, V133, P17, DOI 10.1111/ane.12417; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lindsey JW, 2010, EUR J NEUROL, V17, P1263, DOI 10.1111/j.1468-1331.2010.03005.x; Lucas RM, 2011, NEUROLOGY, V77, P371, DOI 10.1212/WNL.0b013e318227062a; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Montalban X., 2014, MULT SCLER RELAT DIS, V3, P764; Munger KL, 2011, MULT SCLER J, V17, P1185, DOI 10.1177/1352458511408991; Munger KL, 2015, NEUROLOGY, V85, P1694, DOI 10.1212/WNL.0000000000002099; Niesters HGM, 2000, J CLIN MICROBIOL, V38, P712, DOI 10.1128/JCM.38.2.712-715.2000; Otto C, 2016, MED HYPOTHESES, V91, P109, DOI 10.1016/j.mehy.2016.04.025; Pakpoor J, 2013, MULT SCLER J, V19, P162, DOI 10.1177/1352458512449682; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ruprecht K, 2008, NERVENARZT, V79, P399, DOI 10.1007/s00115-007-2335-8; Ruprecht K, 2014, J NEUROIMMUNOL, V272, P56, DOI 10.1016/j.jneuroim.2014.04.005; Schlemm L, 2016, J NEUROIMMUNOL, V297, P56, DOI 10.1016/j.jneuroim.2016.05.012; Simpson S, 2014, ACTA NEUROL SCAND, V130, P328, DOI 10.1111/ane.12268; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Thorley-Lawson DA, 2005, EPSTEIN-BARR VIRUS, P309; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Yea C, 2013, NEUROLOGY, V81, P1392, DOI 10.1212/WNL.0b013e3182a841e4; Zivadinov R, 2009, J NEUROL NEUROSUR PS, V80, P620, DOI 10.1136/jnnp.2008.154906; Zivadinov R, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000190; Zivadinov R, 2014, J NEUROIMMUNOL, V273, P58, DOI 10.1016/j.jneuroim.2014.04.012; Zivadinov R, 2009, J NEUROIMMUNOL, V209, P123, DOI 10.1016/j.jneuroim.2009.01.023	44	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175279	10.1371/journal.pone.0175279	http://dx.doi.org/10.1371/journal.pone.0175279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388676	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000399375800034
J	Mazuel, L; Blanc, J; Repond, C; Bouchaud, V; Raffard, G; Deglon, N; Bonvento, G; Pellerin, L; Bouzier-Sore, AK				Mazuel, Leslie; Blanc, Jordy; Repond, Cendrine; Bouchaud, Veronique; Raffard, Gerard; Deglon, Nicole; Bonvento, Gilles; Pellerin, Luc; Bouzier-Sore, Anne-Karine			A neuronal MCT2 knockdown in the rat somatosensory cortex reduces both the NMR lactate signal and the BOLD response during whisker stimulation	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; MONOCARBOXYLATE TRANSPORTER MCT2; INSULIN-RECEPTOR EXPRESSION; ADULT-MOUSE BRAIN; IN-VIVO; PYRUVATE-CARBOXYLASE; CONFOCAL MICROSCOPY; MAGNETIC-RESONANCE; AEROBIC GLYCOLYSIS; DOWN-REGULATION	Although several in vitro and ex vivo evidence support the existence of lactate exchange between astrocytes and neurons, a direct demonstration in vivo is still lacking. In the present study, a lentiviral vector carrying a short hairpin RNA (shRNA) was used to downregulate the expression of the monocarboxylate transporter type 2 (MCT2) in neurons of the rat somatosensory cortex (called Si BF) by -25%. After one hour of whisker stimulation, HRMAS 1H-NMR spectroscopy analysis of S-IBF perchloric acid extracts showed that while an increase in lactate content is observed in both uninjected and shRNA-control injected extracts, such an effect was abrogated in shMCT2 injected rats. A 13C -incorporation analysis following [1-13C]glucose infusion during the stimulation confirmed that the elevated lactate observed during activation originates from newly synthesized [3-13C]lactate, with blood derived [1-13C]glucose being the precursor. Moreover, the analysis of the 13C -labeling of glutamate in position C3 and C4 indicates that upon activation, there is an increase in TCA cycle velocity for control rats while a decrease is observed for MCT2 knockdown animals. Using in vivo localized 1H-NMR spectroscopy, an increase in lactate levels is observed in the S-IBF area upon whisker stimulation for shRNA-control injected rats but not for MCT2 knockdown animals. Finally, while a robust BOLD fMRI response was evidenced in control rats, it was absent in MCT2 knockdown rats. These data not only demonstrate that glucose derived lactate is locally produced following neuronal activation but also suggest that its use by neurons via MCT2 is probably essential to maintain synaptic activity within the barrel cortex.	[Mazuel, Leslie; Blanc, Jordy; Pellerin, Luc; Bouzier-Sore, Anne-Karine] Univ Bordeaux, CNRS, UMR 5536, Ctr Resonance Magnet Syst Biol, 146 Rue Leo Saignat, Bordeaux, France; [Pellerin, Luc] Dept Physiol, 7 Rue Bugnon, Lausanne, Switzerland; [Deglon, Nicole] Univ Lausanne Hosp, Dept Clin Neurosci, Lab Cellular & Mol Neurotherapies LCMN, Lausanne, Switzerland; [Deglon, Nicole] Univ Lausanne Hosp, Neurosci Res Ctr CRN, LCMN, Lausanne, Switzerland; [Deglon, Nicole; Bouzier-Sore, Anne-Karine] Univ Paris Saclay, CNRS UMR 9199, Univ Paris Sud, Mol Imaging Ctr MIRCen, Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Bouzier-Sore, AK (corresponding author), Univ Bordeaux, CNRS, UMR 5536, Ctr Resonance Magnet Syst Biol, 146 Rue Leo Saignat, Bordeaux, France.	akb@rmsb.u-bordeaux2.fr	Bonvento, Gilles/F-6023-2013; Deglon, Nicole/A-2265-2012; Pellerin, Luc/A-8912-2017	Bonvento, Gilles/0000-0002-2886-4228; Deglon, Nicole/0000-0003-4475-9476; Pellerin, Luc/0000-0002-1016-1970; Bouzier-Sore, Anne-Karine/0000-0002-3470-0940; Mazuel, Leslie/0000-0002-0180-871X	French State in the context of the "Investments for the future" Programme IdEx; LabEx TRAIL [ANR-10-IDEX, ANR-10-LABX-57]; international French (ANR)/Swiss (FNS) grant [ANR-15-CE37-0012]; FNS [310030E-16427]	French State in the context of the "Investments for the future" Programme IdEx; LabEx TRAIL; international French (ANR)/Swiss (FNS) grant(French National Research Agency (ANR)); FNS(Swiss National Science Foundation (SNSF))	Anne-Karine Bouzier-Sore has received financial support from the French State in the context of the "Investments for the future" Programme IdEx and the LabEx TRAIL, reference ANR-10-IDEX and ANR-10-LABX-57. Anne-Karine Bouzier-Sore and Luc Pellerin have received financial support from an international French (ANR)/Swiss (FNS) grant, references ANR-15-CE37-0012 and FNS no 310030E-16427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; BRAND A, 1992, BIOCHIMIE, V74, P941, DOI 10.1016/0300-9084(92)90078-S; Brix B, 2012, J NEUROSCI, V32, P9727, DOI 10.1523/JNEUROSCI.0879-12.2012; Chiry O, 2008, BRAIN RES, V1226, P61, DOI 10.1016/j.brainres.2008.06.025; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Dobbins RL, 2003, CURR OPIN CLIN NUTR, V6, P501, DOI 10.1097/00075197-200309000-00003; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FREEMAN R, 1981, J MAGN RESON, V42, P341, DOI 10.1016/0022-2364(81)90227-4; Grillo CA, 2007, PHYSIOL BEHAV, V92, P691, DOI 10.1016/j.physbeh.2007.05.043; Grillo CA, 2011, BEHAV BRAIN RES, V222, P230, DOI 10.1016/j.bbr.2011.03.052; Hassel B, 2000, J CEREBR BLOOD F MET, V20, P327, DOI 10.1097/00004647-200002000-00014; Kacem K, 1998, GLIA, V23, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Mangia S, 2007, J NEUROSCI RES, V85, P3340, DOI 10.1002/jnr.21371; Marcillac F, 2011, GLIA, V59, P1987, DOI 10.1002/glia.21240; Merienne N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00106; Merle M, 2002, J NEUROCHEM, V82, P47, DOI 10.1046/j.1471-4159.2002.00924.x; Mosso A, 1884, ATTI REALE ACAD SFMN, VXIX, P531; Nagase M, 2014, J NEUROSCI, V34, P2605, DOI 10.1523/JNEUROSCI.4687-12.2014; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Robinet C, 2011, NEUROSCIENCE, V192, P155, DOI 10.1016/j.neuroscience.2011.06.059; Robinet C, 2010, J CEREBR BLOOD F MET, V30, P286, DOI 10.1038/jcbfm.2009.208; Rodrigues Tiago B, 2013, Front Neuroenergetics, V5, P9, DOI 10.3389/fnene.2013.00009; ROTHMAN DL, 1985, P NATL ACAD SCI USA, V82, P1633, DOI 10.1073/pnas.82.6.1633; Roy C S, 1890, J Physiol, V11, P85; Samoylova TI, 2002, J NEUROIMMUNOL, V127, P13, DOI 10.1016/S0165-5728(02)00071-1; Sampol Denys, 2013, Front Neuroenergetics, V5, P5, DOI 10.3389/fnene.2013.00005; Sandrone S, 2014, BRAIN, V137, P621, DOI 10.1093/brain/awt091; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; Serres S, 2005, J NEUROSCI RES, V79, P19, DOI 10.1002/jnr.20277; Serres S, 2003, NMR BIOMED, V16, P430, DOI 10.1002/nbm.838; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Zimmer ER, 2017, NATURE NEUROSCIENCE	56	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174990	10.1371/journal.pone.0174990	http://dx.doi.org/10.1371/journal.pone.0174990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388627	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800016
J	Nauffal, V; Zhang, YY; Tanawuttiwat, T; Blasco-Colmenares, E; Rickard, J; Marine, JE; Butcher, B; Norgard, S; Dickfeld, TM; Ellenbogen, KA; Guallar, E; Tomaselli, GF; Cheng, AA				Nauffal, Victor; Zhang, Yiyi; Tanawuttiwat, Tanyanan; Blasco-Colmenares, Elena; Rickard, John; Marine, Joseph E.; Butcher, Barbara; Norgard, Sanaz; Dickfeld, Timm-Michael; Ellenbogen, Kenneth A.; Guallar, Eliseo; Tomaselli, Gordon F.; Cheng, Alan			Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD	PLOS ONE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; C-REACTIVE PROTEIN; HEART-FAILURE; CARDIOVERTER-DEFIBRILLATOR; BROAD-SPECTRUM; PACEMAKER; ANEMIA; DYSFUNCTION; PREDICTOR; MORBIDITY	Background Cardiac resynchronization therapy (CRT) devices reduce mortality through pacing-induced cardiac resynchronization and implantable cardioverter defibrillator (ICD) therapy for ventricular arrhythmias (VAs). Whether certain factors can predict if patients will benefit more from implantation of CRT pacemakers (CRT-P) or CRT defibrillators (CRT-D) remains unclear. Methods and results We followed 305 primary prevention CRT-D recipients for the two primary outcomes of HF hospitalization and ICD therapy for VAs. Serum biomarkers, electrocardiographic and clinical variables were collected prior to implant. Multivariable analysis using Cox-proportional hazards model was used to fit the final models. Among 282 patients with follow-up outcome data, 75 (26.6%) were hospitalized for HF and 31 (11%) received appropriate ICD therapy. Independent predictors of HF hospitalization were atrial fibrillation (HR = 1.8 (1.1,2.9)), NYHA class III/IV (HR = 2.2 (1.3,3.6)), ejection fraction < 20% (HR = 1.7 (1.1,2.7)), HS-IL6 > 4.03pg/ml (HR = 1.7 (1.1,2.9)) and hemoglobin (< 12g/dl) (HR = 2.2 (1.3,3.6)). Independent predictors of appropriate therapy included BUN > 20mg/dL (HR = 3.0 (1.3,7.1)), HS-CRP > 9.42mg/L (HR = 2.3 (1.1,4.7)), no beta blocker therapy (HR = 3.2 (1.4,7.1)) and hematocrit >= 38% (HR = 2.7 (1.03,7.0)). Patients with 0-1 risk factors for appropriate therapy (IR 1 per 100 person-years) and >= 3 risk factors for HF hospitalization (IR 23 per 100-person-years) were more likely to die prior to receiving an appropriate ICD therapy. Conclusions Clinical and biomarker data can risk stratify CRT patients for HF progression and VAs. These findings may help characterize subgroups of patients that may benefit more from the use of CRT-P vs. CRT-D systems.	[Nauffal, Victor; Tanawuttiwat, Tanyanan; Rickard, John; Marine, Joseph E.; Butcher, Barbara; Norgard, Sanaz; Tomaselli, Gordon F.; Cheng, Alan] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Zhang, Yiyi; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Dickfeld, Timm-Michael] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Ellenbogen, Kenneth A.] Virginia Commonwealth Univ, Dept Med, Med Coll Virginia Campus, Richmond, VA 23298 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; Virginia Commonwealth University	Cheng, AA (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	alcheng@jhmi.edu	Ellenbogen, Kenneth/AAJ-3992-2021; Tanawuttiwat, Tanyanan/AAA-5694-2020		National Institutes of Health [R01 HL091062, R01 HL103946]; Johns Hopkins Murex Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Murex Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by National Institutes of Health R01 HL091062 to GT and National Institutes of Health R01 HL103946 to AC. VN was supported by the Johns Hopkins Murex Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Bogale N, 2012, EUR J HEART FAIL, V14, P61, DOI 10.1093/eurjhf/hfr158; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cheng A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000083; Choi EY, 2012, AM HEART J, V164, P251, DOI 10.1016/j.ahj.2012.05.010; Ellenbogen KA, 2010, CIRCULATION, V122, P2660, DOI 10.1161/CIRCULATIONAHA.110.992552; Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007; Hjalmarson A, 1999, LANCET, V353, P2001; Kleijn L, 2012, HEART, V98, P1237, DOI 10.1136/heartjnl-2012-301954; Looi KL, 2014, HEART, V100, P794, DOI 10.1136/heartjnl-2014-305537; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Michelucci A, 2007, J CARD FAIL, V13, P207, DOI 10.1016/j.cardfail.2006.11.013; Morani G, 2013, EUROPACE, V15, P1273, DOI 10.1093/europace/eut032; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nauffal V, 2015, J AM COLL CARDIOL, V66, P2911, DOI 10.1016/j.jacc.2015.10.048; O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Rao RK, 2007, CIRCULATION, V115, P2136, DOI 10.1161/CIRCULATIONAHA.106.634444; Santini M, 2011, J AM COLL CARDIOL, V57, P167, DOI 10.1016/j.jacc.2010.08.624; Saxon LA, 2006, CIRCULATION, V114, P2766, DOI 10.1161/CIRCULATIONAHA.106.642892; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Singh JP, 2011, CIRCULATION, V123, P1159, DOI 10.1161/CIRCULATIONAHA.110.000646; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Theuns DAMJ, 2012, PACE, V35, P275, DOI 10.1111/j.1540-8159.2011.03289.x; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; van Bommel RJ, 2010, EUR HEART J, V31, P2783, DOI 10.1093/eurheartj/ehq252; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Wu KC, 2012, CIRC-CARDIOVASC IMAG, V5, P178, DOI 10.1161/CIRCIMAGING.111.968024	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							0175205	10.1371/journal.pone.0175205	http://dx.doi.org/10.1371/journal.pone.0175205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388657	Green Submitted, gold, Green Published			2022-12-27	WOS:000399375800028
J	Chen, L; Yang, J; Xing, ZH; Yuan, F; Shu, Y; Zhang, YH; Kong, XY; Huang, T; Li, HP; Cai, YD				Chen, Lei; Yang, Jing; Xing, Zhihao; Yuan, Fei; Shu, Yang; Zhang, YunHua; Kong, XiangYin; Huang, Tao; Li, HaiPeng; Cai, Yu-Dong			An integrated method for the identification of novel genes related to oral cancer	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; GROWTH-FACTOR; SHORTEST-PATH; C-MYC; PROTEIN-INTERACTION; GASTRIC-CANCER; CLINICOPATHOLOGICAL FEATURES	Cancer is a significant public health problem worldwide. Complete identification of genes related to one type of cancer facilitates earlier diagnosis and effective treatments. In this study, two widely used algorithms, the random walk with restart algorithm and the shortest path algorithm, were adopted to construct two parameterized computational methods, namely, an RWR-based method and an SP-based method; based on these methods, an integrated method was constructed for identifying novel disease genes. To validate the utility of the integrated method, data for oral cancer were used, on which the RWR-based and SP-based methods were trained, thereby building two optimal methods. The integrated method combining these optimal methods was further adopted to identify the novel genes of oral cancer. As a result, 85 novel genes were inferred, among which eleven genes (e.g., MYD88, FGFR2, NF-kappa BIA) were identified by both the RWR-based and SP-based methods, 70 genes (e.g., BMP4, IFNG, KITLG) were discovered only by the RWR-based method and four genes (L1R1, MCM6, NOG and CXCR3) were predicted only by the SP-based method. Extensive analyses indicate that several novel genes have strong associations with cancers, indicating the effectiveness of the integrated method for identifying disease genes.	[Chen, Lei; Yang, Jing; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Xing, Zhihao; Shu, Yang; Kong, XiangYin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Yuan, Fei] Binzhou Med Univ Hosp, Dept Sci & Technol, Binzhou, Shandong, Peoples R China; [Zhang, YunHua] Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China; [Li, HaiPeng] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, CAS Key Lab Computat Biol, Shanghai, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Binzhou Medical University; Anhui Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.; Li, HP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, CAS Key Lab Computat Biol, Shanghai, Peoples R China.	tohuangtao@126.com; lihaipeng@picb.ac.cn; cai_yud@126.com	Chen, Lei/A-2275-2011; Zhang, Yu-Hang/AAQ-9012-2021; Xing, Zhihao/AAH-6061-2020	Chen, Lei/0000-0003-3068-1583; Zhang, Yu-Hang/0000-0003-3825-0796; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31371335]; Natural Science Foundation of Shanghai [17ZR1412500]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	This study was supported by the National Natural Science Foundation of China (31371335), Natural Science Foundation of Shanghai (17ZR1412500), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2008, IARC PUBL, VIX, P1; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; BAENZIGER NL, 1972, J BIOL CHEM, V247, P2723; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BLANKENSTEIN T, 1991, J EXP MED, V173, P1047, DOI 10.1084/jem.173.5.1047; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Cai YD, 2017, J PROTEOME RES, V16, P1027, DOI 10.1021/acs.jproteome.6b00950; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Care MA, 2009, HUM MUTAT, V30, P485, DOI 10.1002/humu.20917; Chang BL, 2004, CANCER RES, V64, P1997, DOI 10.1158/0008-5472.CAN-03-2340; Chang PY, 2013, CLIN CHEM LAB MED, V51, P1291, DOI 10.1515/cclm-2012-0504; Chen L, 2016, PROTEIN PEPTIDE LETT, V23, P1081, DOI 10.2174/0929866523666161021165506; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29849; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen LJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0521-1; Chen X, 2016, THEOR COMPUT SCI, V623, P146, DOI 10.1016/j.tcs.2015.12.006; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Elcin AE, 2017, EXP CELL RES; Elgizouli M, 2016, CLIN EXP IMMUNOL, V183, P221, DOI 10.1111/cei.12706; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao YF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/891945; Gormen T. H., 1990, INTRO ALGORITHMS; Gozgit JM, 2013, CANCER CHEMOTH PHARM, V71, P1315, DOI 10.1007/s00280-013-2131-z; Graham TR, 2009, PROSTATE, V69, P168, DOI 10.1002/pros.20870; Groeger S, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0185-5; Gu B, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P3532; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haroun F, 2015, CANCER CHEMOTH PHARM, V75, P207, DOI 10.1007/s00280-014-2632-4; Haudenschild DR, 2004, CANCER RES, V64, P8276, DOI 10.1158/0008-5472.CAN-04-2251; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MF, 1999, ORAL ONCOL, V35, P296, DOI 10.1016/S1368-8375(98)00119-5; ISHITOYA J, 1989, BRIT J CANCER, V59, P559, DOI 10.1038/bjc.1989.113; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Karamouzis MV, 2012, CRIT REV ONCOL HEMAT, V84, P8, DOI 10.1016/j.critrevonc.2012.02.010; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohavi R., 1995, INT JOINT C ART INT, V14; Koontongkaew S, 2000, ORAL ONCOL, V36, P334, DOI 10.1016/S1368-8375(99)00093-7; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LAHAV J, 1993, BIOCHIM BIOPHYS ACTA, V1182, P1, DOI 10.1016/0925-4439(93)90146-R; Laimer K, 2007, CANCER, V110, P326, DOI 10.1002/cncr.22813; Lang T, 2016, BIOMED PHARMACOTHER, V84, P1967, DOI 10.1016/j.biopha.2016.11.002; LARGEY JS, 1993, CANCER, V71, P1933, DOI 10.1002/1097-0142(19930315)71:6<1933::AID-CNCR2820710602>3.0.CO;2-D; LAURI D, 1991, JNCI-J NATL CANCER I, V83, P1321, DOI 10.1093/jnci/83.18.1321; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li YN, 2015, LUNG CANCER, V89, P232, DOI 10.1016/j.lungcan.2015.06.009; Liao RG, 2013, CANCER RES, V73, P5195, DOI 10.1158/0008-5472.CAN-12-3950; Lin C.-B., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/967182; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; Lucenteforte E, 2009, ORAL ONCOL, V45, P461, DOI 10.1016/j.oraloncology.2008.09.002; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Mitchell KO, 2000, CANCER RES, V60, P6318; Miyamoto R, 2003, ORAL ONCOL, V39, P610, DOI 10.1016/S1368-8375(03)00048-4; Muller M, 2015, CLIN EXP IMMUNOL, V182, P90, DOI 10.1111/cei.12668; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nagatsuka H, 2001, ORAL ONCOL, V37, P599, DOI 10.1016/S1368-8375(01)00051-3; Nanda MS, 2011, ASIAN PAC J CANCER P, V12, P67; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nishiyama H, 2008, INT J CLIN ONCOL, V13, P282, DOI 10.1007/s10147-008-0815-x; Noda M, 1999, Jpn J Clin Oncol, V29, P592; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pal SK, 2016, J ORAL PATHOL MED, V1, P1; Patel BP, 2005, J SURG ONCOL, V90, P81, DOI 10.1002/jso.20240; Pavia M, 2006, AM J CLIN NUTR, V83, P1126, DOI 10.1093/ajcn/83.5.1126; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Pradelli E, 2009, INT J CANCER, V125, P2586, DOI 10.1002/ijc.24665; Pranzatelli MR, 2013, CLIN EXP IMMUNOL, V172, P427, DOI 10.1111/cei.12065; QIN ZH, 1993, J EXP MED, V178, P355, DOI 10.1084/jem.178.1.355; Sakata K, 1996, J ORAL PATHOL MED, V25, P302, DOI 10.1111/j.1600-0714.1996.tb00266.x; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Shang ZJ, 2006, INT J ORAL MAX SURG, V35, P533, DOI 10.1016/j.ijom.2005.09.006; Shiraki M, 2005, MODERN PATHOL, V18, P1482, DOI 10.1038/modpathol.3800455; Shridhar K, 2016, ORAL ONCOL, V53, P1, DOI 10.1016/j.oraloncology.2015.11.012; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Su R, 2016, J MICROSC-OXFORD, V264, P127, DOI 10.1111/jmi.12421; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Tang W, 2016, ONCOTARGET, V7, P85613, DOI 10.18632/oncotarget.12828; Traer E, 2012, LEUKEMIA, V26, P1140, DOI 10.1038/leu.2011.325; Tsantoulis PK, 2007, ORAL ONCOL, V43, P523, DOI 10.1016/j.oraloncology.2006.11.010; Tucci M, 2014, EXPERT REV CLIN IMMU, V10, P1395, DOI 10.1586/1744666X.2014.955851; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; Walser TC, 2007, J IMMUNOTHER, V30, P490, DOI 10.1097/CJI.0b013e318031b551; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wang GH, 2016, TUMOR BIOL, V37, P12597, DOI 10.1007/s13277-016-5126-7; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Warnakulasuriya S, 2005, ORAL ONCOL, V41, P244, DOI 10.1016/j.oraloncology.2004.08.010; Wei LY, 2017, IEEE T NANOBIOSCI, V16, P240, DOI 10.1109/TNB.2017.2661756; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; Wei LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122118; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; WENZEL CT, 1995, ARCH OTOLARYNGOL, V121, P1279; Werkmeister R, 2000, ORAL ONCOL, V36, P100, DOI 10.1016/S1368-8375(99)00069-X; Wu YW, 2015, ACTA PHARMACOL SIN, V36, P1395, DOI 10.1038/aps.2015.91; Xi SC, 2006, JNCI-J NATL CANCER I, V98, P181, DOI 10.1093/jnci/djj020; Xia WY, 1997, CLIN CANCER RES, V3, P3; Xiang W, 2015, REV NEUROSCIENCE, V26, P407, DOI 10.1515/revneuro-2014-0067; Yao L, 2000, ORAL ONCOL, V36, P539, DOI 10.1016/S1368-8375(00)00048-8; Zaharieva BM, 2003, J PATHOL, V201, P603, DOI 10.1002/path.1481; Zeigler-Johnson C, 2004, CANCER RES, V64, P8461, DOI 10.1158/0008-5472.CAN-04-1651; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zhang JR, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/7604641; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhao XQ, 2007, CANCER RES, V67, P4443, DOI 10.1158/0008-5472.CAN-07-0185; Zhou HF, 2016, BIOMED PHARMACOTHER, V82, P479, DOI 10.1016/j.biopha.2016.04.069; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5	142	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175185	10.1371/journal.pone.0175185	http://dx.doi.org/10.1371/journal.pone.0175185			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384236	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900113
J	Hernandes, FR; Canziani, MEF; Barreto, FC; Santos, RO; Moreira, VD; Rochitte, CE; Carvalho, AB				Hernandes, Fabiana Rodrigues; Fernandes Canziani, Maria Eugenia; Barreto, Fellype Carvalho; Santos, Rodrigo Oliveira; Moreira, Valeria de Melo; Rochitte, Carlos Eduardo; Carvalho, Aluizio Barbosa			The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CORONARY CALCIFICATION; ARTERIAL CALCIFICATIONS; ALL-CAUSE; MORTALITY; IMPACT; RISK	Parathyroidectomy (PTX) may cause low levels of PTH, leading to an excessive reduction of bone turnover, which is associated with poor outcomes in dialysis patients, including vascular calcification (VC). We aimed to prospectively investigate the impact of PTX on bone remodeling and its potential consequence on the progression of VC in hemodialysis patients. In this prospective study, 19 hemodialysis patients with severe secondary hyperparathyroidism (sHPT) were evaluated. All patients underwent laboratorial tests and coronary tomography at baseline and, 6 and 12 months after PTX; bone biopsy was performed at baseline and 12-month. At baseline, all patients had increased PTH levels up to 2500 pg/mL and high turnover bone disease in their bone biopsies. Fourteen (74%) patients had VC. During the follow-up, there was a significant decrease of PTH at 6 and 12-month. At 12-month, 90% of the patients evolved to low turnover bone disease. During the period of the hungry bone syndrome (first 6 months), no change of coronary calcium score was observed. However, calcium score increased significantly thereafter (12(th) month). There was an association between VC progression and the severity of low turnover bone disease. In conclusion, the shift from high to low turnover bone disease after PTX occurs in parallel to VC progression, contributing to the understanding of the complex pathophysiology involving mineral metabolism and cardiovascular disease in hemodialysis patients.	[Hernandes, Fabiana Rodrigues; Fernandes Canziani, Maria Eugenia; Carvalho, Aluizio Barbosa] Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil; [Barreto, Fellype Carvalho] Univ Fed Parana, Nephrol Div, Curitiba, Parana, Brazil; [Santos, Rodrigo Oliveira] Univ Fed Sao Paulo, Head & Neck Surg Div, Sao Paulo, Brazil; [Moreira, Valeria de Melo; Rochitte, Carlos Eduardo] Univ Sao Paulo, Cardiol Div, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Carvalho, AB (corresponding author), Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil.	aluizio@uol.com.br	Barreto, Fellype C/C-6517-2012; Canziani, Maria E F/AGI-3240-2022	Barreto, Fellype C/0000-0002-6394-9227; Santos, Rodrigo/0000-0003-1172-4621	National Counsel of Technological and Scientific Development (CNPq)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author (FRH) received financial support National Counsel of Technological and Scientific Development (CNPq).; Financial support: National Counsel of Technological and Scientific Development (CNPq).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ammirati AL, 2007, PERITON DIALYSIS INT, V27, P340; Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Custódio Melani Ribeiro, 2013, Braz. J. Nephrol., V35, P308, DOI 10.5935/0101-2800.20130050; Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fotheringham J, 2011, NEPHRON CLIN PRACT, V119, pC113, DOI 10.1159/000326683; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Histomorphometry Nomenclature Committee, 2013, J BONE MINER RES, V28, P1; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, KIDNEY INT S, pS70; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Malluche HH, 1986, METHODOLOGY MINERALI, P17; McCullagh P, 2019, GEN LINEAR MODELS, DOI [10.1201/9780203753736, DOI 10.1007/978-1-4899-3242-6, DOI 10.1201/9780203753736]; MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS125; Noordzij M, 2011, NEPHROL DIAL TRANSPL, V26, P1662, DOI 10.1093/ndt/gfq582; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Santos RO, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/631243; Savazzi G M, 1993, Eur J Med, V2, P363; Spiegel DM, 2007, NEPHROL DIAL TRANSPL, V22, P3568, DOI 10.1093/ndt/gfm424; Tomiyama C, 2010, J BONE MINER RES, V25, P499, DOI 10.1359/jbmr.090735; Yajima A, 2010, J BONE MINER RES, V25, P2374, DOI 10.1002/jbmr.126	30	21	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174811	10.1371/journal.pone.0174811	http://dx.doi.org/10.1371/journal.pone.0174811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384171	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900040
J	LaFollette, MR; O'Haire, ME; Cloutier, S; Blankenberger, WB; Gaskill, BN				LaFollette, Megan R.; O'Haire, Marguerite E.; Cloutier, Sylvie; Blankenberger, Whitney B.; Gaskill, Brianna N.			Rat tickling: A systematic review of applications, outcomes, and moderators	PLOS ONE			English	Review							50-KHZ ULTRASONIC VOCALIZATIONS; DIFFERENTIAL RATES; SPRAGUE-DAWLEY; BEHAVIOR; STRESS; PLAY; REWARD; NEUROGENESIS; AMPHETAMINE; RESPONSES	Introduction Rats initially fear humans which can increase stress and impact study results. Additionally, studying positive affective states in rats has proved challenging. Rat tickling is a promising habituation technique that can also be used to model and measure positive affect. However, current studies use a variety of methods to achieve differential results. Our objective was to systematically identify, summarize, and evaluate the research on tickling in rats to provide direction for future investigation. Our specific aims were to summarize current methods used in tickling experiments, outcomes from tickling, and moderating factors. Methods We systematically evaluated all articles about tickling identified from PubMed, Scopus, Web of Science, and PsychInfo. Our inclusion criteria were publication in a peer-reviewed journal and collection of original, empirical data on rats using the handling method of tickling. One researcher extracted information from each article. Bias was assessed by 2 investigators using the SYRCLE bias assessment tool. Results We identified 32 articles (56 experiments) published in peer-reviewed journals about rat tickling for inclusion. A wide variety of strains, sexes, and ages of rats were included. The most common method used for tickling was cycling through 15 seconds of tickling and 15 seconds of rest for 2 minutes for 3 to 5 days. Experiments with a control for tickling (N = 22) showed that tickling increases positive vocalization, approach behavior, decreases anxiety measures, improves handling, and in some cases decreases stress hormones. Tickling juvenile, individually housed rats with a trait predisposition to respond more positively to tickling, results in the most positive outcomes. Methods to reduce bias were insufficiently reported. Conclusions We conclude that tickling is a promising method for improving rat welfare and investigating positive affect. However, the establishment of tickling best practices is essential as the outcomes from tickling can be moderated by several factors.	[LaFollette, Megan R.; Gaskill, Brianna N.] Purdue Univ, Dept Anim Sci, Ctr Anim Welf Sci, Coll Agr, W Lafayette, IN 47907 USA; [O'Haire, Marguerite E.] Purdue Univ, Coll Vet Med, Ctr Human Anim Bond, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Cloutier, Sylvie] Canadian Council Anim Care, Assessment & Accreditat Sect, Ottawa, ON, Canada; [Blankenberger, Whitney B.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University	LaFollette, MR (corresponding author), Purdue Univ, Dept Anim Sci, Ctr Anim Welf Sci, Coll Agr, W Lafayette, IN 47907 USA.	meglafollette@gmail.com	LaFollette, Megan/AAF-1034-2019	LaFollette, Megan/0000-0003-0643-2210				Bayne Kathryn, 2002, ILAR J, V43, P4; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Boulay D, 2013, BEHAV PHARMACOL, V24, P543, DOI 10.1097/FBP.0b013e3283654044; Brudzynski SM, 2011, PHARMACOL BIOCHEM BE, V100, P119, DOI 10.1016/j.pbb.2011.08.006; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2011, NEUROSCI BIOBEHAV R, V35, P1831, DOI 10.1016/j.neubiorev.2010.11.011; Burgdorf J, 2009, DEV PSYCHOBIOL, V51, P34, DOI 10.1002/dev.20343; Cloutier S, 2008, APPL ANIM BEHAV SCI, V112, P158, DOI 10.1016/j.applanim.2007.07.003; Cloutier S, 2015, APPL ANIM BEHAV SCI, V164, P81, DOI 10.1016/j.applanim.2014.12.012; Cloutier S, 2014, J AM ASSOC LAB ANIM, V53, P168; Cloutier S, 2013, APPL ANIM BEHAV SCI, V143, P85, DOI 10.1016/j.applanim.2012.10.006; Cloutier S, 2012, APPL ANIM BEHAV SCI, V140, P161, DOI 10.1016/j.applanim.2012.06.001; Garcia EJ, 2016, PSYCHOPHARMACOLOGY, V233, P625, DOI 10.1007/s00213-015-4132-6; Garcia EJ, 2015, BEHAV BRAIN RES, V287, P207, DOI 10.1016/j.bbr.2015.03.049; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Himmler SM, 2014, J COMP PSYCHOL, V128, P318, DOI 10.1037/a0036104; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hori M, 2014, PHYSIOL BEHAV, V131, P62, DOI 10.1016/j.physbeh.2014.04.008; Hori M, 2013, NEUROREPORT, V24, P241, DOI 10.1097/WNR.0b013e32835edbfa; Hori M, 2013, NEUROSCI LETT, V536, P85, DOI 10.1016/j.neulet.2012.12.054; Hori M, 2009, MOL MED REP, V2, P157, DOI 10.3892/mmr_00000077; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Koiv K, 2016, EUR NEUROPSYCHOPHARM, V26, P631, DOI 10.1016/j.euroneuro.2016.02.011; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Macleod MR, 2009, J CEREBR BLOOD F MET, V29, P221, DOI 10.1038/jcbfm.2008.101; Mallo T, 2009, NEUROSCIENCE, V164, P963, DOI 10.1016/j.neuroscience.2009.08.041; Mallo T, 2007, BEHAV BRAIN RES, V177, P269, DOI 10.1016/j.bbr.2006.11.022; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Natusch C, 2010, PHARMACOL BIOCHEM BE, V96, P251, DOI 10.1016/j.pbb.2010.05.013; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Panksepp J, 2007, BEHAV BRAIN RES, V182, P231, DOI 10.1016/j.bbr.2007.02.015; Paredes-Ramos P, 2012, PHYSIOL BEHAV, V107, P17, DOI 10.1016/j.physbeh.2012.05.017; PELLIS SM, 1990, DEV PSYCHOBIOL, V23, P215, DOI 10.1002/dev.420230303; Pellis SM, 2002, ARCH SEX BEHAV, V31, P17, DOI 10.1023/A:1014070916047; Popik P, 2014, BEHAV BRAIN RES, V260, P53, DOI 10.1016/j.bbr.2013.11.029; Popik P, 2012, BEHAV BRAIN RES, V234, P223, DOI 10.1016/j.bbr.2012.06.028; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Raudkivi K, 2012, ACTA NEUROPSYCHIATR, V24, P208, DOI 10.1111/j.1601-5215.2011.00619.x; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Roccaro-Waldmeyer DM, 2016, BEHAV BRAIN RES, V298, P167, DOI 10.1016/j.bbr.2015.11.004; Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schwarting RKW, 2007, BEHAV BRAIN RES, V182, P208, DOI 10.1016/j.bbr.2007.01.029; Scotney RL, 2015, JAVMA-J AM VET MED A, V247, P1121, DOI 10.2460/javma.247.10.1121; VANDERSCHUREN LJMJ, 1995, PHYSIOL BEHAV, V58, P119, DOI 10.1016/0031-9384(94)00385-I; Wohr M, 2009, NEUROSCIENCE, V163, P1024, DOI 10.1016/j.neuroscience.2009.07.043; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; Yamamuro T, 2013, BEHAV BRAIN RES, V236, P236, DOI 10.1016/j.bbr.2012.09.001; Yamamuro T, 2010, NEUROSCI RES, V68, P285, DOI 10.1016/j.neures.2010.09.001	55	31	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175320	10.1371/journal.pone.0175320	http://dx.doi.org/10.1371/journal.pone.0175320			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384364	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900156
J	Ribeiro, MM; Piotti, A; Ricardo, A; Gaspar, D; Costa, R; Parducci, L; Vendramin, GG				Ribeiro, Maria Margarida; Piotti, Andrea; Ricardo, Alexandra; Gaspar, Daniel; Costa, Rita; Parducci, Laura; Vendramin, Giovanni Giuseppe			Genetic diversity and divergence at the Arbutus unedo L. (Ericaceae) westernmost distribution limit	PLOS ONE			English	Article							PINE PINUS-PINASTER; STRAWBERRY TREE; POPULATION-GENETICS; MARKERS; FIRE; CONSERVATION; CHLOROPLAST; HISTORY; VARIABILITY; ECOSYSTEMS	Mediterranean forests are fragile ecosystems vulnerable to recent global warming and reduction of precipitation, and a long-term negative effect is expected on vegetation with increasing drought and in areas burnt by fires. We investigated the spatial distribution of genetic variation of Arbutus unedo in the western Iberia Peninsula, using plastid markers with conservation and provenance regions design purposes. This species is currently undergoing an intense domestication process in the region, and, like other species, is increasingly under the threat from climate change, habitat fragmentation and wildfires. We sampled 451 trees from 15 natural populations from different ecological conditions spanning the whole species' distribution range in the region. We applied Bayesian analysis and identified four clusters ( north, centre, south, and a single-population cluster). Hierarchical AMOVA showed higher differentiation among clusters than among populations within clusters. The relatively low within-clusters differentiation can be explained by a common postglacial history of nearby populations. The genetic structure found, supported by the few available palaeobotanical records, cannot exclude the hypothesis of two independent A. unedo refugia in western Iberia Peninsula during the Last Glacial Maximum. Based on the results we recommend a conservation strategy by selecting populations for conservation based on their allelic richness and diversity and careful seed transfer consistent with current species' genetic structure.	[Ribeiro, Maria Margarida; Ricardo, Alexandra] Inst Politecn Castelo Branco, Escola Super Agr, Dept Recursos Nat & Desenvolvimento Sustentavel, Castelo Branco, Portugal; [Ribeiro, Maria Margarida; Parducci, Laura] Uppsala Univ, Plant Ecol Dept Ecol & Genet, Evolutionary Biol Ctr, Norbyvagen 18D, Uppsala, Sweden; [Ribeiro, Maria Margarida; Costa, Rita] Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal; [Piotti, Andrea; Vendramin, Giovanni Giuseppe] CNR, Inst Biosci & BioResources, Via Madonna del Piano 10, Florence, Italy; [Gaspar, Daniel; Costa, Rita] Inst Nacl Invest Agr Vet IP, INIAV, Av Republ, Quinta Do Marques Oeiras, Portugal	Polytechnic Institute of Castelo Branco; Uppsala University; Universidade de Lisboa; Forest Research Centre; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV)	Ribeiro, MM (corresponding author), Inst Politecn Castelo Branco, Escola Super Agr, Dept Recursos Nat & Desenvolvimento Sustentavel, Castelo Branco, Portugal.; Ribeiro, MM (corresponding author), Uppsala Univ, Plant Ecol Dept Ecol & Genet, Evolutionary Biol Ctr, Norbyvagen 18D, Uppsala, Sweden.; Ribeiro, MM (corresponding author), Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal.	mataide@ipcb.pt	Parducci, Laura/B-8918-2012; Ribeiro, Maria Margarida/O-7373-2019; Costa, Rita L/B-5190-2016; Costa, Rita Lourenco/Q-4564-2019; Ribeiro, Maria Margarida/M-4235-2013; Piotti, Andrea/C-1304-2009; Parducci, Laura/H-9355-2019	Parducci, Laura/0000-0003-1956-4757; Ribeiro, Maria Margarida/0000-0003-4684-1262; Costa, Rita L/0000-0001-9503-6126; Costa, Rita Lourenco/0000-0001-9503-6126; Ribeiro, Maria Margarida/0000-0003-4684-1262; Piotti, Andrea/0000-0002-3324-5325; Parducci, Laura/0000-0003-1956-4757	Fundacao para a Ciencia e a Tecnologia [PTDC/AGR-FOR/3746/2012, UID/AGR/00239/2013, SFRH/BSAB/113895/2015]; Fundação para a Ciência e a Tecnologia [UID/AGR/00239/2013, PTDC/AGR-FOR/3746/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Fundacao para a Ciencia e a Tecnologia grant PTDC/AGR-FOR/3746/2012 funded MMR, RC, AR and DG. Grants UID/AGR/00239/2013 and SFRH/BSAB/113895/2015 additionally funded MMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Celikel G, 2008, SCI HORTIC-AMSTERDAM, V118, P115, DOI 10.1016/j.scienta.2008.05.028; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dury M, 2011, IFOREST, V4, P82, DOI 10.3832/ifor0572-004; ELKASSABY YA, 1995, TREE PHYSIOL, V15, P545, DOI 10.1093/treephys/15.7-8.545; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fady B, 2012, ANN FOREST SCI, V69, P421, DOI 10.1007/s13595-012-0219-y; FAO, 2010, 2 FAO; Figueiral I, 2002, QUATERNARY SCI REV, V21, P549, DOI 10.1016/S0277-3791(01)00022-1; Fletcher WJ, 2007, HOLOCENE, V17, P481, DOI 10.1177/0959683607077027; Freeman JS, 2007, ANN FOREST SCI, V64, P639, DOI 10.1051/forest:2007042; Garcia Couto MA, 2011, IBERIAN CLIMATE ATLA; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gomes F, 2016, MYCORRHIZA, V26, P177, DOI 10.1007/s00572-015-0656-1; Gomes F, 2013, J FORESTRY RES, V24, P227, DOI 10.1007/s11676-012-0302-0; Gomes F, 2010, NEW BIOTECHNOL, V27, P882, DOI 10.1016/j.nbt.2010.02.009; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Heuertz M, 2010, J BIOGEOGR, V37, P541, DOI 10.1111/j.1365-2699.2009.02223.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Lefevre F, 2004, FOREST ECOL MANAG, V197, P257, DOI 10.1016/j.foreco.2004.05.017; Lefevre F, 2014, ANN FOREST SCI, V71, P723, DOI 10.1007/s13595-013-0272-1; Lopes L, 2012, SCI HORTIC-AMSTERDAM, V142, P57, DOI 10.1016/j.scienta.2012.04.031; Lopez GA, 2001, SILVAE GENET, V50, P244; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Mateus J, 1992, THESIS; MESLEARD F, 1989, OECOLOGIA, V80, P127, DOI 10.1007/BF00789941; Miguel MG, 2014, MOLECULES, V19, P15799, DOI 10.3390/molecules191015799; Nei M., 1987, MOL EVOLUTIONARY GEN; Feliner GN, 2014, PERSPECT PLANT ECOL, V16, P265, DOI 10.1016/j.ppees.2014.07.002; Oliveira SLJ, 2012, INT J WILDLAND FIRE, V21, P48, DOI 10.1071/WF10131; Ouborg NJ, 2006, J ECOL, V94, P1233, DOI 10.1111/j.1365-2745.2006.01167.x; Panagos P, 2012, LAND USE POLICY, V29, P329, DOI 10.1016/j.landusepol.2011.07.003; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pausas JG, 2014, NEW PHYTOL, V204, P55, DOI 10.1111/nph.12921; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedro J.G., 1994, PORTUGAL ATLAS AMBIE; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Queiroz PF, 2011, PTDCCTEGEX712982006; R Core Team, 2013, R LANG ENV STAT COMP; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Ribeiro MM, 2001, THEOR APPL GENET, V102, P97, DOI 10.1007/s001220051623; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Santiso X, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw003; Santiso X, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01264; Santos L, 2003, HOLOCENE, V13, P459, DOI 10.1191/0959683603hl638rp; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; SEALY JR, 1949, J ECOL, V37, P365, DOI 10.2307/2256613; Takrouni MM, 2012, SCI HORTIC-AMSTERDAM, V146, P92, DOI 10.1016/j.scienta.2012.08.005; Takrouni MM, 2010, SCI HORTIC-AMSTERDAM, V126, P330, DOI 10.1016/j.scienta.2010.07.031; Torres JA, 2002, PLANT ECOL, V160, P207, DOI 10.1023/A:1015864821706; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vendramin GG, 1998, THEOR APPL GENET, V97, P456, DOI 10.1007/s001220050917; Vincenzi S, 2014, PLANT ECOL, V215, P689, DOI 10.1007/s11258-014-0342-y; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; White T. L., 2007, FOREST GENETICS	60	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175239	10.1371/journal.pone.0175239	http://dx.doi.org/10.1371/journal.pone.0175239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384294	Green Published, gold			2022-12-27	WOS:000399371900132
J	Rosales-Mayor, E; Polverino, E; Raguer, L; Alcaraz, V; Gabarrus, A; Ranzani, O; Menendez, R; Torres, A				Rosales-Mayor, Edmundo; Polverino, Eva; Raguer, Laura; Alcaraz, Victoria; Gabarrus, Albert; Ranzani, Otavio; Menendez, Rosario; Torres, Antoni			Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations	PLOS ONE			English	Article							CYSTIC-FIBROSIS BRONCHIECTASIS; PSEUDOMONAS-AERUGINOSA; SEVERITY INDEX; MICROBIOLOGY; COLONIZATION; VALIDATION; MORTALITY	Bronchiectasis (BE) is a chronic and heterogeneous respiratory disease that requires a multidimensional scoring system to properly assess severity. The aim of this study was to compare the severity stratification by 2 validated scores (BSI and FACED) in a BE cohort and to determine their predictive capacity for exacerbations and hospitalizations. Moreover, we proposed a modified version of FACED which was created to better predict the risk of exacerbations in clinical practice. We performed a prospective cohort study including BE patients > 18 years old with a follow-up period of 1-year. One-hundred eighty-two patients (40% males; mean age 68) were studied. Patients were stratified according to the number of exacerbations during the follow-up, and according to BSI and FACED scores. BSI classified most of our patients as severe 99 (54.4%) or moderate 47 (25.8%), while FACED mainly classified as mild 108 (59.3%) or moderate 61 (33.5%). BSI and FACED showed an area under ROC curve (AUC) for exacerbations of 0.808 and 0.734; and for hospitalizations (due to BE exacerbations) of 0.893 and 0.809, respectively. Subsequently, we modified FACED by adding previous exacerbations (Exa-FACED) and this new score classified patients as mild 48.4%, moderate 34.6% and severe 17.0%, with an improved AUC for exacerbations (0.760) and hospitalizations (0.820). Despite previous validations of BSI and FACED, they classified our patients very differently. As expected, FACED showed poor prognostic capacity for exacerbations. We support the Exa-FACED score to predict the risk future exacerbations for been easy to use in clinical practice.	[Rosales-Mayor, Edmundo; Polverino, Eva; Alcaraz, Victoria; Gabarrus, Albert; Ranzani, Otavio; Torres, Antoni] Hosp Clin Barcelona, Serv Neumol, CIBERES, Fundacio Clin,IDIBAPS, Barcelona, Spain; [Raguer, Laura] Univ Barcelona, Fac Med, Barcelona, Spain; [Menendez, Rosario] Hosp Univ & Politecn La Fe Valencia, Serv Neumol, Inst Invest Sanitaria La Fe, CIBERES, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari i Politecnic La Fe	Torres, A (corresponding author), Hosp Clin Barcelona, Serv Neumol, CIBERES, Fundacio Clin,IDIBAPS, Barcelona, Spain.	atorres@clinic.cat	Ranzani, Otavio T./K-1196-2012; Rosales-Mayor, Edmundo/E-6728-2019; POLVERINO, eva/AAI-6053-2021; Torres, Antoni/H-6128-2017; Alcaraz-Serrano, Victoria/ABR-7677-2022; Menéndez, Rosario/G-9723-2016	Ranzani, Otavio T./0000-0002-4677-6862; Rosales-Mayor, Edmundo/0000-0001-9493-1241; Torres, Antoni/0000-0002-8643-2167; Alcaraz-Serrano, Victoria/0000-0001-6036-9545; Menéndez, Rosario/0000-0002-3592-3839; Polverino, Eva/0000-0002-4058-5109; Gabarrus, Albert/0000-0003-3492-1310	Ayuda a la Investigacion de la Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR),Espana [106/2012]	Ayuda a la Investigacion de la Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR),Espana	This work was supported by the Ayuda a la Investigacion Nro.106/2012 de la Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR),Espana.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Angrill J, 2002, THORAX, V57, P15, DOI 10.1136/thorax.57.1.15; [Anonymous], 1993, INTRO BOOTSTRAP; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chawla K, 2015, J GLOB INFECT DIS, V7, P18, DOI 10.4103/0974-777X.150885; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; de la Rosa D, 2016, CHRON RESP DIS; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ellis HC, 2016, EUR RESPIR J, V47, P482, DOI 10.1183/13993003.01312-2015; Finch S, 2015, ANN AM THORAC SOC, V12, P1602, DOI 10.1513/AnnalsATS.201506-333OC; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Macfarlane JG, 2010, THORAX, V65, pA177, DOI 10.1136/thx.2010.151068.41; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; McDonnell MJ, 2016, MULTIDIMENSIONAL SEV; McShane PJ, 2013, AM J RESP CRIT CARE, V188, P647, DOI 10.1164/rccm.201303-0411CI; Minov J, 2015, Open Respir Med J, V9, P46, DOI 10.2174/1874306401509010046; NICOTRA MB, 1995, CHEST, V108, P955, DOI 10.1378/chest.108.4.955; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Polverino E, 2015, J INFECTION, V71, P28, DOI 10.1016/j.jinf.2015.03.009; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2	25	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175171	10.1371/journal.pone.0175171	http://dx.doi.org/10.1371/journal.pone.0175171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384311	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900109
J	Galizia, G; Lieto, E; Auricchio, A; Cardella, F; Mabilia, A; Diana, A; Castellano, P; De Vita, F; Orditura, M				Galizia, Gennaro; Lieto, Eva; Auricchio, Annamaria; Cardella, Francesca; Mabilia, Andrea; Diana, Anna; Castellano, Paolo; De Vita, Ferdinando; Orditura, Michele			Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; 7TH EDITION; TOTAL GASTRECTOMY; D2 GASTRECTOMY; END-POINTS; SURVIVAL; CLASSIFICATION; LYMPHADENECTOMY; UNION; SPLENECTOMY	Background In gastric cancer, the current AJCC numeric-based lymph node staging does not provide information on the anatomical extent of the disease and lymphadenectomy. A new anatomical location-based node staging, proposed by Choi, has shown better prognostic performance, thus soliciting Western world validation. Study design Data from 284 gastric cancers undergoing radical surgery at the Second University of Naples from 2000 to 2014 were reviewed. The lymph nodes were reclassified into three groups (lesser and greater curvature, and extraperigastric nodes); presence of any metastatic lymph node in a given group was considered positive, prompting a new N and TNM stage classification. Receiver-operating-characteristic (ROC) curves for censored survival data and bootstrap methods were used to compare the capability of the two models to predict tumor recurrence. Results More than one third of node positive patients were reclassified into different N and TNM stages by the new system. Compared to the current staging system, the new classification significantly correlated with tumor recurrence rates and displayed improved indices of prognostic performance, such as the Bayesian information criterion and the Harrell C-index. Higher values at survival ROC analysis demonstrated a significantly better stratification of patients by the new system, mostly in the early phase of the follow-up, with a worse prognosis in more advanced new N stages, despite the same current N stage. Conclusions This study suggests that the anatomical location-based classification of lymph node metastasis may be an important tool for gastric cancer prognosis and should be considered for future revision of the TNM staging system.	[Galizia, Gennaro; Lieto, Eva; Auricchio, Annamaria; Cardella, Francesca; Mabilia, Andrea; Castellano, Paolo] Univ Campania Luigi Vanvitelli, Sch Med, Dept Surg Sci, Div Surg Oncol, Naples, Italy; [Diana, Anna; De Vita, Ferdinando; Orditura, Michele] Univ Campania Luigi Vanvitelli, Sch Med, F Magrassi Dept Clin & Expt Med & Surg, Div Med Oncol, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Galizia, G (corresponding author), Univ Campania Luigi Vanvitelli, Sch Med, Dept Surg Sci, Div Surg Oncol, Naples, Italy.	gennaro.galizia@unina2.it	Diana, Anna/AAJ-3588-2021; Galizia, Gennaro/A-3924-2010	GALIZIA, Gennaro/0000-0002-6897-0391; diana, anna/0000-0003-1131-8690				Ajani JA., 2017, AJCC CANC STAGING MA, P203, DOI [10.1007/978-3-319-40618-3_17, DOI 10.1007/978-3-319-40618-3_17]; [Anonymous], 1997, P AM STAT ASS BIOM S; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Birgisson H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-438; Chae S, 2011, GASTRIC CANCER, V14, P166, DOI 10.1007/s10120-011-0024-6; Choi YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149555; Choi YY, 2016, GASTRIC CANCER, V19, P206, DOI 10.1007/s10120-015-0472-5; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Degiuli M, 2014, BRIT J SURG, V101, P23, DOI 10.1002/bjs.9345; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Fang WL, 2011, WORLD J SURG, V35, P2723, DOI 10.1007/s00268-011-1275-4; Galizia G, 2015, SURGERY, V157, P285, DOI 10.1016/j.surg.2014.09.012; Gertler R, 2011, ANN SURG, V253, P689, DOI 10.1097/SLA.0b013e31821111b5; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hayashi H, 2000, SURGERY, V127, P129, DOI 10.1067/msy.2000.102171; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hermanek P, 1987, UICC TNM CLASSIFICAT; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jiang L, 2013, J SURG ONCOL, V107, P807, DOI 10.1002/jso.23325; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Kim DH, 2012, J SURG ONCOL, V105, P26, DOI 10.1002/jso.22026; Kong SH, 2012, ANN SURG, V255, P50, DOI 10.1097/SLA.0b013e31821d4d75; Koziol JA, 2009, BIOMETRICAL J, V51, P467, DOI 10.1002/bimj.200800228; Lee KG, 2016, ANN SURG ONCOL, V23, P1234, DOI 10.1245/s10434-015-4980-7; Lonjon G, 2014, ANN SURG, V259, P18, DOI 10.1097/SLA.0000000000000256; Lowenfeld L, 2015, ANN SURG ONCOL, V22, pS863, DOI 10.1245/s10434-015-4677-y; Marrelli D, 2015, WORLD J GASTROENTERO, V21, P7954, DOI 10.3748/wjg.v21.i26.7954; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; Oba K, 2013, JNCI-J NATL CANCER I, V105, P1600, DOI 10.1093/jnci/djt270; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reim D, 2013, J CLIN ONCOL, V31, P263, DOI 10.1200/JCO.2012.44.4315; Sano T, 2017, ANN SURG, V265, P277, DOI 10.1097/SLA.0000000000001814; Sano T, 2017, GASTRIC CANCER, V20, P217, DOI 10.1007/s10120-016-0601-9; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Sobin LH., 2010, TNM CLASSIFICATION M; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; UICC, 2017, TNM CLASSIFICATION M; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Watanabe M, 2016, WORLD J SURG, V40, P1165, DOI 10.1007/s00268-015-3362-4; Wood M., 2004, SIGNIFICANCE, V1, P180, DOI DOI 10.1111/J.1740-9713.2004.00067.X; Xiao LB, 2011, WORLD J GASTROENTERO, V17, P5123, DOI 10.3748/wjg.v17.i46.5123; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018; Zhao FM, 2016, J CLIN ONCOL, V34, P1436, DOI 10.1200/JCO.2016.66.4581	48	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173619	10.1371/journal.pone.0173619	http://dx.doi.org/10.1371/journal.pone.0173619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380037	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500020
J	Sasai, K; Takao-Rikitsu, E; Sukezane, T; Yanagita, E; Nakagawa, H; Itoh-Yagi, M; Izumi, Y; Itoh, T; Akagi, T				Sasai, Ken; Takao-Rikitsu, Etsuko; Sukezane, Taiko; Yanagita, Emmy; Nakagawa, Harumi; Itoh-Yagi, Machiko; Izumi, Yukina; Itoh, Tomoo; Akagi, Tsuyoshi			Engineering cancer stem-like cells from normal human lung epithelial cells	PLOS ONE			English	Article							ORIGIN; ADENOCARCINOMA; SUBPOPULATIONS; IDENTIFICATION; REGENERATION; EXPRESSION; VITRO	It has been proposed that a subpopulation of tumour cells with stem cell-like characteristics, known as cancer stem cells (CSCs), drives tumour initiation and generates tumour heterogeneity, thus leading to cancer metastasis, recurrence, and drug resistance. Although there has been substantial progress in CSC research into many solid tumour types, an understanding of the biology of CSCs in lung cancer remains elusive, mainly because of their heterogeneous origins and high plasticity. Here, we demonstrate that engineered lung cancer cells derived from normal human airway basal epithelial cells possessed CSC-like characteristics in terms of multilineage differentiation potential and strong tumour-initiating ability. Moreover, we established an in vitro 3D culture system that allowed the in vivo differentiation process of the CSC-like cells to be recapitulated. This engineered CSC model provides valuable opportunities for studying the biology of CSCs and for exploring and evaluating novel therapeutic approaches and targets in lung CSCs.	[Sasai, Ken; Takao-Rikitsu, Etsuko; Sukezane, Taiko; Nakagawa, Harumi; Itoh-Yagi, Machiko; Izumi, Yukina; Akagi, Tsuyoshi] KAN Res Inst Inc, Kobe, Hyogo, Japan; [Yanagita, Emmy; Itoh, Tomoo] Kobe Univ, Div Diagnost Pathol, Grad Sch Med, Kobe, Hyogo, Japan	KAN Research Institute; Kobe University	Akagi, T (corresponding author), KAN Res Inst Inc, Kobe, Hyogo, Japan.	t-akagi@kan.eisai.co.jp		Yagi, Machiko/0000-0001-5880-5766	Eisai Inc.	Eisai Inc.(Eisai Co Ltd)	Our institute is the subsidiary of Eisai Inc., and the funding for the work was from the research and development budget of Eisai Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akunuru S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.93; Akunuru S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016951; Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fukui T, 2013, EUR RESPIR J, V42, P1332, DOI 10.1183/09031936.00144012; Hardavella G, 2016, TRANSL LUNG CANCER R, V5, P272, DOI 10.21037/tlcr.2016.02.01; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Malkoski SP, 2012, CLIN CANCER RES, V18, P2173, DOI 10.1158/1078-0432.CCR-11-2557; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Radyuk SN, 2003, BIOCHEM BIOPH RES CO, V305, P624, DOI 10.1016/S0006-291X(03)00830-1; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sasai K, 2008, AM J SURG PATHOL, V32, P1220, DOI 10.1097/PAS.0b013e318164c3f0; Sasai K, 2011, CANCER RES, V71, P2541, DOI 10.1158/0008-5472.CAN-10-2221; Schilders KAA, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0358-z; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Templeton Amanda K, 2014, Stem Cell Investig, V1, P9, DOI 10.3978/j.issn.2306-9759.2014.03.06; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Xu X, 2014, GENE DEV, V28, P1929, DOI 10.1101/gad.243717.114; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175147	10.1371/journal.pone.0175147	http://dx.doi.org/10.1371/journal.pone.0175147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380052	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500102
J	Zeng, Y; Liu, BR; Rubio, MT; Wang, XY; Ojcius, DM; Tang, RP; Durrbach, A; Ru, ZT; Zhou, YS; Lone, YC				Zeng, Yang; Liu, Bingrun; Rubio, Marie-Therese; Wang, Xinyue; Ojcius, David M.; Tang, Ruoping; Durrbach, Antoine; Ru, Zhitao; Zhou, Yusen; Lone, Yu-Chun			Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells	PLOS ONE			English	Article							CD34(+) CELLS; MICE; MODEL; ENGRAFTMENT; SYSTEM; GENERATION; DISEASE; INNATE	Research on human immunology has been hindered by the lack of optimal small animal models, given that the protective immune responses of human and non-human species show significant differences. However, due to ethical constraints[ 1] and the high cost of clinical trials, it is urgent to improve the current animal models that can mimic faithfully human physiology, particularly the human immune system (HIS). HIS mice had been generated recently by engrafting human hematopoietic stem cells (hHSCs) or human peripheral mononuclear cells (hPBMCs) into highly immuno-deficient mice such as NSG, NOG or NRG mice. However, a major experimental drawback for studies using these models is the rapid onset of Graft-versus-Host Disease (GvHD). In the present study, we overcome this limitation by generating new immuno-deficient mice named "HUMAMICE" (HLA-A2(+/+)/DR1(+/+)/H2- beta(2)m(-/-)/IA beta(-/-)/Rag2(-/-)/IL2r gamma(-/-)/Perf(-/-)mice), which expressed human HLA molecules instead of mouse MHC molecules (H-2), and whose immuno-deficient status was reversed by transferring functional HLA-matched PBMCs thus producing mice with an immuno-competent status with a functional human immune system. We showed that in this HLA-matched context, the hPBMC-transfer led to high lymphocytes engraftment rates without GvHD over three months in this novel mouse model. Furthermore, to evaluate the utility of the hPBMC-HUMAMICE, we immunized them with commercial vaccine of Hepatitis B virus (HBsAg, Hepvac@) which resulted in robust and reproducible production of high levels of HBsAg-specific antibodies, implying that both transferred T and B lymphocytes were functional in HUMAMICE. These responses are comparable to those observed in human clinical trials with this identical vaccine. In conclusion, these findings indicated that the HLA-matched-hPBMC-HUMAMICE represents a promising model for dissecting human immune responses in various human diseases, including infectious diseases, cancers and tumors, and to facilitate the development of novel vaccines and cellular therapies.	[Zeng, Yang; Ru, Zhitao; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zeng, Yang; Liu, Bingrun; Wang, Xinyue; Durrbach, Antoine; Ru, Zhitao; Lone, Yu-Chun] Univ Paris Saclay, Univ Paris Sud, Hosp Paul Brousse, INSERM U1197 Ex U1014, Villejuif, France; [Rubio, Marie-Therese] CHRU Nancy, Hop Brabois, Serv Hernatol Med Interne, Vandoeuvre Les Nancy, France; [Rubio, Marie-Therese] Biopole Univ Lorraine, CNRS, IMoPa, UMR 7365, Vandoeuvre Les Nancy, France; [Ojcius, David M.] Univ Pacific, Arthur Dugoni Sch Dent, Dept Biomed Sci, San Francisco, CA USA; [Tang, Ruoping] Hop St Antoine, AP HP, Tumorotheque Serv Hernatol, Paris, France; [Durrbach, Antoine] Univ Paris Sud, IFRNT, Nephrol Dept, Le Kremlin Bicetre, Orsay, France	Beijing Institute of Microbiology & Epidemiology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU de Nancy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; University of the Pacific; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Lone, YC (corresponding author), Univ Paris Saclay, Univ Paris Sud, Hosp Paul Brousse, INSERM U1197 Ex U1014, Villejuif, France.	yu-chun.lone@inserm.fr	Ojcius, David/ABE-6557-2020	LONE, Yu Chun/0000-0002-7417-4930; Ojcius, David/0000-0003-1461-4495	CAS President's International Fellowship Initiative (PIFI); National Project of Infectious Disease [2012ZX10004502]	CAS President's International Fellowship Initiative (PIFI); National Project of Infectious Disease	This work was supported by grant from CAS President's International Fellowship Initiative (PIFI). Yusen Zhou was supported by the National Project of Infectious Disease (2012ZX10004502).	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Becker PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013137; Capitano ML, 2015, STEM CELLS, V33, P1975, DOI 10.1002/stem.1988; Christianson SW, 1997, J IMMUNOL, V158, P3578; Chung YS, 2015, CLIN IMMUNOL, V157, P156, DOI 10.1016/j.clim.2015.02.005; D'Aveni M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010435; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Gonzalez L, 2013, IMMUNOL RES, V57, P326, DOI 10.1007/s12026-013-8471-2; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; HESSELTON RM, 1993, J INFECT DIS, V168, P630, DOI 10.1093/infdis/168.3.630; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, ANN NY ACAD SCI, V1150, P46, DOI 10.1196/annals.1447.009; Lang J, 2011, CLIN IMMUNOL, V140, P102, DOI 10.1016/j.clim.2011.04.002; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Misharin AV, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-190; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Nervi B, 2007, EXP HEMATOL, V35, P1823, DOI 10.1016/j.exphem.2007.06.007; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Pearson Todd, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1521s81; Rozemuller H, 2004, EXP HEMATOL, V32, P1118, DOI 10.1016/j.exphem.2004.08.002; Ru ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032247; SAXON A, 1991, J CLIN INVEST, V87, P658, DOI 10.1172/JCI115043; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Spranger S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-30; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van den Berg TK, 2008, TRENDS IMMUNOL, V29, P203, DOI 10.1016/j.it.2008.02.004; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241	34	17	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173754	10.1371/journal.pone.0173754	http://dx.doi.org/10.1371/journal.pone.0173754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399128	gold, Green Published, Green Submitted			2022-12-27	WOS:000399949000004
J	Lin, WH; Lee, SS; Wu, JY; Kuo, YH; Hsieh, TF				Lin, Wenhsu; Lee, Shangsen; Wu, Jengyuan; Kuo, Yuhung; Hsieh, Tengfu			5-alpha-reductase inhibitor therapy postpones urine retention and prostate surgery in patients with prostate enlargement and a maximum uroflow rate of less than 15 ml/sec	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; FOLLOW-UP; FINASTERIDE; EFFICACY; RISK; HYPERPLASIA; VALIDATION; INCREASES; STROKE	Background This study investigated the risk of transurethral resection of prostate (TURP) and acute urine retention (AUR) in relation to 5-alpha-reductase inhibitor (5ARI) therapy. Methods We identified 22,687 patients who were newly diagnosed with PE and low urinary tract symptoms (LUTS) between January 1, 2002 and December 31, 2011. We further classified study subjects who had moderate to severe LUTS and a maximum uroflow rate of less than 15ml/sec into three groups by their defined daily dose (DDD) of 5ARI used. The control group consisted of 7-28 cumulative DDD (cDDD) 5ARI users, while the short-term treatment group was 29-179cDDD 5ARI users, and the long-term treatment group was users of more than 180cDDD 5ARI. Each patient was monitored to identify those who subsequently developed TURP and AUR. Results TURP and AUR are detected in 5.6% of control group, 7.6% of short-term treatment group and 5.5% of long-term treatment group during 10-year follow up. Compared with the control group, there was no difference in the risk of TURP and AUR in the short-term and long-term treatment groups (HR = 1.41, 95% CI 0.76 to 2.62 and HR = 0.81, 95% CI 0.42 to 1.56, respectively). Conclusion 5ARI therapy did not change the risk of TURP and AUR events in patients with PE, moderate to severe LUTS and a maximum uroflow rate of less than 15 ml/sec in 10 years of followup. But long-term 5ARI used can postpone AUR and TURP for 8.16 months.	[Lin, Wenhsu] Minist Hlth & Welf, Nantou Hosp, Dept Urol, Nantou, Taiwan; [Lee, Shangsen; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Urol, Taichung, Taiwan; [Lee, Shangsen; Wu, Jengyuan; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Surg, Taichung, Taiwan; [Lee, Shangsen; Wu, Jengyuan; Hsieh, Tengfu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wu, Jengyuan; Kuo, Yuhung; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Urol, Taichung, Taiwan.; Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Surg, Taichung, Taiwan.; Hsieh, TF (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan.	hdf95@yahoo.com.tw						Armitage JN, 2007, BRIT MED J, V335, P1199, DOI 10.1136/bmj.39377.617269.55; Cathcart P, 2006, J UROLOGY, V176, P200, DOI 10.1016/S0022-5347(06)00509-X; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Chen JS, 2012, BJU INT, V110, pE896, DOI 10.1111/j.1464-410X.2012.11471.x; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Cindolo L, 2013, INT UROLOGY NEPHROLO; Ekman P, 1998, EUR UROL, V33, P312, DOI 10.1159/000019566; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Hsieh TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119694; Kirby RS, 2003, UROLOGY, V61, P119, DOI 10.1016/S0090-4295(02)02114-3; Lee SS, 2015, PROSTATE; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu HY, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1423-8; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Silva J, 2014, CURR OPIN UROL, V24, P21, DOI 10.1097/MOU.0000000000000007; Wu C, 2011, PROSTATE CANCER P D, V14, P326, DOI 10.1038/pcan.2011.28	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175356	10.1371/journal.pone.0175356	http://dx.doi.org/10.1371/journal.pone.0175356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394903	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800030
J	Hosaka, T; Sugimoto, K; Numata, S				Hosaka, Tetsuro; Sugimoto, Koun; Numata, Shinya			Effects of childhood experience with nature on tolerance of urban residents toward hornets and wild boars in Japan	PLOS ONE			English	Article							ECOSYSTEM DISSERVICES; LETHAL CONTROL; ACCEPTABILITY; ATTITUDES; SERVICES; CONSERVATION; PERCEPTIONS; EXTINCTION; CONFLICTS; BENEFITS	Urban biodiversity conservation often aims to promote the quality of life for urban residents by providing ecosystem services as well as habitats for diverse wildlife. However, biodiversity inevitably brings some disadvantages, including problems and nuisances caused by wildlife. Although some studies have reported that enhancement of nature interaction among urban children promotes their affective attitude toward of favorable animals, its effect on tolerance toward problem-causing wildlife is unknown. In this study, we assessed the tolerance of 1,030 urban residents in Japan toward hornets and wild boar, and analyzed the effects of childhood experience with nature on tolerance using a structural equation model. The model used sociodemographic factors and childhood nature experience as explanatory variables, affective attitude toward these animals as a mediator, and tolerance as a response variable. The public tolerance toward hornets and boars was low; over 60% of the respondents would request the removal of hornets and wild boar from nearby green spaces by government services, even when the animals had not caused any damage. Tolerance was lower in females and elderly respondents. Childhood experience with nature had a greater influence on tolerance than did sociodemographic factors in the scenario where animals have not caused any problems; however, its effect was only indirect via promoting positive affective attitude toward wildlife when the animals have caused problems. Our results suggest that increasing people's direct experience with nature is important to raise public tolerance, but its effect is limited to cases where wildlife does not cause any problems. To obtain wider support for conservation in urban areas, conservationists, working together with municipal officials, educators and the media, should provide relevant information on the ecological functions performed by problem-causing wildlife and strategies for avoiding the problems that wildlife can cause.	[Hosaka, Tetsuro; Sugimoto, Koun; Numata, Shinya] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Tourism Sci, 1-1 Minami Osawa, Hachioji, Tokyo, Japan	Tokyo Metropolitan University	Hosaka, T (corresponding author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Tourism Sci, 1-1 Minami Osawa, Hachioji, Tokyo, Japan.	tetsurau@yahoo.co.jp	Hosaka, Tetsuro/I-2847-2018		Advanced Research Program of Asian Human Research Fund by Tokyo Metropolitan Government	Advanced Research Program of Asian Human Research Fund by Tokyo Metropolitan Government	This study was supported by the Advanced Research Program of Asian Human Research Fund by Tokyo Metropolitan Government.	Azmy MM, 2016, URBAN FOR URBAN GREE, V18, P117, DOI 10.1016/j.ufug.2016.05.014; Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118; Barendse Mariska., 2015, PACKAGE LAVAAN; Bezak P, 2008, ENVIRON SCI-TOKYO, V5, P161, DOI [DOI 10.1080/15693430802055524, 10.1080/15693430802055524]; Bixler RD, 1997, ENVIRON BEHAV, V29, P443, DOI 10.1177/001391659702900401; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Butler JS, 2003, WILDLIFE SOC B, V31, P1027; Cheng JCH, 2012, ENVIRON BEHAV, V44, P31, DOI 10.1177/0013916510385082; Choi MB, 2012, ENTOMOL RES, V42, P308, DOI 10.1111/j.1748-5967.2012.00472.x; Conway TM, 2016, LANDSCAPE URBAN PLAN, V153, P1, DOI 10.1016/j.landurbplan.2016.04.016; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Gore ML, 2009, J WILDLIFE MANAGE, V73, P1407, DOI 10.2193/2008-343; Hosaka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30911; Jacobs M., 2009, HUM DIMENS WILDL, V14, P1, DOI [10.1080/10871200802545765, DOI 10.1080/10871200802545765]; Jacobs MH, 2014, EUR J WILDLIFE RES, V60, P589, DOI 10.1007/s10344-014-0823-2; Jacobs MH, 2014, J NAT CONSERV, V22, P377, DOI 10.1016/j.jnc.2014.03.005; Jiji Kyodo, 2014, JAPAN TIMES; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Kamihogi A., 2009, TOWN DEV BASED LOCAL; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Kansky R, 2014, CONSERV BIOL, V28, P924, DOI 10.1111/cobi.12275; Kawahara AY, 2013, MANAGEMENT OF INSECTS IN RECREATION AND TOURISM, P138; Kellert S.R., 1996, VALUE LIFE BIOL DIVE; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Kobe City, 2009, WILD BOARS; Lyytimaki J, 2015, ECOSYST SERV, V12, P136, DOI 10.1016/j.ecoser.2014.11.008; Lyytimaki J, 2009, URBAN FOR URBAN GREE, V8, P309, DOI 10.1016/j.ufug.2009.09.003; Macromill, 2016, QUAL CONTR POL MACR; Macromill, 2013, SURV LIF MACR MON; Matsuura M., 1988, WHY DO HORNETS STING; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Ministry of Agriculture Forestry and Fisheries, 2012, STAT AGR DAM CAUS WI; Ministry of Health Labor and Welfare, 2014, JAP FIG; Nakamura M., 2007, VESPA URBAN INVASION; Saito M, 2013, PLOS ONE, V31; Sakurai R., 2014, Human Dimensions of Wildlife, V19, P88, DOI 10.1080/10871209.2014.842026; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Siemer W. F., 2009, Human Dimensions of Wildlife, V14, P185, DOI 10.1080/10871200902856138; Sijtsma MTJ, 2012, SOC NATUR RESOUR, V25, P1308, DOI 10.1080/08941920.2012.684850; Soga M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060529; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Soulsbury CD, 2015, WILDLIFE RES, V42, P541, DOI 10.1071/WR14229; van der Ploeg J, 2011, CONSERV LETT, V4, P313, DOI 10.1111/j.1755-263X.2011.00181.x; Vaske J., 2008, SURVEY RES ANAL APPL; von Dohren P, 2015, ECOL INDIC, V52, P490, DOI 10.1016/j.ecolind.2014.12.027; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; Wieczorek Hudenko Heather, 2010, P21; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011	53	15	17	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175243	10.1371/journal.pone.0175243	http://dx.doi.org/10.1371/journal.pone.0175243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388643	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800030
J	Imboden, MT; Welch, WA; Swartz, AM; Montoye, AHK; Finch, HW; Herber, MP; Kaminsky, LA				Imboden, Mary T.; Welch, Whitney A.; Swartz, Ann M.; Montoye, Alexander H. K.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.			Reference standards for body fat measures using GE dual energy x-ray absorptiometry in Caucasian adults	PLOS ONE			English	Article							GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; BEAM INSTRUMENTS; MASS INDEX; WOMEN; LUNAR; DXA; WEIGHT; BONE; MEN	Background Dual energy x-ray absorptiometry (DXA) is an established technique for the measurement of body composition. Reference values for these variables, particularly those related to fat mass, are necessary for interpretation and accurate classification of those at risk for obesity related health complications and in need of lifestyle modifications (diet, physical activity, etc.). Currently, there are no reference values available for GE-Healthcare DXA systems and it is known that whole-body and regional fat mass measures differ by DXA manufacturer. Objective To develop reference values by age and sex for DXA-derived fat mass measurements with GE-Healthcare systems. Methods A de-identified sample of 3,327 participants (2,076 women, 1,251 men) was obtained from Ball State University's Clinical Exercise Physiology Laboratory and University of Wisconsin Milwaukee's Physical Activity & Health Research Laboratory. All scans were completed using a GE Lunar Prodigy or iDXA and data reported included percent body fat (%BF), fat mass index (FMI), and ratios of android-to-gynoid (A/G), trunk/limb, and trunk/leg fat measurements. Percentiles were calculated and a factorial ANOVA was used to determine differences in the mean values for each variable between age and sex. Results Normative reference values for fat mass variables from DXA measurements obtained from GE-Healthcare DXA systems are presented as percentiles for both women and men in 10 year age groups. Women had higher (p<0.01) mean %BF and FMI than men, whereas men had higher (p<0.01) mean ratios of A/G, trunk/limb, and trunk/leg fat measurements than women. Conclusion These reference values provide clinicians and researchers with a resource for interpretation of DXA-derived fat mass measurements specific to use with GE-Healthcare DXA systems.	[Imboden, Mary T.; Montoye, Alexander H. K.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.] Ball State Univ, Muncie, IN 47306 USA; [Welch, Whitney A.; Swartz, Ann M.] Univ Wisconsin, Milwaukee, WI 53201 USA	Ball State University; University of Wisconsin System; University of Wisconsin Milwaukee	Imboden, MT (corresponding author), Ball State Univ, Muncie, IN 47306 USA.	Mstuttle2@bsu.edu			NCI NIH HHS [T32 CA193193] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA193193] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aasen G, 2006, SCAND J CLIN LAB INV, V66, P659, DOI 10.1080/00365510600898214; Fan B, 2014, J CLIN DENSITOM, V17, P344, DOI 10.1016/j.jocd.2013.08.019; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Genton L, 2006, CLIN NUTR, V25, P428, DOI 10.1016/j.clnu.2005.11.002; Gillette-Guyonnet S, 2003, MECH AGEING DEV, V124, P317, DOI 10.1016/S0047-6374(02)00199-9; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hong S, 2011, J KOREAN MED SCI, V26, P1599, DOI 10.3346/jkms.2011.26.12.1599; Kamel EG, 1999, INT J OBESITY, V23, P686, DOI 10.1038/sj.ijo.0800904; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; Kirchengast S, 2008, COLLEGIUM ANTROPOL, V32, P1079; Kirschner MM, 2011, MED SCI SPORT EXER, V43, P317, DOI 10.1249/01.MSS.0000400874.39385.50; Ramos RML, 2012, RADIOLOGIA-MADRID, V54, P410, DOI 10.1016/j.rx.2011.09.023; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Malouf J, 2013, J CLIN DENSITOM, V16, P212, DOI 10.1016/j.jocd.2012.04.003; Min KB, 2015, CLIN ENDOCRINOL, V82, P377, DOI 10.1111/cen.12505; PAFFENBARGER RS, 1986, ACTA MED SCAND, P85; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Pescatello LS., 2014, ACSMS GUIDELINES EXE, P62; Plank LD, 2005, CURR OPIN CLIN NUTR, V8, P305, DOI 10.1097/01.mco.0000165010.31826.3d; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Stults-Kolehmainen MA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.5; Tothill P, 2000, ANN NY ACAD SCI, V904, P63; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wells JCK, 2010, INT J OBESITY, V34, P649, DOI 10.1038/ijo.2009.249; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804	31	51	52	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175110	10.1371/journal.pone.0175110	http://dx.doi.org/10.1371/journal.pone.0175110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388669	Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800020
J	Zhai, L; Liu, M; Wang, TT; Zhang, HY; Li, S; Guo, YL				Zhai, Li; Liu, Min; Wang, Tingting; Zhang, Hongyan; Li, Shan; Guo, Yunliang			Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; NADPH OXIDASE; STROKE; STRESS; NEUROPROTECTION; ACTIVATION; THERAPY; KINASE	Background and purpose Thrombolysis is used to improve cerebral circulation; at the same time, neuroprotective drugs such as antioxidants should also be used. The aim of these experiments was to explore the protective mechanism of an antioxidant, picroside II, on the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Methods To observe the antagonistic effect of picroside II on CI/R damage, the neurological deficit score and the infarct volume were measured. To detect the protective effect of picroside II on nerve cells and the BBB, the morphology and structure of cortical brain tissue were observed, respectively. To investigate the antioxidant effect and mechanism of picroside II, reactive oxygen species (ROS) content, the activity of Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), and the protein levels of Nox2 and Rac-1 were detected. To investigate the protective mechanism of picroside II on the BBB, the levels of ROCK, MLCK, MMP-2 and claudin-5 were tested. Results A higher neurological score, bigger cortex infarction, more damaged neuron structure and injured BBB, increased content of ROS and activity of NADPH oxidase, higher protein levels of Nox2, Rac-1, ROCK, MLCK and MMP-2 and lower levels of claudin-5 were observed in the model group. In the picroside group, the neurological score, neuronal damage, BBB injury, ROS content and NADPH oxidase activity were reduced (P< 0.05), and the protein levels of Rac-1, Nox2, ROCK, MLCK and MMP-2 were down-regulated (P< 0.05), while the expression of claudin-5 was up-regulated (P< 0.05). Conclusions Picroside II could protect the nervous system possibly through reducing the content of ROS by down-regulating the expression of Rac-1 and Nox2 and could protect the BBB through reducing the expression of ROCK, MLCK, and MMP-2, while enhancing the expression of claudin-5.	[Zhai, Li; Wang, Tingting] Qingdao Univ, Clin Med Coll 3, Dept Pharm, Qingdao, Shandong, Peoples R China; [Zhang, Hongyan; Li, Shan; Guo, Yunliang] Qingdao Univ, Affiliated Hosp, Inst Cerebrovasc Dis, Qingdao, Shandong, Peoples R China	Qingdao University; Qingdao University	Guo, YL (corresponding author), Qingdao Univ, Affiliated Hosp, Inst Cerebrovasc Dis, Qingdao, Shandong, Peoples R China.	guogdsd@163.com	wang, tingting/AAK-2640-2020					Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Camire RB, 2014, J PHARMACOL EXP THER, V351, P654, DOI 10.1124/jpet.114.218339; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Enns GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100001; Fleenor BS, 2012, AGING CELL, V11, P269, DOI 10.1111/j.1474-9726.2011.00783.x; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Gu YT, 2013, NEUROPHARMACOLOGY, V75, P407, DOI 10.1016/j.neuropharm.2013.08.004; Guell K, 2014, EXPERT REV NEUROTHER, V14, P1287, DOI 10.1586/14737175.2014.964210; Guellich A, 2013, AM J PHYSIOL-HEART C, V304, pH1505, DOI 10.1152/ajpheart.00669.2012; Guliani A, 2015, IET NANOBIOTECHNOL, V10, P114; Jaffer H, 2011, DRUG DELIV TRANSL RE, V1, P409, DOI 10.1007/s13346-011-0046-y; Kahles T, 2013, ANTIOXID REDOX SIGN, V18, P1400, DOI 10.1089/ars.2012.4721; Kim YH, 2016, J STROKE, V18, P129, DOI 10.5853/jos.2016.00234; Lee JC, 2014, ANAT CELL BIOL, V47, P101, DOI [10.5115/acb.2014.47.2.101, 10.5115/acb.2014.47.3.149]; Li HY, 2014, TRANSL STROKE RES, V5, P618, DOI 10.1007/s12975-014-0354-x; Li Ting-ting, 2010, Zhongguo Yaolixue Yu Dulixue Zazhi, V24, P307; Liu K, 2011, INT J MOL SCI, V12, P1222, DOI 10.3390/ijms12021222; Luscher TF, 2016, EUR HEART J, V37, P857, DOI 10.1093/eurheartj/ehw084; Ma QL, 2013, TRENDS CARDIOVAS MED, V23, P179, DOI 10.1016/j.tcm.2012.11.002; McCann SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110602; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Muir SW, 2008, STROKE, V39, P3303, DOI 10.1161/STROKEAHA.108.519793; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Ren YX, 2015, INT J NEUROSCI, V125, P555, DOI 10.3109/00207454.2014.959121; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Rossi JL, 2013, J NEUROTRAUM, V30, P1672, DOI 10.1089/neu.2013.2898; Tang XN, 2011, ANN NEUROL, V70, P606, DOI 10.1002/ana.22476; Thompson JW, 2012, CURR NEUROPHARMACOL, V10, P354, DOI 10.2174/157015912804143577; Verma PC, 2009, CURR PHARM BIOTECHNO, V10, P641, DOI 10.2174/138920109789069314; Wang JJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/572729; Wang TT, 2015, J MOL NEUROSCI, V57, P335, DOI 10.1007/s12031-015-0623-5; Wang TT, 2015, CLIN EXP PHARMACOL P, V42, P930, DOI 10.1111/1440-1681.12445; Wang TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124099; Wu SM, 2014, INT J STROKE, V9, P101, DOI 10.1111/ijs.12163; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; [张树红 Zhang Shuhong], 2015, [中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V40, P612; Zhang Y, 2014, RHEUMATOL INT, V20, P20	39	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174414	10.1371/journal.pone.0174414	http://dx.doi.org/10.1371/journal.pone.0174414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388666	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800006
J	Anders, F; Teister, J; Liu, A; Funke, S; Grus, FH; Thanos, S; von Pein, HD; Pfeiffer, N; Prokosch, V				Anders, Fabian; Teister, Julia; Liu, Aiwei; Funke, Sebastian; Grus, Franz H.; Thanos, Solon; von Pein, Harald D.; Pfeiffer, Norbert; Prokosch, Verena			Intravitreal injection of beta-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma	PLOS ONE			English	Article							ELEVATED INTRAOCULAR-PRESSURE; HEAT-SHOCK PROTEINS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; OPTIC-NERVE; DBA/2J MICE; AXONAL REGENERATION; INHERITED GLAUCOMA; GENE-EXPRESSION; IRIS ATROPHY	Purpose of this study was to investigate firstly specific proteomic changes within the retina in the course of an animal glaucoma model and to identify secondly new approaches for neuroprotective, therapeutic options in glaucoma by addressing those specific changes. Intraocular pressure was elevated through cauterization of episcleral veins in adult Sprague Dawley rats. Molecular and morphological changes were surveyed using mass spectrometry, optical coherence tomography as well as immunohistochemical cross section- and flat mount stainings. By quantifying more than 1500 retinal proteins, it was found that the HspB5 protein and numerous beta-crystallins showed a uniform and unique shifting expression pattern as a result of different periods of elevated IOP exposure. Crystallins showed a significant downregulation (p<0.05) after 3 weeks of elevated IOP and an upregulation after 7 weeks. Counteracting those typical changes, an intravitreal injection of beta-crystallin B2 at the time of IOP elevation was found to reduce retinal ganglion cell loss (p<0.05), decrease of the retinal nerve fiber layer (p<0.05) and impairment of the optic nerve. Ultimately, proteomic data revealed that beta-crystallin B2 might influence calcium-depended cell signaling pathways with severe effect on apoptosis and gene regulation. In this context especially annexin A5, calcium-transporting ATPase 1 and various histone proteins seem to play a major role.	[Anders, Fabian; Teister, Julia; Liu, Aiwei; Funke, Sebastian; Grus, Franz H.; Pfeiffer, Norbert; Prokosch, Verena] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany; [Thanos, Solon] Westfalian Wilhelms Univ Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany; [von Pein, Harald D.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neuropathol, Mainz, Germany	Johannes Gutenberg University of Mainz; University of Munster; Johannes Gutenberg University of Mainz	Prokosch, V (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany.	vprokosch@gmx.de	Pfeiffer, Norbert/AAO-7586-2020	Liu, Aiwei/0000-0001-6656-3576	Deutsche Forschungsgemeinschaft (DFG) [PR1569/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant PR1569/1-1 to VP).	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; Bohm MRR, 2015, CELL TRANSPLANT, V24, P1829, DOI 10.3727/096368914X684583; Bohm MRR, 2013, GRAEF ARCH CLIN EXP, V251, P63, DOI 10.1007/s00417-012-2157-7; Bohm MRR, 2012, INVEST OPHTH VIS SCI, V53, P8265, DOI 10.1167/iovs.12-10334; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Flammer J, 1999, J GLAUCOMA, V8, P212; Furuyoshi N, 2000, OPHTHALMOLOGICA, V214, P24, DOI 10.1159/000027470; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Ghaffariyeh A, 2011, OPTOMETRY VISION SCI, V88, P80, DOI 10.1097/OPX.0b013e3181fc329f; HEAD MW, 1993, AM J PATHOL, V143, P1743; HEYWOOD R, 1975, BRIT VET J, V131, P213, DOI 10.1016/S0007-1935(17)35342-3; Hitchings R A, 1995, Curr Opin Ophthalmol, V6, P67; Jha P, 2011, MOL IMMUNOL, V48, P2151, DOI 10.1016/j.molimm.2011.07.012; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Jung KH, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00002; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Konishi Y, 2004, BIOCHEM BIOPH RES CO, V313, P977, DOI 10.1016/j.bbrc.2003.12.032; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; McMonnies CW, 2008, OPTOMETRY VISION SCI, V85, P1018, DOI 10.1097/OPX.0b013e3181890e91; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Naskar R, 2006, MOL VIS, V12, P1199; Osborne NN, 1999, BRIT J OPHTHALMOL, V83, P980, DOI 10.1136/bjo.83.8.980; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Piri N, 2016, PROG RETIN EYE RES, V52, P22, DOI 10.1016/j.preteyeres.2016.03.001; Piri N, 2013, MOL NEUROBIOL, V48, P819, DOI 10.1007/s12035-013-8470-2; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Quigley HA, 1996, NUMBER, V80, P389; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Rogers RS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012302; Schallenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033593; Schwartz M, 2000, INVEST OPHTH VIS SCI, V41, P349; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Thanos S, 2004, EXP EYE RES, V79, P119, DOI 10.1016/j.exer.2004.02.005; Tomita G, 2000, Curr Opin Ophthalmol, V11, P116, DOI 10.1097/00055735-200004000-00009; Ueda J, 1998, JPN J OPHTHALMOL, V42, P337, DOI 10.1016/S0021-5155(98)00026-4; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; WATANABE H, 1989, CURR EYE RES, V8, P479, DOI 10.3109/02713688909000028	57	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175451	10.1371/journal.pone.0175451	http://dx.doi.org/10.1371/journal.pone.0175451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384305	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900170
J	Brodska, B; Kracmarova, M; Holoubek, A; Kuzelova, K				Brodska, Barbora; Kracmarova, Marketa; Holoubek, Ales; Kuzelova, Katerina			Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; NUCLEOLAR PROTEIN B23; FAVORABLE PROGNOSIS; NORMAL KARYOTYPE; GENE-MUTATIONS; ARF; EXPRESSION; OLIGOMERIZATION; DOMAIN	Mutations of the gene for nucleophosmin (NPM1) are the most frequent genetic aberration in patients with acute myeloid leukemia (AML). The mechanism of leukemic transformation in this leukemia subtype is not fully understood, but aberrant cytoplasmic localization of mutated NPM (NPMmut) is widely considered as an important factor for leukemia manifestation. We analyzed the subcellular localization of three types of NPM with a C-terminal mutation (A, B and E). Genes for the individual NPM forms were fused with a gene for one of fluorescent protein variants in plasmids, which were transfected into three cell lines with different endogenous NPM expression. Subcellular localization of the fluorescent proteinlabeled NPM was further correlated with the relative expression of all NPM forms. We confirmed a high cytoplasmic expression of NPMmutA and NPMmutB whereas a substantial fraction of NPMmutE was found to be localized in nucleoli. Moreover, we revealed that the localization of fluorescently labeled NPM is affected by the interaction between various forms of the protein.	[Brodska, Barbora; Kracmarova, Marketa; Holoubek, Ales; Kuzelova, Katerina] Inst Hematol & Blood Transfus, Prague 2, Czech Republic	Institute of Hematology Prague	Brodska, B (corresponding author), Inst Hematol & Blood Transfus, Prague 2, Czech Republic.	brodska@uhkt.cz	Kuzelova, Katerina/ADE-8303-2022; Kráčmarová, Markéta/T-8185-2017	Kuzelova, Katerina/0000-0002-9628-6255; Kráčmarová, Markéta/0000-0002-9001-9594; Brodska, Barbora/0000-0002-3703-594X	Ministry of Health, CzechRepublic [00023736, 163 0268A]	Ministry of Health, CzechRepublic(Ministry of Health, Czech RepublicCzech Republic Government)	This work was supported by the Ministry of Health, CzechRepublic (www.mzcr.cz): Project for conceptual development of research organization No.00023736 and Grant No163 0268A. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Alpermann T, 2016, HAEMATOLOGICA, V101, pE55, DOI 10.3324/haematol.2015.133819; Alpermann T, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.51.51; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bolli N, 2009, LEUKEMIA, V23, P501, DOI 10.1038/leu.2008.326; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Braoudaki M, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-41; Brodska B, 2016, J CELL BIOCHEM, V117, P1319, DOI 10.1002/jcb.25420; Chou SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049769; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, LEUKEMIA, V21, P2052, DOI 10.1038/sj.leu.2404839; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V108, P1999, DOI 10.1182/blood-2006-03-007013; Falini B, 2011, BLOOD, V117, P1109, DOI 10.1182/blood-2010-08-299990; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Gruszka AM, 2010, BLOOD, V116, P2096, DOI 10.1182/blood-2010-01-266908; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Huang M, 2013, LEUKEMIA, V27, P1970, DOI 10.1038/leu.2013.222; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Janke H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089560; Koh Y, 2009, INT J HEMATOL, V90, P1, DOI 10.1007/s12185-009-0350-1; Kurki S, 2004, CELL CYCLE, V3, P976; Kuzelova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127637; Liu YF, 2014, MOL CLIN ONCOL, V2, P275, DOI 10.3892/mco.2013.222; Macville M, 1999, CANCER RES, V59, P141; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Prinos Panagiotis, 2011, Int J Biochem Mol Biol, V2, P24; Rashid NU, 2014, BLOOD, V124, P3110, DOI 10.1182/blood-2014-04-569327; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Schnittger S, 2011, LEUKEMIA, V25, P615, DOI 10.1038/leu.2010.299; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168	40	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175175	10.1371/journal.pone.0175175	http://dx.doi.org/10.1371/journal.pone.0175175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384310	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900110
J	Chabirand, A; Loiseau, M; Renaudin, I; Poliakoff, F				Chabirand, Aude; Loiseau, Marianne; Renaudin, Isabelle; Poliakoff, Francoise			Data processing of qualitative results from an interlaboratory comparison for the detection of ''Flavescence doree'' phytoplasma: How the use of statistics can improve the reliability of the method validation process in plant pathology	PLOS ONE			English	Article							ELM YELLOWS GROUP; NESTED-PCR; GRAPEVINE YELLOWS; IDENTIFICATION; AMPLIFICATION; VIRUS; MODEL; ASSAY	A working group established in the framework of the EUPHRESCO European collaborative project aimed to compare and validate diagnostic protocols for the detection of ''Flavescence doree'' (FD) phytoplasma in grapevines. Seven molecular protocols were compared in an interlaboratory test performance study where each laboratory had to analyze the same panel of samples consisting of DNA extracts prepared by the organizing laboratory. The tested molecular methods consisted of universal and group-specific real-time and end-point nested PCR tests. Different statistical approaches were applied to this collaborative study. Firstly, there was the standard statistical approach consisting in analyzing samples which are known to be positive and samples which are known to be negative and reporting the proportion of false-positive and false-negative results to respectively calculate diagnostic specificity and sensitivity. This approach was supplemented by the calculation of repeatability and reproducibility for qualitative methods based on the notions of accordance and concordance. Other new approaches were also implemented, based, on the one hand, on the probability of detection model, and, on the other hand, on Bayes' theorem. These various statistical approaches are complementary and give consistent results. Their combination, and in particular, the introduction of new statistical approaches give overall information on the performance and limitations of the different methods, and are particularly useful for selecting the most appropriate detection scheme with regards to the prevalence of the pathogen. Three real-time PCR protocols (methods M4, M5 and M6 respectively developed by Hren (2007), Pelletier (2009) and under patent oligonucleotides) achieved the highest levels of performance for FD phytoplasma detection. This paper also addresses the issue of indeterminate results and the identification of outlier results. The statistical tools presented in this paper and their combination can be applied to many other studies concerning plant pathogens and other disciplines that use qualitative detection methods.	[Chabirand, Aude] French Agcy Food Environm & Occupat Hlth & Safety, Plant Hlth Lab LSV, Unit Trop Pests & Dis, St Pierre, Reunion Island, France; [Loiseau, Marianne; Renaudin, Isabelle; Poliakoff, Francoise] French Agcy Food Environm & Occupat Hlth & Safety, Plant Hlth Lab LSV, Angers, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Chabirand, A (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Plant Hlth Lab LSV, Unit Trop Pests & Dis, St Pierre, Reunion Island, France.	aude.chabirand@anses.fr		Loiseau, Marianne/0000-0003-3409-4992	ANSES Plant Health Laboratory	ANSES Plant Health Laboratory	This study was supported by the ANSES Plant Health Laboratory and was made possible thanks to the data obtained in the framework of the Euphresco project GRAFDEPI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the ANSES Plant Health Laboratory and was made possible thanks to the data obtained in the framework of the EUPHRESCO project GRAFDEPI. We acknowledge the staff of the participating laboratories involved in this collaborative study, in particular H. Reisenzein (AGES), S. Steyer (CRA-W), K. De Jonghe (ILVO), S. Schaerer (ACW), A. Batlle (IRTA), G. Pasquini (CRA-PAV), E. Angelini (CRA-VIT), A. Bertaccini (DipSA), P. Bianco (DISAA), E. Sousa (INIAV), B. Duduk (IPEP), M. Dermastia (NIB) and N. Ustun (PPRS).	Angelini E, 2007, J MICROBIOL METH, V68, P613, DOI 10.1016/j.mimet.2006.11.015; Anonymous, 2014, Bulletin OEPP, V44, P117, DOI 10.1111/epp.12118; Anonymous, 2014, Bulletin OEPP, V44, P390, DOI 10.1111/epp.12162; [Anonymous], 170252005 ISOIEC; [Anonymous], 161402003 ISO; Chabirand A, 2014, PLANT PATHOL, V63, P20, DOI 10.1111/ppa.12083; Clair D, 2003, VITIS, V42, P151; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; Davison AC, 1997, BOOTSTRAP METHODS TH; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; Feinberg M, 2004, ANAL BIOANAL CHEM, V380, P502, DOI 10.1007/s00216-004-2791-y; Hren M, 2007, PLANT PATHOL, V56, P785, DOI 10.1111/j.1365-3059.2007.01688.x; Ioos R., 2008, Bulletin OEPP, V38, P198, DOI 10.1111/j.1365-2338.2008.01203.x; ISO, 572511994 ISO; Jaeschke R, 2002, USERS GUIDES MED LIT, P121; LaBudde RA, 2010, LEAST COST FORMULATI, pTR296; LEE IM, 1994, PHYTOPATHOLOGY, V84, P559, DOI 10.1094/Phyto-84-559; Macarthur R, 2010, J AOAC INT, V93, P1046; Martini M, 1999, PLANT DIS, V83, P925, DOI 10.1094/PDIS.1999.83.10.925; Massart S, 2008, EUR J PLANT PATHOL, V122, P539, DOI 10.1007/s10658-008-9322-1; Neves Denise Duprat, 2004, Braz J Infect Dis, V8, P311; Olmos A., 2008, VIROL RES TREAT, V1, P1, DOI [10.4137/VRT.S495, DOI 10.4137/VRT.S495]; Pelletier C, 2009, VITIS, V48, P87; PO EP, 2010, EPPO B, V40, P350; Schneider Bernd, 1995, P369, DOI 10.1016/B978-012583805-4/50040-6; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Vidal E, 2012, PHYTOPATHOLOGY, V102, P114, DOI 10.1094/PHYTO-05-11-0139; Wehling P, 2011, J AOAC INT, V94, P335; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	31	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175247	10.1371/journal.pone.0175247	http://dx.doi.org/10.1371/journal.pone.0175247			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384335	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900136
J	Chen, VCH; Yang, YH; Liao, YT; Kuo, TY; Liang, HY; Huang, KY; Huang, YC; Lee, Y; McIntyre, RS; Lin, TC				Chen, Vincent Chin-Hung; Yang, Yao-Hsu; Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You; Huang, Yin-Cheng; Lee, Yena; McIntyre, Roger S.; Lin, Tzu-Chin			The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan (vol 12, e0173762, 2017)	PLOS ONE			English	Correction									[Lin, Tzu-Chin] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Lin, Tzu-Chin] Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Lin, TC (corresponding author), Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan.; Lin, TC (corresponding author), Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan.		Students, MDPU/ABE-8402-2020; McIntyre, Roger/AAU-1000-2020; Lee, Yena/L-5505-2019; Lee, Yena/D-9016-2019	McIntyre, Roger/0000-0003-4733-2523; Lee, Yena/0000-0003-0629-9456; Lee, Yena/0000-0003-0629-9456				Chen VCH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173762	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175617	10.1371/journal.pone.0175617	http://dx.doi.org/10.1371/journal.pone.0175617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384334	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900192
J	Frappe, P; Cogneau, J; Gaboreau, Y; Abenhaim, N; Bayen, M; Calafiore, M; Guichard, C; Jacquet, JP; Lacoin, F; Bertoletti, L				Frappe, Paul; Cogneau, Joel; Gaboreau, Yoann; Abenhaim, Nathan; Bayen, Marc; Calafiore, Matthieu; Guichard, Claude; Jacquet, Jean-Pierre; Lacoin, Francois; Bertoletti, Laurent		CACAO Study Investigators	Areas of improvement in anticoagulant safety. Data from the CACAO study, a cohort in general practice	PLOS ONE			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; DABIGATRAN; WARFARIN; RISK; THROMBOEMBOLISM; CARE	Background Real-world studies on anticoagulants are mostly performed on health insurance databases, limited to reported events, and sometimes far from every-day issues in family practice. We assess the presence of data for safe monitoring of oral anticoagulants in general practice, and compare patients' knowledge of taking an anticoagulant between vitamin K antagonists (VKA) and direct anticoagulants (DOAC), and the general practitioner's perception of their adherence to anticoagulation. Methods The CACAO study is a national cohort study, conducted by general practitioners on ambulatory patients under oral anticoagulant. In the first phase, investigators provided safety data available from medical records at inclusion. They also evaluated patients' knowledge about anticoagulation and graded their perception of patients' adherence. Results Between April and December 2014, 463 general practitioners included 7154 patients. Renal and hepatic function tests were respectively unavailable in 109 (7.5%) and 359 (24.7%) DOAC patients. Among patients with atrial fibrillation, 345 patients (6.9%) had a questionable indication of anticoagulant (CHA2DS2-Vasc< 2). One hundred and thirty-three VKA patients (2.3%) and 70 DOAC patients (4.9%) answered they took no anticoagulant (p< 0.0001). According to general practitioners' perception, 430 patients (6.1%) were classified as "not very " or " not adherent ", with no difference between groups. Conclusions Our results highlight the efforts needed to improve anticoagulant safety in daily practice: decreasing the rate of unknown biological data in patients with DOACs or the rate of patients with VKA with no strong indication of anticoagulation, and improving patient knowledge with regard to their anticoagulant. Patients' adherence seems highly over-estimated by the general practitioners.	[Frappe, Paul] Univ St Etienne, Dept Gen Practice, St Etienne, France; [Frappe, Paul; Bertoletti, Laurent] Univ St Etienne, INSERM, U1059, Sainbiose DVH, St Etienne, France; [Frappe, Paul; Bertoletti, Laurent] CIC EC 1408, St Etienne, France; [Cogneau, Joel; Abenhaim, Nathan; Guichard, Claude; Lacoin, Francois] Inst Rech Med Gen, Paris, France; [Gaboreau, Yoann; Jacquet, Jean-Pierre] Grenoble Alpes Univ, Dept Gen Practice, Grenoble, France; [Gaboreau, Yoann] Grenoble Aloes Univ, TIMC IMAG UMR 5525, Grenoble, France; [Bayen, Marc; Calafiore, Matthieu] Univ Lille, Dept Gen Practice, Lille, France; [Bertoletti, Laurent] CHU St Etienne, Dept Vasc Med & Therapeut, St Etienne, France	Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; Universite de Lille; CHU de St Etienne	Frappe, P (corresponding author), Univ St Etienne, Dept Gen Practice, St Etienne, France.; Frappe, P (corresponding author), Univ St Etienne, INSERM, U1059, Sainbiose DVH, St Etienne, France.; Frappe, P (corresponding author), CIC EC 1408, St Etienne, France.	paul.frappe@univ-st-etienne.ir	CALAFIORE, Matthieu/AAY-6286-2021; Bayen, Marc/Q-8802-2019; Gaboreau, Yoann/P-1069-2019; Bertoletti, Laurent/X-1319-2019	CALAFIORE, Matthieu/0000-0002-4755-5172; Bayen, Marc/0000-0002-9355-3434; Gaboreau, Yoann/0000-0002-8198-099X; Bertoletti, Laurent/0000-0001-8214-3010; COGNEAU, Joel/0000-0003-1673-7528	French government	French government	The CACAO study was supported by the French government (continuing professional development of investigators).	Agence Nationale de Se A curite A du Me A dicament (ANSM), AN VENT MED FRANC 20; Agence Nationale de Securite du Medicament et des Produits de Sante, RAPP ANT FRANC 2014; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bertoletti L, 2016, PHARM RES; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Davidson BL, 2014, JAMA INTERN MED, V174, P947, DOI 10.1001/jamainternmed.2014.946; Douketis J, 2014, CAN FAM PHYSICIAN, V60, P989; Douketis J, 2014, CAN FAM PHYSICIAN, V60, P997; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Kane-Gill SL, 2010, ANN PHARMACOTHER, V44, P983, DOI 10.1345/aph.1M726; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Kodani E, 2016, CIRC J, V80, P843, DOI 10.1253/circj.CJ-16-0066; Laporte S, 2016, PHARM RES; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rodriguez RA, 2013, J THROMB HAEMOST, V11, P390, DOI 10.1111/jth.12086; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Seeger JD, 2015, THROMB HAEMOSTASIS, V114, P1277, DOI 10.1160/TH15-06-0497; ten Cate V, 2016, NETH HEART J, V24, P574, DOI 10.1007/s12471-016-0874-y; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Villines TC, 2015, THROMB HAEMOSTASIS, V114, P1290, DOI 10.1160/TH15-06-0453	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175167	10.1371/journal.pone.0175167	http://dx.doi.org/10.1371/journal.pone.0175167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384199	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900107
J	Gu, CM; Liu, Y; Mohamed, I; Zhang, RH; Wang, X; Nie, XX; Jiang, M; Brooks, M; Chen, F; Li, ZG				Gu, Chiming; Liu, Yi; Mohamed, Ibrahim; Zhang, Runhua; Wang, Xiao; Nie, Xinxin; Jiang, Min; Brooks, Margot; Chen, Fang; Li, Zhiguo			Dynamic Changes of Soil Surface Organic Carbon under Different Mulching Practices in Citrus Orchards on Sloping Land (vol 11, e0168384, 2016)	PLOS ONE			English	Correction									[Mohamed, Ibrahim] Benha Univ, Fac Agr, Soil & Water Dept, Banha, Egypt	Egyptian Knowledge Bank (EKB); Benha University								Gu CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168384	1	0	0	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175600	10.1371/journal.pone.0175600	http://dx.doi.org/10.1371/journal.pone.0175600			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384339	Green Published, gold			2022-12-27	WOS:000399371900176
J	Krishnappa, G; Singh, AM; Chaudhary, S; Ahlawat, AK; Singh, SK; Shukla, RB; Jaiswal, JP; Singh, GP; Solanki, IS				Krishnappa, Gopalareddy; Singh, Anju Mahendru; Chaudhary, Swati; Ahlawat, Arvind Kumar; Singh, Santosh Kumar; Shukla, Ram Bihari; Jaiswal, Jai Prakash; Singh, Gyanendra Pratap; Solanki, Ishwar Singh			Molecular mapping of the grain iron and zinc concentration, protein content and thousand kernel weight in wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; QTL ANALYSIS; QUALITY TRAITS; DENSITY; ENVIRONMENT; POPULATION; GENOTYPE; IMPROVE; YIELD; LINES	Genomic regions responsible for accumulation of grain iron concentration (Fe), grain zinc concentration (Zn), grain protein content (PC) and thousand kernel weight (TKW) were investigated in 286 recombinant inbred lines (RILs) derived from a cross between an old Indian wheat variety WH542 and a synthetic derivative (Triticum dicoccon PI94624/Aegilops squarrosa [409]//BCN). RILs were grown in six environments and evaluated for Fe, Zn, PC, and TKW. The population showed the continuous distribution for all the four traits, that for pooled Fe and PC was near normal, whereas, for pooled Zn, RILs exhibited positively skewed distribution. A genetic map spanning 2155.3cM was constructed using microsatellite markers covering the 21 chromosomes and used for QTL analysis. 16 quantitative trait loci (QTL) were identified in this study. Four QTLs (QGFe. iari-2A, QGFe. iari-5A, QGFe. iari-7A and QGFe. iari-7B) for Fe, five QTLs (QGZn. iari-2A, QGZn. iari-4A, QGZn. iari-5A, QGZn. iari-7A and QGZn. iari-7B) for Zn, two QTLs (QGpc. iari-2A and QGpc. iari-3A) for PC, and five QTLs (QTkw. iari-1A, QTkw. iari-2A, QTkw. iari-2B, QTkw. iari-5B and QTkw. iari-7A) for TKW were identified. The QTLs together explained 20.0%, 32.0%, 24.1% and 32.3% phenotypic variation, respectively, for Fe, Zn, PC and TKW. QGpc. iari-2A was consistently expressed in all the six environments, whereas, QGFe. iari-7B and QGZn. iari-2A were identified in two environments each apart from pooled mean. QTkw. iari-2A and QTkw. iari-7A, respectively, were identified in four and three environments apart from pooled mean. A common region in the interval of Xgwm359-Xwmc407 on chromosome 2A was associated with Fe, Zn, and PC. One more QTL for TKW was identified on chromosome 2A but in a different chromosomal region (Xgwm382-Xgwm359). Two more regions on 5A (Xgwm126-Xgwm595) and 7A (Xbarc49-Xwmc525) were found to be associated with both Fe and Zn. A QTL for TKW was identified (Xwmc525-Xbarc222) in a different chromosomal region on the same chromosome (7A). This reflects at least a partly common genetic basis for the four traits. It is concluded that fine mapping of the regions of the three chromosomes of A genome involved in determining the accumulation of Fe, Zn, PC, and TKW in this mapping population may be rewarding.	[Krishnappa, Gopalareddy; Singh, Anju Mahendru; Chaudhary, Swati; Ahlawat, Arvind Kumar; Singh, Santosh Kumar; Shukla, Ram Bihari; Singh, Gyanendra Pratap] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Krishnappa, Gopalareddy] ICAR Indian Inst Wheat & Barley Res, Div Crop Improvement, Karnal, Haryana, India; [Jaiswal, Jai Prakash] Govind Ballabh Pant Univ Agr & Technol, Pantnagar, Uttarakhand, India; [Solanki, Ishwar Singh] ICAR Indian Agr Res Inst, Reg Stn, Samastipur, Bihar, India; [Singh, Santosh Kumar] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, 720 Westview Dr SW, Atlanta, GA 30310 USA; [Singh, Gyanendra Pratap] ICAR Indian Inst Wheat & Barley Res, Karnal, Haryana, India; [Solanki, Ishwar Singh] Indian Council Agr Res, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Morehouse School of Medicine; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR)	Singh, AM (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.	anju_mahendru@yahoo.co.in			DBT [BT/AGR/Wheat Bioforti/PH-II/2010]	DBT(Department of Biotechnology (DBT) India)	This work is a part outcome of a DBT funded project (BT/AGR/Wheat Bioforti/PH-II/2010) granted to AMS.; This work is a part outcome of a DBT funded project (BT/AGR/Wheat Bioforti/PH-II/2010) granted to AMS. Collaboration of HarvestPlus in calibration of the XRF machine and provision of glass based standards is also acknowledged.	[Anonymous], 2014, OPEN J GENET, DOI DOI 10.4236/OJGEN.2014.43024; Badakhshan H., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P57; Bouis HE, 2003, P NUTR SOC, V62, P403, DOI 10.1079/PNS2003262; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; de Benoist Bruno, 2008, WORLDWIDE PREVALENCE, V7; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Erba D, 2011, J CEREAL SCI, V54, P250, DOI 10.1016/j.jcs.2011.06.011; FAO, 2003, FOOD OUTL; Ficco DBM, 2009, FIELD CROP RES, V111, P235, DOI 10.1016/j.fcr.2008.12.010; Genc Y, 2009, PLANT SOIL, V314, P49, DOI 10.1007/s11104-008-9704-3; Gomez-Becerra HF, 2010, EUPHYTICA, V171, P39, DOI 10.1007/s10681-009-9987-3; Gonzalez-Hernandez JL, 2004, EUPHYTICA, V139, P217, DOI 10.1007/s10681-004-3157-4; Gopalareddy K, 2015, INDIAN J GENET PL BR, V75, P307, DOI 10.5958/0975-6906.2015.00048.6; Grusak MA, 2005, BIOL SCI SER, P265; Gupta V.S., 2011, J WHEAT RES, V3, P14; Hao YF, 2014, MOL BREEDING, V34, P1893, DOI 10.1007/s11032-014-0147-7; HarvestPlus, 2011, HARVESTPLUS ANN REPO; Horton S, 2008, CHALLENGE HUNGER MAL, P3; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; JANSEN RC, 1994, GENETICS, V136, P1447; Joppa LR, 1997, CROP SCI, V37, P1586, DOI 10.2135/cropsci1997.0011183X003700050030x; Kulwal Pawan, 2005, Functional & Integrative Genomics, V5, P254, DOI 10.1007/s10142-005-0136-3; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lincoln SE, 1993, CONSTRUCTING GENETIC; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Mergoum M., 2013, Journal of Plant Breeding and Genetics, V1, P19; Morgounov A, 2007, EUPHYTICA, V155, P193, DOI 10.1007/s10681-006-9321-2; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nezhad KZ, 2012, EUPHYTICA, V186, P127, DOI 10.1007/s10681-011-0559-y; Oury FX, 2006, EUR J AGRON, V25, P177, DOI 10.1016/j.eja.2006.04.011; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; PETERSON CJ, 1986, CEREAL CHEM, V63, P183; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Pu ZE, 2014, J INTEGR AGR, V13, P2322, DOI 10.1016/S2095-3119(13)60640-1; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Roder MS, 1998, GENETICS, V149, P2007; Roshanzamir H., 2013, IRAN J GENET PLANT B, V2, P551; Saleem N., 2015, Scientific Research and Essays, V10, P260; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; Solomons NW., 2003, ENCY FOOD SCI; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Srinivasa J, 2014, THEOR APPL GENET, V127, P1643, DOI 10.1007/s00122-014-2327-6; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Surma M, 2012, PLANT PROD SCI, V15, P192, DOI 10.1626/pps.15.192; Tiwari C, 2016, EUPHYTICA, V207, P563, DOI 10.1007/s10681-015-1544-7; Tiwari VK, 2009, J HERED, V100, P771, DOI 10.1093/jhered/esp030; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Velu G, 2012, FIELD CROP RES, V137, P261, DOI 10.1016/j.fcr.2012.07.018; Welch RM, 2005, J TRACE ELEM MED BIO, V18, P299, DOI 10.1016/j.jtemb.2005.03.001; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; Xu YF, 2012, FIELD CROP RES, V138, P57, DOI 10.1016/j.fcr.2012.09.017; Yasmin Z, 2014, CROP SCI, V54, P255, DOI 10.2135/cropsci2013.04.0214; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang H, 2016, CROP J, V4, P220, DOI 10.1016/j.cj.2016.01.007	61	48	48	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174972	10.1371/journal.pone.0174972	http://dx.doi.org/10.1371/journal.pone.0174972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384292	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900065
J	Kristen, AV; Maurer, MS; Rapezzi, C; Mundayat, R; Suhr, OB; Damy, T				Kristen, Arnt V.; Maurer, Mathew S.; Rapezzi, Claudio; Mundayat, Rajiv; Suhr, Ole B.; Damy, Thibaud		THAOS Investigators	Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)	PLOS ONE			English	Article							SENILE SYSTEMIC AMYLOIDOSIS; BRAIN NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; FIBRIL COMPOSITION; DISEASE SEVERITY; TROPONIN-T; WILD-TYPE; HEREDITARY; CARDIOMYOPATHY; SURVIVAL	Aim: Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin amyloidosis (ATTR) are lacking. Methods and results: Patients (n = 1617) with any of the following cardiac biomarkers, BNP (n = 1079), NT-proBNP (n = 550), troponin T (n = 274), and troponin I (n = 108), available at baseline in the Transthyretin Amyloidosis Outcomes Survey (THAOS) were analyzed for differences between genotypes and phenotypes and their association with survival. Median level of BNP was 68.0 pg/mL (IQR 30.5-194.9), NT-proBNP 337.9 pg/mL (IQR 73.0-2584.0), troponin T 0.03 mu g/L (IQR 0.01-0.05), and troponin I 0.08 mu g/L (IQR 0.04-0.13). NT-proBNP and BNP were higher in wild-type than mutant-type ATTR, troponin T and I did not differ, respectively. Non-Val30Met patients had higher BNP, NT-proBNP and troponin T levels than Val30Met patients, but not troponin I. Late-onset Val30Met was associated with higher levels of troponin I and troponin T compared with early-onset. 115 patients died during a median follow-up of 1.2 years. Mortality increased with increasing quartiles (BNP/NT-proBNP Q1 = 1.7%, Q2 = 5.2%, Q3 = 21.7%, Q4 = 71.3%; troponin T/I Q1 = 6.5%, Q2 = 14.5%, Q3 = 33.9%, Q4 = 45.2%). Three-year overall-survival estimates for BNP/NT-proBNP and troponin T/I quartiles differed significantly (p<0.001). Stepwise risk stratification was achieved by combining NT-proBNP/BNP and troponin T/I. From Cox proportional hazards model, age, modified body mass index, mutation (Val30Met vs. Non-Val30Met) and BNP/NT-proBNP (Q1-Q3 pooled vs. Q4) were identified as independent predictors of survival in patients with mutant-type ATTR. Conclusions: In this ATTR patient cohort, cardiac biomarkers were abnormal in a substantial percentage of patients irrespective of genotype. Along with age, mBMI, and mutation (Val30Met vs. Non-Val30Met), cardiac biomarkers were associated with surrogates of disease severity with BNP/NT-proBNP identified as an independent predictor of survival in ATTR.	[Kristen, Arnt V.] Heidelberg Univ, Dept Cardiol, Amyloidosis Ctr, Heidelberg, Germany; [Maurer, Mathew S.] Columbia Univ, Ctr Adv Cardiac Care, Med Ctr, New York, NY USA; [Rapezzi, Claudio] Univ Bologna, Inst Cardiol, Bologna, Italy; [Rapezzi, Claudio] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Mundayat, Rajiv] Pfizer Inc, New York, NY USA; [Suhr, Ole B.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Damy, Thibaud] CHU Henri Mondor, Dept Cardiol, Amyloidosis Network, Creteil, France	Ruprecht Karls University Heidelberg; Columbia University; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Pfizer; Umea University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Kristen, AV (corresponding author), Heidelberg Univ, Dept Cardiol, Amyloidosis Ctr, Heidelberg, Germany.	Arnt_Kristen@med.uni-heidelberg.de	Conceicao, Isabel/AAC-6075-2022; Hazenberg, Bouke/I-2866-2016	Conceicao, Isabel/0000-0003-0934-9631; Judge, Daniel/0000-0002-3407-0248; Hazenberg, Bouke/0000-0003-1827-0482; Shah, Sanjiv/0000-0002-5655-8201	Pfizer Inc	Pfizer Inc(Pfizer)	THAOS registry is funded by Pfizer Inc. Data collection and analysis in THAOS were supported by Pfizer Inc. Pfizer Inc. provided financial support to enable the development and hosting of THAOS by a database vendor and provided compensation to survey sites for data reporting and quality of life assessment. A Scientific Board comprising participating physicians, clinical experts, and a medical representative of the sponsor gave a dviceon scientific and policy decisions and over saw data review and analysis. The funder provided statistical support, and the statistician participated as an author, but other than this, the funder had no role in the decision to publish, in the interpretation of the findings, or in the writing of the manuscript. Assistance in preparing the manuscript for submission (editing and formatting of tables and text) was provided by Shuang Li, PhD, at Engage Scientific and was funded by Pfizer Inc. The authors take full responsibility for the content of the article.	Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Benson MD, 2012, AMYLOID, V19, P14, DOI 10.3109/13506129.2012.668501; Coelho T, 2013, CURR MED RES OPIN, V29, P63, DOI 10.1185/03007995.2012.754348; Connors LH, 2011, AMYLOID, V18, P157, DOI 10.3109/13506129.2011.574354059; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Damy T, 2013, AMYLOID, V20, P212, DOI 10.3109/13506129.2013.825240; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029; Dispenzieri A, 2003, LANCET, V361, P1787, DOI 10.1016/S0140-6736(03)13396-X; Dungu JN, 2012, HEART, V98, P1546, DOI 10.1136/heartjnl-2012-301924; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hund E, 2001, NEUROLOGY, V56, P431, DOI 10.1212/WNL.56.4.431; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Jacobson DR, 1997, HUM MUTAT, V9, P83, DOI 10.1002/(SICI)1098-1004(1997)9:1<83::AID-HUMU19>3.0.CO;2-L; Kristen AV, 2013, INT J CARDIOL, V164, P179, DOI 10.1016/j.ijcard.2011.06.123; Kristen AV, 2010, BLOOD, V116, P2455, DOI 10.1182/blood-2010-02-267708; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lobato L, 2012, CLIN J AM SOC NEPHRO, V7, P1337, DOI 10.2215/CJN.08720811; Palladini G, 2003, CIRCULATION, V107, P2440, DOI 10.1161/01.CIR.0000068314.02595.B2; Plante-Bordeneuve V, 2013, CURR MED RES OPIN, V29, P77, DOI 10.1185/03007995.2012.754349; Rapezzi C, 2009, CIRCULATION, V120, P1203, DOI 10.1161/CIRCULATIONAHA.108.843334; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ruberg FL, 2012, AM HEART J, V164, P222, DOI 10.1016/j.ahj.2012.04.015; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; Steen H, 2006, J AM COLL CARDIOL, V48, P2192, DOI 10.1016/j.jacc.2006.06.002; Suhr OB, 2003, J INTERN MED, V254, P225, DOI 10.1046/j.1365-2796.2003.01173.x; Suhr OB, 2008, J INTERN MED, V263, P294, DOI 10.1111/j.1365-2796.2007.01888.x; Suhr OB, 2012, AMYLOID, V19, P78, DOI 10.3109/13506129.2012.673139; Westermark P, 2003, AMYLOID, V10, P48; Zand Parsa Amir Farhang, 2012, Indian Heart J, V64, P479, DOI 10.1016/j.ihj.2012.08.003	31	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173086	10.1371/journal.pone.0173086	http://dx.doi.org/10.1371/journal.pone.0173086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384285	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900005
J	Wolkewitz, M; Schumacher, M				Wolkewitz, Martin; Schumacher, Martin			Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data (vol 11, e0160430, 2016)	PLOS ONE			English	Correction																		Wolkewitz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160430	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175660	10.1371/journal.pone.0175660	http://dx.doi.org/10.1371/journal.pone.0175660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384330	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900200
J	Anguera, JA; Brandes-Aitken, AN; Antovich, AD; Rolle, CE; Desai, SS; Marco, EJ				Anguera, Joaquin A.; Brandes-Aitken, Anne N.; Antovich, Ashley D.; Rolle, Camarin E.; Desai, Shivani S.; Marco, Elyse J.			A pilot study to determine the feasibility of enhancing cognitive abilities in children with sensory processing dysfunction	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MODULATION; ADHD; CONNECTIVITY; INTEGRATION; OLDER	Children with Sensory Processing Dysfunction (SPD) experience incoming information in atypical, distracting ways. Qualitative challenges with attention have been reported in these children, but such difficulties have not been quantified using either behavioral or functional neuroimaging methods. Furthermore, the efficacy of evidence-based cognitive control interventions aimed at enhancing attention in this group has not been tested. Here we present work aimed at characterizing and enhancing attentional abilities for children with SPD. A sample of 38 SPD and 25 typically developing children were tested on behavioral, neural, and parental measures of attention before and after a 4-week iPad-based at-home cognitive remediation program. At baseline, 54% of children with SPD met or exceeded criteria on a parent report measure for inattention/hyperactivity. Significant deficits involving sustained attention, selective attention and goal management were observed only in the subset of SPD children with parent-reported inattention. This subset of children also showed reduced midline frontal theta activity, an electroencephalographic measure of attention. Following the cognitive intervention, only the SPD children with inattention/hyperactivity showed both improvements in midline frontal theta activity and on a parental report of inattention. Notably, 33% of these individuals no longer met the clinical cut-off for inattention, with the parentreported improvements persisting for 9 months. These findings support the benefit of a targeted attention intervention for a subset of children with SPD, while simultaneously highlighting the importance of having a multifaceted assessment for individuals with neurodevelopmental conditions to optimally personalize treatment.	[Anguera, Joaquin A.; Brandes-Aitken, Anne N.; Antovich, Ashley D.; Rolle, Camarin E.; Desai, Shivani S.; Marco, Elyse J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Anguera, Joaquin A.; Marco, Elyse J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Marco, Elyse J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Anguera, JA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Anguera, JA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	joaquin.anguera@ucsf.edu			Mickelson-Brody Family Foundation; Wallace Research Foundation; James Gates Family Foundation; Kawaja-Holcombe Family Foundation; SNAP Crowd funding effort	Mickelson-Brody Family Foundation; Wallace Research Foundation; James Gates Family Foundation; Kawaja-Holcombe Family Foundation; SNAP Crowd funding effort	This work was supported by the Mickelson-Brody Family Foundation, the Wallace Research Foundation, the James Gates Family Foundation, the Kawaja-Holcombe Family Foundation (EJM), and the SNAP 2015 Crowd funding effort.	Ahn RR, 2004, AM J OCCUP THER, V58, P287, DOI 10.5014/ajot.58.3.287; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Anguera JA, 2016, DEPRESS ANXIETY; Anguera JA, 2015, CURR OPIN BEHAV SCI, V4, P160, DOI 10.1016/j.cobeha.2015.06.002; Arean PA, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6482; Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Bundy AC, 2007, AM J OCCUP THER, V61, P201, DOI 10.5014/ajot.61.2.201; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; Chang YS, 2016, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00169; Chang YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103038; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dorbath L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00257; Dunn W, 1999, SENSORY PROFILE USER; Garcia-Perez MA, 2014, ATTEN PERCEPT PSYCHO, V76, P621, DOI 10.3758/s13414-013-0574-2; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Greenberg L., 1996, TOVA SCREENING MANUA; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jensen DR, 1997, DETECTING OUTLIERS W, P581; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, J CLIN EXP NEUROPSYC; Koziol LF, 2012, APPL NEUROPSYCH-CHIL, V1, P137, DOI 10.1080/21622965.2012.709422; Koziol LF, 2011, CEREBELLUM, V10, P770, DOI 10.1007/s12311-011-0288-8; KRAMER AF, 1995, J EXP PSYCHOL-APPL, V1, P50, DOI 10.1037/1076-898X.1.1.50; Krasnegor NA, 1997, DEVELOPMENT OF THE P; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Kucian K, 2011, NEUROIMAGE, V57, P782, DOI 10.1016/j.neuroimage.2011.01.070; Lane SJ, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00008; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Liston C, 2011, BIOL PSYCHIAT, V69, P1168, DOI 10.1016/j.biopsych.2011.03.022; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Mangeot SD, 2001, DEV MED CHILD NEUROL, V43, P399, DOI 10.1017/S0012162201000743; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; Miller LJ, 2007, AM J OCCUP THER, V61, P135, DOI 10.5014/ajot.61.2.135; Miller LJ, 2012, RES DEV DISABIL, V33, P804, DOI 10.1016/j.ridd.2011.12.005; Mishra J, 2016, NEURON, V90, P214, DOI 10.1016/j.neuron.2016.04.010; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Owen JP, 2013, NEUROIMAGE-CLIN, V2, P844, DOI 10.1016/j.nicl.2013.06.009; Parush S, 2007, PHYSIOL BEHAV, V90, P553, DOI 10.1016/j.physbeh.2006.11.004; Peng P, 2016, LEARN INDIVID DIFFER, V45, P77, DOI 10.1016/j.lindif.2015.11.012; Pfeiffer B, 2015, PHYS OCCUP THER PEDI, V35, P1, DOI 10.3109/01942638.2014.904471; Rabiner DL, 2010, J ABNORM CHILD PSYCH, V38, P131, DOI 10.1007/s10802-009-9353-x; Rutter M., 2003, SCQ SOCIAL COMMUNICA; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Schatz AM, 2001, ASSESSMENT, V8, P357, DOI 10.1177/107319110100800401; Shalev L, 2007, CHILD NEUROPSYCHOL, V13, P382, DOI 10.1080/09297040600770787; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Steiner NJ, 2011, CLIN PEDIATR, V50, P615, DOI 10.1177/0009922810397887; Tamm L, 2013, DEV COGN NEUROS-NETH, V4, P16, DOI 10.1016/j.dcn.2012.11.004; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; The NIMH Research Domain Criteria (RDoC) Project, 2014, AM J PSYCHIAT, V171, P395; Tucha O, 2011, ADHD-ATTEND DEFICIT, V3, P271, DOI 10.1007/s12402-011-0059-x; Wahlstedt C, 2009, J ABNORM CHILD PSYCH, V37, P551, DOI 10.1007/s10802-008-9286-9; Wechsler D, 1974, WECHSLER INTELLIGENC; Willcutt EG, 2006, THE ETIOLOGY OF ADHD; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Zheng CG, 2012, J COMPUT NEUROSCI, V33, P547, DOI 10.1007/s10827-012-0400-1	63	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172616	10.1371/journal.pone.0172616	http://dx.doi.org/10.1371/journal.pone.0172616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380008	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500006
J	Garcia-Morante, B; Segales, J; Fraile, L; Llarden, G; Coll, T; Sibila, M				Garcia-Morante, Beatriz; Segales, Joaquim; Fraile, Lorenzo; Llarden, Gemma; Coll, Teresa; Sibila, Marina			Potential use of local and systemic humoral immune response parameters to forecast Mycoplasma hyopneumoniae associated lung lesions	PLOS ONE			English	Article							ACTINOBACILLUS-PLEUROPNEUMONIAE; PULMONARY-LESIONS; INFECTED-PIGS; RISK-FACTORS; SWINE; PNEUMONIA; SLAUGHTER; SEROCONVERSION; DURATION; DISEASE	Immunopathological events are key for the development of enzootic pneumonia (EP), which is macroscopically observed as cranioventral pulmonary consolidation (CVPC). This study aimed to investigate the putative association between the humoral immune response against Mycoplasma hyopneumoniae (M. hyopneumoniae) and prevalence and extension of CVPC in 1) experimentally infected pigs, 2) slaughtered pigs and 3) sequentially necropsied pigs in a longitudinal study. CVPC was scored by means of the European Pharmacopoeia recommended methodology. Specific IgG, IgG1 and IgG2 antibodies were assessed in serum. In addition, mucosal IgG and IgA antibodies were analyzed in broncho-alveolar lavage fluid (BALF) from experimentally challenged pigs. The systemic humoral immune response in experimentally infected pigs was delayed in onset whereas humoral respiratory mucosal immune response appeared more rapidly but declined earlier. Although low, BALF IgG antibodies showed the highest correlation with CVPC scores (r = 0.49, p<0.05). In slaughter-aged pigs, both percentage of lungs with CVPC and mean lung lesion score were significantly higher in M. hyopneumoniae seropositive farms compared to the seronegative ones (p<0.001). Similarly, seropositive sequentially necropsied pigs showed more severe CVPC than seronegative ones. Overall, mean serological values might help to forecast prevalence and severity of EP-like lung lesions using a population based approach. Remarkably, the specific systemic humoral immune response was found to be predominated by the IgG2 subclass, suggesting a dominant Th1mediated immune response to M. hyopneumoniae.	[Garcia-Morante, Beatriz; Llarden, Gemma; Sibila, Marina] IRTA UAB, Ctr Recerca Sanitat Anim, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Garcia-Morante, Beatriz] Boehringer Ingelheim Espana SA, Sant Cugat Del Valles, Spain; [Segales, Joaquim] UAB, Ctr Recerca Sanitat Anim, IRTA UAB, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Segales, Joaquim] Fac Vet, Dept Sanitat & Anat Anim, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Fraile, Lorenzo] Univ Lleida, Dept Ciencia Anim, ETSEA, Lleida, Spain; [Coll, Teresa] Boehringer Ingelheim Vet Res Ctr GmbH&Co, Hannover, Germany	Autonomous University of Barcelona; IRTA; Boehringer Ingelheim; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Universitat de Lleida; Boehringer Ingelheim	Sibila, M (corresponding author), IRTA UAB, Ctr Recerca Sanitat Anim, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain.	marina.sibila@irta.cat	Segalés, Joaquim/A-4933-2011; Garcia Morante, Beatriz/AAV-4930-2020; Fraile, Lorenzo/AGE-2172-2022; Fraile, Lorenzo/GQQ-8989-2022; Fraile, Lorenzo/A-1142-2009; Segalés, Joaquim/AAB-4815-2020	Segalés, Joaquim/0000-0002-1539-7261; Garcia Morante, Beatriz/0000-0002-5610-9932; Fraile, Lorenzo/0000-0002-8980-5862; Fraile, Lorenzo/0000-0002-8980-5862; Fraile, Lorenzo/0000-0002-8980-5862; Segalés, Joaquim/0000-0002-1539-7261; Sibila, Marina/0000-0003-3867-1988	Boehringer Ingelheim; Secretaria del Departament d'Economia i Creixement de la Generalitat de Catalunya (Industrial Doctorate) [DI2013-0039]	Boehringer Ingelheim(Boehringer Ingelheim); Secretaria del Departament d'Economia i Creixement de la Generalitat de Catalunya (Industrial Doctorate)	This work was supported by a collaborative agreement for independent research from Boehringer Ingelheim and a grant from Secretaria del Departament d'Economia i Creixement de la Generalitat de Catalunya (Industrial Doctorate: DI2013-0039). Boehringer Ingelheim provided support in the form of salaries for authors BGM and TC. The specific roles of BGM and TC are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen M, 2001, PREV VET MED, V52, P147, DOI 10.1016/S0167-5877(01)00242-2; Chase C.C., 2012, DIS SWINE, VTenth, P264; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; DAVIS JK, 1985, INFECT IMMUN, V50, P647, DOI 10.1128/IAI.50.3.647-654.1985; Fano E, 2005, CAN J VET RES, V69, P223; Feng ZX, 2014, VET J, V202, P128, DOI 10.1016/j.tvjl.2014.06.019; Fraile L, 2010, VET J, V184, P326, DOI 10.1016/j.tvjl.2009.03.029; Furesz SE, 1998, VACCINE, V16, P1971, DOI 10.1016/S0264-410X(98)00120-0; Garcia-Morante B, 2016, J COMP PATHOL, V154, P125, DOI 10.1016/j.jcpa.2015.11.003; Garcia-Morante B, 2016, VET RES, V47, DOI 10.1186/s13567-016-0340-2; HANNAN PCT, 1982, RES VET SCI, V33, P76, DOI 10.1016/S0034-5288(18)32364-6; Katayama M, 2011, ASIAN AUSTRAL J ANIM, V24, P889, DOI 10.5713/ajas.2011.10391; KOBISCH M, 1993, VET RES, V24, P67; Madec F, 1982, J RECH PORCINE FRANC, V14, P405; Merialdi G, 2012, VET J, V193, P234, DOI 10.1016/j.tvjl.2011.11.009; Meyns T, 2011, VET J, V187, P388, DOI 10.1016/j.tvjl.2009.12.027; MORRIS CR, 1995, PREV VET MED, V21, P323, DOI 10.1016/0167-5877(94)00384-U; Muneta Y, 2008, J VET MED SCI, V70, P1065, DOI 10.1292/jvms.70.1065; Nathues H, 2014, TRANSBOUND EMERG DIS, V61, P316, DOI 10.1111/tbed.12033; NOYES EP, 1990, J AM VET MED ASSOC, V197, P1025; Okamba FR, 2010, VACCINE, V28, P4802, DOI 10.1016/j.vaccine.2010.04.089; Park SC, 2002, INFECT IMMUN, V70, P2502, DOI 10.1128/IAI.70.5.2502-2506.2002; Pieters M, 2009, VET MICROBIOL, V134, P261, DOI 10.1016/j.vetmic.2008.08.016; Raymond BBA, 2016, P 4 VETPATH C PATH B; Raymond CR, 2004, VACCINE, V22, P1016, DOI 10.1016/j.vaccine.2003.08.026; Redondo E, 2009, J COMP PATHOL, V140, P260, DOI 10.1016/j.jcpa.2008.12.008; Sarradell J, 2003, VET PATHOL, V40, P395, DOI 10.1354/vp.40-4-395; Sibila M, 2007, VET MICROBIOL, V122, P97, DOI 10.1016/j.vetmic.2007.01.010; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Sitjar M., 1996, Swine Health and Production, V4, P273; Sorensen V, 1997, VET MICROBIOL, V54, P23, DOI 10.1016/S0378-1135(96)01266-7; SUTER M, 1985, INFECT IMMUN, V49, P615, DOI 10.1128/IAI.49.3.615-620.1985; Thacker EL., 2019, DIS SWINE, P779; VANTIL LD, 1991, CAN J VET RES, V55, P347; Vranckx K, 2012, VET MICROBIOL, V156, P315, DOI 10.1016/j.vetmic.2011.11.007; Walker J, 1996, VET IMMUNOL IMMUNOP, V54, P197, DOI 10.1016/S0165-2427(96)05709-1; WALLGREN P, 1994, J VET MED B, V41, P441, DOI 10.1111/j.1439-0450.1994.tb00249.x; Woolard MD, 2004, J IMMUNOL, V172, P6875, DOI 10.4049/jimmunol.172.11.6875; YAGIHASHI T, 1993, VET MICROBIOL, V34, P155, DOI 10.1016/0378-1135(93)90169-8	39	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175034	10.1371/journal.pone.0175034	http://dx.doi.org/10.1371/journal.pone.0175034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380065	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500089
J	Nooij, SAE; Pretto, P; Oberfeld, D; Hecht, H; Bulthoff, HH				Nooij, Suzanne A. E.; Pretto, Paolo; Oberfeld, Daniel; Hecht, Heiko; Buelthoff, Heinrich H.			Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories	PLOS ONE			English	Article							CALCULATING CORRELATION-COEFFICIENTS; OPTOKINETIC DRUM; POSTURAL INSTABILITY; SIMULATOR SICKNESS; PERIPHERAL-VISION; CIRCULAR VECTION; MIXED-MODEL; NYSTAGMUS; SEVERITY; FIELD	This study investigated the role of vection (i.e., a visually induced sense of self-motion), optokinetic nystagmus (OKN), and inadvertent head movements in visually induced motion sickness (VIMS), evoked by yaw rotation of the visual surround. These three elements have all been proposed as contributing factors in VIMS, as they can be linked to different motion sickness theories. However, a full understanding of the role of each factor is still lacking because independent manipulation has proven difficult in the past. We adopted an integrative approach to the problem by obtaining measures of potentially relevant parameters in four experimental conditions and subsequently combining them in a linear mixed regression model. To that end, participants were exposed to visual yaw rotation in four separate sessions. Using a full factorial design, the OKN was manipulated by a fixation target (present/absent), and vection strength by introducing a conflict in the motion direction of the central and peripheral field of view (present/absent). In all conditions, head movements were minimized as much as possible. Measured parameters included vection strength, vection variability, OKN slow phase velocity, OKN frequency, the number of inadvertent head movements, and inadvertent head tilt. Results show that VIMS increases with vection strength, but that this relation varies among participants (R-2 = 0.48). Regression parameters for vection variability, head and eye movement parameters were not significant. These results may seem to be in line with the Sensory Conflict theory on motion sickness, but we argue that a more detailed definition of the exact nature of the conflict is required to fully appreciate the relationship between vection and VIMS.	[Nooij, Suzanne A. E.; Pretto, Paolo; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Oberfeld, Daniel; Hecht, Heiko] Johannes Gutenberg Univ Mainz, Dept Expt Psychol, Mainz, Germany	Max Planck Society; Johannes Gutenberg University of Mainz	Nooij, SAE (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	suzanne.nooij@tuebingen.mpg.de	Oberfeld, Daniel/A-7997-2008; Hecht, Heiko/H-3106-2011; Pretto, Paolo/AAZ-8895-2021; Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Oberfeld, Daniel/0000-0002-6710-3309; Hecht, Heiko/0000-0001-9418-862X; Bülthoff, Heinrich H/0000-0003-2568-0607; Pretto, Paolo/0000-0003-3922-3108	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are very grateful to Daniel Diers for programming the visual stimuli, and to two anonymous reviewers for comments on an earlier version of this manuscript. This study was funded by the Max Planck Society.	Becker W, 2002, EXP BRAIN RES, V144, P554, DOI 10.1007/s00221-002-1104-y; BEHRENS F, 1992, VISION RES, V32, P889, DOI 10.1016/0042-6989(92)90031-D; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Bles W, 1998, BRAIN RES BULL, V47, P481, DOI 10.1016/S0361-9230(98)00115-4; Bonato F, 2006, PERCEPTION, V35, P53, DOI 10.1068/p5062; Bonato F, 2005, AVIAT SPACE ENVIR MD, V76, P823; Bonato F, 2004, AVIAT SPACE ENVIR MD, V75, P306; Bonato F, 2008, PRESENCE-TELEOP VIRT, V17, P283, DOI 10.1162/pres.17.3.283; Bonato F, 2015, AEROSP MED HUM PERF, V86, P440, DOI 10.3357/AMHP.4105.2015; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Bubka A, 2003, AVIAT SPACE ENVIR MD, V74, P315; Bubka A, 2006, AVIAT SPACE ENVIR MD, V77, P811; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; CRAMPTON GH, 1953, J COMP PHYSIOL PSYCH, V46, P451, DOI 10.1037/h0058423; DICHGANS J, 1973, ACTA OTO-LARYNGOL, V76, P339, DOI 10.3109/00016487309121519; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; EBENHOLTZ SM, 1994, AVIAT SPACE ENVIR MD, V65, P1032; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Faugloire E, 2007, EXP BRAIN RES, V177, P520, DOI 10.1007/s00221-006-0700-7; Fischer MH, 1930, J PSYCHOL NEUROL, V41, P273; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; Flanagan MB, 2002, AVIAT SPACE ENVIR MD, V73, P1067; Fouladi RT, 2004, COMMUN STAT-SIMUL C, V33, P807, DOI 10.1081/SAC-200033260; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Golding JF, 2009, AVIAT SPACE ENVIR MD, V80, P516, DOI 10.3357/ASEM.2433.2009; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Hu SQ, 1997, AVIAT SPACE ENVIR MD, V68, P306; HU SQ, 1989, AVIAT SPACE ENVIR MD, V60, P411; Hu SQ, 1998, AVIAT SPACE ENVIR MD, V69, P1162; HU SQ, 1991, AVIAT SPACE ENVIR MD, V62, P308; Ji JTT, 2009, HUM FACTORS, V51, P739, DOI 10.1177/0018720809349708; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Keshavarz B., 2015, FRONT PSYCHOL, V6; Keshavarz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101016; Keshavarz B, 2011, DISPLAYS, V32, P181, DOI 10.1016/j.displa.2011.05.009; Keshavarz B, 2011, HUM FACTORS, V53, P415, DOI 10.1177/0018720811403736; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; Palmisano S, 2007, AVIAT SPACE ENVIR MD, V78, P951, DOI 10.3357/ASEM.2079.2007; Prothero JD, 1999, AVIAT SPACE ENVIR MD, V70, P277; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reason JT., 1975, MOTION SICKNESS; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Schaalje GB, 2002, J AGRIC BIOL ENVIR S, V7, P512, DOI 10.1198/108571102726; Skene SS, 2010, STAT MED, V29, P2825, DOI 10.1002/sim.4073; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; STERN RM, 1985, AVIAT SPACE ENVIR MD, V56, P1074; STERN RM, 1990, AVIAT SPACE ENVIR MD, V61, P712; Stern RM, 1987, GASTROENTEROLOGY, V92, P92, DOI 10.1016/0016-5085(87)90843-2; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Webb NA, 2003, AVIAT SPACE ENVIR MD, V74, P622; Webb NA, 2002, AVIAT SPACE ENVIR MD, V73, P351; Welsch R, 1980, REGRESSION DIAGNOSTI; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; YANG TD, 1991, AVIAT SPACE ENVIR MD, V62, P141; YOUNG LR, 1975, AVIAT SPACE ENVIR MD, V46, P264	60	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175305	10.1371/journal.pone.0175305	http://dx.doi.org/10.1371/journal.pone.0175305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380077	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500116
J	Rosenholm, M; Paro, E; Antila, H; Voikar, V; Rantamaki, T				Rosenholm, Marko; Paro, Emmi; Antila, Hanna; Voikar, Vootele; Rantamaki, Tomi			Repeated brief isoflurane anesthesia during early postnatal development produces negligible changes on adult behavior in male mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; REPEATED MATERNAL SEPARATION; EARLY EXPOSURE; APOPTOTIC NEURODEGENERATION; SEVOFLURANE ANESTHESIA; PREPULSE INHIBITION; DEVELOPING BRAIN; NEONATAL-RATS; MOUSE STRAINS; BIRTH COHORT	Brain development is a complex process regulated by genetic programs and activity-dependent neuronal connectivity. Anesthetics profoundly alter neuronal excitability, and anesthesia during early brain development has been consistently associated with neuroapoptosis, altered synaptogenesis, and persistent behavioral abnormalities in experimental animals. However, the depth, and even more the duration and developmental time point(s) of exposure to anesthesia determine the neuropathological and long-term behavioral consequences of anesthetics. Here, we have investigated adulthood phenotypic changes induced by repeated but brief (30 min) isoflurane anesthesia delivered during two distinct developmental periods in male mice. A set of animals were subjected to anesthesia treatments at postnatal days 7, 8 and 9 (P7-9) when the animals are susceptible to anesthesia-induced neuroapoptosis and reduced synaptogenesis. To control the potential influence of (handling) stress, a separate group of animals underwent repeated maternal separations of similar durations. Another set of animals were exposed to the same treatments at postnatal days 15, 16 and 17 (P15-17), a developmental time period when anesthetics have been shown to increase synaptogenesis. Starting from postnatal week 9 the mouse phenotype was evaluated using a battery of behavioral tests that assess general locomotor activity (home cage activity, open field), learning and memory (water maze) and depression- (saccharin preference, forced swim test), anxiety- (light-dark box, stress-induced hyperthermia) and schizophrenia- (nesting, prepulse inhibition) related endophenotypes. Apart from mild impairment in spatial navigation memory, exposure to anesthesia treatments during P7-9 did not bring obvious behavioral alterations in adult animals. Importantly, maternal separation during the same developmental period produced a very similar phenotype during the water maze. Mice exposed to anesthesia during P15-17 showed mild hyperactivity and risk-taking behavior in adulthood, but were otherwise normal. We conclude that significantly longer administration periods are needed in order for early-life repeated exposures to anesthetics to produce behavioral alterations in adult mice.	[Rosenholm, Marko; Paro, Emmi; Rantamaki, Tomi] Univ Helsinki, Lab Neurotherapeut, Div Physiol & Neurosci, Fac Biol & Environm Sci,Dept Biosci, Helsinki, Finland; [Antila, Hanna; Voikar, Vootele] Univ Helsinki, Neurosci Ctr, Helsinki Inst Life Sci, Helsinki, Finland	University of Helsinki; University of Helsinki	Rantamaki, T (corresponding author), Univ Helsinki, Lab Neurotherapeut, Div Physiol & Neurosci, Fac Biol & Environm Sci,Dept Biosci, Helsinki, Finland.	tomi.rantamaki@heisinki.fi	Voikar, Vootele/V-4542-2019	Voikar, Vootele/0000-0003-4201-8666; Antila, Hanna/0000-0001-8317-4564; Rosenholm, Marko/0000-0002-5437-8282; Rantamaki, Tomi/0000-0002-0052-1434	Academy of Finland [276333, 284569]; Biocenter Finland; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Biocenter Finland; Jane and Aatos Erkko Foundation	This study has been supported by the Academy of Finland (T.R.; grant numbers 276333, 284569). Animal phenotyping was conducted at the Mouse Phenotypic Core Facility (Neuroscience Center, University of Helsinki, Finland) supported by Biocenter Finland and Jane and Aatos Erkko Foundation (V.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Amrock LG, 2015, ANESTHESIOLOGY, V122, P87, DOI 10.1097/ALN.0000000000000477; Ben-Ari Y, 2013, HDB CLIN NEUROLOGY; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Briner A, 2011, ANESTHESIOLOGY, V115, P282, DOI 10.1097/ALN.0b013e318221fbbd; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cao WG, 2012, ANESTHESIOLOGY, V117, P791, DOI 10.1097/ALN.0b013e318266c62d; Creeley CE, 2010, ANESTH ANALG, V110, P442, DOI 10.1213/ANE.0b013e3181c6b9ca; Darbra S, 2013, PSYCHONEUROENDOCRINO, V38, P1397, DOI 10.1016/j.psyneuen.2012.12.007; De Roo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007043; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jeevakumar V, 2015, BEHAV BRAIN RES, V282, P165, DOI 10.1016/j.bbr.2015.01.010; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; JL. Response to neonatal anesthesia, 2008, NEUROSCIENCE, V152, P959; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kohtala S, 2016, ACS CHEM NEUROSCI; Lee B.H., 2014, PLOS ONE, V9; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Mehta M, 2011, BEHAV NEUROSCI, V125, P29, DOI 10.1037/a0021952; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Pedersen CS, 2014, BEHAV BRAIN RES, V273, P63, DOI 10.1016/j.bbr.2014.07.023; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Qiu L, 2016, TOXICOL SCI, V149, P121, DOI 10.1093/toxsci/kfv219; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shen XF, 2013, NEUROTOXICOLOGY, V39, P45, DOI 10.1016/j.neuro.2013.08.007; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tagawa T, 2014, J ANESTH, V28, P815, DOI 10.1007/s00540-014-1822-x; Tao G, 2016, BIOMED RES INT BIOME, V2016, P2016, DOI DOI 10.1155/2016/7919640; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu CQ, 2015, PSYCHONEUROENDOCRINO, V60, P173, DOI 10.1016/j.psyneuen.2015.06.016; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099171; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	44	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175258	10.1371/journal.pone.0175258	http://dx.doi.org/10.1371/journal.pone.0175258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380075	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500113
J	Park, JW; Park, KH; Jung, EY; Choi, SH; Jang, JA; Yoo, HN				Park, Jeong Woo; Park, Kyo Hoon; Jung, Eun Young; Choi, Soo-Hyun; Jang, Ji Ae; Yoo, Ha-Na			Short cervical lengths initially detected in mid-trimester and early in the third trimester in asymptomatic twin gestations: Association with histologic chorioamnionitis and preterm birth	PLOS ONE			English	Article							INTRAAMNIOTIC INFECTION; PLACENTAL HISTOLOGY; AMNIOTIC-FLUID; PREGNANCIES; PREDICTION; METAANALYSIS; WOMEN; RISK; MORBIDITY; LABOR	Objective To determine whether short cervical lengths (<= 20 mm) that were initially detected in mid- trimester and early in the third trimester are independently associated with increased risks of subsequent histologic chorioamnionitis and spontaneous preterm birth (SPTB, defined as a delivery before 34 weeks) in asymptomatic women with twin pregnancies. Material and methods This is a prospective study including 292 consecutive asymptomatic women with twin gestations. Cervical length measurements were carried out at 20 to 24 weeks' gestation and at 28 to 32 weeks' gestation. Both placentas of each twin pair were examined histologically after delivery. The generalized estimation equations models and logistic regression analysis were used for statistical analyses. Results Multivariable generalized estimation equations analysis revealed that short cervical length at mid-trimester was independently associated with an increased risk for subsequent histologic chorioamnionitis, whereas short cervical length initially detected early in the third trimester was not. By using the likelihood of SPTB as an outcome variable, multivariable logistic regression analysis indicated that short mid- trimester cervical length and histologic chorioamnionitis were independently associated with a greater risk for SPTB. Similarly, based on the multivariable analysis, a short third trimester cervical length was independently and significantly associated with a greater risk for SPTB. Conclusions In asymptomatic women with twin pregnancies, a short mid-trimester cervical length is independently associated with an increased risk of both subsequent histologic chorioamnionitis and SPTB, whereas a short cervical length initially detected early in the third trimester is independently associated with preterm delivery, but not subsequent histologic chorioamnionitis.	[Park, Jeong Woo] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Obstet & Gynecol, Gyeonggi, South Korea; [Park, Jeong Woo; Park, Kyo Hoon] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Kyo Hoon; Jung, Eun Young; Choi, Soo-Hyun; Jang, Ji Ae; Yoo, Ha-Na] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea	Inje University; Seoul National University (SNU); Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org		Park, Jeong Woo/0000-0001-6499-0814	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HI 14C1798).	Bartmann C, 2014, AM J REPROD IMMUNOL, V71, P109, DOI 10.1111/aji.12185; Cho SH, 2017, J KOREAN MED SCI, V32, P488, DOI 10.3346/jkms.2017.32.3.488; Conde-Agudelo A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.064; Dulay AT, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.040; Ehsanipoor RM, 2012, ULTRASOUND OBST GYN, V40, P81, DOI 10.1002/uog.10130; Esplin MS, 2014, CLIN OBSTET GYNECOL, V57, P518, DOI 10.1097/GRF.0000000000000037; Fuchs F, 2016, SEMIN FETAL NEONAT M, V21, P113, DOI 10.1016/j.siny.2015.12.010; Fujita MM, 2002, ACTA OBSTET GYN SCAN, V81, P856, DOI 10.1034/j.1600-0412.2002.810910.x; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1047, DOI 10.1016/S0002-9378(96)80051-2; Guzman ER, 1999, AM J OBSTET GYNECOL, V181, P793, DOI 10.1016/S0002-9378(99)70303-0; Hassan S, 2006, J PERINAT MED, V34, P13, DOI 10.1515/JPM.2006.002; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; Jams JD., 1997, AM J OBSTET GYNECOL, V176, pS6; Kalan AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.013; Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047; Kindinger LM, 2016, BJOG-INT J OBSTET GY, V123, P877, DOI 10.1111/1471-0528.13575; Langston C, 1997, ARCH PATHOL LAB MED, V121, P449; Lim AC, 2011, ULTRASOUND OBST GYN, V38, P10, DOI 10.1002/uog.9013; Martin JA, 2011, NATL VITAL STAT REP, V60, P1; Mazor M, 1996, ACTA OBSTET GYN SCAN, V75, P624, DOI 10.3109/00016349609054686; Meath AI, 2005, AM J OBSTET GYNECOL, V192, P1410, DOI 10.1016/j.ajog.2005.01.033; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Oncel MY, 2013, ARCH GYNECOL OBSTET, V287, P893, DOI 10.1007/s00404-012-2678-7; Pelaez LM, 2010, J PERINAT MED, V38, P485, DOI [10.1515/JPM.2010.077, 10.1515/jpm.2010.077]; Phung DT, 2002, AM J OBSTET GYNECOL, V186, P1041, DOI 10.1067/mob.2002.122449; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P757, DOI 10.1016/0002-9378(90)91063-I; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Saccone G, 2015, ACTA OBSTET GYN SCAN, V94, P352, DOI 10.1111/aogs.12600; Suh YH, 2007, J KOREAN MED SCI, V22, P89, DOI 10.3346/jkms.2007.22.1.89; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; van der Ven AJ, 2015, EUR J OBSTET GYN R B, V188, P12, DOI 10.1016/j.ejogrb.2015.02.032; Vayssiere C, 2005, ULTRASOUND OBST GYN, V26, P707, DOI 10.1002/uog.2616; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	34	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175455	10.1371/journal.pone.0175455	http://dx.doi.org/10.1371/journal.pone.0175455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399138	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000038
J	Jirsova, D; Stefka, J; Jirku, M				Jirsova, Dagmar; Stefka, Jan; Jirku, Miloslav			Discordant population histories of host and its parasite: A role for ecological permeability of extreme environment?	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; GENETIC DIVERSITY; CESTODA CARYOPHYLLIDEA; HAEMONCHUS-CONTORTUS; DIVERGENT SELECTION; MITOCHONDRIAL-DNA; MALARIA PARASITES; LOCAL ADAPTATION; FAUNAL TURNOVER; CICHLID FISHES	Biogeographical and ecological barriers strongly affect the course of micro-evolutionary processes in free living organisms. Here we assess the impact of a recently emerged barrier on populations of limnic fauna. Genetic diversity and population structure in a host-parasite system (Wenyonia virilis tapeworm, Synodontis schall catfish) are analyzed in the recently divided Turkana and Nile basins. The two basins, were repeatedly connected during the Holocene wet/dry climatic oscillations, following late Pleistocene dessication of the Turkana basin. Mitochondrial DNA sequences for cytochrome oxidase I gene (cox I) and a whole genome scanning method amplified fragment length polymorphism (AFLP) were employed. A total of 347 cox I sequences (representing 209 haplotypes) and 716 AFLP fragments, as well as 120 cox I sequences (20 haplotypes) and 532 AFLP fragments were obtained from parasites and hosts, respectively. Although results indicate that host and parasite populations share some formative traits (bottlenecks, Nilotic origin), their population histories/patterns differ markedly. Mitochondrial analysis revealed that parasite populations evolve significantly faster and show remarkably higher genetic variability. Analyses of both markers confirmed that the parasites undergo lineage fission, forming new clusters specific for either freshwater or saline parts of Lake Turkana. In congruence with the geological history, these clusters apparently indicate multiple colonisations of Lake Turkana from the Nile. In contrast, the host population pattern indicates fusion of different colonisation waves. Although fish host populations remain connected, saline habitats in Lake Turkana (absent in the Nile), apparently pose a barrier to the gene flow in the parasite, possibly due to its multihost lifecycle, which involves freshwater annelids. Despite partially corroborating mitochondrial results, AFLP data was not sufficiently informative for analyzing populations with recently mixed biogeographic histories.	[Jirsova, Dagmar; Stefka, Jan] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Jirsova, Dagmar; Stefka, Jan; Jirku, Miloslav] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Jirsova, D (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Jirsova, D (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.	dasa.jirsova@gmail.com	Štefka, Jan/G-9267-2014; Jirku, Miloslav/G-7823-2014; Štefka, Jan/N-3924-2019	Štefka, Jan/0000-0002-1283-9730; Jirku, Miloslav/0000-0002-4258-6543; Štefka, Jan/0000-0002-1283-9730; Jirsova, Dagmar/0000-0002-1099-8076				Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Barrows TT, 2014, GEOLOGY, V42, P163, DOI 10.1130/G35238.1; Beerli P, 1997, MIGRATE DOCUMENTATIO; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Berg PR, 2015, GENOME BIOL EVOL, V7, P1644, DOI 10.1093/gbe/evv093; Best A, 2009, AM NAT, V173, P779, DOI 10.1086/598494; Bloszies C, 2015, GLOBAL PLANET CHANGE, V132, P64, DOI 10.1016/j.gloplacha.2015.06.006; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Camberlin P, 2009, MONOGR BIOL, V89, P307; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Day T, 2007, P ROY SOC B-BIOL SCI, V274, P2685, DOI 10.1098/rspb.2007.0809; de Gruijter JM, 2006, MOL CELL PROBE, V20, P317, DOI 10.1016/j.mcp.2006.03.004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumont HJ, 2009, MONOGR BIOL, V89, P1; Elmer KR, 2009, P NATL ACAD SCI USA, V106, P13404, DOI 10.1073/pnas.0902299106; Emerson BC, 2014, MOL ECOL, V23, P5132, DOI 10.1111/mec.12951; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folkertsma RT, 1996, MOL PLANT MICROBE IN, V9, P47, DOI 10.1094/MPMI-9-0047; FRANK SA, 1993, EVOLUTION, V47, P1721, DOI 10.2307/2410216; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Froese R, 2014, FISHBASE INTERNET VE; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Garrick RC, 2014, MOL ECOL, V23, P5276, DOI 10.1111/mec.12919; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; Goodier SAM, 2011, PLOS ONE, P6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HARVEY CPD, 1982, GEOGR J, V148, P327, DOI 10.2307/633150; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hopson A, 1982, 19721975 OV DEV ADM, V1-6; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson KP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2174; Johnson T. C., 2009, LAKE TURKANA ITS LIN, P287; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kautt AF, 2012, MOL ECOL, V21, P4770, DOI 10.1111/j.1365-294X.2012.05738.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan Shahid M., 2013, Evolution Medicine and Public Health, P3, DOI 10.1093/emph/eos003; Koop JAH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0255; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lundberg J.G., 1998, PHYLOGENY CLASSIFICA, P603; MACKIEWICZ JS, 1972, EXP PARASITOL, V31, P417, DOI 10.1016/0014-4894(72)90103-8; Mariaux J, 2008, ZOOL J LINN SOC-LOND, V152, P367, DOI 10.1111/j.1096-3642.2007.00332.x; Martinelli A, 2004, MOL BIOCHEM PARASIT, V136, P117, DOI 10.1016/j.molbiopara.2004.02.011; Mattersdorfer K, 2012, MOL ECOL, V21, P3531, DOI 10.1111/j.1365-294X.2012.05634.x; Matthee CA, 2004, P ROY SOC B-BIOL SCI, V271, P1967, DOI 10.1098/rspb.2004.2806; McKee JK, 2001, PALEOBIOLOGY, V27, P500, DOI 10.1666/0094-8373(2001)027<0500:FTRAMB>2.0.CO;2; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Nejsum P, 2006, VET PARASITOL, V139, P203, DOI 10.1016/j.vetpar.2006.02.025; NYAMWERU C, 1989, GEOGR J, V155, P179, DOI 10.2307/635059; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otero O, 2001, PALAEOGEOGR PALAEOCL, V165, P141, DOI 10.1016/S0031-0182(00)00158-9; Otsen M, 2001, INT J PARASITOL, V31, P1138, DOI 10.1016/S0020-7519(01)00225-9; Patra KP, 2007, EXP PARASITOL, V116, P59, DOI 10.1016/j.exppara.2006.11.011; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinton A, 2013, MOL PHYLOGENET EVOL, V66, P1027, DOI 10.1016/j.ympev.2012.12.009; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Ricketts RD, 1998, LIMNOL OCEANOGR, V43, P811, DOI 10.4319/lo.1998.43.5.0811; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos MH, 2004, INT J PARASITOL, V34, P109, DOI 10.1016/j.ijpara.2003.10.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sambrook J, 2001, MOLECULAR CLONING SA; Schaeffner BC, 2011, SYST PARASITOL, V79, P83, DOI 10.1007/s11230-011-9290-2; Scholz T., 1998, TAPEWORMS GENUS PROT; Scholz T, 2011, FOLIA PARASIT, V58, P197, DOI 10.14411/fp.2011.020; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Simo G, 2008, EXP PARASITOL, V118, P172, DOI 10.1016/j.exppara.2007.07.010; Spurgin LG, 2014, MOL ECOL, V23, P1028, DOI 10.1111/mec.12672; Stefka J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-284; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; Tandon R, 2005, INT J PARASITOL, V35, P813, DOI 10.1016/j.ijpara.2005.02.004; van der Veer M, 2003, EXP PARASITOL, V104, P70, DOI 10.1016/S0014-4894(03)00116-4; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wagner CE, 2014, ECOL LETT, V17, P583, DOI 10.1111/ele.12260; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P3; Xu DD, 2013, MAR BIOTECHNOL, V15, P221, DOI 10.1007/s10126-012-9480-1; Zwickl D.J., 2006, THESIS, P115	95	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175286	10.1371/journal.pone.0175286	http://dx.doi.org/10.1371/journal.pone.0175286			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394904	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800025
J	Liu, IW; Ho, BL; Chen, CF; Han, K; Lin, CJ; Sheng, WY; Hu, HH; Chao, AC				Liu, I-Wen; Ho, Bo-Lin; Chen, Chien-Fu; Han, Ke; Lin, Chung-Jung; Sheng, Wen-Yung; Hu, Han-Hwa; Chao, A-Ching			Vertebral artery terminating in posterior inferior cerebellar artery: A normal variation with clinical significance	PLOS ONE			English	Article							CEREBRAL VASOMOTOR REACTIVITY; VASCULAR DEMENTIA; ISCHEMIC-STROKE; HYPOPLASIA; OCCLUSION; ULTRASONOGRAPHY; MANIPULATION; CIRCULATION; NECK	A vertebral artery (VA) terminating in a posterior inferior cerebellar artery (PICA) is often considered to be a normal variation associated with VA hypoplasia. We aimed to investigate the clinical significance of this cerebrovascular variant. A total of 80 patients with clinically evident cerebrovascular events in posterior circulation were examined by duplex sonography and magnetic resonance angiography (MRA). Eighty healthy subjects who had MRA check-up were recruited as controls. PICA termination of the VA (PICA-VA) was identified as the VA not communicating with the basilar artery (BA) but ending into a PICA. We compared the prevalence of PICA-VA and associated hemodynamic parameters between the patients with and without PICA-VA, and investigated their relationships with VA hypoplasia. The prevalence of PICA-VA was higher in the patient group than in the controls (18.7% vs. 6.3%, p = 0.015). Most measurements (73.3%) of PICA-VA did not fit the criteria of VA hypoplasia. In comparison with the non-PICA-terminating group, the PICA-VA has a smaller diameter (3.7 +/- 0.7 mm vs. 3.0 +/- 0.5 mm, p < 0.001), lower mean velocity (241 +/- 100 mm/ sec vs. 164 +/- 88 mm/ sec, p < 0.01), and higher pulsatility index (1.3 +/- 0.5 vs. 1.9 +/- 0.6, p < 0.001). Moreover, a smaller diameter of the BA (3.2 +/- 0.5 mm vs. 2.5 +/- 0.9 mm, p = 0.004) and the posterior cerebral artery (PCA) (2.0 +/- 0.1 mm vs. 1.6 +/- 0.1 mm, p = 0.006) were also noted in the PICA-VA group. The higher prevalence of PICA-VA in the patient group with smaller diameter of VA, BA and PCA reflected its clinical significance, suggesting that PICA-VA may have a detrimental impact on cerebral hemodynamics. However, the sample is small, and further studies are needed with larger sample size for confirmation.	[Liu, I-Wen; Sheng, Wen-Yung; Hu, Han-Hwa] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Ho, Bo-Lin; Chen, Chien-Fu; Chao, A-Ching] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Ho, Bo-Lin] Kaohsiung Municipal Gangshan Hosp, Dept Neurol, Kaohsiung, Taiwan; [Han, Ke] Jilin Univ, Dept Neurol, Hosp 1, Changchun, Kagawa, Peoples R China; [Han, Ke] Jilin Univ, Neurosci Ctr, Hosp 1, Changchun, Kagawa, Peoples R China; [Lin, Chung-Jung] Natl Yang Ming Univ, Dept Radiol, Taipei Vet Gen Hosp, Sch Med, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Coll Med, Dept Neurol, Taipei, Taiwan; [Chao, A-Ching] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan	Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Jilin University; Jilin University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Medical University	Chao, AC (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.; Chao, AC (corresponding author), Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan.	achch@cc.kmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST104-2314-B-037-029]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Science and Technology, Taiwan (MOST104-2314-B-037-029).	Asil T, 2005, J ULTRAS MED, V24, P1065, DOI 10.7863/jum.2005.24.8.1065; Brandt T, 2005, NEUROLOGY, V65, P1156, DOI 10.1212/01.wnl.0000183154.93624.ac; Chen YY, 2010, ULTRASOUND MED BIOL, V36, P38, DOI 10.1016/j.ultrasmedbio.2009.08.012; Chuang YM, 2006, EUR NEUROL, V55, P193, DOI 10.1159/000093868; FRISONI GB, 1991, STROKE, V22, P1452, DOI 10.1161/01.STR.22.11.1452; Greenberg MS, 2010, HDB NEUROSURGERY, P102; Jeng JS, 2004, ULTRASOUND MED BIOL, V30, P605, DOI 10.1016/j.ultrasmedbio.2004.03.004; Marti S, 2008, J NEUROL, V255, P663, DOI 10.1007/s00415-008-0773-2; MEHALIC T, 1974, SURG NEUROL, V2, P125; MULLER M, 1995, STROKE, V26, P96, DOI 10.1161/01.STR.26.1.96; Noh Y, 2011, J NEUROL, V258, P1775, DOI 10.1007/s00415-011-6005-1; Park JH, 2007, J NEUROL NEUROSUR PS, V78, P954, DOI 10.1136/jnnp.2006.105767; Perren F, 2007, NEUROLOGY, V68, P65, DOI 10.1212/01.wnl.0000250258.76706.98; Saito K, 2004, STROKE, V35, P1068, DOI 10.1161/01.STR.0000125857.63427.59; SCHELLHAS KP, 1980, JAMA-J AM MED ASSOC, V244, P1450, DOI 10.1001/jama.244.13.1450; Siclari F, 2007, AM J NEURORADIOL, V28, P1185, DOI 10.3174/ajnr.A0498; Strupp M, 2000, NEUROLOGY, V54, P1376, DOI 10.1212/WNL.54.6.1376; Tsivgoulis G, 2014, J ALZHEIMERS DIS, V42, pS251, DOI 10.3233/JAD-132441; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; Yeh Ju-Fen, 2005, Acta Neurol Taiwan, V14, P69; Zhu YS, 2013, J CEREBR BLOOD F MET, V33, P1190, DOI 10.1038/jcbfm.2013.66; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	22	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e175264	10.1371/journal.pone.0175264	http://dx.doi.org/10.1371/journal.pone.0175264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394897	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800022
J	Tolnai, S; Beutelmann, R; Klump, GM				Tolnai, Sandra; Beutelmann, Rainer; Klump, Georg M.			Exploring binaural hearing in gerbils (Meriones unguiculatus) using virtual headphones	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; MEDIAL SUPERIOR OLIVE; SOUND LOCALIZATION; BEHAVIORAL SENSITIVITY; MONGOLIAN GERBIL; COINCIDENCE DETECTION; DIRECTIONAL HEARING; LATERAL POSITION; DUPLEX THEORY; SPATIAL CUES	The Mongolian gerbil (Meriones unguiculatus) has become a key species in investigations of the neural processing of sound localization cues in mammals. While its sound localization has been tested extensively under free-field stimulation, many neurophysiological studies use headphones to present signals with binaural localization cues. The gerbil's behavioral sensitivity to binaural cues, however, is unknown for the lack of appropriate stimulation paradigms in awake behaving gerbils. We close this gap in knowledge by mimicking a head-phone stimulation; we use free-field loudspeakers and apply cross-talk cancellation techniques to present pure tones with binaural cues via "virtual headphones" to gerbils trained in a sound localization task. All gerbils were able to lateralize sounds depending on the inter-aural time or level difference (ITD and ILD, respectively). For ITD stimuli, reliable responses were seen for frequencies <= 2.9 kHz, the highest frequency tested with ITD stimuli. ITD sensitivity was frequency-dependent with the highest sensitivity observed at 1 kHz. For stimuli with ITD outside the gerbil's physiological range, responses were cyclic indicating the use of phase information when lateralizing narrow-band sounds. For ILD stimuli, reliable responses were obtained for frequencies >= 2 kHz. The comparison of ITD and ILD thresholds with ITD and ILD thresholds derived from gerbils' free-field performance suggests that ongoing ITD information is the main cue for sound localization at frequencies <2kHz. At 2 kHz, ITD and ILD cues are likely used in a complementary way. Verification of the use of the virtual headphones suggests that they can serve as a suitable substitute for conventional headphones particularly at frequencies <= 2 kHz.	[Tolnai, Sandra; Beutelmann, Rainer; Klump, Georg M.] Carl von Ossietzky Univ Oldenburg, Anim Physiol & Behav Grp, Cluster Excellence Hearing4all, Dept Neurosci,Sch Med & Hlth Sci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Tolnai, S (corresponding author), Carl von Ossietzky Univ Oldenburg, Anim Physiol & Behav Grp, Cluster Excellence Hearing4all, Dept Neurosci,Sch Med & Hlth Sci, Oldenburg, Germany.	sandra.tolnai@uni-oldenburg.de		Beutelmann, Rainer/0000-0001-9708-4113	CRC/Transregio 31 "The Active Auditory System" (Deutsche Forschungsgemeinschaft); Cluster of Excellence "Hearing4all" EXC1077 (Deutsche Forschungsgemeinschaft); A*MIDEX grant - French Government "Investissements d'Avenir" program [ANR-11-IDEX-0001-02]	CRC/Transregio 31 "The Active Auditory System" (Deutsche Forschungsgemeinschaft); Cluster of Excellence "Hearing4all" EXC1077 (Deutsche Forschungsgemeinschaft); A*MIDEX grant - French Government "Investissements d'Avenir" program(French National Research Agency (ANR))	Support was provided by CRC/Transregio 31 "The Active Auditory System" (Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/) (to GMK); and Cluster of Excellence "Hearing4all" EXC1077 (Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/) (to GMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Lena Wallbach, Janna Henrike Mrozek, Linda Arfmann, and Jeremy Giroud for their contribution to data collection and excellent care of the animals during the time of data collection. Jeremy Giroud was supported by the A*MIDEX grant (no ANR-11-IDEX-0001-02) funded by the French Government "Investissements d'Avenir" program. We also wish to thank the two anonymous reviewers for their valuable and appreciated	Akeroyd MA, 2007, J ACOUST SOC AM, V121, P1056, DOI 10.1121/1.2404625; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brughera A, 2013, J ACOUST SOC AM, V133, P2839, DOI 10.1121/1.4795778; Bungert-Kahl P., 2004, Zeitschrift fur Audiologie, V43, P48; Carney LH, 2011, HEARING RES, V275, P89, DOI 10.1016/j.heares.2010.12.006; DAMASKE P, 1971, J ACOUST SOC AM, V50, P1109, DOI 10.1121/1.1912742; Dietz M, 2014, J NEUROPHYSIOL, V111, P1973, DOI 10.1152/jn.00681.2013; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; DON M, 1972, J NEUROPHYSIOL, V35, P493, DOI 10.1152/jn.1972.35.4.493; Ebert CS, 2008, HEARING RES, V235, P134, DOI 10.1016/j.heares.2007.11.003; Feinkohl A, 2016, HEARING RES, V332, P238, DOI 10.1016/j.heares.2015.04.001; Franken TP, 2015, NAT NEUROSCI, V18, P444, DOI 10.1038/nn.3948; Gai Y, 2014, J NEUROPHYSIOL, V112, P802, DOI 10.1152/jn.00044.2013; Gourevitch B, 2012, J ACOUST SOC AM, V132, P9, DOI 10.1121/1.4726052; Green D, 2000, SIGNAL DETECTION THE; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; HOUBEN D, 1979, J ACOUST SOC AM, V66, P1057, DOI 10.1121/1.383377; Keating P, 2014, EUR J NEUROSCI, V39, P197, DOI 10.1111/ejn.12402; Keating P, 2013, JARO-J ASSOC RES OTO, V14, P561, DOI 10.1007/s10162-013-0390-3; Klinge A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026124; KLUMPP RG, 1956, J ACOUST SOC AM, V28, P859, DOI 10.1121/1.1908493; Laumen G, 2016, HEARING RES, V337, P46, DOI 10.1016/j.heares.2016.04.009; Lesica NA, 2010, J NEUROSCI, V30, P11696, DOI 10.1523/JNEUROSCI.0846-10.2010; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; Maier JK, 2006, J ACOUST SOC AM, V119, P1029, DOI 10.1121/1.2159429; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; Plauska A, 2016, J NEUROPHYSIOL, V115, P2950, DOI 10.1152/jn.01146.2015; RYAN A, 1976, J ACOUST SOC AM, V59, P1222, DOI 10.1121/1.380961; Saberi K, 1998, P NATL ACAD SCI USA, V95, P6465, DOI 10.1073/pnas.95.11.6465; SAYERS BM, 1964, J ACOUST SOC AM, V36, P923, DOI 10.1121/1.1919121; SHACKLETON TM, 1991, Q J EXP PSYCHOL-A, V43, P503, DOI 10.1080/14640749108400984; Stange A, 2013, NAT NEUROSCI, V16, P1840, DOI 10.1038/nn.3548; Sumner CJ, 2012, EUR J NEUROSCI, V36, P2428, DOI 10.1111/j.1460-9568.2012.08151.x; Takeuchi T, 2001, J ACOUST SOC AM, V109, P958, DOI 10.1121/1.1349539; Tolnai S, 2017, EUR J NEUROSCI, V45, P460, DOI 10.1111/ejn.13491; TRAHIOTIS C, 1989, J ACOUST SOC AM, V86, P1285, DOI 10.1121/1.398743; van der Heijden M, 2013, NEURON, V78, P936, DOI 10.1016/j.neuron.2013.04.028; Versteegh CPC, 2011, JARO-J ASSOC RES OTO, V12, P301, DOI 10.1007/s10162-010-0255-y; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; WAKEFORD OS, 1974, J ACOUST SOC AM, V55, P649, DOI 10.1121/1.1914577; Welch TE, 2011, J ACOUST SOC AM, V130, P2293, DOI 10.1121/1.3628335; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; YOST WA, 1981, J ACOUST SOC AM, V70, P397, DOI 10.1121/1.386775; Young ED, 1996, J ACOUST SOC AM, V99, P3064, DOI 10.1121/1.414883; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	48	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175142	10.1371/journal.pone.0175142	http://dx.doi.org/10.1371/journal.pone.0175142			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394906	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000399954800018
J	Yamane, H; Takakura, A; Shimadzu, Y; Kodama, T; Lee, JW; Isogai, Y; Ishizuya, T; Takao-Kawabata, R; Iimura, T				Yamane, Hiroshi; Takakura, Aya; Shimadzu, Yukari; Kodama, Toshiyuki; Lee, Ji-Won; Isogai, Yukihiro; Ishizuya, Toshinori; Takao-Kawabata, Ryoko; Iimura, Tadahiro			Acute development of cortical porosity and endosteal naive bone formation from the daily but not weekly short-term administration of PTH in rabbit	PLOS ONE			English	Article							OVARIECTOMIZED CYNOMOLGUS MONKEYS; HUMAN PARATHYROID HORMONE(1-34); POSTMENOPAUSAL WOMEN; FIBROUS DYSPLASIA; MARROW FIBROSIS; DISTAL RADIUS; MECHANICAL-PROPERTIES; VERTEBRAL FRACTURES; TURNOVER MARKERS; THINNER CORTICES	Teriparatide [human parathyroid hormone (1-34)], which exerts an anabolic effect on bone, is used for the treatment of osteoporosis in patients who are at a high risk for fracture. That the once-daily administration of teriparatide causes an increase in cortical porosity in animal models and clinical studies has been a matter of concern. However, it is not well documented that the frequency of administration and/or the total dose of teriparatide affect the cortical porosity. The present study developed 4 teriparatide regimens [20 mu g/kg/day (D20), 40 mu g/kg/day (D40), 140 mu g/kg/week (W140) and 280 mu g/kg/week (W280)] in the rabbit as a model animal with a well-developed Haversian system and osteons. The total weekly doses were equivalent in the low-dose groups (D20 and W140) and in the high-dose groups (D40 and W280). After the short-term (1 month) administration of TPDT, micro-CT, histomorphometry and three-dimensional second harmonic generation (3D-SHG) imaging to visualize the bone collagen demonstrated that daily regimens but not weekly regimens were associated with the significant development of cortical porosity and endosteal naive bone formation by marrow fibrosis. We concomitantly monitored the pharmacokinetics of the plasma teriparatide levels as well as the temporal changes in markers of bone formation and resorption. The analyses in the present study suggested that the daily repeated administration of teriparatide causes more deleterious changes in the cortical microarchitecture than the less frequent administration of higher doses. The findings of the present study may have some implications for use of teriparatide in clinical treatment.	[Yamane, Hiroshi; Takakura, Aya; Shimadzu, Yukari; Isogai, Yukihiro; Ishizuya, Toshinori; Takao-Kawabata, Ryoko] Asahi Kasei Pharma Corp, Pharmaceut Res Ctr, Lab Pharmacol, Shizuoka, Japan; [Takakura, Aya; Iimura, Tadahiro] Ehime Univ, Grad Sch Med, Div Analyt Biomed, Toon City, Ehime, Japan; [Kodama, Toshiyuki] Asahi Kasei Pharma Corp, Lab Safety Assessment & ADME, Pharmaceut Res Ctr, Shizuoka, Japan; [Lee, Ji-Won; Iimura, Tadahiro] Ehime Univ, Div Bioimaging Proteosci Ctr PROS, Toon City, Ehime, Japan; [Isogai, Yukihiro] Asahi Kasei Pharma Corp, Pharmaceut Business Adm Div, Med Affairs Dept, Tokyo, Japan; [Iimura, Tadahiro] Ehime Univ, Div Analyt Biomed, Adv Res Support Ctr ADRES, Toon City, Ehime, Japan; [Iimura, Tadahiro] Ehime Univ Hosp, Artificial Joint Integrated Ctr, Toon City, Ehime, Japan	Asahi Kasei Pharma Corporation; Ehime University; Asahi Kasei Pharma Corporation; Ehime University; Asahi Kasei Pharma Corporation; Ehime University; Ehime University	Takao-Kawabata, R (corresponding author), Asahi Kasei Pharma Corp, Pharmaceut Res Ctr, Lab Pharmacol, Shizuoka, Japan.; Iimura, T (corresponding author), Ehime Univ, Grad Sch Med, Div Analyt Biomed, Toon City, Ehime, Japan.; Iimura, T (corresponding author), Ehime Univ, Div Bioimaging Proteosci Ctr PROS, Toon City, Ehime, Japan.; Iimura, T (corresponding author), Ehime Univ, Div Analyt Biomed, Adv Res Support Ctr ADRES, Toon City, Ehime, Japan.; Iimura, T (corresponding author), Ehime Univ Hosp, Artificial Joint Integrated Ctr, Toon City, Ehime, Japan.	takao.rb@om.asahi-kasei.co.jp; iimura@m.ehime-u.ac.jp	Iimura, Tadahiro/P-3550-2018	Iimura, Tadahiro/0000-0002-1431-0689; Takao-Kawabata, Ryoko/0000-0002-6811-7526	Institute of Medical Science, The University of Tokyo: IMSUT Joint Research Project [2014-241]; Asahi Kasei Pharma Corporation;  [16K20412];  [26293392]	Institute of Medical Science, The University of Tokyo: IMSUT Joint Research Project; Asahi Kasei Pharma Corporation; ; 	This study was funded by the Asahi Kasei Pharma Corporation. The funder provided support in the form of salaries for authors [HY, AT, YS, TK, YI, Tol, and RT-K], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was also partly supported by Grant Numbers 16K20412 and 26293392 to J-WL and Tal, respectively. This work was also partly supported by The Institute of Medical Science, The University of Tokyo: IMSUT Joint Research Project (2014-241) to Tal.	Bala Y, 2015, CURR OPIN RHEUMATOL, V27, P406, DOI 10.1097/BOR.0000000000000183; Bandeira L, 2016, F1000RES, P5; Black DM, 2008, J CLIN ENDOCR METAB, V93, P2166, DOI 10.1210/jc.2007-2781; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Burr DB, 2001, J BONE MINER RES, V16, P157, DOI 10.1359/jbmr.2001.16.1.157; Chen PQ, 2005, J BONE MINER RES, V20, P962, DOI 10.1359/JBMR.050105; Diab T, 2006, BONE, V38, P427, DOI 10.1016/j.bone.2005.09.002; Elder G, 2002, J BONE MINER RES, V17, P2094, DOI 10.1359/jbmr.2002.17.12.2094; Fox J, 2006, CALCIFIED TISSUE INT, V79, P262, DOI 10.1007/s00223-006-0108-1; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Glorieux FH, 2006, J BONE MINER RES, V21, pP110, DOI 10.1359/JBMR.06S221; Hansen MF, 2006, J BONE MINER RES, V21, pP58, DOI 10.1359/JBMR.06S211; Hansen S, 2013, J BONE MINER RES, V28, P736, DOI 10.1002/jbmr.1784; Hirano T, 2000, CALCIFIED TISSUE INT, V66, P456, DOI 10.1007/s002230010091; Hirano T, 1999, J BONE MINER RES, V14, P536, DOI 10.1359/jbmr.1999.14.4.536; Inoue J, 1985, Nihon Seikeigeka Gakkai Zasshi, V59, P409; Jee W. S. S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P232; Jerome CP, 2001, BONE, V28, P150, DOI 10.1016/S8756-3282(00)00430-0; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kobayashi S, 2003, BONE, V32, P163, DOI 10.1016/S8756-3282(02)00947-X; Lotinun S, 2005, ENDOCRINOLOGY, V146, P4074, DOI 10.1210/en.2005-0480; Marie PJ, 1997, AM J PATHOL, V150, P1059; Miller MA, 2008, BONE, V42, P1175, DOI 10.1016/j.bone.2008.01.029; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; RAO DS, 1993, NEW ENGL J MED, V328, P171, DOI 10.1056/NEJM199301213280304; Rubin MR, 2002, OSTEOPOROSIS INT, V13, P267, DOI 10.1007/s001980200026; Sato M, 2004, J BONE MINER RES, V19, P623, DOI 10.1359/JBMR.040112; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Shigdel R, 2015, BONE, V81, P1, DOI 10.1016/j.bone.2015.06.016; Stein EM, 2013, J BONE MINER RES, V28, P1029, DOI 10.1002/jbmr.1841; Sugimoto T, 2014, OSTEOPOROSIS INT, V25, P1173, DOI 10.1007/s00198-013-2516-1; Takakura A, 2017, BONE RESEARCH FORTHC; Takao-Kawabata R, 2015, CALCIFIED TISSUE INT, V97, P156, DOI 10.1007/s00223-015-9998-0; UZAWA T, 1995, BONE, V16, P477; Weinstein LS, 2006, J BONE MINER RES, V21, pP120, DOI 10.1359/JBMR.06S223; Yamamoto T, 2016, ENDOCRINOLOGY, V157, P2604, DOI 10.1210/en.2015-2028; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	43	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175329	10.1371/journal.pone.0175329	http://dx.doi.org/10.1371/journal.pone.0175329			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394900	gold, Green Published, Green Submitted			2022-12-27	WOS:000399954800028
J	Hwang, DJ; Lee, KM; Park, MS; Choi, SH; Park, JI; Cho, JH; Park, KH; Woo, SJ				Hwang, Duck Jin; Lee, Kyoung Min; Park, Moon Seok; Choi, Sung Hee; Park, Ji In; Cho, Joon Hee; Park, Kyu Hyung; Woo, Se Joon			Association between diabetic foot ulcer and diabetic retinopathy	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; RISK-FACTORS; PREVALENCE; NEUROPATHY; EPIDEMIOLOGY; PREDICTION; AMPUTATION; MORBIDITY; PRESSURE; MELLITUS	Purpose We aimed to investigate the prevalence of diabetic retinopathy (DR) in patients with diabetic foot ulcer (DFU) and elucidate the association between DR and DFU severities and their shared risk factors. Methods A retrospective review was conducted on DFU patients who underwent ophthalmic and vascular examinations within 6 months; 100 type 2 diabetic patients with DFU were included. The medical records of 2496 type 2 diabetic patients without DFU served as control data. DR prevalence and severity were assessed in DFU patients. DFU patients were compared with the control group regarding each clinical variable. Additionally, DFU patients were divided into two groups according to DR severity and compared. Results Out of 100 DFU patients, 90 patients (90%) had DR and 55 (55%) had proliferative DR (PDR). There was no significant association between DR and DFU severities (R = 0.034, p = 0.734). A multivariable analysis comparing type 2 diabetic patients with and without DFUs showed that the presence of DR [OR, 226.12; 95% confidence interval (CI), 58.07-880.49; p < 0.001] and proliferative DR [OR, 306.27; 95% CI, 64.35-1457.80; p < 0.001), higher HbA1c (%, OR, 1.97, 95% CI, 1.46-2.67; p < 0.001), higher serum creatinine (mg/dL, OR, 1.62, 95% CI, 1.06-2.50; p = 0.027), older age (years, OR, 1.12; 95% CI, 1.06-1.17; p < 0.001), higher pulse pressure (mmHg, OR, 1.03; 95% CI, 1.00-1.06; p = 0.025), lower cholesterol (mg/dL, OR, 0.94; 95% CI, 0.92-0.97; p < 0.001), lower BMI (kg/m(2), OR, 0.87, 95% CI, 0.75-1.00; p = 0.044) and lower hematocrit (%, OR, 0.80, 95% CI, 0.74-0.87; p < 0.001) were associated with DFUs. In a subgroup analysis of DFU patients, the PDR group had a longer duration of diabetes mellitus, higher serum BUN, and higher serum creatinine than the non-PDR group. In the multivariable analysis, only higher serum creatinine was associated with PDR in DFU patients (OR, 1.37; 95% CI, 1.05-1.78; p = 0.021). Conclusions Diabetic retinopathy is prevalent in patients with DFU and about half of DFU patients had PDR. No significant association was found in terms of the severity of these two diabetic complications. To prevent blindness, patients with DFU, and especially those with high serum creatinine, should undergo retinal examinations for timely PDR diagnosis and management.	[Hwang, Duck Jin; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea; [Hwang, Duck Jin] HanGil Eye Hosp, Dept Ophthalmol, Incheon, South Korea; [Lee, Kyoung Min; Park, Moon Seok] Seoul Natl Univ, Dept Orthoped Surg, Bundang Hosp, Seongnam, South Korea; [Choi, Sung Hee] Seoul Natl Univ, Bundang Hosp, Dept Endocrinol, Coll Med, Seongnam, South Korea; [Park, Ji In] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea; [Cho, Joon Hee] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Kyu Hyung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kangwon National University Hospital; Hallym University; Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea.	sejoon1@snu.ac.kr	; Woo, Se Joon/I-7357-2013	Park, Ji In/0000-0003-4662-3759; Woo, Se Joon/0000-0003-3692-7169; Hwang, Daniel Duck-Jin/0000-0003-1808-3169	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2016R1D1A11303934724]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant 2016R1D1A11303934724 funded by the Korean government (MSIP). The funding organization had no role in the design or conduct of this research.	Apelqvist J, 2000, DIABETES-METAB RES, V16, pS75, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR139>3.0.CO;2-8; BORSSEN B, 1990, DIABETIC MED, V7, P438, DOI 10.1111/j.1464-5491.1990.tb01420.x; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Brod M, 1998, QUAL LIFE RES, V7, P365; Brooks B, 2001, DIABETIC MED, V18, P528, DOI 10.1046/j.1464-5491.2001.00493.x; Carrington AL, 1996, DIABETES RES CLIN PR, V32, P19, DOI 10.1016/0168-8227(96)01198-9; Clark N, 2003, DIABETES CARE, V26, P3333; Cohen JA, 1998, MUSCLE NERVE, V21, P72, DOI 10.1002/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2; Coyne KS, 2004, FAM PRACT, V21, P447, DOI 10.1093/fampra/cmh417; Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312; Harrison ML, 2011, BLOOD PRESS MONIT, V16, P138, DOI 10.1097/MBP.0b013e328346a839; Jiang YF, 2015, WOUND REPAIR REGEN, V23, P222, DOI 10.1111/wrr.12263; Khandekar R, 2003, BRIT J OPHTHALMOL, V87, P1061, DOI 10.1136/bjo.87.9.1061; Liu CB, 2015, INT J LOW EXTR WOUND, V14, P28, DOI 10.1177/1534734614568375; Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Monami M, 2009, DIABETES CARE, V32, P897, DOI 10.2337/dc08-1679; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; OHARE JA, 1994, IRISH J MED SCI, V163, P132, DOI 10.1007/BF02965972; Pinto A, 2008, METABOLISM, V57, P676, DOI 10.1016/j.metabol.2008.01.004; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Sampson CJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0006-6; Shahbazian H, 2013, PAK J MED SCI, V29, P730, DOI 10.12669/pjms.293.3473; Sharma Sanjay, 2005, Curr Opin Ophthalmol, V16, P155, DOI 10.1097/01.icu.0000161227.21797.3d; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tennvall GR, 2000, J DIABETES COMPLICAT, V14, P235; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Vileikyte L, 2001, DIABETES-METAB RES, V17, P246, DOI 10.1002/dmrr.216; Wagner F W Jr, 1981, Foot Ankle, V2, P64; WAGNER FW, 1987, ORTHOPEDICS, V10, P163; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5	31	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175270	10.1371/journal.pone.0175270	http://dx.doi.org/10.1371/journal.pone.0175270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388680	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800033
J	Scully, JY; Moudon, AV; Hurvitz, PM; Aggarwal, A; Drewnowski, A				Scully, Jason Y.; Moudon, Anne Vernez; Hurvitz, Philip M.; Aggarwal, Anju; Drewnowski, Adam			GPS or travel diary: Comparing spatial and temporal characteristics of visits to fast food restaurants and supermarkets	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEMS; ENVIRONMENT; NEIGHBORHOOD; EXPOSURE; HEALTH; CONSUMPTION; TRACKING; ADULTS; ASSOCIATIONS; DIETARY	To assess differences between GPS and self-reported measures of location, we examined visits to fast food restaurants and supermarkets using a spatiotemporal framework. Data came from 446 participants who responded to a survey, filled out travel diaries of places visited, and wore a GPS receiver for seven consecutive days. Provided by Public Health Seattle King County, addresses from food permit data were matched to King County tax assessor parcels in a GIS. A three-step process was used to verify travel-diary reported visits using GPS records: (1) GPS records were temporally matched if their timestamps were within the time window created by the arrival and departure times reported in the travel diary; (2) the temporally matched GPS records were then spatially matched if they were located in a food establishment parcel of the same type reported in the diary; (3) the travel diary visit was then GPS-sensed if the name of food establishment in the parcel matched the one reported in the travel diary. To account for errors in reporting arrival and departure times, GPS records were temporally matched to three time windows: the exact time, +/-10 minutes, and +/-30 minutes. One third of the participants reported 273 visits to fast food restaurants; 88% reported 1,102 visits to supermarkets. Of these, 77.3 percent of the fast food and 78.6 percent supermarket visits were GPS-sensed using the +/-10-minute time window. At this time window, the mean travel-diary reported fast food visit duration was 14.5 minutes (SD 20.2), 1.7 minutes longer than the GPS-sensed visit. For supermarkets, the reported visit duration was 23.7 minutes (SD 18.9), 3.4 minutes longer than the GPS-sensed visit. Travel diaries provide reasonably accurate information on the locations and brand names of fast food restaurants and supermarkets participants report visiting.	[Scully, Jason Y.; Moudon, Anne Vernez; Hurvitz, Philip M.] Univ Washington, Urban Form Lab, Dept Urban Design & Planning, Seattle, WA 98195 USA; [Hurvitz, Philip M.; Aggarwal, Anju; Drewnowski, Adam] Univ Washington, Dept Epidemiol, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scully, JY (corresponding author), Univ Washington, Urban Form Lab, Dept Urban Design & Planning, Seattle, WA 98195 USA.	jscully@uw.edu	Drewnowski, Adam/HCI-4117-2022		NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK076608]	NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (award R01 DK076608; Contact Principal Investigator: A. Drewnowski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Brown AF, 2008, J GEN INTERN MED, V23, P1137, DOI 10.1007/s11606-008-0601-5; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Burgoine T, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-85; Cerin E, 2011, APPETITE, V56, P693, DOI 10.1016/j.appet.2011.02.006; Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003; Chen C, 2010, TRANSPORT RES A-POL, V44, P830, DOI 10.1016/j.tra.2010.08.004; Christian WJ, 2012, SPAT SPATIO-TEMPORAL, V3, P287, DOI 10.1016/j.sste.2012.09.001; Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; Elgethun K, 2007, J EXPO SCI ENV EPID, V17, P196, DOI 10.1038/sj.jes.7500496; Food Marketing Institute, 2014, SUP FACTS; Forsyth Ann, 2010, J Transp Land Use, V3, P43; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330; Goodman J., 2008, GROCERY SHOPPING WHO; Hamrick K, 2011, USDA EC RES SERV EC; Hurvitz PM, 2012, AM J PREV MED, V42, P411, DOI 10.1016/j.amepre.2011.11.015; Jiao J, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.18; Kelly P, 2013, TRANSPORT REV, V33, P443, DOI 10.1080/01441647.2013.815288; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Lee C, 2006, ANN EPIDEMIOL, V16, P387, DOI 10.1016/j.annepidem.2005.03.003; Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Moudon AV, 2013, PUBLIC HEALTH NUTR, V16, P1238, DOI 10.1017/S1368980013000773; Moudon AV, 2011, AM J PREV MED, V41, P88, DOI 10.1016/j.amepre.2011.03.009; Oches S, 2013, QSR; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Paz-Soldan VA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002888; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Rehm CD, 2012, SOC SCI MED, V75, P491, DOI 10.1016/j.socscimed.2012.03.041; Shareck M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-40; Stopher P, 2011, TRANSP RES REC J TRA; Stopher PR, 2007, TRANSPORT RES A-POL, V41, P367, DOI 10.1016/j.tra.2006.09.005; Thornton LE, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.27; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	38	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174859	10.1371/journal.pone.0174859	http://dx.doi.org/10.1371/journal.pone.0174859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388619	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800013
J	Ariane, M; Allouche, MH; Bussone, M; Giacosa, F; Bernard, F; Barigou, M; Alexiadis, A				Ariane, Mostapha; Allouche, Mohamed Hatem; Bussone, Marco; Giacosa, Fausto; Bernard, Frederic; Barigou, Mostafa; Alexiadis, Alessio			Discrete multi-physics: A mesh-free model of blood flow in flexible biological valve including solid aggregate formation	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; SMOOTHED PARTICLE HYDRODYNAMICS; COMPLEX NETWORK; MOLECULAR-DYNAMICS; TIME-SERIES; TRANSPORT	We propose a mesh-free and discrete (particle-based) multi-physics approach for modelling the hydrodynamics in flexible biological valves. In the first part of this study, the method is successfully validated against both traditional modelling techniques and experimental data. In the second part, it is further developed to account for the formation of solid aggregates in the flow and at the membrane surface. Simulations of various types of aggregates highlight the main benefits of discrete multi-physics and indicate the potential of this approach for coupling the hydrodynamics with phenomena such as clotting and calcification in biological valves.	[Ariane, Mostapha; Barigou, Mostafa; Alexiadis, Alessio] Univ Birmingham, Sch Chem Engn, Birmingham, W Midlands, England; [Allouche, Mohamed Hatem] Univ Euromediterraneenne Fes, INSA Euromediterranee, Fes, Morocco; [Bussone, Marco; Giacosa, Fausto] LivaNova Sorin, Saluggia, Vercelli, Italy; [Bernard, Frederic] Univ Bourgogne Franche Comte, Lab Interdisciplinaire Carnot Bourgogne, Dijon, France	University of Birmingham; Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM)	Ariane, M; Alexiadis, A (corresponding author), Univ Birmingham, Sch Chem Engn, Birmingham, W Midlands, England.	mxa437@bham.ac.uk; A.Alexiadis@bham.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/N033698/1]; EPSRC [EP/N033698/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N033698/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) grant number: EP/N033698/1.	Alexiadis A, 2017, COMPUT BIOL MED, V81, P188, DOI 10.1016/j.compbiomed.2017.01.003; Alexiadis A., 2015, LUT S DYN CAPS VES C, P80; Alexiadis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124678; Alexiadis A, 2014, INT J NUMER METH ENG, V100, P713, DOI 10.1002/nme.4782; Alexiadis A, 2014, INT J NUMER METH ENG, V98, P534, DOI 10.1002/nme.4646; Bajd F, 2013, BIOPHYS J, V104, P1181, DOI 10.1016/j.bpj.2013.01.029; Bavo AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154517; De Hart J, 2000, J BIOMECH, V33, P1079, DOI 10.1016/S0021-9290(00)00068-3; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Gray JP, 2001, COMPUT METHOD APPL M, V190, P6641, DOI 10.1016/S0045-7825(01)00254-7; Halevi R, 2015, J BIOMECH, V48, P489, DOI 10.1016/j.jbiomech.2014.12.004; Harrison SE, 2008, PROG COMPUT FLUID DY, V8, P121, DOI 10.1504/PCFD.2008.018084; Hosseini SM, 2009, CHEM ENG SCI, V64, P4488, DOI 10.1016/j.ces.2008.11.028; Hou GN, 2012, COMMUN COMPUT PHYS, V12, P337, DOI 10.4208/cicp.291210.290411s; Ledesma-Alonso R, 2014, J FLUID MECH, V739, P338, DOI 10.1017/jfm.2013.611; Liu GR, 2016, PARTICLE METHODS MUL; Lobovsky L., 2007, APPL COMPUT MECH, V1, P521; Marom G, 2015, ARCH COMPUT METHOD E, V22, P595, DOI 10.1007/s11831-014-9133-9; Narracott Andrew, 2005, J Artif Organs, V8, P56, DOI 10.1007/s10047-004-0274-8; Panteleev MA, 2015, THROMB RES, V136, P699, DOI 10.1016/j.thromres.2015.07.025; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Sinnott MD, 2012, COMPUT BIOL MED, V42, P492, DOI 10.1016/j.compbiomed.2012.01.002; van Loon R, 2006, J COMPUT PHYS, V217, P806, DOI 10.1016/j.jcp.2006.01.032; van Loon R, 2004, INT J NUMER METH FL, V46, P533, DOI 10.1002/fld.775	28	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174795	10.1371/journal.pone.0174795	http://dx.doi.org/10.1371/journal.pone.0174795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384341	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900036
J	de Vreeze, J; Matschke, C				de Vreeze, Jort; Matschke, Christina			Keeping up appearances: Strategic information exchange by disidentified group members	PLOS ONE			English	Article							SOCIAL IDENTITY; PERFORMANCE; COOPERATION; IDENTIFICATION; DISSONANCE; PUNISHMENT; KNOWLEDGE; DILEMMAS; BEHAVIOR; MOTIVES	Information exchange is a crucial process in groups, but to date, no one has systematically examined how a group member's relationship with a group can undermine this process. The current research examined whether disidentified group members (i. e., members who have a negative relationship with their group) strategically undermine the group outcome in information exchange. Disidentification has been found to predict negative group-directed behaviour, but at the same time disidentified members run the risk of being punished or excluded from the group when displaying destructive behaviour. In three studies we expected and found that disidentified group members subtly act against the interest of the group by withholding important private information, while at the same time they keep up appearances by sharing important information that is already known by the other group members. These findings stress the importance of taking a group member's relationship with a group into account when considering the process of information exchange.	[de Vreeze, Jort; Matschke, Christina] Leibniz Inst Wissensmedien, D-72076 Tubingen, Germany	Leibniz Institut fur Wissensmedien	de Vreeze, J (corresponding author), Leibniz Inst Wissensmedien, D-72076 Tubingen, Germany.	j.devreeze@iwm-tuebingen.de	Matschke, Christina/AAK-9188-2021		Science Campus Tuebingen; European Social Fund in Baden-Wuerttemberg [01PF 08005 C]	Science Campus Tuebingen; European Social Fund in Baden-Wuerttemberg	This work was supported by the Science Campus Tuebingen and the European Social Fund in Baden-Wuerttemberg (grandnumber:01PF 08005 C).	Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Becker JC, 2014, SELF IDENTITY, V13, P294, DOI 10.1080/15298868.2013.819991; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Borenstein M, 2009, INTRO META ANAL; BREWER MB, 1986, J PERS SOC PSYCHOL, V50, P543, DOI 10.1037/0022-3514.50.3.543; Brewer MB, 1996, J PERS SOC PSYCHOL, V71, P83, DOI 10.1037/0022-3514.71.1.83; Brodbeck FC, 2007, ACAD MANAGE REV, V32, P459, DOI 10.5465/AMR.2007.24351441; Cabrera A, 2002, ORGAN STUD, V23, P687, DOI 10.1177/0170840602235001; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; De Cremer D, 1999, EUR J SOC PSYCHOL, V29, P871, DOI 10.1002/(SICI)1099-0992(199911)29:7<871::AID-EJSP962>3.0.CO;2-I; De Dreu CKW, 2008, PERS SOC PSYCHOL REV, V12, P22, DOI 10.1177/1088868307304092; Ditrich L, 2016, GR PROCESS INTERGR R; DOOSJE B, 1995, J EXP SOC PSYCHOL, V31, P410, DOI 10.1006/jesp.1995.1018; Dukerich J.M., 1998, IDENTITY ORG BUILDIN, P245; Ellemers N, 2012, SCIENCE, V336, P848, DOI 10.1126/science.1220987; Elsbach KD, 1999, RES ORGAN BEHAV, V21, P163; Elsbach KD, 2001, ORGAN SCI, V12, P393, DOI 10.1287/orsc.12.4.393.10638; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Glasford DE, 2008, J EXP SOC PSYCHOL, V44, P1057, DOI 10.1016/j.jesp.2007.10.004; Hamstra M.R.W., 2015, MOTIV SCI, V1, P184, DOI [10.1037/mot0000019, DOI 10.1037/MOT0000019]; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Kreiner GE, 2004, J ORGAN BEHAV, V25, P1, DOI 10.1002/job.234; Landkammer F, 2016, J EXP PSYCHOL GEN, V145, P1670, DOI 10.1037/xge0000232; Matschke C, 2010, EUR J SOC PSYCHOL, V40, P891, DOI 10.1002/ejsp.756; Matschke C, 2010, INT J INTERCULT REL, V34, P465, DOI 10.1016/j.ijintrel.2010.04.008; Mesmer-Magnus JR, 2009, J APPL PSYCHOL, V94, P535, DOI 10.1037/a0013773; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; MORELAND RL, 1982, ADV EXP SOC PSYCHOL, V15, P137, DOI 10.1016/S0065-2601(08)60297-X; MULLEN B, 1992, EUR J SOC PSYCHOL, V22, P103, DOI 10.1002/ejsp.2420220202; MULLEN B, 1994, PSYCHOL BULL, V115, P210, DOI 10.1037/0033-2909.115.2.210; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Packer DJ, 2008, PERS SOC PSYCHOL REV, V12, P50, DOI 10.1177/1088868307309606; Poortvliet PM, 2007, PERS SOC PSYCHOL B, V33, P1435, DOI 10.1177/0146167207305536; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; SNYDER CR, 1986, J PERS SOC PSYCHOL, V51, P382, DOI 10.1037/0022-3514.51.2.382; STASSER G, 1985, J PERS SOC PSYCHOL, V48, P1467, DOI 10.1037/0022-3514.48.6.1467; STASSER G, 1987, J PERS SOC PSYCHOL, V53, P81, DOI 10.1037/0022-3514.53.1.81; Steinel W, 2004, J PERS SOC PSYCHOL, V86, P419, DOI 10.1037/0022-3514.86.3.419; Steinel W, 2010, ORGAN BEHAV HUM DEC, V113, P85, DOI 10.1016/j.obhdp.2010.07.001; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H, 1974, SOC SCI INFORM, V13, P65, DOI 10.1177/053901847401300204; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Toma C, 2015, SOC PERSONAL PSYCHOL, V9, P455, DOI 10.1111/spc3.12191; Toma C, 2013, BRIT J SOC PSYCHOL, V52, P161, DOI 10.1111/j.2044-8309.2012.02105.x; Toma C, 2009, PERS SOC PSYCHOL B, V35, P793, DOI 10.1177/0146167209333176; Turner J.C., 1987, REDISCOVERING SOCIAL; Van Vugt M, 2004, J PERS SOC PSYCHOL, V86, P585, DOI 10.1037/0022-3514.86.4.585; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wittenbaum GM, 2004, COMMUN MONOGR, V71, P286, DOI 10.1080/0363452042000299894; Zdaniuk B, 2001, J EXP SOC PSYCHOL, V37, P502, DOI 10.1006/jesp.2000.1474; Zou X, 2008, J EXP SOC PSYCHOL, V44, P1151, DOI 10.1016/j.jesp.2008.02.001	55	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175155	10.1371/journal.pone.0175155	http://dx.doi.org/10.1371/journal.pone.0175155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384322	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900103
J	Okumura, M; Ishikawa, A; Aoyama, T; Yamada, S; Uwabe, C; Imai, H; Matsuda, T; Yoneyama, A; Takeda, T; Takakuwa, T				Okumura, Misaki; Ishikawa, Aoi; Aoyama, Tomoki; Yamada, Shigehito; Uwabe, Chigako; Imai, Hirohiko; Matsuda, Tetsuya; Yoneyama, Akio; Takeda, Tohoru; Takakuwa, Tetsuya			Cartilage formation in the pelvic skeleton during the embryonic and early-fetal period	PLOS ONE			English	Article							HUMAN VERTEBRAL COLUMN; HUMAN HIP-JOINT; SEX-DIFFERENCES; PROPER	The pelvic skeleton is formed via endochondral ossification. However, it is not known how the normal cartilage is formed before ossification occurs. Furthermore, the overall timeline of cartilage formation and the morphology of the cartilage in the pelvis are unclear. In this study, cartilage formation in the pelvic skeletons of 25 human fetuses (crown-rump length [CRL] = 11.9-75.0 mm) was observed using phase-contrast computed tomography and 7T magnetic resonance imaging. The chondrification center of the ilium, ischium, and pubis first appeared simultaneously at Carnegie stage (CS) 18, was located around the acetabulum, and grew radially in the later stage. The iliac crest formed at CS20 while the iliac body's central part remained chondrified. The iliac body formed a discoid at CS22. The growth rate was greater in the ilium than in the sacrum-coccyx, pubis, and ischium. Connection and articulation formed in a limited period, while the sacroiliac joint formed at CS21. The articulation of the pubic symphysis, connection of the articular column in the sacrum, and Y-shape connection of the three parts of the hip bones to the acetabulum were observed at CS23; the connection of the ischium and pubic ramus was observed at the early-fetal stage. Furthermore, the degree of connection at the center of the sacrum varied among samples. Most of the pelvimetry data showed a high correlation with CRL. The transverse and antero-posterior lengths of the pelvic inlet of the lesser pelvis varied among samples (R-2 = 0.11). The subpubic angle also varied (65-90 degrees) and was not correlated with CRL (R-2 = 0.22). Moreover, cartilaginous structure formation appeared to influence bone structure. This study provides valuable information regarding the morphogenesis of the pelvic structure.	[Okumura, Misaki; Ishikawa, Aoi; Aoyama, Tomoki; Yamada, Shigehito; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito; Uwabe, Chigako] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan; [Imai, Hirohiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan; [Yoneyama, Akio; Takeda, Tohoru] Kitasato Univ, Allied Hlth Sci, Sagamihara, Kanagawa, Japan	Kyoto University; Kyoto University; Kyoto University; Kitasato University	Takakuwa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tez@hs.med.kyoto-u.ac.jp	Yamada, Shigehito/G-2061-2010; Yoneyama, Akio/ABH-5357-2020	Yamada, Shigehito/0000-0002-8194-6927; Yoneyama, Akio/0000-0001-6925-6723	Japan Society for the Promotion of Science [26220004, 15H01119, 15K15014, 16K15535, 15K08134, 15H05270, 15H01121]; Grants-in-Aid for Scientific Research [17H05296, 16H03167, 15H01121] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants 26220004, 15H01119, 15K15014, 16K15535, 15K08134, 15H05270, and 15H01121 from the Japan Society for the Promotion of Science.	ANDERSEN H, 1962, ACTA ANAT, V48, P258, DOI 10.1159/000141844; BADGLEY CE, 1949, J BONE JOINT SURG AM, V31-A, P341, DOI 10.2106/00004623-194931020-00011; Bardeen CR, 1905, AM J ANAT, V4, P265, DOI 10.1002/aja.1000040302; BARDEEN CR, 1908, ANAT REC, V2, P99; Biwasaka H, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2011.11.032; Blechscmidt E., 1961, THE STAGES OF HUMAN; BOUCHER BJ, 1957, AM J PHYS ANTHROPOL, V15, P581, DOI 10.1002/ajpa.1330150409; COLEMAN WH, 1969, AM J PHYS ANTHROPOL, V31, P125, DOI 10.1002/ajpa.1330310202; Drake R, 2019, GRAYS ANATOMY STUDEN; GARDNER E, 1970, AM J ANAT, V129, P121, DOI 10.1002/aja.1001290202; GARDNER E, 1950, AM J ANAT, V87, P163, DOI 10.1002/aja.1000870202; GLENISTER TW, 1954, J ANAT, V88, P413; Haque M, 2016, J CLIN DIAGN RES, V10, pAC1, DOI 10.7860/JCDR/2016/17699.7051; Khomiakovlu S, 1987, ARKH ANAT GISTOL EMB, V93, P47; LAURENSON RD, 1964, ANAT RECORD, V148, P197, DOI 10.1002/ar.1091480209; Lee W, 2010, ULTRASOUND OBST GYN, V35, P163, DOI 10.1002/uog.7477; Magee J, 2012, J ANAT, V221, P240, DOI 10.1111/j.1469-7580.2012.01535.x; Momose A, 2001, NUCL INSTRUM METH A, V467, P917, DOI 10.1016/S0168-9002(01)00523-X; NISHIMURA H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; NOBACK CR, 1951, AM J ANAT, V89, P1, DOI 10.1002/aja.1000890102; Nowlan NC, 2015, EUR CELLS MATER, V29, P1; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; O'Rahilly R. R, 2006, EMBRYONIC HUMAN BRAI; ORAHILLY R, 1972, AM J ANAT, V134, P291, DOI 10.1002/aja.1001340303; ORAHILLY R, 1990, J ANAT, V168, P95; ORAHILLY R, 1979, ANAT EMBRYOL, V157, P167, DOI 10.1007/BF00305157; Schaefer Maureen, 2009, JUVENILE OSTEOLOGY L; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; SINGH S, 1978, J ANAT, V125, P619; Strayer L M, 1943, Yale J Biol Med, V16, P13; STRAYER LM, 1971, CLIN ORTHOP RELAT R, P221; STREETER GL, 1949, CONTRIB EMBRYOL, V33, P151; TANAKA O, 1976, Okajimas Folia Anatomica Japonica, V53, P173; Weinstein SL, 1997, CLIN ORTHOP RELAT R, P227; Yamada S, 2004, BIRTH DEFECTS RES A, V70, P495, DOI 10.1002/bdra.20048; Yoneyama A, 2004, NUCL INSTRUM METH A, V523, P217, DOI 10.1016/j.nima.2003.12.008; Yoneyama A, 2011, ADVANCED BIOMEDICAL ENGINEERING-BOOK, P107	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173852	10.1371/journal.pone.0173852	http://dx.doi.org/10.1371/journal.pone.0173852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384153	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900009
J	Baker, LA; Kirkpatrick, B; Rosa, GJM; Gianola, D; Valente, B; Sumner, JP; Baltzer, W; Hao, ZL; Binversie, EE; Volstad, N; Piazza, A; Sample, SJ; Muir, P				Baker, Lauren A.; Kirkpatrick, Brian; Rosa, Guilherme J. M.; Gianola, Daniel; Valente, Bruno; Sumner, Julia P.; Baltzer, Wendy; Hao, Zhengling; Binversie, Emily E.; Volstad, Nicola; Piazza, Alexander; Sample, Susannah J.; Muir, Peter			Genome-wide association analysis in dogs implicates 99 loci as risk variants for anterior cruciate ligament rupture	PLOS ONE			English	Article							ACL RECONSTRUCTION; INJURY RISK; GENE; MODEL; ANGIOGENESIS; NEWFOUNDLAND; PREVALENCE; EXPRESSION; OUTCOMES; PACKAGE	Anterior cruciate ligament (ACL) rupture is a common condition that can be devastating and life changing, particularly in young adults. A non-contact mechanism is typical. Second ACL ruptures through rupture of the contralateral ACL or rupture of a graft repair is also common. Risk of rupture is increased in females. ACL rupture is also common in dogs. Disease prevalence exceeds 5% in several dog breeds, similar to 100 fold higher than human beings. We provide insight into the genetic etiology of ACL rupture by genome-wide association study (GWAS) in a high-risk breed using 98 case and 139 control Labrador Retrievers. We identified 129 single nucleotide polymorphisms (SNPs) within 99 risk loci. Associated loci (P< 5E-04) explained approximately half of phenotypic variance in the ACL rupture trait. Two of these loci were located in uncharacterized or non-coding regions of the genome. A chromosome 24 locus containing nine genes with diverse functions met genome-wide significance (P = 3.63E-0.6). GWAS pathways were enriched for c-type lectins, a gene set that includes aggrecan, a gene set encoding antimicrobial proteins, and a gene set encoding membrane transport proteins with a variety of physiological functions. Genotypic risk estimated for each dog based on the risk contributed by each GWAS locus showed clear separation of ACL rupture cases and controls. Power analysis of the GWAS data set estimated that similar to 172 loci explain the genetic contribution to ACL rupture in the Labrador Retriever. Heritability was estimated at 0.48. We conclude ACL rupture is a moderately heritable highly polygenic complex trait. Our results implicate c-type lectin pathways in ACL homeostasis.	[Baker, Lauren A.; Hao, Zhengling; Binversie, Emily E.; Volstad, Nicola; Piazza, Alexander; Sample, Susannah J.; Muir, Peter] Univ Wisconsin Madison, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Kirkpatrick, Brian; Rosa, Guilherme J. M.; Gianola, Daniel; Valente, Bruno] Univ Wisconsin Madison, Dept Anim Sci, Coll Agr & Life Sci, Madison, WI USA; [Valente, Bruno] Univ Wisconsin Madison, Dept Dairy Sci, Coll Agr & Life Sci, Madison, WI USA; [Sumner, Julia P.] Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA; [Baltzer, Wendy] Oregon State Univ, Dept Clin Sci, Coll Vet Med, Corvalis, OR USA; [Sumner, Julia P.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Oregon State University; Cornell University	Muir, P (corresponding author), Univ Wisconsin Madison, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	peter.muir@wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005; Piazza, Alexander/0000-0002-4637-8442; Binversie, Emily/0000-0003-1991-0867; Baltzer, Wendy/0000-0001-5295-9641; Sumner, Julia/0000-0003-4635-9791	Morris Animal Foundation [D13CA-020]; Robert Draper Technology Innovation Fund from the University of Wisconsin-Madison; Melita Grunow Family Professorship in Companion Animal Health; National Institutes of Health [T32OD10999, K01OD019743-01A1]; NLM training grant [NLM5T15LM007359]; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019743] Funding Source: NIH RePORTER	Morris Animal Foundation; Robert Draper Technology Innovation Fund from the University of Wisconsin-Madison; Melita Grunow Family Professorship in Companion Animal Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Morris Animal Foundation (D13CA-020, www.morrisanimalfoundation.org), the Robert Draper Technology Innovation Fund from the University of Wisconsin-Madison and the Melita Grunow Family Professorship in Companion Animal Health. Lauren Baker received support from the National Institutes of Health (T32OD10999) and is supported by an NLM training grant to the Computation and Informatics in Biology and Medicine Training Program (NLM5T15LM007359). Susannah Sample received support from the National Institutes of Health (K01OD019743-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AEG, 2014, ANIM GENET, V45, P542, DOI 10.1111/age.12162; Baird AEG, 2014, CONNECT TISSUE RES, V55, P275, DOI 10.3109/03008207.2014.910199; Beynnon BD, 2006, AM J SPORT MED, V34, P757, DOI 10.1177/0363546505282624; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Brophy RH, 2012, AM J SPORT MED, V40, P2517, DOI 10.1177/0363546512459476; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Chuang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106389; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Dohrn MF, 2013, J NEUROL, V260, P3093, DOI 10.1007/s00415-013-7124-7; Flynn RK, 2005, AM J SPORT MED, V33, P23, DOI 10.1177/0363546504265678; Gerard HC, 2001, ARTHRITIS RHEUM-US, V44, P1689, DOI 10.1002/1529-0131(200107)44:7<1689::AID-ART293>3.0.CO;2-K; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Gregory MH, 2012, ARTHRITIS, V2012, DOI DOI 10.1155/2012/764621; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Halper J, 2014, ADV EXP MED BIOL, V802, P49, DOI 10.1007/978-94-007-7893-1_4; HARNER CD, 1994, AM J SPORT MED, V22, P37, DOI 10.1177/036354659402200107; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; Hoffman GE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Johnson JS, 2015, J BONE JOINT SURG AM, V97A, P71, DOI 10.2106/JBJS.N.00246; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Khoschnau S, 2008, AM J SPORT MED, V36, P2432, DOI 10.1177/0363546508320805; Kitayama K, 2009, EXP CELL RES, V315, P206, DOI 10.1016/j.yexcr.2008.10.028; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Liao WJ, 2015, ONCOTARGET, V6, P24132, DOI 10.18632/oncotarget.4432; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Malila S, 2011, GENET MOL RES, V10, P4158, DOI 10.4238/2011.October.31.1; Mannion S, 2014, BRIT J SPORT MED, V48, P1640, DOI 10.1136/bjsports-2013-093201; Miur P, 2007, MICROB PATHOGENESIS, V42, P47, DOI 10.1016/j.micpath.2006.10.002; Miyasaka K. C., 1991, AM J KNEE SURG, V4, P3; Muir P, 1997, COMP CONT EDUC PRACT, V19, P1149; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Nielen ALJ, 2001, AM J VET RES, V62, P1198, DOI 10.2460/ajvr.2001.62.1198; O'Connell K, 2015, EUR J SPORT SCI, V15, P341, DOI 10.1080/17461391.2014.936324; Obeidat M, 2014, AM J PHYSIOL-RENAL, V307, pF623, DOI 10.1152/ajprenal.00070.2014; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Personnic N, 2014, FEBS J, V281, P2977, DOI 10.1111/febs.12836; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; Posthumus M, 2012, SCAND J MED SCI SPOR, V22, P523, DOI 10.1111/j.1600-0838.2010.01270.x; Posthumus M, 2010, BRIT J SPORT MED, V44, P1160, DOI 10.1136/bjsm.2009.060756; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Proffen BL, 2013, THE ACL HANDBOOK; Rahim M, 2014, J ORTHOP RES, V32, P1612, DOI 10.1002/jor.22705; Reif U, 2004, VET SURG, V33, P368, DOI 10.1111/j.1532-950X.2004.04053.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Schierding W, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00039; September AV, 2007, BRIT J SPORT MED, V41, P241, DOI 10.1136/bjsm.2006.033035; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Sutton KM, 2013, J AM ACAD ORTHOP SUR, V21, P41, DOI 10.5435/JAAOS-21-01-41; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Varoga D, 2006, J PATHOL, V209, P166, DOI 10.1002/path.1974; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Waggett AD, 2006, EUR J CELL BIOL, V85, P1145, DOI 10.1016/j.ejcb.2006.06.002; Webster KE, 2014, AM J SPORT MED, V42, P641, DOI 10.1177/0363546513517540; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilke VL, 2006, JAVMA-J AM VET MED A, V228, P61, DOI 10.2460/javma.228.1.61; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Wright RW, 2011, J BONE JOINT SURG AM, V93A, P1159, DOI [10.2106/JBJS.J.00898, 10.2106/JBJSJ.00898]; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Young NJ, 2009, MATRIX BIOL, V28, P311, DOI 10.1016/j.matbio.2009.05.002; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	71	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173810	10.1371/journal.pone.0173810	http://dx.doi.org/10.1371/journal.pone.0173810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379989	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500025
J	Gervais, O; Pong-Wong, R; Navarro, P; Haley, CS; Nagamine, Y				Gervais, Olivier; Pong-Wong, Ricardo; Navarro, Pau; Haley, Chris S.; Nagamine, Yoshitaka			Antagonistic genetic correlations for milking traits within the genome of dairy cattle	PLOS ONE			English	Article							WIDE ASSOCIATION; LOCI; VARIANCE; NUCLEOTIDE; RESISTANCE; SELECTION; YIELD; TOOL; QTL	Genome-wide association studies can be applied to identify useful SNPs associated with complex traits. Furthermore, regional genomic mapping can be used to estimate regional variance and clarify the genomic relationships within and outside regions but has not previously been applied to milk traits in cattle. We applied both single SNP analysis and regional genomic mapping to investigate SNPs or regions associated with milk yield traits in dairy cattle. The deregressed breeding values of three traits, total yield (kg) of milk (MLK), fat (FAT), and protein (PRT) in 305 days, from 2,590 Holstein sires in Japan were analyzed. All sires were genotyped with 40,646 single-nucleotide polymorphism (SNP) markers. A genome-wide significant region (P < 0.01) common to all three traits was identified by regional genomic mapping on chromosome (BTA) 14. In contrast, single SNP analysis identified significant SNPs only for MLK and FAT (P < 0.01), but not PRT in the same region. Regional genomic mapping revealed an additional significant region (P < 0.01) for FAT on BTA5 that was not identified by single SNP analysis. The additive whole-genomic effects estimated in the regional genomic mapping analysis for the three traits were positively correlated with one another (0.830-0.924). However, the regional genomic effects obtained by using a window size of 20 SNPs for FAT on BTA14 were negatively correlated (P < 0.01) with the regional genomic effect for MLK (-0.940) and PRT (-0.878). The BTA14 regional effect for FAT also showed significant negative correlations (P < 0.01) with the whole genomic effects for MLK (-0.153), FAT (-0.172), and PRT (-0.181). These negative genomic correlations between loci are consistent with the negative linkage disequilibrium expected for traits under directional selection. Such antagonistic correlations may hamper the fixation of the FAT increasing alleles on BTA14. In summary, regional genomic mapping found more regions associated with milk production traits than did single SNP analysis. In addition, the existence of non-zero covariances between regional and whole genomic effects may influence the detection of regional effects, and antagonistic correlations could hamper the fixation of major genes under intensive selection.	[Gervais, Olivier] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Pong-Wong, Ricardo; Haley, Chris S.] Univ Edinburgh, Roslin Inst & RDSVS, Edinburgh, Midlothian, Scotland; [Navarro, Pau; Haley, Chris S.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC,Human Genet Unit, Edinburgh, Midlothian, Scotland; [Nagamine, Yoshitaka] Nihon Univ, Bioresource Sci, Fujisawa, Kanagawa, Japan	Kyoto University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Nihon University	Nagamine, Y (corresponding author), Nihon Univ, Bioresource Sci, Fujisawa, Kanagawa, Japan.	nagamine.yoshitaka@nihon-u.ac.Jp	Navarro, Pau/AAJ-8091-2021	Navarro, Pau/0000-0001-5576-8584; Pong-Wong, Ricardo/0000-0001-9808-2742; Haley, Chris/0000-0002-9811-0210	Biotechnology and Biological Sciences Research Council [BBS/E/D/30002275] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696] Funding Source: researchfish; BBSRC [BBS/E/D/20211553, BB/J002844/1, BBS/E/D/20211550] Funding Source: UKRI; MRC [MC_PC_U127592696] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002844/1, BBS/E/D/20211550, BBS/E/D/20211553] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Brotherstone S, 2005, PHILOS T R SOC B, V360, P1479, DOI 10.1098/rstb.2005.1668; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Caballero A, 2015, GENETICS, V201, P1601, DOI 10.1534/genetics.115.177220; Canela-Xandri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10162; George AW, 2000, GENETICS, V156, P2081; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Henderson C. R, 1984, APPL LINEAR MODELS A; ITOH Y, 1991, GENET SEL EVOL, V23, P301, DOI 10.1051/gse:19910404; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Matika O, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0191-3; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENETICS, V157, P1819; Nagamine Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remington DL, 2015, EVOLUTION, V69, P3025, DOI 10.1111/evo.12775; Riggio V, 2013, HEREDITY, V110, P420, DOI 10.1038/hdy.2012.90; Rowe SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081189; Thaller G, 2003, J ANIM SCI, V81, P1911; Uemoto Yoshinobu, 2013, Frontiers in Genetics, V4, P232, DOI 10.3389/fgene.2013.00232; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/183242706778024928; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175105	10.1371/journal.pone.0175105	http://dx.doi.org/10.1371/journal.pone.0175105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380033	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500099
J	Labeit, AM; Peinemann, F				Labeit, Alexander Michael; Peinemann, Frank			Determinants of a GP visit and cervical cancer screening examination in Great Britain	PLOS ONE			English	Article							HEALTH-CARE; DEMAND; BREAST; MODEL; ATTENDANCE; SMOKING	Objective In the UK, women are requested to attend a cervical cancer test every 3 years as part of the NHS Cervical Screening Programme. This analysis compares the determinants of a cervical cancer screening examination with the determinants of a GP visit in the same year and investigates if cervical cancer screening participation is more likely for women who visit their GP. Methods A recursive probit model was used to analyse the determinants of GP visits and cervical cancer screening examinations. GP visits were considered to be endogenous in the cervical cancer screening examination. The analysed sample consisted of 52,551 observations from 8,386 women of the British Household Panel Survey. Results The analysis showed that a higher education level and a worsening self-perceived health status increased the probability of a GP visit, whereas smoking decreased the probability of a GP visit. GP visits enhanced the uptake of a cervical cancer screening examination in the same period. The only variables which had the same positive effect on both dependent variables were higher education and living with a partner. The probability of a cervical cancer screening examination increased also with previous cervical cancer screening examinations and being in the recommended age groups. All other variables had different results for the uptake of a GP visit or a cervical cancer screening examination. Conclusions Most of the determinants of visiting a GP and cervical cancer screening examination differ from each other and a GP visit enhances the uptake of a smear test.	[Labeit, Alexander Michael] Univ Sheffield, Sch Hlth & Related Sci, Sheffield, S Yorkshire, England; [Peinemann, Frank] FOM Univ Appl Sci Econ & Management, Essen, Germany; [Peinemann, Frank] Univ Hosp Cologne, Childrens Hosp, Cologne, Germany	University of Sheffield; University of Cologne	Labeit, AM (corresponding author), Univ Sheffield, Sch Hlth & Related Sci, Sheffield, S Yorkshire, England.	alabeit.publications@gmail.com	Labeit, Alexander/AAB-2707-2019; Peinemann, Frank/H-2800-2019	Peinemann, Frank/0000-0002-4727-1313; Labeit, Alexander Michael/0000-0002-4709-4767				BANGJENSEN J, 2012, J PUBLIC HLTH OXF, P1; Biewenga P, 2011, CANCER-AM CANCER SOC, V117, P768, DOI 10.1002/cncr.25658; Brice J., 2010, BRIT HOUSEHOLD PANEL; Carrieri V, 2013, APPL ECON, V45, P239, DOI 10.1080/00036846.2011.597729; Challier B, 2000, CANCER CAUSE CONTROL, V11, P157, DOI 10.1023/A:1008998322628; Contoyannis P, 2004, J APPL ECONOMET, V19, P473, DOI 10.1002/jae.755; CROPPER ML, 1977, J POLIT ECON, V85, P1273, DOI 10.1086/260637; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Government Statistical Service, 2002, CERV STAT B CERV SCR; Greene WH, 1998, J ECON EDUC, V29, P291, DOI 10.2307/1182919; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Jenkins S. P., 2010, ISER WORKING PAPER S, V2010-33; JEPSON R, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4140; KENKEL DS, 1994, APPL ECON, V26, P313, DOI 10.1080/00036849400000078; Kenkel DS, 2000, HANDB ECON, V17, P1675; KULIK JA, 1987, HEALTH PSYCHOL, V6, P15, DOI 10.1037/0278-6133.6.1.15; Labeit A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003387; Labeit A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02362; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; Lairson DR, 2005, SOC SCI MED, V61, P1608, DOI 10.1016/j.socscimed.2005.03.015; Lin SJ, 2008, J R SOC PROMO HEALTH, V128, P327, DOI 10.1177/1466424007092802; Macmillan Cancer Support, CERV SCREEN; MAJEED FA, 1994, BRIT MED J, V308, P1272, DOI 10.1136/bmj.308.6939.1272; Manderbacka K, 1998, INT J EPIDEMIOL, V27, P208, DOI 10.1093/ije/27.2.208; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; Marra G, 2011, CAN J STAT, V39, P259, DOI 10.1002/cjs.10100; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; NHS, CERV SCREEN PROGR; NHS, NHS CHOIC CERV SCREE; Office for National Statistics, 2014, CERV CANC IS MOST CO; Patnick J, 2002, BUILDING EXPERIENCE; Peckham Stephen, 2011, Qual Prim Care, V19, P317; PERKINS KA, 1993, HEALTH PSYCHOL, V12, P410, DOI 10.1037/0278-6133.12.5.410; Pfeifer C., 2012, NORDIC J HLTH EC, V1, P135, DOI DOI 10.5617/NJHE.195; Polisson M., 2011, WORKING PAPER; Public Health England, CERV SCREEN PROGR; Public Health England, UKNSC POL DAT UK NSC; Rodvall Y, 2005, EUR J CANCER PREV, V14, P459, DOI 10.1097/01.cej.0000178078.21910.da; Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032; Scholes D, 1999, CANCER CAUSE CONTROL, V10, P339, DOI 10.1023/A:1008993619060; Scott A, 2000, HANDB ECON, V17, P1175; SELDEN TM, 1993, J HEALTH ECON, V12, P109, DOI 10.1016/0167-6296(93)90043-E; Vesco KK, 2011, SCREENING CERVICAL C; VISCUSI WK, 1990, J POLIT ECON, V98, P1253, DOI 10.1086/261733; Wacker M, 2013, BMC HEALTH SERV RES, P13; Zweifel P., 2009, HEALTH ECON	47	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174363	10.1371/journal.pone.0174363	http://dx.doi.org/10.1371/journal.pone.0174363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379990	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500044
J	Perisic, T; Zhang, ZY; Foehr, P; Hopfner, U; Klutz, K; Burgkart, RH; Slobodianski, A; Goeldner, M; Machens, HG; Schilling, AF				Perisic, Tatjana; Zhang, Ziyang; Foehr, Peter; Hopfner, Ursula; Klutz, Kathrin; Burgkart, Rainer H.; Slobodianski, Alexei; Goeldner, Moritz; Machens, Hans-Gunther; Schilling, Arndt F.			Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for geneticallymodified fibroblasts	PLOS ONE			English	Article							ECTOPIC BONE-FORMATION; OSTEOCLASTIC BIORESORPTION; DELIVERY; THERAPY; CELLS; RECONSTRUCTION; SYSTEM; CANCER; GENERATION; FRACTURE	Recent advances in gene delivery into cells allow improved therapeutic effects in gene therapy trials. To increase the bioavailability of applied cells, it is of great interest that transfected cells remain at the application site and systemic spread is minimized. In this study, we tested clinically used biodegradable poly(lactic acid-co-glycolic acid) (PLGA) scaffolds (Vicryl & Ethisorb) as transient carriers for genetically modified cells. To this aim, we used human fibroblasts and examined attachment and proliferation of untransfected cells on the scaffolds in vitro, as well as the mechanical properties of the scaffolds at four time points (1, 3, 6 and 9 days) of cultivation. Furthermore, the adherence of cells transfected with green fluorescent protein (GFP) and vascular endothelial growth factor (VEGF165) and also VEGF165 protein secretion were investigated. Our results show that human fibroblasts adhere on both types of PLGA scaffolds. However, proliferation and transgene expression capacity were higher on Ethisorb scaffolds most probably due to a different architecture of the scaffold. Additionally, cultivation of the cells on the scaffolds did not alter their biomechanical properties. The results of this investigation could be potentially exploited in therapeutic regiments with areal delivery of transiently transfected cells and may open the way for a variety of applications of cell-based gene therapy, tissue engineering and regenerative medicine.	[Perisic, Tatjana; Hopfner, Ursula; Klutz, Kathrin; Slobodianski, Alexei; Machens, Hans-Gunther; Schilling, Arndt F.] Tech Univ Munich, Klinikum Rechts Isar, Expt Plast Surg, Dept Plast Surg & Hand Surg, Munich, Germany; [Zhang, Ziyang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Orthoped, Wuhan, Hubei, Peoples R China; [Foehr, Peter; Burgkart, Rainer H.] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed & Sportsorthopaed, Munich, Germany; [Goeldner, Moritz] Johnson & Johnson Med GmbH, Norderstedt, Germany; [Schilling, Arndt F.] Univ Med Ctr Gottingen, Klin Unfallchirurg Orthopadie & Plast Chirurg, Gottingen, Germany; [Goeldner, Moritz] Hamburg Univ Technol, Inst Technol & Innovat Management, Hamburg, Germany	Technical University of Munich; Huazhong University of Science & Technology; Technical University of Munich; Johnson & Johnson; University of Gottingen; Hamburg University of Technology	Schilling, AF (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Expt Plast Surg, Dept Plast Surg & Hand Surg, Munich, Germany.; Schilling, AF (corresponding author), Univ Med Ctr Gottingen, Klin Unfallchirurg Orthopadie & Plast Chirurg, Gottingen, Germany.	arndt.schilling@med.uni-goettingen.de		Foehr, Peter/0000-0003-1042-546X	National Natural Science Foundation of China [81401538]; Johnson & Johnson Medical GmbH, Norderstedt, Germany; Johnson & Johnson Medical GmbH	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Johnson & Johnson Medical GmbH, Norderstedt, Germany; Johnson & Johnson Medical GmbH	This work was partly supported by a grant to Dr. Ziyang Zhang from National Natural Science Foundation of China (Grant No. No. 81401538). This study was also partly supported by an unrestricted the grant of Johnson & Johnson Medical GmbH, Norderstedt, Germany. Johnson & Johnson Medical GmbH provided support in the form of salaries for author MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barbolt TA, 2001, NEUROL RES, V23, P813, DOI 10.1179/016164101101199405; Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228; Buchel P, 2005, J ORAL MAXIL SURG, V63, P646, DOI 10.1016/j.joms.2004.11.013; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Chang H-I, TECH; Chmielewski M, 2014, IMMUNOL REV, V257, P83, DOI 10.1111/imr.12125; Conde J, 2016, NAT MATER, V15, P1128, DOI [10.1038/nmat4707, 10.1038/NMAT4707]; Conde J, 2016, NAT MATER, V15, P353, DOI [10.1038/nmat4497, 10.1038/NMAT4497]; Conde J, 2015, ADV FUNCT MATER, V25, P4183, DOI 10.1002/adfm.201501283; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; Das D, 2012, ADV BIOCHEM ENG BIOT, V126, P317, DOI 10.1007/10_2011_119; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Dong YZ, 2016, NANO LETT, V16, P842, DOI 10.1021/acs.nanolett.5b02428; Guo X, 2012, ACCOUNTS CHEM RES, V45, P971, DOI 10.1021/ar200151m; Hadjipanayi E, 2013, J CONTROL RELEASE, V169, P91, DOI 10.1016/j.jconrel.2013.04.008; Hadjipanayi E, 2012, J CONTROL RELEASE, V161, P852, DOI 10.1016/j.jconrel.2012.04.048; Hadjipanayi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135618; Hadjipanayi E, 2013, ORGANOGENESIS, V9, P261, DOI 10.4161/org.25970; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Jang JH, 2010, GENE THER, V17, P1384, DOI 10.1038/gt.2010.81; Jensen SA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006839; Keller J, 2012, PLOS ONE, V7; Korenkov M, 2005, Hernia, V9, P252, DOI 10.1007/s10029-005-0341-y; Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9; Lee JB, 2012, NAT MATER, V11, P316, DOI [10.1038/nmat3253, 10.1038/NMAT3253]; Lohmeyer JA, 2011, LANGENBECK ARCH SURG, V396, P543, DOI 10.1007/s00423-011-0761-3; Manabe T, 2003, CLIN CANCER RES, V9, P3158; Newman MI, 2010, AESTHET PLAST SURG, V34, P297, DOI 10.1007/s00266-010-9498-6; Pape SA, 2000, J BURN CARE REHABIL, V21, P390; Pendegrass CJ, 2006, J BONE JOINT SURG BR, V88B, P1245, DOI 10.1302/0301-620X.88B9.17748; Perisic T, 2015, GENE THER MOL BIOL, V17, P42; Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267; Riss TL, 2004, CELL VIABILITY ASSAY; Seidl RO, 2000, HNO, V48, P753, DOI 10.1007/s001060050654; Spanholtz TA, 2011, J SURG RES, V171, P329, DOI 10.1016/j.jss.2010.03.033; Spiro AS, 2010, J TRAUMA, V69, P1473, DOI 10.1097/TA.0b013e3181dc59e4; Spiro AS, 2010, J ORTHOP RES, V28, P785, DOI 10.1002/jor.21044; Stone GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007334; Weiss RA, 2000, J INFECTION, V40, P21, DOI 10.1053/jinf.1999.0604; Winkler T, 2010, ACTA BIOMATER, V6, P4127, DOI 10.1016/j.actbio.2010.04.015; Winkler T, 2010, INT J ARTIF ORGANS, V33, P198, DOI 10.1177/039139881003300404; Wittenburg G, 2014, BRIT J ORAL MAX SURG, V52, P409, DOI 10.1016/j.bjoms.2014.02.023; Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037; Wunsch L, 2005, EUR J PEDIATR SURG, V15, P164, DOI 10.1055/s-2004-830356; Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019192; Zhang ZY, 2011, BIOMATERIALS, V32, P4109, DOI 10.1016/j.biomaterials.2011.02.036	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174860	10.1371/journal.pone.0174860	http://dx.doi.org/10.1371/journal.pone.0174860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380080	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500069
J	Tanaka, N; Yamashita, T; Sato, A; Vogel, V; Tanaka, Y				Tanaka, Nobuyuki; Yamashita, Tadahiro; Sato, Asako; Vogel, Viola; Tanaka, Yo			Simple agarose micro-confinement array and machine-learning-based classification for analyzing the patterned differentiation of mesenchymal stem cells	PLOS ONE			English	Article							CYTOSKELETAL TENSION; MATRIX ELASTICITY; GEOMETRIC CONTROL; HIGH-THROUGHPUT; FATE; SHAPE; HYDROGELS; GROWTH; FORCE; MECHANOTRANSDUCTION	The geometrical confinement of small cell colonies gives differential cues to cells sitting at the periphery versus the core. To utilize this effect, for example to create spatially graded differentiation patterns of human mesenchymal stem cells (hMSCs) in vitro or to investigate underpinning mechanisms, the confinement needs to be robust for extended time periods. To create highly repeatable micro-fabricated structures for cellular patterning and high-throughput data mining, we employed here a simple casting method to fabricate more than 800 adhesive patches confined by agarose micro-walls. In addition, a machine learning based image processing software was developed (open code) to detect the differentiation patterns of the population of hMSCs automatically. Utilizing the agarose walls, the circular patterns of hMSCs were successfully maintained throughout 15 days of cell culture. After staining lipid droplets and alkaline phosphatase as the markers of adipogenic and osteogenic differentiation, respectively, the mega-pixels of RGB color images of hMSCs were processed by the software on a laptop PC within several minutes. The image analysis successfully showed that hMSCs sitting on the more central versus peripheral sections of the adhesive circles showed adipogenic versus osteogenic differentiation as reported previously, indicating the compatibility of patterned agarose walls to conventional microcontact printing. In addition, we found a considerable fraction of undifferentiated cells which are preferentially located at the peripheral part of the adhesive circles, even in differentiation-inducing culture media. In this study, we thus successfully demonstrated a simple framework for analyzing the patterned differentiation of hMSCs in confined microenvironments, which has a range of applications in biology, including stem cell biology.	[Tanaka, Nobuyuki; Sato, Asako; Tanaka, Yo] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Yamashita, Tadahiro; Vogel, Viola] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Zurich, Switzerland; [Tanaka, Yo] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; Swiss Federal Institutes of Technology Domain; ETH Zurich; Osaka University	Tanaka, Y (corresponding author), RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan.; Tanaka, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	yo.tanaka@riken.jp	Tanaka, Nobuyuki/AAM-4278-2020; Tanaka, Yo/ABE-5075-2020; Vogel, Viola/O-8025-2015	Tanaka, Nobuyuki/0000-0002-4698-5867; Tanaka, Yo/0000-0003-1034-5718; Vogel, Viola/0000-0003-2898-7671; Yamashita, Tadahiro/0000-0003-2168-9567	JSPS Bilateral Programs; JSPS KAKENHI [25709081, 15K18004]; ERC Advanced Grant from the European Research Council [233157]; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (TY), JSPS KAKENHI [25709081, 15K18004]; Grants-in-Aid for Scientific Research [15K18004] Funding Source: KAKEN	JSPS Bilateral Programs; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ERC Advanced Grant from the European Research Council; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (TY), JSPS KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 233157, https://erc.europa.eu/projects-and-results/erc-funded-projects/project/mechanochem-switches; JSPS Postdoctoral Fellowships for Research Abroad, http://www.jsps.go.jp/english/e-ab/index.html; JSPS KAKENHI Grant Number 25709081, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25709081/, and 15K18004, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15K18004/; and JSPS Bilateral Programs, http://www.jsps.go.jp/english/e-bilat/index.html.; The authors would like to thank Prof. Sandra Hoffman and Prof. Ralph Muller for kindly providing us the bone marrow-derived hMSCs, Dr. Melanie Burkhardt for discussions on experimental protocols, and Dr. H. R. Ueda for useful discussions. The study was partially supported by the ERC Advanced Grant (233157) from the European Research Council (VV), Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (TY), JSPS KAKENHI Grant Number 25709081 (YT) and 15K18004 (NT), and JSPS Bilateral Programs.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bellas E, 2014, CURR OPIN CELL BIOL, V31, P92, DOI 10.1016/j.ceb.2014.09.006; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cho WK, 2010, BIOMATERIALS, V31, P9565, DOI 10.1016/j.biomaterials.2010.08.037; Ciresan D, 2012, DEEP NEURAL NETWORKS, P1; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]; Ihalainen TO, 2015, NAT MATER, V14, P1252, DOI [10.1038/NMAT4389, 10.1038/nmat4389]; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; LONZA, POIET HUM BON MARR; Mammoto T, 2013, ANNU REV CELL DEV BI, V29, P27, DOI 10.1146/annurev-cellbio-101512-122340; Mason B. N., 2012, ENG BIOMATERIALS REG, DOI [10.1007/978-1-4614-1080-5, DOI 10.1007/978-1-4614-1080-5_2]; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109; Pasca SP, 2014, ANNU REV NEUROSCI, V37, P479, DOI 10.1146/annurev-neuro-062012-170328; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Raschka Sebastian, DOES DEEP LEARNING W; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sandra H, 2007, BIOMATERIALS, V28, P1152; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001; Strulson MK, 2012, LANGMUIR, V28, P4318, DOI 10.1021/la2035533; Sugio Y, 2004, SENSOR ACTUAT B-CHEM, V99, P156, DOI 10.1016/S0925-4005(03)00550-1; Tanaka N, 2016, RSC ADV, V6, P54754, DOI 10.1039/c6ra11563b; Tanaka N, 2014, BIOMATERIALS, V35, P9802, DOI 10.1016/j.biomaterials.2014.08.043; Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Vahey MD, 2014, CURR OPIN CELL BIOL, V26, P60, DOI 10.1016/j.ceb.2013.10.001; Vedula SRK, 2014, METHOD CELL BIOL, V120, P235, DOI 10.1016/B978-0-12-417136-7.00016-1; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Willaert Ronnie G., 2015, Fermentation-Basel, V1, P38, DOI 10.3390/fermentation1010038	48	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173647	10.1371/journal.pone.0173647	http://dx.doi.org/10.1371/journal.pone.0173647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380036	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500021
J	Wang, YB; Lin, MJ; Gao, X; Pedram, P; Du, JL; Vikram, C; Gulliver, W; Zhang, HW; Sun, G				Wang, Yongbo; Lin, Meiju; Gao, Xiang; Pedram, Pardis; Du, Jianling; Vikram, Chandurkar; Gulliver, Wayne; Zhang, Hongwei; Sun, Guang			High dietary selenium intake is associated with less insulin resistance in the Newfoundland population	PLOS ONE			English	Article							BETA-CELL FUNCTION; OXIDATIVE STRESS; SERUM SELENIUM; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; GLUCOSE-METABOLISM; TOENAIL SELENIUM; CENTRAL OBESITY; ADIPOSE-TISSUE; TRACE-ELEMENTS	As an essential nutrient, Selenium (Se) is involved in many metabolic activities including mimicking insulin function. Data on Se in various biological samples and insulin resistance are contradictory, moreover there is no large study available regarding the relationship of dietary Se intake with insulin resistance in the general population. To investigate the association between dietary Se intake and variation of insulin resistance in a large population based study, a total of 2420 subjects without diabetes from the CODING (Complex Diseases in the Newfoundland Population: Environment and Genetics) study were assessed. Dietary Se intake was evaluated from the Willett Food Frequency questionnaire. Fasting blood samples were used for the measurement of glucose and insulin. Insulin resistance was determined with the homeostasis model assessment (HOMA-IR). Body composition was measured using dual energy X-ray absorptiometry. Analysis of covariance showed that high HOMA-IR groups in both males and females had the lowest dietary Se intake (fag/kg/ day) (p < 0.01), being 18% and 11% lower than low HOMA-IR groups respectively. Insulin resistance decreased with the increase of dietary Se intake in females but not in males after controlling for age, total calorie intake, physical activity level, serum calcium, serum magnesium, and body fat percentage (p < 0.01). Partial correlation analysis showed that dietary Se intake was negatively correlated with HOMA-IR after adjusting for the Se confounding factors in subjects whose dietary Se intake was below 1.6 mu g/kg/day (r = -0.121 for males and -0.153 for females, p < 0.05). However, the negative correlation was no longer significant when dietary Se intake was above 1.6 pg/kg/day. Our findings suggest that higher dietary Se intake is beneficially correlated with lower insulin resistance when total dietary Se intake was below 1.6 pg/kg/day. Above this cutoff, this beneficial effect disappears.	[Wang, Yongbo; Du, Jianling] Dalian Med Univ, Dept Endocrinol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Lin, Meiju] Dalian Univ, Dept Biliary Minimally Invas Surg, Affiliated Zhongshan Hosp, Dalian, Liaoning, Peoples R China; [Gao, Xiang; Pedram, Pardis; Gulliver, Wayne; Zhang, Hongwei; Sun, Guang] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Vikram, Chandurkar] Mem Univ Newfoundland, Fac Med, Div Endocrinol, St John, NF, Canada	Dalian Medical University; Dalian University; Memorial University Newfoundland; Memorial University Newfoundland	Gulliver, W; Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada.	WGulliver@newlabresearch.com; gain@mun.ca			Canadian Institutes of Health Research (CIHR) [MOP192552]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This project has been funded by a Canadian Institutes of Health Research (CIHR) (operating grant: MOP192552). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2012, ANN NUTR METAB, V60, P157, DOI 10.1159/000335470; Arganini C, 2012, GENDER DIFFERENCES I; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Azab SFA, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-20; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Becker DJ, 1996, DIABETOLOGIA, V39, P3, DOI 10.1007/BF00400407; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Brigelius-Flohe R, 2004, ARCH BIOCHEM BIOPHYS, V423, P66, DOI 10.1016/j.abb.2003.12.008; Cahill F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058278; Chen L, 2014, FERTIL STERIL, V102, P1167, DOI 10.1016/j.fertnstert.2014.06.027; Chen ZH, 2014, DIABETES CARE, V37, P3294, DOI 10.2337/dc14-1433; Combs GF, 2009, AM J CLIN NUTR, V89, P1808, DOI 10.3945/ajcn.2008.27356; Coudray C, 1997, J AM COLL NUTR, V16, P584; Dhanya BL, 2014, BIOL TRACE ELEM RES, V161, P107, DOI 10.1007/s12011-014-0076-7; EZAKI O, 1990, J BIOL CHEM, V265, P1124; Farinha JB, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0011-2; Faure P, 2004, EUR J CLIN INVEST, V34, P475, DOI 10.1111/j.1365-2362.2004.01362.x; Faure P, 2007, J TRACE ELEM MED BIO, V21, P113, DOI 10.1016/j.jtemb.2006.12.005; Fontaine-Bisson B, 2014, AM J CLIN NUTR, V99, P384, DOI 10.3945/ajcn.113.073387; Furnsinn C, 1996, LIFE SCI, V59, P1989, DOI 10.1016/S0024-3205(96)00550-4; Gao H, 2014, DIABETIC MED, V31, P787, DOI 10.1111/dme.12429; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Green KK, 2010, CLIN MED INSIGHTS-EN, V3, P25; Hamasaki H, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/526201; Hei YJ, 1998, MOL CELL BIOCHEM, V178, P367, DOI 10.1023/A:1006819906820; Honek J, 2014, P NATL ACAD SCI USA, V111, P14906, DOI 10.1073/pnas.1415825111; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394; Jamilian M, 2015, CLIN ENDOCRINOL, V82, P885, DOI 10.1111/cen.12699; Kim HN, 2014, BIOL TRACE ELEM RES, V158, P152, DOI 10.1007/s12011-014-9934-6; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Mao S, 2014, ENDOCRINE, V47, P758, DOI 10.1007/s12020-014-0298-7; Marucci A, 2015, ACTA DIABETOL, V52, P991, DOI 10.1007/s00592-015-0804-2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattmiller SA, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.17; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; MCNEILL JH, 1991, DIABETES, V40, P1675, DOI 10.2337/diabetes.40.12.1675; Mueller AS, 2006, J NUTR BIOCHEM, V17, P548, DOI 10.1016/j.jnutbio.2005.10.006; Ozkaya M, 2009, BIOL TRACE ELEM RES, V128, P144, DOI 10.1007/s12011-008-8263-z; Park K, 2012, DIABETES CARE, V35, P1544, DOI 10.2337/dc11-2136; Puchau B, 2010, BIOL TRACE ELEM RES, V133, P304, DOI 10.1007/s12011-009-8443-5; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Rayman MP, 2013, FREE RADICAL BIO MED, V65, P1557, DOI 10.1016/j.freeradbiomed.2013.04.003; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Razavi M, 2016, HORM METAB RES, V48, P185, DOI 10.1055/s-0035-1559604; Rocourt CRB, 2013, NUTRIENTS, V5, P1349, DOI 10.3390/nu5041349; Rotter I, 2015, INT J ENV RES PUB HE, V12, P3944, DOI 10.3390/ijerph120403944; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Stranges S, 2011, ATHEROSCLEROSIS, V217, P274, DOI 10.1016/j.atherosclerosis.2011.03.027; Stranges S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-564; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Tanguy S, 2012, MOL NUTR FOOD RES, V56, P1106, DOI 10.1002/mnfr.201100766; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Wang XD, 2008, DIABETOLOGIA, V51, P1515, DOI 10.1007/s00125-008-1055-3; Wang XH, 2014, AASRI PROC, V6, P2, DOI 10.1016/j.aasri.2014.05.002; Wang Y., 2016, NUTRIENTS, V8; Wei J, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0007-2; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yoshimura Eiichi, 2011, Obes Res Clin Pract, V5, pe79, DOI 10.1016/j.orcp.2011.01.001	70	35	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174149	10.1371/journal.pone.0174149	http://dx.doi.org/10.1371/journal.pone.0174149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380029	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500032
J	Moon, SJ; Ahn, CH; Cho, YM				Moon, Sun Joon; Ahn, Chang Ho; Cho, Young Min			Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014	PLOS ONE			English	Article							LACTIC-ACIDOSIS; RENAL-DISEASE; TYPE-2; EQUATION; YOUNG; HYPERGLYCEMIA; MANAGEMENT; CLEARANCE; THERAPY; VALUES	Background The metformin label has recently been changed from serum creatinine (sCr)-based to estimated glomerular filtration rate (eGFR)-based indication, which is expected to expand its use for patients with mild renal insufficiency. However, because the sCr level is lower in Asians than in Caucasians at the same level of renal function, this change might not expand metformin use in the Asian population. We investigated the effect of this change among Korean patients with diabetes. Methods Data from the Korean National Health and Nutrition Examination Survey 2009 to 2014 were used and included 4,127 adult patients with diabetes. The metformin eligibility was assessed by the sCr level (1.4 mg/dL for women and 1.5 mg/dL for men) or by eGFR categories (contraindicated, <30; indeterminate, >= 30, <45; likely safe, >= 45 mL/min/1.73 m(2)) calculated by various eGFR equations including MDRD equation. We designated the 'expanding' and 'contracting' population as those who are likely safe according to eGFR among sCr-ineligible patients and those contraindicated according to eGFR among sCr-eligible patients, respectively. Results were weighted to the whole Korean adult population. Results All eGFR equations showed expansion in the population for whom metformin is likely safe, ranging from 14.3% to 19.9% of the sCr-ineligible population. With the MDRD equation, the expanding population was 15,264 (15.8%) and the contracting population was 0 (0.0%). Male sex and younger age were significantly associated with the expanding population. Conclusions Contrary to our concern, prescribing metformin according to eGFR substantially expanded the indication of its use among the Korean diabetic patients.	[Moon, Sun Joon; Ahn, Chang Ho; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU)	Cho, YM (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ymchomd@snu.ac.kr		Cho, Young Min/0000-0002-2331-6126				Bodmer M, 2008, DIABETES CARE, V31, P2086, DOI 10.2337/dc08-1171; Canadian Diabetes Association, 2013, CLIN PRACT GUID; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COHEN RD, 1973, DIABETOLOGIA, V9, P43, DOI 10.1007/BF01225999; Couchoud C, 1999, KIDNEY INT, V55, P1878, DOI 10.1046/j.1523-1755.1999.00411.x; Du Bois D, 1989, Nutrition, V5, P303; Ezzati T M, 1992, Vital Health Stat 2, P1; Friesecke S, 2010, CRITICAL CARE, V14, P1; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; Holstein A, 2005, DIABETOLOGIA, V48, P2454, DOI 10.1007/s00125-005-0026-1; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Jung JH, 2015, DIABETES METAB J, V39, P307, DOI 10.4093/dmj.2015.39.4.307; Kalantar-Zadeh K, 2016, DIABETES CARE, V39, P1281, DOI 10.2337/dc15-2327; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee EK, 2009, DIABETES RES CLIN PR, V83, P44, DOI 10.1016/j.diabres.2008.09.047; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lipska KJ, 2011, DIABETES CARE, V34, P1431, DOI 10.2337/dc10-2361; Misbin RI, 2004, DIABETES CARE, V27, P1791, DOI 10.2337/diacare.27.7.1791; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Institute for Health and Care Excellence, 2015, NICE GUID MAN TYP 2; Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Scheen AJ, 1996, CLIN PHARMACOKINET, V30, P359, DOI 10.2165/00003088-199630050-00003; Tuot DS, 2015, DIABETES CARE, V38, P2059, DOI 10.2337/dc15-0542; U.S. Food and Drug Administration, 1994, METF HYDR TABL; US Food and Drug Administration. FDA drug safety communication, 2016, FDA REV WARN REG US; Yeung RO, 2014, LANCET DIABETES ENDO, V2, P935, DOI 10.1016/S2213-8587(14)70137-8	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175334	10.1371/journal.pone.0175334	http://dx.doi.org/10.1371/journal.pone.0175334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399132	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000031
J	Zhang, M; Liu, BX				Zhang, Mei; Liu, Baoxiu			Identification of a rice metal tolerance protein OsMTP11 as a manganese transporter	PLOS ONE			English	Article							DIFFUSION FACILITATOR FAMILY; HEAVY-METAL; TRANSCRIPTIONAL ACTIVATION; YEAST; GENE; ARABIDOPSIS; EXPRESSION; PATHWAY; STRESS; TRANSFORMATION	Metal tolerance proteins (MTPs) are a gene family of cation efflux transporters that occur widely in plants and might serve an essential role in metal homeostasis and tolerance. Our research describes the identification, characterization, and localization of OsMTP11, a member of the MTP family from rice. OsMTP11 was expressed constitutively and universally in different tissues in rice plant. Heterologous expression in yeast showed that OsMTP11 complemented the hypersensitivity of mutant strains to Mn, and also complemented yeast mutants to other metals, including Co and Ni. Real time RT-PCR analysis demonstrated OsMTP11 expression was substantially enhanced following 4 h under Cd, Zn, Ni, and Mn treatments, suggesting possible roles of OsMTP11 involvement in heavy metal stress responses. Promoter analysis by transgenic assays with GUS as a reporter gene and mRNA in situ hybridization experiments showed that OsMTP11 was expressed specifically in conducting tissues in rice. DNA methylation assays of genomic DNA in rice treated with Cd, Zn, Ni, and Mn revealed that decreased DNA methylation levels were present in the OsMTP11 promoter region, which was consistent with OsMTP11 induced-expression patterns resulting from heavy metal stress. This result suggested that DNA methylation is one of major factors regulating expression of OsMTP11 through epigenetic mechanisms. OsMTP11 fused to green fluorescent protein (GFP) localized to the entire onion epidermal cell cytoplasm, while vacuolar membrane exhibited increased GFP signals, consistent with an OsMTP11 function in cation sequestration. Our results indicated that OsMTP11 might play vital roles in Mn and other heavy metal transportation in rice.	[Zhang, Mei; Liu, Baoxiu] Chinese Acad Sci, South China Bot Garden, Prov Key Lab Appl Bot, Guangzhou, Guangdong, Peoples R China; [Liu, Baoxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, M (corresponding author), Chinese Acad Sci, South China Bot Garden, Prov Key Lab Appl Bot, Guangzhou, Guangdong, Peoples R China.	zhangmei@scbg.ac.cn		Zhang, Mei/0000-0003-0976-3867	National Natural Sciences Foundation of China [31271702, 31570257]; Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	This research was supported by the National Natural Sciences Foundation of China (Grant nos. 31271702 and 31570257) and Knowledge Innovation Project for Young Scientists of the South China Botanical Garden, awarded to M.Zhang. The funders had no role in the study design, data collection and analysis, decision to publish, preparation of the manuscript.	Aichinger E, 2010, METHODS MOL BIOL, V655, P433, DOI 10.1007/978-1-60761-765-5_29; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; BACHHAWAT AK, 1993, YEAST, V9, P175, DOI 10.1002/yea.320090208; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Erbasol I, 2013, BIOMETALS, V26, P795, DOI 10.1007/s10534-013-9658-7; Fei Y, 2016, PROTOPLASMA; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37; Graham LA, 1995, J BIOL CHEM; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Meyer P, 2011, FEBS LETT, V585, P2008, DOI 10.1016/j.febslet.2010.08.017; Migocka M, 2014, J EXP BOT, V65, P5367, DOI 10.1093/jxb/eru295; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muthukumar B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-32; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Porto MS, 2014, MOL BIOTECHNOL, V56, P38, DOI 10.1007/s12033-013-9713-1; Qi XT, 2007, PLANT PHYSIOL, V143, P50, DOI 10.1104/pp.106.080283; Searle P F, 1987, Experientia Suppl, V52, P407; Sharma SS, 2016, PLANT CELL ENVIRON, V39, P1112, DOI 10.1111/pce.12706; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh S, 2015, FRONT PLANT SCI, P6; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Ueno D, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.170, 10.1038/nplants.2015.170]; van der Zaal BJ, 1999, PLANT PHYSIOL, V119, P1047, DOI 10.1104/pp.119.3.1047; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wang Y, 2005, CELL RES, V15, P604, DOI 10.1038/sj.cr.7290330; Wimalarathna RN, 2012, BIOCHEM BIOPH RES CO, V422, P658, DOI 10.1016/j.bbrc.2012.05.047; Xu J, 2009, PLANT CELL REP, V28, P1235, DOI 10.1007/s00299-009-0723-1; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9	50	40	44	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174987	10.1371/journal.pone.0174987	http://dx.doi.org/10.1371/journal.pone.0174987			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394944	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800011
J	Jeng, JS; Hsieh, FI; Yeh, HL; Chen, WH; Chiu, HC; Tang, SC; Liu, CH; Lin, HJ; Hsu, SP; Lo, YK; Chan, L; Chen, CH; Lin, RT; Chen, YW; Lee, JT; Yeh, CH; Sun, MH; Lai, TC; Sun, Y; Sun, MC; Chen, PL; Chiang, TR; Lin, SK; Yip, BS; Chen, CI; Bai, CH; Chen, ST; Chiou, HY; Lien, LM; Hsu, CY				Jeng, Jiann-Shing; Hsieh, Fang-I; Yeh, Hsu-Ling; Chen, Wei-Hung; Chiu, Hou-Chang; Tang, Sung-Chun; Liu, Chung-Hsiang; Lin, Huey-Juan; Hsu, Shih-Pin; Lo, Yuk-Keung; Chan, Lung; Chen, Chih-Hung; Lin, Ruey-Tay; Chen, Yu-Wei; Lee, Jiunn-Tay; Yeh, Chung-Hsin; Sun, Ming-Hui; Lai, Ta-Chang; Sun, Yu; Sun, Mu-Chien; Chen, Po-Lin; Chiang, Tsuey-Ru; Lin, Shinn-Kuang; Yip, Bak-Sau; Chen, Chin-I; Bai, Chi-Huey; Chen, Sien-Tsong; Chiou, Hung-Yi; Lien, Li-Ming; Hsu, Chung Y.		Taiwan Stroke Registry Investigato	Impact of MCA stenosis on the early outcome in acute ischemic stroke patients	PLOS ONE			English	Article							CEREBRAL-ARTERY STENOSIS; INTRACRANIAL ATHEROSCLEROTIC STROKE; OCCLUSIVE CEREBROVASCULAR-DISEASE; TRANSCRANIAL DOPPLER ULTRASOUND; MAGNETIC-RESONANCE ANGIOGRAPHY; NORTHERN MANHATTAN STROKE; RISK-FACTORS; METABOLIC SYNDROME; CHINESE PATIENTS; TAIWAN	Background Asians have higher frequency of intracranial arterial stenosis. The present study aimed to compare the clinical features and outcomes of ischemic stroke patients with and without middle cerebral artery (MCA) stenosis, assessed by transcranial sonography (TCS), based on the Taiwan Stroke Registry (TSR). Methods Patients with acute ischemic stroke or transient ischemic attack registered in the TSR, and received both carotid duplex and TCS assessment were categorized into those with stenosis (>= 50%) and without (< 50%) in the extracranial internal carotid artery (ICA) and MCA,respectively. Logistic regression analysis, Kaplan-Meier method and Cox proportional hazard model were applied to assess relevant variables between groups. Results Of 6003 patients, 23.3% had MCA stenosis, 10.1% ICA stenosis, and 3.9% both MCA and ICA stenosis. Patients with MCA stenosis had greater initial NIHSS, higher likelihood of stroke-in-evolution, and more severe disability than those without (all p < 0.001). Patients with MCA stenosis had higher prevalence of hypertension, diabetes and hypercholesterolemia. Patients with combined MCA and extracranial ICA stenosis had even higher NIHSS, worse functional outcome, higher risk of stroke recurrence or death (hazard ratio, 2.204; 95% confidence intervals, 1.440-3.374; p < 0.001) at 3 months after stroke than those without MCA stenosis. Conclusions In conclusion, MCA stenosis was more prevalent than extracranial ICA stenosis in ischemic stroke patients in Taiwan. Patients with MCA stenosis, especially combined extracranial ICA stenosis, had more severe neurological deficit and worse outcome.	[Jeng, Jiann-Shing; Tang, Sung-Chun] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Hsieh, Fang-I; Chiou, Hung-Yi] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan; [Yeh, Hsu-Ling; Chen, Wei-Hung; Chiu, Hou-Chang; Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan; [Liu, Chung-Hsiang] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Lin, Huey-Juan] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Hsu, Shih-Pin] E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lo, Yuk-Keung] Kaohsiung Vet Gen Hosp, Neurol Sect, Kaohsiung, Taiwan; [Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chen, Chih-Hung] Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chen, Yu-Wei] Landseed Hosp, Dept Neurol, Taoyuan, Taiwan; [Lee, Jiunn-Tay] Tri Serv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Yeh, Chung-Hsin] Yuan Rung Hosp, Dept Neurol, Changhua, Taiwan; [Sun, Ming-Hui] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lai, Ta-Chang] Cheng Hsin Gen Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Chen, Po-Lin] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Chiang, Tsuey-Ru] Cathay Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Shinn-Kuang] Buddhist Tzu Chi Gen Hosp, Dept Neurol, Taipei Branch, New Taipei, Taiwan; [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Dept Neurol, Hsinchu Branch, Hsinchu, Taiwan; [Chen, Chin-I] Taipei Med Univ, Wan Fang Hosp, Dept Neurol, Taipei, Taiwan; [Bai, Chi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan; [Chen, Sien-Tsong] Chang Gung Mem Hosp, Dept Neurol, Linkou, Taiwan; [Lien, Li-Ming] Taipei Med Univ, Coll Med, Dept Neurol, Taipei, Taiwan; [Hsu, Chung Y.] China Med Univ & Hosp, Grad Inst Clin Med Sci, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chi Mei Hospital; E-Da Hospital; Kaohsiung Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tri-Service General Hospital; Cheng Hsin General Hospital; Changhua Christian Hospital; Taichung Veterans General Hospital; Cathay General Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lien, LM (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan.; Lien, LM (corresponding author), Taipei Med Univ, Coll Med, Dept Neurol, Taipei, Taiwan.	limingmd@ms28.hinet.net	Chan, Lung/AAM-3231-2021; Chan, Lung/AAI-6349-2020	Chan, Lung/0000-0001-5795-4460; Chiou, Hung Yi/0000-0002-4545-9697; JENG, JIANN-SHING/0000-0002-1456-3686; Hsu, Chung Y./0000-0002-5632-2733; Tang, Sung-Chun/0000-0003-3731-5973; Yip, Bak-Sau/0000-0001-7942-8293	Bureau of Health Promotion; Department of Health Taiwan Stroke Registry grant [DOH-9598-HP-1102]; Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; Center of Excellence for Clinical Trial and Research in Neuroscience, Taiwan [DOH102-TD-B-111-003]; Ministry of Health and Welfare, Taiwan [MOHW105-TDU-B-212-133018]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325B-039 -006]; Taiwan Ministry of Science and Technology [MOST 105-2314-B-341-004]; Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302103-DR-17]; Chi-Chin Huang Stroke Research Center, Taipei, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Bureau of Health Promotion; Department of Health Taiwan Stroke Registry grant; Department of Health Clinical Trial and Research Center of Excellence; Center of Excellence for Clinical Trial and Research in Neuroscience, Taiwan; Ministry of Health and Welfare, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Taiwan Ministry of Science and Technology; Shin Kong Wu Ho-Su Memorial Hospital; Chi-Chin Huang Stroke Research Center, Taipei, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This project was funded by the Bureau of Health Promotion, Department of Health Taiwan Stroke Registry grant (DOH-9598-HP-1102); Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), Center of Excellence for Clinical Trial and Research in Neuroscience (DOH102-TD-B-111-003), Taiwan; the Ministry of Health and Welfare (MOHW105-TDU-B-212-133018), Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092), NRPB Stroke Clinical Trial Consortium (MOST 103-2325B-039 -006); Taiwan Ministry of Science and Technology (MOST 105-2314-B-341-004); Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302103-DR-17); Dr. Chi-Chin Huang Stroke Research Center, Taipei, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Battistella V, 2014, EUR J NEUROL, V21, P956, DOI 10.1111/ene.12385; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; De Silva DA, 2007, STROKE, V38, P2592, DOI 10.1161/STROKEAHA.107.484584; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Famakin BM, 2009, STROKE, V40, P1999, DOI 10.1161/STROKEAHA.108.546150; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Hao Q, 2010, J NEUROIMAGING, V20, P122, DOI 10.1111/j.1552-6569.2008.00337.x; Holzer Katrin, 2009, BMC Med Imaging, V9, P13, DOI 10.1186/1471-2342-9-13; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Jeng JS, 2010, EXPERT REV CARDIOVAS, V8, P1423, DOI 10.1586/ERC.10.129; JENG JS, 1994, STROKE, V25, P1989, DOI 10.1161/01.STR.25.10.1989; Kappelle IJ, 1999, STROKE, V30, P282, DOI 10.1161/01.STR.30.2.282; Kern R, 2005, NEUROLOGY, V65, P859, DOI 10.1212/01.wnl.0000175983.76110.59; Lee SJ, 2003, ARCH NEUROL-CHICAGO, V60, P1561, DOI 10.1001/archneur.60.11.1561; Liu HM, 1996, STROKE, V27, P650, DOI 10.1161/01.STR.27.4.650; Meseguer E, 2010, ANN NEUROL, V68, P9, DOI 10.1002/ana.21921; Nahab F, 2008, STROKE, V39, P1039, DOI 10.1161/STROKEAHA.107.499475; Navarro JC, 2007, CEREBROVASC DIS, V23, P325, DOI 10.1159/000099130; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; Qureshi AI, 2014, LANCET, V383, P984, DOI 10.1016/S0140-6736(13)61088-0; Rincon F, 2009, CEREBROVASC DIS, V28, P65, DOI 10.1159/000219299; ROTHER J, 1994, CEREBROVASC DIS, V4, P273, DOI 10.1159/000108494; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Stelagowski M, 2010, ANN VASC SURG, V24, P786, DOI 10.1016/j.avsg.2010.02.033; Tang SC, 2005, J ULTRAS MED, V24, P451, DOI 10.7863/jum.2005.24.4.451; Turan TN, 2010, STROKE, V41, P1636, DOI 10.1161/STROKEAHA.110.584672; Wang YJ, 2014, STROKE, V45, P663, DOI 10.1161/STROKEAHA.113.003508; Weimar C, 2006, ARCH NEUROL-CHICAGO, V63, P1287, DOI 10.1001/archneur.63.9.1287; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Zhao LM, 2011, STROKE, V42, P3429, DOI 10.1161/STROKEAHA.111.621235	40	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175434	10.1371/journal.pone.0175434	http://dx.doi.org/10.1371/journal.pone.0175434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388675	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800055
J	Kanari, K; Sakamoto, K; Kaneko, H				Kanari, Kei; Sakamoto, Kiyomi; Kaneko, Hirohiko			Effect of visual attention on the properties of optokinetic nystagmus	PLOS ONE			English	Article							MOTION STIMULI; EYE-MOVEMENTS; MICROSACCADES; STATIONARY; SMOOTH; TARGET	It has been demonstrated that optokinetic nystagmus (OKN) gain increases through attention to peripheral motion when the central visual field is occluded. However, how the properties of OKN change when two areas containing motion in different directions are presented in the peripheral visual field is still unclear. In this study, we investigated whether OKN corresponding to the attended motion in the periphery occurred while the observer was maintaining fixation at the center. We presented two areas with different directions of motion arranged on the left and right, top and bottom, or center and surrounding (concentric) areas in the display. Observers counted targets appearing on the attended area in the stimulus to maintain their attention on it. The results indicate that attention enhances the gain and frequency of OKN corresponding to the attended motion even in the case of stimuli having several areas with different directions of motion.	[Kanari, Kei; Kaneko, Hirohiko] Tokyo Inst Technol, Sch Engn, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan; [Sakamoto, Kiyomi] Panasonic Corp, Groupwide CTO Off, Tech Informat Serv Dept, Kadoma, Osaka, Japan	Tokyo Institute of Technology; Panasonic	Kanari, K (corresponding author), Tokyo Inst Technol, Sch Engn, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan.	kei.kanari@ip.titech.ac.jp	Kanari, Kei/AAY-5764-2020	Kanari, Kei/0000-0003-4379-5758	Japan Science and Technology Agency [AS2621022H]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by A-STEP FS (no. AS2621022H) from Japan Science and Technology Agency. URL: https://www.jst.go.jp/EN/index.html. Grant Recipient: HK. Panasonic Corporation provided support in the form of salaries for authors [KS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abadi RV, 2005, PERCEPTION, V34, P1015, DOI 10.1068/p5251b; BARNES GR, 1985, EXP BRAIN RES, V59, P548; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carpenter RHS, 1991, EYE MOVEMENTS; CHENG M, 1975, EXP BRAIN RES, V23, P129; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Dichgans J., 1977, CONTROL GAZE BRAIN S, P261; DUBOIS MFW, 1979, VISION RES, V19, P1105, DOI 10.1016/0042-6989(79)90005-1; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; GRESTY M, 1979, ACTA OTO-LARYNGOL, V87, P477, DOI 10.3109/00016487909126455; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; HOWARD IP, 1987, VISION RES, V27, P1807, DOI 10.1016/0042-6989(87)90109-X; Kleiner M, 2007, PERCEPTION, V36, P14; KOWLER E, 1984, VISION RES, V24, P1789, DOI 10.1016/0042-6989(84)90010-5; Maruyama M, 2003, EXP BRAIN RES, V151, P411, DOI 10.1007/s00221-003-1497-2; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; MURASUGI CM, 1989, EXP BRAIN RES, V77, P183; MURASUGI CM, 1986, VISION RES, V26, P1155, DOI 10.1016/0042-6989(86)90049-0; MURPHY BJ, 1975, VISION RES, V15, P1263, DOI 10.1016/0042-6989(75)90172-8; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Posner MI, CHRONOMETRIC EXPLORA, P197; Rubinstein NJ, 2011, INVEST OPHTH VIS SCI, V52, P462, DOI 10.1167/iovs.10-6016; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072041; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052955; van Die G, 1982, Hum Neurobiol, V1, P111; VANDENBERG AV, 1988, EXP BRAIN RES, V70, P597, DOI 10.1007/BF00247608; VIRSU V, 1979, EXP BRAIN RES, V37, P475; Williams IM, 2006, J CLIN NEUROSCI, V13, P828, DOI 10.1016/j.jocn.2005.10.010	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175453	10.1371/journal.pone.0175453	http://dx.doi.org/10.1371/journal.pone.0175453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388668	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800057
J	Neves, RAF; Fernandes, T; dos Santos, LN; Nascimento, SM				Neves, Raquel A. F.; Fernandes, Taina; dos Santos, Luciano Neves; Nascimento, Silvia M.			Toxicity of benthic dinoflagellates on grazing, behavior and survival of the brine shrimp Artemia salina	PLOS ONE			English	Article							OSTREOPSIS CF. OVATA; HARMFUL ALGAL BLOOMS; PARALYTIC SHELLFISH TOXINS; PROROCENTRUM-LIMA; ALEXANDRIUM-FUNDYENSE; DINOPHYCEAE; PHYTOPLANKTON; PALYTOXIN; RESPONSES; COPEPODS	Harmful algae may differently affect their primary grazers, causing sub-lethal effects and/ or leading to their death. The present study aim to compare the effects of three toxic benthic dinoflagellates on clearance and grazing rates, behavioral changes, and survival of Artemia salina. Feeding assays consisted in 1-h incubations of brine shrimps with the toxic Prorocentrum lima, Gambierdiscus excentricus and Ostreopsis cf. ovata and the non-toxic Tetraselmis sp. Brine shrimps fed unselectively on all toxic and non-toxic algal preys, without significant differences in clearance and ingestion rates. Acute toxicity assays were performed with dinoflagellate cells in two growth phases during 7-h to assess differences in cell toxicity to A. salina. Additionally, exposure to cell-free medium was performed to evaluate its effects on A. salina survival. The behavior of brine shrimps significantly changed during exposure to the toxic dinoflagellates, becoming immobile at the bottom by the end of the trials. Dinoflagellates significantly affected A. salina survival with 100% mortality after 7-h exposure to cells in exponential phase (all treatments) and to P. lima in stationary phase. Mortality rates of brine shrimps exposed to O. cf. ovata and G. excentricus in stationary phase were 91% and 75%, respectively. However, incubations of the brine shrimps with cell-free medium did not affect A. salina survivorship. Significant differences in toxic effects between cell growth phases were only found in the survival rates of A. salina exposed to G. excentricus. Acute exposure to benthic toxic dinoflagellates induced harmful effects on behavior and survival of A. salina. Negative effects related to the toxicity of benthic dinoflagellates are thus expected on their primary grazers making them more vulnerable to predation and vectors of toxins through the marine food webs.	[Neves, Raquel A. F.; Fernandes, Taina; Nascimento, Silvia M.] Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Ecol & Recursos Marinhos, Lab Microalgas Marinhas, Rio De Janeiro, Brazil; [dos Santos, Luciano Neves] Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Ecol & Recursos Marinhos, Lab Ictiol Teor & Aplicada, Rio De Janeiro, Brazil; [dos Santos, Luciano Neves; Nascimento, Silvia M.] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Biodiversidade Neotrop PPGBIO, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro	dos Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Ecol & Recursos Marinhos, Lab Ictiol Teor & Aplicada, Rio De Janeiro, Brazil.; dos Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Biodiversidade Neotrop PPGBIO, Rio De Janeiro, Brazil.	luciano.santos@unirio.br	Neves, Raquel A. F./D-5128-2015; Nascimento, Silvia M/G-4460-2013; Santos, Luciano/M-4377-2015	Neves, Raquel A. F./0000-0002-2627-9666; Nascimento, Silvia M/0000-0002-5149-4181; Santos, Luciano/0000-0002-5279-5672	Graduate Course in Neotropical Biodiversity (PPGBIO-UNIRIO); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ [E-26/203.493/2015]	Graduate Course in Neotropical Biodiversity (PPGBIO-UNIRIO); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Partial funding was provided by the Graduate Course in Neotropical Biodiversity (PPGBIO-UNIRIO) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (grant n<SUP>o</SUP> E-26/203.493/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoroni Stefano, 2016, Advances in Oceanography and Limnology, V7, P1, DOI 10.4081/aiol.2016.5591; Ajuzie CC, 2007, J APPL PHYCOL, V19, P513, DOI 10.1007/s10811-007-9164-9; Aligizaki K, 2009, P 7 INT C MOLL SHELL, P1; Aligizaki K, 2011, TOXICON, V57, P390, DOI 10.1016/j.toxicon.2010.11.014; [Anonymous], 2012, GLOBAL ECOLOGY OCEAN; Bagoien E, 1996, MAR BIOL, V126, P361, DOI 10.1007/BF00354618; Basti L, 2009, AQUACULTURE, V291, P41, DOI 10.1016/j.aquaculture.2009.02.029; Beattie KA, 2003, AQUAT TOXICOL, V62, P219, DOI 10.1016/S0166-445X(02)00091-7; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Demaret A, 1995, P 6 INT C TOX MAR PH, P427; Engstrom-Ost J, 2002, J EXP MAR BIOL ECOL, V276, P95, DOI 10.1016/S0022-0981(02)00241-1; Faimali M, 2012, MAR ENVIRON RES, V76, P97, DOI 10.1016/j.marenvres.2011.09.010; Fleming L. E., 1998, HARMFUL ALGAE, P245; FORWARD RB, 1993, J PLANKTON RES, V15, P693, DOI 10.1093/plankt/15.6.693; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Furlan M, 2013, HARMFUL ALGAE, V21-22, P20, DOI 10.1016/j.hal.2012.11.004; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Gayoso AM, 2002, J SHELLFISH RES, V21, P461; Giussani V, 2016, HARMFUL ALGAE, V57, P49, DOI 10.1016/j.hal.2016.05.005; Graneli E., 2002, 10 INT C HARMF ALG S, P113; Graneli E, 2011, HARMFUL ALGAE, V10, P165, DOI 10.1016/j.hal.2010.09.002; Guerrini F, 2010, TOXICON, V55, P211, DOI 10.1016/j.toxicon.2009.07.019; Guillard R.R.L., 1995, MANUAL HARMFUL MARIN, P45; Guisande C, 2002, MAR ECOL PROG SER, V240, P105, DOI 10.3354/meps240105; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hegaret H, 2007, J SHELLFISH RES, V26, P549, DOI 10.2983/0730-8000(2007)26[549:DFROFS]2.0.CO;2; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Holland WC, 2013, TOXICON, V65, P15, DOI 10.1016/j.toxicon.2012.12.016; Hoppenrath M, 2013, HARMFUL ALGAE, V27, P1, DOI 10.1016/j.hal.2013.03.006; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hwang BS, 2013, BIOORG MED CHEM LETT, V23, P3023, DOI 10.1016/j.bmcl.2013.03.020; Issam E, 2010, ECOTOX ENVIRON SAFE, V73, P762, DOI 10.1016/j.ecoenv.2009.12.015; KELLY AM, 1992, ENVIRON BIOL FISH, V33, P275, DOI 10.1007/BF00005871; Koike K, 1998, TOXICON, V36, P2039, DOI 10.1016/S0041-0101(98)00132-9; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lasley-Rasher RS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0176; Lawrence J. E., 1998, HARMFUL ALGAE, P78; Lee KW, 2014, HARMFUL ALGAE, V37, P62, DOI 10.1016/j.hal.2014.05.007; Leps J, 2003, MULTIVARIATE ANAL EC; Lincoln JA, 2001, HYDROBIOLOGIA, V453, P107, DOI 10.1023/A:1013163816771; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; Lopes VM, 2014, AQUAT TOXICOL, V146, P205, DOI 10.1016/j.aquatox.2013.11.011; Mangialajo L, 2008, MAR POLLUT BULL, V56, P1209, DOI 10.1016/j.marpolbul.2008.02.028; Marcoval MA, 2013, ESTUAR COAST SHELF S, V131, P235, DOI 10.1016/j.ecss.2013.05.034; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MURATA M, 1982, B JPN SOC SCI FISH, V48, P549; Nascimento SM, 2016, HARMFUL ALGAE, V57, P39, DOI 10.1016/j.hal.2016.05.006; Nascimento SM, 2012, HARMFUL ALGAE, V13, P1, DOI 10.1016/j.hal.2011.09.008; Nascimento SM, 2015, PHYCOLOGIA, V54, P628, DOI 10.2216/15-61.1; Nascimento SM, 2005, TOXICON, V45, P633, DOI 10.1016/j.toxicon.2004.12.023; Neves RAF, 2015, AQUAT TOXICOL, V160, P96, DOI 10.1016/j.aquatox.2015.01.010; Nunes BS, 2006, ENVIRON POLLUT, V144, P453, DOI 10.1016/j.envpol.2005.12.037; OHMAN MD, 1991, BIOL BULL, V181, P500, DOI 10.2307/1542370; Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Ramos V, 2010, MAR DRUGS, V8, P2021, DOI 10.3390/md8072021; Rhodes L., 2008, P 6 INT C MOLL SHELL, P168; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Samson JC, 2008, J FISH BIOL, V72, P168, DOI 10.1111/j.1095-8649.2007.01698.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Shumway SE, 2006, HARMFUL ALGAE, V5, P442, DOI 10.1016/j.hal.2006.04.013; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Silva NJ, 2013, J PLANKTON RES, V35, P855, DOI 10.1093/plankt/fbt026; Sopanen S, 2011, J PLANKTON RES, V33, P1564, DOI 10.1093/plankt/fbr052; Tan ZJ, 2007, BIOMED ENVIRON SCI, V20, P235; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; Turner JT, 2005, DEEP-SEA RES PT II, V52, P2801, DOI 10.1016/j.dsr2.2005.06.011; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; Turner JT, 1998, MAR ECOL-P S Z N I, V19, P195, DOI 10.1111/j.1439-0485.1998.tb00462.x; Vasconcelos V, 2010, MAR DRUGS, V8, P59, DOI 10.3390/md8010059; Wu Zhen-Xing, 2006, Acta Ecologica Sinica, V26, P3942	70	25	25	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175168	10.1371/journal.pone.0175168	http://dx.doi.org/10.1371/journal.pone.0175168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388672	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800026
J	Aklilu, E; Gebresilassie, A; Yared, S; Kindu, M; Tekie, H; Balkew, M; Warburg, A; Hailu, A; Gebre-Michael, T				Aklilu, Esayas; Gebresilassie, Araya; Yared, Solomon; Kindu, Mizan; Tekie, Habte; Balkew, Meshesha; Warburg, Alon; Hailu, Asrat; Gebre-Michael, Teshome			Studies on sand fly fauna and ecological analysis of Phlebotomus orientalis in the highland and lowland foci of kala-azar in northwestern Ethiopia	PLOS ONE			English	Article							VISCERAL-LEISHMANIASIS; POTENTIAL DISTRIBUTION; POPULATION-DYNAMICS; SPECIES COMPOSITION; DOMESTIC HABITATS; BERGEROTI DIPTERA; BREEDING SITES; ENDEMIC FOCUS; AMHARA REGION; PSYCHODIDAE	Background Visceral leishmaniasis (VL) also known as kala-azar is a growing health problem in Ethiopia with an estimated annual VL incidence between 3700 and 7400. The disease is mainly endemic in northwestern parts of the country. The aim of the current study was to determine the sand fly fauna and ecology of Phlebotomus orientalis in two endemic and ecologically distinct areas of northwestern Ethiopia. Methods Sand flies were collected using CDC light traps, sticky traps and pyrethrum spray catches from peri-domestic, mixed forest, farm field and indoor habitats from both Libo-Kemkem (May 2011-April 2012) and Metema (October 2012-September 2013) districts. Results A total of 51,411 sand fly specimens were collected and identified (10,776 from highland and 40, 635 from the lowland areas). Seven species were found in the highland area: two Phlebotomus spp. (P. orientalis and P. rodhaini) and five Sergentomyia species. Whereas 19 species were found in the lowland area: six Phlebotomus (P. orientalis, P. rodhaini, P. Phle-geroti, P. duboscqi, P. papatasi and P. martini) and 13 Sergentomyia species. Of the Phlebotomus spp., P. orientalis was the predominant species in both the highland (99.9%) and lowland (93.7%) areas. Indoor collections using pyrethrum spray catches and sticky traps indicated that P. orientalis has a strong exophilic and exophagic behaviors in both districts. In both areas, this species showed seasonal occurrence and showing abundance during the dry months (March-May/June) of the year and increasing in numbers till the rain season, when numbers dropped dramatically. Mean density of P. orientalis in the two areas had positive and significant correlation with mean temperature in light trap collections (P<0.05). However, mean density of P. orientalis in the two areas in sticky trap collections had positive and insignificant association with the temperature (P>0.05). Regarding the rainfall pattern, density of P. orientalis had negative and statistically insignificant correlation (for light trap collections for both areas) and significant correlation (for sticky trap collections for lowland area). Conclusions The current study indicated the variation in sand fly fauna between the highland and lowland districts, wherein, P. orientalis was found to be the most abundant Phlebotomus species. The study also determined that P. orientalis exhibits distinct seasonality, where its abundance increases during the dry season and disappears when the rainy period starts in both study areas. This entomological observation on the bionomics of P. orientalis provides significant evidence for considering vector control or preventive measures in the areas studied.	[Aklilu, Esayas; Kindu, Mizan] Mada Walabu Univ, Dept Biol, Bale, Ethiopia; [Gebresilassie, Araya; Yared, Solomon] Jigjiga Univ, Dept Biol, Jigjiga, Ethiopia; [Tekie, Habte] Univ Addis Ababa, Dept Zool Sci, Addis Ababa, Ethiopia; [Balkew, Meshesha; Gebre-Michael, Teshome] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Warburg, Alon] Hebrew Univ Jerusalem, Hadassah Med Sch, Fac Med,Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet,Inst Med Res Israel Ca, Jerusalem, Israel; [Hailu, Asrat] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Hebrew University of Jerusalem; Addis Ababa University	Aklilu, E (corresponding author), Mada Walabu Univ, Dept Biol, Bale, Ethiopia.	reyeesayas@gmail.com	Warburg, Alon/ABE-9946-2020; Hailu, Asrat/AAM-6982-2020; Yared, Solomon/AAX-2429-2021	Warburg, Alon/0000-0001-7929-3114; Yared, Solomon/0000-0003-1510-8316; Maasho, Habte Tekie/0000-0003-2228-5249	Bill and Melinda Gates Foundation Global Health Program [OPPGH5336]	Bill and Melinda Gates Foundation Global Health Program(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336) provided financial support.; Authors are grateful to the people of Libo-Kemkem and Metema districts for their determined support during the study. We also thank our field and laboratory assistant Mr. Gashaw Mihiret for his helps in carrying out this study. The Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336) provided financial support.	Abonnenc E, 1965, MEM OFF RECH SCI TEC, V5, P1; Alexander B, 2000, MED VET ENTOMOL, V14, P109, DOI 10.1046/j.1365-2915.2000.00237.x; Alvar J, 2007, AM J TROP MED HYG, V77, P275; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ASHFORD RW, 1992, T ROY SOC TROP MED H, V86, P379, DOI 10.1016/0035-9203(92)90229-6; Bashaye S, 2009, AM J TROP MED HYG, V81, P34, DOI 10.4269/ajtmh.2009.81.34; Elnaiem DA, 1998, ANN TROP MED PARASIT, V92, P229, DOI 10.1080/00034989860085; Elnaiem DA, 1997, ANN TROP MED PARASIT, V91, P307, DOI 10.1080/00034989761157; Gebre-Michael T, 2007, ANN TROP MED PARASIT, V101, P367, DOI 10.1179/136485907X176382; Gebre-Michael T, 2004, ACTA TROP, V90, P73, DOI 10.1016/j.actatropica.2003.09.021; Gebre-Michael T, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-6; GEBREMICHAEL T, 1993, T ROY SOC TROP MED H, V87, P10, DOI 10.1016/0035-9203(93)90399-B; GebreMichael T, 1997, J MED ENTOMOL, V34, P383, DOI 10.1093/jmedent/34.4.383; GebreMichael T, 1996, MED VET ENTOMOL, V10, P53, DOI 10.1111/j.1365-2915.1996.tb00082.x; Gebresilassie A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0849-7; Gemetchu T., 1983, Sinet (Addis Ababa), V6, P65; Guernaoui S, 2006, ACTA TROP, V97, P346, DOI 10.1016/j.actatropica.2006.01.001; Gupta A, 2013, INT J TROP DIS HLTH, V3, P73; Hailu A., 2006, EPIDEMIOLOGY ECOLOGY, P615, DOI DOI 10.1186/1756-3305-2-60; Heip Carlo H. R., 1998, Oceanis, V24, P61; HOOGSTRAAL H, 1969, AM J TROP MED HYG, V18, P1091, DOI 10.4269/ajtmh.1969.18.1091; JANINI R, 1995, J MED ENTOMOL, V32, P822, DOI 10.1093/jmedent/32.6.822; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Lambert M, 2002, ANN TROP MED PARASIT, V96, P631, DOI 10.1179/000349802125001474; LANE RP, 1986, SYST ENTOMOL, V11, P439, DOI 10.1111/j.1365-3113.1986.tb00535.x; Lemma W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-359; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; Moncaz A, 2014, ACTA TROP, V139, P5, DOI 10.1016/j.actatropica.2014.06.013; Moncaz A, 2014, ACTA TROP, V137, P88, DOI 10.1016/j.actatropica.2014.05.005; Ozbel Y, 2011, J VECTOR ECOL, V36, pS99, DOI 10.1111/j.1948-7134.2011.00118.x; PERKINS PV, 1988, T ROY SOC TROP MED H, V82, P695, DOI 10.1016/0035-9203(88)90204-0; QUATE LAURENCE W., 1964, J MED ENTOMOL, V1, P213, DOI 10.1093/jmedent/1.3.213; Seblova V, 2013, PLOS NEG TROPL DIS, V4, P2187; Service M. W., 1993, FIELD SAMPLING METHO; Shabtai IA, 2014, SOIL TILL RES, V136, P19, DOI 10.1016/j.still.2013.09.007; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Thomson MC, 1999, TROP MED INT HEALTH, V4, P105, DOI 10.1046/j.1365-3156.1999.00368.x; Wheeler AS, 1996, MED VET ENTOMOL, V10, P295, DOI 10.1111/j.1365-2915.1996.tb00747.x; WHO, 2006, WHO TECH REP SER, V936, P1; WHO, 2010, WHO TECH REP SER, V949, P1	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175308	10.1371/journal.pone.0175308	http://dx.doi.org/10.1371/journal.pone.0175308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384307	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900152
J	Dar, QA; Schott, EM; Catheline, SE; Maynard, RD; Liu, ZY; Kamal, F; Farnsworth, CW; Ketz, JP; Mooney, RA; Hilton, MJ; Jonason, JH; Prawitt, J; Zuscik, MJ				Dar, Qurratul-Ain; Schott, Eric M.; Catheline, Sarah E.; Maynard, Robert D.; Liu, Zhaoyang; Kamal, Fadia; Farnsworth, Christopher W.; Ketz, John P.; Mooney, Robert A.; Hilton, Matthew J.; Jonason, Jennifer H.; Prawitt, Janne; Zuscik, Michael J.			Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis	PLOS ONE			English	Article							HYALURONIC-ACID SYNTHESIS; II COLLAGEN; KNEE OSTEOARTHRITIS; CHONDROITIN SULFATE; GLUCOSAMINE SULFATE; THERAPEUTIC AGENTS; INDUCED ARTHRITIS; ANIMAL-MODELS; CARTILAGE; RATS	Osteoarthritis (OA) is a degenerative joint disease for which there are no disease modifying therapies. Thus, strategies that offer chondroprotective or regenerative capability represent a critical unmet need. Recently, oral consumption of a hydrolyzed type 1 collagen (hCol1) preparation has been reported to reduce pain in human OA and support a positive influence on chondrocyte function. To evaluate the tissue and cellular basis for these effects, we examined the impact of orally administered hCol1 in a model of posttraumatic OA (PTOA). In addition to standard chow, male C57BL/6J mice were provided a daily oral dietary supplement of hCol1 and a meniscal-ligamentous injury was induced on the right knee. At various time points post-injury, hydroxyproline (hProline) assays were performed on blood samples to confirm hCol1 delivery, and joints were harvested for tissue and molecular analyses were performed, including histomorphometry, OARSI and synovial scoring, immunohistochemistry and mRNA expression studies. Confirming ingestion of the supplements, serum hProline levels were elevated in experimental mice administered hCol1. In the hCol1 supplemented mice, chondroprotective effects were observed in injured knee joints, with dose-dependent increases in cartilage area, chondrocyte number and proteoglycan matrix at 3 and 12 weeks post-injury. Preservation of cartilage and increased chondrocyte numbers correlated with reductions in MMP13 protein levels and apoptosis, respectively. Supplemented mice also displayed reduced synovial hyperplasia that paralleled a reduction in Tnf mRNA, suggesting an anti-inflammatory effect. These findings establish that in the context of murine knee PTOA, daily oral consumption of hCol1 is chondroprotective, anti-apoptotic in articular chondrocytes, and anti-inflammatory. While the underlying mechanism driving these effects is yet to be determined, these findings provide the first tissue and cellular level information explaining the already published evidence of symptom relief supported by hCol1 in human knee OA. These results suggest that oral consumption of hCol1 is disease modifying in the context of PTOA.	[Dar, Qurratul-Ain; Schott, Eric M.; Catheline, Sarah E.; Maynard, Robert D.; Liu, Zhaoyang; Kamal, Fadia; Farnsworth, Christopher W.; Ketz, John P.; Mooney, Robert A.; Jonason, Jennifer H.; Zuscik, Michael J.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Dar, Qurratul-Ain] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Schott, Eric M.; Catheline, Sarah E.; Maynard, Robert D.; Farnsworth, Christopher W.; Mooney, Robert A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Kamal, Fadia; Ketz, John P.; Jonason, Jennifer H.; Zuscik, Michael J.] Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Hilton, Matthew J.] Duke Univ, Orthopaed Cellular Dev & Genome Labs, Durham, NC USA; [Prawitt, Janne] Rousselot BVBA, Ghent, Belgium	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Duke University	Zuscik, MJ (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.; Zuscik, MJ (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA.	michael_zuscik@urmc.rochester.edu	Kamal, Fadia/AAP-1798-2021	Zuscik, Michael/0000-0003-0461-8708; Hilton, Matthew/0000-0003-3165-267X; Liu, Zhaoyang/0000-0002-8032-1167; Catheline, Sarah/0000-0003-3550-7699	Rousselot BVBA [057066]; NIH/NIAMS [5P50 AR054041-5471, 5R01 AR063071, 5T32 AR053459, 1P30 AR069655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063071, P30AR069655] Funding Source: NIH RePORTER	Rousselot BVBA; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Rousselot BVBA contract number 057066 (MJZ, study design, data collection, data analysis, data interpretation, writing), NIH/NIAMS 5P50 AR054041-5471 (MJZ, study design, data interpretation, writing), NIH/NIAMS 5R01 AR063071 (MJH, study design), NIH/NIAMS 5T32 AR053459 (data collection, data analysis, data interpretation), and NIH/NIAMS Core Center Grant 1P30 AR069655 (data collection).	Asserin J, 2015, J COSMET DERMATOL-US, V14, P291, DOI 10.1111/jocd.12174; Blaker CL, 2016, J ORTHOP RES; Bottegoni C, 2014, CARBOHYD POLYM, V109, P126, DOI 10.1016/j.carbpol.2014.03.033; Bruyere O, 2006, ANN RHEUM DIS, V65, P1050, DOI 10.1136/ard.2005.045914; Bruyere O, 2007, DRUG AGING, V24, P573, DOI 10.2165/00002512-200724070-00005; Bruyere O, 2016, SEMIN ARTHRITIS RHEU, V45, pS12, DOI 10.1016/j.semarthrit.2015.11.011; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Christgau S, 2004, CLIN EXP RHEUMATOL, V22, P36; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Deal CL, 1999, RHEUM DIS CLIN N AM, V25, P379, DOI 10.1016/S0889-857X(05)70074-0; Deparle LA, 2005, J VET PHARMACOL THER, V28, P385, DOI 10.1111/j.1365-2885.2005.00668.x; FDA, 1975, DAT SEL COMM GRAS SU; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Goldring MB., 2015, POSTRAUMATIC ARTHRIT, P201; Golightly Y. M., 2015, POSTTRAUMATIC ARTHRI, P317; Guillerminet F, 2010, BONE, V46, P827, DOI 10.1016/j.bone.2009.10.035; Gupta RC, 2009, J VET PHARMACOL THER, V32, P577, DOI 10.1111/j.1365-2885.2009.01079.x; Hamada D, 2015, ARTHRITIS RHEUMATOLO; Hamada D, 2014, METHODS MOL BIOL, V1130, P61, DOI 10.1007/978-1-62703-989-5_5; Henrotin Y, 2014, SEMIN ARTHRITIS RHEU, V43, P579, DOI 10.1016/j.semarthrit.2013.10.005; Hunter DJ, 2014, BEST PRACT RES CL RH, V28, P61, DOI 10.1016/j.berh.2014.01.007; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Ingberg E, 2012, GEN COMP ENDOCR, V175, P188, DOI 10.1016/j.ygcen.2011.11.014; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Jackix ED, 2010, J MED FOOD, V13, P1385, DOI 10.1089/jmf.2009.0256; Jiang JX, 2014, AGRO FOOD IND HI TEC, V25, P19; Kawaguchi T, 2012, BIOL PHARM BULL, V35, P422, DOI 10.1248/bpb.35.422; Kraus VB, 2011, OSTEOARTHR CARTILAGE, V19, P515, DOI 10.1016/j.joca.2010.08.019; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lugo JP, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0130-8; Malfait AM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0747-6; Matsuda N, 2006, J NUTR SCI VITAMINOL, V52, P211, DOI 10.3177/jnsv.52.211; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; Mevel E, 2014, DRUG DISCOV TODAY, V19, P1649, DOI 10.1016/j.drudis.2014.06.012; Mooney RA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3529; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; NAGLERANDERSON C, 1986, P NATL ACAD SCI USA, V83, P7443, DOI 10.1073/pnas.83.19.7443; Nakatani S, 2009, OSTEOARTHR CARTILAGE, V17, P1620, DOI 10.1016/j.joca.2009.07.001; Nomura Y, 2005, NUTRITION, V21, P1120, DOI 10.1016/j.nut.2005.03.007; Oesser S, 1999, J NUTR, V129, P1891, DOI 10.1093/jn/129.10.1891; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Ohara H, 2010, BIOSCI BIOTECH BIOCH, V74, P2096, DOI 10.1271/bbb.100193; Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x; Raabe O, 2010, HISTOCHEM CELL BIOL, V134, P545, DOI 10.1007/s00418-010-0760-4; Ragle RL, 2012, DRUG AGING, V29, P717, DOI 10.1007/s40266-012-0006-3; Ramadass SK, 2016, EUR J PHARM SCI, V91, P216, DOI 10.1016/j.ejps.2016.05.015; Salmon JH, 2016, OSTEOARTHR CARTILAGE, V24, P1500, DOI 10.1016/j.joca.2016.03.012; Sampson ER, 2011, J ORTHOP RES, V29, P1145, DOI 10.1002/jor.21368; Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214; Shigemura Y, 2014, FOOD CHEM, V159, P328, DOI 10.1016/j.foodchem.2014.02.091; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; Van Vijven JPJ, 2012, OSTEOARTHR CARTILAGE, V20, P809, DOI 10.1016/j.joca.2012.04.008; Watanabe-Kamiyama M, 2010, J AGR FOOD CHEM, V58, P835, DOI 10.1021/jf9031487; Yoshinari O, 2013, J MED FOOD, V16, P1039, DOI 10.1089/jmf.2013.2911; Yu SPC, 2015, EXPERT OPIN EMERG DR, V20, P361, DOI 10.1517/14728214.2015.1037275; Zhang LZ, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.37; Zhang YZ, 2010, J NUTR SCI VITAMINOL, V56, P208, DOI 10.3177/jnsv.56.208; ZHANG ZYJ, 1990, J IMMUNOL, V145, P2489	64	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174705	10.1371/journal.pone.0174705	http://dx.doi.org/10.1371/journal.pone.0174705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384173	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900027
J	Dobierzewska, A; Soman, S; Iilanes, SE; Morris, AJ				Dobierzewska, Aneta; Soman, Sony; Iilanes, Sebastian E.; Morris, Andrew J.			Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; PLACENTAL SYNCYTIOTROPHOBLAST; EXTRAVILLOUS TROPHOBLAST; IN-VITRO; PREGNANCY; SPHINGOSINE-1-PHOSPHATE; METABOLISM; APOPTOSIS; CERAMIDE; RISK	Introduction Preeclampsia (PE) is a gestational disorder, manifested in the second half of pregnancy by maternal hypertension, proteinuria and generalized edema. PE is a major cause of maternal and fetal morbidity and mortality, accounting for nearly 40% of all premature births worldwide. Bioactive sphingolipids are emerging as key molecules involved in etiopathogenesis of PE, characterized by maternal angiogenic imbalance and symptoms of metabolic syndrome. The aim of this study was to compare the cross-gestational profile of circulating bioactive sphingolipids in maternal plasma from preeclamptic (PE) versus normotensive control (CTL) subjects with the goal of identifying sphingolipids as candidate first trimester biomarkers of PE for early prediction of the disease. Methods A prospective cohort of patients was sampled at the first, second and third trimester of pregnancy for each patient (11-14, 22-24, and 32-36 weeks A gestation). A retrospective stratified study design was used to quantify different classes of sphingolipids in maternal plasma. We used a reverse-phase high-performance liquid chromatography-tandem mass spectrometry (HPLC-ESI-MS/MS) approach for determining different sphingolipid molecular species (sphingosine- 1-phosphate (S1P), dihydro-sphingosine-1-phosphate (DH-S1P), sphingomyelins (SM) and ceramides (Cer)) in cross-gestational samples of human plasma from PE (n = 7, 21 plasma samples across pregnancy) and CTL (n = 7, 21 plasma samples across pregnancy) patients. Results Plasma levels of angiogenic S1P did not change significantly in control and in preeclamptic patients A group across gestation. DH-S1P was significantly decreased in second trimester plasma of PE patients in comparison to their first trimester, which could contribute to reduced endothelial barrier observed in PE. The major ceramide species (Cer 16: 0 and Cer 24: 0) tended to be up-regulated in plasma of control and PE subjects across gestation. The levels of a less abundant plasma ceramide species (Cer 14: 0) were significantly lower in first trimester plasma of PE patients when compared with their gestational-matched control samples (p = 0.009). Major plasma sphingomyelin species (SM 16: 0, SM 18: 1 and SM 24: 0) tended to be higher in control pregnancies across gestation. However, in PE patients, SM 16: 0, SM 18: 0 and SM 18: 1 showed significant up-regulation across gestation, pointing to atherogenic properties of the sphingomyelins and particularly the potential contribution of SM 18: 0 to the disease development. In addition, two major sphingomyelins, SM 16: 0 and SM 18: 0, were significantly lower in first trimester plasma of PE patients versus first trimester samples of respective controls (p = 0.007 and p = 0.002, respectively). Conclusions Cross-gestational analysis of maternal plasma of preeclamptic and normotensive women identifies differences in the biochemical profile of major sphingolipids (DH-S1P, sphingomyelins and ceramides) between these two groups. In addition, first trimester maternal plasma sphingolipids (Cer 14: 0, SM 16: 0 and SM 18: 0) may serve in the future as early biomarkers of PE occurrence and development.	[Dobierzewska, Aneta; Iilanes, Sebastian E.] Univ Los Andes, Dept Obstet & Gynecol, Fac Med, Santiago, Chile; [Dobierzewska, Aneta; Iilanes, Sebastian E.] Univ Los Andes, Lab Reprod Biol, Fac Med, Santiago, Chile; [Soman, Sony; Morris, Andrew J.] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY USA; [Soman, Sony; Morris, Andrew J.] Univ Kentucky, Coll Med, Gill Heart Inst, Lexington, KY USA; [Soman, Sony; Morris, Andrew J.] US Dept Vet Affairs, Med Ctr Lexington, Lexington, KY USA	Universidad de los Andes - Chile; Universidad de los Andes - Chile; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Dobierzewska, A (corresponding author), Univ Los Andes, Dept Obstet & Gynecol, Fac Med, Santiago, Chile.; Dobierzewska, A (corresponding author), Univ Los Andes, Lab Reprod Biol, Fac Med, Santiago, Chile.	adobierzewska@uandes.cl		Illanes, Sebastian/0000-0001-5433-9315	FAI Inicacion grant (Fondo de Ayuda a la Investigacion Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; NIH; Department of Veterans Affairs; Veterans Affairs [I01CX001550, IS1BX003153] Funding Source: NIH RePORTER	FAI Inicacion grant (Fondo de Ayuda a la Investigacion Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by FAI Inicacion grant (Fondo de Ayuda a la Investigacion Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia" to AD and grants from the NIH and Department of Veterans Affairs to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Baig S, 2013, PLACENTA, V34, P436, DOI 10.1016/j.placenta.2013.02.004; Brown SHJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163972; Deevska GM, 2012, BIOSCIENCE REP, V32, P479, DOI 10.1042/BSR20120036; Dobierzewska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157221; Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Grammatikos G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138130; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Huppertz B, 2003, PLACENTA, V24, P181, DOI 10.1053/plac.2002.0903; Huppertz B, 1999, LAB INVEST, V79, P1687; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kaneko-Tarui T, 2007, BIOL REPROD, V77, P658, DOI 10.1095/biolreprod.107.061044; Kemp B, 2002, HISTOCHEM CELL BIOL, V117, P401, DOI 10.1007/s00418-002-0396-0; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Korkes HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110747; Lagana AS, 2016, J MATERN-FETAL NEO M, V29, P3019, DOI 10.3109/14767058.2015.1113522; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Mikat B., 2012, ISRN OBSTET GYNECOL, V2012; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Newhouse SM, 2007, PLACENTA, V28, P999, DOI 10.1016/j.placenta.2007.04.008; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Romanowicz L, 2010, MOL CELL BIOCHEM, V340, P81, DOI 10.1007/s11010-010-0403-z; Romanowicz L, 2009, CLIN BIOCHEM, V42, P1719, DOI 10.1016/j.clinbiochem.2009.07.011; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh AT, 2012, MOL CELL ENDOCRINOL, V362, P48, DOI 10.1016/j.mce.2012.05.009; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Skaznik-Wikiel ME, 2006, BIOL REPROD, V74, P569, DOI 10.1095/biolreprod.105.046714; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Wu Zhexue, 2014, J Lifestyle Med, V4, P17, DOI 10.15280/jlm.2014.4.1.17; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zhao YY, 2014, INT REV CEL MOL BIO, V313, P1, DOI 10.1016/B978-0-12-800177-6.00001-3	45	20	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175118	10.1371/journal.pone.0175118	http://dx.doi.org/10.1371/journal.pone.0175118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384202	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900091
J	Irwin, J; Ferguson, E; Simms, LA; Hanigan, K; Carbonnel, F; Radford-Smith, G				Irwin, James; Ferguson, Emma; Simms, Lisa A.; Hanigan, Katherine; Carbonnel, Franck; Radford-Smith, Graham			A rolling phenotype in Crohn's disease	PLOS ONE			English	Article							WORKING PARTY; MAINTENANCE; GASTROENTEROLOGY; CLASSIFICATION; METHOTREXATE; REMISSION; THERAPY; COHORT	Background and aim The Montreal classification of disease behaviour in Crohn's disease describes progression of disease towards a stricturing and penetrating phenotype. In the present paper, we propose an alternative representation of the long-term course of Crohn's disease complications, the rolling phenotype. As is commonly observed in clinical practice, this definition allows progression to a more severe phenotype (stricturing, penetrating) but also, regression to a less severe behaviour (inflammatory, or remission) over time. Methods All patients diagnosed with Crohn's Disease between 01/01/1994 and 01/03/2008, managed at a single centre and observed for a minimum of 5 years, had development and resolution of all complications recorded. A rolling phenotype was defined at each time point based on all observed complications in the three years prior to the time point. Phenotype was defined as B1, B2, B3, or B23 (penetrating and stenotic). The progression over time of the rolling phenotype was compared to that of the cumulative Montreal phenotype. Results 305 patients were observed a median of 10.0 (Intraquartile range 7.3-13.7) years. Longitudinal progression of rolling phenotype demonstrated a consistent proportion of patients with B1 (70%), B2 (20%), B3 (5%) and B23 (5%) phenotypes. These proportions were observed regardless of initial phenotype. In contrast, the cumulative Montreal phenotype progressed towards a more severe phenotype with time (B1 (39%), B2 (26%), B3(35%) at 10 years). Conclusion A rolling phenotype provides an alternative view of the longitudinal burden of intra-abdominal complications in Crohn's disease. From this viewpoint, 70% of patients have durable freedom from complication over time (>3 years).	[Irwin, James; Ferguson, Emma; Simms, Lisa A.; Hanigan, Katherine; Radford-Smith, Graham] QIMR Berghofer Med Res Inst, Inflammatory Bowel Dis Res Grp, Brisbane, Qld, Australia; [Irwin, James; Radford-Smith, Graham] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia; [Irwin, James; Ferguson, Emma; Radford-Smith, Graham] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Carbonnel, Franck] Hop Univ Paris Sud, Site Bicetre Assistance Publ Hop Paris, Serv Gastroenterol, Paris, France; [Carbonnel, Franck] Univ Paris Saclay, Fac Med, Univ Paris Sud, UVSQ,INSERM,CESP, Villejuif, France	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Irwin, J (corresponding author), QIMR Berghofer Med Res Inst, Inflammatory Bowel Dis Res Grp, Brisbane, Qld, Australia.; Irwin, J (corresponding author), Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia.; Irwin, J (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.	James.Irwin@midcentraldhb.govt.nz	Radford-Smith, Graham/H-2792-2013; Radford-Smith, Graham L/G-5749-2017	Radford-Smith, Graham/0000-0002-2047-6239; Radford-Smith, Graham L/0000-0002-2047-6239; Irwin, James/0000-0002-6804-1752; Simms, Lisa/0000-0002-5387-7397				Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; GREENSTEIN AJ, 1988, GUT, V29, P588, DOI 10.1136/gut.29.5.588; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Magro F, 2014, AM J GASTROENTEROL, V109, P1026, DOI 10.1038/ajg.2014.97; MUNKHOLM P, 1995, SCAND J GASTROENTERO, V30, P699, DOI 10.3109/00365529509096316; Pearson DC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000067; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramadas AV, 2010, GUT, V59, P1200, DOI 10.1136/gut.2009.202101; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Sandborn WJ, 1996, COCHRANE DATABASE SY; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Tang LY, 2006, CLIN GASTROENTEROL H, V4, P1130, DOI 10.1016/j.cgh.2006.06.021; Tarrant KM, 2008, AM J GASTROENTEROL, V103, P3082, DOI 10.1111/j.1572-0241.2008.02212.x	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174954	10.1371/journal.pone.0174954	http://dx.doi.org/10.1371/journal.pone.0174954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384331	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900063
J	Jansen, JM; Wartchow, C; Jahnke, W; Fong, SS; Tsang, T; Pfister, K; Zavorotinskaya, T; Bussiere, D; Cheng, JM; Crawford, K; Dai, YM; Dove, J; Fang, E; Feng, Y; Florent, JM; Fuller, J; Gossert, AD; Hekmat-Nejad, M; Henry, C; Klopp, J; Lenahan, WP; Lingel, A; Ma, S; Meyer, A; Mishina, Y; Narberes, J; Pardee, G; Ramurthy, S; Rieffel, S; Stuart, D; Subramanian, S; Tandeske, L; Widger, S; Widmer, A; Winterhalter, A; Zaror, I; Hardy, S				Jansen, Johanna M.; Wartchow, Charles; Jahnke, Wolfgang; Fong, Susan; Tsang, Tiffany; Pfister, Keith; Zavorotinskaya, Tatiana; Bussiere, Dirksen; Cheng, Jan Marie; Crawford, Kenneth; Dai, Yumin; Dove, Jeffrey; Fang, Eric; Feng, Yun; Florent, Jean-Michel; Fuller, John; Gossert, Alvar D.; Hekmat-Nejad, Mohammad; Henry, Chrystele; Klopp, Julia; Lenahan, William P.; Lingel, Andreas; Ma, Sylvia; Meyer, Arndt; Mishina, Yuji; Narberes, Jamie; Pardee, Gwynn; Ramurthy, Savithri; Rieffel, Sebastien; Stuart, Darrin; Subramanian, Sharadha; Tandeske, Laura; Widger, Stephania; Widmer, Armin; Winterhalter, Aurelie; Zaror, Isabel; Hardy, Stephen			Inhibition of prenylated KRAS in a lipid environment	PLOS ONE			English	Article							STATE 1(T) INHIBITORS; ONCOGENIC K-RAS; H-RAS; EFFECTOR INTERACTIONS; NUCLEOTIDE EXCHANGE; DYNAMIC PROPERTIES; PLASMA-MEMBRANE; PROTEIN-KINASE; ACTIVATED RAS; BINDING-SITE	RAS mutations lead to a constitutively active oncogenic protein that signals through multiple effector pathways. In this chemical biology study, we describe a novel coupled biochemical assay that measures activation of the effector BRAF by prenylated KRAS(G12V) in a lipid-dependent manner. Using this assay, we discovered compounds that block biochemical and cellular functions of KRAS(G12V) with low single-digit micromolar potency. We characterized the structural basis for inhibition using NMR methods and showed that the compounds stabilized the inactive conformation of KRAS(G12V). Determination of the biophysical affinity of binding using biolayer interferometry demonstrated that the potency of inhibition matches the affinity of binding only when KRAS is in its native state, namely post-translationally modified and in a lipid environment. The assays we describe here provide a first-time alignment across biochemical, biophysical, and cellular KRAS assays through incorporation of key physiological factors regulating RAS biology, namely a negatively charged lipid environment and prenylation, into the in vitro assays. These assays and the ligands we discovered are valuable tools for further study of KRAS inhibition and drug discovery.	[Jansen, Johanna M.; Pfister, Keith; Zavorotinskaya, Tatiana; Dai, Yumin; Fang, Eric; Feng, Yun; Gossert, Alvar D.; Ma, Sylvia; Rieffel, Sebastien; Zaror, Isabel] Novartis Inst BioMed Res, Dept Global Discovery Chem, Emeryville, CA USA; [Fong, Susan; Fuller, John; Henry, Chrystele] Novartis Inst BioMed Res, Ctr Prote Chem, Basel, Switzerland; [Cheng, Jan Marie; Fuller, John; Hekmat-Nejad, Mohammad] Novartis Inst BioMed Res, Dept Oncol, Emeryville, CA USA; [Dai, Yumin; Fuller, John; Hekmat-Nejad, Mohammad; Henry, Chrystele; Lenahan, William P.; Lingel, Andreas] Novartis Inst BioMed Res, Dept Oncol, Cambridge, MA USA	Novartis; Novartis; Novartis; Novartis	Jansen, JM (corresponding author), Novartis Inst BioMed Res, Dept Global Discovery Chem, Emeryville, CA USA.	johanna.jansen@novartis.com	Fang, Eric/GXV-4491-2022; Wartchow, Charles A./W-4985-2019; Lingel, Andreas/AAP-5078-2021	Wartchow, Charles/0000-0002-0123-1455; Gossert, Alvar/0000-0001-7732-495X; Jansen, Johanna/0000-0003-3937-6243	Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	This research was funded by Novartis Institutes for BioMedical Research. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Araki M, 2011, J BIOL CHEM, V286, P39644, DOI 10.1074/jbc.M111.227074; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cromm PM, 2015, ANGEW CHEM INT EDIT, V54, P13516, DOI 10.1002/anie.201504357; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Gillette WK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15916; Gossert AD, 2011, J AM CHEM SOC, V133, P210, DOI 10.1021/ja108383x; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Hocker HJ, 2013, P NATL ACAD SCI USA, V110, P10201, DOI 10.1073/pnas.1300016110; Holderfield M, 2013, CANCER CELL, V23, P594, DOI 10.1016/j.ccr.2013.03.033; Howell BA, 2009, LANGMUIR, V25, P12056, DOI 10.1021/la901644h; Huynh MV, 2016, MINI-REV MED CHEM, V16, P383, DOI 10.2174/1389557515666151001154352; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; Kalbitzer HR, 2013, ENZYMES, V33, P69, DOI 10.1016/B978-0-12-416749-0.00004-X; Kapoor S, 2012, EUR BIOPHYS J BIOPHY, V41, P801, DOI 10.1007/s00249-012-0841-5; Kovacs H, 2014, J BIOMOL NMR, V58, P101, DOI 10.1007/s10858-013-9808-9; Kuroda S, 1996, J BIOL CHEM, V271, P14680, DOI 10.1074/jbc.271.25.14680; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin E, 2011, NOVARTIS EVALUATION, P223; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; McDonald CB, 2010, ARCH BIOCHEM BIOPHYS, V494, P216, DOI 10.1016/j.abb.2009.12.011; Okada T, 1996, J BIOL CHEM, V271, P4671; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prakash P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004469; Rosnizeck IC, 2014, BIOCHEMISTRY-US, V53, P3867, DOI 10.1021/bi401689w; Rosnizeck IC, 2012, ANGEW CHEM INT EDIT, V51, P10647, DOI 10.1002/anie.201204148; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schuffenhauer A, 2005, CURR TOP MED CHEM, V5, P751, DOI 10.2174/1568026054637700; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Upadhyaya P, 2015, ANGEW CHEM INT EDIT, V54, P7602, DOI 10.1002/anie.201502763; van Hattum H, 2014, CHEM BIOL, V21, P1185, DOI 10.1016/j.chembiol.2014.08.001; Wang WR, 2012, BIOORG MED CHEM LETT, V22, P5766, DOI 10.1016/j.bmcl.2012.07.082; Winter JJG, 2015, J MED CHEM, V58, P2265, DOI 10.1021/jm501660t; Wittinghofer A, 2000, ANGEW CHEM INT EDIT, V39, P4193, DOI 10.1002/1521-3773(20001201)39:23<4192::AID-ANIE4192>3.0.CO;2-Y; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	58	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174706	10.1371/journal.pone.0174706	http://dx.doi.org/10.1371/journal.pone.0174706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384226	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900028
J	Liao, J; Wang, KY; Yao, WR; Yi, XF; Yan, HH; Chen, M; Lan, XP				Liao, Jian; Wang, Kaiyu; Yao, Weirong; Yi, Xunfei; Yan, Huihui; Chen, Min; Lan, Xiaopeng			Cloning, expression and antioxidant activity of a thioredoxin peroxidase from Branchiostoma belcheri tsingtaunese	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; AMPHIOXUS; PEROXIREDOXINS; CELL; EVOLUTION; REDUCTASE; PROTEIN	Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes that catalyze the thioredoxindependent reduction of hydroperoxides. In this study, a novel thioredoxin peroxidase (Bbt-TPx1), a member of the peroxiredoxin superfamily, was found by EST sequence analysis of a cDNA library of Branchiostoma belcheri tsingtaunese ovary. The sequence of a full-length cDNA clone contained an open reading frame encoding a polypeptide of 198 amino acid residues, with a calculated molecular weight of 22,150 Da. The expression patterns of the protein at different developmental stages and adult amphioxus tissues indicate that this enzyme may play important roles in anti-oxidation and innate immunity. The recombinant Bbt-TPx1 protein was expressed with a polyhistidine-tag in Escherichia coli and purified using Ni chromatography followed by SP cation exchange chromatography. The rBbt-TPx1 protein existed as a dimer under non-reducing conditions, and was dissociated into monomers by dithiothreitol (DTT); it might predominantly exist in oligomeric form. The rBbt-TPx1 protein showed a significant thiol-dependent peroxidase activity, removing hydrogen peroxide in the presence of dithiothreitol (DTT), but not glutathione (GSH). Protection of plasmid DNA and the thiol-protein from damage by metal-catalyzed oxidation (MCO) in vitro was also revealed.	[Liao, Jian; Wang, Kaiyu; Yi, Xunfei; Yan, Huihui; Chen, Min; Lan, Xiaopeng] Fuzhou Gen Hosp Nanjing Command, Inst Lab Med, Fuzhou, Fujian Province, Peoples R China; [Yao, Weirong] First Hosp Longhai, Clin Lab, Zhangzhou, Fujian Province, Peoples R China		Chen, M; Lan, XP (corresponding author), Fuzhou Gen Hosp Nanjing Command, Inst Lab Med, Fuzhou, Fujian Province, Peoples R China.	fzcmin@qq.com; lanxp@sina.com			Key Project of Science and Technology of Fujian Province [2012Y0058]	Key Project of Science and Technology of Fujian Province	This work was supported by the Key Project of Science and Technology of Fujian Province(No.2012Y0058).	Bhattacharyya S, 2015, SCAND J IMMUNOL, V82, P477, DOI 10.1111/sji.12350; Camejo D, 2015, J PROTEOMICS, V119, P112, DOI 10.1016/j.jprot.2015.01.022; Choi J, 2013, BIOCHEM BIOPH RES CO, V435, P634, DOI 10.1016/j.bbrc.2013.05.035; Dip PV, 2014, BBA-BIOENERGETICS, V1837, P1932, DOI 10.1016/j.bbabio.2014.08.007; Du JC, 2004, DEV COMP IMMUNOL, V28, P961, DOI 10.1016/j.dci.2004.04.001; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Holland LZ, 2013, SEMIN CELL DEV BIOL, V24, P101, DOI 10.1016/j.semcdb.2012.12.007; Huang CY, 2014, MOL BIOL REP, V41, P155, DOI 10.1007/s11033-013-2848-0; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lian FM, 2012, J BIOL CHEM, V287, P17077, DOI 10.1074/jbc.M112.357368; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; LIM YS, 1994, BIOCHEM BIOPH RES CO, V199, P199, DOI 10.1006/bbrc.1994.1214; Minguillon C, 2003, DEVELOPMENT, V130, P5903, DOI 10.1242/dev.00811; Mizohata E, 2005, J MOL BIOL, V354, P317, DOI 10.1016/j.jmb.2005.09.006; SAURI H, 1995, BIOCHEM BIOPH RES CO, V208, P964, DOI 10.1006/bbrc.1995.1428	17	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175162	10.1371/journal.pone.0175162	http://dx.doi.org/10.1371/journal.pone.0175162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384204	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900105
J	Petrichella, S; Johnson, N; He, B				Petrichella, Sara; Johnson, Nessa; He, Bin			The influence of corticospinal activity on TMS-evoked activity and connectivity in healthy subjects: A TMS-EEG study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DIRECTED TRANSFER-FUNCTION; CORTICAL FUNCTIONAL CONNECTIVITY; PRIMARY MOTOR CORTEX; HIGH-RESOLUTION EEG; STIMULUS-INTENSITY; COIL ORIENTATION; BRAIN; RESPONSES; VARIABILITY	Combined transcranial magnetic stimulation (TMS) and electroencephalography (EEG) can be used to analyze cortical reactivity and connectivity. However, the effects of corticospinal and peripheral muscle activity on TMS-evoked potentials (TEPs) are not well understood. The aim of this paper is to evaluate the relationship between cortico-spinal activity, in the form of peripheral motor-evoked potentials (MEPs), and the TEPs from motor areas, along with the connectivity among activated brain areas. TMS was applied to left and right motor cortex (M1), separately, at motor threshold while multi-channel EEG responses were recorded in 17 healthy human subjects. Cortical excitability and source imaging analysis were performed for all trials at each stimulation location, as well as comparing trials resulting in MEPs to those without. Connectivity analysis was also performed comparing trials resulting in MEPs to those without. Cortical excitability results significantly differed between the MEP and no-MEP conditions for left M1 TMS at 60 ms (CP1, CP3, C1) and for right M1 TMS at 54 ms (CP6, C6). Connectivity analysis revealed higher outflow and inflow between M1 and somatosensory cortex bi-directionally for trials with MEPs than those without for both left M1 TMS (at 60, 100, 164 ms) and right M1 TMS (at 54, 100, and 164 ms). Both TEP amplitudes and connectivity measures related to motor and somatosensory areas ipsilateral to the stimulation were shown to correspond with peripheral MEP amplitudes. This suggests that cortico-spinal activation, along with the resulting somatosensory feedback, affects the cortical activity and dynamics within motor areas reflected in the TEPs. The findings suggest that TMS-EEG, along with adaptive connectivity estimators, can be used to evaluate the cortical dynamics associated with sensorimotor integration and proprioceptive manipulation along with the influence of peripheral muscle feedback.	[Petrichella, Sara; Johnson, Nessa; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Petrichella, Sara] Univ Campus Biomed, Dept Comp Sci & Comp Engn, Rome, Italy; [He, Bin] Univ Minnesota, Inst Engn Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University Campus Bio-Medico - Rome Italy; University of Minnesota System; University of Minnesota Twin Cities	He, B (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	binhe@umn.edu		Johnson, Nessa/0000-0002-1020-6091	National Science Foundation [CBET 1264782]; National Institutes of Health, NIH [NIH EY023101, NIH EB008389]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Science Foundation, CBET 1264782 [B.H.], www.nsf.gov; National Institutes of Health, NIH EY023101 [B.H.], NIH EB008389 [B.H.], www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P401, DOI 10.1016/0168-5597(89)90029-4; [Anonymous], [No title captured]; Arnold M, 1998, IEEE T BIO-MED ENG, V45, P553, DOI 10.1109/10.668741; Astolfi L, 2004, MAGN RESON IMAGING, V22, P1457, DOI 10.1016/j.mri.2004.10.006; Astolfi L, 2005, CLIN NEUROPHYSIOL, V116, P920, DOI 10.1016/j.clinph.2004.10.012; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Casula EP, 2014, NEUROIMAGE, V98, P225, DOI 10.1016/j.neuroimage.2014.04.065; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Ding M., 2013, NEURAL ENG, P545; Edelman BJ, 2015, ENGINEERING-PRC, V1, P292, DOI [10.15302/J-ENG-2015078, 10.15302/j-eng-2015078]; Ellaway PH, 1998, ELECTROMYOGR MOTOR C, V109, P104, DOI 10.1016/S0924-980X(98)00007-1; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Ferreri F, 2016, CLIN NEUROPHYSIOL, V127, pe330; Ferreri F, 2016, HUM BRAIN MAPP; Ferreri F, 2014, HUM BRAIN MAPP, V35, P1969, DOI 10.1002/hbm.22306; Ferreri F, 2012, J NEUROPHYSIOL, V108, P314, DOI 10.1152/jn.00796.2011; Ferreri F, 2011, NEUROIMAGE, V54, P90, DOI 10.1016/j.neuroimage.2010.07.056; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Giambattistelli F, 2013, HUM BRAIN MAPP; Gomez LJ, 2015, IEEE T BIO-MED ENG, V62, P361, DOI 10.1109/TBME.2014.2353993; Guo T, 2015, IEEE T BIOMED ENG, V62, P2532; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Huber R, 2008, J NEUROSCI, V28, P7911, DOI 10.1523/JNEUROSCI.1636-08.2008; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Johnson MD, 2013, IEEE T BIO-MED ENG, V60, P610, DOI 10.1109/TBME.2013.2244890; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Klein-Flugge MC, 2013, J NEUROSCI, V33, P5564, DOI 10.1523/JNEUROSCI.2448-12.2013; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Lee WH, 2015, IEEE T BIO-MED ENG, V62, P2095, DOI 10.1109/TBME.2015.2425406; Lu M, 2015, IEEE T BIO-MED ENG, V62, P2911, DOI 10.1109/TBME.2015.2452261; Maki H, 2010, NEUROSCI LETT, V478, P24, DOI 10.1016/j.neulet.2010.04.059; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Nikouline V, 1999, CLIN NEUROPHYSIOL, V110, P1325, DOI 10.1016/S1388-2457(99)00070-X; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROSSINI PM, 1991, BRAIN RES, V567, P111, DOI 10.1016/0006-8993(91)91442-4; Schulz H, 2014, CEREB CORTEX, V24, P1708, DOI 10.1093/cercor/bht024; ter Braack EM, 2015, BRAIN TOPOGR, V28, P520, DOI 10.1007/s10548-013-0312-z; Tiitinen H, 1999, CLIN NEUROPHYSIOL, V110, P982, DOI 10.1016/S1388-2457(99)00038-3; vanderKamp W, 1996, J CLIN NEUROPHYSIOL, V13, P164, DOI 10.1097/00004691-199603000-00007; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Ziemann U, 2000, J CLIN NEUROPHYSIOL, V17, P397, DOI 10.1097/00004691-200007000-00005	57	33	34	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174879	10.1371/journal.pone.0174879	http://dx.doi.org/10.1371/journal.pone.0174879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384197	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900048
J	Ranucci, M; Porta, A; Bari, V; Pistuddi, V; La Rovere, MT				Ranucci, Marco; Porta, Alberto; Bari, Vlasta; Pistuddi, Valeria; La Rovere, Maria Teresa			Baroreflex sensitivity and outcomes following coronary surgery	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ARTERY-BYPASS SURGERY; ATRIAL-FIBRILLATION; CARDIAC-SURGERY; MYOCARDIAL-INFARCTION; AUTONOMIC DYSFUNCTION; RISK STRATIFICATION; RENAL DYSFUNCTION; FAILURE PATIENTS; VAGUS NERVE	Postoperative atrial fibrillation, acute kidney dysfunction and low cardiac output following coronary surgery are associated with morbidity and mortality. The purpose of this study is to determine if the preoperative autonomic control is a determinant of these postoperative complications. This is a prospective cohort study on 150 adult patients undergoing surgical coronary revascularization with cardiopulmonary bypass. The patients received an autonomic control assessment after the induction of anesthesia. Baroreflex sensitivity was computed by spectral analysis and expressed as BRSaHF and BRSaLF for measure respectively in the high and low frequency domains. Atrial fibrillation was adjudicated at any postoperative time during the hospital stay. Acute kidney dysfunction was defined as any increase of serum creatinine levels from preoperative values within the first 48 hours after surgery, and acute kidney injury was adjudicated at a 50% increase. Low cardiac ouput syndrome was defined as the need for inotropic support > 48 hours. Thirty-eight (26.4%) patients experienced postoperative atrial fibrillation; 32 (22.2%) had acute kidney dysfunction and 5 (3.5%) acute kidney injury; 14(10%) had a low cardiac output state. No indices of baroreflex sensitivity were associated with atrial fibrillation or acute kidney injury. A low value of BRS alpha LF was associated with acute kidney dysfunction and low cardiac output state. A BRS alpha LF < 3 msec/mmHg was an independent risk factor for acute kidney dysfunction (odds ratio 3.0, 95% confidence interval 1.02-8.8, P = 0.045) and of low cardiac output state (odds ratio 17.0, 95% confidence interval 2.9-99, P = 0.002). Preoperative baroreflex sensitivity is linked to postoperative complications through a number of possible mechanisms, including an autonomic nervous system-mediated vasoconstriction, a poor response to hypotension, and an increased inflammatory reaction.	[Ranucci, Marco; Porta, Alberto; Bari, Vlasta; Pistuddi, Valeria] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [La Rovere, Maria Teresa] IRCCS Ist Clin Sci Maugeri, Dept Cardiol, Ist Montescano, Pavia, Italy	IRCCS Policlinico San Donato; University of Milan; Istituti Clinici Scientifici Maugeri IRCCS	Ranucci, M (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy.	cardioanestesia@virgilio.it	Bari, Vlasta/J-8591-2016; Pistuddi, Valeria/J-9047-2016; La Rovere, Maria Teresa/D-6796-2019; Ranucci, Marco/K-1040-2016	Bari, Vlasta/0000-0002-5346-2677; Pistuddi, Valeria/0000-0002-5781-3972; La Rovere, Maria Teresa/0000-0002-1884-5058; Ranucci, Marco/0000-0002-4915-3572	IRCCS Policlinico San Donato, a Clinical Research Hospital; Italian Ministry of Health	IRCCS Policlinico San Donato, a Clinical Research Hospital; Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by the IRCCS Policlinico San Donato, a Clinical Research Hospital partially funded by the Italian Ministry of Health.	Ackland GL, 2016, CRIT CARE MED, V44, pE614, DOI 10.1097/CCM.0000000000001606; Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; BASELLI G, 1987, INT J BIOMED COMPUT, V20, P51, DOI 10.1016/0020-7101(87)90014-6; Bauernschmitt R, 2007, PACE, V30, P77, DOI 10.1111/j.1540-8159.2007.00568.x; Chamchad D, 2006, ANESTH ANALG, V103, P1109, DOI 10.1213/01.ane.0000239330.45658.76; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; COUMEL P, 1994, EUR HEART J, V15, P9, DOI 10.1093/eurheartj/15.suppl_A.9; De Ferrari GM, 2007, J AM COLL CARDIOL, V50, P2285, DOI 10.1016/j.jacc.2007.08.043; Deschamps A, 2013, J CARDIOTHOR VASC AN, V27, P485, DOI 10.1053/j.jvca.2012.07.016; Dimmer C, 1998, AM J CARDIOL, V82, P22, DOI 10.1016/S0002-9149(98)00231-8; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Gouveia S, 2015, CLIN SCI, V129, P1163, DOI 10.1042/CS20150341; Hakala T, 2002, SCAND CARDIOVASC J, V36, P167, DOI 10.1080/cdv.36.3.167.171; Hogue CW, 1998, CIRCULATION, V98, P429, DOI 10.1161/01.CIR.98.5.429; Inoue T, 2016, KIDNEY INT, V90, P462, DOI 10.1016/j.kint.2016.07.009; Jideus L, 2001, SCAND CARDIOVASC J, V35, P238; Johns EJ, 2011, COMPR PHYSIOL, V1, P731, DOI 10.1002/cphy.c100043; Katsube Y, 1996, AM J CARDIOL, V78, P1007, DOI 10.1016/S0002-9149(96)00525-5; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; La Rovere MT, 2014, ANN NONINVAS ELECTRO, V19, P303, DOI 10.1111/anec.12170; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Lankhorst S, 2015, ANAESTHESIA, V70, P336, DOI 10.1111/anae.12904; Liotta M, 2014, AM J CARDIOL, V113, P70, DOI 10.1016/j.amjcard.2013.09.012; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x; Mostarda C, 2011, J CARD FAIL, V17, P519, DOI 10.1016/j.cardfail.2011.02.007; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pinna GD, 2005, J AM COLL CARDIOL, V46, P1314, DOI 10.1016/j.jacc.2005.06.062; Porta A, 2013, J APPL PHYSIOL, V115, P1032, DOI 10.1152/japplphysiol.00537.2013; Provenchere S, 2003, ANESTH ANALG, V96, P1258, DOI 10.1213/01.ANE.0000055803.92191.69; Shen FM, 2004, SHOCK, V21, P556, DOI 10.1097/01.shk.0000126647.51109.5c; Simula S, 2013, CLIN PHYSIOL FUNCT I, V33, P70, DOI 10.1111/j.1475-097X.2012.01165.x; Smith ML, 1992, J CARDIOVASC ELECTR, V2, P441; Stammers AN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007250; Toner A, 2016, BRIT J ANAESTH, V117, P324, DOI 10.1093/bja/aew257; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	42	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175008	10.1371/journal.pone.0175008	http://dx.doi.org/10.1371/journal.pone.0175008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384188	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900072
J	Shelomi, M				Shelomi, Matan			De novo transcriptome analysis of the excretory tubules of Carausius morosus (Phasmatodea) and possible functions of the midgut 'appendices'	PLOS ONE			English	Article							MALPIGHIAN TUBULES; STICK INSECT; RNA-SEQ; DIGESTIVE-SYSTEM; ACTIVE-TRANSPORT; ORTHOPTERA; REVEALS; WATER; ELIMINATION; EXPRESSION	The Malpighian tubules are the insect excretory organs, responsible for ion and water homeostasis and elimination of nitrogenous wastes. Post-genomic assays suggest they also metabolize and detoxify xenobiotic compounds and have antimicrobial properties. The Phasmatodea have an additional, unique set of excretory organs referred to predominantly as midgut appendices. Their function and how it compares to phasmid and other insect Malpighian tubules is unknown. Hypotheses include carbonic anhydrase activity, calcium and metal cation sequestration, and xenobiotic transport. This work presents the first comparative transcriptomic analysis of the Phasmatodean excretory organs, using the model insect Carausius morosus. I produced de novo transcriptomes of the midgut appendices, midgut wall, and Malpighian tubules, and looked for differentially expressed genes associated with putative organ functions. The appendices differentially and highly express lipid transport and metabolism proteins, and the biomineralization gene otopetrin. The Malpighian tubules differentially and highly express acid phosphatases and multiple transporter types, while appendices express fat-soluble vitamin and peptide transporters. Many defense proteins such as multidrug resistance proteins, ABC transporters, cytochrome P450's, and glutathione- S-transferases were differentially expressed in specific excretory organs. I hypothesize that the appendices and Malpighian tubules both have defensive / xenobiotic metabolism functions, but each likely target different substrates. Phasmid Malpighian tubules excrete as in other insects, while the appendices may predominantly regulate amino acids, fats, and fat-soluble compounds. Lipid metabolism in insects is poorly understood, and the Phasmatodea may thus serve as a model for studying this further.	[Shelomi, Matan] Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan; [Shelomi, Matan] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Thuringen, Germany	National Taiwan University; Max Planck Society	Shelomi, M (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan.; Shelomi, M (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Jena, Thuringen, Germany.	mshelomi@ntu.edu.tw	Shelomi, Matan/AAF-6194-2020	Shelomi, Matan/0000-0003-4413-4097	National Science Foundation (USA) Postdoctoral Research Fellowship in Biology [DBI-1402883]; Max Planck Society (Germany)	National Science Foundation (USA) Postdoctoral Research Fellowship in Biology; Max Planck Society (Germany)(Max Planck Society)	This research was funded by the National Science Foundation (USA) Postdoctoral Research Fellowship in Biology, GrantNo. DBI-1402883, and by the Max Planck Society (Germany) through David Heckel of the Max Planck Institute for Chemical Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; ANESHANSLEY DJ, 1989, J INSECT PHYSIOL, V35, P41, DOI 10.1016/0022-1910(89)90034-6; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; ATZBACHER U, 1974, J INSECT PHYSIOL, V20, P1989, DOI 10.1016/0022-1910(74)90106-1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Bordas L, 1897, B MUSEUM HIST NATURE, V2, P378; Bradler Sven, 2015, Entomologie Heute, V27, P1; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; de Sinety R., 1901, CELLULE, V19, P117, DOI [10.5962/bhl.part.17087, DOI 10.5962/BHL.PART.17087]; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Heymons R, 1897, SITZUNGSBERICHTE KON, V16, P363; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-41; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Lison L, 1937, CELL TISSUE RES, V28, P179; Lison L., 1942, RECHERCHES HISTOPHYS; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Maddrell S, 2004, J EXP BIOL, V207, P894, DOI 10.1242/jeb.00846; MADDRELL SH, 1974, J EXP BIOL, V61, P357; MADDRELL SHP, 1976, J EXP BIOL, V64, P267; MADDRELL SHP, 1992, J EXP BIOL, V172, P417; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; MEULEMANS W, 1992, J CELL SCI, V101, P349; Monteiro EC, 2014, ARTHROPOD STRUCT DEV, V43, P123, DOI 10.1016/j.asd.2013.11.005; MOSCONA A, 1950, Q J MICROSC SCI, V91, P183; NIJHOUT HF, 1975, J EXP BIOL, V62, P221; O'Donnell MJ, 2009, J EXP BIOL, V212, P363, DOI 10.1242/jeb.023739; O'Donnell M, 2008, ADV INSECT PHYSIOL, V35, P1, DOI 10.1016/S0065-2806(08)00001-5; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Palm N. B., 1952, Arkiv for Zoologi Stockholm (NS), V3, P195; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Pantel J, 1919, CR HEBD ACAD SCI, V168, P242; RAMSAY JA, 1955, J EXP BIOL, V32, P200; RAMSAY JA, 1954, J EXP BIOL, V31, P104; RAMSAY JA, 1958, J EXP BIOL, V35, P871; RAMSAY JA, 1956, J EXP BIOL, V33, P697; RAMSAY JA, 1952, J EXP BIOL, V29, P110; RAMSAY JA, 1955, J EXP BIOL, V32, P183; SAVAGE AA, 1962, Q J MICROSC SCI, V103, P417; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; SHAPIRO JP, 1988, ANNU REV ENTOMOL, V33, P297, DOI 10.1146/annurev.en.33.010188.001501; Sharpe ML, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2006-2; Shelomi Matan, 2015, Journal of Orthoptera Research, V24, P29; Shelomi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-917; Shelomi M, 2014, J MORPHOL, V275, P623, DOI 10.1002/jmor.20243; Strauss AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098637; TAYLOR HH, 1971, Z ZELLFORSCH MIK ANA, V122, P411, DOI 10.1007/BF00936077; TAYLOR HH, 1971, Z ZELLFORSCH MIK ANA, V118, P333, DOI 10.1007/BF00331192; TAYLOR HH, 1973, Z ZELLFORSCH MIK ANA, V141, P479, DOI 10.1007/BF00307119; TAYLOR HH, 1974, COMP BIOCHEM PHYSIOL, V47, P1129, DOI 10.1016/0300-9629(74)90087-5; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang GX, 2014, DIABETES, V63, P1340, DOI 10.2337/db13-1139; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Wu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157783; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yi SX, 2001, ARCH INSECT BIOCHEM, V46, P152, DOI 10.1002/arch.1025; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16; Zhu JS, 2010, INSECT BIOCHEM MOLEC, V40, P23, DOI 10.1016/j.ibmb.2009.12.004	69	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174984	10.1371/journal.pone.0174984	http://dx.doi.org/10.1371/journal.pone.0174984			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384348	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900068
J	Wang, KA; Wang, JC; Lin, CL; Tseng, CH				Wang, Kevin A.; Wang, Jia-Chi; Lin, Cheng-Li; Tseng, Chun-Hung			Association between fibromyalgia syndrome and peptic ulcer disease development	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; IRRITABLE-BOWEL-SYNDROME; CENTRAL-NERVOUS-SYSTEM; HELICOBACTER-PYLORI; MITOCHONDRIAL DYSFUNCTION; INTESTINAL PERMEABILITY; OXIDATIVE STRESS; GASTRIC-MUCOSA; CHRONIC PAIN; MECHANISMS	Purpose The correlation of fibromyalgia syndrome (FMS) with peptic ulcer disease (PUD) is unclear. We therefore conducted a cohort study to investigate whether FMS is correlated with an increased risk of PUD. Methods In this study, we established an FMS cohort comprising 26068 patients aged more than 20 years who were diagnosed with FMS from 2000 to 2011. Furthermore, we established a control cohort by randomly choosing 104269 people without FMS who were matched to the FMS patients by gender, age, and index year. All patients were free of PUD at the baseline. Cox proportional hazard regressions were performed to compute the hazard ratio of PUD after adjustment for demographic characteristics and comorbidities. Results The prevalence of comorbidities was significantly higher in the FMS patients than in the controls. The incidence of PUD was 29.8 and 19.4 per 1000 person-years in the FMS and control cohorts, respectively. In addition, the FMS cohort exhibited a 1.40-fold higher risk of PUD (95% confidence interval = 1.35-1.45) compared with the control cohort. After control for confounding factors, the medications (selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and antidepressants) taken by the FMS patients did not increase the risk of PUD. Conclusion FMS patients exhibit a higher risk of PUD than that of patients without FMS.	[Wang, Kevin A.] Shin Kong Mem Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Wang, Kevin A.] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Wang, Jia-Chi] Natl Yang Ming Univ, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wang, Jia-Chi] Taipei Vet Gen Hosp, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tseng, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ Hosp, Dept Neurol, Taichung, Taiwan.	Tseng.nm@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019, MOHW106-TDU-B-212-113004]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005, MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); the Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital; the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; the Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bazzichi L, 2016, CLIN EXP RHEUMATOL, V34, pS145; Bellato E, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/426130; Calandre EP, 2015, EXPERT OPIN PHARMACO, V16, P1347, DOI 10.1517/14656566.2015.1047343; Calvino-Fernandez M, 2010, REV ESP ENFERM DIG, V102, P41, DOI 10.4321/s1130-01082010000100006; Chang L, 1998, EUR J SURG, V164, P32, DOI 10.1080/11024159850191210; Chen CH, 2016, ONCOTARGET, V7, P64380, DOI 10.18632/oncotarget.9062; Chen HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003670; Cordero MD, 2010, NEUROENDOCRINOL LETT, V31, P169; Dall M, 2011, SCAND J GASTROENTERO, V46, P1039, DOI 10.3109/00365521.2011.580100; Erin Lawson E, 2015, FIBROMYALGIA CLIN GU, P1; Goebel A, 2008, RHEUMATOLOGY, V47, P1223, DOI 10.1093/rheumatology/ken140; Itatsu T, 2011, INTERNAL MED, V50, P713, DOI 10.2169/internalmedicine.50.4644; Jacobson SA, 2015, AGING CLIN EXP RES, V27, P75, DOI 10.1007/s40520-014-0238-7; Jong JCF, 2003, BR J CLIN PHARM, V55, P591; Lauche R, 2015, EVID-BASED COMPL ALT, V2015, P610; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Liao CH, 2014, J PSYCHOSOM RES, V77, P541, DOI 10.1016/j.jpsychores.2014.08.005; MARTIN LF, 1982, SURGERY, V92, P337; MASI AT, 1994, BAILLIERE CLIN RHEUM, V8, P957, DOI 10.1016/S0950-3579(05)80056-1; Meeus M, 2013, EXPERT OPIN THER TAR, V17, P1081, DOI 10.1517/14728222.2013.818657; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Oliveira Paula J., 2012, PSYCHOSOCIAL FACTORS; Pimentel M, 2004, ANN RHEUM DIS, V63, P450, DOI 10.1136/ard.2003.011502; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Ruiz-Cabello P, 2016, J ACAD NUTR DIET; Sanchez-Dominguez B, 2015, MITOCHONDRION, V21, P69, DOI 10.1016/j.mito.2015.01.010; SATO N, 1978, BIOCHIM BIOPHYS ACTA, V538, P236, DOI 10.1016/0304-4165(78)90351-3; Slim M, 2015, RHEUMATOL INT, V35, P433, DOI 10.1007/s00296-014-3109-9; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Stisi S, 2008, REUMATISMO, V60, P25, DOI 10.4081/reumatismo.2008.1s.25; Thieme Kati, 2009, Curr Rheumatol Rep, V11, P443; Torpy DJ, 1996, BAILLIERE CLIN RHEUM, V10, P181; TRIADAFILOPOULOS G, 1991, DIGEST DIS SCI, V36, P59, DOI 10.1007/BF01300088; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; VERIM S, 2016, J BACK MUSCULOSKELET; Vincent A, 2013, PAIN MANAG NURS, V14, P228, DOI 10.1016/j.pmn.2011.05.001; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; Wallace Daniel J, 2004, Curr Pain Headache Rep, V8, P364; Wolfe F, 2013, EUR J PAIN, V17, P581, DOI 10.1002/j.1532-2149.2012.00234.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarandi SS, 2016, J NEUROGASTROENTEROL, V22, P201, DOI 10.5056/jnm15146; Zhang C, 2014, HELICOBACTER, V19, P330, DOI 10.1111/hel.12138	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175370	10.1371/journal.pone.0175370	http://dx.doi.org/10.1371/journal.pone.0175370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384332	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900164
J	Dharmayanthi, AB; Terai, Y; Sulandari, S; Zein, MSA; Akiyama, T; Satta, Y				Dharmayanthi, Anik Budhi; Terai, Yohei; Sulandari, Sri; Zein, M. Syamsul Arifin; Akiyama, Toyoko; Satta, Yoko			The origin and evolution of fibromelanosis in domesticated chickens: Genomic comparison of Indonesian Cemani and Chinese Silkie breeds	PLOS ONE			English	Article							SELECTION; NUMBER; PIGMENTATION; HITCHHIKING; FRAMEWORK; PATTERNS; REVEALS; ALLELE; LOCI; SNP	Like Chinese Silkie, Indonesian Ayam Cemani exhibits fibromelanosis or dermal hyperpigmentation and possesses complex segmental duplications on chromosome 20 that involve the endothelin 3 gene, EDN3. A genomic region, DR1 of 127 kb, together with another region, DR2 of 171 kb, was duplicated by unequal crossing over, accompanied by inversion of one DR2. Quantitative PCR and copy number variation analyses on the Cemani genome sequence confirmed the duplication of EDN3. These genetic arrangements are identical in Cemani and Silkie, indicating a single origin of the genetic cause of Fm. The two DR1s harbor two distinct EDN3 haplotypes in a form of permanent heterozygosity, although they remain allelic in the ancestral Red Jungle Fowl population and some domesticated chicken breeds, with their allelic divergence time being as recent as 0.3 million years ago. In Cemani and Silkie breeds, artificial selection favoring the Fm phenotype has left an unambiguous record for selective sweep that extends in both directions from tandemly duplicated EDN3 loci. This highly homozygous tract is different in length between Cemani and Silkie, reflecting their distinct breeding histories. It is estimated that the Fm phenotype came into existence at least 6600-9100 years ago, prior to domestication of Cemani and Silkie, and that throughout domestication there has been intense artificial selection with strength s > 50% in each breed.	[Dharmayanthi, Anik Budhi; Terai, Yohei; Satta, Yoko] SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Dharmayanthi, Anik Budhi; Sulandari, Sri; Zein, M. Syamsul Arifin] Indonesian Inst Sci LIPI, Museum Zool Bogoriense, Cibinong, Indonesia; [Akiyama, Toyoko] Keio Univ, Dept Biol, Yokohama, Kanagawa, Japan	Graduate University for Advanced Studies - Japan; Bogor Zoology Museum; Indonesian Institute of Sciences; Keio University	Satta, Y (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	sattayk@soken.ac.jp		Dharmayanthi, Anik Budhi/0000-0003-4635-6099; Satta, Yoko/0000-0002-5305-493X	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr. Naoyuki Takahata for helpful discussion and critical reading of early versions of this manuscript and Drs. Monty Slatkin and Wen-Hsiung Li for comments and suggestions. We are deeply grateful to the ABRC in Nagoya University, and to the JSAC for providing us with chickens as well as blood and DNA samples. We are grateful for the support of SOKENDAI and LIPI throughout this project. ABD expresses her sincere thanks to the MEXT for a scholarship. SS passed away before the completion of this study. YS is responsible for the integrity and validity of the data collected by the deceased author.	Akiyama T, 2013, SKIN PIGMENTATION, P175; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Bateson W, 1911, J GENET, V1, P185, DOI 10.1007/BF02981551; Bellwood PS, 1979, MANS CONQUEST PACIFI; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brodkorb P., 1964, Bulletin of the Florida State Museum Biological Sciences, V8, P195; Charlesworth B, 2012, ELEMENTS EVOLUTIONAR; Chen H, 2015, THEOR POPUL BIOL, V99, P18, DOI 10.1016/j.tpb.2014.11.001; Chen H, 2013, G3-GENES GENOM GENET, V3, P1429, DOI 10.1534/g3.113.006197; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; HUDSON RR, 1987, GENETICS, V116, P153; Hutt F.B., 1949, GENETICS OF THE FOWL; Johnsson M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12950; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; KAPLAN NL, 1989, GENETICS, V123, P887; LAHAV R, 1994, DIFFERENTIATION, V58, P133; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Lambrecht K., 1933, HDB PALAOMITHOLOGIE; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Liang M, 2014, GENETICS, V197, P953, DOI 10.1534/genetics.114.162362; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mugal CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-86; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pritchard JK, 2000, GENETICS, V155, P945; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Shinomiya A, 2011, GENETICS, V111; Slatkin M, 2008, GENET RES, V90, P129, DOI 10.1017/S0016672307008944; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smyth Jr JR, 1994, MELANIN PIGMENTATION; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Xiang H, 2014, P NATL ACAD SCI USA, V111, P17564, DOI 10.1073/pnas.1411882111; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80	56	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173147	10.1371/journal.pone.0173147	http://dx.doi.org/10.1371/journal.pone.0173147			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379963	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500012
J	Cao, GQ; Cheng, DZ; Ye, LC; Pan, YY; Yang, F; Lyu, SX				Cao, Guoquan; Cheng, Dezhi; Ye, Lechi; Pan, Yiyuan; Yang, Fan; Lyu, Shixu			Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; LUNG METASTASES; RADIOFREQUENCY ABLATION; CARCINOMA; SURVIVAL; RECURRENCE	Objective To analyze the benefits and prognostic factors after surgical resection of pulmonary metastases from colorectal cancer (CRC). Methods From Jan. 2004 to Jan. 2015, continuous 88 cases diagnosed with pulmonary metastases from CRC, including 15 cases of synchronous metastases and 73 metachronous metastases, were analyzed in the retrospective study. Results All of these 88 cases underwent curative pulmonary resection including 8 cases of simultaneous surgery. The one-year, three-year and five-year survival of the 88 cases were 93.4%, 60.2% and 35.7%, respectively. 63 patients just have one metastasis, and 25 patients have more than one metastasis. Additionally, the one-year, three-year and five-year survival was 98.1%, 70.2% and 40.3% respectively in one metastasis group, while 80.1%, 37.9% and 22.5% respectively in more than one metastasis group (p = 0.003). DFS of 37 metachronous metastases were equal or greater than 18 months, and DFS of 36 metachronous metastases were less than 18 months. The one-year, three-year and five-year survival was 97.8%, 77.9% and 41.4% respectively in the DFS >= 18 month group, while 88.2%, 44.6% and 28.1% respectively in the DFS<18 month group ( p = 0.01). Conclusion Surgical resection of pulmonary metastases from colorectal cancer can improve survival rate in selected patients. It seems that the number of metastases is an independence prognostic factor in surgical treatment. Furthermore, longer DFI implies longer survival for resectable CRC pulmonary metastases.	[Cao, Guoquan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Peoples R China; [Cheng, Dezhi] Wenzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Wenzhou, Peoples R China; [Ye, Lechi; Pan, Yiyuan; Yang, Fan; Lyu, Shixu] Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Lyu, SX (corresponding author), Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China.	1059647116@qq.corn	Pan, Yi/AAJ-2341-2021		zhejiang provincial natural science foundation [LY15H160058, LY15H030016]; Wenzhou city science and technology projects [2015Y0452]	zhejiang provincial natural science foundation(Natural Science Foundation of Zhejiang Province); Wenzhou city science and technology projects	This work was supported by LY15H160058, http://www.zjnsf.gov.cn/, zhejiang provincial natural science foundation, Lechi Ye. Decision to publish; LY15H030016, http://www.zinsf.gov.cn/, zhejiang provincial natural science foundation, Guoquan Cao. Data collection and analysis; 2015Y0452, Wenzhou city science and technology projects, Shixu Lyu. Study design.	Abdelnour-Berchtold E, 2016, WORLD J SURG, V40, P373, DOI 10.1007/s00268-015-3254-7; Cho JH, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0621-7; Cho S, 2013, INTERACT CARDIOV TH, V17, P303, DOI 10.1093/icvts/ivt164; Hachimaru A, 2016, INTERACT CARDIOV TH, V22, P826, DOI 10.1093/icvts/ivv382; Ibrahim Tony, 2016, J Gastrointest Cancer, V47, P223, DOI 10.1007/s12029-016-9818-4; Iizasa T, 2006, ANN THORAC SURG, V82, P254, DOI 10.1016/j.athoracsur.2006.02.027; Kolodziejski L, 1999, EUR J SURG ONCOL, V25, P410, DOI 10.1053/ejso.1999.0667; Lencioni R, 2008, LANCET ONCOL, V9, P621, DOI 10.1016/S1470-2045(08)70155-4; Maeda R, 2016, WORLD J SURG, V40, P1318, DOI 10.1007/s00268-016-3424-2; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Nakajima Jun, 2008, Interact Cardiovasc Thorac Surg, V7, P212; Osoegawa A, 2016, ANN THORAC CARDIOVAS, V22, P6, DOI 10.5761/atcs.oa.14-00345; Pennathur A, 2009, ANN THORAC SURG, V87, P1030, DOI 10.1016/j.athoracsur.2008.12.061; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Rotolo N, 2007, SURG ONCOL, V16, pS141, DOI 10.1016/j.suronc.2007.10.007; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Shiono S, 2005, ANN THORAC SURG, V79, P278, DOI 10.1016/j.athoracsur.2004.06.096; Takakura Y, 2010, COLORECTAL DIS, V12, pE68, DOI 10.1111/j.1463-1318.2009.02070.x; Treasure T, 2008, EUR J CARDIO-THORAC, V33, P300, DOI 10.1016/j.ejcts.2007.10.015; Vogelsang H, 2004, BRIT J SURG, V91, P1066, DOI 10.1002/bjs.4602; Vogl TJ, 2008, EUR RADIOL, V18, P2449, DOI 10.1007/s00330-008-1056-0; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175284	10.1371/journal.pone.0175284	http://dx.doi.org/10.1371/journal.pone.0175284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394911	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800024
J	Li, M; Li, SS; Du, X; Wu, T; Li, X; Ma, CS; Huo, Y; Hu, DY; Gao, RL; Wu, YF				Li, Min; Li, Shenshen; Du, Xin; Wu, Tao; Li, Xian; Ma, Changsheng; Huo, Yong; Hu, Dayi; Gao, Runlin; Wu, Yangfeng			Factors attributed to the higher in-hospital mortality of ST elevation myocardial infarction patients admitted during off-hour in comparison with those during regular hour	PLOS ONE			English	Article							ADMISSION; WEEKEND; MANAGEMENT	Background In-hospital mortality of patients with ST elevation myocardial infarction (STEMI) admitted during off-hour was reported higher than those admitted during regular hour, but which factors cause the difference remains largely unknown though the difference in medical resources was often accused. Methods and results This registry-based study recruited 7456 STEMI patients prospectively from 99 level two hospitals across China. Generalized linear mixed models were applied to quantify the risk of in-hospital death attributed to admission time and the explainers of its change, accounting for the clustering of patients within hospitals. There were 45.2% patients admitted during regular hour and 54.8% during off-hour. In-hospital mortality was 7.0% for patients admitted during regular hour and 8.3% for those during off-hour (p<0.05). Generalized linear mixed models adjusting for age, gender and education showed that patients' disease severity at admission and medical treatments received after admission could explain the risk difference attributed to admission time by 55% and 20%, respectively. After all factors accounted, the residual relative risk difference left only 6% (adjusted OR = 0.94) and became no longer significant. Conclusions The regular-and-off-hour mortality difference exists among STEMI patients in Chinese level two hospitals, which could be attributed primarily to disease severity at admission and secondly to the poorer medical treatments. These results call for public attention to the more severity of STEMI patients admitted during off-hour in addition to improving medical resources for STEMI at off-hour.	[Li, Min; Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Li, Shenshen; Wu, Tao; Li, Xian; Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Du, Xin; Ma, Changsheng] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Huo, Yong] Peking Univ, Hosp 1, Beijing, Peoples R China; [Hu, Dayi] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Gao, Runlin] Chinese Acad Med Sci, Cardiovasc Inst, Dept Cardiol, Beijing, Peoples R China; [Gao, Runlin] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Gao, Runlin] Peking Union Med Coll, Beijing, Peoples R China	Peking University; Peking University; Capital Medical University; Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.	ywu@georgeinstitute.org.cn		Li, Xian/0000-0001-5445-4022	Sanofi, China	Sanofi, China(Sanofi-Aventis)	Source of funding for CPACS-3 was from Sanofi, China, through an unrestricted research grant. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The principal investigators had full access to all data in the study and final responsibility for the decision to submit for publications. Drs RLG and YFW are principal investigators of CPACS-3 study, which is funded by Sanofi, China. No author is an employee or consultant of Sanofi, or have any interests related to products of Sanofi. No author has relationships with companies that might have an interest in the submitted work in the previous 3 years. Their spouses, partners, or children have no financial relationships that may be relevant to the submitted work. We could 100% assure you that "the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Berger A, 2008, AM J CARDIOL, V101, P422, DOI 10.1016/j.amjcard.2007.09.092; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Cheng TO, 2013, INT J CARDIOL, V169, P1, DOI 10.1016/j.ijcard.2013.08.117; Estevez-Loureiro R, 2010, EUROINTERVENTION, V6, P343, DOI 10.4244/EIJV6I3A57; Fournier S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119157; Isogai T, 2015, INT J CARDIOL, V179, P315, DOI 10.1016/j.ijcard.2014.11.070; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Kumar G, 2015, J AM COLL CARDIOL, V65, P217, DOI 10.1016/j.jacc.2014.09.083; Li SS, 2015, AM HEART J, V169, P349, DOI 10.1016/j.ahj.2014.12.005; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Qiu JP, 2011, CHINESE MED J-PEKING, V124, P805, DOI 10.3760/cma.j.issn.0366-6999.2011.06.002; ROGOT E, 1976, AM J EPIDEMIOL, V103, P198, DOI 10.1093/oxfordjournals.aje.a112218; Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393; Waxman Amalia, 2003, Food and Nutrition Bulletin, V24, P281; Zhang R, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-59	17	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175485	10.1371/journal.pone.0175485	http://dx.doi.org/10.1371/journal.pone.0175485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388683	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800059
J	Li, YZ; Shipley, B				Li, Yuanzhi; Shipley, Bill			An experimental test of CSR theory using a globally calibrated ordination method	PLOS ONE			English	Article							PLANT FUNCTIONAL TYPES; COMMUNITIES; TRAITS	Can CSR theory, in conjunction with a recently proposed globally calibrated CSR ordination ("StrateFy"), using only three easily measured leaf traits (leaf area, specific leaf area and leaf dry matter content) predict the functional signature of herbaceous vegetation along experimentally manipulated gradients of soil fertility and disturbance? To determine this, we grew 37 herbaceous species in mixture for five years in 24 experimental mesocosms differing in factorial levels of soil resources (stress) and density-independent mortality (disturbance). We measured 16 different functional traits and then ordinated the resulting vegetation within the CSR triangle using StrateFy. We then calculated community-weighted mean (CWM) values of the competitor (C-CWM), stress-tolerator (S-CWM) and ruderal (R-CWM) scores for each mesocosm. We found a significant increase in S-CWM from low to high stress mesocosms, and an increase in R-CWM from lowly to highly disturbed mesocosms. However, C-CWM did not decline significantly as intensity of stress or disturbance increased, as predicted by CSR theory. This last result likely arose because our herbaceous species were relatively poor competitors in global comparisons and thus no strong competitors in our species pool were selectively favoured in low stress and low disturbed mesocosms. Variation in the 13 other traits, not used by StrateFy, largely argeed with the predictions of CSR theory. StrateFy worked surprisingly well in our experimental study except for the C-dimension. Despite loss of some precision, it has great potential applicability in future studies due to its simplicity and generality.	[Li, Yuanzhi; Shipley, Bill] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	University of Sherbrooke	Shipley, B (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada.	bill.shipley@usherbrooke.ca	Shipley, Bill/A-4578-2011; Li, Yuan/GXV-1310-2022	Shipley, Bill/0000-0002-7026-3880; 	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-05989]; China Research Council Doctoral Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); China Research Council Doctoral Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada RGPIN-2014-05989 and the China Research Council Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boatman ND, 2011, AGR ECOSYST ENVIRON, V143, P8, DOI 10.1016/j.agee.2011.05.003; CAMPBELL BD, 1992, ECOLOGY, V73, P15, DOI 10.2307/1938717; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eler K, 2005, PHYTON-ANN REI BOT A, V45, P417; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Grime J. P., 2001, PLANT STRATEGIES VEG; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Hunt, 2007, COMP PLANT ECOLOGY C; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pierce S, 2017, FUNCT ECOL, V31, P444, DOI 10.1111/1365-2435.12722; Pierce S, 2013, FUNCT ECOL, V27, P1002, DOI 10.1111/1365-2435.12095; RCore Team, 2020, R LANG ENV STAT COMP; Shipley B, 2016, OECOLOGIA, V180, P923, DOI 10.1007/s00442-016-3549-x; Wheeler B., 2016, IMPERM PERMUTATION T; Zelnik I, 2008, COMMUNITY ECOL, V9, P1, DOI 10.1556/ComEc.9.2008.1.1	21	30	31	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175404	10.1371/journal.pone.0175404	http://dx.doi.org/10.1371/journal.pone.0175404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388622	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800051
J	Tian, FW; Yu, LL; Zhai, QX; Xiao, Y; Shi, Y; Jiang, JC; Liu, XM; Zhao, JX; Zhang, H; Chen, W				Tian, Fengwei; Yu, Leilei; Zhai, Qixiao; Xiao, Yue; Shi, Ying; Jiang, Jinchi; Liu, Xiaoming; Zhao, Jianxin; Zhang, Hao; Chen, Wei			The therapeutic protection of a living and dead Lactobacillus strain against aluminum-induced brain and liver injuries in C57BL/6 mice	PLOS ONE			English	Article							INDUCED EXPERIMENTAL COLITIS; LACTIC-ACID BACTERIA; OXIDATIVE STRESS; PLANTARUM CCFM8610; ALZHEIMERS-DISEASE; CADMIUM TOXICITY; NITRIC-OXIDE; RATS; INFLAMMATION; BEHAVIOR	Our previous study found that Lactobacillus plantarum CCFM639 had the ability to alleviate acute aluminum (Al) toxicity when the strain was introduced simultaneously with Al exposure. This research was designed to elucidate the therapeutic effects of living and dead L. plantarum CCFM639 against chronic Al toxicity and to gain insight into the protection modes of this strain. Animals were assigned into control, Al only, Al + living CCFM639, and Al + dead CCFM639 groups. The Al exposure model was established by drinking water for the first 4 weeks. The strain was given after Al exposure by oral gavage at 10(9) colony-forming units once per day for 12 weeks. The results show that the Al binding ability of dead CCFM639 was similar to that of living CCFM639 in vitro. The ingestion of living or dead CCFM639 has similar effects on levels of Al and trace element in tissues, but living strains led to more significant amelioration of oxidative stress and improvement of memory deficits in Al-exposed mice. In conclusion, in addition to intestinal Al sequestration, CCFM639 treatment offers direct protection against chronic Al toxicity by alleviation of oxidative stress. Therefore, L. plantarum CCFM639 has a potential as dietary supplement ingredient that provides protection against Al-induced injury.	[Tian, Fengwei; Yu, Leilei; Zhai, Qixiao; Xiao, Yue; Shi, Ying; Jiang, Jinchi; Liu, Xiaoming; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Tian, Fengwei; Yu, Leilei; Zhai, Qixiao; Zhang, Hao; Chen, Wei] UK China Joint Ctr Probiot Bacteria, Norwich, Norfolk, England; [Chen, Wei] Beijing Technol Business Univ, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China	Jiangnan University; Beijing Technology & Business University	Chen, W (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Chen, W (corresponding author), UK China Joint Ctr Probiot Bacteria, Norwich, Norfolk, England.; Chen, W (corresponding author), Beijing Technol Business Univ, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.	chenwei66@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Zhang, Hao/HHM-1940-2022		National Natural Science Foundation of China [31371721, 31601452, 31470161]; National Natural Science Foundation of China Key Program [31530056]; National Natural Science Foundation of Jiangsu Province [BK20160175]; BBSRC Newton Fund Joint Centre Award; Self-determined Research Program of Jiangnan University [JUSRP 115A23]; Grain Industry Research Special Funds for Public Welfare Projects [201513006-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China Key Program(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); BBSRC Newton Fund Joint Centre Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Self-determined Research Program of Jiangnan University; Grain Industry Research Special Funds for Public Welfare Projects	This work was supported by the National Natural Science Foundation of China [grant number 31371721]; the National Natural Science Foundation of China Key Program [grant numbers 31530056]; the National Natural Science Foundation of China [grant numbers 31601452]; the National Natural Science Foundation of China [grant numbers 31470161]; the National Natural Science Foundation of Jiangsu Province [grant number BK20160175]; BBSRC Newton Fund Joint Centre Award, the Self-determined Research Program of Jiangnan University [grant numbers JUSRP 115A23]; Grain Industry Research Special Funds for Public Welfare Projects [grant numbers 201513006-03].	Aguilar F, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.754; Amaretti A, 2013, APPL MICROBIOL BIOT, V97, P809, DOI 10.1007/s00253-012-4241-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Belkhelfa M, 2014, J INTERF CYTOK RES, V34, P839, DOI 10.1089/jir.2013.0085; Benchabane S, 2016, INT J IMMUNOPATH PH, V29, P386, DOI 10.1177/0394632016651273; Bharathi, 2006, BRAIN RES REV, V52, P275, DOI 10.1016/j.brainresrev.2006.04.003; Bhasin P, 2014, ENVIRON TOXICOL, V29, P320, DOI 10.1002/tox.21760; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Ding R, 2010, BRAIN RES, V1324, P96, DOI 10.1016/j.brainres.2010.02.024; Do TKL, 2009, ASIA PAC J CLIN NUTR, V18, P326; Exley C, 1996, J TOXICOL ENV HEALTH, V48, P569, DOI 10.1080/009841096161078; Gareau MG, ADV EXP MED BIOL, P357; Gilgun-Sherki Y, 2003, J MOL NEUROSCI, V21, P1, DOI 10.1385/JMN:21:1:1; Guo CH, 2011, CLIN BIOCHEM, V44, P1309, DOI 10.1016/j.clinbiochem.2011.08.1132; Halttunen T, 2008, LETT APPL MICROBIOL, V46, P160, DOI 10.1111/j.1472-765X.2007.02276.x; Javed H, 2011, BRAIN RES, V1389, P133, DOI 10.1016/j.brainres.2011.02.072; Kumar A, 2009, BEHAV BRAIN RES, V205, P384, DOI 10.1016/j.bbr.2009.07.012; Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6; Li M, 2015, TOXICOL RES-UK, V4, P1366, DOI 10.1039/c5tx00050e; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; Linardaki ZI, 2013, FOOD CHEM TOXICOL, V52, P163, DOI 10.1016/j.fct.2012.11.016; Mahieu S, 2009, TOXICOL LETT, V190, P9, DOI 10.1016/j.toxlet.2009.06.852; Malhi H, 2008, REGEN MED, V3, P165, DOI 10.2217/17460751.3.2.165; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; Ozcelik D, 2003, BIOL TRACE ELEM RES, V96, P209, DOI 10.1385/BTER:96:1-3:209; Park EJ, 2015, ARCH TOXICOL, V89, P371, DOI 10.1007/s00204-014-1256-0; Park EJ, 2014, ARCH TOXICOL, V88, P323, DOI 10.1007/s00204-013-1134-1; Prakash D, 2013, NEUROMOL MED, V15, P192, DOI 10.1007/s12017-012-8210-1; Ribes D, 2008, EXP NEUROL, V214, P293, DOI 10.1016/j.expneurol.2008.08.017; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Sethi P, 2009, PHARMACOL BIOCHEM BE, V93, P31, DOI 10.1016/j.pbb.2009.04.005; Shrivastava S, 2015, J ENVIRON PATHOL TOX, V34, P11, DOI 10.1615/JEnvironPatholToxicolOncol.2015011778; Sivakumar S, 2012, ENVIRON TOXICOL PHAR, V34, P791, DOI 10.1016/j.etap.2012.09.007; Songisepp E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-22; Stacchiotti A, 2008, EXP GERONTOL, V43, P330, DOI 10.1016/j.exger.2008.01.009; Toumi R, 2014, INT J IMMUNOPATH PH, V27, P615, DOI 10.1177/039463201402700418; Toumi R, 2013, IMMUNOPHARM IMMUNOT, V35, P403, DOI 10.3109/08923973.2013.790413; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7; Yang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079734; Yang Y, 2016, BIOL TRACE ELEM RES; Yokel RA, 2002, BRAIN RES, V930, P101, DOI 10.1016/S0006-8993(02)02234-5; Yu LL, 2017, BIOL TRACE ELEM RES, V176, P342, DOI 10.1007/s12011-016-0843-8; Yu LL, 2016, APPL MICROBIOL BIOT, V100, P1891, DOI 10.1007/s00253-015-7135-7; Zatta P, 2002, COORDIN CHEM REV, V228, P271, DOI 10.1016/S0010-8545(02)00074-7; Zhai QX, 2014, APPL ENVIRON MICROB, V80, P4063, DOI 10.1128/AEM.00762-14; Zhai QX, 2013, APPL ENVIRON MICROB, V79, P1508, DOI 10.1128/AEM.03417-12; Zhang C, 2013, PLOS ONE, V8; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147; Zhu YZ, 2012, FOOD CHEM TOXICOL, V50, P2911, DOI 10.1016/j.fct.2012.05.041	53	14	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175398	10.1371/journal.pone.0175398	http://dx.doi.org/10.1371/journal.pone.0175398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388664	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800049
J	Britten, L; Coats, R; Ichiyama, R; Raza, W; Jamil, F; Astill, S				Britten, Laura; Coats, Rachel; Ichiyama, Ronaldo; Raza, Wajid; Jamil, Firas; Astill, Sarah			Bimanual reach to grasp movements after cervical spinal cord injury	PLOS ONE			English	Article							TO-GRASP; PREHENSION MOVEMENTS; KINEMATIC CHARACTERISTICS; QUADRIPLEGIC PATIENTS; OBJECT DISTANCE; 2 HANDS; COORDINATION; ARM; PLASTICITY; PATTERNS	Injury to the cervical spinal cord results in bilateral deficits in arm/hand function reducing functional independence and quality of life. To date little research has been undertaken to investigate control strategies of arm/hand movements following cervical spinal cord injury (cSCI). This study aimed to investigate unimanual and bimanual coordination in patients with acute cSCI using 3D kinematic analysis as they performed naturalistic reach to grasp actions with one hand, or with both hands together (symmetrical task), and compare this to the movement patterns of uninjured younger and older adults. Eighteen adults with a cSCI (mean 61.61 years) with lesions at C4-C8, with an American Spinal Injury Association (ASIA) grade B to D and 16 uninjured younger adults (mean 23.68 years) and sixteen uninjured older adults (mean 70.92 years) were recruited. Participants with a cSCI produced reach-to-grasp actions which took longer, were slower, and had longer deceleration phases than uninjured participants. These differences were exacerbated during bimanual reach-to-grasp tasks. Maximal grasp aperture was no different between groups, but reached earlier by people with cSCI. Participants with a cSCI were less synchronous than younger and older adults but all groups used the deceleration phase for error correction to end the movement in a synchronous fashion. Overall, this study suggests that after cSCI a level of bimanual coordination is retained. While there seems to be a greater reliance on feedback to produce both the reach to grasp, we observed minimal disruption of the more impaired limb on the less impaired limb. This suggests that bimanual movements should be integrated into therapy.	[Britten, Laura; Ichiyama, Ronaldo; Astill, Sarah] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Coats, Rachel] Univ Leeds, Sch Psychol, Fac Med & Hlth, Leeds, W Yorkshire, England; [Raza, Wajid; Jamil, Firas] Pinderfields Gen Hosp, Yorkshire Reg Spinal Injuries Ctr, Wakefield, England	University of Leeds; University of Leeds; Pinderfields Hospital	Britten, L (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	L.E.Britten@leeds.ac.uk	Coats, Rachel/AAH-6980-2019; Astill, Sarah/Z-3237-2019	Coats, Rachel/0000-0003-4415-408X; Britten, Laura/0000-0002-1010-5135; Astill, Sarah/0000-0002-9443-6934; Ichiyama, Ronaldo/0000-0002-7640-8032	University of Leeds; NHS Yorkshire; North West Spinal Injuries Centres	University of Leeds; NHS Yorkshire; North West Spinal Injuries Centres	We are grateful for the support from The University of Leeds and NHS Yorkshire and North West Spinal Injuries Centres and would also like to thank all of the participants involved within the study.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Cacho EWA, 2011, INT J REHABIL RES, V34, P65, DOI 10.1097/MRR.0b013e32833d6cf3; Backus D, 2014, ARCH PHYS MED REHAB, V95, P1447, DOI 10.1016/j.apmr.2014.03.011; Balasubramanian S, 2012, IEEE T BIO-MED ENG, V59, P2126, DOI 10.1109/TBME.2011.2179545; Barreca S, 2006, PHYSIOTHER CAN, V58, P148, DOI DOI 10.3138/PTC.58.2.148; Bingham GP, 2008, EXP BRAIN RES, V184, P283, DOI 10.1007/s00221-007-1107-9; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Calabro FJ, 2016, J NEUROPHYSIOL, V115, P157, DOI 10.1152/jn.00692.2015; Coats RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047222; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; FOWLER B, 1991, Q J EXP PSYCHOL-A, V43, P205, DOI 10.1080/14640749108400967; GENTILUCCI M, 1992, BEHAV BRAIN RES, V47, P71, DOI 10.1016/S0166-4328(05)80253-0; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Hoffman Larisa, 2013, Top Spinal Cord Inj Rehabil, V19, P288, DOI 10.1310/sci1904-288; Hoffman LR, 2010, J NEUROL PHYS THER, V34, P193, DOI 10.1097/NPT.0b013e3181fbe692; Hoffmann G, 2006, NEUROSCIENCE, V139, P749, DOI 10.1016/j.neuroscience.2005.12.018; Hoffmann G, 2002, CAH PSYCHOL COGN, V21, P305; Jackson GM, 1999, BRIT J PSYCHOL, V90, P247, DOI 10.1348/000712699161396; Jacquier-Bret J, 2008, IEEE ENG MED BIO, P5366, DOI 10.1109/IEMBS.2008.4650427; Jeannerod M., 1984, J MOTOR BEHAV; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; Koshland GF, 2005, EXP BRAIN RES, V164, P133, DOI 10.1007/s00221-005-2218-9; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Laffont I, 2000, SPINAL CORD, V38, P354, DOI 10.1038/sj.sc.3100999; Marsh BC, 2011, BRAIN RES BULL, V84, P327, DOI 10.1016/j.brainresbull.2010.07.011; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Mason AH, 2013, EXP BRAIN RES, V231, P153, DOI 10.1007/s00221-013-3678-y; Mason AH, 2009, HUM MOVEMENT SCI, V28, P48, DOI 10.1016/j.humov.2008.09.002; Mateo S, 2013, SPINAL CORD, V51, P144, DOI 10.1038/sc.2012.101; Mateo S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-9; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Reft J, 2002, SPINAL CORD, V40, P186, DOI 10.1038/sj.sc.3101277; Riek S, 2003, EXP BRAIN RES, V153, P59, DOI 10.1007/s00221-003-1581-7; Spooren AIF, 2009, J REHABIL MED, V41, P497, DOI 10.2340/16501977-0387; Stahl VA, 2014, EXPT BRAIN RES, P1; Thibaudier Y, 2014, J NEUROPHYSIOL, V112, P2006, DOI 10.1152/jn.00236.2014; Thompson C, 2014, J SPINAL CORD MED; Trombly CA, 1999, AM J OCCUP THER, V53, P333, DOI 10.5014/ajot.53.4.333; Waller SM, 2008, NEUROREHABILITATION, V23, P29	44	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175457	10.1371/journal.pone.0175457	http://dx.doi.org/10.1371/journal.pone.0175457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384247	gold, Green Published			2022-12-27	WOS:000399371900171
J	Chan, M; Chiang, CL; Lee, V; Cheung, S; Leung, R; Wong, M; Lee, F; Blanck, O				Chan, Mark; Chiang, Chi Leung; Lee, Venus; Cheung, Steven; Leung, Ronnie; Wong, Matthew; Lee, Frankle; Blanck, Oliver			Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas	PLOS ONE			English	Article							BODY RADIATION-THERAPY; LUNG-CANCER PATIENTS; TRANSARTERIAL CHEMOEMBOLIZATION; CT; MOTION; TUMOR; SBRT; STRATEGIES; GUIDANCE	Background Aim of this study was to comparatively evaluate the accuracy of respiration-correlated (4D) and uncorrelated (3D) cone beam computed tomography (CBCT) in localizing lipiodolized hepatocellular carcinomas during stereotactic body radiotherapy (SBRT). Methods 4D-CBCT scans of eighteen HCCs were acquired during free-breathing SBRT following trans-arterial chemo-embolization (TACE) with lipiodol. Approximately 1320 x-ray projections per 4D-CBCT were collected and phase-sorted into ten bins. A 4D registration work-flow was followed to register the reconstructed time-weighted average CBCT with the planning mid-ventilation (MidV) CT by an initial bone registration of the vertebrae and then tissue registration of the lipiodol. For comparison, projections of each 4D-CBCT were combined to synthesize 3D-CBCT without phase-sorting. Using the lipiodolized tumor, uncertainties of the treatment setup estimated from the absolute and relative lipiodol position to bone were analyzed separately for 4D-and 3D-CBCT. Results Qualitatively, 3D-CBCT showed better lipiodol contrast than 4D-CBCT primarily because of a tenfold increase of projections used for reconstruction. Motion artifact was observed to subside in 4D-CBCT compared to 3D-CBCT. Group mean, systematic and random errors estimated from 4D-and 3D-CBCT agreed to within 1 mm in the cranio-caudal (CC) and 0.5 mm in the anterior-posterior (AP) and left-right (LR) directions. Systematic and random errors are largest in the CC direction, amounting to 4.7 mm and 3.7 mm from 3D-CBCT and 5.6 mm and 3.8 mm from 4D-CBCT, respectively. Safety margin calculated from 3D-CBCT and 4D-CBCT differed by 2.1, 0.1 and 0.0 mm in the CC, AP, and LR directions. Conclusions 3D-CBCT is an adequate alternative to 4D-CBCT when lipoid is used for localizing HCC during free-breathing SBRT. Similar margins are anticipated with 3D- and 4D-CBCT.	[Chan, Mark; Blanck, Oliver] Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Kiel, Germany; [Chiang, Chi Leung; Lee, Venus; Cheung, Steven; Leung, Ronnie; Wong, Matthew; Lee, Frankle] Tuen Mun Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chiang, Chi Leung; Lee, Venus] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chiang, Chi Leung] Univ Hong Kong, Shenzhen Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Kiel; Schleswig Holstein University Hospital; Tuen Mun Hospital; University of Hong Kong; University of Hong Kong	Chan, M (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Kiel, Germany.	markkhchan@yahoo.com	Chan, Mark/ABF-5313-2021; Leung, Ronnie/CAG-2088-2022	Chan, Mark/0000-0002-0187-2703; Chiang, Chi-Leung/0000-0002-9836-6478; Blanck, Oliver/0000-0003-1391-1308				Case RB, 2009, INT J RADIAT ONCOL, V75, P302, DOI 10.1016/j.ijrobp.2009.03.058; Chan MKH, 2016, STRAHLENTHER ONKOL, V192, P92, DOI 10.1007/s00066-015-0929-9; Chan MKH, 2013, J APPL CLIN MED PHYS, V14; Choi BO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-351; Dawson LA, 2006, ACTA ONCOL, V45, P856, DOI 10.1080/02841860600936369; Hoogeman MS, 2005, RADIOTHER ONCOL, V74, P177, DOI 10.1016/j.radonc.2004.12.010; Hugo GD, 2007, INT J RADIAT ONCOL, V69, P1634, DOI 10.1016/j.ijrobp.2007.08.023; Jones BL, 2014, J PHYS CONF SER, V489, DOI 10.1088/1742-6596/489/1/012035; Koo JE, 2010, INT J RADIAT ONCOL, V78, P180, DOI 10.1016/j.ijrobp.2009.07.1730; Lagendijk JJW, 2008, RADIOTHER ONCOL, V86, P25, DOI 10.1016/j.radonc.2007.10.034; Lee A, 2012, INT J RADIAT ONCOL, V84, pS333, DOI 10.1016/j.ijrobp.2012.07.876; Li W, 2015, INT J RADIAT ONCOL, V93, pE182, DOI 10.1016/j.ijrobp.2015.07.1014; Lu B, 2010, J APPL CLIN MED PHYS, V11, P231, DOI 10.1120/jacmp.v11i3.3274; Rit S, 2011, RADIOTHER ONCOL, V100, P356, DOI 10.1016/j.radonc.2011.08.018; Seppenwoolde Y, 2011, PHYS MED BIOL, V56, P5445, DOI 10.1088/0031-9155/56/17/001; Sonke JJ, 2009, INT J RADIAT ONCOL, V74, P567, DOI 10.1016/j.ijrobp.2008.08.004; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Sweeney RA, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-81; Velec M, 2014, PRACT RADIAT ONCOL, V4, P160, DOI 10.1016/j.prro.2013.07.001; Wolthaus JWH, 2008, MED PHYS, V35, P3998, DOI 10.1118/1.2966347; Wolthaus JWH, 2008, INT J RADIAT ONCOL, V70, P1229, DOI 10.1016/j.ijrobp.2007.11.042; Yang J, 2014, INT J RADIAT ONCOL, V90, P952, DOI 10.1016/j.ijrobp.2014.07.028; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460; Zhong R, 2012, RADIOTHER ONCOL; Zhong RM, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-77	26	7	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174929	10.1371/journal.pone.0174929	http://dx.doi.org/10.1371/journal.pone.0174929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384187	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900055
J	Chen, HC; Chung, CH; Wang, CH; Lin, JC; Chang, WK; Lin, FH; Tsao, CH; Wu, YF; Chien, WC				Chen, Hsin-Chien; Chung, Chi-Hsiang; Wang, Chih-Hung; Lin, Jung-Chun; Chang, Wei-Kuo; Lin, Fu -Huang; Tsao, Chang-Huei; Wu, Yung-Fu; Chien, Wu-Chien			Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection	PLOS ONE			English	Article							B-VIRUS; C-VIRUSES; TAIWAN; EPIDEMIOLOGY; VACCINATION; COMMUNITY	The etiology of sudden sensorineural hearing loss (SSNHL) remains unclear. Possible causes of SSNHL include vascular diseases, viral infection, and autoimmune disorders. Therefore, we investigated whether hepatitis virus infection is correlated with the risk of SSNHL. Using data from the Taiwan Longitudinal Health Insurance Database, we conducted a retrospective matched-cohort study to compare patients diagnosed with hepatitis B or C virus (HBV/HCV) infections from January 1, 2000, to December 31, 2010, (N = 170,942) with frequency-matched controls (N = 512,826) at a ratio of 1: 3 by sex, age, and index year. We followed each patient until the end of 2010 and evaluated the incidence of SSNHL. At the end of the follow-up period, 647 (0.38%, 647/170,942) patients developed SSNHL in the HBV/HCV group compared with 978 (0.19%, 978/512,826) in the control groups, with a statistical significance of P < 0.001 (using the log-rank test). The incidence rate ratio of SSNHL was 5.743-fold higher in the HBV/HCV group than in the control group (283.17 vs. 49.31 per 100,000 person-years, P < 0.001). The risk of SSNHL increased with HBV/HCV infection, and an adjusted hazard ratio of 5.103 (95% CI, 4.585-5.678) was determined using Cox proportional hazards regression. This study contributes to the awareness of the increased risk of SSNHL in HBV/HCV-infected populations. Our findings suggest that an underlying viral infection contributes to the development of SSNHL.	[Chen, Hsin-Chien; Wang, Chih-Hung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chung, Chi-Hsiang; Tsao, Chang-Huei; Wu, Yung-Fu; Chien, Wu-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu -Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lin, Jung-Chun; Chang, Wei-Kuo] Natl Def Med Ctr, Triserv Gen Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chien, WC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.	doc30459@gmail.com	Wang, Chih-Hung/AAR-9766-2020; Chung, Chi-Hsiang/AAY-3386-2021		Ministry of Science and Technology, Taiwan [MOST 103-2314-B-016 -018 -MY2, MOST 103-2314-B-016-018 -MY2]; Tri-Service General Hospital [TSGH-C105-008]; National Defense Medical Research grants, Taiwan, ROC [MAB-104-058, MAB-105-019]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; National Defense Medical Research grants, Taiwan, ROC	This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-016 -018 -MY2 to HC Chen), Tri-Service General Hospital (TSGH-C105-008 to HC Chen), National Defense Medical Research grants, Taiwan, ROC (MAB-104-058 and MAB-105-019 to HC Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-016-018 -MY2 to HC Chen); Tri-Service General Hospital (TSGH-C105-108 to HC Chen); and National Defense Medical Research grants, Taiwan, ROC (MAB-104-058 and MAB-105-019 to HC Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuShakra M, 1997, LUPUS, V6, P543, DOI 10.1177/096120339700600612; BYL FM, 1984, LARYNGOSCOPE, V94, P647; Chang MC, 2014, WORLD J GASTROENTERO, V20, P5060, DOI 10.3748/wjg.v20.i17.5060; Chen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002276; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gozdas HT, 2015, INDIAN J PHARMACOL, V47, P121, DOI 10.4103/0253-7613.150377; Hagr A, 2011, SAUDI J GASTROENTERO, V17, P114, DOI 10.4103/1319-3767.77240; Huang CC, 2009, OTOLARYNG HEAD NECK, V141, P659, DOI 10.1016/j.otohns.2009.05.006; Mendes-Correa MCJ, 2011, BRAZ J INFECT DIS, V15, P87, DOI [10.1590/S1413-86702011000100017, 10.1016/S1413-8670(11)70147-7]; Joglekar S, 2010, AM J OTOLARYNG, V31, P221, DOI 10.1016/j.amjoto.2009.02.006; KOIDE J, 1988, ACTA OTO-LARYNGOL, P21; Lin C, 2013, JAMA OTOLARYNGOL, V139, P251, DOI 10.1001/jamaoto.2013.1709; Lin RJ, 2012, LARYNGOSCOPE, V122, P624, DOI 10.1002/lary.22480; Masuda M, 2012, OTOL NEUROTOL, V33, P1142, DOI 10.1097/MAO.0b013e3182635417; Mentel R, 2004, J MED VIROL, V72, P625, DOI 10.1002/jmv.20014; Nasab Mohamad Shayani, 2012, Oman Med J, V27, P418, DOI 10.5001/omj.2012.103; Orlando MP, 1997, ANN NY ACAD SCI, V830, P319, DOI 10.1111/j.1749-6632.1997.tb51903.x; Pacher BM, 2015, REV SOC BRAS MED TRO, V48, P603, DOI 10.1590/0037-8682-0058-2015; Qureshi MO, 2012, JCPSP-J COLL PHYSICI, V22, P632, DOI 10.2012/JCPSP.632634; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; So H, 2007, JARO-J ASSOC RES OTO, V8, P338, DOI 10.1007/s10162-007-0084-9; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Wu CS, 2006, AUDIOL NEURO-OTOL, V11, P151, DOI 10.1159/000091198; Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5	29	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175266	10.1371/journal.pone.0175266	http://dx.doi.org/10.1371/journal.pone.0175266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384326	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900142
J	Cho, D; Shin, TJ; Ham, J; Choi, DH; Kim, S; Jeong, S; Kim, HI; Kim, JG; Lee, B				Cho, Dongrae; Shin, Teo Jeon; Ham, Jinsil; Choi, Dong-Hyuk; Kim, Seonghyun; Jeong, Seongwook; Kim, Hyoung-Ihl; Kim, Jae Gwen; Lee, Boreom			Differential modulation of thalamo-parietal interactions by varying depths of isoflurane anesthesia	PLOS ONE			English	Article							INFORMATION INTEGRATION; INDUCED UNCONSCIOUSNESS; IMPAIRED CONSCIOUSNESS; ATTENTIONAL MODULATION; ALPHA OSCILLATIONS; RETICULAR NUCLEUS; BRAIN; MECHANISMS; NEURONS; MODEL	The thalamus is thought to relay peripheral sensory information to the somatosensory cortex in the parietal lobe. Long-range thalamo-parietal interactions play an important role in inducing the effect of anesthetic. However, whether these interaction changes vary with different levels of anesthesia is not known. In the present study, we investigated the influence of different levels of isoflurane-induced anesthesia on the functional connectivity between the thalamus and the parietal region. Microelectrodes were implanted in rats to record local field potentials (LFPs). The rats underwent different levels of isoflurane anesthesia [deep anesthesia: isoflurane (ISO) 2.5 vol%, light anesthesia (ISO 1 vol%), awake, and recovery state] and LFPs were recorded from four different brain areas (left parietal, right parietal, left thalamus, and right thalamus). Partial directed coherence (PDC) was calculated for these areas. With increasing depth of anesthesia, the PDC in the thalamus-to-parietal direction was significantly increased mainly in the high frequency ranges; however, in the parietal-to-thalamus direction, the increase was mainly in the low frequency band. For both directions, the PDC changes were prominent in the alpha frequency band. Functional interactions between the thalamus and parietal area are augmented proportionally to the anesthesia level. This relationship may pave the way for better understanding of the neural processing of sensory inputs from the periphery under different levels of anesthesia.	[Cho, Dongrae; Ham, Jinsil; Choi, Dong-Hyuk; Kim, Seonghyun; Kim, Hyoung-Ihl; Kim, Jae Gwen; Lee, Boreom] Gwangju Inst Sci & Technol, Inst Integrated Technol, Dept Biomed Sci & Engn, Gwangju, South Korea; [Shin, Teo Jeon] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul, South Korea; [Shin, Teo Jeon] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea; [Jeong, Seongwook] Chonnam Natl Univ, Dept Anesthesiol & Pain Med, Sch Med, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Seoul National University (SNU); Chonnam National University	Kim, JG; Lee, B (corresponding author), Gwangju Inst Sci & Technol, Inst Integrated Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.	jaekim@gist.ac.kr; leebr@gist.ac.kr		Cho, Dongrae/0000-0002-3741-3410; Kim, Jae/0000-0002-1010-7712	GIST Research Institute (GRI); Biomedical Integrated Technology Research" Project through a grant provided by GIST; Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2016R1D1A1B03933840]	GIST Research Institute (GRI); Biomedical Integrated Technology Research" Project through a grant provided by GIST; Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education	This work was supported by the GIST Research Institute (GRI) in 2017. It was also supported by Biomedical Integrated Technology Research Project through a grant provided by GIST and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (2016R1D1A1B03933840).	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Boly M, 2013, THE JOURNAL OF NEURO, V32, P7082; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gottschalk A, 2009, ANESTHESIOLOGY, V110, P996, DOI 10.1097/ALN.0b013e31819db923; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Liu XL, 2013, ANESTHESIOLOGY, V118, P59, DOI 10.1097/ALN.0b013e318277a801; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Mashour GA, 2013, ANESTHESIOLOGY, V118, P13, DOI 10.1097/ALN.0b013e318277a9c6; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Pratt JA, 2015, J PSYCHOPHARMACOL, V29, P127, DOI 10.1177/0269881114565805; R Core Team, 2013, R LANG ENV STAT COMP; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shin TJ, 2016, NEUROSCI LETT, V627, P18, DOI 10.1016/j.neulet.2016.05.045; Sun Y, 2009, IEEE T BIO-MED ENG, V56, P2721, DOI 10.1109/TBME.2009.2025966; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Tononi G, 2010, ARCH ITAL BIOL, V148, P299; Tzovara A, 2015, BRAIN, V138, P1160, DOI 10.1093/brain/awv041; Vahle-Hinz C, 2007, EXP BRAIN RES, V176, P159, DOI 10.1007/s00221-006-0604-6; Velly LJ, 2007, ANESTHESIOLOGY, V107, P202, DOI 10.1097/01.anes.0000270734.99298.b4; Vijayan S, 2012, P NATL ACAD SCI USA, V109, P18553, DOI 10.1073/pnas.1215385109; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Xu X, 2015, WORLD J NEUROSCIENCE, V5, P99	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175191	10.1371/journal.pone.0175191	http://dx.doi.org/10.1371/journal.pone.0175191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384227	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900115
J	Chu, CL; Dui, QL; Li, CQ; Zhang, LL; Zhou, XY; Zuo, F; Zhang, YM; Li, F; Xie, GF; Li, YQ				Chu, Chuanlian; Dui, Quanlin; Li, Changqing; Zhang, Linlu; Zhou, Xiaoyan; Zuo, Fang; Zhang, Yanmin; Li, Fang; Xie, Guofeng; Li, Yanqing			Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn	PLOS ONE			English	Article							DILATED INTERCELLULAR SPACES; MINIMAL CHANGE ESOPHAGITIS; GASTROESOPHAGEAL-REFLUX; NORMAL VALUES; SYMPTOM ANALYSIS; ACID; POPULATION; CLASSIFICATION; ASSOCIATION; MULTICENTER	Aims To assess the contribution of 24-h esophageal multichannel intraluminal impedance and pH (MII-pH) monitoring and high resolution endoscopy (HRE) with i-scan imaging in differentiating non erosive reflux disease (NERD) from functional heartburn (FH). Methods This is a retrospective cohort study of patients with heartburn from the Endoscopy Unit. NERD patients and FH patients were defined by 24-h MII-pH monitoring and white light endoscopy. Minimal mucosal changes were assessed by HRE with i-scan imaging. Results Total of 156 consecutive patients with heartburn but without esophageal mucosal erosions were studied. Forty-eight of these subjects had NERD, with increased acid exposure time (AET) and positive SAP and/or SI. Eighteen had FH with normal AET and negative SAP and SI. When compared to FH patients and healthy controls, NERD patients had significantly increased number of total acid reflux episodes, as well as increased number of weakly acidic reflux episodes (p<0.01). The rate of proximal reflux episodes in NERD patients was higher than that of FH patients and healthy controls (p<0.01). Irregular or blurring of the Z-line (58.3%) and white mucosal turbidity (47.9%) were the most common endoscopic findings of minimal mucosal changes observed in this study. NERD patients had more prevalent minimal changes than FH patients and the controls (87.5% vs. 66.6% vs. 61.9%; p = 0.004) with sensitivity of 87.5%. Histopathological evaluation showed that NERD patients had significantly higher average scores of intercellular spaces dilation (2.82 +/- 0.9 vs. 1.2 +/- 0.6, p = 0.005) and papillae elongation (2.65 +/- 1.0 vs. 1.5 +/- 0.8, p = 0.014), but not for basal cell proliferation (1.6 +/- 1.3 vs. 1.0 +/- 0.9, p = 0.070). The histological scores of the NERD patients were 7.1 +/- 1.2, which were higher than those of FH patients (3.4 +/- 1.0, p = 0.004). Conclusions Minimal mucosal changes could be useful markers to support clinical diagnosis of NERD. Combination of 24-h MII-pH monitoring and i-scan high resolution endoscopy can distinguish patients with NERD from those with FH.	[Chu, Chuanlian; Dui, Quanlin; Zhang, Linlu; Zhou, Xiaoyan; Zuo, Fang; Zhang, Yanmin; Li, Fang] Shandong Univ, Jinan Cent Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China; [Li, Changqing; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China; [Xie, Guofeng] Univ Maryland, Sch Med, Maryland VA Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; University System of Maryland; University of Maryland Baltimore	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China.	liyanqing@sdu.edu.cn			Science Technology Development Project of Shangdong Province [2013G0021804]; Science Technology Development Project of Jinan City [201121001]	Science Technology Development Project of Shangdong Province; Science Technology Development Project of Jinan City	This work was supported by grants from the Science Technology Development Projects of Shangdong Province and Jinan City, award ID number 2013G0021804 and 201121001, respectively (CC and YL).	Altorki NK, 2008, ANN SURG, V247, P434, DOI 10.1097/SLA.0b013e318163a2ff; Calabrese C, 2003, ALIMENT PHARM THER, V18, P525, DOI 10.1046/j.1365-2036.2003.01713.x; Calabrese C, 2005, AM J GASTROENTEROL, V100, P537, DOI 10.1111/j.1572-0241.2005.40476.x; Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023; Caviglia R, 2005, AM J GASTROENTEROL, V100, P543, DOI 10.1111/j.1572-0241.2005.40978.x; Choung RS, 2012, NEUROGASTROENT MOTIL, V24, P229, DOI 10.1111/j.1365-2982.2011.01845.x; Chu CL, 2012, AM J GASTROENTEROL, V107, P864, DOI 10.1038/ajg.2012.44; Edebo A, 2007, ENDOSCOPY, V39, P195, DOI 10.1055/s-2006-945112; Frazzoni M, 2016, J GASTROENTEROLOGY; Galmiche JP, 2006, GASTROENTEROLOGY, V130, P1459, DOI 10.1053/j.gastro.2005.08.060; Hongo M, 2006, J GASTROENTEROL, V41, P95, DOI 10.1007/s00535-006-1775-4; Hongo M, 2008, J GASTROENTEROL, V43, P448, DOI 10.1007/s00535-008-2186-5; Hoshihara Yoshio, 2004, Nihon Rinsho, V62, P1459; Joh T, 2007, J GASTROENTEROL, V42, P444, DOI 10.1007/s00535-007-2022-3; JOHNSTON BT, 1995, SCAND J GASTROENTERO, V30, P1, DOI 10.3109/00365529509093228; Kandulski A, 2013, ALIMENT PHARM THER, V38, P643, DOI 10.1111/apt.12428; Kandulski A, 2015, CLIN GASTROENTEROL H, V13, P1075, DOI 10.1016/j.cgh.2014.11.033; Kim JH, 2011, ENDOSCOPY, V43, P190, DOI 10.1055/s-0030-1256101; Kim MS, 2011, CLIN ENDOSC, V44, P27, DOI 10.5946/ce.2011.44.1.27; Lei WY, 2012, DIGESTION, V85, P27, DOI 10.1159/000334715; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Luo X, 2016, WORLD J GASTROENTERO, V22, P3845, DOI 10.3748/wjg.v22.i14.3845; Manner H, 2008, AM J GASTROENTEROL, V103, P2589, DOI 10.1111/j.1572-0241.2008.02083.x; Netinatsunton N, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0417-4; Pehl C, 2004, EUR J GASTROEN HEPAT, V16, P375, DOI 10.1097/00042737-200404000-00002; Rey JW, 2016, DIS ESOPHAGUS, V29, P185, DOI 10.1111/dote.12308; Savarino E, 2013, J GASTROENTEROL, V48, P473, DOI 10.1007/s00535-012-0672-2; Savarino E, 2012, J GASTROENTEROL, V47, P159, DOI 10.1007/s00535-011-0480-0; Savarino E, 2011, DIGEST LIVER DIS, V43, P940, DOI 10.1016/j.dld.2011.07.014; Savarino E, 2011, DIGEST LIVER DIS, V43, P542, DOI 10.1016/j.dld.2011.01.016; Shay S, 2004, AM J GASTROENTEROL, V99, P1037, DOI 10.1111/j.1572-0241.2004.04172.x; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Slaughter JC, 2011, CLIN GASTROENTEROL H, V9, P868, DOI 10.1016/j.cgh.2011.07.009; Tack J, 2005, GUT, V54, P1370, DOI 10.1136/gut.2004.053355; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vela MF, 2011, AM J GASTROENTEROL, V106, P844, DOI 10.1038/ajg.2010.476; WEUSTEN BLAM, 1994, GASTROENTEROLOGY, V107, P1741, DOI 10.1016/0016-5085(94)90815-X; Xiao YL, 2009, DIGESTION, V79, P109, DOI 10.1159/000209220; Zentilin P, 2006, DIGEST LIVER DIS, V38, P226, DOI 10.1016/j.dld.2005.12.011; Zerbib F, 2006, AM J GASTROENTEROL, V101, P1956, DOI 10.1111/j.1572-0241.2006.00711.x; Zerbib Frank, 2012, Curr Gastroenterol Rep, V14, P181, DOI 10.1007/s11894-012-0255-7	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175263	10.1371/journal.pone.0175263	http://dx.doi.org/10.1371/journal.pone.0175263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384225	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900141
J	Dobrakowski, P; Bogocz, M; Cholewa, K; Rajchel, M; Kapica-Topczewska, K; Wawrzyniak, S; Bartosik-Psujek, H; Kulakowska, A; Koziarska, D; Adamczyk-Sowa, M				Dobrakowski, Pawel; Bogocz, Michel; Cholewa, Kamil; Rajchel, Mateusz; Kapica-Topczewska, Katarzyna; Wawrzyniak, Slawomir; Bartosik-Psujek, Halina; Kulakowska, Aline; Koziarska, Dorota; Adamczyk-Sowa, Monika			Month of birth and level of insolation as risk factors for multiple sclerosis in Poland	PLOS ONE			English	Article							VITAMIN-D; DIAGNOSTIC-CRITERIA; HEWITTS TEST; SEASON; POPULATION	Introduction Many studies have shown that people born in the spring are at a higher risk of developing multiple sclerosis (MS). This may be associated with lower levels of sun exposure, and consequently, lower levels of vitamin D3 during pregnancy. However, these relationships have not been verified thus far in any countries in Central Europe. Objective The aim of our study was to determine the frequency distribution of births for each calendar month in patients suffering from MS in Poland. Methods We analyzed data for 2574 patients diagnosed with MS (1758 women, 816 men) living in Poland for an extended period. We added corrections resulting from the frequency distribution of births for the years in which the patients were born. We applied the Hewitt test for seasonality with Rogerson modification for 3-, 4-, or 6-month pulses or periods. Moreover, we examined the average number hours of sunshine in every month of the year. Results The rank-sums for successive 3- and 4-month segments indicated the period from September to December and from October to December as having a significantly lower incidence (p = 0.027 and p = 0.054, respectively). We did not find a correlation between with hours of sunshine in the first trimester of pregnancy, the child's birth month, and the child developing MS. Conclusions We were able to confirm a seasonal variation in the risk of MS in Poland. However, these findings did not correlate with hours of sunshine during the first trimester of pregnancy.	[Dobrakowski, Pawel; Bogocz, Michel; Cholewa, Kamil; Rajchel, Mateusz; Adamczyk-Sowa, Monika] Med Univ Silesia, Dept Neurol Zabrze, Zabrze, Poland; [Kapica-Topczewska, Katarzyna; Kulakowska, Aline] Med Univ Bialystok, Dept Neurol, Bialystok, Poland; [Wawrzyniak, Slawomir] 10th Mil Hosp Policlin, Dept Neurol, Bydgoszcz, Poland; [Bartosik-Psujek, Halina] Rzeszow State Hosp 2, Dept Clin Neurol, Rzeszow, Poland; [Koziarska, Dorota] Pomeranian Med Univ, Dept Neurol, Szczecin, Poland	Medical University Silesia; Medical University of Bialystok; Pomeranian Medical University	Dobrakowski, P (corresponding author), Med Univ Silesia, Dept Neurol Zabrze, Zabrze, Poland.	paweldobrakowski@interia.pl	kapica-topczewska, katarzyna/ABD-9114-2020	Adamczyk-Sowa, Monika/0000-0002-6894-9891; Bartosik-Psujek, Halina/0000-0002-2860-6456				Akhtar S, 2015, MULT SCLER J, V21, P147, DOI 10.1177/1352458514541578; Balbuena LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155181; Barros P, 2013, CLIN NEUROL NEUROSUR, V115, P1762, DOI 10.1016/j.clineuro.2013.04.007; Bayes HK, 2010, EUR NEUROL, V63, P36, DOI 10.1159/000268163; Becker J, 2013, J NEUROL SCI, V329, P6, DOI 10.1016/j.jns.2013.03.001; Cendrowski W, 2012, MED BIOL SCI, V26, P39; Cendrowski W, 2014, AKTUAL NEUROL, V14, P16, DOI 10.15557/AN.2014.0001; Chaudhuri A, 2005, MED HYPOTHESES, V64, P608, DOI 10.1016/j.mehy.2004.06.022; de Abreu DAF, 2009, MULT SCLER J, V15, P1146, DOI 10.1177/1352458509106780; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Fiddes B, 2013, ANN NEUROL, V73, P714, DOI 10.1002/ana.23925; Givon U, 2012, NEUROEPIDEMIOLOGY, V38, P64, DOI 10.1159/000334437; Grytten N, 2013, MULT SCLER J, V19, P1028, DOI 10.1177/1352458512471094; HEWITT D, 1971, BRIT J PREV SOC MED, V25, P174; Hintzen R, 2013, NAT REV NEUROL, V9, P489, DOI 10.1038/nrneurol.2013.156; JAMES WH, 1995, ACTA NEUROL SCAND, V92, P430; Kimura T, 1983, MED BIOL; Munger KL, 2016, JAMA NEUROL, V73, P515, DOI 10.1001/jamaneurol.2015.4800; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Rogerson PA, 1996, INT J EPIDEMIOL, V25, P644, DOI 10.1093/ije/25.3.644; Saastamoinen KP, 2012, MULT SCLER J, V18, P563, DOI 10.1177/1352458511426814; SADOVNICK AD, 1994, ACTA NEUROL SCAND, V89, P190; Salemi G, 2000, ACTA NEUROL SCAND, V101, P381, DOI 10.1034/j.1600-0404.2000.90336.x; Salzer J, 2010, ACTA NEUROL SCAND, V121, P20, DOI 10.1111/j.1600-0404.2009.01181.x; Sidhom Y, 2015, MULT SCLER RELAT DIS, V4, P491, DOI 10.1016/j.msard.2015.08.002; Sotgiu S, 2006, J NEUROL, V253, P38, DOI 10.1007/s00415-005-0917-6; Staples J, 2010, BMJ-BRIT MED J, V29, P340; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Torkildsen O, 2012, ACTA NEUROL SCAND, V126, P58, DOI 10.1111/ane.12040; TROMP SW, 1977, PROGR BIOMETEOROLO 2, V1, P164; Verheul F, 2013, ACTA NEUROL SCAND, V127, P301, DOI 10.1111/ane.12007; WALTER SD, 1980, J EPIDEMIOL COMMUN H, V34, P147, DOI 10.1136/jech.34.2.147; Wiberg MA, 1994, J ORTHOMOL MED, V9, P71; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63	36	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175156	10.1371/journal.pone.0175156	http://dx.doi.org/10.1371/journal.pone.0175156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384281	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900104
J	Eckstrand, CD; Sparger, EE; Pitt, KA; Murphy, BG				Eckstrand, C. D.; Sparger, E. E.; Pitt, K. A.; Murphy, B. G.			Peripheral and central immune cell reservoirs in tissues from asymptomatic cats chronically infected with feline immunodeficiency virus	PLOS ONE			English	Article							T-CELLS; OX40; PHASE; CD134; FIV; IMMUNOPHENOTYPE; TRANSMISSION; SUBSETS; BLOOD; CD4+	Feline immunodeficiency virus (FIV) infection in cats results in life-long viral persistence and progressive immunopathology. We have previously described a cohort of experimentally infected cats demonstrating a progressive decline of peripheral blood CD4+ T-cell over six years in the face of apparent peripheral viral latency. More recently we reported findings from this same cohort that revealed popliteal lymph node tissue as sites for ongoing viral replication suggesting that tissue reservoirs are important in FIV immunopathogenesis during the late asymptomatic phase of infection. Results reported herein characterize important tissue reservoirs of active viral replication during the late asymptomatic phase by examining biopsied specimens of spleen, mesenteric lymph node (MLN), and intestine from FIV-infected and uninfected control cats. Peripheral blood collected coincident with harvest of tissues demonstrated severe CD4+ T-cell depletion, undetectable plasma viral gag RNA and rarely detectable peripheral blood mononuclear cell (PBMC)-associated viral RNA (vRNA) by real-time PCR. However, vRNA was detectable in all three tissue sites from three of four FIV-infected cats despite the absence of detectable vRNA in plasma. A novel in situ hybridization assay identified B cell lymphoid follicular domains as microanatomical foci of ongoing FIV replication. Additionally, we demonstrated that CD4+ leukocyte depletion in tissues, and CD4+ and CD21+ leukocytes as important cellular reservoirs of ongoing replication. These findings revealed that tissue reservoirs support foci of ongoing viral replication, in spite of highly restricted viral replication in blood. Lentiviral eradication strategies will need address tissue viral reservoirs.	[Eckstrand, C. D.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Sparger, E. E.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Pitt, K. A.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Murphy, B. G.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA USA	Washington State University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Eckstrand, CD (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	ceckstrand@vetmed.wsu.edu	Eckstrand, Chrissy/C-8743-2018	Eckstrand, Chrissy/0000-0002-6844-0251	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis [2014-16-F]; Bernice Barbour Foundation; Peter C. Kennedy Endowed Fellowship in Anatomic Pathology; Graduate Student Support System; Graduate Studies Dissertation Year Fellowship; Northern California Chapter of the ARCS Foundation	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); Bernice Barbour Foundation; Peter C. Kennedy Endowed Fellowship in Anatomic Pathology; Graduate Student Support System; Graduate Studies Dissertation Year Fellowship; Northern California Chapter of the ARCS Foundation	This work was funded by the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis (Grant number 2014-16-F, http://www.vetmed.ucdavis.edu/ccah/index.cfm) and the Bernice Barbour Foundation (http://bemicebarbour.org/). Graduate student funding was provided by the Peter C. Kennedy Endowed Fellowship in Anatomic Pathology (SVM, UCD), the Graduate Student Support System (SVM, UCD), the Graduate Studies Dissertation Year Fellowship (UCD), and the Northern California Chapter of the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beczkowski PM, 2015, VET MICROBIOL, V176, P50, DOI 10.1016/j.vetmic.2014.12.023; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; Bienzle D, 2003, VET IMMUNOL IMMUNOP, V96, P19, DOI 10.1016/S0165-2427(03)00132-6; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; BROWN PJ, 1991, J COMP PATHOL, V104, P345, DOI 10.1016/S0021-9975(08)80145-4; BROWN WC, 1991, J VIROL, V65, P3359, DOI 10.1128/JVI.65.6.3359-3364.1991; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; Dean GA, 1996, J VIROL, V70, P5165, DOI 10.1128/JVI.70.8.5165-5169.1996; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; DOW SW, 1990, J ACQ IMMUN DEF SYND, V3, P658; Eckstrand CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146285; Eckstrand CD, 2016, VET SCI, V3; Endo Y, 1997, J VET MED SCI, V59, P739, DOI 10.1292/jvms.59.739; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Hartmann K, 2011, VET IMMUNOL IMMUNOP, V143, P190, DOI 10.1016/j.vetimm.2011.06.003; Howard KE, 2005, J IMMUNOL METHODS, V302, P36, DOI 10.1016/j.jim.2005.04.019; Howard KE, 2007, AIDS RES HUM RETROV, V23, P720, DOI 10.1089/aid.2006.0025; Joshi A, 2004, VIROLOGY, V321, P307, DOI 10.1016/j.virol.2004.01.014; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; McDonnel SJ, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-69; McDonnel SJ, 2012, VIRUSES-BASEL, V4, P878, DOI 10.3390/v4050878; Murphy B, 2014, VIRUS RES, V179, P34, DOI 10.1016/j.virusres.2013.11.017; Murphy B, 2012, VIRUS RES, V169, P117, DOI 10.1016/j.virusres.2012.07.017; Murphy B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-12; Murphy KM., 2016, JANEWAYS IMMUNOBIOLO, V9, DOI DOI 10.1201/9781315533247; Raskin RE., 2015, CANINE FELINE CYTOLO; Rogers AB, 1998, J INFECT DIS, V178, P960, DOI 10.1086/515692; Rogers AB, 2002, AM J PATHOL, V161, P1143, DOI 10.1016/S0002-9440(10)64391-X; Schmitz JE, 2011, IMMUNOBIOLOGY, V98, P3757; Shacklett BL, 2003, J VIROL, V77, P5621, DOI 10.1128/JVI.77.10.5621-5631.2003; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Siliciano JD, METHODS MOL BIOL, P3; Sparger EE, 1987, FIV MODEL HIV OVERVI, P149; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Vahlenkamp TW, 2004, J IMMUNOL, V172, P4752, DOI 10.4049/jimmunol.172.8.4752; Willett BJ, 2007, J VIROL, V81, P9665, DOI 10.1128/JVI.01020-07	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175327	10.1371/journal.pone.0175327	http://dx.doi.org/10.1371/journal.pone.0175327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384338	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900158
J	Gossenheimer, AN; Bem, T; Carneiro, MLF; de Castro, MS				Gossenheimer, Agnes Nogueira; Bem, Tamires; Fernandes Carneiro, Mara Lucia; de Castro, Mauro Silveira			Impact of distance education on academic performance in a pharmaceutical care course	PLOS ONE			English	Article								The objective of this study was to compare the performance of pharmacy students from a Pharmaceutical Care course, taught in both distance education (DE) and campus-based formats using active methodologies. For two semesters, students (n = 82) taking the course studied half the subject in the distance education format and half in person. Questionnaires were applied at the beginning of the semester aimed to outline the demographic profile of the students. Their grade in the course was evaluated to determine their performance. The Module 1 (Information on Medication) average on the campus-based was 7.1225 and on DE was 7.5519, (p = 0.117). The Module 2 (Pharmaceutical Services) average on the campusbased was 7.1595 and on distance education was 7.7025, (p = 0.027*). There was a difference in learning outcomes in the Pharmaceutical Care Course between face-to-face and distant education. Therefore, the student performance was better in the distance education module, indicating distance education can be satisfactorily used in Pharmacy Programs.	[Gossenheimer, Agnes Nogueira; Bem, Tamires; de Castro, Mauro Silveira] Univ Fed Rio Grande do Sul, Sch Pharm, Porto Alegre, RS, Brazil; [Fernandes Carneiro, Mara Lucia] Univ Fed Rio Grande do Sul, Inst Psychol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Gossenheimer, AN (corresponding author), Univ Fed Rio Grande do Sul, Sch Pharm, Porto Alegre, RS, Brazil.	ag.far@hotmail.com	Carneiro, Mára Lúcia Fernandes/A-4423-2013; Gossenheimer, Agnes N/H-4813-2016	Carneiro, Mára Lúcia Fernandes/0000-0002-3787-1737; Gossenheimer, Agnes N/0000-0002-7424-8426	CAPES-Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior	CAPES-Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior	Funded by CAPES-Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior http://www.capes.gov.bri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2001, COMM ED DIV NAT COMM; Allen M, CLASSROOM COMMUNICAT; Bower B., 2001, ONLINE J DISTANCE LE, V4; Callahan AL, 1998, AM SOC ENG ED ANN C; Carnevale D., 2000, CHRON HIGHER EDUC, V47, pA46; Carr S, 2000, CHRON HIGHER EDUC, V46, pA48; Carr S., 2000, CHRONICLE OF HIGHER, V46, pA48; Chisholm MA, 2000, AM J PHARM EDUC, V64, P152; Fainholc B, 2007, PROGRAMAS PROFESSORE; Guadagnin LA, 2003, REV NOVAS TECNOLOGIA, VII, P88; Halaban P, 2010, COMUNICACION VIRTUAL; Hara N., 1999, STUDENTS FRUSTRATION; Harrison LC, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7407124; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Lenz TL, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj700490; MacLaughlin EJ, 2004, AM J PHARM EDUC, V68, DOI 10.5688/aj680358; Martinez-Sanchez AM, 2009, LAT AM J PHARM, V28, P100; Mattheos N, 2001, Eur J Dent Educ, V5, P67, DOI 10.1034/j.1600-0579.2001.005002067.x; Mesquita AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123141; Middleton AJ, 1997, INT J INSTR MEDIA, V24, P133; Navarro P, 1999, J COMPUT HIGH EDUC, P11; Oliveira SO, NASCIMENTO NOVA; Ried LD, 2004, AM J PHARM EDUC, V68, DOI 10.5688/aj680365; Russell T. L., 1999, NO SIGNIFICANT DIFFE; Schoech D, 2000, RES SOCIAL WORK PRAC, V10, P467, DOI 10.1177/104973150001000407; Wade WE, 1999, AM J PHARM EDUC, V63, P82	26	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175117	10.1371/journal.pone.0175117	http://dx.doi.org/10.1371/journal.pone.0175117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384362	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900090
J	Li, HT; Wang, YG; Liu, ZM; Yuan, Y; Huang, WT; Zhang, N; He, AN; Shen, Z; Sun, YJ; Yao, Y				Li, Hongtao; Wang, Yonggang; Liu, Zimei; Yuan, Yuan; Huang, Wentao; Zhang, Na; He, Aina; Shen, Zan; Sun, Yuanjue; Yao, Yang			Lack of association between platelet indices and disease stage in osteosarcoma at diagnosis	PLOS ONE			English	Article							VOLUME/PLATELET COUNT RATIO; STUDY-GROUP PROTOCOLS; GASTRIC-CANCER; PROGNOSTIC-FACTORS; TUMOR PROGRESSION; SURVIVAL; METASTASIS; EXTREMITY; SARCOMA; VOLUME	Purpose The purpose of this study was to investigate the relationship between platelet indices [ mean platelet volume (MPV), platelet count (PLT), platelet distribution width (PDW) and plateletcrit (PCT)] at diagnosis in osteosarcoma. Methods The information of 233 patients with osteosarcoma at diagnosis between 2007 and 2015 was retrospectively reviewed. Clinical parameters such as gender, age, size and site of tumor, and tumor necrosis rate after neoadjuvant chemotherapy were analyzed. Results No significant difference was noted in the mean values of MPV, PLT, PDW and PCT among stage I, II and III patients. In localized patients, the median disease-free survival (DFS) values were 42 and 22 months in the PLT<300x10(9) /L and >= 300x10(9) /L groups, respectively, but the difference was not statistically significant (P = 0.2611). No difference in the DFS among the three different levels of MPV was observed. Conclusion No significantly different platelet indices were noted among the different stages. Although a shorter median DFS was found in localized patients with PLT >= 300x10(9) /L, there was still a lack of strong evidence to demonstrate the association between platelet indices and osteosarcoma.	[Li, Hongtao; Wang, Yonggang; Liu, Zimei; Yuan, Yuan; He, Aina; Shen, Zan; Yao, Yang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai, Peoples R China; [Huang, Wentao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Pathol, Shanghai, Peoples R China; [Zhang, Na; Sun, Yuanjue] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp South Campus 6, Dept Oncol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yao, Y (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai, Peoples R China.	sunyuanjue@163.com; yangyao_6@hotmail.com		Li, Hongtao/0000-0001-6532-2092	National Natural Scientific Foundation of China (NSFC) [81102038, 81172105]	National Natural Scientific Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (NSFC) (No. 81102038, 81172105). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2008, INT J LAB HEMATOL, V30, P214, DOI 10.1111/j.1751-553X.2007.00947.x; Alsweedan SA, 2008, J PEDIAT HEMATOL ONC, V30, P953, DOI 10.1097/MPH.0b013e318182e7a9; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Cho SY, 2013, PLATELETS, V24, P375, DOI 10.3109/09537104.2012.701028; Eppert K, 2005, MODERN PATHOL, V18, P388, DOI 10.1038/modpathol.3800265; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gu M, 2015, BREAST CANC; Heras P, 2010, SCAND J GASTROENTERO, V45, P1005, DOI 10.3109/00365521003797221; Hernandez-Rodriguez NA, 2002, INT J BIOL MARKER, V17, P189, DOI 10.1177/172460080201700308; Inagaki N, 2014, LUNG CANCER, V83, P97, DOI 10.1016/j.lungcan.2013.08.020; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kebapcilar L, 2009, ARCH GYNECOL OBSTET, V280, P187, DOI 10.1007/s00404-008-0884-0; Kilincalp S, 2014, PLATELETS, V25, P592, DOI 10.3109/09537104.2013.783689; Kumagai S, 2015, MOL CLIN ONCOL, V3, P197, DOI 10.3892/mco.2014.436; Li JY, 2014, ASIAN PAC J CANCER P, V15, P10501, DOI 10.7314/APJCP.2014.15.23.10501; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Maraz A, 2013, ANTICANCER RES, V33, P1725; Matowicka-Karna J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/401623; Meyers PA, 1997, PEDIATR CLIN N AM, V44, P973, DOI 10.1016/S0031-3955(05)70540-X; Nakamura T, 2013, BONE JOINT J, V95B, P411, DOI 10.1302/0301-620X.95B3.30344; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Osada J, 2010, NEOPLASMA, V57, P145, DOI 10.4149/neo_2010_02_145; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Riedl J, 2014, THROMB HAEMOSTASIS, V111, P670, DOI 10.1160/TH13-07-0603; Rutkowski P, 2003, J SURG ONCOL, V84, P151, DOI 10.1002/jso.10305; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Sulzbacher I, 2003, MODERN PATHOL, V16, P66, DOI 10.1097/01.MP.0000043522.76788.0A; Takagi S, 2014, CANCER SCI, V105, P983, DOI 10.1111/cas.12464; THOMPSON CB, 1988, BLOOD, V72, P1; Vazquez-Santiago M, 2016, COMPUT BIOL MED, V69, P226, DOI 10.1016/j.compbiomed.2015.12.023; Xiao H, 2014, TUMOR BIOL, V35, P1023, DOI 10.1007/s13277-013-1136-x	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174668	10.1371/journal.pone.0174668	http://dx.doi.org/10.1371/journal.pone.0174668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384168	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900025
J	Miranda, P; Gil-Santana, L; Oliveira, MG; Mesquita, EDD; Silva, E; Rauwerdink, A; Cobelens, F; Oliveira, MM; Andrade, BB; Kritski, A				Miranda, Pryscila; Gil-Santana, Leonardo; oliveira, Marina G.; Mesquita, Eliene D. D.; Silva, Elisangela; Rauwerdink, Anneloek; Cobelens, Frank; Oliveira, Martha M.; Andrade, Bruno B.; Kritski, Afranio			Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HOUSEHOLD CONTACTS; IRON; BIOMARKERS; THERAPY; INFECTION; DISEASE; MARKERS; ANEMIA; COHORT	Background Clinical trials that evaluate new anti-tubercular drugs and treatment regimens take years to complete due to the slow clearance of Mycobacterium tuberculosis infection and the lack of early biomarkers that predict treatment outcomes. Host Inflammation markers have been associated with tuberculosis (TB) pathogenesis. In the present study, we tested if circulating levels of C-reactive protein (CRP) and ferritin reflect mycobacterial loads and inflammation in pulmonary TB (PTB) patients undergoing anti-tuberculous therapy (ATT). Methods Prospective measurements of CRP and ferritin, used as readouts of systemic inflammation, were performed in cryopreserved serum samples from 165 Brazilian patients with active PTB initiating ATT. Associations between levels of these laboratory parameters with mycobacterial loads in sputum as well as with sputum conversion at day 60 of ATT were tested. Results Circulating levels of both ferritin and CRP gradually decreased over time on ATT. At pretreatment, concentrations of these parameters were unable to distinguish patients with positive from those with negative acid-fast bacilli (AFB) in sputum cultures. However, patients who remained with positive cultures at day 60 of ATT exhibited heightened levels of these inflammatory markers compared to those with negative cultures at that time point. Conclusions CRP and Ferritin levels in serum may be useful to identify patients with positive cultures at day 60 of ATT.	[Miranda, Pryscila; oliveira, Marina G.; Kritski, Afranio] Univ Fed Rio de Janeiro, TB Acad Program, Med Sch, Rio De Janeiro, Brazil; [Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Andrade, Bruno B.] Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil; [Mesquita, Eliene D. D.] State Secretary Hlth Rio de Janeiro, Ary Parreira Inst, Rio De Janeiro, Brazil; [Silva, Elisangela] State Univ North Fluminense Darcy Ribeiro, Recognize Biol Lab, Ctr Biosci & Biotechnol, Rio De Janeiro, Brazil; [Silva, Elisangela; Oliveira, Martha M.; Andrade, Bruno B.; Kritski, Afranio] Rede Brasileira Pesquisas TB Rede TB, Rio De Janeiro, Brazil; [Rauwerdink, Anneloek; Cobelens, Frank] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Oliveira, Martha M.] Fundacao Oswaldo Cruz, Dev Ctr Technol Hlth CDTS, Rio De Janeiro, Brazil; [Andrade, Bruno B.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Andrade, Bruno B.] Laureate Int Univ, Univ Salvador UNIFACS, Salvador, BA, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Amsterdam; Academic Medical Center Amsterdam; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Escola Bahiana de Medicina e Saude Publica; Universidade Salvador (UNIFACS)	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.	bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020; Silva, Elisangela/AAW-5193-2020; Kritski, Afranio/I-6760-2016	Silva, Elisangela/0000-0001-9833-1825; kritski, afranio/0000-0002-5900-6007; Andrade, Bruno/0000-0001-6833-3811; Cobelens, Frank/0000-0002-4367-1133	CNPq /INCT [573548/2008-0]; Faperj [E-26/110.974/2011]; CNPq (produtividade em pesquisa); FAPERJ (Cientistas do Nosso Estado); Fundacao de Amparo a Pesquisa da Bahia (FAPESB); Fundacao Oswaldo Cruz (FIOCRUZ)	CNPq /INCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (produtividade em pesquisa)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Cientistas do Nosso Estado)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by CNPq /INCT 573548/2008-0; Faperj Process: Processo - E-26/110.974/2011. AK is the recipient of a career award from CNPq (produtividade em pesquisa) and FAPERJ (Cientistas do Nosso Estado). LG-S received scientific initiation fellowship from Fundacao de Amparo a Pesquisa da Bahia (FAPESB) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	El Idrissi HB, 2015, NUTR HOSP, V32, P2848, DOI 10.3305/nh.2015.32.6.9827; Clifford V, 2015, TUBERCULOSIS, V95, P217, DOI 10.1016/j.tube.2015.01.003; Friis H, 2009, BRIT J NUTR, V102, P310, DOI 10.1017/S0007114508162122; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Jacobs R, 2016, CYTOKINE, V81, P50, DOI 10.1016/j.cyto.2016.02.004; Koethe JR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-19; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Kuznetsov IA, 2013, B EXP BIOL MED+, V154, P618, DOI 10.1007/s10517-013-2013-8; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48; Minchella PA, 2015, TUBERCULOSIS, V95, P288, DOI 10.1016/j.tube.2015.02.042; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Oliveira MG, 2014, J BRAS PNEUMOL, V40, P403, DOI 10.1590/S1806-37132014000400008; Petersen E, 2015, LANCET INFECT DIS, V15, P6, DOI 10.1016/S1473-3099(14)71055-2; Plit ML, 1998, INT J TUBERC LUNG D, V2, P590; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Sivakolundu S, 2013, T ROY SOC TROP MED H, V107, P43, DOI 10.1093/trstmh/trs005; Subbian S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/385402; Tacke F, 2016, CRIT CARE MED, V44, P1049, DOI 10.1097/CCM.0000000000001607; Tanaka M, 2015, BONE MARROW TRANSPL, V50, P727, DOI 10.1038/bmt.2015.17; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Walzl G, 2014, COLD SPRING HARB PER, V5; WHO, 1998, LAB SERV TUB CONTR 2; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, FACT SHEETS TUB	26	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175278	10.1371/journal.pone.0175278	http://dx.doi.org/10.1371/journal.pone.0175278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384354	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900145
J	Oguchi, ME; Noguchi, K; Fukuda, M				Oguchi, Mai E.; Noguchi, Kenta; Fukuda, Mitsunori			TBC1 D12 is a novel Rab11-binding protein that modulates neurite outgrowth of PC12 cells	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; RAB SMALL GTPASES; BINDING-PROTEIN; AMPA RECEPTORS; TRAFFICKING; IDENTIFICATION; MELANOCYTES; DOMAIN; GAPS; ENDOSOMES	Recycling endosomes are generally thought to play a central role in endocytic recycling, but recent evidence has indicated that they also participate in other cellular events, including cytokinesis, autophagy, and neurite outgrowth. Rab small GTPases are key regulators in membrane trafficking, and although several Rab isoforms, e.g., Rab11, have been shown to regulate recycling endosomal trafficking, the precise mechanism by which these Rabs regulate recycling endosomes is not fully understood. In this study, we focused on a RabGTPase-activating protein (Rab-GAP), one of the key regulators of Rabs, and comprehensively screened 43 mammalian Tre-2/Bub2/Cdc16 (TBC)/Rab-GAP-domain-containing proteins (TBC proteins) for proteins that specifically localize on recycling endosomes in mouse embryonic fibroblasts (MEFs). Four of the 43 mammalian TBC proteins screened, i.e., TBC1 D11, TBC1 D12, TBC1 D14, and EVI5, were found to colocalize well with transferrin receptor, a well-known recycling endosome marker. We further investigated the biochemical properties of TBC1 D12, a previously uncharacterized TBC protein. The results showed that TBC1 D12 interacted with active Rab11 through its middle region and that it did not display Rab11-GAP activity in vitro. The recycling endosomal localization of TBC1 D12 was found to depend on the expression of Rab11. We also found that TBC1 D12 expression had no effect on common Rab11-dependent cellular events, e.g., transferrin recycling, in MEFs and that it promoted neurite outgrowth, a specialized Rab11-dependent cellular event, of PC12 cells independently of its GAP activity. These findings indicated that TBC1 D12 is a novel Rab11binding protein that modulates neurite outgrowth of PC12 cells.	[Oguchi, Mai E.; Noguchi, Kenta; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan [15H04367]; Grants-in-Aid for Scientific Research [17H05682] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (grant number 15H04367 to M. F.). There was no additional external funding received for this study.	Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Frasa MAM, 2010, CURR BIOL, V20, P198, DOI 10.1016/j.cub.2009.12.053; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Homma Y, 2016, MOL BIOL CELL, V27, P2107, DOI 10.1091/mbc.E16-02-0091; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kobayashi Hotaka, 2015, Methods Mol Biol, V1298, P207, DOI 10.1007/978-1-4939-2569-8_18; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kuroda TS, 2005, METHOD ENZYMOL, V403, P431, DOI 10.1016/S0076-6879(05)03038-7; Lamb CA, 2016, EMBO J, V35, P281, DOI 10.15252/embj.201592695; Longatti A, 2012, AUTOPHAGY, V8, P1682, DOI 10.4161/auto.21486; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Marubashi S, 2016, J BIOL CHEM, V291, P1427, DOI 10.1074/jbc.M115.684043; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Villarroel-Campos D, 2016, CYTOSKELETON, V73, P498, DOI 10.1002/cm.21303; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104	45	11	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174883	10.1371/journal.pone.0174883	http://dx.doi.org/10.1371/journal.pone.0174883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384198	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900049
J	Shamshery, P; Wang, RQ; Tran, DV; Winter, AG				Shamshery, Pulkit; Wang, Ruo-Qian; Tran, Davis V.; Winter, Amos G.			Modeling the future of irrigation: A parametric description of pressure compensating drip irrigation emitter performance	PLOS ONE			English	Article								Drip irrigation is a means of distributing the exact amount of water a plant needs by dripping water directly onto the root zone. It can produce up to 90% more crops than rain-fed irrigation, and reduce water consumption by 70% compared to conventional flood irrigation. Drip irrigation may enable millions of poor farmers to rise out of poverty by growing more and higher value crops, while not contributing to overconsumption of water. Achieving this impact will require broadening the engineering knowledge required to design new, low-cost, low-power drip irrigation technology, particularly for poor, off-grid communities in developing countries. For more than 50 years, pressure compensating (PC) drip emitters-which can maintain a constant flow rate under variations in pressure, to ensure uniform water distribution on a field-have been designed and optimized empirically. This study presents a parametric model that describes the fluid and solid mechanics that govern the behavior of a common PC emitter architecture, which uses a flexible diaphragm to limit flow. The model was validated by testing nine prototypes with geometric variations, all of which matched predicted performance to within R-2 = 0.85. This parametric model will enable irrigation engineers to design new drip emitters with attributes that improve performance and lower cost, which will promote the use of drip irrigation throughout the world.	[Shamshery, Pulkit; Wang, Ruo-Qian; Tran, Davis V.; Winter, Amos G.] MIT, Dept Mech Engn, Global Engn & Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Shamshery, P (corresponding author), MIT, Dept Mech Engn, Global Engn & Res Lab, Cambridge, MA 02139 USA.	ps544@mit.edu	Wang, Ruo-Qian/B-8313-2009	Wang, Ruo-Qian/0000-0003-2052-8948; Shamshery, Pulkit/0000-0003-1944-5977	Jain Irrigation Systems Ltd.; Tata Center for Technology and Design at MIT	Jain Irrigation Systems Ltd.; Tata Center for Technology and Design at MIT	Funding for this study was provided by Jain Irrigation Systems Ltd. and the Tata Center for Technology and Design at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2009, PRESSURE DROP RECTAN; [Anonymous], 1997, IND STAND IRR EQ EM; [Anonymous], 1952, US Patent, Patent No. [2,607,369, 2607369]; Bletzinger K, 2006, PARTITIONED STRATEGI; Burney J, 2010, P NATL ACAD SCI USA, V107, P1848, DOI 10.1073/pnas.0909678107; Burt C., 2013, LOW PRESSURE TESTING; Cervantes-Godoy D, 2009, EC IMPORTANCE AGR PO, P23; Duan Z, 2012, PRESSURE DROP FULLY; FAO, 2006, FARM FIELD SCH LAND, P100; FAO, 1997, IRR TECHN TRANSF SUP; Felippa CA, 2001, PARTITIONED ANAL COU; Ghugal YM, 2011, LAT AM J SOLIDS STRU, V8, P183, DOI 10.1590/S1679-78252011000200005; Girma M., 2015, INT J WATER RESOURCE, V7, P29, DOI [10.5897/IJWREE2014.0556, DOI 10.5897/IJWREE2014.0556, 10.5897/ijwree2014.0556]; Heil M, 2008, SOLVERS LARGE DISPLA; Irz X., 2001, Development Policy Review, V19, P449, DOI 10.1111/1467-7679.00144; Judy J, 2002, CHARACTERIZATION FRI; Kays WM, 1984, COMPACT HEAT EXCHANG, Vthird; Lelea D, 2004, EXPT RES MICROTUBE H; Matthies HG, 2003, PARTITIONED STRONG C; Mazher Iqbal, 2014, International Journal of Agriculture and Crop Sciences (IJACS), V7, P185; Muzychka YS, 2009, PRESSURE DROP LAMINA; Namara R.E., 2005, ADOPTION IMPACTS MIC; Nkya K., 2015, Journal of Environment and Earth Science, V5, P45; Sivanappan R. K., 1994, Irrigation and Drainage Systems, V8, P49, DOI 10.1007/BF00880798; Teng J.-T., 2012, FLUID DYNAMICS COMPU, P403; The World Bank, ACC EL POP; Timoshenko S., 1987, THEORY PLATES SHELLS; UNEP, 2013, SMALLH FOOD SEC ENV; Young WC., 2012, ROARKS FORMULAS STRE, V8	29	15	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175241	10.1371/journal.pone.0175241	http://dx.doi.org/10.1371/journal.pone.0175241			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384355	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900134
J	Simonetto, C; Azizova, TV; Barjaktarovic, Z; Bauersachs, J; Jacob, P; Kaiser, JC; Meckbach, R; Schollnberger, H; Eidemuller, M				Simonetto, Cristoforo; Azizova, Tamara V.; Barjaktarovic, Zarko; Bauersachs, Johann; Jacob, Peter; Kaiser, Jan Christian; Meckbach, Reinhard; Schollnberger, Helmut; Eidemuller, Markus			A mechanistic model for atherosclerosis and its application to the cohort of Mayak workers	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PRODUCTION-ASSOCIATION; INFLAMMATORY RESPONSE; IONIZING-RADIATION; CARCINOGENESIS; MACROPHAGE; RISK; CANCER; ATHEROGENESIS; INSTABILITY	We propose a stochastic model for use in epidemiological analysis, describing the age-dependent development of atherosclerosis with adequate simplification. The model features the uptake of monocytes into the arterial wall, their proliferation and transition into foam cells. The number of foam cells is assumed to determine the health risk for clinically relevant events such as stroke. In a simulation study, the model was checked against the age-dependent prevalence of atherosclerotic lesions. Next, the model was applied to incidence of atherosclerotic stroke in the cohort of male workers from the Mayak nuclear facility in the Southern Urals. It describes the data as well as standard epidemiological models. Based on goodness-of-fit criteria the risk factors smoking, hypertension and radiation exposure were tested for their effect on disease development. Hypertension was identified to affect disease progression mainly in the late stage of atherosclerosis. Fitting mechanistic models to incidence data allows to integrate biological evidence on disease progression into epidemiological studies. The mechanistic approach adds to an understanding of pathogenic processes, whereas standard epidemiological methods mainly explore the statistical association between risk factors and disease outcome. Due to a more comprehensive scientific foundation, risk estimates from mechanistic models can be deemed more reliable. To the best of our knowledge, such models are applied to epidemiological data on cardiovascular diseases for the first time.	[Simonetto, Cristoforo; Barjaktarovic, Zarko; Jacob, Peter; Kaiser, Jan Christian; Meckbach, Reinhard; Schollnberger, Helmut; Eidemuller, Markus] Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany; [Azizova, Tamara V.] Southern Urals Biophys Inst, Ozyorsk, Chelyabinsk Reg, Russia; [Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Jacob, Peter] RADRISK, Schliersee, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute; Hannover Medical School	Simonetto, C (corresponding author), Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany.	cristoforo.simonetto@helmholtz-muenchen.de	Simonetto, Cristoforo/AAE-7124-2020; Azizova, Tamara V./R-5295-2019; Schöllnberger, Helmut/K-1446-2016	Simonetto, Cristoforo/0000-0003-4816-3514; Azizova, Tamara V./0000-0001-6954-2674; Schöllnberger, Helmut/0000-0002-4398-6565	Federal Ministry of Education and Research (BMBF) [02NUK026]; Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Federal Office for Radiation Protection (BfS) [3611S30022]; EU [295823]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Federal Office for Radiation Protection (BfS); EU(European Commission)	This work was supported by the Federal Ministry of Education and Research (BMBF, www.bmbf.de) with contract number 02NUK026 (PASSOS). Furthermore, it was supported by the Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety and the Federal Office for Radiation Protection (BfS, www.bfs.de, contract 3611S30022) and by the EU Seventh Framework (ec.europa.eu/research/fp7) project ProCardio (contract number 295823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anspaugh LR, 2002, RADIAT ENVIRON BIOPH, V41, P19, DOI 10.1007/s00411-002-0148-5; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Bulelzai MAK, 2012, J THEOR BIOL, V297, P1, DOI 10.1016/j.jtbi.2011.11.023; Chien A, 2011, AM J NEURORADIOL, V32, P1249, DOI 10.3174/ajnr.A2483; Cilia M, 2013, J R SOC INTERFACE, V11; Cohen A, 2014, B MATH BIOL, V76, P1117, DOI 10.1007/s11538-014-9948-4; DAVIES MJ, 1993, BRIT HEART J, V69, P377; DAVIES RB, 1977, BIOMETRIKA, V64, P247, DOI 10.2307/2335690; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Eidemuller M, 2015, MUTAT RES-FUND MOL M, V775, P1, DOI 10.1016/j.mrfmmm.2015.03.002; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hegyi L, 1996, J PATHOL, V180, P423, DOI 10.1002/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1; Heidenreich WF, 2007, RADIAT RES, V168, P750, DOI 10.1667/RR0919.1; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Hinkle Janice L, 2007, J Neurosci Nurs, V39, P285; Ibragimov AI, 2005, MATH MED BIOL, V22, P305, DOI 10.1093/imammb/dqi011; James F., 2004, MINUIT USERS GUIDE; Jeon J, 2008, MATH BIOSCI, V213, P56, DOI 10.1016/j.mbs.2008.02.006; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kaiser JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111024; Kreuzer M, 2015, MUTAT RES-REV MUTAT, V764, P90, DOI 10.1016/j.mrrev.2015.03.002; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Kruglov A., 2002, HIST SOVIET ATOMIC I; Le Gallic C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128539; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Little M.P., 2015, CARDIO ONCOLOGY, V1, P1, DOI DOI 10.1186/S40959-015-0007-6; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Ougrinovskaia A, 2010, B MATH BIOL, V72, P1534, DOI 10.1007/s11538-010-9509-4; Parton A, 2015, BRIEF BIOINFORMATICS; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; ROSS R, 1977, AM J PATHOL, V86, P675; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santoro F, 2014, CLIN RES CARDIOL, V103, P955, DOI 10.1007/s00392-014-0718-y; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Shuryak I, 2010, RADIAT RES, V174, P357, DOI 10.1667/RR2143.1; Simonetto C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125904; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Stary HC, 2000, AM J CLIN NUTR, V72, p1297S, DOI 10.1093/ajcn/72.5.1297s; Stewart FA, 2013, CLIN ONCOL-UK, V25, P617, DOI 10.1016/j.clon.2013.06.012; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Tan WY, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-26; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Vasilenko EK, 2010, AAHP SPEC SESS HLTH; Xu JP, 2013, INTERV NEUROL, V2, P183, DOI 10.1159/000363068; ZHANG S, 2013, DISCRETE CONT S NOV, P825; Zollner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126238	69	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175386	10.1371/journal.pone.0175386	http://dx.doi.org/10.1371/journal.pone.0175386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384359	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900167
J	Zhang, HR; Xin, HN; Li, XW; Li, HJ; Li, MF; Lu, W; Bai, LQ; Wang, XH; Liu, JM; Jin, Q; Gao, L				Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Lu, Wei; Bai, Liqiong; Wang, Xinhua; Liu, Jianmin; Jin, Qi; Gao, Lei			A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China	PLOS ONE			English	Article							CIGARETTE-SMOKING; RISK-FACTORS; ASSOCIATION; PREVALENCE; REACTIVITY; EXPOSURE	Objectives China has high burden on both of tuberculosis (TB) and tobacco use. This study aims to explore the potential link between smoking and TB infection using baseline survey data of a large-scale population-based prospective study in rural China Methods Between July 1 and Sept 30, 2013, based on the baseline survey of a population-based, prospective study in rural China, the relationship between smoking and TB infection, assessed by interferon-gamma release assays (IGRA), was investigated among the total study population and only among those smokers, respectively. Results A total of 21,008 eligible rural registered residents (>= 5 years old) from 4 rural sites were included in the analysis. Ever-smokers were more likely to be QuantiFERON-TB Gold InTube (QFT) positive than never smokers with an adjusted odds ratio (OR) of 1.34 (95% confidence interval (CI): 1.21-1.49). Among ever smokers, a significant linear dose-response relation was observed between duration of smoking (by years) and QFT positivity (p < 0.001). Stratified analysis suggested that such an association was not influenced by gender and age. Evidence for interaction of smoking status with age was found. Conclusions Our results provide further evidence to support smoking might increase host susceptibility to TB infection. Populations under high risk of infection, such as elderly smokers, should be prior to TB infection controlling under a premise of community level intervention.	[Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China; [Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, Ctr TB, Beijing, Peoples R China; [Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Jin, Qi; Gao, Lei] Peking Union Med Coll, Beijing, Peoples R China; [Lu, Wei] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Bai, Liqiong] Hunan Prov Inst TB Prevent & Control, Changsha, Hunan, Peoples R China; [Wang, Xinhua] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Liu, Jianmin] Sixth Peoples Hosp Zhengzhou, Zhengzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jiangsu Provincial Center for Disease Control & Prevention	Gao, L (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China.; Gao, L (corresponding author), Chinese Acad Med Sci, Ctr TB, Beijing, Peoples R China.; Gao, L (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	gaolei@ipbcams.ac.cn	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Science and Technology Major Project of China [2013ZX10003004-002, 2014ZX10003001-001]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT13007]; Sanming Project of Medicine in Shenzhen [GCZX2015043015340574]	National Science and Technology Major Project of China; Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Sanming Project of Medicine in Shenzhen	This work was supported by the National Science and Technology Major Project of China (grant number: 2013ZX10003004-002, 2014ZX10003001-001), and the Program for Changjiang Scholars and Innovative Research Team in University of China (grant number: IRT13007) and the Sanming Project of Medicine in Shenzhen (GCZX2015043015340574). The content is solely the responsibility of the authors and the funding sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; and decision to submit the article for publication.	Anderson RH, 1997, AM J PREV MED, V13, P175, DOI 10.1016/S0749-3797(18)30190-9; Aryanpur M, 2016, INT J TUBERC LUNG D, V20, P679, DOI 10.5588/ijtld.15.0662; Aryanpur Mahshid, 2016, Tanaffos, V15, P17; Bai KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156677; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Gao L, 2016, EUR RESPIR J, V48, P168, DOI 10.1183/13993003.00235-2016; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; He GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124097; Horne DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049050; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Loddenkemper R, 2016, PNEUMOLOGIE, V70, P17, DOI 10.1055/s-0041-109601; Matsunaga K, 2002, J INFECT DIS, V185, P229, DOI 10.1086/338449; McCurdy SA, 1997, AM J IND MED, V32, P600, DOI 10.1002/(SICI)1097-0274(199712)32:6&lt;600::AID-AJIM5&gt;3.0.CO;2-T; Ministry of Health of the Peoples Republic of China, 2013, WST4282013 MIN HLTH; NISAR M, 1993, THORAX, V48, P1257, DOI 10.1136/thx.48.12.1257; Oni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047072; Patra J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001835; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Plant AJ, 2002, EPIDEMIOL INFECT, V128, P37, DOI 10.1017/S0950268801006434; Robbins CS, 2004, AM J RESP CELL MOL, V30, P202, DOI 10.1165/rcmb.2003-0259OC; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; Solsona J, 2001, EUR J EPIDEMIOL, V17, P123, DOI 10.1023/A:1017580329538; Wei XL, 2015, T ROY SOC TROP MED H, V109, P545, DOI 10.1093/trstmh/trv063; World Health Organization, 2007, WHO THE UN MON TB TO; Zhang XL, 2011, TROP MED INT HEALTH, V16, P1511, DOI 10.1111/j.1365-3156.2011.02869.x	33	43	47	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175183	10.1371/journal.pone.0175183	http://dx.doi.org/10.1371/journal.pone.0175183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384350	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900112
J	Berry, HR; Tate, RJ; Conway, BA				Berry, Helen R.; Tate, Rothwelle J.; Conway, Bernard A.			Transcutaneous spinal direct current stimulation induces lasting fatigue resistance and enhances explosive vertical jump performance	PLOS ONE			English	Article							DC STIMULATION; MOTOR CORTEX; PLASTICITY; BDNF; CORD; EXCITABILITY; MODULATION; EXERCISE; DENSITY; MODEL	Transcutaneous spinal direct current stimulation (tsDCS) is a non-invasive neuromodulatory intervention that has been shown to modify excitability in spinal and supraspinal circuits in animals and humans. Our objective in this study was to explore the functional neuromodulatory potential of tsDCS by examining its immediate and lasting effects over the repeated performance of a whole body maximal exercise in healthy volunteers. Using a double-blind, randomized, crossover, sham-controlled design we investigated the effects of 15 min of anodal tsDCS on repeated vertical countermovement jump (VCJ) performance at 0, 20, 60, and 180 minutes post-stimulation. Measurements of peak and take-off velocity, vertical displacement, peak power and work done during countermovement and push-off VCJ phases were derived from changes in vertical ground reaction force (12 performance parameters) in 12 healthy participants. The magnitude and direction of change in VCJ performance from pre-to post-stimulation differed significantly between sham and active tsDCS for 7 of the 12 VCJ performance measures (P < 0.05). These differences comprised of a post-sham fatigue in VCJ displacement/ work done, peak to peak power and take-off velocity, and a resilience to this fatigue effect post-active tsDCS. In addition there was also an enhancement of countermovement performance and total work done (P < 0.05). These changes did not vary across repeated VCJ performances over time post-tsDCS (P > 0.05). Our original findings demonstrate that one single session of anodal tsDCS in healthy subjects can prevent fatigue and maintain or enhance different aspects of whole body explosive motor power over repeated sets of VCJs performed over a period of three hours. The observed effects are discussed in relation to alterations in central fatigue mechanisms, muscle contraction mode during jump execution and changes in spinal cord excitability. These findings have important implications for power endurance sport performance and for neuromotor rehabilitation.	[Berry, Helen R.; Conway, Bernard A.] Univ Strathclyde, Dept Biomed Engn, Ctr Excellence Rehabil Res, Glasgow, Lanark, Scotland; [Tate, Rothwelle J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde; University of Strathclyde	Berry, HR (corresponding author), Univ Strathclyde, Dept Biomed Engn, Ctr Excellence Rehabil Res, Glasgow, Lanark, Scotland.	helen.berry@strath.ac.uk		Conway, Bernard A/0000-0002-0069-0131; Berry, Helen Russell/0000-0001-9008-9253; Tate, Rothwelle/0000-0001-5857-4267	Scottish Government Healthcare Directives grant	Scottish Government Healthcare Directives grant	Project conducted with funding allocated to the Centre for Excellence in Rehabilitation Research group from the Scottish Government Healthcare Directives grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Ahmed Z, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12696; Ahmed Z, 2011, J APPL PHYSIOL, V110, P1414, DOI 10.1152/japplphysiol.01390.2010; Cogiamanian Filippo, 2012, Front Psychiatry, V3, P63, DOI 10.3389/fpsyt.2012.00063; Cogiamanian F, 2011, PAIN, V152, P370, DOI 10.1016/j.pain.2010.10.041; Cogiamanian F, 2008, CLIN NEUROPHYSIOL, V119, P2636, DOI 10.1016/j.clinph.2008.07.249; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cormie P, 2009, J STRENGTH COND RES, V23, P177, DOI 10.1519/JSC.0b013e3181889324; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Duchateau J, 2016, J EXP BIOL, V219, P197, DOI 10.1242/jeb.123158; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gutierrez-Davila M, 2014, SPORT BIOMECH, V13, P135, DOI 10.1080/14763141.2014.910832; HARMAN EA, 1990, MED SCI SPORT EXER, V22, P825, DOI 10.1249/00005768-199012000-00015; Hubli M, 2013, CLIN NEUROPHYSIOL, V124, P1187, DOI 10.1016/j.clinph.2012.11.021; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Lamy JC, 2013, J NEUROPHYSIOL, V110, P109, DOI 10.1152/jn.00116.2013; Lamy JC, 2012, J NEUROPHYSIOL, V108, P906, DOI 10.1152/jn.10898.2011; Lim CY, 2011, NEUROREPORT, V22, P819, DOI 10.1097/WNR.0b013e32834b939d; Linthorne NP, 2001, AM J PHYS, V69, P1198, DOI 10.1119/1.1397460; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; McCulloch C.E., 2005, ENCY BIOSTATISTICS; McMaster B., J SCI MED SPORT; Merzagora AC, 2010, NEUROIMAGE, V49, P2304, DOI 10.1016/j.neuroimage.2009.10.044; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Noakes TD, 2005, BRIT J SPORT MED, V39, P120, DOI 10.1136/bjsm.2003.010330; Parazzini M, 2014, CLIN NEUROPHYSIOL, V125, P2260, DOI 10.1016/j.clinph.2014.02.027; Song WG, 2015, J NEUROPHYSIOL, V113, P2801, DOI 10.1152/jn.00784.2014; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vitor-Costa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144916; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Winkler T, 2010, CLIN NEUROPHYSIOL, V121, P957, DOI 10.1016/j.clinph.2010.01.014; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807	38	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173846	10.1371/journal.pone.0173846	http://dx.doi.org/10.1371/journal.pone.0173846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379980	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399353500027
J	Skirgard, H; Roberts, SG; Yencken, L				Skirgard, Hedvig; Roberts, Sean G.; Yencken, Lars			Why are some languages confused for others? Investigating data from the Great Language Game	PLOS ONE			English	Article							TONOGENESIS; PERCEPTION; SUPPORT; DANISH	In this paper we explore the results of a large-scale online game called 'the Great Language Game', in which people listen to an audio speech sample and make a forced-choice guess about the identity of the language from 2 or more alternatives. The data include 15 million guesses from 400 audio recordings of 78 languages. We investigate which languages are confused for which in the game, and if this correlates with the similarities that linguists identify between languages. This includes shared lexical items, similar sound inventories and established historical relationships. Our findings are, as expected, that players are more likely to confuse two languages that are objectively more similar. We also investigate factors that may affect players' ability to accurately select the target language, such as how many people speak the language, how often the language is mentioned in written materials and the economic power of the target language community. We see that non-linguistic factors affect players' ability to accurately identify the target. For example, languages with wider ` global reach' are more often identified correctly. This suggests that both linguistic and cultural knowledge influence the perception and recognition of languages and their similarity.	[Skirgard, Hedvig] Australian Natl Univ, Coll Asia & Pacific, Sch Culture Hist & Language,Dept Linguist, Wellsprings Linguist Diver Laureate Project, Acton, ACT, Australia; [Roberts, Sean G.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Gelderland, Netherlands	Australian National University; Max Planck Society	Roberts, SG (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Gelderland, Netherlands.	sean.roberts@mpi.nl		Skirgard, Hedvig/0000-0002-7748-2381; Roberts, Sean/0000-0001-5990-9161	Max Planck society; ERC Advanced Grant [269484]	Max Planck society(Max Planck SocietyFoundation CELLEX); ERC Advanced Grant(European Research Council (ERC))	SGR is supported by the Max Planck society and an ERC Advanced Grant No. 269484 INTERACT to Stephen Levinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SR is supported by the Max Planck society and an ERC Advanced Grant No. 269484 INTERACT to Stephen Levinson. Many thanks to our reviewers for thorough feedback, Siva Kalyan and Harald Hammarstrom for very helpful comments and Mikael Parkvall for sharing information on GDP from the countries involved in the study.	[Anonymous], 2014, ETHNOLOGUE LANGUAGES; Bakker P, 2011, J PIDGIN CREOLE LANG, V26, P5, DOI 10.1075/jpcl.26.1.02bak; Becker RA, 2016, R PACKAGE VERSION 3; Beekes R., 1995, COMPARATIVE INDO EUR; Bentz C, 2013, LANG DYN CHANG, V3, P1, DOI 10.1163/22105832-13030105; Blanc Haim, 1965, FIELD YIDDISH, P185; Borcard D, 2012, ECOLOGY, V93, P1473; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Central Intelligence Agency, 2012, WORLD FACTBOOK; Clopper C., 2004, THESIS; Clopper CG, 2012, J AUTISM DEV DISORD, V42, P740, DOI 10.1007/s10803-011-1305-y; Clopper CG, 2009, J PHONETICS, V37, P436, DOI 10.1016/j.wocn.2009.07.004; Cojocaru Dana, 2003, ROMANIAN GRAMMAR; Croft W., 2000, EXPLAINING LANGUAGE; Dennis Preston, 1999, HANDBOOK OF PERCEPTU; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Garde M, 2015, THE 46TH ANNUAL CONF; Georg S, 1999, J LINGUIST, V35, P65, DOI 10.1017/S0022226798007312; Good J, 2013, LANGUOID DOCULECT AN; Gooskens C, 2006, AVT PUBL, V23, P101; Gooskens C, 2010, SPEECH COMMUN, V52, P1022, DOI 10.1016/j.specom.2010.06.005; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Hammarstro H, 2015, GLOTTOLOG 2 4; Harmon Luke J, 2010, POOR STATISTICAL PER, V64, P2173; Haspelmath M, 2008, WORLD ATLAS OF LANGU; Hay J, 2007, ANNU REV ANTHROPOL, V36, P89, DOI 10.1146/annurev.anthro.34.081804.120633; Hay J, 2006, LINGUIST REV, V23, P351, DOI 10.1515/TLR.2006.014; HOLM S, 1979, SCAND J STAT, V6, P65; Holman EricW., 2007, LINGUIST TYPOL, V11, P393, DOI [DOI 10.1515/LINGTY.2007.027, 10.1515/lingty.2007.027]; Hothorn T, 2012, PARTY A LABORATORY F; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jager G, 2016, THE EVOLUTION OF LAN; Kang Y, 2013, LINGUA, V134, P62, DOI 10.1016/j.lingua.2013.06.002; Kirby JP, 2014, J PHONETICS, V43, P69, DOI 10.1016/j.wocn.2014.02.001; Kirk NW, 2013, 54TH ANNUAL MEETING; Larsen AB, 1917, NABOOPPOSISJON D KNO, P97; Lebenswerd P. J., 2012, THESIS; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Lewis MP, THE PROBLEM OF LANGU; Maddieson I, 2013, TONE; Matisoff JA, 1973, SOUTHERN CALIFORNIA, V1; McMahon A, 2003, T PHILOL SOC, V101, P7, DOI 10.1111/1467-968X.00108; McNamara T., 2005, LANG POLICY-NETH, V4, P351, DOI [10.1007/s10993-005-2886-0, DOI 10.1007/S10993-005-2886-0]; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Miles J., 2014, TOLERANCE AND VARIAN; MORAN STEVEN, 2014, PHOIBLE ONLINE; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Robbeets M, 2005, IS JAPANESE RELATED; Roberts G, 2010, INTERACT STUD, V11, P138, DOI 10.1075/is.11.1.o6rob; Rubin DL, 1992, NONLANGUAGE FACTORS, V4, P511; Schrijver P., 1999, THE CELTIC CONTRIBUT; Schuppert A, 2015, LINGUISTICS, V53, P375, DOI 10.1515/ling-2015-0003; Spruit M. R., 2006, Literary & Linguistic Computing, V21, P493, DOI 10.1093/llc/fql043; Strongman T, 1967, STEREOTYPED REACTION, V6, P164; Thurston William R., 1987, PROCESSES OF CHANGE; Villanueva-Rivera LJ, 2011, LANDSCAPE ECOL, V26, P1233, DOI 10.1007/s10980-011-9636-9; Wagner L, 2014, J CHILD LANG, V41, P1062, DOI 10.1017/S0305000913000330; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wichmann S, 2013, THE ASJP DATABASE VE; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011	65	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0165934	10.1371/journal.pone.0165934	http://dx.doi.org/10.1371/journal.pone.0165934			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ES2JD	28379970	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500001
J	Tsai, CW; Ting, IW; Yeh, HC; Kuo, CC				Tsai, Ching-Wei; Ting, I-Wen; Yeh, Hung-Chieh; Kuo, Chin-Chi			Longitudinal change in estimated GFR among CKD patients: A 10-year follow-up study of an integrated kidney disease care program in Taiwan	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; FUNCTION DECLINE; RENAL-FUNCTION; MORTALITY RISK; PROGRESSION; POPULATION; STAGE; OUTCOMES; ADULTS; LIPIDS	Background This study examined the progression of chronic kidney disease (CKD) by using average annual decline in estimated GFR (eGFR) and its risk factors in a 10-year follow-up CKD cohort. Methods A prospective, observational cohort study, 4600 individuals fulfilled the definition of CKD, with or without proteinuria, were followed for 10 years. The eGFR was estimated by the MDRD equation. Linear regression was used to estimate participants' annual decline rate in eGFR. We defined subjects with annual eGFR decline rate <1 ml/min/1.73 m(2) as non-progression and the decline rate over 3 ml/min/1.73 m2 as rapid progression. Results During the follow-up period, 2870 (62.4%) individuals had annual eGFR decline rate greater than 1 ml/min/1.73 m(2). The eGFR decline rate was slower in individuals with CKD diagnosed over the age of 60 years than those with onset at a younger age. Comparing to subjects with decline rate < 1 ml/min/1.73 m(2) /year, the odds ratio (OR) of developing rapid CKD progression for diabetes, proteinuria and late onset of CKD was 1.72 (95% CI: 1.48-2.00), 1.89(1.63-2.20) and 0.68 (0.56-0.81), respectively. When the model was adjusted for the latest CKD stage, comparing to those with CKD stage 1, patients with stage 4 and stage 5 have significantly higher risks for rapid progression (OR, 5.17 (2.60-10.25), 19.83 (10.05-39.10), respectively). However, such risk was not observed among patients with the latest CKD stage 2 and 3. The risk for incident ESRD was 17% higher for each 1 ml/min/1.73 m 2 increasing in annual decline rate. Conclusions Not everyone with CKD develops ESRD after a 10-year follow-up. Absolute annual eGFR decline rate can help clinicians to better predict the progression of CKD. Individuals with renal function decline rate over 3 ml/min/1.73m(2)/year require intensive CKD care.	[Tsai, Ching-Wei; Ting, I-Wen; Yeh, Hung-Chieh; Kuo, Chin-Chi] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Tsai, Ching-Wei; Ting, I-Wen; Yeh, Hung-Chieh; Kuo, Chin-Chi] China Med Univ Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan; [Tsai, Ching-Wei; Kuo, Chin-Chi] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Tsai, Ching-Wei; Kuo, Chin-Chi] China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kuo, CC (corresponding author), China Med Univ Hosp, Div Nephrol, Taichung, Taiwan.; Kuo, CC (corresponding author), China Med Univ Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan.; Kuo, CC (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Kuo, CC (corresponding author), China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan.	chinchik@gmail.com						Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P63; Baba M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129036; CAPPELLI P, 1992, NEPHRON, V62, P31, DOI 10.1159/000186991; Chang YK, 2015, NEPHROLOGY, V20, P243, DOI 10.1111/nep.12380; Chen IR, 2014, CLIN J AM SOC NEPHRO, V9, P1183, DOI 10.2215/CJN.09810913; Cheng TYD, 2008, AM J KIDNEY DIS, V52, P1051, DOI 10.1053/j.ajkd.2008.05.030; Cohen E, 2014, JOURNAL OF NEPHROLOG; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Heerspink HJL, 2014, AM J KIDNEY DIS, V63, P244, DOI 10.1053/j.ajkd.2013.09.016; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hirayama A, 2015, AM J HYPERTENS, V28, P1150, DOI 10.1093/ajh/hpv003; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Kovesdy CP, 2016, J AM SOC NEPHROL, V27, P2447, DOI 10.1681/ASN.2015060687; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lewis J, 2004, J AM SOC NEPHROL, V15, P3175, DOI 10.1097/01.ASN.0000146688.74084.A3; Lin CM, 2013, J FORMOS MED ASSOC, V112, P773, DOI 10.1016/j.jfma.2013.10.021; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; LOCATELLI F, 1992, MINER ELECTROL METAB, V18, P295; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Rosansky SJ, 2012, AM J NEPHROL, V36, P1, DOI 10.1159/000339327; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; System USRD, 2015, 2015 USRDS ANNUAL DA; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Vidt DG, 2011, CLIN THER, V33, P717, DOI 10.1016/j.clinthera.2011.05.004; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6	40	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173843	10.1371/journal.pone.0173843	http://dx.doi.org/10.1371/journal.pone.0173843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380035	gold, Green Published			2022-12-27	WOS:000399353500026
J	Wei, ZW; Hui, XL; Li, XH; Zhang, YZ; Jiang, LC; Li, J; Guan, ZB; Cai, YJ; Liao, XR				Wei, Zhiwen; Hui, Xiaolong; Li, Xunhang; Zhang, Yanzhou; Jiang, Leichun; Li, Jing; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru			The rhizospheric microbial community structure and diversity of deciduous and evergreen forests in Taihu Lake area, China	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PYROSEQUENCING-BASED ANALYSIS; BACTERIAL COMMUNITY; COMPARATIVE METAGENOMICS; COOCCURRENCE PATTERNS; RARE BIOSPHERE; SOIL-PH; IMPACT; BIOGEOGRAPHY; ENVIRONMENT	Soil bacteria are important drivers of biogeochemical cycles and participate in many nutrient transformations in the soil. Meanwhile, bacterial diversity and community composition are related to soil physic-chemical properties and vegetation factors. However, how the soil and vegetation factors affect the diversity and community composition of bacteria is poorly understood, especially for bacteria associated with evergreen and deciduous trees in subtropical forest ecosystems. In the present paper, the microbial communities of rhizospheric soils associated with different types of trees were analyzed by Illumina MiSeq sequencing the V3-V4 region of the 16S rRNA gene. A total of 121,219 effective 16S rRNA gene sequences were obtained, which were classified into 29 bacterial phyla and 2 archaeal phyla. The dominant phyla across all samples (>5% of good-quality sequences in each sample) were Proteobacteria, Acidobacteria, Firmicutes and Bacteroidetes. The bacterial community composition and diversity were largely affected by both soil pH and tree species. The soil pH was the key factor influencing bacterial diversity, with lower pH associated with less diverse communities. Meanwhile, the contents of NO3 were higher in evergreen tree soils than those associated with deciduous trees, while less NH4+ than those associated with deciduous trees, leading to a lower pH and indirectly influencing the diversity and composition of the bacteria. The co-occurrence patterns were assessed by network analysis. A total of 415 pairs of significant and robust correlations (co-occurrence and negative) were identified from 89 genera. Sixteen hubs of co-occurrence patterns, mainly under the phyla Acidobacteria, Proteobacteria, Firmicutes and Bacteroidetes, may play important roles in sustaining the stability of the rhizospheric microbial communities. In general, our results suggested that local environmental conditions and soil pH were important in shaping the bacterial community of the Taihu Lake zone in east China.	[Wei, Zhiwen; Li, Jing; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Wei, Zhiwen] Jiangsu Normal Univ, Key Lab Biotechnol Med Plant Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China; [Hui, Xiaolong] Zhengzhou Univ Light Ind, Sch Food & Biol Engn, Zhengzhou, Henan, Peoples R China; [Li, Xunhang] Jiangxi Agr Univ, Biosci & Engn Coll, Nanchang, Jiangxi, Peoples R China; [Zhang, Yanzhou] Yancheng Teachers Univ, Sch Marine & Biol Engn, Yancheng, Jiangsu, Peoples R China; [Jiang, Leichun] Wuxi Plum Garden & Hengshan Scen Area, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangsu Normal University; Zhengzhou University of Light Industry; Jiangxi Agricultural University; Yancheng Teachers University	Liao, XR (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China.	laoxiangru@163.com	Hui, XIAO/GZH-2322-2022		Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province [BY2014023-28]; Agricultural Support Project, Wuxi Science & Technology Development [CLEO1N1310]; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou [13021ry08]	Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province; Agricultural Support Project, Wuxi Science & Technology Development; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou	This study was supported by Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province (BY2014023-28); Agricultural Support Project, Wuxi Science & Technology Development (CLEO1N1310); the Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou (no. 13021ry08).	[Anonymous], 1999, LYT1237 STAT FOR ADM; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Augusto L, 2002, ANN FOREST SCI, V59, P233, DOI 10.1051/forest:2002020; Baek Dong-Heon, 2007, International Journal of Oral Biology, V32, P75; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Barra Caracciolo A., 2011, CHEM ECOL, V27, P43, DOI DOI 10.1080/02757540.2016.53408; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Coates JD, 2002, APPL ENVIRON MICROB, V68, P2445, DOI 10.1128/AEM.68.5.2445-2452.2002; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Cristobal HA, 2015, FOLIA MICROBIOL, V60, P183, DOI 10.1007/s12223-014-0351-1; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dokulil M., 2000, AQUAT ECOSYST HEALTH, V3, P81, DOI DOI 10.1016/S1463-4988(99)00067-6; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Eilers KG, 2010, SOIL BIOL BIOCHEM, V42, P896, DOI 10.1016/j.soilbio.2010.02.003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Guo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086881; HALL A, 1993, APPL GEOCHEM, V8, P101, DOI 10.1016/0883-2927(93)90059-P; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Han D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086887; Harrell JFE, 2008, HMISC HARREL MISCELL; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hjort K, 2014, APPL MICROBIOL BIOT, V98, P2819, DOI 10.1007/s00253-013-5287-x; Hu XL, 2016, APPL ENVIRON MICROB, V82, P2506, DOI 10.1128/AEM.03409-15; Huang QY, 2013, FEMS MICROBIOL ECOL, V85, P452, DOI 10.1111/1574-6941.12134; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Kanokratana P, 2011, MICROB ECOL, V61, P518, DOI 10.1007/s00248-010-9766-7; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee KCY, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0099-5; Lee SH, 2013, J MICROBIOL, V51, P484, DOI 10.1007/s12275-013-3312-5; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu GS, 1996, SOIL PHYS CHEM ANAL, P166; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Livermore JA, 2013, ENVIRON SCI TECHNOL, V47, P7672, DOI 10.1021/es4012788; Llado S, 2016, BIOL FERT SOILS, V52, P251, DOI 10.1007/s00374-015-1072-6; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Massenssini AM, 2015, APPL SOIL ECOL, V91, P8, DOI 10.1016/j.apsoil.2015.02.009; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Pankhurst C, 1997, BIOL INDICATORS SOIL; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Pennanen T, 1999, MICROB ECOL, V38, P168, DOI 10.1007/s002489900161; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rose NL, 2004, J PALEOLIMNOL, V32, P41, DOI 10.1023/B:JOPL.0000025282.06961.42; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Spatharis S, 2011, ECOL INDIC, V11, P697, DOI 10.1016/j.ecolind.2010.09.009; Stratford JP, 2014, BIORESOURCE TECHNOL, V156, P84, DOI 10.1016/j.biortech.2014.01.041; Su WZ, 2010, LANDSCAPE URBAN PLAN, V95, P61, DOI 10.1016/j.landurbplan.2009.12.003; Sul WJ, 2013, SOIL BIOL BIOCHEM, V65, P33, DOI 10.1016/j.soilbio.2013.05.007; Taha M, 2015, APPL BIOCHEM BIOTECH, V175, P3709, DOI 10.1007/s12010-015-1539-9; Tao Y, 2014, APPL ENVIRON MICROB, V80, P2254, DOI 10.1128/AEM.04070-13; TARAS MJ, 1950, ANAL CHEM, V22, P1020, DOI 10.1021/ac60044a014; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Uren NC, 2007, RHIZOSPHERE BIOCH OR, P1, DOI [10.1201/9781420005585.ch1, DOI 10.1201/9781420005585.CH1]; Uroz S, 2012, APPL ENVIRON MICROB, V78, P3020, DOI 10.1128/AEM.06742-11; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; van Beek TA, 1998, FITOTERAPIA, V69, P195; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wang J, 2013, CHALLENGING ICT APPL, P48, DOI DOI 10.4018/978-1-4666-1999-9; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Wu FY, 2012, INT J PHYTOREMEDIAT, V14, P543, DOI 10.1080/15226514.2011.604691; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Yin Yun-long, 2002, Journal of Plant Resources and Environment, V11, P46; Yuan HZ, 2014, ENVIRON EARTH SCI, V71, P783, DOI 10.1007/s12665-013-2480-2; [张彪 Zhang Biao], 2010, [水土保持研究, Research of Soil and Water Conservation], V17, P96; Zhang Y., 2011, ANAL TUTORIAL SOIL W, P66; Zhang Y, 2012, B ENVIRON CONTAM TOX, V89, P1009, DOI 10.1007/s00128-012-0784-7; Zhao DY, 2014, APPL MICROBIOL BIOT, V98, P9119, DOI 10.1007/s00253-014-5920-3; Zhao HX, 2013, CHINESE GEOGR SCI, V23, P203, DOI 10.1007/s11769-013-0593-x; Zimmermann J, 2006, ANTON LEEUW INT J G, V89, P203, DOI 10.1007/s10482-005-9020-3	104	37	39	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174411	10.1371/journal.pone.0174411	http://dx.doi.org/10.1371/journal.pone.0174411			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379996	gold, Green Submitted, Green Published			2022-12-27	WOS:000399353500046
J	Guo, YW; Yu, P; Liu, ZM; Maimaiti, Y; Chen, C; Zhang, YK; Yin, XJ; Wang, S; Liu, CP; Huang, T				Guo, Yawen; Yu, Pan; Liu, Zeming; Maimaiti, Yusufu; Chen, Chen; Zhang, Yunke; Yin, Xingjie; Wang, Shan; Liu, Chunping; Huang, Tao			Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis	PLOS ONE			English	Review							ESTROGEN-RECEPTOR; FREE SURVIVAL; RELAPSE-FREE; EXPRESSION; FOXA1; DIFFERENTIATION; ASSOCIATION; PREDICT; MARKER; WOMEN	The potential prognostic value of GATA binding protein 3 (GATA3) in breast cancer has recently increased, although the evidence is inconclusive. This meta-analysis of 10 articles involving 5,080 breast cancer patients explored the prognostic and clinicopathological value of GATA3 in breast cancer. Time to tumor progression (TTP) and overall survival (OS) were primary endpoints. Pooled hazard ratio (HR), pooled risk ratio (RR), and 95% confidence interval (CI) were calculated to evaluate the association between GATA3, prognosis, and clinicopathological parameters. High GATA3 expression predicts breast cancer, with a HR (HR = 0.671; 95% CI = 0.475-0.947; P = 0.023) of TTP, but is not associated with OS (HR = 0.889; 95% CI = 0.789-1.001; P = 0.052). GATA3 overexpression is associated with positive ER (RR = 3.155; 95% CI = 1.680-5.923; P = 0.000), positive PR (RR = 3.949; 95% CI = 1.567-9.954, P = 0.004), lower nuclear grade (RR = 0.435; 95% CI = 0.369-0.514; P = 0.000), and smaller tumor size (RR = 0.816; 95% CI = 0.709-0.940; P = 0.005). High GATA3 expression may predict TTP in breast cancer, and such patients may show better clinicopathological features.	[Guo, Yawen; Yu, Pan; Liu, Zeming; Chen, Chen; Zhang, Yunke; Yin, Xingjie; Wang, Shan; Liu, Chunping; Huang, Tao] Huazhong Univ Sci & Technol, Dept Breast & Thyroid Surg, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Maimaiti, Yusufu] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Gen Surg, Urumqi, Peoples R China	Huazhong University of Science & Technology	Liu, CP; Huang, T (corresponding author), Huazhong Univ Sci & Technol, Dept Breast & Thyroid Surg, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China.	lcp191@163.com; huangtaowh@163.com		Liu, Zeming/0000-0001-6132-4701	National Natural Science Foundation of China [NSFC 81550009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the the National Natural Science Foundation of China: NSFC 81550009 (http//www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Bong Pau Ni Ivyna, 2010, Malays J Pathol, V32, P117; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Demir H, 2010, J BUON, V15, P774; Dolled-Filhart M, 2006, CLIN CANCER RES, V12, P6459, DOI 10.1158/1078-0432.CCR-06-1383; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Gulbahce HE, 2013, HUM PATHOL, V44, P2427, DOI 10.1016/j.humpath.2013.05.022; Guo YW, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156323, 10.1007/s11468-015-0008-1]; Hisamatsu Y, 2015, BREAST CANCER-TOKYO, V22, P520, DOI 10.1007/s12282-013-0515-x; Hosoda M, 2014, BREAST CANCER RES TR, V144, P249, DOI 10.1007/s10549-014-2867-0; Izzo F, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0491-x; Jiang YZ, 2014, CANCER-AM CANCER SOC, V120, P1329, DOI 10.1002/cncr.28566; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Liu JJ, 2016, CANCER LETT, V376, P104, DOI 10.1016/j.canlet.2016.03.038; McCleskey BC, 2015, AM J CLIN PATHOL, V144, P756, DOI 10.1309/AJCP5MMR1FJVVTPK; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Min KW, 2016, VIRCHOWS ARCH, V468, P409, DOI 10.1007/s00428-015-1894-5; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Naylor MJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1661; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tevosian SG, 2014, REPRODUCTION, V148, pR1, DOI 10.1530/REP-14-0086; Thakkar A, 2015, BIOMARK INSIGHTS, V10, P103, DOI [10.4137/BMIMI.S30559, 10.4137/BMI.S30559]; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Voduc D, 2008, CANCER EPIDEM BIOMAR, V17, P365, DOI 10.1158/1055-9965.EPI-06-1090; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010	31	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174843	10.1371/journal.pone.0174843	http://dx.doi.org/10.1371/journal.pone.0174843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394898	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800008
J	Pironti, A; Pfeifer, N; Walter, H; Jensen, BEO; Zazzi, M; Gomes, P; Kaiser, R; Lengauer, T				Pironti, Alejandro; Pfeifer, Nico; Walter, Hauke; Jensen, Bjorn-Erik O.; Zazzi, Maurizio; Gomes, Perpetua; Kaiser, Rolf; Lengauer, Thomas			Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; COMPUTATIONAL MODELS; PHENOTYPIC RESISTANCE; HIV-INFECTION; MUTATIONS; PROTEASE; RECOMMENDATIONS; PERFORMANCE; ZIDOVUDINE	Antiretroviral treatment history and past HIV-1 genotypes have been shown to be useful predictors for the success of antiretroviral therapy. However, this information may be unavailable or inaccurate, particularly for patients with multiple treatment lines often attending different clinics. We trained statistical models for predicting drug exposure from current HIV-1 genotype. These models were trained on 63,742 HIV-1 nucleotide sequences derived from patients with known therapeutic history, and on 6,836 genotype-phenotype pairs (GPPs). The mean performance regarding prediction of drug exposure on two test sets was 0.78 and 0.76 (ROC-AUC), respectively. The mean correlation to phenotypic resistance in GPPs was 0.51 (PhenoSense) and 0.46 (Antivirogram). Performance on prediction of therapy-success on two test sets based on genetic susceptibility scores was 0.71 and 0.63 (ROC-AUC), respectively. Compared to geno2pheno[resistance], our novel models display a similar or superior performance. Our models are freely available on the internet via www.geno2pheno.org. They can be used for inferring which drug compounds have previously been used by an HIV-1-infected patient, for predicting drug resistance, and for selecting an optimal antiretroviral therapy. Our data-driven models can be periodically retrained without expert intervention as clinical HIV-1 databases are updated and therefore reduce our dependency on hard-to-obtain GPPs.	[Pironti, Alejandro; Pfeifer, Nico; Lengauer, Thomas] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Walter, Hauke] Med Infektiol Zentrum Berlin, Berlin, Germany; [Walter, Hauke] Med Lab Stendal, Stendal, Germany; [Jensen, Bjorn-Erik O.] Univ Clin Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Gomes, Perpetua] HEM Ctr Hosp Lisboa Ocidental, SPC, LMCBM, Lab Biol Mol, Lisbon, Portugal; [Gomes, Perpetua] Inst Super Ciencias Saude Sul, CiiEM, Caparica, Portugal; [Kaiser, Rolf] Univ Clin Cologne, Inst Virol, Cologne, Germany	Max Planck Society; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Siena; University of Cologne	Pironti, A (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany.	apironti@mpi-inf.mpg.de	Pfeifer, Nico/G-1559-2016; Zazzi, Maurizio/K-3422-2018; Gomes, Perpetua/I-5652-2012	Zazzi, Maurizio/0000-0002-0344-6281; Walter, Henrik/0000-0002-9403-6121; Lengauer, Thomas/0000-0003-3801-2640; Gomes, Perpetua/0000-0003-3271-8255	Bundesminiterium fur Gesundheit, HIV-HEP-MASTER [IIA5-2013-2514AUK375]; German Health Ministry [MASTER/HIV-HEP]	Bundesminiterium fur Gesundheit, HIV-HEP-MASTER; German Health Ministry [MASTER/HIV-HEP]	This work was supported by Bundesminiterium fur Gesundheit, HIV-HEP-MASTER (IIA5-2013-2514AUK375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Health Ministry [MASTER/HIV-HEP].	Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bickel S, 2008, MULTITASK LEARNING H, P56; Bogojeska J, 2012, P 15 INT C ART INT S, P118; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; Faria NR, 2013, INFECT GENET EVOL J; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Garcia-Lerma JG, 2004, J VIROL, V78, P7545, DOI 10.1128/JVI.78.14.7545-7552.2004; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Hachiya A, 2012, J BIOL CHEM, V287, P29988, DOI 10.1074/jbc.M112.351551; Hanna GJ, 2001, CLIN INFECT DIS, V32, P774, DOI 10.1086/319231; Hastie T., 2009, UNSUPERVISED LEARNIN; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kantor Rami, 2003, AIDS Reviews, V5, P25; Kempf DJ, 1997, ANTIMICROB AGENTS CH, V41, P654, DOI 10.1128/AAC.41.3.654; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Langs-Barlow A, 2014, VIRUSES-BASEL, V6, P3855, DOI 10.3390/v6103855; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lundgren J, 2014, GUIDELINES VERSION 7; Mackie NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0b013e3283636179; Obermeier M, 2012, INTERVIROLOGY, V55, P102, DOI 10.1159/000331999; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pironti A., 2016, THESIS; Platt J., PROBABILISTIC OUTPUT, P61; Prosperi MCF, 2012, AIDS REV, V14, P145; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013753; R Core Team, 2021, R LANGUAGE ENV STAT; Revell AD, 2014, HIV MED, V15, P442, DOI 10.1111/hiv.12156; Revell AD, 2014, J ANTIMICROB CHEMOTH, V69, P1104, DOI 10.1093/jac/dkt447; Revell AD, 2011, AIDS, V25, P1855, DOI 10.1097/QAD.0b013e328349a9c2; Rhee SY, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-13; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Saigo H, 2011, STAT APPL GENET MOL, P10; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Scherrer AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037983; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh K, 2014, VIRUSES-BASEL, V6, P3535, DOI 10.3390/v6093535; Svicher V, 2010, NEW MICROBIOL, V33, P195; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Theys K, 2013, FUTURE MICROBIOL, V8, P303, DOI [10.2217/FMB.13.10, 10.2217/fmb.13.10]; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Wainberg MA, 2012, MOL BIOL INT, V2012, P1; Wang K, 2004, ANTIVIR THER, V9, P703; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4; Zaccarelli M, 2009, ANTIVIR THER, V14, P285; Zazzi M, 2011, HIV MED, V12, P211, DOI 10.1111/j.1468-1293.2010.00871.x; Zazzi M, 2012, INTERVIROLOGY, V55, P123, DOI 10.1159/000332008	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174992	10.1371/journal.pone.0174992	http://dx.doi.org/10.1371/journal.pone.0174992			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394945	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800012
J	Jorgensen, O; Backstrom, M; Bjorklund, F				Jorgensen, Oyvind; Backstrom, Martin; Bjorklund, Fredrik			Judgments of warmth and competence in a computerized paradigm: Little evidence of proposed impression formation asymmetries	PLOS ONE			English	Article							SOCIAL COGNITION; EXTREMITY BIASES; NEGATIVITY; MODEL; ATTRIBUTION; INFORMATION; POSITIVITY; DOMINANCE; BEHAVIOR	Much of what we know concerning impression formation is based on experimental methods where the participant receives a list of traits or behaviors and is asked to make trait judgments or meta-cognitive judgments. The present study aimed to put some well-known effects from the impression formation literature to a test in a more dynamic computerized environment, more akin to many real world impression formation scenarios. In three studies participants were introduced to multiple target persons. They were given information about the target persons' behavior, one at a time, while making ratings of their warmth and competence, and their probability of performing related behaviors in the future. In neither of the studies the negativity effect of warmth or the positivity effect of competence were reproduced.	[Jorgensen, Oyvind] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden; [Backstrom, Martin; Bjorklund, Fredrik] Lund Univ, Dept Psychol, Lund, Sweden	Kristianstad University; Lund University	Jorgensen, O (corresponding author), Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden.	oyvind.jorgensen@hkr.se		Bjorklund, Fredrik/0000-0001-9970-6465	Swedish Research Council [2349]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council, grant VR 2008: 2349. http://vrproj.vr.se/detail.asp?arendeid=60232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele AE, 2014, ADV EXP SOC PSYCHOL, V50, P195, DOI 10.1016/B978-0-12-800284-1.00004-7; Abele AE, 2011, J EXP SOC PSYCHOL, V47, P935, DOI 10.1016/j.jesp.2011.03.028; D'Angelo J, 2016, COMMUN RES, V43, P49, DOI 10.1177/0093650213491112; De Bruin ENM, 1999, EUR J SOC PSYCHOL, V29, P305, DOI 10.1002/(SICI)1099-0992(199903/05)29:2/3<305::AID-EJSP929>3.0.CO;2-R; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Jones EE, 1966, ADV EXP SOC PSYCHOL, V2, P220; KELLERMANN K, 1989, HUM COMMUN RES, V16, P147, DOI 10.1111/j.1468-2958.1989.tb00208.x; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; REEDER GD, 1993, PERS SOC PSYCHOL B, V19, P586, DOI 10.1177/0146167293195010; REEDER GD, 1979, PSYCHOL REV, V86, P61, DOI 10.1037/0033-295X.86.1.61; REEDER GD, 1983, J PERS SOC PSYCHOL, V44, P736, DOI 10.1037/0022-3514.44.4.736; ROTHBART M, 1986, J PERS SOC PSYCHOL, V50, P131, DOI 10.1037/0022-3514.50.1.131; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; SKOWRONSKI JJ, 1987, J PERS SOC PSYCHOL, V52, P689, DOI 10.1037/0022-3514.52.4.689; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Uleman J.S., 2013, OXFORD HDB SOCIAL CO, P53, DOI [10.1093/oxfordhb/9780199730018.013.0004, DOI 10.1093/OXFORDHB/9780199730018.013.0004]; WOJCISZKE B, 2005, EUROPEAN REV SOCIAL, V0016; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001; WOJCISZKE B, 1993, J PERS SOC PSYCHOL, V64, P327, DOI 10.1037/0022-3514.64.3.327	22	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175210	10.1371/journal.pone.0175210	http://dx.doi.org/10.1371/journal.pone.0175210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388687	gold, Green Published			2022-12-27	WOS:000399375800029
J	Bilal, A; Dai, WH; Larson, M; Beebo, QN; Xie, QC				Bilal, Ahmed; Dai, Wenhong; Larson, Magnus; Beebo, Qaid Naamo; Xie, Qiancheng			Qualitative simulation of bathymetric changes due to reservoir sedimentation: A Japanese case study	PLOS ONE			English	Article							TRANSPORT; RAINFALL; RUNOFF; BASIN; FLOW; DAM	Sediment-dynamics modeling is a useful tool for estimating a dam's lifespan and its cost-benefit analysis. Collecting real data for sediment-dynamics analysis from conventional field survey methods is both tedious and expensive. Therefore, for most rivers, the historical record of data is either missing or not very detailed. Available data and existing tools have much potential and may be used for qualitative prediction of future bathymetric change trend. This study shows that proxy approaches may be used to increase the spatiotemporal resolution of flow data, and hypothesize the river cross-sections and sediment data. Sediment-dynamics analysis of the reach of the Tenryu River upstream of Sakuma Dam in Japan was performed to predict its future bathymetric changes using a 1D numerical model (HEC-RAS). In this case study, only annually-averaged flow data and the river's longitudinal bed profile at 5-year intervals were available. Therefore, the other required data, including river cross-section and geometry and sediment inflow grain sizes, had to be hypothesized or assimilated indirectly. The model yielded a good qualitative agreement, with an R-2 ( coefficient of determination) of 0.8 for the observed and simulated bed profiles. A predictive simulation demonstrated that the useful life of the dam would end after the year 2035 (+/- 5 years), which is in conformity with initial detailed estimates. The study indicates that a sedimentdynamic analysis can be performed even with a limited amount of data. However, such studies may only assess the qualitative trends of sediment dynamics.	[Bilal, Ahmed; Dai, Wenhong; Xie, Qiancheng] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Dai, Wenhong] State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Dai, Wenhong] Natl Engn Res Ctr Water Resources Efficient Utili, Nanjing, Jiangsu, Peoples R China; [Larson, Magnus; Beebo, Qaid Naamo] Lund Univ, Dept Water Resources Engn, Lund, Sweden	Hohai University; Lund University	Dai, WH (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China.; Dai, WH (corresponding author), State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China.; Dai, WH (corresponding author), Natl Engn Res Ctr Water Resources Efficient Utili, Nanjing, Jiangsu, Peoples R China.	wdai@hhu.edu.cn	Bilal, Ahmed/J-6971-2019	Bilal, Ahmed/0000-0002-6903-1126; Xie, Qiancheng/0000-0003-0820-617X	National Natural Science Foundation of China [51479071]; "111 Project" [B12032]; Jiangsu Colleges and Universities Academic Building Engineering Project [YS11001];  [2016YFC0402501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111 Project"(Ministry of Education, China - 111 Project); Jiangsu Colleges and Universities Academic Building Engineering Project; 	This research is supported by the funding received by National Key R&D Program of China (No.2016YFC0402501) to WD, National Natural Science Foundation of China (51479071) to WD, the "111 Project" (B12032) to WD and the Jiangsu Colleges and Universities Academic Building Engineering Project (YS11001) to WD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2015, HYDROL EARTH SYST SC, V19, P631, DOI 10.5194/hess-19-631-2015; Brunner G, 2010, HEC RAS RIVER ANAL S; Cheng PD, 2013, J HYDRODYN, V25, P620, DOI 10.1016/S1001-6058(11)60404-7; Fang NF, 2011, GEOMORPHOLOGY, V135, P158, DOI 10.1016/j.geomorph.2011.08.013; Gomez B, 2009, GLOBAL PLANET CHANGE, V67, P153, DOI 10.1016/j.gloplacha.2009.02.002; Hobgen SE, 2014, GEOGR ANN A, V96, P513, DOI 10.1111/geoa.12076; Huang G, 2011, WORLD J MECH, V01, P115; Ishibashi K, 2004, ANN GEOPHYS-ITALY, V47, P339; JCLD, 2009, DAMS JAP PAST PRES F; Jimenez JA, 2003, J WATERW PORT C-ASCE, V129, P70, DOI 10.1061/(ASCE)0733-950X(2003)129:2(70); Jin ZW, 2016, J HYDRODYN, V28, P153, DOI 10.1016/S1001-6058(16)60616-9; Kail J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130228; Khan MS, 2012, LIFE SCI J, V9, P221; Lopez P, 2016, SCI TOTAL ENVIRON, V540, P158, DOI 10.1016/j.scitotenv.2015.06.033; Maswood M, 2016, INT J RIVER BASIN MA, V14, P103, DOI 10.1080/15715124.2015.1089250; Melesse AM, 2011, AGR WATER MANAGE, V98, P855, DOI 10.1016/j.agwat.2010.12.012; Micic V, 2013, SCI TOTAL ENVIRON, V458, P90, DOI 10.1016/j.scitotenv.2013.03.102; Ministry of Land Insfrastructure Transport and Tourism (MLIT), 2008, WAT RES JAP; MLIT, 2007, TABL MAJ RIV JAP; Mohammad ME, 2016, SEDIMENT MOSUL DAM R, P235; Morris G.L., 1998, RESERVOIR SEDIMENTAT; Paskett CJ, 1982, WATER INT, V7, P59; Sato S, 2008, COMPREHENSIVE STUDY; Sumil T, 2004, RESERVOIR SEDIMENTAT; Swenson JB, 2005, J GEOPHYS RES-EARTH, V110, P1, DOI 10.1029/2004JF000265; Tigrek S., 2011, RESERVOIR SEDIMENT M; Toffaleti F.B., 1968, PROCEDURE COMPUTATIO; Tuset J, 2016, SCI TOTAL ENVIRON, V540, P114, DOI 10.1016/j.scitotenv.2015.07.075; Van Rijn LC, 1989, HDB SEDIMENT TRANSPO; Wang C, 2015, J HYDRODYN, V27, P24, DOI 10.1016/S1001-6058(15)60453-X; Wang F, 2015, SCI TOTAL ENVIRON, V508, P166, DOI 10.1016/j.scitotenv.2014.11.055; Zeleke Takele, 2013, Lakes & Reservoirs Research and Management, V18, P366, DOI 10.1111/lre.12047	32	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174931	10.1371/journal.pone.0174931	http://dx.doi.org/10.1371/journal.pone.0174931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384361	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900057
J	Gautschi, I; van Bemmelen, MX; Schild, L				Gautschi, Ivan; van Bemmelen, Miguel Xavier; Schild, Laurent			Proton and non-proton activation of ASIC channels	PLOS ONE			English	Article							SENSING ION CHANNELS; NA+ CHANNEL	The Acid-Sensing Ion Channels (ASIC) exhibit a fast desensitizing current when activated by pH values below 7.0. By contrast, non-proton ligands are able to trigger sustained ASIC currents at physiological pHs. To analyze the functional basis of the ASIC desensitizing and sustained currents, we have used ASIC1a and ASIC2a mutants with a cysteine in the pore vestibule for covalent binding of different sulfhydryl reagents. We found that ASIC1a and ASIC2a exhibit two distinct currents, a proton-induced desensitizing current and a sustained current triggered by sulfhydryl reagents. These currents differ in their pH dependency, their sensitivity to the sulfhydryl reagents, their ionic selectivity and their relative magnitude. We propose a model for ASIC1 and ASIC2 activity where the channels can function in two distinct modes, a desensitizing mode and a sustained mode depending on the activating ligands. The pore vestibule of the channel represents a functional site for binding non-proton ligands to activate ASIC1 and ASIC2 at neutral pH and to prevent channel desensitization.	[Gautschi, Ivan; van Bemmelen, Miguel Xavier; Schild, Laurent] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Laurent.Schild@unil.ch			Swiss National Fund [310030_135378]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Fund (www.snf.ch), grant number 310030_135378 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Browne LE, 2014, P NATL ACAD SCI USA, V111, P521, DOI 10.1073/pnas.1318582111; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kreple CJ, 2014, NAT NEUROSCI, V17, P1083, DOI 10.1038/nn.3750; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Roy S, 2013, FASEB J; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; van Bemmelen MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135191; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175293	10.1371/journal.pone.0175293	http://dx.doi.org/10.1371/journal.pone.0175293			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384246	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900148
J	Gretscher, H; Tempelmann, S; Haun, DBM; Liebal, K; Kaminski, J				Gretscher, Heinz; Tempelmann, Sebastian; Haun, Daniel B. M.; Liebal, Katja; Kaminski, Juliane			Prelinguistic human infants and great apes show different communicative strategies in a triadic request situation	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; GESTURAL COMMUNICATION; AUDITORY INFORMATION; POINT; ATTENTION; EYES; EVOLUTION; IMPACT; OTHERS; ACT	In the present research, we investigate the communicative strategies of 20 month old human infants and great apes when requesting rewards from a human experimenter. Infants and apes both adapted their signals to the attentional state of the experimenter as well as to the location of the reward. Yet, while infants frequently positioned themselves in front of the experimenter and pointed towards a distant reward, apes either remained in the experimenter's line of sight and pointed towards him or moved out of sight and pointed towards the reward. Further, when pointing towards a reward that was placed at a distance from the experimenter, only the infants, and not the apes, took the experimenter's attentional state into account. These results demonstrate that prelinguistic human infants and nonhuman apes use different means when guiding others' attention to a location; indicating that differing cognitive mechanisms may underlie their pointing gestures.	[Gretscher, Heinz; Kaminski, Juliane] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Tempelmann, Sebastian] Univ Appl Sci & Arts Northwestern Switzerland, Liestal, Switzerland; [Tempelmann, Sebastian; Liebal, Katja] Free Univ Berlin, Cluster Languages Emot, Berlin, Germany; [Haun, Daniel B. M.] Univ Leipzig, Leipzig Res Ctr Early Child Dev, Leipzig, Germany; [Haun, Daniel B. M.] Univ Leipzig, Dept Early Child Dev & Culture, Leipzig, Germany; [Kaminski, Juliane] Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England	Max Planck Society; Free University of Berlin; Leipzig University; Leipzig University; University of Portsmouth	Gretscher, H (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	heinz.gretscher@gmx.de	Liebal, Katja/AAQ-7910-2020	Liebal, Katja/0000-0003-2447-8327	VolkswagenStiftung, Germany	VolkswagenStiftung, Germany(Volkswagen)	This research is part of the project 'Evolutionary Roots of Human Social Interaction (ROSI),' which was funded by the VolkswagenStiftung, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONCOHEN S, 1989, BRIT J DEV PSYCHOL, V7, P113, DOI 10.1111/j.2044-835X.1989.tb00793.x; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Bates D, LME4 LINEAR MIXED EF; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Brauer J, 2008, ANIM COGN, V11, P175, DOI 10.1007/s10071-007-0097-0; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Camaioni L., 1993, NEW PERSPECTIVES EAR, P82; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; D'Entremont B, 2007, CHILD DEV, V78, P723, DOI 10.1111/j.1467-8624.2007.01026.x; Deak GO, 2000, DEV PSYCHOL, V36, P511, DOI 10.1037/0012-1649.36.4.511; Douglas PH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13999; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gomez J, 2005, GESTURE, V5, P91, DOI [10.1075/gest.5.1-2.08gom, DOI 10.1075/GEST.5.1.08GOM, DOI 10.1075/GEST.5.1-2.08GOM]; Grosse G, 2010, DEV PSYCHOL, V46, P1710, DOI 10.1037/a0020727; Halina M, 2016, APE POINTING M UNPUB; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hobaiter C, 2014, J COMP PSYCHOL, V128, P82, DOI 10.1037/a0033757; Hopkins WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079338; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Knudsen B, 2013, J COGN DEV, V14, P424, DOI 10.1080/15248372.2012.689387; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 2015, CHILD DEV, V86, P1623, DOI 10.1111/cdev.12404; Leavens DA, 2011, J COGN EDUC PSYCHOL, V10, P9, DOI 10.1891/1945-8959.10.1.9; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Legerstee M., 2008, FIRST LANG, V28, P281, DOI DOI 10.1177/0142723708091045; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Liszkowski U, 2007, J CHILD LANG, V34, P1, DOI 10.1017/S0305000906007689; Liszkowski U, 2011, J COGN EDUC PSYCHOL, V10, P32, DOI 10.1891/1945-8959.10.1.32; Liszkowski U, 2009, PSYCHOL SCI, V20, P654, DOI 10.1111/j.1467-9280.2009.02346.x; Lyn H, 2010, PSYCHOL SCI, V21, P360, DOI 10.1177/0956797610362218; Melis AP, 2006, J COMP PSYCHOL, V120, P154, DOI 10.1037/0735-7036.120.2.154; Melis AP, 2010, DEVELOPMENTAL SCI, V13, P479, DOI 10.1111/j.1467-7687.2009.00892.x; Menzel E. W., 1973, PRECULTURAL PRIMATE, P192; Moll H, 2004, DEVELOPMENTAL SCI, V7, pF1, DOI 10.1111/j.1467-7687.2004.00315.x; Moll H, 2014, J COGN DEV, V15, P12, DOI 10.1080/15248372.2012.710865; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Plooij FX., 1978, ACTION GESTURE SYMBO, P111; Povinelli DJ, 1996, MONOGR SOC RES CHILD, V61, P1, DOI 10.1111/j.1540-5834.1996.tb00481.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rivas E, 2005, J COMP PSYCHOL, V119, P404, DOI 10.1037/0735-7036.119.4.404; Roberts AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4088; Russell JL, 2005, ANIM COGN, V8, P263, DOI 10.1007/s10071-005-0253-3; Shwe HI, 1997, DEV PSYCHOL, V33, P630, DOI 10.1037/0012-1649.33.4.630; Tempelmann S, 2013, INTERACT STUD, V14, P7, DOI 10.1075/is.14.1.02tem; Tempelmann S, 2011, ANIM COGN, V14, P433, DOI 10.1007/s10071-011-0378-5; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; Tomasello M, 1997, HUM DEV, V40, P7, DOI 10.1159/000278540; Tomasello M, 2007, CHILD DEV, V78, P705, DOI 10.1111/j.1467-8624.2007.01025.x; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van der Goot MH, 2014, CHILD DEV, V85, P444, DOI 10.1111/cdev.12141; Weatherall D., 2006, USE NONHUMAN PRIMATE; Williamson RA, 2015, J COGN DEV, V16, P252, DOI 10.1080/15248372.2013.824884; Zimmermann F, 2009, ANIM COGN, V12, P347, DOI 10.1007/s10071-008-0194-8	66	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175227	10.1371/journal.pone.0175227	http://dx.doi.org/10.1371/journal.pone.0175227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384300	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900127
J	Hinnouho, GM; Singh-Manoux, A; Gueguen, A; Matta, J; Lemogne, C; Goldberg, M; Zins, M; Czernichow, S				Hinnouho, Guy-Marino; Singh-Manoux, Archana; Gueguen, Alice; Matta, Joane; Lemogne, Cedric; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien			Metabolically healthy obesity and depressive symptoms: 16-year follow-up of the Gazel cohort study	PLOS ONE			English	Article							RISK; OVERWEIGHT; ASSOCIATION; ADOLESCENTS; MORTALITY; DISEASE; WEIGHT; PEOPLE	Aims The health correlates of the metabolically healthy obese (MHO) phenotype, particularly in relation to depressive symptoms remains unclear. Accordingly, we examined the risk of depressive symptoms in this phenotype using a 16-year follow-up prospective study. Methods A sample of 14 475 participants (75% men), aged 44-59 years in 1996, was drawn from the Gazel cohort. Obesity was defined as body mass index (BMI) >= 30 kg/m(2) and metabolic health as having none of the self-reported following cardiovascular risk factors: hypertension, type 2 diabetes and dyslipidemia. Depressive symptoms were assessed by the Center for Epidemiologic Studies Depression (CES-D) scale in 1996, 1999, 2002, 2005, 2008 and 2012. Generalized Estimating Equations (GEE) were used to estimate the risk of depressive symptoms during a follow-up of 16 years. Results In multivariate analyses, metabolically unhealthy normal weight [Odds Ratio (OR) = 1.37; 95% Confidence Interval (CI): 1.25-1.51], overweight [1.44 (1.31-1.59)] and obese [1.30 (1.10-1.54)] but not MHO participants [1.04 (0.81-1.32)] had higher risk of depressive symptoms at the start of follow-up compared to metabolically healthy normal weight individuals. Depressive symptoms decreased over time in metabolically healthy normal weight individuals [0.52 (0.50-0.55)], this decrease was less marked only in metabolically unhealthy obese participants [1.22 (1.07-1.40)]. Compared to MHO participants, metabolically unhealthy obese individuals were at increased risk of depression at the start of follow-up, but with a similar reduction of this risk over time. Conclusion Poor metabolic health, irrespective of BMI was associated with greater depressive symptoms at the start of follow-up, whereas a poorer course of depressive symptoms over time was observed only in those with both obesity and poor metabolic health.	[Hinnouho, Guy-Marino; Gueguen, Alice; Matta, Joane; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien] INSERM, UMS 011, Villejuif, France; [Hinnouho, Guy-Marino; Singh-Manoux, Archana] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Hinnouho, Guy-Marino; Singh-Manoux, Archana; Goldberg, Marcel; Zins, Marie] Univ Versailles St Quentin Yvelines, Versailles, France; [Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Matta, Joane] Holy Spirit Univ, Dept Nutr, Jounieh, Lebanon; [Lemogne, Cedric; Czernichow, Sebastien] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Lemogne, Cedric] Hop Univ Paris Ouest, AP HP, Serv Psychiat Adulte & Sujet Age, Paris, France; [Lemogne, Cedric] Inserm U894, Ctr Psychiat & Neurosci, Paris, France; [Czernichow, Sebastien] Hop Europeen Georges Pompidou, Dept Nutr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Czernichow, S (corresponding author), INSERM, UMS 011, Villejuif, France.; Czernichow, S (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France.; Czernichow, S (corresponding author), Hop Europeen Georges Pompidou, Dept Nutr, Paris, France.	sebastien.czernichow@aphp.fr	Zins, Marie/AAX-6551-2021; Singh-Manoux, Archana/F-6804-2013; Goldberg, Marcel/I-7834-2012; Lemogne, Cédric/Q-6091-2019	Singh-Manoux, Archana/0000-0002-1244-5037; Goldberg, Marcel/0000-0002-6161-5880; 	Electricite de France-Gaz de France; INSERM; 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); EDF-GDF (Electricite De France-Gaz De France); INSERM (Institut National de la Sante et de la Recherche Medicale)	Electricite de France-Gaz de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); EDF-GDF (Electricite De France-Gaz De France); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The GAZEL Cohort Study was funded by Electricite de France-Gaz de France and INSERM, and received grants from the 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET).; The authors express their thanks to EDF-GDF (Electricite De France-Gaz De France), especially to the Service General de Medecine de Controle, and to the "Caisse centrale d'action sociale du personnel des industries electrique et gaziere". We also wish to acknowledge the Population-based Cohort Unit, UMS 011 INSERM Versailles St-Quentin University responsible for the GAZEL database management. The GAZEL Cohort Study was funded by EDF-GDF (Electricite De France-Gaz De France) and INSERM (Institut National de la Sante et de la Recherche Medicale), and received grants from the 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET).	Akbaraly TN, 2009, DIABETES CARE, V32, P499, DOI 10.2337/dc08-1358; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Despres JP, 2012, J CLIN ENDOCR METAB, V97, P2283, DOI 10.1210/jc.2012-2081; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Hamer M, 2012, MOL PSYCHIATR, V17, P940, DOI 10.1038/mp.2012.30; Hinnouho GM, 2014, EUR HEART J; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Jokela M, 2013, MOL PSYCHIAT; Koenigsberg HW, 2004, J PSYCHIATR RES, V38, P503, DOI 10.1016/j.jpsychires.2004.03.006; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Melchior M, 2010, PSYCHIAT RES, V177, P92, DOI 10.1016/j.psychres.2009.08.002; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Yau PL, 2010, DIABETOLOGIA, V53, P2298, DOI 10.1007/s00125-010-1857-y	31	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174678	10.1371/journal.pone.0174678	http://dx.doi.org/10.1371/journal.pone.0174678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384219	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900026
J	Hoopes, SL; Gruzdev, A; Edin, ML; Graves, JP; Bradbury, JA; Flake, GP; Lih, FB; DeGraff, LM; Zeldin, DC				Hoopes, Samantha L.; Gruzdev, Artiom; Edin, Matthew L.; Graves, Joan P.; Bradbury, J. Alyce; Flake, Gordon P.; Lih, Fred B.; DeGraff, Laura M.; Zeldin, Darryl C.			Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice	PLOS ONE			English	Article							BLOOD-PRESSURE REGULATION; CYTOCHROME-P450 EPOXYGENASES; HYPERPOLARIZING FACTORS; IDENTIFICATION; ANGIOGENESIS; METHYLATION; RECOVERY; HEART; ACIDS	Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid into epoxyeicosatrienoic acids (EETs), which play an important role in blood pressure regulation, protection against ischemia-reperfusion injury, angiogenesis, and inflammation. Epoxide hydrolases metabolize EETs to their corresponding diols (dihydroxyeicosatrienoic acids; DHETs) which are biologically less active. Microsomal epoxide hydrolase (EPHX1, mEH) and soluble epoxide hydrolase (EPHX2, sEH) were identified >30 years ago and are capable of hydrolyzing EETs to DHETs. A novel epoxide hydrolase, EPHX3, was recently identified by sequence homology and also exhibits epoxide hydrolase activity in vitro with a substrate preference for 9,10-epoxyoctadecamonoenoic acid (EpOME) and 11,12-EET. EPHX3 is highly expressed in the skin, lung, stomach, esophagus, and tongue; however, its endogenous function is unknown. Therefore, we investigated the impact of genetic disruption of Ephx3 on fatty acid epoxide hydrolysis and EET-related physiology in mice. Ephx3(-/-) mice were generated by excising the promoter and first four exons of the Ephx3 gene using Cre-LoxP methodology. LC-MS/MS analysis of Ephx3(-/-) heart, lung, and skin lysates revealed no differences in endogenous epoxide: diol ratios compared to wild type (WT). Ephx3(-/-) mice also exhibited no change in plasma levels of fatty acid epoxides and diols relative to WT. Incubations of cytosolic and microsomal fractions prepared from Ephx3(-/-) and WT stomach, lung, and skin with synthetic 8,9-EET, 11,12-EET, and 9,10-EpOME revealed no significant differences in rates of fatty acid diol formation between the genotypes. Ephx3(-/-) hearts had similar functional recovery compared to WT hearts following ischemia/reperfusion injury. Following intranasal lipopolysaccharide (LPS) exposure, Ephx3(-/-) mice were not different from WT in terms of lung histology, bronchoalveolar lavage fluid cell counts, or fatty acid epoxide and diol levels. We conclude that genetic disruption of Ephx3 does not result in an overt phenotype and has no significant effects on the metabolism of EETs or EpOMEs in vivo.	[Hoopes, Samantha L.; Gruzdev, Artiom; Edin, Matthew L.; Graves, Joan P.; Bradbury, J. Alyce; Flake, Gordon P.; Lih, Fred B.; DeGraff, Laura M.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, Div Intramural Res, POB 12233, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019	Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	National Institute of Environmental Health Sciences [Z01ES025034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES103005, ZIAES025034, Z01ES025034, ZICES102546, ZIAES103005] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (Z01ES025034 to D.C.Z.).	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Arand M, 2003, DRUG METAB REV, V35, P365, DOI 10.1081/DMR-120026498; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Decker M, 2012, J LIPID RES, V53, P2038, DOI 10.1194/jlr.M024448; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Graves JP, 2015, DRUG METAB DISPOS, V43, P1169, DOI 10.1124/dmd.115.064139; Harris TR, 2008, ARCH BIOCHEM BIOPHYS, V472, P139, DOI 10.1016/j.abb.2008.01.016; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Larsen BT, 2008, CIRC RES, V102, P59, DOI 10.1161/CIRCRESAHA.107.159129; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175348	10.1371/journal.pone.0175348	http://dx.doi.org/10.1371/journal.pone.0175348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384353	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900162
J	Lin, Y; Zhu, Y; Chen, C; Wang, W; Chen, TT; Li, T; Li, YH; Liu, BQ; Lian, Y; Lu, L; Zou, YX; Liu, YZ				Lin, Ying; Zhu, Yi; Chen, Chuan; Wang, Wei; Chen, Tingting; Li, Tao; Li, Yonghao; Liu, Bingqian; Lian, Yu; Lu, Lin; Zou, Yuxian; Liu, Yizhi			Facing the challenges in ophthalmology clerkship teaching: Is flipped classroom the answer?	PLOS ONE			English	Article							STUDENT PERFORMANCE; MEDICAL-EDUCATION; LECTURES; MEMORY	Recent reform of medical education highlights the growing concerns about the capability of the current educational model to equip medical school students with essential skills for future career development. In the field of ophthalmology, although many attempts have been made to address the problem of the decreasing teaching time and the increasing load of course content, a growing body of literature indicates the need to reform the current ophthalmology teaching strategies. Flipped classroom is a new pedagogical model in which students develop a basic understanding of the course materials before class, and use in-class time for learner-centered activities, such as group discussion and presentation. However, few studies have evaluated the effectiveness of the flipped classroom in ophthalmology education. This study, for the first time, assesses the use of flipped classroom in ophthalmology, specifically glaucoma and ocular trauma clerkship teaching. A total number of 44 international medical school students from diverse background were enrolled in this study, and randomly divided into two groups. One group took the flipped glaucoma classroom and lecture based ocular trauma classroom, while the other group took the flipped ocular trauma classroom and lecture-based glaucoma classroom. In the traditional lecture-based classroom, students attended the didactic lecture and did the homework after class. In the flipped classroom, students were asked to watch the prerecorded lectures before the class, and use the class time for homework discussion. Both the teachers and students were asked to complete feedback questionnaires after the classroom. We found that the two groups did not show differences in the final exam scores. However, the flipped classroom helped students to develop skills in problem solving, creative thinking and team working. Also, compared to the lecture-based classroom, both teachers and students were more satisfied with the flipped classroom. Interestingly, students had a more positive attitude towards the flipped ocular trauma classroom than the flipped glaucoma classroom regarding the teaching process, the course materials, and the value of the classroom. Therefore, the flipped classroom model in ophthalmology teaching showed promise as an effective approach to promote active learning.	[Lin, Ying; Zhu, Yi; Chen, Chuan; Wang, Wei; Chen, Tingting; Li, Tao; Li, Yonghao; Liu, Bingqian; Lian, Yu; Lu, Lin; Zou, Yuxian; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhu, Yi; Chen, Chuan] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	Sun Yat Sen University; University of Miami	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	lylytulip@126.com; driulin@126.com; 786086795@qq.com	liu, yi/GXE-9662-2022; Chen, Chuan/I-1348-2019; Zhu, Yi/R-2283-2017	Chen, Chuan/0000-0001-5701-0857; Zhu, Yi/0000-0002-1778-8880	Teaching Reform Research Program of Sun Yat-sen University [2016-150-Ying Lin, 2016-3Bingqian Liu]; National Natural Science Foundation of China [81500709, 81570862, 81371019, 81670872]; Medical Scientific Research Foundation of Guangdong Province [B2012126, A2016460]; Project of Fundamental Research Funds, of State Key Laboratory of Ophthalmology [2011Q09, 2012KF03, 2014QN04]; Fundamental Research Funds for the Universities [l3ykpy43]	Teaching Reform Research Program of Sun Yat-sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province; Project of Fundamental Research Funds, of State Key Laboratory of Ophthalmology; Fundamental Research Funds for the Universities	This study was supported by Teaching Reform Research Program of Sun Yat-sen University (2016-150-Ying Lin and 2016-3Bingqian Liu), the National Natural Science Foundation of China (Grant Nos. 81500709, 81570862, 81371019, and 81670872), and the Medical Scientific Research Foundation of Guangdong Province (Grant Nos. B2012126 and A2016460), the Project of Fundamental Research Funds, of State Key Laboratory of Ophthalmology (Grant Nos. 2011Q09, 2012KF03, and 2014QN04), the Fundamental Research Funds for the Universities(Grant No. l3ykpy43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Chan JJ, 2001, CLIN EXP OPHTHALMOL, V29, P416, DOI 10.1046/j.1442-9071.2001.d01-26.x; Al Faris EA, 2013, J CONT MED ED, V2, P85, DOI [10.5455/jcme.20140620013233, DOI 10.5455/JCME.20140620013233]; Altintas L, 2014, ADV PHYSIOL EDUC, V38, P46, DOI 10.1152/advan.00129.2013; Biggs JB, 1987, STUDY PROCESS QUESTI; Bloom B.S., 1956, HDB COGNITIVE DOMAIN, V19, P56; Chan CC, 2011, ARCH OPHTHALMOL-CHIC, V129, P791, DOI 10.1001/archophthalmol.2011.120; Fandakova Y, 2016, MIND BRAIN EDUC, V10, P135, DOI 10.1111/mbe.12123; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Hannafin M., 2014, HDB RES ED COMMUNICA, P641, DOI [10.1007/978-1-4614-3185-5_51, DOI 10.1007/978-1-4614-3185-5_51, DOI 10.1007/978-1-4614-3185-5]; Harp SF, 1997, J EDUC PSYCHOL, V89, P92, DOI 10.1037/0022-0663.89.1.92; Hsu SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167598; Huang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154250; Markant DB, 2016, MIND BRAIN EDUC, V10, P142, DOI 10.1111/mbe.12117; Mccoy L, 2015, J AM OSTEOPATH ASSOC, V115, P202, DOI 10.7556/jaoa.2015.042; Mitchell-Holder S., 2016, HUMANIZING ONLINE TE; Peine A, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0679-0; Prober CG, 2013, ACAD MED, V88, P1407, DOI 10.1097/ACM.0b013e3182a368bd; Prober CG, 2012, NEW ENGL J MED, V366, P1657, DOI 10.1056/NEJMp1202451; RAMSDEN P, 1991, STUD HIGH EDUC, V16, P129, DOI 10.1080/03075079112331382944; STUART J, 1978, LANCET, V2, P514; Succar T, 2016, SURV OPHTHALMOL, V61, P83, DOI 10.1016/j.survophthal.2015.09.001; Swing SR, 2007, MED TEACH, V29, P648, DOI 10.1080/01421590701392903; Tolks D, 2016, GMS J MED EDU, V33, DOI 10.3205/zma001045; Tune JD, 2013, ADV PHYSIOL EDUC, V37, P316, DOI 10.1152/advan.00091.2013; Whillier S, 2015, J CHIPROPR EDUC, V29, P127, DOI 10.7899/JCE-14-28	25	45	45	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174829	10.1371/journal.pone.0174829	http://dx.doi.org/10.1371/journal.pone.0174829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384167	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900041
J	Ma, GW; Chu, YK; Zhang, WJ; Qin, FY; Xu, SS; Yang, H; Rong, EG; Du, ZQ; Wang, SZ; Li, H; Wang, N				Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Yang, Hua; Rong, En-Guang; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning			Polymorphisms of FST gene and their association with wool quality traits in Chinese Merino sheep	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; FOLLISTATIN; IDENTIFICATION; EXPRESSION; ACTIVINS; PATTERNS; DEFECTS; PROTEIN; BRAIN	Follistatin (FST) is involved in hair follicle morphogenesis. However, its effects on hair traits are not clear. This study was designed to investigate the effects of FSTgene single nucleotide polymorphisms (SNP) on wool quality traits in Chinese Merino sheep (Junken Type). We performed gene expression analysis, SNP detection, and association analysis of FST gene with sheep wool quality traits. The real-time RT-PCR analysis showed that FSTgene was differentially expressed in adult skin between Chinese Merino sheep (Junken Type) and Suffolk sheep. Immunostaining showed that FST was localized in inner root sheath (IRS) and matrix of hair follicle (HF) in both SF and Suffolk sheep. Sequencing analysis identified a total of seven SNPs (termed SNPs 1-7) in the FSTgene in Chinese Merino sheep (Junken Type). Association analysis showed that SNP2 (Chr 16. 25,633,662 G>A) was significantly associated with average wool fiber diameter, wool fineness SD, and wool crimp (P < 0.05). SNP4 (Chr 16. 25,633,569 C>T) was significantly associated with wool fineness SD and CV of fiber diameter (P < 0.05). Similarly, the haplotypes derived from these seven identified SNPs were also significantly associated with average wool fiber diameter, wool fineness SD, CV of fiber diameter, and wool crimp (P < 0.05). Our results suggest that FST influences wool quality traits and its SNPs 2 and 4 might be useful markers for marker-assisted selection and sheep breeding.	[Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China; [Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Yang, Hua] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Med, Shihezi, Peoples R China; [Rong, En-Guang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; China Agricultural University	Wang, N (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.	wangning@neau.edu.cn			Domain Specific projects for transgenic biological breeding [2014ZX08009-002, 2009ZX08009-160B]; National High Technology Research and Development Program of China (863 program) [2013AA102506]; Postgraduate Technology Innovation Project of Northeast Agricultural University [yjscx14006]	Domain Specific projects for transgenic biological breeding; National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Postgraduate Technology Innovation Project of Northeast Agricultural University	This study was supported by Domain Specific projects for transgenic biological breeding (2014ZX08009-002 and 2009ZX08009-160B), The National High Technology Research and Development Program of China (863 program) (grant no. 2013AA102506) and Postgraduate Technology Innovation Project of Northeast Agricultural University (yjscx14006).	Chen HY, 2011, INDIAN J ANIM SCI, V81, P391; Correa AM, 2016, GENETICS AND MOLECUL, V15; Cottle D., 2010, INT SHEEP WOOL HDB, VVolume 1, P711; De Marco P, 2006, BIRTH DEFECTS RES A, V76, P86, DOI 10.1002/bdra.20225; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gan W, 2015, GENET MOL RES, V14, P6699, DOI 10.4238/2015.June.18.14; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Jakubauskiene E, 2012, FEBS LETT, V586, P3698, DOI 10.1016/j.febslet.2012.08.028; Jhaveri S, 1998, MOL CELL NEUROSCI, V12, P206, DOI 10.1006/mcne.1998.0710; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; KONDO S, 1989, BIOCHEM BIOPH RES CO, V161, P1267, DOI 10.1016/0006-291X(89)91379-X; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Lembeye F, 2014, ARCH MED VET, V46, P103, DOI 10.4067/S0301-732X2014000100014; Ling YH, 2014, GENET MOL RES, V13, P5617, DOI 10.4238/2014.July.25.17; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Michael RG, 2014, MOL CLONING LAB MANU; Nakamura M, 2003, FASEB J, V17, P497, DOI 10.1096/fj.02-0247fje; NAYLOR GRS, 1995, WOOL TECH SHEEP BREE, V43, P254; Patel K, 1998, INT J BIOCHEM CELL B, V30, P1087, DOI 10.1016/S1357-2725(98)00064-8; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Rong EG, 2015, J ANIM SCI, V93, P4601, DOI 10.2527/jas.2015-8963; Shi G. Q., 2010, GRASS FEED LIVEST, V2, P4; Strucken EM, 2014, J ANIM SCI, V92, P1939, DOI 10.2527/jas.2013-7247; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Zhang YR, 2014, GENET MOL RES, V13, P8105, DOI 10.4238/2014.October.7.5; Zhou H, 2015, J ANIM BREED GENET, V132, P301, DOI 10.1111/jbg.12138; Zou C, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080203	32	15	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174868	10.1371/journal.pone.0174868	http://dx.doi.org/10.1371/journal.pone.0174868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384189	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900046
J	Machisa, MT; Christofides, N; Jewkes, R				Machisa, Mercilene T.; Christofides, Nicola; Jewkes, Rachel			Mental ill health in structural pathways to women's experiences of intimate partner violence	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; POSTTRAUMATIC-STRESS-DISORDER; ATTENDING ANTENATAL CLINICS; SOUTH-AFRICAN STRESS; DOMESTIC VIOLENCE; DEPRESSIVE SYMPTOMS; RELATIONSHIP POWER; LOW-INCOME; PREVALENCE; MULTICOUNTRY	Background Depression, post-traumatic stress disorder (PTSD), and binge drinking are among mental health effects of child abuse and intimate partner violence (IPV) experiences among women. Emerging data show the potential mediating role of mental ill health in the relationship of child abuse and IPV. There is evidence that PTSD, depression and alcohol abuse are comorbid common mental disorders and that a bidirectional relationship exists between depression and IPV in some settings. Furthermore, the temporal direction in the relationship of alcohol abuse and women's IPV experiences from different studies is unclear. We undertook a study with women from the general population to investigate the associations of child abuse, mental ill health and IPV; and describe the underlying pathways between them. Methods Data is from a household survey employing a multi-stage random sampling approach with 511 women from Gauteng, South Africa. IPV was measured using the WHO Multi-country Study on Women's Health and Domestic Violence Questionnaire. Child abuse was measured using a short form of the Childhood Trauma Questionnaire. Depression was measured using the Centre for Epidemiologic Studies Depression Scale (CESD). PTSD symptoms were measured using the Harvard Trauma Questionnaire. Binge drinking was measured using the Alcohol Use Disorders Identification Test (AUDIT) scale. All data analyses were conducted in Stata 13. Regression modelling was used to test the association between variables. Structural equation modelling with full information maximum likelihood estimation accounting for missing data was done to analyse the underlying pathways between variables. Results Fifty percent of women experienced IPV in their lifetime and 18% experienced IPV in the 12 months before the survey. Twenty three percent of women were depressed, 14% binge drank and 11.6% had PTSD symptoms. Eighty six percent of women had experienced some form of child abuse. Sociodemographic factors associated with recent IPV in multivariate models were younger age and foreign nationality. Depression, PTSD and binge drinking mediated the relationship of child abuse and recent IPV. Depression, PTSD and binge drinking were also effects of recent IPV. Other factors associated with recent IPV experience included relationship control, having a partner who regularly consumed alcohol and experiencing other life traumatic experiences Conclusion Mental ill health plays a mediating role in the relationship of child abuse and recent IPV experiences among women. Conversely, IPV also negatively affects women's mental health. Interventions to reducing the incidence of IPV could help alleviate the burden of mental ill health among women and vice versa. Effective integration of mental health services in primary health care, detection of symptoms, brief interventions and strengthened referral mechanisms for sustained community-based care are necessary in responding to victims of intimate partner violence. Response for abused children needs to take similar approaches and reduce the long-term mental health effects associated with violent exposures.	[Machisa, Mercilene T.; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Machisa, Mercilene T.; Christofides, Nicola; Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Witwatersrand	Machisa, MT (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Machisa, MT (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	Mercilene.Machisa@mrc.ac.za	Machisa, Mercilene/ABD-2257-2020	Machisa, Mercilene/0000-0001-7275-1100; Jewkes, Rachel/0000-0002-4330-6267				Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Abrahams N, 2013, AFR J PSYCHIATRY, V16, P288, DOI [10.4314/ajpsy.v16i4.39, http://dx.doi.org/10.4314/ajpsy.v16i4.39]; Abrahams N., 2017, SAJP-S AFR J PSYCHI, V23, P8, DOI DOI 10.4102/SAJPSYCHIATRY.V23I1.959; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Bandura A., 1973, AGGRESSION SOCIAL LE; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Beyer K, 2015, TRAUMA VIOLENCE ABUS, V16, P16, DOI 10.1177/1524838013515758; Brundtland GH, 2001, JAMA-J AM MED ASSOC, V286, P2391, DOI 10.1001/jama.286.19.2391; Callender T., 2010, MENTAL HLTH RESPONSE; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Cashmore J, 2018, EVALUATION CHILD SEX; Christofides N, 2010, AIDS CARE, V22, P279, DOI 10.1080/09540120903193617; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Collins A, 2013, S AFR CRIME Q, P29; Devries K, 2011, SOC SCI MED, V73, P79, DOI 10.1016/j.socscimed.2011.05.006; Devries KM, 2014, ADDICTION, V109, P379, DOI 10.1111/add.12393; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Ensink K, 1997, S AFR MED J, V87, P1526; Fergusson DM, 1997, CHILD ABUSE NEGLECT, V21, P789, DOI 10.1016/S0145-2134(97)00039-2; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Genderlinks, 2013, WAR HOM FIND GBV PRE; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Hatcher A. M., 2016, J INTERPERS VIOLENCE; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Herman AA, 2009, SAMJ S AFR MED J, V99, P339; Hooper D., 2008, ARTICLES, V2, DOI DOI 10.1080/10705519909540118; Hox J., 1998, FAMILY SCI REV, V11; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jewkes K., 2002, 19 INT AIDS C BARC S, P7; Jewkes R, 2000, REPROD HEALTH MATTER, V8, P93, DOI 10.1016/S0968-8080(00)90010-7; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2002, BMJ-BRIT MED J, V324, P253, DOI 10.1136/bmj.324.7332.253; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R., 2010, CHILD ABUSE NEGLECT; Jewkes R., 2013, INTIMATE PARTNER VIO, P65, DOI DOI 10.1159/000342013; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Jina R, 2013, BEST PRACT RES CL OB, V27, P15, DOI 10.1016/j.bpobgyn.2012.08.012; Jina R, 2012, J INTERPERS VIOLENCE, V27, P862, DOI 10.1177/0886260511423247; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Kubany ES, 2003, J TRAUMA STRESS, V16, P81, DOI 10.1023/A:1022019629803; Kunitz SJ, 1998, CHILD ABUSE NEGLECT, V22, P1079, DOI 10.1016/S0145-2134(98)00089-1; Lalanne C., 2009, TEST MEDIATION MODER; Leadley K, 2000, J SUBST ABUSE, V11, P253, DOI 10.1016/S0899-3289(00)00025-0; Lindert J, 2014, INT J PUBLIC HEALTH, V59, P359, DOI 10.1007/s00038-013-0519-5; Machisa M. T. JR, 2011, WAR HOME GAUTENG GBV; Machisa MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150986; Maniglio R, 2009, CLIN PSYCHOL REV, V29, P647, DOI 10.1016/j.cpr.2009.08.003; Margolin G, 2000, ANNU REV PSYCHOL, V51, P445, DOI 10.1146/annurev.psych.51.1.445; McLaughlin J, 2012, CLIN PSYCHOL REV, V32, P677, DOI 10.1016/j.cpr.2012.08.002; Mills-Fairweather C., 2014, STUDY VIOLENCE WOMEN; Mollica R., 1993, HARVARD TRAUMA UNPUB; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Moultrie A., 2006, S AFR HEAL REV, V2006, P347; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2014, NEW ENGL J MED, V370, P498, DOI 10.1056/NEJMp1315214; Peltzer K, 1999, PSYCHOL REP, V85, P646, DOI 10.2466/PR0.85.6.646-650; Petersen I., 2010, MENTAL HLTH PROMOTIO; Petersen I, 2011, SAMJ S AFR MED J, V101, P751; PRETORIUS TB, 1991, PSYCHOL REP, V69, P1179, DOI 10.2466/PR0.69.8.1179-1185; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roberts L. J., 1997, GENDER DIFFERENCES S; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schrieber, 1999, HE MUST GIVE ME MONE; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Seedat S, 2000, S AFR J CHILD ADOLES, V12, P38, DOI DOI 10.1080/16826108.2000.9632366; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Statsa, 2011, CENS 2011; Suliman S., 2005, ANN GEN PSYCHIAT, V4; Swopes RM, 2013, VIOLENCE VICTIMS, V28, P513, DOI 10.1891/0886-6708.VV-D-12-00026; Traut A, 2002, Curationis, V25, P67; Tsai A. C., 2015, AM J EPIDEMIOL; Ventevogel P, 2014, INT REV PSYCHIATR, V26, P669, DOI 10.3109/09540261.2014.966067; WHO, 2013, RESPONDING INTIMATE; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization, 2000, WHO MULTICOUNTRY STU, P913; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	91	42	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175240	10.1371/journal.pone.0175240	http://dx.doi.org/10.1371/journal.pone.0175240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384241	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900133
J	Nijland, H; Gerbers, JG; Bulstra, SK; Overbosch, J; Stevens, M; Jutte, PC				Nijland, H.; Gerbers, J. G.; Bulstra, S. K.; Overbosch, J.; Stevens, M.; Jutte, P. C.			Evaluation of accuracy and precision of CT-guidance in Radiofrequency Ablation for osteoid osteoma in 86 patients	PLOS ONE			English	Article								Background and purpose Osteoid osteoma is a benign skeletal tumour that accounts for 2-3% of all bone tumours. The male-to-female ratio is around 4: 1 and it predominates in children and young adults. The most common symptom is pain, frequently at night-time. Historically the main form of treatment has been surgical excision. With the development of Radiofrequency Ablation (RFA) there is a percutaneus alternative. Success rates of RFA are lower but the main advantage is the minimal invasive character of the therapy and the low complication rate. As a result of the minimal invasiveness the hospitalization-and rehabilitation periods are relatively short. However, in current literature no values for accuracy and precision are known for the CT-guided positioning. Methods Accuracy and precision of the needle position are determined for 86 procedures. Furthermore the population is divided into groups based on tumour diameter, location and procedure outcome. Results The clinical success rate was 81.4%. In 79% of procedures complete ablation was achieved. Accuracy was 2.84 mm on average, precision was 2.94 mm. Accuracy was significantly lower in more profound lesions. Accuracy in tibia and fibula was significantly higher compared to the femur. No significant difference was found between different tumour diameters. Interpretation The accuracy and precision found are considered good. Needle position is of major importance for procedure outcomes. The question however rises how the results of this therapy will turn out in treatment of larger tumours.	[Nijland, H.; Gerbers, J. G.; Bulstra, S. K.; Stevens, M.; Jutte, P. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Overbosch, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen	Nijland, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	h.nijland@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; jutte, paul/0000-0002-6022-2807; Nijland, Hendricus/0000-0002-0130-2452				Busser WMH, 2011, CARDIOVASC INTER RAD, V34, P180, DOI 10.1007/s00270-010-9950-7; Cantwell CP, 2004, EUR RADIOL, V14, P607, DOI 10.1007/s00330-003-2171-6; Ghanem I, 2006, CURR OPIN PEDIATR, V18, P36, DOI 10.1097/01.mop.0000193277.47119.15; KRANSDORF MJ, 1991, RADIOGRAPHICS, V11, P671, DOI 10.1148/radiographics.11.4.1887121; Okada Kiyoshi, 2014, Eur J Orthop Surg Traumatol, V24, P231, DOI 10.1007/s00590-013-1180-7; Rachbauer F, 2003, ARCH ORTHOP TRAUM SU, V123, P86, DOI 10.1007/s00402-003-0478-z; Rosenthal DI, 2003, RADIOLOGY, V229, P171, DOI 10.1148/radiol.2291021053; ROSENTHAL DI, 1992, RADIOLOGY, V183, P29, DOI 10.1148/radiology.183.1.1549690; Toothaker LE., 1991, MULTIPLE COMP RES, P37; Widmann G, 2013, INT J MED ROBOT COMP, V9, P274, DOI 10.1002/rcs.1435	10	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0169171	10.1371/journal.pone.0169171	http://dx.doi.org/10.1371/journal.pone.0169171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384223	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900001
J	Oliveira, LC; Saraiva, TDL; Silva, WM; Pereira, UP; Campos, BC; Benevides, LJ; Rocha, FS; Figueiredo, HCP; Azevedo, V; Soares, SC				Oliveira, Leticia C.; Saraiva, Tessalia D. L.; Silva, Wanderson M.; Pereira, Ulisses P.; Campos, Bruno C.; Benevides, Leandro J.; Rocha, Flavia S.; Figueiredo, Henrique C. P.; Azevedo, Vasco; Soares, Siomar C.			Analyses of the probiotic property and stress resistance-related genes of Lactococcus lactis subsp lactis NCDO 2118 through comparative genomics and in vitro assays	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS STRAINS; CHITIN-BINDING PROTEIN; ACID BACTERIA; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; MOLECULAR CHARACTERIZATION; EFFLUX PUMPS; SEQUENCE; CREMORIS; IDENTIFICATION; DATABASE	Lactococcus lactis subsp. lactis NCDO 2118 was recently reported to alleviate colitis symptoms via its anti-inflammatory and immunomodulatory activities, which are exerted by exported proteins that are not produced by L. lactis subsp. lactis IL1403. Here, we used in vitro and in silico approaches to characterize the genomic structure, the safety aspects, and the immunomodulatory activity of this strain. Through comparative genomics, we identified genomic islands, phage regions, bile salt and acid stress resistance genes, bacteriocins, adhesion-related and antibiotic resistance genes, and genes encoding proteins that are putatively secreted, expressed in vitro and absent from IL1403. The high degree of similarity between all Lactococcus suggests that the Symbiotic Islands commonly shared by both NCDO 2118 and KF147 may be responsible for their close relationship and their adaptation to plants. The predicted bacteriocins may play an important role against the invasion of competing strains. The genes related to the acid and bile salt stresses may play important roles in gastrointestinal tract survival, whereas the adhesion proteins are important for persistence in the gut, culminating in the competitive exclusion of other bacteria. Finally, the five secreted and expressed proteins may be important targets for studies of new anti-inflammatory and immunomodulatory proteins. Altogether, the analyses performed here highlight the potential use of this strain as a target for the future development of probiotic foods.	[Oliveira, Leticia C.; Saraiva, Tessalia D. L.; Silva, Wanderson M.; Campos, Bruno C.; Benevides, Leandro J.; Rocha, Flavia S.; Azevedo, Vasco; Soares, Siomar C.] Univ Fed Minas Gerais, Inst Biol Sci, Lab Cellular & Mol Genet, Belo Horizonte, MG, Brazil; [Silva, Wanderson M.] Univ Estadual Londrina, Dept Prevent Vet Med, Londrina, PR, Brazil; [Figueiredo, Henrique C. P.] Univ Fed Minas Gerais, Official Lab, Fisheries Minist, Vet Sch, Belo Horizonte, MG, Brazil; [Soares, Siomar C.] Univ Fed Triangulo Mineiro, Dept Microbiol Immunol & Parasitol, Inst Biol & Nat Sci, Uberaba, MG, Brazil; [Silva, Wanderson M.] Natl Inst Agr Technol, Buenos Aires, DF, Argentina; [Benevides, Leandro J.] Commensal & Probiot Host Interact Lab, UMR Micalis 1319, Jouy En Josas, France	Universidade Federal de Minas Gerais; Universidade Estadual de Londrina; Universidade Federal de Minas Gerais; Universidade Federal do Triangulo Mineiro; Instituto Nacional de Tecnologia Agropecuaria (INTA); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Soares, SC (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Lab Cellular & Mol Genet, Belo Horizonte, MG, Brazil.; Soares, SC (corresponding author), Univ Fed Triangulo Mineiro, Dept Microbiol Immunol & Parasitol, Inst Biol & Nat Sci, Uberaba, MG, Brazil.	siomar@icbn.uftm.edu.br	Azevedo, Vasco/B-1556-2019; Pereira, Ulisses/AAM-2055-2020; Silva, Bruno/K-7757-2015; Azevedo, Vasco A.C/F-4315-2011; de Castro Oliveira, Letícia/E-6649-2017; Figueiredo, Henrique César Pereira/M-5310-2017; de Rocha, Flávia/A-2565-2019; de Castro Soares, Siomar/I-2705-2012	Azevedo, Vasco/0000-0002-4775-2280; Pereira, Ulisses/0000-0003-4868-4459; Azevedo, Vasco A.C/0000-0002-4775-2280; de Castro Oliveira, Letícia/0000-0002-2036-4456; Figueiredo, Henrique César Pereira/0000-0002-1022-6842; de Castro Soares, Siomar/0000-0001-7299-3724; Silva, Bruno/0000-0002-0417-7060	National Counsel of Technological and Scientific Development; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa de Minas Gerais	National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Support was provided by: National Counsel of Technological and Scientific Development [http://cnpq.br/]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [https://www.capes.gov.br/]; Fundacao de Amparo a Pesquisa de Minas Gerais [http://www.fapemig.br/en/].	Achour-Rokbani A, 2010, APPL ENVIRON MICROB, V76, P948, DOI 10.1128/AEM.01738-09; Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Ainsworth S, 2013, GENOME ANNOUNC, P1; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Alvarez-Sieiro P, 2016, APPL MICROBIOL BIOT, V100, P2939, DOI 10.1007/s00253-016-7343-9; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Blauwkamp TA, 2003, MOL MICROBIOL, V48, P1017, DOI 10.1046/j.1365-2958.2003.03479.x; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bolotin A, 2012, J BACTERIOL, V194, P1241, DOI 10.1128/JB.06629-11; Branco KMGR, 2010, BRAZ J MED BIOL RES, V43, P338, DOI [10.1590/S0100-879X2010007500013, 10.1590/S0100-879X2010000400003]; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Carvalho AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068470; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Charteris WP, 1998, J FOOD PROTECT, V61, P1636, DOI 10.4315/0362-028X-61.12.1636; Charteris WP, 1998, J APPL MICROBIOL, V84, P759; Christensen JE, 1999, ANTON LEEUW INT J G, V76, P217, DOI 10.1023/A:1002001919720; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Cronin M, 2011, INT J FOOD MICROBIOL, V149, P4, DOI 10.1016/j.ijfoodmicro.2011.01.019; Curty N, 2014, J PROTEOMICS, V97, P126, DOI 10.1016/j.jprot.2013.07.003; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Diaz-Muniz I, 2006, J APPL MICROBIOL, V101, P872, DOI 10.1111/j.1365-2672.2006.02965.x; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Even S, 2003, MICROBIOL-SGM, V149, P1935, DOI 10.1099/mic.0.26146-0; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Nader-Macias MEF, 2008, J IND MICROBIOL BIOT, V35, P1387, DOI 10.1007/s10295-008-0438-2; Fernandez E, 2011, APPL ENVIRON MICROB, V77, P5324, DOI 10.1128/AEM.02991-10; Flemming HC, 2001, WATER SCI TECHNOL, V43, P9, DOI 10.2166/wst.2001.0328; Frees D, 2003, INT J FOOD MICROBIOL, V87, P293, DOI 10.1016/S0168-1605(03)00104-1; Gao Y, 2011, J BACTERIOL, V193, P2886, DOI 10.1128/JB.00358-11; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; GODON JJ, 1992, APPL ENVIRON MICROB, V58, P4045, DOI 10.1128/AEM.58.12.4045-4047.1992; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Kamba A, 2013, MICROBIAL PATHOGENS, P1853; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Kato H, 2012, J BACTERIOL, V194, P2102, DOI 10.1128/JB.00074-12; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Kelly WJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00257; Khalid K., 2011, International Journal of Biosciences (IJB), V1, P1; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Luerce TD, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-33; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Martinussen J, 2001, J BACTERIOL, V183, P2785, DOI 10.1128/JB.183.9.2785-2794.2001; Mateos LM, 2006, INT MICROBIOL, V9, P207; Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008; Mazzoli R, 2010, AMINO ACIDS, V39, P727, DOI 10.1007/s00726-010-0507-5; McCulloch JA, 2014, GENOME ANNOUNC, V2; Melo Alan Lane De, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P17, DOI 10.1590/S0036-46651993000100003; Miyoshi A, 2004, FEMS MICROBIOL LETT, V239, P205, DOI 10.1016/j.femsle.2004.08.018; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Morelli L, 2000, Curr Issues Intest Microbiol, V1, P59; Morita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023184; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nardi RMD, 2005, J APPL MICROBIOL, V99, P649, DOI 10.1111/j.1365-2672.2005.02632.x; Nishitani Y, 2009, INT IMMUNOPHARMACOL, V9, P1444, DOI 10.1016/j.intimp.2009.08.018; Nomura M, 1999, INT J SYST BACTERIOL, V49, P163, DOI 10.1099/00207713-49-1-163; O'Sullivan E, 1999, APPL ENVIRON MICROB, V65, P2287; Oliveira LC, 2014, GENOME ANNOUNC, P2; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Pan WH, 2006, ANAEROBE, V12, P148, DOI 10.1016/j.anaerobe.2006.03.001; Paule BJA, 2004, PROTEIN EXPRES PURIF, V34, P311, DOI 10.1016/j.pep.2003.12.003; Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725, DOI 10.1128/AEM.63.5.1725-1731.1997; Pfeiler EA, 2007, TRENDS MICROBIOL, V15, P546, DOI 10.1016/j.tim.2007.09.010; Radziwill-Bienkowska JM, 2016, APPL MICROBIOL BIOT, V100, P9605, DOI 10.1007/s00253-016-7813-0; Ruiz L, 2009, MICROBIOL-SGM, V155, P957, DOI 10.1099/mic.0.024273-0; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Sanders JW, 1999, FEMS MICROBIOL REV, V23, P483, DOI 10.1111/j.1574-6976.1999.tb00409.x; Santos AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S5-S6; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Sharples GJ, 2002, MOL MICROBIOL, V44, P549, DOI 10.1046/j.1365-2958.2002.02916.x; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; Silva BC, 2013, BENEF MICROBES, V4, P267, DOI 10.3920/BM2012.0048; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Smeianov VV, 2007, APPL ENVIRON MICROB, V73, P2661, DOI 10.1128/AEM.00005-07; Smit BA, 2005, APPL ENVIRON MICROB, V71, P303, DOI 10.1128/AEM.71.1.303-311.2005; Soares SC, 2016, J BIOTECHNOL, V232, P2, DOI 10.1016/j.jbiotec.2015.09.008; Soares SC, 2013, J BIOTECHNOL, V167, P135, DOI 10.1016/j.jbiotec.2012.11.003; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Steinberg RS, 2014, BENEF MICROBES, V5, P409, DOI 10.3920/BM2013.0075; Tynkkynen S, 1998, INT J FOOD MICROBIOL, V41, P195, DOI 10.1016/S0168-1605(98)00051-8; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Verma A, 2009, INFECT IMMUN, V77, P4940, DOI 10.1128/IAI.01420-08; Vinderola CG, 2003, FOOD RES INT, V36, P895, DOI 10.1016/S0963-9969(03)00098-X; Vlieg JETV, 2006, CURR OPIN BIOTECH, V17, P183, DOI 10.1016/j.copbio.2006.02.007; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Xanthopoulos V, 1997, LACTIC ACID BACTERIA; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zhang B, 2015, SCI REPORTS, P5; Zhang H, 2016, SCI REPORTS, P6; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	106	34	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175116	10.1371/journal.pone.0175116	http://dx.doi.org/10.1371/journal.pone.0175116			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384209	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900089
J	Then, CK; Chi, NF; Chung, KH; Kuo, L; Liu, KH; Hu, CJ; Shen, SC; Lin, YK				Then, Chee-Kin; Chi, Nai-Fang; Chung, Kuo-Hsuan; Kuo, Lynn; Liu, Kao-Hui; Hu, Chaur-Jong; Shen, Shing-Chuan; Lin, Yen-Kuang			Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan	PLOS ONE			English	Article							POPULATION-BASED COHORT; DEPRESSIVE SYMPTOMS; ALZHEIMER-DISEASE; TEMPORAL RELATIONSHIP; CELL-PROLIFERATION; BIPOLAR DISORDER; MAJOR DEPRESSION; SERTRALINE; STRESS; MEDICATIONS	Depression and dementia are common mental health problems and are associated in several ways. Early-life depression is associated with increased risk of later life dementia, and depression can present as a preclinical symptom or consequence of dementia. Despite the plausible relationship between these two clinical entities, the potential association between antidepressant medication and dementia has rarely been investigated. We conducted a 9-year retrospective analysis of Taiwan's National Health Insurance Research Database (NHIRD), enrolling 5819 cases who had received prescriptions of antidepressants between 2003 and 2006, and 23,276 (with ratio of 1: 4) age, sex, and index date-matched controls. The hazard ratio (HR) of dementia among antidepressant users with depression was 2.42 (95% confidence interval (CI): 1.15-5.10), for those without depression was 4.05 (95% CI: 3.19-5.15), compared to antidepressant non-users respectively. Among the 6 classes of common antidepressants used in Taiwan, the adjusted HRs were 3.66 (95% CI: 2.62-5.09) for SSRIs, 4.73 (95% CI: 2.54-8.80) for SNRI, 3.26 (95% CI: 2.30-4.63) for TCAs, 6.62 (95% CI: 3.34-13.13) for TeCA, 4.94 (95% CI: 2.17-11.24) for MAOI, and 4.48 (95% CI: 3.13-6.40) for SARI. Furthermore, the multivariate analysis result showed that the adjusted HRs of cumulative defined daily doses (cDDDs) were 3.74 (95% CI: 2.91-4.82), 3.73 (95% CI: 2.39-5.80) and 5.22 (95% CI: 3.35-8.14) for those who had cDDDs of <90, 90-180 and >180 compared to those who had taken no antidepressant medication. This is a retrospective study based on secondary data, hence, we could not claim causality between antidepressant medication and dementia. However, a potential association between antidepressant and occurrence of dementia after controlling for the status of depression was observed. Lack of patients' data about smoking status and body mass index in NHIRD, which are considered related to dementia, was also a limitation in this study. In this study, we concluded that antidepressant medication is a potential risk factor for dementia, independent from any effect of depression itself.	[Then, Chee-Kin] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Then, Chee-Kin; Shen, Shing-Chuan] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chi, Nai-Fang; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Coll Med, Taipei, Taiwan; [Chi, Nai-Fang; Hu, Chaur-Jong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ, Sch Med, Dept Psychiat, Coll Med, Taipei, Taiwan; [Kuo, Lynn] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Liu, Kao-Hui] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, Taipei, Taiwan; [Liu, Kao-Hui] Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Biostat Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; University of Connecticut; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University	Shen, SC (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.; Lin, YK (corresponding author), Taipei Med Univ, Biostat Ctr, Taipei, Taiwan.	scshen@tmu.edu.tw; robbinlin@tmu.edu.tw	Chi, Nai-Fang/E-2851-2017; Chi, Nai-Fang/G-3561-2016; Kuo, Lynn/AAQ-6409-2021	Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923; Kuo, Lynn/0000-0002-1903-4425; Chung, Kuo-Hsuan/0000-0002-5570-3972; Then, Chee Kin/0000-0003-3551-0767	Ministry of Science and Technology (MOST), Taiwan [MOST 103-2320-B-038-024, MOST 105-2 314-B-038-013-MY3]; National Science Council (NSC), Taiwan [NSC 102-2 314-B-038-042, NSC101-2314-B-038-013]; Taipei Medical University (TMU) [TMU104-F-004, TMU104-AE1-B09]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan); National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University (TMU)	This work was supported by the Ministry of Science and Technology (MOST), Taiwan [grant numbers MOST 103-2320-B-038-024, MOST 105-2 314-B-038-013-MY3]; the National Science Council (NSC), Taiwan [grant number NSC 102-2 314-B-038-042,NSC101-2314-B-038-013];and Taipei Medical University (TMU) [grant number TMU104-F-004, TMU104-AE1-B09]. The funders had no role instudy design, data collection and analysis, decision to publish,or preparation of the manuscript.	Andrews PW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00117; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Bartholoma P, 2002, BIOCHEM PHARMACOL, V63, P1507, DOI 10.1016/S0006-2952(02)00882-1; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen H, 2006, NEUROREPORT, V17, P863, DOI 10.1097/01.wnr.0000221827.03222.70; Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen S, 2014, TOXICOL SCI, V137, P404, DOI 10.1093/toxsci/kft254; Cheng BH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004655; Chong MY, 2001, BRIT J PSYCHIAT, V178, P29, DOI 10.1192/bjp.178.1.29; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chung CM, 2016, ONCOTARGET, V7, P11687, DOI 10.18632/oncotarget.7049; Coupland C, 2011, BRITISH MEDICAL JOUR, V343; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Hodge JM, 2013, BIOL PSYCHIAT, V74, P32, DOI 10.1016/j.biopsych.2012.11.003; Howland RH, 2011, DRUG SAFETY, V34, P709, DOI 10.2165/11593960-000000000-00000; Hsiao FY, 2014, J AM MED DIR ASSOC, V15, P509, DOI 10.1016/j.jamda.2014.02.009; Hsieh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143668; Kessing LV, 2009, J AFFECT DISORDERS, V117, P24, DOI 10.1016/j.jad.2008.11.020; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Lee CWS, 2016, J CLIN PSYCHIAT, V77, P117, DOI 10.4088/JCP.14m09580; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Li Y, 2012, TOXICOL SCI, V127, P582, DOI 10.1093/toxsci/kfs100; MacQueen GM, 2017, PSYCHIAT CLIN NEUROS, V71, P18, DOI 10.1111/pcn.12463; Madhusoodanan S, 2010, ANN CLIN PSYCHIATRY, V22, P148; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Moore RA, 2012, COCHRANE DB SYST REV; Moret Chantal, 2006, Neuropsychiatr Dis Treat, V2, P537, DOI 10.2147/nedt.2006.2.4.537; Mossello E, 2008, DEMENT GERIATR COGN, V25, P372, DOI 10.1159/000121334; Muliyala KP, 2010, ANN INDIAN ACAD NEUR, V13, P69, DOI 10.4103/0972-2327.74248; Nierenberg AA, 2008, J OCCUP ENVIRON MED, V50, P428, DOI 10.1097/JOM.0b013e31816b5034; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Schatzberg AF, 2009, AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 4TH EDITION, P1; Schipke CG, 2011, J PSYCHIATR RES, V45, P242, DOI 10.1016/j.jpsychires.2010.06.005; Schmitt JAJ, 2002, J PSYCHOPHARMACOL, V16, P207, DOI 10.1177/026988110201600303; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Shilyansky C, 2016, LANCET PSYCHIAT, V3, P425, DOI 10.1016/S2215-0366(16)00012-2; Sun Y, 2014, PLOS ONE, V9; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; Wu C. S., 2009, PHARMACOEPIDEM DR S, V21, P980, DOI DOI 10.1002/PDS.3255; Xia ZL, 1997, INT J IMMUNOPHARMACO, V19, P645; Yang D, 2012, EUR J NEUROSCI, V36, P2573, DOI 10.1111/j.1460-9568.2012.08187.x	53	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175187	10.1371/journal.pone.0175187	http://dx.doi.org/10.1371/journal.pone.0175187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384235	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900114
J	Bytautiene, J; Baranauskas, G				Bytautiene, Juntaute; Baranauskas, Gytis			Rat superior colliculus neurons respond to large visual stimuli flashed outside the classical receptive field	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CONTRAST SENSITIVITY; EVOKED-POTENTIALS; ALBINO-RAT; CORTEX; MOUSE; FEEDBACK; URETHANE; AWAKE; CELLS	Spatial integration of visual stimuli is a crucial step in visual information processing yet it is often unclear where this integration takes place in the visual system. In the superficial layers of the superior colliculus that form an early stage in visual information processing, neurons are known to have relatively small visual receptive fields, suggesting limited spatial integration. Here it is shown that at least for rats this conclusion may be wrong. Extracellular recordings in urethane-anaesthetized young adult rats (1.5-2 months old) showed that large stimuli of over 10 could evoke detectable responses well outside the borders of 'classical' receptive fields determined by employing 2-3.5 stimuli. The presence of responses to large stimuli well outside these 'classical' receptive fields could not be explained neither by partial overlap between the visual stimulus and the receptive field, nor by reflections or light dispersion from the stimulation site. However, very low frequency (<0.1 Hz) residual responses to small stimuli presented outside the receptive field may explain the obtained results if we assume that the frequency of action potentials during a response to a stimulus outside RF is proportional to the stimulus area. Thus, responses to large stimuli outside RF may be predicted by scaling according to the stimulus area of the responses to small stimuli. These data demonstrate that neurons in the superficial layers of the superior colliculus are capable of integrating visual stimuli over much larger area than it can be deduced from the classical receptive field.	[Bytautiene, Juntaute; Baranauskas, Gytis] Lithuanian Univ Hlth Sci, Neurophysiol Lab, Neurosci Inst, Kaunas, Lithuania	Lithuanian University of Health Sciences	Baranauskas, G (corresponding author), Lithuanian Univ Hlth Sci, Neurophysiol Lab, Neurosci Inst, Kaunas, Lithuania.	gytis.baranauskas@lsmuni.lt			Lithuanian Research Council via the European Social Fund under the Global Grant measure [VP1-3.1:SMM-07-K-02-059]; Fund for Studies of Faculty of Medicine of Lithuanian University of Health Science	Lithuanian Research Council via the European Social Fund under the Global Grant measure(Research Council of Lithuania (LMTLT)); Fund for Studies of Faculty of Medicine of Lithuanian University of Health Science(Research Council of Lithuania (LMTLT))	This project was funded in part by the Lithuanian Research Council via the European Social Fund under the Global Grant measure, grant number VP1-3.1:SMM-07-K-02-059 to GB and by the Fund for Studies of the Faculty of Medicine of Lithuanian University of Health Science to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Baranauskas G, 2013, THE PROPERTIES OF CO; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Binns KE, 1997, DEV BRAIN RES, V99, P263, DOI 10.1016/S0165-3806(97)00004-7; Binns KE, 1997, J PHYSIOL-LONDON, V504, P629, DOI 10.1111/j.1469-7793.1997.629bd.x; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Carrasco MM, 2005, J NEUROPHYSIOL, V94, P1962, DOI 10.1152/jn.00166.2005; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690, DOI 10.1152/jn.1975.38.3.690; DRAGER UC, 1975, NATURE, V253, P203, DOI 10.1038/253203a0; Durand S, 2016, J NEUROSCI, V36, P12144, DOI 10.1523/JNEUROSCI.1741-16.2016; DYER RS, 1987, PHYSIOL BEHAV, V41, P327, DOI 10.1016/0031-9384(87)90396-9; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Felisberti F, 1999, VISUAL NEUROSCI, V16, P943, DOI 10.1017/S0952523899165143; FUKUDA Y, 1978, JPN J PHYSIOL, V28, P385; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Girman SV, 2007, J NEUROPHYSIOL, V98, P161, DOI 10.1152/jn.00059.2007; Glickfeld LL, 2014, CURR OPIN NEUROBIOL, V24, P28, DOI 10.1016/j.conb.2013.08.009; Graham NV, 2011, VISION RES, V51, P1397, DOI 10.1016/j.visres.2011.02.007; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; HETZLER BE, 1981, NEUROPHARMACOLOGY, V20, P969, DOI 10.1016/0028-3908(81)90028-9; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY NK, 1968, EXP NEUROL, V20, P312, DOI 10.1016/0014-4886(68)90076-9; Kato R, 2011, EUR J NEUROSCI, V33, P1952, DOI 10.1111/j.1460-9568.2011.07729.x; Lahiri SN, 1999, ANN STAT, V27, P386, DOI 10.1214/aos/1018031117; Liu YJ, 2011, BRAIN BEHAV EVOLUT, V77, P193, DOI 10.1159/000327045; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; OYSTER CW, 1975, J NEUROPHYSIOL, V38, P301, DOI 10.1152/jn.1975.38.2.301; Paxinos G., 2007, THE RAT BRAIN IN STE; Politis D.N., 1992, EXPLORING LIMITS BOO, P263; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; POWERS MK, 1978, VISION RES, V18, P1533, DOI 10.1016/0042-6989(78)90008-1; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Razak KA, 2003, J NEUROPHYSIOL, V90, P110, DOI 10.1152/jn.01029.2002; RIGDON GC, 1988, PHARMACOL BIOCHEM BE, V30, P421, DOI 10.1016/S0091-3057(88)80003-0; Rind EC, 1999, TRENDS NEUROSCI, V22, P215, DOI 10.1016/S0166-2236(98)01332-0; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; Sharma SC, 2008, PROG BRAIN RES, V173, P479, DOI 10.1016/S0079-6123(08)01133-3; Snyder AC, 2014, J NEUROSCI, V34, P11222, DOI 10.1523/JNEUROSCI.0762-14.2014; Svirskis G, 2009, J NEUROSCI METH, V180, P22, DOI 10.1016/j.jneumeth.2009.02.012; TIAO YC, 1976, J COMP NEUROL, V168, P483; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Webb BS, 2002, VISUAL NEUROSCI, V19, P583, DOI 10.1017/S0952523802195046; Zhao XY, 2014, NEURON, V84, P202, DOI 10.1016/j.neuron.2014.08.037	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174409	10.1371/journal.pone.0174409	http://dx.doi.org/10.1371/journal.pone.0174409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379979	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500045
J	Kaczmarek, DJ; Kokordelis, P; Kramer, B; Glassner, A; Wolter, F; Goeser, F; Lutz, P; Schwarze-Zander, C; Boesecke, C; Strassburg, CP; Rockstroh, JK; Spengler, U; Nattermann, J				Kaczmarek, Dominik J.; Kokordelis, Pavlos; Kraemer, Benjamin; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Lutz, Philipp; Schwarze-Zander, Carolynne; Boesecke, Christoph; Strassburg, Christian P.; Rockstroh, Juergen K.; Spengler, Ulrich; Nattermann, Jacob			Alterations of the NK cell pool in HIV/HCV co-infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-KILLER-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; T-CELLS; ANTIVIRAL TREATMENT; SURFACE EXPRESSION; CYTOLYTIC FUNCTION; IMMUNE ACTIVATION	Background A relevant proportion of human immunodeficiency virus (HIV) infected patients is co-infected with the hepatitis C virus (HCV). HCV co-infection in HIV-positive patients is associated with faster progression of liver disease in comparison to HCV mono-infection. Natural killer (NK) cells critically modulate the natural course of HCV infection. Both HIV and HCV mono-infection are associated with alterations of the NK cell pool. However, little data is available concerning phenotype and function of NK cells in HIV/HCV co-infection. Methods A total of 34 HIV/HCV co-infected, 35 HIV and 39 HCV mono-infected patients and 43 healthy control persons were enrolled into this study. All HIV-positive patients were under effective antiretroviral therapy. NK cell phenotype, IFN-y production and degranulation were studied by flow cytometry. Results NK cell frequency in HIV/HCV co-infection was significantly lower than in healthy individuals but did not differ from HIV and HCV mono-infection. HIV/HCV co-infection was associated with significantly decreased expression of the maturation/differentiation markers CD27/62U 127 on NK cells but increased expression of CD57 compared to healthy controls. Of note, expression also differed significantly from HCV mono-infection but was similar to HIV mono infection, suggesting a pronounced impact of HIV on these alterations. Similar findings were made with regard to the NK cell receptors NKG2A/C and NKp30. More importantly, NK cells in co-infection displayed a highly impaired functional activity with significantly lower IFN-y production and degranulation than in healthy donors as well as HIV and HCV mono-infection, suggesting a synergistic effect of both viruses. Conclusions Our data indicate that HIV/HCV co-infection is associated with significant alterations of the NK cell pool, which might be involved in the rapid progression of liver disease in co-infected patients and which mainly reflect alterations observed in HIV mono-infection.	[Kaczmarek, Dominik J.; Kokordelis, Pavlos; Kraemer, Benjamin; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Lutz, Philipp; Schwarze-Zander, Carolynne; Boesecke, Christoph; Strassburg, Christian P.; Rockstroh, Juergen K.; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Kaczmarek, Dominik J.; Kokordelis, Pavlos; Kraemer, Benjamin; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Lutz, Philipp; Schwarze-Zander, Carolynne; Boesecke, Christoph; Strassburg, Christian P.; Rockstroh, Juergen K.; Spengler, Ulrich; Nattermann, Jacob] German Ctr Infect Res DZIF, Bonn, Germany	University of Bonn; German Center for Infection Research	Kaczmarek, DJ (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Kaczmarek, DJ (corresponding author), German Ctr Infect Res DZIF, Bonn, Germany.	dominik.kaczmarek@ukbonn.de	Krämer, Benjamin/AAC-9618-2019; Goeser, Felix/AAT-4315-2021	Krämer, Benjamin/0000-0002-1385-9709; Goeser, Felix/0000-0003-3190-9981; Kaczmarek, Dominik/0000-0003-0093-7832; Lutz, Philipp/0000-0002-4921-200X	BONFOR [0-107.0116]; German Research Foundation (DFG) [SFB/TR 57]; DFG [KR4521/1-1]; H.W. and J. Hector Foundation [M69]; German Center for Infection Research (DZIF) [TTU 04.810]	BONFOR; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); H.W. and J. Hector Foundation; German Center for Infection Research (DZIF)	This work was supported by a BONFOR grant (0-107.0116 [DK]), the German Research Foundation (DFG SFB/TR 57 [US, JN], DFG KR4521/1-1 [BK], the H.W. and J. Hector Foundation (grant number M69 [J N]) and the German Center for Infection Research (DZIF TTU 04.810 [JN]).	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; Andreoni M, 2012, EUR REV MED PHARMACO, V16, P1473; Azzoni L, 2002, J IMMUNOL, V168, P5764, DOI 10.4049/jimmunol.168.11.5764; Bengner M, 2014, AGE, V36, P571, DOI 10.1007/s11357-013-9587-y; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Benjamini Y, 2001, ANN STAT, V29, P1165; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bisio F, 2013, IMMUNOL LETT, V152, P16, DOI 10.1016/j.imlet.2013.03.003; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Boesecke C, 2012, SEMIN LIVER DIS, V32, P130, DOI 10.1055/s-0032-1316468; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Dessouki O, 2010, BIOCHEM BIOPH RES CO, V393, P331, DOI 10.1016/j.bbrc.2010.02.008; Dillon SM, 2014, JAIDS-J ACQ IMM DEF, V65, P259, DOI 10.1097/01.qai.0000435603.50598.2b; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Goeser F, 2015, AIDS; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Gonzalez VD, 2008, CLIN IMMUNOL, V128, P46, DOI 10.1016/j.clim.2008.03.521; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Gonzalez VD, 2009, J IMMUNOL, V183, P6612, DOI 10.4049/jimmunol.0901437; Goodier MR, 2003, CLIN EXP IMMUNOL, V134, P470, DOI 10.1111/j.1365-2249.2003.02329.x; Harrison RJ, 2010, CLIN EXP IMMUNOL, V161, P306, DOI 10.1111/j.1365-2249.2010.04169.x; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; HO HN, 1993, J IMMUNOL, V150, P3070; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P27, DOI 10.1189/jlb.0907649; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kanof ME, 2001, CURR PROTOC IMMUNOL; Kokordelis P, 2013, HEPATOLOGY; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Marras F, 2013, P NATL ACAD SCI USA, V110, P11970, DOI 10.1073/pnas.1302090110; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mela CM, 2005, AIDS, V19, P1761, DOI 10.1097/01.aids.0000183632.12418.33; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nattermann J, 2005, ANTIVIR THER, V10, P95; Nattermann J, 2011, J HEPATOL, V55, P265, DOI 10.1016/j.jhep.2011.01.005; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; Oliviero B, 2013, J HEPATOL, V59, P38, DOI 10.1016/j.jhep.2013.03.003; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Parsons MS, 2014, J IMMUNOL, V192, P308, DOI 10.4049/jimmunol.1301247; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Silva A, 2008, INT IMMUNOL, V20, P625, DOI 10.1093/intimm/dxn022; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005	66	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174465	10.1371/journal.pone.0174465	http://dx.doi.org/10.1371/journal.pone.0174465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380039	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500049
J	Lluveras-Tenorio, A; Vinciguerra, R; Galano, E; Blaensdorf, C; Emmerling, E; Colombini, MP; Birolo, L; Bonaduce, I				Lluveras-Tenorio, Anna; Vinciguerra, Roberto; Galano, Eugenio; Blaensdorf, Catharina; Emmerling, Erwin; Colombini, Maria Perla; Birolo, Leila; Bonaduce, Ilaria			GC/MS and proteomics to unravel the painting history of the lost Giant Buddhas of Bamiyan (Afghanistan)	PLOS ONE			English	Article							POLYCHROMY; PROTEINS; PIGMENTS; MEDIA	A chemical investigation of the organic paint binders of the Giant Buddhas of Bamiyan was performed using an analytical approach based on mass spectrometry, combining traditional gas chromatography/mass spectrometry protocols with advanced proteomics methodologies. The research was carried out on a selection of rescued fragments. The data revealed the use of egg proteins as the paint binders of the original layers, in accordance with the traditional use of this proteinaceous medium in antiquity, spanning from the Mediterranean basin to the Far East, and already in the Bronze Age. Egg tempera was thus known to artists of the region in the first centuries AD, probably also due to the position of the Bamiyan valley, which was connected to the Silk Road. Milk was found in the first historical overpaintings. A new proteomics approach was used, which was able to identify the source of the milk proteins present in the restoration layers, despite their age and degradation. In particular cow's and goat's milk were both found, in agreement with the documented presence of rich pastures in the Bamiyan valley when the historical restorations were carried out. Investigating the materials of the Giant Buddhas not only enabled us to obtain isolated data on these invaluable works of art, which are now lost, but contributes to understanding the big "puzzle" of our past and the development of our culture, by implementing and supporting written sources, stylistic and anthropological studies with molecular data.	[Lluveras-Tenorio, Anna; Colombini, Maria Perla; Bonaduce, Ilaria] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy; [Vinciguerra, Roberto; Galano, Eugenio; Birolo, Leila] Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy; [Blaensdorf, Catharina; Emmerling, Erwin] Tech Univ Muenchen, Lehrstuhl Restaurierung Kunsttechnol & Konservier, Munich, Germany; [Colombini, Maria Perla] Natl Res Council Italy ICVBC CNR, Inst Conservat & Promot Cultural Heritage, Sesto Fiorentino, Italy; [Birolo, Leila] Dist Ad Alta Tecnol Beni Culturali DATABENC Scarl, Naples, Italy	University of Pisa; University of Naples Federico II; Technical University of Munich; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Conservazione e la Valorizzazione dei Beni Culturali (ICVBC-CNR)	Bonaduce, I (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.; Birolo, L (corresponding author), Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy.; Birolo, L (corresponding author), Dist Ad Alta Tecnol Beni Culturali DATABENC Scarl, Naples, Italy.	leila@unipi.it; ilaria.bonaduce@unipi.it	; BONADUCE, ILARIA/I-8801-2012	colombini, maria perla/0000-0002-1666-8596; BIROLO, Leila/0000-0002-0915-7501; BONADUCE, ILARIA/0000-0003-0346-8373; Lluveras-Tenorio, Anna/0000-0002-0600-5668	UNESCO; Auswartiges Amt Germany; Italian Ministry of Education, University and Research (MIUR) [2010329WPF_001]; Distretto ad Alta Tecnologia dei Beni Culturali (DATABENC scarl)	UNESCO; Auswartiges Amt Germany; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Distretto ad Alta Tecnologia dei Beni Culturali (DATABENC scarl)	UNESCO and Auswartiges Amt Germany provided financial support for the whole conservation project at Technische Universitaet Muenchen, Lehrstuhl fur Restaurierung, Kunsttechnologie und Konservierungswissenschaft; EE received the funding. "PRIN2010-2011," Project No.2010329WPF_001 funded by the Italian Ministry of Education, University and Research (MIUR) provided partial financial support for the research at the University of Pisa; MPC received the fundings. Distretto ad Alta Tecnologia dei Beni Culturali (DATABENC scarl) provided partial financial support for the research carried out at the University of Naples.; The authors wish to thank Gennaro Marino and Piero Pucci for helpful discussions and constructive comments, and Distretto ad Alta Tecnologia dei Beni Culturali (DATABENC scarl) for financial support. UNESCO and Auswartiges Amt Germany are thanked for financial support. Authors are very grateful to Prof. Erika Ribechini from the University of Pisa for the useful discussion of the data.	Abdul Samad F, 2011, EVALUATION EFFECT LA; [Anonymous], 2009, GIANT BUDDHAS BAMIYA; Birstein V.J, 1975, STUD CONSERV, V20, P8, DOI DOI 10.1179/SIC.1975.20.1.002; Blansdorf C, 2009, GIANT BUDDHAS BAMIYA, P237; Blansdorf C., 2009, GIANT BUDDHAS BAMIYA, P231; Bonaduce I, 2012, NEW INSIGHTS AGEING; Bonaduce I, 2008, J CULT HERIT, V9, P103, DOI 10.1016/j.culher.2007.08.002; Bonaduce I, 2007, J CHROMATOGR A, V1175, P275, DOI 10.1016/j.chroma.2007.10.056; Bonaduce I, 2016, TOPICS CURR CHEM, V374, DOI 10.1007/s41061-015-0007-x; Bonaduce I, 2009, J CHROMATOGR A, V1216, P5931, DOI 10.1016/j.chroma.2009.06.033; Brecoulaki H, 2012, J ARCHAEOL SCI, V39, P2866, DOI 10.1016/j.jas.2012.04.018; Cauzzi D, 2013, J CULT HERIT, V14, P70, DOI 10.1016/j.culher.2012.02.011; Ce Wu, 2012, JOURNEY W; Colombini MP, 2010, ACCOUNTS CHEM RES, V43, P715, DOI 10.1021/ar900185f; Cotte M, 2008, J ANAL ATOM SPECTROM, V23, P820, DOI 10.1039/b801358f; Dallongeville S, 2016, CHEM REV, V116, P2, DOI 10.1021/acs.chemrev.5b00037; Delmonaco G, 2014, NAT SCI ARCHAEOL, P69, DOI 10.1007/978-3-642-30051-6_5; Duce C, 2013, DALTON T, V42, P5975, DOI 10.1039/c2dt32203j; Duce C, 2012, ANAL BIOANAL CHEM, V402, P2183, DOI 10.1007/s00216-011-5684-x; Francioni F., 2003, EUROPEAN J INT LAW, V14, P619, DOI DOI 10.1093/EJIL/14.4.619; Gambino M, 2013, J BIOSCIENCES, V38, P397, DOI 10.1007/s12038-013-9321-z; Ghezzi L, 2015, J THERM ANAL CALORIM, V122, P315, DOI 10.1007/s10973-015-4759-x; Grunwald JE, 2009, GIANT BUDDHAS BAMIYA, V19; Hackin J, 1928, E ART, V1, P109; HIGUCHI T, 1995, WORLD ARCHAEOL, V27, P282, DOI 10.1080/00438243.1995.9980308; Leo G, 2011, ANAL CHEM, V83, P2056, DOI 10.1021/ac1027275; Liuveras A, 2010, ANAL CHEM, V82, P376, DOI 10.1021/ac902141m; Lluveras-Tenorio A, 2015, APPL PHYS A-MATER, V121, P879, DOI 10.1007/s00339-015-9362-2; Lluveras-Tenorio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049383; Margottini C, 2004, LANDSLIDES, V1, P41, DOI 10.1007/s10346-003-0010-0; Mills J., 2000, ORGANIC CHEM MUSEUM, V2; Nussinovitch A, 2010, PLANT GUM EXUDATES OF THE WORLD: SOURCES, DISTRIBUTION, PROPERTIES, AND APPLICATIONS, P1; Pallecchi P, 2009, J ARCHAEOL SCI, V36, P2635, DOI 10.1016/j.jas.2009.07.019; Paramasivan S., 1939, WALL PAINTINGS BAGH, P85; Pellegrini D, 2016, MICROCHEM J, V124, P31, DOI 10.1016/j.microc.2015.07.018; Rasmussen KL, 2012, J ARCHAEOL SCI, V39, P2956, DOI 10.1016/j.jas.2012.04.041; Stephanie Pfeffer CB, 2009, GIANT BUDDHAS BAMIYA, P217; Sun Y-z, 2012, SCI CONSERVATION ARC, V2; Taniguchi Y., 2008, P 15 TRIENNIAL M ICO, P397; Vinciguerra R, 2015, ANAL CHEM, V87, P10178, DOI 10.1021/acs.analchem.5b02423; Wei SY, 2012, J ARCHAEOL SCI, V39, P1628, DOI 10.1016/j.jas.2012.01.011	41	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172990	10.1371/journal.pone.0172990	http://dx.doi.org/10.1371/journal.pone.0172990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ES2JD	28379960	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500010
J	Nyongesa, MK; Sigilai, A; Hassan, AS; Thoya, J; Odhiambo, R; Van de Vijver, FJR; Newton, CRJC; Abubakar, A				Nyongesa, Moses K.; Sigilai, Antipa; Hassan, Amin S.; Thoya, Janet; Odhiambo, Rachael; Van de Vijver, Fons J. R.; Newton, Charles R. J. C.; Abubakar, Amina			A mixed methods approach to adapting and evaluating the functional assessment of HIV infection (FAHI), Swahili version, for use with low literacy populations	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMMUNODEFICIENCY-VIRUS-INFECTION; HIV/AIDS; IMPACT; VALIDATION; OUTCOMES; QUESTIONNAIRE; INSTRUMENTS; RELIABILITY; THERAPY	Background Despite bearing the largest HIV-related burden, little is known of the Health-Related Quality of Life (HRQoL) among people living with HIV in sub-Saharan Africa. One of the factors contributing to this gap in knowledge is the lack of culturally adapted and validated measures of HRQoL that are relevant for this setting. Aims We set out to adapt the Functional Assessment of HIV Infection (FAHI) Questionnaire, an HIV-specific measure of HRQoL, and evaluate its internal consistency and validity. Methods The three phase mixed-methods study took place in a rural setting at the Kenyan Coast. Phase one involved a scoping review to describe the evidence base of the reliability and validity of FAHI as well as the geographical contexts in which it has been administered. Phase two involved in-depth interviews (n = 38) to explore the content validity, and initial piloting for face validation of the adapted FAHI. Phase three was quantitative (n = 103) and evaluated the internal consistency, convergent and construct validities of the adapted interviewer-administered questionnaire. Results In the first phase of the study, we identified 16 studies that have used the FAHI. Most (82%) were conducted in North America. Only seven (44%) of the reviewed studies reported on the psychometric properties of the FAHI. In the second phase, most of the participants (37 out of 38) reported satisfaction with word clarity and content coverage whereas 34 (89%) reported satisfaction with relevance of the items, confirming the face validity of the adapted questionnaire during initial piloting. Our participants indicated that HIV impacted on their physical, functional, emotional, and social wellbeing. Their responses overlapped with items in four of the five subscales of the FAHI Questionnaire establishing its content validity. In the third phase, the internal consistency of the scale was found to be satisfactory with subscale Cronbach's a ranging from 0.55 to 0.78. The construct and convergent validity of the tool were supported by acceptable factor loadings for most of the items on the respective sub scales and confirmation of expected significant correlations of the FAHI subscale scores with scores of a measure of common mental disorders. Conclusion The adapted interviewer-administered Swahili version of FAHI questionnaire showed initial strong evidence of good psychometric properties with satisfactory internal consistency and acceptable validity (content, face, and convergent validity). It gives impetus for further validation work, especially construct validity, in similar settings before it can be used for research and clinical purposes in the entire East African region.	[Nyongesa, Moses K.; Sigilai, Antipa; Hassan, Amin S.; Thoya, Janet; Odhiambo, Rachael; Newton, Charles R. J. C.; Abubakar, Amina] Kenya Govt Med Res Ctr, Ctr Geog Med Coast, Kilifi, Kenya; [Nyongesa, Moses K.; Sigilai, Antipa; Abubakar, Amina] Pwani Univ, Kilifi, Kenya; [Van de Vijver, Fons J. R.] Tilburg Univ, Tilburg, Netherlands; [Van de Vijver, Fons J. R.] North West Univ, Potchefstroom, South Africa; [Van de Vijver, Fons J. R.] Univ Queensland, Brisbane, Qld, Australia; [Newton, Charles R. J. C.; Abubakar, Amina] Univ Oxford, Oxford, England	Kenya Medical Research Institute; Pwani University; Tilburg University; North West University - South Africa; University of Queensland; University of Oxford	Nyongesa, MK (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Coast, Kilifi, Kenya.; Nyongesa, MK (corresponding author), Pwani Univ, Kilifi, Kenya.	MKachama@kemri-wellcome.org	Nyongesa, Moses/AAZ-8780-2021; Nyongesa, Moses/AAG-7796-2020; van de Vijver, Fons/A-4317-2012; Newton, Charles RJC/B-7578-2014; Abubakar, Amina/F-1479-2017	Nyongesa, Moses/0000-0002-7761-0718; Nyongesa, Moses/0000-0002-7761-0718; van de Vijver, Fons/0000-0003-0220-2485; Newton, Charles RJC/0000-0002-6999-5507; Hassan, Amin S./0000-0001-5296-4264; Odhiambo, Rachel/0000-0002-7525-0659; Abubakar, Amina/0000-0002-3686-7904	IUPsyS; ICP Change Fellowship Award; Jacobs Foundation/NRC/international Congress of Psychology; Wellcome Trust [084538]	IUPsyS; ICP Change Fellowship Award; Jacobs Foundation/NRC/international Congress of Psychology; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by IUPsyS and ICP2012 Change Fellowship Award to Amina Abubakar, fellowship awards were funds by Jacobs Foundation/NRC/international Congress of Psychology. Moses Kachama Nyongesa was funded through a strategic award by Wellcome Trust grant number 084538.	Abrams DI, 2000, INT J STD AIDS, V11, P659, DOI 10.1258/0956462001915020; Abubakar A, 2009, HERODOTUS ETHNOGRAPH, P169; Abubakar A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2854-y; Badia X, 1999, AIDS, V13, P1727, DOI 10.1097/00002030-199909100-00017; Basavaraj K H, 2010, Indian J Sex Transm Dis AIDS, V31, P75, DOI 10.4103/0253-7184.74971; Bernal H, 1997, NURS RES, V46, P179, DOI 10.1097/00006199-199705000-00009; BOZZETTE SA, 1994, MED CARE, V32, P716, DOI 10.1097/00005650-199407000-00005; Byrne S, 2013, AIDS CARE, V25, P118, DOI 10.1080/09540121.2012.687811; Cella D, 2010, HIV CLIN TRIALS; Cella DF, 1996, QUAL LIFE RES, V5, P450, DOI 10.1007/BF00449920; Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clayson DJ, 2006, PHARMACOECONOMICS, V24, P751, DOI 10.2165/00019053-200624080-00003; Davis EA, 2001, ANN PHARMACOTHER, V35, P546, DOI 10.1345/aph.10222; Diamond C, 2010, QUAL LIFE RES, V19, P149, DOI 10.1007/s11136-009-9565-0; Dolan P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2577; Earthman CP, 2002, JPEN-PARENTER ENTER, V26, P357, DOI 10.1177/0148607102026006357; Feinberg J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/349165; GANZ PA, 1993, QUAL LIFE RES, V2, P109, DOI 10.1007/BF00435730; Hasanah CI, 2011, QUAL LIFE RES, V20, P91, DOI 10.1007/s11136-010-9729-y; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Holding P, SYSTEMATIC APPROACH; Holmes WC, 1997, QUAL LIFE RES, V6, P561, DOI 10.1023/A:1018464200708; Louwagie GM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-244; Lubeck DP, 1997, QUAL LIFE RES, V6, P494, DOI 10.1023/A:1018404014821; NACC, 2014, KEN HIV COUNT PROF 2; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; O'Brien KK, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-88; Olagunju AT, 2012, HIV AIDS REV, V11, P31, DOI 10.1016/j.hivar.2012.02.002; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Peterman AH, 1997, QUAL LIFE RES, V6, P572, DOI 10.1023/A:1018416317546; Pietersma S, 2013, INT J WELLBEING, V3; Pitt J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-5; Rao D, 2007, AIDS PATIENT CARE ST, V21, P339, DOI 10.1089/apc.2006.0124; Robberstad Bjarne, 2010, Cost Eff Resour Alloc, V8, P5, DOI 10.1186/1478-7547-8-5; Sikkema KJ, 2005, QUAL LIFE RES, V14, P991, DOI 10.1007/s11136-004-2959-0; Swindells S, 1999, INT J STD AIDS, V10, P383, DOI 10.1258/0956462991914302; Tomita A, 2014, AIDS BEHAV, V18, P1801, DOI 10.1007/s10461-014-0800-5; Tomita A, 2014, AIDS BEHAV, V18, P1114, DOI 10.1007/s10461-013-0682-y; Vaus D., 2002, ANAL SOCIAL SCI DATA; Viala-Danten M, 2010, QUAL LIFE RES, V19, P1215, DOI 10.1007/s11136-010-9674-9; Vidrine DJ, 2005, QUAL LIFE RES, V14, P923, DOI 10.1007/s11136-004-2148-1; Winston A, 2010, HIV CLIN TRIALS; World Health Organization, 2013, GLOB HLTH OBS GHO DA; Wouters E, 2007, QUAL LIFE RES, V16, P1461, DOI 10.1007/s11136-007-9260-y; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175021	10.1371/journal.pone.0175021	http://dx.doi.org/10.1371/journal.pone.0175021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380073	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500086
J	Wolosin, JM; Zamudio, A; Wang, Z				Wolosin, J. Mario; Zamudio, Aldo; Wang, Zheng			Application of JC1 for non-toxic isolation of cells with MDR transporter activity by flow cytometry	PLOS ONE			English	Article							SIDE-POPULATION CELLS; CANCER RESISTANCE PROTEIN; HEMATOPOIETIC STEM-CELLS; RAT-LIVER MITOCHONDRIA; FUMITREMORGIN-C; P-GLYCOPROTEIN; BONE-MARROW; HOECHST-33342; MEMBRANE; ABCG2	The DNA intercalating dye Hoechst 33342 or its close analog DCV are actively removed from cells by the multidrug resistance transporter ABCG2, a protein overexpressed in metastatic cells and somatic stem cells. In bivariate blue-red flow cytometry fluorescent plots active Hoechst or DCV efflux combined with a concentration dependent bathochromic shifts of these nuclear dyes leads to the segregation of the transporter-rich cells into a distinct cell cohort tilted towards the shorter wavelength axis of the plot, the cohort is generically known as the side population (SP). This feature has facilitated the surface marker-independent isolation of live stem cells. A drawback, though, is the known toxicity of Hoechst dyes. In this study we show that JC1, a bathochromic mitochondrial membrane potential-sensitive dye applied at proper concentration, can yield flow cytometry fluorescent emission bivariate plots containing a low JC1 accumulation (JC1(low)) cohort. Using a combination of multiple cell lines, ABC-transporter inhibitors and viral vector-driven insertion of the ABCG2 gene or ABCG2 and ABCB1 shRNAs we demonstrate that JC1(low) can be generated by either of the two aforementioned multidrug resistance transporters. Complete wash out of mitochondrial bound JC1 required more than 24 h. In spite of this tight binding, the dye did not affect either the mitochondrial membrane potentials or the proliferation rate. In contrast, contemporaneous with its nuclear accumulation, Hoechst 33342 or DVC, caused changes in the fluorescent emission of mitochondrial membrane potential sensitive dyes resembling the effects caused by the mitochondrial uncoupler FCCP. In a number of cell lines exposure to Hoechst resulted in marked slow-down of proliferation and abolition of ABCG2 transport activity during the subsequent 2 days but in K562 cells the exposure induced cell extended death. Overall, its lack of toxicity vis. a vis. the toxicity and genotoxicity of the DNA intercalating dyes makes JC1 an ideal tool for isolating live cells expressing high multidrug resistance transport activity.	[Wolosin, J. Mario; Zamudio, Aldo; Wang, Zheng] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Wolosin, J. Mario] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wolosin, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA.; Wolosin, JM (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	Jmario.wolosin@mssm.edu		wolosin, j. mario/0000-0002-6751-2794	National Institutes of Health [EY 014878]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY014878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health [grant number EY 014878] and by Unrestricted Grant to The Department of Ophthalmology from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci MA, INVEST OPHTHALMOL VI, V50, P4162; Allen JD, 2002, MOL CANCER THER, V1, P417; Antczak C, 2014, ASSAY DRUG DEV TECHN, V12, P28, DOI 10.1089/adt.2013.521; Boesch M, 2014, ONCOTARGET, V5, P7027, DOI 10.18632/oncotarget.2053; Boesch M, 2012, CYTOM PART A, V81A, P517, DOI 10.1002/cyto.a.22038; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Chaoui D, 2006, CYTOM PART B-CLIN CY, V70B, P189, DOI 10.1002/cyto.b.20100; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Gardner RV, 1998, STEM CELLS, V16, P112, DOI 10.1002/stem.160112; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Jackson C, 2015, CURR EYE RES, V23, P1; Kim M, 2003, J NEUROSCI, V23, P10703; Kuhnel JM, 1997, LEUKEMIA, V11, P1147, DOI 10.1038/sj.leu.2400698; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; LIBBUS BL, 1987, MUTAT RES, V182, P265, DOI 10.1016/0165-1161(87)90011-2; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Mease K, 2012, J PHARM SCI-US, V101, P1888, DOI 10.1002/jps.23069; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mordente A, 2012, ADV EXP MED BIOL, V942, P385, DOI 10.1007/978-94-007-2869-1_18; Rabindran SK, 2000, CANCER RES, V60, P47; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Selver OB, 2016, MOL VIS, V22, P138; Selver OB, 2011, INVEST OPHTH VIS SCI, V52, P4330, DOI 10.1167/iovs.10-5897; SIEMANN DW, 1986, CANCER RES, V46, P3556; Singh S, 2004, J PHOTOCH PHOTOBIO B, V77, P45, DOI 10.1016/j.jphotobiol.2004.08.009; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; VANZANT G, 1983, CYTOMETRY, V4, P40, DOI 10.1002/cyto.990040106; Weidner LD, 2015, J PHARMACOL EXP THER, V354, P384, DOI 10.1124/jpet.115.225482; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Zamudio A, 2016, EXP EYE RES, V145, P48, DOI 10.1016/j.exer.2015.10.021; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	35	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174905	10.1371/journal.pone.0174905	http://dx.doi.org/10.1371/journal.pone.0174905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380010	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500076
J	Verma, SK; Thareja, S				Verma, Sant Kumar; Thareja, Suresh			Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors	PLOS ONE			English	Article							ALDOSE REDUCTASE HOLOENZYME; DIABETES COMPLICATIONS TRIAL; MOLECULAR-FIELD ANALYSIS; RESOLUTION STRUCTURES; PTP-1B INHIBITORS; DRUG DESIGN; DERIVATIVES; DOCKING; ENZYME; FIDARESTAT	Aldose reductase (ALR2) inhibition is the most legitimate approach for the management of diabetic complications. The limited triumph in the drug development against ALR2 is mainly because of its close structural similarity with the other members of aldo-keto reductase (AKR) superfamily viz. ALR1, AKR1B10; and lipophilicity problem i.e. poor diffusion of synthetic aldose reductase inhibitors (ARIs) to target tissues. The literature evidenced that naturally occurring curcumin demonstrates relatively specific and non-competitive inhibition towards human recombinant ALR2 over ALR1 and AKR1B10; however beta-diketone moiety of curcumin is a specific substrate for liver AKRs and accountable for it's rapid in vivo metabolism. In the present study, structure based comprehensive modelling studies were used to map the pharmacophoric features/spatial fingerprints of curcumin analogues responsible for their ALR2 specificity along with potency on a data set of synthetic curcumin analogues and naturally occurring curcuminoids. The data set molecules were also screened for drug-likeness or ADME parameters, and the screening data strongly support that curcumin analogues could be proposed as a good drug candidate for the development of ALR2 inhibitors with improved pharmacokinetic profile compared to curcuminoids due to the absence of beta-diketone moiety in their structural framework.	[Verma, Sant Kumar; Thareja, Suresh] Guru Ghasidas Cent Univ, Sch Pharmaceut Sci, Bilaspur, CG, India	Guru Ghasidas Vishwavidyalaya	Thareja, S (corresponding author), Guru Ghasidas Cent Univ, Sch Pharmaceut Sci, Bilaspur, CG, India.	sureshthareja@gmail.com			Indian Council of Medical Research (ICMR) [45/54/2014-PHA-BMS]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	SKV has received support from the Indian Council of Medical Research (ICMR) in the form of a Senior Research Fellowship (SRF, No. 45/54/2014-PHA-BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SKV is thankful to Indian Council of Medical Research (ICMR) for providing him support in the form of Senior Research Fellowship (No. 45/54/2014-PHA-BMS). We are also thankful to Dr. Rene Thomsen for the Molegro Virtual Docker (MVD) software.	Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Aggarwal BB, 2007, MOL TARGETS THERAPEU; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2013, VLIFE MOL DES SUIT V; [Anonymous], 2013, TSAR 3D VERS 3 3; [Anonymous], 2014, VEGA ZZ VERS 3 0 3 1; [Anonymous], 2012, MOL VIRT DOCK VERS 6; BHATNAGAR A, 1992, BIOCHEM MED METAB B, V48, P91, DOI 10.1016/0885-4505(92)90055-4; Changjin Z., 2013, DIABETES MELLITUS IN, P17, DOI [DOI 10.5772/54642, 10.5772/54642]; Cosconati S, 2009, J MED CHEM, V52, P5578, DOI 10.1021/jm901045w; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Das U, 2009, CURR MED CHEM, V16, P2001, DOI 10.2174/092986709788682218; Du ZY, 2006, ARCH PHARM, V339, P123, DOI 10.1002/ardp.200500205; El-Kabbani O, 2005, J MED CHEM, V48, P5536, DOI 10.1021/jm050412o; El-Kabbani O, 2004, J MED CHEM, V47, P4530, DOI 10.1021/jm0497794; El-Kabbani O, 2004, PROTEINS, V55, P805, DOI 10.1002/prot.20001; El-Kabbani O, 2003, PROTEINS, V50, P230, DOI 10.1002/prot.10278; Foppiano M, 1997, LANCET, V349, P399, DOI 10.1016/S0140-6736(97)80018-9; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; GONZALEZ RG, 1984, DIABETES, V33, P196, DOI 10.2337/diabetes.33.2.196; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; HOTTA N, 1990, EXP EYE RES, V50, P625, DOI 10.1016/0014-4835(90)90104-3; Hotta N, 2006, DIABETES CARE, V29, P1538, DOI 10.2337/dc05-2370; Ishii H, 1998, J MOL MED, V76, P21, DOI 10.1007/s109-1998-8101-y; Kumar PA, 2007, EXP EYE RES, V85, P739, DOI 10.1016/j.exer.2006.08.002; Lagisetty P, 2010, BIOORGAN MED CHEM, V18, P6109, DOI 10.1016/j.bmc.2010.06.055; Lahlou M., 2013, PHARM PHARMACOL-RUSS, V4, P17, DOI [10.4236/pp.2013.43A003, DOI 10.4236/PP.2013.43A003]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Matsuoka K, 2007, DIABETES RES CLIN PR, V77, pS263, DOI 10.1016/j.diabres.2007.01.069; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Muthenna P, 2009, FEBS LETT, V583, P3637, DOI 10.1016/j.febslet.2009.10.042; Nishikawa T, 2000, KIDNEY INT, V58, pS26, DOI 10.1046/j.1523-1755.2000.07705.x; Oates, 1999, Expert Opin Investig Drugs, V8, P2095, DOI 10.1517/13543784.8.12.2095; Ottana R, 2011, EUR J MED CHEM, V46, P2797, DOI 10.1016/j.ejmech.2011.03.068; Pfeifer MA, 1997, DIABETES, V46, pS82, DOI 10.2337/diab.46.2.S82; Reddy Aramati B M, 2010, Recent Pat Cardiovasc Drug Discov, V5, P25; Robinson D. D., 2006, SOMFA2 VERSION 2 0 0; Robinson DD, 1999, J MED CHEM, V42, P573, DOI 10.1021/jm9810607; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; Rosemond MJC, 2004, CHEM-BIOL INTERACT, V147, P129, DOI 10.1016/j.cbi.2003.12.001; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Shehzad A, 2010, DRUG FUTURE, V35, P113, DOI 10.1358/dof.2010.035.02.1426640; Srivastava S, 2006, DIABETES, V55, P901, DOI 10.2337/diabetes.55.04.06.db05-0932; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Suzen S, 2003, CURR MED CHEM, V10, P1329, DOI 10.2174/0929867033457377; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; VANHEYNINGEN R, 1959, NATURE, V184, P194, DOI 10.1038/184194b0; Verma SK, 2016, MED CHEM RES, V25, P1433, DOI 10.1007/s00044-016-1584-0; Verma SK, 2016, RSC ADV, V6, P33857, DOI 10.1039/c6ra03067j; Verma SK, 2016, LETT DRUG DES DISCOV, V13, P295, DOI 10.2174/1570180812666150819002954; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Walker JD, 2013, ENVIRON TOXICOL CHEM, V22, P1653; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; Yadav B, 2010, BIOORGAN MED CHEM, V18, P6701, DOI 10.1016/j.bmc.2010.07.063	58	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175318	10.1371/journal.pone.0175318	http://dx.doi.org/10.1371/journal.pone.0175318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399135	gold, Green Submitted, Green Published			2022-12-27	WOS:000399949000029
J	Luz, TCB; Osorio-de-Castro, CGS; Magarinos-Torres, R; Wettermark, B				Borges Luz, Tatiana Chama; Serpa Osorio-de-Castro, Claudia Garcia; Magarinos-Torres, Rachel; Wettermark, Bjorn			Trends in medicines procurement by the Brazilian federal government from 2006 to 2013	PLOS ONE			English	Article							DRUG UTILIZATION; HEALTH SYSTEM; EXPENDITURE; STRATEGIES; ACCESS; PRICE	The costs of medicines pose a growing burden on healthcare systems worldwide. A comprehensive understanding of current procurement processes provides strong support for the development of effective policies. This study examined Brazilian Federal Government pharmaceutical procurement data provided by the Integrated System for the Administration of General Services (SIASG) database, from 2006 to 2013. Medicine purchases were aggregated by volume and expenditure for each year. Data on expenditure were adjusted for inflation using the Extended National Consumer Price Index (IPCA) for December 31, 2013. Lorenz distribution curves were used to study the cumulative proportion of purchased therapeutic classes. Expenditure variance analysis was performed to determine the impact of each factor, price and/or volume, on total expenditure variation. Annual expenditure on medicines increased 2.72 times, while the purchased volume of drugs increased 1.99 times. A limited number of therapeutic classes dominated expenditure each year. Drugs for infectious diseases drove the increase in expenditures from 2006 to 2009 but were replaced by antineoplastic and immunomodulating agents beginning in 2010. Immunosuppressants (L04), accounted for one third of purchases since 2010, showing the most substantial growth in expenditures during the period (250-fold increase). The overwhelming price-related increase in expenditures caused by these medicines is bound to have a relevant impact on the sustainability of the pharmaceutical supply system. We observed increasing trends in expenditures, especially in specific therapeutic classes. We propose the development and implementation of better medicine procurement systems, and strategies to allow for monitoring of product price, effectiveness, and safety. This must be done with ongoing assessment of pharmaceutical innovations, therapeutic value and budget impact.	[Borges Luz, Tatiana Chama] Fundacao Oswaldo Cruz, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil; [Borges Luz, Tatiana Chama; Wettermark, Bjorn] Karolinska Inst, Dept Med, Clin Epidemiol, Stockholm, Sweden; [Serpa Osorio-de-Castro, Claudia Garcia] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Pharmaceut Policies & Pharmaceut Serv NAF, Rio De Janeiro, RJ, Brazil; [Magarinos-Torres, Rachel] Fed Fluminense Univ, Sch Pharm, Niteroi, RJ, Brazil; [Wettermark, Bjorn] Stockholm Cty Council, Publ Healthcare Serv Comm, Dept Healthcare Dev, Stockholm, Sweden	Fundacao Oswaldo Cruz; Karolinska Institutet; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Stockholm County Council	Luz, TCB (corresponding author), Fundacao Oswaldo Cruz, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil.; Luz, TCB (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol, Stockholm, Sweden.	tatianachama@cpqrr.fiocruz.br	Luz, Tatiana/AAC-7948-2022; de Castro, Claudia Garcia Serpa Osorio/H-1549-2012	Luz, Tatiana/0000-0003-1323-3105; de Castro, Claudia Garcia Serpa Osorio/0000-0003-4875-7216	Brazilian Science Without Borders Program [25381.000033/2014-57]; Brazilian National Research Counsel (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq) [303342/2013-7]	Brazilian Science Without Borders Program; Brazilian National Research Counsel (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq)	This work was supported by: Brazilian Science Without Borders Program: grant number 25381.000033/2014-57(TCBL,scholarship); Brazilian National Research Counsel (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq): grant number 303342/2013-7 (CGSOC,productivitygrant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurea AP, 012012 CONTA SAT SAU; Aurea AP, 2011, PROGRAMAS ASSITENCIA; Blavin F, 2014, MED CARE RES REV, V71, P416, DOI 10.1177/1077558714533820; Boecking W, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-894; Canadian Institute for Health Information (CIHI), 2013, PRESCR DRUG SPEND CA; Carrilho FJ, 2015, REFERENTE PUBLICA CO; Chaves GC, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005459; de Meijer C, 2013, EUR J AGEING, V10, P353, DOI 10.1007/s10433-013-0280-x; Gerdtham UG, 2004, PHARMACOECONOMICS, V22, P29, DOI 10.2165/00019053-200422010-00003; Hallas J, 2005, PHARMACOEPIDEM DR S, V14, P455, DOI 10.1002/pds.1063; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hoffman JM, 2012, AM J HEALTH-SYST PH, V69, P405, DOI 10.2146/ajhp110697; Jekel JF., 2014, EPIDEMIOLOGY BIOSTAT, V4th; Leite ID, 2015, CAD SAUDE PUBLICA, V31, P1551, DOI 10.1590/0102-311X00111614; Liu SZ, 2003, MED CARE, V41, P1331, DOI 10.1097/01.MLR.0000100579.91550.C4; Magrini N, 2015, B WORLD HEALTH ORGAN, V93, P283, DOI 10.2471/BLT.15.154385; Martin AB, 2016, HLTH AFF MILLWOOD, V1, P150; Meiners C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023478; Morgan S, 2004, MED CARE, V42, P635, DOI 10.1097/01.mlr.0000129494.36245.4b; Morgan SG, 2002, HEALTH SERV RES, V37, P1243, DOI 10.1111/1475-6773.01058; Santos-Pinto CDB, 2013, CAD SAUDE PUBLICA, V29, P1056; Shi LZ, 2014, PHARMACOECONOMICS, V32, P257, DOI 10.1007/s40273-013-0072-3; Siersema PD, 2016, J CROHNS COLITIS, V29; 't Hoen EFM, 2016, LANCET, V387, P2272, DOI 10.1016/S0140-6736(16)30656-0; Vieira FS, 2011, REV SAUDE PUBL, V45, P906, DOI 10.1590/S0034-89102011005000048; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925; Wettermark B, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-128; WHO, 2013, GUID ATC CLASS DDD A; World Health Organization, 2011, WORLD MED SITUATION2; World Health Organization UNICEF, 1999, OP PRINC GOOD PHARM	31	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174616	10.1371/journal.pone.0174616	http://dx.doi.org/10.1371/journal.pone.0174616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388648	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800007
J	Harris, VK; Bell, L; Langan, RA; Tuddenham, J; Landy, M; Sadiq, SA				Harris, Violaine K.; Bell, Lena; Langan, Ruth -Anne; Tuddenham, John; Landy, Mark; Sadiq, Saud A.			Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response	PLOS ONE			English	Article							GROWTH-FACTOR; TGF-BETA; INTERLEUKIN-12; MIGRATION; CELLS	Fetuin-A is a biomarker of disease activity in multiple sclerosis. Our aim was to investigate whether Fetuin-A plays a direct role in the neuroinflammatory response in the mouse EAE model. Peak Fetuin-A expression in the CNS and in peripheral lymphoid tissue correlated with peak EAE disease activity. Fetuin-A-deficient mice showed reduced EAE severity associated with an accumulation of splenic monocyte and dendritic cell populations, increased IL-12p40, ASC1, and IL-1 beta expression, and an increase in T regulatory cells. The upregulation of Fetuin-A in LPS-stimulated dendritic cells and microglia further supports an intrinsic role of Fetuin-A in regulating innate immune activation during EAE.	[Harris, Violaine K.; Bell, Lena; Langan, Ruth -Anne; Tuddenham, John; Landy, Mark; Sadiq, Saud A.] Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA		Harris, VK (corresponding author), Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA.	vharris@tischms.org	Sadiq, Saud/AAA-9871-2020	Landy, Mark/0000-0002-2789-0774; Pai, Ruth-Anne/0000-0001-9413-7611; Harris, Violaine/0000-0002-3057-3059; Tuddenham, John/0000-0002-0186-2652	Shubert Foundation	Shubert Foundation	This research was supported by grants to SS from the Shubert Foundation. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Chatterjee P, 2013, J BIOL CHEM, V288, P28324, DOI 10.1074/jbc.C113.495473; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Du CG, 1998, J LEUKOCYTE BIOL, V64, P92, DOI 10.1002/jlb.64.1.92; Dziegielewska KM, 1998, IMMUNOL LETT, V60, P31, DOI 10.1016/S0165-2478(97)00126-0; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Harris VK, 2013, MULT SCLER J, V19, P1462, DOI 10.1177/1352458513477923; Harris VK, 2012, J NEUROL SCI, V313, P167, DOI 10.1016/j.jns.2011.08.036; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Heim CE, 2015, J IMMUNOL, V194, P3861, DOI 10.4049/jimmunol.1402689; Inoue M, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/859145; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Li HM, 2008, J IMMUNOL, V181, P2483, DOI 10.4049/jimmunol.181.4.2483; Mirshafiey A, 2009, NEUROPHARMACOLOGY, V56, P929, DOI 10.1016/j.neuropharm.2009.02.007; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Muccioli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2785; Ohnishi T, 1997, EUR J BIOCHEM, V243, P753, DOI 10.1111/j.1432-1033.1997.00753.x; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Pollak Y, 2000, J NEUROIMMUNOL, V104, P31, DOI 10.1016/S0165-5728(99)00257-X; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175575	10.1371/journal.pone.0175575	http://dx.doi.org/10.1371/journal.pone.0175575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388685	gold, Green Submitted, Green Published			2022-12-27	WOS:000399375800064
J	Schmidt, C; Fischer, T; Ruckert, RI; Oberwahrenbrock, T; Harms, L; Kronenberg, G; Kunte, H				Schmidt, Charlotte; Fischer, Thomas; Rueckert, Ralph-Ingo; Oberwahrenbrock, Timm; Harms, Lutz; Kronenberg, Golo; Kunte, Hagen			Identification of neovascularization by contrast-enhanced ultrasound to detect unstable carotid stenosis	PLOS ONE			English	Article							PLAQUE NEOVASCULARIZATION; INTRAPLAQUE NEOVASCULARIZATION; ATHEROSCLEROSIS; HEMORRHAGE; ARTERY; US; ANGIOGENESIS; INFLAMMATION; EXPRESSION; DISEASE	Background Plaque neovascularization accompanies local inflammation and critically contributes to plaque instability. Correct identification of intraplaque neovascularization by contrast-enhanced ultrasound (CEUS) may provide an additional risk marker in carotid stenosis. This pilot study investigates the correlation between histological evaluation of carotid plaque specimens and pre-surgery CEUS to identify neovascularization. Methods 17 patients with high-grade internal carotid artery (ICA) stenosis were studied. CEUS was performed in all patients shortly before carotid endarterectomy. Neovascularization, infiltration of T cells and macrophages along with intraplaque hemorrhage were studied in excised plaques by immunohistochemistry. Ultrasound-based four-level and two-level classification systems for neovascularization were used. CEUS findings were compared with histological findings. Results Scores on the CEUS-based four-level and two-level classifications were robustly correlated with the density of intraplaque vessels (r = 0.635, p = 0.006 and r = 0.578, p = 0.015, respectively). Histological evaluation of regions with strong and prolonged intraplaque enhancement typically showed strong intraplaque neovascularization in conjunction with acute intraplaque hemorrhage. Moreover, higher grades of intraplaque neovascularization as determined by ultrasound were associated with a higher percentage of macrophage-rich areas. Conclusion CEUS is a technique well suited to gauge the degree of neovascularization of carotid plaques. Future research will have to define the reliability and validity of CEUS in everyday clinical practice. Further, our study suggests that CEUS may also be useful to pick up features of vulnerable plaques such as acute intraplaque hemorrhages.	[Schmidt, Charlotte; Harms, Lutz; Kronenberg, Golo; Kunte, Hagen] Charite, Charite Ctr Neurol Neurosurg & Psychiat 15, Berlin, Germany; [Fischer, Thomas] Charite Univ Med Berlin, Inst Radiol, Berlin, Germany; [Rueckert, Ralph-Ingo] Franziskus Krankenhaus Berlin, Berlin, Germany; [Oberwahrenbrock, Timm] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Kronenberg, Golo] Univ Med Rostock, Klin & Poliklin Psychiat & Psychotherapie, Zentrum Nervenheilkunde, Rostock, Germany; [Kunte, Hagen] MSB Med Sch Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock	Kunte, H (corresponding author), Charite, Charite Ctr Neurol Neurosurg & Psychiat 15, Berlin, Germany.; Kunte, H (corresponding author), MSB Med Sch Berlin, Berlin, Germany.	hagen.kunte@charite.de		Kronenberg, Golo/0000-0002-5310-9849				Ammirati E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/718329; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Cattaneo M, 2016, INT J CARDIOL, V223, P917, DOI 10.1016/j.ijcard.2016.08.261; Coli S, 2008, J AM COLL CARDIOL, V52, P223, DOI 10.1016/j.jacc.2008.02.082; HENNERICI M, 1987, BRAIN, V110, P777, DOI 10.1093/brain/110.3.777; Hjelmgren O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166918; Huang PT, 2010, WORLD J CARDIOL, V2, P89, DOI 10.4330/wjc.v2.i4.89; Ibrahimi P, 2013, ATHEROSCLEROSIS, V231, P323, DOI 10.1016/j.atherosclerosis.2013.09.035; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kopriva D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143138; Kunte H, 2013, CASE REP VASC MED, V2013, P1; Kunte H, 2008, J VASC SURG, V47, P513, DOI 10.1016/j.jvs.2007.11.045; Kunte H, 2013, NEUROLOGY, V80, P122, DOI 10.1212/WNL.0b013e31827b1b06; Kunte H, 2012, NEUROLOGY, V79, P2081, DOI 10.1212/WNL.0b013e3182749f4c; Leong-Poi H, 2005, CIRCULATION, V111, P3248, DOI 10.1161/CIRCULATIONAHA.104.481515; Li CL, 2014, ULTRASOUND MED BIOL, V40, P1827, DOI 10.1016/j.ultrasmedbio.2014.02.010; Magnoni M, 2015, J CARDIOL, V65, P261, DOI 10.1016/j.jjcc.2015.01.004; Mangla R, 2011, RADIOGRAPHICS, V31, P1201, DOI 10.1148/rg.315105014; Moreno PR, 2006, CURR MOL MED, V6, P457, DOI 10.2174/156652406778018635; Owen DR, 2010, RADIOLOGY, V255, P638, DOI 10.1148/radiol.10091365; Partovi S, 2012, AM J ROENTGENOL, V198, pW13, DOI 10.2214/AJR.11.7312; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Rothwell PM, 2003, STROKE, V34, P514, DOI 10.1161/01.STR.0000054671.71777.C7; Saito K, 2014, STROKE, V45, P3073, DOI 10.1161/STROKEAHA.114.006483; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Staub D, 2010, STROKE, V41, P41, DOI 10.1161/STROKEAHA.109.560342; ten Kate GL, 2013, J VASC SURG, V57, P539, DOI 10.1016/j.jvs.2012.07.028; Teng ZZ, 2014, J BIOMECH, V47, P847, DOI 10.1016/j.jbiomech.2014.01.013; Thapar A, 2012, RADIOLOGY, V262, P672, DOI 10.1148/radiol.11110968; van Dijk AC, 2015, AM J NEURORADIOL, V36, P2127, DOI 10.3174/ajnr.A4414; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829; Yuan C, 1998, CIRCULATION, V98, P2666, DOI 10.1161/01.CIR.98.24.2666	33	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175331	10.1371/journal.pone.0175331	http://dx.doi.org/10.1371/journal.pone.0175331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388659	Green Published, gold, Green Submitted			2022-12-27	WOS:000399375800041
J	Abdelaziz, A; Fong, AT; Geni, A; Garba, U; Khan, S; Akhunzada, A; Talebian, H; Choo, KKR				Abdelaziz, Ahmed; Fong, Ang Tan; Geni, Abdullah; Garba, Usman; Khan, Suleman; Akhunzada, Adnan; Talebian, Hamid; Choo, Kim-Kwang Raymond			Distributed controller clustering in software defined networks	PLOS ONE			English	Article							FUTURE	Software Defined Networking (SDN) is an emerging promising paradigm for network management because of its centralized network intelligence. However, the centralized control architecture of the software-defined networks (SDNs) brings novel challenges of reliability, scalability, fault tolerance and interoperability. In this paper, we proposed a novel clustered distributed controller architecture in the real setting of SDNs. The distributed cluster implementation comprises of multiple popular SDN controllers. The proposed mechanism is evaluated using a real world network topology running on top of an emulated SDN environment. The result shows that the proposed distributed controller clustering mechanism is able to significantly reduce the average latency from 8.1% to 1.6%, the packet loss from 5.22% to 4.15%, compared to distributed controller without clustering running on HP Virtual Application Network (VAN) SDN and Open Network Operating System (ONOS) controllers respectively. Moreover, proposed method also shows reasonable CPU utilization results. Furthermore, the proposed mechanism makes possible to handle unexpected load fluctuations while maintaining a continuous network operation, even when there is a controller failure. The paper is a potential contribution stepping towards addressing the issues of reliability, scalability, fault tolerance, and inter-operability.	[Abdelaziz, Ahmed; Fong, Ang Tan; Geni, Abdullah; Garba, Usman; Talebian, Hamid] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Khan, Suleman] Monash Univ, Sch Informat Technol, Kuala Lumpur, Malaysia; [Akhunzada, Adnan] Comsats Inst Informat Technol, Dept Comp Sci, Islamabad, Pakistan; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX USA	Universiti Malaya; Monash University; Monash University Sunway; COMSATS University Islamabad (CUI); University of Texas System; University of Texas at San Antonio (UTSA)	Fong, AT (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	angtf@um.edu.my	Gani, Abdullah/C-2888-2009; Akhunzada, Adnan/N-7917-2017; Khan, Suleman/X-3827-2019; Choo, Kim-Kwang Raymond/A-3634-2009; Abdelaziz, ahmed/AAT-4539-2020; ANG, TAN FONG/B-5495-2010	Gani, Abdullah/0000-0002-4388-020X; Akhunzada, Adnan/0000-0001-8370-9290; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Abdelaziz, ahmed/0000-0002-3685-5997; ANG, TAN FONG/0000-0001-6819-3660; Garba, Usman Haruna/0000-0001-9627-2278; Khan, Suleman/0000-0003-1190-258X				Azodolmolky S., 2013, SOFTWARE DEFINED NET; Beheshti N, 2012, GLOB COMM C GLOBECOM; Chandrabose S. P, 2014, P 3 WORKSH HOT TOP S; DIXIT A., 2013, ACM SIGCOMM COMPUTER; Dixon C, 2014, IBM J RES DEV, V58, DOI 10.1147/JRD.2014.2300365; Feamster N, 2014, ACM SIGCOMM COMP COM, V44, P87, DOI 10.1145/2602204.2602219; Foukas X, 2013, SOFTWARE DEFINED NET; Guan X, 2013, RES ED EXP WORKSH GR; Gude N, 2008, ACM SIGCOMM COMP COM, V38, P105, DOI 10.1145/1384609.1384625; Hakiri A, 2014, COMPUT NETW, V75, P453, DOI 10.1016/j.comnet.2014.10.015; Hassas Yeganeh Soheil, 2012, P 1 WORKSH HOT TOP S; Heller B., 2012, P 1 WORKSH HOT TOP S; Hu Y., 2012, J CHINA U POSTTELECO, V19, P92, DOI 10.1016/s1005-8885(11)60438-x; Hu YN, 2014, CHINA COMMUN, V11, P38, DOI 10.1109/CC.2014.6821736; Jimenez Y, 2014, NETW C 2014 IFIP; Khan S., 2016, IEEE COMMUNICATIONS; Khan S, 2016, IEEE NETWORK, V30, P6, DOI 10.1109/MNET.2016.1600051NM; Knight S, 2011, IEEE J SEL AREA COMM, V29, P1765, DOI 10.1109/JSAC.2011.111002; Koponen T., 2010, ONIX DISTRIBUTED CON; Kreutz D, 2015, P IEEE, V103, P14, DOI 10.1109/JPROC.2014.2371999; Lantz B., 2010, P 9 ACM SIGCOMM WORK, P1; Lee YJ, 2005, IEEE WIR COMM NETW C; Metzler A., 2013, 10 THINGS LOOK SDN C; Mogul JC, 2010, P 9 ACM SIGCOMM WORK; Nunes BAA, 2014, IEEE COMMUN SURV TUT, V16, P1617, DOI 10.1109/SURV.2014.012214.00180; Stribling J, 2009, FLEXIBLE WIDE AREA S; Tahaei H, 2017, MEASUREMENT, V95, P317, DOI 10.1016/j.measurement.2016.10.026; Tavakoli A., 2009, P 8 ACM WORKSH HOT T; Tootoonchian A, 2012, PART 2 USENIX WORKSH; Tootoonchian A., 2010, PROC USENIX WORKSHOP; Urgaonkar R, 2010, 2010 IEEE NETW OP MA; Voellmy Andreas, 2012, P ACM SIGCOMM 2012 C; Yang M, 2014, J SYST ENG ELECTRON, V25, P934, DOI 10.1109/JSEE.2014.00107; Yazici V., 2014, ARXIV14017651; Yu M., 2011, COMPUT COMMUN REV, V41, P351, DOI DOI 10.1145/1851182.1851224	35	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174715	10.1371/journal.pone.0174715	http://dx.doi.org/10.1371/journal.pone.0174715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384312	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900030
J	Ke, CC; Lin, CS; Yeh, CC; Chung, CL; Hung, CJ; Liao, CC; Chen, TL				Ke, Chi-Chen; Lin, Chao-Shun; Yeh, Chun-Chieh; Chung, Chi-Li; Hung, Chih-Jen; Liao, Chien-Chang; Chen, Ta-Liang			Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study (vol 10, e0133064, 2015)	PLOS ONE			English	Correction									[Lin, Chao-Shun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ, Sch Med, Coll Med, Dept Anesthesiol, Taipei, Taiwan	Taipei Medical University								Ke CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133064	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175603	10.1371/journal.pone.0175603	http://dx.doi.org/10.1371/journal.pone.0175603			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384280	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900179
J	Onodera, Y; Takahashi, K; Goto, M; Anzai, M; Ono, N; Shirasawa, H; Sato, W; Miura, H; Sato, N; Sato, A; Kumazawa, Y; Terada, Y				Onodera, Yohei; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Ono, Natsuki; Shirasawa, Hiromitsu; Sato, Wataru; Miura, Hiroshi; Sato, Naoki; Sato, Akira; Kumazawa, Yukiyo; Terada, Yukihiro			The location of "8"-shaped hatching influences inner cell mass formation in mouse blastocysts	PLOS ONE			English	Article							IN-VITRO; ZONA-PELLUCIDA; TIME-LAPSE; EMBRYOS; TROPHECTODERM; IMPLANTATION	The hatching of a blastocyst where the blastocyst portions on the inside and the outside of the zona pellucida feature a figure-of-eight shape is termed "8"-shaped hatching; this type of hatching has been reported to affect the proper presentation of the inner cell mass (ICM) in both human and mouse embryos. Here, our aim was to investigate the factors that affect ICM presentation during "8"-shaped hatching. We performed IVF by using B6D2F1 female mice and ICR male mice, and used the 104 captured blastocysts. Embryos were maintained in KSOM at 37 degrees C in a 5% CO2, 5% O-2, and 90% N-2 environment, and their growth behavior was monitored individually and continuously using time-lapse cinematography. At 120 h after insemination, embryos were immunostained and examined under a confocal microscope. We used the hatching form to identify "8-shaped hatching, and we classified the "8" shaped- hatching blastocysts into two groups, one in which the hatching site was near the ICM center, and the other in which the hatching site was far from the ICM center. We measured each group for ICM size and the number of Oct3/4-positive cells. Of the 95 hatching or hatched embryos, 74 were "8"-shaped-hatching blastocysts, and in these embryos, the ICM was significantly wider when the hatching site was near the ICM than when the hatching site was far from the ICM (P = 0.0091). Moreover, in the "8"-shaped-hatching blastocysts in which the ICM was included in the blastocyst portion outside the zona pellucida. the portion defined as the "outside blastocyst". after the collapse of this outside blastocyst, the ICM adhered to the trophectoderm of the outside blastocyst, opposite the hatching site. Our results indicate that in "8"-shaped-hatching blastocysts, the hatching site and the collapse of outside blastocyst affect ICM formation. Thus, the assessment of "8"-shaped hatching behaviors could yield indices for accurately evaluating embryo quality.	[Onodera, Yohei; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Ono, Natsuki; Shirasawa, Hiromitsu; Sato, Wataru; Miura, Hiroshi; Sato, Naoki; Sato, Akira; Kumazawa, Yukiyo; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan	Akita University	Onodera, Y (corresponding author), Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan.	onoderay@med.akita-u.ac.jp			Japan Society for the Promotion of Science [26462473]; Grants-in-Aid for Scientific Research [15K15593] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https/7wwispsgoipterglisiitindexMoll, Grant Number 26462473).	Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Barcroft LC, 2003, DEV BIOL, V256, P342, DOI 10.1016/S0012-1606(02)00127-6; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Bodri D, 2016, FERTIL STERIL, V105, P1476, DOI 10.1016/j.fertnstert.2016.02.014; Cheon YP, 1999, ZYGOTE, V7, P123, DOI 10.1017/S0967199499000477; DeMeestere I, 1997, INT J FERTIL WOMEN M, V42, P219; EDWARDS R G, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P114, DOI 10.1007/BF01139357; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Kim J, 2004, MOL CELLS, V17, P248; Kirkegaard K, 2013, FERTIL STERIL, V100, P1277, DOI 10.1016/j.fertnstert.2013.07.005; Laeno AMA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109470; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; Marcos J, 2015, HUM REPROD, V30, P2501, DOI 10.1093/humrep/dev216; Mio Y Iwata K Yumoto K Maeda K ., 2014, J HLTH MED INFO, V5, P143, DOI DOI 10.4172/2157-7420.1000143; Mio Y, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.023; Miyata H, 2010, FERTIL STERIL, V94, P2444, DOI 10.1016/j.fertnstert.2010.01.056; Niimura S, 2003, J REPROD DEVELOP, V49, P413, DOI 10.1262/jrd.49.413; Otsuki J, 2016, FERTIL STERIL, V106, P640, DOI 10.1016/j.fertnstert.2016.05.007; PERONA RM, 1986, DEV BIOL, V114, P42, DOI 10.1016/0012-1606(86)90382-9; Richter KS, 2001, FERTIL STERIL, V76, P1157, DOI 10.1016/S0015-0282(01)02870-9; TALANSKY BE, 1988, GAMETE RES, V21, P277, DOI 10.1002/mrd.1120210309; Thomas M, 1997, J CELL SCI, V110, P1597; Togashi K, 2015, J ASSIST REPROD GEN, V32, P969, DOI 10.1007/s10815-015-0479-1; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; WATSON AJ, 1992, MOL REPROD DEV, V33, P492, DOI 10.1002/mrd.1080330417; Yan Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145172	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175150	10.1371/journal.pone.0175150	http://dx.doi.org/10.1371/journal.pone.0175150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384351	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900101
J	Vincent-Chong, VK; Salahshourifar, I; Woo, KM; Anwar, A; Razali, R; Gudimella, R; Rahman, ZAA; Ismail, SM; Kallarakkal, TG; Ramanathan, A; Mustafa, WMW; Abraham, MT; Tay, KK; Zain, RB				Vincent-Chong, Vui King; Salahshourifar, Iman; Woo, Kar Mun; Anwar, Arif; Razali, Rozaimi; Gudimella, Ranganath; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Kallarakkal, Thomas George; Ramanathan, Anand; Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Tay, Keng Kiong; Zain, Rosnah Binti			Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance	PLOS ONE			English	Article							DNA COPY NUMBER; CANCER; HEAD; BIOMARKERS; OVEREXPRESSION; PROGRESSION; ACTIVATION; EXPRESSION; DELETION; RISK	Background Cancers of the oral cavity are primarily oral squamous cell carcinomas (OSCCs). Many of the OSCCs present at late stages with an exceptionally poor prognosis. A probable limitation in management of patients with OSCC lies in the insufficient knowledge pertaining to the linkage between copy number alterations in OSCC and oral tumourigenesis thereby resulting in an inability to deliver targeted therapy. Objectives The current study aimed to identify copy number alterations (CNAs) in OSCC using array comparative genomic hybridization (array CGH) and to correlate the CNAs with clinico-pathologic parameters and clinical outcomes. Materials and methods Using array CGH, genome-wide profiling was performed on 75 OSCCs. Selected genes that were harboured in the frequently amplified and deleted regions were validated using quantitative polymerase chain reaction (qPCR). Thereafter, pathway and network functional analysis were carried out using Ingenuity Pathway Analysis (IPA) software. Results Multiple chromosomal regions including 3q, 5p, 7p, 8q, 9p, 10p, 11 q were frequently amplified, while 3p and 8p chromosomal regions were frequently deleted. These findings were in confirmation with our previous study using ultra-dense array CGH. In addition, amplification of 8q, 11q, 7p and 9p and deletion of 8p chromosomal regions showed a significant correlation with clinico-pathologic parameters such as the size of the tumour, metastatic lymph nodes and pathological staging. Co-amplification of 7p, 8q, 9p and 11q regions that harbored amplified genes namely CCND1, EGFR, TPM2 and LRP12 respectively, when combined, continues to be an independent prognostic factor in OSCC. Conclusion Amplification of 3q, 5p, 7p, 8q, 9p, 10p, 11q and deletion of 3p and 8p chromosomal regions were recurrent among OSCC patients. Co-alteration of 7p, 8q, 9p and 11q was found to be associated with clinico-pathologic parameters and poor survival. These regions contain genes that play critical roles in tumourigenesis pathways.	[Vincent-Chong, Vui King; Salahshourifar, Iman; Woo, Kar Mun; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Oral Canc Res & Coordinating Ctr, Fac Dent, Kuala Lumpur, Malaysia; [Vincent-Chong, Vui King; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Dept Oral & Maxillofacial Clin Sci, Fac Dent, Kuala Lumpur, Malaysia; [Salahshourifar, Iman] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran; [Anwar, Arif; Razali, Rozaimi; Gudimella, Ranganath] Sengen Sdn Bhd, High Impact Res HIR Bldg, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan] Hosp Kuala Lumpur, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Abraham, Mannil Thomas] Hosp Tengku Ampuan Rahimah, Dept Oral & Maxillofacial Surg, Klang, Selangor Darul, Malaysia; [Tay, Keng Kiong] Hosp Umum Kuching, Dept Oral Surg, Kuching, Sarawak, Malaysia	Universiti Malaya; Universiti Malaya; Islamic Azad University	Zain, RB (corresponding author), Univ Malaya, Oral Canc Res & Coordinating Ctr, Fac Dent, Kuala Lumpur, Malaysia.; Zain, RB (corresponding author), Univ Malaya, Dept Oral & Maxillofacial Clin Sci, Fac Dent, Kuala Lumpur, Malaysia.	rosnahbz12@yahoo.corn	Ramanathan, Anand/J-2943-2014; RAZALI, ROZAIMI/O-8694-2017; Razali, Rozaimi/AAF-9115-2021; George, Thomas/B-7774-2010	Ramanathan, Anand/0000-0001-6496-7139; RAZALI, ROZAIMI/0000-0002-8996-3975; Razali, Rozaimi/0000-0002-8996-3975; George, Thomas/0000-0002-5986-6170	High Impact Research MoE from the Ministry of Education Malaysia [UM.C/625/1/HIR/DENT/08]	High Impact Research MoE from the Ministry of Education Malaysia	This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/DENT/08 from the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; Ariffin OZ, 2011, NCR REPORT 2007; Bronstad I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-111; Chen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135074; Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Deschler DG, 2014, OTOLARYNG HEAD NECK, V151, P375, DOI 10.1177/0194599814538605; Dienstmann R, 2015, CANCER DISCOV, V5, P118, DOI 10.1158/2159-8290.CD-14-1118; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Ghani WMN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-82; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li Y, 2014, CANCER INFORM, V13, P129, DOI 10.4137/CIN.S14073; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Nieva P, 2012, CARCINOGENESIS, V33, P452, DOI 10.1093/carcin/bgr271; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Mendez E, 2009, CLIN CANCER RES, V15, P1353, DOI 10.1158/1078-0432.CCR-08-1816; Mutation C, 2015, NAT METHODS, V12, P615, DOI DOI 10.1038/NMETH.3440; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Que L, 2016, ONCOL REP, V35, P89, DOI 10.3892/or.2015.4374; Shah J P, 1990, Oncology (Williston Park), V4, P61; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Sobin LH, 2011, TNM CLASSIFICATION M; Toomes C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/gcc.10191; Towle R, 2014, CANCER MED-US, V3, P1170, DOI 10.1002/cam4.307; Uchida K, 2011, ONCOL REP, V26, P463, DOI 10.3892/or.2011.1327; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Viet CT, 2010, HEAD NECK-J SCI SPEC, V32, P1246, DOI 10.1002/hed.21358; Vincent-Chong VK, 2015, HEAD NECK; Vincent-Chong VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054705; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Woolgar JA, 2006, ORAL ONCOL, V42, P229, DOI 10.1016/j.oraloncology.2005.05.008; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Zain RB, 2013, CELL TISSUE BANK, V14, P45, DOI 10.1007/s10561-012-9298-0; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174865	10.1371/journal.pone.0174865	http://dx.doi.org/10.1371/journal.pone.0174865			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384287	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900045
J	Wong, E; Sastri, AR; Lin, FS; Hsieh, CH				Wong, Esther; Sastri, Akash R.; Lin, Fan-Sian; Hsieh, Chih-hao			Modified FlowCAM procedure for quantifying size distribution of zooplankton with sample recycling capacity	PLOS ONE			English	Article							EAST CHINA SEA; BODY-SIZE; METABOLIC THEORY; GROWTH-RATES; ECOLOGY	We have developed a modified FlowCAM procedure for efficiently quantifying the size distribution of zooplankton. The modified method offers the following new features: 1) prevents animals from settling and clogging with constant bubbling in the sample container; 2) prevents damage to sample animals and facilitates recycling by replacing the built-in peristaltic pump with an external syringe pump, in order to generate negative pressure, creates a steady flow by drawing air from the receiving conical flask (i.e. vacuum pump), and transfers plankton from the sample container toward the main flowcell of the imaging system and finally into the receiving flask; 3) aligns samples in advance of imaging and prevents clogging with an additional flowcell placed ahead of the main flowcell. These modifications were designed to overcome the difficulties applying the standard FlowCAM procedure to studies where the number of individuals per sample is small, and since the FlowCAM can only image a subset of a sample. Our effective recycling procedure allows users to pass the same sample through the FlowCAM many times (i.e. bootstrapping the sample) in order to generate a good size distribution. Although more advanced FlowCAM models are equipped with syringe pump and Field of View (FOV) flowcells which can image all particles passing through the flow field; we note that these advanced setups are very expensive, offer limited syringe and flowcell sizes, and do not guarantee recycling. In contrast, our modifications are inexpensive and flexible. Finally, we compared the biovolumes estimated by automated FlowCAM image analysis versus conventional manual measurements, and found that the size of an individual zooplankter can be estimated by the FlowCAM image system after ground truthing.	[Wong, Esther; Lin, Fan-Sian; Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Wong, Esther] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Sastri, Akash R.] Univ Victoria, Ocean Networks Canada, Victoria, BC, Canada; [Sastri, Akash R.] Univ Victoria, Biol Dept, Victoria, BC, Canada; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Dept Life Sci, Taipei, Taiwan; [Hsieh, Chih-hao] Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan; [Hsieh, Chih-hao] Natl Ctr Theoret Sci, Taipei, Taiwan	National Taiwan University; Hong Kong University of Science & Technology; University of Victoria; University of Victoria; National Taiwan University; Academia Sinica - Taiwan	Hsieh, CH (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.; Hsieh, CH (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Dept Life Sci, Taipei, Taiwan.; Hsieh, CH (corresponding author), Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan.; Hsieh, CH (corresponding author), Natl Ctr Theoret Sci, Taipei, Taiwan.	chsieh@ntu.edu.tw	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272	National Center for Theoretical Sciences; Foundation for the Advancement of Outstanding Scholarship; Ministry of Science and Technology of Taiwan	National Center for Theoretical Sciences; Foundation for the Advancement of Outstanding Scholarship; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by the National Center for Theoretical Sciences, Foundation for the Advancement of Outstanding Scholarship, and Ministry of Science and Technology of Taiwan to CHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2014, J PLANKTON RES, V36, P170, DOI 10.1093/plankt/fbt069; Alvarez E, 2012, J PLANKTON RES, V34, P454, DOI 10.1093/plankt/fbs017; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Buskey EJ, 2006, HARMFUL ALGAE, V5, P685, DOI 10.1016/j.hal.2006.02.003; Chang CW, 2014, ECOLOGY, V95, P897, DOI 10.1890/13-0742.1; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Garcia-Comas C, 2016, J PLANKTON RES, V38, P1006, DOI 10.1093/plankt/fbw039; Garcia-Comas C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2129; Garcia-Comas C, 2014, PROG OCEANOGR, V121, P141, DOI 10.1016/j.pocean.2013.10.010; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Ide K, 2008, J PLANKTON RES, V30, P275, DOI 10.1093/plankt/fbm108; Kimmerer WJ, 2007, MAR ECOL PROG SER, V336, P187, DOI 10.3354/meps336187; Krupica KL, 2012, CONT SHELF RES, V36, P29, DOI 10.1016/j.csr.2012.01.008; Le Bourg B, 2015, J PLANKTON RES, V37, P666, DOI 10.1093/plankt/fbv025; Lin KY, 2013, BIOGEOSCIENCES, V10, P1877, DOI 10.5194/bg-10-1877-2013; Litchman E, 2013, J PLANKTON RES, V35, P473, DOI 10.1093/plankt/fbt019; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; SHELDON RW, 1967, J FISH RES BOARD CAN, V24, P909, DOI 10.1139/f67-081; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327	20	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175235	10.1371/journal.pone.0175235	http://dx.doi.org/10.1371/journal.pone.0175235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384288	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900130
J	Yuan, J; Hou, L; Wei, X; Shang, ZC; Cheng, F; Zhang, SX				Yuan, Jie; Hou, Lin; Wei, Xin; Shang, Zhengchun; Cheng, Fei; Zhang, Shuoxin			Decay and nutrient dynamics of coarse woody debris in the Qinling Mountains, China	PLOS ONE			English	Article							MIXED-CONIFER FORESTS; BROAD-LEAVED FOREST; DECOMPOSITION RATES; DEAD TREES; NATIONAL-PARK; CARBON; TEMPERATE; CHRONOSEQUENCE; ATTRIBUTES; NITROGEN	As an ecological unit, coarse woody debris (CWD) plays an essential role in productivity, nutrient cycling, carbon sequestration, community regeneration and biodiversity. However, thus far, the information on quantification the decomposition and nutrient content of CWD in forest ecosystems remains considerably limited. In this study, we conducted a long-term (1996-2013) study on decay and nutrient dynamics of CWD for evaluating accurately the ecological value of CWD on the Huoditang Experimental Forest Farm in the Qinling Mountains, China. The results demonstrated that there was a strong correlation between forest biomass and CWD mass. The single exponential decay model well fit the CWD density loss at this site, and as the CWD decomposed, the CWD density decreased significantly. Annual temperature and precipitation were all significantly correlated with the annual mass decay rate. The K contents and the C/ N ratio of the CWD decreased as the CWD decayed, but the C, N, P, Ca and Mg contents increased. We observed a significant CWD decay effect on the soil C, N and Mg contents, especially the soil C content. The soil N, P, K, Ca and Mg contents exhibited large fluctuations, but the variation had no obvious regularity and changed with different decay times. The results showed that CWD was a critical component of nutrient cycling in forest ecosystems. Further research is needed to determine the effect of diameter, plant tissue components, secondary wood compounds, and decomposer organisms on the CWD decay rates in the Qinling Mountains, which will be beneficial to clarifying the role of CWD in carbon cycles of forest ecosystems.	[Yuan, Jie; Hou, Lin; Wei, Xin; Shang, Zhengchun; Cheng, Fei; Zhang, Shuoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Hou, Lin; Zhang, Shuoxin] Qinling Natl Forest Ecosyst Res Stn, Ningshan, Shaanxi, Peoples R China; [Shang, Zhengchun] Yangtze Univ, Coll Agr, Jingzhou, Hubei, Peoples R China	Northwest A&F University - China; Yangtze University	Zhang, SX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.; Zhang, SX (corresponding author), Qinling Natl Forest Ecosyst Res Stn, Ningshan, Shaanxi, Peoples R China.	sxzhang@nwsuaf.edu.cn		Yuan, Jie/0000-0002-5094-7441	State Forestry Administration of China [201004036]	State Forestry Administration of China	This research was funded by the project of Technical management system for increasing the capacity of carbon sink and water regulation of mountain forests in the Qinling Mountains (201004036) from the State Forestry Administration of China. Shuoxin Zhang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakala T, 2008, FOREST ECOL MANAG, V255, P410, DOI 10.1016/j.foreco.2007.09.008; Aakala T, 2007, CAN J FOREST RES, V37, P50, DOI 10.1139/X06-201; ARTHUR MA, 1990, CAN J FOREST RES, V20, P730, DOI 10.1139/x90-096; Baker TR, 2007, OECOLOGIA, V152, P495, DOI 10.1007/s00442-007-0667-5; Beets PN, 2008, FOREST ECOL MANAG, V256, P548, DOI 10.1016/j.foreco.2008.05.036; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Brais S, 2005, FOREST ECOL MANAG, V220, P216, DOI 10.1016/j.foreco.2005.08.013; Brischke C, 2008, WOOD SCI TECHNOL, V42, P663, DOI 10.1007/s00226-008-0190-9; Brown PM, 1998, CAN J FOREST RES, V28, P932, DOI 10.1139/cjfr-28-6-932; BUSSE MD, 1994, SOIL SCI SOC AM J, V58, P221, DOI 10.2136/sssaj1994.03615995005800010033x; Carmona MR, 2002, FOREST ECOL MANAG, V164, P265, DOI 10.1016/S0378-1127(01)00602-8; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Chen C., 1996, J NW FOR COLL, V11, P92; Chen H., 1992, CHINESE J APPL ECOLO, V3, P99; Chen H, 1991, CHINESE J ECOL, V10, P45; Chen H, 1992, CHINESE J ECOL, V11, P17; Clark DB, 2002, FOREST ECOL MANAG, V164, P237, DOI 10.1016/S0378-1127(01)00597-7; Creed IF, 2004, CAN J FOREST RES, V34, P744, DOI 10.1139/X03-212; Dai LM, 2000, CHINESE J APPL ECOLO, V13, P107; Dunn CJ, 2012, FOREST ECOL MANAG, V276, P71, DOI 10.1016/j.foreco.2012.03.013; FAHEY TJ, 1983, ECOL MONOGR, V53, P51, DOI 10.2307/1942587; Fraver S, 2013, ECOSYSTEMS, V16, P1262, DOI 10.1007/s10021-013-9682-z; Fravolini G, 2016, SCI TOTAL ENVIRON, V569, P1064, DOI 10.1016/j.scitotenv.2016.06.167; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Ganjegunte GK, 2004, FOREST ECOL MANAG, V187, P197, DOI 10.1016/S0378-1127(03)00332-3; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Garrett Loretta, 2007, New Zealand Journal of Forestry Science, V37, P227; Ge XG, 2013, SOIL SCI, V178, P442, DOI 10.1097/SS.0000000000000004; Goldin SR, 2015, APPL VEG SCI, V18, P134, DOI 10.1111/avsc.12120; Gough CM, 2007, FOREST ECOL MANAG, V244, P60, DOI 10.1016/j.foreco.2007.03.039; Graham SA, 1925, ECOLOGY, V6, P397, DOI 10.2307/1929106; Harmon M.E., 1996, GUIDELINES MEASUREME; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1987, CAN J FOREST RES, V17, P1265, DOI 10.1139/x87-196; Holub SM, 2001, CAN J FOREST RES, V31, P1894, DOI 10.1139/cjfr-31-11-1894; Hou Ping, 2001, Yingyong Shengtai Xuebao, V12, P309; Janisch JE, 2002, TREE PHYSIOL, V22, P77, DOI 10.1093/treephys/22.2-3.77; Janisch JE, 2005, ECOSCIENCE, V12, P151, DOI 10.2980/i1195-6860-12-2-151.1; Jomura M, 2008, FOREST ECOL MANAG, V255, P149, DOI 10.1016/j.foreco.2007.09.002; Kang Y.X., 1996, J NW FORESTRY COLL, V11, P1; Kim RH, 2006, ECOL RES, V21, P819, DOI 10.1007/s11284-006-0034-8; Krankina ON, 1999, CAN J FOREST RES, V29, P20, DOI 10.1139/cjfr-29-1-20; Laiho R, 2004, CAN J FOREST RES, V34, P763, DOI 10.1139/X03-241; Laiho R, 1999, CAN J FOREST RES, V29, P1592, DOI 10.1139/cjfr-29-10-1592; Lei R.D., 1996, J NW FORESTRY COLL, V11, P43; LI LH, 1996, ACTA PHYTOECOLOGICA, V20, P132; Li LH, 1998, ACTA PHYTOECOL SIN, V22, P434; Li Zhou, 2007, Journal of Forestry Research (Harbin), V18, P48, DOI 10.1007/s11676-007-0009-9; Liu WenYao, 1995, Acta Botanica Sinica, V37, P807; Liu YanYan, 2010, Scientia Silvae Sinicae, V46, P8; Lu Ming-he, 2006, Journal of Tropical and Subtropical Botany, V14, P107; Mac Nally R, 2001, BIOL CONSERV, V99, P191, DOI 10.1016/S0006-3207(00)00180-4; Mackensen J, 2003, AUST J BOT, V51, P27, DOI 10.1071/BT02014; MARRA JL, 1994, CAN J FOREST RES, V24, P1811, DOI 10.1139/x94-234; Muller-Using S, 2009, EUR J FOREST RES, V128, P287, DOI 10.1007/s10342-009-0264-8; Nilsson SG, 2002, FOREST ECOL MANAG, V161, P189, DOI 10.1016/S0378-1127(01)00480-7; Olajuyigbe SO, 2011, FOREST ECOL MANAG, V262, P1109, DOI 10.1016/j.foreco.2011.06.010; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Palviainen M, 2010, FOREST ECOL MANAG, V259, P390, DOI 10.1016/j.foreco.2009.10.034; Pedlar JH, 2002, FOREST ECOL MANAG, V158, P189, DOI 10.1016/S0378-1127(00)00711-8; Preston CM, 1998, FOREST ECOL MANAG, V111, P51, DOI 10.1016/S0378-1127(98)00307-7; Ringvall A, 1999, FOREST ECOL MANAG, V119, P163, DOI 10.1016/S0378-1127(98)00521-0; Santiago LS, 2000, BIOTROPICA, V32, P633, DOI 10.1646/0006-3606(2000)032[0633:UOCWDB]2.0.CO;2; Silva LFSG, 2016, FOREST ECOL MANAG, V364, P1, DOI 10.1016/j.foreco.2015.12.045; Sefidi K, 2016, IFOREST, V9, P658, DOI 10.3832/ifor1080-008; Shorohova E, 2014, FOREST ECOL MANAG, V315, P173, DOI 10.1016/j.foreco.2013.12.025; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; SOLLINS P, 1987, CAN J FOREST RES, V17, P1585, DOI 10.1139/x87-243; Spears JDH, 2003, CAN J FOREST RES, V33, P2193, DOI 10.1139/X03-148; Stevenson SK, 2006, FOREST ECOL MANAG, V233, P176, DOI 10.1016/j.foreco.2006.06.023; Stewart GH, 2011, CANADIAN J FOREST RE, V24, P1989; Stone JN, 1998, CAN J FOREST RES, V28, P788, DOI 10.1139/cjfr-28-5-788; [唐旭利 Tang Xuli], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P484; Tobin B, 2007, FORESTRY, V80, P455, DOI 10.1093/forestry/cpm024; Wang CK, 2002, OECOLOGIA, V132, P374, DOI 10.1007/s00442-002-0987-4; Wang Wen-juan, 2009, Yingyong Shengtai Xuebao, V20, P773; Weedon JT, 2009, ECOL LETT, V12, P45, DOI 10.1111/j.1461-0248.2008.01259.x; Wei X, 2011, CANADIAN J FOREST RE, V27, P148, DOI DOI 10.1139/X96-169; Wenger KF, 1984, FORESTRY HDB, VSecond; Wilcke W, 2005, FOREST ECOL MANAG, V205, P139, DOI 10.1016/j.foreco.2004.10.044; Woodall Christopher W, 2008, Carbon Balance Manag, V3, P5, DOI 10.1186/1750-0680-3-5; World Reference Base for Soil Resources, 2014, WORLD SOIL RESOURCES, V106; Wu Jia-bing, 2005, Journal of Forestry Research (Harbin), V16, P247, DOI 10.1007/BF02856826; Yamashita S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131510; Yan E., 2006, FRONTIERS BIOL CHINA, V1, P76, DOI [10.1007/s11515-005-0019-y, DOI 10.1007/S11515-005-0019-Y]; Yang FF, 2010, FOREST ECOL MANAG, V259, P1666, DOI 10.1016/j.foreco.2010.01.046; Yang Li-pan, 2007, Yingyong Shengtai Xuebao, V18, P2153; Yang LY, 2002, CHIN J APPL ECOL, V13, P1069; Yatskov M, 2003, CAN J FOREST RES, V33, P1211, DOI [10.1139/x03-033, 10.1139/X03-033]; Yuan Jie, 2014, Acta Ecologica Sinica - International Journal, V34, P232, DOI 10.1016/j.chnaes.2014.05.001; [袁杰 YUAN Jie], 2011, [西北林学院学报, Journal of Northwest Forestry College], V26, P90; Zell J, 2009, ECOL MODEL, V220, P904, DOI 10.1016/j.ecolmodel.2009.01.020; Zhang, 2010, J SUBTROP RESOUR ENV, V5, P46; [张修玉 ZHANG Xiu-Yu], 2009, [生态学报, Acta Ecologica Sinica], V29, P5227; Zhao XH, 1995, J JILIN FORESTRY U, V11, P200; [赵玉涛 Zhao Yutao], 2002, [山地学报, Journal of mountain science], V20, P12; ZIMMERMAN JK, 1995, OIKOS, V72, P314, DOI 10.2307/3546116	98	19	21	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175203	10.1371/journal.pone.0175203	http://dx.doi.org/10.1371/journal.pone.0175203			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384317	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900118
J	Chereau, F; Madec, Y; Sabina, C; Obel, N; Ruiz-Mateos, E; Chrysos, G; Fidler, S; Lehmann, C; Zangerle, R; Wittkop, L; Reiss, P; Hamouda, O; Perez, VE; Leal, M; Mocroft, A; De Olalla, PG; Ammassari, A; Monforte, AD; Mussini, C; Segura, F; Castagna, A; Cavassini, M; Grabar, S; Morlat, P; De Wit, S; Lambotte, O; Meyer, L				Chereau, Fanny; Madec, Yoann; Sabina, Caroline; Obel, Niels; Ruiz-Mateos, Ezequiel; Chrysos, Georgios; Fidler, Sarah; Lehmann, Clara; Zangerle, Robert; Wittkop, Linda; Reiss, Peter; Hamouda, Osamah; Estrada Perez, Vicente; Leal, Manuel; Mocroft, Amanda; Garcia De Olalla, Patricia; Ammassari, Adriana; Monforte, Antonella D'Arminio; Mussini, Cristina; Segura, Ferran; Castagna, Antonella; Cavassini, Matthias; Grabar, Sophie; Morlat, Philippe; De Wit, Stephane; Lambotte, Olivier; Meyer, Laurence		HIV Controllers Project; Collaboration Observational HIV	Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; T-CELLS; INVERSE PROBABILITY; NATURAL-HISTORY; RNA LEVELS; INFECTION; PROGRESSION; REPLICATION; ACTIVATION; ABSENCE	Objective HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. The objective was to identify factors associated with loss of virological control. Methods HICs were identified in COHERE on the basis of >= 5 consecutive viral loads (VL) <= 500 copies/mL over >= 1 year whilst ART-naive, with the last VL <= 500 copies/mL measured >= 5 years after HIV diagnosis. Loss of virological control was defined as 2 consecutive VL > 2000 copies/mL. Duration of HIV control was described using cumulative incidence method, considering loss of virological control, ART initiation and death during virological control as competing outcomes. Factors associated with loss of virological control were identified using Cox models. CD4 and CD8 dynamics were described using mixed-effect linear models. Results We identified 1067 HICs; 86 lost virological control, 293 initiated ART, and 13 died during virological control. Six years after confirmation of HIC status, the probability of losing virological control, initiating ART and dying were 13%, 37%, and 2%. Current lower CD4/CD8 ratio and a history of transient viral rebounds were associated with an increased risk of losing virological control. CD4 declined and CD8 increased before loss of virological control, and before viral rebounds. Discussion Expansion of CD8 and decline of CD4 during HIV control may result from repeated low-level viremia. Our findings suggest that in addition to superinfection, other mechanisms, such as low grade viral replication, can lead to loss of virological control in HICs.	[Chereau, Fanny; Meyer, Laurence] Univ Paris Saclay, Le Kremlin Bicetre, France; [Chereau, Fanny; Meyer, Laurence] Univ Paris Sud, Le Kremlin Bicetre, France; [Chereau, Fanny; Meyer, Laurence] Univ Versailles Saint Quentin en Yvelines, Le Kremlin Bicetre, France; [Chereau, Fanny; Meyer, Laurence] INSERM, CESP, U1018, Le Kremlin Bicetre, France; [Madec, Yoann] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Sabina, Caroline; Mocroft, Amanda] UCL, Res Dept Infect & Populat Hlth, Royal Free Campus,Rowland Hill St, London, England; [Obel, Niels] Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Ruiz-Mateos, Ezequiel; Leal, Manuel] Univ Seville, Virgen Rocio Univ Hosp CSIC, Inst Biomed Seville, Lab Immunovirol,Clin Unit Infect Dis Microbiol &, Seville, Spain; [Chrysos, Georgios] Tzaneio Gen Hosp Piraeus, Infect Dis Unit, Dept Med, Piraeus, Greece; [Fidler, Sarah] Imperial Coll, London, England; [Lehmann, Clara] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Lehmann, Clara] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany; [Zangerle, Robert] Med Univ Innsbruck, Dept Dermatol & Venereol, Innsbruck, Austria; [Wittkop, Linda] Univ Bordeaux, ISPED,Serv Informat Med, INSERM,Pole Sante Publ,Ctr INSERM, Bordeaux Populat Hlth,U1219, Bordeaux, France; [Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Reiss, Peter] Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Hamouda, Osamah] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Estrada Perez, Vicente] IdISSC Univ Complutense, Hosp Clin San Carlos, Madrid, Spain; [Garcia De Olalla, Patricia] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Garcia De Olalla, Patricia] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Ammassari, Adriana] IRCCS, Ist Nazl Malattie Infett L Spallanzani, Rome, Italy; [Monforte, Antonella D'Arminio] Univ Hosp, ASST Santi Paolo & Carlo, Dept Hlth Sci, Infect Dis Unit, Milan, Italy; [Mussini, Cristina] Univ Modena & Reggio Emilia, Clin Infect Dis, Modena, Italy; [Segura, Ferran] Parc Tauli Hosp Univ, Infect Dis Serv, Barcelona, Spain; [Segura, Ferran] Univ Autonoma Barcelona, Barcelona, Spain; [Castagna, Antonella] San Raffaele Vita Salute Univ, Milan, Italy; [Cavassini, Matthias] Univ Lausanne, Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Grabar, Sophie] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Grabar, Sophie] UPMC Univ Paris 06, Paris, France; [Grabar, Sophie] Univ Paris 05, Hop Cochin Hotel Dieu Paris, Paris, France; [Morlat, Philippe] Univ Bordeaux, CHU Bordeaux, INSERM, Serv Med Interne & Malad Infectieuses,U1219, Bordeaux, France; [De Wit, Stephane] Univ Libre Bruxelles, St Pierre Univ Hosp, Dept Infect Dis, Brussels, Belgium; [Lambotte, Olivier] Univ Paris Sud, UMR 1184, Le Kremlin Bicetre, France; [Lambotte, Olivier] IDMIT, DSV iMETI, CEA, Fontenay Aux Roses, France; [Lambotte, Olivier] INSERM, Immunol Viral Infect & Autoimmune Dis, U1184, Le Kremlin Bicetre, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Rigshospitalet; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Imperial College London; University of Cologne; German Center for Infection Research; University of Cologne; Medical University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Amsterdam; Academic Medical Center Amsterdam; Robert Koch Institute; Hospital Clinico San Carlos; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; IRCCS Lazzaro Spallanzani; Universita di Modena e Reggio Emilia; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Vita-Salute San Raffaele University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Libre de Bruxelles; Vrije Universiteit Brussel; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Meyer, L (corresponding author), Univ Paris Saclay, Le Kremlin Bicetre, France.; Meyer, L (corresponding author), Univ Paris Sud, Le Kremlin Bicetre, France.; Meyer, L (corresponding author), Univ Versailles Saint Quentin en Yvelines, Le Kremlin Bicetre, France.; Meyer, L (corresponding author), INSERM, CESP, U1018, Le Kremlin Bicetre, France.	laurence.meyer@inserm.fr	Perez Hoyos, Santiago/O-1075-2019; Sabin, Caroline/C-2464-2008; Grabar, Sophie/AAM-9857-2020; Castagna, Antonella/K-3280-2018; Lambotte, Olivier/GRT-0160-2022; Antinori, Andrea/K-7125-2016; DORRUCCI, MARIA/C-6485-2016; Ruiz-Mateos, Ezequiel/P-9741-2019; Mussini, Cristina/K-8672-2016; Wittkop, Linda/E-3319-2014; cavassini, matthias/F-8987-2017; Kouyos, Roger/G-6226-2014	Perez Hoyos, Santiago/0000-0001-9797-4917; Sabin, Caroline/0000-0001-5173-2760; Castagna, Antonella/0000-0002-8338-9714; Antinori, Andrea/0000-0003-2121-4684; DORRUCCI, MARIA/0000-0002-8543-6430; Ruiz-Mateos, Ezequiel/0000-0001-6747-7813; Mussini, Cristina/0000-0002-6615-4198; Wittkop, Linda/0000-0003-2403-0960; Obel, Niels/0000-0002-5031-0045; van der Valk, Marc/0000-0002-8290-6425; Ammassari, Adriana/0000-0002-0284-0340; Chereau, Fanny/0000-0002-5651-9800; cavassini, matthias/0000-0003-0933-7833; Egger, Matthias/0000-0001-7462-5132; Puoti, Massimo/0000-0003-3278-7138; Fidler, Sarah/0000-0003-1676-7583; Kouyos, Roger/0000-0002-9220-8348; Madec, Yoann/0000-0002-6201-1261	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, The Netherlands; Augustinus Foundation, Denmark; European Union [260694]; Medical Research Council [MR/M004236/1, MR/L00528X/1] Funding Source: researchfish; MRC [MR/M004236/1, MR/L00528X/1] Funding Source: UKRI	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France(ANRS); HIV Monitoring Foundation, The Netherlands(Netherlands Government); Augustinus Foundation, Denmark; European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The COHERE study group has received unrestricted funding from: Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, The Netherlands; and the Augustinus Foundation, Denmark. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. A list of the funders of the participating cohorts can be found at www.COHERE.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boufassa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018726; Cabrera-Munoz E, 2012, MINI-REV MED CHEM, V12, P1049, DOI 10.2174/138955712802762185; Cao W, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20697; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; European AIDS Clinical Society, GUID 2015 VERS 8; Fine JP, 2012, J AM STAT ASS; Geskus RB, 2015, DATA ANAL COMPETING, V82; Goujard C, 2009, CLIN INFECT DIS, V49, P982, DOI 10.1086/605504; Huang XJ, 2013, JAIDS-J ACQ IMM DEF, V62, P441, DOI 10.1097/QAI.0b013e31827f5c9a; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Krantz EM, 2011, JAIDS-J ACQ IMM DEF, V57, P396, DOI 10.1097/QAI.0b013e318221c62a; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Leon A, 2016, AIDS, V30, P1209, DOI 10.1097/QAD.0000000000001050; Lodi S, 2010, AIDS, V24, P2697, DOI 10.1097/QAD.0b013e32833ef6c4; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2013, AIDS, V27, P2451, DOI 10.1097/01.aids.0000431945.72365.01; Noel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131922; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Peris-Pertusa A, 2010, JAIDS-J ACQ IMM DEF, V55, P29, DOI 10.1097/QAI.0b013e3181e69609; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Rachinger A, 2008, CLIN INFECT DIS, V47, pE86, DOI 10.1086/592978; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; van der Wal WM, 2011, J STAT SOFTW, V43, P1; van Geloven N, 2014, STAT MED, V33, P4671, DOI 10.1002/sim.6280; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; World Health Organization, CONS GUID US ANT DRU	36	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173893	10.1371/journal.pone.0173893	http://dx.doi.org/10.1371/journal.pone.0173893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380038	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500028
J	Feng, GZ; An, BG; Yang, FQ; Wang, H; Zhang, LB				Feng, Guozhong; An, Baiguo; Yang, Fengqin; Wang, Han; Zhang, Libiao			Relevance popularity: A term event model based feature selection scheme for text classification	PLOS ONE			English	Article							ALGORITHM; METRICS	Feature selection is a practical approach for improving the performance of text classification methods by optimizing the feature subsets input to classifiers. In traditional feature selection methods such as information gain and chi-square, the number of documents that contain a particular term (i.e. the document frequency) is often used. However, the frequency of a given term appearing in each document has not been fully investigated, even though it is a promising feature to produce accurate classifications. In this paper, we propose a new feature selection scheme based on a term event Multinomial naive Bayes probabilistic model. According to the model assumptions, the matching score function, which is based on the prediction probability ratio, can be factorized. Finally, we derive a feature selection measurement for each term after replacing inner parameters by their estimators. On a benchmark English text datasets (20 Newsgroups) and a Chinese text dataset (MPH-20), our numerical experiment results obtained from using two widely used text classifiers (naive Bayes and support vector machine) demonstrate that our method outperformed the representative feature selection methods.	[Feng, Guozhong; Yang, Fengqin; Wang, Han; Zhang, Libiao] Northeast Normal Univ, Sch Comp Sci & Informat Technol, Key Lab Intelligent Informat Proc Jilin Univ, Changchun 130117, Peoples R China; [Feng, Guozhong] Northeast Normal Univ, Key Lab Appl Stat, MOE, Changchun 130024, Peoples R China; [Feng, Guozhong; Wang, Han] Northeast Normal Univ, Inst Computat Biol, Changchun 130117, Peoples R China; [An, Baiguo] Capital Univ Econ & Business, Sch Stat, Beijing 100070, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Capital University of Economics & Business	Zhang, LB (corresponding author), Northeast Normal Univ, Sch Comp Sci & Informat Technol, Key Lab Intelligent Informat Proc Jilin Univ, Changchun 130117, Peoples R China.	lbzhang@nenu.edu.cn	Wang, Han/GPT-0015-2022	Feng, Guozhong/0000-0002-1953-2766	National Natural Science Funds of China [11501095, 11601349, 61402098, 61403400]; Jilin Provincial Science and Technology Department of China [20170520051JH, 20170204002GX, 20140520072JH, 20140520076JH]; Jilin Province Development and Reform Committee of China [2013C036-5, [2013]779, 2014Y097, 2015Y056, 2014Y10]; Scientific Research Level Improvement Quota Project of Capital University of Economics and Business,; Changchun Science and Technology Bureau of China [14KP009]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science and Technology Department of China; Jilin Province Development and Reform Committee of China; Scientific Research Level Improvement Quota Project of Capital University of Economics and Business,; Changchun Science and Technology Bureau of China	This work was supported by the National Natural Science Funds of China (11501095, 11601349, 61402098, 61403400), Jilin Provincial Science and Technology Department of China (20170520051JH, 20170204002GX, 20140520072JH, 20140520076JH), Jilin Province Development and Reform Committee of China (2013C036-5, [2013]779, 2014Y097, 2015Y056, 2014Y100), Scientific Research Level Improvement Quota Project of Capital University of Economics and Business, Changchun Science and Technology Bureau of China (14KP009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubaid H, 2016, 2016 WORLD SYMPOSIUM ON COMPUTER APPLICATIONS & RESEARCH (WSCAR), P47, DOI 10.1109/WSCAR.2016.26; Cai D., 2010, PROC 16 ACM SIGKDD I, P333, DOI 10.1145/1835804.1835848; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Debole F, 2004, STUD FUZZ SOFT COMP, V138, P81; Deng Z.-H., 2004, AS PAC WEB C; Erenel Z, 2012, ENG APPL ARTIF INTEL, V25, P1505, DOI 10.1016/j.engappai.2012.06.013; Feng GZ, 2015, PATTERN RECOGN LETT, V65, P109, DOI 10.1016/j.patrec.2015.07.028; Feng GZ, 2012, INFORM PROCESS MANAG, V48, P283, DOI 10.1016/j.ipm.2011.08.002; Ge RQ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0990-0; GLASSER GJ, 1962, J AM STAT ASSOC, V57, P648, DOI 10.2307/2282402; Jones KS, 2000, INFORM PROCESS MANAG, V36, P779, DOI DOI 10.1016/S0306-4573(00)00015-7; Jurafsky Dan, 2014, SPEECH LANGUAGE PROC, V3; Lan M., 2005, INT S NEUR NETW; Lan M, 2009, IEEE T PATTERN ANAL, V31, P721, DOI 10.1109/TPAMI.2008.110; Lewis D. D., 1998, LECT NOTES COMPUTER, P4, DOI DOI 10.1007/BFB0026666; Li YJ, 2008, IEEE T KNOWL DATA EN, V20, P641, DOI 10.1109/TKDE.2007.190740; Lin YJ, 2016, INFORM SCIENCES, V372, P256, DOI 10.1016/j.ins.2016.08.039; Liu L., 2015, MATH PROBL ENG; Liu M, 2014, INFORM SCIENCES, V282, P70, DOI 10.1016/j.ins.2014.05.029; Lopez FR, 2007, LECT NOTES COMPUT SC, V4394, P468; Marcacini RM, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P237; McCallum A., 1998, AAAI 98 WORKSH LEARN; Mesleh AM, 2011, PATTERN RECOGN LETT, V32, P1922, DOI 10.1016/j.patrec.2011.07.010; Ogura H, 2011, EXPERT SYST APPL, V38, P4978, DOI 10.1016/j.eswa.2010.09.153; Qian W., NEUROCOMPUTING, V015, P210; Robertson S., 1976, J AM SOC INFORM SCI; Rogati M., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P659, DOI 10.1145/584792.584911; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Shang WQ, 2007, EXPERT SYST APPL, V33, P1, DOI 10.1016/j.eswa.2006.04.001; Singh S. R., 2010, JOURNAL OF MACHINE L; SPARCK-JONES K, 1973, INFORM STORAGE RET, V9, P619, DOI 10.1016/0020-0271(73)90043-0; Tang W, 2016, ONCOTARGET, V7, P85613, DOI 10.18632/oncotarget.12828; Wang DQ, 2014, PATTERN RECOGN LETT, V45, P1, DOI 10.1016/j.patrec.2014.02.013; Wang YW, 2015, KNOWL-BASED SYST, V73, P311, DOI 10.1016/j.knosys.2014.10.013; Zhang JR, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/7604641; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	38	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174341	10.1371/journal.pone.0174341	http://dx.doi.org/10.1371/journal.pone.0174341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379986	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500043
J	Wan, XH; Koster, K; Qian, LS; Desmond, E; Brostrom, R; Hou, SB; Douglas, JT				Wan, Xuehua; Koster, Kent; Qian, Lishi; Desmond, Edward; Brostrom, Richard; Hou, Shaobin; Douglas, James T.			Genomic analyses of the ancestral Manila family of Mycobacterium tuberculosis	PLOS ONE			English	Article							SER/THR PROTEIN-KINASE; ABC TRANSPORTER; PHOSPHORYLATION; IDENTIFICATION; ALIGNMENTS; RESISTANCE; SELECTION; VIRUSES; DISEASE; RV1747	With its airborne transmission and prolonged latency period, Mycobacterium tuberculosis spreads worldwide as one of the most successful bacterial pathogens and continues to kill millions of people every year. M. tuberculosis lineage 1 is inferred to originate ancestrally based on the presence of the 52-bp TbD1 sequence and analysis of single nucleotide polymorphisms. Previously, we briefly reported the complete genome sequencing of M. tuberculosis strains 96121 and 96075, which belong to the ancient Manila family and modern Beijing family respectively. Here we present the comprehensive genomic analyses of the Manila family in lineage 1 compared to complete genomes in lineages 2-4. Principal component analysis of the presence and absence of CRISPR spacers suggests that Manila isolate 96121 is distinctly distant from lineages 2-4. We further identify a truncated whiB5 gene and a putative operon consisting of genes encoding a putative serine/threonine kinase PknH and a putative ABC transporter, which are only found in the genomes of Manila family isolates. Six single nucleotide polymorphisms are uniquely conserved in 38 Manila strains. Moreover, when compared to M. tuberculosis H37Rv, 59 proteins are under positive selection in Manila family isolate 96121 but not in Beijing family isolate 96075. The unique features further serve as biomarkers for Manila strains and may shed light on the limited transmission of this ancestral lineage outside of its Filipino host population.	[Wan, Xuehua; Hou, Shaobin] Univ Hawaii, Adv Studies Genom Prote & Bioinformat, Honolulu, HI USA; [Koster, Kent; Qian, Lishi; Douglas, James T.] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Desmond, Edward] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA; [Brostrom, Richard] Hawaii State Dept Hlth, TB Control Program, Honolulu, HI USA	University of Hawaii System; University of Hawaii System; California Department of Public Health	Douglas, JT (corresponding author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.	jtd379@gmail.com	Wan, Xuehua/AAE-4237-2022	Wan, Xuehua/0000-0002-6367-848X	University of Hawai'i Office of Research Services; Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii; College of Natural Sciences; University of Hawaii; Leahi Trust of the Hawaii Community Foundation	University of Hawai'i Office of Research Services; Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii; College of Natural Sciences; University of Hawaii; Leahi Trust of the Hawaii Community Foundation	This research was supported by the University of Hawai'i Office of Research Services and the Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii. Partial funding for the work described here was provided by the Dean of the College of Natural Sciences, Dr. William Ditto, to JTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shuli Kang for advice regarding Roary pipeline, and acknowledge the support of The Leahi Trust of the Hawaii Community Foundation and The University of Hawaii.	[Anonymous], 2015, GLOB TUB REP; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Burge SW, 2012, RFAM 11 0 10 YEARS R; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gardner SN, 2013, PLOS ONE, V8; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schwalb B., 2015, LSD LOTS SUPERIOR DE; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; van Dongen Stijn, 2000, INFORM SYSTEMS INS R, V2000; Wan X, 2014, GENOME ANNOUNC, V2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2014, GLOB TUB REP; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Y, 2011, COMPUT BIOL CHEM, V35, P319, DOI 10.1016/j.compbiolchem.2011.08.001; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175330	10.1371/journal.pone.0175330	http://dx.doi.org/10.1371/journal.pone.0175330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394899	gold, Green Submitted, Green Published			2022-12-27	WOS:000399954800029
J	Fan, CY; Huang, WY; Lin, CS; Su, YF; Lo, CH; Tsao, CC; Liu, MY; Lin, CL; Kao, CH				Fan, Chao-Yueh; Huang, Wen-Yen; Lin, Chun-Shu; Su, Yu-Fu; Lo, Cheng-Hsiang; Tsao, Chih-Cheng; Liu, Ming-Yueh; Lin, Cheng-Li; Kao, Chia-Hung			Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study	PLOS ONE			English	Article							PRIMARY TUMORS; ASSOCIATION; AUSTRALIA; NEOPLASMS; MEN	Purpose The rising incidence and life expectancy associated with prostate cancer (PCa) has led to increasing interest in predicting the risk of second primary malignancies (SPMs) among PCa survivors, although data regarding SPMs after PCa are controversial. Methods We identified 30,964 patients from the National Health Insurance Research Database in Taiwan who had newly diagnosed PCa between 2000 and 2010. Each patient was randomly frequency-matched with an individual without PCa, based on age, comorbidity, and index year. Competing-risks regression models were used to estimate subhazard ratios (SHRs) of SPMs development associated with PCa. The Bonferroni adjustment was used in multiple comparisons. Results Men with PCa had a trend of lower risk of developing overall SPMs compared to those without PCa (adjusted SHR = 0.94, 99.72% confidence interval [CI] = 0.89-1.00, p = 0.06). The risks of lung and liver cancer were significantly lower. In contrast, these patients had a significantly higher risk of thyroid cancer. There is a trend for a higher risk of developing SPMs in the urinary bladder and rectum/anus. Further analyses indicated that PCa patients who received radiation therapy (RT) had an increased risk of overall SPMs, hematologic malignancies, esophageal cancer, liver cancer, lung cancer, and urinary bladder cancer compared with those who did not receive RT. Conclusion Men with PCa tended to have a lower risk of SPMs, but a significantly higher risk of subsequent thyroid cancer. Continued cancer surveillance is required among PCa survivors, especially in specific sites and in individuals who received RT.	[Fan, Chao-Yueh; Huang, Wen-Yen; Lin, Chun-Shu; Su, Yu-Fu; Lo, Cheng-Hsiang; Tsao, Chih-Cheng; Liu, Ming-Yueh] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	huang, wen/GXW-0661-2022		project of Tri-service General Hospital [TSGH-C106-038]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, (Taiwan) [MOHW104-TDU-B-212-124-002]	project of Tri-service General Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, (Taiwan)	This study is supported in part by study project of Tri-service General Hospital (TSGH-C106-038); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B-212-124-002,Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	American Cancer Society, 2011, CANC FACTS FIG 2012; Braisch U, 2012, EUR J CANCER PREV, V21, P552, DOI 10.1097/CEJ.0b013e328351c748; Cassetti T, 2008, TUMORI, V94, P7; Cluze C, 2009, EUR J CANCER PREV, V18, P343, DOI 10.1097/CEJ.0b013e32832abd76; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; Davis EJ, 2014, CANCER-AM CANCER SOC, V120, P2735, DOI 10.1002/cncr.28769; Dawson DM, 1998, J NATL CANCER I, V90, P519, DOI 10.1093/jnci/90.7.519; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Heard A, 2005, CANCER CAUSE CONTROL, V16, P475, DOI 10.1007/s10552-004-8023-0; Hellawell GO, 2007, BJU INT, V99, P698, DOI 10.1111/j.1464-410X.2007.06779_1.x; Huang KW, 2016, EUR J INTERN MED, V32, P91, DOI 10.1016/j.ejim.2016.04.016; Joung JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140693; Kawakami S, 1997, UROL INT, V59, P243, DOI 10.1159/000283072; Kleinerman RA, 1985, J NATL CANC I MONOGR, V68, P139; Levi F, 1999, CANCER, V86, P1567, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1567::AID-CNCR25>3.0.CO;2-Z; LISKOW AS, 1987, CANCER, V59, P380, DOI 10.1002/1097-0142(19870115)59:2<380::AID-CNCR2820590236>3.0.CO;2-E; McCredie M, 1996, CANCER CAUSE CONTROL, V7, P337, DOI 10.1007/BF00052939; Nelson WG, 2012, PROSTATE INFLAMMATIO, P103; Osterlind A, 1985, J NATL CANC I MONOGR, V68, P341; Peng YC, 2015, BRIT J CLIN PHARMACO, V80, P755, DOI 10.1111/bcp.12641; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Singh A, 2005, J UROLOGY, V173, P1526, DOI 10.1097/01.ju.0000154700.80042.c6; TEPPO L, 1985, J NATL CANCER I, V75, P207; Tomaszewski JJ, 2015, ANN SURG ONCOL, V22, P1043, DOI 10.1245/s10434-014-4066-y; Van Hemelrijck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102596; Wallis CJD, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i851	27	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175217	10.1371/journal.pone.0175217	http://dx.doi.org/10.1371/journal.pone.0175217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384363	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900123
J	Hu, CC; Zhang, CL; Sun, L; Zhang, Y; Xie, WL; Zhang, BW; Chang, Q				Hu, Chaochao; Zhang, Chenling; Sun, Lei; Zhang, Yi; Xie, Wenli; Zhang, Baowei; Chang, Qing			The mitochondrial genome of pin-tailed snipe Gallinago stenura, and its implications for the phylogeny of Charadriiformes	PLOS ONE			English	Article							CHROICOCEPHALUS-SAUNDERSI CHARADRIIFORMES; TRANSFER-RNA GENES; SUBSTITUTION MODELS; SEQUENCES; BIRDS; NUCLEOTIDE; EVOLUTION; PROGRAM; REANALYSIS; SELECTION	The Charadriiformes, among the most diverse orders of bird, is a good source to research on evolution. The mitochondrial genome sequencing database has rapidly increased in recent years, while Charadriiformes mitogenome has not been well studied. In this research, we determined the complete mitogenome sequence of Gallinago stenura, and comparatively analysed 20 mitogenomes of Charadriiformes. The mitogenomes display moderate size variation, and most of variation due to mutations in the control region. In 13 protein-coding genes, we found: 1. The GC skews are always negative, while the negative AT skews are found in 5 genes, 2. The average uncorrected pairwise distances reveal heterogeneity of evolutionary rate for each gene, 3. The ATG and TAA, respectively, are observed the most commonly start and stop codon. The highest dN/dS is detected for ATP8 (0.16) among Charadriiformes, while the lowest for COI (0.01), indicating that 13 protein-coding genes are evolving under the purifying selection. Predicted secondary structures of tRNAs indicate that the sequences and structures of anticodon, amino acceptor, and T psi C arms are highly conserved, and most nucleotide variation is restricted to dihydrouridine arms with obvious indel polymorphisms. A total of 15 conserved sequence boxes were recognized in the control regions, and the 4 bp (5' -AAAC-3') and 7 bp (5' -AAACAAC-3') repeat sequences occurred frequently. Phylogenomic analysis based on the nearly complete mitochondrial genomes strongly supported the monophyly of the order, and the suborder Charadrii is at the basal of Charadriiformes. Moreover, our results well resolved the complexity family-level relationships and clearly depicted the evolutionary processes of Charadriiformes, based on 12 mitochondrial protein-coding genes from 18 families. This study improves our understanding of mitogenomic structure and evolution, which can provide further insights into our understanding of phylogeny and taxonomy in Charadriiformes.	[Hu, Chaochao] Nanjing Normal Univ, Analyt & Testing Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Chenling] Jiangsu Second Normal Univ, Fac Life Sci & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Sun, Lei] Utah State Univ, Dept Biol Engn, 4105 Old Main Hill, Logan, UT 84322 USA; [Zhang, Yi; Xie, Wenli; Chang, Qing] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei, Anhui, Peoples R China	Nanjing Normal University; Jiangsu Second Normal University; Utah System of Higher Education; Utah State University; Nanjing Normal University; Anhui University	Chang, Q (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	qingchangnj@163.com			National Natural Science Foundation of China [31071901, 41271057]; Natural Science Research of Jiangsu Higher Education Institutions of China [16KJB180012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research of Jiangsu Higher Education Institutions of China	This research was supported by grants from the Program of National Natural Science Foundation of China (#31071901 and #41271057) and Natural Science Research of Jiangsu Higher Education Institutions of China (#16KJB180012).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177; Barbosa A, 1999, BIOL J LINN SOC, V67, P313, DOI 10.1111/j.1095-8312.1999.tb01936.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; BJORKLUND M, 1994, AUK, V111, P825; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CHU PC, 1995, CONDOR, V97, P174, DOI 10.2307/1368995; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ericson PGP, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-16; Fain MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-35; Friesen VL, 2015, J ORNITHOL, V156, pS27, DOI 10.1007/s10336-015-1235-0; Gibson R, 2012, MOL PHYLOGENET EVOL, V64, P66, DOI 10.1016/j.ympev.2012.03.008; Gower DJ, 2006, MOL BIOL EVOL, V23, P227, DOI DOI 10.1093/M0LBEV/MSJ025; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Jiang L, 2014, PLOS ONE, V10; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Li X., 2014, BIORESOUR BIOPROCESS, V1, P1, DOI DOI 10.3109/19401736.2014.953080; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livezey BC, 2010, ZOOL J LINN SOC-LOND, V160, P567, DOI 10.1111/j.1096-3642.2010.00635.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Paton TA, 2006, MOL PHYLOGENET EVOL, V39, P657, DOI 10.1016/j.ympev.2006.01.011; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Reynolds JD, 1997, BEHAV ECOL, V8, P126, DOI 10.1093/beheco/8.2.126; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Ryu SH, 2012, MITOCHONDR DNA, V23, P134, DOI 10.3109/19401736.2012.660927; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Smith NA, 2015, J AVIAN BIOL, V46, P125, DOI 10.1111/jav.00487; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmermans MJTN, 2014, MOL PHYLOGENET EVOL, V79, P169, DOI 10.1016/j.ympev.2014.05.031; Van Tuinen M, 2004, J AVIAN BIOL, V35, P191, DOI 10.1111/j.0908-8857.2004.03362.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang ZH, 2000, GENETICS, V155, P431; Yoon KB, 2015, GENE, V572, P227, DOI 10.1016/j.gene.2015.07.022; Zhang L, 2015, SCI REP, V6, P28; Zhou X., 2016, INT J AUDIOL, V1, P1, DOI DOI 10.18632/0NC0TARGET.6418; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	52	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175244	10.1371/journal.pone.0175244	http://dx.doi.org/10.1371/journal.pone.0175244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384231	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900135
J	Lopez-Varela, E; Garcia-Basteiro, AL; Augusto, OJ; Fraile, O; Bulo, H; Ira, T; Gondo, K; van Ingen, J; Naniche, D; Sacarlal, J; Alonso, PL				Lopez-Varela, Elisa; Garcia-Basteiro, Alberto L.; Augusto, Orvalho J.; Fraile, Oscar; Bulo, Helder; Ira, Tasmiya; Gondo, Kizito; van Ingen, Jakko; Naniche, Denise; Sacarlal, Jahit; Alonso, Pedro L.			High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis (vol 12, e0169757, 2017)	PLOS ONE			English	Correction													van Ingen, Jakko/D-5526-2014; Naniche, Denise S/S-1814-2018; Sacarlal, Jahit/R-3172-2016; Alonso, Pedro L/AAZ-3645-2020; varela, elisa lopez/ABE-4092-2020; Augusto, Orvalho/J-8767-2019	van Ingen, Jakko/0000-0002-0581-2003; Naniche, Denise S/0000-0002-4495-6325; Sacarlal, Jahit/0000-0003-1059-217X; Alonso, Pedro L/0000-0003-3292-3443; varela, elisa lopez/0000-0002-6725-5687; Augusto, Orvalho/0000-0002-0005-3968				Lopez-Varela E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169757	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175613	10.1371/journal.pone.0175613	http://dx.doi.org/10.1371/journal.pone.0175613			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384365	Green Published, gold			2022-12-27	WOS:000399371900188
J	Fernandez, CE; Rejas, D				Fernandez, Carla Eloisa; Rejas, Danny			Effects of UVB radiation on grazing of two cladocerans from high-altitude Andean lakes	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; ULTRAVIOLET-RADIATION; VERTICAL-DISTRIBUTION; DAPHNIA-MAGNA; DNA-REPAIR; CRUSTACEAN ZOOPLANKTON; FOOD CONCENTRATION; B RADIATION; DAMAGE; EXPOSURE	Climate change and water extraction may result in increased exposition of the biota to ultraviolet -B radiation (UVB) in high-altitude Andean lakes. Although exposition to lethal doses in these lakes is unlikely, sub-lethal UVB doses may have strong impacts in key compartments such as zooplankton. Here, we aimed at determining the effect of sub-lethal UVB doses on filtration rates of two cladoceran species (Daphnia pulicaria and Ceriodaphnia dubia). We firstly estimated the Incipient Limiting Concentration (ILC) and the Gut Passage Time (GPT) for both species. Thereafter we exposed clones of each species to four increasing UVB doses (treatments): i) DUV-0 (Control), ii) DUV-1 (0.02 MJ m(2)), iii) DUV-2 (0.03 MJ m(2)) and iv) DUV-3 (0.15 MJ m(2)); and estimated their filtration rates using fluorescent micro-spheres. Our results suggest that increasing sub-lethal doses of UVB radiation may strongly disturb the structure and functioning of high-altitude Andean lakes. Filtration rates of D. pulicaria were not affected by the lowest dose applied (DUV-1), but decreased by 50% in treatments DUV-2 and DUV-3. Filtration rates for C. dubia were reduced by more than 80% in treatments DUV-1 and DUV-2 and 100% of mortality occurred at the highest UVB dose applied (DUV-3).	[Fernandez, Carla Eloisa; Rejas, Danny] Univ Mayor San Simon, Unidad Limnol & Recursos Acuat, Cochabamba, Bolivia; [Fernandez, Carla Eloisa] Lund Univ, Div Water Resources Engn, Lund, Sweden	Lund University	Fernandez, CE (corresponding author), Univ Mayor San Simon, Unidad Limnol & Recursos Acuat, Cochabamba, Bolivia.; Fernandez, CE (corresponding author), Lund Univ, Div Water Resources Engn, Lund, Sweden.	carlaelo.fernandez@gmail.com	Espinoza, Carla Eloisa Fernández/M-7497-2014	Espinoza, Carla Eloisa Fernández/0000-0002-2200-5991; Rejas, Danny/0000-0003-2561-1214	Sweedish International Development Cooperation Agency (SIDA); Universidad Mayor de San Simon (UMSS); GIRH cooperation; Project FC-18	Sweedish International Development Cooperation Agency (SIDA); Universidad Mayor de San Simon (UMSS); GIRH cooperation; Project FC-18	This study was funded by the agreement between the Sweedish International Development Cooperation Agency (SIDA; vvww.sida.se/English/) and the Universidad Mayor de San Simon (UMSS). Project FC-18 and project GIRH cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2004, LIMNOL OCEANOGR, V49, P225, DOI 10.4319/lo.2004.49.1.0225; Boersma M, 2006, ARCH HYDROBIOL, V167, P489, DOI 10.1127/0003-9136/2006/0167-0489; Bornman JF, 2015, PHOTOCH PHOTOBIO SCI, V14, P88, DOI 10.1039/c4pp90034k; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Brown James H., 2007, P1; Campero M, 2011, REV BOLIVIANA ECOLOG, P83; Cauchie H-M, 2001, NOTE USE FLUORESCENT; Ceresoli N, 2003, INTERCIENCIA, V28, P469; Connelly SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131847; Connelly SJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P144, DOI 10.1111/j.1751-1097.2008.00408.x; Coronell JS, 2007, WETLANDS, V27, P1166, DOI 10.1672/0277-5212(2007)27[1166:HPTPIB]2.0.CO;2; Daugherty HE, 1971, C LAT AM GEOGR 1971; de Bernardi R., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P1; De Los Rios P, 2007, BIOLOGIA, V62, P210, DOI 10.2478/s11756-007-0031-6; De los Rios-Escalante P, 2015, CRUSTACEANA, V88, P208, DOI 10.1163/15685403-00003401; DeMott WR, 2010, ECOLOGY, V91, P540, DOI 10.1890/08-2103.1; ECHEVARRIA F, 1990, J PLANKTON RES, V12, P415, DOI 10.1093/plankt/12.2.415; Fields DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026333; Fischer C, 2013, J EXP BIOL, V216, P3090, DOI 10.1242/jeb.087064; Fischer JM, 2006, HYDROBIOLOGIA, V563, P217, DOI 10.1007/s10750-005-0007-x; Fischer JM, 2006, PHOTOCHEM PHOTOBIOL, V82, P547, DOI 10.1562/2005-08-30-RA-664; Flint SD, 2009, J PHOTOCH PHOTOBIO B, V97, P48, DOI 10.1016/j.jphotobiol.2009.07.010; Gianuca AT, 2016, P ROYAL SOC B; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; Hansson L-A, 2009, P ROYAL SOC B; Hansson LA, 2016, ECOLOGY, V97, P279, DOI 10.1890/15-1014.1; Moresino RDH, 2014, J PLANKTON RES, V36, P877, DOI 10.1093/plankt/fbu010; Hock AN, 2008, BOLIVIA LIFE ATACAMA; Hofstede R, 2003, RAMOS MUNDO; Huebner JD, 2006, PHOTOCHEM PHOTOBIOL, V82, P1656, DOI 10.1562/2006-05-03-RA-890; Huebner JD, 2013, PHOTOCHEM PHOTOBIOL, V89, P103, DOI 10.1111/j.1751-1097.2012.01197.x; Huebner JD, 2009, PHOTOCHEM PHOTOBIOL, V85, P374, DOI 10.1111/j.1751-1097.2008.00454.x; Hurtubise RD, 1998, LIMNOL OCEANOGR, V43, P1082, DOI 10.4319/lo.1998.43.6.1082; Hutchinson G., 1957, COLD SPRIG HARB S QU, P66; Hylander S, 2013, AQUAT ECOL, V47, P467, DOI 10.1007/s10452-013-9459-7; Hylander S, 2010, J PLANKTON RES, V32, P971, DOI 10.1093/plankt/fbq037; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Kumar S, 2015, INT J PHARM BIOL SCI, V9, P1; Lampert W., 2007, LIMNOECOLOGY ECOLOGY, V2; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; LEHMAN JT, 1976, LIMNOL OCEANOGR, V21, P501, DOI 10.4319/lo.1976.21.4.0501; Ma ZL, 2012, ACTA OCEANOL SIN, V31, P126, DOI 10.1007/s13131-012-0230-2; Magrin G., 2007, CLIMATE CHANGE 2007; Martinez G, 2000, REV CHIL HIST NAT, V73, P47; Martynova DM, 2010, J PLANKTON RES, V32, P441, DOI 10.1093/plankt/fbp144; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Mitchell David L., 1993, P345; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; MURTAUGH PA, 1985, J PLANKTON RES, V7, P415, DOI 10.1093/plankt/7.3.415; Muylaert K, 2003, AQUAT ECOL, V37, P137, DOI 10.1023/A:1023988702926; Navarro L, 2009, RED VISUAL, P1; Nevalainen L, 2016, QUATERNARY SCI REV, V144, P44, DOI 10.1016/j.quascirev.2016.05.022; Nevalainen L, 2015, FRESHWATER BIOL, V60, P2435, DOI 10.1111/fwb.12670; Pescheck F, 2014, J PHOTOCH PHOTOBIO B, V132, P85, DOI 10.1016/j.jphotobiol.2014.02.006; R Core Team, 2021, R LANGUAGE ENV STAT; Rautio M, 2002, LIMNOL OCEANOGR, V47, P295, DOI 10.4319/lo.2002.47.1.0295; Rautio M, 2003, POLAR BIOL, V26, P659, DOI 10.1007/s00300-003-0533-9; Rautio Milla, 2010, Freshwater Reviews, V3, P105, DOI 10.1608/FRJ-3.2.157; Rautio M, 2009, AQUAT BIOL, V7, P93, DOI 10.3354/ab00184; Rejas D, 2012, REV BOLIVIANA ECOLOG, V30, P1; Rhee JS, 2012, COMP BIOCHEM PHYS C, V155, P359, DOI 10.1016/j.cbpc.2011.10.005; Rios PD, 2007, POL J ENVIRON STUD, V16, P481; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; ROMANOVSKY YE, 1985, OIKOS, V44, P243, DOI 10.2307/3544696; Saito H, 2003, J EXP MAR BIOL ECOL, V282, P135, DOI 10.1016/S0022-0981(02)00468-9; Siebeck O., 1994, Advances in Limnology, V43, P197; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smirnov NN, 1974, CHYDORIDAE FAUNA USS, V1; Smirnov NN, 1971, CRUSTACEA, V1, P1; Smirnov NN, 2013, PHYSL CLADOCERA PHYS, P99; Souza MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032046; Sommaruga R, 2003, COMP SER PHOTOCHEM, V1, P485; Straskrabova AV, 1999, J LIMNOLOGY, V58, P77; Thrane JE, 2014, ECOSYSTEMS, V17, P1040, DOI 10.1007/s10021-014-9776-2; Uttieri M., 2014, DAPHNIA BIOL MATH PE, P309; Vincent Warwick F., 1993, Environmental Reviews, V1, P1; Wang JH, 2011, ACTA OCEANOL SIN, V30, P113, DOI 10.1007/s13131-011-0111-x; Wetzel R.G, 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; WIEDNER C, 1995, HYDROBIOLOGIA, V302, P89, DOI 10.1007/BF00027033; Williamson CE, 2003, COMP SER PHOTOCHEM, V1, P547; Won EJ, 2015, AQUAT TOXICOL, V165, P1, DOI 10.1016/j.aquatox.2015.05.002; WUBBEN D, 2002, PROC INT ASSOC THE 6, V27, P3354; Wubben DL, 2001, NEW ZEAL J MAR FRESH, V35, P635, DOI 10.1080/00288330.2001.9517029; Zaratti F, 2014, PHOTOCH PHOTOBIO SCI, V13, P980, DOI 10.1039/c4pp00006d; Zellmer ID, 2006, ARCH HYDROBIOL, V167, P515, DOI 10.1127/0003-9136/2006/0167-0515; Zellmer ID, 2004, ARCT ANTARCT ALP RES, V36, P370, DOI 10.1657/1523-0430(2004)036[0370:EOSDID]2.0.CO;2; Zellmer ID, 1996, HYDROBIOLOGIA, V319, P87, DOI 10.1007/BF00016876	89	7	7	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174334	10.1371/journal.pone.0174334	http://dx.doi.org/10.1371/journal.pone.0174334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379975	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500041
J	Ilyechova, EY; Tsymbalenko, NV; Puchkova, LV				Ilyechova, Ekaterina Y.; Tsymbalenko, Nadezhda V.; Puchkova, Ludmila V.			The role of subcutaneous adipose tissue in supporting the copper balance in rats with a chronic deficiency in holo-ceruloplasmin	PLOS ONE			English	Article							TRANSPORTING ATPASES; SILVER IONS; METABOLISM; EXPRESSION; HEPHAESTIN; MECHANISM; PROTEINS; OXIDASES; REVEALS; GENES	We have previously shown that (1) an acute deficiency in blood serum holo-ceruloplasmin (Cp) developed in rats that were fed fodder containing silver ions (Ag-fodder) for one month and (2) the deficiency in holo-Cp was compensated by non-hepatic holo-Cp synthesis in rats that were chronically fed Ag-fodder for 6 months (Ag-rats). The purpose of the present study is to identify the organ(s) that compensate for the hepatic holo-Cp deficiency in the circulation. This study was performed on rats that were fed Ag-fodder (40 mg Ag.kg(-1) body mass daily) for 6 months. The relative expression levels of the genes responsible for copper status were measured by RT-PCR. The in vitro synthesis and secretion of [C-14] Cp were analyzed using a metabolic labeling approach. Oxidase activity was determined using a gel assay with o-dianisidine. Copper status and some hematological indexes were measured. Differential centrifugation, immunoblotting, immunoelectrophoresis, and atomic absorption spectrometry were included in the investigation. In the Ag-rats, silver accumulation was tissue-specific. Skeletal muscles and internal (IAT) and subcutaneous (SAT) adipose tissues did not accumulate silver significantly. In SAT, the mRNAs for the soluble and glycosylphosphatidylinositol-anchored ceruloplasmin isoforms were expressed, and their relative levels were increased two-fold in the Ag-rats. In parallel, the levels of the genes responsible for Cp metallation (Ctr1 and Atp7a/b) increased correspondingly. In the SAT of the Ag-rats, Cp oxidase activity was observed in the Golgi complex and plasma membrane. Moreover, full-length [14 C] Cp polypeptides were released into the medium by slices of SAT. The possibilities that SAT is part of a system that controls the copper balance in mammals, and it plays a significant role in supporting copper homeostasis throughout the body are discussed.	[Ilyechova, Ekaterina Y.; Tsymbalenko, Nadezhda V.; Puchkova, Ludmila V.] Inst Expt Med, Dept Mol Genet, St Petersburg, Russia; [Ilyechova, Ekaterina Y.; Tsymbalenko, Nadezhda V.; Puchkova, Ludmila V.] ITMO Univ, Int Res & Educ Ctr Funct Mat & Devices Optoelect, St Petersburg, Russia; [Puchkova, Ludmila V.] Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Dept Biophys, St Petersburg, Russia	Institute of Experimental Medicine; ITMO University; Peter the Great St. Petersburg Polytechnic University	Ilyechova, EY (corresponding author), Inst Expt Med, Dept Mol Genet, St Petersburg, Russia.; Ilyechova, EY (corresponding author), ITMO Univ, Int Res & Educ Ctr Funct Mat & Devices Optoelect, St Petersburg, Russia.	ilichevaey@gmail.com		Ilyechova, Ekaterina/0000-0002-5623-2156	Russian Foundation for Basic Research grants [16-34-60219, 14-04-01640, 15-04-06770-a]	Russian Foundation for Basic Research grants(Russian Foundation for Basic Research (RFBR))	The work was supported by Russian Foundation for Basic Research grants 16-34-60219 (EYI), 14-04-01640 (NVT), 15-04-06770-a (LVP), http://www.rfbr.ru/rffi/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Arciello M, 2015, BIOMETALS, V28, P1017, DOI 10.1007/s10534-015-9886-0; Arner E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080274; Arredondo M, 2014, BIOMETALS, V27, P115, DOI 10.1007/s10534-013-9691-6; Babich PS, 2013, CANCER BIOL THER, V14, P614, DOI 10.4161/cbt.24594; Banha J, 2008, FREE RADICAL BIO MED, V44, P483, DOI 10.1016/j.freeradbiomed.2007.10.032; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Brewer GJ, 2014, J TRACE ELEM MED BIO, V28, P372, DOI 10.1016/j.jtemb.2014.07.015; Easter RN, 2010, VASC MED, V15, P61, DOI 10.1177/1358863X09346656; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; FLEMING RE, 1991, AM J PHYSIOL, V260, pL68, DOI 10.1152/ajplung.1991.260.2.L68; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y; Gambling L, 2003, J NUTR, V133, p1554S, DOI 10.1093/jn/133.5.1554S; Giurgea N, 2005, MED SCI MONITOR, V11, pRA48; Gletsu-Miller N, 2012, INT J OBESITY, V36, P328, DOI 10.1038/ijo.2011.159; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Harvey LJ, 2009, AM J CLIN NUTR, V89, p2009S, DOI 10.3945/ajcn.2009.27230E; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Ilyechova EY, 2014, METALLOMICS, V6, P1970, DOI 10.1039/c4mt00107a; Ilyechova E, 2011, J TRACE ELEM MED BIO, V25, P27, DOI 10.1016/j.jtemb.2010.08.002; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; JAEGER JL, 1991, BIOCHEM J, V280, P671, DOI 10.1042/bj2800671; Kaplan JH, 2016, BIOPHYS J, V110, P7, DOI 10.1016/j.bpj.2015.11.025; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Li S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12410; Lin C, 2015, METALLOMICS, V7, P1285, DOI 10.1039/c5mt00097a; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Malinouski M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4301, 10.1038/ncomms6167]; MASON KE, 1979, J NUTR, V109, P1979, DOI 10.1093/jn/109.11.1979; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MOSHKOV KA, 1979, EUR J BIOCHEM, V94, P127, DOI 10.1111/j.1432-1033.1979.tb12879.x; Mostad EJ, 2011, EXP BIOL MED, V236, P298, DOI 10.1258/ebm.2010.010256; Opazo CM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00143; OWEN JA, 1961, CLIN CHIM ACTA, V6, P441, DOI 10.1016/0009-8981(61)90074-2; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Platonova N A, 2005, Izv Akad Nauk Ser Biol, P141; Prohaska JR, 2011, ADV NUTR, V2, P89, DOI 10.3945/an.110.000208; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; SKINNER MK, 1983, BIOL REPROD, V28, P1225, DOI 10.1095/biolreprod28.5.1225; Sokolov AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P631, DOI 10.1134/S0006297912060107; Sugawara N, 2000, ARCH TOXICOL, V74, P190, DOI 10.1007/s002040000115; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Vashchenko G, 2011, ARCH BIOCHEM BIOPHYS, V514, P50, DOI 10.1016/j.abb.2011.07.010; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Zatulovskaia YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140797; Zatulovskiy EA, 2012, J INORG BIOCHEM, V116, P88, DOI 10.1016/j.jinorgbio.2012.07.003	53	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175214	10.1371/journal.pone.0175214	http://dx.doi.org/10.1371/journal.pone.0175214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380026	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500107
J	Rios-Toro, JJ; Marquez-Coello, M; Garcia-Alvarez, JM; Martin-Aspas, A; Rivera-Fernandez, R; de Benito, AS; Giron-Gonzalez, JA				Rios-Toro, Juan-Jesus; Marquez-Coello, Mercedes; Garcia-Alvarez, Jose-Maria; Martin-Aspas, Andres; Rivera-Fernandez, Ricardo; Saez de Benito, Ana; Giron-Gonzalez, Jose-Antonio			Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; INTENSIVE-CARE UNITS; MYELOID CELLS; EMERGENCY-DEPARTMENT; DIAGNOSTIC-VALUE; ORGAN FAILURE; PRESEPSIN; CD163; MORTALITY; MEDIATOR	Background The objective of this study was to explore the diagnostic and prognostic value of soluble triggering receptor expressed on myeloid cell 1 (sTREM-1), soluble cluster of differentiation 14 (sCD14), soluble cluster of differentiation 163 (sCD163), interleukin-6 (IL-6), procalcitonin (PCT), and C-reactive protein (CRP) serum levels for patients with severe sepsis and septic shock in an intensive care unit (ICU). Methods Fifty patients admitted at the ICU with the diagnosis of severe sepsis or septic shock were studied. SOFA and APACHE II scores as well as serum biomarkers were measured at days 0, 2 and 5. The influence of these variables on 28-day mortality was analyzed. Twenty healthy individuals served as controls. Results Baseline serum concentrations of sTREM-1, sCD163, IL-6 and PCT correlated with SOFA score. Only sTREM-1 levels correlated with APACHE II score. The 28-day mortality rate for all patients was 42%. The absence of risk factors for infection, presence of septic shock, baseline values of sCD14 and decrease of PCT and IL-6 from baseline to day 5 were variables associated to mortality in the univariate analysis. The unique independent factor associated to mortality in the multivariate analysis was a decrease of PCT higher than 50% from days 0 to 5. Conclusions Serum levels of sTREM-1 are correlated with the severity of sepsis. A 50% decrease of PCT was the unique variable associated with survival in the multivariate analysis.	[Rios-Toro, Juan-Jesus; Garcia-Alvarez, Jose-Maria; Rivera-Fernandez, Ricardo] Hosp Serrania Ronda, Intens Care Unit, Malaga, Spain; [Marquez-Coello, Mercedes; Martin-Aspas, Andres; Giron-Gonzalez, Jose-Antonio] Univ Cadiz, Infect Unit, Hosp Univ Puerta Mar,Fac Med, Inst Invest & Innovac Ciencias Biomed Cadiz INiBI, Cadiz, Spain; [Saez de Benito, Ana] Univ Cadiz, Biochem, Hosp Univ Puerta Mar,Fac Med, Inst Invest & Innovac Ciencias Biomed Cadiz INiBI, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Giron-Gonzalez, JA (corresponding author), Univ Cadiz, Infect Unit, Hosp Univ Puerta Mar,Fac Med, Inst Invest & Innovac Ciencias Biomed Cadiz INiBI, Cadiz, Spain.	joseantonio.giron@uca.es	Godino, Ana Saez-Benito/K-6357-2013; Girón-González, José-Antonio/AAG-4199-2020; Girón-González, José-Antonio/H-3990-2014; Rivera-Fernandez, Ricardo/M-1724-2013	Godino, Ana Saez-Benito/0000-0002-7864-9147; Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; Marquez-Coello, Mercedes/0000-0003-3948-6258; Martin-Aspas, Andres/0000-0002-3086-9095; Rivera-Fernandez, Ricardo/0000-0001-7383-4901				Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Behnes M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0507-z; Bloos F, 2011, CRIT CARE, V15, DOI 10.1186/cc10087; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Cannon Chad M, 2013, J Intensive Care Med, V28, P355, DOI 10.1177/0885066612453025; Clec'h C, 2004, CRIT CARE MED, V32, P1166, DOI 10.1097/01.CCM.0000126263.00551.06; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Dai XG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0941-6; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Garnacho-Montero J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1000-z; Giamarellos-Bourboulis EJ, 2006, INTENS CARE MED, V32, P237, DOI 10.1007/s00134-005-0017-1; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; HACK CE, 1989, BLOOD, V74, P1704; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Huang DT, 2008, ANN EMERG MED, V52, P48, DOI 10.1016/j.annemergmed.2008.01.003; Jing JY, 2009, INTENS CARE MED, V35, P587, DOI 10.1007/s00134-008-1333-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kweon OJ, 2014, J CRIT CARE, V29, P965, DOI 10.1016/j.jcrc.2014.06.014; Labelle A, 2012, CRIT CARE MED, V40, P2016, DOI 10.1097/CCM.0b013e318250aa72; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Li ZY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/641039; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Macdonald SPJ, 2014, ACAD EMERG MED, V21, P1257, DOI 10.1111/acem.12515; Mahdy AM, 2006, CLIN VACCINE IMMUNOL, V13, P492, DOI 10.1128/CVI.13.4.492-495.2006; Maruna P, 2000, PHYSIOL RES, V49, pS57; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pioli PA, 2004, J LEUKOCYTE BIOL, V76, P500, DOI 10.1189/jlb.1203617; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Prkno A, 2013, CRIT CARE, V17, DOI 10.1186/cc13157; Prucha M, 2015, CLIN CHIM ACTA, V440, P97, DOI 10.1016/j.cca.2014.11.012; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Riedel S, 2013, CLIN LAB MED, V33, P413, DOI 10.1016/j.cll.2013.03.006; Schaer DJ, 2002, ATHEROSCLEROSIS, V163, P199, DOI 10.1016/S0021-9150(01)00756-0; Schneider CP, 2009, SHOCK, V31, P568, DOI 10.1097/SHK.0b013e318193cb52; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Su LX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/969875; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tamura M, 2014, J INFECT CHEMOTHER, V20, P97, DOI 10.1016/j.jiac.2013.09.005; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vodnik T, 2013, CLIN CHEM LAB MED, V51, P2053, DOI 10.1515/cclm-2013-0061; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Wu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133057; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-53	60	52	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175254	10.1371/journal.pone.0175254	http://dx.doi.org/10.1371/journal.pone.0175254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380034	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500111
J	Shim, E				Shim, Eunha			Cost-effectiveness of dengue vaccination in Yucatan, Mexico using a dynamic dengue transmission model	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; VECTOR CONTROL; VIRUS SEROTYPES; ECONOMIC-IMPACT; INFECTION; VACCINES; DISEASE; ILLNESS; BURDEN; THAILAND	Background The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health systems with consequent morbidities and mortalities. On December 9 th, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In anticipation of a vaccine rollout, analysis of the cost-effectiveness of the dengue vaccination program that quantifies the dynamics of disease transmission is essential. Methods We developed a dynamic transmission model of dengue in Yucatan, Mexico and its proposed vaccination program to incorporate herd immunity into our analysis of cost-effectiveness analysis. Our model also incorporates important characteristics of dengue epidemiology, such as clinical cross-immunity and susceptibility enhancement upon secondary infection. Using our model, we evaluated the cost-effectiveness and economic impact of an imperfect dengue vaccine in Yucatan, Mexico. Conclusions Our study indicates that a dengue vaccination program would prevent 90% of cases of symptomatic DF incidence as well as 90% of dengue hemorrhagic fever (DHF) incidence and dengue-related deaths annually. We conclude that a dengue vaccine program in Yucata A n, Mexico would be very cost-effective as long as the vaccination cost per individual is less than $ 140 and $ 214 from health care and societal perspectives, respectively. Furthermore, at an exemplary vaccination cost of $ 250 USD per individual on average, dengue vaccination is likely to be cost-effective 43% and 88% of the time from health care and societal perspectives, respectively.	[Shim, Eunha] Soongsil Univ, Dept Math, Seoul, South Korea	Soongsil University	Shim, E (corresponding author), Soongsil Univ, Dept Math, Seoul, South Korea.	alicia@ssu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058208]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF; http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education (2015R1D1A1A01058208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Adams B, 2006, J THEOR BIOL, V242, P337, DOI 10.1016/j.jtbi.2006.03.002; Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2; Lorono-Pino MA, 2014, TROP MED INT HEALTH, V19, P1267, DOI 10.1111/tmi.12364; Amarasinghe A, 2010, HUMAN VACCINES, V6; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; [Anonymous], 2016, NAT BIOTECHNOL, V34, P8, DOI 10.1038/nbt0116-8b; [Anonymous], 2016, UNDATA D A DATA ACCE; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bianco S, 2009, CHAOS, V19, DOI 10.1063/1.3270261; Billings L, 2007, J THEOR BIOL, V246, P18, DOI 10.1016/j.jtbi.2006.12.023; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Constenla D, 2015, PHARMACOECONOMICS, V33, P1107, DOI 10.1007/s40273-015-0294-7; Coudeville L, 2015, VACCINE; Coudeville L, 2016, VACCINE; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036; Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Flasche S, 2016, COMPARATIVE MODELLIN; Goamez-Carro S, 2017, JOURNAL OF EPIDEMIOL, V3, P23; Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004; Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661; Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545; Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kawaguchi I, 2003, P ROY SOC B-BIOL SCI, V270, P2241, DOI 10.1098/rspb.2003.2440; Knipl D, 2015, B MATH BIOL, V77, P2212, DOI 10.1007/s11538-015-0120-6; Lee BY, 2011, AM J TROP MED HYG, V84, P764, DOI 10.4269/ajtmh.2011.10-0624; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Mbah MLN, 2014, J THEOR BIOL, V342, P15, DOI 10.1016/j.jtbi.2013.10.006; Medlock J, 2009, AM NAT, V174, P565, DOI 10.1086/605403; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Orellano PW, 2015, VACCINE; Pandey A, 2015, EPIDEMIOL INFECT, V143, P1276, DOI 10.1017/S0950268814001939; Polwiang S, 2016, PEERJ JOURNAL IN PRE; Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Shim E, 2016, AMERICAN JOURNAL OF; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Tang LIC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-3; Thavara U, 2014, EPIDEMIOL INFECT, V142, P1245, DOI 10.1017/S0950268813001866; Undurraga EA, 2015, ECONOMIC AND DISEASE, V9; Villar L, 2014, THE NEW ENGLAND JOUR; VONALLMEN SD, 1979, AM J TROP MED HYG, V28, P1040, DOI 10.4269/ajtmh.1979.28.1040; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; World Health Organization, 2012, GLOBAL STRATEGY FOR	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175020	10.1371/journal.pone.0175020	http://dx.doi.org/10.1371/journal.pone.0175020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380060	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500085
J	Reiley, BM; Benson, TJ; Everitts, J; Bednarz, JC				Reiley, Bryan M.; Benson, Thomas J.; Everitts, Jeremy; Bednarz, James C.			Does flooding effect the apparent survival and body condition of a ground foraging migrant passerine?	PLOS ONE			English	Article							POPULATION-GROWTH RATE; SWAINSONS-WARBLER; HABITAT QUALITY; MARKED ANIMALS; BIRDS; CONSERVATION; RIVER; ECOLOGY; FOOD; DISTURBANCE	Natural disturbances play a fundamental role in maintaining habitat and landscape heterogeneity; however, these events can also have negative effects on some species. While we know that disturbances can reduce habitat quality for many species, leading to diminished populations and altered community structure, the effect of these events on individuals that continue to occupy affected areas remains unknown. We focused on understanding the impact of flood-mediated reduction of habitat quality on Swainson's Warblers (Limnothlypis swainsonii). In 2008, a catastrophic flood event occurred on the Mississippi River and its tributaries, severely affecting one of two locations where we had studied territorial males since 2004. To determine the impact of flooding on this species, we evaluated how body condition and apparent survival of males differed between locations and in pre-flood (2004-2007) and post-flood (2008-2010) periods. Body condition did not differ between locations after the flood, suggesting that flooding did not cause food limitation for this obligate ground forager. Apparent survival in the post-flood period was lower at both locations and led to near population extirpation at the heavily flood-impacted site. Overall, this study demonstrates the vulnerability of species to extreme hydrological events, an increasing threat due to climate change. Future research should focus on identifying species that are vulnerable to these events and determining appropriate conservation strategies. Conservation for the Swainson's Warbler should focus on identifying and conserving the highest elevation, least flood prone areas within bottomland hardwood forests and managing those areas for thick understory vegetation.	[Reiley, Bryan M.; Everitts, Jeremy] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA; [Reiley, Bryan M.; Benson, Thomas J.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Bednarz, James C.] Univ North Texas, Dept Biol Sci, Denton, TX USA	Arkansas State University; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of North Texas System; University of North Texas Denton	Reiley, BM (corresponding author), Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA.; Reiley, BM (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA.	bryan.reiley@gmail.com			United Stated Fish and Wildlife Service; Arkansas Game and Fish Commission	United Stated Fish and Wildlife Service(US Fish & Wildlife Service); Arkansas Game and Fish Commission	Financial support was provided by the United Stated Fish and Wildlife Service and the Arkansas Game and Fish Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by the U.S. Fish and Wildlife Service and the Arkansas Game and Fish Commission. R. Hines, S. Reagan, and D. Sharp of the White River National Wildlife Refuge provided accommodation and access. We thank N. Anich, C. Roa, A. Zachary, S. Rune, A. Overfield, J. Brown, W. Kohler, N. Bieber, and A. Beeler for their assistance in the field.	Andersen DC, 2000, J MAMMAL, V81, P1087, DOI 10.1644/1545-1542(2000)081<1087:MPORSM>2.0.CO;2; ANICH N. M., 2010, BIRDS N AM ONLINE; Anich NM, 2010, WILSON J ORNITHOL, V122, P165, DOI 10.1676/09-031.1; Anich NM, 2009, AUK, V126, P626, DOI 10.1525/auk.2009.08219; [Anonymous], 2006, SAS MIXED MODELS; BARROW W. C., 1990, THESIS; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; Bednarz JC, 2005, DISTRIBUTION HABITAT, V191, P576; Benson TJ, 2011, J FIELD ORNITHOL, V82, P25, DOI 10.1111/j.1557-9263.2010.00304.x; Benson TJ, 2010, CONDOR, V112, P138, DOI 10.1525/cond.2010.080089; Benson TJ, 2010, WETLANDS, V30, P29, DOI 10.1007/s13157-009-0004-3; Benson TJ, 2009, CONDOR, V111, P694, DOI 10.1525/cond.2009.080074; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Brown JD, 2009, WETLANDS, V29, P586, DOI 10.1672/08-54.1; Brown Margaret E., 1996, Current Ornithology, V13, P67; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chiavacci SJ, 2014, CONDOR, V116, P215, DOI 10.1650/CONDOR-12-157-R1.1; Chiu MC, 2013, IBIS, V155, P377, DOI 10.1111/ibi.12035; DeRagon WR, 1988, THESIS; DiQuinzio DA, 2002, WETLANDS, V22, P179, DOI 10.1672/0277-5212(2002)022[0179:NEOSST]2.0.CO;2; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; Everitts JL, 2015, WILDLIFE SOC B, V39, P292, DOI 10.1002/wsb.536; Golet GH, 2013, RIVER RES APPL, V29, P183, DOI 10.1002/rra.1588; Graves GR, 1998, J FIELD ORNITHOL, V69, P121; Graves GR, 2001, AUK, V118, P650, DOI 10.1642/0004-8038(2001)118[0650:FGTDOS]2.0.CO;2; Hering D, 2004, RIVER RES APPL, V20, P445, DOI 10.1002/rra.759; Hoover JP, 2006, BIOL CONSERV, V127, P37, DOI 10.1016/j.biocon.2005.07.017; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Jacob J, 2003, MAMM BIOL, V68, P102, DOI 10.1078/1616-5047-00068; Johnson DM, 2004, ECOLOGY, V85, P2037, DOI 10.1890/03-0508; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Klaus NA, 2004, ORIOLE, V69, P19; KNOPF FL, 1987, CONDOR, V89, P869, DOI 10.2307/1368536; Knutson MG, 1997, AUK, V114, P367, DOI 10.2307/4089239; Latta SC, 2002, ECOLOGY, V83, P2502, DOI 10.1890/0012-9658(2002)083[2502:DAPROC]2.0.CO;2; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; MEANLEY B, 1970, WILSON BULL, V82, P228; Meanley B., 1966, Living Bird, V5, P151; MEANLEY B, 1971, N AM FAUNA, V69; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Prudhomme C, 2012, HYDROL PROCESS, V26, P1115, DOI 10.1002/hyp.8434; RAPPOLE JH, 1994, AUK, V111, P652; Reiley BM, 2013, CONDOR, V115, P650, DOI 10.1525/cond.2013.120163; Reinert Steven E., 2006, Studies in Avian Biology, P77; Rogers JC, 1988, J CLIMATE, V1, P172, DOI 10.1175/1520-0442(1988)001<0172:PVOTCA>2.0.CO;2; Royan A, 2014, BIOL CONSERV, V177, P64, DOI 10.1016/j.biocon.2014.06.017; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Schramm HL, 2009, WETLANDS, V29, P476, DOI 10.1672/08-62.1; Sharp DW, 2012, WHITE RIVER NATL WIL; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Stahl JT, 2006, ECOL MODEL, V198, P23, DOI 10.1016/j.ecolmodel.2006.04.001; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Thompson J.I., 2005, THESIS; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 1998, ECOSYSTEMS, V1, P493, DOI 10.1007/s100219900045; Twedt DJ, 2009, J WILDLIFE MANAGE, V73, P1140, DOI 10.2193/2008-441; Twedt DJ, 1999, J BIOGEOGR, V26, P1215, DOI 10.1046/j.1365-2699.1999.00348.x; US Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	64	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175179	10.1371/journal.pone.0175179	http://dx.doi.org/10.1371/journal.pone.0175179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394910	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800020
J	Ueki, M; Takeshita, H; Utsunomiya, N; Chino, T; Oyama, N; Hasegawa, M; Kimura-Kataoka, K; Fujihara, J; Iida, R; Yasuda, T				Ueki, Misuzu; Takeshita, Haruo; Utsunomiya, Natsuko; Chino, Takanao; Oyama, Noritaka; Hasegawa, Minoru; Kimura-Kataoka, Kaori; Fujihara, Junko; Iida, Reiko; Yasuda, Toshihiro			Survey of single-nucleotide polymorphisms in the gene encoding human deoxyribonuclease I-like 2 producing loss of function potentially implicated in the pathogenesis of parakeratosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NUCLEAR-DNA; DNASE1L2; SNPS; DIFFERENTIATION; AUTOIMMUNITY; EXPRESSION; APOPTOSIS; RELEVANT	Dysfunction of DNase I-like 2 (DNase 1L2) has been assumed to play a role in the etiology of parakeratosis through incomplete degradation of DNA in the epidermis. However, the pathogenetic background factor for such pathophysiologic conditions remains unknown. In this context, non-synonymous single-nucleotide polymorphisms (SNPs) in DNASE1L2 that would potentially result in loss of in vivo DNase 1L2 activity might serve as a genetic risk factor for such pathophysiologic conditions. Our aim was to effectively survey the non-synonymous SNPs of DNASE1L2 that would produce a loss-of-function variant of the enzyme together with a genetic distribution in the various populations. Here, the effects of all of the SNPs predicted by PolyPhen-2 analysis to be "probably damaging" (score = 1.000), and derived from frameshift/nonsense mutations, on the activity of DNase 1L2 were examined using the corresponding DNase 1L2 variants expressed in COS-7 cells. Genotyping of these SNPs was also performed in three ethnic groups including 14 different populations. Among the 28 SNPs examined, the minor allele of 23 SNPs was defined as a loss-of-function variant resulting in loss of DNase 1L2 function, indicating that Polyphen-2 analysis could be effective for surveys of at least non-synonymous SNPs resulting in loss of function. On the other hand, these minor alleles were not distributed worldwide, thereby avoiding any marked reduction of the enzyme activity in human populations. Furthermore, all of the 19 SNPs originating from frameshift/nonsense mutations found in DNASE1L2 resulted in loss of function of the enzyme. Thus, the present findings suggest that each of the minor alleles for these SNPs may serve as one of genetic risk factors for parakeratotic skin diseases such as psoriasis, even though they lack a worldwide genetic distribution.	[Ueki, Misuzu; Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Dept Med Genet & Biochem, Fukui, Japan; [Takeshita, Haruo; Kimura-Kataoka, Kaori; Fujihara, Junko] Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan; [Utsunomiya, Natsuko; Chino, Takanao; Oyama, Noritaka; Hasegawa, Minoru] Univ Fukui, Fac Med Sci, Dept Dermatol, Fukui, Japan; [Iida, Reiko] Univ Fukui, Fac Med Sci, Dept Life Sci, Fukui, Japan	University of Fukui; Shimane University; University of Fukui; University of Fukui	Takeshita, H (corresponding author), Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan.	htakeshi@meci.shimane-u.ac.jp	Fujihara, Junko/V-7818-2019	Fujihara, Junko/0000-0001-5359-5181; Hasegawa, Minoru/0000-0003-3738-2682; Takenao, Chino/0000-0002-2224-3383; Utsunomiya, Natsuko/0000-0001-6764-3252; Oyama, Noritaka/0000-0003-4934-5205	Japan Society for the Promotion of Science [16H05272, 25460864]; Grants-in-Aid for Scientific Research [16K19295] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/e-grants/ (16H05272 to T.Y. and 25460864 to M.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by Grants-in-Aid from Japan Society for the Promotion of Science (16H05272 to T.Y. and 25460864 to M.U.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Adzubei IA, 2013, CURRENT PROTOCOLS HU; Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Dittmar M, 2009, J AUTOIMMUN, V32, P7, DOI 10.1016/j.jaut.2008.09.005; Eckhart L, 2000, BIOCHEM BIOPH RES CO, V277, P655, DOI 10.1006/bbrc.2000.3698; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Eckhart L, 2012, FRONT BIOSCI-LANDMRK, V17, P2461, DOI 10.2741/4065; Fischer H, 2016, J INVEST DERMATOL; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; Fischer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017581; Fujihara J, 2016, IMMUNOL INVEST, V45, P406, DOI 10.3109/08820139.2016.1157813; Fujihara J, 2010, ELECTROPHORESIS, V31, P3552, DOI 10.1002/elps.201000319; Jager K, 2007, DIFFERENTIATION, V75, P939; Kimura-Kataoka K, 2013, ELECTROPHORESIS, V34, P3361, DOI 10.1002/elps.201300399; Parra D, 2009, CANCER RES, V69, P6676, DOI 10.1158/0008-5472.CAN-09-1208; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rodriguez AM, 1997, GENOMICS, V42, P507, DOI 10.1006/geno.1997.4748; Shiokawa D, 2004, GENOMICS, V84, P95, DOI 10.1016/j.ygeno.2004.02.003; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; Szabo S, 2012, INT J LEGAL MED, V126, P63, DOI 10.1007/s00414-011-0566-5; Ueki M, 2015, GENE, V561, P15, DOI 10.1016/j.gene.2015.01.006; Ueki M, 2014, DNA CELL BIOL, V33, P79, DOI 10.1089/dna.2013.2248; Ueki M, 2014, FEBS J, V281, P376, DOI 10.1111/febs.12608; Ueki M, 2013, ELECTROPHORESIS, V34, P456, DOI 10.1002/elps.201200415; Ueki M, 2010, ELECTROPHORESIS, V31, P2063, DOI 10.1002/elps.201000002; Yasuda T, 1999, BIOCHEM BIOPH RES CO, V260, P280, DOI 10.1006/bbrc.1999.0900; YASUDA T, 1995, ELECTROPHORESIS, V16, P1889, DOI 10.1002/elps.11501601310; Yasuda T, 2010, INT J BIOCHEM CELL B, V42, P1216, DOI 10.1016/j.biocel.2010.04.012; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175083	10.1371/journal.pone.0175083	http://dx.doi.org/10.1371/journal.pone.0175083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394916	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800015
J	Torok, HP; Bellon, V; Konrad, A; Lacher, M; Tonenchi, L; Siebeck, M; Brand, S; De Toni, EN				Toeroek, Helga Paula; Bellon, Victor; Konrad, Astrid; Lacher, Martin; Tonenchi, Laurian; Siebeck, Matthias; Brand, Stephan; De Toni, Enrico Narciso			Functional Toll-Like Receptor (TLR) 2 polymorphisms in the susceptibility to inflammatory bowel disease	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; MICROSATELLITE POLYMORPHISM; INTRON-II; GENETIC RISK; ASSOCIATION; TUBERCULOSIS; PROMOTER; LOCI	Background The recent genome-wide association studies (GWAS) in inflammatory bowel disease (IBD) suggest significant genetic overlap with complex mycobacterial diseases like tuberculosis or leprosy. TLR variants have previously been linked to susceptibility for mycobacterial diseases. Here we investigated the contribution to IBD risk of two TLR2 polymorphisms, the low-prevalence variant Arg753Gln and the GTn microsatellite repeat polymorphism in intron 2. We studied association with disease, possible correlations with phenotype and genegene interactions. Methodology/Principal findings We conducted a large study in 843 patients with Crohn's disease, 426 patients with ulcerative colitis and 805 healthy, unrelated controls, all of European origin. Overall, the frequency for carriers of shorter GT(n) repeats in intron 2 of the TLR2 gene, which have previously been associated with low TLR2 expression and high IL-10 production, was slightly elevated in Crohn's disease and ulcerative colitis compared to healthy controls (16.0% resp. 16.7% vs. 12.8%). The highest frequency of short GT(n) carriers was noted among IBD patients on anti TNF-alpha therapy. However, none of these differences was significant in the multivariate analysis. The Arg753Gln polymorphism showed no association with any clinical subtype of IBD, including extensive colitis, for which such an association was previously described. We found no association with specific phenotypic disease subgroups. Also, epistasis analysis revealed no significant interactions between the two TLR2 variants and confirmed IBD susceptibility genes. Conclusions The two functional relevant polymorphisms in TLR2, the GT(n) microsatellite repeat polymorphism in intron 2 and the Arg753Gln variant do not seem to play a role in the susceptibility to Crohn's disease or ulcerative colitis.	[Toeroek, Helga Paula; Konrad, Astrid; Brand, Stephan; De Toni, Enrico Narciso] Ludwig Maximilians Univ Munchen, Dept Med 2, Munich, Germany; [Bellon, Victor] PSL Res Univ, CBIO Ctr Computat Biol, MINES ParisTech, Fontainebleau, France; [Bellon, Victor] Inst Curie, Paris, France; [Bellon, Victor] INSERM U900, Paris, France; [Lacher, Martin] Univ Leipzig, Dept Pediat Surg, Leipzig, Germany; [Tonenchi, Laurian; Siebeck, Matthias] Ludwig Maximilians Univ Munchen, Dept Gen Visceral Vasc & Transplantat Surg, Munich, Germany; [Brand, Stephan] Kantonsspital St Gallen, Dept Gastroenterol & Hepatol, St Gallen, Switzerland	University of Munich; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Leipzig University; University of Munich; Kantonsspital St. Gallen	Torok, HP (corresponding author), Ludwig Maximilians Univ Munchen, Dept Med 2, Munich, Germany.	helga.toeroek@med.uni-muenchen.de	De Toni, Enrico N/C-6496-2008					Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Cheng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126803; Folwaczny M, 2011, CLIN ORAL INVEST, V15, P435, DOI 10.1007/s00784-010-0396-8; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kormann MSD, 2009, ALLERGY, V64, P636, DOI 10.1111/j.1398-9995.2008.01891.x; Lee SO, 2011, LIVER TRANSPLANT, V17, P1081, DOI 10.1002/lt.22327; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Moore CE, 2004, CLIN DIAGN LAB IMMUN, V11, P1194, DOI 10.1128/CDLI.11.6.1194-1197.2004; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Salie M, 2015, INFECT GENET EVOL, V34, P221, DOI 10.1016/j.meegid.2015.07.004; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Suryadevara NC, 2013, HUM IMMUNOL, V74, P1034, DOI 10.1016/j.humimm.2013.04.009; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Veltkamp M, 2007, CLIN EXP IMMUNOL, V149, P453, DOI 10.1111/j.1365-2249.2007.03428.x; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yang ZQ, 2007, GASTROENTEROLOGY, V133, P1510, DOI 10.1053/j.gastro.2007.07.025; Yim JJ, 2008, HUM IMMUNOL, V69, P572, DOI 10.1016/j.humimm.2008.06.003; Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274; Yim JJ, 2004, FEMS IMMUNOL MED MIC, V40, P163, DOI 10.1016/S0928-8244(03)00342-0; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	32	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175180	10.1371/journal.pone.0175180	http://dx.doi.org/10.1371/journal.pone.0175180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388655	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800027
J	Briant, K; Johnson, N; Swanton, E				Briant, Kit; Johnson, Nicholas; Swanton, Eileithyia			Transmembrane domain quality control systems operate at the endoplasmic reticulum and Golgi apparatus	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; HUMAN CD8 GLYCOPROTEIN; UBIQUITIN LIGASE; PLASMA-MEMBRANE; SECRETORY PATHWAY; HYDROPHOBIC MISMATCH; SURFACE EXPRESSION; RECYCLING PATHWAY; ER RETENTION; DEGRADATION	Multiple protein quality control systems operate to ensure that misfolded proteins are efficiently cleared from the cell. While quality control systems that assess the folding status of soluble domains have been extensively studied, transmembrane domain (TMD) quality control mechanisms are poorly understood. Here, we have used chimeras based on the type I plasma membrane protein CD8 in which the endogenous TMD was substituted with transmembrane sequences derived from different polytopic membrane proteins as a mode to investigate the quality control of unassembled TMDs along the secretory pathway. We find that the three TMDs examined prevent trafficking of CD8 to the cell surface via potentially distinct mechanisms. CD8 containing two distinct non-native transmembrane sequences escape the ER and are subsequently retrieved from the Golgi, possibly via Rer1, leading to ER localisation at steady state. A third chimera, containing an altered transmembrane domain, was predominantly localised to the Golgi at steady state, indicating the existence of an additional quality control checkpoint that identifies non-native transmembrane domains that have escaped ER retention and retrieval. Preliminary experiments indicate that protein retained by quality control mechanisms at the Golgi are targeted to lysosomes for degradation.	[Briant, Kit; Johnson, Nicholas; Swanton, Eileithyia] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Mol & Cellular Funct,Sch Biol Sci, Manchester, Lancs, England; [Briant, Kit] UCL, Fac Life Sci, Dept Struct & Mol Biol, Div Biosci, London, England; [Johnson, Nicholas] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic	University of Manchester; University of London; University College London; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Swanton, E (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Mol & Cellular Funct,Sch Biol Sci, Manchester, Lancs, England.	lisa.swanton@manchester.ac.uk	Johnson, Nicholas/G-5930-2014	Swanton, Eileithyia/0000-0002-3299-4228; Johnson, Nicholas/0000-0002-8247-2874; Briant, Kit/0000-0002-1368-6262	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F017227/1]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), Grant reference BB/F017227/1, http://www.bbsrc.ac.uk/.	Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Babst M, 2014, J CELL BIOL, V205, P11, DOI 10.1083/jcb.201310113; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Briant K, 2015, J CELL SCI, V128, P4112, DOI 10.1242/jcs.171215; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Chu CY, 2014, AM J PHYSIOL-CELL PH, V307, pC296, DOI 10.1152/ajpcell.00310.2013; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cosson P, 2013, TRENDS CELL BIOL, V23, P511, DOI 10.1016/j.tcb.2013.05.005; Cymer F, 2012, BIOL CHEM, V393, P1215, DOI 10.1515/hsz-2012-0231; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P851, DOI 10.1016/j.bbamem.2012.09.012; Dhaunchak AS, 2011, J NEUROSCI, V31, P14961, DOI 10.1523/JNEUROSCI.2097-11.2011; Duque D, 2002, J CHEM PHYS, V116, P10478, DOI 10.1063/1.1477927; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hara T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06992; Hauri HP, 2000, J CELL SCI, V113, P587; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Klumperman J, 1998, J CELL SCI, V111, P3411; Koenig Paul-Albert, 2014, F1000Prime Rep, V6, P49, DOI 10.12703/P6-49; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Li QA, 2010, J BIOL CHEM, V285, P32977, DOI 10.1074/jbc.M110.143024; Li Y, 1999, MOL CELL BIOL, V19, P3588; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Merulla J, 2015, MOL BIOL CELL, V26, P1532, DOI 10.1091/mbc.E14-12-1615; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; PASCALE MC, 1992, J BIOL CHEM, V267, P9940; PASCALE MC, 1992, J BIOL CHEM, V267, P25196; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Roxrud I, 2009, EXP CELL RES, V315, P3014, DOI 10.1016/j.yexcr.2009.07.012; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SARASTE J, 1991, J CELL SCI, V100, P415; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Schlebach JP, 2015, Q REV BIOPHYS, V48, P1, DOI 10.1017/S0033583514000110; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang SY, 2010, MOL BIOL CELL, V21, P1153, DOI 10.1091/mbc.E09-10-0910; Watson HR, 2011, MOL MEMBR BIOL, V28, P216, DOI 10.3109/09687688.2011.572566; Yamasaki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05973	62	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173924	10.1371/journal.pone.0173924	http://dx.doi.org/10.1371/journal.pone.0173924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384259	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900010
J	Chen, XD; Mao, CC; Wu, RS; Zhang, WT; Lin, J; Sun, XW; Chi, CH; Lou, N; Wang, PF; Shen, X; Zhu, GB; Shen, SR				Chen, Xiao-dong; Mao, Chen-chen; Wu, Rui-sen; Zhang, Wei-teng; Lin, Ji; Sun, Xiang-wei; Chi, Chu-huai; Lou, Neng; Wang, Peng-fei; Shen, Xian; Zhu, Guan-bao; Shen, Shu-rong			Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE; PROGNOSTIC-SIGNIFICANCE; MONOCYTE COUNT; SURVIVAL; DISSEMINATION; CHEMOTHERAPY; SENSITIVITY; RECURRENCE; BIOMARKERS; IMPROVES	The aims of the present study were to evaluate the predictive value of the platelet-to-lymphocyte ratio for peritoneal metastasis in patients with gastric cancer and to construct an available preoperative prediction system for peritoneal metastasis. A total of 1080 patients with gastric cancer were enrolled in our study. The preoperative platelet-to-lymphocyte ratio and other serum markers and objective clinical tumor characteristics were evaluated by receiver operating characteristic curves. A logistic analysis was performed to determine the independent predictive indicators of peritoneal metastasis. A prediction system that included the independent predictive indicators was constructed and evaluated by receiver operating characteristic curves. Based on the receiver operating characteristic curves, the ideal platelet- to-lymphocyte ratio cutoff value to predict peritoneal metastasis was 131.00. The logistic analysis showed that the platelet-to-lymphocyte ratio was an independent indicator to predict peritoneal metastasis. The area under the receiver operating characteristic curve was 0.599. When integrating all independent indicators (i.e., platelet-to-lymphocyte ratio, invasion depth, lymphatic invasion, pathological type), the prediction system more reliably predicted peritoneal metastasis with a higher area under the receiver operating characteristic curve (0.769). The preoperative platelet-to-lymphocyte ratio was an indicator that could be used to predict peritoneal metastasis. Our prediction system could be a reliable instrument to discriminate between patients with gastric cancer with and those without peritoneal metastasis.	[Chen, Xiao-dong; Mao, Chen-chen; Wu, Rui-sen; Zhang, Wei-teng; Lin, Ji; Sun, Xiang-wei; Chi, Chu-huai; Lou, Neng; Wang, Peng-fei; Shen, Xian; Zhu, Guan-bao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China; [Shen, Xian] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China; [Shen, Shu-rong] Wenzhou Integrated Tradit Chinese & Western Med H, Dept Breast Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Shen, X; Zhu, GB (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China.; Shen, X (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China.; Shen, SR (corresponding author), Wenzhou Integrated Tradit Chinese & Western Med H, Dept Breast Surg, Wenzhou, Zhejiang, Peoples R China.	shenxian5166@gmail.com; 352161451@qq.com; 995477163@qq.com	chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022					Ahmed A, 2011, AFR HEALTH SCI, V11, P353; Barar J, 2012, BIOIMPACTS, V2, P1, DOI 10.5681/bi.2012.001; Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3; Cannon NA, 2015, J THORAC ONCOL, V10, P280, DOI 10.1097/JTO.0000000000000399; Dhobi MA, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/981654; ELHAG A, 1987, J IMMUNOL, V139, P2406; Hwang Gun Ick, 2004, Cancer Res Treat, V36, P178, DOI 10.4143/crt.2004.36.3.178; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KAY HD, 1983, J IMMUNOL, V130, P475; Kim EY, 2015, ANN SURG ONCOL, V22, P4363, DOI 10.1245/s10434-015-4518-z; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Kishi K, 2016, SURG TODAY; Kurita N, 2010, HEPATO-GASTROENTEROL, V57, P980; Lai H, 2014, TUMOR BIOL, V35, P10547, DOI 10.1007/s13277-014-2355-5; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Liu J, 2016, ONCOTARGET; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Maehara Y, 2000, BRIT J SURG, V87, P353, DOI 10.1046/j.1365-2168.2000.01358.x; Mo A, 2016, MOL CANC RES; Namikawa T, 2016, ONCOLOGY-BASEL, V90, P321, DOI 10.1159/000446373; Nozoe T, 2011, AM J SURG, V201, P186, DOI 10.1016/j.amjsurg.2010.01.030; Ohi M, 2015, ANTICANCER RES, V35, P3511; Osugi J, 2016, J CANCER RES THER, V12, P945, DOI 10.4103/0973-1482.176168; Ozkan E, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-75; Quigley DA, 2015, MOL ONCOL, V9, P2054, DOI 10.1016/j.molonc.2015.10.003; Sakakura C, 2004, BRIT J CANCER, V90, P665, DOI 10.1038/sj.bjc.6601544; Sato Y, 2016, GASTRIC CANC; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Stotz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159448; Takagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073609; Tan KW, 2013, BLOOD, V122, P3666, DOI 10.1182/blood-2012-11-466532; Turner N, 2016, INT J CANCER, V138, P671, DOI 10.1002/ijc.29805; VanCutsem E., 2016, LANCET; Wang JP, 2015, ANN SURG ONCOL, V22, P2965, DOI 10.1245/s10434-015-4388-4; Wang Z, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-19; Wen JH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002266; Yonemura Y, 2005, BRIT J SURG, V92, P370, DOI 10.1002/bjs.4695; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang LN, 2015, TUMOR BIOL, V36, P8213, DOI 10.1007/s13277-015-3560-6	40	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175074	10.1371/journal.pone.0175074	http://dx.doi.org/10.1371/journal.pone.0175074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384215	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900080
J	Hamilton, MJ; Robb, Y; Cumming, S; Gregory, H; Duncan, A; Rahman, M; McKeown, A; McWilliam, C; Dean, J; Wilcox, A; Farrugia, ME; Cooper, A; McGhie, J; Adam, B; Petty, R; Longman, C; Findlay, L; Japp, A; Monckton, DG; Denvir, MA				Hamilton, Mark J.; Robb, Yvonne; Cumming, Sarah; Gregory, Helen; Duncan, Alexis; Rahman, Monika; McKeown, Anne; McWilliam, Catherine; Dean, John; Wilcox, Alison; Farrugia, Maria E.; Cooper, Anneli; McGhie, Josephine; Adam, Berit; Petty, Richard; Longman, Cheryl; Findlay, Lain; Japp, Alan; Monckton, Darren G.; Denvir, Martin A.		Scottish Myotonic Dystrophy Consor	Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study (vol 12, e0174166, 2017)	PLOS ONE			English	Correction													Denvir, Martin A/ABA-3141-2021; Monckton, Darren/B-4943-2013	Monckton, Darren/0000-0002-8298-8264				Hamilton MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174166	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175615	10.1371/journal.pone.0175615	http://dx.doi.org/10.1371/journal.pone.0175615			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384345	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900190
J	Hsu, SY; Ou, CY; Ho, YN; Huang, YH				Hsu, Shih-Yuan; Ou, Chien-Yu; Ho, Yu-Ni; Huang, Yu-Hua			Application of Surgical Apgar Score in intracranial meningioma surgery	PLOS ONE			English	Article							SYSTEM; VALIDATION; CARE	Surgical resection is the main therapeutic option for intracranial meningiomas, but it is not without significant morbidities. The Surgical Apgar Score (SAS), assessed by intraoperative blood pressure, heart rate, and blood loss, was developed for prognostic prediction in general and vascular surgery. We aimed to examine whether the application of SAS in patients undergoing craniotomy for meningioma resection can predict postoperative major complications. We retrospectively enrolled 99 patients that had undergone intracranial meningioma surgery. The patients were subdivided into 2 groups based on whether major complications were present (N = 34) or not (N = 65). We recognized the intergroup differences in SAS and clinical variables. The incidence of 30-day major complications in patients after operation was 34.3%. The lengths of ICU and hospital stay for the morbid cases were prolonged significantly (p = 0.009, p < 0.001, respectively). In the multivariate logistic regression model, SAS was an independent predicting factor of major complications following surgery for intracranial meningiomas (odds ratio, 95% confidence interval = 0.57, 0.38-0.87; p = 0.009), and thus a decrease of one mean SAS increased the rate of major complications by 43%. In conclusions, SAS is an independent predictor of major complications in patients undergoing intracranial meningioma surgery, and provides acceptable risk discrimination. Since this scoring system is relatively simple, objective, and practical, we suggest that SAS be included as an indicator in the guidance for the level of care after craniotomy for meningioma resection.	[Hsu, Shih-Yuan; Ou, Chien-Yu; Huang, Yu-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Hsu, Shih-Yuan; Ou, Chien-Yu; Ho, Yu-Ni; Huang, Yu-Hua] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Ou, Chien-Yu] Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Ho, Yu-Ni] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Huang, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	newlupin2001@yahoo.com.tw						Barie PS, 1996, J TRAUMA, V40, P513, DOI 10.1097/00005373-199604000-00002; Bateman BT, 2005, NEUROSURGERY, V57, P866, DOI 10.1227/01.NEU.0000179923.66729.87; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; Caroli M, 2005, J NEUROSURG, V102, P290, DOI 10.3171/jns.2005.102.2.0290; Cohen-Inbar O, 2010, ACTA NEUROCHIR, V152, P87, DOI 10.1007/s00701-009-0552-6; COPELAND GP, 1991, BRIT J SURG, V78, P356; Gawande AA, 2007, J AM COLL SURGEONS, V204, P201, DOI 10.1016/j.jamcollsurg.2006.11.011; Haynes AB, 2011, SURGERY, V149, P519, DOI 10.1016/j.surg.2010.10.019; Lefering R, 2000, INTENS CARE MED, V26, P1794, DOI 10.1007/s001340000723; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Patil CG, 2010, J NEUROL NEUROSUR PS, V81, P502, DOI 10.1136/jnnp.2009.185074; Poon MTC, 2014, BRIT J NEUROSURG, V28, P303, DOI 10.3109/02688697.2013.841857; Regenbogen SE, 2010, SURGERY, V148, P559, DOI 10.1016/j.surg.2010.01.015; Reynolds PQ, 2011, ANESTHESIOLOGY, V114, P1305, DOI 10.1097/ALN.0b013e318219d734; Sacko O, 2007, NEUROSURGERY, V61, P950, DOI 10.1227/01.neu.0000303190.80049.7d; Schul DB, 2012, NEUROSURGERY, V70, P555, DOI 10.1227/NEU.0b013e318233a99a; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Thorn CC, 2012, WORLD J SURG, V36, P1066, DOI 10.1007/s00268-012-1495-2; Urrutia J, 2015, SPINE J, V15, P105, DOI 10.1016/j.spinee.2013.06.042; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Ziewacz JE, 2013, J NEUROSURG, V118, P270, DOI 10.3171/2012.10.JNS12436	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174328	10.1371/journal.pone.0174328	http://dx.doi.org/10.1371/journal.pone.0174328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384177	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900015
J	Juri, H; Tsuboyama, T; Koyama, M; Yamamoto, K; Nakai, G; Nakamoto, A; Yamamoto, K; Azuma, H; Narumi, Y				Juri, Hiroshi; Tsuboyama, Takahiro; Koyama, Mitsuhiro; Yamamoto, Kiyohito; Nakai, Go; Nakamoto, Atsushi; Yamamoto, Kazuhiro; Azuma, Haruhito; Narumi, Yoshifumi			Assessment of the ability of CT urography with low-dose multi-phasic excretory phases for opacification of the urinary system	PLOS ONE			English	Article							STATISTICAL ITERATIVE RECONSTRUCTION; FILTERED BACK-PROJECTION; MDCT UROGRAPHY; TRACT; EXPERIENCE; RADIATION; SALINE; DELAY	Objective To prospectively evaluate the ability of CT urography with a low-dose multi-phasic excretory phase for opacification of the urinary system. Materials and methods Thirty-two patients underwent CT urography with low-dose multi-phasic s using adaptive iterative dose reduction 3D acquired at 5-, 10-, and 15-minute delays. Opacification scores of the upper urinary tracts and the urinary bladder were assigned for each excretory phase by two radiologists, who recorded whether adequate (>75%) or complete (100%) opacification of the upper urinary tract and urinary bladder was achieved in each patient. Adequate and complete opacification rates of the upper urinary tracts and the urinary bladder were compared among three excretory phases and among combined multi-phasic excretory phases using Cochran's Q test. Results There was no significant difference among three excretory phases with 5-, 10-, and 15-minute delays in adequate (56.3, 43.8, and 63.5%, respectively; P = 0.174) and complete opacification rates (9.3, 15.6, and 18.7%, respectively; P = 0.417) of the upper urinary tracts. Combined tri-phasic excretory phases significantly improved adequate and complete opacification rates to 84.4% and 43.8%, respectively (P = 0.002). In contrast, there were significant differences among three excretory phases for the rate of adequate (31.3, 84.4, and 93.8%, respectively; P<0.001) and complete opacification (21.9, 53.1, and 81.3%, respectively; P<0.001) of the urinary bladder. Multi-phasic excretory phases did not improve these rates because opacification was always better with a longer delay. Conclusion Although multi-phasic acquisition of excretory phases is effective at improving opacification of the upper urinary tracts, complete opacification is difficult even with tri-phasic acquisition.	[Juri, Hiroshi; Koyama, Mitsuhiro; Yamamoto, Kiyohito; Nakai, Go; Yamamoto, Kazuhiro; Narumi, Yoshifumi] Osaka Med Coll, Dept Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka, Japan; [Tsuboyama, Takahiro; Nakamoto, Atsushi] Osaka Univ, Sch Med, Dept Radiol, 2-15 Yamadaoka, Suita, Osaka, Japan; [Azuma, Haruhito] Osaka Med Coll, Dept Urol, 2-7 Daigaku Machi, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka University; Osaka Medical College	Juri, H (corresponding author), Osaka Med Coll, Dept Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka, Japan.	rad103@osaka-med.ac.jp			Toshiba Medical Systems; Daiichi Sankyo	Toshiba Medical Systems; Daiichi Sankyo(Daiichi Sankyo Company Limited)	Both Toshiba Medical Systems and Daiichi Sankyo provided financial support to Yoshifumi Narumi in the form of research materials (Toshiba Medical Systems: adaptive iterative reconstruction algorithm; Daiichi Sankyo: contrast media) rather than research grants. None of the authors are employed by Toshiba Medical Systems or Daiichi Sankyo.These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caloili EM, 2001, ACAD RADIOL, V8, P1100; Caoili EM, 2005, RADIOLOGY, V235, P116, DOI 10.1148/radiol.2351031085; Caoili EM, 2002, RADIOLOGY, V222, P353, DOI 10.1148/radiol.2222010667; Dillman JR, 2007, J COMPUT ASSIST TOMO, V31, P750, DOI 10.1097/RCT.0b013e318033df36; Dillman JR, 2007, ABDOM IMAGING, V32, P519, DOI 10.1007/s00261-007-9185-5; Hack K, 2012, RADIOLOGY, V265, P143, DOI 10.1148/radiol.12110548; Honda O, 2011, BRIT J RADIOL, V84, P335, DOI 10.1259/bjr/57998586; Jinzaki M, 2011, AM J ROENTGENOL, V196, P1102, DOI [10.1590/S1677-55382011000300019, 10.2214/AJR.10.5249]; Juri H, 2013, J COMPUT ASSIST TOMO, V37, P426, DOI 10.1097/RCT.0b013e3182830aa9; Kim S, 2008, RADIOLOGY, V247, P747, DOI 10.1148/radiol.2473070965; Meindl T, 2007, EUR RADIOL, V17, P2512, DOI 10.1007/s00330-007-0600-7; Meindl T, 2006, EUR RADIOL, V16, P1667, DOI 10.1007/s00330-006-0149-x; Metser U, 2012, RADIOLOGY, V264, P110, DOI 10.1148/radiol.12111623; Nawfel RD, 2004, RADIOLOGY, V232, P126, DOI 10.1148/radiol.2321030222; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Silverman SG, 2006, RADIOLOGY, V240, P749, DOI 10.1148/radiol.2403050233; Van der Molen AJ, 2008, EUR RADIOL, V18, P4, DOI 10.1007/s00330-007-0792-x	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174800	10.1371/journal.pone.0174800	http://dx.doi.org/10.1371/journal.pone.0174800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384174	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900037
J	Martino, FP; Miller, PG; Coomber, K; Hancock, L; Kypri, K				Martino, Florentine Petronella; Miller, Peter Graeme; Coomber, Kerri; Hancock, Linda; Kypri, Kypros			Analysis of Alcohol Industry Submissions against Marketing Regulation (vol 12, e0170366, 2017)	PLOS ONE			English	Correction																		Martino FP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170366; MARTINO MP, 2017, PLOS ONE, V12, DOI DOI 10.1371/J0URNAL.P0NE.0170366	2	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175661	10.1371/journal.pone.0175661	http://dx.doi.org/10.1371/journal.pone.0175661			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384352	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900201
J	Milonas, PG; Partsinevelos, GK; Andow, DA				Milonas, Panagiotis G.; Partsinevelos, George K.; Andow, David A.			Effect of male mating history and age on remating by female European corn borer	PLOS ONE			English	Article							OSTRINIA-NUBILALIS LEPIDOPTERA; SELFISH GENETIC ELEMENTS; HELICOVERPA-ARMIGERA; SEXUAL SELECTION; APYRENE SPERM; VIRGIN MALE; FECUNDITY; CONFLICT; BENEFITS; MOTH	If mating with an inferior male has high fitness costs, females may try to avoid mating with these males. Alternatively, females may accept an inferior male to ensure they have obtained at least one mate, and/or to avoid the costs of resisting these males. We hypothesized that females compensate for mating with an inferior male by remating. We tested this hypothesis by measuring remating propensity in females that had mated with an old, multiply-mated male, a 9-day-old virgin male, or a young, virgin male. Females were more likely to remate when they had mated with multiply-mated males than when they had mated with a 9-day-old or young virgin male. We discuss the observed mating behavior by females in terms of sexual selection for multiple mating.	[Milonas, Panagiotis G.; Partsinevelos, George K.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece; [Milonas, Panagiotis G.; Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Milonas, PG (corresponding author), Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece.; Milonas, PG (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN USA.	p.milonas@bpi.gr	Milonas, Panagiotis/AAV-3805-2020	Milonas, Panagiotis/0000-0001-5391-7750; Partsinevelos, Georgios/0000-0002-2515-0158	Fulbright research fellowship	Fulbright research fellowship	The present study was partially funded by a Fulbright research fellowship awarded to Panagiotis Milonas.	Andersson J, 2000, P ROY SOC B-BIOL SCI, V267, P1271, DOI 10.1098/rspb.2000.1138; Andersson Malte, 1994; Andow DA, EUROPEAN CORN BORER; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; COOK PA, 1995, BEHAV ECOL SOCIOBIOL, V36, P261; Cook PA, 1999, NATURE, V397, P486, DOI 10.1038/17257; Cox D. R., 1984, ANAL SURVIVAL DATA; Eliyahu D, 2003, J INSECT PHYSIOL, V49, P569, DOI 10.1016/S0022-1910(03)00028-3; Fadamiro HY, 1999, J INSECT PHYSIOL, V45, P385, DOI 10.1016/S0022-1910(98)00137-1; Fischer K, 2008, P ROY SOC B-BIOL SCI, V275, P1517, DOI 10.1098/rspb.2007.1455; Friedlander M, 2005, ADV INSECT PHYSIOL, V32, P206, DOI 10.1016/S0065-2806(05)32003-0; GELMAN DB, 1982, ANN ENTOMOL SOC AM, V75, P485, DOI 10.1093/aesa/75.5.485; HAMILTON WD, 1990, AM ZOOL, V30, P341; Hinton JL, 2003, GREAT LAKES ENTOMOL, V36, P156; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2009, BIOL LETTERS, V5, P697, DOI 10.1098/rsbl.2009.0066; Hosken DJ, 2009, ANNU REV ENTOMOL, V54, P361, DOI 10.1146/annurev.ento.54.110807.090608; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; KARLSSON B, 1994, OIKOS, V69, P224, DOI 10.2307/3546142; Kokko H, 2013, ENTOMOL EXP APPL, V146, P26, DOI 10.1111/j.1570-7458.2012.01296.x; LaMunyon CW, 1997, ECOL ENTOMOL, V22, P69, DOI 10.1046/j.1365-2311.1997.00033.x; Lupold S, 2011, BEHAV ECOL, V22, P184, DOI 10.1093/beheco/arq193; Milonas PG, 2011, BEHAV ECOL SOCIOBIOL, V65, P1249, DOI 10.1007/s00265-011-1138-x; Milonas PG, 2010, ANIM BEHAV, V79, P509, DOI 10.1016/j.anbehav.2009.12.005; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Muller K, 2016, ANIM BEHAV, V114, P165, DOI 10.1016/j.anbehav.2016.02.005; Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766; Price TAR, 2008, GENETICA, V134, P99, DOI 10.1007/s10709-008-9253-y; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; ROYER L, 1993, FUNCT ECOL, V7, P209, DOI 10.2307/2389889; Schlaepfer MA, 2000, CAN J ZOOL, V78, P2045, DOI 10.1139/cjz-78-11-2045; SUGAWARA T, 1979, J COMP PHYSIOL, V130, P191, DOI 10.1007/BF00614605; Teng ZQ, 2009, PHYSIOL ENTOMOL, V34, P338, DOI 10.1111/j.1365-3032.2009.00696.x; Thornhill R., 1983, pi; Torres-Vila LM, 2005, BEHAV ECOL SOCIOBIOL, V57, P318, DOI 10.1007/s00265-004-0857-7; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Valimaki P, 2010, ANIM BEHAV, V79, P1173, DOI 10.1016/j.anbehav.2010.02.030; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	43	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175512	10.1371/journal.pone.0175512	http://dx.doi.org/10.1371/journal.pone.0175512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384242	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900173
J	Patin, EC; Geffken, AC; Willcocks, S; Leschczyk, C; Haas, A; Nimmerjahn, F; Lang, R; Ward, TH; Schaible, UE				Patin, Emmanuel C.; Geffken, Anna C.; Willcocks, Sam; Leschczyk, Christoph; Haas, Albert; Nimmerjahn, Falk; Lang, Roland; Ward, Theresa H.; Schaible, Ulrich E.			Trehalose dimycolate interferes with FcyR-mediated phagosome maturation through Mincle, SHP-1 and FcyRIIB signalling	PLOS ONE			English	Article							C-TYPE LECTIN; GAMMA RECEPTORS; ACTIVATING RECEPTOR; CORD FACTOR; PHAGOCYTOSIS; INFECTION; RIIB; PHOSPHATASES; TRAFFICKING; MACROPHAGES	The causative agent of tuberculosis, Mycobacterium tuberculosis (M. tuberculosis), contains an abundant cell wall glycolipid and a crucial virulence factor, trehalose-6,6'-dimycolate (TDM). TDM causes delay of phagosome maturation and thus promotes survival of mycobacteria inside host macrophages by a not fully understood mechanism. TDM signals through the Monocyte-INducible C-type LEctin (Mincle), a recently identified pattern recognition receptor. Here we show that recruitment of Mincle by TDM coupled to immunoglobulin (Ig) G-opsonised beads during Fcy receptor (FcyR)-mediated phagocytosis interferes with phagosome maturation. In addition, modulation of phagosome maturation by TDM requires SH2-domain-containing inositol polyphosphate 5' phosphatase (SHP-1) and the FcyRIIB, which strongly suggests inhibitory downstream signalling of Mincle during phagosome formation. Overall, our study reveals important mechanisms contributing to the virulence of TDM.	[Patin, Emmanuel C.; Willcocks, Sam; Ward, Theresa H.; Schaible, Ulrich E.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England; [Patin, Emmanuel C.; Geffken, Anna C.; Leschczyk, Christoph; Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany; [Leschczyk, Christoph; Schaible, Ulrich E.] German Ctr Infect Res, Borstel, Germany; [Haas, Albert] Univ Bonn, Inst Cell Biol, Bonn, Germany; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Div Genet, Dept Biol, Erwin, Germany; [Lang, Roland] Friedrich Alexander Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, Univ Hosp Erlangen, Erlangen, Germany; [Patin, Emmanuel C.] INSERM U1019, Ctr Infect & Immunite Lille, Inst Pasteur Lille, Lille, France	University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel; German Center for Infection Research; University of Bonn; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Schaible, UE (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England.; Schaible, UE (corresponding author), Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany.; Schaible, UE (corresponding author), German Ctr Infect Res, Borstel, Germany.	uschaible@fz-borstel.de	Ward, Theresa H./E-9650-2013	Ward, Theresa H./0000-0002-9881-8649; Lang, Roland/0000-0003-0502-3677	Wellcome Trust UK [WT082825]; German 'Bundesministerium for Bildung und Forschung' (BMBF) program 'Medical Infection Genomics' [0315834C-D]; DFG [SFB 796, TB B6]	Wellcome Trust UK(Wellcome Trust); German 'Bundesministerium for Bildung und Forschung' (BMBF) program 'Medical Infection Genomics'(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was funded by the Wellcome Trust UK (WT082825), to US, https://wellcome.ac.uk; German 'Bundesministerium for Bildung und Forschung' (BMBF) program 'Medical Infection Genomics' (0315834C-D), to US, https://www.bmbf.de/en/index.html; DFG SFB 796, TB B6, to RL. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We thank Otto Holst, Research Center Borstel, Germany, for kindly providing TDM from M. tuberculosis. This work was supported by grants to U. S. from the Wellcome Trust UK (WT082825) and the German 'Bundesministerium fur Bildung und Forschung' (BMBF) program 'Medical Infection Genomics' (0315834C-D), and to R.L. DFG SFB 796, TB B6.	Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Gomez CP, 2012, J IMMUNOL, V189, P2203, DOI 10.4049/jimmunol.1103021; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; Iborra S, 2016, IMMUNITY, V45, P788, DOI 10.1016/j.immuni.2016.09.012; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kant AM, 2002, BLOOD, V100, P1852; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Masumoto M, 1999, J IMMUNOL, V163, P5039; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Patin EC, 2016, INNATE IMMUN; Perley CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098938; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Sydor T, 2013, CELL MICROBIOL, V15, P458, DOI 10.1111/cmi.12050; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhou DL, 2010, J LEUKOCYTE BIOL, V87, P845, DOI 10.1189/jlb.0409289	33	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174973	10.1371/journal.pone.0174973	http://dx.doi.org/10.1371/journal.pone.0174973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384255	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399371900066
J	Paul, CPL; de Graaf, M; Bisschop, A; Holewijn, RM; de Ven, PMV; van Royer, BJ; Mullender, MG; Smit, TH; Helder, MN				Paul, Cornelis P. L.; de Graaf, Magda; Bisschop, Arno; Holewijn, Roderick M.; de Ven, Peter M. van; van Royer, Barend J.; Mullender, Margriet G.; Smit, Theodoor H.; Helder, Marco N.			Static axial overloading primes lumbar caprine intervertebral discs for posterior herniation	PLOS ONE			English	Article							ANNULUS FIBROSUS; CELL-DEATH; BACK-PAIN; IN-VITRO; DEGENERATION; MECHANICS; DISTRIBUTIONS; MORPHOLOGY; THERAPIES; COLLAGEN	Introduction Lumbar hernias occur mostly in the posterolateral region of IVDs and mechanical loading is an important risk factor. Studies show that dynamic and static overloading affect the nucleus and annulus of the IVD differently. We hypothesize there is also variance in the effect of overloading on the IVD's anterior, lateral and posterior annulus, which could explain the predilection of herniations in the posterolateral region. We assessed the regional mechanical and cellular responses of lumbar caprine discs to dynamic and static overloading. Material and methods IVDs (n = 125) were cultured in a bioreactor and subjected to simulated-physiological loading (SPL), high dynamic (HD), or high static (HS) overloading. The effect of loading was determined in five disc regions: nucleus, inner-annulus and anterior, lateral and posterior outer-annulus. IVD height loss and external pressure transfer during loading were measured, cell viability was mapped and quantified, and matrix integrity was assessed. Results During culture, overloaded IVDs lost a significant amount of height, yet the distribution of axial pressure remained unchanged. HD loading caused cell death and disruption of matrix in all IVD regions, whereas HS loading particularly affected cell viability and matrix integrity in the posterior region of the outer annulus. Conclusion Axial overloading is detrimental to the lumbar IVD. Static overloading affects the posterior annulus more strongly, while the nucleus is relatively spared. Hence, static overloading predisposes the disc for posterior herniation. These findings could have implications for working conditions, in particular of sedentary occupations, and the design of interventions aimed at prevention and treatment of early intervertebral disc degeneration.	[Paul, Cornelis P. L.; de Graaf, Magda; Bisschop, Arno; Holewijn, Roderick M.; van Royer, Barend J.; Mullender, Margriet G.; Smit, Theodoor H.; Helder, Marco N.] Vrije Univ Amsterdam, Dept Orthopaed Surg, Med Ctr, Amsterdam Movement Sci, Amsterdam, Netherlands; [de Ven, Peter M. van] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Mullender, Margriet G.] Vrije Univ Amsterdam, Dept Plast Reconstruct & Hand Surg, Med Ctr, Amsterdam, Netherlands; [Smit, Theodoor H.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Amsterdam, Netherlands; [Helder, Marco N.] Vrije Univ Amsterdam, Dept Oral & Maxillofacial Surg, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Paul, CPL (corresponding author), Vrije Univ Amsterdam, Dept Orthopaed Surg, Med Ctr, Amsterdam Movement Sci, Amsterdam, Netherlands.	cpl.paul@gmail.com	Paul/O-8870-2017; Smit, Theo/N-7534-2019; Smit, Theodoor/AAX-6657-2020	Smit, Theo/0000-0002-8906-7433; 	Dutch Government ZonMw Program "Alternatives for life animal testing" [11400090]; Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials	Dutch Government ZonMw Program "Alternatives for life animal testing"; Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials	This work is supported by the Dutch Government ZonMw Program "Alternatives for life animal testing" (grant number 11400090). The development of the LDCS is co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials (BMM project P2.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287; ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; ADAMS MA, 1985, SPINE, V10, P524, DOI 10.1097/00007632-198507000-00006; ADAMS MA, 1982, INT ORTHOP, V6, P249; Alkhatib B, 2014, EUR CELLS MATER, V28, P98, DOI 10.22203/eCM.v028a08; Belavy DL, 2015, EUR SPINE J; Benoist M, 2002, JOINT BONE SPINE, V69, P155, DOI 10.1016/S1297-319X(02)00385-8; Brimacombe JM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005165; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Ding F, 2013, APOPTOSIS, V18, P777, DOI 10.1007/s10495-013-0839-1; Dormans K. W., 2004, P 14 EUR SOC BIOM ES, P224; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Gawri R, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4449; Gregory DE, 2014, SPINE J, V14, P1265, DOI 10.1016/j.spinee.2013.07.489; Guterl CC, 2013, EUR CELLS MATER, V25, P1; Holzapfel GA, 2005, BIOMECH MODEL MECHAN, V3, P125, DOI 10.1007/s10237-004-0053-8; Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468; Hoogendoorn RJ, 2007, SPINE, V32, P1816, DOI 10.1097/BRS.0b013e31811ebac5; Hutton W C, 1987, Acta Orthop Belg, V53, P143; Iatridis JC, 2007, SPINE, V32, P1493, DOI 10.1097/BRS.0b013e318067dd3f; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; INOUE H, 1981, SPINE, V6, P139, DOI 10.1097/00007632-198103000-00006; INOUE H, 1975, ACTA ORTHOP SCAND, V46, P949, DOI 10.3109/17453677508989283; Kanayama M, 2009, J NEUROSURG-SPINE, V11, P501, DOI 10.3171/2009.5.SPINE08675; Kerr D, 2015, CLIN ORTHOP RELAT R, V473, P1920, DOI 10.1007/s11999-014-3803-7; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Lama P, 2013, BONE JOINT J, V95B, P1127, DOI [10.1302/0301-620X.95B8.31660, 10.1302/0301-620X.95138.31660]; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Masuoka K, 2007, SPINE, V32, P1974, DOI 10.1097/BRS.0b013e318133d591; MCNALLY DS, 1993, SPINE, V18, P1525; MCNALLY DS, 1992, SPINE, V17, P66, DOI 10.1097/00007632-199201000-00011; Moore K. L., 2011, ESSENTIAL CLIN ANATO, P293; Mroz T, 2009, AAOS COMPREHENSIVE O, P761; Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Rannou F, 2001, JOINT BONE SPINE, V68, P543, DOI 10.1016/S1297-319X(01)00325-6; Riches PE, 2002, J BIOMECH, V35, P1263, DOI 10.1016/S0021-9290(02)00070-2; Roberts S, 2002, BIOCHEM SOC T, V30, P864, DOI 10.1042/BST0300864; Rutges JPHJ, 2013, OSTEOARTHR CARTILAGE, V21, P2039, DOI 10.1016/j.joca.2013.10.001; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018; van der Veen AJ, 2005, SPINE, V30, pE534, DOI 10.1097/01.brs.0000179306.40309.3a; van der Veen AJ, 2013, J BIOMECH, V46, P2101, DOI 10.1016/j.jbiomech.2013.05.026; Vergroesen PPA, 2014, EUR SPINE J, V23, P2359, DOI 10.1007/s00586-014-3450-4; Vergroesen PP, 2015, OSTEOARTHR CARTILAGE, pS1063; Videman T, 2003, SPINE, V28, P582, DOI 10.1097/00007632-200303150-00013; Vonk LA, 2010, MATRIX BIOL, V29, P209, DOI 10.1016/j.matbio.2009.12.001; Wade KR, 2014, SPINE, V39, P1018, DOI 10.1097/BRS.0000000000000262; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Wilder D G, 1988, J Spinal Disord, V1, P16; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867; Yates JP, 2010, SPINE, V35, P734, DOI 10.1097/BRS.0b013e3181ba3a60	58	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174278	10.1371/journal.pone.0174278	http://dx.doi.org/10.1371/journal.pone.0174278			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384266	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900013
J	Adams, AM; Ahmed, R; Latif, AHMM; Rasheed, S; Das, SK; Hasib, E; Farzana, FD; Ferdous, F; Ahmed, S; Faruque, ASG				Adams, Alayne M.; Ahmed, Rushdia; Latif, A. H. M. Mahbub; Rasheed, Sabrina; Das, Sumon K.; Hasib, Enamul; Farzana, Fahmida Dil; Ferdous, Farzana; Ahmed, Shahnawaz; Faruque, A. S. G.			Impact of fortified biscuits on micronutrient deficiencies among primary school children in Bangladesh	PLOS ONE			English	Article							IRON SUPPLEMENTATION; AGED CHILDREN	Background Micronutrient deficiencies can compromise the development potential of school-aged children, and their later health and productivity as adults. School feeding and school-based fortification approaches have been utilized globally to redress nutritional deficiencies in this age group. Objective We explored the acceptability and micronutrient impact of a Bangladesh Government supported school-based micronutrient fortification program for children attending rural primary schools in 10 disadvantaged sub-districts. Methods We applied a mixed methods approach. The quantitative component assessed the impact of micronutrient fortification on 351 children aged 6-11 years using a cohort pre-post research design with a control group. The qualitative component explored the acceptability of the intervention using focus group discussions, body mapping and semi-structured interviews with teachers, school-going children and school authorities. Results Daily consumption of fortified biscuits by primary school children had a significant positive impact on mean levels of iron, folic acid, vitamin B12, retinol and vitamin D controlling for sex, baseline deficiency status, CRP, and H. pylori. Levels of anemia and vitamin D deficiency were also significantly reduced. Qualitative findings indicated the widespread acceptability of the daily biscuit. Teachers perceived students to be more attentive in class, less tired, and some attributed better school performance to biscuit consumption. Children reported similar improvements in concentration and energy levels. Conclusions This study is among the first in Bangladesh to comprehensively assess a school-based fortification program in terms of its acceptability and impact on micronutrient status of children aged 6-11 years of age. While results strongly support this modality of school feeding, research on the cognitive impacts of micronutrient fortified biscuits will help clarify the case for scaled-up investments in school-based feeding program in Bangladesh and other low and middle income countries.	[Adams, Alayne M.; Ahmed, Rushdia; Rasheed, Sabrina] Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Adams, Alayne M.; Hasib, Enamul] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Adams, Alayne M.] Georgetown Univ, Dept Int Hlth, Washington, DC USA; [Latif, A. H. M. Mahbub] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Latif, A. H. M. Mahbub] St Lukes Int Univ, Ctr Clin Epidemiol, Tokyo, Japan; [Das, Sumon K.; Farzana, Fahmida Dil; Ahmed, Shahnawaz; Faruque, A. S. G.] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Das, Sumon K.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Ferdous, Farzana] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; Georgetown University; University of Dhaka; St. Luke's International Hospital; International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland; University of Tsukuba	Ahmed, R (corresponding author), Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.	rushdia@icddrb.org	Das, Sumon Kumar/T-6384-2019; Latif, Mahbub AHM/ABD-1002-2021; Das, Sumon Kumar/AAD-1551-2019; rasheed, sabrina/A-4145-2010	Latif, Mahbub AHM/0000-0001-7838-2158; Adams, Alayne/0000-0002-0961-9825; rasheed, sabrina/0000-0002-7444-200X; AHMED, RUSHDIA/0000-0001-6917-3266; FERDOUS, FARZANA/0000-0002-6373-3581; Ahmed, Shahnawaz/0000-0001-8339-4137	European Union (EU), through a sub-contract from the James P. Grant School of Public Health; BRAG University, Dhaka Bangladesh [EU/GR-00909]; Department for International Development (DFID) [201888] Funding Source: researchfish	European Union (EU), through a sub-contract from the James P. Grant School of Public Health; BRAG University, Dhaka Bangladesh; Department for International Development (DFID)	This study was supported by the European Union (EU), through a sub-contract from the James P. Grant School of Public Health, BRAG University, Dhaka Bangladesh. Grant number/information: EU/GR-00909. icddr,b acknowledges with gratitude the commitment of EU to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support.	Ahmed A., 2004, IMPACT FEEDING CHILD; Al-Saleh Y, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0369-9; Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4; [Anonymous], 2002, HEL H PYL COMM BACT, p[1, 4]; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 2007, ASS IOD DEF DIS MON; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bundy D, RETHINKING SCH FEEDI; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eccles JS, 1999, FUTURE CHILD, V9, P30, DOI 10.2307/1602703; Franceschi F, 2014, WORLD J GASTROENTERO, V20, P12809, DOI 10.3748/wjg.v20.i36.12809; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Helen Keller International & James P. Grant School of Public Health, 2014, STAT FOOD SEC NUTR B; Hotz C, FOOD NUTR B, V25, pS91; icddrb UNICEF Bangladesh GAIN Institute of Public Health and Nutrition, 2013, NAT MICR STAT SURV 2; Iron deficiency anaemia. Assessment prevention and control, 2001, WHONHD013; Irwin L.G., 2007, EARLY CHILDHOOD DEV; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; Lawson TM, 2012, THESIS; Marschner IC, 2012, BIOSTATISTICS, V13, P179, DOI 10.1093/biostatistics/kxr030; Masalha R, 2008, J PEDIAT NEUROL, V6, P6; Murray-Kolb LE, 2013, CURR OPIN CLIN NUTR, V16, P703, DOI 10.1097/MCO.0b013e3283653ef8; Neyestani TR, 2012, PUBLIC HEALTH NUTR, V15, P324, DOI 10.1017/S1368980011000188; Hieu NT, 2012, BRIT J NUTR, V108, P1419, DOI 10.1017/S0007114511006945; SCRIMSHAW N S, 1992, Proceedings of the National Science Council Republic of China Part B Life Sciences, V16, P46; SESHADRI S, 1989, AM J CLIN NUTR, V50, P675, DOI 10.1093/ajcn/50.3.675; Social protection for food security, 2012, 4 HLPE COMM WORLD FO; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; van Stuijvenberg ME, 1999, AM J CLIN NUTR, V69, P497; Vitale G, 2011, Minerva Gastroenterol Dietol, V57, P369; Walter Tomas, 2003, Food and Nutrition Bulletin, V24, pS104; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 2015, GUID SUG INT AD CHIL; Yoko D., 2010, FINANCIAL INCLUSION	35	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174673	10.1371/Journal.pone.0174673	http://dx.doi.org/10.1371/Journal.pone.0174673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380009	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500057
J	Gates, KC; Goetzmann, LN; Cantlon, JD; Jeckel, KM; Anthony, RV				Gates, Katherine C.; Goetzmann, Lindsey N.; Cantlon, Jeremy D.; Jeckel, Kimberly M.; Anthony, Russell V.			Effect of proline rich 15-deficiency on trophoblast viability and survival	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; INTRAUTERINE GROWTH RESTRICTION; ALPHA-B-CRYSTALLIN; GENE-EXPRESSION; INCREASED APOPTOSIS; BETA SUPERFAMILY; EPITHELIAL-CELLS; MATERNAL SERUM; IN-VITRO; PREGNANCY	Deviations from the normal program of gene expression during early pregnancy can lead to early embryonic loss as well as dysfunctional placentation, which can cause significant morbidity and mortality. Proline rich 15 (PRR15) is a low molecular weight nuclear protein expressed by the trophoblast during early gestation. Lentivirus-mediated knockdown of PRR15 mRNA in ovine trophectoderm led to demise of the embryo by gestational day 15, providing compelling evidence that PRR15 expression is critical during this precarious window of development. Our objective was to determine the effect of PRR15 knockdown on trophoblast gene expression, proliferation, and survival. The first-trimester human trophoblast cell line, ACH-3P, was infected with control lentivirus or a lentivirus expressing a short hairpin (sh) RNA to target PRR15 mRNA for degradation, resulting in a 68% reduction in PRR15 mRNA. Microarray analysis of these cell lines revealed differential expression of genes related to cancer, focal adhesion, and p53 signaling. These changes included significant up-regulation of GDF15, a cytokine increased in pregnancies with preeclampsia. Viability and proliferation decreased in PRR15-deficient cells, which was consistent with down-regulation of cell cycle-related genes CCND1 and CDK6 and an up-regulation of CCNG2 and CDKN1A in the PRR15-deficient cells. TNFSF10, a tumor necrosis factor superfamily member known to induce apoptosis increased significantly in the PRR15-deficient cells. Migration through a basement membrane matrix decreased and an increased population of apoptotic cells was present when treated with shRNA to target PRR15. These results suggest that PRR15 enhances trophoblast viability and survival during early implantation and placentation.	[Gates, Katherine C.; Goetzmann, Lindsey N.; Cantlon, Jeremy D.; Jeckel, Kimberly M.; Anthony, Russell V.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Anthony, RV (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA.	russ.anthany@colostate.edu		Anthony, Russell/0000-0003-3929-626X	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2009-65203-05670]	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture	This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-65203-05670 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RV, 2010, SOC REPROD FERTIL, V67, P119; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bousette N, 2010, P NATL ACAD SCI USA, V107, P18478; Bruchim I, 2009, EXPERT OPIN THER TAR, V13, P1179, DOI 10.1517/14728220903201702; Chaouat G, 1995, HUM REPROD, V10, P55, DOI 10.1093/humrep/10.suppl_2.55; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Glover MD, 2003, BIOL REPROD, V69, P1002, DOI 10.1095/biolreprod.102.015065; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GUILLOMOT M, 1995, J REPROD FERTIL, P39; HAMILTON WJ, 1960, J ANAT, V94, P297; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Hiden U, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-137; Hopfer U, 1996, AM J PHYSIOL-CELL PH, V270, pC1, DOI 10.1152/ajpcell.1996.270.1.C1; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kiba T, 2010, PANCREAS, V39, P627, DOI 10.1097/MPA.0b013e3181c52bc5; Krause R, 1999, GENE, V232, P35, DOI 10.1016/S0378-1119(99)00120-1; Launay N, 2010, J BIOL CHEM, V285, P37324, DOI 10.1074/jbc.M110.124388; Li HS, 2005, J CLIN ENDOCR METAB, V90, P3045, DOI 10.1210/jc.2004-0808; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Meunier D, 2003, ANAT EMBRYOL, V207, P109, DOI 10.1007/s00429-003-0330-9; Meunier D, 2011, MOL CARCINOGEN, V50, P8, DOI 10.1002/mc.20692; Michaylira CZ, 2006, AM J PHYSIOL-GASTR L, V291, pG472, DOI 10.1152/ajpgi.00218.2005; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Morrish DW, 2001, CURR PROTEIN PEPT SC, V2, P245, DOI 10.2174/1389203013381116; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Prakash GJ, 2011, REPROD FERT DEVELOP, V23, P714, DOI 10.1071/RD10315; Purcell SH, 2009, BIOL REPROD, V81, P1112, DOI 10.1095/biolreprod.109.076190; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Sugulle M, 2009, HYPERTENSION, V54, P106, DOI 10.1161/HYPERTENSIONAHA.109.130583; Tarrade A, 2002, BIOL REPROD, V67, P1628, DOI 10.1095/biolreprod.101.001925; Tawfeek MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-10; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Voelkel-Johnson C, 2011, NAT REV UROL, V8, P417, DOI 10.1038/nrurol.2011.81; Watanabe G, 2009, CANCER SCI, V100, P2368, DOI 10.1111/j.1349-7006.2009.01316.x; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Yelich JV, 1997, BIOL REPROD, V57, P1256, DOI 10.1095/biolreprod57.5.1256; Yu DH, 2013, MOL CELL BIOL, V33, P1845, DOI 10.1128/MCB.01124-12; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	57	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174976	10.1371/journal.pone.0174976	http://dx.doi.org/10.1371/journal.pone.0174976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380025	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500083
J	Taylorl, LA; Powell, EC; McGraw, KJ				Taylorl, Lisa A.; Powell, Erin C.; McGraw, Kevin J.			Frequent misdirected courtship in a natural community of colorful Habronattus jumping spidersle	PLOS ONE			English	Article							MATE-CHOICE DECISIONS; REPRODUCTIVE INTERFERENCE; COSMOPHASIS-UMBRATICA; ENERGETIC COSTS; ARANEAE; SIGNALS; BEHAVIOR; SUCCESS; DISPLAY; UV	Male courtship display is common in many animals; in some cases, males engage in courtship indiscriminately, spending significant time and energy courting heterospecifics with whom they have no chance of mating or producing viable offspring. Due to high costs and few if any benefits, we might expect mechanisms to evolve to reduce such misdirected courtship (or 'reproductive interference'). In Habronattus jumping spiders, males frequently court heterospecifics with whom they do not mate or hybridize; females are larger and are voracious predators, posing a severe risk to males who court indiscriminately. In this study, we examined patterns of misdirected courtship in a natural community of four sympatric Habronattus species (H. clypeatus, H. hallani, H. hirsutus, and H. pyrrithrix). We used direct field observations to weigh support for two hypotheses (differential microhabitat use and species recognition signaling) to explain how these species reduce the costs associated with misdirected courtship. We show that, while the four species of Habronattus do show some differences in microhabitat use, all four species still overlap substantially, and in three of the four species individuals equally encountered heterospecifics and conspecifics. Males courted females at every opportunity, regardless of species, and in some cases, this led to aggression and predation by the female. These results suggest that, while differences in microhabitat use might reduce misdirected courtship to some extent, co-existence of these four species may be possible due to complex communication (i.e. species-specific elements of a male's courtship display). This study is the first to examine misdirected courtship in jumping spiders. Studies of misdirected courtship and its consequences in the field are limited and may broaden our understanding of how biodiversity is maintained within a community.	[Taylorl, Lisa A.; Powell, Erin C.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Taylorl, Lisa A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Taylorl, Lisa A.; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Powell, Erin C.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; University of Auckland	Taylorl, LA (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.; Taylorl, LA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Taylorl, LA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	lisa.taylor@ufl.edu			Animal Behavior Society; Sigma Xi; Arizona State University Graduate and Professional Students' Association; National Science Foundation Graduate Research Fellowship; National Science Foundation [IOS-1557867]; University of Florida Open Access Publishing Fund; Direct For Biological Sciences [1557867] Funding Source: National Science Foundation	Animal Behavior Society; Sigma Xi; Arizona State University Graduate and Professional Students' Association; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); University of Florida Open Access Publishing Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by research grants from the Animal Behavior Society, Sigma Xi, and the Arizona State University Graduate and Professional Students' Association, as well as a National Science Foundation Graduate Research Fellowship to LAT. ECP was supported by a National Science Foundation grant (IOS-1557867 to LAT) during writing and publication. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ANDREWS RH, 1982, OECOLOGIA, V52, P281, DOI 10.1007/BF00363851; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Arnqvist Goran, 2005, pUnpaginated; Blackburn GS, 2015, BEHAVIOUR, V152, P1168, DOI 10.1163/1568539X-00003273; Bulbert MW, 2015, ECOL EVOL, V5, P914, DOI 10.1002/ece3.1419; Cady AB, 2011, J ARACHNOL, V39, P161, DOI 10.1636/Hi09-70.1; Clark DL, 2016, ETHOLOGY, V122, P364, DOI 10.1111/eth.12476; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; Costa-Schmidt LE, 2012, ANIM BEHAV, V84, P1201, DOI 10.1016/j.anbehav.2012.08.026; Cross FR, 2009, P NATL ACAD SCI USA, V106, P19416, DOI 10.1073/pnas.0904125106; CUTLER B, 1988, GREAT LAKES ENTOMOL, V21, P129; Elias DO, 2006, J COMP PHYSIOL A, V192, P785, DOI 10.1007/s00359-006-0116-7; Elias DO, 2012, BIOL J LINN SOC, V105, P522, DOI 10.1111/j.1095-8312.2011.01817.x; Elias DO, 2005, ANIM BEHAV, V69, P931, DOI 10.1016/j.anbehav.2004.06.024; Elias DO, 2004, J EXP BIOL, V207, P4105, DOI 10.1242/jeb.01261; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Fea MP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0746; Foelix R., 2011, BIOL SPIDERS, V3; Griswald C.E., 1987, University of California Publications in Entomology, V107, P1; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Groning J, 2007, OIKOS, V116, P1449, DOI 10.1111/j.2007.0030-1299.15850.x; GWYNNE DT, 1983, J AUST ENTOMOL SOC, V22, P79; Hettyey A, 2014, OECOLOGIA, V176, P457, DOI 10.1007/s00442-014-3046-z; Hoback WW, 1997, PHYSIOL ENTOMOL, V22, P286, DOI 10.1111/j.1365-3032.1997.tb01170.x; Hochkirch A, 2007, J ANIM ECOL, V76, P633, DOI 10.1111/j.1365-2656.2007.01241.x; Hoefler CD, 2008, BEHAV ECOL, V19, P974, DOI 10.1093/beheco/arn055; Hoefler CD, 2008, J ARACHNOL, V36, P210, DOI 10.1636/St07-08SC.1; Jackson Robert R., 1997, P340, DOI 10.1017/CBO9780511721946.021; Jackson RR, 1982, SPIDER COMMUNICATION; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kyogoku D, 2015, J EVOLUTION BIOL, V28, P1283, DOI 10.1111/jeb.12646; Li JJ, 2008, CURR BIOL, V18, P699, DOI 10.1016/j.cub.2008.04.020; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Lim MLM, 2007, SCIENCE, V315, P481, DOI 10.1126/science.1134254; LOSOS JB, 1985, COPEIA, P905, DOI 10.2307/1445240; Maddison W, 2003, SYST ENTOMOL, V28, P1, DOI 10.1046/j.1365-3113.2003.00195.x; Maddison W, 2000, SYST BIOL, V49, P400, DOI 10.1080/10635159950127312; MADDISON WP, 1988, J ARACHNOL, V16, P199; Mappes J, 1996, P ROY SOC B-BIOL SCI, V263, P785, DOI 10.1098/rspb.1996.0117; Masta SE, 2002, P NATL ACAD SCI USA, V99, P4442, DOI 10.1073/pnas.072493099; Nelson XJ, 2012, BIOL J LINN SOC, V107, P664, DOI 10.1111/j.1095-8312.2012.01965.x; Ptacek MB, 2000, BEHAV PROCESS, V51, P111, DOI 10.1016/S0376-6357(00)00123-6; Quinones- Lebron SG, 2016, SCI REPORTS, P6; RICHMAN DB, 1982, J ARACHNOL, V10, P47; Richman DB, 1973, THESIS; South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991; Su KFY, 2006, ANIM BEHAV, V71, P531, DOI 10.1016/j.anbehav.2005.04.024; Taylor LA, 2012, COLOR COMMUNICATION; Taylor LA, 2014, J ARACHNOL, V42, P268, DOI 10.1636/0161-8202-42.3.268; Taylor LA, 2013, BEHAV ECOL, V24, P955, DOI 10.1093/beheco/art011; Taylor LA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1133, DOI 10.1007/s00265-010-1127-5; Warburton K, 1996, ANIM BEHAV, V52, P371, DOI 10.1006/anbe.1996.0181; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101; WELLS KD, 1989, BEHAV ECOL SOCIOBIOL, V25, P13, DOI 10.1007/BF00299706; Woods WA, 2007, AM NAT, V170, P702, DOI 10.1086/521964; World Spider Catalog, 2016, WORLD SPIDER CATALOG; Zurek DB, 2015, CURR BIOL, V25, pR403, DOI 10.1016/j.cub.2015.03.033	61	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173156	10.1371/journal.pone.0173156	http://dx.doi.org/10.1371/journal.pone.0173156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379968	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500013
J	Chen, LW; Chen, FP; Hsieh, CW; Kuo, SF; Chien, RN				Chen, Li-Wei; Chen, Fang-Ping; Hsieh, Chia-Wen; Kuo, Sheng-Fong; Chien, Rong-Nan			Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; TUMOR-NECROSIS-FACTOR; POSTMENOPAUSAL WOMEN; SERUM LEPTIN; FACTOR-ALPHA; OSTEOPOROSIS; DISEASE; MEN; GASTRITIS; ESTROGEN	Helicobacter pylori (H. pylori) infection may induce inflammatory cytokines or adipokines that influence bone turnover and bone fracture risk. This study aimed to evaluate the association among H. pylori infection, adipokines, and 10-year fracture risk using the Fracture Risk Assessment Tool scale. From August 2013 to February 2016, a community-based cohort was surveyed by Keelung Chang-Gung Memorial Hospital. Subjects were included if they were older than 40 years and not pregnant. All participants underwent a standardized questionnaire survey, physical examination, urea breath test, and blood tests. A total of 2,689 participants (1,792 women) were included in this cross-sectional study. In both sexes, participants with a high fracture risk were older and had higher adiponectin values than participants without a high fracture risk (mean age, female: 72.9 +/- 5.6 vs. 55.8 +/- 7.3 years, P < 0.0001; male: 78.9 +/- 4.7 vs. 58.1 +/- 8.9 years, P < 0.001) (adiponectin, female: 10.8 +/- 6.3 vs. 8.7 +/- 5.2 ng/ml, P < 0.001; male: 9.7 +/- 6.1 vs. 5.5 +/- 3.8 ng/ml, P < 0.001). Adiponectin was correlated with high fracture risk in both sexes, but H. pylori infection and leptin was not. In logistic regression analysis, adiponectin could not predict high fracture risk when adjusting the factor of body mass index (BMI) in men group. In conclusion, H. pylori infection and leptin could not predict 10-year fracture risk in either sex. Adiponectin was correlated with bone fracture risk in both sexes and the correlation might be from the influence of BMI.	[Chen, Li-Wei; Chien, Rong-Nan] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Keelung, Taiwan; [Chen, Li-Wei; Hsieh, Chia-Wen; Kuo, Sheng-Fong; Chien, Rong-Nan] Univ Keelung, Keelung, Taiwan; [Chen, Li-Wei; Hsieh, Chia-Wen; Kuo, Sheng-Fong; Chien, Rong-Nan] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chen, Fang-Ping] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Keelung, Taiwan; [Kuo, Sheng-Fong] Chang Gung Mem Hosp, Metab & Endocrinol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chien, RN (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Keelung, Taiwan.; Chien, RN (corresponding author), Univ Keelung, Keelung, Taiwan.; Chien, RN (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	ronald@cgmh.org.hiv	Chen, Li-Wei/ABA-5139-2021	Chen, Li-Wei/0000-0001-8805-2275	Chang-Gung Memorial Hospital [CMRPG2B0123, CMRPG2B0173]	Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from Chang-Gung Memorial Hospital (No CMRPG2B0123 and CMRPG2B0173). The funder has no role in this study.	Adachi Y, 2000, CALCIFIED TISSUE INT, V66, P119, DOI 10.1007/s002230010025; Akkaya N, 2011, J PHYS THER SCI, V23, P61, DOI 10.1589/jpts.23.61; Asaoka D, 2015, THER CLIN RISK MANAG, V11, P381, DOI 10.2147/TCRM.S80647; Asaoka D, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/340765; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Biver E, 2011, J CLIN ENDOCR METAB, V96, P2703, DOI 10.1210/jc.2011-0047; Breidert M, 1999, SCAND J GASTROENTERO, V34, P954, DOI 10.1080/003655299750025039; Chao AS, 2015, TAIWAN J OBSTET GYNE, V54, P722, DOI 10.1016/j.tjog.2015.10.005; Chen LW, 2007, HEPATO-GASTROENTEROL, V54, P2209; Crabtree JE, 1996, ALIMENT PHARM THER, V10, P29, DOI 10.1046/j.1365-2036.1996.22164003.x; Dubuc GR, 1998, METABOLISM, V47, P429, DOI 10.1016/S0026-0495(98)90055-5; Figura N, 2005, DIGEST DIS SCI, V50, P847, DOI 10.1007/s10620-005-2651-4; Kakehasi Adriana M., 2007, Arq. Gastroenterol., V44, P266, DOI 10.1590/S0004-28032007000300016; Kakehasi AM, 2009, DIGEST DIS SCI, V54, P819, DOI 10.1007/s10620-008-0417-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Kim JW, 2015, BONE, V75, P27, DOI 10.1016/j.bone.2015.02.013; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P75, DOI 10.1007/s00198-011-1747-2; Lim S, 2004, BONE, V35, P792, DOI 10.1016/j.bone.2004.05.016; Lin SC, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/814756; Liu H, 2008, ANN INTERN MED, V148, P685, DOI 10.7326/0003-4819-148-9-200805060-00009; Liu K, 2015, CLIN CHIM ACTA, V444, P260, DOI 10.1016/j.cca.2015.02.040; Lubkowska A, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/975178; Mechanick JI, 2010, ENDOCR PRACT, V16, P270, DOI 10.4158/EP.16.2.270; Mohiti-Ardekani J, 2014, J BONE MINER METAB, V32, P400, DOI 10.1007/s00774-013-0511-4; Napoli N, 2010, BONE, V47, P1001, DOI 10.1016/j.bone.2010.08.010; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Odabasi E, 2000, EUR J ENDOCRINOL, V142, P170, DOI 10.1530/eje.0.1420170; Ozdem S, 2007, DIGEST DIS SCI, V52, P967, DOI 10.1007/s10620-006-9292-0; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Schulte CMS, 2004, ALIMENT PHARM THERAP, V20, P43, DOI 10.1111/j.1365-2036.2004.02057.x; Siris E, 2014, OSTEOPOROSIS INT, V25, P1439, DOI 10.1007/s00198-014-2655-z; Suzuki T, 2010, OSTEOPOROSIS INT, V21, P71, DOI 10.1007/s00198-009-0970-6; TEPPO AM, 1987, CLIN CHEM, V33, P2024; Thalmaier U, 2002, INFECT IMMUN, V70, P3149, DOI 10.1128/IAI.70.6.3149-3155.2002	41	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175365	10.1371/journal.pone.0175365	http://dx.doi.org/10.1371/journal.pone.0175365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388631	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800045
J	Murphy, SN; Avillach, P; Bellazzi, R; Phillips, L; Gabetta, M; Eran, A; McDuffie, MT; Kohane, IS				Murphy, Shawn N.; Avillach, Paul; Bellazzi, Riccardo; Phillips, Lori; Gabetta, Matteo; Eran, Alal; McDuffie, Michael T.; Kohane, Isaac S.			Combining clinical and genomics queries using i2b2-Three methods	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; RHEUMATOID-ARTHRITIS; INTEGRATING BIOLOGY; GENETIC-VARIANTS; SEQUENCING DATA; INFORMATICS; DISCOVERY; FRAMEWORK; BEDSIDE	We are fortunate to be living in an era of twin biomedical data surges: a burgeoning representation of human phenotypes in the medical records of our healthcare systems, and high-throughput sequencing making rapid technological advances. The difficulty representing genomic data and its annotations has almost by itself led to the recognition of a biomedical "Big Data" challenge, and the complexity of healthcare data only compounds the problem to the point that coherent representation of both systems on the same platform seems insuperably difficult. We investigated the capability for complex, integrative genomic and clinical queries to be supported in the Informatics for Integrating Biology and the Bedside (i2b2) translational software package. Three different data integration approaches were developed: The first is based on Sequence Ontology, the second is based on the tranSMART engine, and the third on CouchDB. These novel methods for representing and querying complex genomic and clinical data on the i2b2 platform are available today for advancing precision medicine.	[Murphy, Shawn N.; Phillips, Lori] Partners HealthCare, Res IS & Comp, Charlestown, MA 02129 USA; [Murphy, Shawn N.; Avillach, Paul; Eran, Alal; McDuffie, Michael T.; Kohane, Isaac S.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Murphy, Shawn N.] Massachusetts Gen Hosp, Comp Sci Lab, Boston, MA 02114 USA; [Avillach, Paul; Eran, Alal; McDuffie, Michael T.; Kohane, Isaac S.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Bellazzi, Riccardo; Gabetta, Matteo] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy; [Bellazzi, Riccardo] Fdn S Maugeri, IRCCS, Pavia, Italy; [Bellazzi, Riccardo] Univ Pavia, Ctr Hlth Technol, Pavia, Italy; [Gabetta, Matteo] Biomeris Srl, Via Ferrata, Pavia, Italy	Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University of Pavia	Murphy, SN (corresponding author), Partners HealthCare, Res IS & Comp, Charlestown, MA 02129 USA.; Murphy, SN (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Murphy, SN (corresponding author), Massachusetts Gen Hosp, Comp Sci Lab, Boston, MA 02114 USA.	snmurphy@partners.org	Eran, Alal/AAA-8776-2021; Bellazzi, Riccardo/J-6432-2018	Bellazzi, Riccardo/0000-0002-6974-9808; Eran, Alal/0000-0001-6784-7597	National Human Genome Research Institute [RO1 HG009174-01]; National Institutes of Health Centers of Excellence for Big Data Computing in the Biomedical Sciences [1U54HG007963-01]; National Institutes of Health through the NIH [U54LM008748ISK]; National Institute of Biomedical Imaging and Bioengineering [R01EB014947]; Amazon Web Service Research Grant [EDU_R_FY2015_Q2_Harvard]; Rete Ematologica Lombarda (REL) biotechnology cluster for the implementation of genomic analysis and the development of innovative treatments in hematological malignancies; Fondazione Cariplo; Regione Lombardia; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009174] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health Centers of Excellence for Big Data Computing in the Biomedical Sciences; National Institutes of Health through the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Amazon Web Service Research Grant; Rete Ematologica Lombarda (REL) biotechnology cluster for the implementation of genomic analysis and the development of innovative treatments in hematological malignancies; Fondazione Cariplo(Fondazione Cariplo); Regione Lombardia(Regione Lombardia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by: National Human Genome Research Institute RO1 HG009174-01, SNM; National Institutes of Health Centers of Excellence for Big Data Computing in the Biomedical Sciences 1U54HG007963-01, SNM ISK; National Institutes of Health through the NIH Road map for Medical Research U54LM008748ISK; National Institute of Biomedical Imaging and Bioengineering R01EB014947, SNM; Amazon Web Service Research Grant: EDU_R_FY2015_Q2_Harvard Me dical School_Avillach, PA; and the Rete Ematologica Lombarda (REL) biotechnology cluster for the implementation of genomic analysis and the development of innovative treatments in hematological malignancies", jointly funded by the Fondazione Cariplo and the Regione Lombardia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson J. C., 2010, COUCHDB DEFINITIVE G; Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; Avillach P, 2013, J AM MED INFORM ASSN, V20, P184, DOI 10.1136/amiajnl-2012-000933; Cattell R, 2010, SIGMOD REC, V39, P12, DOI 10.1145/1978915.1978919; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Gabetta M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0861-0; Girardeau Y, 2015, DRUG SAFETY, P1; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Kimball R., 1996, DATA WAREHOUSE TOOLK; Kohane IS, 2012, J AM MED INFORM ASSN, V19, P181, DOI 10.1136/amiajnl-2011-000492; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Lander ES, 2015, NEW ENGL J MED, V373, P5, DOI 10.1056/NEJMp1506446; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Mandl KD, 2015, NAT BIOTECHNOL, V33, P360, DOI 10.1038/nbt.3180; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Nadkarni PM, 1998, J AM MED INFORM ASSN, V5, P511, DOI 10.1136/jamia.1998.0050511; National Research Council (US) Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Neuraz A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003405; Reese MG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r88; Savaiano J., 2013, BRING HEALTHCARES DA; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Szalma S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-68; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wheeler DA, 2013, GENOME RES, V23, P1054, DOI 10.1101/gr.157602.113; Wolstencroft K, 2013, NUCLEIC ACIDS RES, V41, pW557, DOI 10.1093/nar/gkt328; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223	33	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0172187	10.1371/journal.pone.0172187	http://dx.doi.org/10.1371/journal.pone.0172187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388645	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800001
J	Belic, JJ; Kumar, A; Kotaleski, JH				Belic, Jovana J.; Kumar, Arvind; Kotaleski, Jeanette Hellgren			Interplay between periodic stimulation and GABAergic inhibition in striatal network oscillations	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; SPINY PROJECTION NEURONS; BASAL GANGLIA; FIRE NEURONS; OUTPUT; ROLES; ORGANIZATION; FEEDFORWARD; NEOSTRIATUM; MECHANISMS	Network oscillations are ubiquitous across many brain regions. In the basal ganglia, oscillations are also present at many levels and a wide range of characteristic frequencies have been reported to occur during both health and disease. The striatum, the main input nucleus of the basal ganglia, receives massive glutamatergic inputs from the cortex and is highly susceptible to external oscillations. However, there is limited knowledge about the exact nature of this routing process and therefore, it is of key importance to understand how time-dependent, external stimuli propagate through the striatal circuitry. Using a network model of the striatum and corticostriatal projections, we try to elucidate the importance of specific GABAergic neurons and their interactions in shaping striatal oscillatory activity. Here, we propose that fast-spiking interneurons can perform an important role in transferring cortical oscillations to the striatum especially to those medium spiny neurons that are not directly driven by the cortical oscillations. We show how the activity levels of different populations, the strengths of different inhibitory synapses, degree of outgoing projections of striatal cells, ongoing activity and synchronicity of inputs can influence network activity. These results suggest that the propagation of oscillatory inputs into the medium spiny neuron population is most efficient, if conveyed via the fast-spiking interneurons. Therefore, pharmaceuticals that target fast-spiking interneurons may provide a novel treatment for regaining the spectral characteristics of striatal activity that correspond to the healthy state.	[Belic, Jovana J.; Kotaleski, Jeanette Hellgren] KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, Stockholm, Sweden; [Belic, Jovana J.; Kumar, Arvind; Kotaleski, Jeanette Hellgren] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Sci & Technol, Stockholm, Sweden; [Belic, Jovana J.] Univ Freiburg, Bernstein Ctr Freiburg, Freiburg, Germany; [Kotaleski, Jeanette Hellgren] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology; University of Freiburg; Karolinska Institutet	Belic, JJ (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, Stockholm, Sweden.; Belic, JJ (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Sci & Technol, Stockholm, Sweden.; Belic, JJ (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Freiburg, Germany.	belic@kth.se		Kotaleski, Jeanette/0000-0002-0550-0739	European Union Seventh Framework Programme (FP7) [604102]; European Horizon Framework Programme [720270]; Swedish Research Council; NIAAA [2R01AA016022]; Swedish e-Science Research Center; EuroSPIN - an Erasmus Mundus Joint Doctoral program	European Union Seventh Framework Programme (FP7); European Horizon Framework Programme; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Swedish e-Science Research Center; EuroSPIN - an Erasmus Mundus Joint Doctoral program	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604102 (Human Brain Project); The European Horizon2020 Framework Programme under grant agreement no 720270 (Human Brain Project SGA1); The Swedish Research Council; NIAAA (grant 2R01AA016022); Swedish e-Science Research Center; EuroSPIN - an Erasmus Mundus Joint Doctoral program. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bahuguna J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004233; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beatty JA, 2015, J NEUROPHYSIOL, V113, P688, DOI 10.1152/jn.00827.2014; Belic JJ, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00026, 10.3389/fnsys.7016.00026]; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00045; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Boraud T., 2005, OSCILLATIONS BASAL G, P1; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brunel N, 1998, J THEOR BIOL, V195, P87, DOI 10.1006/jtbi.1998.0782; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Bruno RM, 2011, CURR OPIN NEUROBIOL, V21, P701, DOI 10.1016/j.conb.2011.06.003; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dupre KB, 2016, NEUROBIOL DIS, V86, P1, DOI 10.1016/j.nbd.2015.11.009; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Gonzalez OJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100899; GRAYBIEL AM, 1995, TRENDS NEUROSCI, V18, P60; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Halje P, 2012, J NEUROSCI, V32, P16541, DOI 10.1523/JNEUROSCI.3047-12.2012; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hjorth J, 2009, J NEUROSCI, V29, P5276, DOI 10.1523/JNEUROSCI.6031-08.2009; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kemp J. M., 1978, PHILOS T R SOC B, V262, P441; Klaus A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00057; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Kumar A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00086; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Plenz D, 2003, TRENDS NEUROSCI, V26, P436, DOI 10.1016/S0166-2236(03)00196-6; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reig R, 2014, NEURON, V83, P1200, DOI 10.1016/j.neuron.2014.07.033; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Stamey W, 2008, NEUROLOGIST, V14, P89, DOI 10.1097/NRL.0b013e31816606a7; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tepper JM, 2006, MICROCIRCUITS INTERF, P127; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; Tunstall MJ, 2002, J NEUROPHYSIOL, V88, P1263, DOI 10.1152/jn.2002.88.3.1263; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; Yim MY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002254; Zheng T, 2002, J NEUROPHYSIOL, V87, P1007, DOI 10.1152/jn.00519.2001	69	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175135	10.1371/journal.pone.0175135	http://dx.doi.org/10.1371/journal.pone.0175135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384268	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900097
J	Calderaro, A; Buttrini, M; Piergianni, M; Montecchini, S; Martinelli, M; Covan, S; Piccolo, G; Medici, MC; Arcangeletti, MC; Chezzi, C; De Conto, F				Calderaro, Adriana; Buttrini, Mirko; Piergianni, Maddalena; Montecchini, Sara; Martinelli, Monica; Covan, Silvia; Piccolo, Giovanna; Medici, Maria Cristina; Arcangeletti, Maria Cristina; Chezzi, Carlo; De Conto, Flora			Evaluation of a modified meropenem hydrolysis assay on a large cohort of KPC and VIM carbapenemase-producing Enterobacteriaceae	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; IDENTIFICATION; GENES	Carbapenem-resistant Enterobacteriaceae (CRE) have spread globally and represent a serious and growing threat to public health. The introduction of rapid and sensitive methods for the detection of carbapenemase-producing bacteria is of increasing importance. The carbapenemase production can be detected using non-molecular methods (such as the modified Hodge test, the synergy test, the Carba NP test and the antibiotic hydrolysis assays) and DNA-based methods. In this study, we propose a modified version of a previously described meropenem hydrolysis assay (MHA) by MALDI-TOF MS for the phenotypic detection in 2h of carbapenemase-producing Enterobacteriaceae. The MHA was successfully applied to detect carbapenemase activity in 981 well-characterized Enterobacteriaceae strains producing KPC or VIM carbapenemases, and in 146 carbapenem fully susceptible strains. This assay, applied also to NDM and OXA-48-producing strains and to CRE with resistance mechanisms other than carbapenemase production, has proved to be able to distinguish between carbapenemase-producing and-nonproducing Enterobacteriaceae. As already stated and as observed in our hands, MHA by MALDI-TOF MS analysis is independent from the type of carbapenemases involved, it is faster and easier to perform/ interpret than culture-based methods. On the other hand, it cannot detect other carbapenem resistance mechanisms, such as porin alterations and efflux mechanisms.	[Calderaro, Adriana; Buttrini, Mirko; Piergianni, Maddalena; Montecchini, Sara; Martinelli, Monica; Covan, Silvia; Piccolo, Giovanna; Medici, Maria Cristina; Arcangeletti, Maria Cristina; Chezzi, Carlo; De Conto, Flora] Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, Parma, Italy	University of Parma; University Hospital of Parma	Calderaro, A (corresponding author), Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, Parma, Italy.	adriana.calderaro@unipr.it	De Conto, Flora/H-9760-2019; piccolo, giovanna/HHZ-8454-2022	De Conto, Flora/0000-0002-0493-2353; 				AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07; Bisiklis A, 2007, CLIN MICROBIOL INFEC, V13, P1201, DOI 10.1111/j.1469-0691.2007.01832.x; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; CDC, 2013, ANTIBIOTIC RESISTANC; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI; Hall BG, 2003, J MOL EVOL, V57, P249, DOI 10.1007/s00239-003-2471-0; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Lasserre C, 2015, J CLIN MICROBIOL, V53, P2163, DOI 10.1128/JCM.03467-14; Lau AF, 2014, J CLIN MICROBIOL, V52, P2804, DOI 10.1128/JCM.00694-14; Ledeboer N. A., 2011, Journal of Clinical Microbiology, V49, pS20, DOI 10.1128/JCM.00771-11; Monaco M, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.42.20939; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2013, J ANTIMICROB CHEMOTH, V68, P487, DOI 10.1093/jac/dks426; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Oviano M, 2016, INT J ANTIMICROB AG, V48, P655, DOI 10.1016/j.ijantimicag.2016.08.024; Papagiannitsis CC, 2015, J CLIN MICROBIOL, V53, P1731, DOI 10.1128/JCM.03094-14; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Wang LJ, 2013, ANAL BIOANAL CHEM, V405, P5259, DOI 10.1007/s00216-013-6913-2	24	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174908	10.1371/journal.pone.0174908	http://dx.doi.org/10.1371/journal.pone.0174908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384185	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900050
J	Cullis, PS; Gudlaugsdottir, K; Andrews, J				Cullis, Paul Stephen; Gudlaugsdottir, Katrin; Andrews, James			A systematic review of the quality of conduct and reporting of systematic reviews and meta-analyses in paediatric surgery	PLOS ONE			English	Review							CONGENITAL DIAPHRAGMATIC-HERNIA; SURGICAL ASSOCIATION OUTCOMES; URETEROPELVIC JUNCTION OBSTRUCTION; GASTROESOPHAGEAL-REFLUX DISEASE; MINIMALLY INVASIVE SURGERY; GAP ESOPHAGEAL ATRESIA; INTESTINAL ROTATIONAL ABNORMALITIES; NUTRITION-ASSOCIATED CHOLESTASIS; SHORT-BOWEL SYNDROME; HIRSCHSPRUNGS-DISEASE	Objective Our objective was to evaluate quality of conduct and reporting of published systematic reviews and meta-analyses in paediatric surgery. We also aimed to identify characteristics predictive of review quality. Background Systematic reviews summarise evidence by combining sources, but are potentially prone to bias. To counter this, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was published to aid in reporting. Similarly, the Assessing the Methodological Quality of Systematic Reviews (AMSTAR) measurement tool was designed to appraise methodology. The paediatric surgical literature has seen an increasing number of reviews over the past decade, but quality has not been evaluated. Methods Adhering to PRISMA guidelines, we performed a systematic review with a priori design to identify systematic reviews and meta-analyses of interventions in paediatric surgery. From 01/2010 to 06/2016, we searched: MEDLINE, EMBASE, Cochrane, Centre for Reviews and Dissemination, Web of Science, Google Scholar, reference lists and journals. Two reviewers independently selected studies and extracted data. We assessed conduct and reporting using AMSTAR and PRISMA. Scores were calculated as the sum of reported items. We also extracted author, journal and article characteristics, and used them in exploratory analysis to determine which variables predict quality. Results 112 articles fulfilled eligibility criteria (53 systematic reviews; 59 meta-analyses). Overall, 68% AMSTAR and 56.8% PRISMA items were reported adequately. Poorest scores were identified with regards a priori design, inclusion of structured summaries, including the grey literature, citing excluded articles and evaluating bias. 13 reviews were pre-registered and 6 in PRISMA-endorsing journals. The following predicted quality in univariate analysis:, word count, Cochrane review, journal h-index, impact factor, journal endorses PRISMA, PRISMA adherence suggested in author guidance, article mentions PRISMA, review includes comparison of interventions and review registration. The latter three variables were significant in multivariate regression. Conclusions There are gaps in the conduct and reporting of systematic reviews in paediatric surgery. More endorsement by journals of the PRISMA guideline may improve review quality, and the dissemination of reliable evidence to paediatric clinicians.	[Cullis, Paul Stephen; Gudlaugsdottir, Katrin; Andrews, James] Royal Hosp Children, Dept Surg Paediat, Glasgow, Lanark, Scotland; [Cullis, Paul Stephen; Andrews, James] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of Glasgow	Cullis, PS; Andrews, J (corresponding author), Royal Hosp Children, Dept Surg Paediat, Glasgow, Lanark, Scotland.; Cullis, PS; Andrews, J (corresponding author), Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland.	paul.cullis@nhs.net; jamesandrews@nhs.net		Andrews, James/0000-0003-0097-9215; Cullis, Paul/0000-0003-4479-6621				Adie S, 2015, ANN SURG, V261, P685, DOI 10.1097/SLA.0000000000000836; Aikenhead A, 2011, CLIN OBES, V1, P12, DOI 10.1111/j.1758-8111.2010.00003.x; Al-Hozaim O, 2010, J PEDIATR SURG, V45, P1500, DOI 10.1016/j.jpedsurg.2009.12.001; Allen CJ, 2015, J PEDIATR SURG, V50, P177, DOI 10.1016/j.jpedsurg.2014.10.042; Allin B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150864; Allin BSR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116908; Alzahem A, 2011, PEDIATR SURG INT, V27, P605, DOI 10.1007/s00383-010-2840-x; [Anonymous], 2016, CERTIFICATION GUIDEL; Apelt N, 2013, J PEDIATR SURG, V48, P1789, DOI 10.1016/j.jpedsurg.2013.05.024; Autorino R, 2014, EUR UROL, V65, P430, DOI 10.1016/j.eururo.2013.06.053; Aworanti O, 2014, EUR J PEDIATR SURG, V24, P365, DOI 10.1055/s-0034-1370780; Baker L, 2015, J PEDIATR SURG, V50, P718, DOI 10.1016/j.jpedsurg.2015.02.021; Beres AL, 2013, SURGERY, V154, P328, DOI 10.1016/j.surg.2013.04.036; Berg RNWV, 2016, UROL ONCOL-SEMIN ORI, V34, P24, DOI 10.1016/j.urolonc.2015.07.003; Berger M, 2012, EUR J PEDIATR SURG, V22, P109, DOI 10.1055/s-0032-1311695; Billingham MJ, 2010, EUR J PEDIATR SURG, V20, P73, DOI 10.1055/s-0029-1241871; Black JA, 2013, OBES REV, V14, P634, DOI 10.1111/obr.12037; Blakely ML, 2013, J AM COLL SURG, V217; Borruto FA, 2010, J PEDIATR SURG, V45, P2464, DOI 10.1016/j.jpedsurg.2010.07.007; Braga LH, 2011, J UROLOGY, V186, P266, DOI 10.1016/j.juro.2011.03.044; Castagnetti M, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00041; Castagnetti M, 2010, J UROLOGY, V184, P1469, DOI 10.1016/j.juro.2010.06.044; Chan E, 2014, J PEDIATR SURG, V49, P694, DOI 10.1016/j.jpedsurg.2014.02.049; Chan E, 2014, PEDIATR SURG INT, V30, P87, DOI 10.1007/s00383-013-3429-y; Chang SJ, 2015, WORLD J UROL, V33, P1855, DOI 10.1007/s00345-015-1526-3; Chen Y, 2013, J PEDIATR SURG, V48, P642, DOI 10.1016/j.jpedsurg.2012.12.036; Chua ME, 2014, J PEDIATR SURG, V49, P1659, DOI 10.1016/j.jpedsurg.2014.06.013; Connor MJ, 2015, AM J SURG, V209, P747, DOI 10.1016/j.amjsurg.2014.09.019; Corbett HJ, 2015, J PEDIATR UROL, V11, P328, DOI 10.1016/j.jpurol.2015.08.014; Coyle D, 2015, PEDIATR SURG INT, V31, P711, DOI 10.1007/s00383-015-3732-x; Cullis PS, 2015, ANN SURG; Cundy TP, 2014, BJU INT, V114, P582, DOI 10.1111/bju.12683; Cundy TP, 2014, J PEDIATR SURG, V49, P646, DOI 10.1016/j.jpedsurg.2013.12.014; Cundy TP, 2014, EUR J PEDIATR SURG, V24, P127, DOI 10.1055/s-0033-1347297; D'Antonio F, 2015, PEDIATRICS, V136, pE159, DOI 10.1542/peds.2015-0017; Das A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006388.pub2; Dellenmark-Blom M, 2015, QUAL LIFE RES, V24, P2433, DOI 10.1007/s11136-015-0975-x; Dicken BJ, 2011, J PEDIATR SURG, V46, P1618, DOI 10.1016/j.jpedsurg.2011.04.002; Ding J, 2013, J PEDIATR SURG, V48, P1088, DOI 10.1016/j.jpedsurg.2013.01.026; Dingemann C, 2014, EUR J PEDIATR SURG, V24, P14, DOI 10.1055/s-0033-1350060; Dingemann J, 2013, EUR J PEDIATR SURG, V23, P474, DOI 10.1055/s-0033-1333639; Doodnath R, 2010, PEDIATR SURG INT, V26, P1107, DOI 10.1007/s00383-010-2694-2; Downard CD, 2012, J PEDIATR SURG, V47, P2111, DOI 10.1016/j.jpedsurg.2012.08.011; Eaton S, 2013, J PEDIATR SURG, V48, P281, DOI 10.1016/j.jpedsurg.2012.11.004; Ekenze Sebastian O, 2015, Lancet, V385 Suppl 2, pS35, DOI 10.1016/S0140-6736(15)60830-3; Ells LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011740; Elyas R, 2010, J UROLOGY, V183, P2012, DOI 10.1016/j.juro.2010.01.035; Espinel AG, 2014, OTOLARYNG HEAD NECK, V150, P739, DOI 10.1177/0194599814527232; Esposito C, 2014, J LAPAROENDOSC ADV S, V24, P811, DOI 10.1089/lap.2014.0194; Evans C, 2011, J PEDIATR SURG, V46, P2119, DOI 10.1016/j.jpedsurg.2011.06.033; Feng SG, 2016, PEDIATR SURG INT, V32, P253, DOI 10.1007/s00383-015-3845-2; Feng SG, 2015, SURG LAPARO ENDO PER, V25, P275, DOI 10.1097/SLE.0000000000000161; Friedmacher F, 2015, PEDIATR SURG INT, V31, P821, DOI 10.1007/s00383-015-3742-8; Friedmacher F, 2012, PEDIATR SURG INT, V28, P899, DOI 10.1007/s00383-012-3142-2; Friedmacher F, 2011, PEDIATR SURG INT, V27, P1053, DOI 10.1007/s00383-011-2958-5; Frongia G, 2013, J PEDIATR SURG, V48, P1794, DOI 10.1016/j.jpedsurg.2013.05.018; Gallo G, 2012, EUR J PEDIATR SURG, V22, P420, DOI 10.1055/s-0032-1331459; Oliveira DEG, 2016, J PEDIATR UROL, V12, P19, DOI 10.1016/j.jpurol.2015.10.003; Gosemann JH, 2013, EUR J PEDIATR SURG, V23, P94, DOI 10.1055/s-0033-1343085; Grant NH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009394.pub2; Graziano K, 2015, J PEDIATR SURG, V50, P1783, DOI 10.1016/j.jpedsurg.2015.06.019; Grivell RM, 2014, COCHRANE DATABASE SY; Guo J, 2011, PEDIATR SURG INT, V27, P943, DOI 10.1007/s00383-011-2889-1; Hall NJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0783-1; Hall NJ, 2011, J PEDIATR SURG, V46, P767, DOI 10.1016/j.jpedsurg.2011.01.019; Healy DA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001352; Healy JM, 2016, PEDIATR SURG INT, V32, P321, DOI 10.1007/s00383-015-3839-0; Heloury Y, 2012, J PEDIATR SURG, V47, P415, DOI 10.1016/j.jpedsurg.2011.08.003; Hofmann AD, 2014, PEDIATR SURG INT, V30, P757, DOI 10.1007/s00383-014-3529-3; Hofmeester MJ, 2015, EUR J PEDIATR SURG, V25, P389, DOI 10.1055/s-0034-1544052; Huang EY, 2011, J PEDIATR SURG, V46, P2000, DOI 10.1016/j.jpedsurg.2011.06.017; Huang YD, 2015, INT J CLIN EXP MED, V8, P4922; Ishii H, 2014, J PEDIATR UROL, V10, P1020, DOI 10.1016/j.jpurol.2014.08.003; Ishii H, 2015, BJU INT, V115, P867, DOI 10.1111/bju.12927; Ito Y, 2014, PEDIATR INT, V56, P497, DOI 10.1111/ped.12429; Jia WQ, 2011, EUR J PEDIATR SURG, V21, P77, DOI 10.1055/s-0030-1261926; Kamdem AF, 2015, J PEDIATR SURG, V50, P659, DOI 10.1016/j.jpedsurg.2015.01.012; Kapralik J, 2016, J PEDIATR SURG, V51, P508, DOI 10.1016/j.jpedsurg.2015.11.022; Kunz SN, 2013, J PEDIATR SURG, V48, P845, DOI 10.1016/j.jpedsurg.2013.01.020; Landisch R, 2015, J PEDIATR SURG, V50, P1971, DOI 10.1016/j.jpedsurg.2015.08.002; Lane V, 2010, PEDIATR SURG INT, V26, P141, DOI 10.1007/s00383-009-2475-y; Lansdale N, 2010, ANN SURG, V252, P20, DOI 10.1097/SLA.0b013e3181dca0e8; Lauriti G, 2014, JPEN-PARENTER ENTER, V38, P70, DOI 10.1177/0148607113496280; Lee SL, 2010, J PEDIATR SURG, V45, P2181, DOI 10.1016/j.jpedsurg.2010.06.038; LeeVan E, 2016, J TRAUMA ACUTE CARE, V80, P519, DOI 10.1097/TA.0000000000000950; Liang Z, 2011, EUR J PEDIATR SURG, V21, P147, DOI 10.1055/s-0031-1271733; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lip SZL, 2013, ARCH DIS CHILD, V98, P20, DOI 10.1136/archdischild-2012-302051; Livingston MH, 2015, J PEDIATR SURG, V50, P707, DOI 10.1016/j.jpedsurg.2015.02.020; Ma LS, 2015, PEDIATR SURG INT, V31, P261, DOI 10.1007/s00383-015-3662-7; Macrae D., 2009, CRITICAL CARE MED, V37(S); Maguire SA, 2013, CHILD ABUSE NEGLECT, V37, P430, DOI 10.1016/j.chiabu.2012.10.009; Mahant S, 2010, ARCH PEDIAT ADOL MED, V164, P201, DOI 10.1001/archpediatrics.2009.271; Marshall AP, 2013, J SURG RES, V179; Martin K, 2011, J PEDIATR SURG, V46, P933, DOI 10.1016/j.jpedsurg.2011.02.031; Mauritz FA, 2013, J GASTROINTEST SURG, V17, P1883, DOI 10.1007/s11605-013-2305-3; Mauritz FA, 2011, J GASTROINTEST SURG, V15, P1872, DOI 10.1007/s11605-011-1644-1; Mc Laughlin D, 2014, PEDIATR SURG INT, V30, P853, DOI 10.1007/s00383-014-3543-5; McAteer JP, 2013, JAMA PEDIATR, V167, P468, DOI 10.1001/jamapediatrics.2013.25; McGee RG, 2013, J PAEDIATR CHILD H, V49, P319, DOI 10.1111/jpc.12156; Mei H, 2011, J ENDOUROL, V25, P727, DOI 10.1089/end.2010.0544; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morris RK, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17590; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Mullassery D, 2014, PEDIATR HEMAT ONCOL, V31, P703, DOI 10.3109/08880018.2014.947009; Nagler EVT, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001532.pub4; Narayanan SK, 2013, J PEDIATR SURG, V48, P2336, DOI 10.1016/j.jpedsurg.2013.07.020; Nasr A, 2013, EUR J PEDIATR SURG, V23, P191, DOI 10.1055/s-0033-1347916; Nasr A, 2010, J PEDIATR SURG, V45, P880, DOI 10.1016/j.jpedsurg.2010.02.012; Nataraja RM, 2013, J LAPAROENDOSC ADV S, V23, P795, DOI 10.1089/lap.2012.0522; Nicolau AE, 2011, CHIRURGIA-BUCHAREST, V106, P59; OCEBM Levels of Evidence Working Group, OXF LEV EV 2; Oomen MWN, 2012, SURG ENDOSC, V26, P2104, DOI 10.1007/s00464-012-2174-y; Ostlie DJ, 2010, J PEDIATR SURG, V45, P1940, DOI 10.1016/j.jpedsurg.2010.05.008; Parolini F, 2016, J PEDIATR SURG, V51, P304, DOI 10.1016/j.jpedsurg.2015.10.043; Parolini F, 2014, INT J PEDIATR OTORHI, V78, P985, DOI 10.1016/j.ijporl.2014.04.011; Peters RT, 2013, J PEDIATR SURG, V48, P707, DOI 10.1016/j.jpedsurg.2012.11.049; Peycelon M, 2014, EUR J PEDIATR SURG, V24, P443, DOI 10.1055/s-0034-1396419; Pfistermuller KLM, 2015, J PEDIATR UROL, V11, P54, DOI 10.1016/j.jpurol.2014.12.006; Puligandla PS, 2015, J PEDIATR SURG, V50, P1958, DOI 10.1016/j.jpedsurg.2015.09.010; Rangel SJ, 2012, J PEDIATR SURG, V47, P225, DOI 10.1016/j.jpedsurg.2011.10.007; Reddy PP, 2010, INDIAN J UROL, V26, P555, DOI 10.4103/0970-1591.74459; Rees CM, 2008, ANN SURG, V248, P44, DOI 10.1097/SLA.0b013e318176bf81; Reveiz L, 2010, J CLIN EPIDEMIOL, V63, P1216, DOI 10.1016/j.jclinepi.2010.01.013; Righetti Laura, 2015, World J Clin Pediatr, V4, P160, DOI 10.5409/wjcp.v4.i4.160; Romao RLP, 2012, J PEDIATR SURG, V47, P1496, DOI 10.1016/j.jpedsurg.2012.01.009; Ross AR, 2015, PEDIATR SURG INT, V31, P473, DOI 10.1007/s00383-015-3691-2; Routh JC, 2010, J UROLOGY, V184, P1615, DOI 10.1016/j.juro.2010.03.119; Ruttenstock E, 2010, PEDIATR SURG INT, V26, P1101, DOI 10.1007/s00383-010-2695-1; Rynja SP, 2011, J PEDIATR UROL, V7, P504, DOI 10.1016/j.jpurol.2011.02.008; Saldana LJ, 2013, J LAPAROENDOSC ADV S, V23, P467, DOI 10.1089/lap.2012.0467; Salim A, 2013, BRIT J SURG, V100, P2; Sauerland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001546.pub3; Scholfield DW, 2016, J LAPAROENDOSC ADV S, V26, P53, DOI 10.1089/lap.2015.0121; Schulz K.F., 2010, PLOS MED, V7; Sebastian van As A B, 2010, Afr J Paediatr Surg, V7, P129, DOI 10.4103/0189-6725.70409; Shalaby MS, 2014, J PEDIAT SURG CASE R, V2, P228, DOI 10.1016/j.epsc.2014.04.005; Sharp N, 2015, EUROPEAN J PEDIAT SU, V26, P143; Shawyer AC, 2015, PEDIATR SURG INT, V31, P17, DOI 10.1007/s00383-014-3626-3; Shawyer AC, 2015, PEDIATR SURG INT, V31, P61, DOI 10.1007/s00383-014-3623-6; Shawyer AC, 2014, PEDIATR SURG INT, V30, P987, DOI 10.1007/s00383-014-3548-0; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Shen HJ, 2015, PEDIATR SURG INT, V31, P529, DOI 10.1007/s00383-015-3705-0; Shteynshlyuger A, 2013, J PEDIATR UROL, V9, P683, DOI 10.1016/j.jpurol.2012.08.002; Siddiqui MRS, 2011, PEDIATR SURG INT, V27, P359, DOI 10.1007/s00383-010-2698-y; Siminas S, 2015, ANN SURG, V262, P925, DOI 10.1097/SLA.0000000000001191; Sklar CM, 2014, J LAPAROENDOSC ADV S, V24, P518, DOI 10.1089/lap.2013.0415; Snoek KG, 2016, ANN SURG, V263, P867, DOI 10.1097/SLA.0000000000001533; Sola JE, 2010, J SURG RES, V161, P95, DOI 10.1016/j.jss.2009.05.007; Stanger JD, 2013, J PEDIATR SURG, V48, P983, DOI 10.1016/j.jpedsurg.2013.02.070; Suominen JS, 2015, PEDIATR BLOOD CANCER, V62, P385, DOI 10.1002/pbc.25343; Svensson JF, 2012, EUR J PEDIATR SURG, V22, P185, DOI 10.1055/s-0032-1320014; Symeonidis EN, 2016, INT J SURG, V29, P53, DOI 10.1016/j.ijsu.2016.03.040; Szylberg L, 2014, PRZ GASTROENTEROL, V9, P264, DOI 10.5114/pg.2014.46160; Tan YW, 2016, J PEDIATR-US, V171, P153, DOI 10.1016/j.jpeds.2015.12.074; Terui K, 2015, PEDIATR SURG INT, V31, P891, DOI 10.1007/s00383-015-3765-1; Thompson AJ, 2013, J PEDIATR SURG, V48, P1413, DOI 10.1016/j.jpedsurg.2013.02.059; Thomson D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006063; Thyoka M, 2013, PEDIATR RADIOL, V43, P898, DOI 10.1007/s00247-013-2693-2; van Dalen EC, 2015, COCHRANE DATABASE SY; van den Hondel D, 2014, EUR J PEDIATR SURG, V24, P61, DOI 10.1055/s-0033-1351663; van der Heijden MJE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133608; van der Vlies CH, 2010, J PEDIATR SURG, V45, P1044, DOI 10.1016/j.jpedsurg.2010.01.002; Vernon-Roberts A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006151.pub3; Wang FR, 2013, PEDIATR SURG INT, V29, P811, DOI 10.1007/s00383-013-3335-3; Wayne C, 2015, PEDIATR SURG INT, V31, P327, DOI 10.1007/s00383-015-3676-1; Weih S, 2012, LANGENBECK ARCH SURG, V397, P1043, DOI 10.1007/s00423-011-0874-8; Wenk K, 2015, J PEDIATR SURG, V50, P2147, DOI 10.1016/j.jpedsurg.2015.08.056; Westgarth-Taylor C, 2013, SURG ENDOSC, V27, P3696, DOI 10.1007/s00464-013-2950-3; White JT, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0550-6; Wilkinson DJ, 2012, J PEDIATR UROL, V8, P307, DOI 10.1016/j.jpurol.2010.11.008; Wright I, 2013, J UROLOGY, V190, P652, DOI 10.1016/j.juro.2013.02.3234; Yang CL, 2011, J PEDIATR SURG, V46, P1824, DOI 10.1016/j.jpedsurg.2011.04.001; Yang G, 2013, PEDIATR SURG INT, V29, P1273, DOI 10.1007/s00383-013-3345-1; Youssef F, 2016, J PEDIATR SURG, V51, P718, DOI 10.1016/j.jpedsurg.2016.02.010; Zani A, 2015, MINERVA PEDIATR, V67, P457; Zani-Ruttenstock E, 2015, PEDIATR SURG INT, V31, P53, DOI 10.1007/s00383-014-3624-5; Zhao LL, 2015, PEDIATR SURG INT, V31, P347, DOI 10.1007/s00383-015-3680-5; Zhong HJ, 2014, J LAPAROENDOSC ADV S, V24, P111, DOI 10.1089/lap.2013.0429; Zhu Y, 2016, HERNIA, V20, P297, DOI 10.1007/s10029-015-1423-0	181	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175213	10.1371/journal.pone.0175213	http://dx.doi.org/10.1371/journal.pone.0175213			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384296	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000399371900122
J	Frutos, MC; Gastaldello, R; Balangero, M; Remondegul, C; Blanco, S; Otsuki, K; Vicente, ACP; Elias, D; Mangeaud, A; Natesl, S; Gallego, S				Frutos, Maria C.; Gastaldello, Rene; Balangero, Marcos; Remondegul, Carlos; Blanco, Sebastian; Otsuki, Koko; Paulo Vicente, Ana Carolina; Elias, David; Mangeaud, Arnaldo; Natesl, Silvia; Gallego, Sandra			Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission	PLOS ONE			English	Article							T-LYMPHOTROPIC VIRUS; CELL LEUKEMIA-VIRUS; BLOOD-DONORS; SPASTIC PARAPARESIS; TYPE-1 INFECTION; PREGNANT-WOMEN; I INFECTION; SUBTYPE B; BRAZIL; SEROPREVALENCE	Background Molecular and epidemiological studies of transmission routes and risk factors for infection by HTLV-1 are extremely important in order to implement control measures, especially because of the high prevalence of HTLV-1 in several regions of the world. San Salvador de Jujuy, Northwest Argentina, is a highly endemic area for HTLV-1 and foci of tropical spastic paraparesis/HTLV-1-associated myelopathy. Objective To gain further insight into the role of intrafamilial transmission of HTLV-1 in a highly endemic region in Argentina. Method Cross-sectional study in Northwest Argentina. Epidemiological data and blood samples were collected from 28 HTLV-1 infected subjects (index cases) and 92 close relatives/cohabitants. HTLV-1 infection was diagnosed by detection of antibodies and proviral DNA. The LTR region was sequenced and analyzed for genetic distances (VESPA software), in addition to determination and identification of polymorphisms to define HTLV-1 family signatures. Results Fifty seven of the 120 subjects enrolled had antibodies against HTLV-1 and were typified as HTLV-1 by PCR. The prevalence rate of HTLV-1 infection in family members of infected index cases was 31.52% (29/92). The infection was significantly associated with gender, age and prolonged lactation. Identity of LTR sequences and presence of polymorphisms revealed high prevalence of mother-to-child and interspousal transmission of HTLV-1 among these families. Conclusion There is an ongoing and silent transmission of HTLV-1 through vertical and sexual routes within family clusters in Northwest Argentina. This evidence highlights that HTLV-1 infection should be considered as a matter of public health in Argentina, in order to introduce preventive measures as prenatal screening and breastfeeding control.	[Frutos, Maria C.; Gastaldello, Rene; Balangero, Marcos; Blanco, Sebastian; Natesl, Silvia; Gallego, Sandra] Univ Nacl Cordoba, Inst Virol Dr JM Vanella, Fac Ciencias Med, Cordoba, Argentina; [Remondegul, Carlos] Hosp San Roque, Dept Enfermedades Infecc, San Salvador De Jujuy, Argentina; [Otsuki, Koko; Paulo Vicente, Ana Carolina] Fundacao Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, Brazil; [Elias, David; Mangeaud, Arnaldo] Univ Nacl Cordoba, Dept Matemat, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina	National University of Cordoba; Fundacao Oswaldo Cruz; National University of Cordoba	Frutos, MC (corresponding author), Univ Nacl Cordoba, Inst Virol Dr JM Vanella, Fac Ciencias Med, Cordoba, Argentina.	mariaceliafrutos@gmail.com	Frutos, Celia/AAU-9948-2020	Frutos, Maria Celia/0000-0002-6349-6264; Blanco, Sebastian/0000-0001-7832-2833; Mangeaud, Arnaldo Pedro/0000-0002-7370-7256	SeCyT UNC [202/2016]	SeCyT UNC(Secretaria de Ciencia y Tecnologia (SECYT))	Authors state that the research was totally supported by SeCyT UNC 202/2016 URL:http://www.unc.edu.ar/investigacion and that there was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berini CA, 2013, SEX TRANSM INFECT, V89, P333, DOI 10.1136/sextrans-2012-050594; Berini CA, 2012, AIDS RES HUM RETROV, V28, P902, DOI [10.1089/aid.2011.0311, 10.1089/AID.2011.0311]; Berini CA, 2010, J MED VIROL, V82, P873, DOI 10.1002/jmv.21728; Martins RMB, 2010, J CLIN VIROL, V48, P155, DOI 10.1016/j.jcv.2010.03.004; Brun RO, 2004, MEDICINA-BUENOS AIRE, V64, P125; CARTIER L, 1995, REV MED CHILE, V123, P7; Catalan-Soares B, 2004, REV PANAM SALUD PUBL, V16, P387, DOI 10.1590/S1020-49892004001200004; Cooper CMJ, 2010, W INDIAN MED J, V59, P35; da Costa CA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002272; Dominguez MC, 2015, BIOMEDICA, V35, P337, DOI 10.7705/biomedica.v35i3.2601; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Eirin ME, 2010, J MED VIROL, V82, P2116, DOI 10.1002/jmv.21834; Eshima N, 2009, J CLIN VIROL, V45, P135, DOI 10.1016/j.jcv.2009.03.012; Romanelli LCF, 2013, AIDS RES HUM RETROV, V29, P1199, DOI [10.1089/aid.2013.0086, 10.1089/AID.2013.0086]; Gallego S, 1997, VIRAL IMMUNOL, V10, P149, DOI 10.1089/vim.1997.10.149; Gastaldello R, 2005, J MED VIROL, V76, P386, DOI 10.1002/jmv.20370; Gastaldello R, 2004, JAIDS-J ACQ IMM DEF, V35, P301, DOI 10.1097/00126334-200403010-00012; Gastaldello R, 2008, AIDS RES HUM RETROV, V24, P1139, DOI 10.1089/aid.2007.0299; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Mello MAG, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-28; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152; Houinato D, 1998, INT J EPIDEMIOL, V27, P146, DOI 10.1093/ije/27.1.146; Ita F, 2014, INT J INFECT DIS, V19, P46, DOI 10.1016/j.ijid.2013.10.005; KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851; Kakuda K, 2002, AM J TROP MED HYG, V66, P404, DOI 10.4269/ajtmh.2002.66.404; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; LIU HF, 1994, AIDS RES HUM RETROV, V10, P1135, DOI 10.1089/aid.1994.10.1135; Lu S C, 2001, Kaohsiung J Med Sci, V17, P126; Macia C, 2016, BIOMEDICA, V36, P108, DOI [10.7705/biomedica.v36i0.2942, 10.7705/biomedica.v3610.2942]; Monteiro DLM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003146; Malan R, 2010, MEDICINA-BUENOS AIRE, V70, P71; MONTGOMERY RD, 1993, T ROY SOC TROP MED H, V87, P154, DOI 10.1016/0035-9203(93)90467-5; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Ribeiro MA, 2010, REV PANAM SALUD PUBL, V27, P330, DOI 10.1590/S1020-49892010000500002; Rouet F, 1999, INT J CANCER, V81, P330, DOI 10.1002/(SICI)1097-0215(19990505)81:3&lt;330::AID-IJC3&gt;3.0.CO;2-2; Vandamme AM, 1997, J MED VIROL, V52, P1, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;1::AID-JMV1&gt;3.0.CO;2-8; Zihlmann KF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001705	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174920	10.1371/journal.pone.0174920	http://dx.doi.org/10.1371/journal.pone.0174920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384180	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900051
J	Gouveia, L; Janvier, A; Dupuis, F; Duval, M; Sultan, S				Gouveia, Lucie; Janvier, Annie; Dupuis, France; Duval, Michel; Sultan, Serge			Comparing two types of perspective taking as strategies for detecting distress amongst parents of children with cancer: A randomised trial	PLOS ONE			English	Article							EMPATHY; PATIENT; SYMPTOMS; PROGRAM; BURNOUT; WOULD; RECOGNITION; ADOLESCENTS; AGREEMENT; ACCURACY	Objective To compare two perspective taking strategies on (i) clinicians' ability to accurately identify negative thoughts and feelings of parents of children with cancer, and (ii) clinician distress. Methods Sixty-three hematology-oncology professionals and nursing students watched a video featuring parents of children with cancer. Participants were randomly assigned to one of two groups. In the imagine-self group, they were instructed to imagine the feelings and life consequences which they would experience if they were in the parents' position. In the imagine-other group, they were instructed to imagine the feelings and life consequences experienced by the parents. Parent-clinician agreement on thoughts/feelings was evaluated (standard stimulus paradigm). Clinician distress was also assessed. Results The intervention was effective in manipulating perspective type. The groups did not significantly differ on parent-clinician agreement. Concentrating on personal feelings (imagine-self strategy) did predict lower agreement when controlling for trait empathy. Clinician distress was higher in the imagine-self group. Conclusion Although the link between perspective type and detection of distress remains unclear, the results suggest that clinicians who highly focus on their own feelings tend to be less accurate on parental distress and experience more distress themselves. Practice implications This research could potentially improve communication training and burnout prevention.	[Gouveia, Lucie; Janvier, Annie; Dupuis, France; Duval, Michel; Sultan, Serge] St Justine Univ Hosp Ctr UHC, Montreal, PQ, Canada; [Gouveia, Lucie; Sultan, Serge] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Janvier, Annie; Duval, Michel; Sultan, Serge] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Dupuis, France] Univ Montreal, Fac Nursing, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Gouveia, L (corresponding author), St Justine Univ Hosp Ctr UHC, Montreal, PQ, Canada.; Gouveia, L (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	lucie.gouveia@umontreal.ca		Gouveia, Lucie/0000-0003-1588-3945	FRQSC doctoral scholarship; CHU Sainte-Justine Foundation (Center of Psychosocial Oncology)	FRQSC doctoral scholarship; CHU Sainte-Justine Foundation (Center of Psychosocial Oncology)	This study was supported by an FRQSC 2015-2018 doctoral scholarship awarded to Lucie Gouveia and by the CHU Sainte-Justine Foundation (Center of Psychosocial Oncology, Dr. Sultan). These funding sources were not involved in the study nor in the preparation of this article.	BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Batson D. C., HDB IMAGINATION MENT, P267, DOI DOI 10.4324/9780203809846.CH18; Bonvicini KA, 2009, PATIENT EDUC COUNS, V75, P3, DOI 10.1016/j.pec.2008.09.007; Chidambaram S, 2014, J COMMUNITY SUPPORT, V12, P370, DOI 10.12788/jcso.0080; COKE JS, 1978, J PERS SOC PSYCHOL, V36, P752, DOI 10.1037/0022-3514.36.7.752; Coulehan JL, 2001, ANN INTERN MED, V135, P221, DOI 10.7326/0003-4819-135-3-200108070-00022; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH, 2004, PERS SOC PSYCHOL B, V30, P1625, DOI 10.1177/0146167204271183; del Barrio V, 2004, PSYCHOL REP, V95, P257, DOI 10.2466/pr0.95.1.257-262; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukui S, 2009, PSYCHO-ONCOLOGY, V18, P1156, DOI 10.1002/pon.1429; Gery I, 2009, PSYCHIAT RES, V165, P252, DOI 10.1016/j.psychres.2007.11.006; Gouveia Lucie, 2015, BMC Psychol, V3, P6, DOI 10.1186/s40359-015-0063-6; GROSS JJ, 1995, PERS INDIV DIFFER, V19, P555, DOI 10.1016/0191-8869(95)00055-B; Gross JJ, 2013, BERKELEY EXPRESSIVIT; Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905; Haverman L, 2013, J PEDIATR-US, V163, P1140, DOI 10.1016/j.jpeds.2013.06.011; Hojat M, 2011, ACAD MED, V86, P989, DOI 10.1097/ACM.0b013e31822203d8; ICKES W, 1993, J PERS, V61, P587, DOI 10.1111/j.1467-6494.1993.tb00783.x; Ickes W., 2013, HDB CLOSE RELATIONSH, P348, DOI DOI 10.1093/OXFORDHB/9780195398694.013.0016; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Keller M, 2004, ANN ONCOL, V15, P1243, DOI 10.1093/annonc/mdh318; Laffan AJ, 2015, J PSYCHOSOC ONCOL, V33, P686, DOI 10.1080/07347332.2015.1082170; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamothe M, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-15; Lampic C, 1996, CANCER NURS, V19, P419, DOI 10.1097/00002820-199612000-00002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Leclair T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159773; Ljungman L, 2015, PSYCHO-ONCOLOGY, V24, P1792, DOI 10.1002/pon.3856; Lobchuk MM, 2007, J PAIN SYMPTOM MANAG, V33, P130, DOI 10.1016/j.jpainsymman.2006.07.015; Lobchuk MM, 2006, ONCOL NURS FORUM, V33, P273, DOI 10.1188/06.ONF.273-282; Lobchuk MM, 2003, SOC SCI MED, V57, P2379, DOI 10.1016/S0277-9536(03)00132-1; MARANGONI C, 1995, J PERS SOC PSYCHOL, V68, P854, DOI 10.1037/0022-3514.68.5.854; Merckaert I, 2008, PSYCHO-ONCOLOGY, V17, P260, DOI 10.1002/pon.1233; Mullins LL, 2015, FAM RELAT, V64, P176, DOI 10.1111/fare.12104; Myers MW, 2014, MOTIV EMOTION, V38, P224, DOI 10.1007/s11031-013-9377-y; NIGHTINGALE SD, 1991, J GEN INTERN MED, V6, P420, DOI 10.1007/BF02598163; Patel SK, 2011, PSYCHO-ONCOLOGY, V20, P1324, DOI 10.1002/pon.1859; Pehrson C, 2016, PATIENT EDUC COUNS, V99, P610, DOI 10.1016/j.pec.2015.11.021; Picard J, 2016, PSYCHOL HEALTH MED, V21, P354, DOI 10.1080/13548506.2015.1054407; Rogers C. R., 1959, PSYCHOL STUDY SCI FO, V3, P184; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schmid PC, 2010, MOTIV EMOTION, V34, P288, DOI 10.1007/s11031-010-9170-0; Spinetta JJ, 2002, MED PEDIATR ONCOL, V38, P114, DOI 10.1002/mpo.1283; Sultan S, 2015, EUROPEAN JOURNAL OF; Werner A, 2012, PSYCHO-ONCOLOGY, V21, P818, DOI 10.1002/pon.1975; Wiener L, 2015, PEDIATR BLOOD CANCER, V62, pS419, DOI 10.1002/pbc.25675; Yagil D, 2015, PATIENT EDUC COUNS, V98, P1631, DOI 10.1016/j.pec.2015.07.008; Yarnold PR, 1996, PSYCHOL HEALTH MED, V1, P207, DOI DOI 10.1080/13548509608400019; Zenasni F, 2012, BRIT J GEN PRACT, V62, P346, DOI 10.3399/bjgp12X652193	55	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175342	10.1371/journal.pone.0175342	http://dx.doi.org/10.1371/journal.pone.0175342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384315	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900160
J	Guo, Y; Du, ZY; Chen, J; Zhang, ZJ				Guo, Yan; Du, Ziyi; Chen, Jiang; Zhang, Zhongjun			QTL mapping of wheat plant architectural characteristics and their genetic relationship with seven QTLs conferring resistance to sheath blight	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BREAD WHEAT; RICE CULTIVARS; DISEASE; DNA; RUST; L.	Sheath blight is one of the most devastating wheat diseases worldwide. Breeding resistant cultivars is the most powerful strategy to defeat the disease. Plant resistance on "disease escape" works through modulation of morphological traits and shows sustainable resistance to disease. Plant architectural traits have been reported to play a significant role in disease response. Therefore, exploring the genetic relationship between plant architecture and disease resistance is of importance to the understanding of plant resistance via "disease escape". Using an F-9 population of 266 RILs ( Recombinant Inbred Lines) derived from the cross of Luke x AQ24788-83, we have generated a linkage map of 631 markers on 21 chromosomes. In this study, we present the QTL identification of fourteen plant architectural characteristics and heading time from two years and analyze their genetic relationships with seven previously published QTLs to sheath blight (QSBs, QSe. cau), including plant height (PH), the space between the flag leaf and penultimate leaf (fdR), heading date (Hd), and other traits. Twelve stable QTLs of the morphological traits were identified with good consistency across five replicates. For the seven previously published QSBs, we found no significant association with plant height. However, some of the QSBs displayed strong associations with plant architectural traits and heading date. Especially, Q(fdR). cau-1AS, Q(Hd). cau-2BS, Q(fdR). cau-5DL, and Q(fdR). cau-6BL were respectively mapped to the same regions as QSe. cau-1AS, QSe. cau-2BS, QSe. cau-5DL, and QSe. cau-6BL. Taken together, we have demonstrated that plant height did not exert a direct influence on the resistance to sheath blight conferred by the seven QSBs and that the plant architecture and heading date did exhibit a tight relationship with the resistance. Therefore, this study provides a novel evidence to help understand sheath blight resistance in wheat. In addition, the linked morphological characteristics and the generated flanking markers will facilitate breeding for resistance to sheath blight in wheat.	[Guo, Yan; Du, Ziyi; Chen, Jiang; Zhang, Zhongjun] China Agr Univ, Plant Pathol Dept, Coll Plant Protect, Beijing, Peoples R China	China Agricultural University	Guo, Y (corresponding author), China Agr Univ, Plant Pathol Dept, Coll Plant Protect, Beijing, Peoples R China.	guoyan001@cau.edu.cn			National Natural Science Foundation of China [30871612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30871612).	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Channamallikarjuna V, 2010, MOL BREEDING, V25, P155, DOI 10.1007/s11032-009-9316-5; Che KP, 2003, THEOR APPL GENET, V106, P293, DOI 10.1007/s00122-002-1001-6; Chen J, 2013, THEOR APPL GENET, V126, P2865, DOI 10.1007/s00122-013-2178-6; Dey S, 2016, AUSTRALAS PLANT PATH, V45, P145, DOI 10.1007/s13313-016-0404-9; Dong ZP, 2003, ACTA AGR BOREALI SIN, P103; Du ZY, 2015, THEOR APPL GENET, V128, P1579, DOI 10.1007/s00122-015-2533-x; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Han YP, 2003, ACTA BOT SIN, V45, P825; Han Yue-Peng, 2002, Acta Genetica Sinica, V29, P622; Kunihiro Yasufumi, 2002, Acta Genetica Sinica, V29, P50; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEE FN, 1983, PLANT DIS, V67, P829, DOI 10.1094/PD-67-829; LI ZK, 1995, THEOR APPL GENET, V91, P382, DOI 10.1007/BF00220903; Mallard S, 2005, THEOR APPL GENET, V110, P1401, DOI 10.1007/s00122-005-1954-3; Pan XB, 1999, CHINESE SCI BULL, V44, P1783, DOI 10.1007/BF02886159; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pinson SRM, 2005, CROP SCI, V45, P503, DOI 10.2135/cropsci2005.0503; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sato H, 2004, BREEDING SCI, V54, P265, DOI 10.1270/jsbbs.54.265; SAVARY S, 1995, PHYTOPATHOLOGY, V85, P959, DOI 10.1094/Phyto-85-959; Sharma A, 2009, CROP SCI, V49, P256, DOI 10.2135/cropsci2008.03.0124; Singh A, 2014, THEOR APPL GENET, V127, P1005, DOI 10.1007/s00122-014-2280-4; Singh A, 2016, THEOR APPL GENET, V129, P243, DOI 10.1007/s00122-015-2624-8; Song YY, 2011, MYCORRHIZA, V21, P721, DOI 10.1007/s00572-011-0380-4; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Srinivasachary, 2013, PLANT PATHOL, V62, P888, DOI 10.1111/j.1365-3059.2012.02695.x; Srinivasachary, 2011, EUPHYTICA, V178, P1, DOI 10.1007/s10681-010-0296-7; Taguchi-Shiobara F, 2013, BREEDING SCI, V63, P301, DOI 10.1270/jsbbs.63.301; Wang ChenJiaoZi, 2015, Journal of South China Agricultural University, V36, P82; Willocquet L, 2012, EUPHYTICA, V183, P227, DOI 10.1007/s10681-011-0451-9; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Wu W, 2014, PLANT PATHOL, V63, P98, DOI 10.1111/ppa.12078; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhong Xu-Hua, 2006, Zhongguo Shuidao Kexue, V20, P535; Zou JH, 2000, THEOR APPL GENET, V101, P569, DOI 10.1007/s001220051517	37	12	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174939	10.1371/journal.pone.0174939	http://dx.doi.org/10.1371/journal.pone.0174939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384183	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900058
J	Hartwig, FP; de Mola, CL; Davies, NM; Victora, CG; Relton, CL				Hartwig, Fernando Pires; de Mola, Christian Loret; Davies, Neil Martin; Victora, Cesar Gomes; Relton, Caroline L.			Breastfeeding effects on DNA methylation in the offspring: A systematic literature review (vol 12, e0173070, 2017)	PLOS ONE			English	Correction													Victora, Cesar Gomes/Y-2455-2019; Relton, Caroline/AAC-5904-2019	Victora, Cesar Gomes/0000-0002-2465-2180; 	Medical Research Council [MC_UU_12013/2] Funding Source: Medline; MRC [MC_UU_12013/2] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hartwig FP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173070	1	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175604	10.1371/journal.pone.0175604	http://dx.doi.org/10.1371/journal.pone.0175604			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384327	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900180
J	Hauke, CA; Taylor, RK				Hauke, Caitlyn A.; Taylor, Ronald K.			Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus	PLOS ONE			English	Article							EL-TOR BIOTYPE; SOLUBLE COLONIZATION FACTOR; CLASSICAL CTX PROPHAGE; VIBRIO-CHOLERAE; PROTECTIVE ANTIGEN; WHOLE-CELL; O1; GENES; MUCOSAL; BANGLADESH	The use of whole cell killed (WCK) oral cholera vaccines is an important strategy for cholera prevention in endemic areas. To overcome current vaccine limitations, we engineered strains of V. cholerae to be non-toxigenic and to express the protective protein colonization factor, toxin-coregulated pilus (TCP), under scale-up conditions potentially amenable to vaccine production. Two V. cholerae clinical strains were selected and their cholera toxin genes deleted. The tcp operon was placed under control of a rhamnose-inducible promoter. Production and stability of TCP were assessed under various conditions. The strains lack detectable cholera toxin production. The addition of 0.1% rhamnose to the growth medium induced robust production of TCP and TcpA antigen. The strains produced intact TCP in larger growth volumes (1 L), and pili appeared stable during heat-killing or acid treatment of the bacterial cultures. To date, no WCK cholera vaccines have included TCP. We have constructed putative strains of V. cholerae for use in a vaccine that produce high levels of stable TCP antigen, which has not previously been achieved.	[Hauke, Caitlyn A.; Taylor, Ronald K.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Hauke, CA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	caitlyn.a.hauke@dartmouth.edu			National Institute of Allergy and Infectious Diseases [AI025096]; National Institute of Allergyand Infectious Diseases training [AI007363, AI007519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025096] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergyand Infectious Diseases training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases [AI025096 to R.K.T.] and National Institute of Allergyand Infectious Diseases training grants [AI007363 and AI007519 to C.A.H.], (https://www.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Asaduzzaman M, 2004, INFECT IMMUN, V72, P4448, DOI 10.1128/IAI.72.8.4448-4454.2004; Attridge SR, 1999, J BIOTECHNOL, V73, P109, DOI 10.1016/S0168-1656(99)00114-5; Baik YO, 2015, VACCINE, V33, P6360, DOI 10.1016/j.vaccine.2015.08.075; BENENSON AS, 1968, B WORLD HEALTH ORGAN, V38, P347; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Bishop AL, 2011, EXPERT REV VACCINES, V10, P79, DOI [10.1586/erv.10.150, 10.1586/ERV.10.150]; Bougoudogo F, 1995, B I PASTEUR, V93, P273, DOI 10.1016/0020-2452(96)85762-9; DELORENZO RA, 1994, AM J EMERG MED, V12, P262, DOI 10.1016/0735-6757(94)90264-X; Dharmasena MN, 2009, MICROBIOL-SGM, V155, P2353, DOI 10.1099/mic.0.025726-0; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Martinez RM, 2010, CURR PROTOC MICROBIO; Meeks MD, 2001, INFECT IMMUN, V69, P7687, DOI 10.1128/IAI.69.12.7687-7694.2001; Mukhopadhyay AK, 2014, CURR TOP MICROBIOL, V379, P17, DOI 10.1007/82_2014_363; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; Rollenhagen JE, 2006, INFECT IMMUN, V74, P5834, DOI 10.1128/IAI.00438-06; SAKAZAKI R, 1971, JPN J MED SCI BIOL, V24, P93, DOI 10.7883/yoken1952.24.93; Sambrook J., 2001, MOL CLONING LAB MANU; SHARMA DP, 1989, MICROB PATHOGENESIS, V7, P437, DOI 10.1016/0882-4010(89)90024-7; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUN D, 1991, INFECT IMMUN, V59, P114, DOI 10.1128/IAI.59.1.114-118.1991; SUN D, 1990, J INFECT DIS, V161, P1231, DOI 10.1093/infdis/161.6.1231; Taylor R K, 1986, Ann Sclavo Collana Monogr, V3, P51; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WHO, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization [Internet], 2015, CHOLERA	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175170	10.1371/journal.pone.0175170	http://dx.doi.org/10.1371/journal.pone.0175170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384206	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900108
J	Kumar, S; Archak, S; Tyagi, RK; Kumar, J; Vikas, VK; Jacob, SR; Srinivasan, K; Radhamani, J; Parimalan, R; Sivaswamy, M; Jayaprakash, P; Tyagi, S; Yadav, M; Rani, J; Deepali; Sharma, S; Bhagat, I; Meeta, M; Bains, NS; Chowdhury, AK; Saha, BC; Bhattacharya, PM; Kumari, J; Singh, MC; Gangwar, OP; Prasad, P; Bharadwaj, SC; Gogoi, R; Sharma, JB; Kumar, GMS; Saharan, MS; Singh, AK; Khan, Z; Bag, M; Roy, A; Prasad, TV; Sharma, RK; Dutta, M; Sharma, I; Bansal, KC				Kumar, Sundeep; Archak, Sunil; Tyagi, R. K.; Kumar, Jagdish; Vikas, V. K.; Jacob, Sherry R.; Srinivasan, Kalyani; Radhamani, J.; Parimalan, R.; Sivaswamy, M.; Jayaprakash, P.; Tyagi, Sandhya; Yadav, Mamata; Rani, Jyotisna; Deepali; Sharma, Sandeep; Bhagat, Indoo; Meeta, Madhu; Bains, N. S.; Chowdhury, A. K.; Saha, B. C.; Bhattacharya, P. M.; Kumari, Jyoti; Singh, M. C.; Gangwar, O. P.; Prasad, P.; Bharadwaj, S. C.; Gogoi, Robin; Sharma, J. B.; Kumar, Sandeep G. M.; Saharan, M. S.; Singh, Amit Kumar; Khan, Z.; Bag, Manas; Roy, Anirban; Prasad, T. V.; Sharma, R. K.; Dutta, M.; Sharma, Indu; Bansal, K. C.			Evaluation of 19,460 Wheat Accessions Conserved in the Indian National Genebank to Identify New Sources of Resistance to Rust and Spot Blotch Diseases (vol 11, e0167702, 2016)	PLOS ONE			English	Correction									[Jayaprakash, P.] Indian Agr Res Inst, ICAR, Reg Stn Wellington, The Nilgiris 643231, Tamil Nadu, India; [Singh, Amit Kumar; Khan, Z.] Natl Bur Plant Genet Resources, ICAR, Pusa Campus, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Jayaprakash, P (corresponding author), Indian Agr Res Inst, ICAR, Reg Stn Wellington, The Nilgiris 643231, Tamil Nadu, India.		Jayaprakash*, P/ABC-7625-2020; Bag, Manas Kumar/ABA-4776-2021; Saharan, Mahender/AAI-9831-2020; SINGH, AMIT KUMAR/Q-7438-2018; Bhardwaj, Subhash Chander/U-2644-2017; Gangwar, Om Prakash/ABA-5954-2021	Bag, Manas Kumar/0000-0002-5429-2497; SINGH, AMIT KUMAR/0000-0001-8579-6519; Bhardwaj, Subhash Chander/0000-0002-4070-8412; 				Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167702	1	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175610	10.1371/journal.pone.0175610	http://dx.doi.org/10.1371/journal.pone.0175610			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384321	gold, Green Published			2022-12-27	WOS:000399371900185
J	Lahti, S; Ludwig, JM; Xing, MZ; Sun, LY; Zeng, DX; Kim, HS				Lahti, Steven; Ludwig, Johannes M.; Xing, Minzhi; Sun, Lingyi; Zeng, Dexing; Kim, Hyun S.			In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RENAL-CELL CARCINOMA; EXPRESSION; LEVEL	Purpose Sunitinib drug eluting beads (DEB) are a novel anti-angiogenic bead preparation for use in transarterial chemoembolization. However, systematic studies of sunitinib DEB's effect on cancer cells have not been reported. Herein, we assess their direct biologic efficacy against carcinoma cell lines and correlate cell viability with drug release in vitro. Materials and methods Sunitinib-HCl (10mg/mL) in Milli-Q water was mixed with LC Bead (R) 300-500 mu m (Biocom-patibles UK Ltd.). Loading and release were assessed by measurement of drug UV absorbance using UV-visible spectrophotometer. Viability of human colorectal cancer (CRC, HCT116 and HT29) and hepatocellular carcinoma (HCC, HepG2) cells upon exposure to sunitinib DEB was measured using a bioluminescent assay. Drug concentration during exposure was quantified using HPLC. Results When added to cultured HepG2 cells, sunitinib DEB rapidly inhibited viability with a significant decrease observed within 1 hour of incubation. Viability of HCT116 and HT29 cells decreased relatively slower, with significant reductions observed after 8 and 24 hours, respectively. After 24 hours there was nearly complete inhibition of all three cell lines. There was no difference in viability observed between cells treated with 5 mu l, 10 mu L, or 20 mu L of sunitinib DEB. HPLC analysis of the cell culture supernatant demonstrated saturation of the cell medium within approximately 4 hours for each amount added, with sunitinib achieving a final concentration of 17.61 mu M (SE +/- 1.01). Conclusions Sunitinib can be efficiently loaded to and released from LC beads, and the resulting sunitinib DEB demonstrate strong in vitro inhibition of human CRC and HCC cells.	[Lahti, Steven; Ludwig, Johannes M.; Xing, Minzhi; Kim, Hyun S.] Pittsburgh Sch Med, Intervent Oncol Translat Lab, Presbyterian South Tower, Pittsburgh, PA 15213 USA; [Ludwig, Johannes M.; Xing, Minzhi; Kim, Hyun S.] Yale Sch Med, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06510 USA; [Sun, Lingyi; Zeng, Dexing] Univ Pittsburgh, Sch Med, Dept Radiol, Mol Imaging Lab, Pittsburgh, PA 15213 USA; [Kim, Hyun S.] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Kim, HS (corresponding author), Pittsburgh Sch Med, Intervent Oncol Translat Lab, Presbyterian South Tower, Pittsburgh, PA 15213 USA.; Kim, HS (corresponding author), Yale Sch Med, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06510 USA.; Zeng, DX (corresponding author), Univ Pittsburgh, Sch Med, Dept Radiol, Mol Imaging Lab, Pittsburgh, PA 15213 USA.; Kim, HS (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.	zengd@upmc.edu; kevin.kim@yale.edu	sun, lingyi/A-1211-2018	Kim, Hyun/0000-0002-3077-9989				[Anonymous], 2014, STUDENT PRODUCT MONO; Bates RC, 2003, CURR BIOL, V13, P1721, DOI 10.1016/j.cub.2003.09.002; Bize P, 2016, RADIOLOGY, V280, P425, DOI 10.1148/radiol.2016150361; Brown KT, 2016, J CLIN ONCOL; Facciorusso A, 2016, DIG LIVER DIS; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Fuchs K, 2014, J VASC INTERV RADIOL, V25, P379, DOI 10.1016/j.jvir.2013.11.039; Gadaleta CD, 2011, CRIT REV ONCOL HEMAT, V80, P40, DOI 10.1016/j.critrevonc.2010.10.005; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Habib A, 2015, NAT REV CLIN ONCOL, V12, P481, DOI 10.1038/nrclinonc.2015.78; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Li T, 2012, J CLIN PATHOL, V65, P808, DOI 10.1136/jclinpath-2012-200721; Li X, 2004, WORLD J GASTROENTERO, V10, P2878; Liu DM, 2015, FUTURE ONCOL, V11, P1421, DOI 10.2217/fon.15.3; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Peng S, 2014, HEPATOLOGY, V60, P1264, DOI 10.1002/hep.27236; Schmid TA, 2016, THER ADV UROL, V8, P348, DOI 10.1177/1756287216663979; Sergio A, 2008, AM J GASTROENTEROL, V103, P914, DOI 10.1111/j.1572-0241.2007.01712.x; Shim JH, 2008, CANCER SCI, V99, P2037, DOI 10.1111/j.1349-7006.2008.00909.x; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043158	21	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174539	10.1371/journal.pone.0174539	http://dx.doi.org/10.1371/journal.pone.0174539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384190	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900019
J	Nassal, DM; Wan, XP; Liu, HY; Laurita, KR; Deschenes, I				Nassal, Drew M.; Wan, Xiaoping; Liu, Haiyan; Laurita, Kenneth R.; Deschenes, Isabelle			KChIP2 regulates the cardiac Ca2+ transient and myocyte contractility by targeting ryanodine receptor activity	PLOS ONE			English	Article							SINGLE-CHANNEL ACTIVITY; I-TO; ALZHEIMERS-DISEASE; VENTRICULAR MYOCYTES; POTASSIUM CHANNELS; N-TERMINUS; PROTEIN; PRESENILINS; CALSENILIN; HYPERTROPHY	Pathologic electrical remodeling and attenuated cardiac contractility are featured characteristics of heart failure. Coinciding with these remodeling events is a loss of the K+ channel interacting protein, KChIP2. While, KChIP2 enhances the expression and stability of the Kv4 family of potassium channels, leading to a more pronounced transient outward K+ current, I-to,I-f, the guinea pig myocardium is unique in that Kv4 expression is absent, while KChIP2 expression is preserved, suggesting alternative consequences to KChIP2 loss. Therefore, KChIP2 was acutely silenced in isolated guinea pig myocytes, which led to significant reductions in the Ca2+ transient amplitude and prolongation of the transient duration. This change was reinforced by a decline in sarcomeric shortening. Notably, these results were unexpected when considering previous observations showing enhanced I-Ca,I-L and prolonged action potential duration following KChIP2 loss, suggesting a disruption of fundamental Ca2+ handling proteins. Evaluation of SERCA2a, phospholamban, RyR, and sodium calcium exchanger identified no change in protein expression. However, assessment of Ca2+ spark activity showed reduced spark frequency and prolonged Ca2+ decay following KChIP2 loss, suggesting an altered state of RyR activity. These changes were associated with a delocalization of the ryanodine receptor activator, presenilin, away from sarcomeric banding to more diffuse distribution, suggesting that RyR open probability are a target of KChIP2 loss mediated by a dissociation of presenilin. Typically, prolonged action potential duration and enhanced Ca2+ entry would augment cardiac contractility, but here we see KChIP2 fundamentally disrupts Ca2+ release events and compromises myocyte contraction. This novel role targeting presenilin localization and RyR activity reveals a significance for KChIP2 loss that reflects adverse remodeling observed in cardiac disease settings.	[Nassal, Drew M.; Wan, Xiaoping; Liu, Haiyan; Laurita, Kenneth R.; Deschenes, Isabelle] Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA; [Nassal, Drew M.; Deschenes, Isabelle] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University	Deschenes, I (corresponding author), Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA.; Deschenes, I (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	isabelle.deschenes@case.edu			National Institute of Health R01s [R01HL096962, 1R01HL132520]; American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate [13PRE17060106]; T32 Training Grant [HL105338-01]; NIH R01s [R01HL096962, 1R01HL132520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105338, R01HL096962, R01HL132520] Funding Source: NIH RePORTER	National Institute of Health R01s; American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate; T32 Training Grant; NIH R01s(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health R01s (R01HL096962 and 1R01HL132520) (ID), an American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate 13PRE17060106 (DMN) and a T32 Training Grant HL105338-01 (DMN).; This work was supported by NIH R01s (R01HL096962 and 1R01HL132520) (ID), an American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate 13PRE17060106 (DMN) and a T32 Training Grant HL105338-01 (DMN).	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cowburn RF, 2007, PHYSIOL BEHAV, V92, P93, DOI 10.1016/j.physbeh.2007.05.053; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; El-Armouche A, 2010, BIOCHEM BIOPH RES CO, V402, P340, DOI 10.1016/j.bbrc.2010.10.030; Elder GA, 2010, BRAIN STRUCT FUNCT, V214, P127, DOI 10.1007/s00429-009-0227-3; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Findlay I, 2003, AM J PHYSIOL-HEART C, V284, pH598, DOI 10.1152/ajpheart.00687.2002; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Hayrapetyan V, 2008, CELL CALCIUM, V44, P507, DOI 10.1016/j.ceca.2008.03.004; Jin HW, 2010, J MOL CELL CARDIOL, V48, P1169, DOI 10.1016/j.yjmcc.2009.12.019; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058334; Link WA, 2004, J NEUROSCI, V24, P5346, DOI 10.1523/JNEUROSCI.1460-04.2004; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nassal DM, 2017, ELIFE, V6, DOI 10.7554/eLife.17304; Nassal DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146561; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Payne AJ, 2013, EXP NEUROL, V250, P143, DOI 10.1016/j.expneurol.2013.09.001; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Rybalchenko V, 2008, INT J BIOCHEM CELL B, V40, P84, DOI 10.1016/j.biocel.2007.06.023; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Zaidi NF, 2002, NEUROSCIENCE, V114, P247, DOI 10.1016/S0306-4522(02)00251-8; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175221	10.1371/journal.pone.0175221	http://dx.doi.org/10.1371/journal.pone.0175221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384221	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900124
J	Nordenvall, AS; Norrby, C; Butwicka, A; Frisen, L; Nordenstrom, A; Almqvist, C; Nordenskjold, A				Nordenvall, Anna Skarin; Norrby, Christina; Butwicka, Agnieszka; Frisen, Louise; Nordenstrom, Anna; Almqvist, Catarina; Nordenskjold, Agneta			Psychosocial outcomes in adult men born with hypospadias: A register-based study	PLOS ONE			English	Article							CHILDHOOD; ADJUSTMENT; SURGERY; ADOLESCENTS; CHILDREN; HEALTH; BOYS; LIFE	In this nationwide matched cohort study, we have investigated whether being born with hypospadias affect subsequent psychosocial outcomes in adulthood. We analyzed prospectively collected data from national Swedish registers. Data on the diagnoses were collected from the National Patient Register and the Medical Birth Register. Data on psychosocial outcomes such as educational and income level, marital status and disability pension were collected from Statistics Sweden. The effects of covariates, such as age, county of birth, presence of other malformations and psychiatric illness, were taken into account. The associations between hypospadias and psychosocial outcomes were calculated using conditional logistic regression and expressed as odds ratios (OR) and 95% confidence intervals (CI). We included 4378 men diagnosed with hypospadias, born between 1969 and 1993 in Sweden. Patients with hypospadias were matched with unaffected men by year of birth and birth county. We did not detect any differences in educational or income level. The probability of entering marriage (OR 1.02, 95% CI 0.90-1.14) did not differ, regardless of phenotype. We did, however, detect a 40% increased probability of receiving a disability pension, (OR 1.39, 95% CI 1.20-1.61). In conclusion, men born with hypospadias in Sweden do not differ from unaffected men with respect to the majority of psychosocial outcomes studied. They are, however, at increased risk of receiving a disability pension, which motivates further investigations.	[Nordenvall, Anna Skarin; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Nordenvall, Anna Skarin; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Nordenvall, Anna Skarin; Nordenskjold, Agneta] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden; [Norrby, Christina; Butwicka, Agnieszka; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Butwicka, Agnieszka] Med Univ Warsaw, Dept Child Psychiat, Warsaw, Poland; [Frisen, Louise] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Frisen, Louise] Child & Adolescent Psychiat Res Ctr, Stockholm, Sweden; [Nordenstrom, Anna] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Nordenstrom, Anna] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Endocrinol, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Medical University of Warsaw; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Nordenvall, AS; Nordenskjold, A (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Nordenvall, AS; Nordenskjold, A (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.; Nordenvall, AS; Nordenskjold, A (corresponding author), Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden.	anna.skarin-nordenvall@ki.se; agneta.nordenskjold@ki.se	Butwicka, Agnieszka/X-4297-2018; Nordenström, Anna/ABC-6970-2021	Butwicka, Agnieszka/0000-0002-7247-2141; Skarin Nordenvall, Anna/0000-0003-3034-9222; Nordenstrom, Anna/0000-0003-0405-3401; Nordenskjold, Agneta/0000-0001-6638-4631	Swedish Research Council [K2012-64X-14506-10-5]; Stockholm City Council; Foundation Frimurare Barnhuset in Stockholm; Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council; Foundation Frimurare Barnhuset in Stockholm; Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM)	We acknowledge financial support from the Swedish Research Council grant no. K2012-64X-14506-10-5, the Stockholm City Council, the Foundation Frimurare Barnhuset in Stockholm and the Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho MO, 2000, EUR UROL, V37, P95, DOI 10.1159/000020107; [Anonymous], 2016, WHO CAN RECEIVE SICK; BERG R, 1981, J UROLOGY, V125, P313, DOI 10.1016/S0022-5347(17)55019-3; BERG R, 1982, ACTA PSYCHIAT SCAND, V66, P398, DOI 10.1111/j.1600-0447.1982.tb06721.x; Butwicka A, 2015, J CHILD PSYCHOL PSYC, V56, P155, DOI 10.1111/jcpp.12290; Hardwicke JT, 2015, J PLAST RECONSTR AES; Jack SE, 2016, NELSON TXB PEDIAT, P2586; MITTENDORFER RUIZ EML, 2011, SJUKSKRIVNING PSYKIS; Mondaini N, 2002, UROL INT, V68, P81, DOI 10.1159/000048423; Mureau MAM, 1997, J PEDIATR PSYCHOL, V22, P371, DOI 10.1093/jpepsy/22.3.371; Ortqvist L, 2015, J UROLOGY, V193, P975, DOI 10.1016/j.juro.2014.09.103; Rynja SP, 2011, J PEDIATR UROL, V7, P504, DOI 10.1016/j.jpurol.2011.02.008; Rynja SP, 2009, J UROLOGY, V182, P1736, DOI 10.1016/j.juro.2009.03.073; SANDBERG DE, 1989, J PEDIATR PSYCHOL, V14, P491, DOI 10.1093/jpepsy/14.4.491; Sandberg DE, 2001, J PEDIATR PSYCHOL, V26, P465, DOI 10.1093/jpepsy/26.8.465; Schonbucher VB, 2008, J PEDIATR-US, V152, P865, DOI 10.1016/j.jpeds.2007.11.036; Thorup J, 2014, CURR OPIN ENDOCRINOL, V21, P227, DOI 10.1097/MED.0000000000000063; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; Wang WW, 2010, ANDROLOGIA, V42, P384, DOI 10.1111/j.1439-0272.2010.01061.x	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174923	10.1371/journal.pone.0174923	http://dx.doi.org/10.1371/journal.pone.0174923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384289	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900053
J	Reid, VL; McDonald, R; Nwosu, AC; Mason, SR; Probert, C; Ellershaw, JE; Coyle, S				Reid, Victoria Louise; McDonald, Rachael; Nwosu, Amara Callistus; Mason, Stephen R.; Probert, Chris; Ellershaw, John E.; Coyle, Seamus			A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying	PLOS ONE			English	Review							PALLIATIVE PROGNOSTIC SCORE; SYSTEMIC INFLAMMATORY RESPONSE; TERMINALLY-ILL PATIENTS; PREDICTOR MODELS; IMPENDING DEATH; SURVIVAL-TIME; LACTATE-DEHYDROGENASE; CLINICAL SIGNS; HEART-RATE; CARE	Background The Neuberger review made a number of recommendations to improve end of life care, including research into the biology of dying. An important aspect of the biology of dying is the identification of biomarkers as indices of disease processes. Biomarkers have the potential to inform the current, limited understanding of the dying process and assist clinicians in recognising dying, in particular how to distinguish dying from reversible acute deterioration. Objectives To critically appraise the literature on biological factors that may be used as prognostic indicators in advanced cancer patients and to identify candidate biomarkers of the dying process that can be measured serially in cancer patients' bodily fluids. Methods A systematically structured review was conducted using three electronic databases. A hand search of six peer-reviewed journals and conference abstracts was also conducted. Studies reporting prognostic biomarkers in cancer patients with a median survival of <= 90 days and post-mortem studies were included. Final levels of evidence and recommendations were made using the Evidence Based Medicine modified GRADE system. Results 30 articles were included. Seven prognostic biological factors demonstrated Grade A evidence (lymphocyte count, white blood cell count, serum C-reactive protein, albumin, sodium, urea and alkaline phosphatase). An additional eleven prognostic factors were identified with Grade B evidence (platelet count, international normalised ratio, serum vitamin B12, prealbumin, bilirubin, cholesterol, aspartate aminotransferase, alanine transaminase, lactate dehydrogenase, pseudocholinesterase and urate). A number of biomarkers were specifically identified in the last two weeks of life but limitations exist. No post-mortem studies met the inclusion criteria. Conclusion The biology of dying is an important area for future research, with the evidence focused on signs, symptoms and prognostic factors. This review identifies a number of common themes shared amongst advanced cancer patients and highlights candidate biomarkers which may be indicative of a common biological process to dying.	[Reid, Victoria Louise; Nwosu, Amara Callistus; Mason, Stephen R.; Ellershaw, John E.; Coyle, Seamus] Univ Liverpool, Marie Curie Palliat Care Inst Liverpool, Liverpool, Merseyside, England; [McDonald, Rachael] Aintree Univ Hosp NHS Fdn Trust, Renal Med, Liverpool, Merseyside, England; [Probert, Chris] Univ Liverpool, Dept Gastroenterol, Liverpool, Merseyside, England	University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Liverpool	Reid, VL; Coyle, S (corresponding author), Univ Liverpool, Marie Curie Palliat Care Inst Liverpool, Liverpool, Merseyside, England.	victoria.reid@nhs.net; s.coyle@liverpool.ac.uk		Nwosu, Amara Callistus/0000-0003-0014-3741; Reid, Victoria/0000-0003-2804-8308; Mason, Stephen/0000-0002-4020-6869; Coyle, Seamus/0000-0002-4761-9703; Ellershaw, John/0000-0001-9789-3180; Probert, Christopher/0000-0003-4550-0239	Marie Curie [MCCC-FCO-11-L, MCCC-APCU-15] Funding Source: researchfish	Marie Curie(European Commission)		Abdel-Karim IA, 2007, J PALLIAT MED, V10, P894, DOI 10.1089/jpm.2006.0240; Alsirafy Samy A, 2009, J Support Oncol, V7, P154; Alsirafy SA, 2009, J PALLIAT MED, V12, P177, DOI 10.1089/jpm.2008.0200; Amano K, 2016, J PAIN SYMPTOM MANAG, V51, P860, DOI 10.1016/j.jpainsymman.2015.11.025; [Anonymous], 2006, METHODS DEV NICE PUB, P1; Baba M, 2015, EUR J CANCER, V51, P1618, DOI 10.1016/j.ejca.2015.04.025; Baba M, 2015, J PAIN SYMPTOM MANAG, V49, P853, DOI 10.1016/j.jpainsymman.2014.10.010; Barry H, 2016, ESSENTIAL EVIDENCE P; Baur M, 2001, ACTA MED AUST, V28, P135, DOI 10.1046/j.1563-2571.2001.01033.x; Bruera S, 2014, J PAIN SYMPTOM MANAG, V48, P510, DOI 10.1016/j.jpainsymman.2013.10.019; Chang C, 2012, CANCER ASSOCIATED IM; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Coyle S, 2015, EUROPEAN ASSOCIATION, V2015, P206; Coyle S, 2016, PALLIATIVE MED, V30, pNP1; Cui J, 2014, J PALLIAT MED, V17, P545, DOI 10.1089/jpm.2013.0368; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Elmehdawi RR, 2008, LIBYAN J MED, V3, P84, DOI 10.4176/071221; FAHN HJ, 1991, J UROLOGY, V145, P248, DOI 10.1016/S0022-5347(17)38305-2; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Feliu J, 2011, JNCI-J NATL CANCER I, V103, P1613, DOI 10.1093/jnci/djr388; Geissbuhler P, 2000, J PAIN SYMPTOM MANAG, V20, P93, DOI 10.1016/S0885-3924(00)00169-X; Glare P, 2001, J PAIN SYMPTOM MANAG, V22, P891, DOI 10.1016/S0885-3924(01)00341-4; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; Hawker S, 2002, QUAL HEALTH RES, V12, P1284, DOI 10.1177/1049732302238251; Ho SY, 2003, J FORMOS MED ASSOC, V102, P544; Hui D, 2015, CANCER-AM CANCER SOC, V121, P960, DOI 10.1002/cncr.29048; Hui D, 2014, ONCOLOGIST, V19, P681, DOI 10.1634/theoncologist.2013-0457; Hyodo I, 2010, JPN J CLIN ONCOL, V40, P442, DOI 10.1093/jjco/hyp182; Iwase S, 2004, EUR CYTOKINE NETW, V15, P312; Kadhim H, 2012, MED HYPOTHESES, V78, P793, DOI 10.1016/j.mehy.2012.03.010; Kadhim H, 2010, NEUROSCI LETT, V480, P122, DOI 10.1016/j.neulet.2010.06.021; Kehl KA, 2013, AM J HOSP PALLIAT ME, V30, P601, DOI 10.1177/1049909112468222; Kelly L, 2007, ANN ONCOL, V18, P1395, DOI 10.1093/annonc/mdm138; Kennedy C, 2014, BMJ SUPPORT PALLIAT, V4, P263, DOI 10.1136/bmjspcare-2013-000621; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Kim ES, 2014, KOREAN J FAM MED, V35, P283, DOI 10.4082/kjfm.2014.35.6.283; Kontoyiannis DP, 2002, CLIN INFECT DIS, V34, P400, DOI 10.1086/338404; Lam P. T., 2007, Hong Kong Medical Journal, V13, P453; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lichter I, 1990, J Palliat Care, V6, P7; Liu J, 2005, INCIDENCE PROGNOSTIC, V2, P511; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; Mallik S, 2016, SUPPORT CARE CANCER, V24, P1771, DOI 10.1007/s00520-015-2962-8; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Miura T, 2015, SUPPORT CARE CANCER, V23, P3149, DOI 10.1007/s00520-015-2693-x; Nakano T, 1998, BRIT J CANCER, V77, P907, DOI 10.1038/bjc.1998.150; Neuberger J, 2013, MORE CARE LESS PATHW, P1; Niki K, 2016, PALLIATIVE MED, V30, pNP1; O'Gorman P, 2000, NUTR CANCER, V37, P36, DOI 10.1207/S15327914NC3701_4; Pasanisi F, 2001, NUTRITION, V17, P581, DOI 10.1016/S0899-9007(01)00579-2; Paulsen O, 2016, PALLIATIVE MED, V30, pNP1; Pautex S, 2013, J PALLIAT MED, V16, P669, DOI 10.1089/jpm.2012.0369; Pedersen LM, 1996, ACTA ONCOL, V35, P691, DOI 10.3109/02841869609084000; Penel N, 2005, ORAL ONCOL, V41, P884, DOI 10.1016/j.oraloncology.2005.04.013; PERRY EK, 1982, NEUROSCI LETT, V29, P303, DOI 10.1016/0304-3940(82)90334-2; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Shin HS, 2006, J PAIN SYMPTOM MANAG, V31, P493, DOI 10.1016/j.jpainsymman.2005.11.014; Simmons CPL, 2017, J PAIN SYMPTOM MANAG; Strasser F, 2002, HEMATOL ONCOL CLIN N, V16, P589, DOI 10.1016/S0889-8588(02)00011-4; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Suh SY, 2007, EUR J CANCER, V43, P1051, DOI 10.1016/j.ejca.2007.01.031; Tankersley CG, 2003, J APPL PHYSIOL, V95, P1681, DOI 10.1152/japplphysiol.00190.2003; Tankersley CG, 2003, AM J PHYSIOL-REG I, V284, pR742, DOI 10.1152/ajpregu.00416.2002; Tarumi Y, 2011, J PAIN SYMPTOM MANAG, V42, P419, DOI 10.1016/j.jpainsymman.2010.12.013; Taylor P, 2015, PALLIATIVE MED, V29, P120, DOI 10.1177/0269216314554967; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Tucci M, 2009, PROSTATE CANCER P D, V12, P94, DOI 10.1038/pcan.2008.10; Vigano A, 1999, J PALLIATIVE CARE, V15, P32, DOI 10.1177/082585979901500406; Walsh D, 2002, SUPPORT CARE CANCER, V10, P523, DOI 10.1007/s00520-002-0376-x; WON C, 1983, CANCER, V52, P2261, DOI 10.1002/1097-0142(19831215)52:12<2261::AID-CNCR2820521217>3.0.CO;2-K; Wrafter S, 2016, PALLIATIVE MED, V30, pNP1; Wu CW, 1996, AM J GASTROENTEROL, V91, P1417; Yoon J, 2015, SUPPORT CARE CANCER, V23, P1735, DOI 10.1007/s00520-014-2522-7	81	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175123	10.1371/journal.pone.0175123	http://dx.doi.org/10.1371/journal.pone.0175123			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384249	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900092
J	Riba, A; Deres, L; Eros, K; Szabo, A; Magyar, K; Sumegi, B; Toth, K; Halmosi, R; Szabados, E				Riba, Adam; Deres, Laszlo; Eros, Krisztian; Szabo, Aliz; Magyar, Klara; Sumegi, Balazs; Toth, Kalman; Halmosi, Robert; Szabados, Eszter			Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; DYSFUNCTION; MINOCYCLINE; REPERFUSION; INHIBITION; THERAPY; DISEASE; ASSAY	In addition to their anti-bacterial action, tetracyclines also have complex biological effects, including the modification of mitochondrial protein synthesis, metabolism and gene-expression. Long-term clinical studies have been performed using tetracyclines, without significant side effects. Previous studies demonstrated that doxycycline (DOX), a major tetracyclin antibiotic, exerted a protective effect in animal models of heart failure; however, its exact molecular mechanism is still unknown. Here, we provide the first evidence that DOX reduces oxidative stress D induced mitochondrial fragmentation and depolarization in H9c2 cardiomyocytes and beneficially alters the expression of Mfn-2, OPA-1 and Drp-1 -the main regulators of mitochondrial fusion and fission D in our isoproterenol (ISO)-induced heart failure model, ultimately decreasing the severity of heart failure. In mitochondria, oxidative stress causes a shift toward fission which leads to mitochondrial fragmentation and cell death. Protecting mitochondria from oxidative stress, and the regulation of mitochondrial dynamics by drugs that shift the balance toward fusion, could be a novel therapeutic approach for heart failure. On the basis of our findings, we raise the possibility that DOX could be a novel therapeutic agent in the future treatment of heart failure.	[Riba, Adam; Deres, Laszlo; Eros, Krisztian; Magyar, Klara; Toth, Kalman; Halmosi, Robert; Szabados, Eszter] Univ Pecs, Dept Med 1, Pecs, Hungary; [Riba, Adam; Deres, Laszlo; Eros, Krisztian; Magyar, Klara; Sumegi, Balazs; Halmosi, Robert; Szabados, Eszter] Univ Pecs, Szentagothai ResearchCtr, Pecs, Hungary; [Szabo, Aliz; Sumegi, Balazs; Toth, Kalman] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Sumegi, Balazs; Toth, Kalman] MTA PTE Nucl Mitochondrial Interact Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs	Halmosi, R (corresponding author), Univ Pecs, Dept Med 1, Pecs, Hungary.; Halmosi, R (corresponding author), Univ Pecs, Szentagothai ResearchCtr, Pecs, Hungary.	halmosi.robert@pte.hu	Halmosi, Róbert/AAK-1880-2020	Halmosi, Robert/0000-0002-6965-7743	Hungarian National Research Foundations [OTKA K104220, PTE AOK-KA-2015-05, GINOP-2.3.3-15-2016-00025, GINOP 2.3.2-15-2016-00022]; MTA-PTE Nuclear-Mitochondrial Interactions Research Group, University of Pecs	Hungarian National Research Foundations(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA-PTE Nuclear-Mitochondrial Interactions Research Group, University of Pecs	This study was supported by Hungarian National Research Foundations (OTKA K104220, PTE AOK-KA-2015-05, GINOP-2.3.3-15-2016-00025 grant, GINOP 2.3.2-15-2016-00022 grant) and MTA-PTE Nuclear-Mitochondrial Interactions Research Group, University of Pecs.	Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091848; Antonio RC, 2014, MOL CELL BIOCHEM, V386, P99, DOI 10.1007/s11010-013-1848-7; Bernardino ALF, 2009, J INFECT DIS, V199, P1379, DOI 10.1086/597807; Camp TM, 2004, J HEART LUNG TRANSPL, V23, P729, DOI 10.1016/j.healun.2003.06.005; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chung AWY, 2008, LONG TERM DOXYCYCLIN; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deres L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102148; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Elewa MAF, 2015, CLIN EXP METASTAS, V32, P479, DOI 10.1007/s10585-015-9721-6; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Giacomotto J, 2013, HUM MOL GENET, V22, P4562, DOI 10.1093/hmg/ddt302; Godefroy E, 2014, CELL REP, V9, P1856, DOI 10.1016/j.celrep.2014.10.067; Gompels LL, 2006, J RHEUMATOL, V33, P224; Grieve D.J., 2003, OXIDATIVE STRESS HEA; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; Gupte TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126829; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352; Hori Y, 2009, BIOL PHARM BULL, V32, P1678, DOI 10.1248/bpb.32.1678; Hughes BG, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0424-y; Knowlton AA, 2014, J CARDIOVASC PHARM, V63, P196, DOI 10.1097/01.fjc.0000432861.55968.a6; LANGEVITZ P, 1992, J RHEUMATOL, V19, P1502; Liaudet L, 2000, PROTECTION HEMORRHAG; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Massie BM, J AM COLL CARDIOLOGY; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Okonko DO, 2015, NAT REV CARDIOL, V12, P6, DOI 10.1038/nrcardio.2014.189; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Ozcinar E, 2014, CARDIOVASC TOXICOL, V14, P64, DOI 10.1007/s12012-013-9231-1; Palfi A, 2006, J MOL CELL CARDIOL, V41, P149, DOI 10.1016/j.yjmcc.2006.03.427; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3; Ramani GV, 2010, MAYO CLIN PROC, V85, P180, DOI 10.4065/mcp.2009.0494; Roberts AW, 2009, DIABETES VASC DIS RE, V6, P153, DOI 10.1177/1479164109338774; Sawyer D.B., 2000, MITOCHONDRIAL OXIDAT; Schulze CJ, 2013, CRIT CARE MED, V41, P2512, DOI 10.1097/CCM.0b013e318292373c; Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Smith CJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3491; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; TEERLINK JR, 1994, CIRC RES, V75, P105, DOI 10.1161/01.RES.75.1.105; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Voigt W, 2005, METH MOLEC MED, V110, P39; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252	50	33	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175195	10.1371/journal.pone.0175195	http://dx.doi.org/10.1371/journal.pone.0175195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384228	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900116
J	Heim, B; Pertl, MT; Stefani, A; Delazer, M; Heidbreder, A; Zamarian, L; Brandauer, E; Seppi, K; Hogl, B; Poewe, W; Djamshidian, A				Heim, Beatrice; Pertl, Marie-Theres; Stefani, Ambra; Delazer, Margarete; Heidbreder, Anna; Zamarian, Laura; Brandauer, Elisabeth; Seppi, Klaus; Hoegl, Birgit; Poewe, Werner; Djamshidian, Atbin			Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation	PLOS ONE			English	Article							PARKINSONS-DISEASE; REFLECTION IMPULSIVITY; SYNDROME RLS; DOPAMINERGIC AUGMENTATION; CONCLUSIONS; DISORDERS; ASSOCIATION; VALIDATION; BEHAVIORS; COMMUNITY	Objectives To investigate decision making in patients with primary restless legs syndrome (RLS) with and without augmentation treated with dopaminergic medication. Methods A total of 64 non-demented RLS patients treated with dopaminergic medication with and without augmentation were included in this study. We used an information sampling task to assess how much evidence participants gather before making a decision. Performance was compared to the results of 21 healthy controls. Results All patients with and without augmentation gathered less information than healthy controls before making a decision (p< 0.001), but there was no difference between the two patient groups (p = 1.0). Furthermore, both patient groups made more irrational decisions (e. g. decisions against the evidence they had at the time) than healthy controls (p <= 0.002). In addition, RLS patients with augmentation made significantly more irrational decisions than RLS patients without augmentation (p = 0.037) and controls (p< 0.001). Conclusions Our results show that RLS patients treated with dopaminergic drugs, regardless of having augmentation or not, jumped to conclusions and decided significantly more often against the evidence they had at the time of their decision. However, those with augmentation performed worse than all other groups and made more often irrational decisions, a phenomenon which is also common in patients with substance abuse or behavioural addictions. Thus, jumping to conclusions and deciding with a higher degree of uncertainty as well as irrational decision making is more common in RLS patients treated with dopaminergic medication particularly in those with augmentation.	[Heim, Beatrice; Pertl, Marie-Theres; Stefani, Ambra; Delazer, Margarete; Heidbreder, Anna; Zamarian, Laura; Brandauer, Elisabeth; Seppi, Klaus; Hoegl, Birgit; Poewe, Werner; Djamshidian, Atbin] Med Univ Innsbruck, Dept Neurol, Innsbruck, Tyrol, Austria; [Djamshidian, Atbin] Univ London, Dept Mol Neurosci, London, England; [Djamshidian, Atbin] Univ London, Reta Lila Weston Inst Neurol Studies, London, England	Medical University of Innsbruck; University of London; University College London; University of London; University College London	Djamshidian, A (corresponding author), Med Univ Innsbruck, Dept Neurol, Innsbruck, Tyrol, Austria.; Djamshidian, A (corresponding author), Univ London, Dept Mol Neurosci, London, England.; Djamshidian, A (corresponding author), Univ London, Reta Lila Weston Inst Neurol Studies, London, England.	atbin.djamshidian-tehrani@i-med.ac.at	Zamarian, Laura/J-9575-2018; Heidbreder, Anna/GLR-3355-2022; Stefani, Ambra/AAK-2172-2020	Zamarian, Laura/0000-0002-1640-4179; Heidbreder, Anna/0000-0002-9552-7619; Stefani, Ambra/0000-0003-4259-8824; Heim, Beatrice/0000-0002-6749-3044; Seppi, Klaus/0000-0001-6503-1455; Hogl, Birgit/0000-0003-1894-7641; Delazer, Margarete/0000-0001-6482-4445; Djamshidian, Atbin/0000-0001-7174-6000				Al-Khaled M, 2015, PARKINSONISM RELAT D, V21, P1330, DOI 10.1016/j.parkreldis.2015.09.026; Averbeck BB, 2011, SCHIZOPHR RES, V127, P115, DOI 10.1016/j.schres.2010.08.009; Banca P, 2015, ADDICT BIOL; Bayard S, 2013, SLEEP, V36, P1501, DOI 10.5665/sleep.3044; Bayard S, 2010, MOVEMENT DISORD, V25, P2634, DOI 10.1002/mds.23326; Chang Y, 2015, CLIN IMAG, V39, P20, DOI 10.1016/j.clinimag.2014.07.010; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Cornelius JR, 2010, SLEEP, V33, P81; Costa FHD, 2016, NEUROPSYCHOLOGIA, V85, P19, DOI 10.1016/j.neuropsychologia.2016.03.002; Djamshidian A, 2013, J PARKINSON DIS, V3, P139, DOI 10.3233/JPD-130178; Djamshidian A, 2013, ADDICTION, V108, P771, DOI 10.1111/add.12080; Djamshidian A, 2012, MOVEMENT DISORD, V27, P1137, DOI 10.1002/mds.25105; Evans SL, 2015, NEUROPSYCH DIS TREAT, V11, P1615, DOI 10.2147/NDT.S56870; Fulda S, 2010, MOVEMENT DISORD, V25, P2641, DOI 10.1002/mds.23353; Furl N, 2011, J NEUROSCI, V31, P17572, DOI 10.1523/JNEUROSCI.4236-11.2011; Gamaldo CE, 2008, SLEEP MED, V9, P500, DOI 10.1016/j.sleep.2007.07.014; Garcia-Borreguero D, 2016, SLEEP MED IN PRESS; Garcia-Borreguero D, 2007, MOVEMENT DISORD, V22, pS476, DOI 10.1002/mds.21610; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garcia-Borreguero D, 2016, SLEEP MED, V21, P1, DOI 10.1016/j.sleep.2016.01.017; Garety P, 2013, SCHIZOPHR RES, V150, P570, DOI 10.1016/j.schres.2013.08.035; Heim B, 2016, NEUROLOGY, V87, P36, DOI 10.1212/WNL.0000000000002803; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Kalaydjian A, 2009, SLEEP MED, V10, P672, DOI 10.1016/j.sleep.2008.07.004; Lee HB, 2008, J NEUROPSYCH CLIN N, V20, P101, DOI 10.1176/jnp.2008.20.1.101; Lee HB, 2014, J NEUROPSYCH CLIN N, V26, P87, DOI 10.1176/appi.neuropsych.12120394; Lunt L, 2012, J NEUROPSYCHOL, V6, P65, DOI 10.1111/j.1748-6653.2011.02005.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pearson VE, 2006, SLEEP MED, V7, P25, DOI 10.1016/j.sleep.2005.05.006; Poletti M, 2012, MOVEMENT DISORD, V27, P1679, DOI 10.1002/mds.25129; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Scholz H, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-73; Voon V, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv074; Voon V, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-117; Voon V, 2010, PSYCHOPHARMACOLOGY, V207, P645, DOI 10.1007/s00213-009-1697-y; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571; Winkelmann J, 2005, J NEUROL, V252, P67, DOI 10.1007/s00415-005-0604-7; Ye Z, 2011, HUM BRAIN MAPP, V32, P800, DOI 10.1002/hbm.21067	39	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174793	10.1371/journal.pone.0174793	http://dx.doi.org/10.1371/journal.pone.0174793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380045	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500064
J	Mendoza-Denton, R; Patt, C; Fisher, A; Eppig, A; Young, I; Smith, A; Richards, MA				Mendoza-Denton, Rodolfo; Patt, Colette; Fisher, Aaron; Eppig, Andrew; Young, Ira; Smith, Andrew; Richards, Mark A.			Differences in STEM doctoral publication by ethnicity, gender and academic field at a large public research university	PLOS ONE			English	Article							DIVERSITY	Two independent surveys of PhD students in STEM fields at the University of California, Berkeley, indicate that underrepresented minorities (URMs) publish at significantly lower rates than non-URM males, placing the former at a significant disadvantage as they compete for postdoctoral and faculty positions. Differences as a function of gender reveal a similar, though less consistent, pattern. A conspicuous exception is Berkeley's College of Chemistry, where publication rates are tightly clustered as a function of ethnicity and gender, and where PhD students experience a highly structured program that includes early and systematic involvement in research, as well as clear expectations for publishing. Social science research supports the hypothesis that this more structured environment hastens the successful induction of diverse groups into the high-performance STEM academic track.	[Mendoza-Denton, Rodolfo; Fisher, Aaron] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Patt, Colette; Young, Ira] Univ Calif Berkeley, Div Math & Phys Sci, Berkeley, CA 94720 USA; [Eppig, Andrew] Univ Calif Berkeley, Off Planning & Anal, Berkeley, CA USA; [Eppig, Andrew] Univ Calif Berkeley, Off Equ & Inclus, Berkeley, CA 94720 USA; [Young, Ira] Univ Calif Berkeley, Div Social Sci, Berkeley, CA 94720 USA; [Smith, Andrew] Univ Calif Berkeley, Grad Div, Berkeley, CA 94720 USA; [Richards, Mark A.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mendoza-Denton, R (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	rmd@berkeley.edu			National Science Foundation [1038192, 1306747]; Kapor Center for Social Impact; Direct For Education and Human Resources [1306747] Funding Source: National Science Foundation; Division Of Human Resource Development [1306595] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Kapor Center for Social Impact; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division Of Human Resource Development(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This research is supported by the National Science Foundation (nsf.gov) under Award Numbers 1038192 and 1306747, as well as grant from the Kapor Center for Social Impact (kaporcenter.org), to MAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Allen-Ramdial SAA, 2014, BIOSCIENCE, V64, P612, DOI 10.1093/biosci/biu076; [Anonymous], 2015, NSF SURV EARN DOCT; Austin AE, 2002, J HIGH EDUC, V73, P94, DOI 10.1353/jhe.2002.0001; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cohen J., 2003, APPL MULTIPLE REGRES; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Davis T. E, 2014, THESIS; Dovidio JF, 2000, PSYCHOL SCI, V11, P315, DOI 10.1111/1467-9280.00262; Estrada M, 2016, CELL BIOL ED, V15, P1; Hollander M., 1973, NONPARAMETRIC STAT M; Laursen SL, 2014, J CHEM EDUC, V91, P1762, DOI 10.1021/ed4006997; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Nettles M., 2006, 3 MAGIC LETT; ORR RH, 1961, AM DOC, V12, P15, DOI 10.1002/asi.5090120104; The Committee on Equal Opportunities in Science and Engineering, 2013, BIENN REP C BROAD PA; Waaijer C, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/JOURNAL.PONE.0164784; Walker G., 2008, FORMATION SCHOLARS; Weinstein R. S., 2002, REACHING HIGHER; Whittaker JA, 2014, INNOV HIGH EDUC, V39, P263, DOI 10.1007/s10755-013-9277-9	21	32	32	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174296	10.1371/journal.pone.0174296	http://dx.doi.org/10.1371/journal.pone.0174296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380061	Green Published, gold			2022-12-27	WOS:000399353500040
J	Mifsud, B; Martincorena, I; Darbo, E; Sugar, R; Schoenfelder, S; Fraser, P; Luscombe, NM				Mifsud, Borbala; Martincorena, Inigo; Darbo, Elodie; Sugar, Robert; Schoenfelder, Stefan; Fraser, Peter; Luscombe, Nicholas M.			GOTHiC, a probabilistic model to resolve complex biases and to identify real interactions in Hi-C data	PLOS ONE			English	Article							HUMAN GENOME; CHROMATIN; ORGANIZATION; PRINCIPLES	Hi-C is one of the main methods for investigating spatial co-localisation of DNA in the nucleus. However, the raw sequencing data obtained from Hi-C experiments suffer from large biases and spurious contacts, making it difficult to identify true interactions. Existing methods use complex models to account for biases and do not provide a significance threshold for detecting interactions. Here we introduce a simple binomial probabilistic model that resolves complex biases and distinguishes between true and false interactions. The model corrects biases of known and unknown origin and yields a p-value for each interaction, providing a reliable threshold based on significance. We demonstrate this experimentally by testing the method against a random ligation dataset. Our method outperforms previous methods and provides a statistical framework for further data analysis, such as comparisons of Hi-C interactions between different conditions. GOTHiC is available as a BioConductor package (http://www.bioconductor.org/packages/release/bioc/html/GOTHiC.html).	[Mifsud, Borbala; Martincorena, Inigo; Darbo, Elodie; Sugar, Robert; Luscombe, Nicholas M.] Francis Crick Inst, London, England; [Mifsud, Borbala; Luscombe, Nicholas M.] UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London, England; [Schoenfelder, Stefan; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Okinawa, Japan; [Mifsud, Borbala] Queen Mary Univ London, Sch Med & Dent, William Harvey Res Inst, London, England; [Martincorena, Inigo] Wellcome Trust Sanger Inst, Hinxton, England; [Darbo, Elodie] Bordeaux Bioinformat Ctr, Bordeaux, France	Francis Crick Institute; University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Okinawa Institute of Science & Technology Graduate University; University of London; Queen Mary University London; Wellcome Trust Sanger Institute	Mifsud, B (corresponding author), Francis Crick Inst, London, England.; Mifsud, B (corresponding author), UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London, England.; Mifsud, B (corresponding author), Queen Mary Univ London, Sch Med & Dent, William Harvey Res Inst, London, England.	b.mifsud@qmul.ac.uk	Mifsud, Borbala/AAB-5379-2020	Martincorena, Inigo/0000-0003-1122-4416; Mifsud, Borbala/0000-0003-3429-3094	MRC [MR/L016311/1] Funding Source: UKRI; Medical Research Council [MR/L016311/1] Funding Source: Medline; Cancer Research UK [16358, 21777] Funding Source: researchfish; The Francis Crick Institute [10110, 10111] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute		Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bau A D, 2010, NATURE, V18, P107; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Hu M, 2012, BIOINFORMATICS; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jin F, ALL RIGHTS RESERVED, V503, P290; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Li W, 2014, BIOINFORMATICS, P1; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Shavit Y, 2014, MOL BIOSYST, V10, P1576, DOI 10.1039/c4mb00142g; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	17	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174744	10.1371/journal.pone.0174744	http://dx.doi.org/10.1371/journal.pone.0174744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379994	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500062
J	Hahn, F; Schmalen, A; Setz, C; Friedrich, M; Schlosser, S; Kolle, J; Sprenger, R; Rauch, P; Fraedrichl, K; Reif, T; Karius-Fischer, J; Balasubramanyam, A; Henklein, P; Fossen, T; Schubert, U				Hahn, Friedrich; Schmalen, Adrian; Setz, Christian; Friedrich, Melanie; Schloesser, Stefan; Koelle, Julia; Sprenger, Robert; Rauch, Pia; Fraedrichl, Kirsten; Reif, Tatjana; Karius-Fischer, Julia; Balasubramanyam, Ashok; Henklein, Petra; Fossen, Torgils; Schubert, Ulrich			Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AMYLOID BETA-PROTEIN; TYPE-1 P6; MOLECULAR CHARACTERIZATION; MEMBRANE ASSOCIATION; ANTIGEN PRESENTATION; VPU-PROTEIN; N-TERMINUS; P6(GAG); DOMAIN	There is a significantly higher risk for type II diabetes in HIV-1 carriers, albeit the molecular mechanism for this HIV-related pathology remains enigmatic. The 52 amino acid HIV-1 p6 Gag protein is synthesized as the C-terminal part of the Gag polyprotein Pr55. In this context, p6 promotes virus release by its two late (L-) domains, and facilitates the incorporation of the viral accessory protein Vpr. However, the function of p6 in its mature form, after proteolytic release from Gag, has not been investigated yet. We found that the mature p6 represents the first known viral substrate of the ubiquitously expressed cytosolic metalloendopeptidase insulin-degrading enzyme (IDE). IDE is sufficient and required for degradation of p6, and p6 is approximately 100-fold more efficiently degraded by IDE than its eponymous substrate insulin. This observation appears to be specific for HIV-1, as p6 proteins from HIV-2 and simian immunodeficiency virus, as well as the 51 amino acid p9 from equine infectious anaemia virus were insensitive to IDE degradation. The amount of virus-associated p6, as well as the efficiency of release and maturation of progeny viruses does not depend on the presence of IDE in the host cells, as it was shown by CRISPR/Cas9 edited IDE KO cells. However, HIV-1 mutants harboring IDE-insensitive p6 variants exhibit reduced virus replication capacity, a phenomenon that seems to depend on the presence of an X4-tropic Env. Furthermore, competing for IDE by exogenous insulin or inhibiting IDE by the highly specific inhibitor 6bK, also reduced virus replication. This effect could be specifically attributed to IDE since replication of HIV-1 variants coding for an IDE-insensitive p6 were inert towards IDE-inhibition. Our cumulative data support a model in which removal of p6 during viral entry is important for virus replication, at least in the case of X4 tropic HIV-1.	[Hahn, Friedrich; Schmalen, Adrian; Setz, Christian; Friedrich, Melanie; Schloesser, Stefan; Koelle, Julia; Sprenger, Robert; Rauch, Pia; Fraedrichl, Kirsten; Reif, Tatjana; Karius-Fischer, Julia; Schubert, Ulrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Virol, Erlangen, Germany; [Balasubramanyam, Ashok] Baylor Coll Med, Diabet Res Ctr, Translat Metab Unit, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Henklein, Petra] Charite, Inst Biochem, Berlin, Germany; [Fossen, Torgils] Univ Bergen, Dept Chem, Bergen, Norway; [Fossen, Torgils] Univ Bergen, Ctr Pharm, Bergen, Norway	University of Erlangen Nuremberg; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bergen; University of Bergen	Schubert, U (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Virol, Erlangen, Germany.	Orich.Schubert@viro.med.uni-erlangen.de		Hahn, Friedrich/0000-0003-3011-8416; Henklein, Petra/0000-0001-7468-8926; Schmalen, Adrian/0000-0003-2462-2675	Deutsche Forschungsgemeinschaft [SFB643A1, GRK 1071]; Interdisziplinaere Zentrum fuer Klinische Forschung(IZKF) [A70]; NIH [RO1DK81553]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinaere Zentrum fuer Klinische Forschung(IZKF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	US received funding from "Deutsche Forschungsgemeinschaft", grant number SFB643A1, URL: http://gepris.dfg.de/gepris/projekt/5486111. US received funding from"Deutsche Forschungsgemeinschaft", graduate program GRK 1071, URL: http://gepris.dfg.de/gepris/projekt/440477. US received funding from "Interdisziplinaere Zentrum fuer Klinische Forschung(IZKF)", IZKF grant A70, URL: http:// www.izkf.uk-erlangen.de/. US received funding from the NIH, grant RO1DK81553, URL: https:// grants.nih.gov/grants/funding/r01.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Andras IE, 2013, IUBMB LIFE, V65, P43, DOI 10.1002/iub.1106; Andreoni M, 1997, AIDS RES HUM RETROV, V13, P555, DOI 10.1089/aid.1997.13.555; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Bruns K, 2003, J BIOL CHEM, V278, P43188, DOI 10.1074/jbc.M305413200; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Flys T, 2005, AIDS RES HUM RETROV, V21, P739, DOI 10.1089/aid.2005.21.739; Fossen T, 2005, J BIOL CHEM, V280, P42515, DOI 10.1074/jbc.M507375200; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Friedrich M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040117; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GERMINARIO RJ, 1995, AIDS RES HUM RETROV, V11, P555, DOI 10.1089/aid.1995.11.555; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; Gottwein E, 2005, J VIROL, V79, P9134, DOI 10.1128/JVI.79.14.9134-9144.2005; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Gurer C, 2005, J VIROL, V79, P910, DOI 10.1128/JVI.79.2.910-917.2005; Gutierrez AD, 2012, ENDOCRINE, V41, P1, DOI 10.1007/s12020-011-9565-z; Hahn F, 2014, VIRUSES-BASEL, V6, P3738, DOI 10.3390/v6103738; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hulse RE, 2009, VITAM HORM, V80, P635, DOI 10.1016/S0083-6729(08)00622-5; Kohler G, 1981, CHARACTERIZATION MON; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; KONDO E, 1995, J VIROL, V69, P2759, DOI 10.1128/JVI.69.5.2759-2764.1995; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; LIU HM, 1995, J VIROL, V69, P7630, DOI 10.1128/JVI.69.12.7630-7638.1995; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Marlowe N, 2004, AIDS RES HUM RETROV, V20, P1119, DOI 10.1089/aid.2004.20.1119; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martins AN, 2016, J VIROL, V90, P768, DOI 10.1128/JVI.01640-15; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Mo XY, 1999, J IMMUNOL, V163, P5851; Muller B, 2002, J VIROL, V76, P1015, DOI 10.1128/JVI.76.3.1015-1024.2002; Mwaengo DM, 1998, J VIROL, V72, P8976, DOI 10.1128/JVI.72.11.8976-8987.1998; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PAN LZ, 1993, J CLIN MICROBIOL, V31, P283, DOI 10.1128/JCM.31.2.283-288.1993; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peters S, 2001, J VIROL, V75, P9644, DOI 10.1128/JVI.75.20.9644-9653.2001; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radestock B, 2013, J VIROL, V87, P724, DOI 10.1128/JVI.02162-12; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reche P., 2015, SEQUENCE IDENTITY SI; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; SCHMIDT M, 1994, FEBS LETT, V356, P238, DOI 10.1016/0014-5793(94)01277-6; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; SCHUBERT U, 1995, J VIROL, V69, P7699, DOI 10.1128/JVI.69.12.7699-7711.1995; Schubert U, 1999, J VIROL, V73, P887, DOI 10.1128/JVI.73.2.887-896.1999; Sharma A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-74; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHENG NJ, 1994, J VIROL, V68, P6207, DOI 10.1128/JVI.68.10.6207-6214.1994; Solbak SMO, 2013, BBA-BIOMEMBRANES, V1828, P816, DOI 10.1016/j.bbamem.2012.11.010; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tamiya S, 2004, J VIROL, V78, P12030, DOI 10.1128/JVI.78.21.12030-12040.2004; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Votteler J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-11; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Yu XG, 2002, AIDS, V16, P321, DOI 10.1097/00002030-200202150-00002	93	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174254	10.1371/journal.pone.0174254	http://dx.doi.org/10.1371/journal.pone.0174254			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388673	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800003
J	Omachi, T; Ichikawa, T; Kimura, Y; Ueda, K; Kioka, N				Omachi, Tomohiro; Ichikawa, Takafumi; Kimura, Yasuhisa; Ueda, Kazumitsu; Kioka, Noriyuki			Vinculin association with actin cytoskeleton is necessary for stiffness-dependent regulation of vinculin behaviore	PLOS ONE			English	Article							FOCAL ADHESIONS; CELL; ACTIVATION; TALIN; RECRUITMENT; VINEXIN; ORGANIZATION; COMPLEX; PROTEIN	The extracellular matrix (ECM) is a major regulator of cell behavior. Recent studies have indicated the importance of the physical properties of the ECM, including its stiffness, for cell migration and differentiation. Using actomyosin-generated forces, cells pull the ECM and sense stiffness via cell-ECM adhesion structures called focal adhesions (FAs). Vinculin, an actin-binding FA protein, has emerged as a major player in FA-mediated mechanotransduction. Although vinculin is important for sensing ECM stiffness, the role of vinculin binding to actin in the ECM stiffness-mediated regulation of vinculin behavior remains unknown. Here, we show that an actin binding-deficient mutation disrupts the ECM stiffness-dependent regulation of CSB (cytoskeleton stabilization buffer) resistance and the stable localization of vinculin. These results suggest that the vinculin-actin interaction participates in FA-mediated mechanotransduction.	[Omachi, Tomohiro; Ichikawa, Takafumi; Kimura, Yasuhisa; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Ichikawa, Takafumi; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Kioka, N (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.; Kioka, N (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto, Japan.	nkioka@kais.kyoto-u.ac.jp		Kimura, Yasuhisa/0000-0001-6466-1324; Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Naito Foundation; Japan Society for the Promotion of Science [24380185, 26660291, 16K15090]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25221203, 26112707]; Japan Agency for Medical Research and development	Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by The Naito Foundation(NK), a Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 24380185)(NK), a Grant-in-aid for Exploratory Research (JSPS KAKENHI Grant Number 26660291, 16K15090)(NK) from The Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html), Grants-in-Aid for Scientific Research (S) (25221203)(KU) and a Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Number 26112707) (NK) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http//www.mext.go.jp/en/), and the Advanced Research and Development Programs for Medical Innovation (NK) from Japan Agency for Medical Research and development (http://www.amed.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton P, 2016, EXP CELL RES, V343, P21, DOI 10.1016/j.yexcr.2015.11.017; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Golji J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002995; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Holle AW, 2013, STEM CELLS, V31, P2467, DOI 10.1002/stem.1490; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Jannie KM, 2015, BIOCHEM J, V465, P383, DOI 10.1042/BJ20140872; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Kim LY, 2016, J MOL BIOL, V428, P10, DOI 10.1016/j.jmb.2015.09.031; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Kioka N, 2010, EXP CELL RES, V316, P1728, DOI 10.1016/j.yexcr.2010.03.019; Kuroda M, 2017, J CELL SCI; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Nagasato AI, 2017, BIOSCI BIOTECH BIOCH, V81, P1136, DOI 10.1080/09168451.2017.1289074; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Patel PN, 2005, J BIOMED MATER RES A, V73A, P313, DOI 10.1002/jbm.a.30291; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; Xu WM, 1998, DEVELOPMENT, V125, P327; Yamashita H, 2014, J CELL SCI, V127, P1875, DOI 10.1242/jcs.133645; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07	39	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							0175324	10.1371/journal.pone.0175324	http://dx.doi.org/10.1371/journal.pone.0175324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388663	Green Submitted, gold, Green Published			2022-12-27	WOS:000399375800040
J	Damantil, S; Bourron, O; Doulazmi, M; Sossol, ALM; Nguyen-Michell, VH; Mariani, J; Kinugawa, K				Damantil, Sarah; Bourron, Olivier; Doulazmi, Mohamed; Sossol, Anne-Laure Mandengue; Vi-Huong Nguyen-Michell; Mariani, Jean; Kinugawa, Kiyoka			Relationship between sleep parameters, insulin resistance and age-adjusted insulin like growth factor-1 score in non diabetic older patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; APNEA SYNDROME; GLUCOSE-INTOLERANCE; METABOLIC SYNDROME; HEART HEALTH; METAANALYSIS; ASSOCIATION; ADULTS	Background Sleep complaints are prevalent in older patients. Sleepiness, short or long sleep duration and obstructive sleep apnea (OSA) are associated with insulin resistance (IR). These parameters have not yet been considered together in the same study exploring the possible association between IR and sleep in older patients. IR is involved in cardiovascular and metabolic diseases, pathologies which are highly prevalent in older patients. Here we assess, in older non-diabetic patients with sleep complaints, the associations between IR and sleep parameters objectively recorded by polysomnography (PSG) rather than self-report. The Growth Hormone/Insulin like growth factor-1 axis could play a role in the development of IR during sleep disorders. The second objective of this study was to analyze the association between sleep parameters and age-adjusted IGF-1 score, which could explain the association between OSA and IR. Methods 72 non-diabetic older patients, mean age 74.5 7.8 years, were included in this observational study. We evaluated anthropometric measures, subjective and objective sleepiness, polysomnography, Homeostatic Model Assessment for IR (HOMA-IR) and age-adjusted IGF-1 score. A multivariate regression was used to determine factors associated with HOMA-IR. Results The 47 OSA patients were over-weight but not obese and had higher IR than the non-OSA patients. In multilinear regression analysis, apnea-hypopnea index was independently associated with IR after adjustment for several confounding factors. Neither IGF-1 level nor IGF-1 score were different in the two groups. Conclusions We demonstrate that in non-diabetic older patients with sleep complaints, OSA is independently associated with IR, regardless of anthropometric measurements and sleep parameters (sleep duration/sleepiness/arousals). Targeting OSA to reduce IR could be useful in the elderly, although further exploration is required.	[Damantil, Sarah; Sossol, Anne-Laure Mandengue; Vi-Huong Nguyen-Michell; Mariani, Jean; Kinugawa, Kiyoka] Grp Hosp Pitie Salpetriere Charles Foix, APHP, DHU FAST, Funct Explorat Unit Older Patients, Paris, France; [Damantil, Sarah; Doulazmi, Mohamed; Sossol, Anne-Laure Mandengue; Mariani, Jean; Kinugawa, Kiyoka] UPMC Univ Paris 06, Sorbonne Univ, UMR 8256, Biol Adaptat & Aging, Paris, France; [Damantil, Sarah] Univ Milan, Milan, Italy; [Bourron, Olivier] Hop La Pitie Salpetriere, APHP, Diabetol Dept, Paris, France; [Bourron, Olivier] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Bourron, Olivier] INSERM, UMR S 1138, Ctr Rech Cordeliers, Paris, France; [Doulazmi, Mohamed; Sossol, Anne-Laure Mandengue; Mariani, Jean; Kinugawa, Kiyoka] CNRS, UMR 8256, Biol Adaptat & Aging, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Kinugawa, K (corresponding author), Grp Hosp Pitie Salpetriere Charles Foix, APHP, DHU FAST, Funct Explorat Unit Older Patients, Paris, France.	kiyoka.kinugawa@aphp.fr	Damanti, Sarah/ABI-2999-2020; Kinugawa, Kiyoka/AAM-7853-2020	Mariani, Jean/0000-0002-2701-1581; Damanti, Sarah/0000-0002-2399-3688; Kinugawa, Kiyoka/0000-0001-6914-6102; Bourron, Olivier/0000-0001-7348-7161; Doulazmi, Mohamed/0000-0002-0313-1490				Aleman-Mateo H, 2014, J GERONTOL A-BIOL, V69, P871, DOI 10.1093/gerona/glt193; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; Baoying H, 2014, BMJ OPEN, V4; Barcelo A, 2008, THORAX, V63, P946, DOI 10.1136/thx.2007.093740; Borel AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071000; Bourron O, 2015, J CLIN ENDOCR METAB, V100, P1879, DOI 10.1210/jc.2014-3968; Chen LD, 2015, GROWTH HORM IGF RES, V25, P75, DOI 10.1016/j.ghir.2014.12.006; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Gianotti L, 2002, J CLIN ENDOCR METAB, V87, P5052, DOI 10.1210/jc.2001-011441; Grant RW, 2004, DRUG AGING, V21, P141, DOI 10.2165/00002512-200421030-00001; Iber C., 2007, AASM MANUAL SCORING; Iftikhar Imran H, 2013, Ann Am Thorac Soc, V10, P115, DOI 10.1513/AnnalsATS.201209-081OC; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Makino S, 2012, CLIN ENDOCRINOL, V76, P593, DOI 10.1111/j.1365-2265.2011.04237.x; Malhotra A, 2006, AM J MED, V119, pe9, DOI DOI 10.1016/J.AMJMED.2005.01.077; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Onen F, 2013, SLEEP BREATH, V17, P343, DOI 10.1007/s11325-012-0700-8; Pamidi Sushmita, 2012, Front Neurol, V3, P126; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Pyykkonen AJ, 2014, ANN MED, V46, P324, DOI 10.3109/07853890.2014.902226; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Shah N, 2013, J CLIN SLEEP MED, V9, P1245, DOI 10.5664/jcsm.3260; Shechter A, 2012, AM J PHYSIOL-REG I, V303, pR883, DOI 10.1152/ajpregu.00222.2012; Strand LB, 2015, DIABETES CARE; Tanno S, 2014, SLEEP MED; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Ursavas A, 2007, LUNG, V185, P309, DOI 10.1007/s00408-007-9026-x; Xu SY, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0102-3; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174876	10.1371/journal.pone.0174876	http://dx.doi.org/10.1371/journal.pone.0174876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384333	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900047
J	Li, JM; Liu, HY; Yang, M; Du, LS				Li, Junmin; Liu, Haiyan; Yang, Ming; Du, Leshan			No evidence for local adaptation to salt stress in the existing populations of invasive Solidago canadensis in China	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TOLERANCE; SALINITY; PLANTS; MECHANISMS	Local adaptation is an important mechanism underlying the adaptation of plants to environmental heterogeneity, and the toxicity of salt results in strong selection pressure on salt tolerance in plants and different ecotypes. Solidago canadensis, which is invasive in China, has spread widely and has recently colonized alkali sandy loams with a significant salt content. A common greenhouse experiment was conducted to test the role of local adaptation in the successful invasion of S. canadensis into salty habitats. Salt treatment significantly decreased the growth of S. canadensis, including rates of increase in the number of leaves and plant height; the root, shoot, and total biomass. Furthermore, salt stress significantly reduced the net photosynthetic rate, stomatal conductance, transpiration rate and relative chlorophyll content but significantly increased peroxidase activity and the proline content of S. canadensis and the root/shoot ratio. Two-way analysis of variance showed that salt treatment had a significant effect on the physiological traits of S. canadensis, except for the intercellular CO2 concentration, whereas the population and the salt x population interaction had no significant effect on any physiological traits. Most of the variation in plasticity existed within and not among populations, excep for the root/shoot ratio. S. canadensis populations from soil with moderate/high salt levels grew similarly to S. canadensis populations from soils with low salt levels. No significant correlation between salt tolerance indices and soil salinity levels was observed. The plasticity of the proline content, intercellular CO2 concentration and chlorophyll content had significant correlations with the salt tolerance index. These findings indicate a lack of evidence for local adaption in the existing populations of invasive S. canadensis in China; instead, plasticity might be more important than local adaptation in influencing the physiological traits and salt tolerance ability across the S. canadensis distribution.	[Li, Junmin; Liu, Haiyan; Du, Leshan] Taizhou Univ, Zhejiang Prov Key Lab Evolutionary Ecol & Conserv, Taizhou, Zhejiang, Peoples R China; [Liu, Haiyan; Yang, Ming] Shanxi Normal Univ, Sch Life Sci, Linfen, Shanxi, Peoples R China; [Liu, Haiyan; Du, Leshan] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Taizhou University; Shanxi Normal University; Chinese Research Academy of Environmental Sciences	Li, JM (corresponding author), Taizhou Univ, Zhejiang Prov Key Lab Evolutionary Ecol & Conserv, Taizhou, Zhejiang, Peoples R China.; Yang, M (corresponding author), Shanxi Normal Univ, Sch Life Sci, Linfen, Shanxi, Peoples R China.	lijm@tzc.edu.cn; mycorrhiza@sina.com	李, 钧敏/L-7390-2019		National Key Research and Development Program [2016YFC1201102, 2016YFC1201100]; National Natural Science Foundation of China [31270461]; Qianjiang Talents Project of Zhejiang Province [QJD1302021]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Project of Zhejiang Province	This study was financially support by the National Key Research and Development Program (2016YFC1201102; 2016YFC1201100), the National Natural Science Foundation of China (No. 31270461), and the Qianjiang Talents Project of Zhejiang Province (type D) (No. QJD1302021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates E., 2007, World Journal of Agricultural Sciences, V3, P71; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Cheplick GP, 2006, AM J BOT, V93, P539, DOI 10.3732/ajb.93.4.539; Dong M, 2006, ACTA PHYTOTAXON SIN, V44, P72, DOI 10.1360/aps050068; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; Droste T, 2010, PLANT ECOL, V207, P297, DOI 10.1007/s11258-009-9673-5; Du LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170049; Du LS, 2016, ACTA OECOL, V71, P22, DOI 10.1016/j.actao.2016.01.003; Fischer G., 2008, GLOBAL AGROECOLOGICA; Godoy O, 2011, BIOL INVASIONS, V13, P1615, DOI 10.1007/s10530-010-9919-0; Gondim FA, 2013, THEOR EXP PLANT PHYS, V25, P251, DOI 10.1590/S2197-00252013000400003; Grassein F, 2014, GLOBAL CHANGE BIOL, V20, P1452, DOI 10.1111/gcb.12445; Huang QQ, 2015, ECOL EVOL, V5, P1169, DOI 10.1002/ece3.1424; Kawecki TJ, ECOLOGY LETT, V7, P1225; Keser LH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00273; Kuhn NL, 1997, ESTUARIES, V20, P391, DOI 10.2307/1352352; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Li JM, 2016, OECOLOGIA, V182, P755, DOI 10.1007/s00442-016-3699-x; Li JM, 2012, ACTA PHYSIOL PLANT, V34, P1747, DOI 10.1007/s11738-012-0971-5; Liu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149262; Liu YJ, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plv141; Lortie CJ, 1996, INT J PLANT SCI, V157, P484, DOI 10.1086/297365; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Minchinton TE, 2006, J ECOL, V94, P342, DOI 10.1111/j.1365-2745.2006.01099.x; Moran EV., 2014, 99 ESA ANN CONV 2014; MULLIGAN GA, 1970, CAN J BOTANY, V48, P859, DOI 10.1139/b70-119; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Nasim M, 2009, J PLANT NUTR, V32, P1427, DOI 10.1080/01904160903092648; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Riis T, 2010, ANN BOT-LONDON, V106, P813, DOI 10.1093/aob/mcq176; Rouifed S, 2012, ENVIRON MANAGE, V50, P1027, DOI 10.1007/s00267-012-9934-2; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schittko C, 2014, BIOL INVASIONS, V16, P1465, DOI 10.1007/s10530-013-0584-y; Si CC, 2014, BIOL INVASIONS, V16, P2323, DOI 10.1007/s10530-014-0667-4; Siebenkas A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv029; Song H., 2010, CHINESE J INFORM TRA, V53, P1849; SULTAN SE, 1987, EVOL BIOL, V21, P127; [孙万春 Sun Wanchun], 2002, [中国农业科学, Scientia Agricultura Sinica], V35, P1560; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WANG Y, 2013, PLOS ONE, V2013; [徐高峰 Xu Gaofeng], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1258; Xu Xiangqin, 2011, Shengwu Duoyangxing, V19, P519, DOI 10.3724/SP.J.1003.2011.09048; Zhu JK, 2010, PLANT PHYSIOL, V124, P941; Zhu Lin., 2012, THESIS	50	8	10	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175252	10.1371/journal.pone.0175252	http://dx.doi.org/10.1371/journal.pone.0175252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384230	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900138
J	Koami, H; Sakamoto, Y; Sakurai, R; Ohta, M; Imahase, H; Yahata, M; Umeka, M; Miike, T; Nagashima, F; Iwamura, T; Yamada, KC; Inoue, S				Koami, Hiroyuki; Sakamoto, Yuichiro; Sakurai, Ryota; Ohta, Miho; Imahase, Hisashi; Yahata, Mayuko; Umeka, Mitsuru; Miike, Toru; Nagashima, Futoshi; Iwamura, Takashi; Yamada, Kosuke Chris; Inoue, Satoshi			Thromboelastometric analysis of the risk factors for return of spontaneous circulation in adult patients with out-of-hospital cardiac arrest	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CARDIOPULMONARY-RESUSCITATION; PULMONARY-EMBOLISM; COAGULATION; HYPERFIBRINOLYSIS; MANAGEMENT; SURGERY; THERAPY	It is well known that coagulopathy is observed in patients with out-of-hospital cardiac arrest (OHCA). Thrombolytic therapy for those patients has been controversial until now. The purpose of this study was to identify a significant predictor for return of spontaneous circulation (ROSC) of OHCA patients in the emergency department (ED) using whole blood viscoelastic testing. Adult non-trauma OHCA patients transported to our hospital that underwent thromboelastometry (ROTEM) during cardiopulmonary resuscitation between January 2013 and December 2015 were enrolled in this study. We divided patients into two groups based on the presence or absence of ROSC, and performed statistical analysis utilizing patient characteristics, prehospital data, laboratory data, and ROTEM data. Seventy-five patients were enrolled. The ROSC group and non-ROSC group included 23 and 52 patients, respectively. The logistic regression analysis, utilizing significant parameters by univariate analysis, demonstrated that lactate level [odds ratio (OR) 0.880, 95% confidence interval (CI) 0.785-0.986, p = 0.028] and A30 of EXTEM test [OR 1.039, 95% CI 1.010-1.070, p = 0.009] were independent risk factors for ROSC. The cut-off values of lactate and A30 in EXTEM were 12.0 mmol/L and A 48.0 mm, respectively. We defined a positive prediction for ROSC if the patient presented lower lactate level (<12.0 mmol/L) and higher A30 of EXTEM (>= 48.0 mm) with high specificity (94.7%) and accuracy (75.0%). The present study showed that lactate level and ROTEM parameter of clot firmness were reliable predictors of ROSC in the ED for adult patients with OHCA.	[Koami, Hiroyuki; Sakamoto, Yuichiro; Iwamura, Takashi] Saga Univ, Dept Emergency & Crit Care Med, Fac Med, Saga, Japan; [Sakurai, Ryota; Ohta, Miho; Imahase, Hisashi; Yahata, Mayuko; Umeka, Mitsuru; Miike, Toru; Nagashima, Futoshi; Yamada, Kosuke Chris] Saga Univ Hosp, Adv Emergency Care Ctr, Saga, Japan; [Inoue, Satoshi] Saga Univ, Div Trauma Surg & Surg Crit Care, Fac Med, Saga, Japan	Saga University; Saga University; Saga University	Koami, H (corresponding author), Saga Univ, Dept Emergency & Crit Care Med, Fac Med, Saga, Japan.	hkoami@cc.saga-u.ac.jp	Koami, Hiroyuki/L-7981-2018	Koami, Hiroyuki/0000-0001-6268-4602				Abu-Laban RB, 2002, NEW ENGL J MED, V346, P1522, DOI 10.1056/NEJMoa012885; Ahn Y, 2016, CRITICAL CARE HDB MA, P322; Alamo JM, 2013, TRANSPL P, V45, P3637, DOI 10.1016/j.transproceed.2013.11.008; Bottiger BW, 2008, NEW ENGL J MED, V359, P2651, DOI 10.1056/NEJMoa070570; BOTTIGER BW, 1995, CIRCULATION, V92, P2572, DOI 10.1161/01.CIR.92.9.2572; Bozeman WP, 2006, RESUSCITATION, V69, P399, DOI 10.1016/j.resuscitation.2005.09.027; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Engberink RHGO, 2014, J CARDIOTHOR VASC AN, V28, P210, DOI 10.1053/j.jvca.2013.12.004; Gando S, 1999, THROMB RES, V96, P107, DOI 10.1016/S0049-3848(99)00073-0; Janata K, 2003, RESUSCITATION, V57, P49, DOI 10.1016/S0300-9572(02)00430-6; Keuper W, 2007, RESUSCITATION, V73, P189, DOI 10.1016/j.resuscitation.2006.08.030; Koami H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004514; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; Lederer W, 2001, RESUSCITATION, V50, P71, DOI 10.1016/S0300-9572(01)00317-3; Li X, 2006, RESUSCITATION, V70, P31, DOI 10.1016/j.resuscitation.2005.11.016; Nakayama Y, 2015, BRIT J ANAESTH, V114, P91, DOI 10.1093/bja/aeu339; Schochl H, 2013, RESUSCITATION, V84, P454, DOI 10.1016/j.resuscitation.2012.08.318; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; Viersen VA, 2012, RESUSCITATION, V83, P1451, DOI 10.1016/j.resuscitation.2012.05.008	20	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175257	10.1371/journal.pone.0175257	http://dx.doi.org/10.1371/journal.pone.0175257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380019	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500112
J	Mondal, A; Venkataramaiah, M; Rajamohan, G; Srinivasan, VB				Mondal, Amitabha; Venkataramaiah, Manjunath; Rajamohan, Govindan; Srinivasan, Vijaya Bharathi			Occurrence of Diverse Antimicrobial Resistance Determinants in Genetically Unrelated Biocide Tolerant Klebsiella pneumoniae (vol 11, e0166730, 2016)	PLOS ONE			English	Correction																		Mondal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166730	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175487	10.1371/journal.pone.0175487	http://dx.doi.org/10.1371/journal.pone.0175487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380066	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500117
J	Takashio, S; Nagai, T; Sugano, Y; Honda, S; Okada, A; Asaumi, Y; Aiba, T; Noguchi, T; Kusano, KF; Ogawa, H; Yasuda, S; Anzai, T				Takashio, Seiji; Nagai, Toshiyuki; Sugano, Yasuo; Honda, Satoshi; Okada, Atsushi; Asaumi, Yasuhide; Aiba, Takeshi; Noguchi, Teruo; Kusano, Kengo F.; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa		NaDEF Investigators	Persistent increase in cardiac troponin Tat hospital discharge predicts repeat hospitalization in patients with acute decompensated heart failure	PLOS ONE			English	Article							NATIONAL REGISTRY; OUTCOMES; INSIGHTS; RELEASE	Background High-sensitive cardiac troponin T (hsTnT) is a sensitive biomarker of myocardial damage and predictor of acute decompensated heart failure (ADHF). However, there is little information on changes over time in hsTnT level during ADHF management. The aim of this prospective study was to evaluate changes in hsTnT levels between admission and at discharge in patients with ADHF, and identify factors that determine such levels and their prognostic significance. Methods and results We evaluated 404 ADHF patients with abnormal hsTnT levels (>0.0135 ng/ml) on admission. The median (interquartile ranges) hsTnT levels on admission, at discharge, and percent changes in hsTnT levels were 0.038 (0.026 to 0.065), 0.032 (0.021 to 0.049) ng/ml, and -12.0 (-39.8 to 7.4) % respectively. The numbers of patients with falling (hsTnT decrease > -15%), stable (hsTnT change between-15 and +15%) and rising (hsTnT increase > +15%) hsTnT level at discharge were 190, 146, and 68, respectively. The percent change in B-type natriuretic peptide (BNP) levels was greater in the falling group, compared to the stable (p<0.001) and rising groups (p<0.001). Changes in hsTnT levels correlated significantly with changes in BNP levels (p = 0.22, p<0.001). Multivariate Cox regression analysis identified rising or stable hsTnT at discharge as a significant predictor of heart failure-related rehospitalization (hazard ratio: 1.69; 95% confidence interval: 1.06 to 2.70; p = 0.03). Conclusions Persistent increase in hsTnT levels at discharge correlated with inadequate decrease of BNP levels, and was a predictor of poor clinical outcome, with repeat heart failure hospitalizations.	[Takashio, Seiji; Nagai, Toshiyuki; Sugano, Yasuo; Honda, Satoshi; Okada, Atsushi; Asaumi, Yasuhide; Aiba, Takeshi; Noguchi, Teruo; Kusano, Kengo F.; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa; NaDEF Investigators] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan	Anzai, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan.	anzai@ncvc.go.jp	Honda, Satoshi/GXG-5198-2022	Asaumi, Yasuhide/0000-0002-9009-7234; Honda, Satoshi/0000-0002-1393-4270	Japan Cardiovascular Research Foundation (Toshihisa Anzai) [24-4-2]; Japan Society for the Promotion of Science (Seiji Takashio) [26860574]; Japan Agency for Medical Research and Development (Toshiyuki Nagai) [201439103A]; Japan Society for the Promotion of Science (Toshiyuki Nagai) [15K19402]	Japan Cardiovascular Research Foundation (Toshihisa Anzai); Japan Society for the Promotion of Science (Seiji Takashio)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (Toshiyuki Nagai)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (Toshiyuki Nagai)	This work was supported by Grants-in-Aid for Young Scientists B from Japan Society for the Promotion of Science (Seiji Takashio, 26860574), Grant from the Japan Cardiovascular Research Foundation (Toshihisa Anzai, 24-4-2), Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (Toshiyuki Nagai, 15K19402), and a Grant from the Japan Agency for Medical Research and Development (Toshiyuki Nagai, 201439103A).	Braga JR, 2013, CIRC-HEART FAIL, V6, P193, DOI 10.1161/CIRCHEARTFAILURE.112.000075; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Felker GM, 2015, EUR J HEART FAIL, V17, P1262, DOI 10.1002/ejhf.341; Felker GM, 2012, EUR J HEART FAIL, V14, P1257, DOI 10.1093/eurjhf/hfs110; Feng J, 2001, CIRCULATION, V103, P2035; Gheorghiade M, 2005, AM J CARDIOL, V96, p11G, DOI 10.1016/j.amjcard.2005.07.016; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Espartero MEG, 2014, EUR J INTERN MED, V25, P739, DOI 10.1016/j.ejim.2014.08.005; Hessel MHM, 2008, PFLUG ARCH EUR J PHY, V455, P979, DOI 10.1007/s00424-007-0354-8; Kociol RD, 2010, J AM COLL CARDIOL, V56, P1071, DOI 10.1016/j.jacc.2010.06.016; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Metra M, 2013, J AM COLL CARDIOL, V61, P196, DOI 10.1016/j.jacc.2012.11.005; Nieminen MS, 2008, EUR J HEART FAIL, V10, P140, DOI 10.1016/j.ejheart.2007.12.012; O'Connor CM, 2011, CIRC-HEART FAIL, V4, P724, DOI 10.1161/CIRCHEARTFAILURE.111.961581; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Sherwood MW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000403; Takashio S, 2013, J AM COLL CARDIOL, V62, P632, DOI 10.1016/j.jacc.2013.03.065; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; Xue Y, 2011, EUR J HEART FAIL, V13, P37, DOI 10.1093/eurjhf/hfq210; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173336	10.1371/journal.pone.0173336	http://dx.doi.org/10.1371/journal.pone.0173336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379962	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500016
J	Waugh, K; Snell-Bergeon, J; Michels, A; Dong, F; Steck, AK; Frohnert, BI; Norris, JM; Rewers, M				Waugh, Kathleen; Snell-Bergeon, Janet; Michels, Aaron; Dong, Fran; Steck, Andrea K.; Frohnert, Brigitte I.; Norris, Jill M.; Rewers, Marian			Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)	PLOS ONE			English	Article							T-CELL RESPONSES; HIGH-RISK; AUTOANTIBODIES; CYTOKINES; CHILDREN; INSULIN; ASSAY; PROGRESSION; APPEARANCE; CHEMOKINES	Background Type 1 diabetes (TID) is characterized by a loss of pancreatic islet beta cell function resulting in loss of insulin production. Genetic and environmental factors may trigger immune responses targeting beta cells thus generating islet antibodies (IA). Immune response pathways involve a cascade of events, initiated by cytokines and chemokines, producing inflammation which can result in tissue damage. Methods A nested case-control study was performed to identify temporal changes in cytokine levels in 75 DAISY subjects: 25 diagnosed T1D, 25 persistent IA, and 25 controls. Serum samples were selected at four time points: (T1) earliest, (T2) just prior to IA, (T3) just after IA, and (T4) prior to T1D diagnosis or most recent. Cytokines (IFN-alpha 2a, IL-6, IL-17, IL-1 beta, IP-10, MCP-1, IFN-gamma, IL-1 alpha, and IL-1ra) were measured using the Meso Scale Discovery system Human Custom Cytokine 9-Plex assay. Results Multivariate mixed models adjusting for HLA risk, first-degree relative status, age, and gender, showed MCP-1 and IFN-gamma to be significantly higher at T3 in T1D compared to IA subjects. At T4, IP-10 was significantly higher in IA subjects than controls. Conclusions This repeated measures nested case-control study identified increased inflammatory markers in IA children who developed T1D compared to IA children who had not progressed to clinical disease. It also showed increased inflammation in both T1D and IA children when compared to controls. Results suggest inflammation may be related to both the development of IA and progression to T1D.	[Waugh, Kathleen; Snell-Bergeon, Janet; Michels, Aaron; Dong, Fran; Steck, Andrea K.; Frohnert, Brigitte I.; Rewers, Marian] Univ Colorado Denver, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA; [Norris, Jill M.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Waugh, K (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA.	kathleen.waugh@ucdenver.edu		Snell-Bergeon, Janet/0000-0002-9337-3740	National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK032493-32]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032083, K12DK094712, K08DK095995, R01DK032493] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx), grant 5R01DK032493-32 to MR. The funder supports the overall cohort study design, The Natural History of Pre-diabetic Autoimm unity (DAISY), including participant biological sample and data collection as well as analysis. The Principal Investigator makes decisions for nested case-control experiments, analysis, and publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx), grant 5R01DK032493-32 to MR.	Alkanani AK, 2012, DIABETES, V61, P2525, DOI 10.2337/db12-0099; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bonifacio E, 2005, CLIN IMMUNOL, V115, P173, DOI 10.1016/j.clim.2005.01.004; Cabrera SM, 2016, TRANSL RES, V167, P214, DOI 10.1016/j.trsl.2015.04.011; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Cieslak M, 2015, ACTA BIOCHIM POL, V62, P15; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; GIANANI R, 1995, DIABETES, V44, P1340, DOI 10.2337/diabetes.44.11.1340; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/BF00408469; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Hawa MI, 2009, DIABETES CARE, V32, P160, DOI 10.2337/dc08-1419; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Kawasaki E, 2004, DIABETES RES CLIN PR, V66, pS27, DOI 10.1016/j.diabres.2003.09.015; Lee JM, 2015, J PEDIATR-US, V167, P449, DOI 10.1016/j.jpeds.2015.04.067; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Nakayama M, 2015, P NATL ACAD SCI USA, V112, P4429, DOI 10.1073/pnas.1502967112; Nicoletti F, 2002, DIABETOLOGIA, V45, P1107, DOI 10.1007/s00125-002-0879-5; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Rewers M, 1996, J AUTOIMMUN, V9, P405, DOI 10.1006/jaut.1996.0055; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Ryden A, 2009, DIABETES-METAB RES, V25, P335, DOI 10.1002/dmrr.958; Shrestha SS, 2011, DIABETES CARE, V34, P1097, DOI 10.2337/dc10-2177; Stechova K, 2007, DIABETES-METAB RES, V23, P462, DOI 10.1002/dmrr.718; Steck AK, 2016, J AUTOIMMUN, V72, P113, DOI 10.1016/j.jaut.2016.05.010; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; Wang C, 2010, IEEE INFOCOM SER, DOI 10.1109/PEDG.2010.5545769; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081	31	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174840	10.1371/journal.pone.0174840	http://dx.doi.org/10.1371/journal.pone.0174840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380011	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500067
J	Wei, LH; Yan, S; Teo, YY; Huang, YZ; Wang, LX; Yu, G; Sawa, WY; Ong, RTH; Lu, Y; Zhang, C; Xu, SH; Jin, L; Li, H				Wei, Lan-Hai; Yan, Shi; Teo, Yik-Ying; Huang, Yun-Zhi; Wang, Ling -Xiang; Yu, Ge; Sawa, Woei-Yuh; Ong, Rick Twee-Hee; Lu, Yan; Zhang, Chao; Xu, Shu-Hua; Jin, Li; Li, Hui			Phylogeography of Y-chromosome haplogroup O3a2b2-N6 reveals patrilineal traces of Austronesian populations on the eastern coastal regions of Asia	PLOS ONE			English	Article							READ ALIGNMENT; DIVERSITY; ISLAND; ACCURATE; ORIGINS; HISTORY; MTDNA; EXPANSION; ADMIXTURE; SEQUENCE	Austronesian diffusion is considered one of the greatest dispersals in human history; it led to the peopling of an extremely vast region, ranging from Madagascar in the Indian Ocean to Easter Island in Remote Oceania. The Upsilon-chromosome haplogroup O3a2b*-P164(xM134), a predominant paternal lineage of Austronesian populations, is found at high frequencies in Polynesian populations. However, the internal phylogeny of this haplogroup remains poorly investigated. In this study, we analyzed-seventeen Y-chromosome sequences of haplogroup O3a2b*-P164(xM134) and generated a revised phylogenetic tree of this lineage based on 310 non-private Y-chromosome polymorphisms. We discovered that all available O3a2b*-P164(xM134) samples belong to the newly defined haplogroup O3a2b2-N6 and samples from Austronesian populations belong to the sublineage O3a2b2a2-F706. Additionally, we genotyped a series of Y-chromosome polymorphisms in a large collection of samples from China. We confirmed that the sublineage O3a2b2a2b-B451 is unique to Austronesian populations. We found that O3a2b2-N6 samples are widely distributed on the eastern coastal regions of Asia, from Korea to Vietnam. Furthermore, we propose- that the O3a2b2a2b-B451 lineage represents a genetic connection between ancestors of Austronesian populations and ancient populations in North China, where foxtail millet was domesticated about 11,000 years ago. The large number of newly defined Y-chromosome polymorphisms and the revised phylogenetic tree of O3a2b2-N6 will be helpful to explore the origin of proto-Austronesians and the early diffusion process of Austronesian populations.	[Wei, Lan-Hai; Yan, Shi; Huang, Yun-Zhi; Wang, Ling -Xiang; Yu, Ge; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China; [Wei, Lan-Hai] Inst Natl Langues & Civilisat Orientales, Paris, France; [Teo, Yik-Ying; Sawa, Woei-Yuh; Ong, Rick Twee-Hee] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Lu, Yan; Zhang, Chao; Xu, Shu-Hua] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG Partner, Shanghai, Peoples R China; [Zhang, Chao; Xu, Shu-Hua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Shu-Hua] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Xu, Shu-Hua; Jin, Li] Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China	Fudan University; National University of Singapore; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Li, H (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China.	LHCA@Fudan.edu.cn	Zhang, Chao/HHN-2713-2022; Wei, Lan-Hai/R-6876-2018; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Yan, Shi/GYR-3441-2022; Xu, Shuhua/AAH-7620-2020	Zhang, Chao/0000-0002-0687-9058; Wei, Lan-Hai/0000-0003-3119-7400; Jin, Li/0000-0002-4546-2415; Yan, Shi/0000-0001-8304-8445; Xu, Shuhua/0000-0002-1975-1002	National Natural Science Foundation of China [31222030, 31671297, 31401060, 31271338, 31501011, 91331204]; MOE Scientific Research Project [113022A]; Shanghai Shuguang Project [14SG05]; Ministry of Science and Technology of China (MOST) [2016YFC0900300]; Science and Technology Commission of Shanghai Municipality (STCSM) [14YF1406800]; Future Scientists Project of China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Scientific Research Project; Shanghai Shuguang Project; Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); Future Scientists Project of China Scholarship Council	This study was supported by the National Natural Science Foundation of China (31222030 and 31671297 to HL, 31401060 to YS, 31271338 to LJ, 31501011 to YL, 91331204 to SHX), MOE Scientific Research Project (113022A to HL), Shanghai Shuguang Project (14SG05 to HL), Ministry of Science and Technology of China (MOST) (2016YFC0900300 to HL) and Science and Technology Commission of Shanghai Municipality (STCSM) (14YF1406800 to YL). LHW was supported by Future Scientists Project of China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellwood P, 2006, BLACKW STUD GLOB ARC, P96, DOI 10.1002/9780470774670.ch6; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bellwood Peter, 2001, AUSTRONESIAN TAIWAN, P337; BLUST R, 1976, WORLD ARCHAEOL, V8, P19, DOI 10.1080/00438243.1976.9979650; Brandao A, 2016, HUM GENET, V135, P363, DOI 10.1007/s00439-016-1640-3; Cauquelin J., 2004, ABORIGINES TAIWAN PU; Chang K-C, 1995, AUSTRONESIAN STUDIES, P161; Chang KC, 1996, T AM PHILOS SOC, V86, P36, DOI 10.2307/1006620; Delfin F, 2012, MOL BIOL EVOL, V29, P545, DOI 10.1093/molbev/msr186; Ellis N, 2002, GENOME RES, V12, P339; Fogg Wayne, 1983, ORIGINS CHINESE CIVI; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Greenhill SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009573; Guedes JD, 2013, ANTIQUITY, V87, P758, DOI 10.1017/S0003598X00049449; Ilumae AM, 2016, AM J HUM GENET, V99, P163, DOI 10.1016/j.ajhg.2016.05.025; Jiao T., 2007, NEOLITHIC SE CHINA C; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Li K.-T., 2013, COMPANION CHINESE AR, P612; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Loo JH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-21; Lu DS, 2016, AM J HUM GENET, V99, P580, DOI 10.1016/j.ajhg.2016.07.002; Mirabal S, 2012, GENE, V492, P339, DOI 10.1016/j.gene.2011.10.042; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Ross Malcolm, 2005, J AUSTRONESIAN STUDI, V1, P1; Sagart L, 2008, ROUTLEDGE STUD EARLY, V5, P133; Scheinfeldt L, 2006, MOL BIOL EVOL, V23, P1628, DOI 10.1093/molbev/msl028; Scholes C, 2011, AM J PHYS ANTHROPOL, V146, P62, DOI 10.1002/ajpa.21544; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Soares PA, 2016, HUM GENET, V135, P309, DOI 10.1007/s00439-015-1620-z; Stanley DJ, 1996, GEOLOGY, V24, P1083, DOI 10.1130/0091-7613(1996)024<1083:NSDAAF>2.3.CO;2; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Terrell JE, 1997, CURR ANTHROPOL, V38, P155, DOI 10.1086/204604; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Trejaut JA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-77; Weber S, 2010, ARCHAEOL ANTHROP SCI, V2, P79, DOI 10.1007/s12520-010-0030-3; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Xu SH, 2012, P NATL ACAD SCI USA, V109, P4574, DOI 10.1073/pnas.1118892109; Yan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105691; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; [朱诚 Zhu Cheng], 2016, [科学通报, Chinese Science Bulletin], V61, P374; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	52	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175080	10.1371/journal.pone.0175080	http://dx.doi.org/10.1371/journal.pone.0175080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ES2JD	28380021	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500094
J	Au, NT; Reyes, M; Boyer, BB; Hopkins, SE; Black, J; O'Brien, D; Fohner, AE; Yracheta, J; Thornton, T; Austin, MA; Burke, W; Thummel, KE; Rettiel, AE				Au, Nicholas T.; Reyes, Morayma; Boyer, Bert B.; Hopkins, Scarlett E.; Black, Jynene; O'Brien, Diane; Fohner, Alison E.; Yracheta, Joe; Thornton, Timothy; Austin, Melissa A.; Burke, Wylie; Thummel, Kenneth E.; Rettiel, Allan E.			Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; VITAMIN-K; FISH-OIL; MYOCARDIAL-INFARCTION; CHRONIC DISEASE; HEART-DISEASE; RISK; PLASMA; HEALTH; CYP4F2	Fish and marine animals are important components of the subsistence diet of Alaska Native people, resulting in a high omega 3 PUFA intake. The historical record for circumpolar populations highlights a tendency for facile bleeding, possibly related to omega 3 PUFA effects on platelet activation and/or vitamin K-dependent clotting factors. To evaluate these two scenarios in Yup'ik people of southwestern Alaska, we examined the association between dietary omega 3 PUFA intake and activities of clotting factor II, V, fibrinogen, PT, INR, PTT, and sP-selectin in 733 study participants, using the nitrogen isotope ratio of red blood cells as a biomarker of omega 3 PUFA consumption. sP-selectin alone correlated strongly and inversely with omega 3 PUFA consumption. Approximately 36% of study participants exhibited PIVKA-II values above the threshold of 2 ng/ml, indicative of low vitamin K status. To assess genetic influences on vitamin K status, study participants were genotyped for common vitamin K cycle polymorphisms in VKORC1, GGCX and CYP4F2. Only CYP4F2*3 associated significantly with vitamin K status, for both acute (plasma vitamin K) and long-term (PIVKA-II) measures. These findings suggest: (i) a primary association of omega 3 PUFAs on platelet activation, as opposed to vitamin K-dependent clotting factor activity, (ii) that reduced CYP4F2 enzyme activity associates with vitamin K status. We conclude that high omega 3 PUFA intake promotes an anti-platelet effect and speculate that the high frequency of the CYP4F2*3 allele in Yup'ik people (similar to 45%) evolved in response to a need to conserve body stores of vitamin K due to environmental limitations on its availability.	[Au, Nicholas T.; Rettiel, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Reyes, Morayma] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Boyer, Bert B.; Hopkins, Scarlett E.; Black, Jynene; O'Brien, Diane] Univ Alaska Fairbanks, Ctr Alaska Native Hlth Res, Fairbanks, AK 99775 USA; [Fohner, Alison E.] Univ Washington, Publ Hlth Genet, Seattle, WA 98195 USA; [Yracheta, Joe; Rettiel, Allan E.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Thornton, Timothy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Austin, Melissa A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Burke, Wylie] Univ Washington, Dept Med Eth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alaska System; University of Alaska Fairbanks; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rettiel, AE (corresponding author), Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.	bboyer@alaska.edu; rettie@um.edu	O'Brien, Diane/B-2919-2010	O'Brien, Diane/0000-0001-5807-9661	National Institutes of Health [U01GM092676, R01GM109743, TL1 RR025016, P30 ES007033, P30 GM103325, R01DK074842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was conducted with funding from the following National Institutes of Health (https://grants.nih.gov/funding/index.htm) grants: U01GM092676, R01GM109743, TL1 RR025016, P30 ES007033, P30 GM103325, R01DK074842.	Andriamampandry M, 1998, CR ACAD SCI III-VIE, V321, P415, DOI 10.1016/S0764-4469(98)80306-5; Athinarayanan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095366; Au N-T., 2014, GEN ENV FACT AFF HEM; Baye TM, 2011, PERS MED, V8, P59, DOI 10.2217/PME.10.75; Bevans CG, 2013, BBA-GEN SUBJECTS, V1830, P4202, DOI 10.1016/j.bbagen.2013.04.018; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Colussi Gianluca, 2007, Recent Pat Cardiovasc Drug Discov, V2, P13, DOI 10.2174/157489007779606158; Dashti HS, 2014, AM J CLIN NUTR, V100, P1462, DOI 10.3945/ajcn.114.093146; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; Edson KZ, 2013, BIOCHEMISTRY-US, V52, P8276, DOI 10.1021/bi401208m; Eschen O, 2004, NUTR METAB CARDIOVAS, V14, P180, DOI 10.1016/S0939-4753(04)80002-4; Fohner AE, 2015, PHARMACOGENET GENOM, V25, P343, DOI 10.1097/FPC.0000000000000143; Fu XY, 2009, ANAL CHEM, V81, P5421, DOI 10.1021/ac900732w; Greer FR, 1998, ARCH DIS CHILD, V79, P300, DOI 10.1136/adc.79.4.300; Hirai K, 2015, THROMB RES, V135, P861, DOI 10.1016/j.thromres.2015.02.019; JONES DY, 1991, AM J CLIN NUTR, V53, P943, DOI 10.1093/ajcn/53.4.943; Kishi K, 1992, Radiat Med, V10, P189; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Makhoul Z, 2011, EUR J CLIN NUTR, V65, P808, DOI 10.1038/ejcn.2011.39; Marckmann P, 1997, ARTERIOSCL THROM VAS, V17, P3384, DOI 10.1161/01.ATV.17.12.3384; Moertl D, 2011, THROMB HAEMOSTASIS, V106, P457, DOI [10.1160/TH-11-03-0169, 10.1160/TH11-03-0169]; Mohammadi E, 2012, EFFECTS OMEGA 3 FATT; Mohatt GV, 2007, INT J CIRCUMPOL HEAL, V66, P8, DOI 10.3402/ijch.v66i1.18219; Nash SH, 2012, J NUTR, V142, P84, DOI 10.3945/jn.111.147595; Nieuwenhuys CMA, 2001, THROMB RES, V104, P137, DOI 10.1016/S0049-3848(01)00347-4; O'Brien DM, 2009, AM J CLIN NUTR, V89, P913, DOI 10.3945/ajcn.2008.27054; OOSTHUIZEN W, 1994, THROMB HAEMOSTASIS, V72, P557; Paroni R, 2009, J CHROMATOGR B, V877, P351, DOI 10.1016/j.jchromb.2008.12.044; SHAHAR E, 1993, ARTERIOSCLER THROMB, V13, P1205, DOI 10.1161/01.ATV.13.8.1205; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Sommer P, 1966, Vitam Horm, V24, P349; SUTTIE JW, 1988, AM J CLIN NUTR, V47, P475, DOI 10.1093/ajcn/47.3.475; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vecka M, 2012, NEUROENDOCRINOL LETT, V33, P87; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0173616	10.1371/journal.pone.0173616	http://dx.doi.org/10.1371/journal.pone.0173616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376131	Green Submitted, Green Published, gold			2022-12-27	WOS:000399352000001
J	Bogard, JR; Farook, S; Marks, GC; Waid, J; Belton, B; Ali, M; Toufique, K; Mamun, A; Thilsted, SH				Bogard, Jessica R.; Farook, Sami; Marks, Geoffrey C.; Waid, Jillian; Belton, Ben; Ali, Masum; Toufique, Kazi; Mamun, Abdulla; Thilsted, Shakuntala H.			Higher fish but lower micronutrient intakes: Temporal changes in fish consumption from capture fisheries and aquaculture in Bangladesh	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; INCOME COUNTRIES; YOUNG-CHILDREN; HEALTH; INFANTS; FOOD	Malnutrition is one of the biggest challenges of the 21 st century, with one in three people in the world malnourished, combined with poor diets being the leading cause of the global burden of disease. Fish is an under-recognised and undervalued source of micronutrients, which could play a more significant role in addressing this global challenge. With rising pressures on capture fisheries, demand is increasingly being met from aquaculture. However, aquaculture systems are designed to maximise productivity, with little consideration for nutritional quality of fish produced. A global shift away from diverse capture species towards consumption of few farmed species, has implications for diet quality that are yet to be fully explored. Bangladesh provides a useful case study of this transition, as fish is the most important animal-source food in diets, and is increasingly supplied from aquaculture. We conducted a temporal analysis of fish consumption and nutrient intakes from fish in Bangladesh, using nationally representative household expenditure surveys from 1991, 2000 and 2010 (n = 25,425 households), combined with detailed species-level nutrient composition data. Fish consumption increased by 30% from 1991-2010. Consumption of non-farmed species declined by 33% over this period, compensated (in terms of quantity) by large increases in consumption of farmed species. Despite increased total fish consumption, there were significant decreases in iron and calcium intakes from fish (P<0.01); and no significant change in intakes of zinc, vitamin A and vitamin B12 from fish, reflecting lower overall nutritional quality of fish available for consumption over time. Our results challenge the conventional narrative that increases in food supply lead to improvements in diet and nutrition. As aquaculture becomes an increasingly important food source, it must embrace a nutrition-sensitive approach, moving beyond maximising productivity to also consider nutritional quality. Doing so will optimise the complementary role that aquaculture and capture fisheries play in improving nutrition and health.	[Bogard, Jessica R.; Marks, Geoffrey C.; Mamun, Abdulla] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Bogard, Jessica R.] CSIRO, Agr Flagship, St Lucia, Qld, Australia; [Farook, Sami; Toufique, Kazi] Bangladesh Inst Dev Studies, Dhaka, Bangladesh; [Waid, Jillian; Ali, Masum] Helen Keller Int, House 10E, Dhaka, Bangladesh; [Waid, Jillian] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Belton, Ben] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA; [Thilsted, Shakuntala H.] WorldFish, Bayan Lepas, Penang, Malaysia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Bangladesh Institute of Development Studies (BIDS); Ruprecht Karls University Heidelberg; Michigan State University; CGIAR; Worldfish	Bogard, JR (corresponding author), Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia.; Bogard, JR (corresponding author), CSIRO, Agr Flagship, St Lucia, Qld, Australia.	jessica.bogard@live.com	Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022; Abed, Farook Nehad/AAV-4188-2020; Bogard, Jessica R/A-7161-2018; Marks, Geoffrey C/E-7368-2010	Mamun, Abdullah A/0000-0002-1535-8086; Abed, Farook Nehad/0000-0003-0338-0283; Bogard, Jessica R/0000-0001-5503-5284; Marks, Geoffrey C/0000-0002-9497-680X; Thilsted, Shakuntala/0000-0002-4041-1651	Australian Government Research Training Programme Scholarship; Federal Ministry for Economic Cooperation and Development,Germany,through the project "Aquaculture and the poor:improving fish production,consumption and nutrition linkages"; U.S. Agency for International Development (USAID) Feed the Future initiative, through the project "Aquaculture for Income and Nutrition" (AIN), implemented -World Fish, in Bangladesh	Australian Government Research Training Programme Scholarship(Australian Government); Federal Ministry for Economic Cooperation and Development,Germany,through the project "Aquaculture and the poor:improving fish production,consumption and nutrition linkages"; U.S. Agency for International Development (USAID) Feed the Future initiative, through the project "Aquaculture for Income and Nutrition" (AIN), implemented -World Fish, in Bangladesh(United States Agency for International Development (USAID))	JRB was financially supported by an Australian Government Research Training Programme Scholarship. Part of the work was under taken with the financial support of the Federal Ministry for Economic Cooperation and Development,Germany,through the project "Aquaculture and the poor:improving fish production,consumption and nutrition linkages" as well as of the U.S. Agency for International Development (USAID) Feed the Future initiative, through the project "Aquaculture for Income and Nutrition" (AIN), implemented by World Fish,in Bangladesh. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript. The contents and opinions expressed here in are those of the authors and do not necessarily reflect the views of USAID or the United States Government. This work is acontribution to the CGIAR Research Program (CRP)on Fish Agri-Food Systems (FISH).	Allison E., 2011, WORKING PAPER; Bangladesh Bureau of Statistics (BBS), 2010, BANGL HOUS INC EXP S; BBS, 2000, BANGL HOUS INC EXP S; BBS, 1995, REP HOUS EXP 1991 92; BBS, 2003, REP HOUS INC EXP SUR; BBS, 2011, REP BANGL HOUS INC E; BBS, 1992, BANGL HOUS EXP SURV; Belton B, 2014, FOOD POLICY, V44, P77, DOI 10.1016/j.foodpol.2013.11.003; Belton B, 2012, ASIA PAC VIEWP, V53, P133, DOI 10.1111/j.1467-8373.2012.01487.x; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bogard JR, 2015, J FOOD COMPOS ANAL, V42, P120, DOI 10.1016/j.jfca.2015.03.002; Bogard JR, 2016, PUBLIC HEALTH NUTR, P1; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; FAO (Food and Agriculture Organization), 2016, STAT WORLD FISH AQ 2, DOI 10.18356/8e4e0ebf-en; FAO World Health Organization, 2004, VIT MIN REQ HUM NUTR, V2nd ed; Food and Agriculture Organization, 2016, FOOD BALANCE SHEETS; FRSS, 1994, FISH STAT YB BANGL 1; FRSS, 2015, FISH STAT YB BANGL 2; FRSS, 2012, FISH STAT YB BANGL 2; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Hansen M, 1998, J TRACE ELEM MED BIO, V12, P148, DOI 10.1016/S0946-672X(98)80003-5; HLPE, 2020, FOOD SEC NUTR BUILD; Howlader SR, 2012, INVESTING NUTR NOW S; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; INFS, 2013, FOOD COMPOSITION TAB; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP PROM I; Jhingran V., 1985, HATCHERY MANUAL COMM; [JPGSPH HKI], 2011, STAT FOOD SEC NUTR B; Kawarazuka N, 2011, PUBLIC HEALTH NUTR, V14, P1927, DOI 10.1017/S1368980011000814; Kobayashi M, 2015, AQUACULT ECON MANAG, V19, P282, DOI 10.1080/13657305.2015.994240; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Larsen T, 2000, BRIT J NUTR, V83, P191, DOI 10.1017/S0007114500000246; Michaelsen KF, 2011, MATERN CHILD NUTR, V7, P124, DOI 10.1111/j.1740-8709.2011.00302.x; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Nestel P, 2015, HEART LUNG CIRC, V24, P769, DOI 10.1016/j.hlc.2015.03.020; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Sales J, 2011, AQUACULT NUTR, V17, pE271, DOI 10.1111/j.1365-2095.2010.00761.x; Scheers N, 2014, EUR J NUTR, V53, P1327, DOI 10.1007/s00394-013-0632-5; Thilsted SH, 2014, POND POLYCULTURE TEC; UNICEF GAIN Institute of Public Health and Nutrition, 2013, NATL MICRONUTRIENTS; Usher Sarah, 2015, Metab Eng Commun, V2, P93, DOI 10.1016/j.meteno.2015.04.002; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; Wheal MS, 2016, FOOD CHEM, V201, P222, DOI 10.1016/j.foodchem.2016.01.080	45	55	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175098	10.1371/journal.pone.0175098	http://dx.doi.org/10.1371/journal.pone.0175098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384232	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900085
J	Cacciani, L; Agabiti, N; Bargagli, AM; Davoli, M				Cacciani, Laura; Agabiti, Nera; Bargagli, Anna Maria; Davoli, Marina			Access to percutaneous transluminal coronary angioplasty and 30-day mortality in patients with incident STEMI: Differentials by educational level and gender over 11 years	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; HEART-DISEASE MORTALITY; SOCIOECONOMIC POSITION; REVASCULARIZATION PROCEDURES; POPULATION TRENDS; TEMPORAL TRENDS; SEX-DIFFERENCES; ASSOCIATION; OUTCOMES	Background Socioeconomic status and gender are associated with access to cardiac procedures and mortality after AMI, also in countries with universal health care systems. Our objective was to evaluate the association and trends of educational level or gender and the following outcomes: 1) access to PTCA; 2) 30-day mortality. Methods We conducted an observational study based on 14,013 subjects aged 35-74 years, residing in Rome in 2001, and hospitalised for incident STEMI within 2012 in the Lazio region. We estimated adjusted ORs of educational level or gender and: 1) PTCA within 2 days after hospitalisation, 2) 30-day mortality. We evaluated time trends of outcomes, and time trends of educational or gender differentials estimating ORs stratified by time period (two time periods between 2001 and 2012). We performed a hierarchical analysis to account for clustering of hospitals. Results Access to PTCA among patients with incident STEMI increased during the study period, while 30-day mortality was stable. We observed educational differentials in PTCA procedure only in the first time period, and gender differentials in both periods. Patterns for 30-day mortality were less marked, with educational differentials emerging only in the second period, and gender differentials only in the first one, with patients with low educational level and females being disadvantaged. Conclusions Educational differentials in the access to PTCA disappeared in Lazio region over time, coherently with scientific literature, while gender differentials seem to persist. It may be important to assess the role of female gender in patients with STEMI, both from a social and a clinical point of view.	[Cacciani, Laura; Agabiti, Nera; Bargagli, Anna Maria; Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy		Bargagli, AM (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	a.bargagli@deplazio.it	Cacciani, Laura/Y-1409-2019	Cacciani, Laura/0000-0002-5800-3285				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Agabiti Nera, 2011, Epidemiol Prev, V35, P1; Barchielli A, 2015, EPIDEMIOL PREV, V39, P167; Barnhart JA, 2006, J HEALTH CARE POOR U, V17, P559, DOI 10.1353/hpu.2006.0097; Blais C, 2012, CAN J CARDIOL, V28, P169, DOI 10.1016/j.cjca.2011.10.009; Cesaroni G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-41; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Cowburn G, 2009, CARDIOVASCULAR DIS P; Di Domenicantonio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158336; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Eitel I, 2012, CIRC-CARDIOVASC IMAG, V5, P119, DOI 10.1161/CIRCIMAGING.111.965467; Falcone M, 2013, EPIDEMIOL PREV, V37, P386; Fang J, 2006, AM J CARDIOL, V97, P1722, DOI 10.1016/j.amjcard.2006.01.032; Gnavi R, 2014, INT J CARDIOL, V176, P724, DOI 10.1016/j.ijcard.2014.07.107; Greco C, 2015, INT J CARDIOL, V184, P115, DOI 10.1016/j.ijcard.2015.01.073; Jakobsen L, 2012, CIRC-CARDIOVASC INTE, V5, P641, DOI 10.1161/CIRCINTERVENTIONS.112.968271; Journath G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140201; Khera S, 2015, J AM COLL CARDIOL, V66, P1961, DOI 10.1016/j.jacc.2015.08.865; Koopman C, 2013, INT J CARDIOL, V168, P993, DOI 10.1016/j.ijcard.2012.10.036; Lawesson SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000726; Leurent G, 2014, ARCH CARDIOVASC DIS, V107, P291, DOI 10.1016/j.acvd.2014.04.005; Luepker RV, 2010, CIRCULATION, V121, P1280, DOI 10.1161/CIR.0b013e3181d98478; Marmot M, 2015, HLTH GAP CHALLENGE U; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; Nante N, 2009, J EPIDEMIOL COMMUN H, V63, P203, DOI 10.1136/jech.2008.077537; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Philbin EF, 2000, CIRCULATION, V102, P107; Picciotto S, 2006, J EPIDEMIOL COMMUN H, V60, P37, DOI 10.1136/jech.2005.037846; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Sarti S, 2016, SOC SCI RES, V57, P116, DOI 10.1016/j.ssresearch.2015.12.010; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sulo E, 2016, INT J CARDIOL, V212, P122, DOI 10.1016/j.ijcard.2016.03.050; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; World Health Organization, GLOB BURD DIS PROJ; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175038	10.1371/journal.pone.0175038	http://dx.doi.org/10.1371/journal.pone.0175038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384181	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900075
J	Chou, CC; Wei, SY; Lou, YC; Chen, CP				Chou, Chun-Chi; Wei, Shu-Yi; Lou, Yuan-Chao; Chen, Chinpan			In-depth study of DNA binding of Cys(2)His(2) finger domains in testis zinc-finger protein	PLOS ONE			English	Article							NONSPECIFIC DNA; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; LINKER SEQUENCES; RECOGNITION; COMPLEXES; INSIGHTS; AFFINITY; SYSTEM; TRANSITION	Previously, we identified that both fingers 1 and 2 in the three Cys(2)His(2) zinc-finger domains (TZD) of testis zinc-finger protein specifically bind to its cognate DNA; however, finger 3 is non-sequence-specific. To gain insights into the interaction mechanism, here we further investigated the DNA-binding characteristics of TZD bound to non-specific DNAs and its finger segments bound to cognate DNA. TZD in non-specific DNA binding showed smaller chemical shift perturbations, as expected. However, the direction of shift perturbation, change of DNA imino-proton NMR signal, and dynamics on the N-15 backbone atom significantly differed between specific and non-specific binding. Using these unique characteristics, we confirmed that the three single-finger segments (TZD(1), TZD(2) and TZD(3)) and the two-finger segment (TZD(23)) non-specifically bind to the cognate DNA. In comparison, the other two-finger segment (TZD(12)) binding to the cognate DNA features simultaneous nonspecific and semi-specific binding, both slowly exchanged in terms of NMR timescale. The process of TZD binding to the cognate DNA is likely stepwise: initially TZD non-specifically binds to DNA, then fingers 1 and 2 insert cooperatively into the major groove of DNA by semi-specific binding, and finally finger 3 non-specifically binds to DNA, which promotes the specific binding on fingers 1 and 2 and stabilizes the formation of a specific TZD-DNA complex.	[Chou, Chun-Chi; Wei, Shu-Yi; Lou, Yuan-Chao; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Chen, CP (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	bmchinp@ibms.sinica.edu.tw	Chen, Chinpan/O-4202-2018		Academia Sinica; Ministry of Science and Technology [104-0210-01-09-02]; Ministry of Science and Technology, Taiwan, ROC [MOST 103-2311-B-001-026-MY3, MOST 105-2320-B-001-019-MY3]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by funds from Academia Sinica and Ministry of Science and Technology [104-0210-01-09-02] and the Ministry of Science and Technology, Taiwan, ROC [MOST 103-2311-B-001-026-MY3 and MOST 105-2320-B-001-019-MY3].	Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Chou CC, 2010, PROTEINS, V78, P2202, DOI 10.1002/prot.22732; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desjardins G, 2016, BIOCHEMISTRY-US, V55, P4105, DOI 10.1021/acs.biochem.6b00460; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Furu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062314; Garton M, 2015, NUCLEIC ACIDS RES, V43, P9147, DOI 10.1093/nar/gkv919; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; Lee J, 2010, J PHYS CHEM B, V114, P7662, DOI 10.1021/jp1017289; Liu L, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064107; Loth K, 2013, J BIOMOL NMR, V56, P41, DOI 10.1007/s10858-013-9723-0; NEDVED ML, 1994, NUCLEIC ACIDS RES, V22, P4705, DOI 10.1093/nar/22.22.4705; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Sauve S, 2007, J MOL BIOL, V365, P1163, DOI 10.1016/j.jmb.2006.10.044; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Squires A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11643; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Vandevenne M, 2013, J BIOL CHEM, V288, P10616, DOI 10.1074/jbc.M112.441451; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; Vivas P, 2008, J PHYS CHEM B, V112, P5997, DOI 10.1021/jp076042s; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yonetani Y, 2013, J PHYS CHEM B, V117, P7535, DOI 10.1021/jp402664w; Zandarashvili L, 2012, P NATL ACAD SCI USA, V109, pE1724, DOI 10.1073/pnas.1121500109	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175051	10.1371/journal.pone.0175051	http://dx.doi.org/10.1371/journal.pone.0175051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384299	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900077
J	Kim, K; Lee, H; Hong, JP; Cho, MJ; Fava, M; Mischoulon, D; Kim, DJ; Jeon, HJ				Kim, Kiwon; Lee, Haewoo; Hong, Jin Pyo; Cho, Maeng Je; Fava, Maurizio; Mischoulon, David; Kim, Dong Jun; Jeon, Hong Jin			Poor sleep quality and suicide attempt among adults with internet addiction: A nationwide community sample of Korea	PLOS ONE			English	Article							GAMING DISORDER; COLLEGE-STUDENTS; SOCIAL ANXIETY; ADOLESCENTS; DEPRESSION; RISK; SYMPTOMS; ASSOCIATIONS; INHIBITION; PREVALENCE	Purpose Internet addiction (IA) is defined as a psychological dependence on the internet, regardless of the type of activities once logged on, and previous studies have focused on adolescents and young adults. The aim of this study was to investigate the association between suicide attempts and sleep among community-dwelling adults with IA. Methods The Young's Internet Addiction Test (IAT), the Korean version of the Composite International Diagnostic Interview (K-CIDI) and a suicide questionnaire were used in this cross-sectional multistage, cluster sampling population-based study. A total of 3212 adults aged 18-64 years were interviewed face-to-face, and they had been randomly selected through a one-person-per-household method. Results Of the 3212 adults, 204 were assessed as having IA (6.35%). Adults with IA were younger, and more frequently male, unmarried, and unemployed, and had poorer sleep quality than adults without IA (32.8% vs. 19.8%), whereas there was no significant difference in the absolute duration of sleep between the two groups. Adults with IA showed more frequent difficulty initiating and maintaining sleep, non-restorative sleep, daytime functional impairment, and duration of sleep more than 10 hours on weekdays than adults without IA. IA with poor sleep quality was significantly associated with lifetime suicide attempts (AOR = 3.34, 95% CI 1.38-8.05) after adjusting for demographic covariates. Adults with IA who had more sleep problems showed more severe IA, especially those who experienced a previous suicidal attempt. Among mental disorders, IA with poor sleep quality was significantly associated with anxiety disorder and overall psychiatric disorders. Conclusions Among adults with IA, poor sleep quality was found to be associated with more severe IA and lifetime suicide attempt.	[Kim, Kiwon; Hong, Jin Pyo; Kim, Dong Jun; Jeon, Hong Jin] Sungkyunkwan Univ, Dept Psychiat, Depress Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Lee, Haewoo] Seoul Med Ctr, Dept Psychiat, Seoul, South Korea; [Cho, Maeng Je] Seoul Natl Univ, Dept Psychiat & Behav Sci, Coll Med, Seoul, South Korea; [Fava, Maurizio; Mischoulon, David; Jeon, Hong Jin] Harvard Med Sch, Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA 02115 USA; [Kim, Dong Jun; Jeon, Hong Jin] Sungkyunkwan Univ, Samsung Biomed Res Inst SAI HST, Dept Hlth Sci & Technol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul Medical Center; Seoul National University (SNU); Harvard University; Harvard Medical School; Massachusetts General Hospital; Sungkyunkwan University (SKKU)	Jeon, HJ (corresponding author), Sungkyunkwan Univ, Dept Psychiat, Depress Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea.; Jeon, HJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA 02115 USA.; Jeon, HJ (corresponding author), Sungkyunkwan Univ, Samsung Biomed Res Inst SAI HST, Dept Hlth Sci & Technol, Seoul, South Korea.	jeonhj@skku.edu	Fava, Maurizio/AAH-3548-2020	Jeon, Hong Jin/0000-0002-6126-542X	grant of the Korean Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HM14C2567]; Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP) [B0132-15-1003]; Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016M3C7A1947307]	grant of the Korean Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP); Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by a grant of the Korean Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No. HM14C2567; PI, Hong Jin Jeon). This work was partly supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIP) (No. B0132-15-1003, the development of skin adhesive patches for the monitoring and prediction of mental disorders) to Hong Jin Jeon, and by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. NRF-2016M3C7A1947307; PI, Hong Jin Jeon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2014, J ADDICT MED, V8, P282, DOI 10.1097/ADM.0000000000000026; Bener A, 2013, J ADDICT MED, V7, P236, DOI 10.1097/ADM.0b013e3182926b1f; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Bruni O, 2015, J CLIN SLEEP MED, V11, P1433, DOI 10.5664/jcsm.5282; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Chen Y-L, 2016, J SLEEP RES; Cheung LM, 2011, J SLEEP RES, V20, P311, DOI 10.1111/j.1365-2869.2010.00883.x; Cho M., 1999, ANN M KOR NEUR ASS S; Cho M. J., 2005, PRELIMINARY STUDY 20; Cho MJ, 2007, J NERV MENT DIS, V195, P203, DOI 10.1097/01.nmd.0000243826.40732.45; Cho MJ, 2010, ASIAN J PSYCHIATR, V3, P26, DOI 10.1016/j.ajp.2010.01.009; Cho MJ, 2002, J KOREAN NEUROPSYCHI, V41, P123; Choi K, 2009, PSYCHIAT CLIN NEUROS, V63, P455, DOI 10.1111/j.1440-1819.2009.01925.x; Choi SW, 2015, J BEHAV ADDICT, V4, P308, DOI 10.1556/2006.4.2015.043; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Dowling NA, 2014, ADDICTION, V109, P1408, DOI 10.1111/add.12554; Germain A, 2015, SLEEP, V38, P173, DOI 10.5665/sleep.4388; Golding S, 2015, J CLIN SLEEP MED, V11, P1385, DOI 10.5664/jcsm.5270; Higuchi S, 2005, J SLEEP RES, V14, P267, DOI 10.1111/j.1365-2869.2005.00463.x; Husky MM, 2015, ADDICT BEHAV, V45, P45, DOI 10.1016/j.addbeh.2015.01.011; Jeon HJ, 2009, J AFFECT DISORDERS, V119, P210, DOI 10.1016/j.jad.2009.03.002; Kaess M, 2014, EUR CHILD ADOLES PSY, V23, P611, DOI 10.1007/s00787-013-0490-y; Kang SG, 2014, COMPR PSYCHIAT, V55, P319, DOI 10.1016/j.comppsych.2013.08.023; Kay D. B., 2015, INT PSYCHOGERIATR, V28, P1; Kim NR, 2016, PSYCHIAT INVEST, V13, P58, DOI 10.4306/pi.2016.13.1.58; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Knutson KL, 2007, PEDIATRICS, V119, pE1056, DOI 10.1542/peds.2006-2597; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Lai CM, 2015, PUBLIC HEALTH, V129, P1224, DOI 10.1016/j.puhe.2015.07.031; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lee K, 2013, J KOREAN MED SCI, V28, P763, DOI 10.3346/jkms.2013.28.5.763; Lee S, 2007, ACTA PSYCHIAT SCAND, V116, P429, DOI 10.1111/j.1600-0447.2007.01064.x; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117372; Liu T, 2007, CNS SPECTRUMS, V12, P453, DOI 10.1017/S1092852900015339; Loh KK, 2015, NEUROSCIENTIST REV J; Lu DW, 2010, CYBERPSYCH BEH SOC N, V13, P371, DOI 10.1089/cyber.2009.0254; Nie J, 2016, PSYCHIAT RES, V236, P28, DOI 10.1016/j.psychres.2016.01.004; Park S, 2013, AUST NZ J PSYCHIAT, V47, P153, DOI 10.1177/0004867412463613; Perlis ML, 2016, SLEEP MED REV, V29, P101, DOI 10.1016/j.smrv.2015.10.003; Reed P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134538; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Spada MM, 2014, ADDICT BEHAV, V39, P3, DOI 10.1016/j.addbeh.2013.09.007; Taber KH, 2012, J NEUROPSYCH CLIN N, V24, pIV; Wallace P, 2014, EMBO REP, V15, P12, DOI 10.1002/embr.201338222; Weinstein A, 2015, AM J ADDICTION, V24, P117, DOI 10.1111/ajad.12110; Weinstein A, 2015, ANN CLIN PSYCHIATRY, V27, P4; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Wen T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00006; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; World Health Organization, 1997, PROC DEV NEW LANG VE; World Health Organization [WHO], 1997, CIDI COR VERS 2 1 IN, P1; Woznica AA, 2015, SLEEP MED REV, V22, P37, DOI 10.1016/j.smrv.2014.10.004; Yao YW, 2015, PSYCHIAT RES, V229, P302, DOI 10.1016/j.psychres.2015.07.004; Yau YHC, 2015, HARVARD REV PSYCHIAT, V23, P134, DOI 10.1097/HRP.0000000000000051; Yen CF, 2008, SLEEP, V31, P1515, DOI 10.1093/sleep/31.11.1515; Yilmaz S, 2015, INT J PSYCHIAT CLIN, V19, P18, DOI 10.3109/13651501.2014.979834; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Yuan K, 2016, ADDICTION BIOL	59	34	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174619	10.1371/journal.pone.0174619	http://dx.doi.org/10.1371/journal.pone.0174619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384238	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900021
J	Lee, JY; Chang, J				Lee, Jeong-Yoon; Chang, Jun			Universal vaccine against respiratory syncytial virus A and B subtypes	PLOS ONE			English	Article							ATTACHMENT G PROTEIN; CENTRAL UNGLYCOSYLATED REGION; BALB/C MICE; G-GLYCOPROTEIN; RSV INFECTION; PULMONARY EOSINOPHILIA; INTRANASAL DELIVERY; CX3C-CX3CR1 BINDING; INACTIVATED VACCINE; ENHANCED DISEASE	Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infection in infants, young children, and the elderly. Two subtypes of RSV, A and B, circulate alternately at 1-2-year intervals during epidemics. The attachment glycoprotein (G protein) of RSV is one of the major targets for immune responses. In this study, we generated a recombinant fusion protein, GcfAB, which consists of the central regions (a. a. residues 131-230) of the G proteins of both RSV A (A2 strain) and B (B1 strain) subtypes, and investigated immunogenicity, protective efficacy, and immunopathology. We immunized mice with GcfAB plus cholera toxin as a mucosal adjuvant via intranasal ( -IN) or sublingual (SL) routes. The IN group showed higher levels of RSV G-specific antibody responses, including serum IgG and mucosal IgA, compared with the SL group. On the contrary, more vigorous RSV G-specific CD4(+) T-cell responses were elicited in the SL group than in the IN group after RSV-A but not RSV-B viral challenge. Furthermore, the SL group showed more pulmonary eosinophil recruitment and body weight loss than did the IN group after RSV-A challenge. Both IN and SL immunization with GcfAB provided potential protection against both subtypes of infections. Together, these results suggest that vaccination with GcfAB via an IN route could be a universal vaccine regimen preventing both RSV A and B infections.	[Lee, Jeong-Yoon; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	Ewha Womans University	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060008]; Korean Health Technology R& D Project, the Ministry of Health & Welfare, Republic of Korea [HI13C0826]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology; Korean Health Technology R& D Project, the Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060008) and by a grant of Korean Health Technology R& D Project, the Ministry of Health & Welfare (HI13C0826), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Bystrom J, 2013, VIRUSES-BASEL, V5, P777, DOI 10.3390/v5030777; Cane PA, 1996, J MED VIROL, V48, P253, DOI 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7; Castilow EM, 2008, J IMMUNOL, V181, P6692, DOI 10.4049/jimmunol.181.10.6692; Cheon IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094269; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Falsey A R, 2005, Exp Lung Res, V31 Suppl 1, P77; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; Jang JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023797; Johnson TR, 2004, PEDIATR INFECT DIS J, V23, pS46, DOI 10.1097/01.inf.0000108192.94692.d2; KIM HW, 1976, PEDIATR RES, V10, P75, DOI 10.1203/00006450-197601000-00015; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim S, 2012, PLOS ONE; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Murata Y, 2012, VACCINE, V30, P5382, DOI 10.1016/j.vaccine.2012.06.016; Murata Y, 2010, VACCINE, V28, P6242, DOI 10.1016/j.vaccine.2010.07.011; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Papadopoulos NG, 2004, RESP MED, V98, P879, DOI 10.1016/j.rmed.2004.01.009; PIEDRA PA, 1989, VACCINE, V7, P34, DOI 10.1016/0264-410X(89)90008-X; PIEDRA PA, 1993, VACCINE, V11, P1415, DOI 10.1016/0264-410X(93)90170-3; Plotnicky-Gilquin H, 2000, J VIROL, V74, P3455, DOI 10.1128/JVI.74.8.3455-3463.2000; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Power UF, 2001, VACCINE, V19, P2345, DOI 10.1016/S0264-410X(00)00525-9; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Srikiatkhachorn A, 1999, J VIROL, V73, P6590, DOI 10.1128/JVI.73.8.6590-6597.1999; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; TRUDEL M, 1991, VIROLOGY, V185, P749, DOI 10.1016/0042-6822(91)90546-N; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Varga SM, 2001, IMMUNITY, V15, P637, DOI 10.1016/S1074-7613(01)00209-6; WALSH EE, 1989, J GEN VIROL, V70, P2953, DOI 10.1099/0022-1317-70-11-2953; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09	51	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175384	10.1371/journal.pone.0175384	http://dx.doi.org/10.1371/journal.pone.0175384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384263	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900166
J	Liu, HN; Li, XW; Han, BX; Liu, XQ				Liu, Haining; Li, Xianwen; Han, Buxin; Liu, Xiaoqian			Effects of cognitive bias modification on social anxiety: A meta-analysis	PLOS ONE			English	Article							ATTENTION MODIFICATION PROGRAM; GENDER-DIFFERENCES; EMOTIONAL VULNERABILITY; APPROACH-AVOIDANCE; PUBLICATION BIAS; PHOBIA; DISORDER; MODEL; INFORMATION; INDIVIDUALS	Background Cognitive bias modification (CBM), a set of techniques for modifying bias in information processing D is considered a novel intervention for social anxiety disorder (SAD), which has drawn considerable interest from researchers. However, the effects of CBM on SAD are not consistent. Some studies have demonstrated significant positive effects compared to control groups, while others have found no such effects. Aims We conducted a meta-analysis aimed at quantitatively assessing the effects of CBM on SAD at post-test. Method Through a systematic literature search by two independent raters, 34 articles (36 randomized studies) including 2,550 participants were identified. A multilevel modeling approach was employed to assess the effects of CBM on SAD, and to explore the potentially crucial procedures and sample characteristics that enhance the effectiveness of benign training. Results In general, there were small but significant effects of CBM on the primary symptoms of SAD (g = 0.17), cognitive bias (CB) toward threat (g = 0.32), and reactivity in stressful situations (g = 0.25), but non-significant effects on secondary symptoms. However, the interpretation modification program was more effective than was attentional bias modification in reducing SAD primary symptoms and negative CB. Laboratory training procedures produced larger primary symptom reductions compared to Internet-based training, whereas the percentage of contingency and feedback about training performance boosted cognitive effects only. Finally, the following groups were more likely to benefit from CBM: younger participants (primary symptoms and cognitive effects), women (primary symptom effects), and samples with stronger CB (stressor effects). The quality of the randomized controlled trials was less than desirable, as there was some indication of publication bias in our study. Conclusions Current findings broadly supported cognitive theories of SAD that consider a bidirectional or mutually reinforcing relationship between symptoms and CBs. However, the small therapeutic effect observed here indicates that it is necessary to develop more reliable and efficient CBM interventions that are specific to SAD.	[Liu, Haining; Han, Buxin; Liu, Xiaoqian] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China; [Liu, Haining] Chengde Med Univ, Psychol Dept, Chengde, Peoples R China; [Liu, Haining; Han, Buxin; Liu, Xiaoqian] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Xianwen] Nanjing Med Univ, Sch Nursing, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chengde Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Medical University	Han, BX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China.; Han, BX (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	hanbx@psych.ac.cn			Scientific Foundation of the Key Lab of Mental Health, Institute of Psychology, Chinese Academy of Sciences [KLMH2014K02]; National Social Science Foundation (Major Project) [16ZDA233]	Scientific Foundation of the Key Lab of Mental Health, Institute of Psychology, Chinese Academy of Sciences; National Social Science Foundation (Major Project)	This work was supported by the Scientific Foundation of the Key Lab of Mental Health, Institute of Psychology, Chinese Academy of Sciences under Grant KLMH2014K02 and the National Social Science Foundation (Major Project, 16ZDA233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445; Amir N, 2012, J CONSULT CLIN PSYCH, V80, P497, DOI 10.1037/a0026928; Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Amir N, 2010, J ANXIETY DISORD, V24, P178, DOI 10.1016/j.janxdis.2009.10.005; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Asnaani A, 2014, COGNITIVE THER RES, V38, P226, DOI 10.1007/s10608-013-9580-x; Beard C, 2008, BEHAV RES THER, V46, P1135, DOI 10.1016/j.brat.2008.05.012; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; Beard C, 2012, BEHAV COGN PSYCHOTH, V40, P618, DOI 10.1017/S1352465811000671; Beard C, 2011, DEPRESS ANXIETY, V28, P981, DOI 10.1002/da.20873; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Boettcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071760; Boettcher J, 2012, COGNITIVE THER RES, V36, P522, DOI 10.1007/s10608-011-9374-y; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Bunnell BE, 2013, BEHAV THER, V44, P662, DOI 10.1016/j.beth.2013.04.010; Butler E, 2015, COGENT PSYCHOL, V2, DOI 10.1080/23311908.2015.1011905; Cannon MF, 2010, J ANXIETY DISORD, V24, P751, DOI 10.1016/j.janxdis.2010.05.008; Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66; Carleton RN, 2015, J ANXIETY DISORD, V33, P35, DOI 10.1016/j.janxdis.2015.03.011; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; Clarke PJF, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collimore KC, 2010, DEPRESS ANXIETY, V27, P1017, DOI [10.1002/da.20771, 10.1002/da.20759]; Cooper H. M., 2009, HDB RES SYNTHESIS ME; Cortina JM, 2003, ORGAN RES METHODS, V6, P415, DOI 10.1177/1094428103257358; Cramer Phebe, 2015, Psychodyn Psychiatry, V43, P523, DOI 10.1521/pdps.2015.43.4.523; Crippa J. A. S., 2013, INT J BEHAV CONSULTA, V7, P16, DOI DOI 10.1037/h0100961; Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; De Voogd EL, 2014, J BEHAV THER EXP PSY, V45, P252, DOI 10.1016/j.jbtep.2013.11.006; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Emmelkamp PMG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-63; Enock PM, 2014, COGNITIVE THER RES, V38, P200, DOI 10.1007/s10608-014-9606-z; Epkins CC, 2011, CLIN CHILD FAM PSYCH, V14, P329, DOI 10.1007/s10567-011-0101-8; Fox E, 2014, COGNITIVE THER RES, V38, P239, DOI 10.1007/s10608-014-9604-1; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Hedges C, 1986, STAT TECHNIQUES META; Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005; Heeren A, 2015, CLIN PSYCHOL REV, V40, P76, DOI 10.1016/j.cpr.2015.06.001; Heeren A, 2015, J ANXIETY DISORD, V29, P35, DOI 10.1016/j.janxdis.2014.10.007; Heeren A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00538; Heeren A, 2011, J ANXIETY DISORD, V25, P1108, DOI 10.1016/j.janxdis.2011.08.001; Hertel PT, 2011, PERSPECT PSYCHOL SCI, V6, P521, DOI 10.1177/1745691611421205; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hirsch CR, 2006, BEHAV THER, V37, P223, DOI 10.1016/j.beth.2006.02.001; Hirsch CR, 2012, BEHAV RES THER, V50, P636, DOI 10.1016/j.brat.2012.06.007; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Hoppitt L, 2014, BEHAV RES THER, V52, P45, DOI 10.1016/j.brat.2013.10.008; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Julian K, 2012, BEHAV RES THER, V50, P350, DOI 10.1016/j.brat.2012.02.015; Katzelnick DJ, 2014, AM J PSYCHIAT; Keefe JR, 2014, CLIN PSYCHOL REV, V34, P309, DOI 10.1016/j.cpr.2014.03.004; Keogh E, 2004, PAIN, V111, P209, DOI 10.1016/j.pain.2004.06.017; Khalili-Torghabeh S, 2014, J EXP PSYCHOPATHOL, V5, P514, DOI 10.5127/jep.037713; Kimbrel NA, 2008, CLIN PSYCHOL REV, V28, P592, DOI 10.1016/j.cpr.2007.08.003; Kimbrel NA, 2012, PERS INDIV DIFFER, V52, P395, DOI 10.1016/j.paid.2011.10.041; Klumpp H, 2010, COGNITIVE THER RES, V34, P263, DOI 10.1007/s10608-009-9251-0; Kuckertz JM, 2014, BEHAV RES THER, V53, P30, DOI 10.1016/j.brat.2013.12.003; Leichsenring F, 2007, B MENNINGER CLIN, V71, P56, DOI 10.1521/bumc.2007.71.1.56; LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2; Li SW, 2008, BEHAV RES THER, V46, P905, DOI 10.1016/j.brat.2008.04.005; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MacLeod C, 2015, CLIN PSYCHOL SCI, V3, P58, DOI 10.1177/2167702614560749; Mansell W, 2011, CLIN PSYCHOL REV, V31, P189, DOI 10.1016/j.cpr.2010.06.009; Maoz K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00389; Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3; McNally RJ, 2013, BEHAV RES THER, V51, P882, DOI 10.1016/j.brat.2013.10.001; Mellings TMB, 2000, BEHAV RES THER, V38, P243, DOI 10.1016/S0005-7967(99)00040-6; Menne-Lothmann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100925; Mobini S, 2013, COGNITIVE THER RES, V37, P173, DOI 10.1007/s10608-012-9445-8; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morrison AS, 2013, ANNU REV CLIN PSYCHO, V9, P249, DOI 10.1146/annurev-clinpsy-050212-185631; Moser JS, 2012, BIOL PSYCHOL, V89, P387, DOI 10.1016/j.biopsycho.2011.12.001; Mozolic JL, 2011, NEUROBIOL AGING, V32, P655, DOI 10.1016/j.neurobiolaging.2009.04.013; Murphy R, 2007, BEHAV RES THER, V45, P1517, DOI 10.1016/j.brat.2007.01.007; National Collaborating Centre for Mental Health, 2013, SOC ANX DIS REC ASS; Neubauer K, 2013, BEHAV RES THER, V51, P87, DOI 10.1016/j.brat.2012.10.006; Nowalcowski ME, 2015, J BEHAV THER EXP PSY, V49, P44, DOI 10.1016/j.jbtep.2015.04.004; Opitz PC, 2012, NEUROBIOL AGING, V33, P645, DOI 10.1016/j.neurobiolaging.2010.06.004; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rapee RM, 2013, BEHAV RES THER, V51, P207, DOI 10.1016/j.brat.2013.01.005; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rinck M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00481; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643; Schneier F., 2015, ANXIETY DISORDERS GE, P49, DOI [10.1007/978-3-319-130606_3, DOI 10.1007/978-3-319-13060-6_3, 10.1007/978-3- 319-13060-6_3]; Sportel BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064355; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Steinman SA, 2010, J ANXIETY DISORD, V24, P71, DOI 10.1016/j.janxdis.2009.08.008; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Stewart SH, 1997, J ANXIETY DISORD, V11, P179, DOI 10.1016/S0887-6185(97)00005-4; Taylor CT, 2012, BEHAV RES THER, V50, P529, DOI 10.1016/j.brat.2012.05.004; Turk CL, 1998, J ANXIETY DISORD, V12, P209, DOI 10.1016/S0887-6185(98)00010-3; Van Bockstaele B, 2014, PSYCHOL BULL, V140, P682, DOI 10.1037/a0034834; Vassilopoulos SP, 2016, J CHILD FAM STUD, V25, P299, DOI 10.1007/s10826-015-0194-7; Vassilopoulos SP, 2013, BEHAV COGN PSYCHOTH, V41, P103, DOI 10.1017/S1352465812000537; Vassilopoulos SP, 2009, BEHAV RES THER, V47, P1085, DOI 10.1016/j.brat.2009.07.018; Wiers CE, 2016, NEUROIMAGE; Williams AD, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004049; Woody SR, 2015, ASIAN AM J PSYCHOL, V6, P47, DOI 10.1037/a0036548; Xu Y, 2012, J ANXIETY DISORD, V26, P12, DOI 10.1016/j.janxdis.2011.08.006; Zhao X, 2014, PERS INDIV DIFFER, V71, P108, DOI 10.1016/j.paid.2014.07.023	111	29	31	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175107	10.1371/journal.pone.0175107	http://dx.doi.org/10.1371/journal.pone.0175107			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384301	gold, Green Published			2022-12-27	WOS:000399371900086
J	Sun, XF; Ding, ZS; Wang, XB; Hou, HP; Zhou, BY; Yue, Y; Ma, W; Ge, JZ; Wang, ZM; Zhao, M				Sun, Xuefang; Ding, Zaisong; Wang, Xinbing; Hou, Haipeng; Zhou, Baoyuan; Yue, Yang; Ma, Wei; Ge, Junzhu; Wang, Zhimin; Zhao, Ming			Subsoiling practices change root distribution and increase post-anthesis dry matter accumulation and yield in summer maize	PLOS ONE			English	Article							SOIL PHYSICAL-PROPERTIES; LEAF-SENESCENCE; BULK-DENSITY; GRAIN-YIELD; STAY GREEN; TILLAGE; COMPACTION; NITROGEN; WHEAT; HYBRIDS	Subsoiling is an important management practice for improving maize yield, especially for maize planted at high plant density. However, the affected physiological processes have yet to be specifically identified. In this study, field experiments with two soil tillage (CK: notillage, SS: subsoiling) and three planting densities ( low: 45000 plants ha(-1), medium: 67500plants ha(-1), and high: 90000 plants ha(-1)) were conducted from 2010 to 2012 at Xinxiang, Henan province. Yield, canopy function, and root system were investigated to determine the associated physiological processes for improving maize production affected by soil tillage and plant density. Subsoiling significantly increased the grain yield of the low-, medium-, and high-planting densities by 6.21%, 8.92%, and 10.09%, respectively. Yield increase in the SS plots was mainly attributed to greater post-anthesis DMA and improved grain filling compared to CK plots. Greater green leaf area, leaf net photosynthetic rate, F-V/F-m and phi PSII in the SS plots were mainly contributed to enhanced dry matter production post-anthesis. This is mainly because subsoiling increased density of root dry weight in deep soil and root bleeding sap amount due to decreased the bulk density of the 0-30 cm soil profile layer. Density of root dry weight at 10-50 cm depth with SS increased by 40.68%, 32.17%, and 20.14% at low, medium, and high planting densities compared to CK, respectively, while the root bleeding sap amount increased by 17.41%, 15.82%, and 20.91%. These results indicate that subsoiling could change the root distribution and improve soil layer environment for root growth, thus maintaining a higher canopy photosynthetic capacity post-anthesis and in turn promoting DMA and yield, particularly at higher planting densities.	[Sun, Xuefang; Ding, Zaisong; Wang, Xinbing; Hou, Haipeng; Zhou, Baoyuan; Ma, Wei; Ge, Junzhu; Zhao, Ming] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Ecophysiol & Cultivat, Minist Agr, Beijing, Peoples R China; [Yue, Yang; Wang, Zhimin] China Agr Univ, Coll Agron & Biotechnol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University	Zhao, M (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Ecophysiol & Cultivat, Minist Agr, Beijing, Peoples R China.	zhaoming@caas.cn	Wang, Xin/GYU-1129-2022; Zhou, Baoyuan/HDM-1095-2022; Wang, Xin/AAN-8435-2021	Zhou, Baoyuan/0000-0003-0979-4460; Wang, Xin/0000-0002-4457-7376	National Science and Technology Support Project [2013BAD07B00]; State Key Program of China [2016YFD0300103]; National Agricultural Industry and Technology of China [CRRS-02]	National Science and Technology Support Project; State Key Program of China(State Key Development Program for Basic Research of China); National Agricultural Industry and Technology of China	This work was supported by the National Science and Technology Support Project (2013BAD07B00), http://program.most.gov.cn/, and the State Key Program of China (2016YFD0300103), http://service.most.gov.cn/, and the National Agricultural Industry and Technology of China (CRRS-02), http://cars.wmelon.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonietta M, 2014, FIELD CROP RES, V155, P111, DOI 10.1016/j.fcr.2013.09.016; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, FIELD CROP RES, V82, P13, DOI 10.1016/S0378-4290(03)00002-9; Cai HG, 2014, CROP J, V2, P297, DOI 10.1016/j.cj.2014.04.006; Cavigelli MA, 2005, APPL SOIL ECOL, V29, P99, DOI 10.1016/j.apsoil.2004.12.007; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Dai MingHong, 2011, Scientia Agricultura Sinica, V44, P1585; Ding L, 2007, BIOL PLANTARUM, V51, P165, DOI 10.1007/s10535-007-0032-x; Ding ZS, 2014, CROP J, V2, P22, DOI 10.1016/j.cj.2013.12.003; [董学会 Dong Xuehui], 2005, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V25, P587; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Ekelof J, 2015, POTATO RES, V58, P15, DOI 10.1007/s11540-014-9261-5; Escobar-Gutierrez AJ, 2012, FIELD CROP RES, V134, P47, DOI 10.1016/j.fcr.2012.04.013; Gambin BL, 2006, FIELD CROP RES, V95, P316, DOI 10.1016/j.fcr.2005.04.002; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILL KS, 1990, SOIL TILL RES, V18, P37, DOI 10.1016/0167-1987(90)90091-Q; Guan DH, 2015, SOIL TILL RES, V146, P286, DOI 10.1016/j.still.2014.09.016; Hall DJM, 2010, AUST J SOIL RES, V48, P178, DOI 10.1071/SR09078; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Hashemi AM, 2005, AGRON J, V97, P839, DOI 10.2134/agronj2003.0241; Hou HaiPeng, 2013, Acta Agronomica Sinica, V39, P1069, DOI 10.3724/SP.J.1006.2013.01069; [黄智鸿 HUANG Zhihong], 2007, [玉米科学, Maize Science], V15, P95; Ishaq M, 2001, SOIL TILL RES, V59, P57, DOI 10.1016/S0167-1987(00)00189-6; Jones RJ, 1996, CROP SCI, V36, P301, DOI 10.2135/cropsci1996.0011183X003600020015x; Klepper B., 1990, Agronomy, P281; Kumar S, 2012, SUGAR TECH, V14, P398, DOI 10.1007/s12355-012-0170-0; [李飒 Li Sa], 2011, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V17, P325; [梁金凤 LIANG Jinfeng], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P945; Lipiec J, 2012, SOIL TILL RES, V121, P74, DOI 10.1016/j.still.2012.01.013; Liu JL, 2014, AGRON J, V106, P390, DOI 10.2134/agronj2013.0404; Liu TD, 2012, PHOTOSYNTHETICA, V50, P215, DOI 10.1007/s11099-012-0011-0; Lu Hai-dong, 2010, Yingyong Shengtai Xuebao, V21, P895; Marchiori PER, 2014, FIELD CROP RES, V155, P30, DOI 10.1016/j.fcr.2013.09.025; Mosaddeghi MR, 2009, SOIL TILL RES, V104, P173, DOI 10.1016/j.still.2008.10.011; Mu XY, 2016, EUR J AGRON, V78, P32, DOI 10.1016/j.eja.2016.04.010; NITANT HC, 1995, SOIL TILL RES, V34, P17, DOI 10.1016/0167-1987(94)00454-M; Qi WenZeng, 2012, Plant Nutrition and Fertilizer Science, V18, P69; [秦红灵 QIN Hongling], 2008, [中国农业科学, Scientia Agricultura Sinica], V41, P78; Sala RG, 2007, FIELD CROP RES, V101, P19, DOI 10.1016/j.fcr.2006.09.004; Sangoi L., 2001, Ciencia Rural, V31, P159, DOI 10.1590/S0103-84782001000100027; Sasal MC, 2006, SOIL TILL RES, V87, P9, DOI 10.1016/j.still.2005.02.025; [宋日 Song Ri], 2002, [作物学报, Acta Agronomica Sinica], V28, P393; Stirzaker RJ, 1996, PLANT SOIL, V185, P151, DOI 10.1007/BF02257571; Sun XueFang, 2013, Acta Agronomica Sinica, V39, P1284, DOI 10.3724/SP.J.1006.2013.01284; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Tollenaar M, 2011, PL BRED RE, V34, P37; Tollenaar M, 2006, AGRON J, V98, P930, DOI 10.2134/agronj2005.0336; Tolon-Becerra A, 2011, SOIL TILL RES, V117, P184, DOI 10.1016/j.still.2011.10.003; Wang XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129231; Wingler A, 2004, NEW PHYTOL, V161, P781, DOI 10.1111/j.1469-8137.2004.00996.x; [翟振 Zhai Zhen], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P2322; Zhang Y, 2017, CHINESE J ECOAGRICUL, V3; [张子山 Zhang Zishan], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P4794; [赵明 Zhao Ming], 2015, [作物杂志, Crops], P70; Zhou BY, 2016, AGRON J, V108, P1, DOI DOI 10.2134/AGR0NJ2015.0196; Zhu M, 2011, AFR J AGR RES, V6, P2820; ZHU Q, 1988, Acta Agronomica Sinica, V14, P182	58	34	38	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174952	10.1371/journal.pone.0174952	http://dx.doi.org/10.1371/journal.pone.0174952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384233	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900062
J	Cho, GJ; Kang, J				Cho, Geum-Jin; Kang, Jiyeon			Type D personality and post-traumatic stress disorder symptoms among intensive care unit nurses: The mediating effect of resilience	PLOS ONE			English	Article							CONSTRUCT; VALIDITY; GROWTH	The purpose of this study was to investigate the relationship between Type D personality and post-traumatic stress disorder (PTSD) symptoms of intensive care unit (ICU) nurses and to determine the mediating effect of resilience on this relationship. A cross-sectional survey was performed with 179 ICU nurses from 7 hospitals in Gyeong-Nam province, South Korea. The Type D personality, resilience, and PTSD symptoms of subjects were measured using a self-report questionnaire. The mediating effect was analyzed by a series of hierarchical multiple regressions. A total of 38.6% of the study participants turned out to have Type D personality. The Type D personality was positively correlated with PTSD symptoms, and negatively correlated with resilience. There was a negative correlation between resilience and PTSD symptoms. The indirect effect of Type D personality on PTSD symptoms via resilience (beta =.51, p < .001) was smaller than the direct effect (beta =.58, p<.001). Based on the above results, it can be concluded that resilience had a partial mediating effect on the relationship between Type D personality and PTSD symptoms of ICU nurses. Further studies need to be done to develop interventions for enhancing resilience in ICU nurses.	[Cho, Geum-Jin] Dong A Univ, Med Ctr, Neurol Intens Care Unit, Busan, South Korea; [Kang, Jiyeon] Dong A Univ, Dept Nursing, Busan, South Korea	Dong A University; Dong A University	Kang, J (corresponding author), Dong A Univ, Dept Nursing, Busan, South Korea.	jykang@dau.ac.kr	Kang, Jiyeon/AAD-1016-2021	Kang, Jiyeon/0000-0002-8938-7656				American Psychiatric Association, POSTTR STRESS DIS; [Anonymous], 2011, AM J HLTH SCI, DOI DOI 10.19030/AJHS.V2I1.4365; Baek HS, 2010, PSYCHIAT INVEST, V7, P109, DOI 10.4306/pi.2010.7.2.109; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Booth L, 2015, J HEALTH PSYCHOL, V20, P921, DOI 10.1177/1359105315573433; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Czaja AS, 2012, J PEDIATR NURS, V27, P357, DOI 10.1016/j.pedn.2011.04.024; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Dyer JG, 1996, ARCH PSYCHIAT NURS, V10, P276, DOI 10.1016/S0883-9417(96)80036-7; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Geuens N, 2015, BURNOUT RES, V2, P80, DOI [DOI 10.1016/J.BURN.2015.05.003, DOI 10.1016/j.burn.2015.05.003]; Greene T, 2016, J CLIN PSYCHOL MED S, V23, P160, DOI 10.1007/s10880-016-9449-8; Gu Q, 2007, TEACH TEACH EDUC, V23, P1302, DOI 10.1016/j.tate.2006.06.006; Horn SR, 2016, EXP NEUROL; Janoff-Bulman R, 2004, PSYCHOL INQ, V15, P30; Karlsson MR, 2007, J BEHAV MED, V30, P253, DOI 10.1007/s10865-007-9096-5; Kim YH, 2016, J ADV NURS; Kunst MJJ, 2011, CLIN PSYCHOL PSYCHOT, V18, P13, DOI 10.1002/cpp.698; Laschinger HKS, 2015, J NURS MANAGE, V23, P252, DOI 10.1111/jonm.12122; Lim HT, 2011, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2011-91; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mealer M, 2014, AM J CRIT CARE, V23, pE97, DOI 10.4037/ajcc2014747; Mealer M, 2012, INTENS CARE MED, V38, P1445, DOI 10.1007/s00134-012-2600-6; Mealer M, 2012, INT J NURS STUD, V49, P292, DOI 10.1016/j.ijnurstu.2011.09.015; Mealer M, 2009, DEPRESS ANXIETY, V26, P1118, DOI 10.1002/da.20631; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Miller MW, 2003, CLIN PSYCHOL-SCI PR, V10, P373, DOI 10.1093/clipsy/bpg040; Mols F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-9; Mommersteeg PMC, 2012, SCAND J PUBLIC HEALT, V40, P35, DOI 10.1177/1403494811421533; Pai A, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7010007; Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7; Polman R, 2010, BRIT J HEALTH PSYCH, V15, P681, DOI 10.1348/135910709X479069; Shin HY, 2015, CRISISONOMY, V11, P97; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Tekin A, 2016, ARCH ENVIRON OCCUP H, P1; Williams L, 2012, PSYCHOL HEALTH, V27, P1075, DOI 10.1080/08870446.2012.667098; Wooten NR, 2012, SOC WORK HEALTH CARE, V51, P828, DOI 10.1080/00981389.2012.692353; Yu NX, 2017, AIDS CARE, V29, P79, DOI 10.1080/09540121.2016.1210073; 안현의, 2005, [Korean Journal Of Counseling And Psychotherapy, 한국심리학회지: 상담 및 심리치료], V17, P217	39	22	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175067	10.1371/journal.pone.0175067	http://dx.doi.org/10.1371/journal.pone.0175067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380063	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500092
J	da Silva, LG; Kawanishi, K; Henschel, P; Kittle, A; Sanei, A; Reebin, A; Miquelle, D; Stein, AB; Watson, A; Kekule, LB; Machado, RB; Eizirik, E				da Silva, Lucas G.; Kawanishi, Kae; Henschel, Philipp; Kittle, Andrew; Sanei, Arezoo; Reebin, Alexander; Miquelle, Dale; Stein, Andrew B.; Watson, Anjali; Kekule, Laurence Bruce; Machado, Ricardo B.; Eizirik, Eduardo			Mapping black panthers: Macroecological modeling of melanism in leopards (Panthera pardus)	PLOS ONE			English	Article							NATURAL-SELECTION; COLOR VARIATION; EVOLUTION; HABITAT; NICHE; GENETICS; CAT	The geographic distribution and habitat association of most mammalian polymorphic phenotypes are still poorly known, hampering assessments of their adaptive significance. Even in the case of the black panther, an iconic melanistic variant of the leopard (Panthera pardus), no map exists describing its distribution. We constructed a large database of verified records sampled across the species' range, and used it to map the geographic occurrence of melanism. We then estimated the potential distribution of melanistic and non-melanistic leopards using niche-modeling algorithms. The overall frequency of melanism was ca. 11%, with a significantly non-random spatial distribution. Distinct habitat types presented significantly different frequencies of melanism, which increased in Asian moist forests and approached zero across most open/dry biomes. Niche modeling indicated that the potential distributions of the two phenotypes were distinct, with significant differences in habitat suitability and rejection of niche equivalency between them. We conclude that melanism in leopards is strongly affected by natural selection, likely driven by efficacy of camouflage and/or thermoregulation in different habitats, along with an effect of moisture that goes beyond its influence on vegetation type. Our results support classical hypotheses of adaptive coloration in animals (e.g. Gloger's rule), and open up new avenues for in-depth evolutionary analyses of melanism in mammals.	[da Silva, Lucas G.; Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Kawanishi, Kae] Malaysian Conservat Alliance Tigers, Petaling Jaya, Malaysia; [Henschel, Philipp] Panthera Lion Program, New York, NY USA; [Kittle, Andrew; Watson, Anjali] Wilderness & Wildlife Conservat Trust, Colombo, Sri Lanka; [Sanei, Arezoo] Asian Leopard Specialist Soc, Tehran, Iran; [Reebin, Alexander; Miquelle, Dale] Wildlife Conservat Soc, New York, NY USA; [Stein, Andrew B.] Landmark Coll, Putney, VT USA; [Stein, Andrew B.] Botswana Predator Conservat Trust, Maun, Botswana; [Kekule, Laurence Bruce] BK Wildlife Photog Co, Bangkok, Thailand; [Machado, Ricardo B.] Univ Brasilia, Brasilia, DF, Brazil; [Eizirik, Eduardo] Inst Procarnivoros, Atibaia, SP, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Wildlife Conservation Society; Universidade de Brasilia	da Silva, LG; Eizirik, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.; Eizirik, E (corresponding author), Inst Procarnivoros, Atibaia, SP, Brazil.	lucas.silva@pucrs.br; eduardo.eizirik@pucrs.br	Machado, Ricardo Bomfim/J-5894-2012; Machado, Ricardo/GXM-8198-2022; Eizirik, Eduardo/K-8034-2012; Gonçalves da Silva, Lucas/B-8702-2014; Silva, Diego/GRF-5446-2022; Silva, Lucas/GQH-8201-2022	Machado, Ricardo Bomfim/0000-0002-6508-9005; Eizirik, Eduardo/0000-0002-9658-0999; Gonçalves da Silva, Lucas/0000-0002-7993-9015; Kittle, Andrew/0000-0002-7334-4766; Sanei, Arezoo/0000-0002-8873-2489	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [150529/2014-7]; CNPq/Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), www.cnpq.br., Grant 150529/2014-7, awarded to EE and LGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company 'BK Wildlife Photography' provided support in the form of salaries for author LBK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; Authors would like to thank Rafael D. Loyola, Marcio B. Martins, Kristofer Helgen, Katia B. Ferraz, Francesca Palmeira, Everton Quadros, Regis Lahm, Eileen Westwig, Esther Langan, Milind Pariwakam, Biswajit Mohanty, Kashmira Kakati, Anhar Harahap, Vidya Athreya, Jane Budd, Arash Ghoddousi, Ezequiel Fabiano, Peter Crawshaw Jr., Guy Balme, David Stanton, Yury Shibnev, Dipankar Ghose and Joao F. Moraes for location records and/or helpful discussions. We also thank Drs. Tim Caro and Andrew Kitchener for insightful comments on a previous version of this manuscript, which helped improve our analyses and interpretations of the observed patterns. We thank the American Museum of Natural History, Smithsonian Institution, Panthera, Wildlife Conservation Society, World Wild Fund, Asian Leopard Specialist Group, Cape Leopard Trust, and the IUCN Cat Specialist Group for assistance with data collection, and CNPq/Brazil for financial support to L.G. Silva, R.B. Machado and E. Eizirik. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2010, P ROYAL SOC BIOL SCI, P277; [Anonymous], [No title captured]; Baylis HA, 1927, J NAT HIST, V9, P214; Beddard FE, 1985, ANIMAL COLORATION CO; Burtt EH, 2004, CONDOR, V106, P681, DOI 10.1650/7383; Calabrese JM, 2013, GLOBAL ECOL BIOGEOGR; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Cott H.B., 1940, ADAPTIVE COLORATION; da Silva LG, 2016, J ZOOL, V299, P295, DOI 10.1111/jzo.12358; Daniel J. C., 1996, THE LEOPARD IN INDIA; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik Eduardo, 2003, Cat News, V38, P37; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esri, 2010, ARCGIS SOFTW; Fischer MM, 2011, SPRINGERBR REG SCI, P1, DOI 10.1007/978-3-642-21720-3; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Gloger, 1833, ABANDERN VOGEL DURCH; Hammond S., 2001, BLACK LEOPARD SPOTTE; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; Hedges L, 2015, J WILDLIFE MANAGE, V79, P846, DOI 10.1002/jwmg.901; Henschel P, IUCN 2008 IUCN RED L; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Jacobson AP, 2016, PEER J; Kawanishi K, 2010, J ZOOL, V282, P201, DOI 10.1111/j.1469-7998.2010.00731.x; Koyabu DB, 2008, INT J PRIMATOL, V29, P531, DOI 10.1007/s10764-007-9152-6; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Luo SJ, 2014, MOL ECOL, V23, P2072, DOI 10.1111/mec.12716; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; MEN Majerus, 1998, EVOLUTION ACTION; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Mukherjee S, 2010, PLOS ONE, V5; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ortolani A, 1996, CARNIVORES BEHAV ECO, V2; PEARSON RG, 2007, SPECIES DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; POCOCK R. I., 1930, JOUR BOMBAY NAT HIST SOC, V34, P64; Pocock RI, 1930, J BOMBAY NATURAL HIS, V34, P307; Poulton EB, 1890, COLORS ANIMALS THEIR; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Schneider A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004892; Schneider AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032824; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sterndale RA, 1984, NATURAL HIST MAMMALI; Sunquist ME, 2002, WILD CATS WORLD; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Thapa Kamal, 2013, Cat News, V58, P26; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Wallace A. R., 1877, MACMILLANS MAGAZINE, V36, P384; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wei CTK, 2015, TROP CONSERV SCI, V8, P732, DOI 10.1177/194008291500800310; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wilting A, 2016, J ZOOLOGY	63	23	24	9	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0170378	10.1371/journal.pone.0170378	http://dx.doi.org/10.1371/journal.pone.0170378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379961	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500003
J	Vaskaninova, V; Ahlberg, PE				Vaskaninova, Valeria; Ahlberg, Per E.			Unique diversity of acanthothoracid placoderms (basal jawed vertebrates) in the Early Devonian of the Prague Basin, Czech Republic: A new look at Radotina and Holopetalichthys	PLOS ONE			English	Article							EVOLUTION; DERMOSKELETON; GNATHOSTOME; ORIGIN; FISH	The taxonomy of Early Devonian placoderm material from the Lochkovian and Pragian of the Prague basin, previously attributed to the genera Radotina and Holopetalichthys, is revised. The Pragian species Radotina tesselata Gross 1958 shares detailed similarities with the holotype of the Lochkovian Radotina kosorensis Gross 1950, which is also the holotype of the genus; the assignation of both species to Radotina is supported. However, the Lochkovian material previously attributed to Radotina kosorensis also contains two unrecognised taxa, distinguishable from Radotina at the generic level: these are here named Tlamaspis and Sudaspis. The disputed genus Holopetalichthys, synonymised with Radotina by some previous authors, is shown to be valid. Furthermore, whereas Radotina, Tlamaspis and Sudaspis can all be assigned to the group Acanthothoracii, on the basis of several features including possession of a projecting prenasal region of the endocranium, Holopetalichthys lacks such a region and is probably not an acanthothoracid. Skull roof patterns and other aspects of morphology vary greatly between these taxa. Radotina has a substantially tesselated skull roof, whereas the skull roofs of Tlamaspis and Holopetalichthys appear to lack tesserae altogether. Tlamaspis has an extremely elongated facial region and appears to lack a premedian plate. Sudaspis has a long prenasal region, but unlike Tlamaspis the postnasal face is not elongated. Past descriptions of the braincase of ' Radotina' and the skull roofs of ' Radotina' and ' Holopetalichthys' incorporate data from more than one taxon, giving rise to spurious characterisations including an apparently extreme degree of skull roof variability. These descriptions should all be disregarded.	[Vaskaninova, Valeria] Charles Univ Prague, Fac Sci, Inst Geol & Palaeontol, Prague, Czech Republic; [Vaskaninova, Valeria; Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden	Charles University Prague; Uppsala University	Vaskaninova, V (corresponding author), Charles Univ Prague, Fac Sci, Inst Geol & Palaeontol, Prague, Czech Republic.; Vaskaninova, V (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden.	va.vaska@gmail.com	Vaškaninová, Valéria/AAK-9246-2020; Vaškaninová, Valéria/M-8941-2017	Vaškaninová, Valéria/0000-0003-4034-8637; Vaškaninová, Valéria/0000-0003-4034-8637; Ahlberg, Per/0000-0001-9054-2900	Charles University Grant Agency project GAUK [1154214]; Charles University SW project [2016-2603041]; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; SYNTHESYS grant [CZ-TAF-5748]; Swedish Research Council [2014-4102]	Charles University Grant Agency project GAUK; Charles University SW project; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; SYNTHESYS grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by the Charles University Grant Agency project GAUK no. 1154214 < http://www.cuni.cz/UKEN-65.html >, the Charles University SW project no. 2016-2603041 < http://cuni.cz/UK-3362.html > (to VV); the Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation << https://www.wallenberg.com/kaw/en >, the SYNTHESYS grant CZ-TAF-5748 < http://www.synthesys.info/> and the Swedish Research Council project grant 2014-4102 < http://www.vr.se/> (to PEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews M, 2005, T ROY SOC EDIN-EARTH, V96, P197, DOI 10.1017/S0263593300001309; Barrande J., 1872, SYSTEME SILURIEN CT, V1; BAYER F., 1905, KATALOG CESKYCH FOSS; Brazeau MD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2210; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole J., 2010, P59; Bystrow AP, 1956, VESTN LENINGR U GEOL, V18, p5 ; CaAp P, 2003, CZECH GEOLOGICAL SUR; CHLUPAC I., 2002, EXPLANATORY REMARKS, V1; Chlupac I, 2002, GEOLOGICKA MINULOST; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R., 1978, Handbook of Paleoichthyology, V2, P1; Donoghue P. C. J., 2006, J EXPT ZOOL MOL DEV, V306, P1; Dupret V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171241; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dupret V, 2011, J VERTEBR PALEONTOL, V31, P531, DOI 10.1080/02724634.2011.558148; Dupret V, 2010, CR PALEVOL, V9, P369, DOI 10.1016/j.crpv.2010.07.005; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gardiner B.G., 1984, Journal of Vertebrate Paleontology, V4, P379; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet DF, 1984, P LINN SOC N S W, V07, P211; Grose W., 1958, Notizblatt des Hessischen Landesamtes fuer Bodenforschung, V86, P7; Gross W., 1959, Palaeontographica, V113A, P1; Gross W., 1950, ABHANDLUNGEN AKAD WI, V1, P1; Gross W., 1962, C INT CTR NATL RECHE, V104, P69; Hawthorn JR, 2008, J VERTEBR PALEONTOL, V28, P951, DOI 10.1671/0272-4634-28.4.951; Hejna M., 2014, CESKY KRAS BEROUN, VXL, P5; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1972, MIDDLE UPPER DEVONIA; Jarvik E., 1980, BASIC STRUCTURE EVOL; King B, 2016, SYST BIOL, V107; Lelievre H., 1993, P139; Long J.A., 1988, Memoir of the Association of Australasian Palaeontologists, V7, P65; Mark-Kurik E, 1973, EESTI NSV TEAD AKAD, V22, P311; MCCOY F., 1848, ANN MAGAZINE NATURAL, V2, P1, DOI 10.1080/03745485809496133; Miles R. S., 1971, PALAEOZOIC FISHES; Miles RS, 1973, ARTICULATED ACANTHOD; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Olive S, 2011, GEODIVERSITAS, V33, P393, DOI 10.5252/g2011n3a1; Orvig T., 1975, PROBLEMES ACTUELS PA, V218, P41; Perner J., 1918, GEOLOGIE PALAONTOLOG, P318; Qiao T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163157; Rocek Z., 2002, HIST OBRATLOVCU EVOL; Ryll B, 2014, EVOL DEV, V16, P123, DOI 10.1111/ede.12071; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; Stensio Erik A., 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; Vaskaninova V, 2009, SPOLOCNY GEOLOGICKY, P195; Vaskaninova V, 2011, SPECIAL PUBLICATION, V12, P51; Vaskaninova V, 2014, B GEOSCI, V89, P635, DOI 10.3140/bull.geosci.1450; Vaskaninova V, 2014, GFF, V136, P281, DOI 10.1080/11035897.2014.880510; vonsKoenen A., 1895, ABHANDLUNGEN KONIGLI, V40, P1; Wang NZ, 2005, J VERTEBR PALEONTOL, V25, P745, DOI 10.1671/0272-4634(2005)025[0745:HOTGDA]2.0.CO;2; Westoll TS, 1967, ZOOL J LINN SOC-LOND, V47, P83, DOI DOI 10.1111/J.1096-3642.1967.TB01397.X; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; Zhu M, 2016, SCIENCE, V354, P334, DOI 10.1126/science.aah3764; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu Min, 1996, Vertebrata Palasiatica, V34, P253	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174794	10.1371/journal.pone.0174794	http://dx.doi.org/10.1371/journal.pone.0174794			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380002	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500065
J	Wang, AH; Wang, FG; Zhang, WW; Ma, XD; Li, XW; Yi, QF; Li, DL; Duan, L; Yan, YH; Xing, FW				Wang, Ai-Hua; Wang, Fa-Guo; Zhang, Wan-Wan; Ma, Xiao-Dong; Li, Xu-Wen; Yi, Qi-Fei; Li, Dong-Lin; Duan, Lei; Yan, Yue-Hong; Xing, Fu-Wu			Revision of series Gravesiana (Adiantum L.) based on morphological characteristics, spores and phylogenetic analyses	PLOS ONE			English	Article							CHLOROPLAST DNA; DRYOPTERIDACEAE; ORIGIN	Since the adoption of some ambiguous and quantitative characters in Flora Republicae Popularis Sinicae 3(1), species identifications of the series Gravesiana have been in disarray, requiring clarification. Two hundred and fifty-nine individuals from 47 different populations were collected for the estimation of morphological characters and phylogenetic analyses. Spores of 26 populations were observed through scanning electron microscope. Our results were different from those of previous research: (1) six identifiable species, rather than five species observed previously, were confirmed in the series Gravesiana, they are A. gravesii, A. juxtapositum, A. mariesii, A. dentatum, A. longzhouensis and A. obovatum, of which the latter three are newly recognized species. (2) Thirteen characters were measured and estimated through the program Mesquite v. 2.71. The character whether the pinna stalks were 1/3-1/2 times longer than the pinna was used to distinguish A. gravesii and A. lianxianense previously and was found to be unreliable here, whereas such characters as the height of the plant (H), pinna aligned forms (FP), number of pinna (NP), pinna margin (M), number of veins flabellate at base (NV), sori number and shape per pinna (NSS), pinna texture (T), and powder-covered or not on the abaxial surface of the pinna (P) are estimated to be stable and reliable characters useful for identification. Descriptions of new species and their retrieve keys are also listed. (3) Surface ornamentations and spore sizes are helpful for us to distinguish species in series Gravesiana.	[Wang, Ai-Hua; Wang, Fa-Guo; Zhang, Wan-Wan; Ma, Xiao-Dong; Li, Xu-Wen; Yi, Qi-Fei; Li, Dong-Lin; Duan, Lei; Xing, Fu-Wu] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Wang, Ai-Hua] Guangxi Teachers Educ Univ, Minist Educ, Key Lab Environm Change & Resources Use Beibu Gul, Nanning, Peoples R China; [Wang, Ai-Hua; Ma, Xiao-Dong; Li, Dong-Lin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Xu-Wen] Guangzhou Inst Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Yan, Yue-Hong] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Nanning Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xing, FW (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	xinfw@scib.ac.cn	Duan, Lei/HGT-9132-2022; Ma, Xiao-dong/AAX-1333-2021; Duan, Lei/HGT-9055-2022	Ma, Xiao-dong/0000-0002-6537-7920; Duan, Lei/0000-0001-6152-5458	Youth Innovation Promotion Association of Chinese Academy of Sciences [2013229]; Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [201214ZS]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA13020500]	Youth Innovation Promotion Association of Chinese Academy of Sciences; Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013229), and the Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (201214ZS), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA13020500).; We thank Ri-Hong JIANG in Guangxi Forestry Group for his help with many collection sites provided; we also thank Yun-Xiao LIU (South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, China) for their help with the morphology figures. This work was funded by the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013229), and the Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (201214ZS), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA13020500).	[Anonymous], 2014, IUCN GUID US IUCN RE; Baker JG, 1880, GARDENERS CHRONICLE, V16, P494; Ching R.-C., 1957, ACTA PHYTOTAXONOMICA, V6, P312; Ching RC, 1930, SINENSIA, V1, P50; Doyle J. J., 1987, PHYTOCHEM B, P11; Hall T.A., 1999, BIOEDIT USER FRIENDL; Hance HF, 1875, J BOT BRIT FOREIGN, V13, P197; Harris JG, 2001, PLANT IDENTIFICATION, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin YX, 1980, ACTA PHYTOTAXONOMICA, V18, P102; Little DP, 2003, AM J BOT, V90, P508, DOI 10.3732/ajb.90.3.508; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; Lu JM, 2005, J PLANT RES, V118, P129, DOI 10.1007/s10265-005-0201-y; Maddison W, 2009, MESQUITE VERSION 2 7; Nylander JAA., 2004, MRMODELTEST 2 2; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shing K.H., 1990, FLORA REPUBLICAE POP, V3, P173; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Wang AH, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0361-9; Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01157; Wang QX, 2010, SPORES POLYPODIALES, P10; Yan YueHong, 2012, Biodiversity Science, V20, P517, DOI 10.3724/SP.J.1003.2012.05215; [严岳鸿 Yan Yuehong], 2011, [广西植物, Guihaia], V31, P5; Zhang WY, 2014, SYST BOT, V39, P1034, DOI 10.1600/036364414X682616	27	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172729	10.1371/journal.pone.0172729	http://dx.doi.org/10.1371/journal.pone.0172729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379966	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500007
J	Zhang, JJ; Kong, QY				Zhang, Jian-Jun; Kong, Qingyao			Locomotor activity: A distinctive index in morphine self-administration in rats	PLOS ONE			English	Article							BEHAVIORAL SENSITIZATION; SEEKING BEHAVIOR; HEROIN-SEEKING; KAPPA-AGONIST; REINSTATEMENT; COCAINE; ADDICTION; RECEPTORS; RELAPSE	Self-administration of addictive drugs is a widely used tool for studying behavioral, neurobiological, and genetic factors in addiction. However, how locomotor activity is affected during self-administration of addictive drugs has not been extensively studied. In our present study, we tested the locomotor activity levels during acquisition, extinction and reinstatement of morphine self-administration in rats. We found that compared with saline self-administration (SA), rats that trained with morphine SA had higher locomotor activity. Rats that successfully acquired SA also showed higher locomotor activity than rats that failed in acquiring SA. Moreover, locomotor activity was correlated with the number of drug infusions but not with the number of inactive pokes. We also tested the locomotor activity in the extinction and the morphine-primed reinstatement session. Interestingly, we found that in the first extinction session, although the number of active pokes did not change, the locomotor activity was significantly lower than in the last acquisition session, and this decrease can be maintained for at least six days. Finally, morphine priming enhanced the locomotor activity during the reinstatement test, regardless of if the active pokes were significantly increased or not. Our results clearly suggest that locomotor activity, which may reflect the pharmacological effects of morphine, is different from drug seeking behavior and is a distinctive index in drug self administration.	[Zhang, Jian-Jun] Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Jian-Jun] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Zhang, Jian-Jun; Kong, Qingyao] Peking Univ, Coll Life Sci, Lab Neurobiol, Beijing, Peoples R China; [Zhang, Jian-Jun; Kong, Qingyao] Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Zhang, JJ (corresponding author), Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China.; Zhang, JJ (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.; Zhang, JJ (corresponding author), Peking Univ, Coll Life Sci, Lab Neurobiol, Beijing, Peoples R China.; Zhang, JJ (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China.	zhangjj@psych.ac.cn			National Natural Science Research Foundation of China (NSFC) [31400880]	National Natural Science Research Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Research Foundation of China (NSFC: 31400880).	Bailey A, 2010, EUR J NEUROSCI, V31, P742, DOI 10.1111/j.1460-9568.2010.07104.x; Deiana S, 2007, NEUROPHARMACOLOGY, V52, P646, DOI 10.1016/j.neuropharm.2006.09.007; Dempsey S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00087; DEWIT H, 1983, PSYCHOPHARMACOLOGY, V79, P29, DOI 10.1007/BF00433012; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Frankel PS, 2007, PHARMACOL BIOCHEM BE, V86, P511, DOI 10.1016/j.pbb.2007.01.012; Gardner EL, 2000, AM J ADDICTION, V9, P285, DOI 10.1080/105504900750047355; GRIFFITHS RR, 1975, PSYCHOPHARMACOLOGIA, V43, P81, DOI 10.1007/BF00437619; Hough LB, 2014, EUR J PHARMACOL, V740, P255, DOI 10.1016/j.ejphar.2014.07.028; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Knackstedt LA, 2007, J PHARMACOL EXP THER, V322, P1103, DOI 10.1124/jpet.107.122861; KUCZENSKI R, 1991, J NEUROSCI, V11, P2703; Landa L, 2014, EUR J PHARMACOL, V730, P77, DOI 10.1016/j.ejphar.2014.02.028; Liu Z, 2012, AGU FALL M, V1, DOI DOI 10.1016/J.NEULET.2012.05.003; Liu Z, 2012, NEUROSCI LETT, V526, P39, DOI 10.1016/j.neulet.2012.07.042; Pautassi RM, 2012, PHARMACOL BIOCHEM BE, V100, P630, DOI 10.1016/j.pbb.2011.11.005; Marinelli M, 1998, PSYCHOPHARMACOLOGY, V139, P281, DOI 10.1007/s002130050717; Mizoguchi H, 2010, PSYCHOPHARMACOLOGY, V212, P215, DOI 10.1007/s00213-010-1946-0; NARITA M, 1993, JPN J PHARMACOL, V62, P15, DOI 10.1254/jjp.62.15; ROBERTS DCS, 1993, PSYCHOPHARMACOLOGY, V111, P215, DOI 10.1007/BF02245526; Shalev U, 2001, J NEUROSCI, V21; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174272	10.1371/journal.pone.0174272	http://dx.doi.org/10.1371/journal.pone.0174272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380023	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500038
J	Choi, IS; Choi, BH				Choi, In-Su; Choi, Byoung-Hee			The distinct plastid genome structure of Maackia fauriei (Fabaceae: Papilionoideae) and its systematic implications for genistoids and tribe Sophoreae	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; PHYLOGENETIC-RELATIONSHIPS; THERMOPSIDEAE LEGUMINOSAE; DNA; LEGUMES; STYPHNOLOBIUM; SEQUENCES; PHYLOGEOGRAPHY; EVOLUTION; INSIGHTS	Traditionally, the tribe Sophoreae sensu lato has been considered a basal but also heterogeneous taxonomic group of the papilionoid legumes. Phylogenetic studies have placed Sophoreae sensu stricto (s.s.) as a member of the core genistoids. The recently suggested new circumscription of this tribe involved the removal of traditional members and the inclusion of Euchresteae and Thermopsideae. Nonetheless, definitions and inter-and intra-taxonomic issues of Sophoreae remain unclear. Within the field of legume systematics, the molecular characteristics of a plastid genome (plastome) have an important role in helping to define taxonomic groups. Here, we examined the plastome of Maackia fauriei, belonging to Sophoreae s.s., to elucidate the molecular characteristics of Sophoreae. Its gene contents are similar to the plastomes of other typical legumes. Putative pseudogene rps16 of Maackia and Lupinus species imply independent functional gene loss from the genistoids. Our overall examination of that loss among legumes suggests that it is common among all major clades of Papilionoideae. The M. fauriei plastome has a novel 24-kb inversion in its large single copy region, as well as previously recognized 50-kb and 36-kb inversions. The 36-kb inversion is shared by the core genistoids. The 24-kb inversion is present in the eight genera belonging to three tribes: Euchresteae, Sophoreae s. s., and Thermopsideae. The phylogenetic distribution of this 24-kb inversion strongly supports the monophyly of members of Sophoreae s. s. with Euchresteae and Thermopsideae. Hence, it can be used as a putative synapomorphic characteristic for the newly circumscribed Sophoreae, including Euchresteae and Thermopsideae. However, plastome conformation suggests a slightly narrower taxonomic group because of heterogeneous results from Bolusanthus and Dicraeopetalum. The phylogenetic analysis, based on plastome sequences from 43 legumes, represents well our understanding of legume systematics while resolving the genistoid clade as a sister group to an Old World clade. It also demonstrates the value that plastomes are powerful marker for systematic studies of basal papilionoid legumes.	[Choi, In-Su; Choi, Byoung-Hee] Inha Univ, Dept Biol Sci, Incheon, South Korea	Inha University	Choi, BH (corresponding author), Inha Univ, Dept Biol Sci, Incheon, South Korea.	bhchoi@inha.ac.kr			Inha University grant	Inha University grant	This research was supported by Inha University grant.	Aoki K, 2006, AM J BOT, V93, P1852, DOI 10.3732/ajb.93.12.1852; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Cardoso D, 2013, S AFR J BOT, V89, P58, DOI 10.1016/j.sajb.2013.05.001; Cardoso D, 2012, AM J BOT, V99, P1991, DOI 10.3732/ajb.1200380; Chappil J.A., 1995, ADV LEGUM SYSTEMAT 7, P1; Choi IS, 2016, MITOCHONDRIAL DNA A, V27, P2838, DOI 10.3109/19401736.2015.1053118; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Crisp MD, 2000, ADV LEGUME SYSTEMATI, V9, P249; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Doyle J. J., 2000, ADV LEGUME SYSTEMATI, V9, P1; Doyle JJ, 1997, AM J BOT, V84, P541, DOI 10.2307/2446030; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2007, MOL PHYLOGENET EVOL, V45, P952, DOI 10.1016/j.ympev.2007.09.014; Fougere-Danezan M, 2010, ANN BOT-LONDON, V105, P311, DOI 10.1093/aob/mcp280; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Han JE, 2010, BOT J LINN SOC, V164, P221, DOI 10.1111/j.1095-8339.2010.01084.x; HERENDEEN PS, 1995, ADV LEGUM SYSTEMAT, P123; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kajita T, 2001, SYST BOT, V26, P515; Kellar PR, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400108; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kite GC, 2003, BIOCHEM SYST ECOL, V31, P1409, DOI 10.1016/S0305-1978(03)00118-2; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee JH, 2013, J PLANT RES, V126, P193, DOI 10.1007/s10265-012-0519-1; Lee ST, 2013, BIOCHEM SYST ECOL, V49, P87, DOI 10.1016/j.bse.2013.03.018; Lee WK, 2004, J PLANT RES, V117, P209, DOI 10.1007/s10265-004-0150-x; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; PALOMINO G, 1993, ANN MO BOT GARD, V80, P284, DOI 10.2307/2399828; Pennington RT, 2001, SYST BOT, V26, P537; PENNINGTON RT, 2005, LEGUMES WORLD, P227; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; POLHILL RM, 1981, ADV LEGUME SYSTEMATI, V1, P213; POLHILL RM, 1994, PHYTOCHEMICAL DICT L, V1, pR69; Sabir J, 2014, PLANT BIOTECHNOL J, V12, P743, DOI 10.1111/pbi.12179; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schwarz EN, 2015, J SYST EVOL, V53, P458, DOI 10.1111/jse.12179; SOUSA M, 1993, ANN MO BOT GARD, V80, P270, DOI 10.2307/2399827; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stull GW, 2015, AM J BOT, V102, P1794, DOI 10.3732/ajb.1500298; Sugahara K, 2011, J PLANT RES, V124, P75, DOI 10.1007/s10265-010-0356-z; TUCKER SC, 1994, AM J BOT, V81, P368, DOI 10.2307/2445465; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HC, 2006, BOT J LINN SOC, V151, P365, DOI 10.1111/j.1095-8339.2006.00512.x; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Williams AV, 2016, MOL PHYLOGENET EVOL, V96, P1, DOI 10.1016/j.ympev.2015.11.021; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang ML, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/864804	60	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173766	10.1371/journal.pone.0173766	http://dx.doi.org/10.1371/journal.pone.0173766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399123	gold, Green Submitted, Green Published			2022-12-27	WOS:000399949000005
J	Ito, T; Ichinosawa, T; Shimizu, T				Ito, Tatsuro; Ichinosawa, Takahiro; Shimizu, Takehiko			Streptococcal adhesin SspA/B analogue peptide inhibits adherence and impacts biofilm formation of Streptococcus mutans	PLOS ONE			English	Article							SURFACE PROTEIN-PEPTIDES; COMPETITIVE-BINDING; ORAL STREPTOCOCCI; GORDONII; ANTIGEN; SALIVARIUS; CYSTEINE; BIOLOGY; FAMILY; DOMAIN	Streptococcus mutans, the major causative agent of dental caries, adheres to tooth surfaces via the host salivary glycoprotein-340 (gp340). This adherence can be competitively inhibited by peptides derived from the SspA/B adhesins of Streptococcus gordonii, a human commensal microbe that competes for the same binding sites. Ssp(A4K-A11K), a doublelysine substituted SspA/B peptide analogue, has been shown to exhibit superior in vitro binding affinity for a gp340-derived peptide (SRCRP2), suggesting that Ssp(A4K-A11K) may be of clinical interest. In the present work, we tested the inhibitory effects of Ssp(A4K-A11K) on adherence and biofilm formation of S. mutans by reconstructing an artificial oral environment using saliva-coated polystyrene plates and hydroxyapatite disks. Bacterial adherence (adherence period: 1 h) was assessed by an enzyme-linked immunosorbent assay using biotinylated bacterial cells. Biofilm formation (periods: 8, 11, or 14 h) was assessed by staining and imaging of the sessile cells, or by recovering biofilm cells and plating for cell counts. The pH values of the culture media were measured as a biofilm acido-genicity indicator. Bactericidality was measured by loss of optical density during culturing in the presence of the peptide. We observed that 650 mu M Ssp(A4K-A11K) significantly inhibited adherence of S. mutans to saliva-coated polystyrene; a similar effect was seen on bacterial affinity for SRCRP2. Ssp(A4K-A11K) had lesser effects on the adherence of commensal streptococci. Pretreatment of polystyrene and hydroxyapatite with 650 mu M Ssp(A4K-A11K) significantly attenuated biofilm formation, whether tested with glucose- or sucrose-containing media. The SspA/B peptide's activity did not reflect bactericidality. Strikingly, pH in Ssp-treated 8-h (6.8 +/- 0.06) and 11-h (5.5 +/- 0.06) biofilms showed higher values than the critical pH. Thus, Ssp(A4K-A11K) acts by inhibiting bacterial adherence and cariogrnic biofilm formation. We further consider these results in the context of the safety, specificity, and stability properties of the Ssp(A4K-A11K) peptide.	[Ito, Tatsuro; Ichinosawa, Takahiro; Shimizu, Takehiko] Nihon Univ, Sch Dent Matsudo, Dept Pediat Dent, Chiba, Japan; [Ito, Tatsuro; Shimizu, Takehiko] Nihon Univ, Res Inst Oral Sci, Chiba, Japan	Nihon University; Nihon University	Ito, T (corresponding author), Nihon Univ, Sch Dent Matsudo, Dept Pediat Dent, Chiba, Japan.; Ito, T (corresponding author), Nihon Univ, Res Inst Oral Sci, Chiba, Japan.	ito.tatsuro@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K20610]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) 15K20610 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2012, ACTA ODONTOL SCAND, V70, P504, DOI 10.3109/00016357.2011.640277; APPELBAUM B, 1979, INFECT IMMUN, V25, P717, DOI 10.1128/IAI.25.2.717-728.1979; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2013, ODONTOLOGY, V101, P2, DOI 10.1007/s10266-012-0092-z; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Cheng RP, 2007, BIOCHEMISTRY-US, V46, P10528, DOI 10.1021/bi700701z; de Sousa DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131941; DEMUTH DR, 1990, J BIOL CHEM, V265, P7120; Demuth DR, 1996, MOL MICROBIOL, V20, P403, DOI 10.1111/j.1365-2958.1996.tb02627.x; DEMUTH DR, 1990, MICROB PATHOGENESIS, V9, P199, DOI 10.1016/0882-4010(90)90022-I; FORESTER H, 1983, J GEN MICROBIOL, V129, P2779; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hamada T, 2004, INFECT IMMUN, V72, P4819, DOI 10.1128/IAI.72.8.4819-4826.2004; Ito T, 2016, OJST, V6, P81; Ito T, 2015, OJST, V5, P259; Ito T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032063; Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213; Kim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145844; Koba H, 2009, ORAL MICROBIOL IMMUN, V24, P162, DOI 10.1111/j.1399-302X.2008.00490.x; LILJEMARK WF, 1977, J DENT RES, V56, P157, DOI 10.1177/00220345770560021001; Liljemark WF, 1996, CRIT REV ORAL BIOL M, V7, P180, DOI 10.1177/10454411960070020601; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Oho T, 2004, INFECT IMMUN, V72, P6181, DOI 10.1128/IAI.72.10.6181-6184.2004; OKAHASHI N, 1989, MOL MICROBIOL, V3, P221, DOI 10.1111/j.1365-2958.1989.tb01811.x; Okuda K, 2010, ARCH ORAL BIOL, V55, P754, DOI 10.1016/j.archoralbio.2010.06.014; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Ruhl S, 2000, INFECT IMMUN, V68, P6346, DOI 10.1128/IAI.68.11.6346-6354.2000; RUSSELL RRB, 1979, J GEN MICROBIOL, V114, P109, DOI 10.1099/00221287-114-1-109; Sendamangalam V, 2011, BIOFOULING, V27, P13, DOI 10.1080/08927014.2010.535897; Shimotoyodome A, 2007, ANTIMICROB AGENTS CH, V51, P3634, DOI 10.1128/AAC.00380-07; Sissons CH, 2000, ORAL MICROBIOL IMMUN, V15, P317, DOI 10.1034/j.1399-302x.2000.150509.x; Yoneda M, 2012, INT J DENT, V2012, DOI 10.1155/2012/814913	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175483	10.1371/journal.pone.0175483	http://dx.doi.org/10.1371/journal.pone.0175483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394940	gold, Green Published, Green Submitted			2022-12-27	WOS:000399954800037
J	Xu, WJ; Zheng, LJ; Zheng, Y				Xu, Wenjian; Zheng, Lijun; Zheng, Yong			Prevalence of non-contact and contact childhood sexual abuse: An Internet-based sample of men who have sex with men in China	PLOS ONE			English	Article							HIV-RISK BEHAVIORS; CULTURAL-FACTORS; PHYSICAL ABUSE; BISEXUAL MEN; GAY MEN; METAANALYSIS; WOMEN; INFECTION; HISTORY; VICTIMIZATION	Background The prevalence of childhood sexual abuse (CSA) is high among Western men who have sex with men (MSM), and CSA is associated with certain socio-demographic variables and with human immunodeficiency virus (HIV) status. Little is known about CSA among Chinese MSM; therefore, we explored the prevalence and frequency of non-contact (e.g., sexual invitations, exhibitionism) and contact (e.g., intercourse, genital contact) forms of CSA in an Internet-based sample of MSM in China. We also examined the associations between the participants' socio-demographic characteristics and HIV status, and their histories of CSA. Methods We surveyed MSM from 30 Chinese provinces in 2014-2015; 1,030 (mean age = 25.15 years, SD = 6.32) and 1,020 (mean age = 25.05 years, SD = 5.95) respondents were eligible for inclusion in the non-contact and contact CSA groups, respectively. Results Prevalence of non-contact and contact CSA was 36.2% and 29.8%, respectively; 20.4% and 15.0% had experienced non-contact and contact CSA >= 3 times, respectively. Most respondents were young adults, well educated, single, had never "come out," and self-identified as gay or bisexual men. Univariate analyses showed that respondents who had experienced contact CSA were more likely to be HIV-positive than those who had never experienced contact CSA. Multivariate analyses showed that non-contact CSA was associated with less education, being in a relationship with a woman or a man, and having "come out." Contact CSA was associated with less education, higher income, and being in a relationship with a man. Respondents who had experienced non-contact CSA >= 3 times were more likely to be less educated, "out," and to be in a relationship with a woman or a man. Respondents who had experienced contact CSA >= 3 times were more likely to be less educated and to be in a relationship with a man. Conclusions It is necessary to pay closer attention to CSA among MSM and other sexual minorities in China.	[Xu, Wenjian; Zheng, Lijun; Zheng, Yong] Southwest Univ, MOE, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Xu, Wenjian; Zheng, Lijun; Zheng, Yong] Southwest Univ, Fac Psychol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Zheng, Y (corresponding author), Southwest Univ, MOE, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Zheng, Y (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	zhengy@swu.edu.cn						[Anonymous], 2014, NATL CTR AIDS STD CO; Austin SB, 2008, AM J PUBLIC HEALTH, V98, P1015, DOI 10.2105/AJPH.2006.099473; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Blain LM, 2012, CHILD ABUSE NEGLECT, V36, P413, DOI 10.1016/j.chiabu.2012.03.003; Brennan DJ, 2007, AM J PUBLIC HEALTH, V97, P1107, DOI 10.2105/AJPH.2005.071423; Brewer MB, 2007, PSYCHOL REV, V114, P133, DOI 10.1037/0033-295X.114.1.133; CARBALLODIEGUEZ A, 1995, CHILD ABUSE NEGLECT, V19, P595, DOI 10.1016/0145-2134(95)00018-4; Catania JA, 2008, CHILD ABUSE NEGLECT, V32, P925, DOI 10.1016/j.chiabu.2007.12.010; Chen J, 2014, PLOS ONE, V9; Chen JQ, 2006, J ADOLESCENT HEALTH, V38, P544, DOI 10.1016/j.jadohealth.2005.04.001; Chen JQ, 2014, CHIN J WOMEN CHILD H, V5, p71 ; Chow EPF, 2013, SEX TRANSM DIS, V40, P964, DOI 10.1097/OLQ.0000000000000050; COLLINGS SJ, 1995, CHILD ABUSE NEGLECT, V19, P1, DOI 10.1016/0145-2134(94)00098-F; Dunne MP, 2003, CHILD ABUSE NEGLECT, V27, P141, DOI 10.1016/S0145-2134(02)00539-2; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Fleming JM, 1997, MED J AUSTRALIA, V166, P65, DOI 10.5694/j.1326-5377.1997.tb138722.x; Friedman MS, 2011, AM J PUBLIC HEALTH, V101, P1481, DOI 10.2105/AJPH.2009.190009; Futa KT, 2001, CLIN PSYCHOL-SCI PR, V8, P189, DOI 10.1093/clipsy/8.2.189; Homma Y, 2012, J ADOLESCENT HEALTH, V51, P18, DOI 10.1016/j.jadohealth.2011.12.032; Jiang J, 2014, CHIN J AIDS STD, V22, p818 ; Jinich S, 1998, AIDS BEHAV, V2, P41, DOI DOI 10.1023/A:1022307323744; Kenny MC, 2000, CLIN PSYCHOL REV, V20, P905, DOI 10.1016/S0272-7358(99)00022-7; Lehavot K, 2011, J CONSULT CLIN PSYCH, V79, P159, DOI 10.1037/a0022839; Lenderking WR, 1997, J GEN INTERN MED, V12, P250, DOI 10.1046/j.1525-1497.1997.012004250.x; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; Lu HY, 2013, DRUG ALCOHOL DEPEN, V133, P317, DOI 10.1016/j.drugalcdep.2013.06.013; Meyer IH, 2002, J SEX RES, V39, P139, DOI 10.1080/00224490209552133; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2015, ARCH SEX BEHAV, V44, P1869, DOI 10.1007/s10508-015-0488-2; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; Pereda N, 2009, CLIN PSYCHOL REV, V29, P328, DOI 10.1016/j.cpr.2009.02.007; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Song Y, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24418; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Sweet T, 2012, JAIDS-J ACQ IMM DEF, V59, P400, DOI 10.1097/QAI.0b013e3182400e75; Tang CSK, 2002, CHILD ABUSE NEGLECT, V26, P23, DOI 10.1016/S0145-2134(01)00306-4; Wei CY, 2016, JAIDS-J ACQ IMM DEF, V71, P87, DOI 10.1097/QAI.0000000000000815; Wei CY, 2009, AM J PUBLIC HEALTH, V99, P1978, DOI 10.2105/AJPH.2008.150037; Welles SL, 2009, AM J PUBLIC HEALTH, V99, P1079, DOI 10.2105/AJPH.2007.133280; WYATT GE, 1985, CHILD ABUSE NEGLECT, V9, P507, DOI 10.1016/0145-2134(85)90060-2; Xu Y, 2015, J CHILD SEX ABUS, V24, P315, DOI 10.1080/10538712.2015.1006746; Zhang JY, 2014, CHIN J AIDS STD, V20, P91; Zheng LJ, 2012, ARCH SEX BEHAV, V41, P683, DOI 10.1007/s10508-011-9819-0; Zhu ZY, 2014, CHIN J QUANT TECHN E, V31, P52	44	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175444	10.1371/journal.pone.0175444	http://dx.doi.org/10.1371/journal.pone.0175444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394934	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800035
J	Manzano-Garcia, G; Ayala, JC				Manzano-Garcia, Guadalupe; Ayala, Juan-Carlos			Insufficiently studied factors related to burnout in nursing: Results from an e-Delphi study	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; PSYCHOLOGICAL EMPOWERMENT; RISK-FACTORS; JOB BURNOUT; NURSES; CARE; PERSONALITY; ENVIRONMENT; PREVALENCE; SATISFACTION	Objective This study aimed to identify potentially important factors in explaining burnout in nursing that have been insufficiently studied or ignored. Methods A three-round Delphi study via e-mail correspondence was conducted, with a group of 40 European experts. The e-Delphi questionnaire consisted of 52 factors identified from a literature review. Experts rated and scored the importance of factors in the occurrence of burnout and the degree of attention given by researchers to each of the variables listed, on a sixpoint Likert scale. We used the agreement percentage (> 80%) to measure the level of consensus between experts. Furthermore, to confirm the level of consensus, we also calculated mean scores and modes. Regardless of the degree of consensus reached by the experts, we have calculated the mean of the stability of the answers for each expert (individual's qualitative stability) and the mean of the stability percentages of the experts (qualitative group stability). Results The response rate in the three rounds was 93.02% (n = 40). Eight new factors were suggested in the first round. After modified, the e-Delphi questionnaire in the second and third rounds had 60 factors. All the factors reached the third round with a consensus level above 80% in terms of the attention that researchers gave them in their studies. Moreover, the data show a total mean qualitative group stability of 96.21%. In the third round 9 factors were classified by experts as 'studied very little', 17 as 'studied little' and 34 as 'well studied' Conclusion Findings show that not all the factors that may influence nursing burnout have received the same attention from researchers. The panel of experts has identified factors that, although important in explaining burnout, have been poorly studied or even forgotten. Our results suggest that further study into factors such as a lack of recognition of part of the tasks that nurses perform, feminine stereotype or excessive bureaucracy is needed for a better understanding of this syndrome and improve the quality of life in nurses.	[Manzano-Garcia, Guadalupe] Univ La Rioja, Dept Sci Educ, La Rioja, Spain; [Ayala, Juan-Carlos] Univ La Rioja, Dept Econ & Business, La Rioja, Spain	Universidad de La Rioja; Universidad de La Rioja	Ayala, JC (corresponding author), Univ La Rioja, Dept Econ & Business, La Rioja, Spain.	juan-carlos.ayala@unirioja.es	manzano, guadalupe/AAA-5932-2019; Ayala, Juan/AAA-5954-2019	Ayala Calvo, Juan-Carlos/0000-0002-0883-2149				Abdo SAM, 2015, E MEDITERR HEALTH J, V21, P906, DOI 10.26719/2015.21.12.906; Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Albendin L, 2016, REV LAT AM PSICOL, V48, P137, DOI 10.1016/j.rlp.2015.05.004; Allen J, 2002, WESTERN J NURS RES, V24, P905, DOI 10.1177/019394502237701; [Anonymous], 2004, Nurs Stand, V18, P14; Ariapooran Saeed, 2014, Iran J Nurs Midwifery Res, V19, P279; Bakker AB, 2000, ANXIETY STRESS COPIN, V13, P247, DOI 10.1080/10615800008549265; Bakker AB, 2002, ANXIETY STRESS COPIN, V15, P245, DOI 10.1080/1061580021000020716; Berry J. W., 2002, CROSS CULTURAL PSYCH, DOI DOI 10.1017/CBO9780511974274; Bianchi R, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00158; Brady Mike, 2015, Emerg Nurse, V23, P32, DOI 10.7748/en.23.4.32.e1448; Canadas-De La Fuente GA, 2015, INT J NURS STUD, V52, P240, DOI 10.1016/j.ijnurstu.2014.07.001; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; Clausen T, 2012, J ADV NURS, V68, P127, DOI 10.1111/j.1365-2648.2011.05724.x; Consiglio C, 2014, MED LAV, V105, P255; Currie EJ, 2013, INT NURS REV, V60, P67, DOI 10.1111/j.1466-7657.2012.00997.x; DAJANI JS, 1979, TECHNOL FORECAST SOC, V13, P83, DOI 10.1016/0040-1625(79)90007-6; das Merces MC, 2016, PSICOL-REFLEX CRIT, V29, DOI 10.1186/s41155-016-0051-7; Elst TV, 2016, NURS OUTLOOK, V64, P542, DOI 10.1016/j.outlook.2016.06.004; Engelbrecht M, 2008, P EUR APPL BUS C EAB, P8; Errasti-Ibarrondo B, 2012, AN SIST SANIT NAVAR, V35, P269, DOI 10.4321/s1137-66272012000200009; Fairclough Norman., 2001, LANGUAGE POWER, V2ndedition; Finfgeld-Connett D, 2005, J NURS SCHOLARSHIP, V37, P4, DOI 10.1111/j.1547-5069.2005.00004.x; Furingsten L, 2015, NURS ETHICS, V22, P176, DOI 10.1177/0969733014533234; Garrosa E, 2010, INT J NURS STUD, V47, P205, DOI 10.1016/j.ijnurstu.2009.05.014; Gil-Monte Pedro R., 2002, Psicol. Estud., V7, P3, DOI 10.1590/S1413-73722002000100003; Gordon, 2006, COMPLEXITIES CARE NU, P122; Gordon S., 2005, NURSING ODDS, P290; Grzywacz JG, 2006, RES NURS HEALTH, V29, P414, DOI 10.1002/nur.20133; Hamaideh Shaher H, 2011, Issues Ment Health Nurs, V32, P234, DOI 10.3109/01612840.2010.546494; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Iliopoulou KK, 2010, J ADV NURS, V66, P2520, DOI 10.1111/j.1365-2648.2010.05424.x; Kanter R.M., 2008, MEN WOMEN CORPORATIO; Kearns S., 2009, WHY PUBLIC IMAGE NUR; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; Kiekkas P, 2006, J CLIN NURS, V15, P178, DOI 10.1111/j.1365-2702.2006.01243.x; Kubo Tomohide, 2013, Sangyo Eiseigaku Zasshi, V55, P90; Lanquetin JP, 2013, SOINS PSYCHIAT, V284, P12; Laschinger H.K.S., 2003, LONGWOODS REV, V1, P2, DOI DOI 10.12927/HCQ.2003.17242; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Leineweber C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096991; Leiter MP, 2004, R OCC ST W, V3, P91; Leiter MP, 2008, J NURS MANAGE, V16, P1; Li BY, 2013, INT J NURS STUD, V50, P281, DOI 10.1016/j.ijnurstu.2012.07.001; Li H, 2004, WORLDV EVID-BASED NU, V1, P185; Listone HA, 2008, DELPHI METHOD TECHNI; Loera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114987; Lohmer M, 2013, PSYCHOTHERAPEUT, V58, P117, DOI 10.1007/s00278-013-0966-8; Manojlovich M, 2002, J NURS ADMIN, V32, P586, DOI 10.1097/00005110-200211000-00006; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; Maslach C., 2008, TRUTH BURNOUT ORG CA; Maslach C, 2016, MASLACH BURNOUT INVE; Maslach C., 2005, HDB STRESS MED HLTH, P153, DOI DOI 10.1201/9781420039702.CH8; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; Meadus RJ, 2011, NURS FORUM, V46, P269, DOI 10.1111/j.1744-6198.2011.00239.x; Montalban FM, 2000, REV PSICOLOGIA TRABA, V16, P103; Moreno-Jimenez B., 2003, REV COLOMB PSICOL, V12, P9; Mullan B, 2008, J RES NURS, V13, P527, DOI 10.1177/1744987107085500; Nie ZH, 2015, INT J CLIN EXP MED, V8, P19144; O'Brien JL, 2011, NEPHROL NURS J, V38, P475; Olanrewaju A.S., 2013, INT, V1, P112; Palaiou K, 2016, PERS INDIV DIFFER, V88, P12, DOI 10.1016/j.paid.2015.08.029; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Prandir R, 2007, AGORA ENFERMERIA, V11, P1156; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Ramelet AS, 2012, AUST CRIT CARE, V25, P41, DOI 10.1016/j.aucc.2011.08.003; Rousseau D., 1995, PSYCHOL CONTRACTS OR; Sanclemente-Vinue I, 2014, METAS ENFERM, V17, P1138; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli W.B., 2007, HDB HUMAN FACTORS ER, P217; Schwarzkopf K, 2002, BURNOUT RES, V3, P25; Seligman MEP, 2003, PSYCHOL INQ, V14, P159; Shirom A, 2005, WORK STRESS, V19, P263, DOI 10.1080/02678370500376649; Singh C, 2016, INT J MENT HEALTH NU, V25, P50; Singh C, 2015, ISSUES MENT HEALTH N, V36, P528, DOI 10.3109/01612840.2014.996838; SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865; Sun C, 2012, J NURS RES, V64, P466; Tartakovsky E, 2013, RES DEV DISABIL, V34, P3807, DOI 10.1016/j.ridd.2013.08.026; Tausch N, 2010, SOC PSYCHOL-GERMANY, V41, P169, DOI 10.1027/1864-9335/a000024; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Tunlind A, 2015, INTENS CRIT CARE NUR, V31, P116, DOI 10.1016/j.iccn.2014.07.005; Van Bogaert P, 2013, INT J NURS STUD, V50, P1667, DOI 10.1016/j.ijnurstu.2013.05.010; VANYPEREN NW, 1992, J APPL SOC PSYCHOL, V22, P173, DOI 10.1111/j.1559-1816.1992.tb01534.x; Vargas C, 2014, INT J CLIN HLTH PSYC, V14, P28, DOI 10.1016/S1697-2600(14)70034-1; Workgroup of European Nurse Researchers (WENR), 2012, WORKGROUP EUROPEAN N; Wu S, 2016, ONCOL NURS FORUM, V43, pE161, DOI 10.1188/16.ONF.E161-E169	88	11	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175352	10.1371/journal.pone.0175352	http://dx.doi.org/10.1371/journal.pone.0175352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388660	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800042
J	Tsai, WC; Kung, PT; Wang, YH; Huang, KH; Liu, SA				Tsai, Wen-Chen; Kung, Pei-Tseng; Wang, Yueh-Hsin; Huang, Kuang-Hua; Liu, Shih-An			Influence of time interval from diagnosis to treatment on survival for oral cavity cancer: A nationwide cohort study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TREATMENT DELAY; NECK-CANCER; HEAD; IMPACT; EXPERIENCE; PROGNOSIS	Objectives We aimed to explore the relationship between the time interval from diagnosis to treatment and survival of oral cavity squamous cell carcinoma patients. Materials and methods A population-based study was conducted between 2004 and 2010. Claims data of oral squamous cell carcinoma patients were retrieved from the Taiwan Cancer Registry Database. Secondary data were obtained from Taiwan's National Health Insurance Research Database. Results A total of 21,263 patients were included in the final analysis. The majority of the patients received treatment within 30 days of diagnosis (n = 18,193, 85.5%), while 572 patients (2.7%) underwent treatment after 120 days. The patients who were treated after 120 days had a higher risk of death when compared to those treated within 30 days (Hazard ratio: 1.32, 95% Confidence intervals: 1.19 to 1.47). Conclusion A longer time interval from diagnosis to treatment was found to be associated with a poorer prognosis among patients suffering from oral squamous cell carcinoma.	[Tsai, Wen-Chen; Wang, Yueh-Hsin; Huang, Kuang-Hua] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Liu, Shih-An] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Liu, Shih-An] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Liu, Shih-An] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liu, SA (corresponding author), Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan.; Liu, SA (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Liu, SA (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	saliu@vghtc.gov.tw	; Tsai, Wen-Chen/O-3095-2015	Wang, Yueh-Hsin/0000-0002-1282-5945; Tsai, Wen-Chen/0000-0002-9684-0789	Ministry of Science and Technology, Taiwan, Republic of China [MOST 104-2410-H-039-002]	Ministry of Science and Technology, Taiwan, Republic of China	This study was funded by grants from the Ministry of Science and Technology, Taiwan, Republic of China (MOST 104-2410-H-039-002) (WCT). Website: https://www.most.gov.tw/en/public. The Ministry of Science and Technology had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Chen SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131305; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elit LM, 2014, J CLIN ONCOL, V32, P27, DOI 10.1200/JCO.2013.51.3671; Esmaelbeigi F, 2014, ARCH IRAN MED, V17, P253, DOI 014174/AIM.007; Gomez DR, 2015, RADIOTHER ONCOL, V115, P257, DOI 10.1016/j.radonc.2015.04.010; Hansen RP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-284; Hansen RP, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-100; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Huo Q, 2015, ANN SURG ONCOL, V22, P883, DOI 10.1245/s10434-014-4076-9; Joshi P, 2014, INDIAN J CANCER, V51, P95, DOI 10.4103/0019-509X.137934; Kowalski LP, 2001, ORAL ONCOL, V37, P94, DOI 10.1016/S1368-8375(00)00066-X; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040767; Liao CT, 2010, ANN SURG ONCOL, V17, P2984, DOI 10.1245/s10434-010-1174-1; Lin JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124322; Liu SA, 2012, EUR ARCH OTO-RHINO-L, V269, P1665, DOI 10.1007/s00405-011-1806-5; Murphy CT, 2016, J CLIN ONCOL, V34, P169, DOI 10.1200/JCO.2015.61.5906; Ohlstein JF, 2015, JAMA OTOLARYNGOL, V141, P804, DOI 10.1001/jamaoto.2015.1467; Perri T, 2014, INT J GYNECOL CANCER, V24, P1326, DOI 10.1097/IGC.0000000000000211; Ragin C, 2016, CARCINOGENESIS; Stefanuto P, 2014, OR SURG OR MED OR PA, V117, P424, DOI 10.1016/j.oooo.2013.12.407; Teppo H, 2009, ORAL ONCOL, V45, P692, DOI 10.1016/j.oraloncology.2008.10.012; Tsai WC, 2015, ORAL ONCOL, V51, P105, DOI 10.1016/j.oraloncology.2014.11.006; van Harten MC, 2015, ORAL ONCOL, V51, P272, DOI 10.1016/j.oraloncology.2014.12.003; van Harten MC, 2014, ORAL ONCOL, V50, P282, DOI 10.1016/j.oraloncology.2013.12.018; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Xavier FD, 2014, CLINICS, V69, P367, DOI 10.6061/clinics/2014(05)12; Yun YH, 2012, ANN ONCOL, V23, P2731, DOI 10.1093/annonc/mds101	28	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175148	10.1371/journal.pone.0175148	http://dx.doi.org/10.1371/journal.pone.0175148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388649	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800025
J	Wang, B; Studdert, DM; Sarpatwari, A; Franklin, JM; Landon, J; Kesselheim, AS				Wang, Bo; Studdert, David M.; Sarpatwari, Ameet; Franklin, Jessica M.; Landon, Joan; Kesselheim, Aaron S.			The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine	PLOS ONE			English	Article							UNITED-STATES; TEMPORARY RECOMMENDATIONS	In the past decade, the federal government has frequently investigated and prosecuted pharmaceutical manufacturers for illegal promotion of drugs for indications not approved by the Food and Drug Administration (FDA) ("off-label" uses). State governments can choose to coordinate with the federal investigation, or pursue their own independent state investigations. One of the largest-ever off-label prosecutions relates to the atypical antipsychotic drug olanzapine (Zyprexa). In a series of settlements between 2008 and 2010, Eli Lilly paid $1.4 billion to the federal government and over $290 million to state governments. We examined the effect of these settlements on off-label prescribing of this medication, taking advantage of geographical differences in states' involvement in the investigations and the timing of the settlements. However, we did not find a reduction in off-label prescribing; rather, there were no prescribing changes among states that joined the federal investigation, those that pursued independent state investigations, and states that pursued no investigations at all. Since the settlements of state investigations of off-label prescribing do not appear to significantly impact prescribing rates, policymakers should consider alternate ways of reducing the prevalence of non-evidence-based off-label use to complement their ongoing investigations.	[Wang, Bo] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Wang, Bo; Sarpatwari, Ameet; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 75 Francis St, Boston, MA 02115 USA; [Wang, Bo; Sarpatwari, Ameet; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA; [Studdert, David M.] Stanford Univ, Ctr Hlth Policy, Ctr Primary Care & Outcomes Res, Stanford Med Sch, Stanford, CA USA; [Studdert, David M.] Stanford Univ, Stanford Law Sch, Stanford, CA USA; [Franklin, Jessica M.; Landon, Joan] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Franklin, Jessica M.; Landon, Joan] Harvard Med Sch, Boston, MA USA	Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 75 Francis St, Boston, MA 02115 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	akesselheim@partners.org	Studdert, David/AAF-3116-2021; Kesselheim, Aaron/R-6793-2017	Studdert, David/0000-0003-0585-5537; Kesselheim, Aaron/0000-0002-8867-2666	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Greenwall Foundation	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Greenwall Foundation	Dr. Kesselheim's work is funded by the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science and Greenwall Foundation. No other coauthors have funding statements or financial disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administrative Office of the U.S. Courts, 2016, PACER PUBL ACC COURT; [Anonymous], 2010, INDIANAPOLIS BUSINES; [Anonymous], 2008, INF HEALTHC PROF CON; Berenson A., 2006, NY TIMES; Braillon A, 2016, HEALTH POLICY, V120, P890, DOI 10.1016/j.healthpol.2016.06.012; Buse JB, 2003, J CLIN EPIDEMIOL, V56, P164, DOI 10.1016/S0895-4356(02)00588-7; Conti RM, 2013, J CLIN ONCOL, V31, P1134, DOI 10.1200/JCO.2012.42.7252; Degrassat-Theas A, 2015, HEALTH POLICY, V119, P1399, DOI 10.1016/j.healthpol.2015.09.003; Eli Lilly and Company, 2010, LILL REP 4 QUART FUL; Eli Lilly and Company, 2008, EL LILL CO RES INV I; Justice Department Press Release, 2022, JUST DEP INV LEADS S; Kesselheim AS, 2008, ANN INTERN MED, V149, P342, DOI 10.7326/0003-4819-149-5-200809020-00009; Kesselheim AS, 2011, HLTH AFF MILLWOOD, V30, P2381; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Sheller P.C., 1 4 BILLION SETTLEME; Sohn M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003784; US Department of Justice, 2012, GLAXOSMITHKLINE PLEA; US Department of Justice, 2009, EL LILL CO AGR PAY 1; US Department of Justice, 2013, JOHNS JOHNS PAY MOR; US Department of Justice, 2012, ABB LAB PAY 1 5 BILL; US Food and Drug Administration, APPR PACK; US Food and Drug Administration, 2009, FED REGISTER, V74, P1694; US Food and Drug Administration, GUID IND DISTR SCI M; Wang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152195; Wang B, 2015, AM HEART J, V169, P379, DOI 10.1016/j.ahj.2014.12.014; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539	27	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175313	10.1371/journal.pone.0175313	http://dx.doi.org/10.1371/journal.pone.0175313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388667	Green Published, gold			2022-12-27	WOS:000399375800039
J	Bruckner, A; Heethoff, M; Bluthgen, N				Brueckner, Adrian; Heethoff, Michael; Bluethgen, Nico			The relationship between epicuticular long-chained hydrocarbons and surface area-volume ratios in insects (Diptera, Hymenoptera, Lepidoptera)	PLOS ONE			English	Article							CUTICULAR HYDROCARBON; RESPONSE DIVERSITY; WATER-BALANCE; DROSOPHILA; PERMEABILITY; PHEROMONES; PROFILES; LIPIDS; COMMUNICATION; RESILIENCE	Long-chain cuticular hydrocarbons (CHCs) are common components of the epicuticle of terrestrial arthropods. CHC serve as a protective barrier against environmental influences but also act as semiochemicals in animal communication. Regarding the latter aspect, speciesor intra-functional group specific CHCs composition and variation are relatively well studied. However, comparative knowledge about the relationship of CHC quantity and their relation to surface area-volume ratios in the context of water loss and protection is fragmentary. Hence, we aim to study the taxon-specific relationship of the CHC amount and surface-area to volume ratio related to their functional role (e.g. in water loss). We focused on flower visiting insects and analyzed the CHC amounts of three insect orders (Hymenoptera, Lepidoptera and Diptera) using gas chromatography-mass spectrometry (GC-MS). We included 113 species from two grassland plots, quantified their CHCs, and measured their body mass and surface area. We found differences in the surface area, CHCs per body mass and the CHC density (= amount of CHCs per surface area) across the three insect taxa. Especially the Hymenoptera had a higher CHC density compared to Diptera and Lepidoptera. CHC density could be explained by surface area-volume ratios in Hymenoptera but not in Diptera and Lepidoptera. Unexpectedly, CHC density decreased with increasing surface area-volume ratios.	[Brueckner, Adrian; Heethoff, Michael; Bluethgen, Nico] Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany	Technical University of Darmstadt	Bruckner, A (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany.	adrian.brueckner@gmail.com	Blüthgen, Nico/F-5983-2010		German National Academic Foundation (Studienstiftung des deutschen Volkes); DFG Priority Program 1374 "Biodiversity-Exploratories" [BL9602-1]	German National Academic Foundation (Studienstiftung des deutschen Volkes); DFG Priority Program 1374 "Biodiversity-Exploratories"	AB was supported by a scholarship for under graduate students as well as a PhD scholarship provided by the German National Academic Foundation (Studienstiftung des deutschen Volkes). This work has partly been funded by the DFG Priority Program 1374 "Biodiversity-Exploratories" (BL9602-1) to NB funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, R LANG ENV STAT COMP; Arcaz AC, 2016, J EXP BIOL, V219, P1675, DOI 10.1242/jeb.135665; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Cariveau DP, 2013, ECOL LETT, V16, P903, DOI 10.1111/ele.12126; Chung H, 2015, BIOESSAYS, V37, P822, DOI 10.1002/bies.201500014; Colazza S, 2007, J CHEM ECOL, V33, P1405, DOI 10.1007/s10886-007-9300-7; Ferveur JF, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P325, DOI 10.1017/CBO9780511711909.016; Freund L, 2014, APPL VEG SCI, V17, P74, DOI 10.1111/avsc.12052; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Galilei G, 1638, DISCORSI DIMOSTRAZIO; Gefen E, 2015, COMP BIOCHEM PHYS A, V182, P58, DOI 10.1016/j.cbpa.2014.12.004; Gibbs AG, 1998, AM ZOOL, V38, P471; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Gibbs AG, 2002, J INSECT PHYSIOL, V48, P391, DOI 10.1016/S0022-1910(02)00059-8; Gibbs AG, 2001, PHYSIOL BIOCHEM ZOOL, V74, P520, DOI 10.1086/322162; Gibbs AG, 1995, COMP BIOCH PHYSL B, V112, P391; Gibbs AG, 2011, J INSECT PHYSIOL, V57, P1066, DOI 10.1016/j.jinsphys.2011.05.003; Gibbs AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P100, DOI 10.1017/CBO9780511711909.007; Hadley N. F, 1994, WATER RELATIONS TERR; HADLEY NF, 1981, INSECT BIOCHEM, V11, P173, DOI 10.1016/0020-1790(81)90093-7; HADLEY NF, 1977, INSECT BIOCHEM, V7, P277, DOI 10.1016/0020-1790(77)90025-7; HADLEY NF, 1989, PROG LIPID RES, V28, P1, DOI 10.1016/0163-7827(89)90005-2; HICKMAN JC, 1975, OECOLOGIA, V21, P117, DOI 10.1007/BF00345554; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ingleby FC, 2015, INSECTS, V6, P732, DOI 10.3390/insects6030732; Jennings JH, 2014, J INSECT PHYSIOL, V61, P16, DOI 10.1016/j.jinsphys.2013.12.004; Kather R, 2012, PHYSIOL ENTOMOL, V37, P25, DOI 10.1111/j.1365-3032.2011.00826.x; Kuhsel S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8989; Kuhsel S, 2016, INSECT SCI; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Liebig J, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P254, DOI 10.1017/CBO9780511711909.014; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; Menzel F, P R SOC LON IN PRESS; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Millar JG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P390, DOI 10.1017/CBO9780511711909.019; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Nehring V, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0089-5; Nelson DR, 1995, INSECT WAXES; Peters MK, 2016, J BIOGEOGR; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Raspotnig G, 2008, ANN ZOOL, V58, P445, DOI 10.3161/000345408X326771; Rosillo-Calle F., 2007, BIOMASS ASSESSMENT H; Saint-Germain M, 2007, J APPL ECOL, V44, P330, DOI 10.1111/j.1365-2664.2006.01269.x; Sharma KR, 2015, CELL REP, V12, P1261, DOI 10.1016/j.celrep.2015.07.031; Stinziano JR, 2015, COMP BIOCHEM PHYS A, V180, P38, DOI 10.1016/j.cbpa.2014.11.004; TOOLSON EC, 1982, J EXP ZOOL, V222, P249, DOI 10.1002/jez.1402220307; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; von Beeren Christoph, 2011, BMC Ecology, V11, P30, DOI 10.1186/1472-6785-11-30; Wachter GA, 2015, MOL ECOL, V24, P863, DOI 10.1111/mec.13077; Witjes S, 2009, J CHEM ECOL, V35, P1320, DOI 10.1007/s10886-009-9720-7; Wurdack M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1777	54	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175001	10.1371/journal.pone.0175001	http://dx.doi.org/10.1371/journal.pone.0175001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384308	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900070
J	Kolbel, H; Hauffa, BP; Wudy, SA; Bouikidis, A; Della Marina, A; Schara, U				Kolbel, Heike; Hauffa, Berthold P.; Wudy, Stefan A.; Bouikidis, Anastasios; Della Marina, Adela; Schara, Ulrike			Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III (vol 12, e0173144, 2017)	PLOS ONE			English	Correction													Wudy, Stefan/ABC-7173-2020					Kolbel H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173144	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175611	10.1371/journal.pone.0175611	http://dx.doi.org/10.1371/journal.pone.0175611			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384258	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900186
J	Madsen, DE; Nichols, TC; Merricks, EP; Waters, EK; Wiinberg, B				Madsen, Daniel Elenius; Nichols, Timothy C.; Merricks, Elizabeth P.; Waters, Emily K.; Wiinberg, Bo			Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test - Demonstrated in vitro and ex vivo	PLOS ONE			English	Article							ANIMAL-MODELS; FACTOR-VIII; HEMOSTASIS	Introduction Canine models of severe haemophilia resemble their human equivalents both regarding clinical bleeding phenotype and response to treatment. Therefore pre-clinical studies in haemophilia dogs have allowed researchers to make valuable translational predictions regarding the potency and efficacy of new anti-haemophilia drugs (AHDs) in humans. To refine in vivo experiments and reduce number of animals, such translational studies are ideally preceded by in vitro prediction of compound efficacy using a plasma based global coagulation method. One such widely used method is the thrombin generation test (TGT). Unfortunately, commercially available TGTs are incapable of distinguishing between normal and haemophilia canine plasma, and therefore in vitro prediction using TGT has so far not been possible in canine plasma material. Aim Establish a modified TGT capable of: 1) distinguishing between normal and haemophilia canine plasma, 2) monitoring correlation between canine plasma levels of coagulation factor VIII (FVIII) and IX (FIX) and thrombin generation, 3) assessing for agreement between compound activity and thrombin generation in ex vivo samples. Methods A modified TGT assay was established where coagulation was triggered using a commercially available activated partial thromboplastin time reagent. Results With the modified TGT a significant difference was observed in thrombin generation between normal and haemophilia canine plasma. A dose dependent thrombin generation was observed when assessing haemophilia A and B plasma spiked with dilution series of FVIII and FIX, respectively. Correlation between FVIII activity and thrombin generation was observed when analyzing samples from haemophilia A dogs dosed with canine FVIII. Limit of detection was 0.1% (v/v) FVIII or FIX. Conclusion A novel modified TGT suitable for monitoring and prediction of replacement therapy efficacy in plasma from haemophilia A and B dogs was established.	[Madsen, Daniel Elenius; Wiinberg, Bo] Novo Nordisk AS, Global Res, Translat Haemophilia Pharmacol, Malov, Denmark; [Nichols, Timothy C.; Merricks, Elizabeth P.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Waters, Emily K.] Novo Nordisk AS, Global Res, Haemophilia Biol, Malov, Denmark	Novo Nordisk; University of North Carolina; University of North Carolina Chapel Hill; Novo Nordisk	Madsen, DE (corresponding author), Novo Nordisk AS, Global Res, Translat Haemophilia Pharmacol, Malov, Denmark.	dlm@novonordisk.com			Novo Nordisk A/S, Denmark	Novo Nordisk A/S, Denmark(Novo Nordisk)	This work was funded Novo Nordisk A/S, Denmark, a commercial company. Novo Nordisk A/S, Denmark also provided support in the form of salaries for authors DEM, EPM and BW, and unrestricted funding for author TCN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran-Miranda CP, 2005, HAEMOPHILIA, V11, P326, DOI 10.1111/j.1365-2516.2005.01107.x; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; BRINKHOUS KM, 1989, P NATL ACAD SCI USA, V86, P1382, DOI 10.1073/pnas.86.4.1382; Dargaud Y, 2010, HAEMOPHILIA, V16, P223, DOI 10.1111/j.1365-2516.2009.02082.x; Dargaud Y, 2012, THROMB RES, V130, P929, DOI 10.1016/j.thromres.2012.07.017; Den Uijl IEM, 2011, HAEMOPHILIA, V17, P849, DOI 10.1111/j.1365-2516.2011.02539.x; EVANS JP, 1989, P NATL ACAD SCI USA, V86, P10095, DOI 10.1073/pnas.86.24.10095; Franchini M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-24; Hansson KM, 2015, HAEMOPHILIA OFFICIAL; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Kempton CL, 2014, BLOOD, V124, P3365, DOI 10.1182/blood-2014-05-577643; Lozier JN, 2013, SEMIN HEMATOL, V50, P175, DOI 10.1053/j.seminhematol.2013.03.023; Lozier JN, 2002, P NATL ACAD SCI USA, V99, P12991, DOI 10.1073/pnas.192219599; Luna-Zaizar H, 2014, HAEMOPHILIA, V20, pE7, DOI 10.1111/hae.12309; Sabatino DE, 2012, PROG MOL BIOL TRANSL, V105, P151, DOI 10.1016/B978-0-12-394596-9.00006-8; Sabatino DE, 2009, BLOOD, V114, P4562, DOI 10.1182/blood-2009-05-220327; Santagostino E, 2010, J THROMB HAEMOST, V8, P737, DOI 10.1111/j.1538-7836.2010.03767.x; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; von Drygalski A, 2014, J THROMB HAEMOST, V12, P363, DOI 10.1111/jth.12489; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175030	10.1371/journal.pone.0175030	http://dx.doi.org/10.1371/journal.pone.0175030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384182	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900074
J	Suttisunhakul, V; Pumpuang, A; Ekchariyawat, P; Wuthiekanun, V; Elrod, MG; Turner, P; Currie, BJ; Phetsouvanh, R; Dance, DAB; Limmathurotsakul, D; Peacock, SJ; Chantratita, N				Suttisunhakul, Vichaya; Pumpuang, Apinya; Ekchariyawat, Peeraya; Wuthiekanun, Vanaporn; Elrod, Mindy G.; Turner, Paul; Currie, Bail J.; Phetsouvanh, Rattanaphone; Dance, David A. B.; Limmathurotsakul, Direk; Peacock, Sharon J.; Chantratita, Narisara			Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of Burkholderia pseudomallei from Asia and Australia and differentiation between Burkholderia species	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MALDI-TOF MS; III SECRETION SYSTEM; RAPID IDENTIFICATION; PCR ASSAY; CLINICAL-EVALUATION; DIAGNOSIS; MELIOIDOSIS; ACCURACY; CLUSTER	Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is increasingly used for rapid bacterial identification. Studies of Burkholderia pseudomallei identification have involved small isolate numbers drawn from a restricted geographic region. There is a need to expand the reference database and evaluate B. pseudomallei from a wider geographic distribution that more fully captures the extensive genetic diversity of this species. Here, we describe the evaluation of over 650 isolates. Main spectral profiles (MSP) for 26 isolates of B. pseudomallei (N = 5) and other Burkholderia species (N = 21) were added to the Biotyper database. MALDI-TOF MS was then performed on 581 B. pseudomallei, 19 B. mallei, 6 B. thailandensis and 23 isolates representing a range of other bacterial species. B. pseudomallei originated from northeast and east Thailand (N = 524), Laos (N = 12), Cambodia (N = 14), Hong Kong (N = 4) and Australia (N = 27). All 581 B. pseudomallei were correctly identified, with 100% sensitivity and specificity. Accurate identification required a minimum inoculum of 5 x 10(7) CFU/ml, and identification could be performed on spiked blood cultures after 24 hours of incubation. Comparison between a dendrogram constructed from MALDI-TOF MS main spectrum profiles and a phylogenetic tree based on recA gene sequencing demonstrated that MALDI-TOF MS distinguished between B. pseudomallei and B. mallei, while the recA tree did not. MALDI-TOF MS is an accurate method for the identification of B. pseudomallei, and discriminates between this and other related Burkholderia species.	[Suttisunhakul, Vichaya; Ekchariyawat, Peeraya; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Pumpuang, Apinya] Navamindradhiraj Univ, Dept Clin Pathol, Fac Med, Bangkok, Thailand; [Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Elrod, Mindy G.] Ctr Dis Control & Prevent CDC, Div High Consequence Pathogens & Pathol, Bacterial Special Pathogens Branch, Natl Ctr Zoonot & Emerging Infect Dis, Atlanta, GA USA; [Turner, Paul] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Turner, Paul] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Currie, Bail J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia; [Currie, Bail J.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Phetsouvanh, Rattanaphone; Dance, David A. B.] Mahosot Hosp, Microbiol Lab, Wellcome Trust Res Unit, Lao Oxford Mahosot Hosp, Viangchan, Laos; [Phetsouvanh, Rattanaphone; Dance, David A. B.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Dance, David A. B.; Peacock, Sharon J.] London Sch Hyg & Trop Med, London, England; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Centers for Disease Control & Prevention - USA; University of Oxford; Charles Darwin University; Menzies School of Health Research; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Mahidol University	Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.; Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	narisara@tropmedres.ac	Chantratita, Narisara/P-2169-2019; Peacock, Sharon J/ABE-6331-2020	Dance, David/0000-0001-9189-7244; Peacock, Sharon/0000-0002-1718-2782; Turner, Paul/0000-0002-1013-7815	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U01AI115520]; Faculty of Tropical Medicine Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI115520] Funding Source: NIH RePORTER	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK(Wellcome Trust); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Faculty of Tropical Medicine Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z to NC) (http://www.wellcome.ac.uk) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number U01AI115520 to NC (https://www.nih.gov). VS was supported by a Ph.D. scholarship from Faculty of Tropical Medicine Mahidol University (www.tm.mahidol.ac.th). The funder had no role in study design and interpretation, or the decision to publish, or preparation of the manuscript.	Amornchai P, 2007, J CLIN MICROBIOL, V45, P3774, DOI 10.1128/JCM.00935-07; Anuntagool N, 2000, J MED MICROBIOL, V49, P1075, DOI 10.1099/0022-1317-49-12-1075; Boyd MA, 2015, J APPL MICROBIOL, V118, P1199, DOI 10.1111/jam.12769; Calderaro A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36082; Calderaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088895; Chantratita N, 2006, AM J TROP MED HYG, V74, P345, DOI 10.4269/ajtmh.2006.74.345; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Chantratita N, 2008, J CLIN MICROBIOL, V46, P568, DOI 10.1128/JCM.01817-07; Chantratita N, 2007, AM J TROP MED HYG, V77, P814, DOI 10.4269/ajtmh.2007.77.814; Chantratita N, 2013, AM J TROP MED HYG, V89, P971, DOI 10.4269/ajtmh.13-0212; Cox Christopher R, 2014, Bacteriophage, V4, pe29011; Dingle TC, 2014, J CLIN MICROBIOL, V52, P3490, DOI 10.1128/JCM.01238-14; Drevinek M, 2012, LETT APPL MICROBIOL, V55, P40, DOI 10.1111/j.1472-765X.2012.03255.x; Duval BD, 2014, AM J TROP MED HYG, V90, P1043, DOI 10.4269/ajtmh.14-0025; Elschner MC, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0283-7; Espinal P, 2012, CLIN MICROBIOL INFEC, V18, P1097, DOI 10.1111/j.1469-0691.2011.03696.x; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P1007, DOI 10.1111/j.1469-0691.2010.03339.x; Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003; Gekenidis MT, 2014, APPL ENVIRON MICROB, V80, P4234, DOI 10.1128/AEM.00740-14; Ginther JL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003892; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Houghton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002727; Inglis TJJ, 2012, AM J TROP MED HYG, V86, P1039, DOI 10.4269/ajtmh.2012.11-0454; Jang HR, 2015, INT J INFECT DIS, V38, P62, DOI 10.1016/j.ijid.2015.07.012; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229; Koh TH, 2003, J CLIN MICROBIOL, V41, P1809, DOI 10.1128/JCM.41.4.1809.2003; Lasch P, 2015, J CLIN MICROBIOL, V53, P2632, DOI 10.1128/JCM.00813-15; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lowe P, 2006, J CLIN MICROBIOL, V44, P854, DOI 10.1128/JCM.44.3.854-856.2006; Lowe P, 2002, J CLIN MICROBIOL, V40, P4625, DOI 10.1128/JCM.40.12.4625-4627.2002; Meumann EM, 2006, J CLIN MICROBIOL, V44, P3028, DOI 10.1128/JCM.00913-06; Niyompanich S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144128; Niyompanich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099160; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Saidani N, 2015, TRAVEL MED INFECT DI, V13, P367, DOI 10.1016/j.tmaid.2015.08.007; Sim BMQ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r89; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaipadungpanit J, 2014, EMERG INFECT DIS, V20, P1947, DOI 10.3201/eid2011.140832; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Walewski V., 2016, New Microbes and New Infections, V12, P31, DOI 10.1016/j.nmni.2016.04.004; Wang H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00415; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812; Wuthiekanun V, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000496; Zong ZY, 2012, J MED MICROBIOL, V61, P1483, DOI 10.1099/jmm.0.041525-0	50	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175294	10.1371/journal.pone.0175294	http://dx.doi.org/10.1371/journal.pone.0175294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384252	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000399371900149
J	Clarke, G; Fistein, E; Holland, A; Barclay, M; Theimann, P; Barclay, S				Clarke, Gemma; Fistein, Elizabeth; Holland, Anthony; Barclay, Matthew; Theimann, Pia; Barclay, Stephen			Preferences for care towards the end of life when decision-making capacity may be impaired: A large scale cross-sectional survey of public attitudes in Great Britain and the United States	PLOS ONE			English	Article							PHYSICIAN-ASSISTED DEATH	Background There is continuing public debate about treatment preferences at the end of life, and the acceptability and legal status of treatments that sustain or end life. However, most surveys use binary yes/no measures, and little is known about preferences in neurological disease when decision-making capacity is lost, as most studies focus on cancer. This study investigates changes in public preferences for care towards the end of life, with a focus on measures to sustain or end life. Methods Large-scale international public opinion surveys using a six-stage patient vignette, respondents chose a level of intervention for each stage as health and decision-making capacity deteriorated. Cross-sectional representative samples of the general public in Great Britain and the USA (N = 2016). Primary outcome measure: changes in respondents' preferences for care, measured on a four-point scale designed before data collection. The scale ranged from: maintaining life at all costs; to intervention with agreement; to no intervention; to measures for ending life. Results There were no significant differences between GB and USA. Preference for measures to sustain life at all costs peaked at short-term memory loss (30.2%, n = 610). Respondents selecting 'measures to help me die peacefully' increased from 3.9% to 37.0% as the condition deteriorated, with the largest increase occurring when decision-making capacity was lost (10.3% to 23.0%). Predictors of choosing 'measures to help me die peacefully' at any stage were: previous personal experience (OR = 1.34, p<0.010), and older age (OR = 1.09 per decade, p<0.010). Negative predictors: living with children (OR = 0.72, p<0.010) and being of "black" race/ethnicity (OR = 0.45, p<0.001). Conclusions Public opinion was uniform between GB and USA, but markedly heterogeneous. Despite contemporaneous capacitous consent providing an essential legal safeguard in most jurisdictions, there was a high prevalence of preference for "measures to end my life peacefully" when decision-making capacity was compromised, which increased as dementia progressed. In contrast, a significant number chose preservation of life at all costs, even in end stage dementia. It is challenging to respect the longstanding values of people with dementia concerning either the inviolability of life or personal autonomy, whilst protecting those without decision-making capacity.	[Clarke, Gemma; Fistein, Elizabeth; Barclay, Matthew; Theimann, Pia; Barclay, Stephen] Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge Biomed Campus,Forvie Site,Robinson Way, Cambridge, England; [Holland, Anthony] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Douglas House, Cambridge, England	University of Cambridge; University of Cambridge	Clarke, G (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge Biomed Campus,Forvie Site,Robinson Way, Cambridge, England.	gcc29@medschl.cam.ac.uk	Barclay, Matthew Edward/Q-2626-2019	Barclay, Matthew Edward/0000-0003-1148-1922; Clarke, Gemma/0000-0001-8438-7131	Dunhill Medical Trust [R317/1113]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England at Cambridgeshire and Peterborough NHS Foundation Trust; Health Foundation; National Institute for Health Research (NIHR); National Institute for Health Research [NF-SI-0509-10211] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England at Cambridgeshire and Peterborough NHS Foundation Trust(National Institute for Health Research (NIHR)); Health Foundation; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Dunhill Medical Trust [grant number R317/1113]. AH and SB are supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England at Cambridgeshire and Peterborough NHS Foundation Trust. AH is also supported by the Health Foundation. The funders had no role in the design, undertaking or writing of this paper, and no part in the decision to submit for publication. This paper presents independent research partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.; All authors meet the criteria for authorship. GC, AH, SB designed the research, undertook analysis, and contributed to writing the paper. EF, MB, PT undertook analysis, and contributed to writing the paper. This paper presents independent research partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	AMA, 2009, H140952 AMA; Barter C, 1999, USES VIGNETTES QUALI; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; BMA, 2016, END LIF CAR PHYS ASS; Burstein P, 2003, POLIT RES QUART, V56, P29, DOI 10.1177/106591290305600103; Clarke G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061475; Clarke G, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0034-8; Cohen-Almagor R, 2004, EUTHANASIA NETHERLAN; Cox K, 2013, BMJ SUPPORT PALLIAT, V3, P37, DOI 10.1136/bmjspcare-2012-000203; Davis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4437; Dresser Rebecca, 1986, Ariz Law Rev, V28, P373; Dugan A, 2015, SUPPORT DOCTOR ASSIS; Fischer KE, 2012, HEALTH POLICY, V107, P218, DOI 10.1016/j.healthpol.2012.07.005; Godlee F, 2015, ASSISTED DYING D TIM, V09, P46; Hawkins O, 2015, CBP7186; IpsosMORI, 2015, PUBL ATT ASS DYING P; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Lewis-Black M, 2004, ENCY SOCIAL SCI RES; Magelssen M, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0107-3; McGuinness F, 2012, HOUSE LORDS STAT SN; McLean J, 2008, RISK PROTECTIVE FACT; Periyakoil VS, 2016, J PALLIAT MED, V19, P1060, DOI 10.1089/jpm.2016.0160; Prokopetz JJZ, 2012, NEW ENGL J MED, V367, P97, DOI 10.1056/NEJMp1205283; Quill TE, 2016, JAMA-J AM MED ASSOC, V315, P245, DOI 10.1001/jama.2015.16210; Shapiro RY, 2011, PUBLIC OPIN QUART, V75, P982, DOI 10.1093/poq/nfr053; Thulesius HO, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-13; WALTER T, 1991, SOCIOLOGY, V25, P293, DOI 10.1177/0038038591025002009; Yang YT, 2016, JAMA-J AM MED ASSOC, V315, P247, DOI 10.1001/jama.2015.16194; YouGov, 2014, MAJ PUBL WOULD PROB; YouGov, 2013, WESTM FAITH DEB YOUG; Zulman DM, 2014, J GEN INTERN MED, V29, P529, DOI 10.1007/s11606-013-2616-9	31	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172104	10.1371/journal.pone.0172104	http://dx.doi.org/10.1371/journal.pone.0172104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379955	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500004
J	Huang, DTN; Lu, CY; Shao, PL; Chang, LY; Wang, JY; Chang, YH; Lai, MJ; Chi, YH; Huang, LM				Huang, Daniel Tsung-Ning; Lu, Chun-Yi; Shao, Pei-Lan; Chang, Luan-Yin; Wang, Jin-Yuan; Chang, Yi-Hsuan; Lai, Mei-Ju; Chi, Ya-Hui; Huang, Li-Min			In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery	PLOS ONE			English	Article							GENE; CELLS; MICE; H5N1; INFECTION; PROTEIN; MATRIX	Background Influenza virus infection is a major threat to human health. Small interfering RNA (siRNA) is a promising approach for the prevention and treatment of viral infections. In this study, we constructed a series of DNA vector-based short hairpin RNAs (shRNAs) that target various genes of the influenza A virus using the polymerase III U6-RNA promoter to prevent influenza virus infection in vitro and in a mouse model. Results Three sets of DNA vector-based shRNA, two targeting genes encoding the polymerase acidic protein (PA) and one targeting polymerase basic protein 2 (PB2), efficiently inhibited the replication of influenza virus A/WSN/33(H1 N1) in vitro. We also successfully prevented influenza virus A/WSN/33(H1N1) infection in a C57BU6 mouse model by intratracheal delivery of anti-PB2 shRNA. Conclusions Our findings suggest that the PB2-targeting shRNA plasmid showed potential for use as an RNAi-based therapeutic for influenza virus infection.	[Huang, Daniel Tsung-Ning; Wang, Jin-Yuan] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Huang, Daniel Tsung-Ning; Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lu, Chun-Yi; Shao, Pei-Lan; Chang, Luan-Yin; Chang, Yi-Hsuan; Lai, Mei-Ju; Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Chi, Ya-Hui] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan	Mackay Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Huang, DTN (corresponding author), Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.; Huang, DTN; Huang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Huang, LM (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan.	zoning12huang@gmail.com; lmhuang@ntu.edu.tw	Chi, Ya-Hui/ABE-8550-2020	Chi, Ya-Hui/0000-0002-9216-0938; LU, CHUN-YI/0000-0002-5240-2808; CHANG, LUAN-YIN/0000-0003-2632-1956; HUANG, LI-MIN/0000-0002-9291-260X; Huang, Daniel Tsung-Ning/0000-0001-6940-6701				Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Barik S, 2015, METHODS MOL BIOL, V1218, P251, DOI 10.1007/978-1-4939-1538-5_14; Betakova T, 2013, ACTA VIROL, V57, P97, DOI 10.4149/av_2013_02_97; Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Jeong JH, 2009, BIOCONJUGATE CHEM, V20, P5, DOI 10.1021/bc800278e; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Li WY, 2011, ARCH VIROL, V156, P1979, DOI 10.1007/s00705-011-1087-8; Li YC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-603; Matskevich AA, 2009, J INNATE IMMUN, V1, P389, DOI 10.1159/000191408; Mauskopf Josephine, 2013, J Med Econ, V16, P264, DOI 10.3111/13696998.2012.752376; McMillen CM, 2016, VIROLOGY, V497, P171, DOI 10.1016/j.virol.2016.07.019; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Rajput R, 2012, NUCLEIC ACID THER, V22, P414, DOI 10.1089/nat.2012.0359; Stiver G, 2003, CAN MED ASSOC J, V168, P49; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Wu YH, 2008, BIOCHEM BIOPH RES CO, V365, P369, DOI 10.1016/j.bbrc.2007.10.196; Zhang W, 2009, BIOCHEM BIOPH RES CO, V390, P421, DOI 10.1016/j.bbrc.2009.09.039; Zhou HB, 2007, ANTIVIR RES, V76, P186, DOI 10.1016/j.antiviral.2007.07.002; Zhou K, 2008, J BIOTECHNOL, V135, P140, DOI 10.1016/j.jbiotec.2008.03.007	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174523	10.1371/journal.pone.0174523	http://dx.doi.org/10.1371/journal.pone.0174523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380007	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500051
J	Poulsen, SS; Knudsen, KB; Jackson, P; Weydahl, IEK; Saber, AT; Wallin, H; Vogel, U				Poulsen, Sarah S.; Knudsen, Kristina B.; Jackson, Petra; Weydahl, Ingrid E. K.; Saber, Anne T.; Wallin, Hakan; Vogel, Ulla			Multi-walled carbon nanotube-physicochemical properties predict the systemic acute phase response following pulmonary exposure in mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM-AMYLOID-A; TITANIUM-DIOXIDE NANOPARTICLES; PARTICULATE AIR-POLLUTION; GENE-EXPRESSION CHANGES; CARDIOVASCULAR-DISEASE; INFLAMMATORY RESPONSES; SUSTAINED INFLAMMATION; LUNG INFLAMMATION; MESSENGER-RNA	Pulmonary exposure to multi-walled carbon nanotubes (MWCNTs) has been linked to an increased risk of developing cardiovascular disease in addition to the well-documented physicochemical-dependent adverse lung effects. A proposed mechanism is through a strong and sustained pulmonary secretion of acute phase proteins to the blood. We identified physicochemical determinants of MWCNT-induced systemic acute phase response by analyzing effects of pulmonary exposure to 14 commercial, well-characterized MWCNTs in female C57BLI6J mice pulmonary exposed to 0, 6, 18 or 54 lag MWCNT/mouse. Plasma levels of acute phase response proteins serum amyloid A1/2 (SAA1/2) and SAA3 were determined on day 1, 28 or 92. Expression levels of hepatic Saal and pulmonary Saa3 mRNA levels were assessed to determine the origin of the acute phase response proteins. Pulmonary Saa3 mRNA expression levels were greater and lasted longer than hepatic Saal mRNA expression. Plasma SAA1/2 and SAA3 protein levels were related to time and physicochemical properties using adjusted, multiple regression analyses. SAA3 and SAA1/2 plasma protein levels were increased after exposure to almost all of the MWCNTs on day 1, whereas limited changes were observed on day 28 and 92. SAA1/2 and SAA3 protein levels did not correlate and only SAA3 protein levels correlated with neutrophil influx. The multiple regression analyses revealed a protective effect of MWCNT length on SAA1/2 protein level on day 1, such that a longer length resulted in lowered SAA1/2 plasma levels. Increased SAA3 protein levels were positively related to dose and content of Mn, Mg and Co on day 1, whereas oxidation and diameter of the MWCNTs were protective on day 28 and 92, respectively. The results of this study reveal very differently controlled pulmonary and hepatic acute phase responses after MWCNT exposure. As the responses were influenced by the physicochemical properties of the MWCNTs, this study provides the first step towards designing MWCNT that induce less SAA.	[Poulsen, Sarah S.; Knudsen, Kristina B.; Jackson, Petra; Weydahl, Ingrid E. K.; Saber, Anne T.; Wallin, Hakan; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Wallin, Hakan] Univ Copenhagen, Inst Publ Hlth, Copenhagen K, Denmark; [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	National Research Centre for the Working Environment; University of Copenhagen; Technical University of Denmark	Poulsen, SS (corresponding author), Natl Res Ctr Working Environm, Copenhagen O, Denmark.	spo@nrcwo.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Wallin, Håkan/I-6459-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Wallin, Håkan/0000-0001-7716-0166; Poulsen, Sarah S/0000-0001-7456-0017; bram knudsen, kristina/0000-0001-9362-2893	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation [20110092173-3]; Danish Centre for Nanosafety	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation; Danish Centre for Nanosafety	This work was supported by Danish Centre for Nanosafety [grant# 20110092173-3] [https llarbejdstilsynet dkidaiom% 20arbeicistilsynet/arbeidsmiljoforskningsfonden] from the Danish Working Environment Research Foundation and Danish Centre for Nanosafety 2.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; BANKA CL, 1995, J LIPID RES, V36, P1058; Beg S, 2011, J PHARM PHARMACOL, V63, P141, DOI 10.1111/j.2042-7158.2010.01167.x; Birch ME, 2011, ANN OCCUP HYG, V55, P1016, DOI 10.1093/annhyg/mer073; Bourdon JA, 2012, ENVIRON MOL MUTAGEN, V53, P462, DOI 10.1002/em.21706; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Cao Y, 2014, TOXICOL SCI, V138, P104, DOI 10.1093/toxsci/kft328; Chen LC, 2005, INHAL TOXICOL, V17, P217, DOI 10.1080/08958370590912815; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gordon T, 2000, TOXICOL SCI, V56, P2, DOI 10.1093/toxsci/56.1.2; Grosse Y, 2014, LANCET ONCOL, V15, P1427, DOI 10.1016/S1470-2045(14)71109-X; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Halappanavar S, 2015, ENVIRON MOL MUTAGEN, V56, P245, DOI 10.1002/em.21936; Halappanavar S, 2011, ENVIRON MOL MUTAGEN, V52, P425, DOI 10.1002/em.20639; Hamilton RF, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-57; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI [10.1080/08958370801942238, 10.1080/08958370801942238 ]; Harding AH, 2012, OCCUP ENVIRON MED, V69, P417, DOI 10.1136/oemed-2011-100313; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Husain M, 2015, TOXICOL APPL PHARM, V289, P573, DOI 10.1016/j.taap.2015.11.003; Husain M, 2015, NANOTOXICOLOGY, V9, P1013, DOI 10.3109/17435390.2014.996192; Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, COB HARD MET COB SUL, V86; Jackson P., 2011, MUTAT RES, V745, P73, DOI DOI 10.1016/J.MRGENT0X.2011.09.018; Jackson P, 2015, ENVIRON MOL MUTAGEN, V56, P183, DOI 10.1002/em.21922; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kim JE, 2015, NANOTOXICOLOGY, V9, P613, DOI 10.3109/17435390.2014.963186; King PT, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0068-z; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008; Kuschner WG, 1997, ENVIRON HEALTH PERSP, V105, P1234, DOI 10.1289/ehp.971051234; Kyjovska ZO, 2015, ENVIRON MOL MUTAGEN, V56, P41, DOI 10.1002/em.21888; Labib S, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0125-9; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Lee HY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741403; Lee JH, 2010, INHAL TOXICOL, V22, P369, DOI 10.3109/08958370903367359; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Liu XY, 2010, CARBON, V48, P1961, DOI 10.1016/j.carbon.2010.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Manley PN, 2006, MED HYPOTHESES, V66, P784, DOI 10.1016/j.mehy.2005.10.018; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Mezaki T, 2003, JPN HEART J, V44, P601, DOI 10.1536/jhj.44.601; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Moller P, 2016, CRIT REV TOXICOL, V46, P437, DOI 10.3109/10408444.2016.1149451; MUHLE H, 1987, ANN OCCUP HYG, V31, P755, DOI 10.1093/annhyg/31.4B.755; Murphy FA, 2011, AM J PATHOL, V178, P2587, DOI 10.1016/j.ajpath.2011.02.040; Nanogenotox, 2013, DEL 4 1 SUMM REP PRI; National Institute for Occupational Safety and Health NIOSH, 2013, NIOSH CURR INT B, V65; NIOSH, 1978, OCC SAF HLTH GUID CO; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Nurkiewicz TR, 2004, ENVIRON HEALTH PERSP, V112, P1299, DOI 10.1289/ehp.7001; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Poulsen SS, 2016, NANOTOXICOLOGY, V10, P1263, DOI 10.1080/17435390.2016.1202351; Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011; Poulsen SS, 2015, TOXICOL APPL PHARM, V283, P210, DOI 10.1016/j.taap.2015.01.011; Poulsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080452; Reddy A. R., 2010, ENVIRON TOXICOL, V27, P211, DOI DOI 10.1002/T0X.20632; Reverri EJ, 2014, FREE RADICAL BIO MED, V76, P261, DOI 10.1016/j.freeradbiomed.2014.08.005; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rittinghausen S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0059-z; Rong Yi, 2015, Prev Med Rep, V2, P920, DOI 10.1016/j.pmedr.2015.10.005; Saber AT, 2014, WIRES NANOMED NANOBI, V6, P517, DOI 10.1002/wnan.1279; Saber AT, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-12; Saber AT, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0148-2; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011; Shvedova AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150628; Skafar DF, 1997, J CLIN ENDOCR METAB, V82, P3913, DOI 10.1210/jc.82.12.3913; Snyder-Talkington BN, 2013, TOXICOL APPL PHARM, V272, P476, DOI 10.1016/j.taap.2013.06.026; Stapleton PA, 2012, INT J MOL SCI, V13, P13781, DOI 10.3390/ijms131113781; Takagi A, 2012, CANCER SCI, V103, P1440, DOI 10.1111/j.1349-7006.2012.02318.x; Thompson LC, 2014, NANOTOXICOLOGY, V8, P38, DOI 10.3109/17435390.2012.744858; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Ursini CL, 2012, TOXICOL IN VITRO, V26, P831, DOI 10.1016/j.tiv.2012.05.001; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Vietti G, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0123-y; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wang XJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-24; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	100	53	53	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174167	10.1371/journal.pone.0174167	http://dx.doi.org/10.1371/journal.pone.0174167			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380028	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500034
J	Ruff, JS; Saffarini, RB; Ramoz, LL; Morrison, LC; Baker, S; Laverty, SM; Tvrdik, P; Capecchi, MR; Potts, WK				Ruff, James S.; Saffarini, Raed B.; Ramoz, Leda L.; Morrison, Linda C.; Baker, Shambralyn; Laverty, Sean M.; Tvrdik, Petr; Capecchi, Mario R.; Potts, Wayne K.			Mouse fitness measures reveal incomplete functional redundancy of Hox paralogous group 1 proteins	PLOS ONE			English	Article							MAGNIFIES INBREEDING DEPRESSION; NEURAL CREST; BRAIN-STEM; INNER-EAR; GENE; HINDBRAIN; EVOLUTION; EQUIVALENCE; CONSUMPTION; KNOCKOUT	Here we assess the fitness consequences of the replacement of the Hoxa1 coding region with its paralog Hoxb1 in mice (Mus musculus) residing in semi-natural enclosures. Previously, this Hoxa1(B1) swap was reported as resulting in no discernible embryonic or physiological phenotype (i.e., functionally redundant), despite the 51% amino acid sequence differences between these two Hox proteins. Within heterozygous breeding cages no differences in litter size nor deviations from Mendelian genotypic expectations were observed in the outbred progeny; however, within semi-natural population enclosures mice homozygous for the Hoxa1(B1) swap were out-reproduced by controls resulting in the mutant allele being only 87.5% as frequent as the control in offspring born within enclosures. Specifically, Hoxa1 B1 founders produced only 77.9% as many offspring relative to controls, as measured by homozygous pups, and a 22.1% deficiency of heterozygous offspring was also observed. These data suggest that Hoxa1 and Hoxb1 have diverged in function through either sub-or neo-functionalization and that the HoxA1 and HoxB1 proteins are not mutually interchangeable when expressed from the Hoxa1 locus. The fitness assays conducted under naturalistic conditions in this study have provided an ultimate-level assessment of the postulated equivalence of competing alleles. Characterization of these differences has provided greater understanding of the forces shaping the maintenance and diversifications of Hox genes as well as other paralogous genes. This fitness assay approach can be applied to any genetic manipulation and often provides the most sensitive way to detect functional differences.	[Ruff, James S.; Saffarini, Raed B.; Ramoz, Leda L.; Morrison, Linda C.; Baker, Shambralyn; Potts, Wayne K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Laverty, Sean M.] Univ Cent Oklahoma, Dept Math & Stat, Edmond, OK USA; [Tvrdik, Petr] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Capecchi, Mario R.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; University of Central Oklahoma; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Potts, WK (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	Potts@biology.utah.edu	Tvrdik, Petr/AAK-4398-2021	Ruff, James/0000-0002-8292-8640	National Institutes of Health [R01-GM039578, R01-GM109500]; National Science Foundation [IBN-0344907]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109500, R01GM039578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01-GM039578 and National Science Foundation Grant IBN-0344907, both to WKP. The work was partially conducted while WKP was supported by National Institutes of Health grant R01-GM109500. LLR was supported by the National Science Foundation funded Western Alliance to Expand Student Opportunities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2015, DEV GENES EVOL, V225, P353, DOI 10.1007/s00427-015-0518-z; Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Balenger SL, 2014, INTEGR COMP BIOL, V54, P601, DOI 10.1093/icb/icu059; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell G, 2010, P ROY SOC B-BIOL SCI, V277, P1459, DOI 10.1098/rspb.2009.2099; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; Carroll LS, 2006, ADV STUD BEHAV, V36, P173, DOI 10.1016/S0065-3454(06)36004-4; Carroll LS, 2004, EVOLUTION, V58, P1318, DOI 10.1111/j.0014-3820.2004.tb01710.x; Chalfin L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5569; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; Erickson RP, 1999, GENET MED, V1, P151; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; Gaukler SM, 2016, EVOL APPL, V9, P685, DOI 10.1111/eva.12365; Gaukler SM, 2015, NEUROTOXICOL TERATOL, V47, P46, DOI 10.1016/j.ntt.2014.11.002; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddard JM, 1996, DEVELOPMENT, V122, P3217; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Holve S, 2003, AM J MED GENET A, V120A, P169, DOI 10.1002/ajmg.a.20087; Ilmonen P, 2008, J EVOLUTION BIOL, V21, P834, DOI 10.1111/j.1420-9101.2008.01510.x; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Makki N, 2011, DEV BIOL, V357, P295, DOI 10.1016/j.ydbio.2011.06.042; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Nelson AC, 2013, P NATL ACAD SCI USA, V110, P19848, DOI 10.1073/pnas.1310427110; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, P1; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; R Core Team, 2021, R LANGUAGE ENV STAT; Remacle S, 2004, MOL CELL BIOL, V24, P8567, DOI 10.1128/MCB.24.19.8567-8575.2004; Ruff JS, 2015, GENETICS, V201, P727, DOI 10.1534/genetics.115.178079; Ruff JS, 2015, J NUTR, V145, P434, DOI 10.3945/jn.114.202531; Ruff JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3245; Shabalina SA, 1997, P NATL ACAD SCI USA, V94, P13034, DOI 10.1073/pnas.94.24.13034; Studer M, 1998, DEVELOPMENT, V125, P1025; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; Vitobello A, 2011, DEV CELL, V20, P469, DOI 10.1016/j.devcel.2011.03.011; West SA, 2009, SEX ALLOCATION PRINC; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595; Zhao YX, 2001, DEVELOPMENT, V128, P3197	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174975	10.1371/journal.pone.0174975	http://dx.doi.org/10.1371/journal.pone.0174975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380068	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500082
J	Nilsen, KT; N'Diaye, A; MacLachlan, PR; Clarke, JM; Ruan, YF; Cuthbert, RD; Knox, RE; Wiebe, K; Cory, AT; Walkowiak, S; Beres, BL; Graf, RJ; Clarke, FR; Sharpe, AG; Distelfeld, A; Pozniak, CJ				Nilsen, Kirby T.; N'Diaye, Amidou; MacLachlan, P. R.; Clarke, John M.; Ruan, Yuefeng; Cuthbert, Richard D.; Knox, Ron E.; Wiebe, Krystalee; Cory, Aron T.; Walkowiak, Sean; Beres, Brian L.; Graf, Robert J.; Clarke, Fran R.; Sharpe, Andrew G.; Distelfeld, Assaf; Pozniak, Curtis J.			High density mapping and haplotype analysis of the major stem-solidness locus SSt1 in durum and common wheat	PLOS ONE			English	Article							SAWFLY HYMENOPTERA; SPRING WHEAT; RESISTANCE; GENE; INVOLVEMENT; EXPRESSION; MANAGEMENT; PROTEINS; QUALITY; DAMAGE	Breeding for solid-stemmed durum (Triticum turgidum L. var durum) and common wheat (Triticum aestivum L.) cultivars is one strategy to minimize yield losses caused by the wheat stem sawfly (Cephus cinctus Norton). Major stem-solidness QTL have been localized to the long arm of chromosome 3B in both wheat species, but it is unclear if these QTL span a common genetic interval. In this study, we have improved the resolution of the QTL on chromosome 3B in a durum (Kofa/W9262-260D3) and common wheat (Lillian/Vesper) mapping population. Coincident QTL (LOD = 94-127, R-2 = 78-92%) were localized near the telomere of chromosome 3BL in both mapping populations, which we designate SSt1. We further examined the SSt1 interval by using available consensus maps for durum and common wheat and compared genetic to physical intervals by anchoring markers to the current version of the wild emmer wheat (WEW) reference sequence. These results suggest that the SSt1 interval spans a physical distance of 1.6 Mb in WEW (positions 833.4-835.0 Mb). In addition, minor QTL were identified on chromosomes 2A, 2D, 4A, and 5A that were found to synergistically enhance expression of SSt1 to increase stem-solidness. These results suggest that developing new wheat cultivars with improved stem-solidness is possible by combining SSt1 with favorable alleles at minor loci within both wheat species.	[Nilsen, Kirby T.; N'Diaye, Amidou; MacLachlan, P. R.; Clarke, John M.; Wiebe, Krystalee; Cory, Aron T.; Pozniak, Curtis J.] Univ Saskatchewan, Dept Plant Sci, 51 Campus Dr, Saskatoon, SK, Canada; [Ruan, Yuefeng; Cuthbert, Richard D.; Knox, Ron E.; Clarke, Fran R.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Beres, Brian L.; Graf, Robert J.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Sharpe, Andrew G.] Univ Saskatchewan, Global Inst Food Secur, 110 Gymnasium Pl, Saskatoon, SK, Canada; [Distelfeld, Assaf] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, Tel Aviv, Israel	University of Saskatchewan; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; University of Saskatchewan; Tel Aviv University	Pozniak, CJ (corresponding author), Univ Saskatchewan, Dept Plant Sci, 51 Campus Dr, Saskatoon, SK, Canada.	curtis.pozniak@usask.ca	Distelfeld, Assaf/D-4951-2014	Distelfeld, Assaf/0000-0003-1777-3053; Graf, Robert/0000-0003-0922-5049; Cory, Aron/0000-0002-7215-459X; N'Diaye, Amidou/0000-0001-7769-7801; Cuthbert, Richard/0000-0002-1640-4929; Knox, Ron/0000-0002-2030-3899; Nilsen, Kirby/0000-0002-9477-5549	Genome Canada; Genome Prairie; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Saskatchewan and Alberta Wheat Development Commissions; AgriFlex Program of Agriculture; Agri-Food Canada; Robert P. Knowles scholarship	Genome Canada(Genome Canada); Genome Prairie; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Saskatchewan and Alberta Wheat Development Commissions; AgriFlex Program of Agriculture; Agri-Food Canada(Agriculture & Agri Food Canada); Robert P. Knowles scholarship	This research was carried out under the Canadian Triticum Applied Genomics (CTAG2) project. We are grateful for the funding provided by Genome Canada, and project support provided by Genome Prairie. We also acknowledge financial support provided by the Saskatchewan Ministry of Agriculture, Western Grains Research Foundation, and the Saskatchewan and Alberta Wheat Development Commissions. The financial support provided through the AgriFlex Program of Agriculture and Agri-Food Canada is also acknowledged. K. Nilsen acknowledges funding provided by the Robert P. Knowles scholarship administered by the University of Saskatchewan.	Ainslie CN, 1920, W GRASS STEM SAWFLY, P32; Beres BL, 2007, J ECON ENTOMOL, V100, P79, DOI 10.1603/0022-0493(2007)100[79:EOWSSD]2.0.CO;2; Beres BL, 2013, CAN J PLANT SCI, V93, P1169, DOI [10.4141/CJPS2013-035, 10.4141/cjps2013-035]; Beres BL, 2013, CAN J PLANT SCI, V93, P607, DOI [10.4141/CJPS2012-088, 10.4141/cjps2012-088]; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Beres BL, 2009, J ECON ENTOMOL, V102, P2137, DOI 10.1603/029.102.0617; Beres B.L., 2011, PRAIRIE SOILS CROPS, V4, P54; Beres BL, 2011, AGRON J, V103, P1755, DOI 10.2134/agronj2011.0187; Carcamo HA, 2005, ENVIRON ENTOMOL, V34, P1579, DOI 10.1603/0046-225X-34.6.1579; Clarke FR, 2002, CAN J PLANT SCI, V82, P661, DOI 10.4141/P01-053; Clarke J.M., 2012, DURUM WHEAT CHEM TEC; Cook JP, 2004, CROP SCI, V44, P1397, DOI 10.2135/cropsci2004.1397; Criddle N., 1923, Canadian Entomologist, V55, P1; CYMMY I., 2005, LAB PROTOCOLS CIMMYT; DePauw RM, 2005, CAN J PLANT SCI, V85, P397, DOI 10.4141/P04-137; DEPAUW RM, 1982, CAN J PLANT SCI, V62, P593, DOI 10.4141/cjps82-089; HOLMES N. D., 1961, CANADIAN ENT, V93, P250; HOLMES N. D., 1962, CANADIAN ENTOMOL, V94, P348; HOLMES ND, 1984, CAN ENTOMOL, V116, P677, DOI 10.4039/Ent116677-5; Houshmand S, 2007, MOL BREEDING, V20, P261, DOI 10.1007/s11032-007-9088-8; Knodel JJ, 2009, J AGR URBAN ENTOMOL, V26, P183, DOI 10.3954/1523-5475-26.4.183; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lanning SP, 2006, CROP SCI, V46, P1701, DOI 10.2135/cropsci2005.10-0379; LARSON RI, 1962, CAN J GENET CYTOL, V4, P97, DOI 10.1139/g62-014; LARSON RUBY I, 1959, CANADIAN JOUR BOT, V37, P135, DOI 10.1139/b59-012; LARSON RUBY I., 1959, CANADIAN JOUR BOT, V37, P365, DOI 10.1139/b59-028; LARSON RUBY I., 1959, CANADIAN JOUR BOT, V37, P1207, DOI 10.1139/b59-101; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Maccaferri M, 2014, PLANT BIOTECHNOL J; Macedo TB, 2007, J ENTOMOL SCI, V42, P228, DOI 10.18474/0749-8004-42.2.228; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Nilsen KT, 2016, AGRON J, V108, P219, DOI 10.2134/agronj2015.0298; PLATT A. W., 1941, SCI AGRIC [OTTAWA], V22, P139; Pozniak C, 2015, CAN J PLANT IN PRESS; Pozniak CJ, 2015, CAN J PLANT SCI, P1243; Rozen S, 2000, Methods Mol Biol, V132, P365; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Singh AK, 2017, CAN J PLANT SCI, V97, P135, DOI 10.1139/cjps-2016-0044; Singh AK, 2014, CAN J PLANT SCI, V94, P1289, DOI [10.4141/CJPS-2014-048, 10.4141/cjps-2014-048]; Skirycz A, 2008, PLANT J, V56, P779, DOI 10.1111/j.1365-313X.2008.03641.x; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Varella AC, 2015, CROP SCI, V55, P2046, DOI 10.2135/cropsci2014.12.0852; Varella AC, 2016, PLANT BREEDING, V135, P546, DOI 10.1111/pbr.12398; Wallace L.E., 1966, STEM SAWFLIES EC IMP; WALLACE LE, 1973, J ECON ENTOMOL, V66, P1121, DOI 10.1093/jee/66.5.1121; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xu PP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27705; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75	51	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175285	10.1371/journal.pone.0175285	http://dx.doi.org/10.1371/journal.pone.0175285			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399136	Green Published, Green Submitted, gold			2022-12-27	WOS:000399949000025
J	Roitberg, E; Shoshany, M				Roitberg, Elena; Shoshany, Maxim			Can spatial patterns along climatic gradients predict ecosystem responses to climate change? Experimenting with reaction-diffusion simulations	PLOS ONE			English	Article							VEGETATION PATTERNS; PRECIPITATION GRADIENT; SEMIARID WOODLANDS; SOIL; PRODUCTIVITY; PATCHINESS; ORGANIZATION; FACILITATION; COMPETITION; LANDSCAPES	Following a predicted decline in water resources in the Mediterranean Basin, we used reaction-diffusion equations to gain a better understanding of expected changes in properties of vegetation patterns that evolve along the rainfall transition between semi-arid and arid rainfall regions. Two types of scenarios were investigated: the first, a discrete scenario, where the potential consequences of climate change are represented by patterns evolving at discrete rainfall levels along a rainfall gradient. This scenario concerns space-for-time substitutions characteristic of the rainfall gradient hypothesis. The second, a continuous scenario, represents explicitly the effect of rainfall decline on patterns which evolved at different rainfall levels along the rainfall gradient prior to the climate change. The eccentricity of patterns that emerge through these two scenarios was found to decrease with decreasing rainfall, while their solidity increased. Due to their inverse modes of change, their ratio was found to be a highly sensitive indicator for pattern response to rainfall decline. An eccentricity ratio versus rainfall (ER:R) line was generalized from the results of the discrete experiment, where ERs above this line represent developed (recovered) patterns and ERs below this line represent degraded patterns. For the rainfall range of 1.2 to 0.8 mm/day, the continuous rainfall decline experiment with ERs that lie above the ER: R line, yielded patterns less affected by rainfall decline than would be expected according to the discrete representation of ecosystems' response. Thus, for this range, space-for-time substitution represents an overestimation of the consequences of the expected rainfall decline. For rainfall levels below 0.8 mm/day, eccentricity ratios from the discrete and continuous experiments practically converge to the same trend of pattern change along the ER: R line. Thus, the rainfall gradient hypothesis may be valid for regions characterized by this important rainfall range, which typically include desert fringe ecosystems.	[Roitberg, Elena; Shoshany, Maxim] Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel	Technion Israel Institute of Technology	Roitberg, E (corresponding author), Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel.	elenaroitberg@gmail.com		Shoshany, Maxim/0000-0002-6894-8995	Israel Science Foundation [1286/12]; Ministry of Science, Space Infrastructure Research (ISR) [3-13140]	Israel Science Foundation(Israel Science Foundation); Ministry of Science, Space Infrastructure Research (ISR)	The research was funded by Israel Science Foundation Grant number 1286/12 (https://www.isf.org.il/) and Ministry of Science, Space Infrastructure Research (ISR), 3-13140.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; BELSKY AJ, 1986, J ECOL, V74, P841, DOI 10.2307/2260402; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Borgogno F, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000256; Bromley J, 1997, J HYDROL, V198, P1, DOI 10.1016/S0022-1694(96)03322-7; Cantrell RS, 2003, SPATIAL ECOLOGY VIA; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; D'Odorico P, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000176; Dagbovie AS, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0465; Dunkerley DL, 1997, J ARID ENVIRON, V35, P419, DOI 10.1006/jare.1995.0158; Dunkerley DL, 2002, J ARID ENVIRON, V51, P163, DOI 10.1006/jare.2001.0940; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Elmendorf SC, 2015, P NATL ACAD SCI USA, V112, P448, DOI 10.1073/pnas.1410088112; Gilad E, 2007, J THEOR BIOL, V244, P680, DOI 10.1016/j.jtbi.2006.08.006; Gilad E, 2004, CONTINUUM MODELS DIS, V158, P405; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; HilleRisLambers R, 2001, ECOLOGY, V82, P50, DOI 10.1890/0012-9658(2001)082[0050:VPFISA]2.0.CO;2; Imeson AC, 2004, AGR ECOSYST ENVIRON, V104, P333, DOI 10.1016/j.agee.2004.01.033; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2010, THEOR ECOL-NETH, V3, P257, DOI 10.1007/s12080-009-0067-z; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; Leprun JC, 1999, CATENA, V37, P25, DOI 10.1016/S0341-8162(98)00054-X; Ludwig JA, 1999, CATENA, V37, P257, DOI 10.1016/S0341-8162(98)00067-8; LUDWIG JA, 1995, LANDSCAPE ECOL, V10, P51, DOI 10.1007/BF00158553; Manor A, 2008, J THEOR BIOL, V253, P838, DOI 10.1016/j.jtbi.2008.04.012; Mariotti A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044001; MAUCHAMP A, 1994, ECOL MODEL, V71, P107, DOI 10.1016/0304-3800(94)90078-7; Meron E, 2004, CHAOS SOLITON FRACT, V19, P367, DOI 10.1016/S0960-0779(03)00049-3; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; MONTANA C, 1992, J ECOL, V80, P315, DOI 10.2307/2261014; Ni J, 2003, J ARID ENVIRON, V53, P501, DOI 10.1006/jare.2002.1063; Philandras CM, 2011, NAT HAZARD EARTH SYS, V11, P3235, DOI 10.5194/nhess-11-3235-2011; PICKETT S T A, 1989, P110; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2000, PLANT ECOL, V148, P207, DOI 10.1023/A:1009828432690; Saco PM, 2007, HYDROL EARTH SYST SC, V11, P1717, DOI 10.5194/hess-11-1717-2007; Sherratt JA, 2005, J MATH BIOL, V51, P183, DOI 10.1007/s00285-005-0319-5; Sherratt JA, 2014, SIAM J APPL DYN SYST, V13, P1517, DOI 10.1137/140969725; Shoshany M, 2002, GEOMORPHOLOGY, V45, P3, DOI 10.1016/S0169-555X(01)00186-6; Shoshany M, 2006, GEOMORPHOLOGY, V77, P35, DOI 10.1016/j.geomorph.2005.12.009; Stewart J, 2014, ECOL MONOGR, V84, P373, DOI 10.1890/12-1253.1; THIERY JM, 1995, J ECOL, V83, P497, DOI 10.2307/2261602; Tietjen B, 2007, J APPL ECOL, V44, P425, DOI 10.1111/j.1365-2664.2007.01280.x; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Valentin C, 1999, CATENA, V37, P1, DOI 10.1016/S0341-8162(99)00053-3; von Hardenberg J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198101; Yizhaq H, 2014, WATER RESOUR RES, V50, P5743, DOI 10.1002/2014WR015362	52	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174942	10.1371/journal.pone.0174942	http://dx.doi.org/10.1371/journal.pone.0174942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394914	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800009
J	Gao, QQ; Lin, SH; Bai, PG; Du, M; Ni, XL; Ke, DZ; Tong, T				Gao, Qinquan; Lin, Shaohui; Bai, Penggang; Du, Min; Ni, Xiaolei; Ke, Dongzhong; Tong, Tong			FZUlmageReg: A toolbox for medical image registration and dose fusion in cervical cancer radiotherapy	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; NONRIGID REGISTRATION; INTRACAVITARY BRACHYTHERAPY; ACCUMULATION; DEFORMATIONS	The combination external-beam radiotherapy and high-dose-rate brachytherapy is a standard form of treatment for patients with locally advanced uterine cervical cancer. Personalized radiotherapy in cervical cancer requires efficient and accurate dose planning and assessment across these types of treatment. To achieve radiation dose assessment, accurate mapping of the dose distribution from HDR-BT onto EBRT is extremely important. However, few systems can achieve robust dose fusion and determine the accumulated dose distribution during the entire course of treatment. We have therefore developed a toolbox (FZUlmageReg), which is a user-friendly dose fusion system based on hybrid image registration for radiation dose assessment in cervical cancer radiotherapy. The main part of the software consists of a collection of medical image registration algorithms and a modular design with a user-friendly interface, which allows users to quickly configure, test, monitor, and compare different registration methods for a specific application. Owing to the large deformation, the direct application of conventional state-of-the-art image registration methods is not sufficient for the accurate alignment of EBRT and HDRBT images. To solve this problem, a multi-phase non-rigid registration method using local landmark-based free-form deformation is proposed for locally large deformation between EBRT and HDR-BT images, followed by intensity-based free-form deformation. With the transformation, the software also provides a dose mapping function according to the deformation field. The total dose distribution during the entire course of treatment can then be presented. Experimental results clearly show that the proposed system can achieve accurate registration between EBRT and HDR-BT images and provide radiation dose warping and fusion results for dose assessment in cervical cancer radiotherapy in terms of high accuracy and efficiency.	[Gao, Qinquan; Lin, Shaohui; Du, Min; Ke, Dongzhong] Fuzhou Univ, Fujian Prov Key Lab Med Instrument & Pharmaceut T, Fuzhou, Fujian Province, Peoples R China; [Bai, Penggang] Fujian Prov Canc Hosp, Fuzhou, Fujian Province, Peoples R China; [Ni, Xiaolei] First Hosp Longyan City, Longyan, Fujian Province, Peoples R China; [Tong, Tong] MGH Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Cambridge, MA 02115 USA	Fuzhou University	Ke, DZ (corresponding author), Fuzhou Univ, Fujian Prov Key Lab Med Instrument & Pharmaceut T, Fuzhou, Fujian Province, Peoples R China.; Tong, T (corresponding author), MGH Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Cambridge, MA 02115 USA.	kedongz@fzu.edu.cn; ttraveltong@gmail.com			Fujian Provincial Natural Science Foundation of China [2015J01366, 2016J05157]; Foundation of Fujian Provincial Educational and Scientific Research Projects for Young and Middle-aged Teachers of Fujian Province (CN) [JAT160074]; National Natural Science Foundation of China [U1505251]	Fujian Provincial Natural Science Foundation of China; Foundation of Fujian Provincial Educational and Scientific Research Projects for Young and Middle-aged Teachers of Fujian Province (CN); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the Fujian Provincial Natural Science Foundation of China, under Grant 2015J01366 (XLN) and 2016J05157 (QQG), the Foundation of Fujian Provincial Educational and Scientific Research Projects for Young and Middle-aged Teachers of Fujian Province (CN) under grant JAT160074 (QQG), and the National Natural Science Foundation of China, under Grant U1505251 (QQG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadur YA, 2011, SAUDI MED J, V32, P495; Barney BM, 2011, INT J RADIAT ONCOL, V80, P301, DOI 10.1016/j.ijrobp.2010.06.007; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Berendsen FF, 2014, PHYS MED BIOL, V59, P4033, DOI 10.1088/0031-9155/59/4/4033; Bondar L, 2010, MED PHYS, V37, P3760, DOI 10.1118/1.3443436; Christensen GE, 2001, INT J RADIAT ONCOL, V51, P227, DOI 10.1016/S0360-3016(01)01667-4; Crum WR, 2004, BRIT J RADIOL, V77, pS140, DOI 10.1259/bjr/25329214; d'Aische AD, 2005, MED IMAGE ANAL, V9, P538, DOI 10.1016/j.media.2005.04.003; Foskey M, 2005, PHYS MED BIOL, V50, P5869, DOI 10.1088/0031-9155/50/24/008; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; Han K, 2013, INT J RADIAT ONCOL, V87, P111, DOI 10.1016/j.ijrobp.2013.05.033; Ibanez L., 2005, ITK SOFTWARE GUIDE; Jadon R, 2014, CLIN ONCOL-UK, V26, P185, DOI 10.1016/j.clon.2013.11.031; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kessler ML, 2006, BRIT J RADIOL, V79, pS99, DOI 10.1259/bjr/70617164; Kessler ML, 2014, BRIT J RADIOLOGY; Kim H, 2014, J CONTEMP BRACHYTHER, V6, P178, DOI 10.5114/jcb.2014.43240; Kirby N, 2013, MED PHYS, V40, DOI 10.1118/1.4769114; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee S, 1997, IEEE T VIS COMPUT GR, V3, P228, DOI 10.1109/2945.620490; Lim K, 2009, INT J RADIAT ONCOL, V74, P304, DOI 10.1016/j.ijrobp.2008.12.043; Lindegaard JC, 2013, ACTA ONCOL, V52, P1510, DOI 10.3109/0284186X.2013.818253; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Mackie TR, 2003, INT J RADIAT ONCOL, V56, P89, DOI 10.1016/S0360-3016(03)00090-7; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Osorio EMV, 2015, MED PHYS, V42, P206, DOI 10.1118/1.4903300; Potter R, 2011, RADIOTHER ONCOL, V100, P116, DOI 10.1016/j.radonc.2011.07.012; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schnabel JA, 2001, INT C MED IM COMP CO; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tian J, 2008, IEEE T INF TECHNOL B, V12, P800, DOI 10.1109/TITB.2008.926395; Toita T, 2003, INT J RADIAT ONCOL, V56, P1344, DOI 10.1016/S0360-3016(03)00288-8; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wang H, 2005, PHYS MED BIOL, V50, P2887, DOI 10.1088/0031-9155/50/12/011; Wolf I, P SPIE, V2004; Yan D, 1997, PHYS MED BIOL, V42, P123, DOI 10.1088/0031-9155/42/1/008; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V84, P125, DOI 10.1016/j.ijrobp.2011.11.047; Zhen X, 2015, PHYS MED BIOL, V60, P2981, DOI 10.1088/0031-9155/60/7/2981	39	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174926	10.1371/journal.pone.0174926	http://dx.doi.org/10.1371/journal.pone.0174926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388623	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800014
J	Vicente, CR; Herbinger, KH; Cerutti, C; Romano, CM; Cabidelle, ADA; Froschl, G				Vicente, Creuza Rachel; Herbinger, Karl-Heinz; Cerutti Junior, Crispim; Romano, Camila Malta; Areias Cabidelle, Aline de Souza; Froeschl, Guenter			Determination of clusters and factors associated with dengue dispersion during the first epidemic related to Dengue virus serotype 4 in Vitoria, Brazil	PLOS ONE			English	Article							AEDES-AEGYPTI; ENVIRONMENTAL VARIABLES; RISK-FACTORS; CITY; TRANSMISSION; DYNAMICS; CLIMATE; FEVER	Dengue occurrence is partially influenced by the immune status of the population. Consequently, the introduction of a new Dengue virus serotype can trigger explosive epidemics in susceptible populations. The determination of clusters in this scenario can help to identify hotspots and understand the disease dispersion regardless of the influence of the population herd immunity. The present study evaluated the pattern and factors associated with dengue dispersion during the first epidemic related to Dengue virus serotype 4 in Vitoria, Espirito Santo state, Brazil. Data on 18,861 dengue cases reported in Vitoria from September 2012 to June 2013 were included in the study. The analysis of spatial variation in temporal trend was performed to detect clusters that were compared by their respective relative risk, house index, population density, and income in an ecological study. Overall, 11 clusters were detected. The time trend increase of dengue incidence in the overall study population was 636%. The five clusters that showed a lower time trend increase than the overall population presented a higher incidence in the beginning of the epidemic and, compared to the six clusters with higher time trend increase, they presented higher relative risk for their inhabitants to acquire dengue infection (P-value = 0.02) and a lower income (P-value < 0.01). House index and population density did not differ between the clusters. Early increase of dengue incidence and higher relative risk for acquiring dengue infection were favored in low-income areas. Preventive actions and improvement of infrastructure in low-income areas should be prioritized in order to diminish the magnitude of dengue dispersion after the introduction of a new serotype.	[Vicente, Creuza Rachel; Froeschl, Guenter] Univ Munich LMU, Med Ctr, Ctr Int Hlth, Munich, Germany; [Herbinger, Karl-Heinz; Froeschl, Guenter] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Cerutti Junior, Crispim] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Brazil; [Romano, Camila Malta] Univ Sao Paulo, Inst Trop Med, LIM52 LIMHC, Sao Paulo, Brazil; [Areias Cabidelle, Aline de Souza] Coordinat Epidemiol Surveillance, Dept Hlth, Vitoria, Brazil	University of Munich; University of Munich; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Vicente, CR (corresponding author), Univ Munich LMU, Med Ctr, Ctr Int Hlth, Munich, Germany.	vicentecrachel@gmail.com	Cerutti, Crispim/C-4529-2011; Romano, Camila M/C-8185-2013; Romano, Camila/ABC-2883-2020	Romano, Camila/0000-0003-4550-1987	Coordination for the Improvement of Higher Education Personnel (CAPES) [9589-13-9]; Brazilian National Council for Scientific and Technological Development (CNPq) [482261/2010-2]; Federal Ministry for Economic Cooperation and Development (BMZ); German Academic Exchange Services (DAAD); the Center for International Health at Medical Center of the University of Munich, Germany, through the Excellence Centers for Exchange and Development (EXCEED)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal Ministry for Economic Cooperation and Development (BMZ); German Academic Exchange Services (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); the Center for International Health at Medical Center of the University of Munich, Germany, through the Excellence Centers for Exchange and Development (EXCEED)	This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES, www.capes.gov.br) (grant number 9589-13-9 to CRV) and the Brazilian National Council for Scientific and Technological Development (CNPq, www.cnpq.br) (grant number 482261/2010-2 to CCJ). The Federal Ministry for Economic Cooperation and Development (BMZ) and the German Academic Exchange Services (DAAD) fund the Center for International Health at Medical Center of the University of Munich, Germany, through the Excellence Centers for Exchange and Development (EXCEED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51; Bertolacci-Rocha LG, 2014, CAD SAUDE PUBLICA, V30, P1789, DOI 10.1590/0102-311X00003914; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Brazilian Institute of Geography and Statistics, 2010, CENS 2010; Brazilian Ministry of Health, 2013, DENG DIAGN MAN CLIN; Brazilian Ministry of Health, 2012, LEV RAP IND AED AEG; Brazilian National Institute of Meteorology, 2010, WEATH 2010; Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009; Cardoso IM, 2011, REV SOC BRAS MED TRO, V44, P430, DOI 10.1590/S0037-86822011005000044; Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059; Cordeiro R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-355; Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003; Health Department of Vitoria, 2012, RES LEV IND INF PRED; Health Department of Vitoria, 2013, RES LEV IND INF PRED; Jeefoo P, 2011, INT J ENV RES PUB HE, V8, P51, DOI 10.3390/ijerph8010051; Khormi HM, 2012, GEOSPATIAL HEALTH, V6, P171, DOI 10.4081/gh.2012.135; Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937; Kulldorff M., 2015, SATSCAN USER GUIDE V; Maciel-de-Freitas R, 2010, MED VET ENTOMOL, V24, P74, DOI 10.1111/j.1365-2915.2009.00851.x; Medronho Roberto de Andrade, 2006, Rev. bras. epidemiol., V9, P159; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; de Melo PRS, 2007, MEM I OSWALDO CRUZ, V102, P905, DOI 10.1590/S0074-02762007000800003; Stewart-Ibarra A. M., 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0078263; Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4; Teixeira M.G., 1999, INF EPIDEMIOLOGICO S, V8, P5, DOI [10.5123/S0104-16731999000400002, DOI 10.5123/S0104-16731999000400002]; Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002; Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175432	10.1371/journal.pone.0175432	http://dx.doi.org/10.1371/journal.pone.0175432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388694	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800054
J	Asgari, S; Mehrnia, A				Asgari, Shadnaz; Mehrnia, Alireza			A novel low-complexity digital filter design for wearable ECG devices	PLOS ONE			English	Article							FIR FILTER; DISEASE	Wearable and implantable Electrocardiograph (ECG) devices are becoming prevailing tools for continuous real-time personal health monitoring. The ECG signal can be contaminated by various types of noise and artifacts (e.g., powerline interference, baseline wandering) that must be removed or suppressed for accurate ECG signal processing. Limited device size, power consumption and cost are critical issues that need to be carefully considered when designing any portable health monitoring device, including a battery-powered ECG device. This work presents a novel low-complexity noise suppression reconfigurable finite impulse response (FIR) filter structure for wearable ECG and heart monitoring devices. The design relies on a recently introduced optimally-factored FIR filter method. The new filter structure and several of its useful features are presented in detail. We also studied the hardware complexity of the proposed structure and compared it with the state-of-the-art. The results showed that the new ECG filter has a lower hardware complexity relative to the state-of-the-art ECG filters.	[Asgari, Shadnaz] Calif State Univ Long Beach, Dept Biomed Engn, Long Beach, CA 90840 USA; [Asgari, Shadnaz] Calif State Univ Long Beach, Dept Comp Sci & Comp Engn, Long Beach, CA 90840 USA; [Mehrnia, Alireza] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of California System; University of California Los Angeles	Asgari, S (corresponding author), Calif State Univ Long Beach, Dept Biomed Engn, Long Beach, CA 90840 USA.; Asgari, S (corresponding author), Calif State Univ Long Beach, Dept Comp Sci & Comp Engn, Long Beach, CA 90840 USA.	Shadnaz.Asgari@csulb.edu						ADAMS JW, 1983, IEEE T CIRCUITS SYST, V30, P277, DOI 10.1109/TCS.1983.1085356; Appelboom G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-28; Asgari S, 2015, COMPUT BIOL MED, V60, P132, DOI 10.1016/j.compbiomed.2015.03.005; Banos O, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S2-S6; Banos O, 2015, SENSORS-BASEL, V15, P13159, DOI 10.3390/s150613159; Castillo E, 2013, J APPL MATH, DOI 10.1155/2013/763903; Estola K, 1984, HIGH PERFORMANCE FIR, P1462; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; HUHTA JC, 1973, IEEE T BIO-MED ENG, VBM20, P91, DOI 10.1109/TBME.1973.324169; Joshi SL, 2013, INT CONF COMM SYST, P60, DOI 10.1109/CSNT.2013.22; Lee SY, 2009, IEEE T BIOMED CIRC S, V3, P53, DOI 10.1109/TBCAS.2008.2007423; Levkov C, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-50; Lian Y, 2004, REDUCTION NOISES ECG; Lian Y, 2005, P ANN INT IEEE EMBS, P7357; LIM YC, 1986, IEEE T CIRCUITS SYST, V33, P357; MCCLELLAN JH, 1973, IEEE T ACOUST SPEECH, VAU21, P506, DOI 10.1109/TAU.1973.1162525; Mehrnia A, 2004, OPTIMAL IFIR FILTER, V133; Mehrnia A, 2016, IEEE T SIGNAL PROCES, V64, P1061, DOI 10.1109/TSP.2015.2494846; Mehrnia A, 2015, IEEE T CIRCUITS-I, V62, P1815, DOI 10.1109/TCSI.2015.2423773; Mehrnia A, 2015, IEEE T SIGNAL PROCES, V63, P647, DOI 10.1109/TSP.2014.2379647; Nemati E, 2012, IEEE COMMUN MAG, V50, P36, DOI 10.1109/MCOM.2012.6122530; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; PARKS TW, 1972, IEEE T CIRCUITS SYST, VCT19, P189, DOI 10.1109/TCT.1972.1083419; RAITAAHO T, 1994, IEEE T INSTRUM MEAS, V43, P644, DOI 10.1109/19.310181; Remez E., 1962, SER TRANSLATION SERI; SARAMAKI T, 1988, IEEE T CIRCUITS SYST, V35, P70, DOI 10.1109/31.1701; Van Baak T, 2004, 60 HZ AC MAINS FREQU; Williams M, 1989, ASIC DESIGN DIGITAL	30	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175139	10.1371/journal.pone.0175139	http://dx.doi.org/10.1371/journal.pone.0175139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384272	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900099
J	Bjorniand, T; Langaas, M; Grill, V; Mostad, IL				Bjorniand, Thea; Langaas, Mette; Grill, Valdemar; Mostad, Ingrid Lovold			Assessing gene-environment interaction effects of FTO, MC4R and lifestyle factors on obesity using an extreme phenotype sampling design: Results from the HUNT study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; ARTIFICIAL SWEETENERS; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; COMMON VARIANT; FAT MASS; WEIGHT; ASSOCIATION; INSIGHTS	Background Our aim was to assess the influence of age, gender and lifestyle factors on the effect of the obesity-promoting alleles of FTO and MCR4. Methods The HUNT study comprises health information on the population of Nord-Trondelag county, Norway. Extreme phenotype participants (gender-wise lower and upper quartiles of waisthip-ratio and BMI >= 35 kg/m(2)) in the third survey, HUNT3 (2006-08), were genotyped for the single- nucleotide polymorphisms rs9939609 (FTO) and rs17782313 (MC4R); 25686 participants were successfully genotyped. Extreme sampling was chosen to increase power to detect genetic and gene-environment effects on waist-hip-ratio and BMI. Statistical inference was based on linear regression models and a missing-covariate likelihood approach for the extreme phenotype sampling design. Environmental factors were physical activity, diet (artificially sweetened beverages) and smoking. Longitudinal analysis was performed using material from HUNT2 (1995-97). Results Cross-sectional and longitudinal genetic effects indicated stronger genetic associations with obesity in young than in old, as well as differences between women and men. We observed larger genetic effects among physically inactive compared to active individuals. This interaction was age-dependent and seen mainly in 20-40 year olds. We observed a greater FTO effect among men with a regular intake of artificially sweetened beverages, compared to non-drinkers. Interaction analysis of smoking was mainly inconclusive. Conclusions In a large all-adult and area-based population survey the effects of obesity-promoting minoralleles of FTO and MCR4, and interactions with life style factors are age-and genderrelated. These findings appear relevant when designing individualized treatment for and prophylaxis against obesity.	[Bjorniand, Thea; Langaas, Mette] Norwegian Univ Sci & Technol, Fac Informat Technol & Elect Engn, Dept Math Sci, Trondheim, Norway; [Grill, Valdemar; Mostad, Ingrid Lovold] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Grill, Valdemar] Univ Trondheim Hosp, St Olays Hosp, Dept Endocrinol, Trondheim, Norway; [Mostad, Ingrid Lovold] Univ Trondheim Hosp, St Olays Hosp, Dept Clin Nutr & Speech Language Therapy, Clin Clin Serv, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Bjorniand, T (corresponding author), Norwegian Univ Sci & Technol, Fac Informat Technol & Elect Engn, Dept Math Sci, Trondheim, Norway.	thea.bjornland@ntnu.no	Langaas, Mette/AAD-5948-2020; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Langaas, Mette/G-7423-2012	Langaas, Mette/0000-0002-5714-0288; 	Liaison Committee	Liaison Committee	ILM received funding from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (https://helse-midt.no/samarbeidsorganet). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; [Anonymous], 2010, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Boks MPM, 2007, INT J EPIDEMIOL, V36, P1363, DOI 10.1093/ije/dym215; Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027; Cuypers KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046912; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Fesinmeyer MD, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-6; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Hasselbalch AL, 2010, J NUTR, V140, P831, DOI 10.3945/jn.109.114439; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Huang BE, 2007, AM J HUM GENET, V80, P567, DOI 10.1086/512727; Hubacek JA, 2009, CLIN CHEM LAB MED, V47, P389, DOI 10.1515/CCLM.2009.109; Jacobsson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020158; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Krokstad S, 2012, INTERNATIONAL JOURNA; Kvaloy K, 2013, INT J OBESITY, V37, P1221, DOI 10.1038/ijo.2012.220; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Mostad IL, 2014, APPL PHYSIOL NUTR ME, P1; Pinnick KE, 2014, DIABETES, V63, P3785, DOI 10.2337/db14-0385; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi QB, 2014, HUM MOL GENET, V23, P6961, DOI 10.1093/hmg/ddu411; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Rukh G, 2016, INT J OBESITY, V40, P252, DOI 10.1038/ijo.2015.180; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Thorgeirsson TE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.81; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; Yang Qing, 2010, Yale Journal of Biology and Medicine, V83, P101; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	46	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175071	10.1371/journal.pone.0175071	http://dx.doi.org/10.1371/journal.pone.0175071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384342	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900079
J	Jabo, B; Morgan, JW; Martinez, ME; Ghamsary, M; Wieduwilt, MJ				Jabo, Brice; Morgan, John W.; Martinez, Maria Elena; Ghamsary, Mark; Wieduwilt, Matthew J.			Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients	PLOS ONE			English	Article							TREATMENT PATTERNS; CORD BLOOD; CANCER; REMISSION; SURVIVAL; ACCESS; RISK; CALIFORNIA; INTENSITY; OUTCOMES	Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Methods Using the California Cancer Registry, we performed a retrospective, population-based study of patients 15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. Results No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients >= 60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients >= 60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariateadjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.180-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Conclusions Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations	[Jabo, Brice; Morgan, John W.; Ghamsary, Mark] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Martinez, Maria Elena; Wieduwilt, Matthew J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Loma Linda University; University of California System; University of California San Diego	Morgan, JW (corresponding author), Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA.	jmorgan@llu.edu		Wieduwilt, Matthew/0000-0002-5414-9228	National Cancer Institute [N01-PC-35136, N01-PC-35139, N02-PC-15105]; Surveillance Epidemiology and End Results (SEER) program; Centers for Disease Control and Prevention [U58DP000807-01]; National Program for Cancer Registries; California Department of Public Health Cancer Surveillance Branch	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Surveillance Epidemiology and End Results (SEER) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Program for Cancer Registries; California Department of Public Health Cancer Surveillance Branch	This study was supported, in part, by contracts N01-PC-35136, N01-PC-35139 and N02-PC-15105 from the National Cancer Institute and the Surveillance Epidemiology and End Results (SEER) program; contract U58DP000807-01 from the Centers for Disease Control and Prevention and the National Program for Cancer Registries; and the California Department of Public Health Cancer Surveillance Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Barker JN, 2010, BIOL BLOOD MARROW TR, V16, P1541, DOI 10.1016/j.bbmt.2010.08.011; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bierenbaum J, 2012, LEUKEMIA RES, V36, P140, DOI 10.1016/j.leukres.2011.10.018; Burnett AK, 2002, BRIT J HAEMATOL, V118, P385, DOI 10.1046/j.1365-2141.2002.03724.x; Chan JK, 2006, MED CARE, V44, P952, DOI 10.1097/01.mlr.0000220830.46929.43; Cho MM, 2013, DIS COLON RECTUM, V56, P1357, DOI 10.1097/01.dcr.0000436362.81611.de; Cohen RA, 2015, HLTH INSURANCE COVER; Craddock CF, 2008, BONE MARROW TRANSPL, V41, P415, DOI 10.1038/sj.bmt.1705975; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Eleni LD, 2010, J ONCOL, V2010, DOI 10.1155/2010/943823; Fritz A, 2000, INT CLASSIFICATION D; Gyurkocza B, 2011, J NATL COMPR CANC NE, V9, P319, DOI 10.6004/jnccn.2011.0028; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hwang JP, 2004, CANCER-AM CANCER SOC, V101, P2230, DOI 10.1002/cncr.20628; Joshua TV, 2010, CANCER-AM CANCER SOC, V116, P3469, DOI 10.1002/cncr.25297; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laport GG, 2008, BLOOD, V112, P903, DOI 10.1182/blood-2008-03-143115; Majhail NS, 2012, BONE MARROW TRANSPL, V47, P1385, DOI 10.1038/bmt.2011.214; Majhail NS, 2010, BIOL BLOOD MARROW TR, V16, P1070, DOI 10.1016/j.bbmt.2009.12.529; Marks DI, 2006, BONE MARROW TRANSPL, V38, P467, DOI 10.1038/sj.bmt.1705464; Medeiros BC, 2015, ANN HEMATOL, V94, P1127, DOI 10.1007/s00277-015-2351-x; Medeiros BC, 2012, LEUKEMIA RES, V36, P127, DOI 10.1016/j.leukres.2011.10.028; Mitchell JM, 1997, J CLIN ONCOL, V15, P2644, DOI 10.1200/JCO.1997.15.7.2644; Patel MI, 2015, CANCER EPIDEM BIOMAR, V24, P344, DOI 10.1158/1055-9965.EPI-14-0963; Pidala J, 2013, BONE MARROW TRANSPL, V48, P63, DOI 10.1038/bmt.2012.95; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Ragon BK, 2014, BIOL BLOOD MARROW TR, V20, P53, DOI 10.1016/j.bbmt.2013.10.004; Ram R, 2010, CANCER-AM CANCER SOC, V116, P3447, DOI 10.1002/cncr.25136; Ribera JM, 2011, HAEMATOL-HEMATOL J, V96, P1083, DOI 10.3324/haematol.2011.048348; Ruggeri A, 2010, BEST PRACT RES CL HA, V23, P207, DOI 10.1016/j.beha.2010.06.002; Saghari S, 2015, ANN EPIDEMIOL, V25, P250, DOI 10.1016/j.annepidem.2015.01.008; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; U. S. Census Bureau, 2016, SMALL AR INC POV EST; Yanada M, 2006, CANCER-AM CANCER SOC, V106, P2657, DOI 10.1002/cncr.21932; Yang J., 2014, DEV AREA BASED SOCIO; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	38	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174760	10.1371/journal.pone.0174760	http://dx.doi.org/10.1371/journal.pone.0174760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384176	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900034
J	Wu', YP; Li, ZY; Zhu, SF; Lu, L; Cai, ZB				Wu', Yan-Ping; Li, Zheng-Yang; Zhu, Sheng-Fa; Lu, Lei; Cai, Zhen-Bing			Effect of frequency on fretting wear behavior of Ti/TiN multilayer film on depleted uranium	PLOS ONE			English	Article							CORROSION-RESISTANCE; TI ALLOY; COATINGS; EVOLUTION; ADHESION; SURFACE; DAMAGE; 316L	The Ti/TiN multi-layer film was prepared on the depleted uranium (DU) substrate by cathodic arc ion plating equipment. The character of multi-layer film was studied by SEM, XRD and AES, revealed that the surface was composed of small compact particle and the cross-section had a multi-layer structure. The fretting wear performance under different frequencies was performed by a MFT-6000 machine with a ball-on-plate configuration. The wear morphology was analyzed by white light interferometer, OM and SEM with an EDX. The result shows the Ti/TiN multi-layer film could greatly improve the fretting wear performance compared to the DU substrate. The fretting wear running and damaged behavior are strongly dependent on the film and test frequency. The fretting region of DU substrate and Ti/TiN multi-layer under low test frequency is gross slip. With the increase of test frequency, the fretting region of Ti/TiN multi-layer change from gross slip to mixed fretting, then to partial slip.	[Wu', Yan-Ping; Zhu, Sheng-Fa; Lu, Lei] China Acad Engn Phys, Inst Mat, Jiangyou, Sichuan, Peoples R China; [Li, Zheng-Yang; Cai, Zhen-Bing] Southwest Jiaotong Univ, Tribol Res Inst, Key Lab Adv Technol Mat, Chengdu, Peoples R China	Chinese Academy of Engineering Physics; Southwest Jiaotong University	Cai, ZB (corresponding author), Southwest Jiaotong Univ, Tribol Res Inst, Key Lab Adv Technol Mat, Chengdu, Peoples R China.	czb-jiaoda@126.com			National Nature Foundation of China [U1530136, 51375407]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Foundation of China (No. U1530136 and 51375407). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2015, MATER DESIGN, V75, P47, DOI 10.1016/j.matdes.2015.03.007; Amrute AP, 2013, CHEM SCI, V4, P2209, DOI 10.1039/c3sc22067b; Benea L, 2015, MATER DESIGN, V65, P550, DOI 10.1016/j.matdes.2014.09.050; Bundit Jarimopas, 2005, Packaging Technology and Science, V18, P179, DOI 10.1002/pts.687; Cai ZB, 2013, TRIBOL INT, V59, P312, DOI 10.1016/j.triboint.2012.06.009; Cai ZB, 2010, TRIBOL INT, V43, P361, DOI 10.1016/j.triboint.2009.06.016; CHANG F, 1991, SURF COAT TECH, V48, P31, DOI 10.1016/0257-8972(91)90126-H; CHANG FC, 1991, SURF COAT TECH, V49, P87, DOI 10.1016/0257-8972(91)90037-W; Fouvry S, 1997, WEAR, V203, P393, DOI 10.1016/S0043-1648(96)07436-4; Holmes AL, 2014, MUTAT RES-FUND MOL M, V762, P1, DOI 10.1016/j.mrfmmm.2014.02.001; Kim K, 2008, SURF COAT TECH, V202, P5838, DOI 10.1016/j.surfcoat.2008.06.051; Kot M, 2013, MATER DESIGN, V51, P280, DOI 10.1016/j.matdes.2013.04.008; Li LQ, 2011, WEAR, V270, P857, DOI 10.1016/j.wear.2011.02.014; Liu TW, 2007, SURF COAT TECH, V201, P6737, DOI 10.1016/j.surfcoat.2006.09.126; Marc E, 2016, SURF COAT TECH, V308, P226, DOI 10.1016/j.surfcoat.2016.06.091; Mi X, 2016, TRIBOL INT, V100, P400, DOI 10.1016/j.triboint.2016.05.012; Saravanan I, 2015, MATER DESIGN, V67, P469, DOI 10.1016/j.matdes.2014.10.051; Singh AK, 2014, MATER CHEM PHYS, V143, P1446, DOI 10.1016/j.matchemphys.2013.11.063; Wang QZ, 2015, MATER CHEM PHYS, V158, P74, DOI 10.1016/j.matchemphys.2015.03.039; Warmuth AR, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0291; Wu YP, 2016, J NUCL MATER, V478, P7, DOI 10.1016/j.jnucmat.2016.05.035; Xin L, 2016, MATER DESIGN, V104, P152, DOI 10.1016/j.matdes.2016.05.030; Zhou R, 2007, POSTHARVEST BIOL TEC, V46, P20, DOI 10.1016/j.postharvbio.2007.04.006; Zhu MH, 2007, WEAR, V263, P472, DOI 10.1016/j.wear.2007.01.050; Zhu SF, 2014, CORROS SCI, V82, P420, DOI 10.1016/j.corsci.2014.02.011; Zhu SF, 2013, ACS APPL MATER INTER, V5, P6598, DOI 10.1021/am401284e	26	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175084	10.1371/journal.pone.0175084	http://dx.doi.org/10.1371/journal.pone.0175084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384200	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900083
J	Gyurkovics, M; Baumann, T; Carvalho, TS; Assuncao, CM; Lussi, A				Gyurkovics, Milan; Baumann, Tommy; Carvalho, Thiago Saads; Assuncao, Cristiane Meira; Lussi, Adrian			In vitro evaluation of modified surface microhardness measurement, focus variation 3D microscopy and contact stylus profilometry to assess enamel surface loss after erosive-abrasive challenges	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; DENTAL EROSION; TOOTH WEAR; FLUORIDE; SITU	The aim of the study was to compare surface loss values after erosion abrasion cycles obtained with modified surface microhardness measurement (mSMH), focus variation 3D microscopy (FVM) and contact stylus profilometry (CSP). We cut human molars into buccal and lingual halves, embedded them in resin and ground 200 pm of enamel away. The resulting surfaces were polished. To maintain a reference area, we applied Block-Out resin to partly cover the enamel surface. The samples were incubated in artificial saliva (37 degrees C; 1 h), then rinsed in deionized water (10 s) and dried with oil-free air (5 s). We immersed the specimens individually in 30 mL citric acid (1%, pH 3.6) for 2 min (25 degrees C, 70 rpm dynamic conditions) before brushing them (50 strokes, 200 g) in an automatic brushing machine with toothpaste-slurry. We calculated the surface loss as per mSMH, by re-measuring the length of the same six indentations made before the abrasive challenge. The experiment consisted of five experimental groups that received between 2 and 10 erosion abrasion cycles. Each group contained 15 specimens and samples in groups 1, 2, 3, 4 and 5 underwent a total of 2, 4, 6, 8 and 10 cycles, respectively. The resin was removed from the reference area in one piece under 10x magnification and the FVM and CSP were performed. Agreement between the methods was calculated with the intraclass correlation coefficient (ICC) and depicted in Bland-Altman plots. All methods presented a linear pattern of surface loss measurements throughout the experiment, leading overall to a strong, statistically significant correlation between the methods (ICC = 0.85; p<0.001). So, despite the different surface loss values, all methods presented consistent results for surface loss measurement.	[Gyurkovics, Milan; Baumann, Tommy; Carvalho, Thiago Saads; Assuncao, Cristiane Meira; Lussi, Adrian] Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland; [Gyurkovics, Milan] Semmelweis Univ, Dept Conservat Dent, Fac Dent, Budapest, Hungary; [Assuncao, Cristiane Meira] Univ Fed Rio Grande do Sul, Sch Dent, Pediat Dent Div, Porto Alegre, RS, Brazil	University of Bern; Semmelweis University; Universidade Federal do Rio Grande do Sul	Gyurkovics, M (corresponding author), Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.; Gyurkovics, M (corresponding author), Semmelweis Univ, Dept Conservat Dent, Fac Dent, Budapest, Hungary.	miIan.gyurkovics@zmk.unibe.ch	ASSUNCAO, CRISTIANE MEIRA/V-7914-2019; Carvalho, Thiago/GWC-7662-2022; Carvalho, Thiago Saads/B-8945-2012	Carvalho, Thiago Saads/0000-0002-2435-1169; Gyurkovics, Milan/0000-0002-7561-6032; Assuncao, Cristiane Meira/0000-0002-1464-7812; Baumann, Tommy/0000-0002-5950-4137				Attin T, 2014, MONOGR ORAL SCI, V25, P123, DOI 10.1159/000360355; Barbour ME, 2004, J DENT, V32, P591, DOI 10.1016/j.jdent.2004.05.001; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Carvalho TS, 2015, CLIN ORAL INVEST, V19, P1557, DOI 10.1007/s00784-015-1511-7; Carvalho TS, 2014, J DENT, V42, P450, DOI 10.1016/j.jdent.2014.01.004; Carvalho TS, 2015, CARIES RES, V49, P109, DOI 10.1159/000369104; Cheng ZJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015020; Danzl R, 2011, STROJ VESTN-J MECH E, V57, P245, DOI 10.5545/sv-jme.2010.175; Eisenburger M, 2003, CARIES RES, V37, P450, DOI 10.1159/000073399; Field J, 2010, J DENT, V38, P182, DOI 10.1016/j.jdent.2010.01.002; Fujii M, 2011, DENT MATER J, V30, P404, DOI 10.4012/dmj.2010-204; Heurich E, 2010, DENT MATER, V26, P326, DOI 10.1016/j.dental.2009.12.001; Huysmans MCDNJM, 2011, CARIES RES, V45, P60, DOI 10.1159/000325947; Imfeld T, 1996, EUR J ORAL SCI, V104, P151, DOI 10.1111/j.1600-0722.1996.tb00063.x; Jaeggi T, 1999, CARIES RES, V33, P455, DOI 10.1159/000016551; Jaeggi T, 2014, MONOGR ORAL SCI, V25, P55, DOI 10.1159/000360973; Lima JPM, 2013, MICROSC RES TECHNIQ, V76, P904, DOI 10.1002/jemt.22246; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; LUSSI A, 1993, CARIES RES, V27, P387, DOI 10.1159/000261569; Lussi A, 2011, CARIES RES, V45, P2, DOI 10.1159/000325915; Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380; Lussi A, 2014, EUR J ORAL SCI, V122, P353, DOI 10.1111/eos.12144; Mann C, 2014, J DENT, V42, P1411, DOI 10.1016/j.jdent.2014.06.011; Paepegaey AM, 2013, DENT MATER, V29, P1265, DOI 10.1016/j.dental.2013.09.015; Passos VF, 2013, MICROSC RES TECHNIQ, V76, P178, DOI 10.1002/jemt.22150; Ren YF, 2011, J DENT, V39, P672, DOI 10.1016/j.jdent.2011.07.009; Ren YF, 2009, J DENT, V37, P424, DOI 10.1016/j.jdent.2009.01.011; Ren YF, 2009, J DENT, V37, P167, DOI 10.1016/j.jdent.2008.09.008; Rodriguez JM, 2010, DENT MATER, V26, pE221, DOI 10.1016/j.dental.2010.07.001; Schlueter N, 2011, CARIES RES, V45, P13, DOI 10.1159/000326819; Schwendicke F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108064; Stenhagen KR, 2010, CARIES RES, V44, P555, DOI 10.1159/000321536; Voronets J, 2010, CLIN ORAL INVEST, V14, P251, DOI 10.1007/s00784-009-0288-y; Zero DT, 1996, EUR J ORAL SCI, V104, P162, DOI 10.1111/j.1600-0722.1996.tb00065.x; ZERO DT, 1990, CARIES RES, V24, P181, DOI 10.1159/000261263	35	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175027	10.1371/journal.pone.0175027	http://dx.doi.org/10.1371/journal.pone.0175027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380015	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500087
J	Sarojini, H; Billeter, AT; Eichenberger, S; Druen, D; Barnett, R; Gardner, SA; Galbraith, NJ; Polk, HC; Chien, S				Sarojini, Harshini; Billeter, Adrian T.; Eichenberger, Sarah; Druen, Devin; Barnett, Rebecca; Gardner, Sarah A.; Galbraith, Norman J.; Polk, Hiram C., Jr.; Chien, Sufan			Rapid tissue regeneration induced by intracellular ATP delivery-A preliminary mechanistic study	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; T-HELPER-CELL; MACROPHAGE POLARIZATION; ADENOSINE-TRIPHOSPHATE; IN-VITRO; ALTERNATIVE ACTIVATION; MONONUCLEAR PHAGOCYTES; EXTRACELLULAR-MATRIX; LOCAL PROLIFERATION; CYTOKINE PRODUCTION	We have reported a new phenomenon in acute wound healing following the use of intracellular ATP delivery-extremely rapid tissue regeneration, which starts less than 24 h after surgery, and is accompanied by massive macrophage trafficking, in situ proliferation, and direct collagen production. This unusual process bypasses the formation of the traditional provisional extracellular matrix and significantly shortens the wound healing process. Although macrophages/monocytes are known to play a critical role in the initiation and progression of wound healing, their in situ proliferation and direct collagen production in wound healing have never been reported previously. We have explored these two very specific pathways during wound healing, while excluding confounding factors in the in vivo environment by analyzing wound samples and performing in vitro studies. The use of immunohistochemical studies enabled the detection of in situ macrophage proliferation in ATP-vesicle treated wounds. Primary human macrophages and Raw 264.7 cells were used for an in vitro study involving treatment with ATP vesicles, free Mg-ATP alone, lipid vesicles alone, Regranex, or culture medium. Collagen type 1 alpha 1, MCP-1, IL-6, and IL-10 levels were determined by ELISA of the culture supernatant. The intracellular collagen type 1 alpha 1 localization was determined with immunocytochemistry. ATP-vesicle treated wounds showed high immunoreactivity towards BrdU and PCNA antigens, indicating in situ proliferation. Most of the cultured macrophages treated with ATP-vesicles maintained their classic phenotype and expressed high levels of collagen type 1 alpha 1 for a longer duration than was observed with cells treated with Regranex. These studies provide the first clear evidence of in situ macrophage proliferation and direct collagen production during wound healing. These findings provide part of the explanation for the extremely rapid tissue regeneration, and this treatment may hold promise for acute and chronic wound care.	[Sarojini, Harshini; Billeter, Adrian T.; Eichenberger, Sarah; Druen, Devin; Barnett, Rebecca; Gardner, Sarah A.; Galbraith, Norman J.; Polk, Hiram C., Jr.; Chien, Sufan] Univ Louisville, Dept Surg, Louisville, KY 40292 USA	University of Louisville	Chien, S (corresponding author), Univ Louisville, Dept Surg, Louisville, KY 40292 USA.	sufanc@aim.com	Billeter, Adrian/O-2185-2019; Sarojini, Harshini/AAD-4870-2019	Sarojini, Harshini/0000-0002-3103-9712; Galbraith, Norman/0000-0002-6354-6946	NIH [DK74566, AR52984, HL114235, GM106639, DK104625, DK105692, OD021317]; Kentucky Cabinet for Economic Development, Office of Entrepreneurship [KSTC-184-512-12-138, KSTC-184-512-14-174]; Kentucky Science and Technology Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL114235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR052984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK105692, R01DK074566, R43DK104625, R43DK105692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM106639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Cabinet for Economic Development, Office of Entrepreneurship; Kentucky Science and Technology Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by grants DK74566, AR52984, HL114235, GM106639, DK104625, DK105692, and OD021317 from the NIH and in part from the Kentucky Cabinet for Economic Development, Office of Entrepreneurship, under the Grant Agreement KSTC-184-512-12-138, KSTC-184-512-14-174 with the Kentucky Science and Technology Corporation.	Ahuja V, 2007, NUTR WOUND HEALING, P87; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Barbul A, 2008, J NUTR, V138, p2021S, DOI 10.1093/jn/138.10.2021S; Becker LC, 2005, CIRC RES, V96, P812, DOI 10.1161/01.RES.0000165652.82726.d9; Beekman B, 1998, OSTEOARTHR CARTILAGE, V6, P330, DOI 10.1053/joca.1998.0132; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Chiang B, 2007, AM J SURG, V193, P213, DOI 10.1016/j.amjsurg.2006.08.069; Chien, 2006, RECENT RES DEV BIOPH, V5, P1; Chien S, 2012, JOVE-J VIS EXP, V2012, P1; Chien S, 2007, WOUND REPAIR REGEN, V15, P928, DOI 10.1111/j.1524-475X.2007.00285.x; Chien SF, 2010, METHODS MOL BIOL, V605, P377, DOI 10.1007/978-1-60327-360-2_26; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Chvapil M, 1988, J Burn Care Rehabil, V9, P279, DOI 10.1097/00004630-198805000-00009; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Distler JHW, 2006, ARTHRITIS RHEUM-US, V54, P214, DOI 10.1002/art.21497; Eming SA, 2007, AM J PATHOL, V170, P188, DOI 10.2353/ajpath.2007.060370; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Howard JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091787; Howes EL, 1943, SURG GYNECOL OBSTET, V76, P738; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Iwasaki Y, 2011, CELL TISSUE RES, V346, P99, DOI 10.1007/s00441-011-1231-5; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kasiewicz LN, 2016, ACTA BIOMATER, V32, P120, DOI 10.1016/j.actbio.2015.12.023; Khan B, 2013, J SURG RES, V183, P963, DOI 10.1016/j.jss.2013.02.019; Kimura T, 2013, J LEUKOCYTE BIOL, V94, P137, DOI 10.1189/jlb.0812408; La Flamme AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046989; Lansdown ABG, 2001, INT J EXP PATHOL, V82, P35, DOI 10.1046/j.1365-2613.2001.00180.x; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lehmann I, 2008, EXP TOXICOL PATHOL, V60, P185, DOI 10.1016/j.etp.2008.01.009; Lindblad, 1992, WOUND HEALING BIOCH, P248; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Murphy AJ, 2014, CIRC RES, V114, P236, DOI 10.1161/CIRCRESAHA.113.302813; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Patel S, 2016, J WOUND CARE, V25, P46, DOI 10.12968/jowc.2016.25.1.46; Peng XY, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-12; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rorsman C, 2016, J BIOL CHEM, V291, P11608, DOI 10.1074/jbc.M115.705814; Schaffer Michael, 2002, Int J Low Extrem Wounds, V1, P104, DOI 10.1177/1534734602001002005; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Schultz GS, 2005, WORLD WIDE WOUNDS, V1, P1; Toledo-Pereyra L.H., 2010, ORGAN PROCUREMENT PR, P82; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Ueno T, 2000, CLIN CANCER RES, V6, P3282; VAAGE J, 1991, BRIT J CANCER, V63, P758, DOI 10.1038/bjc.1991.169; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; Van den BJ, 2012, J LEUKOCYTE BIOL, V91, P1; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wang JP, 2010, AM J SURG, V199, P823, DOI 10.1016/j.amjsurg.2009.05.040; Wang JP, 2009, ANN PLAS SURG, V62, P180, DOI 10.1097/SAP.0b013e31817fe47e; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Weitkamp B, 1999, FASEB J, V13, P1445, DOI 10.1096/fasebj.13.11.1445; WILLIAMSBOYCE PK, 1986, J ANAT, V149, P55; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang C, 2015, WOUND REPAIR REGEN, V23, pA46; Yang C, 2016, WOUND REPAIR REG SPR, V2016, pW54; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	78	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174899	10.1371/journal.pone.0174899	http://dx.doi.org/10.1371/journal.pone.0174899			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380006	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000399353500075
J	Leifeld, P; Wankmuller, S; Berger, VTZ; Ingold, K; Steiner, C				Leifeld, Philip; Wankmueller, Sandra; Berger, Valentin T. Z.; Ingold, Karin; Steiner, Christiane			Collaboration patterns in the German political science co-authorship network	PLOS ONE			English	Article							COAUTHORSHIP NETWORKS; CITATION NETWORK; SOCIAL CIRCLES; JOURNALS	Research on social processes in the production of scientific output suggests that the collective research agenda of a discipline is influenced by its structural features, such as "invisible colleges "or" groups of collaborators " as well as academic "stars" that are embedded in, or connect, these research groups. Based on an encompassing dataset that takes into account multiple publication types including journals and chapters in edited volumes, we analyze the complete co-authorship network of all 1,339 researchers in German political science. Through the use of consensus graph clustering techniques and descriptive centrality measures, we identify the ten largest research clusters, their research topics, and the most central researchers who act as bridges and connect these clusters. We also aggregate the findings at the level of research organizations and consider the inter-university co-authorship network. The findings indicate that German political science is structured by multiple overlapping research clusters with a dominance of the subfields of international relations, comparative politics and political sociology. A small set of well-connected universities takes leading roles in these informal research groups.	[Leifeld, Philip] Univ Glasgow, Sch Social & Polit Sci, Glasgow, Lanark, Scotland; [Wankmueller, Sandra] Ludwig Maximilians Univ LMU Munich, Geschwister Scholl Inst Polit Sci, Munich, Germany; [Berger, Valentin T. Z.; Steiner, Christiane] Univ Konstanz, Dept Polit & Publ Adm, Constance, Germany; [Ingold, Karin] Univ Bern, Inst Polit Sci, Bern, Switzerland; [Ingold, Karin] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Ingold, Karin] Eawag, Dept Environm Social Sci, Dubendorf, Switzerland	University of Glasgow; University of Munich; University of Konstanz; University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Leifeld, P (corresponding author), Univ Glasgow, Sch Social & Polit Sci, Glasgow, Lanark, Scotland.	Philip.Leifeld@glasgow.ac.uk		Berger, Valentin T. Z./0000-0002-8306-6077				Andersen U., 2003, HANDWORTERBUCH POLIT, V5th; [Anonymous], ZEIT; [Anonymous], INT POLIT SCI REV; [Anonymous], 2004, INFORM ZWISCHEN KULT; Araujo EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090537; Arzheimer K, 2009, POLIT VIERTELJAHR, V50, P604, DOI 10.1007/s11615-009-0149-y; Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182; Bernauer T, 2010, SWISS POLIT SCI REV, V16, P279, DOI 10.1002/j.1662-6370.2010.tb00160.x; Bian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111928; Biscaro C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099502; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2009, LECT NOTES COMPUT SC, V5417, P218, DOI 10.1007/978-3-642-00219-9_21; Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; Cancela J, 2014, EUR POLIT SCI, V13, P327, DOI 10.1057/eps.2014.18; Catala-Lopez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038012; Crane D., 1972, INVISIBLE COLL DIFFU; Cranmer SJ, 2017, AM J POLIT SCI, V61, P237, DOI 10.1111/ajps.12263; Csardi G., 2006, INT J COMPLEX SYST, V2006, P1695, DOI DOI 10.1093/NAR/; Dangles O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157441; Fisher BS, 1998, PS, V31, P847, DOI 10.2307/420730; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Friedkin NE, 1998, STRUCTURAL THEORY SO; Gandhi Jennifer, 2006, REPORT APSA WORKING; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Gustafsson H, 2014, PSYCHOL SPORT EXERC, V15, P620, DOI 10.1016/j.psychsport.2014.07.001; Hancean MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep36152; Hancean MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113271; KADUSHIN C, 1966, AM SOCIOL REV, V31, P786, DOI 10.2307/2091658; KADUSHIN C, 1968, AM SOCIOL REV, V33, P685, DOI 10.2307/2092880; KRACKHARDT D, 1988, SOC PSYCHOL QUART, V51, P123, DOI 10.2307/2786835; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lang PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071415; Leenders R.T.A.J., 1995, STRUCTURE INFLUENCE; Leifeld P, 2016, SWISS POLIT SCI REV, V22, P264, DOI 10.1111/spsr.12193; Li X, 2007, J NANOPART RES, V9, P337, DOI 10.1007/s11051-006-9194-2; Luzar B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094429; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Metz T, 2017, PS-POLIT SCI POLIT, V50, P157, DOI 10.1017/S1049096516002341; Metz T, 2013, POLIT VIERTELJAHR, V54, P256; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Orman GK, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/08/P08001; Pehl M, 2012, EUR POLIT SCI, V11, P54, DOI 10.1057/eps.2011.38; Perc M, 2010, J INFORMETR, V4, P475, DOI 10.1016/j.joi.2010.04.003; Plumper T, 2003, POLIT VIERTELJAHR, V44, P529, DOI 10.1007/s11615-003-0097-x; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salinero MC, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0158413, 10.1371/journal.pone.0158489]; Sarigol E, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0009-x; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569; Zuccala A, 2006, J AM SOC INF SCI TEC, V57, P152, DOI 10.1002/asi.20256	56	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174671	10.1371/journal.pone.0174671	http://dx.doi.org/10.1371/journal.pone.0174671			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388621	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000399375800009
J	Wang, JH; Zhang, L; Huang, ST; Xu, J; Zhou, Y; Yu, XJ; Luo, RZ; Wen, ZS; Jia, WH; Zheng, M				Wang, Jian-Hua; Zhang, Lan; Huang, Shu-Ting; Xu, Jing; Zhou, Yun; Yu, Xing-Juan; Luo, Rong-Zhen; Wen, Zhe-Sheng; Jia, Wei-Hua; Zheng, Min			Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY LIGHT-CHAIN; MUSCLE-CONTRACTION; METASTASIS; TRANSCRIPTION; MIGRATION; INVASION; KINASE; PHOSPHORYLATION; INVASIVENESS	Objective Myosin light chain 9 (MYL9) is necessary for cytoskeletal dynamics and experimental metastasis, but its expression in esophageal squamous cell carcinoma (ESCC) has not been addressed. We investigated the expression pattern and clinical significance of MYL9 in patients with ESCC. Methods We examined MYL9 expression using quantitative real-time PCR and western blotting in NE1 immortalized esophageal epithelial cells, ESCC cell lines, and paired ESCC tissues. MYL9 protein in 136 primary ESCC tissues and other types of solid tumor was detected using immunohistochemistry. The association between MYL9 expression and clinical parameters and survival was evaluated by statistical analysis. Results MYL9 was significantly upregulated in the ESCC cell lines as compared with NE1 cells. In the paired ESCC samples, MYL9 mRNA and protein expression was not significantly different between lesion tissues and the matched adjacent noncancerous tissues. In ESCC tissue, both intratumoral and peritumoral stroma were positive for MYL9. In the 136 ESCC samples, high MYL9 expression in the tumor cells significantly correlated with histological differentiation (p = 0.028), recurrence (p = 0.01), and vital status (p < 0.01). Patients with high MYL9 expression in the tumor cells had poorer overall survival (OS) and recurrence-free survival. Multivariate analysis revealed that high MYL9 expression in tumor cells was an independent and significant risk factor affecting OS after curative treatment (hazard ratio = 2.254, 95% confidence interval = 1.347-3.771, p = 0.002). Conclusions MYL9 expression might be a promising prognostic marker and therapeutic target in ESCC.	[Wang, Jian-Hua] Guangdong Second Prov Gen Hosp, Dept Chest, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan; Huang, Shu-Ting; Zhou, Yun; Zheng, Min] Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan; Huang, Shu-Ting; Xu, Jing; Zhou, Yun; Yu, Xing-Juan; Jia, Wei-Hua; Zheng, Min] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan; Huang, Shu-Ting; Xu, Jing; Zhou, Yun; Yu, Xing-Juan; Jia, Wei-Hua; Zheng, Min] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan] Kunming Med Univ, Yunnan Tumor Hosp, Dept Radiat Oncol, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China; [Luo, Rong-Zhen] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wen, Zhe-Sheng] Sun Yat Sen Univ, Ctr Canc, Dept Chest, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Kunming Medical University; Sun Yat Sen University; Sun Yat Sen University	Wang, JH (corresponding author), Guangdong Second Prov Gen Hosp, Dept Chest, Guangzhou, Guangdong, Peoples R China.; Zheng, M (corresponding author), Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Zheng, M (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Zheng, M (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	wangjh296@163.com; zhengmin@sysucc.org.cn			National Natural Science Foundation of China [81171948, 81372275]; Project of State Key Laboratory of Oncology in South China [030041060004]; Project of Guangzhou Science and Technology Plan [2014J4100238]; Science and Technology Plan Program of Guangdong Province [2016A020215080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of State Key Laboratory of Oncology in South China; Project of Guangzhou Science and Technology Plan; Science and Technology Plan Program of Guangdong Province	This work was supported by the National Natural Science Foundation of China [grant numbers 81171948, 81372275], the Project of State Key Laboratory of Oncology in South China [grant number 030041060004], and the Project of Guangzhou Science and Technology Plan [2014J4100238 to Min Zheng]. In addition, this work has also been sponsored by Science and Technology Plan Program of Guangdong Province (M.Z., No. 2016A020215080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cao R, 2014, BRIT J CANCER, V111, P539, DOI 10.1038/bjc.2014.298; Cermak V, 2010, CELL MOL LIFE SCI, V67, P3557, DOI 10.1007/s00018-010-0395-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franco CA, 2013, DEVELOPMENT, V140, P2321, DOI 10.1242/dev.091074; Gilkes DM, 2014, P NATL ACAD SCI USA, V111, pE384, DOI 10.1073/pnas.1321510111; Gilles L, 2009, BLOOD, V114, P4221, DOI 10.1182/blood-2009-03-209932; Huang YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0820-4; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Ishihara S, 2013, FEBS LETT, V587, P732, DOI 10.1016/j.febslet.2013.01.055; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Ji H, 2014, BIOMED REP, V2, P787, DOI 10.3892/br.2014.323; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Li QJ, 2009, GASTROENTEROLOGY, V137, P1051, DOI 10.1053/j.gastro.2009.03.040; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Lu Y, 2011, AM J TRANSL RES, V3, P8; Luo XG, 2014, CANCER LETT, V344, P129, DOI 10.1016/j.canlet.2013.10.026; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Ogata S, 2009, INT J GYNECOL CANCER, V19, P1473, DOI 10.1111/IGC.0b013e3181c03909; Ouderkirk JL, 2014, CYTOSKELETON, V71, P447, DOI 10.1002/cm.21187; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Szent-Gyorgyi AG, 2004, J GEN PHYSIOL, V123, P631, DOI 10.1085/jgp.200409091; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; Tan X, 2014, TUMOR BIOL, V35, P12189, DOI 10.1007/s13277-014-2527-3; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Yan Z, 2012, ONCOL REP, V28, P1036, DOI 10.3892/or.2012.1891; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024	30	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175280	10.1371/journal.pone.0175280	http://dx.doi.org/10.1371/journal.pone.0175280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388691	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800035
J	Darrah, R; Bederman, I; Vitko, M; Valerio, DM; Drumm, ML; Hodges, CA				Darrah, Rebecca; Bederman, Ilya; Vitko, Megan; Valerio, Dana M.; Drumm, Mitchell L.; Hodges, Craig A.			Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PULMONARY-FUNCTION; NUTRITIONAL-STATUS; MECONIUM ILEUS; CFTR-KNOCKOUT; MODEL; DISEASE; MOUSE; RETARDATION; CHILDREN	Growth deficits are common in cystic fibrosis (CF), but their cause is complex, with contributions from exocrine pancreatic insufficiency, pulmonary complications, gastrointestinal obstructions, and endocrine abnormalities. The CF mouse model displays similar growth impairment despite exocrine pancreatic function and in the absence of chronic pulmonary infection. The high incidence of intestinal obstruction in the CF mouse has been suggested to significantly contribute to the observed growth deficits. Previous studies by our group have shown that restoration of the cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium prevents intestinal obstruction but does not improve growth. In this study, we further investigate growth deficits in CF and gut-corrected CF mice by assessing insulin-like growth factor 1 (IGF-1). IGF-1 levels were significantly decreased in CF and gut-corrected CF adult mice compared to wildtype littermates and were highly correlated with weight. Interestingly, perinatal IGF-1 levels were not significantly different between CF and wildtype littermates, even though growth deficits in CF mice could be detected late in gestation. Since CFTR has been suggested to play a role in water and nutrient exchange in the placenta through its interaction with aquaporins, we analyzed placental aquaporin expression in late-gestation CF and control littermates. While significant differences were observed in Aquaporin 9 expression in CF placentas in late gestation, there was no evidence of placental fluid exchange differences between CF and control littermates. The results from this study indicate that decreased IGF-1 levels are highly correlated with growth in CF mice, independent of CF intestinal obstruction. However, the perinatal growth deficits that are observed in CF mice are not due to decreased IGF-1 levels or differences in placenta-mediated fluid exchange. Further investigation is necessary to understand the etiology of early growth deficits in CF, as growth has been shown to be a significant factor in disease outcomes.	[Darrah, Rebecca] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA; [Darrah, Rebecca; Vitko, Megan; Drumm, Mitchell L.; Hodges, Craig A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Bederman, Ilya; Valerio, Dana M.; Drumm, Mitchell L.; Hodges, Craig A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Hodges, CA (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Hodges, CA (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	craig.hodges@case.edu		Piazza, Megan/0000-0002-1062-7144	Cystic Fibrosis Foundation [Hodges11G0]; National Institutes of Health [P30DK27651, R24RR032425]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Cystic Fibrosis Foundation (Hodges11G0, https://www.cff.org/CFF) and the National Institutes of Health (P30DK27651 and R24RR032425, https://www.nig.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; BOYER PH, 1955, PEDIATRICS, V16, P778; Castro-Parodi M, 2009, PLACENTA, V30, P642, DOI 10.1016/j.placenta.2009.04.012; Cheung KH, 2003, BIOL REPROD, V68, P1505, DOI 10.1095/biolreprod.102.010017; Cohen JC, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-21; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; Cystic Fibrosis Foundation Patient Registry, 2006, 2005 ANNUAL DATA REP; Darrah R, 2016, BIOL RES NURS, V18, P498, DOI 10.1177/1099800416643585; Darrah RJ, 2016, J CYST FIBROS; DAVIS B, 1985, LANCET, V1, P392; DURIE PR, 1989, ACTA PAEDIATR SCAND, P41; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; ECKMAN EA, 1995, AM J PHYSIOL-LUNG C, V269, pL625, DOI 10.1152/ajplung.1995.269.5.L625; FALLER DP, 1995, AM J PHYSIOL-CELL PH, V269, pC148, DOI 10.1152/ajpcell.1995.269.1.C148; Festini F, 2005, J PEDIATR-US, V147, P316, DOI 10.1016/j.jpeds.2005.04.031; Gaskin KJ, 2013, EUR J CLIN NUTR, V67, P558, DOI 10.1038/ejcn.2013.20; GHOSAL S, 1995, ARCH DIS CHILD, V72, P150, DOI 10.1136/adc.72.2.150; HAEUSLER G, 1994, EUR J PEDIATR, V153, P158, DOI 10.1007/BF01958975; HAN VKM, 1988, J CLIN ENDOCR METAB, V66, P422, DOI 10.1210/jcem-66-2-422; Hardin DS, 2005, CLIN ENDOCRINOL, V62, P560, DOI 10.1111/j.1365-2265.2005.02259.x; Hodges CA, 2008, GENESIS, V46, P546, DOI 10.1002/dvg.20433; Hodges CA, 2011, AM J PHYSIOL-GASTR L, V301, pG528, DOI 10.1152/ajpgi.00052.2011; Kent G, 1997, J CLIN INVEST, V100, P3060, DOI 10.1172/JCI119861; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; KOPELMAN H, 1985, NEW ENGL J MED, V312, P329, DOI 10.1056/NEJM198502073120601; Lai HC, 1999, AM J CLIN NUTR, V69, P531; Lai HC, 2000, PEDIATRICS, V105, P53, DOI 10.1542/peds.105.1.53; LEVY E, 1993, PEDIATR RES, V34, P162, DOI 10.1203/00006450-199308000-00011; Mylona P, 1996, MOL HUM REPROD, V2, P693, DOI 10.1093/molehr/2.9.693; Netchine I, 2011, BEST PRACT RES CL EN, V25, P181, DOI 10.1016/j.beem.2010.08.005; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; Pascua P, 2009, PFLUG ARCH EUR J PHY, V459, P203, DOI 10.1007/s00424-009-0704-9; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; ROBERTS CT, 1987, MOL ENDOCRINOL, V1, P243, DOI 10.1210/mend-1-3-243; Rogan MP, 2010, PROC NATL ACAD SCI U; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rosenberg LA, 2006, PEDIATR RES, V59, P191, DOI 10.1203/01.pdr.0000196720.25938.be; Schreiber R, 1999, J BIOL CHEM, V274, P11811, DOI 10.1074/jbc.274.17.11811; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stallings VA, 2008, J AM DIET ASSOC, V108, P832, DOI 10.1016/j.jada.2008.02.020; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Vitko M, 2016, J CYST FIBROS; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175467	10.1371/journal.pone.0175467	http://dx.doi.org/10.1371/journal.pone.0175467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384265	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900172
J	Devarakonda, SB; Myers, MR; Giridhar, D; Dibaji, SAR; Banerjee, RK				Devarakonda, Surendra Balaji; Myers, Matthew R.; Giridhar, Dushyanth; Dibaji, Seyed Ahmad Reza; Banerjee, Rupak Kumar			Enhanced thermal effect using magnetic nano-particles during high-intensity focused ultrasound	PLOS ONE			English	Article							CANCER-THERAPY; DRUG-DELIVERY; ABLATION; MICROCAPSULES; NANOPARTICLES; SOUND	Collateral damage and long sonication times occurring during high-intensity focused ultrasound (HIFU) ablation procedures limit clinical advancement. In this reserarch, we investigated whether the use of magnetic nano-particles (mNPs) can reduce the power required to ablate tissue or, for the same power, reduce the duration of the procedure. Tissue-mimicking phantoms containing embedded thermocouples and physiologically acceptable concentrations (0%, 0.0047%, and 0.047%) of mNPs were sonicated at acoustic powers of 5.2 W, 9.2 W, and 14.5 W, for 30 seconds. Lesion volumes were determined for the phantoms with and without mNPs. It was found that with the 0.047% mNP concentration, the power required to obtain a lesion volume of 13 mm 3 can be halved, and the time required to achieve a 21 mm 3 lesion decreased by a factor of 5. We conclude that mNPs have the potential to reduce damage to healthy tissue, and reduce the procedure time, during tumor ablation using HIFU.	[Devarakonda, Surendra Balaji; Giridhar, Dushyanth; Dibaji, Seyed Ahmad Reza; Banerjee, Rupak Kumar] Univ Cincinnati, Dept Mech Mat Engn, Coll Engn & Appl Sci, Cincinnati, OH 45220 USA; [Myers, Matthew R.] US FDA, Div Solid & Fluid Mech, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University System of Ohio; University of Cincinnati; US Food & Drug Administration (FDA)	Banerjee, RK (corresponding author), Univ Cincinnati, Dept Mech Mat Engn, Coll Engn & Appl Sci, Cincinnati, OH 45220 USA.	Rupak.Banerjee@uc.edu	Devarakonda, Surendra/C-1832-2018	Banerjee, Rupak/0000-0002-7235-9560	NSF [1403356]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant 1403356.	ALLEGRA JR, 1972, J ACOUST SOC AM, V51, P1545, DOI 10.1121/1.1912999; BRAWER S, 1973, PHYS REV B, V7, P1712, DOI 10.1103/PhysRevB.7.1712; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Dasgupta S, 2011, ULTRASONICS, V51, P171, DOI 10.1016/j.ultras.2010.07.007; Day ES, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3156800; Dibaji SAR, 2014, J NANOTECHNOLOGY ENG, V4; Dillon CR, 2012, PHYS MED BIOL, V57, P4527, DOI 10.1088/0031-9155/57/14/4527; Duncan RS, 1998, ANN ONCOLOGY S2, V9; Etheridge ML, 2014, TECHNOLOGY, V2, P214, DOI 10.1142/S2339547814500198; Gelet A, 1999, J UROLOGY, V161, P156, DOI 10.1016/S0022-5347(01)62087-1; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; Hariharan P, 2014, IEEE T ULTRASON FERR, V61, P2019, DOI 10.1109/TUFFC.2014.006702; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Kennedy JE, 2004, ULTRASONICS, V42, P931, DOI 10.1016/j.ultras.2004.01.089; King RL, 2011, IEEE T ULTRASON FERR, V58, P1397, DOI 10.1109/TUFFC.2011.1959; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Luo W, 2006, ADV THER, V23, P861, DOI 10.1007/BF02850207; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; Mitragotri S, 2014, MRS BULL, V39, P219, DOI 10.1557/mrs.2014.11; Morris H, 2008, PHYS MED BIOL, V53, P4759, DOI 10.1088/0031-9155/53/17/020; Ojea-Jimenez I, 2013, CURR DRUG METAB, V14, P518, DOI 10.2174/13892002113149990008; Pinkerton JMM., 1949, P PHYS SOC B, V62, P129, DOI [10.1088/0370-1301/62/2/307, DOI 10.1088/0370-1301/62/2/307]; Righetti R, 1999, ULTRASOUND MED BIOL, V25, P1099, DOI 10.1016/S0301-5629(99)00044-7; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; SIMONS S, 1964, P PHYS SOC LOND, V83, P749, DOI 10.1088/0370-1328/83/5/306; Sun Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-800; Sun Y, 2012, BIOMATERIALS, V33, P5854, DOI 10.1016/j.biomaterials.2012.04.062; Wust P, MAGNETIC NANOPARTICL; Zhou YF, 2011, WORLD J CLIN ONCOL, V2, P8, DOI 10.5306/wjco.v2.i1.8	29	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175093	10.1371/journal.pone.0175093	http://dx.doi.org/10.1371/journal.pone.0175093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384646	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900084
J	Kim, MS; Kim, JY; Noh, SC; Choi, HH				Kim, Mi-sun; Kim, Ju-Young; Noh, Si-Cheol; Choi, Heung-Ho			Thermal characteristics of non-biological vessel phantoms for treatment of varicose veins using high-intensity focused ultrasound	PLOS ONE			English	Article								The ultrasonic treatment of varicose veins uses high-intensity focused ultrasound, in which a blood vessel is contracted by converting acoustic energy into thermal energy. In this study, we propose a phantom of varicose veins that can be applied for the efficient evaluation of ultrasonic treatment in varicose veins. The proposed phantom consisted of glycerol base tissue equivalent material, vessel mimic tube, and blood mimic substances. The vessel mimic tube was placed inner glycerol phantom and it was filled with blood mimic substances. Blood-mimicked substances are prepared by adjusting the concentration of the glycerol solution to be similar to the acoustic properties of the blood, and vessel-mimicking materials are selected by measuring acoustic properties and thermal shrinkage of various materials in a heat-shrinkable tube. The blood vessels surrounding the tissue are replaced with the phantom similar to glycerol-based organization, and venous blood flow is implemented using a DC motor. The heating characteristics according to the ultrasonic wave using the manufactured varicose veins phantom were evaluated. As the sound wave irradiation time and power increased, the contractility of the vessel mimicking materials and the temperature of the surrounding tissues were increased. When the blood-mimicking material was circulated, the highest temperature in the focused region and the contractility of vessel mimicking materials were reduced under the same conditions as used for sonication. The manufactured phantom may contribute to the treatment of varicose veins and can be used to predict the ultrasonic therapeutic efficiency of varicose veins.	[Kim, Mi-sun] Natl Inst Food & Drug Safety Evaluat, Med Device Evaluat Dept, Cheongju, Chungcheongbuk, South Korea; [Kim, Ju-Young; Choi, Heung-Ho] Inje Univ, Dept Biomed Engn, Gimhae, Kyoungsangnam D, South Korea; [Noh, Si-Cheol] Int Univ Korea, Dept Radiol Sci, Jinju, Kyoungsangnam D, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Inje University; International University Korea	Choi, HH (corresponding author), Inje Univ, Dept Biomed Engn, Gimhae, Kyoungsangnam D, South Korea.	hhichoi@inje.ac.kr			Research year of Inje University	Research year of Inje University	This work was supported by a grant from Research year of Inje University in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dasgupta S, 2011, ULTRASONICS, V51, P171, DOI 10.1016/j.ultras.2010.07.007; FRAYNE R, 1993, MED PHYS, V20, P415, DOI 10.1118/1.597141; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Greaby R, 2007, ULTRASOUND MED BIOL, V33, P1269, DOI 10.1016/j.ultrasmedbio.2007.02.011; Henderson PW, 2010, J VASC SURG, V51, P707, DOI 10.1016/j.jvs.2009.10.049; Hoskins PR, 2007, ULTRASOUND MED BIOL, V33, P1527, DOI 10.1016/j.ultrasmedbio.2007.04.020; Huang J.-C., 2002, THESIS; Naoum JJ, 2007, VASCULAR, V15, P242, DOI 10.2310/6670.2007.00069; Petrusca L, 2009, PHYS MED BIOL, V54, P5123, DOI 10.1088/0031-9155/54/17/004; Pichardo S, 2006, ULTRASOUND MED BIOL, V32, P883, DOI 10.1016/j.ultrasmedbio.2006.02.1419; RICKEY DW, 1995, ULTRASOUND MED BIOL, V21, P1163, DOI 10.1016/0301-5629(95)00044-5; Salomir R, 2000, J MAGN RESON IMAGING, V12, P571, DOI 10.1002/1522-2586(200010)12:4<571::AID-JMRI9>3.3.CO;2-U; Senooa Naohiko, 2010, AIP C P, V1359; Ushijimaa Hiroyuki, 2010, AIP C P, V1359	14	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174922	10.1371/journal.pone.0174922	http://dx.doi.org/10.1371/journal.pone.0174922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384210	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900052
J	Klinkhamer, AJ; Wilhite, DR; White, MA; Wroe, S				Klinkhamer, Ada J.; Wilhite, D. Ray; White, Matt A.; Wroe, Stephen			Digital dissection and three-dimensional interactive models of limb musculature in the Australian estuarine crocodile (Crocodylus porosus)	PLOS ONE			English	Article							SOFT-TISSUE ANATOMY; HINDLIMB MUSCULATURE; COMPUTED-TOMOGRAPHY; ASYMMETRICAL GAITS; JAW MUSCULATURE; ALLIGATOR; EVOLUTION; RELEVANCE; LOCOMOTION; MUSCLES	Digital dissection is a relatively new technique that has enabled scientists to gain a better understanding of vertebrate anatomy. It can be used to rapidly disseminate detailed, three-dimensional information in an easily accessible manner that reduces the need for destructive, traditional dissections. Here we present the results of a digital dissection on the appendicular musculature of the Australian estuarine crocodile (Crocodylus porosus). A better understanding of this until now poorly known system in C. porosus is important, not only because it will expand research into crocodilian locomotion, but because of its potential to inform muscle reconstructions in dinosaur taxa. Muscles of the forelimb and hindlimb are described and three-dimensional interactive models are included based on CT and MRI scans as well as fresh-tissue dissections. Differences in the arrangement of musculature between C. porosus and other groups within the Crocodylia were found. In the forelimb, differences are restricted to a single tendon of origin for triceps longus medialis. For the hindlimb, a reduction in the number of heads of ambiens was noted as well as changes to the location of origin and insertion for iliofibularis and gastrocnemius externus.	[Klinkhamer, Ada J.; Wroe, Stephen] Univ New England, Funct Evolut & Anat Res Lab, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Klinkhamer, Ada J.; White, Matt A.] Australian Age Dinosaurs Museum Nat Hist, Winton, Qld, Australia; [Wilhite, D. Ray] Auburn Univ, Dept Anat Physiol & Pharmacol, Coll Vet Med, Auburn, AL 36849 USA; [White, Matt A.] Univ Newcastle, Sch Engn, Callaghan, NSW, Australia	University of New England; Auburn University System; Auburn University; University of Newcastle	Klinkhamer, AJ (corresponding author), Univ New England, Funct Evolut & Anat Res Lab, Sch Environm & Rural Sci, Armidale, NSW, Australia.; Klinkhamer, AJ (corresponding author), Australian Age Dinosaurs Museum Nat Hist, Winton, Qld, Australia.	aklinkha@myune.edu.au		White, Matt/0000-0002-4765-0356; Wroe, Stephen/0000-0002-6365-5915	ARC Discovery [DP140102656, DP140102659]	ARC Discovery(Australian Research Council)	Work was supported by ARC Discovery grants to SW (DP140102656 and DP140102659).	Allen V, 2014, J ANAT, V225, P569, DOI 10.1111/joa.12245; Allen V, 2010, J ANAT, V216, P423, DOI 10.1111/j.1469-7580.2009.01202.x; Baier DB, 2013, J ANATOMY WILEY ONLI, V223, P1; Bates KT, 2012, J ANAT, V220, P212, DOI 10.1111/j.1469-7580.2011.01469.x; Bonnan MF., 2001, THESIS; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Chiasson R.B., 1962, LAB ANATOMY ALLIGATO; Cox PG, 2014, PEERJ, V2, DOI 10.7717/peerj.448; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Curtis N, 2009, PALAEONTOLOGIA ELECT, V12; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Fechner R, 2009, THESIS; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1997, J MORPHOL, V234, P197, DOI 10.1002/(SICI)1097-4687(199711)234:2<197::AID-JMOR6>3.0.CO;2-9; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer Max Cardoso, 2003, Paleobios, V23, P1; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lautenschlager S, 2014, PALAEONTOL Z, V88, P111, DOI 10.1007/s12542-013-0184-2; Lautenschlager S, 2013, J ANAT, V222, P260, DOI 10.1111/joa.12000; Materialise, 2016, MIM MED IM SEG ENG A; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Miller CE, 2008, J R SOC INTERFACE, V5, P465, DOI 10.1098/rsif.2007.1220; Otero A, 2008, AMEGHINIANA, V45, P333; Otero A, 2010, HERPETOL J, V20, P173; Parrish JM, 1987, JSTOR, P396; Pixologic, 2015, ZBRUSH 4R7; Quayle MR, 2014, PEERJ, V2, DOI 10.7717/peerj.355; Reese A. M., 1915, ALLIGATOR ITS ALLIES; Reilly SA, 2005, J EXP BIOL, V208, P993, DOI 10.1242/jeb.01473; Reilly SM, 1998, J EXP BIOL, V201, P2559; Reilly SM, 2003, J EXP BIOL, V206, P4327, DOI 10.1242/jeb.00688; Remes K, 2008, THESIS; Renous S, 2002, J ZOOL, V256, P311, DOI 10.1017/S0952836902000353; Romer AS, 1922, LOCOMOTOR APPARATUS; Romer AS., 1923, B AMNH, P48; ROWE T, 1986, J MORPHOL, V189, P327, DOI 10.1002/jmor.1051890310; Sellers W, 2013, PLOS ONE, V8, P1; Sharp AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117730; Wilhite R., 2003, THESIS; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; ZUG GR, 1974, COPEIA, P550	50	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175079	10.1371/journal.pone.0175079	http://dx.doi.org/10.1371/journal.pone.0175079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384201	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900082
J	Maritz, JM; Sullivan, SA; Prill, RJ; Aksoy, E; Scheid, P; Carlton, JM				Maritz, Julia M.; Sullivan, Steven A.; Prill, Robert J.; Aksoy, Emre; Scheid, Paul; Carlton, Jane M.			Filthy lucre: A metagenomic pilot study of microbes found on circulating currency in New York City	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SKIN; COMMUNITY; PAPER; MONEY; CONTAMINATION; SURFACES; SURVIVAL; PHONES	Background Paper currency by its very nature is frequently transferred from one person to another and represents an important medium for human contact with-and potential exchange of-microbes. In this pilot study, we swabbed circulating $1 bills obtained from a New York City bank in February (Winter) and June (Summer) 2013 and used shotgun metagenomic sequencing to profile the communities found on their surface. Using basic culture conditions, we also tested whether viable microbes could be recovered from bills. Results Shotgun metagenomics identified eukaryotes as the most abundant sequences on money, followed by bacteria, viruses and archaea. Eukaryotic assemblages were dominated by human, other metazoan and fungal taxa. The currency investigated harbored a diverse microbial population that was dominated by human skin and oral commensals, including Propionibacterium acnes, Staphylococcus epidermidis and Micrococcus luteus. Other taxa detected not associated with humans included Lactococcus lactis and Streptococcus thermophilus, microbes typically associated with dairy production and fermentation. Culturing results indicated that viable microbes can be isolated from paper currency. Conclusions We conducted the first metagenomic characterization of the surface of paper money in the United States, establishing a baseline for microbes found on $1 bills circulating in New York City. Our results suggest that money amalgamates DNA from sources inhabiting the human microbiome, food, and other environmental inputs, some of which can be recovered as viable organisms. These monetary communities may be maintained through contact with human skin, and DNA obtained from money may provide a record of human behavior and health. Understanding these microbial profiles is especially relevant to public health as money could potentially mediate interpersonal transfer of microbes.	[Maritz, Julia M.; Sullivan, Steven A.; Aksoy, Emre; Scheid, Paul; Carlton, Jane M.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Prill, Robert J.] IBM Almaden Res Ctr, Accelerated Discovery Lab, San Jose, CA USA; [Aksoy, Emre] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	New York University; International Business Machines (IBM); University of California System; University of California Riverside	Carlton, JM (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	jane.carlton@nyu.edu		Maritz, Julia M./0000-0003-0116-6910	MacCracken Program in the Graduate School of Arts and Science; New York University Grand Challenge project	MacCracken Program in the Graduate School of Arts and Science; New York University Grand Challenge project	JMM is supported by the MacCracken Program in the Graduate School of Arts and Science at New York University. This study was funded by a New York University Grand Challenge project "Microbes, Sewage, Health and Disease: Mapping the New York City Metagenome" to JMC. IBM Almaden Research provided support in the form of salaries and computational resources for author RJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ABRAMS BL, 1972, J AMER MED ASSOC, V219, P1202, DOI 10.1001/jama.219.9.1202; Afshinnekoo E, 2015, CELL SYST, V1, P97, DOI 10.1016/j.cels.2015.07.006; Angelakis E, 2014, FUTURE MICROBIOL, V9, P249, DOI 10.2217/fmb.13.161; [Anonymous], 1884, NATURE; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Bik HM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00226-16; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Dawson P, 2007, J APPL MICROBIOL, V102, P945, DOI 10.1111/j.1365-2672.2006.03171.x; DeLong EF, 2004, NATURE, V428, P25, DOI 10.1038/428025a; Desroches TC, 2014, INDOOR AIR, V24, P533, DOI 10.1111/ina.12100; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; El-Dars FMSE, 2005, INT J ENVIRON HEAL R, V15, P235, DOI 10.1080/09603120500105976; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fischer G, 2003, ARCH MICROBIOL, V179, P75, DOI 10.1007/s00203-002-0495-2; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Gedik H, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-22; Gibbons SM, 2015, APPL ENVIRON MICROB, V81, P765, DOI 10.1128/AEM.03117-14; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HAYDEN NJ, 1994, PLANT PATHOL, V43, P562, DOI 10.1111/j.1365-3059.1994.tb01591.x; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Hsu T, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00018-16; Hubner NO, 2011, AM J NURS, V111, P30, DOI 10.1097/01.NAJ.0000408181.37017.82; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang XP, 1999, J FOOD PROTECT, V62, P805, DOI 10.4315/0362-028X-62.7.805; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Lamichhane J., 2009, NEPAL J SCI TECHNOL, V10, P161; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lax S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0082-9; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Lund AH, 1996, NUCLEIC ACIDS RES, V24, P800, DOI 10.1093/nar/24.4.800; Mathieu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065288; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Meadow JF, 2014, PEERJ, V2, DOI 10.7717/peerj.447; Medrano-Felix A, 2011, J APPL MICROBIOL, V110, P463, DOI 10.1111/j.1365-2672.2010.04901.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Michaels B., 2002, Food Service Technology, V2, P1, DOI 10.1046/j.1471-5740.2002.00030.x; Ojima M, 2002, INT J ENVIRON HEAL R, V12, P41, DOI 10.1080/09603120120110040; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Palaniraj A, 2011, J FOOD ENG, V106, P1, DOI 10.1016/j.jfoodeng.2011.03.035; Pope CTW, 2002, SOUTH MED J, V95, P1408, DOI 10.1097/00007611-200295120-00011; Reserve UF, 2015, COIN CURRENCY SERVIC; Reserve UF, 2015, LONG IS LIFESPAN US; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vriesekoop F, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4040042; Vriesekoop F, 2010, FOODBORNE PATHOG DIS, V7, P1497, DOI 10.1089/fpd.2010.0606; Zhang Q, 2014, RES J BIOTECHNOL, V9, P7	65	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175527	10.1371/journal.pone.0175527	http://dx.doi.org/10.1371/journal.pone.0175527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384336	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900175
J	Saudi, WSW; Sjoblom, M				Saudi, Wan Salman Wan; Sjoblom, Markus			Neuropeptide S reduces duodenal bicarbonate secretion and ethanol-induced increases in duodenal motility in rats	PLOS ONE			English	Article							JEJUNUM IN-VIVO; NITRIC-OXIDE; MUCOSAL PERMEABILITY; ALCOHOL-CONSUMPTION; INTESTINAL WATER; HEART-FAILURE; L-ARGININE; RECEPTOR; ABSORPTION; EXPRESSION	Alcohol disrupts the intestinal mucosal barrier by inducing metabolic and functional changes in epithelial cells. Recently, we showed that neuropeptide S (NPS) decreases duodenal motility and increases mucosal paracellular permeability, suggesting a role of NPS in the pathogenesis of disorders and dysfunctions in the small intestine. The aim of the present study was to investigate the effects of NPS on ethanol-and HCl-induced changes of duodenal mucosal barrier function and motility. Rats were anaesthetized with thiobarbiturate, and a 30-mm segment of the proximal duodenum with an intact blood supply was perfused in situ. The effects on duodenal bicarbonate secretion, the blood-to-lumen clearance of Cr-51-EDTA, motility and transepithelial net fluid flux were investigated. Intravenous (i.v.) administration of NPS significantly reduced duodenal mucosal bicarbonate secretion and stimulated mucosal transepithelial fluid absorption, mechanisms dependent on nitrergic signaling. NPS dose-dependently reduced ethanol-induced increases in duodenal motility. NPS (83 pmol center dot kg(-1)center dot min(-1),i.v.) reduced the bicarbonate and fluid secretory response to luminal ethanol, whereas a 10-fold higher dose stimulated fluid secretion but did not influence bicarbonate secretion. In NPS-treated animals, duodenal perfusion of acid (pH 3) induced greater bicarbonate secretory rates than in controls. Pre-treating animals with N.-nitro-L-arginine methyl ester (L-NAME) inhibited the effect of NPS on bicarbonate secretion. In response to luminal acid, NPS-treated animals had significantly higher paracellular permeability compared to controls, an effect that was abolished by L-NAME. Our findings demonstrate that NPS reduces basal and ethanol-induced increases in duodenal motility. In addition, NPS increases luminal alkalinization and mucosal permeability in response to luminal acid via mechanisms that are dependent on nitric oxide signaling. The data support a role for NPS in neurohumoral regulation of duodenal mucosal barrier function and motility.	[Saudi, Wan Salman Wan; Sjoblom, Markus] Uppsala Univ, Div Physiol, Dept Neurosci, Uppsala, Sweden	Uppsala University	Sjoblom, M (corresponding author), Uppsala Univ, Div Physiol, Dept Neurosci, Uppsala, Sweden.	Markus.Sjoblom@neuro.uu.se	Saudi, Wan Salman Wan/I-5866-2016	Saudi, Wan Salman Wan/0000-0001-6424-2066; Sjoblom, Markus/0000-0002-1406-9389	Uppsala University; Ministry of Education of Malaysia; Universiti Malaysia Sabah	Uppsala University; Ministry of Education of Malaysia; Universiti Malaysia Sabah	The current study was supported by Uppsala University (MS), the Ministry of Education of Malaysia (WSWS) and the Universiti Malaysia Sabah (WSWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; [Anonymous], 2012, PHYSL GASTROINTESTIN; BARAONA E, 1974, GASTROENTEROLOGY, V66, P226; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Han RW, 2009, PEPTIDES, V30, P1313, DOI 10.1016/j.peptides.2009.03.012; ISENBERG JI, 1987, NEW ENGL J MED, V316, P374, DOI 10.1056/NEJM198702123160704; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Levitt MD, 1997, ALCOHOL CLIN EXP RES, V21, P293, DOI 10.1111/j.1530-0277.1997.tb03763.x; Levitt MD, 1997, AM J PHYSIOL-GASTR L, V273, pG951, DOI 10.1152/ajpgi.1997.273.4.G951; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; MAHER MM, 1995, J SURG RES, V58, P687, DOI 10.1006/jsre.1995.1108; MAZZANTI R, 1987, GUT, V28, P52, DOI 10.1136/gut.28.1.52; Mourad FH, 1999, GUT, V44, P143, DOI 10.1136/gut.44.2.143; Mourad FH, 1996, GUT, V39, P539, DOI 10.1136/gut.39.4.539; NYLANDER O, 1989, AM J PHYSIOL, V257, pG653; Nylander O, 2003, AM J PHYSIOL GASTROI, V285; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Petrella C, 2011, PHARMACOL RES, V64, P471, DOI 10.1016/j.phrs.2011.06.007; Pihl L, 2006, ACTA PHYSIOL, V186, P279, DOI 10.1111/j.1748-1716.2006.01559.x; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; SABABI M, 1994, AM J PHYSIOL, V266, pG22, DOI 10.1152/ajpgi.1994.266.1.G22; Saudi WSW, 2015, AM J PHYSIOL-GASTR L, V309, pG625, DOI 10.1152/ajpgi.00104.2015; SCHIRGIDEGEN A, 1995, BRIT J PHARMACOL, V114, P13, DOI 10.1111/j.1476-5381.1995.tb14899.x; SchirgiDegen A, 1996, EUR J PHARMACOL, V316, P257, DOI 10.1016/S0014-2999(96)00683-8; Sommansson A, 2014, ACTA PHYSIOL, V212, P152, DOI 10.1111/apha.12339; Sommansson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102654; Sommansson A, 2013, AM J PHYSIOL-GASTR L, V305, pG95, DOI 10.1152/ajpgi.00074.2013; Sommansson A, 2013, J PINEAL RES, V54, P282, DOI 10.1111/jpi.12013; Sundman L, 2010, NEUROGASTROENT MOTIL, V22, P79, DOI 10.1111/j.1365-2982.2009.01366.x; Takeuchi K, 1999, J PHYSIOL PHARMACOL, V50, P155; Turvill JL, 1999, GUT, V44, P33, DOI 10.1136/gut.44.1.33; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Wapnir RA, 1997, GUT, V40, P602, DOI 10.1136/gut.40.5.602; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175312	10.1371/journal.pone.0175312	http://dx.doi.org/10.1371/journal.pone.0175312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384243	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900153
J	Sproule, MKJ; Chacron, MJ				Sproule, Michael K. J.; Chacron, Maurice J.			Electrosensory neural responses to natural electro-communication stimuli are distributed along a continuum	PLOS ONE			English	Article							LATERAL-LINE LOBE; RECEPTIVE-FIELD ORGANIZATION; INTERNEURON-DIVERSITY-SERIES; CA1 PYRAMIDAL NEURONS; APTERONOTUS-LEPTORHYNCHUS; DENDRITIC MORPHOLOGY; RAT HIPPOCAMPUS; GAIN-CONTROL; CELL-TYPES; FISH	Neural heterogeneities are seen ubiquitously within the brain and greatly complicate classification efforts. Here we tested whether the responses of an anatomically well-characterized sensory neuron population to natural stimuli could be used for functional classification. To do so, we recorded from pyramidal cells within the electrosensory lateral line lobe (ELL) of the weakly electric fish Apteronotus leptorhynchus in response to natural electro-communication stimuli as these cells can be anatomically classified into six different types. We then used two independent methodologies to functionally classify responses: one relies of reducing the dimensionality of a feature space while the other directly compares the responses themselves. Both methodologies gave rise to qualitatively similar results: while ON and OFF-type cells could easily be distinguished from one another, ELL pyramidal neuron responses are actually distributed along a continuum rather than forming distinct clusters due to heterogeneities. We discuss the implications of our results for neural coding and highlight some potential advantages.	[Sproule, Michael K. J.; Chacron, Maurice J.] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Chacron, MJ (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	maurice.chacron@mcgill.ca		Chacron, Maurice/0000-0002-3032-452X	Natural Sciences and Engineering Research Council; Canada Research Chairs	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR)	This research was supported by the Natural Sciences and Engineering Research Council and the Canada Research Chairs (MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Natural Sciences and Engineering Research Council and the Canada Research Chairs (M.J.C).	Aumentado-Armstrong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004430; Avila-Akerberg O, 2010, NEUROSCIENCE, V168, P300, DOI 10.1016/j.neuroscience.2010.03.012; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Baraban SC, 2004, TRENDS NEUROSCI, V27, P135, DOI 10.1016/j.tins.2004.01.008; Bastian J, 1999, J EXP BIOL, V202, P1327; BASTIAN J, 1986, J NEUROSCI, V6, P553; Bastian J, 2004, NEURON, V41, P767, DOI 10.1016/S0896-6273(04)00071-6; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1991, J COMP PHYSIOL A, V168, P393, DOI 10.1007/BF00199600; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; BASTIAN J, 1986, J COMP PHYSIOL A, V158, P505, DOI 10.1007/BF00603796; Berman NJ, 1999, J EXP BIOL, V202, P1243; BOCK HH, 1989, J CLASSIF, V6, P126; Bol K, 2011, J NEUROSCI, V31, P11028, DOI 10.1523/JNEUROSCI.0193-11.2011; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Chacron MJ, 2008, J NEUROPHYSIOL, V99, P1825, DOI 10.1152/jn.01266.2007; Chacron MJ, 2011, CURR OPIN NEUROBIOL, V21, P752, DOI 10.1016/j.conb.2011.05.016; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; Chacron MJ, 2005, J NEUROSCI, V25, P5521, DOI 10.1523/JNEUROSCI.0445-05.2005; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Clarke SE, 2015, NAT REV NEUROSCI, V16, P733, DOI 10.1038/nrn4037; Clarke SE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9764; Clarke SE, 2014, J NEUROSCI, V34, P5583, DOI 10.1523/JNEUROSCI.4988-13.2014; DAVIS TL, 1979, J COMP NEUROL, V188, P599, DOI 10.1002/cne.901880407; Deemyad T, 2013, P NATL ACAD SCI USA, V110, P19609, DOI 10.1073/pnas.1314008110; Dunteman G.H., 1989, PRINCIPAL COMPONENTS; Frank K, 1964, ELECTROPHYSIOLOGICAL, P22, DOI DOI 10.1016/B978-0-12-514105-5.50009-5; Fusi S, 2016, CURR OPIN NEUROBIOL, V37, P66, DOI 10.1016/j.conb.2016.01.010; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; Hitschfeld EM, 2009, ILAR J, V50, P361, DOI 10.1093/ilar.50.4.361; Huang CJG, 2016, J NEUROSCI, V36, P9859, DOI 10.1523/JNEUROSCI.1433-16.2016; Huang CJG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11353; Hupe GJ, 2008, J EXP BIOL, V211, P1657, DOI 10.1242/jeb.013516; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kim J.-O., 1978, INTRO FACTOR ANAL WH; Kim J-O, FACTOR ANAL STAT MET; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Krahe R, 2008, J NEUROPHYSIOL, V100, P852, DOI 10.1152/jn.90300.2008; Krahe R, 2014, CURR OPIN NEUROBIOL, V24, P13, DOI 10.1016/j.conb.2013.08.013; Long J.S., 1983, CONFIRMATORY FACTOR; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; Maler L, 2009, J COMP NEUROL, V516, P394, DOI 10.1002/cne.22120; Maler L, 2009, J COMP NEUROL, V516, P376, DOI 10.1002/cne.22124; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Mardia K.V., 1999, DIRECTIONAL STAT, DOI [10.1002/9780470316979, DOI 10.1002/9780470316979]; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marquez BT, 2013, J EXP BIOL, V216, P2442, DOI 10.1242/jeb.082370; Marsat G, 2012, CURR OPIN NEUROBIOL, V22, P686, DOI 10.1016/j.conb.2012.01.009; Marsat G, 2010, J NEUROPHYSIOL, V104, P2543, DOI 10.1152/jn.00256.2010; Marsat G, 2009, J NEUROPHYSIOL, V102, P714, DOI 10.1152/jn.91366.2008; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; Mejias JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228102; Mejias JF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003180; Metzen MG, 2016, ELIFE, V5, DOI 10.7554/eLife.12993; Mott DD, 2003, TRENDS NEUROSCI, V26, P484, DOI 10.1016/S0166-2236(03)00200-5; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Rabiner L., 1993, FUNDAMENTALS SPEECH; Ratanamahatana CA, 2005, P 5 SIAM INT C DAT M; Rath TM, 2003, PROC CVPR IEEE, P521; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; SAUNDERS J, 1984, J COMP PHYSIOL, V154, P199, DOI 10.1007/BF00604985; Savard M, 2011, NEUROSCIENCE, V172, P270, DOI 10.1016/j.neuroscience.2010.10.061; SCHEICH H, 1973, J NEUROPHYSIOL, V36, P39, DOI 10.1152/jn.1973.36.1.39; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Sharpee TO, 2014, NEURON, V83, P1329, DOI 10.1016/j.neuron.2014.08.040; Simmonds B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004034; Sproule MKJ, 2015, NEUROSCI LETT, V607, P1, DOI 10.1016/j.neulet.2015.09.014; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Toporikova N, 2009, J NEUROPHYSIOL, V102, P2273, DOI 10.1152/jn.00282.2009; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Vonderschen K, 2011, J NEUROPHYSIOL, V106, P3102, DOI 10.1152/jn.00588.2011; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Zakon H, 2002, J PHYSIOL-PARIS, V96, P451, DOI 10.1016/S0928-4257(03)00012-3; Zhang ZBD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28716	82	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175322	10.1371/journal.pone.0175322	http://dx.doi.org/10.1371/journal.pone.0175322			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384244	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900157
J	Valdivieso, P; Toigo, M; Hoppeler, H; Fluck, M				Valdivieso, Paola; Toigo, Marco; Hoppeler, Hans; Fluck, Martin			T/T homozygosity of the tenascin-C gene polymorphism rs2104772 negatively influences exercise-induced angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN SKELETAL-MUSCLE; RAT SOLEUS MUSCLE; ANGIOTENSIN-II; BLOOD-VESSELS; TRANSCRIPT EXPRESSION; HYPERTENSIVE RATS; STRESS; TENDON; CELLS	Background Mechanical stress, including blood pressure related factors, up-regulate expression of the pro-angiogenic extracellular matrix protein tenascin-C in skeletal muscle. We hypothesized that increased capillarization of skeletal muscle with the repeated augmentation in perfusion during endurance training is associated with blood vessel-related expression of tenascin-C and would be affected by the single-nucleotide polymorphism (SNP) rs2104772, which characterizes the non-synonymous exchange of thymidine (T)-to-adenosine (A) in the amino acid codon 1677 of tenascin-C. Methods Sixty-one healthy, untrained, male white participants of Swiss descent performed thirty 30-min bouts of endurance exercise on consecutive weekdays using a cycling ergometer. Genotype and training interactions were called significant at Bonferroni-corrected p-value of 5% (repeated measures ANOVA). Results Endurance training increased capillary-to-fiber-ratio (+11%), capillary density (+7%), and mitochondrial volume density (+30%) in m. vastus lateralis. Tenascin-C protein expression in this muscle was confined to arterioles and venules (80% of cases) and increased after training in A-allele carriers. Prior to training, volume densities of subsarcolemmal and myofibrillar mitochondria in m. vastus lateralis muscle were 49% and 18%, respectively, higher in A/A homozygotes relative to T-nucleotide carriers (A/T and T/T). Training specifically increased capillary-to-fiber ratio in A-nucleotide carriers but not in T/T homozygotes. Genotype specific regulation of angiogenesis was reflected by the expression response of 8 angiogenesis-associated transcripts after exercise, and confirmed by training-induced alterations of the shear stress related factors, vimentin and VEGF A. Conclusion Our findings provide evidence for a negative influence of T/T homozygosity in rs2104772 on capillary remodeling with endurance exercise.	[Valdivieso, Paola; Toigo, Marco; Fluck, Martin] Univ Zurich, Dept Orthoped, Lab Muscle Plast, Balgrist Campus, Zurich, Switzerland; [Hoppeler, Hans; Fluck, Martin] Univ Bern, Inst Anat, Bern, Switzerland	University of Zurich; University of Bern	Fluck, M (corresponding author), Univ Zurich, Dept Orthoped, Lab Muscle Plast, Balgrist Campus, Zurich, Switzerland.; Fluck, M (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	mflueck@research.balgrist.ch		Valdivieso, Paola/0000-0001-9322-4510	Swiss National Science Foundation; RESORTHO Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); RESORTHO Foundation	Financial support was received from the Swiss National Science Foundation (HH, MF), and the RESORTHO Foundation (MF).	Alagappan VKT, 2007, CELL BIOCHEM BIOPHYS, V47, P109, DOI 10.1385/CBB:47:1:109; Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; ASMUSSEN MA, 1994, GENETICS, V138, P1351; Ballard VLT, 2006, FASEB J, V20, P717, DOI 10.1096/fj.05-5131fje; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; BELLISSANT E, 1994, J CARDIOVASC PHARM, V24, P500, DOI 10.1097/00005344-199409000-00020; Bilalic S, 2012, TRANSPL IMMUNOL, V27, P101, DOI 10.1016/j.trim.2012.06.006; Busso T, 2013, EUR J APPL PHYSIOL, V113, P1279, DOI 10.1007/s00421-012-2547-x; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Chu TJ, 2008, PHYSIOL GENOMICS, V34, P185, DOI 10.1152/physiolgenomics.90201.2008; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111; David S, 2013, J PHARMACOL EXP THER, V345, P2, DOI 10.1124/jpet.112.201061; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Egginton S, 1998, J APPL PHYSIOL, V85, P2025, DOI 10.1152/jappl.1998.85.6.2025; Fluck M, 2000, J CELL SCI, V113, P3583; Fluck M, 2005, AM J PHYSIOL-REG I, V289, pR4, DOI 10.1152/ajpregu.00833.2004; Fluck M, 2003, AM J PHYSIOL-REG I, V284, pR792, DOI 10.1152/ajpregu.00060.2002; Flueck M, 2011, SCAND J MED SCI SPOR, V21, P29, DOI 10.1111/j.1600-0838.2011.01339.x; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Flueck M, 2009, HIGH ALT MED BIOL, V10, P183, DOI 10.1089/ham.2008.1104; HAHN AWA, 1993, BIOCHEM BIOPH RES CO, V192, P189, DOI 10.1006/bbrc.1993.1399; HAHN AWA, 1995, J VASC RES, V32, P162, DOI 10.1159/000159090; Hoier B, 2013, EXP PHYSIOL, V98, P585, DOI 10.1113/expphysiol.2012.067967; Hoier B, 2012, J PHYSIOL-LONDON, V590, P595, DOI 10.1113/jphysiol.2011.216135; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Huber-Abel FAM, 2012, EUR J APPL PHYSIOL, V112, P155, DOI 10.1007/s00421-011-1960-x; Imanaka-Yoshida K, 2014, ANAT REC, V297, P1747, DOI 10.1002/ar.22985; Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Kale S, 2005, FASEB J, V19, pA306; KAYAR SR, 1988, J EXP BIOL, V137, P253; LIGHTMAN S, 1987, HYPERTENSION, V10, P390, DOI 10.1161/01.HYP.10.4.390; LIGHTNER VA, 1989, J CELL BIOL, V108, P2483, DOI 10.1083/jcb.108.6.2483; MACKIE EJ, 1992, AM J PATHOL, V141, P377; Mathes S, 2015, ANAT PHYSL S, VS5; Matsuda A, 2005, HUM MOL GENET, V14, P2779, DOI 10.1093/hmg/ddi311; McDonald DM, 2002, CANCER RES, V62, P5381; Nadar SK, 2005, J INTERN MED, V258, P336, DOI 10.1111/j.1365-2796.2005.01550.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prior BM, 1985, J APPL PHYSIOL, V2004, P1119; Saunders CJ, 2013, J ORTHOP RES, V31, P632, DOI 10.1002/jor.22278; Schnittler HJ, 1998, HISTOCHEM CELL BIOL, V110, P161, DOI 10.1007/s004180050277; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; SUTER E, 1995, INT J SPORTS MED, V16, P160, DOI 10.1055/s-2007-972985; Szczepkowska A, 2012, CELL TISSUE RES, V350, P157, DOI 10.1007/s00441-012-1431-7; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Ginkel S, 2016, SCAND J MED SCI SPOR, V26, P1180, DOI 10.1111/sms.12572; van Ginkel S, SCAND J MED SCI SPOR; van Ginkel S, 2015, APPL TRANSL GENOM, V4, P33, DOI 10.1016/j.atg.2015.03.002; Vaughan D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149046; Vaughan D, 2013, EUR J APPL PHYSIOL, V113, P1719, DOI 10.1007/s00421-012-2583-6; Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.physiol.58.1.21; Yang R, 2008, PHYSIOL GENOMICS, V36, P1, DOI 10.1152/physiolgenomics.90291.2008; Zanini A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-132; Zantop T, 2003, ARCH ORTHOP TRAUM SU, V123, P501, DOI 10.1007/s00402-003-0491-2	60	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174864	10.1371/journal.pone.0174864	http://dx.doi.org/10.1371/journal.pone.0174864			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384286	Green Accepted, Green Published, gold			2022-12-27	WOS:000399371900044
J	Zhang, XZ; Wang, HZ; Lv, TY				Zhang, Xizhe; Wang, Huaizhen; Lv, Tianyang			Efficient target control of complex networks based on preferential matching	PLOS ONE			English	Article							CONTROLLABILITY; EMERGENCE	Controlling a complex network towards a desired state is of great importance in many applications. Existing works present an approximate algorithm to find the input nodes used to control partial nodes of the network. However, the input nodes obtained by this algorithm depend on the node matching order and cannot achieve optimum results. Here we present a novel algorithm to find the input nodes for target control based on preferential matching. The algorithm elaborately arranges the matching order of the nodes to reduce the size of the input node set. The results on both synthetic and real networks indicate that the proposed algorithm outperforms the previous algorithm.	[Zhang, Xizhe] Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China; [Zhang, Xizhe; Wang, Huaizhen] Northeastern Univ, Sch Comp Sci & Engn, Shenyang, Liaoning, Peoples R China; [Lv, Tianyang] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin IT CTR, Heilongjiang, Peoples R China; [Lv, Tianyang] IT Ctr, Natl Audit Off, Beijing, Peoples R China	Northeastern University - China; Northeastern University - China; Harbin Engineering University	Zhang, XZ (corresponding author), Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China.; Zhang, XZ (corresponding author), Northeastern Univ, Sch Comp Sci & Engn, Shenyang, Liaoning, Peoples R China.	zhangxizhe@mail.neu.edu.cn	Zhang, Xizhe/H-3429-2019; Zhang, Xizhe/B-9848-2019	Zhang, Xizhe/0000-0002-8684-4591	Fundamental Research Funds for the Central Universities of China [N140404011]; Natural Science Foundation of China [60903009, 71272216, 91546110]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase)	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase)	This work was supported by the Fundamental Research Funds for the Central Universities of China under grand number N140404011, the Natural Science Foundation of China under grant numbers 60903009, 71272216, 91546110, and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Gao JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6415; Handcock M.S., 2003, STATNET R PACKAGE ST; Jia T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05379; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Leskovec J., 2012, ADV NEURAL INFORM PR, P539, DOI DOI 10.1109/ICDM.2012.159; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luenberger D. G., 1979, P IEEE, V69, P1173; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V42, P285; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Murota K., 2000, MATRICES MATROIDS SY; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Piao XF, 2015, PHYSICA A, V421, P98, DOI 10.1016/j.physa.2014.10.081; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Pu CL, 2012, PHYSICA A, V391, P4420, DOI 10.1016/j.physa.2012.04.019; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Slotine J. J. E., 2004, APPL NONLINEAR CONTR; Ulanowicz RE, 2005, NETWORK ANAL TROPHIC, P114; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhang XZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38209	31	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175375	10.1371/journal.pone.0175375	http://dx.doi.org/10.1371/journal.pone.0175375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384303	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900165
J	Beaton, KH; Wong, AL; Lowen, SB; Shelhamer, M				Beaton, Kara H.; Wong, Aaron L.; Lowen, Steven B.; Shelhamer, Mark			Strength of baseline inter-trial correlations forecasts adaptive capacity in the vestibulo-ocular reflex	PLOS ONE			English	Article							MOTOR VARIABILITY; TIME-SERIES; ADAPTATION; REHABILITATION	Individual differences in sensorimotor adaptability may permit customized training protocols for optimum learning. Here, we sought to forecast individual adaptive capabilities in the vestibulo- ocular reflex (VOR). Subjects performed 400 head-rotation steps (400 trials) during a baseline test, followed by 20 min of VOR gain adaptation. All subjects exhibited mean baseline VOR gain of approximately 1.0, variable from trial to trial, and showed desired reductions in gain following adaptation with variation in extent across individuals. The extent to which a given subject adapted was inversely proportional to a measure of the strength and duration of baseline inter-trial correlations (beta). beta is derived from the decay of the autocorrelation of the sequence of VOR gains, and describes how strongly correlated are past gain values; it thus indicates how much the VOR gain on any given trial is informed by performance on previous trials. To maximize the time that images are stabilized on the retina, the VOR should maintain a gain close to 1.0 that is adjusted predominantly according to the most recent error; hence, it is not surprising that individuals who exhibit smaller a (weaker intertrial correlations) also exhibited the best adaptation. Our finding suggests that the temporal structure of baseline behavioral data contains important information that may aid in forecasting adaptive capacities. This has significant implications for the development of personalized physical therapy protocols for patients, and for other cases when it is necessary to adjust motor programs to maintain movement accuracy in response to pathological and environmental changes.	[Beaton, Kara H.; Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Wong, Aaron L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lowen, Steven B.] Harvard Med Sch, Dept Psychiat, McLean Hosp, Belmont, MA USA; [Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; McLean Hospital; Johns Hopkins University	Shelhamer, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.; Shelhamer, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	mjs@dizzy.med.jhu.edu		Shelhamer, Mark/0000-0002-5040-6573; Wong, Aaron/0000-0001-7211-0653	National Aeronautics and Space Administration [NNX10A019G]; National Institutes of Health [T32 EB003383]; National Science Foundation [BCS-1126957]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Aeronautics and Space Administration grant NNX10A019G (MS, KB), National Institutes of Health grant T32 EB003383 (KB), and National Science Foundation grant BCS-1126957 (MS, SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RA, 2005, ARCH NEUROL-CHICAGO, V62, P290, DOI 10.1001/archneur.62.2.290; Cass SP, 1996, AM J OTOL, V17, P581; Chaisanguanthum KS, 2014, J NEUROSCI, V34, P12071, DOI 10.1523/JNEUROSCI.3001-13.2014; Clement G, 2008, NEUROSCIENCE IN SPAC; Cohen HS., 2000, VESTIBULAR REHABILIT, V2nd ed., P373; Conrad M, 1986, CHAOS, P3; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; DEMER JL, 1989, INVEST OPHTH VIS SCI, V30, P159; Glass L., 1988, CLOCKS CHAOS RHYTHMS; HARRIS CM, 1995, VISION RES, V35, P691, DOI 10.1016/0042-6989(94)00163-G; Huang RJ, 2016, SLEEP BREATH, V20, P975, DOI 10.1007/s11325-016-1320-5; Jorns-Haderli M, 2007, J NEUROL NEUROSUR PS, V78, P1113, DOI 10.1136/jnnp.2006.109512; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; NORRE ME, 1989, OTOLARYNG HEAD NECK, V101, P14, DOI 10.1177/019459988910100104; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; Schweigart G, 1997, VISION RES, V37, P1643, DOI 10.1016/S0042-6989(96)00315-X; Shelhamer M., 2006, NONLINEAR DYNAMICS I; SHUMWAYCOOK A, 1990, NEUROL CLIN, V8, P441, DOI 10.1016/S0733-8619(18)30366-9; Smith T, 2002, EVOL COMPUT, V10, P1, DOI 10.1162/106365602317301754; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; West BJ, 2013, FRACTAL PHYSIOLOGY A; Wong AL, 2014, J NEUROPHYSIOL, V111, P2084, DOI 10.1152/jn.00779.2013; Wong AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025225; Wood SJ, 2011, NEUROREHABILITATION, V29, P185, DOI 10.3233/NRE-2011-0694; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174977	10.1371/journal.pone.0174977	http://dx.doi.org/10.1371/journal.pone.0174977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380076	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500084
J	Guo, H; Wei, M; Liu, Y; Zhu, Y; Xu, WT; Meng, L; Wang, N; Shao, CW; Lu, S; Gao, FT; Cui, ZK; Wei, ZF; Zhao, FZ; Chen, SL				Guo, Hua; Wei, Min; Liu, Yang; Zhu, Ying; Xu, Wenteng; Meng, Liang; Wang, Na; Shao, Changwei; Lu, Sheng; Gao, Fengtao; Cui, Zhongkai; Wei, Zhanfei; Zhao, Fazhen; Chen, Songlin			Molecular cloning and expression analysis of the aqp1aa gene in half-smooth tongue sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							SPERM MOTILITY; WATER CHANNELS; MARINE FISH; STRUCTURAL BASIS; CELL-LINE; AQUAPORINS; EVOLUTION; TELEOSTS; SPERMATOGENESIS; ESTABLISHMENT	Aquaporin 1 (AQP1) is a member of the transmembrane water channel family of proteins with special structural features, and two AQP1 paralogous genes (aqplaa and aqplab) are reported in teleosts. In the present study, the aqplaa gene of half-smooth tongue sole (Cynoglossus semilaevis) was cloned and characterized. The full-length cDNA of aqplaa is 1411 bp with a 786 bp open reading frame encoding a 261-amino acid putative protein with a characteristic structure consisting of 6 membrane-spanning alpha-helical domains and two highly conserved asparagine proline alanine motifs. Real-time quantitative PCR revealed that aqplaa mRNA is expressed predominantly in the testis of males and pseudo males, while its expression is low in the ovary and lowest in doublesex and mab-3-related transcription factor 1 (DMRT1) knock out fish and triploid males. In situ hybridization indicated that aqplaa mRNA is expressed mainly in the germ cells of males and pseudo-males, especially in spermatozoa and spermatids. These results suggest that the aqplaa may play a role in spermatogenesis of C. semilaevis.	[Guo, Hua; Wei, Min; Liu, Yang; Zhu, Ying; Xu, Wenteng; Meng, Liang; Wang, Na; Shao, Changwei; Lu, Sheng; Gao, Fengtao; Cui, Zhongkai; Wei, Zhanfei; Zhao, Fazhen; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Guo, Hua; Cui, Zhongkai; Wei, Zhanfei; Chen, Songlin] Shanghai Ocean Univ, Coll Fisheries & Life, Shanghai, Peoples R China; [Wei, Min; Liu, Yang; Zhao, Fazhen; Chen, Songlin] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China; [Zhao, Fazhen; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Nanjing Agricultural University; Qingdao National Laboratory for Marine Science & Technology	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.; Chen, SL (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life, Shanghai, Peoples R China.; Chen, SL (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China.; Chen, SL (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	chensi@ysfri.ac.cn	Xu, Wenteng/Q-1552-2018; Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; guo, hua/0000-0002-0329-0088; Meng, Liang/0000-0003-2642-8446	National Nature Science Foundation of China [31130057, 31530078, 31472269]; Taishan Scholar Climbing Project Fund of Shandong of China; Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2015C03YQ01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Climbing Project Fund of Shandong of China; Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences	This work was supported by grants from National Nature Science Foundation of China (31130057, 31530078, and 31472269), Taishan Scholar Climbing Project Fund of Shandong of China, and Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2015C03YQ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Ahmadpour D, 2014, BBA-GEN SUBJECTS, V1840, P1482, DOI 10.1016/j.bbagen.2013.09.027; An KW, 2008, FISH PHYSIOL BIOCHEM, V34, P185, DOI 10.1007/s10695-007-9175-0; Boj M, 2015, BIOL BULL-US, V229, P93, DOI 10.1086/BBLv229n1p93; Boj M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131524; BROWN D, 1993, EUR J CELL BIOL, V61, P264; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chauvigne F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110783; Chen SL, 2012, MAR BIOTECHNOL, V14, P120, DOI 10.1007/s10126-011-9395-2; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen SongLin, 2011, Journal of Fisheries of China, V35, P925; Cooper TG, 2003, MICROSC RES TECHNIQ, V61, P28, DOI 10.1002/jemt.10314; Cosson J, 2008, J APPL ICHTHYOL, V24, P460, DOI 10.1111/j.1439-0426.2008.01151.x; Cosson J, 2008, REPRODUCTION, V136, P277, DOI 10.1530/REP-07-0522; Cui ZK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42213; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; Dong ZD, 2016, ACTA OCEANOL SIN, V35, P19, DOI 10.1007/s13131-016-0865-2; Eddy EM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; Finn RN, 2015, BIOL BULL-US, V229, P6, DOI 10.1086/BBLv229n1p6; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Fisher JS, 1998, ENDOCRINOLOGY, V139, P3935, DOI 10.1210/en.139.9.3935; Huang HF, 2006, HUM REPROD UPDATE, V12, P785, DOI 10.1093/humupd/dml035; Ishibashi K, 2013, BIOCHIM BIOPHYS ACTA, V1840, P1507; Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Li HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28219; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng L., 2014, COMPUTATIONAL SOCIAL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0107922; Mukhopadhyay R, 2014, BBA-GEN SUBJECTS, V1840, P1583, DOI 10.1016/j.bbagen.2013.11.021; Pandian TJ, 1998, HYDROBIOLOGIA, V384, P167, DOI 10.1023/A:1003332526659; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rato L, 2010, J MEMBRANE BIOL, V236, P215, DOI 10.1007/s00232-010-9294-x; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao CW, 2010, MICRON, V41, P47, DOI 10.1016/j.micron.2009.08.002; Skowronski MT, 2009, J HISTOCHEM CYTOCHEM, V57, P915, DOI 10.1369/jhc.2009.954057; Song J, 2014, BBA-GEN SUBJECTS, V1840, P1566, DOI 10.1016/j.bbagen.2013.10.014; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Sun A, 2015, J FISH BIOL, V86, P46, DOI 10.1111/jfb.12535; Sun Y, 2009, CLONING EXPRESSION A, V55, P335; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wintour EM, 1997, CLIN EXP PHARMACOL P, V24, P1, DOI 10.1111/j.1440-1681.1997.tb01775.x; Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062; Yool AJ, 2012, MOL ASPECTS MED, V33, P553, DOI 10.1016/j.mam.2012.02.001; Zapater C, 2013, DEV BIOL, V377, P345, DOI 10.1016/j.ydbio.2013.03.001; Zapater C, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102533; Zapater C, 2011, MOL BIOL EVOL, V28, P3151, DOI 10.1093/molbev/msr146; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang B, 2011, INT J BIOL SCI, V7, P452, DOI 10.7150/ijbs.7.452; Zhang H, 2015, EXP NEUROL, V265, P152, DOI 10.1016/j.expneurol.2015.01.002; Zhang LY, 2014, MAR GENOM, V18, P45, DOI 10.1016/j.margen.2014.04.004; Zilli L, 2011, THERIOGENOLOGY, V76, P737, DOI 10.1016/j.theriogenology.2011.04.006; Zilli L, 2009, BIOL REPROD, V81, P880, DOI 10.1095/biolreprod.109.077933	61	11	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175033	10.1371/journal.pone.0175033	http://dx.doi.org/10.1371/journal.pone.0175033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380032	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500088
J	Hviid, MM; Skovlund, CW; Morch, LS; Lidegaard, O				Hviid, Malene Meisner; Skovlund, Charlotte Wessel; Morch, Lina Steinrud; Lidegaard, Ozvind			Maternal age and child morbidity: A Danish national cohort study	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; POPULATION-BASED COHORT; PARENTAL AGE; DELAYED CHILDBEARING; BIRTH-ORDER; PREGNANCY; RISK; MALFORMATIONS; DETERMINANTS; FERTILITY	Introduction The mean age at delivery has increased over the latest half of a century. Women of advanced maternal age have increased obstetrical risks and increased risk of chromosomal abnormalities and some other specified diagnoses in the offspring. The aim of this study was to assess the association between maternal age and overall child morbidity according to main diagnosis groups. Material and methods We conducted a national cohort study including 352 027 live firstborn singleton children. The children were born between Jan 1994 and Dec 2009 and followed to Dec 2012. Children were divided into groups according to maternal age: 15-24, 25-29, 30-34, and 35+ years. Poisson regression analyses calculated adjusted incidence rate ratios (IRR) of child morbidities according to main diagnoses groups A-Q of the International Classification of Disease 10 with adjustment for year of birth, body mass index, smoking, and mother's level of education. Results Average follow-up time was 11 years. Compared to children born to women 25 - 29 years, firstborn children to mothers aged 35+ had higher child morbidity in 8 of 19 main diagnosis groups and firstborn children to mothers 15-24 years had higher child morbidity in 12 of 19 main diagnosis groups. Thus, for a majority of diseases a U-shaped correlation was found, with lowest rates in women 25-29 years. Conclusion Firstborn children to both older and younger mothers have higher overall morbidity as compared to children born by mothers 25-29 years.	[Hviid, Malene Meisner] Zealand Univ Hosp, Dept Gynecol, Roskilde, Denmark; [Skovlund, Charlotte Wessel; Morch, Lina Steinrud; Lidegaard, Ozvind] Univ Copenhagen, Rigshosp, Dept Gynecol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hviid, MM (corresponding author), Zealand Univ Hosp, Dept Gynecol, Roskilde, Denmark.	mmhviid@gmail.com		Morch, Lina/0000-0001-6506-2569				Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; BAIRD PA, 1991, LANCET, V337, P527, DOI 10.1016/0140-6736(91)91306-F; Balasch J, 2012, CURR OPIN OBSTET GYN, V24, P187, DOI 10.1097/GCO.0b013e3283517908; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bingley PJ, 2000, BMJ-BRIT MED J, V321, P420, DOI 10.1136/bmj.321.7258.420; Blackburn CM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-101; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; CROEN LA, 1995, AM J PUBLIC HEALTH, V85, P710, DOI 10.2105/AJPH.85.5.710; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; Gilbert WM, 1999, OBSTET GYNECOL, V93, P9, DOI 10.1016/S0029-7844(98)00382-2; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goswmai S, 2015, J PEDIAT-BRAZIL, V91, P471, DOI 10.1016/j.jped.2014.09.009; Hassold T, 1984, AM J HUM GENET, P1349; Hemminki K, 1999, EPIDEMIOLOGY, V10, P271, DOI 10.1097/00001648-199905000-00014; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; Idring S, 2014, INT J EPIDEMIOL, V43, P107, DOI 10.1093/ije/dyt262; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Johnson KJ, 2009, EPIDEMIOLOGY, V20, P475, DOI 10.1097/EDE.0b013e3181a5a332; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; Myrskyla M, 2012, DEMOGRAPHY, V49, P1231, DOI 10.1007/s13524-012-0132-x; Neill MO, 2013, ADV MATERNAL AGE ADV, V8, P1; Olausson PMO, 1997, OBSTET GYNECOL, V89, P451, DOI 10.1097/00006250-199703000-00027; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; PRYSAK M, 1995, OBSTET GYNECOL, V85, P65, DOI 10.1016/0029-7844(94)00330-G; Salem S, 2011, SIGNIFICANT LINEAR A, P755; Salem YS, 2011, ARCH GYNECOL OBSTET, V283, P755, DOI DOI 10.1007/S00404-010-1459-4; Savage T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058869; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Sorensen NO, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0258-1; Statistikbanken. dk, 2012, AV AG 1 TIM MOTH; Stene LC, 2001, BRIT MED J, V323, P369, DOI 10.1136/bmj.323.7309.369; Yib B, 2006, INT J EPIDEMIOL, V35, P1495; Yogev Y, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.039; Ziadeh S., 2001, Archives of Gynecology and Obstetrics, V265, P30, DOI 10.1007/s004040000122	38	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174770	10.1371/journal.pone.0174770	http://dx.doi.org/10.1371/journal.pone.0174770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380000	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500063
J	Leung, C; Duclos, KK; Grunbaum, T; Cloutier, R; Angers, B				Leung, Christelle; Duclos, Kevin Karl; Grunbaum, Thomas; Cloutier, Richard; Angers, Bernard			Asymmetry in dentition and shape of pharyngeal arches in the clonal fish Chrosomus eos-neogaeus: Phenotypic plasticity and developmental instability	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DNA METHYLATION; EMBRYONIC-DEVELOPMENT; KUPFFERS VESICLE; EVOLUTION; CYPRINIDAE; PATTERNS; STRESS; PISCES; CANALIZATION	The effect of the environment may result in different developmental outcomes. Extrinsic signals can modify developmental pathways and result in alternative phenotypes (phenotypic plasticity). The environment can also be interpreted as a stressor and increase developmental instability (developmental noise). Directional and fluctuating asymmetry provide a conceptual background to discriminate between these results. This study aims at assessing whether variation in dentition and shape of pharyngeal arches of the clonal fish Chrosomus eos-neogaeus results from developmental instability or environmentally induced changes. A total of 262 specimens of the Chrosomus eos-neogaeus complex from 12 natural sites were analysed. X-ray microcomputed tomography (X-ray micro-CT) was used to visualize the pharyngeal arches in situ with high resolution. Variation in the number of pharyngeal teeth is high in hybrids in contrast to the relative stability observed in both parental species. The basal dental formula is symmetric while the most frequent alternative dental formula is asymmetric. Within one lineage, large variation in the proportion of individuals bearing basal or alternative dental formulae was observed among sites in the absence of genetic difference. Both dentition and arch shape of this hybrid lineage were explained significantly by environmental differences. Only individuals bearing asymmetric dental formula displayed fluctuating asymmetry as well as directional left-right asymmetry for the arches. The hybrids appeared sensitive to environmental signals and intraspecific variation on pharyngeal teeth was not random but reflects phenotypic plasticity. Altogether, these results support the influence of the environment as a trigger for an alternative developmental pathway resulting in left-right asymmetry in dentition and shape of pharyngeal arches.	[Leung, Christelle; Duclos, Kevin Karl; Grunbaum, Thomas; Angers, Bernard] Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada; [Cloutier, Richard] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada	Universite de Montreal; University of Quebec	Angers, B (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada.	bernard.angers@umontreal.ca	Angers, Bernard/U-9340-2019	Angers, Bernard/0000-0002-0992-140X; Cloutier, Richard/0000-0001-5780-3304	Natural Sciences and Engineering Research Council of Canada [238612, 238600]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, Discovery grant #238612 (RC) and #238600 (BA), http rAvvvvr use rc crsng gc car Protessors-Protesseurs/Grants-Subs/DGIGP- PSIGP_eng asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Angers B, 2007, MOL ECOL, V16, P4562, DOI 10.1111/j.1365-294X.2007.03511.x; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Binet MC, 2005, J FISH BIOL, V67, P1169, DOI 10.1111/j.1095-8649.2005.00802.x; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Bookstein F L, 1997, Med Image Anal, V1, P225; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Collyer ML, 2007, ECOLOGY, V88, P683, DOI 10.1890/06-0727; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Demontis D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14107; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dong GY, 2014, J APPL CLIN MED PHYS, V15, P335, DOI 10.1120/jacmp.v15i4.4956; Dryden I.L., 1998, SANKYA A, V55, P460; EASTMAN JT, 1973, COPEIA, P45; Eastman JT, 1970, THESIS; ELDER JF, 1995, P NATL ACAD SCI USA, V92, P5001, DOI 10.1073/pnas.92.11.5001; Engeman JM, 2009, J MORPHOL, V270, P291, DOI 10.1002/jmor.10688; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; EVANS HOWARD E., 1955, COPEIA, V1955, P31, DOI 10.2307/1439449; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Goddard KA, 1998, J HERED, V89, P151, DOI 10.1093/jhered/89.2.151; Goddard KA, 1989, EVOLUTION ECOLOGY UN, V466, P268; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hubbs C, 1945, PAPERS MICHIGAN ACAD, V30, P229, DOI [10.2307/1438166, DOI 10.2307/1438166]; Huysseune A, 1998, EUR J ORAL SCI, V106, P437, DOI 10.1111/j.1600-0722.1998.tb02211.x; Jordan D.S., 1896, B US NAT MUS, V47, P1, DOI [10.5962/bhl.title.39714, DOI 10.5962/BHL.TITLE.46755]; Klingenberg Christian Peter, 2003, P14; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Leung C, 2016, ECOL EVOL, V6, P5234, DOI 10.1002/ece3.2283; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moller AP, 1997, ASYMMETRY DEV STABIL; Murren CJ, 2015, HEREDITY, V115, P293, DOI 10.1038/hdy.2015.8; New J. G., 1962, Copeia, V1962, P147, DOI 10.2307/1439489; Hung NM, 2015, BIOL CONTROL, V80, P156, DOI 10.1016/j.biocontrol.2014.10.001; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pasco-Viel E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2688; Pasco-Viel E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011293; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PEYER B, 1968, COMPARATIVE ODONTOLO; Qian ML, 2013, DEV BIOL, V374, P85, DOI 10.1016/j.ydbio.2012.11.022; Roff DA, 1996, Q REV BIOL, V71, P3, DOI 10.1086/419266; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SMITH RE, 1981, COPEIA, P222; STASIAK RH, 1977, COPEIA, P771; Stock DW, 2007, J EXP ZOOL PART B, V308B, P523, DOI 10.1002/jez.b.21187; Vergilino R, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0754-5; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	69	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174235	10.1371/journal.pone.0174235	http://dx.doi.org/10.1371/journal.pone.0174235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380079	gold, Green Submitted, Green Published			2022-12-27	WOS:000399353500037
J	Reischauer, C; Gutzeit, A				Reischauer, Carolin; Gutzeit, Andreas			Image denoising substantially improves accuracy and precision of intravoxel incoherent motion parameter estimates	PLOS ONE			English	Article							BAYESIAN PROBABILITY-THEORY; MAGNETIC-RESONANCE IMAGES; DIFFUSION-WEIGHTED MRI; GRADIENT SENSITIZATION; EDGE CONSTRAINTS; NOISE; PERFUSION; RECONSTRUCTION; ACQUISITION; DESIGN	Applicability of intravoxel incoherent motion (IVIM) imaging in the clinical setting is hampered by the limited reliability in particular of the perfusion-related parameter estimates. To alleviate this problem, various advanced postprocessing methods have been introduced. However, the underlying algorithms are not readily available and generally suffer from an increased computational burden. Contrary, several computationally fast image denoising methods have recently been proposed which are accessible online and may improve reliability of IVIM parameter estimates. The objective of the present work is to investigate the impact of image denoising on accuracy and precision of IVIM parameter estimates using comprehensive in-silico and in-vivo experiments. Image denoising is performed with four different algorithms that work on magnitude data: two algorithms which are based on non-local means (NLM) filtering, one algorithm that relies on local principal component analysis (LPCA) of the diffusion-weighted images, and another algorithms that exploits joint rank and edge constraints (JREC). Accuracy and precision of IVIM parameter estimates is investigated in an in-silico brain phantom and an in-vivo ground truth as a function of the signal-to-noise ratio for spatially homogenous and inhomogenous levels of Rician noise. Moreover, precision is evaluated using bootstrap analysis of in-vivo measurements. In the experiments, IVIM parameters are computed a) by using a segmented fit method and b) by performing a biexponential fit of the entire attenuation curve based on nonlinear least squares estimates. Irrespective of the fit method, the results demonstrate that reliability of IVIM parameter estimates is substantially improved by image denoising. The experiments show that the LPCA and the JREC algorithms perform in a similar manner and outperform the NLM-related methods. Relative to noisy data, accuracy of the IVIM parameters in the in-silico phantom improves after image denoising by 76-79%, 79-81%, 84-99% and precision by 74-80%, 80-83%, 84-95% for the perfusion fraction, the diffusion coefficient, and the pseudodiffusion coefficient, respectively, when the segmented fit method is used. Beyond that, the simulations reveal that denoising performance is not impeded by spatially inhomogeneous levels of Rician noise in the image. Since all investigated algorithms are freely available and work on magnitude data they can be readily applied in the clinical setting which may foster transition of IVIM imaging into clinical practice.	[Reischauer, Carolin; Gutzeit, Andreas] Hirslanden Hosp St Anna, Inst Radiol & Nucl Med, Clin Res Unit, Luzern, Switzerland; [Reischauer, Carolin] ETH, Inst Biomed Engn, Zurich, Switzerland; [Reischauer, Carolin] Univ Zurich, Zurich, Switzerland; [Gutzeit, Andreas] Paracelsus Med Univ Salzburg, Dept Radiol, Salzburg, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Paracelsus Private Medical University	Reischauer, C (corresponding author), Hirslanden Hosp St Anna, Inst Radiol & Nucl Med, Clin Res Unit, Luzern, Switzerland.; Reischauer, C (corresponding author), ETH, Inst Biomed Engn, Zurich, Switzerland.; Reischauer, C (corresponding author), Univ Zurich, Zurich, Switzerland.	carolin.reischauer@hirslanden.ch						Aja-Fernandez S, 2008, IEEE T MED IMAGING, V27, P1389, DOI 10.1109/TMI.2008.920609; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Bammer R, 2002, MAGNET RESON MED, V48, P128, DOI 10.1002/mrm.10184; BERNSTEIN MA, 1989, MED PHYS, V16, P813, DOI 10.1118/1.596304; Bretthorst GL, 2005, CONCEPT MAGN RESON A, V27A, P55, DOI 10.1002/cmr.a.20043; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chawla S, 2009, FUTURE ONCOL, V5, P959, DOI [10.2217/fon.09.77, 10.2217/FON.09.77]; Clark H., 1991, 61991 NEMA MS; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Coupe P, 2010, MED IMAGE ANAL, V14, P483, DOI 10.1016/j.media.2010.03.001; Coupe P, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/590183; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Efron B., 1994, INTRO BOOTSTRAP; Freiman M, 2013, MED IMAGE ANAL, V17, P325, DOI 10.1016/j.media.2012.12.001; Griswold MA, 1999, MAGNET RESON MED, V41, P1236, DOI 10.1002/(SICI)1522-2594(199906)41:6<1236::AID-MRM21>3.0.CO;2-T; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Koay CG, 2009, J MAGN RESON, V197, P108, DOI 10.1016/j.jmr.2008.11.015; Lam F, 2016, MAGN RESON MED, V75, P433, DOI 10.1002/mrm.25643; Lam F, 2014, MAGN RESON MED, V71, P1272, DOI 10.1002/mrm.24728; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Lourakis M.I., 2004, LEVMAR LEVENBERG MAR; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; NEIL JJ, 1993, MAGNET RESON MED, V29, P642, DOI 10.1002/mrm.1910290510; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Nowak RD, 1999, IEEE T IMAGE PROCESS, V8, P1408, DOI 10.1109/83.791966; Orton MR, 2014, MAGN RESON MED, V71, P411, DOI 10.1002/mrm.24649; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Svolos P, 2014, CANCER IMAGING, V14, DOI 10.1186/1470-7330-14-20; Tabelow K, 2015, MED IMAGE ANAL, V20, P76, DOI 10.1016/j.media.2014.10.008; Thoeny HC, 2011, CANCER IMAGING, V10, P209, DOI 10.1102/1470-7330.2010.0030; Vos SB, 2016, MAGN RESON MED; Wiest-Daessle N, 2007, LECT NOTES COMPUT SC, V4792, P344; Wu WC, 2015, EUR RADIOL, V25, P2485, DOI 10.1007/s00330-015-3655-x; Wu Wen-liang, 2013, SCI J ELECT ENG, V3, P8, DOI DOI 10.1371/J0URNAL.P0NE.0082679; Zhou MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116986	42	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175106	10.1371/journal.pone.0175106	http://dx.doi.org/10.1371/journal.pone.0175106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380018	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500100
J	Trautmann, J; Meier-Dinkel, L; Gertheiss, J; Morlein, D				Trautmann, Johanna; Meier-Dinkel, Lisa; Gertheiss, Jan; Moerlein, Daniel			Noise and accustomation: A pilot study of trained assessors' olfactory performance	PLOS ONE			English	Article							BOAR TAINT; ACUITY AFFECTS; MUSICAL NOTES; PERCEPTION; PITCH	While recent studies suggest an influence of noise on olfactory performance, it is unclear as to what extent the influence varies between subjects who are accustomed to noise and those who are not. Two groups of panelists were selected: a University panel usually working under silent conditions and an abattoir panel usually working on the slaughter line with abattoir noise. Odor discrimination, odor identification, and odor detection thresholds were studied. Furthermore, a sensory quality control task using 40 boar samples was performed. All tests were accomplished both with and without extraneous noise recorded at an abattoir (70 dB) using headphones. Contrary to the researchers' expectations, abattoir noise hardly affected the olfactory tests nor was the quality control task impaired. Abattoir noise did not influence the perceived intensity of boar taint and the classification results of the testers, regardless of whether they were accustomed to such noise or not. The results indicate that sensory quality control can be conducted in a manufacturing environment with constant noise without diminishing the assessors' performance.	[Trautmann, Johanna; Meier-Dinkel, Lisa; Moerlein, Daniel] Univ Gottingen, Dept Anim Sci, Meat Sci Grp, Gottingen, Germany; [Gertheiss, Jan] Tech Univ Clausthal, Inst Appl Stochast & Operat Res, Clausthal Zellerfeld, Germany	University of Gottingen; TU Clausthal	Morlein, D (corresponding author), Univ Gottingen, Dept Anim Sci, Meat Sci Grp, Gottingen, Germany.	daniel.moerlein@agr.uni-goettingen.de		Morlein, Daniel/0000-0001-8235-4635	Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE)	Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE)	This project (acronym STRAT-E-GER) is supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2003, LME4 PACKAGE R LINEA; Belojevic G, 2003, Noise Health, V6, P77; Core Team R R Development Core Team, 2016, LANG ENV STAT COMP; Crisinel AS, 2012, CHEM SENSES, V37, P151, DOI 10.1093/chemse/bjr085; Crisinel AS, 2010, ATTEN PERCEPT PSYCHO, V72, P1994, DOI 10.3758/APP.72.7.1994; Crisinel AS, 2009, NEUROSCI LETT, V464, P39, DOI 10.1016/j.neulet.2009.08.016; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; HOLTHANSEN K, 1968, PERCEPT MOTOR SKILL, V27, P59, DOI 10.2466/pms.1968.27.1.59; Kuznetsova A., 2016, J STAT SOFTW, V2, P33; Lawless H. T., 2010, SENSORY EVALUATION F; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Meier-Dinkel L, 2015, MEAT SCI, V100, P73, DOI 10.1016/j.meatsci.2014.09.013; Meier-Dinkel L, 2013, MEAT SCI, V94, P19, DOI 10.1016/j.meatsci.2012.12.009; Morlein D, 2016, J AGR FOOD CHEM, V64, P4556, DOI 10.1021/acs.jafc.6b00355; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Revelle W., 2015, PSYCH PROCEDURES PER; Seo HS, 2011, EXP BRAIN RES, V212, P305, DOI 10.1007/s00221-011-2729-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SMITH A, 1986, ENVIRON BEHAV, V18, P214, DOI 10.1177/0013916586182004; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Torchiano M., 2016, EFFICIENT EFFECT SIZ; Trautmann J, 2016, MEAT SCI, V111, P92, DOI 10.1016/j.meatsci.2015.08.011; Trautmann J, 2014, MEAT SCI, V98, P255, DOI 10.1016/j.meatsci.2014.05.037; Walliczek-Dworschak U, 2016, CHEM SENSES, V41, P50, DOI 10.1093/chemse/bjw079; Weinstein N.D., 1982, J ENVIRON PSYCHOL, V2, P87, DOI [10.1016/S0272-4944(82)80041-8, DOI 10.1016/S0272-4944(82)80041-8]	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174697	10.1371/Journal.pone.0174697	http://dx.doi.org/10.1371/Journal.pone.0174697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380041	gold, Green Submitted, Green Published			2022-12-27	WOS:000399353500059
J	Kim, MS; Kim, SY; Kim, JH; Park, B; Choi, HG				Kim, Min-Su; Kim, So Young; Kim, Jin-Hwan; Park, Bumjung; Choi, Hyo Geun			Depression in breast cancer patients who have undergone mastectomy: A national cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; POPULATION-BASED COHORT; MOOD DISORDERS; ANXIETY; PREVALENCE; MANAGEMENT; PRINCIPLES; SURVIVORS; SYMPTOMS; DISEASE	Objective The objective of this study was to compare the incidence of post-operative depression in breast cancer patients who have undergone mastectomy with the incidence of post-operative depression in non-breast cancer participants (controls). Methods Using data from the Korean Health Insurance Review and Assessment Service (HIRA), we selected 2,130 patients with breast cancer who have undergone mastectomy for this national cohort study and matched these patients 1:4 with 8,520 control participants according to age, sex, income, region, and pre-operative depression. The incidence of post-operative depression was measured from mastectomy year to post-op year 10. The MannWhitney U test was used for data analysis, and the false-discovery rate was applied to determine statistical significance (P < 0.05). Results The incidence of depression was higher in the breast cancer with mastectomy group than in the control group up to 3 years after mastectomy). However, there was no difference in the incidence of depression between the breast cancer with mastectomy group and the control group after post-op 4 years. The incidence of depression was higher in the breast cancer with mastectomy group than in the control group up to 2 years after mastectomy, and there was no difference in the incidence of depression between the two groups after post-op 3 years in middle-aged and older adults (>= 40 years old). In young adults (<= 39 years old), the incidence of depression was significantly higher in the breast cancer with mastectomy group than in the control group in mastectomy year. Conclusion Patients undergoing mastectomy for breast cancer experience depression more frequently than healthy people. However, patients overcome their depressive mood symptoms during the postoperative period. Young adults overcome their symptoms more quickly than middle-aged and older adults.	[Kim, Min-Su; Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Jin-Hwan; Park, Bumjung] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019; Kim, Min-Su/AAG-4346-2020	Choi, Hyo Geun/0000-0003-1655-9549; Kim, Min-Su/0000-0001-8311-4174	 [NRF-2015-R1D1A1A01060860]		This work was supported by NRF-2015-R1D1A1A01060860, http://www.nrf.re.kr/.	Agarwal M, 2011, J Assoc Physicians India, V59, P636; Anna G, 2013, SUPPORT CARE CANCER, V21, P2453, DOI 10.1007/s00520-013-1794-7; Ashing K, 2014, PSYCHO-ONCOLOGY, V23, P507, DOI 10.1002/pon.3441; Calkin CV, 2013, ANN MED, V45, P171, DOI 10.3109/07853890.2012.687835; Carota A, 2012, FRONT NEUROL NEUROSC, V30, P70, DOI 10.1159/000333413; Eskelinen M, 2015, ANTICANCER RES, V35, P2215; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Ho SSM, 2013, EUR J ONCOL NURS, V17, P877, DOI 10.1016/j.ejon.2013.04.005; Hopwood P, 2010, BREAST, V19, P84, DOI 10.1016/j.breast.2009.11.007; Huang CJ, 2012, GEN HOSP PSYCHIAT, V34, P242, DOI 10.1016/j.genhosppsych.2011.12.011; Hung YP, 2013, PSYCHO-ONCOLOGY, V22, P2227, DOI 10.1002/pon.3277; Jang JE, 2013, PSYCHO-ONCOLOGY, V22, P922, DOI 10.1002/pon.3083; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Klein D, 2011, BREAST CANCER RES TR, V129, P125, DOI 10.1007/s10549-011-1408-3; Maass SWMC, 2015, MATURITAS, V82, P100, DOI 10.1016/j.maturitas.2015.04.010; McGuire A, 2015, CANCERS, V7, P908, DOI 10.3390/cancers7020815; Ng CG, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0401-7; Qiu JY, 2013, J PSYCHOSOM OBST GYN, V34, P60, DOI 10.3109/0167482X.2013.766791; Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P82; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Service NHIS, NAT SAMPL CHORT; Spiegel D, 2015, BREAST J, V21, P97, DOI 10.1111/tbj.12355; Stewart BaW C. P, 2014, WORLD CANC REPORT 20; Suppli NP, 2014, J CLIN ONCOL, V32, P3831, DOI 10.1200/JCO.2013.54.0419; Vahdaninia M, 2010, SOC PSYCH PSYCH EPID, V45, P355, DOI 10.1007/s00127-009-0068-7; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; Zainal NZ, 2013, ASIAN PAC J CANCER P, V14, P2649, DOI 10.7314/APJCP.2013.14.4.2649; Zdenkowski N, 2016, BREAST, V26, P31, DOI 10.1016/j.breast.2015.12.007	28	40	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175395	10.1371/journal.pone.0175395	http://dx.doi.org/10.1371/journal.pone.0175395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394909	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800032
J	Gong, X; Sanfey, AG				Gong, Xu; Sanfey, Alan G.			Social rank and social cooperation: Impact of social comparison processes on cooperative decision-making	PLOS ONE			English	Article							COMPARISON ORIENTATION; PROSOCIAL BEHAVIOR; AFFECTIVE CONSEQUENCES; INDIVIDUAL-DIFFERENCES; PUBLIC-GOODS; WARM-GLOW; PUNISHMENT; NORMS; STRIATUM; ALTRUISM	Successful navigation of our complex social world requires the capability to recognize and judge the relative status of others. Hence, social comparison processes are of great importance in our interactions, informing us of our relative standing and in turn potentially motivating our behavior. However, so far few studies have examined in detail how social comparison can influence interpersonal decision-making. One aspect of social decision-making that is of particular importance is cooperative behavior, and identifying means of maintaining and promoting cooperation in the provision of public goods is of vital interest to society. Here, we manipulated social comparison by grading performance rankings on a reaction time task, and then measured cooperative decisions via a modified Public Goods Game (PGG). Findings revealed that individuals ranked highest tended to be more cooperative as compared to those who placed in the bottom rank. Interestingly, this effect was regardless of whether the comparison group members were the subsequent players in the PGG or not, and this effect was stronger in those with higher social orientation. In summary, the present research shows how different social comparison processes (assessed via social rankings) can operate in our daily interaction with others, demonstrating an important effect on cooperative behavior.	[Gong, Xu; Sanfey, Alan G.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Sanfey, Alan G.] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Gong, X (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	x.gong@donders.ru.nl	Sanfey, Alan G/D-2350-2010	Gong, Xu/0000-0002-7539-4310; Sanfey, Alan/0000-0002-7421-8294	China Scholarship Council [201206040033]; European Research Council [ERC StG 313454]	China Scholarship Council(China Scholarship Council); European Research Council(European Research Council (ERC)European Commission)	We thank the China Scholarship Council (http://en.csc.edu.cn/, grant number: 201206040033) and the European Research Council (https://erc.europa.eu/, grant number:ERC StG 313454) for their support of this research.	Aldrovandi S, 2013, ACTA PSYCHOL, V144, P538, DOI 10.1016/j.actpsy.2013.09.007; ANDREONI J, 1995, Q J ECON, V110, P1, DOI 10.2307/2118508; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Battigalli P, 2007, AM ECON REV, V97, P170, DOI 10.1257/aer.97.2.170; Bault N, 2011, P NATL ACAD SCI USA, V108, P16044, DOI 10.1073/pnas.1100892108; Bault N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003477; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Buunk AP, 2006, PERS RELATIONSHIP, V13, P397, DOI 10.1111/j.1475-6811.2006.00126.x; Buunk BP, 2005, APPL PSYCHOL-INT REV, V54, P61, DOI 10.1111/j.1464-0597.2005.00196.x; BUUNK BP, 1990, J PERS SOC PSYCHOL, V59, P1238, DOI 10.1037/0022-3514.59.6.1238; Chang LJ, 2011, NEURON, V70, P560, DOI 10.1016/j.neuron.2011.02.056; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; FISHBURN PC, 1977, AM ECON REV, V67, P116; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Fiske ST, 2010, AM PSYCHOL, V65, P698, DOI 10.1037/0003-066X.65.8.698; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Gibbons FX, 1999, J PERS SOC PSYCHOL, V76, P129, DOI 10.1037/0022-3514.76.1.129; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Harle KM, 2010, J ABNORM PSYCHOL, V119, P440, DOI 10.1037/a0018612; HEMPHILL KJ, 1991, J SOC CLIN PSYCHOL, V10, P372, DOI 10.1521/jscp.1991.10.4.372; Hevey D, 1999, PSYCHOL HEALTH, V14, P959; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Karlsson N, 2005, J APPL SOC PSYCHOL, V35, P1206, DOI 10.1111/j.1559-1816.2005.tb02167.x; Kidd M, 2013, J ECON PSYCHOL, V39, P387, DOI 10.1016/j.joep.2013.05.011; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Moor BG, 2012, NEUROIMAGE, V59, P708, DOI 10.1016/j.neuroimage.2011.07.028; Mussweiler T, 2004, J PERS SOC PSYCHOL, V87, P832, DOI 10.1037/0022-3514.87.6.832; Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; OKEEFFE M, 1984, J LABOR ECON, V2, P27, DOI 10.1086/298022; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	54	12	12	10	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175472	10.1371/journal.pone.0175472	http://dx.doi.org/10.1371/journal.pone.0175472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388684	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800058
J	Ha, J; Jo, K; Lim, DJ; Lee, JM; Chang, SA; Kang, MIL; Cha, BY; Kim, MH				Ha, Jeonghoon; Jo, Kwanhoon; Lim, Dong-Jun; Lee, Jung-Min; Chang, Sang-Ah; Kang, Moo I. L.; Cha, Bong Yun; Kim, Min-Hee			Parathyroid hormone and vitamin D are associated with the risk of metabolic obesity in a middle-aged and older Korean population with preserved renal function: A cross-sectional study	PLOS ONE			English	Article							INSULIN-RESISTANCE; SERUM; 25-HYDROXYVITAMIN-D; KDIGO	Background In general, obesity is a major contributor to metabolic syndrome (MetS) and is associated with insulin resistance (IR). Metabolically obese but normal weight (MONW) individuals present metabolic abnormalities and features of MetS despite having a normal range of body mass index (BMI). In recent years, different subtypes of obesity have been introduced, including metabolically healthy obese (MHO) and metabolically obese obese (MOO). Also, it has been reported that vitamin D and parathyroid hormone (PTH) are possibly linked with MetS. Methods and findings In this study, we aimed to evaluate the association between serum 25(OH) D, serum PTH, and the risk of metabolic obesity in four subtypes using nationally representative survey data for a Korean population conducted between 2008 and 2010. Of the 29,235 Korean participants, 18,997 subjects aged under 50 years were excluded. Participants with diabetes (n = 1,520), renal insufficiency (glomerular filtration rate [GFR] < 45 ml/min/1.73 m(2), chronic kidney disease [CKD] stage 3b, 4, and 5 according to KDOQI classification [1]) (n = 49), history of treatment for osteoporosis (n = 455), insufficient data (n = 1,613), and fasting time less than 8 hours prior to blood collection (n = 771) were excluded for analysis. Ultimately, 5,830 adults (2,582 men and 3,248 women) were eligible for the present study. And, subtypes of obesity were divided into four types: Metabolically healthy normal weight (MHNW), Metabolically healthy obese (MHO), Metabolically obese but normal weight (MONW), and Metabolically obese obese (MOO). Female subjects with metabolic obesity were more likely to have higher levels of PTH and Male subjects with metabolic health were more likely to have higher serum 25(OH) D levels Conclusion We concluded that a positive association between serum PTH concentration and metabolic obesity among female subjects and an inverse relationship between serum 25(OH) D levels and the risk of metabolic obesity were found among male subjects. Further prospective studies are necessary to explore the biological mechanisms underlying these sex-specific findings.	[Ha, Jeonghoon; Jo, Kwanhoon; Lim, Dong-Jun; Lee, Jung-Min; Chang, Sang-Ah; Kang, Moo I. L.; Cha, Bong Yun; Kim, Min-Hee] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Catholic University of Korea	Kim, MH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	benedict@catholic.ac.kr	Lim, Dong Jun/AAB-4011-2019; jo, kwanhoon/ABC-6723-2020; Kim, Minhee/M-1628-2019	Lim, Dong Jun/0000-0003-0995-6482; Ha, Jeonghoon/0000-0001-9219-7135				Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Body JJ, 2012, OSTEOPOROSIS INT, V23, pS1, DOI 10.1007/s00198-011-1891-8; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; de Barboza GD, 2015, WORLD J GASTROENTERO, V21, P7142, DOI 10.3748/wjg.v21.i23.7142; Ford ES, 2009, J DIABETES, V1, P296, DOI 10.1111/j.1753-0407.2009.00046.x; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Gallagher EJ, 2008, ENDOCRIN METAB CLIN, V37, P559, DOI 10.1016/j.ecl.2008.05.002; Geetha Loganathan, 2011, J Diabetes Sci Technol, V5, P439; George JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061282; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; HEANEY RP, 1989, J BONE MINER RES, V4, P469; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Ito H, 2012, J DIABETES COMPLICAT, V26, P286, DOI 10.1016/j.jdiacomp.2012.04.011; Kim J, 2015, EUR J CLIN NUTR, V69, P425, DOI 10.1038/ejcn.2014.192; Kim J, 2013, J HUM NUTR DIET, V26, P171, DOI 10.1111/jhn.12098; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lee SH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.46; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muntner P, 2009, CLIN J AM SOC NEPHRO, V4, P186, DOI 10.2215/CJN.03050608; Need AG, 2000, AM J CLIN NUTR, V71, P1577; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Zammit AR, 2016, CARDIORENAL MED, V6, P108, DOI 10.1159/000441624	32	7	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175132	10.1371/journal.pone.0175132	http://dx.doi.org/10.1371/journal.pone.0175132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384340	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900096
J	Patsch, JM; Rasul, S; Huber, FA; Leitner, K; Thomas, A; Kocijan, R; Boutroy, S; Weber, M; Resch, H; Kainberger, F; Schuller-Weidekamm, C; Kautzky-Willer, A				Patsch, Janina M.; Rasul, Sazan; Huber, Florian A.; Leitner, Karoline; Thomas, Anita; Kocijan, Roland; Boutroy, Stephanie; Weber, Michael; Resch, Heinrich; Kainberger, Franz; Schueller-Weidekamm, Claudia; Kautzky-Willer, Alexandra			Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus	PLOS ONE			English	Article							BONE MICROARCHITECTURE; POSTMENOPAUSAL WOMEN; DISTAL RADIUS; AGE; DENSITY; RISK; BMD; ASSOCIATION; TURNOVER; FRACTURE	The goal of our study was to investigate interactions between sex and type 2 diabetes mellitus (T2DM) with regard to morphology of the peripheral skeleton. We recruited 85 subjects (mean age, 57 +/- 11.4 years): women with and without T2DM (n = 17; n = 16); and men with and without T2DM (n = 26; n = 26). All patients underwent high-resolution, peripheral, quantitative, computed tomography (HR-pQCT) imaging of the ultradistal radius (UR) and tibia (UT). Local bone geometry, bone mineral density (BMD), and bone microarchitecture were obtained by quantitative analysis of HR-pQCT images. To reduce the amount of data and avoid multi-collinearity, we performed a factor-analysis of HR-pQCT parameters. Based on factor weight, trabecular BMD, trabecular number, cortical thickness, cortical BMD, and total area were chosen for post-hoc analyses. At the radius and tibia, diabetic men and women exhibited trabecular hypertrophy, with a significant positive main effect of T2DM on trabecular number. At the radius, cortical thickness was higher in diabetic subjects (+20.1%, p = 0.003). Interestingly, there was a statistical trend that suggested attenuation of tibial cortical hypertrophy in diabetic men (cortical thickness, p(interaction) = 0.052). Moreover, we found an expected sexual dichotomy, with higher trabecular BMD, Tb. N, cortical BMD, Ct. Th, and total area in men than in women (p <= 0.003) at both measurement sites. Our results suggest that skeletal hypertrophy associated with T2DM is present in men and women, but appears attenuated at the tibial cortex in men.	[Patsch, Janina M.; Huber, Florian A.] Med Univ Vienna, Div Gen Radiol & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Rasul, Sazan] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Leitner, Karoline; Thomas, Anita; Kautzky-Willer, Alexandra] Med Univ Vienna, Gender Med Unit, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Kocijan, Roland] St Vincent Hosp Vienna, Karl Landsteiner Inst Rheumatol & Gastroenterol, Dept Internal Med 2, Vienna, Austria; [Boutroy, Stephanie] Univ Lyon, INSERM, Res Unit 831, Lyon, France; [Weber, Michael] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Kainberger, Franz; Schueller-Weidekamm, Claudia] Med Univ Vienna, Div Neuroradiol & Musculoskeletal Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Vienna; Medical University of Vienna	Patsch, JM (corresponding author), Med Univ Vienna, Div Gen Radiol & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	janina.patsch@meduniwien.ac.at	Rasul, Sazan/AAX-4248-2021; Patsch, Janina M/AAF-6040-2019; Weber, Michael/L-9836-2016	Patsch, Janina M/0000-0002-5936-5608; Thomas, Anita/0000-0002-1679-3098; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Weber, Michael/0000-0002-8507-2219; Rasul, Sazan/0000-0003-2898-3232				Baker JF, 2013, BONE, V53, P34, DOI 10.1016/j.bone.2012.11.035; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Bouxsein ML, 2009, BEST PRACT RES CL RH, V23, P741, DOI 10.1016/j.berh.2009.09.008; Burghardt AJ, 2010, OSTEOPOROSIS INT, V21, P45; Burghardt AJ, 2010, J CLIN ENDOCR METAB, V95, P5045, DOI 10.1210/jc.2010-0226; Chaitou A, 2010, J BONE MINER RES, V25, P2313, DOI 10.1002/jbmr.124; Cohen A, 2010, OSTEOPOROSIS INT, V21, P263, DOI 10.1007/s00198-009-0945-7; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Davis KA, 2007, CALCIFIED TISSUE INT, V81, P364, DOI 10.1007/s00223-007-9076-3; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Farr JN, 2016, BONE, V82, P28, DOI 10.1016/j.bone.2015.07.027; Gaudio A, 2012, J CLIN ENDOCR METAB, V97, P3744, DOI 10.1210/jc.2012-1901; Heilmeier U, 2015, OSTEOPOROSIS INT, V26, P1283, DOI 10.1007/s00198-014-2988-7; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Karim L, 2016, BONE, V82, P21, DOI 10.1016/j.bone.2015.07.028; Khosla S, 2006, J BONE MINER RES, V21, P124, DOI 10.1359/JBMR.050916; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8; Liu XS, 2010, J BONE MINER RES, V25, P2229, DOI 10.1002/jbmr.111; Macdonald HM, 2011, J BONE MINER RES, V26, P50, DOI 10.1002/jbmr.171; Marshall LM, 2006, J BONE MINER RES, V21, P1197, DOI 10.1359/JBMR.060506; Paccou J, 2016, CALCIFIED TISSUE INT, V98, P465, DOI 10.1007/s00223-015-0100-8; Patsch JM, 2014, BONE, V58, P42, DOI 10.1016/j.bone.2013.08.006; Patsch JM, 2011, J BONE MINER RES, V26, P1584, DOI 10.1002/jbmr.344; Patsch JM, 2012, J BONE MINER RES; Pialat JB, 2011, BONE; PIETSCHMANN P, 1988, DIABETOLOGIA, V31, P892; Pritchard JM, 2012, ARTHRIT CARE RES, V64, P83, DOI 10.1002/acr.20602; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Rubin MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.1; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Shanbhogue VV, 2016, EUR J ENDOCRINOL, V174, P115, DOI 10.1530/EJE-15-0860; Shanbhogue VV, 2016, J CLIN ENDOCR METAB; Shu A, 2011, OSTEOPOROS INT; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vico L, 2008, J BONE MINER RES, V23, P1741, DOI 10.1359/JBMR.080704; Yu EW, 2014, OSTEOPOROS INT	42	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174664	10.1371/journal.pone.0174664	http://dx.doi.org/10.1371/journal.pone.0174664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384358	gold, Green Published, Green Submitted			2022-12-27	WOS:000399371900024
J	Sherry-Lynes, MM; Sengupta, S; Kulkarni, S; Cochran, BH				Sherry-Lynes, Maureen M.; Sengupta, Sejuti; Kulkarni, Shreya; Cochran, Brent H.			Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3	PLOS ONE			English	Article							GENE-EXPRESSION; H3K27 DEMETHYLASE; INK4A/ARF LOCUS; SELF-RENEWAL; CANCER; DIFFERENTIATION; METHYLATION; ACTIVATION; TARGET; EZH2	The growth factor and cytokine regulated transcription factor STAT3 is required for the self-renewal of several stem cell types including tumor stem cells from glioblastoma. Here we show that STAT3 inhibition leads to the upregulation of the histone H3K27me2/3 demethylase Jmjd3 (KDM6B), which can reverse polycomb complex-mediated repression of tissue specific genes. STAT3 binds to the Jmjd3 promoter, suggesting that Jmjd3 is a direct target of STAT3. Overexpression of Jmjd3 slows glioblastoma stem cell growth and neurosphere formation, whereas knockdown of Jmjd3 rescues the STAT3 inhibitor-induced neurosphere formation defect. Consistent with this observation, STAT3 inhibition leads to histone H3K27 demethylation of neural differentiation genes, such as Myt1, FGF21, and GDF15. These results demonstrate that the regulation of Jmjd3 by STAT3 maintains repression of differentiation specific genes and is therefore important for the maintenance of self-renewal of normal neural and glioblastoma stem cells.	[Cochran, Brent H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Cell & Mol Physiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts University; Tufts University	Cochran, BH (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Cell & Mol Physiol, Boston, MA 02111 USA.	Brent.cochran@tufts.edu	sengupta, sejuti/C-7137-2019	sengupta, sejuti/0000-0002-1019-2785; Cochran, Brent/0000-0002-7598-5604	NIH [R01NS072414]; Tufts University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R01NS072414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH R01NS072414 to BHC. Details can be found by searching https://projectreporter.nih.gov/reporter. cfm. Additional funding was provided by Tufts University.There was no additional external funding received for this study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank G. Testa for shRNA to Jmjd3, Y. Shi for anti-Jmjd3 antibodies, P. Khavari for the Jmjd3 retroviral vectors obtained from Addgene, and H. Wakimoto for the MGG8 cell line. S3I-201 (NSC 74859) and STA-21 (NSC 628869) inhibitors were obtained from the NCI/DTP Open Chemical Repository (http://dtp.cancer.gov). The Tufts Neuroscience Core (P30 NS047243) provided the Stratagene qPCR machine. We thank J. Wu and A. Yee for critical reading of the manuscript. This work was supported in part by NIH R01NS072414 to BHC.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Carrillo-Garcia C, 2014, DEVELOPMENT, V141, P773, DOI 10.1242/dev.096131; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; de Vries NA, 2015, CELL REPORTS; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Gallo M, 2015, CANCER CELL, V28, P715, DOI 10.1016/j.ccell.2015.10.005; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Huang XH, 2013, BRAIN RES, V1530, P13, DOI 10.1016/j.brainres.2013.07.043; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Karolchik D., 2009, UCSC GENOME BROWSER; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Li GH, 2010, INT J ONCOL, V37, P103, DOI 10.3892/ijo_00000658; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marei HES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028420; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Park DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01095; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rajan P, 1998, J NEUROSCI, V18, P3620; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Urayama S, 2013, CELL STRUCT FUNCT, V38, P55, DOI 10.1247/csf.12034; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Venneti S, 2013, BRIAN PATHOLOGY ZURI; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang L, 2004, MOL ENDOCRINOL, V18, P1520, DOI 10.1210/me.2003-0458; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang JX, 2015, CANCER LETT, V356, P929, DOI 10.1016/j.canlet.2014.11.003; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	81	34	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174775	10.1371/journal.pone.0174775	http://dx.doi.org/10.1371/journal.pone.0174775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384648	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900035
J	Bromag, DI; Taferner, S; Pillar, M; Yellen, DM; Davidsonr, SM				Bromage, Daniel I.; Taferner, Stasa; Pillar, Mahesh; Yellen, Derek M.; Davidsonr, Sean M.			A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies	PLOS ONE			English	Article							STEM-CELL RECRUITMENT; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; G-CSF; CXCR4 EXPRESSION; SDF-1-CXCR4 AXIS; HEART-FAILURE; FACTOR-1-ALPHA; MOBILIZATION; SDF-1-ALPHA	Background Stromal derived factor-1 alpha (SDF-1 alpha/CXCL12) is a chemokine that is up-regulated in diseases characterised by tissue hypoxia, including myocardial infarction, ischaemic cardiomyopathy and remote ischaemic conditioning (RIC), a technique of cyclical, non-injurious ischaemia applied remote from the heart that protects the heat from lethal ischaemia-reperfusion injury. Accordingly, there is considerable interest in SDF-1 alpha as a potential biomarker of such conditions. However, SDF-1 alpha is rapidly degraded and inactivated by dipeptidyl peptidase 4 and other peptidases, and the kinetics of intact SDF-1 alpha remain unknown. Methods & results To facilitate investigation of full-length SDF-1 alpha we established an ELISA using a novel recombinant human antibody we developed called HCI.SDF1. HCI.SDF1 is specific to the N-terminal sequence of all isoforms of SDF-1 and has a comparable KD to commercially available antibodies. Together with a detection antibody specific to the a-isoform, HCI.SDF1 was used to specifically quantify full-length SDF-1 alpha in blood for the first time. Using RIC applied to the hind limb of Sprague-Dawley rats or the arms of healthy human volunteers, we demonstrate an increase in SDF-1 alpha using a commercially available antibody, as previously reported, but an unexpected decrease in full-length SDF-1 alpha after RIC in both species. Conclusions We report for the first time the development of a novel recombinant antibody specific to fulllength SDF-1. Applied to RIC, we demonstrate a significant decrease in SDF-1 alpha that is at odds with the literature and suggests a need to investigate the kinetics of full-length SDF-1 alpha in conditions characterised by tissue hypoxia.	[Bromage, Daniel I.; Taferner, Stasa; Pillar, Mahesh; Yellen, Derek M.; Davidsonr, Sean M.] UCL, Hatter Cardiovasc Inst, London, England; [Bromage, Daniel I.; Taferner, Stasa; Pillar, Mahesh; Yellen, Derek M.; Davidsonr, Sean M.] Lambeth Wing St Thomas Hosp, Rayne Inst, London, England	University of London; University College London; University of London; King's College London	Davidsonr, SM (corresponding author), UCL, Hatter Cardiovasc Inst, London, England.; Davidsonr, SM (corresponding author), Lambeth Wing St Thomas Hosp, Rayne Inst, London, England.	s.davidson@ucl.ac.uk	Davidson, Sean M/F-5275-2010; Yellon, Derek M/ABD-5110-2021	Davidson, Sean M/0000-0001-5182-4980; Bromage, Daniel/0000-0002-4243-5964; Yellon, Derek/0000-0001-7791-9320	British Heart Foundation (BHF) [PG/15/52/31598]; National Institute of Health Research University College London Hospital Biomedical Research Council [BRC233/CM/SD/101320]; MRC Clinical Research Training Fellow [MR/L002043/1]; Department of Health's NIHR Biomedical Research Centres; MRC [MR/L002043/1] Funding Source: UKRI; Medical Research Council [MR/L002043/1] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); National Institute of Health Research University College London Hospital Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Research Training Fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the British Heart Foundation (BHF PG/15/52/31598) and National Institute of Health Research University College London Hospital Biomedical Research Council (BRC233/CM/SD/101320). Dr. Daniel Bromage is an MRC Clinical Research Training Fellow (grant MR/L002043/1). This work was undertaken at UCLH/UCL, who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Baerts L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141408; Chang LT, 2009, CIRC J, V73, P1097, DOI 10.1253/circj.CJ-08-0497; Chatterjee M, 2013, J THROMBOSIS HAEMOST; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Chung ES, 2015, EUR HEART J, V36, P2228, DOI 10.1093/eurheartj/ehv254; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Damas JK, 2002, CIRCULATION, V106, P36, DOI 10.1161/01.CIR.0000020001.09990.90; Davidson SM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0377-6; Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Fortunato O, 2013, CARDIOVASC RES, V100, P192, DOI 10.1093/cvr/cvt153; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Gray AC, 2016, SCIENCE, V353, P452, DOI 10.1126/science.aag3305; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Jiang Q, 2013, J MOL CELL CARDIOL, V56, P1, DOI 10.1016/j.yjmcc.2012.12.016; Jung C, 2009, PEDIATR DIABETES, V10, P329, DOI 10.1111/j.1399-5448.2008.00486.x; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim BS, 2016, J CARDIOVASC TRANSL, V9, P230, DOI 10.1007/s12265-016-9689-x; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Krebs B, 2001, J IMMUNOL METHODS, V254, P67, DOI 10.1016/S0022-1759(01)00398-2; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Leone AM, 2006, INT J CARDIOL, V111, P202, DOI 10.1016/j.ijcard.2005.06.043; Liu KP, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/510618; Malik A., 2015, CARDIOVASC DRUGS THE; Matsuoka S, 2017, J CARDIOL, V69, P320, DOI 10.1016/j.jjcc.2016.06.011; Mehta NN, 2014, EUR HEART J, V35, P2115, DOI 10.1093/eurheartj/eht481; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Subramanian S, 2014, ARTERIOSCL THROM VAS, V34, P2100, DOI 10.1161/ATVBAHA.114.303579; Theiss HD, 2013, INT J CARDIOL, V168, P3359, DOI 10.1016/j.ijcard.2013.04.121; Tong GX, 2014, INT HEART J, V55, P219, DOI 10.1536/ihj.13-289; Wang WX, 2014, J AM SOC MASS SPECTR, V25, P614, DOI 10.1007/s13361-013-0822-7; Yamani MH, 2005, J AM COLL CARDIOL, V46, P1029, DOI 10.1016/j.jacc.2005.04.059; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	45	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174447	10.1371/journal.pone.0174447	http://dx.doi.org/10.1371/journal.pone.0174447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379992	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500047
J	Hakimian, J; Minasyan, A; Zhe-Ying, L; Loureiro, M; Beltrand, A; Johnston, C; Vorperian, A; Romaneschi, N; Atallah, W; Gomez-Pinilla, F; Walwyn, W				Hakimian, Joshua; Minasyan, Ani; Zhe-Ying, Lily; Loureiro, Mariana; Beltrand, Austin; Johnston, Camille; Vorperian, Alexander; Romaneschi, Nicole; Atallah, Waleed; Gomez-Pinilla, Fernando; Walwyn, Wendy			Specific behavioral and cellular adaptations induced by chronic morphine are reduced by dietary omega-3 polyunsaturated fatty acids	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; DOCOSAHEXAENOIC ACID; NUCLEUS-ACCUMBENS; COGNITIVE IMPAIRMENT; DOPAMINE NEURONS; DRUG-ADDICTION; N-3 PUFAS; BRAIN; COCAINE; OMEGA-3-FATTY-ACIDS	Opiates, one of the oldest known drugs, are the benchmark for treating pain. Regular opioid exposure also induces euphoria making these compounds addictive and often misused, as shown by the current epidemic of opioid abuse and overdose mortalities. In addition to the effect of opioids on their cognate receptors and signaling cascades, these compounds also induce multiple adaptations at cellular and behavioral levels. As omega-3 polyunsaturated fatty acids (n-3 PUFAs) play a ubiquitous role in behavioral and cellular processes, we proposed that supplemental n-3 PUFAs, enriched in docosahexanoic acid (DHA), could offset these adaptations following chronic opioid exposure. We used an 8 week regimen of n-3 PUFA supplementation followed by 8 days of morphine in the presence of this diet. We first assessed the effect of morphine in different behavioral measures and found that morphine increased anxiety and reduced wheel-running behavior. These effects were reduced by dietary n-3 PUFAs without affecting morphine-induced analgesia or hyperlocomotion, known effects of this opiate acting at mu opioid receptors. At the cellular level we found that morphine reduced striatal DHA content and that this was reversed by supplemental n-3 PUFAs. Chronic morphine also increased glutamatergic plasticity and the proportion of Grin2B-NMDARs in striatal projection neurons. This effect was similarly reversed by supplemental n-3 PUFAs. Gene analysis showed that supplemental PUFAs offset the effect of morphine on genes found in neurons of the dopamine receptor 2 (D2)-enriched indirect pathway but not of genes found in dopamine receptor 1(D1)-enriched direct-pathway neurons. Analysis of the D2 striatal connectome by a retrogradely transported pseudorabies virus showed that n-3 PUFA supplementation reversed the effect of chronic morphine on the innervation of D2 neurons by the dorsomedial prefontal and piriform cortices. Together these changes outline specific behavioral and cellular effects of morphine that can be reduced or reversed by dietary n-3 PUFAs.	[Hakimian, Joshua; Minasyan, Ani; Loureiro, Mariana; Beltrand, Austin; Johnston, Camille; Vorperian, Alexander; Romaneschi, Nicole; Atallah, Waleed; Walwyn, Wendy] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Hakimian, Joshua; Minasyan, Ani; Zhe-Ying, Lily; Loureiro, Mariana; Beltrand, Austin; Johnston, Camille; Vorperian, Alexander; Romaneschi, Nicole; Atallah, Waleed; Gomez-Pinilla, Fernando; Walwyn, Wendy] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Zhe-Ying, Lily; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Integrat Biol & Physiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Walwyn, W (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Walwyn, W (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	wwalwyn@g.ucla.edu		Johnston, Camille/0000-0001-9217-8647; Walwyn, Wendy/0000-0001-8101-2844; Hakimian, Joshua/0000-0003-2712-6204; Beltrand, Austin/0000-0002-3644-5488	Shirley and Stefan Hatos Foundation [NIDA: DA005010, NINDS:NS0504650, NIH:P40RR01860]; NIH Virus Center grant [P40RR01860]	Shirley and Stefan Hatos Foundation; NIH Virus Center grant	Support was provided by Shirley and Stefan Hatos Foundation (NIDA: DA005010, NINDS:NS0504650, NIH:P40RR01860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks are due to Dr. David Pena and Maxwell Roth for assistance with the cell counting technique and program. The pseudorabies virus was provided by Dr Lynn Enquist and supported by the NIH Virus Center grant P40RR01860.	Almeida DM, 2015, NUTR NEUROSCI; [Anonymous], 2016, F1000RES; Banerjee G, 2016, ADDICTION, V111, P2021, DOI 10.1111/add.13491; Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016; Bozzatello P, 2016, J CLIN MED, V5, DOI 10.3390/jcm5080067; Buydens-Branchey L, 2003, DRUG ALCOHOL DEPEN, V71, P319, DOI 10.1016/S0376-8716(03)00168-6; Buydens-Branchey L, 2008, PSYCHIAT RES, V157, P95, DOI 10.1016/j.psychres.2007.01.004; Buydens-Branchey L, 2009, AM J ADDICTION, V18, P73, DOI 10.1080/10550490802544003; Cahill CM, 2016, TRENDS PHARMACOL SCI, V37, P963, DOI 10.1016/j.tips.2016.08.002; Cansev M, 2016, NEUROMOL MED, V18, P426, DOI 10.1007/s12017-016-8414-x; Card J.P., 2014, CURR PROTOC NEUROSCI, V68, P1; Card JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021141; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen LH, 2012, CELL SIGNAL, V24, P1565, DOI 10.1016/j.cellsig.2012.03.016; Chen XL, 2007, CELL RES, V17, P689, DOI 10.1038/cr.2007.63; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cicero TJ, 2015, JAMA PSYCHIAT, V72, P424, DOI 10.1001/jamapsychiatry.2014.3043; Compton WM, 2016, NEW ENGL J MED, V374, P1296, DOI 10.1056/NEJMc1601875; Cunha-Oliveira T, 2007, J NEUROCHEM, V101, P543, DOI 10.1111/j.1471-4159.2006.04406.x; Cunha-Oliveira T, 2013, LIFE SCI, V92, P1157, DOI 10.1016/j.lfs.2013.04.016; Cunha-Oliveira T, 2013, TOXICOL LETT, V219, P298, DOI 10.1016/j.toxlet.2013.03.025; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; Dasgupta N, 2014, DRUG ALCOHOL DEPEN, V145, P238, DOI 10.1016/j.drugalcdep.2014.10.005; de Vera IMS, 2016, ACS CHEM BIOL, V11, P1795, DOI 10.1021/acschembio.6b00037; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Enoksson T, 2012, NEUROPHARMACOLOGY, V62, P2463, DOI 10.1016/j.neuropharm.2012.02.020; Erdtmann-Vourliotis M, 1998, MOL BRAIN RES, V61, P51, DOI 10.1016/S0169-328X(98)00197-1; Guo QC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123381; HERON DS, 1982, BIOCHEM PHARMACOL, V31, P2435, DOI 10.1016/0006-2952(82)90543-3; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hoback Jane, 2016, State Legis, V42, P9; Huang CT, 2016, J NUTR BIOCHEM, V29, P97, DOI 10.1016/j.jnutbio.2015.11.009; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Jacobs EH, 2005, EUR J PHARMACOL, V511, P27, DOI 10.1016/j.ejphar.2005.02.009; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Jiang C, 2015, EUR J PAIN, V19, P908, DOI 10.1002/ejp.617; Jones CR, 1996, J NEUROCHEM, V67, P822; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob GF, 2015, EUR J PHARMACOL, V753, P73, DOI 10.1016/j.ejphar.2014.11.044; Kuhn FT, 2015, NEUROTOX RES, V28, P319, DOI 10.1007/s12640-015-9549-5; Larance B, 2015, J SUBST ABUSE TREAT, V58, P51, DOI 10.1016/j.jsat.2015.06.001; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lesperance F, 2011, J CLIN PSYCHIAT, V72, P1054, DOI 10.4088/JCP.10m05966blu; Li YF, 2007, NEUROSCI LETT, V418, P227, DOI 10.1016/j.neulet.2007.03.023; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Lowe AS, 2002, NEUROIMAGE, V17, P902, DOI 10.1006/nimg.2002.1251; Mazzocchi-Jones D, 2015, BRAIN RES BULL, V111, P69, DOI 10.1016/j.brainresbull.2014.12.010; McNamara RK, 2008, SYNAPSE, V62, P725, DOI 10.1002/syn.20542; Miladi-Gorji H, 2012, PHYSIOL BEHAV, V105, P195, DOI 10.1016/j.physbeh.2011.08.010; Miller EC, 2012, MOL PHARMACOL, V82, P333, DOI 10.1124/mol.112.078162; Moniri NH, 2016, BIOCHEM PHARMACOL, V110, P1, DOI 10.1016/j.bcp.2016.01.021; MORABIA A, 1989, BRIT J ADDICT, V84, P173; Pal A, 2013, NEUROCHEM INT, V62, P956, DOI 10.1016/j.neuint.2013.03.011; Pifferi F, 2015, J LIPID RES, V56, P1511, DOI 10.1194/jlr.M058933; Pusceddu MM, 2015, PSYCHONEUROENDOCRINO, V58, P79, DOI 10.1016/j.psyneuen.2015.04.015; Robinson TE, 1999, SYNAPSE, V33, P160; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Rudd R. A., 2016, INCREASES DRUG OPIOI; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; SAMHSA, 2012, RES 2011 NAT SURV DR; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Suzuki H, 1997, INT J VITAM NUTR RES, V67, P272; Taylor AMW, 2015, J NEUROSCI, V35, P8442, DOI 10.1523/JNEUROSCI.4036-14.2015; Trivedi MS, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00444; Trofimiuk E, 2013, PHYSIOL BEHAV, V118, P171, DOI 10.1016/j.physbeh.2013.05.002; U S Department Of Health And Human Services, 2015, J Pain Palliat Care Pharmacother, V29, P133, DOI 10.3109/15360288.2015.1037530; van Elst K, 2014, NEUROSCI BIOBEHAV R, V45, P369, DOI 10.1016/j.neubiorev.2014.07.004; Volkow N., 2016, PRESCRIPTION OPIOID; Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480; Wu A., 2013, NEUROREHABIL NEURAL; Wu XB, 2012, J NEUROSCI RES, V90, P1270, DOI 10.1002/jnr.23025; Zaparoli JX, 2016, EUR ADDICT RES, V22, P153, DOI 10.1159/000439525; Zhang XW, 2016, AGING CLIN EXP RES, V28, P165, DOI 10.1007/s40520-015-0381-9; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954	86	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175090	10.1371/journal.pone.0175090	http://dx.doi.org/10.1371/journal.pone.0175090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380057	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500096
J	Jarillo, J; Morin, JA; Beltran-Heredia, E; Villaluenga, JPG; Ibarra, B; Cao, FJ				Jarillo, Javier; Morin, Jose A.; Beltran-Heredia, Elena; Villaluenga, Juan P. G.; Ibarra, Borja; Cao, Francisco J.			Mechanics, thermodynamics, and kinetics of ligand binding to biopolymers	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI SSB; REPLICATION PROTEIN-A; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; OPTICAL TWEEZERS; STRETCHING DNA; NUCLEIC-ACIDS; MOLECULE; POLYELECTROLYTES	Ligands binding to polymers regulate polymer functions by changing their physical and chemical properties. This ligand regulation plays a key role in many biological processes. We propose here a model to explain the mechanical, thermodynamic, and kinetic properties of the process of binding of small ligands to long biopolymers. These properties can now be measured at the single molecule level using force spectroscopy techniques. Our model performs an effective decomposition of the ligand-polymer system on its covered and uncovered regions, showing that the elastic properties of the ligand-polymer depend explicitly on the ligand coverage of the polymer (i.e., the fraction of the polymer covered by the ligand). The equilibrium coverage that minimizes the free energy of the ligand-polymer system is computed as a function of the applied force. We show how ligands tune the mechanical properties of a polymer, in particular its length and stiffness, in a force dependent manner. In addition, it is shown how ligand binding can be regulated applying mechanical tension on the polymer. Moreover, the binding kinetics study shows that, in the case where the ligand binds and organizes the polymer in different modes, the binding process can present transient shortening or lengthening of the polymer, caused by changes in the relative coverage by the different ligand modes. Our model will be useful to understand ligand-binding regulation of biological processes, such as the metabolism of nucleic acid. In particular, this model allows estimating the coverage fraction and the ligand mode characteristics from the force extension curves of a ligand-polymer system.	[Jarillo, Javier; Beltran-Heredia, Elena; Cao, Francisco J.] Univ Complutense Madrid, Fac Ciencias Fis, Dept Fis Atom Mol & Nucl, Pza Ciencias 1, Madrid, Spain; [Morin, Jose A.; Ibarra, Borja] Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid, Spain; [Morin, Jose A.; Ibarra, Borja] CNB CSIC IMDEA Nanociencia Associated Unit, Unidad Nanobiotecnol, Madrid, Spain; [Villaluenga, Juan P. G.] Univ Complutense Madrid, Dept Fis Aplicada 1, Fac Ciencias Fis, Pza Ciencias 1, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid	Cao, FJ (corresponding author), Univ Complutense Madrid, Fac Ciencias Fis, Dept Fis Atom Mol & Nucl, Pza Ciencias 1, Madrid, Spain.	francao@ucm.es	Cao, Francisco J./B-7794-2008; García Villaluenga, Juan Pedro/H-5155-2015; Jarillo, Javier/AAD-2044-2021; Jarillo, Javier/Q-4591-2018; ibarra, borja/H-5840-2015	Cao, Francisco J./0000-0003-1611-913X; García Villaluenga, Juan Pedro/0000-0001-9540-7134; Jarillo, Javier/0000-0003-2337-0170; Jarillo, Javier/0000-0003-2337-0170; Morin, Jose A./0000-0002-0956-6508; ibarra, borja/0000-0001-6597-797X; Beltran-Heredia, Elena/0000-0003-4251-7289	Banco Santander [GR35/14-920911]; Universidad Complutense de Madrid, Spain [GR35/14-920911]; MINECO, Spain [FIS2010-17440, FIS2015-67765-R, BFU2012-31825, BFU2015-63714-R]; Ministerio de Educacion, Cultura y Deporte, Spain [FPU13/02934, FPU13/02826]	Banco Santander; Universidad Complutense de Madrid, Spain; MINECO, Spain; Ministerio de Educacion, Cultura y Deporte, Spain	This work was supported by grants GR35/14-920911 (Banco Santander and Universidad Complutense de Madrid, Spain), and FIS2010-17440 and FIS2015-67765-R (MINECO, Spain) to JJ, EB, JPGV, and FJC, and by grant BFU2012-31825 and BFU2015-63714-R (MINECO, Spain) to JM and BI. Additionally, JJ and EB acknowledge financial support from FPU13/02934 and FPU13/02826 grants (Ministerio de Educacion, Cultura y Deporte, Spain), respectively.; This work was supported by grants GR35/14-920911 (Banco Santander and Universidad Complutense de Madrid, Spain), and FI52010-17440 and FIS2015-67765-R (MINECO, Spain) to J.J., E.B., J.P.G.V., and F.J.C., and by grant BFU2012-31825 and BFU2015-63714-R (MINECO, Spain) to J.M. and B.I. Additionally, J.J. and E.B. acknowledge financial support from FPU13/02934 and FPU13/02826 grants (Ministerio de Educacion, Cultura y Deporte, Spain), respectively.	Ahmad S, 2006, TRANSIT METAL CHEM, V31, P1003, DOI 10.1007/s11243-006-0100-7; Bell JC, 2015, ELIFE, V4, DOI 10.7554/eLife.08646; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Cesconetto EC, 2013, PHYS CHEM CHEM PHYS, V15, P11070, DOI 10.1039/c3cp50898f; Chaurasiya KR, 2010, PHYS LIFE REV, V7, P299, DOI 10.1016/j.plrev.2010.06.001; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09296; Corless R.M., 1993, MAPLE TECH NEWSL, V9, P12; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; Cruceanu M, 2006, ANAL BIOCHEM, V358, P159, DOI 10.1016/j.ab.2006.08.037; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hatch K, 2008, NUCLEIC ACIDS RES, V36, P294, DOI 10.1093/nar/gkm1014; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Lambert J. H., 1758, ACTA HELVETICA, V3, P128; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Lim CJ, 2013, NUCLEIC ACIDS RES, V41, P746, DOI 10.1093/nar/gks1126; Lohman TM, 1996, BIOCHEMISTRY-US, V35, P5272, DOI 10.1021/bi9527606; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Loregian A, 2007, NUCLEIC ACIDS RES, V35, P4779, DOI 10.1093/nar/gkm506; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marceau Aimee H, 2012, Methods Mol Biol, V922, P1, DOI 10.1007/978-1-62703-032-8_1; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MASCOTTI DP, 1990, P NATL ACAD SCI USA, V87, P3142, DOI 10.1073/pnas.87.8.3142; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McIntosh DB, 2011, MACROMOLECULES, V44, P2328, DOI 10.1021/ma1028196; McIntosh DB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041803; McIntosh DB, 2014, BIOPHYS J, V106, P659, DOI 10.1016/j.bpj.2013.12.018; Mine J, 2007, NUCLEIC ACIDS RES, V35, P7171, DOI 10.1093/nar/gkm752; Montanari A, 2001, PHYS REV LETT, V86, P2178, DOI 10.1103/PhysRevLett.86.2178; Morin JA, 2017, DNA SYNTHESIS DETERM; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; ODIJK T, 1995, MACROMOLECULES, V28, P7016, DOI 10.1021/ma00124a044; Pant K, 2004, J MOL BIOL, V336, P851, DOI 10.1016/j.jmb.2003.12.025; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Rouzina I, 2005, BIOPHYS J, V89, P1941, DOI 10.1529/biophysj.105.063776; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Saleh OA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068301; Siman L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248103; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Stigter D, 1996, BIOPHYS J, V71, P2064, DOI 10.1016/S0006-3495(96)79405-5; Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906; Suksombat S, 2015, ELIFE, V4, DOI 10.7554/eLife.08193; Toan NM, 2006, J PHYS-CONDENS MAT, V18, pS269, DOI 10.1088/0953-8984/18/14/S11; Toan NM, 2005, BIOPHYS J, V89, P80, DOI 10.1529/biophysj.104.058081; Tonks L, 1936, PHYS REV, V50, P955, DOI 10.1103/PhysRev.50.955; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Vladescu ID, 2007, NAT METHODS, V4, P517, DOI 10.1038/nmeth1044; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zhang W, 1996, P NATL ACAD SCI USA, V93, P2511, DOI 10.1073/pnas.93.6.2511; Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	66	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174830	10.1371/journal.pone.0174830	http://dx.doi.org/10.1371/journal.pone.0174830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380044	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500066
J	Liu, RJ; Gao, CF; Chen, HJ; Li, YX; Jin, Y; Qi, H				Liu, Rongjun; Gao, Caifeng; Chen, Huijin; Li, Yaxin; Jin, Ying; Qi, Hong			Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease	PLOS ONE			English	Article							PATHOGENIC T(H)17 CELLS; DIAGNOSTIC-TESTS; SJOGREN-SYNDROME; SYMPTOMS; SIGNS; DIFFERENTIATION; INTERLEUKIN-17; TEARS	We aimed to investigate the expressions of three Th17-associated cytokines, interleukin (IL)-17A, IL-6 and IL-23, in protein and mRNA levels and their correlations with ocular surface parameters in patients with dry eye disease (DED) through a small sample size case control study. A total of 45 female subjects were divided into Sjogren's syndrome (SS) DED group, non-Sjogren's syndrome (non-SS) DED group and control group. Ocular surface disease index (OSDI) was self-answered and clinical tests including tear-film breakup time (BUT), Schirmer I test, cornea fluorescein staining (CFS) were performed. The conjunctival mRNA expressions of these cytokines were investigated by real-time polymerase chain reaction (PCR) and the levels of protein in tears were measured by mutiplex bead analysis. The correlations between cytokines and ocular surface parameters were analyzed. Results show that the expressions of IL-17A and IL-6 in protein and mRNA levels were both significantly increased in the DED group (P<0.05), and also higher in SS group comparing to the non-SS group (P<0.05). Moreover, IL-17A and IL-6 correlated well with ocular surface parameters (all P<0.05, R values range from 0.5-0.8). Despite the expression of IL-23 was significantly increased in the DED group (P<0.05), there was no significant difference found between the expressions of IL-23 in SS group and non-SS group (P>0.05) and no correlation found between the IL-23 and any ocular surface parameter (P>0.05). These findings indicates that the three Th17-associated cytokines, IL-17A, IL-6 and IL-23, play roles in the pathogenesis of DED and the expressions of IL-17A and IL-6 in tears have potential to be diagnostic biomarkers for DED.	[Liu, Rongjun; Gao, Caifeng; Chen, Huijin; Li, Yaxin; Jin, Ying; Qi, Hong] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China; [Gao, Caifeng] Guangdong Women & Children Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Yaxin] First Hosp Fangshan Dist, Beijing, Peoples R China	Peking University	Qi, H (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China.	doctorqihong@hotmail.com			National Natural Science Foundation of China [30872813, 81570813]; LinHu Scientific Research Foundation of Department of Ophthalmology, Peking University Third Hospital; Scientific Research Foundation for the Excellent Returned Overseas Chinese Scholars, Peking University Third Hospital; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); LinHu Scientific Research Foundation of Department of Ophthalmology, Peking University Third Hospital; Scientific Research Foundation for the Excellent Returned Overseas Chinese Scholars, Peking University Third Hospital; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by National Natural Science Foundation of China (No. 30872813); National Natural Science Foundation of China (81570813); the LinHu Scientific Research Foundation of Department of Ophthalmology, Peking University Third Hospital; the Scientific Research Foundation for the Excellent Returned Overseas Chinese Scholars, Peking University Third Hospital; the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2015, CLIN OPHTHALMOL, V9, P1719, DOI 10.2147/OPTH.S89700; Begley CG, 2003, INVEST OPHTH VIS SCI, V44, P4753, DOI 10.1167/iovs.03-0270; Chauhan SK, 2009, MUCOSAL IMMUNOL, V2, P375, DOI 10.1038/mi.2009.21; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; [高彩凤 Gao Caifeng], 2014, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V32, P641; Geerling G, 2011, INVEST OPHTH VIS SCI, V52, P2050, DOI 10.1167/iovs.10-6997g; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gipson IK, 2007, OCUL SURF, V5, P179; Kallarackal GU, 2002, EYE, V16, P594, DOI 10.1038/sj.eye.6700177; Kang MH, 2011, J KOREAN MED SCI, V26, P938, DOI 10.3346/jkms.2011.26.7.938; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Lemp MA, 2007, OCUL SURF, V5, P75; Liu Z, 2013, CHINESE J OPHTHALMOL, V49, P73; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Macri A, 2000, OPHTHALMOLOGY, V107, P1338, DOI 10.1016/S0161-6420(00)00101-9; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moore JE, 2009, BRIT J OPHTHALMOL, V93, P66, DOI 10.1136/bjo.2007.131722; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Oh Joo Youn, 2011, Korean J Ophthalmol, V25, P73, DOI 10.3341/kjo.2011.25.2.73; Pflugfelder Stephen C, 2003, Ocul Surf, V1, P31; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Tan X, 2014, EYE, V28, P608, DOI 10.1038/eye.2014.38; Tishler M, 1998, OPHTHALMOLOGY, V105, P2327, DOI 10.1016/S0161-6420(98)91236-2; Versura P, 2010, CURR EYE RES, V35, P553, DOI 10.3109/02713683.2010.484557; Vitali C, 2002, CLASSIFICATION CRITE; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; Zheng XF, 2010, INVEST OPHTH VIS SCI, V51, P3083, DOI 10.1167/iovs.09-3838; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	34	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173301	10.1371/journal.pone.0173301	http://dx.doi.org/10.1371/journal.pone.0173301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379971	gold, Green Submitted, Green Published			2022-12-27	WOS:000399353500015
J	Oskui, SM; Bhakta, HC; Diamante, G; Liu, HN; Schlenk, D; Grover, WH				Oskui, Shirin Mesbah; Bhakta, Heran C.; Diamante, Gracie; Liu, Huinan; Schlenk, Daniel; Grover, William H.			Measuring the mass, volume, and density of microgram-sized objects in fluid	PLOS ONE			English	Article							SEED IMBIBITION; DRUG DISCOVERY; HUMAN-DISEASE; SINGLE CELLS; MODEL SYSTEM; ZEBRAFISH; BIOMATERIALS; GERMINATION; RESONATORS; MAGNESIUM	Measurements of an object's fundamental physical properties like mass, volume, and density can offer valuable insights into the composition and state of the object. However, many important biological samples reside in a liquid environment where it is difficult to accurately measure their physical properties. We show that by using a simple piece of glass tubing and some inexpensive off-the-shelf electronics, we can create a sensor that can measure the mass, volume, and density of microgram-sized biological samples in their native liquid environment. As a proof-of-concept, we use this sensor to measure mass changes in zebrafish embryos reacting to toxicant exposure, density changes in seeds undergoing rehydration and germination, and degradation rates of biomaterials used in medical implants. Since all objects have these physical properties, this sensor has immediate applications in a wide variety of different fields including developmental biology, toxicology, materials science, plant science, and many others.	[Oskui, Shirin Mesbah; Bhakta, Heran C.; Liu, Huinan; Grover, William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Diamante, Gracie; Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Grover, WH (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	wgrover@engr.ucr.edu		Grover, William/0000-0001-6854-8951	National Science Foundation's Instrument Development for Biological Research program [DBI-1353974]	National Science Foundation's Instrument Development for Biological Research program	This work was supported by the National Science Foundation's Instrument Development for Biological Research program under award DBI-1353974, http://www.nsf.gov. There was no additional external funding received for this study.; This work was supported by the National Science Foundation's Instrument Development for Biological Research program under award DBI-1353974.	[Anonymous], 1998, ISO 15212 1 OSCILLAT; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bryan AK, 2014, LAB CHIP, V14, P569, DOI 10.1039/c3lc51022k; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dohn S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804074; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Grover W., NACL PYTHON CODE PRE; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Lee D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33799; Lele Z, 1996, BIOTECHNOL ADV, V14, P57, DOI 10.1016/0734-9750(96)00004-3; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Mai ED, 2014, PROG NAT SCI-MATER, V24, P554, DOI 10.1016/j.pnsc.2014.08.012; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Moutopoulos DK, 2002, J APPL ICHTHYOL, V18, P200, DOI 10.1046/j.1439-0426.2002.00281.x; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Rasband W, IMAGEJ; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; WOODSTOCK LW, 1988, J SEED TECHNOL, V12, P1; Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	28	7	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174068	10.1371/journal.pone.0174068	http://dx.doi.org/10.1371/journal.pone.0174068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379982	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500030
J	Loeffler, J; Raab, M; Canal-Bruland, R				Loeffler, Jonna; Raab, Markus; Canal-Bruland, Rouwen			Does movement influence representations of time and space?	PLOS ONE			English	Article							LANGUAGE; METAPHORS; MANDARIN; ENGLISH; FUTURE; PERSPECTIVE; COGNITION; FRAMES; THINK; BODY	Embodied cognition posits that abstract conceptual knowledge such as mental representations of time and space are at least partially grounded in sensorimotor experiences. If true, then the execution of whole-body movements should result in modulations of temporal and spatial reference frames. To scrutinize this hypothesis, in two experiments participants either walked forward, backward or stood on a treadmill and responded either to an ambiguous temporal question (Experiment 1) or an ambiguous spatial question (Experiment 2) at the end of the walking manipulation. Results confirmed the ambiguousness of the questions in the control condition. Nevertheless, despite large power, walking forward or backward did not influence the answers or response times to the temporal (Experiment 1) or spatial (Experiment 2) question. A follow-up Experiment 3 indicated that this is also true for walking actively (or passively) in free space (as opposed to a treadmill). We explore possible reasons for the null-finding as concerns the modulation of temporal and spatial reference frames by movements and we critically discuss the methodological and theoretical implications.	[Loeffler, Jonna; Raab, Markus] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Raab, Markus] London South Bank Univ, Sch Appl Sci, London, England; [Canal-Bruland, Rouwen] Friedrich Schiller Univ Jena, Inst Sport Sci, Jena, Germany	German Sport University Cologne; London South Bank University; Friedrich Schiller University of Jena	Loeffler, J (corresponding author), German Sport Univ Cologne, Inst Psychol, Cologne, Germany.	J.Loeffler@dshs-koeln.de	Raab, Markus/B-4919-2009	Canal-Bruland, Rouwen/0000-0002-7731-0934	German Research Foundation (DFG) [RA 940/15-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) - RA 940/15-1.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bender A, 2010, J COGN CULT, V10, P283, DOI 10.1163/156853710X531195; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Borghi AM, 2014, SPRINGERBR PSYCHOL, P1, DOI 10.1007/978-1-4614-9539-0_1; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boroditsky L, 2001, P 23 ANN M COGN SCI; Buccino G, 2016, NEUROSCI BIOBEHAV R, V69, P69, DOI 10.1016/j.neubiorev.2016.07.033; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2009, HUM COGN PROCESS, V24, P127; Clark H.H., 1973, COGNITIVE DEV ACQUIS, P27; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crandall CS, 2016, J EXP SOC PSYCHOL, V66, P93, DOI 10.1016/j.jesp.2015.10.002; Field A.P., 2020, DISCOVERING STAT USI, V4th; Gallagher S., 2005, BODY SHAPES MIND; Gervais WM, 2010, ATTEN PERCEPT PSYCHO, V72, P1437, DOI 10.3758/APP.72.6.1437; Hartmann M, 2014, CONSCIOUS COGN, V30, P201, DOI 10.1016/j.concog.2014.09.007; Hartmann M, 2012, CONSCIOUS COGN, V21, P1558, DOI 10.1016/j.concog.2012.06.015; Hartmann M, 2012, J EXP PSYCHOL HUMAN, V38, P1416, DOI 10.1037/a0026706; Hubbard E, 2010, NEURAL CONSTRAINTS T; Huther L, 2013, P 35 ANN C COGN SCI, P2602; Kiefer M, 2012, TRENDS NEUROSCI EDUC, V1, P15, DOI 10.1016/j.tine.2012.07.002; Kranjec A, 2010, COGNITION, V114, P111, DOI 10.1016/j.cognition.2009.09.008; Kruglanski AW, 2015, PERSONAL SOC PSYCHOL; Lai VT, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00142; LAKOFF G, 1980, J PHILOS, V77, P453, DOI 10.2307/2025464; Lebois LAM, 2015, COGNITIVE SCI, V39, P1764, DOI 10.1111/cogs.12174; Leiner DJ, 2015, SOSCI SURVEY; Lleras M, 2014, METAPHORS WE SPEAK A; Loeffler J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00845; Matlock T, 2005, COGNITIVE SCI, V29, P655, DOI 10.1207/s15516709cog0000_17; Matlock T, 2011, METAPHOR SYMBOL, V26, P260, DOI 10.1080/10926488.2011.609065; McGlone MS, 1998, J EXP PSYCHOL LEARN, V24, P1211, DOI 10.1037/0278-7393.24.5.1211; Merleau-Ponty M, 2009, PHENOMENOLOGIE PERCE; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; Miles LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010825; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; Nunez RE, 2006, METAPHOR SYMBOL, V21, P133, DOI 10.1207/s15327868ms2103_1; Rashidi-Ranjbar N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00072; Richmond J, 2012, EUR J SOC PSYCHOL, V42, P813, DOI 10.1002/ejsp.1906; Rothe-Wulf A, 2015, Q J EXP PSYCHOL, V68, P917, DOI 10.1080/17470218.2014.970205; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2016, PSYCHOL METHODS; Rueschemeyer SA, 2010, EXP PSYCHOL, V57, P260, DOI 10.1027/1618-3169/a000031; Sinha C, 2014, ANN NY ACAD SCI, V1326, P72, DOI 10.1111/nyas.12491; Sullivan JL, 2012, Q J EXP PSYCHOL, V65, P1101, DOI 10.1080/17470218.2011.641025; Torralbo A, 2006, COGNITIVE SCI, V30, P745, DOI 10.1207/s15516709cog0000_67; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Wenke D, 2009, EXP BRAIN RES, V196, P311, DOI 10.1007/s00221-009-1848-8; Wilson AD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00058	51	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0175192	10.1371/journal.pone.0175192	http://dx.doi.org/10.1371/journal.pone.0175192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IO	28376130	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000399352000040
J	Odhiambo, C; Omolo, P; Oyaro, B; Williamson, J; Kinuthia, J; Matemo, D; Drake, A; John-Stewart, G; Zeh, C				Odhiambo, Collins; Omolo, Paul; Oyaro, Boaz; Williamson, John; Kinuthia, John; Matemo, Daniel; Drake, Alison; John-Stewart, Grace; Zeh, Clement			Establishment of reference intervals during normal pregnancy through six months postpartum in western Kenya	PLOS ONE			English	Article							REFERENCE VALUES; LIVER-FUNCTION; BLOOD; TESTS; WOMEN	Background Pregnancy is associated with changes in hematological and biochemistry values, yet there are no African reference intervals for clinical management of pregnant women. We sought to 1) develop laboratory reference intervals during pregnancy and up to 24 weeks postpartum and 2) determine the proportion of women in a previous clinical trial who would be mis-classified as having out-of-range values using reference intervals from a United States (U.S.) population. Methods and findings This was a longitudinal sub-study of 120 clinically healthy, HIV-uninfected, self-selected pregnant women seeking antenatal care services at either of two public hospitals in western Kenya. Blood specimens were obtained from consented women at gestational ages 28 and 36 weeks and at 2, 6, 14 and 24 weeks postpartum. Median and 95% reference intervals were calculated for immune-hematological and biochemistry parameters and compared to reference intervals from a Kenyan and United States (U.S.) population, using Wilcoxon tests. Differences with p <= 0.05 were considered significant. Some hematological parameters, including hemoglobin and neutrophils showed significant variations compared to reference intervals for non-pregnant women. Hemoglobin values were significantly lower during pregnancy but were comparable to the values in non-pregnant women by 6 weeks postpartum. CD4, CD8 and platelets were significantly elevated in early postpartum but declined gradually, reaching normal levels by 24 weeks postpartum. Using the new hemoglobin reference levels from this study to estimate prevalence of 'out of range' values in a prior Kisumu research cohort of pregnant/postpartum women, resulted in 0% out of range values, in contrast to 96.3% using US non-pregnant reference values Conclusion There were substantial differences in U.S. and Kenyan values for immune-hematological parameters among pregnant/postpartum women, specifically in red blood cell parameters in late pregnancy and 2 weeks postpartum. Use of U.S. reference intervals markedly increases likelihood of out of range values, highlighting the need for suitable locally developed reference intervals.	[Odhiambo, Collins; Omolo, Paul; Oyaro, Boaz] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Williamson, John; Zeh, Clement] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Kisumu, Kenya; [Kinuthia, John; Matemo, Daniel] Kenyatta Natl Hosp, Dept Res Program, Nairobi, Kenya; [Drake, Alison; John-Stewart, Grace] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Kenya Medical Research Institute; Kenyatta National Hospital; University of Washington; University of Washington Seattle	Odhiambo, C (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	odhiamboc@hotmail.com	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	odhiambo, collins/0000-0002-5534-8720; John-Stewart, Grace/0000-0002-4301-1573	CDC, Division of HIV and AIDS Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI116298] Funding Source: NIH RePORTER	CDC, Division of HIV and AIDS Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported througha grant from CDC, Division of HIV and AIDS Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Akinbami AA, 2013, INT J WOMENS HEALTH, V5, P227, DOI 10.2147/IJWH.S42110; [Anonymous], 2004, DIV AIDS TABL GRAD S; Bacq Y, 1996, HEPATOLOGY, V23, P1030; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; CARTER J, 1990, AUST NZ J OBSTET GYN, V30, P296, DOI 10.1111/j.1479-828X.1990.tb02014.x; DAHLSTROM BL, 1994, ACTA OBSTET GYN SCAN, V73, P695, DOI 10.3109/00016349409029405; Edelstam G, 2001, SCAND J CLIN LAB INV, V61, P583, DOI 10.1080/003655101753267937; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Ezeilo G C, 1974, East Afr Med J, V51, P936; Harm Sarah K, 2012, Korean J Hematol, V47, P136, DOI 10.5045/kjh.2012.47.2.136; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kelton J, 1988, HEMATOLOGIC DISORDER; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Larsson A, 2008, BJOG-INT J OBSTET GY, V115, P874, DOI 10.1111/j.1471-0528.2008.01709.x; Lurie S, 2008, EUR J OBSTET GYN R B, V136, P16, DOI 10.1016/j.ejogrb.2006.12.013; Milhorat AT, 1942, ARCH NEURO PSYCHIATR, V47, P779, DOI 10.1001/archneurpsyc.1942.02290050081006; Milman N, 2007, EUR J HAEMATOL, V79, P39, DOI 10.1111/j.1600-0609.2007.00873.x; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; Ruiz-Extremera A, 2005, AM J OBSTET GYNECOL, V193, P2010, DOI 10.1016/j.ajog.2005.04.045; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; SHAPER AG, 1971, LANCET, V2, P1021; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175546	10.1371/journal.pone.0175546	http://dx.doi.org/10.1371/journal.pone.0175546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399133	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000047
J	Mejia-Salazar, MF; Goldizen, AW; Menz, CS; Dwyer, RG; Blomberg, SP; Weidner, CL; Cullingham, CI; Bollinger, TK				Mejia-Salazar, Maria Fernanda; Goldizen, Anne W.; Menz, Clementine S.; Dwyer, Ross G.; Blomberg, Simon P.; Weidner, Cheryl L.; Cullingham, Catherine I.; Bollinger, Trent K.			Mule deer spatial association patterns and potential implications for transmission of an epizootic disease	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; ODOCOILEUS-HEMIONUS; SOCIAL-ORGANIZATION; GENETIC-STRUCTURE; PRECLINICAL DIAGNOSIS; BEHAVIOR; SCALE; NETWORKS; DYNAMICS	Animal social behaviour can have important effects on the long-term dynamics of diseases. In particular, preferential spatial relationships between individuals can lead to differences in the rates of disease spread within a population. We examined the concurrent influence of genetic relatedness, sex, age, home range overlap, time of year, and prion disease status on proximal associations of adult Rocky Mountain mule deer (Odocoileus hemionus hemionus) in a chronic wasting disease endemic area. We also quantified the temporal stability of these associations across different sex, age, and disease status classes. We used three years of high frequency telemetry data from 74 individuals to record encounters within 25 m of each other, and to calculate seasonal home range overlap measured by volume of intersection (VI). The strength of pairwise spatial association between adult mule deer was independent of genetic relatedness, age and disease status. Seasonal variation in association strength was not consistent across years, perhaps due to annual changes in weather conditions. The influence of home range overlap on association strength varied seasonally, whereby associations were stronger in pre-rut and fawning than in the rest of the seasons. The sexes of individuals also interacted with both VI and season. At increasing levels of VI, associations were stronger between females than between males and between females and males. The strongest associations in pre-rut were between males, while the strongest in rut were between females and males. The temporal stability of associations was markedly dependant on the sex and the diagnosis of the associating pair. Our findings highlight the importance of considering concurrent effects of biological and environmental factors when seeking to understand the role of social preference in behavioural ecology and disease spread. Applying this knowledge in epidemiological modelling will shed light on the dynamics of disease transmission among mule deer.	[Mejia-Salazar, Maria Fernanda; Weidner, Cheryl L.; Bollinger, Trent K.] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK, Canada; [Goldizen, Anne W.; Menz, Clementine S.; Dwyer, Ross G.; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Cullingham, Catherine I.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bollinger, Trent K.] CWHC, Saskatoon, SK, Canada	University of Saskatchewan; University of Queensland; University of Alberta; University of Saskatchewan	Mejia-Salazar, MF (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK, Canada.	mihicoltia@gmail.com	Cullingham, Catherine/AAE-9591-2020; Blomberg, Simone P/B-7613-2008	Cullingham, Catherine/0000-0002-6715-0674; Blomberg, Simone P/0000-0003-1062-0839; Waldner, Cheryl/0000-0002-7152-4261; Dwyer, Ross/0000-0003-1136-5489	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded primarily by PrioNet Canada a Network of Centres of Excellence of Canada (www.nce-rce.gc.ca). Additional funding and support was provided by Saskatchewan Ministry of Environment (http://environment gov sk ca/) and the Canadian Wildlife Health Cooperative (http://www.ccwhc ca/). MFMS received a scholarship funding from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020; ALBON SD, 1992, J ANIM ECOL, V61, P131, DOI 10.2307/5516; Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson A. E., 1984, MAMMALIAN SPECIES, V219, P1, DOI DOI 10.2307/3504024; Barton K., 2015, PACKAGE MUMIN MULTIM, P63; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Best EC, 2014, ANIM BEHAV, V89, P1, DOI 10.1016/j.anbehav.2013.12.011; Biosa D, 2015, J ZOOL, V296, P30, DOI 10.1111/jzo.12214; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bonnot N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014436; Bouwman KM, 2010, BIOL LETTERS, V6, P462, DOI 10.1098/rsbl.2010.0020; Bowyer RT, 2001, ALCES-N AM MOOSE CON, V37, P371; Bullard F, 1991, ESTIMATING HOME RANG; Burnham KP, 2003, MODEL SELECTION MULT, P149; Calenge C., 2015, HOME RANGE ESTIMATIO, P61; Calenge C, 2015, ANAL HABITAT SELECTI, P224; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canadian Wildlife Health Cooperative, 2017, CHRON WAST DIS TEST; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; Castles M, 2014, ANIM BEHAV, V96, P59, DOI 10.1016/j.anbehav.2014.07.023; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Colson KE, 2016, J MAMMAL, V97, P788, DOI 10.1093/jmammal/gyw006; Colson KE, 2013, CONSERV GENET, V14, P439, DOI 10.1007/s10592-012-0388-0; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; COWAN I. M., 1961, JOUR MAMMAL, V42, P522, DOI 10.2307/1377372; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Cullingham CI, 2011, CAN J ZOOL, V89, P134, DOI 10.1139/Z10-104; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; DASMANN RAYMOND F., 1956, JOUR WILDLIFE MANAGEMENT, V20, P78, DOI 10.2307/3797252; DEVOS A, 1967, AM MIDL NAT, V77, P390, DOI 10.2307/2423349; Dixon JS., 1934, STUDY LIFE HIST FOOD; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Environmental Systems Research Institute (ESRI), 2016, ARCGIS DESKT REL 10; Farine DR, 2015, ANIM BEHAV, V104, pE1, DOI 10.1016/j.anbehav.2014.11.019; Geremia C, 2015, J WILDLIFE DIS, V51, P801, DOI 10.7589/2014-12-284; Government of Canada, 2014, CAN CLIM NORM 1981 2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Iacolina L, 2009, J MAMMAL, V90, P666, DOI 10.1644/08-MAMM-A-074R1.1; Jensen W., 1996, N DAKOTA OUTDOORS, P2; Lingle S, 2003, CAN J ZOOL, V81, P1119, DOI 10.1139/Z03-097; Linsdale JM, 1953, HERD MULE DEER RECOR; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Magle SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056568; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0111; Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Podgorski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099875; PORTER WF, 1991, ENVIRON MANAGE, V15, P809, DOI 10.1007/BF02394818; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Powell JH, 2013, WILDLIFE BIOL, V19, P102, DOI 10.2981/11-081; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2021, R LANGUAGE ENV STAT; Salazar MFM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150830; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; Schauber EM, 2015, J MAMMAL, V96, P16, DOI 10.1093/jmammal/gyu027; Schreuder BEC, 1998, VET REC, V142, P564, DOI 10.1136/vr.142.21.564; Seidel KD., 1992, THESIS; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Skelton NK, 2010, MIGRATION DISPERSAL; Smith JE, 2014, ANIM BEHAV, V92, P291, DOI 10.1016/j.anbehav.2014.02.029; Statistics Canada, 2017, ROAD NETW FIL 2016; Strickland K, 2014, ANIM BEHAV, V97, P53, DOI 10.1016/j.anbehav.2014.08.009; Thomsen BV, 2012, J VET DIAGN INVEST, V24, P878, DOI 10.1177/1040638712453582; Vander Wal E, 2016, BEHAV ECOL, V27, P560, DOI 10.1093/beheco/arv193; Vander Wal E, 2012, MOL ECOL, V21, P1271, DOI 10.1111/j.1365-294X.2011.05431.x; WACHTEL MA, 1978, BIOL BEHAV, V3, P319; Weather Spark, 2016, DAIL WEATH DAT SWIFT; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 2008, ANAL ANIMAL SOC QUAN; Whitehead H., 2014, SOCPROG PROGRAMS ANA, P83; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123	90	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175385	10.1371/journal.pone.0175385	http://dx.doi.org/10.1371/journal.pone.0175385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388681	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800047
J	Xu, B; Wang, YZ; Zhang, SC; Guo, Q; Jin, Y; Chen, JJ; Gao, YH; Ma, HX				Xu, Bo; Wang, Yingzhe; Zhang, Shichao; Guo, Qiang; Jin, Yan; Chen, Jingjing; Gao, Yunhang; Ma, Hongxia			Transcriptomic and physiological analyses of Medicago sativa L. roots in response to lead stress	PLOS ONE			English	Article							HEAVY-METAL STRESS; OXIDATIVE STRESS; PLASMA-MEMBRANE; IRON UPTAKE; RNA-SEQ; TRANSPORTER; TOLERANCE; GROWTH; IDENTIFICATION; ARABIDOPSIS	Lead (Pb) is one of the nonessential and toxic metals that threaten the environment and human health. Medicago sativa L. is a legume with high salt tolerance and high biomass production. It is not only a globally important forage crop but is also an ideal plant for phytore-mediation. However, the biological and molecular mechanisms that respond to heavy metals are still not well defined in M. sativa. In this study, de novo and strand-specific RNA-sequencing was performed to identify genes involved in the Pb stress response in M. sativa roots. A total of 415,350 unigenes were obtained from the assembled cDNA libraries, among which 5,416 were identified as significantly differentially expressed genes (DEGs) (false discovery rate < 0.005) between cDNA libraries from control and Pb-treated plants. Gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the DEGs showed they mainly clustered with terms associated with binding, transport, membranes, and the pathways related to signal and energy metabolism. Moreover, a number of candidate genes included antioxidant enzymes, metal transporters, and transcription factors involved in heavy metal response were upregulated under Pb stress. Quantitative real-time PCR(qRT-PCR) validation of the expression patterns of 10 randomly selected candidate DEGs were consistent with the transcriptome analysis results. Thus, this study offers new information towards the investigation of biological changes and molecular mechanisms related to Pb stress response in plants.	[Xu, Bo; Zhang, Shichao; Guo, Qiang; Jin, Yan; Chen, Jingjing; Gao, Yunhang; Ma, Hongxia] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Wang, Yingzhe] Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Gongzhuling, Jilin, Peoples R China	Jilin Agricultural University; Jilin Academy of Agricultural Sciences	Gao, YH; Ma, HX (corresponding author), Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China.	gaoyunhang@163.com; hongxia0731001@163.com			National Natural Science Foundation of China [31402125]; Special fund for construction National System of Modern Agriculture Industrial Technology [CARS-38]; Special fund for Agro-scientific Research in the Public Interest [201303091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special fund for construction National System of Modern Agriculture Industrial Technology; Special fund for Agro-scientific Research in the Public Interest	This paper was supported by the National Natural Science Foundation of China (no. 31402125), http://www.nsfc.gov.cn/. This funder had a role in experiment and paper publication. It was also supported by a Special fund for construction National System of Modern Agriculture Industrial Technology (CARS-38), http://www.beefsys.com/. This funder had a role in material preparation. It was also supported by Special fund for Agro-scientific Research in the Public Interest (no. 201303091), http://www.moa.gov.cn/. This funder had a role in experiment and data analysis.	Agnello AC, 2016, ENVIRON SCI POLLUT R, V23, P9215, DOI 10.1007/s11356-015-5972-7; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Balusamy SRD, 2013, B ENVIRON CONTAM TOX, V90, P194, DOI 10.1007/s00128-012-0891-5; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Benjamini Y, 2001, ANN STAT, V29, P1165; Benzarti S, 2008, ENVIRON TOXICOL, V23, P607, DOI 10.1002/tox.20405; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Cao DJ, 2015, ECOTOX ENVIRON SAFE, V112, P231, DOI 10.1016/j.ecoenv.2014.11.007; Chen YY, 2011, ENVIRON GEOCHEM HLTH, V33, P515, DOI 10.1007/s10653-010-9368-9; DalCorso G, 2010, PLANT SIGNAL BEHAV, V5, P663, DOI 10.4161/psb.5.6.11425; Deng W, 2015, PLANT CELL PHYSIOL, V56, P1624, DOI 10.1093/pcp/pcv074; Drakiewicz M, 2005, J PLANT PHYSIOL, V162, P1013, DOI 10.1016/j.jplph.2004.10.010; Fan TT, 2016, J EXP BOT, V67, P4685, DOI 10.1093/jxb/erw251; Fang WC, 2000, PLANT SCI, V158, P71, DOI 10.1016/S0168-9452(00)00307-1; Gao J, 2015, BIOCHEM BIOPH RES CO, V458, P287, DOI 10.1016/j.bbrc.2015.01.101; Gao RM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3014-6; Ghelich S, 2014, ENVIRON SCI POLLUT R, V21, P14091, DOI 10.1007/s11356-014-3335-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han YL, 2016, ENVIRON POLLUT, V214, P510, DOI 10.1016/j.envpol.2016.04.048; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Huang HG, 2012, ENVIRON SCI POLLUT R, V19, P1640, DOI 10.1007/s11356-011-0675-1; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Janicka-Russak M, 2008, J EXP BOT, V59, P3721, DOI 10.1093/jxb/ern219; Jiang N, 2010, INT J AGRIC BIOL, V12, P205; Jonak C, 2004, PLANT PHYSIOL, V136, P3276, DOI 10.1104/pp.104.045724; Kabala K, 2008, J PLANT PHYSIOL, V165, P278, DOI 10.1016/j.jplph.2007.03.007; Kaiser BN, 2003, PLANT J, V35, P295, DOI 10.1046/j.1365-313X.2003.01802.x; Kopittke PM, 2007, ENVIRON POLLUT, V150, P280, DOI 10.1016/j.envpol.2007.01.011; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; Lopez ML, 2005, CHEMOSPHERE, V61, P595, DOI 10.1016/j.chemosphere.2005.02.028; Macovei A, 2011, GENE, V470, P20, DOI 10.1016/j.gene.2010.09.004; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; PARRY AD, 1994, PLANT PHYSIOL, V106, P195, DOI 10.1104/pp.106.1.195; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Rossato LV, 2012, ECOTOXICOLOGY, V21, P111, DOI 10.1007/s10646-011-0771-5; Ruley AT, 2004, PLANT PHYSIOL BIOCH, V42, P899, DOI 10.1016/j.plaphy.2004.12.001; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Shen Y, 2013, PHYSIOL PLANTARUM, V147, P270, DOI 10.1111/j.1399-3054.2012.01670.x; Song JB, 2015, FUNCT INTEGR GENOMIC, V15, P495, DOI 10.1007/s10142-015-0438-z; Tauqeer HM, 2016, ECOTOX ENVIRON SAFE, V126, P138, DOI 10.1016/j.ecoenv.2015.12.031; Thapa G, 2012, BIOMETALS, V25, P489, DOI 10.1007/s10534-012-9541-y; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tian SQ, 2015, INT J MOL SCI, V16, P28087, DOI 10.3390/ijms161226084; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang LM, 2015, ENVIRON SCI POLLUT R, V22, P12747, DOI 10.1007/s11356-015-4563-y; WANG Y, 2013, PLOS ONE, V2013; Xiao S, 2008, PLANT J, V54, P141, DOI 10.1111/j.1365-313X.2008.03402.x; Yang LM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00190; Yang Q, 2015, ECOTOX ENVIRON SAFE, V111, P48, DOI 10.1016/j.ecoenv.2014.10.002; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Zhang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122170; Zhang YY, 2013, J HAZARD MATER, V260, P1100, DOI 10.1016/j.jhazmat.2013.06.065; Zhou ZS, 2007, J INORG BIOCHEM, V101, P1, DOI 10.1016/j.jinorgbio.2006.05.011; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zhu FY, 2013, PLANT CELL PHYSIOL, V54, P1549, DOI 10.1093/pcp/pct101	60	19	20	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175307	10.1371/journal.pone.0175307	http://dx.doi.org/10.1371/journal.pone.0175307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388670	gold, Green Submitted, Green Published			2022-12-27	WOS:000399375800038
J	Ahn, BS; Park, SY; Park, JM; Choi, CH; Chun, M; Kim, JI				Ahn, Beom Seok; Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in			Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets	PLOS ONE			English	Article							PROSTATE-CANCER; TREATMENT PLANS; RADIOTHERAPY; IMRT; RAPIDARC; VMAT	Purpose To calculate an optimal collimator angle at each of sectional arcs in a full-arc volumetric modulated arc therapy (VMAT) plan and evaluate dosimetric quality of these VMAT plans comparing full-arc VMAT plans with a fixed collimator angle. Methods Seventeen patients who had irregularly-shaped target in abdominal, head and neck, and chest cases were selected retrospectively. To calculate an optimal collimator angle at each of sectional arcs in VMAT, integrated MLC apertures which could cover all shapes of target determined by beam's-eye view (BEV) within angular sections were obtained for each VMAT plan. The angular sections were 40 degrees, 60 degrees, 90 degrees and 120 degrees. When the collimator settings were rotated at intervals of 2 degrees, we obtained the optimal collimator angle to minimize area size difference between the integrated MLC aperture and collimator settings with 5 mm-margins to the integrated MLC aperture. The VMAT plans with the optimal collimator angles (Colli-VMAT) were generated in the Eclipse (TM). For comparison purposes, one full-arc VMAT plans with a fixed collimator angles (Std-VMAT) were generated. The dose-volumetric parameters and total MUs were evaluated. Results The mean dose-volumetric parameters for target volume of Colli-VMAT were comparable to Std-VMAT. Colli-VMAT improved sparing of most normal organs but for brain stem, compared to Std-VMAT for all cases. There were decreasing tendencies in mean total MUs with decreasing angular section. The mean total MUs for Colli-VMAT with the angular section of 40 degrees (434 +/- 95 MU, 317 +/- 81 MU, and 371 +/- 43 MU for abdominal, head and neck, and chest cases, respectively) were lower than those for Std-VMAT (654 +/- 182 MU, 517 +/- 116 MU, and 533 +/- 25 MU, respectively). Conclusions For an irregularly-shaped target, Colli-VMAT with the angular section of 40 degrees reduced total MUs and improved sparing of normal organs, compared to Std-VMAT.	[Ahn, Beom Seok; Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ, Biomed Res Inst, Coll Med, Seoul, South Korea; [Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.	madangin@gmail.com	Chun, Minsoo/C-4493-2014	Chun, Minsoo/0000-0001-8578-9976	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1C1A1A02036331]; National Research Foundation of Korea (NRF); Korean government (MEST) [2016M2A2A7952290]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. 2015R1C1A1A02036331) and by a grant from the National Research Foundation of Korea (NRF), which is funded by the Korean government (MEST, grant no. 2016M2A2A7952290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allisy A., 1993, J INT COMMISSION RAD, V26, DOI 10.1093/jicru/ndq001; Bortfeld T, 2009, PHYS MED BIOL, V54, pN9, DOI 10.1088/0031-9155/54/1/N02; Cozzi L, 2008, RADIOTHER ONCOL, V89, P180, DOI 10.1016/j.radonc.2008.06.013; de Boer J, 2015, INT J RADIAT ONCOL, V91, P1009, DOI 10.1016/j.ijrobp.2014.11.020; Fogliata A, 2008, RADIOTHER ONCOL, V89, P254, DOI 10.1016/j.radonc.2008.07.021; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Holtzer N, 2012, INT J RADIAT ONCOL, V84, pS28, DOI 10.1016/j.ijrobp.2012.07.079; Kim H, 2014, RADIAT ONCOL J, V32, P187, DOI 10.3857/roj.2014.32.3.187; Kim YS, 2016, RADIAT ONCOL J, V34, P18, DOI 10.3857/roj.2016.34.1.18; Kjaer-Kristoffersen F, 2009, ACTA ONCOL, V48, P227, DOI 10.1080/02841860802266748; Mattes MD, 2016, RADIAT ONCOL J, V34, P145, DOI 10.3857/roj.2015.01592; Ostheimer C, 2016, RADIAT ONCOL J, V34, P313, DOI 10.3857/roj.2016.01935; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Paik EK, 2015, RADIAT ONCOL J, V33, P233, DOI 10.3857/roj.2015.33.3.233; Park JM, 2012, BRIT J RADIOL, V85, pE323, DOI 10.1259/bjr/19088580; Park JM, 2014, BRIT J RADIOL, P87; Park JM, 2012, MED PHYS, V39, P1265, DOI 10.1118/1.3682172; Park JM, 2011, J APPL CLIN MED PHYS, V12, P147, DOI 10.1120/jacmp.v12i4.3563; Schneider U, 2005, INT J RADIAT ONCOL, V61, P1510, DOI 10.1016/j.ijrobp.2004.12.040; 김동욱, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P295, DOI 10.14316/pmp.2013.24.4.295; Treutwein M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-108; Varian Medical Systems, 2015, ECL PHOT EL INST USE; Yoon M, 2010, INT J RADIAT ONCOL, V77, P1477, DOI 10.1016/j.ijrobp.2009.07.011; Zhang PP, 2010, INT J RADIAT ONCOL, V77, P591, DOI 10.1016/j.ijrobp.2009.08.056	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174924	10.1371/journal.pone.0174924	http://dx.doi.org/10.1371/journal.pone.0174924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384262	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900054
J	Ding, PH; Darveau, RP; Wang, CY; Jin, LJ				Ding, Pei-Hui; Darveau, Richard P.; Wang, Cun-Yu; Jin, Lijian			3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and Toll-like receptor signaling in human oral keratinocytes	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; EPITHELIAL-CELLS; INNATE IMMUNITY; EXPRESSION; RECOGNITION; ACTIVATION; MEMBRANES; MOLECULE; MD-1; LBP	Lipopolysaccharide (LPS)-binding protein (LBP) as an acute-phase protein plays a crucial role in innate host response to bacterial challenge. Our previous study shows that LBP expression in human gingiva is associated with periodontal status. Porphyromonas gingivalis is a keystone periodontopathogen, and its LPS with lipid A structural heterogeneity critically accounts for periodontal pathogenesis. This study investigated the effects of LBP and its interactions with two featured isoforms of P. gingivalis LPS (tetra-acylated LPS1435/1449 and penta-acylated LPS1690) on the expression of pro-inflammatory cytokines in human oral keratinocytes (HOKs), and the involvement of Toll-like receptor (TLR) signaling. HOKs were pre-incubated with recombinant human LBP (rhLBP) at 10ng/ml, 100ng/ml and 1 mu g/ml for 1 h, followed by the treatment of P. gingivalis LPS1690 or LPS1435/1449 for 3h or 24h respectively. The expression of IL-6 and IL-8, and involvements of TLR2 and TLR4 were analyzed. The genes associated with TLR signaling were assessed by PCR array. Interestingly, rhLBP per se significantly up-egulated the expression of IL-6 and IL-8 in HOKs (p<0.05), which was blocked by TLR2 antibody (p<0.001). LPS1435/1449 down-regulated more significantly rhLBP-induced IL-6 and IL-8 mRNAs with reference to P. gingivalis LPS1690 (approximately 80% vs. 40%, p<0.05; and 90% vs. 36%, p<0.001, respectively). Moreover, rhLBP markedly down-regulated the gene expression of TLRs and their adaptors such as CD180 (-2.44 folds) and MD-1 (-9.62 folds), while the interaction of P. gingivalis LPS1435/1449 with rhLBP greatly up-regulated both transcripts (7.11 and 4.05 folds, respectively). Notably, P. gingivalis LPS1690-rhLBP interaction dramatically upregulated CD180 transcript (20.86 folds) and significantly down-regulated MD-1 transcript (-6.93 folds). This pioneering study shows that rhLBP enables to enhance the expression of pro-inflammatory cytokines in HOKs through TLR2 signaling pathway. P. gingivalis LPS with different lipid A structures down-regulates to different extents rhLBP-induced cytokine expression, possibly through fine-tuning of the CD180-MD1 complex and relevant TLRs.	[Ding, Pei-Hui] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Periodontol, Hangzhou, Zhejiang, Peoples R China; [Ding, Pei-Hui; Jin, Lijian] Univ Hong Kong, Discipline Periodontol, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Darveau, Richard P.] Univ Washington, Sch Dent, Dept Periodont, D-570,Hlth Sci Bldg, Seattle, WA 98195 USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, CHS, Dept Oral Biol & Med, Room 33-030, Los Angeles, CA 90024 USA	Zhejiang University; University of Hong Kong; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Jin, LJ (corresponding author), Univ Hong Kong, Discipline Periodontol, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	ljjin@hku.hk	Ding, Pei-Hui/CAG-8041-2022		Hong Kong Research Grants Council [768411M, 768713M, 17155216]; Modern Dental Laboratory/HKU Endowment Fund	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund	This study has been supported by the Hong Kong Research Grants Council (General Research Funds 768411M, 768713M and 17155216) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ.; This study has been supported by the Hong Kong Research Grants Council (General Research Funds 768411M, 768713M and 17155216) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The authors have declared that no competing interests exist.	Ahren IL, 2001, J INFECT DIS, V184, P926, DOI 10.1086/323398; Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Curtis MA, 2011, INFECT IMMUN, V79, P1187, DOI 10.1128/IAI.00900-10; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Ding PH, 2014, J PERIODONTAL RES, V49, P1, DOI 10.1111/jre.12081; Ding PH, 2013, MOL ORAL MICROBIOL, V28, P129, DOI 10.1111/omi.12010; Ding PH, 2013, INNATE IMMUN-LONDON, V19, P66, DOI 10.1177/1753425912450348; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Gutsmann T, 2001, BIOL CHEM, V382, P425, DOI 10.1515/BC.2001.052; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Miyake K, 1998, J IMMUNOL, V161, P1348; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Muller M, 2003, J ENDOTOXIN RES, V9, P181, DOI 10.1179/096805103125001595; Nagai Y, 2005, J IMMUNOL, V174, P7043, DOI 10.4049/jimmunol.174.11.7043; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; Ren L, 2005, J PERIODONTOL, V76, P1950, DOI 10.1902/jop.2005.76.11.1950; Ren L, 2005, J PERIODONTAL RES, V40, P407, DOI 10.1111/j.1600-0765.2005.00822.x; Ren L, 2004, J PERIODONTAL RES, V39, P242, DOI 10.1111/j.1600-0765.2004.00732.x; Roes S, 2006, J BIOL CHEM, V281, P2757, DOI 10.1074/jbc.M507634200; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Vreugdenhil ACE, 2000, J IMMUNOL, V165, P4561, DOI 10.4049/jimmunol.165.8.4561; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173223	10.1371/journal.pone.0173223	http://dx.doi.org/10.1371/journal.pone.0173223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4YU	28384159	Green Published, gold, Green Submitted			2022-12-27	WOS:000416013800001
J	Nyflot, LT; Stray-Pedersen, B; Forsen, L; Vangen, S				Nyflot, Lill Trine; Stray-Pedersen, Babill; Forsen, Lisa; Vangen, Siri			Duration of labor and the risk of severe postpartum hemorrhage: A case-control study	PLOS ONE			English	Article							PROLONGED 2ND-STAGE; ELECTIVE INDUCTION; OXYTOCIN RECEPTORS; PROGRESSION; MORBIDITY; DELIVERY	Objective Our main objective was to investigate the association between duration of active labor and severe postpartum hemorrhage. We examined the effect of the total duration of active labor, the effect of each stage of active labor, and the gradient effect of duration of labor on severe postpartum hemorrhage. Methods A case-control study was generated from a source population of all women admitted for delivery at Oslo University Hospital and Drammen Hospital in Buskerud municipality during the time period January 1, 2008 to December 31, 2011. The study population included all cases of severe postpartum hemorrhage (n = 859) and a random sample of controls (n = 1755). Severe postpartum hemorrhage was defined as postpartum blood loss >= 1500 mL or need for blood transfusion. Prolonged labor was defined as duration of active labor >12 hours according to the definition of the World Health Organization. We used logistic multi-variable regression in the analysis. Results We observed a significantly longer mean duration of labor in women who experienced severe postpartum hemorrhage compared to controls (5.4 versus 3.8 hours, p<0.001). Women with severe postpartum hemorrhage also had a longer duration of all stages of active labor compared to controls. The association between the duration of active labor and severe postpartum changed from a linear dose-response association to a threshold association after adjusting for augmentation with oxytocin, induction of labor, primiparity, and fever during labor. Compared to controls, women with severe postpartum hemorrhage were more likely to have a prolonged labor >12 hours (adjusted odds ratio = 2.44, 95% confidence interval: 1.69-3.53, p< 0.001). Conclusion Prolonged active labor (duration > 12 hours) was associated with severe postpartum hemorrhage. Increased vigilance seems required when the labor is prolonged to reduce the risk of severe postpartum hemorrhage.	[Nyflot, Lill Trine] Oslo Univ Hosp, Div Obstet & Gynecol, Oslo, Norway; [Nyflot, Lill Trine; Stray-Pedersen, Babill; Vangen, Siri] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Forsen, Lisa] Norwegian Inst Publ Hlth, Oslo, Norway; [Forsen, Lisa; Vangen, Siri] Oslo Univ Hosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Nyflot, LT (corresponding author), Oslo Univ Hosp, Div Obstet & Gynecol, Oslo, Norway.; Nyflot, LT (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	l.t.nyflot@medisin.uio.no			South Eastern Norway Regional Health Authority	South Eastern Norway Regional Health Authority	This work was supported by the South Eastern Norway Regional Health Authority (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority). The funding source had no role in the design, collection, analysis and interpretation of data, or writing of or decision to submit the article for publication.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Altman MR, 2006, BIRTH-ISS PERINAT C, V33, P315, DOI 10.1111/j.1523-536X.2006.00129.x; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Bergstrom S, 2003, J NUTR, V133, p1656S, DOI 10.1093/jn/133.5.1656S; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Cheng Y, 2009, AM J OBSTET GYNECOL, V201, pS46, DOI 10.1016/j.ajog.2009.10.097; Cheng YW, 2007, AM J OBSTET GYNECOL, V196, P585, DOI 10.1016/j.ajog.2007.03.021; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Harper LM, 2012, OBSTET GYNECOL, V119, P1113, DOI 10.1097/AOG.0b013e318253d7aa; Hoffman MK, 2006, OBSTET GYNECOL, V107, P1029, DOI 10.1097/01.AOG.0000210528.32940.c6; Janni W, 2002, ACTA OBSTET GYN SCAN, V81, P214, DOI 10.1034/j.1600-0412.2002.810305.x; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Kleinbaum DG, 1982, PRINCIPLES QUANTITAT; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Laughon SK, 2012, AM J OBSTET GYNECOL, V206, pe1, DOI DOI 10.1016/J.AJ0G.2012.03.003; Le Ray C, 2011, EUR J OBSTET GYN R B, V158, P167, DOI 10.1016/j.ejogrb.2011.04.035; Magalhaes JKRS, 2009, REPROD SCI, V16, P501, DOI 10.1177/1933719108329954; Magann EF, 2005, SOUTH MED J, V98, P419, DOI 10.1097/01.SMJ.0000152760.34443.86; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Moore J, 2012, J PERINAT NEONAT NUR, V26, P242, DOI 10.1097/JPN.0b013e31826288a9; Moore LE, 2006, CLIN OBSTET GYNECOL, V49, P698, DOI 10.1097/00003081-200609000-00026; Mozurkewich E, 2009, BJOG-INT J OBSTET GY, V116, P626, DOI 10.1111/j.1471-0528.2008.02065.x; ODriscoll K, 1980, ACTIVE MANAGEMENT LA; Phaneuf S, 2000, J REPROD FERTIL, V120, P91, DOI 10.1530/reprod/120.1.91; Phaneuf S, 1997, J ENDOCRINOL, V154, P7, DOI 10.1677/joe.0.1540007; STONES RW, 1993, EUR J OBSTET GYN R B, V48, P15, DOI 10.1016/0028-2243(93)90047-G; Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; World Health Organization, 2006, MAN PROL OBSTR LAB; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	34	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175306	10.1371/journal.pone.0175306	http://dx.doi.org/10.1371/journal.pone.0175306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384337	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000399371900151
J	Jonas, JB; Weber, P; Nagaoka, N; Ohno-Matsui, K				Jonas, Jost B.; Weber, Pascal; Nagaoka, Natsuko; Ohno-Matsui, Kyoko			Glaucoma in high myopia and parapapillary delta zone	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE DAMAGE; INTRAOCULAR-PRESSURE; LAMINA-CRIBROSA; AXIAL LENGTH; BEIJING EYE; PATHOGENESIS; PREVALENCE; NEUROPATHY; HISTOLOGY	Purpose To examine the prevalence of glaucomatous optic neuropathy (GON) in a medium myopic to highly myopic group of patients and its association with parapapillary gamma zone and parapapillary delta zone. Methods The retrospective observational hospital-based study included patients who had attended the Tokyo High Myopia Clinics within January 2012 and December 2012 and for whom fundus photographs were available. GON was defined based on the appearance of the optic nerve head on the fundus photographs. Results The study included 519 eyes (262 individuals) with a mean age of 62.0 +/- 14.3 years (range: 13-89 years) and mean axial length of 29.5 +/- 2.2 mm (range: 23.2-35.3mm). GON was present in 141 (27.2%; 95% confidence intervals (CI): 23.3, 31.0%) eyes. Prevalence of GON increased from 12.2% (1.7, 22.7) in eyes with an axial length of <26.5mm to 28.5% (24.4, 32.5) in eyes with an axial length of >= 26.5mm, to 32.6% (27.9, 37.2) in eyes with an axial length of >= 28mm, to 36.0% (30.5, 41.4) in eyes with an axial length of >= 29mm, and GON prevalence increased to 42.1% (35.5, 48.8) in eyes with an axial length of >= 30mm. In multivariate analysis, higher GON prevalence was associated (Nagelkerke r(2) : 0.28) with larger parapapillary delta zone diameter (P<0.001; odds ratio (OR): 1.86; 95% CI: 1.33,2.61), longer axial length (P<0.001; OR: 1.45; 95% CI: 1.26,1.67) and older age (P = 0.01; OR: 1.03; 95% CI: 1.01,1.05). If parapapillary delta zone width was replaced by the vertical disc diameter, higher GON prevalence was associated (r(2) : 0.24) with larger vertical optic disc diameter (P = 0.04; OR: 1.70; 95% CI: 1.03,2.81), after adjusting for longer axial length (P<0.001; OR: 1.44; 95% CI: 1.26,1.64) and older age (P<0.001; OR: 1.04; 95% CI: 1.02,1.06). Conclusions Axial elongation associated increase in GON prevalence (mean: 28.1% in a medium to highly myopic study population) was associated with parapapillary delta zone as surrogate for an elongated peripapillary scleral flange and with larger optic disc size.	[Jonas, Jost B.; Weber, Pascal] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Nagaoka, Natsuko; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan	Ruprecht Karls University Heidelberg; Tokyo Medical & Dental University (TMDU)	Ohno-Matsui, K (corresponding author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan.	k.ohno.oph@tmd.ac.jp		Jonas, Jost/0000-0003-2972-5227	Japanese Society for Promotion of Science [15H04993, 15K15629]	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Japanese Society for Promotion of Science (numbers 15H04993 and 15K15629; to KOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Burgoyne CF, 2001, J GLAUCOMA, V10, pS16, DOI 10.1097/00061198-200110001-00007; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Dai Y, 2015, INVEST OPHTH VIS SCI, V56, P7076, DOI 10.1167/iovs.14-16033; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; Jonas JB, 2002, AM J OPHTHALMOL, V134, P547, DOI 10.1016/S0002-9394(02)01644-6; Jonas JB, 2016, ASIA-PAC J OPHTHALMO, V5, P5, DOI 10.1097/APO.0000000000000170; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pe273, DOI 10.1111/aos.12324; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe248, DOI 10.1111/j.1755-3768.2010.02088.x; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Kuzin AA, 2010, OPHTHALMOLOGY, V117, P1713, DOI 10.1016/j.ophtha.2010.01.035; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nagaoka N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138825; Ren RJ, 2009, INVEST OPHTH VIS SCI, V50, P2175, DOI 10.1167/iovs.07-1429; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Xu L, 2008, ACTA OPHTHALMOL, V86, P229, DOI 10.1111/j.1600-0420.2007.01026.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	24	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175120	10.1371/journal.pone.0175120	http://dx.doi.org/10.1371/journal.pone.0175120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380081	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500101
J	Piedra-Carrasco, N; Fabrega, A; Calero-Caceres, W; Cornejo-Sanchez, T; Brown-Jaque, M; Mir-Cros, A; Muniesa, M; Gonzalez-Lopez, JJ				Piedra-Carrasco, Nuria; Fabrega, Anna; Calero-Caceres, William; Cornejo-Sanchez, Thais; Brown-Jaque, Maryury; Mir-Cros, Alba; Muniesa, Maite; Jose Gonzalez-Lopez, Juan			Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; PREVALENCE; DIVERSITY; VIRULENCE; PLASMIDS; SUSCEPTIBILITY; IDENTIFICATION	The increasing resistance to carbapenems is an alarming threat in the fight against multiresistant bacteria. The dissemination properties of antimicrobial resistance genes are supported by their detection in a diverse population of bacteria, including strains isolated from the environment. The objective of this study was to investigate the presence of carbapenemase- producing Enterobacteriaceae (CPE) collected from a river ecosystem in the Barcelona metropolitan area (Spain). Identification of beta-lactamases and other resistance determinants was determined as was the antimicrobial susceptibility profile. Moreover, screening of virulence factors, plasmid addiction systems, plasmid partition systems and replicon typing was performed. The results identified 8 isolates belonging to different species (Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella oxytoca, Raoultella ornithinolytica). The most prevalent enzyme was KPC-2 (n = 6), followed by VIM-1 (n = 2) and IMI-2 (n = 1), whereas no OXA-48-type was detected. In addition, one strain was positive for both KPC-2 and VIM-1 enzymes. All the carbapenemase- encoding plasmids carried at least one plasmid addiction or partition system, being vagCD and parAB the most frequently detected, respectively. E. coli and K. pneumoniae isolates carried a low number of virulence-associated factors and none of the detected clones has previously been identified in the clinical setting. These findings support the high dissemination potential of the carbapanemase-encoding genes and reinforce the idea that the environment is another reservoir that may play an important role in the capture, selection and dissemination of carbapenem resistance genes.	[Piedra-Carrasco, Nuria; Fabrega, Anna; Cornejo-Sanchez, Thais; Mir-Cros, Alba; Jose Gonzalez-Lopez, Juan] Univ Autonoma Barcelona, VHIR, Hosp Vall dHebron, Dept Clin Microbiol, Barcelona, Spain; [Calero-Caceres, William; Brown-Jaque, Maryury; Muniesa, Maite] Univ Barcelona, Dept Genet Microbiol & Stat, Fac Biol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona	Fabrega, A; Gonzalez-Lopez, JJ (corresponding author), Univ Autonoma Barcelona, VHIR, Hosp Vall dHebron, Dept Clin Microbiol, Barcelona, Spain.	anna.fabrega@vhir.org; jjgonzal@vhebron.net	González-López, Juanjo/C-5366-2014; Fàbrega-Santamaria, Anna/W-7009-2018; Muniesa, Maite/K-4577-2014; Brown, Maryury/AAA-2827-2020; Cáceres, William Calero/K-8827-2015	González-López, Juanjo/0000-0003-2419-5909; Fàbrega-Santamaria, Anna/0000-0002-3866-2291; Muniesa, Maite/0000-0001-5549-1394; Cáceres, William Calero/0000-0003-3819-9206; Brown Jaque, Maryury Andrea/0000-0002-9236-5247	Ministerio de Economia y Competitividad; Institute de Salud Carlos III; European Regional Development Fund (ERDF) 'A Way to Achieve Europe'; Spanish Network for Research in Infectious Diseases; Spanish Ministry of Health [FIS PI15/00604]; REIPI [RD12/0015/0003]; hD fellowship SENESCYT from the Republic of Ecuador Government; grant from COLCIENCIAS (Republic of Colombia)	Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (ERDF) 'A Way to Achieve Europe'; Spanish Network for Research in Infectious Diseases; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); REIPI; hD fellowship SENESCYT from the Republic of Ecuador Government; grant from COLCIENCIAS (Republic of Colombia)	This study was supported by the Ministerio de Economia y Competitividad (littp:// www.mineco.gob.es/), Institute de Salud Carlos III (http://www.isciii.es/), co-financed by the European Regional Development Fund (ERDF) 'A Way to Achieve Europe' (http://ec.europa.eu/regional_policy/en/funding/erdf/), the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0003) (http://reipi.org/), and the Spanish Ministry of Health (FIS PI15/00604 to JGL). NPC is financially supported by the REIPI RD12/0015/0003. WC-C is recipient of PhD fellowship SENESCYT 2012 from the Republic of Ecuador Government. MB-J has a grant from COLCIENCIAS (Republic of Colombia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2015, CLIN MICROBIOL INFEC, V21, P230, DOI 10.1016/j.cmi.2014.10.008; Adler A, 2014, CLIN MICROBIOL INFEC, V20, pO516, DOI 10.1111/1469-0691.12560; Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; Aubron C, 2005, EMERG INFECT DIS, V11, P260, DOI 10.3201/eid1102.030684; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Calero-Caceres W, 2017, ENVIRON POLLUT, V223, P384, DOI 10.1016/j.envpol.2017.01.035; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123063; Chouchani C, 2013, SCAND J INFECT DIS, V45, P95, DOI 10.3109/00365548.2012.717712; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2016, PERFORMANCE STANDARD; Dolejska M, 2016, J ANTIMICROB CHEMOTH, V71, P63, DOI 10.1093/jac/dkv306; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, BREAKPOINT TABLES FO; Gonzalez-Gonzalez A, 2013, INFECT GENET EVOL, V13, P187, DOI 10.1016/j.meegid.2012.09.003; Gudeta DD, 2016, J ANTIMICROB CHEMOTH; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hansen DS, 2012, SCAND J INFECT DIS, V44, P174, DOI 10.3109/00365548.2011.632642; Hazen TH, 2014, ANTIMICROB AGENTS CH, V58, P4814, DOI 10.1128/AAC.02573-14; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kieffer N, 2016, ANTIMICROB AGENTS CH, V60, P2585, DOI 10.1128/AAC.02632-15; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Mnif B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-147; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Muniesa M, 2012, WATER RES, V46, P6410, DOI 10.1016/j.watres.2012.09.015; Oteo J, 2015, ANTIMICROB AGENTS CH, V59, P3406, DOI 10.1128/AAC.00086-15; Oteo J, 2014, ANTIMICROB AGENTS CH, V58, P3874, DOI 10.1128/AAC.02738-13; Papagiannitsis CC, 2012, INT J ANTIMICROB AG, V39, P178, DOI 10.1016/j.ijantimicag.2011.09.024; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Picao RC, 2013, DIAGN MICR INFEC DIS, V76, P80, DOI 10.1016/j.diagmicrobio.2013.02.001; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Rojo-Bezares B, 2012, ANTIMICROB AGENTS CH, V56, P1146, DOI 10.1128/AAC.05478-11; Ruiz-Garbajosa P, 2016, J ANTIMICROB CHEMOTH, V71, P348, DOI 10.1093/jac/dkv355; Sabater S, 2015, CONTRIBUTIONS TO SCI, P161; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Walckenaer E, 2008, J MICROBIOL METH, V75, P405, DOI 10.1016/j.mimet.2008.07.011; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; Yu YS, 2006, ANTIMICROB AGENTS CH, V50, P1610, DOI 10.1128/AAC.50.4.1610-1611.2006; Zhang XZ, 2012, DIAGN MICR INFEC DIS, V73, P204, DOI 10.1016/j.diagmicrobio.2012.02.007	41	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175246	10.1371/journal.pone.0175246	http://dx.doi.org/10.1371/journal.pone.0175246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380016	gold, Green Published, Green Submitted			2022-12-27	WOS:000399353500109
J	Pinero, JC; Souder, SK; Vargas, RI				Pinero, Jaime C.; Souder, Steven K.; Vargas, Roger I.			Vision-mediated exploitation of a novel host plant by a tephritid fruit fly	PLOS ONE			English	Article							BACTROCERA-CUCURBITAE DIPTERA; MELON FLY; FLIES DIPTERA; LOCATION; BEHAVIOR; BAIT; ECOLOGY; INSECT; APHIDS; PAPAYA	Shortly after its introduction into the Hawaiian Islands around 1895, the polyphagous, invasive fruit fly Bactrocera (Zeugodacus) cucurbitae (Coquillett) (Diptera: Tephritidae) was provided the opportunity to expand its host range to include a novel host, papaya (Carica papaya). It has been documented that female B. cucurbitae rely strongly on vision to locate host fruit. Given that the papaya fruit is visually conspicuous in the papaya agro-ecosystem, we hypothesized that female B. cucurbitae used vision as the main sensory modality to find and exploit the novel host fruit. Using a comparative approach that involved a series of studies under natural and semi-natural conditions in Hawaii, we assessed the ability of female B. cucurbitae to locate and oviposit in papaya fruit using the sensory modalities of olfaction and vision alone and also in combination. The results of these studies demonstrate that, under a variety of conditions, volatiles emitted by the novel host do not positively stimulate the behavior of the herbivore. Rather, vision seems to be the main mechanism driving the exploitation of the novel host. Volatiles emitted by the novel host papaya fruit did not contribute in any way to the visual response of females. Our findings highlight the remarkable role of vision in the host-location process of B. cucurbitae and provide empirical evidence for this sensory modality as a potential mechanism involved in host range expansion.	[Pinero, Jaime C.] Lincoln Univ, Cooperat Res & Extens, Jefferson City, MO 65101 USA; [Souder, Steven K.; Vargas, Roger I.] USDA ARS, Daniel K Inouye US Pacific Basin Agr Res Ctr, Hilo, HI USA	Lincoln University - Missouri; United States Department of Agriculture (USDA)	Pinero, JC (corresponding author), Lincoln Univ, Cooperat Res & Extens, Jefferson City, MO 65101 USA.	pineroj@lincolnu.edu		Pinero, Jaime/0000-0003-1069-5603	United States Department of Agriculture (USDA); Lincoln University Cooperative Extension and Research	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Lincoln University Cooperative Extension and Research	This study has been financed by the United States Department of Agriculture (USDA) and Lincoln University Cooperative Extension and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of a proprietary product does not constitute an endorsement or a recommendation by the USDA for its use. USDA is an equal opportunity provider and employer.	ALUJA M, 1993, J CHEM ECOL, V19, P2671, DOI 10.1007/BF00980700; Back E. A., 1917, USDA B, V491; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; BUSH GUY L., 1966, BULL MUS COMP ZOOL HARVARD UNIV, V134, P431; Carvalho FA, 2015, CLADISTICS, V31, P321, DOI 10.1111/cla.12095; Dhillon MK, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.40; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; Dorn S., 2009, Biorational tree-fruit pest management, P85, DOI 10.1079/9781845934842.0085; Drew R., 2016, KEYS TROPICAL FRUIT; Fischer S, 2004, ENVIRON ENTOMOL, V33, P81, DOI 10.1603/0046-225X-33.1.81; Gassmann AJ, 2006, FUNCT ECOL, V20, P478, DOI 10.1111/j.1365-2435.2006.01118.x; Gish M, 2006, J INSECT BEHAV, V19, P143, DOI 10.1007/s10905-005-9009-9; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Jacquard C, 2013, BIOL INVASIONS, V15, P759, DOI 10.1007/s10530-012-0324-8; LIQUIDO NJ, 1989, J ECON ENTOMOL, V82, P213, DOI 10.1093/jee/82.1.213; Miller NW, 2004, ANN ENTOMOL SOC AM, V97, P1063, DOI 10.1603/0013-8746(2004)097[1063:SAOPBA]2.0.CO;2; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Otalora-Luna F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053120; Pinero JC, 2011, B ENTOMOL RES, V101, P373, DOI 10.1017/S0007485310000386; Pinero JC, 2006, ENTOMOL EXP APPL, V121, P261, DOI [10.1111/j.1570-8703.2006.00485.x, 10.1111/j.1570-7458.2006.00485.x]; Pinero JC, 2009, ENTOMOL EXP APPL, V133, P208, DOI 10.1111/j.1570-7458.2009.00912.x; Pinero JC, 2004, J INSECT BEHAV, V17, P493, DOI 10.1023/B:JOIR.0000042537.09796.5f; PROKOPY RJ, 1978, ENTOMOL EXP APPL, V24, P609, DOI 10.1007/BF02385116; Prokopy RJ, 2003, J ECON ENTOMOL, V96, P1485, DOI 10.1603/0022-0493-96.5.1485; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Reeves JL, 2011, ENVIRON ENTOMOL, V40, P855, DOI 10.1603/EN10212; Ryckewaert P, 2010, FRUITS, V65, P113, DOI 10.1051/fruits/20010006; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; SEVERIN H. H. P., 1914, Annals of the Entomological Society of America, V7, P178, DOI 10.1093/aesa/7.3.177; StatSoft Inc, 2013, STAT DAT AN SOFTW SY; TALLAMY DW, 2000, P SESS HOST SPEC TES, P11; VARGAS RI, 1990, J ECON ENTOMOL, V83, P1344, DOI 10.1093/jee/83.4.1344; VARGAS RI, 1991, J ECON ENTOMOL, V84, P1695, DOI 10.1093/jee/84.6.1695; Vayssieres J.F., 1999, THESIS; Virgilio M, 2010, MOL ECOL, V19, P2713, DOI 10.1111/j.1365-294X.2010.04662.x; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	40	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174636	10.1371/journal.pone.0174636	http://dx.doi.org/10.1371/journal.pone.0174636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380069	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500054
J	Zhao, YJ; Healy, BC; Rotstein, D; Guttmann, CRG; Bakshi, R; Weiner, HL; Brodley, CE; Chitnis, T				Zhao, Yijun; Healy, Brian C.; Rotstein, Delia; Guttmann, Charles R. G.; Bakshi, Rohit; Weiner, Howard L.; Brodley, Carla E.; Chitnis, Tanuja			Exploration of machine learning techniques in predicting multiple sclerosis disease course	PLOS ONE			English	Article							SHORT-TERM DISABILITY; NATURAL-HISTORY; BRAIN ATROPHY; MRI; ABNORMALITIES; PROGRESSION; EVOLUTION	Objective To explore the value of machine learning methods for predicting multiple sclerosis disease course. Methods 1693 CLIMB study patients were classified as increased EDSS >= 1.5 (worsening) or not (non-worsening) at up to five years after baseline visit. Support vector machines (SVM) were used to build the classifier, and compared to logistic regression (LR) using demographic, clinical and MRI data obtained at years one and two to predict EDSS at five years follow-up. Results Baseline data alone provided little predictive value. Clinical observation for one year improved overall SVM sensitivity to 62% and specificity to 65% in predicting worsening cases. The addition of one year MRI data improved sensitivity to 71% and specificity to 68%. Use of non-uniform misclassification costs in the SVM model, weighting towards increased sensitivity, improved predictions (up to 86%). Sensitivity, specificity, and overall accuracy improved minimally with additional follow-up data. Predictions improved within specific groups defined by baseline EDSS. LR performed more poorly than SVM in most cases. Race, family history of MS, and brain parenchymal fraction, ranked highly as predictors of the non-worsening group. Brain T2 lesion volume ranked highly as predictive of the worsening group. Interpretation SVM incorporating short-term clinical and brain MRI data, class imbalance corrective measures, and classification costs may be a promising means to predict MS disease course, and for selection of patients suitable for more aggressive treatment regimens.	[Zhao, Yijun] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Healy, Brian C.; Rotstein, Delia; Guttmann, Charles R. G.; Bakshi, Rohit; Weiner, Howard L.; Chitnis, Tanuja] Brigham & Womens Hosp, Partners MS Ctr, Brookline, MA 02115 USA; [Healy, Brian C.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA	Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Chitnis, T (corresponding author), Brigham & Womens Hosp, Partners MS Ctr, Brookline, MA 02115 USA.	tchitnis@partners.org	Guttmann, Charles RG/J-3093-2018	Guttmann, Charles/0000-0002-7006-9762	National MS Society [RG-4256A4/2]; Pilot grant [PV2873]	National MS Society(National Multiple Sclerosis Society); Pilot grant	Drs. Healy and Chitnis would like to acknowledge Merck Serono Inc. for research support during the completion of this manuscript. This work is supported in part by grants from the National MS Society (RG-4256A4/2 (to TC) and Pilot grant PV2873 (to CB). The study funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs. Healy and Chitnis would like to acknowledge Merck Serono Inc. for research support during the completion of this manuscript. This work is supported in part by grants from the National MS Society (RG-4256A4/2 (to TC) and Pilot grant PV2873 (to CB). We would like to thank Mariann Polgar-Turcsanyi, MS, for her role in managing the Partners MS Center research database.	Amato M. P., 2000, Neurological Sciences, V21, pS831, DOI 10.1007/s100720070021; Bejarano B, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-67; Bergamaschi R, 2013, EUR J NEUROL, V20, P995, DOI 10.1111/ene.12020; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bosma LVAE, 2012, MULT SCLER J, V18, P345, DOI 10.1177/1352458511419880; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Cristianini Na J S-T, 2000, INTRO SUPPORT VECTOR; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Gauthier SA, 2007, NEUROLOGY, V68, P2059, DOI 10.1212/01.wnl.0000264890.97479.b1; Gauthier SA, 2006, AUTOIMMUN REV, V5, P532, DOI 10.1016/j.autrev.2006.02.012; Gauthier SA, 2009, ARCH NEUROL-CHICAGO, V66, P234, DOI 10.1001/archneurol.2008.567; Gourraud PA, 2014, ANN NEUROLOGY; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Healy BC, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/189624; Heesen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059042; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; Minneboo A, 2008, J NEUROL NEUROSUR PS, V79, P917, DOI 10.1136/jnnp.2007.124123; Mowry EM, 2011, NEUROL CLIN, V29, P279, DOI 10.1016/j.ncl.2011.01.001; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Sormani MP, 2014, ANN NEUROL, V75, P43, DOI 10.1002/ana.24018; Sormani MP, 2011, MULT SCLER J, V17, P541, DOI 10.1177/1352458510391837; Wei XC, 2002, J MAGN RESON IMAGING, V15, P203, DOI 10.1002/jmri.10053; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; WOLFSON C, 1985, Neuroepidemiology, V4, P227, DOI 10.1159/000110234; WOLFSON C, 1987, Neuroepidemiology, V6, P101, DOI 10.1159/000110105; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341	32	79	83	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174866	10.1371/journal.pone.0174866	http://dx.doi.org/10.1371/journal.pone.0174866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379999	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500071
J	Acion, L; Kelmansky, D; van der Laan, M; Sahker, E; Jones, D; Arndt, S				Acion, Laura; Kelmansky, Diana; van der Laan, Mark; Sahker, Ethan; Jones, DeShauna; Arndt, Stephan			Use of a machine learning framework to predict substance use disorder treatment success	PLOS ONE			English	Article							DRUG-ABUSE; UNMET NEED; DISPARITIES; COMPLETION; RISK; ALCOHOL	There are several methods for building prediction models. The wealth of currently available modeling techniques usually forces the researcher to judge, a priori, what will likely be the best method. Super learning (SL) is a methodology that facilitates this decision by combining all identified prediction algorithms pertinent for a particular prediction problem. SL generates a final model that is at least as good as any of the other models considered for predicting the outcome. The overarching aim of this work is to introduce SL to analysts and practitioners. This work compares the performance of logistic regression, penalized regression, random forests, deep learning neural networks, and SL to predict successful substance use disorders (SUD) treatment. A nationwide database including 99,013 SUD treatment patients was used. All algorithms were evaluated using the area under the receiver operating characteristic curve (AUC) in a test sample that was not included in the training sample used to fit the prediction models. AUC for the models ranged between 0.793 and 0.820. SL was superior to all but one of the algorithms compared. An explanation of SL steps is provided. SL is the first step in targeted learning, an analytic framework that yields double robust effect estimation and inference with fewer assumptions than the usual parametric methods. Different aspects of SL depending on the context, its function within the targeted learning framework, and the benefits of this methodology in the addiction field are discussed.	[Acion, Laura; Kelmansky, Diana] Univ Buenos Aires, CONICET, Fac Ciencias Exactas Nat, Inst Calculo, Buenos Aires, DF, Argentina; [Acion, Laura; Sahker, Ethan; Jones, DeShauna; Arndt, Stephan] Univ Iowa, Iowa Consortium Substance Abuse Res & Evaluat, Iowa City, IA USA; [van der Laan, Mark] Univ Calif Berkeley, Div Biostat, Berkeley, CA USA; [Sahker, Ethan] Univ Iowa, Dept Psychol, Counseling Psychol Program, Iowa City, IA USA; [Sahker, Ethan] Univ Iowa, Quantitat Fdn, Coll Educ, Iowa City, IA USA; [Arndt, Stephan] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Psychiat, Iowa City, IA USA; [Arndt, Stephan] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Iowa; University of California System; University of California Berkeley; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Acion, L (corresponding author), Univ Buenos Aires, CONICET, Fac Ciencias Exactas Nat, Inst Calculo, Buenos Aires, DF, Argentina.; Acion, L (corresponding author), Univ Iowa, Iowa Consortium Substance Abuse Res & Evaluat, Iowa City, IA USA.	laura.acion@ic.fcen.uba.ar	Sahker, Ethan/AAC-5365-2020; Arndt, Stephan/A-6976-2013	Arndt, Stephan/0000-0003-0783-8204; Acion, Laura/0000-0001-5213-6012	Consejode Investigaciones Cientificas y Tecnicas Postdoctoral Fellowship [2651/2014]; CONICET [2651/2014]	Consejode Investigaciones Cientificas y Tecnicas Postdoctoral Fellowship; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by Consejode Investigaciones Cientificas y Tecnicas Postdoctoral Fellowship 2651/2014 awarded to LA.; This work was partially funded by postdoctoral fellowship 2651/2014 awarded to Dr. Acion by CONICET. The authors thank all open source software developers that made the analysis possible.	Acion L, 2006, STAT MED, V25, P591, DOI 10.1002/sim.2256; Acion L, 2013, ADDICTION, V108, P1418, DOI 10.1111/add.12161; Aiello SK, 2015, CONTRIBUTIONS H2O TE; Alang SM, 2015, PSYCHIATR REHABIL J, V38, P293, DOI 10.1037/prj0000113; Arndt S, 2013, DRUG ALCOHOL DEPEN, V132, P547, DOI 10.1016/j.drugalcdep.2013.03.015; Bembom O, 2007, STAT APPL GENET MOL, V6; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brierley P, 2011, HERITAGE PROVIDER NE; Compton WM, 2003, AM J PSYCHIAT, V160, P890, DOI 10.1176/appi.ajp.160.5.890; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Evans E, 2009, EVAL PROGRAM PLANN, V32, P204, DOI 10.1016/j.evalprogplan.2008.12.003; Garnick DW, 2009, J SUBST ABUSE TREAT, V36, P265, DOI 10.1016/j.jsat.2008.06.008; Glasheen C, 2015, ADDICT BEHAV, V43, P42, DOI 10.1016/j.addbeh.2014.12.005; Goldklang S, 2003, J SUBST ABUSE TREAT, V25, P9, DOI 10.1016/S0740-5472(03)00050-3; Gowin JL, 2015, DRUG ALCOHOL DEPEN, V152, P93, DOI 10.1016/j.drugalcdep.2015.04.018; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Launay CP, 2015, EUR J INTERN MED, V26, P478, DOI 10.1016/j.ejim.2015.06.002; LeDell EE, 2016, H2OENSEMBLE H2O ENSE; LeDell EE, 2015, SCALABLE ENSEMBLE LE; Marzell MSE., 2016, J ETHN SUBST ABUSE, P1; National Institutes of Health, 2016, RES INSTR NIH OTHER; Pflueger MO, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0447-4; Polley EC., 2011, TARGETED LEARNING CA, P43; RCore Team, 2020, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rose S, 2011, WINE TRADE MEDIEVAL, P101; Rose S., 2016, HDB OF BIG DATA, P411; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Sahker E, 2017, DRUG ALCOHOL DEPEN, V171, P1, DOI 10.1016/j.drugalcdep.2016.11.022; Sahker E, 2016, ARCH WOMEN MENT HLTH, V19, P79, DOI 10.1007/s00737-015-0520-5; Sahker E, 2015, ADDICT BEHAV, V48, P25, DOI 10.1016/j.addbeh.2015.04.006; Sahker E, 2015, J AM COLL HEALTH, V63, P118, DOI 10.1080/07448481.2014.990970; SIMPSON DD, 1993, PSYCHOTHER, V30, P357, DOI 10.1037/0033-3204.30.2.357; Substance Abuse and Mental Health Services Administration, 2013, NEED REC SUBST TREAT; Substance Abuse and Mental Health Services Administration, 2012, NSDUH REP NEED REC S; United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Statistics, 2014, OFF APPL STAT TREATM; Wells K, 2001, AM J PSYCHIAT, V158, P2027, DOI 10.1176/appi.ajp.158.12.2027; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Zarkin GA, 2002, J SUBST ABUSE TREAT, V23, P261, DOI 10.1016/S0740-5472(02)00273-8	42	49	49	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175383	10.1371/journal.pone.0175383	http://dx.doi.org/10.1371/journal.pone.0175383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394905	Green Published, gold			2022-12-27	WOS:000399954800031
J	Le Guillou-Guillemette, H; Pivert, A; Bouthry, E; Henquell, C; Petsaris, O; Ducancelle, A; Veillon, P; Vallet, S; Alain, S; Thibault, V; Abravanel, F; Rosenbere, AA; Andre-Garnier, E; Bour, JB; Baazia, Y; Trimoulet, P; Andre, P; Gaudy-Graffin, C; Bettinger, D; Larrat, S; Signori-Schmuck, A; Saoudin, H; Pozzetto, B; Lagathu, G; Minjolle-Cha, S; Stoll-Keller, F; Pawlotsky, JM; Izopet, J; Payan, C; Lunel-Fabiani, F; Lemaire, C				Le Guillou-Guillemette, Helene; Pivert, Adeline; Bouthry, Elise; Henquell, Cecile; Petsaris, Odile; Ducancelle, Alexandra; Veillon, Pascal; Vallet, Sophie; Alain, Sophie; Thibault, Vincent; Abravanel, Florence; Rosenbere, Arielle A.; Andre-Garnier, Elisabeth; Bour, Jean-Baptiste; Baazia, Yazid; Trimoulet, Pascale; Andre, Patrice; Gaudy-Graffin, Catherine; Bettinger, Dominique; Larrat, Sylvie; Signori-Schmuck, Anne; Saoudin, Henia; Pozzetto, Bruno; Lagathu, Gisele; Minjolle-Cha, Sophie; Stoll-Keller, Francoise; Pawlotsky, Jean-Michel; Izopet, Jacques; Payan, Christopher; Lunel-Fabiani, Francoise; Lemaire, Christophe			Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SINGLE-NUCLEOTIDE SUBSTITUTIONS; RNA RECOMBINATION; NS5A PROTEIN; V3 DOMAIN; EVOLUTION; SEQUENCE; INTERFERON; 1B; POPULATION	Background The emergence of new strains in RNA viruses is mainly due to mutations or intra and inter-genotype homologous recombination. Non-homologous recombinations may be deleterious and are rarely detected. In previous studies, we identified HCV-1b strains bearing two tandemly repeated V3 regions in the NS5A gene without ORF disruption. This polymorphism may be associated with an unfavorable course of liver disease and possibly involved in liver carcinogenesis. Here we aimed at characterizing the origin of these mutant strains and identifying the evolutionary mechanism on which the V3 duplication relies. Methods Direct sequencing of the entire NS5A and E1 genes was performed on 27 mutant strains. Quasispecies analyses in consecutive samples were also performed by cloning and sequencing the NS5A gene for all mutant and wild strains. We analyzed the mutant and wild-type sequence polymorphisms using Bayesian methods to infer the evolutionary history of and the molecular mechanism leading to the duplication-like event. Results Quasispecies were entirely composed of exclusively mutant or wild-type strains respectively. Mutant quasispecies were found to have been present since contamination and had persisted for at least 10 years. This V3 duplication-like event appears to have resulted from non-homologous recombination between HCV-1b wild-type strains around 100 years ago. The association between increased liver disease severity and these HCV-1b mutants may explain their persistence in chronically infected patients. Conclusions These results emphasize the possible consequences of non-homologous recombination in the emergence and severity of new viral diseases.	[Le Guillou-Guillemette, Helene; Pivert, Adeline; Bouthry, Elise; Ducancelle, Alexandra; Veillon, Pascal; Lunel-Fabiani, Francoise] CHU Angers, Lab Virol, Angers, France; [Le Guillou-Guillemette, Helene; Pivert, Adeline; Bouthry, Elise; Ducancelle, Alexandra; Veillon, Pascal; Lunel-Fabiani, Francoise] LUNAM Univ, HIFIH Lab, UPRES 3859, SFR 4208, Angers, France; [Henquell, Cecile] CHU Clermont Ferrand, Lab Virol, Clermont Ferrand, France; [Petsaris, Odile; Vallet, Sophie; Payan, Christopher] CHRU, LUBEM, Dept Bacteriol Virol Hyg Hosp & Parasitol Mycol, Brest, France; [Alain, Sophie] CHU Limoges, Lab Virol, Limoges, France; [Thibault, Vincent] CHU Pitie Salpetriere, Lab Virol, Paris, France; [Abravanel, Florence; Izopet, Jacques] CHU Purpan, CNR VHE, INSERM, Lab Virol,U1043, Toulouse, France; [Rosenbere, Arielle A.] Univ Paris 05, Lab Virol, AP HP, GHU Cochin, Paris, France; [Andre-Garnier, Elisabeth] CHU Hotel Dieu, Lab Virol, Nantes, France; [Bour, Jean-Baptiste] CHU, Lab Virol, Dijon, France; [Baazia, Yazid] CHU Avicenne, Lab Virol, Bobigny, France; [Trimoulet, Pascale] CHU Bordeaux, Hop Pellegrin Tripode, Lab Virol, Bordeaux, France; [Andre, Patrice] Hop Croix Rousse, Ctr Biol Nord, Lab Virol, Lyon, France; [Gaudy-Graffin, Catherine] Univ Tours, INSERM, CHU Tours, U966, Tours, France; [Bettinger, Dominique] CHU Besancon, Lab Virol, Besancon, France; [Larrat, Sylvie; Signori-Schmuck, Anne] CHU, Lab Virol, Unit Virus Host Cell Interact, UMI 3265,UJF,EMBL,CNRS, Grenoble, France; [Saoudin, Henia; Pozzetto, Bruno] CHU St Etienne, Lab Bacteriol Virol, St Etienne, France; [Lagathu, Gisele; Minjolle-Cha, Sophie] CHU Rennes, Lab Virol, Rennes, France; [Stoll-Keller, Francoise] CHU Strasbourg, Inst Virol, INSERM, U748, Strasbourg, France; [Pawlotsky, Jean-Michel] CHU Henri Mondor, Lab Virol Bacteriol, Creteil, France; [Lemaire, Christophe] Univ Angers, IRHS, QUASAV SFR4207, Angers, France; [Bouthry, Elise] Lab Cerba, Ivry, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; CHU Clermont Ferrand; CHU Brest; Universite de Bretagne Occidentale; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU Bordeaux; CHU Lyon; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU de St Etienne; CHU Rennes; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite d'Angers	Le Guillou-Guillemette, H (corresponding author), CHU Angers, Lab Virol, Angers, France.; Le Guillou-Guillemette, H (corresponding author), LUNAM Univ, HIFIH Lab, UPRES 3859, SFR 4208, Angers, France.	heleguillou@chu-angers.fr	Alain, sophie/O-9106-2016; Abrvaanel, florence/K-3776-2014; THIBAULT, Vincent/J-7193-2015; Pawlotsky, Jean-Michel/R-8159-2018; THIBAULT, Vincent/AAB-5241-2020; Ducancelle, Alexandra/D-6393-2014; ABRAVANEL, Florence/AAC-2993-2021; André, Patrice/M-8139-2014	THIBAULT, Vincent/0000-0001-6517-2901; THIBAULT, Vincent/0000-0001-6517-2901; Ducancelle, Alexandra/0000-0003-3173-8000; ABRAVANEL, Florence/0000-0002-1753-1065; André, Patrice/0000-0002-5834-7395; POZZETTO, Bruno/0000-0002-2603-8467; Pawlotsky, Jean-Michel/0000-0003-0745-7559; IZOPET, JACQUES/0000-0002-8462-3234	Agence Nationale de Recherche sur le VIH et les hepatites (ANRS)	Agence Nationale de Recherche sur le VIH et les hepatites (ANRS)	This work was funded by the Agence Nationale de Recherche sur le VIH et les hepatites (ANRS, AO Mars 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326; Galli A, 2014, TRENDS MICROBIOL, V22, P354, DOI 10.1016/j.tim.2014.02.005; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerotto M, 2001, BLOOD, V98, P2657, DOI 10.1182/blood.V98.9.2657; Gmyl AP, 2003, RNA, V9, P1221, DOI 10.1261/rna.5111803; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0; Gritsun TS, 2006, VIROLOGY, V354, P215, DOI 10.1016/j.virol.2006.07.036; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmblat B, 2014, MBIO, V5, DOI 10.1128/mBio.01119-14; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Le Guillou-Guillemette H, 2015, J CLIN VIROL, V69, P203, DOI 10.1016/j.jcv.2015.06.096; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Mes THM, 2011, J GEN VIROL, V92, P279, DOI 10.1099/vir.0.024414-0; Morel V, 2011, J VIRAL HEPATITIS, V18, P77, DOI 10.1111/j.1365-2893.2010.01367.x; Nagai M, 2003, J GEN VIROL, V84, P447, DOI 10.1099/vir.0.18773-0; Nora T, 2007, J VIROL, V81, P7620, DOI 10.1128/JVI.00083-07; Omland Lars Haukali, 2010, Clin Epidemiol, V2, P179; Palmer BA, 2014, J VIROL, V88, P13709, DOI 10.1128/JVI.01732-14; Pawlotsky JM, 2014, EASL ANN M 2014 LOND; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petsaris O, 2016, J CLIN VIROL, V74, P19, DOI 10.1016/j.jcv.2015.11.011; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Scheel TKH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003228; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Shi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041997; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Simon- Loriere E, 2013, MOL BIOL EVOL; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Suchard MA, 2003, SYST BIOL, V52, P649, DOI 10.1080/10635150390238879; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; Veillon P, 2004, PATHOL BIOL, V52, P505, DOI 10.1016/j.patbio.2004.07.011; Veillon P, 2007, WORLD J GASTROENTERO, V13, P1195, DOI 10.3748/wjg.v13.i8.1195; Vuillaume F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002028; Walker PR, 2007, AIDS RES HUM RETROV, V23, P204, DOI 10.1089/aid.2006.0080; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; Wen HL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-115	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174651	10.1371/journal.pone.0174651	http://dx.doi.org/10.1371/journal.pone.0174651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394908	Green Submitted, Green Published, gold			2022-12-27	WOS:000399954800007
J	Diggle, CP; Martinez-Garay, I; Molnar, Z; Brinkworth, MH; White, E; Fowler, E; Hughes, R; Hayward, BE; Carr, IM; Watson, CM; Crinnion, L; Asipu, A; Woodman, B; Coletta, PL; Markham, AF; Dear, TN; Bonthron, DT; Peckham, M; Morrison, EE; Sheridan, E				Diggle, Christine P.; Martinez-Garay, Isabel; Molnar, Zoltan; Brinkworth, Martin H.; White, Ed; Fowler, Ewan; Hughes, Ruth; Hayward, Bruce E.; Carr, Ian M.; Watson, Christopher M.; Crinnion, Laura; Asipu, Aruna; Woodman, Ben; Coletta, P. Louise; Markham, Alexander F.; Dear, T. Neil; Bonthron, David T.; Peckham, Michelle; Morrison, Ewan E.; Sheridan, Eamonn			A tubulin alpha 8 mouse knockout model indicates a likely role in spermatogenesis but not in brain development	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATION; SERTOLI-CELLS; MICROTUBULES; MUTATIONS; ACETYLATION; SNAP29; TUBA8; MICE; ACETYLTRANSFERASE; DETYROSINATION	Tubulin alpha 8 (Tuba8) is the most divergent member of the highly conserved alpha tubulin family, and uniquely lacks two key post-translational modification sites. It is abundantly expressed in testis and muscle, with lower levels in the brain. We previously identified homozygous hypomorphic TUBA8 mutations in human subjects with a polymicrogyria (PMG) syndrome, suggesting its involvement in development of the cerebral cortex. We have now generated and characterized a Tuba8 knockout mouse model. Homozygous mice were confirmed to lack Tuba8 protein in the testis, but did not display PMG and appeared to be neurologically normal. In response to this finding, we re-analyzed the human PMG subjects using whole exome sequencing. This resulted in identification of an additional homozygous loss-of-function mutation in SNAP29, suggesting that SNAP29 deficiency, rather than TUBA8 deficiency, may underlie most or all of the neurodevelopmental anomalies in these subjects. Nonetheless, in the mouse brain, Tuba8 specifically localised to the cerebellar Purkinje cells, suggesting that the human mutations may affect or modify motor control. In the testis, Tuba8 localisation was cell-type specific. It was restricted to spermiogenesis with a strong acrosomal localization that was gradually replaced by cytoplasmic distribution and was absent from spermatozoa. Although the knockout mice were fertile, the localisation pattern indicated that Tuba8 may have a role in spermatid development during spermatogenesis, rather than as a component of the mature microtubule-rich flagellum itself.	[Diggle, Christine P.; Hayward, Bruce E.; Carr, Ian M.; Asipu, Aruna; Woodman, Ben; Coletta, P. Louise; Markham, Alexander F.; Dear, T. Neil; Bonthron, David T.; Morrison, Ewan E.; Sheridan, Eamonn] Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England; [Martinez-Garay, Isabel; Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Brinkworth, Martin H.] Univ Bradford, Sch Med Sci, Bradford, W Yorkshire, England; [White, Ed; Fowler, Ewan] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Hughes, Ruth; Peckham, Michelle] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Watson, Christopher M.; Crinnion, Laura] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Martinez-Garay, Isabel] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Fowler, Ewan] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Hayward, Bruce E.] NIDDK, NIH, Bethesda, MD 20892 USA; [Dear, T. Neil] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Saint James's University Hospital; University of Leeds; University of Oxford; University of Bradford; University of Leeds; University of Leeds; Saint James's University Hospital; Cardiff University; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); South Australian Health & Medical Research Institute (SAHMRI)	Diggle, CP (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England.	c.p.diggle@leeds.ac.uk	Garay, Isabel Martinez/AAI-8951-2021; Molnar, Zoltan/J-7281-2012; Peckham, Michelle/J-4991-2015	Garay, Isabel Martinez/0000-0001-6849-7496; Molnar, Zoltan/0000-0002-6852-6004; Peckham, Michelle/0000-0002-3754-2028; Fowler, Ewan/0000-0001-5580-2156; Hughes, Ruth/0000-0001-6167-8286	WellcomeTrust [094279/Z/10/Z]; Medical Research Council [MR/L01629X/1, MR/N026039/1, 1371002] Funding Source: researchfish; MRC [MR/L01629X/1, MR/N026039/1] Funding Source: UKRI	WellcomeTrust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a research grant(094279/Z/10/Z) awarded to ES by the WellcomeTrust, https://wellcome.ac.uk/. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; BARRA HS, 1974, BIOCHEM BIOPH RES CO, V60, P1384, DOI 10.1016/0006-291X(74)90351-9; Bhagwat S, 2014, FERTIL STERIL, V101, P95, DOI 10.1016/j.fertnstert.2013.09.016; Braun A, 2010, AM J HUM GENET, V86, P819, DOI 10.1016/j.ajhg.2010.03.019; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Correa LM, 2002, TOXICOL SCI, V69, P175, DOI 10.1093/toxsci/69.1.175; De Gendt K, 2011, BIOL REPROD, V85, P934, DOI 10.1095/biolreprod.110.090704; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fuchs-Telem D, 2011, BRIT J DERMATOL, V164, P610, DOI 10.1111/j.1365-2133.2010.10133.x; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Khodiyar VK, 2007, GENOMICS, V90, P285, DOI 10.1016/j.ygeno.2007.04.008; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LHERNAULT SW, 1985, J CELL BIOL, V100, P457, DOI 10.1083/jcb.100.2.457; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Luo JP, 2010, MOL REPROD DEV, V77, P348, DOI 10.1002/mrd.21153; McDonald-McGinn DM, 2013, J MED GENET, V50, P80, DOI 10.1136/jmedgenet-2012-101320; OKE BO, 1993, BIOL REPROD, V48, P621, DOI 10.1095/biolreprod48.3.621; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Session DR, 2001, FERTIL STERIL, V75, P669, DOI 10.1016/S0015-0282(00)01794-5; Sheridan E, 2010, AM J HUM GENET, V86, P822, DOI 10.1016/j.ajhg.2010.03.020; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Stanchi F, 2000, BIOCHEM BIOPH RES CO, V270, P1111, DOI 10.1006/bbrc.2000.2571; Tang El, 2014, ENDOCRINOLOGY; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Wakamiya M, 1998, HUM MOL GENET, V7, P1835, DOI 10.1093/hmg/7.12.1835; Watson CM, 2014, HUM MUTAT, V35, P434, DOI 10.1002/humu.22490; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Yamada D, 2006, MOL CELL BIOL, V26, P3610, DOI 10.1128/MCB.26.9.3610-3624.2006	36	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174264	10.1371/journal.pone.0174264	http://dx.doi.org/10.1371/journal.pone.0174264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388629	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000399375800004
J	Suzuki, S; Nakajima, T; Irie, S; Ariyasu, R; Komiyama, T; Ohki, Y				Suzuki, Shinya; Nakajima, Tsuyoshi; Irie, Shun; Ariyasu, Ryohei; Komiyama, Tomoyoshi; Ohki, Yukari			Vestibular stimulation-induced facilitation of cervical premotoneuronal systems in humans	PLOS ONE			English	Article							SOLEUS H-REFLEX; PROPRIOSPINAL NEURONS; CORTICOSPINAL EXCITATION; VOLUNTARY CONTRACTION; EMG RESPONSES; SPINAL-CORD; CAT; FORELIMB; MODULATION; NERVE	It is unclear how descending inputs from the vestibular system affect the excitability of cervical interneurons in humans. To elucidate this, we investigated the effects of galvanic vestibular stimulation (GVS) on the spatial facilitation of motor-evoked potentials (MEPs) induced by combined pyramidal tract and peripheral nerve stimulation. To assess the spatial facilitation, electromyograms were recorded from the biceps brachii muscles (BB) of healthy subjects. Transcranial magnetic stimulation (TMS) over the contralateral primary motor cortex and electrical stimulation of the ipsilateral ulnar nerve at the wrist were delivered either separately or together, with interstimulus intervals of 10 ms (TMS behind). Anodal/cathodal GVS was randomly delivered with TMS and/or ulnar nerve stimulation. The combination of TMS and ulnar nerve stimulation facilitated BB MEPs significantly more than the algebraic summation of responses induced separately by TMS and ulnar nerve stimulation (i.e., spatial facilitation). MEP facilitation significantly increased when combined stimulation was delivered with GVS (p < 0.01). No significant differences were found between anodal and cathodal GVS. Furthermore, single motor unit recordings showed that the short-latency excitatory peak in peri-stimulus time histograms during combined stimulation increased significantly with GVS. The spatial facilitatory effects of combined stimulation with short interstimulus intervals (i.e., 10 ms) indicate that facilitation occurred at the premotoneuronal level in the cervical cord. The present findings therefore suggest that GVS facilitates the cervical interneuron system that integrates inputs from the pyramidal tract and peripheral nerves and excites motoneurons innervating the arm muscles.	[Suzuki, Shinya; Nakajima, Tsuyoshi; Irie, Shun; Ariyasu, Ryohei; Ohki, Yukari] Kyorin Univ, Dept Integrat Physiol, Sch Med, Mitaka, Tokyo, Japan; [Suzuki, Shinya; Komiyama, Tomoyoshi] Tokyo Gakugei Univ, United Grad Sch Educ, Div Hlth & Sports Educ, Koganei, Tokyo, Japan; [Komiyama, Tomoyoshi] Chiba Univ, Fac Educ, Div Hlth & Sports Sci, Chiba, Chiba, Japan	Kyorin University; Tokyo Gakugei University; Chiba University	Nakajima, T (corresponding author), Kyorin Univ, Dept Integrat Physiol, Sch Med, Mitaka, Tokyo, Japan.	tsunakaj@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [25702033, 26560282, 23500617, 26120002]; Grants-in-Aid for Scientific Research [26120002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI: 25702033 and 26560282 (TN), 23500617 and 26120002 (YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1981, EXP NEUROL, V72, P592, DOI 10.1016/0014-4886(81)90008-X; Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P308, DOI 10.1007/BF00236286; AOYAMA M, 1971, BRAIN RES, V35, P250, DOI 10.1016/0006-8993(71)90612-3; ASHBY P, 1977, J NEUROL NEUROSUR PS, V40, P910, DOI 10.1136/jnnp.40.9.910; Baldissera F, 1990, Neuroreport, V1, P191, DOI 10.1097/00001756-199011000-00003; Blouin J, 2015, MULTISENS RES, V28, P487, DOI 10.1163/22134808-00002501; Bradnam LV, 2011, J NEUROPHYSIOL, V105, P2582, DOI 10.1152/jn.01084.2010; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Chiba R, 2013, ADV INTELL SYST, V194, P479; Coats A C, 1973, Adv Otorhinolaryngol, V19, P318; Cohen Bernard, 2011, Front Neurol, V2, P90, DOI 10.3389/fneur.2011.00090; Cohen J.E., 1988, STAT POWER ANAL BEHA; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; DAWSON GD, 1956, J PHYSIOL-LONDON, V131, P436, DOI 10.1113/jphysiol.1956.sp005473; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Delwaide PJ, 1973, HUMAN REFLEXES PATHO, V3, P336; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; DIETZ V, 1978, BRAIN RES, V142, P576, DOI 10.1016/0006-8993(78)90921-6; ERULKAR SD, 1966, J NEUROPHYSIOL, V29, P626, DOI 10.1152/jn.1966.29.4.626; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Ghanim Z, 2009, J APPL PHYSIOL, V106, P893, DOI 10.1152/japplphysiol.90594.2008; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GRACIES JM, 1991, J PHYSIOL-LONDON, V434, P151, DOI 10.1113/jphysiol.1991.sp018463; Hirschfeld H, 1997, J VESTIBUL RES-EQUIL, V7, P265, DOI 10.1016/S0957-4271(96)00180-2; Iglesias C, 2007, J PHYSIOL-LONDON, V582, P1361, DOI 10.1113/jphysiol.2007.133199; ILLERT M, 1981, EXP BRAIN RES, V42, P269; ILLERT M, 1977, EXP BRAIN RES, V29, P323; Kennedy PM, 2001, CLIN NEUROPHYSIOL, V112, P2159, DOI 10.1016/S1388-2457(01)00665-4; KERNELL D, 1990, BRAIN RES, V507, P176, DOI 10.1016/0006-8993(90)90542-J; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Lowrey CR, 2009, MUSCLE NERVE, V40, P213, DOI 10.1002/mus.21275; LUND S, 1983, ACTA PHYSIOL SCAND, V117, P307, DOI 10.1111/j.1748-1716.1983.tb07212.x; MACEFIELD G, 1989, BRAIN, V112, P1519, DOI 10.1093/brain/112.6.1519; MAEDA M, 1975, EXP BRAIN RES, V22, P69; Marigold DS, 2003, J NEUROPHYSIOL, V89, P1727, DOI 10.1152/jn.00683.2002; MCILROY WE, 1995, NEUROSCI LETT, V184, P177, DOI 10.1016/0304-3940(94)11200-3; Nakajima T, 2005, BRAIN RES, V1053, P146, DOI 10.1016/j.brainres.2005.06.033; NAKAJIMA T, 2017, FRONT HUM NEUROSCI, V11; Nakajima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104910; Nicolas G, 2001, J PHYSIOL-LONDON, V533, P903, DOI 10.1111/j.1469-7793.2001.t01-1-00903.x; NIELSEN J, 1993, ACTA PHYSIOL SCAND, V147, P385, DOI 10.1111/j.1748-1716.1993.tb09515.x; Pauvert V, 1998, J PHYSIOL-LONDON, V508, P301, DOI 10.1111/j.1469-7793.1998.301br.x; PETERSON BW, 1971, BRAIN RES, V27, P373, DOI 10.1016/0006-8993(71)90264-2; Pierrot-Deseilligny E, 2002, MUSCLE NERVE, V26, P155, DOI 10.1002/mus.1240; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; PierrotDeseilligny E, 1996, PROG NEUROBIOL, V48, P489, DOI 10.1016/0301-0082(96)00002-0; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Sasada S, 2016, J NEUROPHYSIOL, V115, P2065, DOI 10.1152/jn.00638.2015; SCHOR RH, 1986, J NEUROPHYSIOL, V56, P1147, DOI 10.1152/jn.1986.56.4.1147; SCHOR RH, 1981, J NEUROPHYSIOL, V46, P167, DOI 10.1152/jn.1981.46.1.167; SHINODA Y, 1986, J COMP NEUROL, V249, P226, DOI 10.1002/cne.902490208; STEPHENS JA, 1976, NATURE, V263, P343, DOI 10.1038/263343a0; Stinear JW, 2004, MUSCLE NERVE, V29, P506, DOI 10.1002/mus.20003; SUZUKI JI, 1964, EXP NEUROL, V10, P393, DOI 10.1016/0014-4886(64)90031-7; Suzuki S, 2015, GALVANIC VESTIBULAR; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Tsushima E, 2013, METHODS MED DATA ANA; Wardman DL, 2002, ADV EXP MED BIOL, V508, P119; Watson SRD, 2003, CLIN NEUROPHYSIOL, V114, P1456, DOI 10.1016/S1388-2457(03)00121-4; Watson SRD, 1997, ELECTROMYOGR MOTOR C, V105, P476, DOI 10.1016/S0924-980X(97)00044-1; WILSON VJ, 1988, PROG BRAIN RES, V76, P137; ZANETTE G, 1995, EVOKED POTENTIAL, V96, P114, DOI 10.1016/0168-5597(94)00212-W; Zink R, 1997, NEUROSCI LETT, V232, P171, DOI 10.1016/S0304-3940(97)00610-1	69	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175131	10.1371/journal.pone.0175131	http://dx.doi.org/10.1371/journal.pone.0175131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388686	Green Submitted, Green Published, gold			2022-12-27	WOS:000399375800022
J	Fievet, B; du Bois, PB; Laguionie, P; Morillon, M; Arnaud, M; Cunin, P				Fievet, Bruno; du Bois, Pascal Bailly; Laguionie, Philippe; Morillon, Mehdi; Arnaud, Mireille; Cunin, Pascal			A dual pathways transfer model to account for changes in the radioactive caesium level in demersal and pelagic fish after the Fukushima Dai-ichi nuclear power plant accident (vol 12, e0172442, 2017)	PLOS ONE			English	Correction													Laguionie, Philippe/GPF-5447-2022					Fievet B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172442; FLEVET B, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0172442	2	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175614	10.1371/journal.pone.0175614	http://dx.doi.org/10.1371/journal.pone.0175614			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384254	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900189
J	Gao, P; Pinkston, KL; Bourgogne, A; Murray, BE; van Hoof, A; Harvey, BR				Gao, Peng; Pinkston, Kenneth L.; Bourgogne, Agathe; Murray, Barbara E.; van Hoof, Ambro; Harvey, Barrett R.			Functional studies of E-faecalis RNase J2 and its role in virulence and fitness	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; MESSENGER-RNA; BACILLUS-SUBTILIS; GENE-EXPRESSION; RESPONSE REGULATOR; BIOFILM FORMATION; RIBONUCLEASES J1; SERINE-PROTEASE; DEGRADATION; ANTIBODY	Post-transcriptional control provides bacterial pathogens a method by which they can rapidly adapt to environmental change. Dual exo- and endonucleolytic activities of RNase J enzymes contribute to Gram-positive RNA processing and decay. First discovered in Bacillus subtilis, RNase J1 plays a key role in mRNA maturation and degradation, while the function of the paralogue RNase J2 is largely unknown. Previously, we discovered that deletion of the Enterococcus faecalis rnjB gene significantly attenuates expression of a major virulence factor involved in enterococcal pathogenesis, the Ebp pili. In this work, we demonstrate that E. faecalis rnjB encodes an active RNase J2, and that the ribonuclease activity of RNase J2 is required for regulation of Ebp pili. To further investigate how rnjB affects E. faecalis gene expression on a global scale, we compared transcriptomes of the E. faecalis strain OG1RF with its isogenic rnjB deletion mutant (Delta rnjB). In addition to Ebp pili regulation, previously demonstrated to have a profound effect on the ability of E. faecalis to form biofilm or establish infection, we identified that rnjB regulates the expression of several other genes involved in bacterial virulence and fitness, including gls24 (a virulence factor important in stress response). We further demonstrated that the E. faecalis RNase J2 deletion mutant is more sensitive to bile salt and greatly attenuated in in vivo organ infection as determined by an IV-sublethal challenge infection mouse model, indicating that E. faecalis RNase J2 plays an important role in E. faecalis virulence.	[Gao, Peng; Pinkston, Kenneth L.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Mol Imaging, Houston, TX 77030 USA; [Bourgogne, Agathe; Murray, Barbara E.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA; [Murray, Barbara E.; van Hoof, Ambro; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Mol Imaging, Houston, TX 77030 USA.; Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA.; Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	barrett.harvey@uth.tmc		van Hoof, Ambro/0000-0002-7800-9764	John S. Dunn Foundation; National Institutes of Health (NIH) from NIAID [R01 AI047923-14, R01 GM099790]; National Science Foundation (NSF) [MCB-1020739]; Dunn Foundation; NIH from NIAID [R01 AI047923-14]; NSF [MCB-1020739]; NIH [R01 GM099790]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099790] Funding Source: NIH RePORTER	John S. Dunn Foundation; National Institutes of Health (NIH) from NIAID; National Science Foundation (NSF)(National Science Foundation (NSF)); Dunn Foundation; NIH from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was provided in part by the John S. Dunn Foundation to BRH, the National Institutes of Health (NIH) grant R01 AI047923-14 from NIAID to BEM and grant R01 GM099790 to AvH, and by the National Science Foundation (NSF) grant MCB-1020739 to AvH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for this work was provided in part by the Dunn Foundation to BRH, NIH grant R01 AI047923-14 from NIAID to BEM and NSF MCB-1020739, NIH R01 GM099790 to AvH.	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2007, J BACTERIOL, V189, P6490, DOI 10.1128/JB.00594-07; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Bugrysheva JV, 2010, MOL MICROBIOL, V75, P731, DOI 10.1111/j.1365-2958.2009.07012.x; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Condon C, 1996, P NATL ACAD SCI USA, V93, P6992, DOI 10.1073/pnas.93.14.6992; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; Condon C, 2011, CURR OPIN MICROBIOL, V14, P148, DOI 10.1016/j.mib.2011.01.010; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DebRoy S, 2014, SCIENCE, V345, P937, DOI 10.1126/science.1255091; Deikus G, 2008, J BIOL CHEM, V283, P17158, DOI 10.1074/jbc.M801461200; Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Gao P, 2010, J BACTERIOL; Gao P, 2013, J BACTERIOL, V195, P4761, DOI 10.1128/JB.00706-13; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; Kinder M, 2015, MABS-AUSTIN, V7, P494, DOI 10.1080/19420862.2015.1022692; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Nannini EC, 2005, INFECT IMMUN, V73, P7772, DOI 10.1128/IAI.73.11.7772-7774.2005; Newman JA, 2011, STRUCTURE, V19, P1241, DOI 10.1016/j.str.2011.06.017; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pinkston KL, 2014, INFECT IMMUN, V82, P1540, DOI 10.1128/IAI.01403-13; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Shioya K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023948; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; Sinturel F, 2009, RNA, V15, P2057, DOI 10.1261/rna.1670909; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Xu Y, 1997, INFECT IMMUN, V65, P4207, DOI 10.1128/IAI.65.10.4207-4215.1997; Yao SY, 2007, NUCLEIC ACIDS RES, V35, P4464, DOI 10.1093/nar/gkm460	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175212	10.1371/journal.pone.0175212	http://dx.doi.org/10.1371/journal.pone.0175212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384222	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900121
J	Heyselaar, E; Hagoort, P; Segaert, K				Heyselaar, Evelien; Hagoort, Peter; Segaert, Katrien			How social opinion influences syntactic processing-An investigation using virtual reality	PLOS ONE			English	Article							LANGUAGE PRODUCTION; RESPONSES; COMPUTERS; COMMUNICATION; PERSISTENCE; PERCEPTION; BEHAVIOR	The extent to which you adapt your grammatical choices to match that of your interlocutor's (structural priming) can be influenced by the social opinion you have of your interlocutor. However, the direction and reliability of this effect is unclear as different studies have reported seemingly contradictory results. We have operationalized social perception as the ratings of strangeness for different avatars in a virtual reality study. The use of avatars ensured maximal control over the interlocutor's behaviour and a clear dimension along which to manipulate social perceptions toward this interlocutor. Our results suggest an inverted U-shaped curve in structural priming magnitude for passives as a function of strangeness: the participants showed the largest priming effects for the intermediately strange, with a decrease when interacting with the least- or most-strange avatars. The relationship between social perception and priming magnitude may thus be non-linear. There seems to be a 'happy medium' in strangeness, evoking the largest priming effect. We did not find a significant interaction of priming magnitude with any social perception.	[Heyselaar, Evelien; Hagoort, Peter] Max Planck Inst Psycholinguist, Neurobiol Language Dept, Nijmegen, Netherlands; [Hagoort, Peter] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Segaert, Katrien] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England	Max Planck Society; Radboud University Nijmegen; University of Birmingham	Heyselaar, E (corresponding author), Max Planck Inst Psycholinguist, Neurobiol Language Dept, Nijmegen, Netherlands.	evelien.heyselaar@mpi.nl	Heyselaar, Evelien/AAG-7354-2021; Hagoort, Peter/B-7417-2012; Segaert, Katrien/AAT-9387-2021	Segaert, Katrien/0000-0002-3002-5837				Andonova E, 2013, P 35 ANN C COGN SCI, p1738 ; Bargh J.A., 2012, PSYCHOL TODAY; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beck C., 2015, J BUS ETHICS, P1; Bergmann K., 2015, FRONTIERS ICT, V2, DOI [10.3389/fict.2015.00007, DOI 10.3389/FICT.2015.00007]; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; BOCK K, 1992, PSYCHOL REV, V99, P150, DOI 10.1037/0033-295X.99.1.150; Bower, 2012, BEHAV SCI, V181, P26, DOI [10.1002/scin.5591811025, DOI 10.1002/SCIN.5591811025]; Branigan HP, 2006, LANG COGNITIVE PROC, V21, P974, DOI 10.1080/016909600824609; Branigan HP, 2011, COGNITION, V121, P41, DOI 10.1016/j.cognition.2011.05.011; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; CHARNY IW, 1966, FAM PROCESS, V5, P179, DOI 10.1111/j.1545-5300.1966.00179.x; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Coyle JM, 2012, PLOS ONE, P7; Dale R, 2005, P 27 ANN M COGN SCI, P184; Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037/0022-3514.75.4.862; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Ferreira VS, 2006, LANG COGNITIVE PROC, V21, P1011, DOI 10.1080/016909600824609; Fogg BJ, 1997, CHI97 EXTENDED ABSTR; GILES H, 1992, HUM COMMUN RES, V18, P500, DOI 10.1111/j.1468-2958.1992.tb00570.x; Giles H., 1975, SPEECH STYLES SOCIAL; Giles Howard, 1991, CONTEXTS ACCOMMODATI; Gong L, 2008, COMPUT HUM BEHAV, V24, P1494, DOI 10.1016/j.chb.2007.05.007; Heyselaar E, 2017, BEHAV RES METHODS, V49, P46, DOI 10.3758/s13428-015-0688-7; Jaeger T.F., 2008, P 30 ANN C COGNITIVE, P1061; Johnson PCD, 2015, METHODS ECOL EVOL, V6, P133, DOI 10.1111/2041-210X.12306; Kuhlen AK, 2013, PSYCHON B REV, V20, P54, DOI 10.3758/s13423-012-0341-8; Lee EJ, 2010, COMPUT HUM BEHAV, V26, P665, DOI 10.1016/j.chb.2010.01.003; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; LOTT AJ, 1961, J ABNORM SOC PSYCH, V62, P408, DOI 10.1037/h0041109; MAURER RE, 1983, J COUNS PSYCHOL, V30, P158, DOI 10.1037/0022-0167.30.2.158; Moon Y, 2000, J CONSUM RES, V26, P323, DOI 10.1086/209566; Nass C, 2000, J SOC ISSUES, V56, P81, DOI 10.1111/0022-4537.00153; Nass C, 1999, J APPL SOC PSYCHOL, V29, P1093, DOI 10.1111/j.1559-1816.1999.tb00142.x; NATALE M, 1975, J PERS SOC PSYCHOL, V32, P790, DOI 10.1037/0022-3514.32.5.790; Pearson J, 2006, ADAPTIVE LANGUAGE BE, P1177; R Core Development Team, 2011, R LANG ENV STAT COMP; Scheepers C, 2003, COGNITION, V89, P179, DOI 10.1016/S0010-0277(03)00119-7; Schoot L, 2014, 20 ANN ARCH MECH LAN, P57; Schoot L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153521; Segaert K, 2011, PLOS ONE, P6; Segaert K., 2016, J MEM LANG; Street R.L., 1983, J LANG SOC PSYCHOL, V2, P37, DOI [DOI 10.1177/0261927X8300200103, 10.1177/0261927X8300200103]; Tesink CMJY, 2009, J COGNITIVE NEUROSCI, V21, P2085, DOI 10.1162/jocn.2008.21161; Van Berkum JJA, 2008, J COGNITIVE NEUROSCI, V20, P580, DOI 10.1162/jocn.2008.20054; Vitevitch MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079701; Weatherholtz K, 2014, LANG VAR CHANGE, V26, P387, DOI 10.1017/S0954394514000155; Whittinghill D. M., 2015, GAM DEV C SAN FRANC	52	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174405	10.1371/journal.pone.0174405	http://dx.doi.org/10.1371/journal.pone.0174405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384163	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900017
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			The prevalence of and factors associated with high-risk alcohol consumption in Korean adults: The 2009-2011 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BINGE DRINKING; PREDICTORS; DISEASE; MEN	Background The consequences of alcohol consumption on health outcomes are largely determined by two separate, but related, dimensions of drinking: the total volume of alcohol consumed and the pattern of drinking. Most epidemiological studies focus on the amount of alcohol consumed and do not consider the pattern of drinking. Objectives This study evaluated the prevalence of and factors associated with high-risk and heavy alcohol drinking in Korean adults. Methods This study analyzed 15,215 of the 28,009 participants in the 2009-2011 Korea National Health and Nutrition Examination Survey (KNHANES). High-risk alcohol drinking was defined as Alcohol Use Disorders Identification Test (AUDIT) scores >= 16, which provides a framework for intervention to identify hazardous and harmful drinking patterns as the cause of alcohol-use disorders, according to World Health Organization guidelines. Results The prevalence of high-risk drinking was 15.1%, with the highest prevalence of 17.2% in middle-aged adults (45-64 years). In men, the prevalence of high-risk alcohol drinking was 23.7%, with the highest prevalence found in middle-aged adults. In women, the prevalence of high-risk alcohol drinking was 4.2%, with the highest prevalence found in younger adults. Men had higher weighted mean AUDIT scores than women (10.0 vs. 4.0, P<0.001), and age was negatively associated with the AUDIT score (P<0.001). Elementary school graduates had higher mean AUDIT scores than senior high school (P = 0.003) or college (P<0.001) graduates. Regarding occupation, clerical support workers (P = 0.002) and service and sales workers (P<0.001) had higher mean AUDIT scores than managers and professionals. Logistic regression analyses of high-risk alcohol drinking using sex, age, education level, number of family members, household income, and occupation as covariates was performed. Women had a lower risk of high-risk alcohol drinking (odds ratio (OR) 0.14, 95% CI: 0.13-0.16, P<0.001) than men. Regarding age, compared to control subjects aged 19-29 years, adults aged 60-69 and older than 70 years had 0.67-(95% CI: 0.51-0.89, P = 0.005) and 0.29-fold (95% CI: 0.20-0.70, P<0.001) lower risks, respectively, of high-risk alcohol drinking, whereas adults aged 30-59 had an increased risk of high-risk alcohol drinking. Using elementary school graduates as controls, senior high school (OR: 0.70, 95% CI: 0.55-0.87, P = 0.002) and college (OR: 0.54, 95% CI: 0.42-0. 70, P<0.001) graduates had lower risks of high-risk alcohol drinking. Regarding occupation, compared to managers and professionals as controls, service and sales workers had a greater risk of high-risk alcohol drinking (OR: 1.36, 95% CI: 1.07-1.73, P = 0.011). The number of family members and household income did not influence high-risk alcohol drinking. Conclusions In a representative sample of Korean adults, the prevalence of high-risk alcohol drinking was 15.1%, with the highest prevalence of 28.3% found in middle-aged men (45-64 years). This study suggests that younger age, male sex, low education level, and service and sales workers are at risk for a high-risk drinking pattern.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Coll Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Coll Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Barnes AJ, 2013, AM J DRUG ALCOHOL AB, V39, P108, DOI 10.3109/00952990.2012.694537; Caetano R, 2016, AM J ADDICTION, V25, P478, DOI 10.1111/ajad.12418; Chung Woo-Jin, 2006, J Prev Med Public Health, V39, P21; da Costa JSD, 2004, REV SAUDE PUBL, V38, P284, DOI 10.1590/S0034-89102004000200019; Elisaus P, 2015, EUR J PUBLIC HLTH, V2015; Han SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150029; Hibell B, 2009, SUBSTANCE USE STUDEN; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000825; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Hong JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167210; Hong SW, 2015, ALCOHOL, V49, P275, DOI 10.1016/j.alcohol.2015.02.004; Hyeon JH, 2016, ASIA PAC J CLIN NUTR, V25, P308, DOI 10.6133/apjcn.2016.25.2.17; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; Kydd RM, 2015, ALCOHOL ALCOHOLISM, V50, P333, DOI 10.1093/alcalc/agu106; Moreira LB, 1996, J STUD ALCOHOL, V57, P253, DOI 10.15288/jsa.1996.57.253; Naimi TS, 2010, AM J PREV MED, V38, P201, DOI 10.1016/j.amepre.2009.09.039; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Parikh RB, 2015, AM J ADDICTION, V24, P621, DOI 10.1111/ajad.12275; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Song DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163222; Stickley A, 2013, ADDICT BEHAV, V38, P1988, DOI 10.1016/j.addbeh.2012.12.009; Tavolacci MP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2863-x; Torikka A, 2016, ALCOHOL ALCOHOL, V2016; Vladimirov D, 2016, SCAND J PUBLIC HEALT, V44, P249, DOI 10.1177/1403494815622088; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, WORLD PREV HEAV EP D; World Health Organization, 2015, WORLD LTOT ALC PER C	30	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175299	10.1371/journal.pone.0175299	http://dx.doi.org/10.1371/journal.pone.0175299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384270	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900150
J	Kasaras, A; Kunze, R				Kasaras, Alexis; Kunze, Reinhard			Dual-targeting of Arabidopsis DMP1 isoforms to the tonoplast and the plasma membrane	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASES; ENDOPLASMIC-RETICULUM; TRANSLATION INITIATION; PLANT-CELLS; GOLGI NETWORK; K+ CHANNEL; PROTEIN; LOCALIZATION; TRANSPORTERS; THALIANA	The reports of dual-targeted proteins in plants have steadily increased over the past years. The vast majority of these proteins are soluble proteins distributed between compartments of the non-secretory pathway, predominantly chloroplasts and mitochondria. In contrast, dual-targeted transmembrane proteins, especially of the secretory pathway, are rare and the mechanisms leading to their differential targeting remain largely unknown. Here, we report dual-targeting of the Arabidopsis DUF679 Membrane Protein 1 (DMP1) to the tonoplast (TP) and the plasma membrane (PM). In Arabidopsis and tobacco two equally abundant DMP1 isoforms are synthesized by alternative translation initiation: a full length protein, DMP1.1, and a truncated one, DMP1.2, which lacks the N-terminal 19 amino acids including a TP-targeting dileucine motif. Accumulation of DMP1.1 and DMP1.2 in the TP and the PM, respectively, is Brefeldin A-sensitive, indicating transit via the Golgi. However, DMP1.2 interacts with DMP1.1, leading to extensive rerouting of DMP1.2 to the TP and "eclipsed" localization of DMP1.2 in the PM where it is barely visible by confocal laser scanning micros-copy but clearly detectable by membrane fractionation. It is demonstrated that eGFP fusion to either DMP1 terminus can cause mistargeting artifacts: C-terminal fusion to DMP1.1 or DMP1.2 results in altered ER export and N-terminal fusion to DMP1.1 causes mistargeting to the PM, presumably by masking of the TP targeting signal. These results illustrate how the interplay of alternative translation initiation, presence or absence of targeting information and rerouting due to protein-protein interaction determines the ultimate distribution of a transmembrane protein between two membranes.	[Kasaras, Alexis; Kunze, Reinhard] Free Univ Berlin, Inst Biol Appl Genet, DCPS, Berlin, Germany	Free University of Berlin	Kunze, R (corresponding author), Free Univ Berlin, Inst Biol Appl Genet, DCPS, Berlin, Germany.	reinhard.kunze@fu-berlin.de		Kunze, Reinhard/0000-0002-3304-5550	Deutsche Forschungsgemeinschaft (Forschergruppe FOR 948) [KU715/10-2]	Deutsche Forschungsgemeinschaft (Forschergruppe FOR 948)	This work was supported by the Deutsche Forschungsgemeinschaft (Forschergruppe FOR 948 grant no. KU715/10-2 to RK).	Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Carrie C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25034; Carrie C, 2009, FEBS J, V276, P1187, DOI 10.1111/j.1742-4658.2009.06876.x; Carrie C, 2013, BBA-MOL CELL RES, V1833, P253, DOI 10.1016/j.bbamcr.2012.05.029; Cho EJ, 2011, MOL CELLS, V32, P459, DOI 10.1007/s10059-011-0150-3; Christensen AC, 2005, PLANT CELL, V17, P2805, DOI 10.1105/tpc.105.035287; CREISSEN G, 1995, PLANT J, V8, P167, DOI 10.1046/j.1365-313X.1995.08020167.x; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Duchene AM, 2001, J BIOL CHEM, V276, P15275, DOI 10.1074/jbc.M011525200; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; Gao CJ, 2012, PLANT CELL, V24, P2086, DOI 10.1105/tpc.112.096057; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grefen C, 2012, BIOTECHNIQUES, V53, P311, DOI 10.2144/000113941; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; Hooks KB, 2012, J PLANT PHYSIOL, V169, P1631, DOI 10.1016/j.jplph.2012.05.026; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jung C, 2011, TRAFFIC, V12, P1774, DOI 10.1111/j.1600-0854.2011.01276.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kasaras A, 2010, PLANT BIOLOGY, V12, P140, DOI 10.1111/j.1438-8677.2010.00381.x; Kasaras A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-54; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Komarova NY, 2012, TRAFFIC, V13, P1090, DOI 10.1111/j.1600-0854.2012.01370.x; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Larisch N, 2012, TRAFFIC, V13, P1012, DOI 10.1111/j.1600-0854.2012.01366.x; Lee J, 2011, PLANT CELL, V23, P1588, DOI 10.1105/tpc.110.082230; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Mackenzie SA, 2005, TRENDS CELL BIOL, V15, P548, DOI 10.1016/j.tcb.2005.08.007; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mikosch M, 2009, CURR OPIN PLANT BIOL, V12, P685, DOI 10.1016/j.pbi.2009.09.020; Mikosch M, 2009, TRAFFIC, V10, P1481, DOI 10.1111/j.1600-0854.2009.00962.x; Mitschke J, 2009, NEW PHYTOL, V183, P224, DOI 10.1111/j.1469-8137.2009.02832.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pedrazzini E, 2013, TRAFFIC, V14, P622, DOI 10.1111/tra.12051; Porter BW, 2015, PLANT SCI, V234, P174, DOI 10.1016/j.plantsci.2015.02.013; Puyaubert J, 2008, PLANT PHYSIOL, V146, P478, DOI 10.1104/pp.107.111534; Ratajczak R, 1999, PLANTA, V208, P205, DOI 10.1007/s004250050551; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Robert N, 2012, PLANT MOL BIOL, V78, P431, DOI 10.1007/s11103-012-9874-5; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; Schneider S, 2006, PLANT PHYSIOL, V141, P565, DOI 10.1104/pp.106.077123; Schwacke R, 2007, MOL GENET GENOMICS, V277, P631, DOI 10.1007/s00438-007-0214-4; Silva-Filho MC, 2003, CURR OPIN PLANT BIOL, V6, P589, DOI 10.1016/j.pbi.2003.09.008; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Sunderland PA, 2006, PLANT J, V47, P356, DOI 10.1111/j.1365-313X.2006.02791.x; Suwastika IN, 2008, CELL STRUCT FUNCT, V33, P185, DOI 10.1247/csf.08024; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Teardo E, 2011, BBA-BIOENERGETICS, V1807, P359, DOI 10.1016/j.bbabio.2010.11.008; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Wamboldt Y, 2009, PLANT CELL, V21, P157, DOI 10.1105/tpc.108.063644; Wang H, 2011, MOL PLANT, V4, P845, DOI 10.1093/mp/ssr011; Wang XF, 2014, PLANT CELL, V26, P4102, DOI 10.1105/tpc.114.129759; Weichert A, 2012, PLANTA, V235, P311, DOI 10.1007/s00425-011-1508-7; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Xicluna J, 2007, J BIOL CHEM, V282, P486, DOI 10.1074/jbc.M607607200; Yamada K, 2010, J BIOL CHEM, V285, P1138, DOI 10.1074/jbc.M109.054288; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yuen CYL, 2013, BIOMOLECULES, V3, P848, DOI 10.3390/biom3040848; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104	85	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174062	10.1371/journal.pone.0174062	http://dx.doi.org/10.1371/journal.pone.0174062			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384172	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900012
J	Brito, B				Brito, Brenda			Potential trajectories of the upcoming forest trading mechanism in Para State, Brazilian Amazon	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; DESIGNING PAYMENTS; DEFORESTATION; LESSONS	In 2012, the Brazilian government revised the federal Forest Code that governs the use of forest resources on rural properties. The revisions included a forest trading mechanism whereby landowners who deforested more than what is legally allowed before 2008 could absolve their deforestation "debts" by purchasing Environmental Reserve Quotas (CRA) from landowners who conserved more forest than legally required. CRA holds promise as a tool to complement command-and-control initiatives to reduce deforestation and incentivize restoration. However, the success of this instrument depends on how its implementation is governed. This study builds on a few recent assessments of the potential of the CRA in Brazil but that are focused on biophysical potential by assessing how a few key implementation decisions may influence the CRA market development. Specifically, this study estimates how decisions on who can participate will likely influence the potential forest surplus and forest debt for the CRA market, and takes into account governance characteristics relevant to the State of Para, eastern Amazonia. In particular, the study evaluates the effects in the CRA market eligibility after simulating a validation of properties in the environmental rural registry (CAR) and assessing different scenarios surrounding land tenure status of properties. Results show how regulatory decisions on CRA market eligibility will determine the extent to which CRA will serve as a tool to support forest conservation or as a low-cost path to help illegal deforesters to comply with legislation, but with limited additional environmental benefits. The study reviews regulatory options that would reduce the risk of forest oversupply, and thereby increase the additionality of the areas eligible for CRA. Overall, the study demonstrates the importance of including governance as well as biophysical characteristics in assessing the potential of forest trading tools to deliver additional environmental conservation and restoration benefits.	[Brito, Brenda] Stanford Univ, Stanford Law Sch, Palo Alto, CA 94304 USA; [Brito, Brenda] Amazon Inst People & Environm Imazon, Belem, Para, Brazil	Stanford University	Brito, B (corresponding author), Stanford Univ, Stanford Law Sch, Palo Alto, CA 94304 USA.; Brito, B (corresponding author), Amazon Inst People & Environm Imazon, Belem, Para, Brazil.	brendabrito@gmail.com			Capes (Comissao de Aperfeigoamento de Pessoal do Nivel Superior)/CsF-Lemann, Scholarship [94773-13-6]; Gordon and Betty Moore Foundation [4005]	Capes (Comissao de Aperfeigoamento de Pessoal do Nivel Superior)/CsF-Lemann, Scholarship; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by Capes (Comissao de Aperfeigoamento de Pessoal do Nivel Superior)/CsF-Lemann, Scholarship Proc 94773-13-6 (httplAwfw capes gov bri) and Gordon and Betty Moore Foundation, grant 4005 (https://www.moore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, COTAS RESERVA AMBIEN; [Anonymous], 2005, PAYMENTS ENV SERVICE; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Assuncao Juliano., 2012, DEFORESTATION SLOWDO; Barreto P, 2008, QUEM DONO AMAZO ONIA; Barreto Paulo, 2012, BRASIL ATINGIRA SUA; Brito B, 2015, REGULARIZACAO FUNDIA; Brito B, 2013, UNRESOLVED LAND TENU, P1; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Mcconnell V, 2003, WELL CAN MARKETS DEV; MDA, 2015, REL DES 2009 2014 PL; Micol L, 2013, POTENCIAL APLICAC CO; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nunes S, 2016, LAND USE POLICY, V57, P749, DOI 10.1016/j.landusepol.2016.04.022; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Soares B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152311; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Whately M, 2013, PROGRAMA MUNICIPIOS, P96; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010	22	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174154	10.1371/journal.pone.0174154	http://dx.doi.org/10.1371/journal.pone.0174154			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379984	Green Submitted, gold, Green Published			2022-12-27	WOS:000399353500033
J	Li, L; Dai, XY; Wang, Y; Yang, YF; Zhao, X; Wang, L; Zeng, MH				Li, Lin; Dai, Xingyang; Wang, Ying; Yang, Yanfei; Zhao, Xia; Wang, Lei; Zeng, Minghua			RNA-seq-based analysis of drug-resistant Salmonella enterica serovar Typhimurium selected in vivo and in vitro	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; INFECTION MODEL; SYSTEMS; EFFLUX; ANTIMICROBIALS; MECHANISMS; MUTATIONS	The aim of this study was to characterize the mechanism of fluoroquinolone (FQ) resistance in Salmonella Typhimurium. We established the Caenorhabditis elegans-Salmonella Typhimurium model to select for ciprofloxacin resistance in Salmonella Typhimurium colonizing C. elegans, generating the resistant strains TN4. Gradient doses of ciprofloxacin were used to generate the resistant strain TW4 in vitro. RNA sequencing was used to establish the whole-transcriptome profile of three strains of Salmonella Typhimurium. The gene expression patterns of resistant strains TN4 and TW4 differed from those of the parental strain. In TN4, 2,277 genes were differentially expressed (1,833 upregulated and 444 downregulated) relative to the parental strain, and in TW4, 3,464 genes were differentially expressed (3,433 upregulated and 31 downregulated). Among these differentially expressed genes, 28 were associated with drug resistance and 26 were associated with the two-component systems in the two resistant strains. Seven different pathways were significantly sffected in two strains. Efflux pump overexpression was identified as one of the main mechanisms underlying FQ resistance in the two resistant strains. TW4 differentially expressed more efflux pump genes than TN4 and most of these genes were more strongly expressed than in TN4. However, expression of the efflux pump repressor gene and the mar operon was downregulated in TN4 but not in TW4. Two-component systems are also important in drug resistance. Our findings provide an important basis for further studies of the complex network that regulate FQ resistance in Salmonella.	[Li, Lin; Dai, Xingyang; Wang, Ying; Yang, Yanfei; Zhao, Xia; Wang, Lei; Zeng, Minghua] Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China	Anhui Agricultural University	Zeng, MH (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China.	zmhahau@126.com	yang, yanfei/GZK-2283-2022; Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240	National Natural Science Foundation of China [31201957]; Key Program in the Youth Elite Support Plan in Universities of Anhui Province [gxyqZD2016041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program in the Youth Elite Support Plan in Universities of Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (grant number 31201957) and the Key Program in the Youth Elite Support Plan in Universities of Anhui Province (grant number gxyqZD2016041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Chen S, 2007, ANTIMICROB AGENTS CH, V51, P535, DOI 10.1128/AAC.00600-06; CLSI, 2013, PERFORMANCE STANDARD; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; Epstein H F, 1995, CAENORHABDITIS ELEGA; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hu WS, 2011, ANTIMICROB AGENTS CH, V55, P3829, DOI 10.1128/AAC.00216-11; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nishino K, 2002, J BACTERIOL, V184, P2319, DOI 10.1128/JB.184.8.2319-2323.2002; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Paulander W, 2007, ANTIMICROB AGENTS CH, V51, P766, DOI 10.1128/AAC.00615-06; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Randall LP, 2001, APPL ENVIRON MICROB, V67, P1190, DOI 10.1128/AEM.67.3.1190-1197.2001; ROSNER JL, 1994, J BACTERIOL, V176, P6262, DOI 10.1128/jb.176.20.6262-6269.1994; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Smith KP, 2009, ARCH MICROBIOL, V191, P903, DOI 10.1007/s00203-009-0521-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webber MA, 2001, ANTIMICROB AGENTS CH, V45, P1550, DOI 10.1128/AAC.45.5.1550-1552.2001	26	7	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175234	10.1371/journal.pone.0175234	http://dx.doi.org/10.1371/journal.pone.0175234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380031	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500108
J	Hu, HC; Chen, JKC; Tsai, CM; Chen, HY; Tung, TH; Li, LPH				Hu, Hao-Chun; Chen, Joshua Kuang-Chao; Tsai, Chia-Mi; Chen, Hsing-Yi; Tung, Tao-Hsin; Li, Lieber Po-Hung			Evolution of impedance field telemetry after one day of activation in cochlear implant recipients(vol 12, e0173367, 2017)	PLOS ONE			English	Correction													Li, Lieber/AAG-7397-2022; Li, Lieber/AFL-7454-2022		Cheng Hsin General Hospital [105-11]	Cheng Hsin General Hospital	This work was supported by Cheng Hsin General Hospital (105-11) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hu HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173367	1	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175833	10.1371/journal.pone.0175833	http://dx.doi.org/10.1371/journal.pone.0175833			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394922	gold, Green Published, Green Submitted			2022-12-27	WOS:000399954800049
J	Amagasa, S; Fukushima, N; Kikuchi, H; Oka, K; Takamiya, T; Odagiri, Y; Inoue, S				Amagasa, Shiho; Fukushima, Noritoshi; Kikuchi, Hiroyuki; Oka, Koichiro; Takamiya, Tomoko; Odagiri, Yuko; Inoue, Shigeru			Types of social participation and psychological distress in Japanese older adults: A five-year cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONGITUDINAL ANALYSIS; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; HEALTH; GENDER; ASSOCIATION; RISK; PERFORMANCE; PREDICTORS	Introduction The most effective type of social participation against psychological distress in older adults is not well documented. The aim of this study was to examine whether different types of social participation are associated with changes in psychological distress level in older men and women in Japan. Methods Two thousand seven hundred community-dwelling older adults (aged 65-74 years, 50% women) were randomly selected from the resident registry of three cities. Of these, participants who reported social participation and psychological distress level in the baseline survey in 2010 were followed up. Psychological distress was evaluated based on K6 scales at baseline and follow-up (in 2015). Social participation level was examined using question items from the National Health and Nutrition Survey in Japan. Exploratory factor analysis was used to derive the underlying factor structure. Multiple linear regression analysis was used to examine the association between social participation and changes in psychological distress level after adjusting for covariates stratified by both gender and age group or living arrangement. Results Data from 825 community-dwelling older adults (45.3% women) were analyzed. Social participation was categorized into two types using factor analysis: community involvement (volunteer activities, community events, clubs for the elderly) and individual relationship (friendship, communication with family and friends, hobbies). During the 5-year follow-up, 29.5% of participants reported a deterioration in psychological distress. Higher community involvement was independently associated with lower risk of psychological distress for older women (beta = 0.099, p = 0.047), whereas there were no associations with individual relationship for either gender. Furthermore, in older women living with others, higher community involvement was also associated with lower risk of psychological distress (beta = 0.110, p = 0.048). Conclusion Community involvement provides older women with mental health benefits regardless of individual relationship level. Promoting community involvement may be an effective strategy for healthy mental aging.	[Amagasa, Shiho; Fukushima, Noritoshi; Kikuchi, Hiroyuki; Takamiya, Tomoko; Odagiri, Yuko; Inoue, Shigeru] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan; [Oka, Koichiro] Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama, Japan	Tokyo Medical University; Waseda University	Inoue, S (corresponding author), Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan.	inoue@tokyo-med.ac.jp	Oka, Koichiro/K-3297-2019	Odagiri, Yuko/0000-0002-7603-4800; Amagasa, Shiho/0000-0002-6047-0771; Oka, Koichiro/0000-0001-5571-042X	Meiji Yasuda Life Foundation of Health and Welfare;  [25282209];  [16H03249];  [15H02964]	Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); ; ; 	This work received support from Grant in-Aid for Scientific Research (25282209) https://www.jsps.go.jp/english/e-grants/ (SI), Grant-in-Aid for Scientific Research (16H03249) https://www.jsps.go.jp/english/e-grants/ (SI), Grant-in-Aid for Scientific Research (15H02964) https://www.jsps.go.jp/english/e-grants/ (SI), and Meiji Yasuda Life Foundation of Health and Welfare http://www.my-zaidan.or.jp/ (NF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-249; BARNETT PA, 1988, PSYCHOL BULL, V104, P97, DOI 10.1037/0033-2909.104.1.97; Bath Peter A, 2005, Eur J Ageing, V2, P24, DOI 10.1007/s10433-005-0019-4; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Chiao C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-292; Croezen S, 2015, AM J EPIDEMIOL, V182, P168, DOI 10.1093/aje/kwv015; Demura Shinichi, 2003, Journal of Physiological Anthropology and Applied Human Science, V22, P159, DOI 10.2114/jpa.22.159; Domenech-Abella J, 2017, SOCIAL PSYCHIAT PSYC; Drapeau A., 2011, MENTAL ILLNESSES UND; Ferrari AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069637; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057; HUPPERT FA, 1995, PSYCHOL MED, V25, P1073, DOI 10.1017/S0033291700037569; Inoue S, 2011, J EPIDEMIOL, V21, P481, DOI 10.2188/jea.JE20110044; KASPER J, 1995, J MENTAL HLTH AGING, V0001; Kavanagh AM, 2006, J EPIDEMIOL COMMUN H, V60, P490, DOI 10.1136/jech.2005.043562; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kendler KS, 2005, AM J PSYCHIAT, V162, P250, DOI 10.1176/appi.ajp.162.2.250; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177; Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076; Levasseur M, 2008, AM J PHYS MED REHAB, V87, P830, DOI 10.1097/PHM.0b013e318186b5bd; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Levasseur Melanie, 2009, Arch Gerontol Geriatr, V49, pe91, DOI 10.1016/j.archger.2008.08.013; Mirowsky J, 2002, J HEALTH SOC BEHAV, V43, P152, DOI 10.2307/3090194; Norton MC, 2006, J GERONTOL B-PSYCHOL, V61, pP129, DOI 10.1093/geronb/61.3.P129; Ojike N, 2016, CARDIORENAL MED, V6, P198, DOI 10.1159/000443933; Phyllis Moen, 1992, AM J SOCIOLOGY, V97; Robinson KL, 2004, ANN EPIDEMIOL, V14, P467, DOI 10.1016/j.annepidem.2003.11.007; Roh HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132838; Rosness TA, 2016, AGING MENT HEALTH, V20, P603, DOI 10.1080/13607863.2015.1031639; Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Schmitz N, 2009, CAN J PSYCHIAT, V54, P526, DOI 10.1177/070674370905400805; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, pP227, DOI 10.1093/geronb/63.4.P227; Takagi D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-701; Tokuda Y, 2009, VALUE HEALTH, V12, P568, DOI 10.1111/j.1524-4733.2008.00449.x; Tomioka K, 2016, J GERONTOLOGY B; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875; von Bonsdorff MB, 2011, AGING CLIN EXP RES, V23, P162, DOI 10.3275/7200; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Zebhauser A, 2015, AGING MENT HEALTH, V19, P773, DOI 10.1080/13607863.2014.977769	45	56	58	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175392	10.1371/journal.pone.0175392	http://dx.doi.org/10.1371/journal.pone.0175392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388661	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800048
J	Baghaie, A; Tafti, AP; Owen, HA; D'Souza, RM; Yu, ZY				Baghaie, Ahmadreza; Tafti, Ahmad Pahlavan; Owen, Heather A.; D'Souza, Roshan M.; Yu, Zeyun			Three-dimensional reconstruction of highly complex microscopic samples using scanning electron microscopy and optical flow estimation	PLOS ONE			English	Article							3D RECONSTRUCTION; SURFACE RECONSTRUCTION; SEM; STEREO; PHOTOGRAMMETRY; NANOPARTICLES; IMAGES	Scanning Electron Microscope (SEM) as one of the major research and industrial equipment for imaging of micro-scale samples and surfaces has gained extensive attention from its emerge. However, the acquired micrographs still remain two-dimensional (2D). In the current work a novel and highly accurate approach is proposed to recover the hidden third-dimension by use of multi-view image acquisition of the microscopic samples combined with pre/postprocessing steps including sparse feature-based stereo rectification, nonlocal-based optical flow estimation for dense matching and finally depth estimation. Employing the proposed approach, three-dimensional (3D) reconstructions of highly complex microscopic samples were achieved to facilitate the interpretation of topology and geometry of surface/shape attributes of the samples. As a byproduct of the proposed approach, high-definition 3D printed models of the samples can be generated as a tangible means of physical understanding. Extensive comparisons with the state-of-the-art reveal the strength and superiority of the proposed method in uncovering the details of the highly complex microscopic samples.	[Baghaie, Ahmadreza] Univ Wisconsin, Dept Elect Engn, Milwaukee, WI 53201 USA; [Tafti, Ahmad Pahlavan] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Owen, Heather A.] Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA; [D'Souza, Roshan M.] Univ Wisconsin, Dept Mech Engn, Milwaukee, WI 53201 USA; [Yu, Zeyun] Univ Wisconsin, Dept Elect Engn & Comp Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Baghaie, A (corresponding author), Univ Wisconsin, Dept Elect Engn, Milwaukee, WI 53201 USA.	abaghaie@uwm.edu	P. Tafti, Ahmad/ABC-1866-2021; Valiyaveettill, Suresh/D-4848-2009; Baghaie, Ahmadreza/H-9772-2019	P. Tafti, Ahmad/0000-0001-9650-2862; Valiyaveettill, Suresh/0000-0001-6990-660X; Baghaie, Ahmadreza/0000-0002-4496-8940				Aguilar J. J., 1996, Measurement, V18, P193, DOI 10.1016/S0263-2241(96)00065-6; Anbarasu M, 2015, SPECTROCHIM ACTA A, V135, P536, DOI 10.1016/j.saa.2014.07.059; Augusto I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161184; Baghaie A, 2017, J IMAGING, V3, DOI 10.3390/jimaging3010012; Baghaie A, 2015, LECT NOTES COMPUT SC, V9474, P406, DOI 10.1007/978-3-319-27857-5_37; Baghaie A, 2014, LECT NOTES COMPUT SC, V8888, P1, DOI 10.1007/978-3-319-14364-4_1; Baghaie A, 2014, LECT NOTES COMPUT SC, V8641, P69, DOI 10.1007/978-3-319-09994-1_7; Bettini E, 2011, ELECTROCHIM ACTA, V56, P9413, DOI 10.1016/j.electacta.2011.08.028; Black MJ, 1996, COMPUT VIS IMAGE UND, V63, P75, DOI 10.1006/cviu.1996.0006; BROWNRIGG DRK, 1984, COMMUN ACM, V27, P807, DOI 10.1145/358198.358222; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Carli L, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/3/035103; Cignoni P, 2008, ERCIM NEWS, V73, P6; Connell JL, 2013, P NATL ACAD SCI USA, V110, P18380, DOI 10.1073/pnas.1309729110; Danzl R, 2001, INTEGRATING SHAPE FR; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Egerton R., 2005, PHYS PRINCIPLES ELEC; Eulitz M, 2015, J STRUCT BIOL, V191, P190, DOI 10.1016/j.jsb.2015.06.010; Faugeras O. D., 1988, International Journal of Pattern Recognition and Artificial Intelligence, V2, P485, DOI 10.1142/S0218001488000285; Fortun D, 2015, COMPUT VIS IMAGE UND, V134, P1, DOI 10.1016/j.cviu.2015.02.008; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Fusiello A, 2008, INT C PATT RECOG, P1490; Gontard LC, 2016, ULTRAMICROSCOPY, V169, P80, DOI 10.1016/j.ultramic.2016.07.006; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hughes L, 2014, PROTOPLASMA, V251, P395, DOI 10.1007/s00709-013-0580-1; Kim Ki Woo, 2016, [Applied Microscopy, 한국현미경학회지], V46, P71; Kodama T, 2005, J ELECTRON MICROSC, V54, P429, DOI 10.1093/jmicro/dfi062; KOENDERINK JJ, 1991, J OPT SOC AM A, V8, P377, DOI 10.1364/JOSAA.8.000377; Li YY, 2009, COMMUN MATH SCI, V7, P741; Limandri S, 2016, MICRON, V84, P54, DOI 10.1016/j.micron.2016.02.001; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma ZY, 2013, IEEE I CONF COMP VIS, P49, DOI 10.1109/ICCV.2013.13; Marinello F, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/6/065705; Marr D, 1991, RETINA NEOCORTEX, P263; Matsumoto Y., 2000, Proceedings Fourth IEEE International Conference on Automatic Face and Gesture Recognition (Cat. No. PR00580), P499, DOI 10.1109/AFGR.2000.840680; Moisan L, 2004, INT J COMPUT VISION, V57, P201, DOI 10.1023/B:VISI.0000013094.38752.54; Monasse P, 2011, IMAGE PROCESS ON LIN, V1, P187, DOI 10.5201/ipol.2011.m_qer; Morita S., 2015, NONCONTACT ATOMIC FO; Narayan K, 2015, NAT METHODS, V12, P1021, DOI [10.1038/NMETH.3623, 10.1038/nmeth.3623]; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Paluszynski J, 2005, VACUUM, V78, P533, DOI 10.1016/j.vacuum.2005.01.081; Peddie CJ, 2014, MICRON, V61, P9, DOI 10.1016/j.micron.2014.01.009; Pintus R, 2008, IEEE T INSTRUM MEAS, V57, P989, DOI 10.1109/TIM.2007.911580; Raspanti M, 2005, MICROSC RES TECHNIQ, V67, P1, DOI 10.1002/jemt.20176; Roy S, 2012, IEEE ENG MED BIO, P4361, DOI 10.1109/EMBC.2012.6346932; Samak D, 2007, CIRP ANN-MANUF TECHN, V56, P149, DOI 10.1016/j.cirp.2007.05.036; Sand Peter, 2008, International Journal of Computer Vision, V80, P72, DOI 10.1007/s11263-008-0136-6; Schmidt R, 2010, ACM SIGGRAPH 2010 TA, V2010, P6; Shen SH, 2013, IEEE T IMAGE PROCESS, V22, P1901, DOI 10.1109/TIP.2013.2237921; Slowko W, 2013, ACTA PHYS POL A, V123, P877, DOI [10.1263/APhysPolA.123.877, 10.12693/APhysPolA.123.877]; Strelcov E, 2015, NANOSCALE, V7, P3022, DOI 10.1039/c4nr06767c; Sun DQ, 2014, INT J COMPUT VISION, V106, P115, DOI 10.1007/s11263-013-0644-x; Sun DQ, 2010, PROC CVPR IEEE, P2432, DOI 10.1109/CVPR.2010.5539939; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Tafti A.P., 2016, COMPUT METHOD BIOMEC, P1; Tafti AP, 2016, MICRON, V87, P33, DOI 10.1016/j.micron.2016.05.004; Tafti AP, 2015, MICRON, V78, P54, DOI 10.1016/j.micron.2015.07.005; Tola E, 2010, IEEE T PATTERN ANAL, V32, P815, DOI 10.1109/TPAMI.2009.77; Ubelaker DH, 2002, J FORENSIC SCI, V47, P19; Volkert CA, 2007, MRS BULL, V32, P389, DOI 10.1557/mrs2007.62; Vynnyk T., 2010, J EUR OPT SOC, V5; Wang TR, 2016, INT J PHARMACEUT, V511, P219, DOI 10.1016/j.ijpharm.2016.07.005; WOODHAM RJ, 1980, OPT ENG, V19, P139, DOI 10.1117/12.7972479; Xiao JJ, 2006, LECT NOTES COMPUT SC, V3951, P211; Xie J., 2011, APPL NOTE; Yoon KJ, 2006, IEEE T PATTERN ANAL, V28, P650, DOI 10.1109/TPAMI.2006.70; Zhang Q, 2014, PROC CVPR IEEE, P2830, DOI 10.1109/CVPR.2014.362; Zhou W., 2007, SCAN ELECTRON MICROS; Zolotukhin A. A., 2013, Pattern Recognition and Image Analysis, V23, P168, DOI 10.1134/S105466181301015X	73	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175078	10.1371/journal.pone.0175078	http://dx.doi.org/10.1371/journal.pone.0175078			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384216	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900081
J	Dasch, B; Kalies, H; Feddersen, B; Ruderer, C; Hiddemann, W; Bausewein, C				Dasch, Burkhard; Kalies, Helen; Feddersen, Berend; Ruderer, Caecilie; Hiddemann, Wolfgang; Bausewein, Claudia			Care of cancer patients at the end of life in a German university hospital: A retrospective observational study from 2014	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EARLY PALLIATIVE CARE; CELL LUNG-CANCER; SINGLE-CENTER ANALYSIS; OF-LIFE; CHEMOTHERAPY USE; CARDIOPULMONARY-RESUSCITATION; MEDICINE CONSULTATION; QUALITY; ONCOLOGY	Background Cancer care including aggressive treatment procedures during the last phase of life in patients with incurable cancer has increasingly come under scrutiny, while integrating specialist palliative care at an early stage is regarded as indication for high quality end-of-life patient care. Aim To describe the demographic and clinical characteristics and the medical care provided at the end of life of cancer patients who died in a German university hospital. Methods Retrospective cross-sectional study on the basis of anonymized hospital data for cancer patients who died in the Munich University Hospital in 2014. Descriptive analysis and multivariate logistic regression analyses for factors influencing the administration of aggressive treatment procedures at the end of life. Results Overall, 532 cancer patients died. Mean age was 66.8 years, 58.5% were men. 110/532 (20.7%) decedents had hematologic malignancies and 422/532 (79.3%) a solid tumor. Patients underwent the following medical interventions in the last 7/30 days: chemotherapy (7.7%/38.3%), radiotherapy (2.6%/6.4%), resuscitation (8.5%/10.5%), surgery (15.2%/31.0%), renal replacement therapy (12.0%/16.9%), blood transfusions (21.2%/39.5%), CT scan (33.8%/60.9%). In comparison to patients with solid tumors, patients with hematologic malignancies were more likely to die in intensive care (25.4% vs. 49.1%; p = 0.001), and were also more likely to receive blood transfusions (OR 2.21; 95% CI, 1.36 to 3.58; p = 0.001) and renal replacement therapy (OR 2.65; 95% CI, 1.49 to 4.70; p = 0.001) in the last 7 days of life. Contact with the hospital palliative care team had been initiated in 161/532 patients (30.3%). In 87/161 cases (54.0%), the contact was initiated within the last week of the patient's life. Conclusions Overambitious treatments are still reality at the end of life in cancer patients in hospital but patients with solid tumors and hematologic malignancies have to be differentiated. More efforts are necessary for the timely inclusion of specialist palliative care.	[Dasch, Burkhard; Kalies, Helen; Feddersen, Berend; Bausewein, Claudia] Ludwig Maximilian Univ Munich, Munich Univ Hosp, Dept Palliat Med, Munich, Germany; [Ruderer, Caecilie] Specialized Palliat Home Care, Dist Of Berchtesgaden, Germany; [Ruderer, Caecilie] Specialized Palliat Home Care, Dist Of Traunstein, Germany; [Hiddemann, Wolfgang] Ludwig Maximilian Univ Munich, Munich Univ Hosp, Dept Internal Med 3, Munich, Germany	University of Munich; University of Munich	Dasch, B (corresponding author), Ludwig Maximilian Univ Munich, Munich Univ Hosp, Dept Palliat Med, Munich, Germany.	burkharddasch@web.de		Bausewein, Claudia/0000-0002-0958-3041				Adam H, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-26; American Society of Clinical Oncology (ASCO), INT PALL CAR STAND O; Assi T, 2016, SUPPORT CARE CANCER, V24, P1603, DOI 10.1007/s00520-015-2959-3; Bailey FA, 2012, J PALLIAT MED, V15, P751, DOI 10.1089/jpm.2011.0321; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Bausewein C, 2016, PALLIATIVE MED, V30, P6, DOI 10.1177/0269216315589898; BEDELL SE, 1984, NEW ENGL J MED, V310, P1089, DOI 10.1056/NEJM198404263101706; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Billingham MJ, 2013, BMJ SUPPORT PALLIAT, V3, P144, DOI 10.1136/bmjspcare-2012-000292; Bird GT, 2012, BRIT J ANAESTH, V108, P452, DOI 10.1093/bja/aer449; Boyaci N, 2014, HEMATOLOGY, V19, P338, DOI 10.1179/1607845413Y.0000000130; Braga S, 2007, PSYCHO-ONCOL, V16, P863, DOI 10.1002/pon.1140; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Chen JS, 2009, RESUSCITATION, V80, P1388, DOI 10.1016/j.resuscitation.2009.08.015; Cherny N, 2010, ANN ONCOL, V21, P362, DOI 10.1093/annonc/mdp318; Chu DT, 2009, LUNG CANCER, V66, P250, DOI 10.1016/j.lungcan.2009.01.022; Cohen J, 2015, BRIT J CANCER, V113, P1397, DOI 10.1038/bjc.2015.312; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Dalgaard KM, 2014, PALLIAT SUPPORT CARE, V12, P495, DOI 10.1017/S1478951513001338; Davis MP, 2015, ANN PALLIAT MED, V4, P99, DOI 10.3978/j.issn.2224-5820.2015.04.04; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fadul N, 2009, CANCER-AM CANCER SOC, V115, P2013, DOI 10.1002/cncr.24206; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Gaertner J, 2015, ANN PALLIAT MED, V4, P156, DOI 10.3978/j.issn.2224-5820.2015.07.02; Gaertner J, 2011, SUPPORT CARE CANCER, V19, P1037, DOI 10.1007/s00520-011-1131-y; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Howell Debra A, 2010, BMC Palliat Care, V9, P9, DOI 10.1186/1472-684X-9-9; Hui D, 2015, ANN PALLIAT MED, V4, P89, DOI 10.3978/j.issn.2224-5820.2015.04.01; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1572, DOI 10.1002/cncr.28614; Kao S, 2009, ANN ONCOL, V20, P1555, DOI 10.1093/annonc/mdp027; Klinger CA, 2014, PALLIATIVE MED, V28, P111, DOI 10.1177/0269216313493342; Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft Deutsche Krebshilfe AWMF), 2015, PALL PAT NICHT HEILB; Lordick F, 2012, FORUM, V27, P367; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; Magarotto R, 2011, TUMORI J, V97, P573, DOI 10.1700/989.10714; Martoni AA, 2007, TUMORI J, V93, P417; May P, 2014, J PALLIAT MED, V17, P1054, DOI 10.1089/jpm.2013.0594; Murillo JR, 2006, ONCOLOGIST, V11, P1095, DOI 10.1634/theoncologist.11-10-1095; Nappa U, 2011, ANN ONCOL, V22, P2375, DOI 10.1093/annonc/mdq778; Pacetti P, 2015, SUPPORT CARE CANCER, V23, P3277, DOI 10.1007/s00520-015-2733-6; Pantilat SZ, 2010, ARCH INTERN MED, V170, P2038, DOI 10.1001/archinternmed.2010.460; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; Radbruch L, 2015, ANAL SELECTED TREATM; Reisfield GM, 2006, RESUSCITATION, V71, P152, DOI 10.1016/j.resuscitation.2006.02.022; Saito AM, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-14; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Starks H, 2013, J PALLIAT MED, V16, P1215, DOI 10.1089/jpm.2013.0163; Swetz KM, 2010, CANCER J, V16, P467, DOI 10.1097/PPO.0b013e3181f28ab3; Taberner Bonastre Pilar, 2016, Farm Hosp., V40, P14, DOI 10.7399/fh.2016.40.1.8918; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Yun YH, 2007, ONCOLOGY-BASEL, V72, P164, DOI 10.1159/000112802; Zhi WI, 2015, ANN PALLIAT MED, V4, P122, DOI 10.3978/j.issn.2224-5820.2015.07.03; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	65	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175124	10.1371/journal.pone.0175124	http://dx.doi.org/10.1371/journal.pone.0175124			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384214	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900093
J	Esposito, F; Angileri, FF; Kruse, P; Cavallo, LM; Solari, D; Esposito, V; Tomasell, F; Cappabianca, P				Esposito, Felice; Angileri, Filippo Flavio; Kruse, Peter; Cavallo, Luigi Maria; Solari, Domenico; Esposito, Vincenzo; Tomasell, Francesco; Cappabianca, Paolo			Fibrin Sealants in Dura Sealing: A Systematic Literature Review (vol 11, e0151533, 2016)	PLOS ONE			English	Correction									[Esposito, Vincenzo] IRCCS Neuromed, Pozzilli, Isernia, Italy	IRCCS Neuromed			Esposito, Felice/F-4238-2012; Angileri, Filippo/AAL-4851-2021; Esposito, Felice/AAC-4646-2019; Esposito, Vincenzo/E-9994-2011	Esposito, Felice/0000-0003-1051-5924; Esposito, Felice/0000-0003-1051-5924; Esposito, Vincenzo/0000-0001-7316-5461				Esposito F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151533	1	1	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175619	10.1371/journal.pone.0175619	http://dx.doi.org/10.1371/journal.pone.0175619			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384304	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900193
J	Hall, JA; Yerramilli, M; Obare, E; Li, J; Yerramilli, M; Jewell, DE				Hall, Jean A.; Yerramilli, Maha; Obare, Edward; Li, Jun; Yerramilli, Murthy; Jewell, Dennis E.			Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones	PLOS ONE			English	Article							CALCIUM-OXALATE; FUNCTION BIOMARKERS; IDENTICAL-TWINS; URINARY-TRACT; RENAL-DISEASE; NEPHROLITHIASIS; RISK; DOGS; MINNESOTA; UROLITHS	Serum concentrations of symmetric dimethylarginine (SDMA) correlate with renal function in cats and SDMA has been shown to be a more reliable and earlier marker for chronic kidney disease (CKD) compared with serum creatinine (Cr). Calcium oxalate uroliths tend to develop in mid-to-older aged cats and kidney stones may cause a reduction in renal function with increased SDMA, but normal serum Cr. The purpose of this retrospective study was to determine if cats with kidney stones had increased serum SDMA concentrations, and whether SDMA increased earlier than serum creatinine concentrations. Cats in the colony with kidney stones diagnosed between August 2010 and December 2015 (n = 43) were compared with healthy geriatric cats (n = 21) without kidney stones. Serum SDMA concentrations were determined by liquid chromatography-mass spectrometry and serum Cr concentrations were determined by enzymatic colorimetry. Cats with kidney stones were diagnosed antemortem by radiographic imaging (n = 12) or by postmortem necropsy (n = 31). Retrospectively, serum SDMA was found to be increased above the upper reference limit in 39 of 43 cats with kidney stones. Serum Cr was increased above the upper reference limit in 18 of 43 cats; 6 of these 18 cats had terminal azotemia only. The mean time that serum SDMA was increased before serum Cr was increased was 26.9 months (range 0 to 60 months). Kidney stones were composed of calcium oxalate in 30 of 34 cats. The lifespan for cats with kidney stones (mean, 12.5 years; range, 6.1 to 18.1 years) was shorter (P < 0.001) than for control cats (mean, 15.2 years; range, 13.0 to 17.2 years), suggesting that non-obstructive kidney stones have an effect on mortality rate or rate of CKD progression. In conclusion, if SDMA concentrations are elevated in mid-to-older aged cats, further imaging studies are warranted to check for the presence of kidney stones.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Yerramilli, Maha; Obare, Edward; Li, Jun; Yerramilli, Murthy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA; [Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS; IDEXX Laboratories, Inc	performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS; IDEXX Laboratories, Inc	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hilispetcom/our-company.html). Hill's Pet Nutrition, Inc. and IDEXX Laboratories, Inc. provided support in the form of salaries for authors [DJ] and [MY,EO,JL, MY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams LG, 2013, NEW ZEAL VET J, V61, P212, DOI 10.1080/00480169.2013.775691; Bartges JW, 2013, AM J VET RES, V74, P1347, DOI 10.2460/ajvr.74.10.1347; Bartges JW, 1999, VET CLIN N AM-SMALL, V29, P45, DOI 10.1016/S0195-5616(99)50004-1; Berent AC, 2011, J VET EMERG CRIT CAR, V21, P86, DOI 10.1111/j.1476-4431.2011.00628.x; Cannon AB, 2007, JAVMA-J AM VET MED A, V231, P570, DOI 10.2460/javma.231.4.570; Goldfarb DS, 2005, KIDNEY INT, V67, P1053, DOI 10.1111/j.1523-1755.2005.00170.x; Haleblian GE, 2007, BJU INT, V100, P621, DOI 10.1111/j.1464-410X.2007.06936.x; Hall JA, 2016, J VET INTERN MED, V30, P794, DOI 10.1111/jvim.13942; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; HERRING LC, 1962, J UROLOGY, V88, P545, DOI 10.1016/S0022-5347(17)64842-0; Hesse A, 1984, URINARY STONE, P57; HIATT RA, 1982, KIDNEY INT, V22, P63, DOI 10.1038/ki.1982.133; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Keddis MT, 2013, CURR OPIN NEPHROL HY, V22, P390, DOI 10.1097/MNH.0b013e32836214b9; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; KIRK CA, 1995, J AM VET MED ASSOC, V207, P1429; Monga M, 2006, J UROLOGY, V175, P2125, DOI 10.1016/S0022-5347(06)00272-2; Monico CG, 2008, AM J KIDNEY DIS, V52, P1096, DOI 10.1053/j.ajkd.2008.07.041; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P183, DOI 10.1016/j.cvsm.2008.09.011; ROBERTSON WG, 1978, BRIT J UROL, V50, P449, DOI 10.1111/j.1464-410X.1978.tb06189.x; Ross SJ, 2007, JAVMA-J AM VET MED A, V230, P1854, DOI 10.2460/javma.230.12.1854; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; SOUCIE JM, 1994, KIDNEY INT, V46, P893, DOI 10.1038/ki.1994.347; Whitley E, 2002, CRIT CARE, V6, P509, DOI 10.1186/cc1820	29	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174854	10.1371/journal.pone.0174854	http://dx.doi.org/10.1371/journal.pone.0174854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384169	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900042
J	Lichtenhan, JT; Hirose, K; Buchman, CA; Duncan, RK; Salt, AN				Lichtenhan, J. T.; Hirose, K.; Buchman, C. A.; Duncan, R. K.; Salt, A. N.			Direct administration of 2-Hydroxypropyl-Beta-Cyclodextrin into guinea pig cochleae: Effects on physiological and histological measurements	PLOS ONE			English	Article							OUTER HAIR CELL; LOW-FREQUENCY; OPERATING POINT; OTOACOUSTIC EMISSIONS; DRUG-DELIVERY; HEARING-LOSS; SALICYLATE; ELECTROMOTILITY; PERILYMPH; PRESTIN	2-Hydroxypropyl-Beta-Cyclodextrin (HP beta CD) can be used to treat Niemann-Pick type C disease, Alzheimer's disease, and atherosclerosis. But, a consequence is that HP beta CD can cause hearing loss. HP beta CD was recently found to be toxic to outer hair cells (OHCs) in the organ of Corti. Previous studies on the chronic effects of in vivo HP beta CD toxicity did not know the intra-cochlear concentration of HP beta CD and attributed variable effects on OHCs to indirect drug delivery to the cochlea. We studied the acute effects of known HP beta CD concentrations administered directly into intact guinea pig cochleae. Our novel approach injected solutions through pipette sealed into scala tympani in the cochlear apex. Solutions were driven along the length of the cochlear spiral toward the cochlear aqueduct in the base. This method ensured that therapeutic levels were achieved throughout the cochlea, including those regions tuned to mid to low frequencies and code speech vowels and background noise. A wide variety of measurements were made. Results were compared to measurements from ears treated with the HP beta CD analog methyl-beta-cyclodextrin (M beta CD), salicylate that is well known to attenuate the gain of the cochlear amplifier, and injection of artificial perilymph alone (controls). Histological data showed that OHCs appeared normal after treatment with a low dose of HP beta CD, and physiological data was consistent with attenuation of cochlear amplifier gain and disruption of non-linearity associated with transferring acoustic sound into neural excitation, an origin of distortion products that are commonly used to objectively assess hearing and hearing loss. A high dose of HP beta CD caused sporadic OHC losses and markedly affected all physiologic measurements. M beta CD caused virulent destruction of OHCs and physiologic responses. Toxicity of HP beta CD to OHC along the cochlear length is variable even when a known intra-cochlear concentration is administered, at least for the duration of our acute studies.	[Lichtenhan, J. T.; Hirose, K.; Buchman, C. A.; Salt, A. N.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Duncan, R. K.] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Lichtenhan, JT (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	jlichtenhan@wustl.edu		Salt, Alec/0000-0003-3462-9256; Lichtenhan, Jeffery/0000-0002-6050-7845	National Institutes of Health [RO1 DC014997, RO1 DC011315, RO1 DC001368]; National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014997, R01DC001368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by RO1 DC014997 (J.T.L.), RO1 DC011315 (K.H.), and RO1 DC001368 (A.N.S.) from the National Institutes of Health, National Institute on Deafness and Other Communication Disorders.	Bian L, 1998, J ACOUST SOC AM, V104, P2261, DOI 10.1121/1.423739; Bian L, 2002, J ACOUST SOC AM, V112, P198, DOI 10.1121/1.1488943; Brown DJ, 2009, J ACOUST SOC AM, V125, P2129, DOI 10.1121/1.3083228; Brownell WE, 2011, PFLUG ARCH EUR J PHY, V461, P677, DOI 10.1007/s00424-011-0942-5; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Chen ZQ, 2005, J CONTROL RELEASE, V110, P1, DOI 10.1016/j.jconrel.2005.09.003; Chen ZQ, 2006, J NEUROSCI METH, V150, P67, DOI 10.1016/j.jneumeth.2005.05.017; Chertoff ME, 2008, J ACOUST SOC AM, V124, P2174, DOI 10.1121/1.2967890; Chertoff Mark E., 2001, Seminars in Hearing, V22, P325, DOI 10.1055/s-2001-19108; Chertoff ME, 2003, J ACOUST SOC AM, V114, P3251, DOI 10.1121/1.1625932; Chubinskiy-Nadezhdin VI, 2011, BIOCHEM BIOPH RES CO, V412, P80, DOI 10.1016/j.bbrc.2011.07.046; Coisne C, 2016, MOLECULES, V21, DOI 10.3390/molecules21121748; Cronin S, 2015, JARO-J ASSOC RES OTO, V16, P599, DOI 10.1007/s10162-015-0528-6; Crow AL, 2015, G3-GENES GENOM GENET, V5, P2329, DOI 10.1534/g3.115.021592; Crumling MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053280; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; DIELER R, 1991, J NEUROCYTOL, V20, P637, DOI 10.1007/BF01187066; DOLAN DF, 1989, J ACOUST SOC AM, V86, P2167, DOI 10.1121/1.398477; EGGERMONT JJ, 1979, J ACOUST SOC AM, V65, P463, DOI 10.1121/1.382345; Frank G, 1997, HEARING RES, V113, P57, DOI 10.1016/S0378-5955(97)00131-7; Frank G, 1996, HEARING RES, V98, P104, DOI 10.1016/0378-5955(96)00083-4; Kakehata S, 1996, J NEUROSCI, V16, P4881; Kang WS, 2016, OTOL NEUROTOL; KUJAWA SG, 1992, HEARING RES, V64, P73, DOI 10.1016/0378-5955(92)90169-N; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Le Prell CG, 2014, NEUROSCI LETT, V571, P17, DOI 10.1016/j.neulet.2014.04.024; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lichtenhan JT, 2014, JARO-J ASSOC RES OTO, V15, P395, DOI 10.1007/s10162-014-0447-y; Lichtenhan JT, 2008, J ACOUST SOC AM, V123, P2200, DOI 10.1121/1.2885748; Lichtenhan JT, 2013, EAR HEARING, V34, P42, DOI 10.1097/AUD.0b013e31825f9bd3; Lichtenhan JT, 2012, JARO-J ASSOC RES OTO, V13, P17, DOI 10.1007/s10162-011-0296-x; Lichtenhan JT, 2016, J NEUROSCI METHODS; Lichtenhan JT, 2015, AUDITORY NERVE OVERL; MILLS DM, 1993, J ACOUST SOC AM, V94, P2108, DOI 10.1121/1.407483; Rodrigues HA, 2013, EUR J NEUROSCI, V38, P2978, DOI 10.1111/ejn.12300; Salt AN, 2015, JARO-J ASSOC RES OTO, V16, P357, DOI 10.1007/s10162-015-0512-1; Salt AN, 2013, J ACOUST SOC AM, V133, P1561, DOI 10.1121/1.4789005; Salt AN, 2009, HEARING RES, V250, P63, DOI 10.1016/j.heares.2009.02.001; Salt AN, 2001, HEARING RES, V154, P88, DOI 10.1016/S0378-5955(01)00223-4; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Shera CA, 2010, JARO-J ASSOC RES OTO, V11, P343, DOI 10.1007/s10162-010-0217-4; Sirjani DB, 2004, J ACOUST SOC AM, V115, P1219, DOI 10.1121/1.1647479; Yamashita T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005500; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8; Zimmer S, 2016, MOLECULES, V21	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175236	10.1371/journal.pone.0175236	http://dx.doi.org/10.1371/journal.pone.0175236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384320	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900131
J	Rahmandad, H; Jalali, MS; Paynabar, K				Rahmandad, Hazhir; Jalali, Mohammad S.; Paynabar, Kamran			A flexible method for aggregation of prior statistical findings	PLOS ONE			English	Article							SIMULATED MOMENTS; METAANALYSIS; MODELS; INTERVENTIONS; HETEROGENEITY; BIAS	Rapid growth in scientific output requires methods for quantitative synthesis of prior research, yet current meta-analysis methods limit aggregation to studies with similar designs. Here we describe and validate Generalized Model Aggregation (GMA), which allows researchers to combine prior estimated models of a phenomenon into a quantitative meta-model, while imposing few restrictions on the structure of prior models or on the metamodel. In an empirical validation, building on 27 published equations from 16 studies, GMA provides a predictive equation for Basal Metabolic Rate that outperforms existing models, identifies novel nonlinearities, and estimates biases in various measurement methods. Additional numerical examples demonstrate the ability of GMA to obtain unbiased estimates from potentially mis-specified prior studies. Thus, in various domains, GMA can leverage previous findings to compare alternative theories, advance new models, and assess the reliability of prior studies, extending meta-analysis toolbox to many new problems.	[Rahmandad, Hazhir; Jalali, Mohammad S.] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Paynabar, Kamran] Georgia Inst Technol, Ind & Syst Engn, Atlanta, GA 30332 USA	Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology	Rahmandad, H (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hazhir@mit.edu	Rahmandad, Hazhir/B-4474-2013; Jalali, Mohammad S./Q-2188-2019	Rahmandad, Hazhir/0000-0002-2784-9042; Jalali, Mohammad S./0000-0001-6769-2732	National Institutes of Health Office of Behavioral and Social Sciences Research and NHLBI [R21HL113680]	National Institutes of Health Office of Behavioral and Social Sciences Research and NHLBI	Partial financial support for this research was provided through National Institutes of Health Office of Behavioral and Social Sciences Research and NHLBI, grant R21HL113680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1985, WHO TECH REP SER, P1; Ault A, 2003, SCIENCE, V300, P2024, DOI 10.1126/science.300.5628.2024; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; Beaumont MA, 2002, GENETICS, V162, P2025; Beigl P, 2008, WASTE MANAGE, V28, P200, DOI 10.1016/j.wasman.2006.12.011; Borenstein M, 2009, INTRO META ANAL; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Buhaug H, 2014, CLIMATIC CHANGE, V127, P391, DOI 10.1007/s10584-014-1266-1; Chatterjee N, 2016, J AM STAT ASSOC, V111, P107, DOI 10.1080/01621459.2015.1123157; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickersin K, 2010, SCIENCE, V329, P516, DOI 10.1126/science.1189330; DUFFIE D, 1993, ECONOMETRICA, V61, P929, DOI 10.2307/2951768; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037//1082-989X.6.2.161; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; GOURIEROUX C, 1993, J APPL ECONOM, V8, pS85, DOI 10.1002/jae.3950080507; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hubbard R, 1996, J BUS RES, V35, P153, DOI 10.1016/0148-2963(95)00084-4; Institute of Medicine (IOM), 2005, DIET REF INT EN CARB; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jackson D, 2015, STATISTICAL METHODS; Khatib T, 2012, RENEW SUST ENERG REV, V16, P2864, DOI 10.1016/j.rser.2012.01.064; Kuhn T.S., 2012, STRUCTURE SCI REVOLU; LAIRD NM, 1987, J AM STAT ASSOC, V82, P739, DOI 10.2307/2288778; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; McClain MR, 2000, PREV MED, V31, P1, DOI 10.1006/pmed.2000.0682; MCFADDEN D, 1989, ECONOMETRICA, V57, P995, DOI 10.2307/1913621; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; Nam IS, 2003, STAT MED, V22, P2309, DOI 10.1002/sim.1410; Paynabar K, 2012, J QUAL TECHNOL, V44, P265, DOI 10.1080/00224065.2012.11917899; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; Sabounchi NS, 2013, INT J OBESITY, V37, P1364, DOI 10.1038/ijo.2012.218; Schmidt F.L., 2015, METHODS META ANAL CO; Schmidt H., 2009, HDB RES SYNTHESIS ME, P317; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; WACHTER KW, 1988, SCIENCE, V241, P1407, DOI 10.1126/science.3420397; Wang ZM, 2005, AM J CLIN NUTR, V81, P799, DOI 10.1093/ajcn/81.4.799; Wood SN, 2010, NATURE, V466, P1102, DOI 10.1038/nature09319	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175111	10.1371/journal.pone.0175111	http://dx.doi.org/10.1371/journal.pone.0175111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384282	Green Submitted, Green Published, gold			2022-12-27	WOS:000399371900087
J	Hayat, T; Haider, F; Muhammad, T; Alsaedi, A				Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer; Alsaedi, Ahmed			Darcy-Forchheimer flow with Cattaneo-Christov heat flux and homogeneous-heterogeneous reactions	PLOS ONE			English	Article							VARIABLE THERMAL-CONDUCTIVITY; NANOFLUID NATURAL-CONVECTION; NONLINEAR STRETCHING SURFACE; HOMOTOPY ANALYSIS METHOD; BOUNDARY-LAYER FLOW; POROUS-MEDIA; VISCOELASTIC FLUID; PERMEABLE CHANNEL; MIXED CONVECTION; CARBON NANOTUBES	Here Darcy-Forchheimer flow of viscoelastic fluids has been analyzed in the presence of Cattaneo-Christov heat flux and homogeneous-heterogeneous reactions. Results for two viscoelastic fluids are obtained and compared. A linear stretching surface has been used to generate the flow. Flow in porous media is characterized by considering the Darcy-Forchheimer model. Modified version of Fourier's law through Cattaneo-Christov heat flux is employed. Equal diffusion coefficients are employed for both reactants and auto catalyst. Optimal homotopy scheme is employed for solutions development of nonlinear problems. Solutions expressions of velocity, temperature and concentration fields are provided. Skin friction coefficient and heat transfer rate are computed and analyzed. Here the temperature and thermal boundary layer thickness are lower for Cattaneo-Christov heat flux model in comparison to classical Fourier's law of heat conduction. Moreover, the homogeneous and heterogeneous reactions parameters have opposite behaviors for concentration field.	[Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	taseer@math.qau.edu.pk	Alsaedi, Ahmed/A-2094-2013; Muhammad, Taseer/F-9103-2018; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Muhammad, Taseer/0000-0002-0838-2731; 				Akbar NS, 2015, J MAGN MAGN MATER, V381, P405, DOI 10.1016/j.jmmm.2014.12.087; Akbar NS, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14185-0; Ariel PD, 2003, J COMPUT APPL MATH, V154, P1, DOI 10.1016/S0377-0427(02)00744-6; Bachok N, 2011, COMMUN NONLINEAR SCI, V16, P4296, DOI 10.1016/j.cnsns.2011.01.008; Cattaneo C., 1948, ATTI SEMIN MAT FIS ATTI SEM MAT FIS U M, V3, P83; CHAUDHARY MA, 1995, FLUID DYN RES, V16, P335, DOI 10.1016/0169-5983(95)90813-H; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Dehghan M, 2010, NUMER METH PART D E, V26, P448, DOI 10.1002/num.20460; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Forchheimer P, 1901, Z VER DTSCH ING, V45, P1781; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Haddad SAM, 2014, INT J HEAT MASS TRAN, V68, P659, DOI 10.1016/j.ijheatmasstransfer.2013.09.039; Hayat T, 2017, J TAIWAN INST CHEM E, V70, P119, DOI 10.1016/j.jtice.2016.11.002; Hayat T, 2016, INT J NUMER METHOD H, V26, P2355, DOI 10.1108/HFF-08-2015-0333; Hayat T, 2016, J MOL LIQ, V220, P200, DOI 10.1016/j.molliq.2016.04.012; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4929523; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4905780; Hayat T, 2017, J MOL LIQ, V230, P608, DOI 10.1016/j.molliq.2017.01.074; Hayat T, 2016, RESULTS PHYS, V6, P897, DOI 10.1016/j.rinp.2016.10.017; Hayat T, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110346; Hayat T, 2016, ADV POWDER TECHNOL, V27, P1992, DOI 10.1016/j.apt.2016.07.002; Hayat T, 2017, INT J THERM SCI, V111, P274, DOI 10.1016/j.ijthermalsci.2016.08.009; Hayat T, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4964684; Hayat T, 2016, J MOL LIQ, V221, P1121, DOI 10.1016/j.molliq.2016.06.083; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155185; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Imtiaz M, 2016, J MOL LIQ, V221, P245, DOI 10.1016/j.molliq.2016.05.060; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Karniadakis G, 2005, MICROFLOWS NANOFLOWS; Karniadakis GE., 2002, MICROFLOWS; Li J, 2016, J MOL LIQ, V221, P19, DOI 10.1016/j.molliq.2016.05.051; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Majeed A, 2016, J MOL LIQ, V223, P528, DOI 10.1016/j.molliq.2016.07.145; Malvandi A., 2013, J THERMODYN, V2013, DOI DOI 10.1155/2013/764827; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Muskat M., 1946, FLOW HOMOGENEOUS FLU, V763, P100; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Nield DA, 1999, CONVECTION POROUS ME, V2nd; Pal D, 2012, INT COMMUN HEAT MASS, V39, P913, DOI 10.1016/j.icheatmasstransfer.2012.05.012; Sadiq MA, 2016, RESULTS PHYS, V6, P884, DOI 10.1016/j.rinp.2016.10.019; Sajid M, 2017, J MOL LIQ, V233, P115, DOI 10.1016/j.molliq.2017.02.081; Seddeek MA, 2006, J COLLOID INTERF SCI, V293, P137, DOI 10.1016/j.jcis.2005.06.039; Shehzad SA, 2016, J MOL LIQ, V224, P274, DOI 10.1016/j.molliq.2016.09.109; Sheikholeslami M, 2017, J MOL LIQ, V229, P566, DOI 10.1016/j.molliq.2016.12.107; Sheikholeslami M, 2017, INT J HEAT MASS TRAN, V109, P82, DOI 10.1016/j.ijheatmasstransfer.2017.01.096; Sheikholeslami M, 2017, COMPUT METHOD APPL M, V317, P419, DOI 10.1016/j.cma.2016.12.028; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2017, J MOL LIQ, V229, P137, DOI 10.1016/j.molliq.2016.12.024; Sheikholeslami M, 2017, PHYS LETT A, V381, P494, DOI 10.1016/j.physleta.2016.11.042; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Tan WC, 2005, INT J NONLIN MECH, V40, P515, DOI 10.1016/j.ijnonlinmec.2004.07.016; Tanveer A, 2017, J MOL LIQ, V233, P131, DOI 10.1016/j.molliq.2017.03.001; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Turkyilmazoglu M, 2016, MEDITERR J MATH, V13, P4019, DOI 10.1007/s00009-016-0730-8; Turkyilmazoglu M, 2016, FILOMAT, V30, P1633, DOI 10.2298/FIL1606633T; Turkyilmazoglu M, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4945650; Waqas M, 2016, J MOL LIQ, V220, P642, DOI 10.1016/j.molliq.2016.04.086; Zeeshan A, 2016, J MOL LIQ, V215, P549, DOI 10.1016/j.molliq.2015.12.110	60	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174938	10.1371/journal.pone.0174938	http://dx.doi.org/10.1371/journal.pone.0174938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380014	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500079
J	Loos, J; Nostlinger, C; Vuylsteke, B; Deblonde, J; Ndungu, M; Kint, I; Manirankunda, L; Reyniers, T; Adobea, D; Laga, M; Colebunders, R				Loos, Jasna; Nostlinger, Christiana; Vuylsteke, Bea; Deblonde, Jessika; Ndungu, Morgan; Kint, Ilse; Manirankunda, Lazare; Reyniers, Thijs; Adobea, Dorothy; Laga, Marie; Colebunders, Robert			First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium	PLOS ONE			English	Article							POPULATIONS; PREVENTION; IMMIGRANTS; INFECTION; COUNTRIES	Introduction While sub-Saharan African migrants are the second largest group affected by HIV in Europe, sound HIV prevalence estimates based on representative samples of these heterogeneous communities are lacking. Such data are needed to inform prevention and public health policy. Methods This community-based, cross-sectional study combined oral fluid HIV testing with an electronic behavioral survey. Adopting a two-stage time location sampling HIV prevalence estimates for a representative sample of adult sub-Saharan African migrants in Antwerp, Belgium were obtained. Sample proportions and estimated adjusted population proportions were calculated for all variables. Univariable and multivariable logistic regression analysis explored factors independently associated with HIV infection. Results Between December 2013 and October 2014, 744 sub-Saharan African migrants were included (37% women). A substantial proportion was socially, legally and economically vulnerable: 21% were probably of undocumented status, 63% had financial problems in the last year and 9% lacked stable housing. Sexual networks were mostly African and crossed national borders, i.e. sexual encounters during travels within Europa and Africa. Concurrency is common, 34% of those in a stable relationship had a partner on the side in the last year. HIV prevalence was 5.9%(95%CI:3.4%-10.1%) among women and 4.2% (95% CI:1.6%-10.6%) among men. Although high lifetime HIV testing was reported at community level (73%), 65.2% (CI95%:32.4%-88.0%) of sub-Saharan African migrants were possibly undiagnosed. Being 45 years or older, unprotected sex when travelling within Europe in the last year, high intentions to use condoms, being unaware of their last sexual partners' HIV status, recent HIV testing and not having encountered partner violence in the last year were independently associated with HIV infection in multivariable logical regression. In univariable analysis, HIV infection was additionally associated to unemployment. Conclusions This is the first HIV prevalence study among adult sub-Saharan African migrants resettling in a European city based on a representative sample. HIV prevalence was high and could potentially increase further due to the high number of people with an undiagnosed HIV infection, social vulnerability, high levels of concurrency and mainly African sexual networks. Given this population's mobility, an aligned European combination prevention approach addressing these determinants is urgently needed.	[Loos, Jasna; Nostlinger, Christiana; Vuylsteke, Bea; Manirankunda, Lazare; Reyniers, Thijs; Laga, Marie] Inst Trop Med, HIV & Sexual Hlth Unit, Dept Publ Hlth, Antwerp, Belgium; [Deblonde, Jessika] Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Epidemiol Infect Dis Unit, Brussels, Belgium; [Ndungu, Morgan; Adobea, Dorothy] Inst Trop Med, Dept Publ Hlth, HIV & Sexual Hlth Unit, TOGETHER Project, Antwerp, Belgium; [Kint, Ilse; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, AIDS Reference Ctr, Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Fac Med & Hlth Sci, Epidemiol Global Hlth Inst, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp	Loos, J (corresponding author), Inst Trop Med, HIV & Sexual Hlth Unit, Dept Publ Hlth, Antwerp, Belgium.	jloos@itg.be	Reyniers, Thijs/C-7466-2018; Loos, Jasna/GVS-6862-2022	Reyniers, Thijs/0000-0003-3756-921X; Colebunders, Robert/0000-0002-1919-1340	Scientific Fund for Research on AIDS	Scientific Fund for Research on AIDS	This work was supported by the Scientific Fund for Research on AIDS, managed by the King Baudouin Foundation (https Away kbs trb betent Activities/Calls0tberne-795t12531cOd45a9B td55t1cc0769f8a&themeNameaMedicallit 20scierbfic3t2Otesearch).	Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; Alvarez-el Arco D, 2015, 15 EUR AIDS C BARC O; Arrey AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159488; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Deblonde J, 2011, HEALTH POLICY, V103, P101, DOI 10.1016/j.healthpol.2011.06.012; Desgrees-du-Lou A, 2016, AIDS, V30, P645, DOI 10.1097/QAD.0000000000000957; European Centre for Disease Prevention and Control World Health Organisation Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Fransen K, 2013, J VIROL METHODS, V194, P46, DOI 10.1016/j.jviromet.2013.08.004; Gokengin D, 2014, INT J STD AIDS, V25, P695, DOI 10.1177/0956462414531244; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hernando V, 2015, JAIDS-J ACQ IMM DEF, V70, P204, DOI 10.1097/QAI.0000000000000717; Karon JM, 2012, J URBAN HEALTH, V89, P565, DOI 10.1007/s11524-012-9676-8; Loos Jasna, 2016, JMIR Public Health Surveill, V2, pe33, DOI 10.2196/publichealth.5519; Loos Jasna, 2016, JMIR Res Protoc, V5, pe48, DOI 10.2196/resprot.5162; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Marks G, 2015, J ACQ IMMUN DEF SYND, V39, P446; Marsicano E, 2013, CULT HEALTH SEX, V15, P819, DOI 10.1080/13691058.2013.785024; MAYISHA II Collaborative Group, 2005, ASS FEAS ACC ITY COM; NAT, 2014, HIV BLACK AFR COMM U; Ndiaye B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-11; Nostlinger C, 2016, AIDS CARE, V28, P119, DOI 10.1080/09540121.2016.1146398; Perez-Molina JA, 2009, J TRAVEL MED, V16, P248, DOI 10.1111/j.1708-8305.2009.00308.x; Platt L, 2013, SEX TRANSM INFECT, V89, P311, DOI 10.1136/sextrans-2012-050491; Public Health England, 2015, HIV UK SIT REP 2015; Roberfroid DDM., 2015, WHAT HLTH CARE UNDOC; Sadler KE, 2007, SEX TRANSM INFECT, V83, P523, DOI 10.1136/sti.2007.027128; Saracino A, 2008, AIDS PATIENT CARE ST, V22, P691, DOI 10.1089/apc.2008.0016; Sasse A, 2015, EPIDEMIOLOGIE AIDS H; UNAIDS GNP+, 2013, POS HLTH DIGN PREV O; van Veen MG, 2011, INT J STD AIDS, V22, P245, DOI 10.1258/ijsa.2009.008511; Xia Q, 2013, AIDS BEHAV, V17, P3120, DOI 10.1007/s10461-013-0528-7	33	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174677	10.1371/journal.pone.0174677	http://dx.doi.org/10.1371/journal.pone.0174677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380051	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500058
J	Metzler-Zebell, BU; Lawlor, PG; Magowan, E; McCormack, UM; Curiao, T; Hollmann, M; Ertl, R; Aschenbach, JR; Zebell, Q				Metzler-Zebell, Barbara U.; Lawlor, Peadar G.; Magowan, Elizabeth; McCormack, Ursula M.; Curiao, Tania; Hollmann, Manfred; Ertl, Reinhard; Aschenbach, Joerg R.; Zebell, Qendrim			Finishing pigs that are divergent in feed efficiency show small differences in intestinal functionality and structure	PLOS ONE			English	Article							NUTRIENT DIGESTIBILITY; ENZYME-ACTIVITIES; BARRIER FUNCTION; GENE-EXPRESSION; PERFORMANCE; MORPHOLOGY; HEALTH; VARIABILITY; SELECTION; GROWTH	Controversial information is available regarding the feed efficiency-related variation in intestinal size, structure and functionality in pigs. The present objective was therefore to investigate the differences in visceral organ size, intestinal morphology, mucosal enzyme activity, intestinal integrity and related gene expression in low and high RFI pigs which were reared at three different geographical locations (Austria, AT; Northern Ireland, NI; Republic of Ireland, ROI) using similar protocols. Pigs (n = 369) were ranked for their RFI between days 42 and 91 postweaning and low and high RFI pigs (n = 16 from AT, n = 24 from NI, and n = 60 from ROI) were selected. Pigs were sacrificed and sampled on similar to day 110 of life. In general, RFI-related variation in intestinal size, structure and function was small. Some energy saving mechanisms and enhanced digestive and absorptive capacity were indicated in low versus high RFI pigs by shorter crypts, higher duodenal lactase and maltase activity and greater mucosal permeability (P < 0.05), but differences were mainly seen in pigs from AT and to a lesser degree in pigs from ROI. Additionally, low RFI pigs from AT had more goblet cells in duodenum but fewer in jejunum compared to high RFI pigs (P < 0.05). Together with the lower expression of TLR4 and TNFA in low versus high RFI pigs from AT and ROI (P < 0.05), these results might indicate differences in the innate immune response between low and high RFI pigs. Results demonstrated that the variation in the size of visceral organs and intestinal structure and functionality was greater between geographic location (local environmental factors) than between RFI ranks of pigs. In conclusion, present results support previous findings that the intestinal size, structure and functionality do not significantly contribute to variation in RFI of pigs.	[Metzler-Zebell, Barbara U.] Univ Clin Swine, Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Vienna, Austria; [Lawlor, Peadar G.; McCormack, Ursula M.; Curiao, Tania] Fermoy Co, Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Moorepk, Cork, Ireland; [Magowan, Elizabeth] Agri Food & Biosci Inst, Agr Branch, Large Pk, Hillsborough, North Ireland; [McCormack, Ursula M.] Waterford Co, Waterford Inst Technol, Dept Sci & Comp, Waterford, Ireland; [Hollmann, Manfred] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Animals & Vet Publ Hlth, Vienna, Austria; [Ertl, Reinhard] Univ Vet Med, VetCore Facil Res, Vienna, Austria; [Ertl, Reinhard] Free Univ Berlin, Berlin, Germany; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Berlin, Germany	University of Veterinary Medicine Vienna; Teagasc; Agri-Food & Biosciences Institute; South East Technological University (SETU); University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Free University of Berlin; Free University of Berlin	Metzler-Zebell, BU (corresponding author), Univ Clin Swine, Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at	Aschenbach, Joerg R/R-7572-2016; McCormack, Ursula/M-3010-2019	Aschenbach, Joerg R/0000-0001-5080-1007; McCormack, Ursula/0000-0002-9485-0502; Curiao, Tania/0000-0002-5269-0387; Ertl, Reinhard/0000-0001-7485-3661	European Union's Seventh Framework Programme for research, technological development and demonstration [311794]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project (ECO-FCE) has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 311794.	Barea R, 2010, J ANIM SCI, V88, P2062, DOI 10.2527/jas.2009-2395; Boddicker N, 2011, ANIMAL, V5, P1344, DOI 10.1017/S175173111100036X; CASPARY WF, 1992, AM J CLIN NUTR, V55, P299, DOI 10.1093/ajcn/55.1.299s; Chen H, 2015, J NUTR, V145, P51, DOI 10.3945/jn.114.201772; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Douglas SL, 2015, ANIMAL, V9, P1210, DOI 10.1017/S1751731115000269; Fitzsimons C, 2014, ANIMAL, V8, P949, DOI 10.1017/S1751731114000652; Gondret F, 2014, J ANIM SCI, V92, P4865, DOI 10.2527/jas.2014-7995; Harris AJ, 2012, J ANIM SCI, V90, P164, DOI 10.2527/jas.53855; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lalles JP, 2012, J ANIM SCI, V90, P421, DOI 10.2527/jas.53904; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Liu YL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0040-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; Martin L, 2013, ARCH ANIM NUTR, V67, P248, DOI 10.1080/1745039X.2013.801138; McCormack UM, 2016, 67 ANN M EUR FED AN, P199; Metzler-Zebeli B, 2017, BR POULT SC IN PRESS; Metzler-Zebeli BU, 2016, J ANIM SCI, V94, P2890, DOI 10.2527/jas.2016-0375; Metzler-Zebeli BU, 2012, J NUTR, V142, P668, DOI 10.3945/jn.111.153007; Metzler-Zebeli BU, 2016, ANIMAL IN PRESS; Meunier-Salaun MC, 2014, ANIMAL, V8, P1898, DOI 10.1017/S1751731114001839; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; Nain S, 2012, POULTRY SCI, V91, P888, DOI 10.3382/ps.2011-01661; Naumann C., 2012, CHEM UNTERSUCHUNG FU; Noblet J, 2013, ANIMAL, V7, P1259, DOI 10.1017/S1751731113000463; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Saintilan R, 2015, ANIMAL, V9, P18, DOI 10.1017/S1751731114002171; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vigors S, 2016, ANIMAL, V10, P1848, DOI 10.1017/S1751731116000847; Vigors S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148145; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Yen J.T., 2001, SWINE NUTR, P21; Young JM, 2011, J ANIM SCI, V89, P639, DOI 10.2527/jas.2010-2892	39	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174917	10.1371/journal.pone.0174917	http://dx.doi.org/10.1371/journal.pone.0174917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380012	Green Published, gold			2022-12-27	WOS:000399353500078
J	Ribera, J; Fink, S; Bas, MD; Schwarze, FWMR				Ribera, Javier; Fink, Siegfried; del Carmen Bas, Maria; Schwarze, Francis W. M. R.			Integrated control of wood destroying basidiomycetes combining Cu-based wood preservatives and Trichoderma spp	PLOS ONE			English	Article							TREATED DISTRIBUTION POLES; BIOLOGICAL-CONTROL; DECAY; ROT; BIOCONTROL; MECHANISMS; STRAINS; FUNGI; RESISTANCE; ISOLATE	The production of new generation of wood preservatives (without addition of a co-biocide) in combination with an exchange of wood poles on identical sites with high fungal inoculum, has resulted in an increase of premature failures of wood utility poles in the last decades. Wood destroying basidiomycetes inhabiting sites where poles have been installed, have developed resistance against wood preservatives. The objective of the in vitro studies was to identify a Trichoderma spp. with a highly antagonistic potential against wood destroying basidiomycetes that is capable of colonizing Cu-rich environments. For this purpose, the activity of five Trichoderma spp. on Cu-rich medium was evaluated according to its growth and sporulation rates. The influence of the selected Trichoderma spp. on wood colonization and degradation by five wood destroying basidiomycetes was quantitatively analyzed by means of dry weight loss of wood specimens. Furthermore, the preventative effect of the selected Trichoderma spp. in combination with four Cu-based preservatives was also examined by mass loss and histological changes in the wood specimens. Trichoderma harzianum (T-720) was considered the biocontrol agent with higher antagonistic potential to colonize Cu-rich environments (up to 0.1% CuSO4 amended medium). T. harzianum demonstrated significant preventative effect on wood specimens against four wood destroying basidiomycetes. The combined effect of T. harzianum and Cu-based wood preservatives demonstrated that after 9 months incubation with two wood destroying basidiomycetes, wood specimens treated with 3.8 kg m-(3) copper-chromium had weight losses between 55-65%, whereas containers previously treated with T. harzianum had significantly lower weight losses (0-25%). Histological studies on one of the wood destroying basidiomycetes revealed typical decomposition of wood cells by brown-rot fungi in Cu-impregnated samples, that were notably absent in wood specimens previously exposed to T. harzianum. It is concluded that carefully selected Trichoderma isolates can be used for integrated wood protection against a range of wood destroying basidiomycetes and may have potential for integrated wood protection in the field.	[Ribera, Javier; Schwarze, Francis W. M. R.] Empa, Appl Wood Mat, St Gallen, Switzerland; [Ribera, Javier; Fink, Siegfried; Schwarze, Francis W. M. R.] Albert Ludwigs Univ Freiburg, Forstbot, Freiburg, Germany; [del Carmen Bas, Maria] Univ Politecn Valencia, Appl Stat & Operat Res & Qual, Valencia, Spain	Swiss Federal Laboratories for Materials Science & Technology (EMPA); University of Freiburg; Universitat Politecnica de Valencia	Ribera, J (corresponding author), Empa, Appl Wood Mat, St Gallen, Switzerland.; Ribera, J (corresponding author), Albert Ludwigs Univ Freiburg, Forstbot, Freiburg, Germany.	javier.ribera@empa.ch	Ribera, Javier/V-7140-2019; del Carmen Bas Cerdá, María/J-4354-2016; Schwarze, Francis/Y-2157-2018	del Carmen Bas Cerdá, María/0000-0002-1221-0641; Ribera, Dr. Javier/0000-0001-6677-3020; Schwarze, Francis/0000-0003-3306-8303	Swiss CTI [17001.1]	Swiss CTI	The authors are pleased to acknowledge the financial support by the Swiss CTI (Project No. 17001.1 PFLS-LS).	Arland P, 2006, BIORESOURCE TECHNOL, V97, P1018, DOI 10.1016/j.biortech.2005.04.046; Benitez T, 2004, INT MICROBIOL, V7, P249; Bollmus S., 2012, IRGWP1240584; Brown HL, 1999, INT BIODETER BIODEGR, V44, P225, DOI 10.1016/S0964-8305(99)00083-9; BRUCE A, 1991, HOLZFORSCHUNG, V45, P307, DOI 10.1515/hfsg.1991.45.4.307; BRUCE A, 1991, FOREST PROD J, V41, P63; BRUCE A, 1986, MATER ORGANISMEN, V21, P165; BRUCE A, 1990, MATER ORGANISMEN, V25, P15; Bruce A, 1986, MAT ORG, V27, P1; CERVANTES C, 1994, FEMS MICROBIOL REV, V14, P121, DOI 10.1016/0168-6445(94)90002-7; Civardi C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142578; Civardi C, 2015, ENVIRON POLLUT, V200, P126, DOI 10.1016/j.envpol.2015.02.018; Errasquin EL, 2003, CHEMOSPHERE, V50, P137; European Committee for Standardization (CEN), 2001, 807 CEN ENV EUR COMM; European Committee for Standardization (CEN), 1996, 113 CEN EUR COMM STA; European Committee for Standardization (CEN), 1989, 252 CEN EUR COMM STA; Freeman MH, 2008, FOREST PROD J, V58, P6; Gandia M, 2014, FUNGAL GENET BIOL, V67, P58, DOI 10.1016/j.fgb.2014.04.002; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2000, PLANT DIS, V84, P377, DOI 10.1094/PDIS.2000.84.4.377; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Herrera-Estrella A., 2004, Fungal biotechnology in agricultural, food, and environmental applications, P147; HIGHLEY TL, 1988, MATER ORGANISMEN, V23, P157; Hingston JA, 2001, ENVIRON POLLUT, V111, P53, DOI 10.1016/S0269-7491(00)00030-0; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Humar M, 2007, HOLZ ROH WERKST, V65, P329, DOI 10.1007/s00107-006-0157-1; Kartal SN, 2015, INT BIODETER BIODEGR, V99, P95, DOI 10.1016/j.ibiod.2015.01.004; Kredics L, 2003, FOOD TECHNOL BIOTECH, V41, P37; Kredics L, 2001, LETT APPL MICROBIOL, V33, P112, DOI 10.1046/j.1472-765x.2001.00963.x; Kredics L, 2001, B ENVIRON CONTAM TOX, V66, P249, DOI 10.1007/s001280000231; Kundu A., 2008, Asian Journal of Experimental Sciences, V22, P373; Lebow S, 2003, ENVIRON SCI TECHNOL, V37, P4077, DOI 10.1021/es0343048; Lohwag GK, 1937, MIKROCHEMIE, V23, P198; MORRELL JJ, 1990, WOOD FIBER SCI, V22, P10; MURPHY RJ, 1983, T BRIT MYCOL SOC, V81, P165, DOI 10.1016/S0007-1536(83)80223-X; Obanda DN, 2008, BIORESOURCE TECHNOL, V99, P7312, DOI 10.1016/j.biortech.2007.12.077; Racic G, 2016, ENV SCI POLLUT RES; Ribera J, 2016, J TROP FOR SCI, V28, P457; Ribera J, 2016, HOLZFORSCHUNG; RICARD J, 1976, J I WOOD SCI, V7, P6; Schubert M, 2008, BIOL CONTROL, V45, P111, DOI 10.1016/j.biocontrol.2008.01.001; SCHULZE B, 1937, HOLZ ROH WERKST, V1, P548; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Schwarze F. W. M. R., 2003, Mycological Progress, V2, P267, DOI 10.1007/s11557-006-0064-1; Schwarze Francis W. M. R., 2007, Fungal Biology Reviews, V21, P133, DOI 10.1016/j.fbr.2007.09.001; Schwarze FWMR, 2012, BIOL CONTROL, V61, P160, DOI 10.1016/j.biocontrol.2012.01.016; Schwarze FWMR, 1998, NEW PHYTOL, V139, P721, DOI 10.1046/j.1469-8137.1998.00238.x; SCORE AJ, 1994, INT BIODETER BIODEGR, V33, P115, DOI 10.1016/0964-8305(94)90031-0; SIEBER TN, 1995, MYCOL RES, V99, P274, DOI 10.1016/S0953-7562(09)80897-6; Susi P, 2011, J ENVIRON MANAGE, V92, P1681, DOI 10.1016/j.jenvman.2011.03.004; SUTTER HP, 1983, MATER ORGANISMEN, V18, P241; Ting ASY, 2009, WORLD J MICROB BIOT, V25, P1431, DOI 10.1007/s11274-009-0030-6; Tripathi P, 2013, CLEAN TECHNOL ENVIR, V15, P541, DOI 10.1007/s10098-012-0553-7; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; WILCOX WW, 1993, IAWA J, V14, P127; Young GY, 1961, 2223 USDA FOR SERV F	56	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174335	10.1371/journal.pone.0174335	http://dx.doi.org/10.1371/journal.pone.0174335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379978	Green Published, gold			2022-12-27	WOS:000399353500042
J	Tampuu, A; Matiisen, T; Kodelja, D; Kuzovkin, I; Korjus, K; Aru, J; Aru, J; Vicente, R				Tampuu, Ardi; Matiisen, Tambet; Kodelja, Dorian; Kuzovkin, Ilya; Korjus, Kristjan; Aru, Juhan; Aru, Jaan; Vicente, Raul			Multiagent cooperation and competition with deep reinforcement learning	PLOS ONE			English	Article							NEURAL-NETWORKS; GAME	Evolution of cooperation and competition can appear when multiple adaptive agents share a biological, social, or technological niche. In the present work we study how cooperation and competition emerge between autonomous agents that learn by reinforcement while using only their raw visual input as the state representation. In particular, we extend the Deep Q-Learning framework to multiagent environments to investigate the interaction between two learning agents in the well-known video game Pong. By manipulating the classical rewarding scheme of Pong we show how competitive and collaborative behaviors emerge. We also describe the progression from competitive to collaborative behavior when the incentive to cooperate is increased. Finally we show how learning by playing against another adaptive agent, instead of against a hard-wired algorithm, results in more robust strategies. The present work shows that Deep Q-Networks can become a useful tool for studying decentralized learning of multiagent systems coping with high-dimensional environments.	[Tampuu, Ardi; Matiisen, Tambet; Kodelja, Dorian; Kuzovkin, Ilya; Korjus, Kristjan; Aru, Jaan; Vicente, Raul] Univ Tartu, Inst Comp Sci, Computat Neurosci Lab, Tartu, Estonia; [Aru, Juhan] Swiss Fed Inst Technol, Dept Math, Zurich, Switzerland; [Kodelja, Dorian] CEA, LIST, Lab Vis & Content Engn, F-91191 Gif Sur Yvette, France	University of Tartu; Swiss Federal Institutes of Technology Domain; ETH Zurich; CEA; UDICE-French Research Universities; Universite Paris Saclay	Vicente, R (corresponding author), Univ Tartu, Inst Comp Sci, Computat Neurosci Lab, Tartu, Estonia.	raul.vicente.zafra@ut.ee	Kuzovkin, Ilya (Eli)/AAD-1476-2022; Aru, Jaan/H-3967-2015	Kuzovkin, Ilya (Eli)/0000-0001-6054-8607; Matiisen, Tambet/0000-0002-6815-1580; Aru, Jaan/0000-0003-3927-452X	NVIDIA Corporation; Estonian Research Council [PUT438]	NVIDIA Corporation; Estonian Research Council(Estonian Research Council)	All authors gratefully acknowledge the support of NVIDIA Corporation with the donation of one GeForce GTX TITAN X GPU used for this research. RV also thanks the financial support of the Estonian Research Council via the grant PUT438 (https://www.etis.ee/Portal/Projects/Display/e3760907-3178-4863-b7a1-2c2628d6c67a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andres Laan and Taivo Pungas for fruitful early discussions about the project. We gratefully acknowledge the support of NVIDIA Corporation with the donation of one GeForce GTX TITAN X GPU used for this research. We also thank the financial support of the Estonian Research Council via the grant PUT438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binmore K, 2008, TOPOI-INT REV PHILOS, V27, P17, DOI 10.1007/s11245-008-9033-4; Busoniu L, 2008, IEEE T SYST MAN CY C, V38, P156, DOI 10.1109/TSMCC.2007.913919; Claus C, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P746; Foerster J. N., 2016, ARXIV160202672; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Hasselt H. V., 2010, ADV NEURAL INFORM PR, P2613, DOI DOI 10.5555/2997046.2997187; Koutnik J, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1061; Lewis D., 2008, CONVENTION PHILOS ST; Lin L.-J., 1993, REINFORCEMENT LEARNI; Mnih V., 2013, ARXIV13125602, DOI DOI 10.1038/NATURE14236; Mnih V, 2014, ADV NEUR IN, V27; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mott B, 2003, STELLA MULTIPLATFORM; Poole D. L., 2010, ARTIFICIAL INTELLIGE; Schaul T., 2015, CORR; Schmidhuber J., 2015, ARXIV151109249; Schwartz HM, 2014, MULTI-AGENT MACHINE LEARNING: A REINFORCEMENT APPROACH, P1, DOI 10.1002/9781118884614; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Skyrms B., 2010, SIGNALS EVOLUTION LE, DOI [DOI 10.1093/ACPROF:OSO/9780199580828.001.0001, 10.1093/acprof:oso/9780199580828.001.0001]; Springenberg JT, 2014, ARXIV; Sukhbaatar S, 2015, ADV NEUR IN, V28; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; van der Ree M, 2013, IEEE SYMP ADAPT DYNA, P108, DOI 10.1109/ADPRL.2013.6614996; Wang L, 2012, NONLINEAR DYNAM, V67, P2009, DOI 10.1007/s11071-011-0125-0; Watkins C. J. C. H., 1989, LEARNING DELAYED REW; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244	30	272	288	32	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172395	10.1371/journal.pone.0172395	http://dx.doi.org/10.1371/journal.pone.0172395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380078	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500005
J	Mitsuishi, T; Hamatani, S; Hirooka, S; Fukasawa, N; Aizawa, D; Hara, Y; Dobashi, A; Goda, K; Fukuda, T; Saruta, M; Urashima, M; Ikegami, M				Mitsuishi, Takehiro; Hamatani, Shigeharu; Hirooka, Shinichi; Fukasawa, Nei; Aizawa, Daisuke; Hara, Yuko; Dobashi, Akira; Goda, Kenichi; Fukuda, Takahiro; Saruta, Masayuki; Urashima, Mitsuyoshi; Ikegami, Masahiro			Clinicopathological characteristics of duodenal epithelial neoplasms: Focus on tumors with a gastric mucin phenotype (pyloric gland-type tumors)	PLOS ONE			English	Article							BRUNNERS GLAND; FOVEOLAR METAPLASIA; ADENOCARCINOMA; ADENOMA; BULB; HYPERPLASIA; CARCINOMA; PORTION; LESIONS	Objective Epithelial tumors less commonly occur in the duodenum than in the stomach or large intestine. The clinicopathological characteristics of duodenal epithelial tumors remain a matter of debate. We therefore studied resected specimens to investigate the clinicopathological characteristics of duodenal epithelial tumors. Materials and methods Among duodenal epithelial tumors resected endoscopically or surgically in our hospital, we studied the clinicopathological characteristics of 110 adenomas or intramucosal carcinomas. The grade of atypia of all tumors was classified into 3 groups according to the World Health Organization (WHO) 2010 classification. The tumors were immunohistochemically evaluated to determine the frequency of differentiation toward fundic glands. Results As for patient characteristics, there were 76 men (75.2%) and 25 women (24.8%), with a median age of 65 years (range, 34 to 84). The tumors most commonly arose in the first to second part of the duodenum. Many lesions were flat, and the median tumor diameter was 8.0 mm. The lesions were classified into 2 types according to mucin phenotype: intestinal-type tumors (98 lesions, 89.1%) and gastric-type tumors (12 lesions, 10.9%). Intestinal-type tumors were subdivided into 2 groups: tubular-type tumors (91 lesions, 82.7%) and tubulo-villous- type tumors (7 lesions, 6.4%). Gastric-type tumors were classified into 2 types: foveolar type (3 lesions, 2.7%) and pyloric gland-type (PG) tumors (9 lesions, 8.2%). The grade of atypia was significantly higher in gastric-type tumors (p<0.01). PG tumors were gastric-type tumors characterized by pyloric glands and findings suggesting differentiation toward fundic glands. Conclusions About 10% of the duodenal tumors had a gastric-type mucin phenotype. Gastric-type tumors showed high-grade atypia. In particular, PG tumors showed similarities to PG tumors of the stomach, such as differentiation toward fundic glands.	[Mitsuishi, Takehiro; Hamatani, Shigeharu; Hirooka, Shinichi; Fukasawa, Nei; Aizawa, Daisuke; Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Minato Ku, Tokyo, Japan; [Hara, Yuko; Dobashi, Akira; Goda, Kenichi] Jikei Univ, Dept Endoscopy, Sch Med, Minato Ku, Tokyo, Japan; [Fukuda, Takahiro] Jikei Univ, Dept Pathol, Sch Med, Div Neuropathol,Minato Ku, Tokyo, Japan; [Saruta, Masayuki] Jikei Univ, Dept Internal Med, Sch Med, Div Gastroenterol & Hepatol,Minato Ku, Tokyo, Japan; [Urashima, Mitsuyoshi] Jikei Univ, Div Mol Epidemiol, Sch Med, Res Ctr Med Sci,Minato Ku, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Jikei University; Jikei University	Mitsuishi, T (corresponding author), Jikei Univ, Dept Pathol, Sch Med, Minato Ku, Tokyo, Japan.	takeccho86@gmail.com	Saruta, Masayuki/ABL-4991-2022	Saruta, Masayuki/0000-0001-8172-3240				Ajioka Yoichi, 1993, Stomach and Intestine, V28, P627; Bandi M, 2015, G CHIR, V36, P183, DOI 10.11138/gchir/2015.36.4.183; DORANDEU A, 1995, ANN PATHOL, V15, P211; Endo M, 2010, DIGEST ENDOSC, V22, P360, DOI 10.1111/j.1443-1661.2010.01014.x; Friedrich-Rust M, 2006, Z GASTROENTEROL, V44, P323, DOI 10.1055/s-2006-926492; Guan CS, 2015, J COLL PHYS SURG PAK; Hida R, 2016, AM J SURG PATHOL; HOEDEMAEKER PJ, 1970, DIGESTION, V3, P165, DOI 10.1159/000197027; ITSUNO M, 1993, GASTROENTEROL JPN, V28, P118; JOHANSEN A, 1973, ACTA PATH MICRO IM A, VA 81, P676; Kakushima N, 2015, WORLD J GASTROENTERO; KAWAMOTO K, 1994, GASTROINTEST ENDOSC, V40, P233, DOI 10.1016/S0016-5107(94)70176-8; Khor TS, 2010, BMJ CASE REP; Kim K, 2013, DIGEST DIS SCI, V58, P194, DOI 10.1007/s10620-012-2320-3; Kojima E, 2006, J JAPAN BILIARY ASS, V20, P635; Kushima R, 2002, VIRCHOWS ARCH, V440, P655, DOI 10.1007/s00428-002-0615-z; Kushima R, 1999, HISTOPATHOLOGY, V35, P38; Kushima R, 2013, PATHOL INT, V63, P318, DOI 10.1111/pin.12070; Lauwers GY, 2010, WHO CLASSIFICATION T, P55; Mann NS, 2000, J CLIN GASTROENTEROL, V30, P303, DOI 10.1097/00004836-200004000-00020; Maruoka D, 2015, ENDOSCOPY S1, V47; Matsubara A, 2015, BR J CANC; Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; MIYAMOTO T, 1991, Stomach and Intestine (Tokyo), V26, P1395; Nakai Hisao, 2001, Stomach and Intestine (Tokyo), V36, P1499; Sakurai T, 2005, AM J SURG PATHOL, V29, P1442, DOI 10.1097/01.pas.0000180449.15827.88; Takahashi M, 2011, STOMACH INTESTINE, V46, P1619; Terada T, 2012, INT J CLIN EXP PATHO, V5, P203; Tomizawa M, 2016, CASE REP GASTROENTER; Tsuji S, 2015, WORLD J GASTROENTERO; Ushiku T, 2014, AM J SURG PATHOL, V38, P1484, DOI 10.1097/PAS.0000000000000278; WOLFF M, 1971, AM J CLIN PATHOL, V55, P604; Xue Y, 2016, MOD PATHOL; You Hyun Seon, 2015, Korean J Gastroenterol, V66, P194, DOI 10.4166/kjg.2015.66.4.194; ZANETTI G, 1981, TUMORI J, V67, P75, DOI 10.1177/030089168106700114	35	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174985	10.1371/journal.pone.0174985	http://dx.doi.org/10.1371/journal.pone.0174985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376132	gold, Green Published, Green Submitted			2022-12-27	WOS:000399352000033
J	Frank, J; Eklund, A				Frank, Jens; Eklund, Ann			Poor construction, not time, takes its toll on subsidised fences designed to deter large carnivores	PLOS ONE			English	Article							WOLF DEPREDATION; TOLERANCE	Large carnivore conservation may be considered as successful in Sweden, as wolf (Canis lupus), lynx (Lynx lynx), brown bear (Ursus arctos), golden eagles (Aquila chrysaetos), and wolverine (Gulo gulo) populations have recovered from extinction or near extinction to viable populations during the last three decades. Particularly the wolf and lynx populations have returned at the cost of an increasing number of carnivore attacks on domestic livestock. To support coexistence between carnivores and livestock production, the Swedish authorities subsidise interventions to prevent or reduce the number of carnivore attacks. The most commonly used intervention is carnivore deterring fencing, and all livestock owners can apply for subsidies to build a fence. To receive reimbursement the fence must be approved by the authorities according to predefined criteria. An important part of any management aiming to be adaptive is evaluating interventions. In this paper we evaluate to what extent previously subsidised fences still meet the criteria 1-15 years after their approval. Of 296 fences that had received subsidies in the county of Varmland, 100 randomly selected fences were revisited in 2016. From this subsample 14% of the fences still met the initial criteria for subsidies. None of the fences that still fulfilled the criteria were more than 8 years old, whereas fences with identified failures occurred in all age groups. Of the 86 fences that failed to meet the criteria, construction failures were the most commonly occurring problem. Maintenance failures, wear and tear, only explain a minor part of the failures. To improve the quality of fencing, as well as the quality and longevity of the subsidies programme, there is a need for improved communication between authorities, and improved communication and support from the authorities to livestock producers before and during construction of fences, as well as more rigorous inspection when the fences are built.	[Frank, Jens; Eklund, Ann] Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Dept Ecol, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Frank, J (corresponding author), Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Dept Ecol, Riddarhyttan, Sweden.	jens.frank@slu.se		Frank, Jens/0000-0002-4489-5171	Swedish EPA [NV-01740-14]; Swedish Research Council Formas [2013-11335-26221-38]	Swedish EPA; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	There was no additional external funding received for this study. Both authors have full-time positions at the Swedish University of Agriculture Sciences and received no specific funding for this work. Our unit received funding from the Swedish EPA (http://www.swedishepa.se) (Grant NV-01740-14) and The Swedish Research Council Formas (http://www.formas.se/en/) (Grant 2013-11335-26221-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2013, AUST VET J, V91, P261, DOI 10.1111/avj.12075; [Anonymous], 2015, KOMPLETTERANDE BESKR; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Frank J, 2016, VILTSKADESTATISTIK 2; Gubbi S, 2006, THESIS; Kaczensky Petra, 1999, Ursus, V11, P59; Karlsson J, 2011, ECOL SOC, V16; MONTAG J, 2003, CARNIVORE DAMAGE PRE, V6, P2; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Nyhus P. J., 2003, CONSERVATION PRACTIC, V4, P39; Olsson O, 1997, WILDLIFE BIOL, V3, P13, DOI 10.2981/wlb.1997.003; Ripple WJ, 2017, BIOSCIENCE, V67, P197; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Shivik JA, 2006, BIOSCIENCE, V56, P253, DOI 10.1641/0006-3568(2006)056[0253:TFTEWN]2.0.CO;2; Statistics Sweden, 2015, AGR STAT 2014; Treves A, 2002, WILDLIFE SOC B, V30, P231; Van Tassell LW, 1999, WILDLIFE SOC B, V27, P479; Woodroffe R., 2005, CONSERV BIOL	19	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e017521	10.1371/journal.pone.0175211	http://dx.doi.org/10.1371/journal.pone.0175211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394912	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800021
J	Miyauchi, S; Navarro, D; Grisel, S; Chevret, D; Berrin, JG; Rosso, MN				Miyauchi, Shingo; Navarro, David; Grisel, Sacha; Chevret, Didier; Berrin, Jean-Guy; Rosso, Marie-Noelle			The integrative omics of white-rot fungus Pycnoporus coccineus reveals co-regulated CAZymes for orchestrated lignocellulose breakdown	PLOS ONE			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASES; GENE-EXPRESSION; CELLOBIOSE DEHYDROGENASE; DEGRADATION; CELLULOSE; OXIDATION; DATABASE; ENZYMES	Innovative green technologies are of importance for converting plant wastes into renewable sources for materials, chemicals and energy. However, recycling agricultural and forestry wastes is a challenge. A solution may be found in the forest. Saprotrophic white-rot fungi are able to convert dead plants into consumable carbon sources. Specialized fungal enzymes can be utilized for breaking down hard plant biopolymers. Thus, understanding the enzymatic machineries of such fungi gives us hints for the efficient decomposition of plant materials. Using the saprotrophic white-rot fungus Pycnoporus coccineus as a fungal model, we examined the dynamics of transcriptomic and secretomic responses to different types of lignocellulosic substrates at two time points. Our integrative omics pipeline (SHIN+GO) enabled us to compress layers of biological information into simple heatmaps, allowing for visual inspection of the data. We identified co-regulated genes with corresponding cosecreted enzymes, and the biological roles were extrapolated with the enriched Carbohydrate-Active Enzyme (CAZymes) and functional annotations. We observed the fungal early responses for the degradation of lignocellulosic substrates including; 1) simultaneous expression of CAZy genes and secretion of the enzymes acting on diverse glycosidic bonds in cellulose, hemicelluloses and their side chains or lignin (i.e. hydrolases, esterases and oxido-reductases); 2) the key role of lytic polysaccharide monooxygenases (LPMO); 3) the early transcriptional regulation of lignin active peroxidases; 4) the induction of detoxification processes dealing with biomass-derived compounds; and 5) the frequent attachments of the carbohydrate binding module 1 (CBM1) to enzymes from the lignocellulose-responsive genes. Our omics combining methods and related biological findings may contribute to the knowledge of fungal systems biology and facilitate the optimization of fungal enzyme cocktails for various industrial applications.	[Miyauchi, Shingo; Navarro, David; Grisel, Sacha; Berrin, Jean-Guy; Rosso, Marie-Noelle] Aix Marseille Univ, INRA, UMR 1163, BBF, Marseille, France; [Chevret, Didier] Univ Paris Saclay, AgroParisTech, INRA, PAPPSO,Micalis Inst, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rosso, MN (corresponding author), Aix Marseille Univ, INRA, UMR 1163, BBF, Marseille, France.	marie-noelle.rosso@inra.fr	BERRIN, Jean-Guy/AAF-3107-2021; BERRIN, Jean-Guy/E-1460-2014; Navarro, David/AAB-2178-2022; miyauchi, shingo/AAP-9669-2021	BERRIN, Jean-Guy/0000-0001-7570-3745; Navarro, David/0000-0002-3266-8270; miyauchi, shingo/0000-0002-0620-5547; Grisel, Sacha/0000-0001-6983-0107	Agence Nationalede la Recherche [ANR-14-CE06-0020]	Agence Nationalede la Recherche(French National Research Agency (ANR))	The research was funded by the Agence Nationalede la Recherche (ANR-14-CE06-0020). The fund was obtained by MNR. http://www.agence-nationale-recherche.fr/en/anr-funded-project/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Beckham GT, 2016, CURR OPIN BIOTECH, V42, P40, DOI 10.1016/j.copbio.2016.02.030; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; Couturier M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0407-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feinerer I, 2008, J STAT SOFTW, V25, P1; Fernandez-Fueyo E, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0462-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fong M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0428-y; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Gaskell J, 2014, APPL ENVIRON MICROB, V80, P5828, DOI 10.1128/AEM.01604-14; Gupta R, 2011, BIODEGRADATION, V22, P797, DOI 10.1007/s10532-010-9404-6; Hori C, 2014, APPL ENV MICROBIOL; Hori C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004759; Johnson Norman L., 1994, COMPUTATIONAL STAT D; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersten P, 2014, FUNGAL GENET BIOL, V72, P124, DOI 10.1016/j.fgb.2014.05.011; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lomascolo A, 2011, APPL MICROBIOL BIOT, V92, P1129, DOI 10.1007/s00253-011-3596-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacDonald J, 2012, APPL ENVIRON MICROB, V78, P1596, DOI 10.1128/AEM.06511-11; Miyauchi S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01335; Nagy LG, 2017, MOL BIOL EVOL, V34, P35, DOI 10.1093/molbev/msw238; Perlack RD, 2011, BIOMASS SUPPLY BIOEN, P1; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; R Core Team, 2013, R LANG ENV STAT COMP; Scarlat N, 2015, ENVIRON DEV, V15, P3, DOI 10.1016/j.envdev.2015.03.006; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wehrens R, 2007, JSS J STAT SOFTW, P21; Wittek P, 2013, EFFICIENT PARALLEL L; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Zhu N, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0461-x	42	41	42	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175528	10.1371/journal.pone.0175528	http://dx.doi.org/10.1371/journal.pone.0175528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394946	Green Published, Green Submitted, gold			2022-12-27	WOS:000399954800043
J	Nagata, N; Iwanari, H; Kumagai, H; Kusano-Arai, O; Ikeda, Y; Aritake, K; Hamakubo, T; Urade, Y				Nagata, Nanae; Iwanari, Hiroko; Kumagai, Hidetoshi; Kusano-Arai, Osamu; Ikeda, Yuichi; Aritake, Kosuke; Hamakubo, Takao; Urade, Yoshihiro			Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ALLERGIC INFLAMMATION; CRTH2; D-2; EOSINOPHILS; BASOPHILS; MODULATION; PATHWAY; BINDING; SYSTEM	Prostaglandin D-2 (PGD(2)) is a lipid mediator involved in sleep regulation and inflammation. PGD(2) interacts with 2 types of G protein-coupled receptors, DP1 and DP2/CRTH2 (chemoattractant receptor homologous molecule expressed on T helper type 2 cells)/GPR44 to show a variety of biological effects. DP1 activation leads to Gs-mediated elevation of the intracellular cAMP level, whereas activation of DP2 decreases this level via the Gi pathway; and it also induces G protein-independent, arrestin-mediated cellular responses. Activation of DP2 by PGD(2) causes the progression of inflammation via the recruitment of lymphocytes by enhancing the production of Th2-cytokines. Here we developed monoclonal antibodies (MAbs) against the extracellular domain of mouse DP2 by immunization of DP2-null mutant mice with DP2-overexpressing BAF3, murine interleukin-3 dependent pro-B cells, to reduce the generation of antibodies against the host cells by immunization of mice. Moreover, we immunized DP2-KO mice to prevent immunological tolerance to mDP2 protein. After cell ELISA, immunocytochemical, and Western blot analyses, we successfully obtained a novel monoclonal antibody, MAb-1D8, that specifically recognized native mouse DP2, but neither human DP2 nor denatured mouse DP2, by binding to a particular 3D receptor conformation formed by the N-terminus and extracellular loop 1, 2, and 3 of DP2. This antibody inhibited the binding of 0.5 nM [H-3]PGD(2) to mouse DP2 (IC50 = 46.3 +/- 18.6 nM), showed antagonistic activity toward 15(R)-15-methyl PGD(2)- induced inhibition of 300 nM forskolin-activated cAMP production (IC50 = 16.9 +/- 2.6 nM), and gave positive results for immunohistochemical staining of DP2-expressing CD4+ Th2 lymphocytes that had accumulated in the kidney of unilateral ureteral obstruction model mice. This monoclonal antibody will be very useful for in vitro and in vivo studies on DP2-mediated diseases.	[Nagata, Nanae; Aritake, Kosuke; Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Nagata, Nanae; Ikeda, Yuichi; Aritake, Kosuke; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka, Japan; [Iwanari, Hiroko; Kusano-Arai, Osamu; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Kumagai, Hidetoshi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Kumagai, Hidetoshi; Ikeda, Yuichi] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	University of Tsukuba; University of Tokyo; University of Tokyo; University of Tokyo	Nagata, N; Urade, Y (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan.; Nagata, N; Urade, Y (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka, Japan.	nagata.nanae.gm@u.tsukuba.ac.jp; urade.yoshihiro.ft@u.tsukuba.ac.jp			Program for Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO) of Japan; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [16H01881, 26293051, 14463492]; Grants-in-Aid for Scientific Research [16K15199, 17K08585] Funding Source: KAKEN	Program for Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO, http://www.nedo.go.jp/) of Japan (to TH); by Takeda Science Foundation (http://www.takeda-sci.or.jp/assist/) (to YU); by Osaka City (http://www.city.osaka.lg.jp/) (to YU); and by the program Grants-in-Aid for Scientific Research (A) to Y.U. (16H01881), (B) to KA (26293051), and (C) to HK (14463492) from Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andresen Bradley T., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P92; Apter AJ, 2014, J ALLERGY CLIN IMMUN, V133, P49, DOI 10.1016/j.jaci.2013.11.005; Arima M, 2008, CURR MOL MED, V8, P365, DOI 10.2174/156652408785160970; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Brandt E. B., 2011, J CLIN CELL IMMUNOL, V2; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; CHARLESWORTH EN, 1991, J IMMUNOL, V146, P671; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Ito H, 2012, J AM SOC NEPHROL, V23, P1797, DOI 10.1681/ASN.2012020126; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Kremer Leonor, 2004, Methods Mol Biol, V239, P243; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miyazaki K, 2013, J NEUROIMMUNOL, V260, P107, DOI 10.1016/j.jneuroim.2013.03.003; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P942, DOI 10.1016/j.jaci.2009.07.006; Ramadhanti Julia, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P270, DOI 10.1089/mab.2013.0007; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Shiraishi Y, 2014, CLIN EXP ALLERGY, V44, P1076, DOI 10.1111/cea.12280; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wright DH, 1999, EUR J PHARMACOL, V377, P101, DOI 10.1016/S0014-2999(99)00358-1; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175452	10.1371/journal.pone.0175452	http://dx.doi.org/10.1371/journal.pone.0175452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394950	gold, Green Published, Green Submitted			2022-12-27	WOS:000399954800036
J	Chiu, SK; Chan, MC; Huang, LY; Lin, YT; Lin, JC; Lu, PL; Siu, LK; Chang, FY; Yeh, KM				Chiu, Sheng-Kang; Chan, Ming-Chin; Huang, Li-Yueh; Lin, Yi-Tsung; Lin, Jung-Chung; Lu, Po-Liang; Siu, L. Kristopher; Chang, Feng-Yee; Yeh, Kuo-Ming			Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; FIELD GEL-ELECTROPHORESIS; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; EMERGENCE; ENTEROBACTERIACEAE; MECHANISMS; CLONE; NONSUSCEPTIBILITY; SUSCEPTIBILITY	Objectives Tigecycline is a treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Emerging tigecycline resistance in CRKP represents a growing threat. Knowledge of the clinical, microbiological, and molecular characteristics of tigecycline- and carbapenem-resistant Klebsiella pneumoniae (TCRKP) is limited. Methods Patients infected with TCRKP were identified from a Taiwanese national surveillance study. Clinical data were collected from medical records. We performed susceptibility tests, carbapenemase gene detection, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Furthermore, we performed quantitative real-time polymerase chain reaction (qRT-PCR) analyses to assess the expression levels of the efflux pump genes acrB and oqxB. Results We identified 16 patients infected with TCRKP, with urinary tract infection (UTI) being the most common type of infection (63%). The all-cause 30-day mortality rate was 44% in patients with TCRKP infection. Patients with a site of infection other than the urinary tract had a significantly higher mortality rate than patients with UTIs (83% vs. 20%, p = 0.035). PFGE and MLST revealed no dominant clone or sequence type. Using qRT-PCR, overexpression of both the acrB and oqxB genes was identified in seven isolates, and overexpression of the oqxB gene was observed in another seven. There was poor correlation between acrB or oqxB expression and tigecycline MICs (r = -0.038 and -0.166, respectively). Conclusions The mortality rate in patients infected with TCRKP in this study was 44% and this is an important subset of patients. The absence of a linear relationship between efflux pump genes expression and MICs indicates that tigecycline resistance may be mediated by other factors. Continuous monitoring of tigecycline resistance among CRKP isolates and resistance mechanisms are necessary.	[Chiu, Sheng-Kang; Lin, Jung-Chung; Siu, L. Kristopher; Chang, Feng-Yee; Yeh, Kuo-Ming] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chiu, Sheng-Kang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chan, Ming-Chin] Triserv Gen Hosp, Natl Def Med Ctr, Infect Control Off, Taipei, Taiwan; [Huang, Li-Yueh; Siu, L. Kristopher] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Lin, Yi-Tsung] Natl Yan Ming Univ, Taipei Vet Gen Hosp, Infect Dis Sect, Dept Med, Taipei, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan	Yeh, KM (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	kmyeh@ndmctsgh.edu.tw	Lu, Po-Liang/D-4499-2009; Chiu, Sheng-Kang/GQO-8638-2022	Lu, Po-Liang/0000-0002-7423-6783; 	Centers for Disease Control, Taiwan [MOHW104-CDC-C-114-144406]; Tri-Service General Hospital [TSGH-C103-124]	Centers for Disease Control, Taiwan; Tri-Service General Hospital	The work was supported by research grants from the Centers for Disease Control, Taiwan (MOHW104-CDC-C-114-144406; http://www.cdc.gov.tw/english/index.aspx; JCL) and Tri-Service General Hospital (TSGH-C103-124; http://www.tsgh.ndmctsgh.edu.tw/; SKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balm MND, 2012, J CLIN MICROBIOL, V50, P475, DOI 10.1128/JCM.05914-11; Bialek-Davenet S, 2015, J ANTIMICROB CHEMOTH, V70, P81, DOI 10.1093/jac/dku340; Bratu S, 2009, J ANTIMICROB CHEMOTH, V64, P278, DOI 10.1093/jac/dkp186; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Clinical and Laboratory Standards Institute, 100S252015 CLIN LAB; D'Agata EMC, 2001, INFECT CONT HOSP EP, V22, P550, DOI 10.1086/501950; De Majumdar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004627; De Majumdar S, 2013, ANTIMICROB AGENTS CH, V57, P1603, DOI 10.1128/AAC.01998-12; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Jeong SH, 2016, ANN LAB MED, V36, P529, DOI 10.3343/alm.2016.36.6.529; Juan CH, 2016, ANTIMICROB AGENTS CH, V60, P7357, DOI 10.1128/AAC.01503-16; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P3582, DOI 10.1128/AAC.01574-08; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Nielsen LE, 2014, ANTIMICROB AGENTS CH, V58, P6151, DOI 10.1128/AAC.03053-14; Nigo M, 2013, ANTIMICROB AGENTS CH, V57, P5743, DOI 10.1128/AAC.00827-13; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Palacios-Baena ZR, 2016, J INFECTION, V72, P152, DOI 10.1016/j.jinf.2015.10.008; Pournaras S, 2016, INT J ANTIMICROB AG, V48, P11, DOI 10.1016/j.ijantimicag.2016.04.017; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rosenblum R, 2011, INT J ANTIMICROB AG, V38, P39, DOI 10.1016/j.ijantimicag.2011.02.012; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Sheng ZK, 2016, J MICROBIOL IMMUNOL, V49, P962, DOI 10.1016/j.jmii.2015.10.014; Sheng ZK, 2014, ANTIMICROB AGENTS CH, V58, P6982, DOI 10.1128/AAC.03808-14; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Sun Y, 2013, INT J ANTIMICROB AG, V41, P110, DOI 10.1016/j.ijantimicag.2012.09.005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; van Duin D, 2014, CLIN MICROBIOL INFEC, V20, pO1117, DOI 10.1111/1469-0691.12714; van Duin D, 2015, INFECT CONT HOSP EP, V36, P942, DOI 10.1017/ice.2015.118; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13; Wu PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep32665; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	38	29	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175140	10.1371/journal.pone.0175140	http://dx.doi.org/10.1371/journal.pone.0175140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388651	gold, Green Published, Green Submitted			2022-12-27	WOS:000399375800023
J	Yagai, T; Matsui, S; Harada, K; Inagaki, FF; Saijou, E; Miura, Y; Nakanuma, Y; Miyajima, A; Tanaka, M				Yagai, Tomoki; Matsui, Satoshi; Harada, Kenichi; Inagaki, Fuyuki F.; Saijou, Eiko; Miura, Yasushi; Nakanuma, Yasuni; Miyajima, Atsushi; Tanaka, Minoru			Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree	PLOS ONE			English	Article							INTRAHEPATIC PERIBILIARY GLANDS; STEM/PROGENITOR CELLS; LIVER-REGENERATION; MOUSE-LIVER; SAM DOMAINS; HEPATOCYTES; PROTEIN; CHOLANGIOCARCINOMA; CHOLANGIOCYTES; HETEROGENEITY	Cholangiocarcinoma (CC) is a type of relatively rare neoplasm in adenocarcinoma. The characteristics of CCs as well as biliary epithelial cells are heterogeneous at the different portion of the biliary tree. There are two candidate stem/progenitor cells of the biliary tree, i.e., biliary tree stem/progenitor cell (BTSC) at the peribiliary gland (PBG) of large bile ducts and liver stem/progenitor cell (LPC) at the canals of Hering of peripheral small bile duct. Although previous reports suggest that intrahepatic CC (ICC) can arise from such stem/progenitor cells, the characteristic difference between BTSC and LPC in pathological process needs further investigation, and the etiology of CC remains poorly understood. Here we show that Sterile alpha motif domain containing 5 (SAMD5) is exclusively expressed in PBGs of large bile ducts in normal mice. Using a mouse model of cholestatic liver disease, we demonstrated that SAMD5 expression was upregulated in the large bile duct at the hepatic hilum, the extrahepatic bile duct and PBGs, but not in proliferating intrahepatic ductules, suggesting that SAMD5 is expressed in BTSC but not LPC. Intriguingly, human ICCs and extrahepatic CCs exhibited striking nuclear localization of SAMD5 while the normal hilar large bile duct displayed slight-to-moderate expression in cytoplasm. In vitro experiments using siRNA for SAMD5 revealed that SAMD5 expression was associated with the cell cycle regulation of CC cell lines. Conclusion: SAMD5 is a novel marker for PBG but not LPC in mice. In humans, the expression and location of SAMD5 could become a promising diagnostic marker for the cell type as well as malignancy of bile ducts and CCs.	[Yagai, Tomoki; Matsui, Satoshi; Inagaki, Fuyuki F.; Saijou, Eiko; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo, Japan; [Matsui, Satoshi; Nakanuma, Yasuni; Tanaka, Minoru] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan; [Harada, Kenichi; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan; [Miura, Yasushi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan; [Yagai, Tomoki] Natl Canc Inst, Natl Inst Hlth, Ctr Canc Res, Lab Metab, Bethesda, MD USA; [Inagaki, Fuyuki F.] Univ Tokyo, Grad Sch Med, Hepato Biliary Pancreat Surg Div, Artificial Organ & Transplantat Div, Tokyo, Japan; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan; Kanazawa University; Waseda University; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tokyo; Shizuoka Cancer Center	Tanaka, M (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan.; Tanaka, M (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan.	m-tanaka@ri.ncgm.go.jp			Japan Society for the Promotion of Science, Japan [2611007, 26253023]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Support was provided by Grants-in-Aid for Scientific Research on Innovative Areas (2611007 to MT) and Scientific Research A (26253023 to AM) from the Japan Society for the Promotion of Science, Japan (https://www.jsps.go.jp.english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2015, J HEPATO-BIL-PAN SCI, V22, P94, DOI 10.1002/jhbp.154; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Carpino G, 2012, J ANAT, V220, P186, DOI 10.1111/j.1469-7580.2011.01462.x; Fickert P, 2002, AM J PATHOL, V161, P2019, DOI 10.1016/S0002-9440(10)64480-X; Glaser S, 2006, WORLD J GASTROENTERO, V12, P3523, DOI 10.3748/wjg.v12.i22.3523; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Inagaki FF, 2013, BIOCHEM BIOPH RES CO, V430, P751, DOI 10.1016/j.bbrc.2012.11.076; ISHIDA F, 1989, LAB INVEST, V60, P260; Katayanagi K, 1998, LIVER, V18, P90; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Luo N, 2010, BMB REP, V43, P355, DOI 10.5483/BMBRep.2010.43.5.355; Marzioni M, 2002, SEMIN LIVER DIS, V22, P227, DOI 10.1055/s-2002-34501; Matsuo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113606; Meruelo AD, 2009, PROTEINS, V74, P1, DOI 10.1002/prot.22232; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Nakanishi Y, 2011, PATHOL INT, V61, P773, DOI 10.1111/j.1440-1827.2011.02738.x; Nakanishi Y, 2009, J HEPATO-BILIARY-PAN, V16, P869, DOI 10.1007/s00534-009-0070-1; Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Paylakhi SH, 2011, MOL VIS, V17, P1209; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sa JK, 2017, ONCOTARGET, V8, P1321, DOI 10.18632/oncotarget.13616; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; TERADA T, 1990, HEPATOLOGY, V12, P92, DOI 10.1002/hep.1840120115; TERADA T, 1995, GASTROENTEROLOGY, V108, P1236, DOI 10.1016/0016-5085(95)90225-2; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Watanabe T, 2014, DIS COLON RECTUM, V57, P23, DOI 10.1097/01.dcr.0000437688.33795.9d; Yagai T, 2014, AM J PATHOL, V184, P2250, DOI 10.1016/j.ajpath.2014.04.018	42	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175355	10.1371/journal.pone.0175355	http://dx.doi.org/10.1371/journal.pone.0175355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388653	gold, Green Submitted, Green Published			2022-12-27	WOS:000399375800043
J	Uren, C; Henn, BM; Franke, A; Wittig, M; van Heiden, PD; Hoal, EG; Moller, M				Uren, Caitlin; Henn, Brenna M.; Franke, Andre; Wittig, Michael; van Heiden, Paul D.; Hoal, Eileen G.; Moller, Mario			A post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN COLORED POPULATION; PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; ANCESTRY; LOCUS; RISK; DISEASE; INDIVIDUALS; ANNOTATION	Utilizing data from published tuberculosis (TB) genome-wide association studies (GWAS), we use a bioinformatics pipeline to detect all polymorphisms in linkage disequilibrium (LD) with variants previously implicated in TB disease susceptibility. The probability that these variants had a predicted regulatory function was estimated using RegulomeDB and Ensembl's Variant Effect Predictor. Subsequent genotyping of these 133 predicted regulatory polymorphisms was performed in 400 admixed South African TB cases and 366 healthy controls in a population-based case-control association study to fine-map the causal variant. We detected associations between tuberculosis susceptibility and six intronic polymorphisms located in MARCO, IFNGR2, ASHAS2, ACACA, NISCH and TLR10. Our post-GWAS approach demonstrates the feasibility of combining multiple TB GWAS datasets with linkage information to identify regulatory variants associated with this infectious disease.	[Uren, Caitlin; van Heiden, Paul D.; Hoal, Eileen G.; Moller, Mario] Stellenbosch Univ, SA MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Franke, Andre; Wittig, Michael] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str, Kiel, Germany	National Research Foundation - South Africa; Stellenbosch University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Kiel	Moller, M (corresponding author), Stellenbosch Univ, SA MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa.	marlom@sun.ac.za	Moller, Marlo/AAC-6973-2020; Franke, Andre/B-2151-2010	Moller, Marlo/0000-0002-0805-6741; Franke, Andre/0000-0003-1530-5811; Uren, Caitlin/0000-0003-2358-0135	Faculty of Medicine and Health Sciences Early-Career Research; NRF National Bioinformatics Functional Genomics [93666]; DFG Cluster of Excellence 306 "Inflammation at Interfaces"	Faculty of Medicine and Health Sciences Early-Career Research; NRF National Bioinformatics Functional Genomics; DFG Cluster of Excellence 306 "Inflammation at Interfaces"	This work was supported by the Faculty of Medicine and Health Sciences Early-Career Research Funding for 2015 and the NRF National Bioinformatics Functional Genomics Grant No 93666 to M. M .A.F. and M.W. are supported through the DFG Cluster of Excellence 306 "Inflammation at Interfaces". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Bastami M, 2016, GENE, V594, P74, DOI 10.1016/j.gene.2016.08.054; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bowdish DME, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-47; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Bukhari M, 2015, INT J IMMUNOGENET, V42, P46, DOI 10.1111/iji.12170; Bulat-Kardum LJ, 2015, SCAND J IMMUNOL, V82, P63, DOI 10.1111/sji.12300; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Campbell H., 2002, Pharmacogenomics Journal, V2, P349; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Chimusa ER, 2016, BIOINFORMATICS, V32, P549, DOI 10.1093/bioinformatics/btv619; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Chimusa ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073971; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; Dalgic N, 2011, DIS MARKERS, V31, P33, DOI [10.1155/2011/545972, 10.3233/DMA-2011-0800]; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Daya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082224; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; DeLorenze GN, 2016, J INFECT DIS, V213, P816, DOI 10.1093/infdis/jiv483; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Gallant CJ, 2010, INT J TUBERC LUNG D, V14, P952; Grant AV, 2016, HUM GENET, V135, P299, DOI 10.1007/s00439-016-1633-2; Haider SA, 2015, BIOGERONTOLOGY, V16, P529, DOI 10.1007/s10522-015-9575-y; Hijikata M, 2012, HUM GENET, V131, P675, DOI 10.1007/s00439-011-1112-8; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong XF, 2013, HUM MOL GENET, V22, P769, DOI 10.1093/hmg/dds484; Kuijl C, 2013, EMBO J, V32, P713, DOI 10.1038/emboj.2013.10; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024069; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oki Noffisat O, 2011, BMC Res Notes, V4, P28, DOI 10.1186/1756-0500-4-28; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Pollard K., 2004, UC BERKELEY DIVISION; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Salie M, 2014, J INFECT DIS, V209, P216, DOI 10.1093/infdis/jit443; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sobota RS, 2016, AM J HUM GENET, V98, P514, DOI 10.1016/j.ajhg.2016.01.015; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; Sveinbjornsson G, 2016, NAT GENET, V48, P318, DOI 10.1038/ng.3498; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Warnes G., 1967, J AM STAT ASSOC, V62, P626; Wei ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10879; World Health Organization, GLOB TUB REP 2016	57	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174738	10.1371/journal.pone.0174738	http://dx.doi.org/10.1371/journal.pone.0174738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384278	Green Published, gold			2022-12-27	WOS:000399371900032
J	Yang, YW; Liu, HH; Lin, TH; Chuang, HY; Hsieh, T				Yang, Yu-Wan; Liu, Hsin-Ho; Lin, Tien-Huang; Chuang, Hsun-Yang; Hsieh, Tengfu			Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus	PLOS ONE			English	Article							LOWER URINARY-TRACT; OVERACTIVE BLADDER; COGNITIVE IMPAIRMENT; TAIWAN; PREVALENCE; QUALITY; PLACEBO; IMPACT	Background The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes mellitus (DM) remain unknown. We investigated the effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with DM. Methods We conducted a cohort study by using the diabetes dataset of the Taiwan National Health Insurance Research Database from 1 January, 2002 to 31 December, 2013. We included 10,938 patients received one type of oxybutynin, solifenacin, or tolterodine, while 564,733 had not. We included a comparable number of patients not receiving oxybutynin, solifenacin, or tolterodine as controls through systematic random sampling matching by age, gender, and the year of the index date with 1 to 1 ratio. The dementia risk was estimated through multivariate Cox proportional hazard regression after adjustment for several confounding factors. Results The dementia event rates were 3.9% in the oxybutynin group, 4.3% in the solifenacin group, 2.2% in the tolterodine group and 1.2% in the control group (P<0.001). The adjusted HRs compared to nonusers of anticholinergic drugs were 2.35 (95% CI, 1.96 to 2.81), 2.16 (95% CI, 1.81 to 2.58), and 2.24 (95% CI, 1.85 to 2.73), respectively, for patients receiving oxybutynin, solifenacin, or tolterodine. Conclusion Our study indicates an association between taking oxybutynin, solifenacin and tolterodine and the subsequent diagnosis of dementia in DM patients. Moreover, the patients using oxybutynin had highest risk. The impact of these three drugs on risk of dementia in non-diabetic populations is warrant.	[Yang, Yu-Wan] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Yu-Wan] China Med Univ, Sch Med, Taichung, Taiwan; [Liu, Hsin-Ho; Lin, Tien-Huang; Chuang, Hsun-Yang; Hsieh, Tengfu] Taichung Tzu Chi Hosp, Dept Urol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Liu, Hsin-Ho; Lin, Tien-Huang; Hsieh, Tengfu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chuang, Hsun-Yang; Hsieh, Tengfu] Taichung Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Hsieh, T (corresponding author), Taichung Tzu Chi Hosp, Dept Urol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan.; Hsieh, T (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hsieh, T (corresponding author), Taichung Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan.	hdf95@yahoo.com.tw						Andersson KE, 2011, EUR UROL, V59, P377, DOI 10.1016/j.eururo.2010.11.040; Bertram S, 2016, ENDOCRINE; Chen CC, 2016, HEALTH POLICY PLANN, V31, P83, DOI 10.1093/heapol/czv024; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Giglio D, 2009, PHARMACOLOGY, V83, P259, DOI 10.1159/000209255; Glavind K, 2011, INT UROGYNECOL J, V22, P907, DOI 10.1007/s00192-011-1411-6; Gormley EA, 2015, J UROLOGY, V193, P1572, DOI 10.1016/j.juro.2015.01.087; Herbison P, 2003, BMJ-BRIT MED J, V326, P841, DOI 10.1136/bmj.326.7394.841; Hsieh HM, 2015, MED CARE, V53, P106, DOI 10.1097/MLR.0000000000000264; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; Ikeda M, 2015, ENDOCR J, V62, P847, DOI 10.1507/endocrj.EJ15-0237; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu RT, 2011, UROLOGY, V78, P1040, DOI 10.1016/j.urology.2011.05.017; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; Maman K, 2014, EUR UROL, V65, P755, DOI 10.1016/j.eururo.2013.11.010; Tuccori M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1541; Wagg A, 2010, INT J CLIN PRACT, V64, P1279, DOI 10.1111/j.1742-1241.2010.02449.x; Wagg A, 2013, EUR UROL, V64, P74, DOI 10.1016/j.eururo.2013.01.002; Womack KB, 2003, ARCH NEUROL-CHICAGO, V60, P771, DOI 10.1001/archneur.60.5.771	25	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175335	10.1371/journal.pone.0175335	http://dx.doi.org/10.1371/journal.pone.0175335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384267	Green Published, gold, Green Submitted			2022-12-27	WOS:000399371900159
J	de Albuquerque, FS; Gregory, A				de Albuquerque, Fabio Suzart; Gregory, Andrew			The geography of hotspots of rarity-weighted richness of birds and their coverage by Natura 2000	PLOS ONE			English	Article							TERRESTRIAL VERTEBRATES; SPECIES RICHNESS; CONSERVATION; SELECTION; ENDEMISM; POLICY; AREAS	A major challenge for biogeographers and conservation planners is to identify where to best locate or distribute high-priority areas for conservation and to explore whether these areas are well represented by conservation actions such as protected areas (PAs). We aimed to identify high-priority areas for conservation, expressed as hotpots of rarity-weighted richness (HRR) sites that efficiently represent species for birds across EU countries, and to explore whether HRR are well represented by the Natura 2000 network. Natura 2000 is an evolving network of PAs that seeks to conserve biodiversity through the persistence of the most patrimonial species and habitats across Europe. This network includes Sites of Community Importance (SCI) and Special Areas of Conservation (SAC), where the latter regulated the designation of Special Protected Areas (SPA). Distribution maps for 416 bird species and complementarity-based approaches were used to map geographical patterns of rarity-weighted richness (RWR) and HRR for birds. We used species accumulation index to evaluate whether RWR was efficient surrogates to identify HRRs for birds. The results of our analysis support the proposition that prioritizing sites in order of RWR is a reliable way to identify sites that efficiently represent birds. HRRs were concentrated in the Mediterranean Basin and alpine and boreal biogeographical regions of northern Europe. The cells with high RWR values did not correspond to cells where Natura 2000 was present. We suggest that patterns of RWR could become a focus for conservation biogeography. Our analysis demonstrates that identifying HRR is a robust approach for prioritizing management actions, and reveals the need for more conservation actions, especially on HRR.	[de Albuquerque, Fabio Suzart] Arizona State Univ, Coll Integrat Sci & Arts, Sci & Math Fac, Mesa, AZ 85212 USA; [Gregory, Andrew] Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA	Arizona State University; University System of Ohio; Bowling Green State University	de Albuquerque, FS (corresponding author), Arizona State Univ, Coll Integrat Sci & Arts, Sci & Math Fac, Mesa, AZ 85212 USA.	Fabio.Albuquerque@asu.edu		Gregory, Andrew/0000-0003-1905-3236	Arizona State University; University of Granada	Arizona State University; University of Granada	This work was partly funded by the Arizona State University and University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119905; Albuquerque FS, 2013, BIOL CONSERV, V159, P45, DOI 10.1016/j.biocon.2012.10.012; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Assuncao-Albuquerque M.J.T., 2012, Web Ecology, V12, P65; Barov B, 2012, CONSERVATION RECOVER; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; BirdLife International, 2008, CRIT END GLOB AUD; Carter F.W., 2002, ENV PROBLEMS E CENTR; Conde A S, 2006, 152 EUR ENV AG; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4; Dudley N., 2010, NATURAL SOLUTIONS PR; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; EC (European Commission), 2000, NAT 2000 EUR NAT YOU; EEA, 2015, NAT 2000 DAT EUR NET; Ellis EC, 2000, ANTHROPOGENIC BIOMES; European Commission, 1996, INT MAN EUR UN HAB V; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferrier S., 2009, SPATIAL CONSERVATION, P13; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Haight R., 2009, SPATIAL CONSERVATION, P43; Hanski I., 2004, MUCH PRACTICAL TOOLS; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A., 2009, SPATIAL CONSERVATION, P58; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pascual LL, 2011, ACTA OECOL, V37, P399, DOI 10.1016/j.actao.2011.05.004; Pressey R. L., 2009, SPATIAL CONSERVATION, P211; R Core Team, 2020, R LANG ENV STAT COMP; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rosin ZM, 2016, J APPL ECOL, V53, P1363, DOI 10.1111/1365-2664.12715; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Stein BA, 2000, PRECIOUS HERITAGE ST; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Wilson K.A., 2009, SPATIAL CONSERVATION	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174179	10.1371/journal.pone.0174179	http://dx.doi.org/10.1371/journal.pone.0174179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379991	Green Published, gold, Green Submitted			2022-12-27	WOS:000399353500035
J	Foley, L; Prins, R; Crawford, F; Humphreys, D; Mitchell, R; Sahlqvist, S; Thomson, H; Ogilvie, D				Foley, Louise; Prins, Richard; Crawford, Fiona; Humphreys, David; Mitchell, Richard; Sahlqvist, Shannon; Thomson, Hilary; Ogilvie, David		M74 Study Team	Effects of living near an urban motorway on the wellbeing of local residents in deprived areas: Natural experimental study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; POPULATION HEALTH; SCALE WEMWBS; UK; DEPRIVATION; INTERVENTIONS; WALKING; PEOPLE; IMPACT	Background Health and wellbeing are partly shaped by the neighbourhood environment. In 2011, an eight kilometre (five mile) extension to the M74 motorway was opened in Glasgow, Scotland, constructed through a predominantly urban, deprived area. We evaluated the effects of the new motorway on wellbeing in local residents. Methods This natural experimental study involved a longitudinal cohort (n = 365) and two cross-sectional samples (baseline n = 980; follow-up n = 978) recruited in 2005 and 2013. Adults from one of three study areas-surrounding the new motorway, another existing motorway, or no motorway-completed a postal survey. Within areas, individual measures of motorway proximity were calculated. Wellbeing was assessed with the mental (MCS-8) and physical (PCS-8) components of the SF-8 scale at both time points, and the short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) at follow-up only. Results In multivariable linear regression analyses, cohort participants living nearer to the new M74 motorway experienced significantly reduced mental wellbeing over time (MCS-8: -3.6, 95% CI -6.6 to -0.7) compared to those living further away. In cross-sectional and repeat cross-sectional analyses, an interaction was found whereby participants with a chronic condition living nearer to the established M8 motorway experienced reduced (MCS-8: -3.7, 95% CI -8.3 to 0.9) or poorer (SWEMWBS: -1.1, 95% CI -2.0 to -0.3) mental wellbeing compared to those living further away. Conclusions We found some evidence that living near to a new motorway worsened local residents' wellbeing. In an area with an existing motorway, negative impacts appeared to be concentrated in those with chronic conditions, which may exacerbate existing health inequalities and contribute to poorer health outcomes. Health impacts of this type of urban regeneration intervention should be more fully taken into account in future policy and planning.	[Foley, Louise; Prins, Richard; Ogilvie, David] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit, Cambridge, England; [Foley, Louise; Prins, Richard; Ogilvie, David] Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England; [Crawford, Fiona] NHS Greater Glasgow & Clyde & Glasgow Ctr Populat, Glasgow, Lanark, Scotland; [Humphreys, David] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Mitchell, Richard] Univ Glasgow, Environm Res Ctr, Inst Hlth & Wellbeing, Soc & Hlth, Glasgow, Lanark, Scotland; [Sahlqvist, Shannon] Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Thomson, Hilary] Univ Glasgow, CSO Social & Publ Hlth Sci Unit, MRC, Glasgow, Lanark, Scotland	University of Cambridge; University of Cambridge; University of Oxford; University of Glasgow; Deakin University; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Foley, L (corresponding author), Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit, Cambridge, England.; Foley, L (corresponding author), Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England.	lf354@medschl.cam.ac.uk		Ogilvie, David/0000-0002-0270-4672; Hilton, Shona/0000-0003-0633-8152; Humphreys, David K./0000-0002-7761-5746; Sahlqvist, Shannon/0000-0002-3714-9533	National Institute for Health Research Public Health Research programme (NIHR PHR) [11/3005/07]; Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council, Medical Research Council; National Institute for Health Research; Wellcome Trust, under the auspices of the UK Clinical Research Collaboration; Medical Research Council [MC_UU_12015/6, MC_UU_12017/4, MC_UU_12017-15]; Chief Scientist Office of the Scottish Government Health Directorate (SPHSU1); Scottish Government; Medical Research Council Special Training Fellowship in Health of the Public Research [G106/1203]; NIHR [11/3005/07]; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12017/15, G106/1203, MR/K023187/1, MC_UU_12017/5] Funding Source: researchfish; National Institute for Health Research [11/3005/07] Funding Source: researchfish; Chief Scientist Office [SPHSU1, SPHSU15] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12017/15, MC_UU_12017/4, MC_UU_12015/6, MC_UU_12017/5, MR/K023187/1, G106/1203] Funding Source: UKRI	National Institute for Health Research Public Health Research programme (NIHR PHR); Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the auspices of the UK Clinical Research Collaboration(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorate (SPHSU1); Scottish Government; Medical Research Council Special Training Fellowship in Health of the Public Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LF is supported by the National Institute for Health Research Public Health Research programme (NIHR PHR; project number 11/3005/07) and the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. DO and RP are supported by the Medical Research Council (MC_UU_12015/6). HT is supported by the Medical Research Council (MC_UU_12017/4 and MC_UU_12017-15) and the Chief Scientist Office of the Scottish Government Health Directorate (SPHSU1). FT is employed in a hybrid role between NHS Greater Glasgow and Clyde and Glasgow Centre for Population Health (GCPH). GCPH is a partnership between NHS Greater Glasgow and Clyde, Glasgow City Council, and the University of Glasgow, funded by the Scottish Government. The baseline phase of the M74 study was developed by David Ogilvie, Richard Mitchell, Nanette Mutrie, Mark Petticrew and Stephen Platt and supported by a Medical Research Council Special Training Fellowship in Health of the Public Research (award number G106/1203). The follow-up phase of the study was developed by Lyndal Bond, Fiona Crawford, Simon Griffin, Shona Hilton, David Humphreys, Andrew Jones, Richard Mitchell, Nanette Mutrie, Shannon Sahlqvist and Hilary Thomson. This article presents independent research funded by the NIHR (project number 11/3005/07). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard D., 1981, LIVABLE STREETS; Batty E., 2010, NEW DEAL COMMUNITIES, V7; Breeze E, 2005, INT J EPIDEMIOL, V34, P276, DOI 10.1093/ije/dyh328; British Medical Association, 2012, HLTH TRANSP HLTH LIV; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Dratva J, 2010, QUAL LIFE RES, V19, P37, DOI 10.1007/s11136-009-9571-2; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Egan M, 2003, AM J PUBLIC HEALTH, V93, P1463, DOI 10.2105/AJPH.93.9.1463; Egan M, 2013, AM J PUBLIC HEALTH, V103, pE47, DOI 10.2105/AJPH.2013.301275; Erdem O, 2015, EUROPEAN J PUBLIC HL; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; Goodman A, 2014, AM J PUBLIC HEALTH, V104, pE38, DOI 10.2105/AJPH.2014.302059; Hart J, 2008, DRIVEN EXCESS IMPACT; Humphreys DK, 2016, J EPIDEMIOL COMMUN H, V70, P941, DOI 10.1136/jech-2015-206381; Jackson RJ, 2003, AM J PUBLIC HEALTH, V93, P1382, DOI 10.2105/AJPH.93.9.1382; Kearns A, 2008, SHARP SURVEY FINDING; Kearns A, 2009, J URBAN REGEN RENEW, V3, P56; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Marques S, 2011, J ENVIRON PSYCHOL, V31, P314, DOI 10.1016/j.jenvp.2010.12.002; National Institute for Health and Clinical Excellence (NICE), 2008, PHYS ACT ENV GUID PR; National Records of Scotland, 2014, LIF EXP AR SCOTL; National Records of Scotland, 2011, 2011 CENS 1 RES POP; Ogilvie D, 2006, AM J PREV MED, V31, P118, DOI 10.1016/j.amepre.2006.03.030; Ogilvie D, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-43; Panter J, 2016, AM J PREV MED, V50, pE45, DOI 10.1016/j.amepre.2015.09.021; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Scottish Government, 2013, SCOTT HLTH SURV MAIN; Stewart-Brown S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-15; Strathclyde Partnership for Transport, 2008, CAT CHANG REG TRANSP; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Thomson H, 2008, J EPIDEMIOL COMMUN H, V62, P932, DOI 10.1136/jech.2007.068775; Thomson H, 2006, J EPIDEMIOL COMMUN H, V60, P108, DOI 10.1136/jech.2005.038885; Thomson H, 2013, CAMPBELL SYSTEMATIC, V2; Walker G, 2005, LOCAL ENVIRON, V10, P361, DOI 10.1080/13549830500160842; Ware JE, 2001, SF 36 PHYS MENTAL HL; Ware JE Jr, 2001, SCORE INTERPRET SING; Watt GCM, 1996, BRIT MED J, V312, P1026; World Health Organisation, 2012, ENV HLTH IN EUR ASS	38	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174882	10.1371/journal.pone.0174882	http://dx.doi.org/10.1371/journal.pone.0174882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379993	gold, Green Accepted, Green Published			2022-12-27	WOS:000399353500073
J	Pastor-Idoate, S; Bonshek, R; Irion, L; Zambrano, I; Carlin, P; Mironov, A; Bishop, P; McLeod, D; Stanga, PE				Pastor-Idoate, Salvador; Bonshek, Richard; Irion, Luciane; Zambrano, Isaac; Carlin, Paul; Mironov, Aleksandr; Bishop, Paul; McLeod, David; Stanga, Paulo Eduardo			Ultrastructural and histopathologic findings after pars plana vitrectomy with a new hypersonic vitrector system. Qualitative preliminary assessment	PLOS ONE			English	Article							ULTRASONIC VITRECTOMY; TISSUE; PHYSICS; ORGANIZATION; LESIONS; RETINA	Purpose Preliminary assessment of a new prototype ultrasound-based hypersonic vitrector (HV) by qualitatively examining the histopathological changes in the retina and vitreous body after pars plana vitrectomy (PPV) and its ability to fragment vitreous collagen. Methods Fourteen porcine cadaveric eyes, 20 eyes in live swine and six human cadaveric eyes underwent PPV using the HV or a pneumatic guillotine vitrector (GV). An additional 4 porcine crystalline lenses were touched with either the HV or GV for 1 minute. Following PPV, human vitreous was removed and processed for electron microscopy (EM). Eyes and lenses were fixed and sectioned for light microscopy (LM). Results There were no macroscopic retinal or optic nerve defects associated with either HV or GV PPVs. Cadaveric retinal specimens showed separation of the inner limiting membrane (ILM) and vacuolization and fragmentation at the nerve fiber layer (NFL) and the ganglion cell layer (GCL). ILM fragmentation and separation were found after PPV in live swine with both vitrectors. Small disruptions of the posterior capsule or structural lens defects were found after HV touch. The EM analysis revealed more fragmentation of human vitreous collagen fibrils after HV compared to GV PPV. Conclusions LM and EM analysis of retina, vitreous, and crystalline lens after PPV showed similar morphological changes using the HV or the GV. Vitreous fragmentation appeared more effective with the HV. Overall this study suggests that the HV may be a promising new technology. More work is needed to quantitatively assess its safety and efficacy.	[Pastor-Idoate, Salvador; Bonshek, Richard; Irion, Luciane; Zambrano, Isaac; Carlin, Paul; Bishop, Paul; McLeod, David; Stanga, Paulo Eduardo] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Pastor-Idoate, Salvador; Stanga, Paulo Eduardo] Manchester Royal Eye Hosp, Manchester Vis Regenerat MVR Lab, Manchester, Lancs, England; [Pastor-Idoate, Salvador; Stanga, Paulo Eduardo] NIHR Wellcome Trust Manchester CRF, Manchester, Lancs, England; [Bonshek, Richard; Irion, Luciane] Manchester Royal Eye Hosp, Natl Specialist Ophthalm Pathol Serv, Manchester, Lancs, England; [Zambrano, Isaac] Manchester Royal Eye Hosp, Eye Bank, Manchester, Lancs, England; [Carlin, Paul] Manchester Royal Eye Hosp, Operating Theatre Serv, Manchester, Lancs, England; [Mironov, Aleksandr] Univ Manchester, Fac Life Sci, Electron Microscopy Core Facil, Manchester, Lancs, England; [Bishop, Paul; McLeod, David; Stanga, Paulo Eduardo] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	Manchester Royal Eye Hospital; University of Manchester; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital; University of Manchester; University of Manchester	Stanga, PE (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.; Stanga, PE (corresponding author), Manchester Royal Eye Hosp, Manchester Vis Regenerat MVR Lab, Manchester, Lancs, England.; Stanga, PE (corresponding author), NIHR Wellcome Trust Manchester CRF, Manchester, Lancs, England.; Stanga, PE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.	retinaspecialist@btinternet.com	PASTOR-IDOATE, SALVADOR/G-2548-2016	PASTOR-IDOATE, SALVADOR/0000-0002-6463-4227; Mironov, Aleksandr/0000-0002-1497-328X	Bausch Lomb	Bausch Lomb	This work was supported by Salvador Pastor-Idoate: Bausch & Lomb: Research Funding; Paulo Stanga: Bausch & Lomb: Consultancy, Equipment, Research Funding, Lecture Fees, Travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSO NN, 1994, ULTRASON SONOCHEM, V1, pS69, DOI 10.1016/1350-4177(94)90031-0; Aretz S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-22; Barnett SB, 1997, ULTRASOUND MED BIOL, V23, P805, DOI 10.1016/S0301-5629(97)00027-6; BAUM G, 1958, AM J OPHTHALMOL, V46, P319, DOI 10.1016/0002-9394(58)90813-4; Bond LJ, 1996, ULTRASOUND MED BIOL, V22, P101, DOI 10.1016/0301-5629(95)02022-5; BOPP S, 1993, GRAEF ARCH CLIN EXP, V231, P295, DOI 10.1007/BF00919108; Bos KJ, 2001, MICRON, V32, P301, DOI 10.1016/S0968-4328(00)00035-4; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; CHAN KK, 1986, ULTRASOUND MED BIOL, V12, P279, DOI 10.1016/0301-5629(86)90337-6; Chang IA, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-27; Cimino WW, 1999, CLIN PLAST SURG, V26, P447; Cimino WW, 1996, ULTRASOUND MED BIOL, V22, P89, DOI 10.1016/0301-5629(95)02021-7; de Nie KF, 2013, GRAEF ARCH CLIN EXP, V251, P1373, DOI 10.1007/s00417-012-2205-3; Fabian ID, 2011, BRIT J OPHTHALMOL, V95, P318, DOI 10.1136/bjo.2009.176495; Ghasemi Falavarjani Khalil, 2012, J Ophthalmic Vis Res, V7, P125; GIRARD LJ, 1976, T AM ACAD OPHTHALMOL, V81, pP432; GOSS S A, 1979, Ultrasound in Medicine and Biology, V5, P181, DOI 10.1016/0301-5629(79)90086-3; Jackson T, 2000, AM J OPHTHALMOL, V129, P116, DOI 10.1016/S0002-9394(99)00377-3; JOHNSON NF, 1976, ACTA OPHTHALMOL, V54, P529; KAPLAN LJ, 1983, ANN OPHTHALMOL, V15, P1132; KARLIN DB, 1969, AM J OPHTHALMOL, V68, P84, DOI 10.1016/0002-9394(69)94937-X; LEITGEB N, 1979, A GRAEF ARCH KLIN EX, V209, P263, DOI 10.1007/BF00419061; Lima LH, 2010, RETINA-J RET VIT DIS, V30, P1515, DOI 10.1097/IAE.0b013e3181ea48f9; Malinowski SM, 2010, RETINA-J RET VIT DIS, V30, P828, DOI 10.1097/IAE.0b013e3181d37554; MARMOR MF, 1977, INVEST OPHTH VIS SCI, V16, P660; O'Daly BJ, 2008, J MATER PROCESS TECH, V200, P38, DOI 10.1016/j.jmatprotec.2007.11.041; RADEK U, 1972, ACUSTICA, V26, P270; Rizzo S, 2011, RETINA-J RET VIT DIS, V31, P2007, DOI 10.1097/IAE.0b013e318213623a; Rofagha S, 2011, CURR OPIN OPHTHALMOL, V22, P137, DOI 10.1097/ICU.0b013e3283436fc5; Ruiz-Moreno JM, 2006, EUR J OPHTHALMOL, V16, P40, DOI 10.1177/112067210601600108; SCHMUT O, 1978, A GRAEF ARCH KLIN EX, V207, P189, DOI 10.1007/BF00411053; Sharif-Kashani P, 2013, RETINA-J RET VIT DIS, V33, P166, DOI 10.1097/IAE.0b013e31825db758; Steel DHW, 2011, OPHTHALMOLOGICA, V226, P27, DOI 10.1159/000328207; Thompson JT, 2011, SURV OPHTHALMOL, V56, P162, DOI 10.1016/j.survophthal.2010.08.003; Wuchinich D, 2015, PHYSCS PROC, V63, P217, DOI 10.1016/j.phpro.2015.03.035; Yao K, 2002, EUR J OPHTHALMOL, V12, P200, DOI 10.1177/112067210201200305	36	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173883	10.1371/journal.pone.0173883	http://dx.doi.org/10.1371/journal.pone.0173883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399127	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000006
J	Shah, J; Weltman, H; Narciso, P; Murphy, C; Poruri, A; Baliga, S; Sharon, L; York, M; Cunningham, G; Miller, S; Caviedes, L; Gilman, R; Desmond, E; Ramasamy, R				Shah, Jyotsna; Weltman, Helena; Narciso, Patricia; Murphy, Christina; Poruri, Akhila; Baliga, Shrikala; Sharon, Leesha; York, Mary; Cunningham, Gail; Miller, Steve; Caviedes, Luz; Gilman, Robert; Desmond, Edward; Ramasamy, Ranjan			Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures	PLOS ONE			English	Article							NUCLEIC-ACID PROBES; NONTUBERCULOUS MYCOBACTERIA; SMEAR PREPARATIONS	Two rapid dual color fluorescence in situ hybridization (FISH) assays were evaluated for detecting M. tuberculosis and related pathogens in cultures. The MN Genus-MTBC FISH assay uses an orange fluorescent probe specific for the Mycobacterium tuberculosis complex (MTBC) and a green fluorescent probe specific for the Mycobacterium and Nocardia genera (MN Genus) to detect and distinguish MTBC from other Mycobacteria and Nocardia. A complementary MTBC-MAC FISH assay uses green and orange fluorescent probes specific for the MTBC and M. avium complex (MAC) respectively to identify and differentiate the two species complexes. The assays are performed on acid-fast staining bacteria from liquid or solid cultures in less than two hours. Forty-three of 44 reference mycobacterial isolates were correctly identified by the MN Genus-specific probe as Mycobacterium species, with six of these correctly identified as MTBC with the MTBC-specific probe and 14 correctly as MAC by the MAC-specific probe. Of the 25 reference isolates of clinically relevant pathogens of other genera tested, only four isolates representing two species of Corynebacterium gave a positive signal with the MN Genus probe. None of these 25 isolates were detected by the MTBC and MAC specific probes. A total of 248 cultures of clinical mycobacterial isolates originating in India, Peru and the USA were also tested by FISH assays. DNA sequence of a part of the 23S ribosomal RNA gene amplified by PCR was obtained from 243 of the 248 clinical isolates. All 243 were confirmed by DNA sequencing as Mycobacterium species, with 157 and 50 of these identified as belonging to the MTBC and the MAC, respectively. The accuracy of the MN Genus-, MTBC-and MAC -specific probes in identifying these 243 cultures in relation to their DNA sequence-based identification was 100%. All ten isolates of Nocardia, (three reference strains and seven clinical isolates) tested were detected by the MN Genus-specific probe but not the MTBC- or MAC-specific probes. The limit of detection for M. tuberculosis was determined to be 5.1x10(4) cfu per ml and for M. avium 1.5x10(4) cfu per ml in liquid cultures with the respective MTBC- and MAC-specific probes in both the MN Genus-MTBC and MTBC-MAC FISH assays. The only specialized equipment needed for the FISH assays is a standard light microscope fitted with a LED light source and appropriate filters. The two FISH assays meet an important diagnostic need in peripheral laboratories of resource-limited tuberculosis- endemic countries.	[Shah, Jyotsna; Weltman, Helena; Narciso, Patricia; Murphy, Christina; Poruri, Akhila; York, Mary; Ramasamy, Ranjan] ID FISH Technol Inc, Palo Alto, CA 94303 USA; [Baliga, Shrikala; Sharon, Leesha] Manipal Univ, Kasturba Med Coll, Mangalore, India; [Cunningham, Gail; Miller, Steve] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Caviedes, Luz; Gilman, Robert] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Iquitos, Peru; [Gilman, Robert] Johns Hopkins Univ, Baltimore, MD USA; [Desmond, Edward] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; University of California System; University of California San Francisco; Universidad Peruana Cayetano Heredia; Johns Hopkins University; California Department of Public Health	Shah, J (corresponding author), ID FISH Technol Inc, Palo Alto, CA 94303 USA.	jyotsna@aol.com	Ramasamy, Ranjan/AAF-3921-2020	Ramasamy, Ranjan/0000-0003-0246-7053; Shah, Jyotsna/0000-0001-9890-366X; Poruri, Akhila/0000-0003-3033-061X	NIH SBIR Phase I Grant [AI075745]; ID-FISH Technology Inc.; NIH SBIR Phase II Grant [AI075745]	NIH SBIR Phase I Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ID-FISH Technology Inc.; NIH SBIR Phase II Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH SBIR Phase I and Phase II Grants # #AI075745. ID-FISH Technology Inc.' provided support in the form of salaries for authors HW, PN, CM, LS and RR; ID-FISH Technology Inc. and IGeneX Inc. provided support inform of salaries to authors JS and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amand ALS, 2005, J CLIN MICROBIOL, V43, P5369, DOI 10.1128/JCM.43.10.5369-5371.2005; [Anonymous], 2016, GLOBAL REPORT DIABET; Asmar S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01184; Brown BA, 1999, INT J SYST BACTERIOL, V49, P1493, DOI 10.1099/00207713-49-4-1493; Centre for Disease Control, 2016, NOC; Chedore P, 2002, J CLIN MICROBIOL, V40, P4077, DOI 10.1128/JCM.40.11.4077-4080.2002; Daou NadineAbiZeid., 2015, ROLE WOMEN NGOS EMPO, V22, P1; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Epson E., 2012, OPEN LONGEV SCI, V6, P92; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Huang JH, 1991, CHEST J, V115, P1033; Kim N, 2015, ANN LAB MED, V35, P500, DOI 10.3343/alm.2015.35.5.500; KOCH ML, 1965, AM REV RESPIR DIS, V91, P283; Lan R, 2011, INT J TUBERC LUNG D, V15, P1669, DOI 10.5588/ijtld.11.0036; Lehtola MJ, 2006, APPL ENVIRON MICROB, V72, P848, DOI 10.1128/AEM.72.1.848-853.2006; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Shah J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136726; St Amand AL, 2005, J CLIN MICROBIOL, V43, P1505, DOI 10.1128/JCM.43.4.1505-1514.2005; Stender H, 1999, J CLIN MICROBIOL, V37, P2760, DOI 10.1128/JCM.37.9.2760-2765.1999; WHO, 2014, TECHN OP CONS IMPL H, P1; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC	23	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174989	10.1371/journal.pone.0174989	http://dx.doi.org/10.1371/journal.pone.0174989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399124	Green Submitted, Green Published, gold			2022-12-27	WOS:000399949000015
J	Madonna, R; Renna, FV; Lanuti, P; Pertetti, M; Marchisio, M; Briguori, C; Condorelli, G; Manzoli, L; De Caterina, R				Madonna, Rosalinda; Renna, Francesca Vera; Lanuti, Paola; Pertetti, Matteo; Marchisio, Marco; Briguori, Carlo; Condorelli, Gerolama; Manzoli, Lamberto; De Caterina, Raffaele			The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; STATIN THERAPY; MYOCARDIAL DAMAGE; ATORVASTATIN RELOAD; STROKE INSIGHTS; INTERVENTION; SIMVASTATIN; EZETIMIBE; REDUCTION; INCREASE	Rationale and objective Endothelial progenitor cells (EPCs) play a role in vascular repair, while circulating endothelial cells (CECs) are biomarkers of vascular damage and regeneration. Statins may promote EPC/CEC mobilization in the peripheral blood. We evaluated whether pre-procedural exposure to different lipid-lowering drugs (statins +/- ezetimibe) can acutely increase levels/activity of EPCs/CECs in patients with stable coronary artery disease (CAD). Methods In a planned sub-analysis of the Rosuvastatin For REduction Of Myocardial DamagE During Coronary AngioplastY (REMEDY) trial, 38 patients with stable CAD on chronic low-dose statin therapy were randomized, in a double-blind, placebo-controlled design, into 4 groups before PCI: i. placebo (n = 11); ii. atorvastatin (80 mg+40 mg, n = 9); iii. rosuvastatin (40 mg twice, n = 9); and iv. rosuvastatin (5 mg) and ezetimibe (10 mg) twice, (n = 9). At baseline and 24 h after treatment-before PCI-, patients underwent blinded analyses of EPCs [colony forming units-endothelial cells (CFU-ECs), endothelial colony-forming cells (ECFCs) and tubulization activity] and CECs in peripheral blood. Results We found no significant treatment effects on parameters investigated such as number of CECs [Median (IQR): i. 0(0), ii. 4.5(27), iii. 1.9(2.3), iv. 1.9(2.3)], CFU-ECs [Median (IQR): i. 27(11), ii. 19(31), iii. 47(36), iv. 30(98)], and ECFCs [Median (IQR): i. 86(84), ii. 7(84), iii. 8/(42.5), iv. 5(2)], as well as tubulization activity [total tubuli (well), Median (IQR): i. 19(7), ii. 5(4), iii. 25(13), iv. 15(24)]. Conclusions In this study, we found no evidence of acute changes in levels or activity of EPCs and CECs after high-dose lipid-lowering therapy in stable CAD patients.	[Madonna, Rosalinda; Renna, Francesca Vera; De Caterina, Raffaele] Univ G dAnnunzio, Ctr Aging Sci & Translat Med CESI MeT, Chieti, Italy; [Madonna, Rosalinda; Lanuti, Paola; Pertetti, Matteo; De Caterina, Raffaele] Univ G dAnnunzio, Inst Cardiol, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Marchisio, Marco; Manzoli, Lamberto] Ctr Aging Sci & Translat Med CESI MeT, Chieti, Italy; [Marchisio, Marco; Manzoli, Lamberto] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Briguori, Carlo] Clin Mediterranea, Naples, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Manzoli, Lamberto] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Manzoli, Lamberto] Reg Healthcare Agcy Abruzzo, Pescara, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Mediterranean Clinic; University of Naples Federico II; University of Ferrara	De Caterina, R (corresponding author), Univ G dAnnunzio, Ctr Aging Sci & Translat Med CESI MeT, Chieti, Italy.; De Caterina, R (corresponding author), Univ G dAnnunzio, Inst Cardiol, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	rdecater@unich.it	Condorelli, Gerolama/AAC-3472-2022; Manzoli, Lamberto/K-1895-2018	Condorelli, Gerolama/0000-0003-0177-8829; Manzoli, Lamberto/0000-0002-8129-9344; Perfetti, Matteo/0000-0002-3741-6179; Madonna, Rosalinda/0000-0001-6455-2777	Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.); Italian Ministry of the University and Research (PRIN projects); CARIPLO Foundation; AstraZeneca Italy	Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.); Italian Ministry of the University and Research (PRIN projects); CARIPLO Foundation(Fondazione Cariplo); AstraZeneca Italy(AstraZeneca)	This study was supported by grants from the Italian Istituto Nazionale Ricerche Cardiovascolari (I.N.R.C.), the Italian Ministry of the University and Research (PRIN projects), and the CARIPLO Foundation (to R.D.C.). The REMEDY Study, including the provision of drug treatments here compared, was initially supported by a grant from AstraZeneca Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almici C, 2014, TRANSPLANTATION, V98, P706, DOI 10.1097/TP.0000000000000385; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Baran C, 2012, STEM CELL REV REP, V8, P963, DOI 10.1007/s12015-011-9321-z; Bergheanu SC, 2008, CURR MED RES OPIN, V24, P2477, DOI [10.1185/03007990802321709, 10.1185/03007990802321709 ]; Briguori C, 2016, ROSUVASTATI IN PRESS; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Chan AW, 2003, CIRCULATION, V107, P1750, DOI 10.1161/01.CIR.0000060541.18923.E9; Chong AY, 2004, CIRCULATION, V110, P1794, DOI 10.1161/01.CIR.0000143073.60937.50; De Caterina R, 2016, ATHEROSCLEROSIS, V248, P216, DOI 10.1016/j.atherosclerosis.2016.03.024; De Caterina R, 2010, J AM COLL CARDIOL, V55, P198, DOI 10.1016/j.jacc.2009.07.062; Del Papa N, 2008, J RHEUMATOL, V35, P1323; Deschaseaux F, 2007, EUR J PHARMACOL, V562, P111, DOI 10.1016/j.ejphar.2007.01.045; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Ellis SG, 2002, CIRCULATION, V106, P1205, DOI 10.1161/01.CIR.0000028146.71416.2E; Fadini GP, 2007, DIABETOLOGIA, V50, P2156, DOI 10.1007/s00125-007-0732-y; Fadini GP, 2010, ACTA OPHTHALMOL, V88, P135, DOI 10.1111/j.1755-3768.2009.01573.x; Farace F, 2007, ANN ONCOL, V18, P1421, DOI 10.1093/annonc/mdm367; Gibson CM, 2009, J AM COLL CARDIOL, V54, P2290, DOI 10.1016/j.jacc.2009.09.010; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2007, ATHEROSCLEROSIS, V192, P413, DOI 10.1016/j.atherosclerosis.2006.05.031; Huang BS, 2012, CLIN CARDIOL, V35, P125, DOI 10.1002/clc.21017; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kim JW, 2014, KOREAN CIRC J, V44, P76, DOI 10.4070/kcj.2014.44.2.76; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Lachmann R, 2012, CYTOM PART A, V81A, P549, DOI 10.1002/cyto.a.22071; Landmesser U, 2005, CIRCULATION, V111, P2356, DOI 10.1161/01.CIR.0000164260.82417.3F; Lanuti P, 2015, CYTOMETRY A; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Madonna R, 2005, J BIOL CHEM, V280, P13503, DOI 10.1074/jbc.M411859200; Madonna R, 2016, EUROPEAN HEART J; Madonna R, 2015, VASC PHARMACOL, V67-69, P2, DOI 10.1016/j.vph.2015.02.018; Mancuso P, 2009, CLIN CANCER RES, V15, P267, DOI 10.1158/1078-0432.CCR-08-0432; Nusca A, 2010, FUTUR CARDIOL, V6, P579, DOI 10.2217/FCA.10.77; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Park A, 2016, STEM CELL REV REP, V12, P327, DOI 10.1007/s12015-016-9647-7; Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Patti G, 2006, J AM COLL CARDIOL, V48, P1560, DOI 10.1016/j.jacc.2006.06.061; Perin E, 2009, CIRCULATION, V107, P2294; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Ricottini E, 2016, AM J CARDIOL, V117, P165, DOI 10.1016/j.amjcard.2015.10.043; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Wang N, 2016, INT J CARDIOL, V206, P143, DOI 10.1016/j.ijcard.2016.01.004; Watanabe E, 2015, J LIPIDS, V2015, DOI 10.1155/2015/109158; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Woywodt A, 2003, HYPERTENSION, V41, P720, DOI 10.1161/01.HYP.0000052948.64125.AB; Xu J, 2009, AM J PHYSIOL-CELL PH, V296, pC535, DOI 10.1152/ajpcell.00310.2008; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167	60	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0172800	10.1371/journal.pone.0172800	http://dx.doi.org/10.1371/journal.pone.0172800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394933	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800001
J	Mayernik, MS; Maull, KE				Mayernik, Matthew S.; Maull, Keith E.			Assessing the uptake of persistent identifiers by research infrastructure users	PLOS ONE			English	Article							ACKNOWLEDGMENT	Significant progress has been made in the past few years in the development of recommendations, policies, and procedures for creating and promoting citations to data sets, software, and other research infrastructures like computing facilities. Open questions remain, however, about the extent to which referencing practices of authors of scholarly publications are changing in ways desired by these initiatives. This paper uses four focused case studies to evaluate whether research infrastructures are being increasingly identified and referenced in the research literature via persistent citable identifiers. The findings of the case studies show that references to such resources are increasing, but that the patterns of these increases are variable. In addition, the study suggests that citation practices for data sets may change more slowly than citation practices for software and research facilities, due to the inertia of existing practices for referencing the use of data. Similarly, existing practices for acknowledging computing support may slow the adoption of formal citations for computing resources.	[Mayernik, Matthew S.; Maull, Keith E.] Univ Corp Atmospher Res UCAR, Natl Ctr Atmospher Res, NCAR UCAR Lib, Boulder, CO 80021 USA	National Center Atmospheric Research (NCAR) - USA	Mayernik, MS (corresponding author), Univ Corp Atmospher Res UCAR, Natl Ctr Atmospher Res, NCAR UCAR Lib, Boulder, CO 80021 USA.	mayernik@ucar.edu	Phillips, Jennifer/H-3252-2018	Phillips, Jennifer/0000-0002-4861-0292; Mayernik, Matthew/0000-0002-4122-0910	U.S. National Science Foundation [1448480]; Direct For Computer & Info Scie & Enginr [1448480] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by the U.S. National Science Foundation, grant #1448480, "EAGER: Tracing the Use of Research Resources Using Persistent Citable Identifiers", P.I. Matthew S. Mayernik, Co-P.I. Keith Maull.; This research was supported by the U.S. National Science Foundation, grant #1448480, "EAGER: Tracing the Use of Research Resources Using Persistent Citable Identifiers ", P.I. Matthew S. Mayernik, Co-P.I. Keith Maull. Thanks to Seth McGinnis (NARCCAP), Steve Worley (NCEP FNL), Don Middleton and Mary Haley (NCL), and David Hart (Yellowstone) for providing information about the case studies. We also thank David Hart and the PLOS reviewers for comments on previous versions of this paper. The National Center for Atmospheric Research is sponsored by the U.S. National Science Foundation.	Ahalt S, 2015, NAT SCI FDN SLOAN FD; Altman M., 2014, IASSIST Q, V37, P62, DOI 10.29173/iq504; [Anonymous], 2013, DATA SCI J, DOI [DOI 10.2481/DSJ.OSOM13-043, 10.2481/dsj.OSOM13-043]; Ball A, 2011, DCC GUIDES; Bandrowski Anita, 2015, F1000Res, V4, P134, DOI 10.12688/f1000research.6555.1; Brase J, 2004, LECT NOTES COMPUT SC, V3232, P488; Brase J., 2015, D LIB MAGAZINE, V21; Cronin B, 2001, J DOC, V57, P427, DOI 10.1108/EUM0000000007089; DataCite, 2015, DATACITE MET SCHEM; Duerr RE, 2011, EARTH SCI INFORM, V4, P139, DOI 10.1007/s12145-011-0083-6; European Commission, 2015, EUR CHART ACC RES IN; Federation of Earth Science Information Partners (ESIP), 2012, INT DAT STEW CIT PRO; Giles CL, 2004, P NATL ACAD SCI USA, V101, P17599, DOI 10.1073/pnas.0407743101; Grassano N, 2017, J ASSOC INF SCI TECH, V68, P999, DOI 10.1002/asi.23737; Klump J, 2012, FALL M 2012; Klump J, 2016, EARTH SCI INFORM, V9, P123, DOI 10.1007/s12145-015-0231-5; Kunze J, 2003, ELECT PERSISTENCE US; Martone M, 2014, JOINT DECLARATION DA, DOI 10.25490/a97f-egyk; Mayernik M. S., 2012, NCARTN492STR; Mayernik MS, 2015, J CLIMATE, V28, P2529, DOI 10.1175/2015JCLI2222.1; Mayernik MS, 2017, DATA SOFTWARE ASSESS; Mayernik MS, 2013, NCARTN494PROC; Mayernik MS, J ASS INFOR IN PRESS; MAYO C, 2016, INT J DIGITAL CURATI, V0011; Mearns L.O., 2009, EOS T AM GEOPHYS UN, V90, P311, DOI [10.1029/2009EO360002, DOI 10.1029/2009EO360002]; Mearns LO, 2012, B AM METEOROL SOC, V93, P1337, DOI 10.1175/BAMS-D-11-00223.1; Naik G, 2017, PEER REV ACTIVISTS P; Paskin N, 2005, DATA SCI J, V4, P12, DOI DOI 10.2481/DSJ.4.12; Paskin N., 2010, ENCY LIB INFORM SCI, V3, P1586, DOI [DOI 10.1081/E-ELIS3-120044418, 10.1081/E-ELIS3-120044418]; Peters I, 2016, SCIENTOMETRICS, V107, P723, DOI 10.1007/s11192-016-1887-4; Robinson-Garcia N, 2016, J ASSOC INF SCI TECH, V67, P2964, DOI 10.1002/asi.23529; Starr J, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.1; Weber N, 2014, 9 INT DIG CUR C SAN; Weber NM, 2014, ADV HUM SOC ASPEC T, P84, DOI 10.4018/978-1-4666-6002-1.ch005; WHITE HD, 1982, LIBR TRENDS, V30, P467	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175418	10.1371/journal.pone.0175418	http://dx.doi.org/10.1371/journal.pone.0175418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394907	Green Published, gold, Green Submitted			2022-12-27	WOS:000399954800034
J	Peshkovskaya, AG; Babkina, TS; Myagkov, MG; Kuliko, IA; Ekshova, KV; Harriff, K				Peshkovskaya, Anastasia G.; Babkina, Tatiana S.; Myagkov, Mikhail G.; Kuliko, Ivan A.; Ekshova, Ksenia V.; Harriff, Kyle			The socialization effect on decision making in the Prisoner's Dilemma game: An eye-tracking study	PLOS ONE			English	Article							RATIONAL COOPERATION; PLAYERS MODELS; EVOLUTION; NETWORKS; CHOICE; RECIPROCITY; MOVEMENTS	We used a mobile eye-tracking system (in the form of glasses) to study the characteristics of visual perception in decision making in the Prisoner's Dilemma game. In each experiment, one of the 12 participants was equipped with eye-tracking glasses. The experiment was conducted in three stages: an anonymous Individual Game stage against a randomly chosen partner (one of the 12 other participants of the experiment); a Socialization stage, in which the participants were divided into two groups; and a Group Game stage, in which the participants played with partners in the groups. After each round, the respondent received information about his or her personal score in the last round and the overall winner of the game at the moment. The study proves that eye-tracking systems can be used for studying the process of decision making and forecasting. The total viewing time and the time of fixation on areas corresponding to noncooperative decisions is related to the participants' overall level of cooperation. The increase in the total viewing time and the time of fixation on the areas of noncooperative choice is due to a preference for noncooperative decisions and a decrease in the overall level of cooperation. The number of fixations on the group attributes is associated with group identity, but does not necessarily lead to cooperative behavior.	[Peshkovskaya, Anastasia G.; Babkina, Tatiana S.; Myagkov, Mikhail G.; Kuliko, Ivan A.; Ekshova, Ksenia V.] Tomsk State Univ, Lab Expt Methods Cognit & Social Sci, Tomsk, Russia; [Peshkovskaya, Anastasia G.] Russian Acad Sci, Tomsk Natl Res Med Ctr, Mental Hlth Res Inst, Tomsk, Russia; [Babkina, Tatiana S.] Skolkovo Inst Sci & Technol, Ctr Design Mfg & Mat, Moscow, Russia; [Myagkov, Mikhail G.; Harriff, Kyle] Univ Oregon, Dept Polit Sci, Eugene, OR USA	Tomsk State University; Russian Academy of Sciences; Tomsk National Research Medical Center; Mental Health Research Institute, Tomsk; Skolkovo Institute of Science & Technology; University of Oregon	Babkina, TS (corresponding author), Tomsk State Univ, Lab Expt Methods Cognit & Social Sci, Tomsk, Russia.; Babkina, TS (corresponding author), Skolkovo Inst Sci & Technol, Ctr Design Mfg & Mat, Moscow, Russia.	t.babkina@skoltech.ru	Peshkovskaya, Anastasia/R-4624-2016; Ekshova, Ksenia/I-5740-2017; Kulikov, Ivan A./E-9229-2014; Babkina, Tatiana/J-6732-2015; Myagkov, Mikhail G./G-6049-2017	Peshkovskaya, Anastasia/0000-0002-3951-395X; Babkina, Tatiana/0000-0002-0504-2643; Kulikov, Ivan/0000-0003-3535-3132	Tomsk State University Academic D.I. Mendeleev Fund Program [8.1.57.2016]; Laboratory of Experimental Methods in Cognitive and Social Sciences, Tomsk State University	Tomsk State University Academic D.I. Mendeleev Fund Program; Laboratory of Experimental Methods in Cognitive and Social Sciences, Tomsk State University	This work was supported by the "The Tomsk State University Academic D.I. Mendeleev Fund Program" under Grant 8.1.57.2016. http://en.science.tsu.ru/activities/mendeleev-fund/. Grant belongs to the Laboratory of Experimental Methods in Cognitive and Social Sciences, Tomsk State University. Every author of the article is the member of the Laboratory of Experimental Methods in Cognitive and Social Sciences, Tomsk State University.	ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Arieli A, 2011, AM ECON J-MICROECON, V3, P68, DOI 10.1257/mic.3.4.68; Aronson Elliot., 1988, SOCIAL ANIMAL; Babkina T., 2016, CEUR WORK P CEUR WORK P, V1627, P13; Berkman ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119685; BOWLBY J, 1982, AM J ORTHOPSYCHIAT, V52, P664, DOI 10.1111/j.1939-0025.1982.tb01456.x; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Dasgupta N., 2004, SOCIAL JUSTICE RES, V17, P143, DOI DOI 10.1023/B:SORE.0000027407.70241.15; Devetag G, 2016, EXP ECON, V19, P177, DOI 10.1007/s10683-015-9432-5; Ellemers N, 1997, J PERS SOC PSYCHOL, V72, P617, DOI 10.1037/0022-3514.72.3.617; ELLISON G, 1994, REV ECON STUD, V61, P567, DOI 10.2307/2297904; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Ho TH, 1998, AM ECON REV, V88, P947; Knoepfle DT, 2009, J EUR ECON ASSOC, V7, P388, DOI 10.1162/JEEA.2009.7.2-3.388; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Lukinova E, 2014, FORESIGHT, V16, P309, DOI 10.1108/FS-11-2012-0086; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Nagel R, 1995, AM ECON REV, V85, P1313; Neugebauer T, 2009, J ECON PSYCHOL, V30, P52, DOI 10.1016/j.joep.2008.04.005; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Rapoport A., 1965, PRISONERS DILEMMA ST; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; STAHL DO, 1994, J ECON BEHAV ORGAN, V25, P309, DOI 10.1016/0167-2681(94)90103-1; STAHL DO, 1995, GAME ECON BEHAV, V10, P218, DOI 10.1006/game.1995.1031; Stewart N, 2016, J BEHAV DECIS MAKING, V29, P137, DOI 10.1002/bdm.1901; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Sun SW, 2016, PHYS LETT A, V380, P1912, DOI 10.1016/j.physleta.2016.03.048; Sun SW, 2015, APPL MATH COMPUT, V252, P249, DOI 10.1016/j.amc.2014.12.044; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167083; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002	38	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175492	10.1371/journal.pone.0175492	http://dx.doi.org/10.1371/journal.pone.0175492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394939	gold, Green Published, Green Submitted			2022-12-27	WOS:000399954800038
J	Xie, JY; Chen, PC; Zhang, JL; Gao, ZS; Neves, H; Zhang, SD; Wen, Q; Chen, WD; Kwok, HF; Lin, Y				Xie, Jian-Yun; Chen, Peng-Chen; Zhang, Jia-Li; Gao, Ze-Shou; Neves, Henrique; Zhang, Shu-Dong; Wen, Qing; Chen, Wei-Dong; Kwok, Hang Fai; Lin, Yao			The prognostic significance of DAPK1 in bladder cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; CONNECTIVITY MAP; GENE; EXPRESSION; MUTATION; PROTEIN; TRAK1; IDENTIFICATION; VEMURAFENIB; METHYLATION	Bladder cancer is one of the leading causes of cancer-related death in men, however, there was only limited effective treatment for invasive bladder cancer. DAPK1 has been shown to play important role in apoptosis and autophagy to suppress cancer progression. Previous results have shown that DAPK1 promoter was hypermethylated in the majority of bladder cancer specimens, however, the prognostic significance of DAPK1 in bladder cancer has yet to be demonstrated. In the present study, we found that DAPK1 expression was negatively associated with tumor stage and a low level expression of DAPK1 in bladder cancer specimens were associated with shorter survival in bladder cancer patients in 3 independent bladder cancer datasets (n = 462). Further investigation showed that FGFR3 knockdown resulted in downregulation of DAPK1 in bladder cancer cell line, suggesting that FGFR3 may be an upstream factor of DAPK1. Further analysis of the 3 independent bladder cancer datasets have identified ACOX1, UPK2, TRAK1, PLEKHG6 and MT1X genes had their expression significantly correlated with that of DAPK1. Knockdown of DAPK1 in bladder cancer T24 cells resulted in downregulation of ACOX1, UPK2 and TRAK1. Interestingly, TRAK1, by itself, was a favorable prognostic marker in the 3 independent bladder cancer datasets. Importantly, by using connectivity mapping with DAPK1-associated gene signature, we found that vemurafenib and trametinib could possibly reverse DAPK1-associated gene signature, suggesting that inhibition of Raf/MEK pathway may be a potential therapeutic approach for bladder cancer. Indeed, treatment of vemurafenib in T24 bladder cancer cells resulted in upregulation of DAPK1 confirming our connectivity mapping, while knockdown of DAPK1 resulted in reduced sensitivity towards inhibition of Braf signaling by vemurafenib. Together, our results suggest that DAPK1 is an important prognostic marker and therapeutic target for bladder cancer and have identified possible therapeutic agents for future testing in bladder cancer models with low DAPK1 expression.	[Xie, Jian-Yun; Zhang, Jia-Li; Gao, Ze-Shou; Chen, Wei-Dong] Fujian Univ Tradit Chinese Med, Dept Urol, Affiliated Peoples Hosp, Fuzhou, Fujian Province, Peoples R China; [Chen, Peng-Chen; Lin, Yao] Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian Province, Peoples R China; [Neves, Henrique; Kwok, Hang Fai] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China; [Chen, Wei-Dong] Univ Ulster, Northern Ireland Ctr Stratified Med, C TRIC Bldg,Altnagelvin Hosp Campus,Glenshane Rd, Londonderry, England; [Wen, Qing] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Fujian University of Traditional Chinese Medicine; Fujian Normal University; University of Macau; Ulster University; Queens University Belfast	Chen, WD (corresponding author), Fujian Univ Tradit Chinese Med, Dept Urol, Affiliated Peoples Hosp, Fuzhou, Fujian Province, Peoples R China.; Lin, Y (corresponding author), Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian Province, Peoples R China.; Kwok, HF (corresponding author), Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China.	13305018298@189.cn; hfkwok@umac.mo; yaolin@fjnu.edu.cn	Chen, Wei/GZK-7348-2022; Kwok, Hang Fai/AAY-2044-2021; Zhang, Shu-Dong/G-1269-2010; Zhang, Shudong/GMW-9520-2022	Kwok, Hang Fai/0000-0002-6349-4517; Zhang, Shu-Dong/0000-0002-7721-0167; Wen, Qing/0000-0003-4325-7829	International S&T Cooperation Program of China [2016YFE0121900]; Science and Technology Development Fund of Macau SAR [FDCT 023/2015/AMJ]; National Natural Science Foundation of China [31640053]; University of Macau [MYRG2015-00065-FHS]; Natural Science Foundation of Fujian Province [2016Y0029, 2016J01573]; Engineering and Physical Sciences Research Council [1232316] Funding Source: researchfish	International S&T Cooperation Program of China; Science and Technology Development Fund of Macau SAR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Macau; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the International S&T Cooperation Program of China (2016YFE0121900) to YL, the Science and Technology Development Fund of Macau SAR (FDCT 023/2015/AMJ) to HFK, the National Natural Science Foundation of China (31640053) to YL, the University of Macau (MYRG2015-00065-FHS) to HFK, and the Natural Science Foundation of Fujian Province (2016Y0029 & 2016J01573) to YL & JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; An YX, 2011, INT J COLORECTAL DIS, V26, P1397, DOI 10.1007/s00384-011-1237-1; Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Christoph F, 2006, BRIT J CANCER, V95, P1701, DOI 10.1038/sj.bjc.6603482; Christoph F, 2007, J CANCER RES CLIN, V133, P343, DOI 10.1007/s00432-006-0174-9; Christoph F, 2006, INT J CANCER, V119, P1396, DOI 10.1002/ijc.21971; Cirone P, 2014, CANCER CHEMOTH PHARM, V73, P525, DOI 10.1007/s00280-014-2376-1; Couffignal C, 2015, UROLOGY, V86, P1185, DOI 10.1016/j.urology.2015.07.036; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; Fahmy O, 2016, CLIN EXP METASTASIS; Gilbert SL, 2006, NAT GENET, V38, P245, DOI 10.1038/ng1715; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Lin Y, 2011, FEBS J, V278, P354, DOI 10.1111/j.1742-4658.2010.07959.x; Lin Y, 2009, MOL CELL BIOCHEM, V328, P101, DOI 10.1007/s11010-009-0079-4; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mitra AP, 2016, THER ADV UROL, V8, P215, DOI 10.1177/1756287216638981; Neuhausen A, 2006, CANCER BIOL THER, V5, P993, DOI 10.4161/cbt.5.8.2885; Pouessel D, 2016, ANN ONCOL, V27, P1311, DOI 10.1093/annonc/mdw170; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Singh PK, 2016, IET POWER ELECTRON, V9, P900, DOI 10.1049/iet-pel.2015.0139; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Webber E, 2008, J MOL BIOL, V382, P638, DOI 10.1016/j.jmb.2008.07.045; Zhang FM, 2009, CANCER LETT, V274, P250, DOI 10.1016/j.canlet.2008.09.031; Zhang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-236; Zheng XK, 2014, MOL MED REP, V9, P1773, DOI 10.3892/mmr.2014.2054	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175290	10.1371/journal.pone.0175290	http://dx.doi.org/10.1371/journal.pone.0175290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388658	Green Published, Green Submitted, gold			2022-12-27	WOS:000399375800036
J	Camara, J; Marimon, JM; Cercenado, E; Larrosa, N; Quesada, MD; Fontanals, D; Cubero, M; Perez-Trallero, E; Fenoll, A; Linares, J; Ardanuy, C				Camara, Jordi; Maria Marimon, Jose; Cercenado, Emilia; Larrosa, Nieves; Quesada, Maria Dolores; Fontanals, Dionisia; Cubero, Meritxell; Perez-Trallero, Emilio; Fenoll, Asuncion; Linares, Josefina; Ardanuy, Carmen			Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain	PLOS ONE			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; GENETIC-STRUCTURE; CHILDREN; EPIDEMIOLOGY; IMPACT; ERA; MASSACHUSETTS; SURVEILLANCE	A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008-2009) and after (2012-2013). The 13-valent pneumococcal conjugate vaccine (PCV13) licensure was conducted in order to analyze the impact of PCV13 introduction for children on adult IPD. A total of 1558 IPD episodes were detected. The incidence of IPD decreased significantly in the second period by-33.9% (95% CI,-40.3% to-26.8%). IPD due to PCV7 serotypes (-52.7%; 95% CI,-64.2% to-37.5%) and to PCV13 additional serotypes (-55.0% 95% CI, -62.0% to-46.7%) significantly decreased whereas IPD due to non-PCV13 serotypes remained stable (1.0% 95% CI,-12.9% to 17.2%). IPD due to all PCV13 additional serotypes significantly declined with the exception of serotype 3 (-11.3%; 95% CI-35.0% to 21.1%). IPD due to two non-PCV13 serotypes varied: serotype 6C that rose (301.6%; 95% CI, 92.7% to 733.3%, p<0.001), related to the expansion of ST386(6C), and serotype 8 that decreased (-34.9%, 95% CI,-57.1 to-1.2, p = 0.049), related to a decline of the ST63(8). The recombinant clone ST6521(11A) (variant of ST156(9V)) increased in frequency. The decrease of serotype 19A IPD was linked to a fall in those antibiotic susceptible clones. In the last period, rates of penicillin-and cefotaxime-resistance remained under 10% and 4%, respectively. Adult IPD decreased after the PCV13 introduction in Spain due to herd protection. The spread of multidrug resistant clones (ST386(6C), ST6521(11A)) related to non-PCV13 serotypes needs further surveillance.	[Camara, Jordi; Cubero, Meritxell; Linares, Josefina; Ardanuy, Carmen] Univ Barcelona, Hosp Univ Bellvitge, IDIBELL, Lhospitalet De Llobregat, Spain; [Maria Marimon, Jose; Perez-Trallero, Emilio] Hosp Univ Donostia, Donostia San Sebastian, Spain; [Maria Marimon, Jose; Cercenado, Emilia; Quesada, Maria Dolores; Cubero, Meritxell; Perez-Trallero, Emilio; Linares, Josefina; Ardanuy, Carmen] GIBER Enfermedades Resp, Madrid, Spain; [Cercenado, Emilia] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Larrosa, Nieves] Hosp Univ Vall dHebron, Barcelona, Spain; [Quesada, Maria Dolores] HU Germans Trias & Pujol, Badalona, Spain; [Fontanals, Dionisia] IU UAB, Corp Sanitaria Parc Tauli, Sabadell, Spain; [Fenoll, Asuncion] ISCIII, Lab Referencia Neumococo, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; General University Gregorio Maranon Hospital; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Instituto de Salud Carlos III	Ardanuy, C (corresponding author), Univ Barcelona, Hosp Univ Bellvitge, IDIBELL, Lhospitalet De Llobregat, Spain.; Ardanuy, C (corresponding author), GIBER Enfermedades Resp, Madrid, Spain.	c.ardanuy@bellvitgehospital.cat	MARIMON, JOSE MARIA/AAM-5581-2021; Ardanuy, Carmen/C-4463-2015; Cubero, Meritxell/AAV-4585-2020; Larrosa, María Nieves/C-5004-2014	MARIMON, JOSE MARIA/0000-0002-2787-7094; Larrosa, María Nieves/0000-0001-8808-0233; Camara, Jordi/0000-0002-0817-0931; Ardanuy, Carmen/0000-0003-0225-607X	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI11/00763, PI14/00627, INT 15/00186]; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias [CIBERES CB06/06/0037]; initiative of the Instituto de Salud Carlos III, Madrid, Spain; European Regional Development Fund (ERDF)	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias; initiative of the Instituto de Salud Carlos III, Madrid, Spain; European Regional Development Fund (ERDF)(European Commission)	This study was supported by grants from Fondo de Investigaciones Sanitarias de la Seguridad Social (PI11/00763, PI14/00627 and INT 15/00186) and from Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias (CIBERES CB06/06/0037), an initiative of the Instituto de Salud Carlos III, Madrid, Spain. Financial support was also provided by the European Regional Development Fund (ERDF).	Aguinagalde L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137565; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2014, EMERG INFECT DIS, V20, P1848, DOI 10.3201/eid2011.131215; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Burgos J, 2014, EUR RESPIR J, V43, P545, DOI 10.1183/09031936.00050413; Chang QZ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0797-z; CLSI, 2015, M100S25 CLSI; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Garcia-Vidal C, 2010, THORAX, V65, P77, DOI 10.1136/thx.2009.123612; Gherardi G, 2012, ANTIMICROB AGENTS CH, V56, P4965, DOI 10.1128/AAC.00830-12; Guevara M, 2014, VACCINE, V32, P2553, DOI 10.1016/j.vaccine.2014.03.054; Hanage WP, 2011, VACCINE, V29, P8877, DOI 10.1016/j.vaccine.2011.09.075; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Hulten KG, 2013, J CLIN MICROBIOL, V51, P1294, DOI 10.1128/JCM.00058-13; Janoir C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090935; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Loman NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064731; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mendes RE, 2014, DIAGN MICR INFEC DIS, V80, P19, DOI 10.1016/j.diagmicrobio.2014.05.020; Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Moraga-Llop F, 2016, PEDIATR INFECT DIS J, V35, P460, DOI 10.1097/INF.0000000000001041; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Picazo J, 2013, PEDIATR INFECT DIS J, V32, P656, DOI 10.1097/INF.0b013e31827e8594; Regev-Yochay G, 2015, VACCINE, V33, P1135, DOI 10.1016/j.vaccine.2015.01.030; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sanz JC, 2011, CLIN MICROBIOL INFEC, V17, P1094, DOI 10.1111/j.1469-0691.2011.03495.x; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tyrrell GJ, 2011, J INFECT DIS, V203, P1345, DOI 10.1093/infdis/jir056; Vila-Corcoles A, 2016, HUM VACC IMMUNOTHER, V12, P2953, DOI 10.1080/21645515.2016.1210744; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Watkins ER, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005034; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	44	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175224	10.1371/journal.pone.0175224	http://dx.doi.org/10.1371/journal.pone.0175224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384325	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900125
J	de Carvalho, JN; Roncalli, AG; Cancela, MD; de Souza, DLB				de Carvalho, Januse Nogueira; Roncalli, Angelo Giuseppe; Cancela, Marianna de Camargo; Bezerra de Souza, Dyego Leandro			Prevalence of multimorbidity in the Brazilian adult population according to socioeconomic and demographic characteristics	PLOS ONE			English	Article							PRIMARY-CARE; HEALTH; MORBIDITY; COUNTRIES; EDUCATION; BURDEN; LIFE	Knowledge on the occurrence of multimorbidity is important from the viewpoint of public policies, as this condition increases the consumption of medicines as well as the utilization and expenses of health services, affecting life quality of the population. The objective of this study was to estimate prevalence of self-reported multimorbidity in Brazilian adults (>= 18 years old) according to socioeconomic and demographic characteristics. A descriptive study is presented herein, based on data from the National Health Survey, which was a household-based survey carried out in Brazil in 2013. Data on 60,202 adult participants over the age of 18 were included. Prevalences and its respective confidence intervals (95%) were estimated according to sex, age, education level, marital status, self-reported skin color, area of residence, occupation and federative units (states). Poisson regression models univariate and multivariate were used to evaluate the association between socioeconomic and demographic variables with multimorbidity. To observe the combinations of chronic conditions the most common groups in pairs, trios, quartets and quintets of chronic diseases were observed. The prevalence of multimorbidity was 23.6% and was higher among women, in individuals over 60 years of age, people with low educational levels, people living with partner, in urban areas and among unemployed persons. The states of the South and Southeast regions presented higher prevalence. The most common groups of chronic diseases were metabolic and musculoskeletal diseases. The results demonstrated high prevalence of multimorbidity in Brazil. The study also revealed that a considerable share of the economically active population presented two or more chronic diseases. Data of this research indicated that socioeconomic and demographic aspects must be considered during the planning of health services and development of prevention and treatment strategies for chronic diseases, and consequently, multimorbidity.	[de Carvalho, Januse Nogueira; Roncalli, Angelo Giuseppe; Bezerra de Souza, Dyego Leandro] Univ Fed Rio Grande do Norte, Collect Hlth Program, Natal, RN, Brazil; [Cancela, Marianna de Camargo] Brazilian Natl Canc Inst, Div Populat Res, Rio De Janeiro, Brazil; [Bezerra de Souza, Dyego Leandro] Univ Fed Rio Grande do Norte, Grad Program Collect Health, Ave Senador Salgado Filho, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; National Cancer Institute (Inca); Universidade Federal do Rio Grande do Norte	de Carvalho, JN (corresponding author), Univ Fed Rio Grande do Norte, Collect Hlth Program, Natal, RN, Brazil.	janusenogueira@hotmail.com	de Camargo Cancela, Marianna/F-7309-2017; De Camargo Cancela, Marianna/D-4053-2015; Bezerra de Souza, D.L.; de Souza/K-2237-2019	De Camargo Cancela, Marianna/0000-0002-8169-8054; Bezerra de Souza, D.L.; de Souza/0000-0001-8426-3120				Afshar S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2008-7; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barreto SM, 2009, REV SAUDE PUBL, V43, P38, DOI 10.1590/S0034-89102009000900006; Bersusa Ana Aparecida Sanches, 2010, Rev. bras. epidemiol., V13, P513, DOI 10.1590/S1415-790X2010000300014; de Souza PRB, 2015, EPIDEMIOL SERV SAUDE, V24, P207, DOI 10.5123/S1679-49742015000200003; Claudia Diederichs, 2011, J GERONTOL A, V66A; Damacena GN, 2015, EPIDEMIOL SERV SAUDE, V24, P197, DOI 10.5123/S1679-49742015000200002; Flesch LD, 2014, ESTUD PSICOL, V19; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Sein-Echaluce MLG, 2013, GAC SANIT, V27, P365, DOI 10.1016/j.gaceta.2012.11.004; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; IBGE - Instituto Brasileiro de Geografia e Estatistica, 2011, PROD PEC MUN, V39, P1; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; McLean G, 2014, BRIT J GEN PRACT, V64, pE440, DOI 10.3399/bjgp14X680545; Menezes AP, 2013, PESQUIS A NACIONAL S, P31; Organizacao Mundial da Saude, 2008, REL MUND SAUD 2008 C; Pache B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1515-x; Pinheiro V, 2009, BEPA, V6; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; San-Jose A, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0038-8; Machado VDSS, 2012, REV BRAS GINECOL OBS, V34, P215, DOI 10.1590/S0100-72032012000500005; Sarkar C, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0313-y; Sousa-Muñoz Rilva Lopes de, 2013, Rev. bras. geriatr. gerontol., V16, P579; Souza VDE, 2013, FATORES ASS COM MULT; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Teixeira RD, 2009, REV ESC ENFERM USP, V43, P412; Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530; Who, 2010, GLOBAL STATUS REPORT, V176; World Health Organization, 2014, NONC DIS NCD COUNT P; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	29	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174322	10.1371/journal.pone.0174322	http://dx.doi.org/10.1371/journal.pone.0174322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384178	Green Submitted, gold, Green Published			2022-12-27	WOS:000399371900014
J	Khuc, E; Bainer, R; Wolf, M; Clay, SM; Weisenberger, DJ; Kemmer, J; Weaver, VM; Hwang, DG; Chan, MF				Khuc, Emily; Bainer, Russell; Wolf, Marie; Clay, Selene M.; Weisenberger, Daniel J.; Kemmer, Jacquelyn; Weaver, Valerie M.; Hwang, David G.; Chan, Matilda F.			Comprehensive characterization of DNA methylation changes in Fuchs endothelial corneal dystrophy	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; PROLIFERATIVE CAPACITY; MISSENSE MUTATIONS; OXIDATIVE STRESS; OCULAR DISEASES; GENE-EXPRESSION; SLC4A11; CANCER; EPIGENETICS; METHYLIGHT	Transparency of the human cornea is necessary for vision. Fuchs Endothelial Corneal Dystrophy (FECD) is a bilateral, heritable degeneration of the corneal endothelium, and a leading indication for corneal transplantation in developed countries. While the early onset, and rarer, form of FECD has been linked to COL8A2 mutations, the more common, late onset form of FECD has genetic mutations linked to only a minority of cases. Epigenetic modifications that occur in FECD are unknown. Here, we report on and compare the DNA methylation landscape of normal human corneal endothelial (CE) tissue and CE from FECD patients using the Illumina Infinium HumanMethylation450 (HM450) DNA methylation array. We show that DNA methylation profiles are distinct between control and FECD samples. Differentially methylated probes (10,961) were identified in the FECD samples compared with the control samples, with the majority of probes being hypermethylated in the FECD samples. Genes containing differentially methylated sites were disproportionately annotated to ontological categories involving cytoskeletal organization, ion transport, hematopoetic cell differentiation, and cellular metabolism. Our results suggest that altered DNA methylation patterns may contribute to loss of corneal transparency in FECD through a global accumulation of sporadic DNA methylation changes in genes critical to basic CE biological processes.	[Khuc, Emily; Wolf, Marie; Clay, Selene M.; Kemmer, Jacquelyn; Hwang, David G.; Chan, Matilda F.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Bainer, Russell; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Bainer, Russell; Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Bainer, Russell; Weaver, Valerie M.] Univ Calif Berkeley, Bay Area Phys Sci Oncol Program, Berkeley, CA 94720 USA; [Weisenberger, Daniel J.] Univ Southern Calif, Dept Biochem & Mol Med, Los Angeles, CA USA; [Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Ctr Regenerat Med & Stem Cell Res, Eli & Edythe Broad, San Francisco, CA 94143 USA; [Chan, Matilda F.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Khuc, Emily] Samuel Merritt Univ, Calif Sch Podiatr Med, Oakland, CA USA; [Bainer, Russell] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Southern California; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Samuel Merritt University; Roche Holding; Genentech	Chan, MF (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.; Chan, MF (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.	matilda.chan@ucsf.edu	Weisenberger, Daniel/AAA-8314-2020	Weisenberger, Daniel/0000-0001-8303-2603; Weaver, Valerie marie/0000-0003-4786-6752; Clay, Selene/0000-0002-7204-9570; Callander, Jacquelyn/0000-0002-7266-9868; wolf, marie/0000-0003-2207-9664	National Institutes of Health [R01 EY022739]; NIH-NCI [U54 CA143836-01]; NIH-NEI [EY002162-Core]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; Research to Prevent Blindness (RPB) Physician-Scientist Award; RPB Unrestricted; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162, R01EY022739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research to Prevent Blindness (RPB) Physician-Scientist Award(Research to Prevent Blindness (RPB)); RPB Unrestricted; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by funds from the National Institutes of Health (R01 EY022739 to MFC, NIH-NCI U54 CA143836-01 to VMW, NIH-NEI EY002162-Core Grant for Vision Research, NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131 to MFC), That Man May See (http://thatmanmaysee.org/), a Research to Prevent Blindness (RPB) Physician-Scientist Award (to MFC, https://www.rpbusa.org/rpb/?) and an RPB Unrestricted Grant (to UCSF Department of Ophthalmology, https://www.rpbusa.org/rpb/?). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yousuf N, 2004, BRIT J OPHTHALMOL, V88, P998, DOI 10.1136/bjo.2003.031948; Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Baird PN, 2013, EPIGENOMICS-UK, V5, P239, DOI [10.2217/EPI.13.19, 10.2217/epi.13.19]; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Bonnin N, 2014, ACTA OPHTHALMOL, V92, pE366, DOI 10.1111/aos.12365; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; Duman F, 2013, AM J OPHTHALMOL, V156, P600, DOI 10.1016/j.ajo.2013.04.034; Eads CA, 1999, CANCER RES, V59, P2302; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P79, DOI 10.1016/bs.pmbts.2015.04.005; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Eghrari AO, 2010, EXPERT REV OPHTHALMO, V5, P147, DOI 10.1586/EOP.10.8; Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Geeleher P, 2013, BIOINFORMATICS, V29, P1851, DOI 10.1093/bioinformatics/btt311; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Hamill CE, 2013, SEMIN OPHTHALMOL, V28, P281, DOI 10.3109/08820538.2013.825283; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jalimarada SS, 2014, MOL VIS, V20, P1668; Jalimarada SS, 2013, INVEST OPHTH VIS SCI, V54, P4330, DOI 10.1167/iovs.13-11929; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Joyce NC, 2009, INVEST OPHTH VIS SCI, V50, P2116, DOI 10.1167/iovs.08-3007; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; Kang PC, 2005, CORNEA, V24, P801, DOI 10.1097/01.ico.0000157407.43699.22; Kao L, 2016, AM J PHYSL CELL PHYS; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kenney MC, 2004, J HISTOCHEM CYTOCHEM, V52, P1341, DOI 10.1369/jhc.4A6385.2004; Koizumi N, 2014, CORNEA, V33, pS25, DOI 10.1097/ICO.0000000000000240; Kopplin LJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P433, DOI 10.1001/archopthalmol.2011.1626; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; Liskova P, 2007, BRIT J OPHTHALMOL, V91, P1717, DOI 10.1136/bjo.2007.115154; Liu J, 2012, INVEST OPHTH VIS SCI, V53, P3270, DOI 10.1167/iovs.11-8724; Liu MM, 2013, CURR GENOMICS, V14, P166, DOI 10.2174/1389202911314030002; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Matthaei M., 2016, TRANSPLANTATION; Matthaei M, 2014, EXP EYE RES, V129, P13, DOI 10.1016/j.exer.2014.10.011; Matthaei M, 2014, INVEST OPHTH VIS SCI, V55, P216, DOI 10.1167/iovs.13-12689; Merhavi E, 2007, INVEST OPHTH VIS SCI, V48, P4403, DOI 10.1167/iovs.07-0272; Otteson Deborah C, 2011, J Ocul Biol Dis Infor, V4, P95, DOI 10.1007/s12177-012-9078-x; Riau AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014687; Riazuddin SA, 2013, AM J HUM GENET, V93, P758, DOI 10.1016/j.ajhg.2013.08.010; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Soumittra N, 2014, J HUM GENET, V59, P444, DOI 10.1038/jhg.2014.55; Stirzaker C, 1997, CANCER RES, V57, P2229; Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Wieben ED, 2014, INVEST OPHTH VIS SCI, V55, P6101, DOI 10.1167/iovs.14-14958; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Yan B, 2014, J CELL PHYSIOL, V229, P825, DOI 10.1002/jcp.24522; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	71	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175112	10.1371/journal.pone.0175112	http://dx.doi.org/10.1371/journal.pone.0175112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384203	Green Published, gold			2022-12-27	WOS:000399371900088
J	Kullberg, A; Sharp, L; Johansson, H; Brandberg, Y; Bergenmar, M				Kullberg, Anna; Sharp, Lena; Johansson, Hemming; Brandberg, Yvonne; Bergenmar, Mia			Patient satisfaction after implementation of person-centred handover in oncological inpatient care - A cross-sectional study	PLOS ONE			English	Article							INFORMATION EXCHANGE; NURSING HANDOVER; BEDSIDE; PARTICIPATION	Effective nurse shift-to-shift handover is a prerequisite for high-quality inpatient care. Combining person-centeredness with the need for improved handover rituals, we introduced and evaluated person-centered handover (PCH) in an oncological inpatient setting. PCH is the shift-to-shift nursing report performed together with the patient according to a set structure focused on patient participation, relevant clinical information, and patient safety. Non-verbal handover, standard at the department, is conducted via the electronic health record, in absence of the patient, and without a set structure. The aim of the study was to compare person-centered handover with non-verbal handover in an oncological inpatient setting with regard to patient satisfaction. A cross-sectional design featuring two points of measurement at one intervention ward and two control wards was applied. The EORTC IN-PATSAT32 questionnaire was used for measuring patient satisfaction. Baseline measurements were taken during the spring of 2014, when all three wards used a non-verbal handover model, and included responses from 116 patients. Follow-up measurements (comparing PCH and non-verbal handover) involved 209 patients and were on-going from September 2014 to May 2015. After the introduction of PCH, one change in patient satisfaction was detected regarding the subscale measuring exchange of information between caregivers. Patients from the intervention ward scored statistically higher after the implementation of PCH when compared to the control wards (p = .0058). The difference remained after a multivariate regression analysis controlling for clinical variables. In conclusion, PCH is feasible in oncological inpatient care but does not seem to affect patient satisfaction.	[Kullberg, Anna; Johansson, Hemming; Brandberg, Yvonne; Bergenmar, Mia] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Sharp, Lena] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Sharp, Lena] Reg Canc Ctr, Stockholm, Sweden; [Johansson, Hemming] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Bergenmar, Mia] Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Kullberg, A (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	anna.kullberg@ki.se	Kullberg, Anna/M-1447-2019	Bergenmar, Mia/0000-0002-7256-6105				Alharbi TSJ, 2012, HEALTH POLICY, V108, P294, DOI 10.1016/j.healthpol.2012.09.003; Blegen Mary A, 2009, J Patient Saf, V5, P139, DOI 10.1097/PTS.0b013e3181b53f6e; Bredart A, 2007, EUR J CANCER, V43, P323, DOI 10.1016/j.ejca.2006.10.016; Bredart A, 2005, EUR J CANCER, V41, P2120, DOI 10.1016/j.ejca.2005.04.041; Chaboyer W, 2010, INT J NURS PRACT, V16, P27, DOI 10.1111/j.1440-172X.2009.01809.x; Chaboyer W, 2009, J NURS CARE QUAL, V24, P136, DOI 10.1097/01.NCQ.0000347450.90676.d9; Cohen MD, 2010, QUAL SAF HEALTH CARE, V19, P493, DOI 10.1136/qshc.2009.033480; Davis K, 2014, MIRROR MIRROR WALL 2; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Farley H, 2014, ANN EMERG MED, V64, P351, DOI 10.1016/j.annemergmed.2014.02.021; Kerr D, 2014, J CLIN NURS, V23, P1685, DOI 10.1111/jocn.12308; Kullberg A, 2015, EUR J ONCOL NURS, V19, P142, DOI 10.1016/j.ejon.2014.10.005; Lee RG, 2003, SOC SCI MED, V56, P449, DOI 10.1016/S0277-9536(02)00045-X; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Malfait S, 2016, J ADV NURS; McMurray A, 2011, COLLEGIAN, V18, P19, DOI 10.1016/j.colegn.2010.04.004; Meum T, 2011, INT J TELEMED APPL, V2011, DOI 10.1155/2011/505426; Novak K, 2012, J PEDIATR NURS, V27, P760, DOI 10.1016/j.pedn.2012.09.001; Papastavrou E, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-26; Sand-Jecklin K, 2014, J CLIN NURS, V23, P2854, DOI 10.1111/jocn.12575; Sharp S, 2015, CONTEMP NURSE, V52, P1, DOI DOI 10.1080/10376178.2015.102098; Smeulers M, 2014, COCHRANE DB SYST REV, V6; Sondergaard Eva Gad, 2013, BMC Res Notes, V6, P378, DOI 10.1186/1756-0500-6-378; Spooner AJ, 2013, INT J NURS PRACT, V19, P214, DOI 10.1111/ijn.12058; Tidwell T, 2011, J NEUROSCI NURS, V43, pE1, DOI 10.1097/JNN.0b013e3182212a1d; Vaismoradi M, 2015, J CLIN NURS, V24, P627, DOI 10.1111/jocn.12664; Vardanalys, 2014, VARDANALYS VARDEN PA; Vines MM, 2014, J NURSES PROF DEV, V30, P166, DOI 10.1097/NND.0000000000000057; Wentworth L, 2012, J NURS CARE QUAL, V27, P125, DOI 10.1097/NCQ.0b013e31823cc9a0; Wolf DM, 2008, J NURS CARE QUAL, V23, P316, DOI 10.1097/01.NCQ.0000336672.02725.a5	31	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175397	10.1371/journal.pone.0175397	http://dx.doi.org/10.1371/journal.pone.0175397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384314	Green Published, Green Submitted, gold			2022-12-27	WOS:000399371900168
J	Peyroux, E; Santaella, N; Broussolle, E; Rigard, C; Favre, E; Brunet, AS; Bost, M; Lachaux, A; Demily, C				Peyroux, Elodie; Santaella, Nelly; Broussolle, Emmanuel; Rigard, Caroline; Favre, Emilie; Brunet, Anne-Sophie; Bost, Muriel; Lachaux, Alain; Demily, Caroline			Social cognition in Wilson's disease: A new phenotype?	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; IMPAIRMENT; BRAIN; ABNORMALITIES; MANIFESTATIONS; RECOGNITION; CIRCUITS; DEFICITS	Studies focusing on neuropsychological impairments in Wilson's disease (WD) have highlighted that patients showing neurological signs present significant deficits in a wide range of cognitive domains. Attentional and executive impairments have also been described in people with hepatic WD. However, social cognition abilities, i.e. cognitive processes required to perceive the emotions, intentions and dispositions of other people, have not been clearly investigated in WD. In this study we examined the social cognitive functioning in 19 patients with WD depending on their clinical status-Neurological versus Non-Neurological ("hepatic") forms-compared to 20 healthy controls. For the very first time, results highlighted that patients with WD had significant impairments in the three major components of social cognition: emotion recognition, Theory of Mind and attributional style. However, these deficits differ depending on the form of the disease: patients with neurological signs showed a wide range of deficits in the three components that were assessed-results notably revealed impairments in recognizing "fear", "anger", and "disgust", a significant Theory of Mind deficit and an "aggression bias"-whereas Non-Neurological patients only showed deficits on test assessing attributional bias, with a trend to react more "aggressively" to ambiguous social situations than healthy controls, as observed in Neurological WD patients, and a specific impairment in "anger" recognition. Our findings are discussed in the light of both neurocognitive impairments and brain damages, and especially those affecting the basal ganglia, as observed in people with WD.	[Peyroux, Elodie; Rigard, Caroline; Demily, Caroline] Le Vinatier Hosp, Genopsy Ctr Diag & Management Genet Psychiat Diso, Lyon, France; [Peyroux, Elodie] Le Vinatier Hosp, Univ Dept Rehabil SUR CL3R, Lyon, France; [Santaella, Nelly] Lumiere Lyon 2 Univ, Lyon, France; [Broussolle, Emmanuel; Favre, Emilie] Hosp Civils Lyon, Pierre Wertheimer Neurol Hosp, Dept Neurol C, Lyon, France; [Broussolle, Emmanuel; Demily, Caroline] CNRS, Ctr Cognit Neurosci, UMR 5229, Lyon, France; [Broussolle, Emmanuel; Lachaux, Alain] Claude Bernard Lyon 1 Univ, Lyon, France; [Favre, Emilie; Brunet, Anne-Sophie; Bost, Muriel; Lachaux, Alain] Hosp Civils Lyon, French Natl Ctr Wilsons Dis, Lyon, France; [Favre, Emilie; Brunet, Anne-Sophie; Lachaux, Alain] Hosp Civils Lyon, Childrens Hosp Lyon, Dept Pediat Gastroenterol Hepatol & Nutr, Lyon, France; [Bost, Muriel] CBPE, Lab Inherited Metab Dis, Lyon, France; [Bost, Muriel] Hop Edouard Herriot, Lab Trace Element & Tox Met Anal, Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon	Peyroux, E (corresponding author), Le Vinatier Hosp, Genopsy Ctr Diag & Management Genet Psychiat Diso, Lyon, France.; Peyroux, E (corresponding author), Le Vinatier Hosp, Univ Dept Rehabil SUR CL3R, Lyon, France.	elodie.peyroux@gmail.com	Broussolle, Emmanuel/H-1592-2017	Broussolle, Emmanuel/0000-0002-0410-9519; alain, lachaux/0000-0003-3852-788X	Le Vinatier Hospital	Le Vinatier Hospital	This project was supported by Le Vinatier Hospital (no specific funding).	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Akil M, 1995, Adv Neurol, V65, P171; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Bandmann O, 2015, LANCET NEUROL, V14, P103, DOI 10.1016/S1474-4422(14)70190-5; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brickenkamp R, 1988, D2 TEST ATTENTION; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frota NAF, 2013, ACTA NEUROL SCAND, V127, P391, DOI 10.1111/ane.12037; Gaudelus B, 2015, ENCEPHALE, V41, P251, DOI 10.1016/j.encep.2014.08.013; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Humphreys L, 2006, BRIT J CLIN PSYCHOL, V45, P231, DOI 10.1348/014466505X50509; Iwanski S, 2015, NEUROPSYCHOLOGY, V29, P25, DOI 10.1037/neu0000103; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Lorincz MT, 2010, ANN NY ACAD SCI, V1184, P173, DOI 10.1111/j.1749-6632.2009.05109.x; Mackinnon A, 2005, ENCEPHALE, V31, P31; Martinez G, 2017, PHENOTYPIC CONTINUUM; MEDALIA A, 1988, ARCH NEUROL-CHICAGO, V45, P502, DOI 10.1001/archneur.1988.00520290030009; Mikol J, 2005, ACTA NEUROPATHOL, V110, P451, DOI 10.1007/s00401-005-1061-1; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; Portala K, 2001, EUR ARCH PSY CLIN N, V251, P262, DOI 10.1007/PL00007543; Pulai S, 2014, NEUROL INDIA, V62, P153, DOI 10.4103/0028-3886.132349; Seniow J, 2003, CLIN NEUROPSYCHOL, V17, P367, DOI 10.1076/clin.17.3.367.18085; Seniow J, 2002, MOVEMENT DISORD, V17, P1077, DOI 10.1002/mds.10195; Stracciari A, 2000, ARCH NEUROL-CHICAGO, V57, P384, DOI 10.1001/archneur.57.3.384; Trocello JM, 2011, J NEUROL NEUROSUR PS, V82, P1119, DOI 10.1136/jnnp.2009.204651; Trocello JM, 2013, NEUROLOGY, V81, P1557, DOI 10.1212/WNL.0b013e3182a95883; Wang K, 2003, NEUROPSYCHOLOGIA, V41, P527, DOI 10.1016/S0028-3932(02)00171-9; Warrington EK., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiss KH, 2013, CLIN TRANSPLANT, V27, P914, DOI 10.1111/ctr.12259; Wenisch E, 2013, REV NEUROL-FRANCE, V169, P944, DOI 10.1016/j.neurol.2013.06.002; Yagci MA, 2015, TRANSPL P, V47, P1469, DOI 10.1016/j.transproceed.2015.04.017; Zimbrean PC, 2014, GEN HOSP PSYCHIAT, V36, P53, DOI 10.1016/j.genhosppsych.2013.08.007	43	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173467	10.1371/journal.pone.0173467	http://dx.doi.org/10.1371/journal.pone.0173467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384152	gold, Green Submitted, Green Published			2022-12-27	WOS:000399371900008
J	Ahrens, LAJ; Vonwil, D; Christensen, J; Shastri, VP				Ahrens, Lucas A. J.; Vonwil, Daniel; Christensen, Jon; Shastri, V. Prasad			Gelatin device for the delivery of growth factors involved in endochondral ossification	PLOS ONE			English	Article							BONE-FORMATION; CROSS-LINKING; ELECTROSPUN GELATIN; CONTROLLED-RELEASE; POLYMER IMPLANTS; STEM-CELLS; TGF-BETA; IN-VITRO; DIFFERENTIATION; VEGF	Controlled release drug delivery systems are well established as oral and implantable dosage forms. However, the controlled release paradigm can also be used to present complex soluble signals responsible for cellular organization during development. Endochondral ossification (EO), the developmental process of bone formation from a cartilage matrix is controlled by several soluble signals with distinct functions that vary in structure, molecular weight and stability. This makes delivering them from a single vehicle rather challenging. Herein, a gelatin-based delivery system suitable for the delivery of small molecules as well as recombinant human (rh) proteins (rhWNT3A, rhFGF2, rhVEGF, rhBMP4) is reported. The release behavior and biological activity of the released molecules was validated using analytical and biological assays, including cell reporter systems. The simplicity of fabrication of the gelatin device should foster its adaptation by the diverse scientific community interested in interrogating developmental processes, in vivo.	[Ahrens, Lucas A. J.; Vonwil, Daniel; Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus, Freiburg, Germany; [Ahrens, Lucas A. J.; Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus, Freiburg, Germany.; Shastri, VP (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	prasad.shastri@gmail.com			Swiss National Science Foundation (SNF) [CRSII3_136179]; Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments [EXC 294]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments(German Research Foundation (DFG))	This study was supported by the Swiss National Science Foundation (SNF) (grant no. CRSII3_136179) to VPS and Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments Grant EXC 294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441; Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Capan Y., 2003, AAPS PHARMSCITECH, V4, P147; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; COSTANTINO HR, 1995, BIO-TECHNOL, V13, P493, DOI 10.1038/nbt0595-493; Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040; Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650; DISILVIO L, 1994, BIOMATERIALS, V15, P931, DOI 10.1016/0142-9612(94)90120-1; DISILVIO L, 1994, J MATER SCI-MATER M, V5, P819, DOI 10.1007/BF00213141; EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L; FOLKMAN J, 1964, J Surg Res, V4, P139, DOI 10.1016/S0022-4804(64)80040-8; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gospodarowicz D., 1986, J CELL PHYSL, V128, P475, DOI DOI 10.1002/JCP.1041280317; Groppa E, 2015, EMBO MOL MED, V7, P1366, DOI 10.15252/emmm.201405003; Guglieri S, 2008, BIOCHEMISTRY-US, V47, P13862, DOI 10.1021/bi801007p; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Iwanaga K, 2003, J MICROENCAPSUL, V20, P767, DOI 10.1080/02652040310001600523; Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Kress H, 2009, NAT METHODS, V6, P905, DOI 10.1038/nmeth.1400; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9; Lee KY, 2000, NATURE, V408, P998, DOI 10.1038/35050141; Lee TJ, 2013, BIOCHEM BIOPH RES CO, V430, P793, DOI 10.1016/j.bbrc.2012.11.067; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; LIU WR, 1991, BIOTECHNOL BIOENG, V37, P177, DOI 10.1002/bit.260370210; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Merino R, 1999, DEVELOPMENT, V126, P5515; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Ofner CM, 1996, PHARM RES-DORDR, V13, P1821; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Paguirigan AL, 2007, NAT PROTOC, V2, P1782, DOI 10.1038/nprot.2007.256; Park K, 2014, J CONTROL RELEASE, V190, P3, DOI 10.1016/j.jconrel.2014.03.054; PARKER KL, 1989, J CLIN ENDOCR METAB, V69, P689, DOI 10.1210/jcem-69-3-689; Parsons-Wingerter P, 2000, ARTERIOSCLER THROMB, V20; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Pluen A, 1999, BIOPHYS J, V77, P542, DOI 10.1016/S0006-3495(99)76911-0; Purpura KA, 2012, BIOMATERIALS, V33, P1271, DOI 10.1016/j.biomaterials.2011.10.051; Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052; RHINE WD, 1980, J PHARM SCI, V69, P265, DOI 10.1002/jps.2600690305; Ribatti D, 1997, J VASC RES, V34, P455, DOI 10.1159/000159256; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sarem M, 2013, CARBOHYD POLYM, V93, P635, DOI 10.1016/j.carbpol.2012.11.099; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Srisuwan T, 2012, TISSUE CELL, V44, P111, DOI 10.1016/j.tice.2011.12.003; SUN H W, 1990, Pediatric Dentistry, V12, P303; Tabata Y, 1998, BIOMATERIALS, V19, P1781, DOI 10.1016/S0142-9612(98)00089-1; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916	82	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175095	10.1371/journal.pone.0175095	http://dx.doi.org/10.1371/journal.pone.0175095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380024	Green Submitted, gold, Green Published			2022-12-27	WOS:000399353500097
J	Coudrat, T; Christopoulos, A; Sexton, PM; Wootten, D				Coudrat, Thomas; Christopoulos, Arthur; Sexton, Patrick Michael; Wootten, Denise			Structural features embedded in G protein coupled receptor co-crystal structures are key to their success in virtual screening	PLOS ONE			English	Article							LIGAND; DOCKING; AGONIST; BETA(2)-ADRENOCEPTOR; PREDICTION; BINDING; GPCRS; STATE	Structure based drug discovery on GPCRs harness atomic detail X-ray binding pockets and large libraries of potential drug lead candidates in virtual screening (VS) to identify novel lead candidates. Relatively small conformational differences between such binding pockets can be critical to the success of VS. Retrospective VS on GPCR/ligand co-crystal structures revealed stark differences in the ability of different structures to identify known ligands, despite being co-crystallized with the same ligand. When using the OpenEye toolkit and the ICM modeling package, we identify criteria associated with the predictive power of binding pockets in VS that consists of a combination of ligand/receptor interaction pattern and predicted ligand/receptor interaction strength. These findings can guide the selection and refinement of GPCR binding pockets for use in SBDD programs and may also provide a potential framework for evaluating the ability of computational GPCR binding pocket refinement tools in improving the predictive power of binding pockets.	[Sexton, Patrick Michael; Wootten, Denise] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; Monash Univ, Dept Pharmacol, Parkville, Vic, Australia	Monash University; Monash University	Sexton, PM; Wootten, D (corresponding author), Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	patrick.sexton@monash.edu; denise.wootten@monash.edu	Wootten, Denise/ABD-5703-2021; Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Wootten, Denise/0000-0003-4563-1642; Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Coudrat, Thomas/0000-0001-9197-1889	National Health and Medical Research Council of Australia (NHMRC) [APP1055134, APP106101044, APP1089966]; NHMRC Career Development Fellow; Melbourne Bioinformatics at the University of Melbourne [VR0024]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellow(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Bioinformatics at the University of Melbourne	This research was supported by the National Health and Medical Research Council of Australia (NHMRC), award numbers APP1055134 and APP106101044 to PMS and APP1089966 to DW, a NHMRC Career Development Fellow. This research was also supported by Melbourne Bioinformatics at the University of Melbourne, grant number VR0024 to PMS. PMS is a NHMRC Principal Research Fellow, and AC a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; BRANDEN CI, 1990, NATURE, V343, P687, DOI 10.1038/343687a0; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciancetta A, 2014, J CHEM INF MODEL, V54, P2243, DOI 10.1021/ci5002857; Costanzi S, 2012, J COMPUT CHEM, V33, P561, DOI 10.1002/jcc.22893; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gatica EA, 2012, J CHEM INF MODEL, V52, P1, DOI 10.1021/ci200412p; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gentry PR, 2013, J MED CHEM, V56, P9351, DOI 10.1021/jm4013246; Goldfeld DA, 2015, J PHYS CHEM B, V119, P824, DOI 10.1021/jp5053612; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jones E., 2001, SCIPY OPEN SOURCE SC; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kooistra AJ, 2015, J CHEM INF MODEL, V55, P1045, DOI 10.1021/acs.jcim.5b00066; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawton G, 2014, PROGR MED CHEM; Lebon G, 2015, MOL PHARM; Lenselink EB, 2014, J CHEM INF MODEL, V54, P1737, DOI 10.1021/ci5000455; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; OpenEye Scientific Software Inc., 2010, OECHEM VERS 1 7 4; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Pearlman DA, 2001, J MED CHEM, V44, P502, DOI 10.1021/jm000375v; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174719	10.1371/journal.pone.0174719	http://dx.doi.org/10.1371/journal.pone.0174719			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380046	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500060
J	Gess, RW; Trinajstic, KM				Gess, Robert W.; Trinajstic, Kate M.			New morphological information on, and species of placoderm fish Africanaspis (Arthrodira, Placodermi) from the Late Devonian of South Africa	PLOS ONE			English	Article							INTERNAL FERTILIZATION; GOGO FORMATION; VERTEBRATE; PRESERVATION; DECAY; MINERALIZATION; LAGERSTATTE; ESTUARINE; AUSTRALIA; NURSERIES	Here we present a new species of placoderm fish, Africanaspis edmountaini sp. nov., and redescribe Africanaspis doryssa on the basis of new material collected from the type locality of Africanaspis. The new material includes the first head shields of Africanaspis doryssa in addition to soft anatomy for both taxa. Hitherto Africanaspis was entirely described from trunk armour and no record of body and fin outlines had been recorded. In addition the first record of embryonic and juvenile specimens of Africanaspis doryssa is presented and provides a growth series from presumed hatchlings to presumed adults. The presence of a greater number of juveniles compared to adults indicates that the Waterloo Farm fossil site in South Africa represents the first nursery site of arthrodire placoderms known from a cold water environment. The preservation of an ontogenetic series demonstrates that variation within the earlier known sample, initially considered to have resulted from ontogenetic change, instead indicates the presence of a second, less common species Africanaspis edmountaini sp. nov. There is some faunal overlap between the Waterloo Farm fossil site and faunas described from Strud in Belgium and Red Hill, Pennsylvania, in north America, supporting the concept of a more cosmopolitan vertebrate fauna in the Famennian than earlier in the Devonian.	[Gess, Robert W.] Rhodes Univ, Geol Dept, Grahamstown, South Africa; [Gess, Robert W.] Univ Witwatersrand, DST NRF Ctr Excellence Palaeosci CoE Pal, 1 Jan Smuts Ave Braamfontein, Johannesburg, South Africa; [Gess, Robert W.] Albany Museum, Somerset St, Grahamstown, South Africa; [Trinajstic, Kate M.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia	Rhodes University; University of Witwatersrand; Rhodes University; Curtin University	Trinajstic, KM (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA, Australia.	K.Trinajstic@curtin.edu.au		Trinajstic, Kate/0000-0002-6519-6396	South African DST/NRF Centre of Excellence in Palaeosciences; South African Millennian Trust; Australian Research Council [ARC DP110101127]; Rhodes University	South African DST/NRF Centre of Excellence in Palaeosciences; South African Millennian Trust; Australian Research Council(Australian Research Council); Rhodes University	Research support by the South African DST/NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences) and support by the South African Millennian Trust is acknowledged by RG and support by an Australian Research Council (ARC DP110101127) grant is acknowledged by KT. Rhodes University is thanked for supporting a visiting fellowship for KT.	Ahlberg P, 2009, NATURE, V460, P888, DOI 10.1038/nature08176; Anderson M. Eric, 1999, Records of the Western Australian Museum Supplement, V57, P151; ANDERSON ME, 1994, S AFR J SCI, V90, P397; Bechard I., 2014, PALAEONTOL ELECTRON, V17, P1, DOI DOI 10.26879/417; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; Briggs DEG, 2005, P ROY SOC B-BIOL SCI, V272, P627, DOI 10.1098/rspb.2004.3006; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Brunton M, 1992, 1ST CAPTURE COELACAN, P225; Cloutier R, 2010, FOSSIL RECORD FISH O; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; Daeschler E. B., 1997, J VERTEBRATE PALEO S, V17, p41A; Daeschler Edward B., 2003, Records of the Australian Museum, V55, P45; Davidson RG, 2005, SCOT J GEOL, V41, P129, DOI 10.1144/sjg41020129; DENISON ROBERT H., 1941, JOUR PALEONTOL, V15, P553; Downs JP, 2011, P ACAD NAT SCI PHILA, V161, P191, DOI 10.1635/053.161.0111; Gess R, 2008, J VERTEBR PALEONTOL; Gess R.W., 2011, HIGH LATITUDE GONDWA; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Gess RW, 2015, ZOOL J LINN SOC-LOND, V175, P360, DOI 10.1111/zoj.12276; Gess RW, 2015, PALAEONTOL Z, V89, P147, DOI 10.1007/s12542-014-0221-9; Gess RW, 1995, PRELIMINARY CATALOGU; Gess RW, 2001, ANN PALEONTOLOGIE; Gross W., 1962, Palaeontologische Zeitschrift H Schmidt-Festband, P45; Gross W, 1965, B I ROYAL SCI NATURE, V41; Hammerschlag N, 2010, MAR ECOL PROG SER, V414, P223, DOI 10.3354/meps08731; Hiller N., 1992, S AFR J GEOL, V95, P203; Igulu MM, 2013, ECOSYSTEMS, V16, P1336, DOI 10.1007/s10021-013-9687-7; Janvier P, 2006, NEW GROENLANDASPIDID; Johanson Z, 2014, PALAEONTOLOGY, V57, P505, DOI 10.1111/pala.12093; Long J, 1995, RECORDS W AUSTR MU S, V17, P34; Long JA, 1997, J VERTEBR PALEONTOL, V17, P253, DOI 10.1080/02724634.1997.10010973; Long J, 2008, J VERTEBR PALEONTOL, V28, p107A; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Miles R.S., 1973, Palaeontographica Abt A, V143, P109; Miles R.S., 1968, EARTH ENV SCI T R SO, V67, P373, DOI [10.1017/S0080456800024078, DOI 10.1017/S0080456800024078]; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Newman MJ, 2001, PALAEONTOLOGY, V44, P43, DOI 10.1111/1475-4983.00168; Obruchev D, 1964, OSNOVY PALEONTOLOGII; Olds AD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1040, DOI 10.1111/geb.12072; Olive S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161540; Olive S, 2015, PALAEONTOLOGY, V58, P981, DOI 10.1111/pala.12190; RITCHIE A, 1975, NATURE, V254, P569, DOI 10.1038/254569a0; Ritchie A, 2005, P LINN SOC N S W; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Sansom RS, 2011, P ROY SOC B-BIOL SCI, V278, P1150, DOI 10.1098/rspb.2010.1641; Schultze H, 1984, P LINN SOC N S W; Sheaves M, 2015, ESTUAR COAST, V38, P401, DOI 10.1007/s12237-014-9846-x; SMITH CL, 1975, SCIENCE, V190, P1105, DOI 10.1126/science.190.4219.1105; Streel M, 2000, EARTH-SCI REV, V52, P121, DOI 10.1016/S0012-8252(00)00026-X; Taylor F, 1993, NEW DEVONIAN FOSSIL, P565; THAMM A.G., 2006, GEOLOGY S AFRICA GEO, P443; Trinajstic K, 2009, ACTA ZOOL-STOCKHOLM, V90, P83, DOI 10.1111/j.1463-6395.2008.00363.x; Trinajstic K, 2007, J VERTEBR PALEONTOL, V27, P571, DOI 10.1671/0272-4634(2007)27[571:OPVAPI]2.0.CO;2; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2015, BIOL REV, V90, P467, DOI 10.1111/brv.12118; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Trinajstic Katherine M., 1999, Records of the Western Australian Museum Supplement, V57, P93; Upeniece I, FOSSIL FISHES LIVING, P167; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Watson DMS, 1927, REPROD COELACANTH FI; WERDELIN L, 1986, LETHAIA, V19, P161, DOI 10.1111/j.1502-3931.1986.tb00727.x; Woodward A, 1891, BRIT MUS NAT HIST, P52; Woodward A. S., 1895, CATALOGUE FOSSIL FIS, DOI 10.5962/bhl.title.162378; Young G.C., 1993, P293; Young GC, 2003, DEVONIAN FISH REMAIN; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033	70	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173169	10.1371/journal.pone.0173169	http://dx.doi.org/10.1371/journal.pone.0173169			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379973	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500014
J	Hasegawa, Y; Tachibana, Y; Ono, T; Kishimoto, H				Hasegawa, Yoko; Tachibana, Yoshihisa; Ono, Takahiro; Kishimoto, Hiromitsu			Flavour-enhanced cortisol release during gum chewing	PLOS ONE			English	Article							SALIVARY CORTISOL; STRESS; RESPONSES; FEEDBACK; DISEASE; REWARD; MOOD; MEN	There is some evidence to suggest that chewing gum reduces chronic stress. However, it remains controversial how the taste and odour properties of chewing gum influence stress. The present study was designed to investigate this issue in human subjects. Using an enzyme-linked immunosorbent assay, we tested salivary cortisol concentration, which is thought to be a stress marker, in 96 adults who chewed gum with different combinations of taste and odour. Subjects could discriminate between the types of gum without prior information. Salivary cortisol concentrations were highest and lowest for the subjects who chewed the most flavourful gum and the least flavourful gum, respectively. These findings suggest that the salivary cortisol level during gum chewing is not a marker of negative emotions (i.e., stressful conditions) as traditionally considered but, rather, an index of positive emotions that can facilitate biological responses to overcome stressful conditions.	[Hasegawa, Yoko; Kishimoto, Hiromitsu] Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo, Japan; [Tachibana, Yoshihisa] Kobe Univ, Grad Sch Med, Div Syst Neurosci, Kobe, Hyogo, Japan; [Ono, Takahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Comprehens Prosthodont, Niigata, Japan	Hyogo College of Medicine; Kobe University; Niigata University	Hasegawa, Y (corresponding author), Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo, Japan.	cem17150@hyo-med.ac.jp		Hasegawa, Yoko/0000-0001-9112-5981	KAKENHI from the Ministry of Education, Science and Culture of Japan [25463043, 16K11640]; Society for Research on Umami Taste and Foundation for Total Health Promotion; Lotte Research Promotion Grant;  [24120522]	KAKENHI from the Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Society for Research on Umami Taste and Foundation for Total Health Promotion; Lotte Research Promotion Grant; 	This study was supported by KAKENHI from the Ministry of Education, Science and Culture of Japan (Grant No. 25463043, No. 16K11640), Grant-in-Aid for Scientific Research on Innovative Areas (No. 24120522), the Society for Research on Umami Taste and Foundation for Total Health Promotion, and a Lotte Research Promotion Grant.	Allen A.P., 2011, J BEHAV NEUROSCIENCE, V9, P7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carnell S, 2012, INT REV PSYCHIATR, V24, P189, DOI 10.3109/09540261.2012.676988; Deiss V, 2009, FOOD QUAL PREFER, V20, P57, DOI 10.1016/j.foodqual.2008.07.004; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Gray G, 2012, APPETITE, V58, P554, DOI 10.1016/j.appet.2011.11.013; Groschl M, 2006, STEROIDS, V71, P1097, DOI 10.1016/j.steroids.2006.09.007; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hasegawa Y, 2009, CLIN ORAL INVEST; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Ladd CO, 2004, BIOL PSYCHIAT, V55, P367, DOI 10.1016/j.biopsych.2003.10.007; Lovallo W. R., 2004, STRESS HLTH BIOL PSY; MANUCK SB, 1986, ARTERIOSCLEROSIS, V6, P2, DOI 10.1161/01.ATV.6.1.2; Matsui F, 2009, ENDOCR J, V56, P1083, DOI 10.1507/endocrj.K09E-186; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Ministry of Environment and Rural and Marine, 2008, EUFOR CHAD MISS GREA, P1; Nishijo H, 2000, J NUTR, V130, p954S, DOI 10.1093/jn/130.4.954S; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Petrowski K, 2014, PSYCHONEUROENDOCRINO, V48, P64, DOI 10.1016/j.psyneuen.2014.06.008; Scholey A, 2009, PHYSIOL BEHAV, V97, P304, DOI 10.1016/j.physbeh.2009.02.028; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith A, 2010, NUTR NEUROSCI, V13, P7, DOI 10.1179/147683010X12611460763526; Spielman AI, 1998, CRIT REV ORAL BIOL M, V9, P267, DOI 10.1177/10454411980090030201; Tahara Yasuaki, 2007, J Prosthodont, V16, P129, DOI 10.1111/j.1532-849X.2007.00178.x; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Yu HC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066447, 10.1371/journal.pone.0055705, 10.1371/journal.pone.0057111]	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173475	10.1371/journal.pone.0173475	http://dx.doi.org/10.1371/journal.pone.0173475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379983	Green Submitted, Green Published, gold			2022-12-27	WOS:000399353500019
J	Ioannidis, J; Donadeu, FX				Ioannidis, Jason; Donadeu, F. Xavier			Changes in circulating microRNA levels can be identified as early as day 8 of pregnancy in cattle	PLOS ONE			English	Article							EXPRESSION PROFILES; DAIRY-COWS; ANGIOGENESIS; MIR-26A; CLUSTER; MIRNAS; GENOME; CELLS; SERUM; TOOLS	Poor reproductive performance remains a major issue in the dairy industry, with low conception rates having a significant impact on milk production through extended calving intervals. A major limiting factor is the lack of reliable methods for early pregnancy diagnosis. Identification of animals within a herd that fail to conceive within 3 weeks after insemination would allow early re-insemination and shorten calving intervals. In a previous study, we found an increase in plasma miR-26a levels in Day 16-pregnant relative to non-pregnant heifers, however changes in miRNA levels that early during pregnancy were very small which likely prevented the identification of robust biomarkers. In this study, we extended our analyses to a wider interval during pregnancy (Days 8 to 60, n = 11 heifers) with the rationale that this may facilitate the identification of additional early pregnancy miRNA biomarkers. Using small RNA sequencing we identified a total of 77 miRNAs that were differentially expressed on Day 60 relative to Day 0 of pregnancy. We selected 14 miRNAs for validation by RT-qPCR and confirmed significant differences in the expression of let-7f, let-7c, miR-30c, miR-101, miR-26a, miR-205 and miR-143 between Days 0 and 60. RT-qPCR profiling throughout Days 0, 8, 16 and 60 of pregnancy showed a distinct increase in circulating levels of miR-26a (3.1-fold, P = 0.046) as early as Day 8 of pregnancy. In summary, in contrast to earlier stages of pregnancy (<= Day 24), marked differences in the levels of multiple miRNAs can be detected in circulation by Day 60 in cattle. Retrospective analyses showed miR-26a levels to be increased in circulation as early as Day 8, sooner than previously reported in any species, suggesting a biological role for this miRNA in the very early events of pregnancy.	[Ioannidis, Jason; Donadeu, F. Xavier] Univ Edinburgh, Roslin Inst & RDSVS, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Donadeu, FX (corresponding author), Univ Edinburgh, Roslin Inst & RDSVS, Roslin, Midlothian, Scotland.	xavier.donadeu@roslin.ed.ac.uk		Donadeu, Xavier/0000-0002-0331-2996; Ioannidis, Jason/0000-0003-1628-4928	BBSRC [BB/K501578/1]; Zoetis Inc; BBSRC [BBS/E/D/20221656, BBS/E/D/10002071] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/10002071, BBS/E/D/20221656, 1248216] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis Inc; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported BBSRC, grant BB/K501578/1 to FXD (http://www.bbsrc.ac.uk/) and Zoetis Inc (https://www.zoetis.com) to FXD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Naby WS, 2011, ZYGOTE, P1; Ahanda MLE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114598; Aungier SPM, 2014, J DAIRY SCI, V97, P3472, DOI 10.3168/jds.2013-7404; Balhara AK, 2013, SCI WORLD J, DOI 10.1155/2013/958540; Barbat A, 2010, J REPROD DEVELOP, V56, pS15, DOI 10.1262/jrd.1056S15; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barturen G, 2014, METHODS NEXT GENERAT, P1; Casey MC, 2015, PEERJ, V3, DOI 10.7717/peerj.829; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Department for Environment Food and Rural Affairs (DEFRA), 2016, AGR UK; Dillon P, 2006, LIVEST SCI, V99, P141, DOI 10.1016/j.livprodsci.2005.06.011; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Diskin MG, 2016, REPROD FERT DEVELOP, V28, P83, DOI 10.1071/RD15366; Elsik CG, 2016, NUCLEIC ACIDS RES, V44, pD834, DOI 10.1093/nar/gkv1077; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Fkih M'hamed I, 2017, MIR 10B MIR 26A MIR; Floris I, 2015, ARTERIOSCL THROM VAS, V35, P664, DOI 10.1161/ATVBAHA.114.304730; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hansen EP, 2016, VET PARASITOL, V223, P30, DOI 10.1016/j.vetpar.2016.03.025; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; Ioannidis J, 2016, CIRCULATING MICRORNA; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; Kilic ID, 2015, GENE, V560, P140, DOI 10.1016/j.gene.2015.01.048; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li ZX, 2011, J IMMUNOL, V186, P6182, DOI 10.4049/jimmunol.1000917; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lucy MC, 2004, ANIM REPROD SCI, V82-3, P495, DOI 10.1016/j.anireprosci.2004.05.004; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miura K, 2015, J OBSTET GYNAECOL RE; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; National Animal Disease Information Service, 2016, FERT DAIR HERDS PREG; Ni B, 2014, J IMMUNOL, V193, P4537, DOI 10.4049/jimmunol.1400124; R Core Team, 2013, LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Smits M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016282; Tabruyn SP, 2013, ANGIOGENESIS, V16, P877, DOI 10.1007/s10456-013-9362-9; Thapa DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020781; Ul Hussain M, 2012, CELL TISSUE RES, V349, P405, DOI 10.1007/s00441-012-1438-0; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Wang T, 2016, BBA-MOL BASIS DIS, V1862, P1443, DOI 10.1016/j.bbadis.2016.05.004; Williams Z, 2013, P NATL ACAD SCI US; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Xu P, 2014, HYPERTENSION; Yeganeh B, 2015, AM J PHYSIOL-LUNG C, V308, pL270, DOI 10.1152/ajplung.00011.2014; Yin X, 2017, MOL MED REP, V15, P551, DOI 10.3892/mmr.2016.6035; Yu J, 2010, EUR J RADIOL, V2, P2, DOI DOI 10.1096/FJ.10-157404; Zgheib C, 2016, J MOL CELL CARDIOL, V92, P203, DOI 10.1016/j.yjmcc.2016.02.009; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553	64	22	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174892	10.1371/journal.pone.0174892	http://dx.doi.org/10.1371/journal.pone.0174892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380001	Green Published, Green Submitted, gold			2022-12-27	WOS:000399353500074
J	Kolipaka, SS; Tamis, WLM; van't Zelfde, M; Persoon, GA; de Longh, HH				Kolipaka, S. S.; Tamis, W. L. M.; van't Zelfde, M.; Persoon, G. A.; de Longh, H. H.			Wild versus domestic prey in the diet of reintroduced tigers (Panthera tigris) in the livestock-dominated multiple-use forests of Panna Tiger Reserve, India	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; TROPICAL DRY FOREST; WESTERN INDIA; FOOD-HABITS; SPACE USE; ABUNDANCE; CONSERVATION; PREDATION; LANDSCAPE; PATTERNS	Grazing livestock in openly accessible areas is a common practice in the multiple-use forests of India; however, its compatibility with the reintroduction of tigers to these areas requires examination. Here, we investigated the diet of tigers in a livestock-dominated multiple-use buffer zone of the Panna Tiger Reserve, India. We hypothesised that the presence of feral cattle, along with open-access grazing practices in multiple-use forests, would increase the incidence of predation on livestock by tigers, even when wild prey are available. We used generalised linear models to test whether predation of livestock versus wild animals was influenced by (1) the sex and age class of tigers, (2) season, and (3) the distance of prey from the core-zone boundary of the reserve. Overall, sub-adult tigers and male tigers killed more livestock than wild prey, even when wild prey was available. In the winter and rainy seasons livestock were killed in higher numbers in the buffer zone than in summers, this may be because of the seasonally changing livestock herding patterns in the area. Further, with increasing distance from the core-zone boundary, all tigers killed more livestock, possibly because livestock were more easily accessible than wild prey. Our results show that open-access and unregulated livestock grazing is not currently compatible with large carnivore conservation in the same landscape. Such practices will lead to an increase in negative tiger-human-livestock interactions. In conclusion, we suggest the need to encourage locals to corral valuable cattle, leaving feral/unwanted livestock for tigers. This simple strategy would benefit both local inhabitants and tiger conservation in the multiple-use forests of India.	[Kolipaka, S. S.; Tamis, W. L. M.; van't Zelfde, M.; de Longh, H. H.] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands; [Kolipaka, S. S.; Persoon, G. A.] Leiden Univ, Inst Cultural Anthropol & Dev Sociol FSW, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Kolipaka, SS (corresponding author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.; Kolipaka, SS (corresponding author), Leiden Univ, Inst Cultural Anthropol & Dev Sociol FSW, Leiden, Netherlands.	kolipaka.s.s@gmail.com	van 't Zelfde, Maarten/K-6708-2013		Madhya Pradesh State Biodiversity Board, India; Louwes Fund for Water and Food; Leiden University; DeFries- Bajpai foundation; M.P. State Biodiversity Board; DeFries-Bajpai Foundation	Madhya Pradesh State Biodiversity Board, India; Louwes Fund for Water and Food; Leiden University; DeFries- Bajpai foundation; M.P. State Biodiversity Board; DeFries-Bajpai Foundation	We thank the Madhya Pradesh State Biodiversity Board, India, Louwes Fund for Water and Food, Leiden University and DeFries- Bajpai foundation for partially funding Kolipaka's studies in the Panna region of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Madhya Pradesh Forest Department and the management and field staff of Panna Tiger Reserve for enthusiastically supporting the study. We thank para-ecologist Mr Sushil Kumar and the volunteers who have contributed to the project. We thank the M.P. State Biodiversity Board, Louwes Fund for Water and Food, Leiden University and DeFries-Bajpai Foundation for partially funding Kolipaka's studies in Panna. We also thank an anonymous reviewer for critically commenting on the manuscript.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bagchi S, 2003, J ZOOL, V260, P285, DOI 10.1017/S0952836903003765; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Biswas S, 2002, J ZOOL, V256, P411, DOI 10.1017/S0952836902000456; Chundawat Raghunandan S., 1999, P123; Chundawat RS, 2016, BIOL CONSERV, V197, P146, DOI 10.1016/j.biocon.2016.03.004; Chundawat Raghunandan Singh, 2008, Journal of the Bombay Natural History Society, V105, P64; Erb KH, 2016, HUMAN ENVIRON INTERA, P295, DOI 10.1007/978-3-319-33326-7_13; GTI, 2012, GLOB TIG REC PROGR 2; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jedrzejewska B, J ZOOL; Jethva BD, 2004, BIOL CONSERV, V116, P351, DOI 10.1016/S0006-3207(03)00218-0; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Kenney J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3337; Kerley LL, 2015, INTEGR ZOOL, V10, P354, DOI 10.1111/1749-4877.12135; Kolipaka S. S., 2015, Journal of Human Ecology, V52, P192; Kuiper TR, 2015, BIOL CONSERV, V191, P546, DOI 10.1016/j.biocon.2015.08.012; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; NIC, 2017, DISTR WIS PER CAP IN; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; R Core Team, 2013, LANG ENV STAT COMP; Rajaratnam R, 2016, PROBLEMATIC WILDLIFE, P143, DOI DOI 10.1007/978-3-319-22246-2; Ramakrishnan U, BIOL CONS, V89, P113; Reddy HS, 2004, MAMMALIAN BIOL Z SAU, V69; Sankar K, 2002, MAMMALIA, V66, P285, DOI 10.1515/mamm.2002.66.2.285; Santoshi N., 2016, HINDUSTAN TIMES 0608; Sarkar MS, 2016, EUR J WILDLIFE RES, V62, P537, DOI 10.1007/s10344-016-1026-9; Sharma RK, 2015, BIOL CONSERV, V190, P8, DOI 10.1016/j.biocon.2015.04.026; Srivastava DP, 2014, THESIS; Talwar DM, 2003, C POL COMM ART DEV S; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x	37	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174844	10.1371/journal.pone.0174844	http://dx.doi.org/10.1371/journal.pone.0174844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379997	Green Published, gold			2022-12-27	WOS:000399353500068
J	Peeters, R; Wolk, L				Peeters, Ronald; Wolk, Leonard			Eliciting interval beliefs: An experimental study	PLOS ONE			English	Article								In this paper we study the interval scoring rule as a mechanism to elicit subjective beliefs under varying degrees of uncertainty. In our experiment, subjects forecast the termination time of a time series to be generated from a given but unknown stochastic process. Subjects gradually learn more about the underlying process over time and hence the true distribution over termination times. We conduct two treatments, one with a high and one with a low volatility process. We find that elicited intervals are better when subjects are facing a low volatility process. In this treatment, participants learn to position their intervals almost optimally over the course of the experiment. This is in contrast with the high volatility treatment, where subjects, over the course of the experiment, learn to optimize the location of their intervals but fail to provide the optimal length.	[Peeters, Ronald] Maastricht Univ, Sch Business & Econ, Dept Econ, Maastricht, Netherlands; [Wolk, Leonard] Vrije Univ Amsterdam, Dept Finance, Amsterdam, Netherlands	Maastricht University; Vrije Universiteit Amsterdam	Peeters, R (corresponding author), Maastricht Univ, Sch Business & Econ, Dept Econ, Maastricht, Netherlands.	r.peeters@maastrichtuniversity.nl	Peeters, Ronald/H-4070-2015	Peeters, Ronald/0000-0001-5261-1119				Bereby-Meyer Y, 2006, AM ECON REV, V96, P1029, DOI 10.1257/aer.96.4.1029; Cettolin E, 2015, COERCION SOCIAL WELF; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Galbiati R, 2013, J ECON BEHAV ORGAN, V94, P34, DOI 10.1016/j.jebo.2013.08.002; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Grosskopf B., 2003, Experimental Economics, V6, P141, DOI 10.1023/A:1025305020751; Harrison GW, 201501 GEORG STAT U; Harrison GW, 201210 GEORG STAT U; Lehrer Jonah., 2009, WE DECIDE; Peeters R, 2015, J ECON BEHAV ORGAN, V113, P1, DOI 10.1016/j.jebo.2015.02.009; Schlag K. H., 2009, WORKING PAPER; Schlag KH, 2015, JUDGM DECIS MAK, V10, P456; SELTEN R, 1986, J ECON BEHAV ORGAN, V7, P47, DOI 10.1016/0167-2681(86)90021-1; Selten R, 1998, GAMES HUMAN BEHAV ES; Tausch F, 2014, J RISK UNCERTAINTY, V48, P167, DOI 10.1007/s11166-014-9187-y; Trautmann ST, 2013, GAME ECON BEHAV, V79, P44, DOI 10.1016/j.geb.2013.01.001; Winkler R., 1970, J APPL METEOROLOGY, V9, P143, DOI [10.1175/1520-0450(1970)0092.0.CO;2, DOI 10.1175/1520-0450(1970)0092.0.CO;2]	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175163	10.1371/journal.pone.0175163	http://dx.doi.org/10.1371/journal.pone.0175163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380020	Green Submitted, gold, Green Published			2022-12-27	WOS:000399353500103
